Citrus Sinensis ID: 003542
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 811 | 2.2.26 [Sep-21-2011] | |||||||
| P25848 | 1307 | Light-sensor Protein kina | N/A | no | 0.323 | 0.200 | 0.346 | 8e-37 | |
| Q2MHE4 | 390 | Serine/threonine-protein | no | no | 0.260 | 0.541 | 0.309 | 2e-23 | |
| P41239 | 450 | Tyrosine-protein kinase C | no | no | 0.262 | 0.473 | 0.321 | 5e-21 | |
| P41240 | 450 | Tyrosine-protein kinase C | yes | no | 0.261 | 0.471 | 0.314 | 4e-20 | |
| Q7T6Y2 | 1624 | Putative serine/threonine | N/A | no | 0.342 | 0.171 | 0.256 | 4e-20 | |
| P41241 | 450 | Tyrosine-protein kinase C | yes | no | 0.261 | 0.471 | 0.310 | 8e-20 | |
| P32577 | 450 | Tyrosine-protein kinase C | no | no | 0.261 | 0.471 | 0.306 | 1e-19 | |
| Q54U31 | 744 | Dual specificity protein | yes | no | 0.267 | 0.291 | 0.317 | 1e-19 | |
| Q0VBZ0 | 450 | Tyrosine-protein kinase C | no | no | 0.261 | 0.471 | 0.314 | 1e-19 | |
| Q3U1V8 | 1077 | Mitogen-activated protein | no | no | 0.282 | 0.212 | 0.315 | 1e-19 |
| >sp|P25848|PHY1_CERPU Light-sensor Protein kinase OS=Ceratodon purpureus GN=PHY1 PE=3 SV=3 | Back alignment and function desciption |
|---|
Score = 156 bits (394), Expect = 8e-37, Method: Compositional matrix adjust.
Identities = 99/286 (34%), Positives = 147/286 (51%), Gaps = 24/286 (8%)
Query: 225 GASSQFKEIQWLGDSFVLRHFYG-ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFF 283
G+S+ ++ WLG + FYG E E+ + L HPNI C +++
Sbjct: 1013 GSSATVEKAVWLGTPVAKKTFYGRNNEDFKREVEILAELCHPNITSMFCS--PLYRRKCS 1070
Query: 284 LVMELMSKDLSCYMRETFGSRRRNS---FSLPVVVDIMLQIARGMEFLHAQKIYHGELNP 340
++MELM DL M+ + FS+ VVDI+LQ + GM +LH + I H +L
Sbjct: 1071 IIMELMDGDLLALMQRRLDRNEDHDSPPFSILEVVDIILQTSEGMNYLHEKGIIHRDLKS 1130
Query: 341 SNIYLKA----RSMEGYFHVKVSGFGLSTARTYASRNTPPASPQNQT-APNPYIWYAPEV 395
NI +K+ +S GY HVKV+ FGLS + ++R + NQT W APEV
Sbjct: 1131 MNILVKSVKVTKSEIGYVHVKVADFGLSKTKDSSTRYS------NQTWNRGTNRWMAPEV 1184
Query: 396 L------AEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRA 449
+ E E + K K+DVYSFGM+C+E+LTG VPF + + + + +
Sbjct: 1185 INLGYESTEGEISFDGKVPKYPLKSDVYSFGMVCYEVLTGDVPFPEEK-NPNNVKRMVLE 1243
Query: 450 GERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKKFM 495
G RP P+ P L L CW+ +P +RPSF+ IC+ L+Y+K +
Sbjct: 1244 GVRPDLPAHCPIELKALITDCWNQDPLKRPSFAVICQKLKYLKYLL 1289
|
Regulatory photoreceptor which exists in two forms that are reversibly interconvertible by light: the Pr form that absorbs maximally in the red region of the spectrum and the Pfr form that absorbs maximally in the far-red region. Photoconversion of Pr to Pfr induces an array of morphogenic responses, whereas reconversion of Pfr to Pr cancels the induction of those responses. Pfr controls the expression of a number of nuclear genes including those encoding the small subunit of ribulose-bisphosphate carboxylase, chlorophyll A/B binding protein, protochlorophyllide reductase, rRNA, etc. It also controls the expression of its own gene(s) in a negative feedback fashion. Ceratodon purpureus (taxid: 3225) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q2MHE4|HT1_ARATH Serine/threonine-protein kinase HT1 OS=Arabidopsis thaliana GN=HT1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 112 bits (279), Expect = 2e-23, Method: Compositional matrix adjust.
Identities = 74/239 (30%), Positives = 116/239 (48%), Gaps = 28/239 (11%)
Query: 250 ESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSF 309
+ +E++ + L HPNIVQ++ C ++ + ++ E MS+ +R + S
Sbjct: 130 QQFKSEVALLSRLFHPNIVQFIAA-C-KKPPVYCIITEYMSQG---NLRMYLNKKEPYSL 184
Query: 310 SLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTY 369
S+ V+ + L I+RGME+LH+Q + H +L +N+ L VKV+ FG S T
Sbjct: 185 SIETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDE-----MRVKVADFGTSCLETQ 239
Query: 370 ASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTG 429
+ + Y W APE++ E+ T K DVYSFG++ +EL T
Sbjct: 240 CR--------EAKGNMGTYRWMAPEMIKEKPYT---------RKVDVYSFGIVLWELTTA 282
Query: 430 KVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRIL 488
+PF+ G ERP P+ L +L K+CW NPS+RP FS+I +L
Sbjct: 283 LLPFQ-GMTPVQAAFAVAEKNERPPLPASCQPALAHLIKRCWSENPSKRPDFSNIVAVL 340
|
Serine/threonine kinase involved in the control of stomatal movement in response to CO(2). Shows a reduced response to ABA or light compared to CO(2). Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P41239|CSK_CHICK Tyrosine-protein kinase CSK OS=Gallus gallus GN=CSK PE=1 SV=1 | Back alignment and function description |
|---|
Score = 103 bits (257), Expect = 5e-21, Method: Compositional matrix adjust.
Identities = 79/246 (32%), Positives = 115/246 (46%), Gaps = 33/246 (13%)
Query: 250 ESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNS 308
++ AE S M L H N+VQ L G EEK ++V E M+K L Y+R SR R+
Sbjct: 231 QAFLAEASVMTQLRHSNLVQ-LLGVIVEEKSGLYIVTEYMAKGSLVDYLR----SRGRSV 285
Query: 309 FSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTART 368
++ L + ME+L A H +L N+ + ++ KVS FGL
Sbjct: 286 LGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNI-----AKVSDFGL----- 335
Query: 369 YASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT 428
T AS T P W APE L E+ K S K+DV+SFG+L +E+ +
Sbjct: 336 -----TKEASSTQDTGKLPVKWTAPEALREK---------KFSTKSDVWSFGILLWEIYS 381
Query: 429 -GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRI 487
G+VP+ L+ + + G + P G P + + KKCW +P RPSF +
Sbjct: 382 FGRVPYPRIPLK--DVVPRVEKGYKMDPPDGCPAIVYEVMKKCWTLDPGHRPSFHQLREQ 439
Query: 488 LRYIKK 493
L +IK+
Sbjct: 440 LVHIKE 445
|
Non-receptor tyrosine-protein kinase that plays an important role in the regulation of cell growth, differentiation, migration and immune response. Phosphorylates tyrosine residues located in the C-terminal tails of Src-family kinases (SFKs). Upon tail phosphorylation, Src-family members engage in intramolecular interactions between the phosphotyrosine tail and the SH2 domain that result in an inactive conformation. To inhibit SFKs, CSK is recruited to the plasma membrane via binding to transmembrane proteins or adapter proteins located near the plasma membrane. Gallus gallus (taxid: 9031) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|P41240|CSK_HUMAN Tyrosine-protein kinase CSK OS=Homo sapiens GN=CSK PE=1 SV=1 | Back alignment and function description |
|---|
Score = 100 bits (250), Expect = 4e-20, Method: Compositional matrix adjust.
Identities = 77/245 (31%), Positives = 113/245 (46%), Gaps = 33/245 (13%)
Query: 250 ESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNS 308
++ AE S M L H N+VQ L G EEK ++V E M+K L Y+R SR R+
Sbjct: 231 QAFLAEASVMTQLRHSNLVQ-LLGVIVEEKGGLYIVTEYMAKGSLVDYLR----SRGRSV 285
Query: 309 FSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTART 368
++ L + ME+L H +L N+ + ++ KVS FGL
Sbjct: 286 LGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV-----AKVSDFGL----- 335
Query: 369 YASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT 428
T AS T P W APE L E+ K S K+DV+SFG+L +E+ +
Sbjct: 336 -----TKEASSTQDTGKLPVKWTAPEALREK---------KFSTKSDVWSFGILLWEIYS 381
Query: 429 -GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRI 487
G+VP+ L+ + + G + P G P + + K CWH + + RPSF +
Sbjct: 382 FGRVPYPRIPLK--DVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 439
Query: 488 LRYIK 492
L +IK
Sbjct: 440 LEHIK 444
|
Non-receptor tyrosine-protein kinase that plays an important role in the regulation of cell growth, differentiation, migration and immune response. Phosphorylates tyrosine residues located in the C-terminal tails of Src-family kinases (SFKs) including LCK, SRC, HCK, FYN, LYN or YES1. Upon tail phosphorylation, Src-family members engage in intramolecular interactions between the phosphotyrosine tail and the SH2 domain that result in an inactive conformation. To inhibit SFKs, CSK is recruited to the plasma membrane via binding to transmembrane proteins or adapter proteins located near the plasma membrane. Suppresses signaling by various surface receptors, including T-cell receptor (TCR) and B-cell receptor (BCR) by phosphorylating and maintaining inactive several positive effectors such as FYN or LCK. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|Q7T6Y2|YR831_MIMIV Putative serine/threonine-protein kinase/receptor R831 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R831 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 100 bits (250), Expect = 4e-20, Method: Compositional matrix adjust.
Identities = 85/332 (25%), Positives = 157/332 (47%), Gaps = 54/332 (16%)
Query: 178 ESAYKEDKWLLIDALKEKKRLGSVVLTKNEQRLVDMLLKKLMVRRRLGASSQFKEI--QW 235
+S Y K + ID + + + S + + N R + + ++ + +++G S +W
Sbjct: 1325 DSNYDSGKIIDIDYMADIDKEDSFLTSANMCRWI-INYDEISIGKQIGLGSYGIVFNGKW 1383
Query: 236 LGDSFVLRHFY------GELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELM 289
G ++ F +L AE++ + L H NIV ++ G C +K +V E M
Sbjct: 1384 KGVDVAVKKFVKQKLSETQLLEFRAEMAFLSELKHSNIVTFI-GAC-IKKPNICIVTEYM 1441
Query: 290 S----KDL--SCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQK--IYHGELNPS 341
+D+ + ++ TF ++ + ++ A G+++LH+ I H ++ P+
Sbjct: 1442 RMGNLRDVLKNPDIKITFANKLK----------LLYGAAMGIDYLHSSNPMIVHRDIKPA 1491
Query: 342 NIYLKARSMEGYFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEG 401
NI + + +F+VK++ FG + + + T +P W APEV+ +
Sbjct: 1492 NILV-----DEHFNVKIADFGFARIKEDNTTMTRCGTP---------CWTAPEVIRGE-- 1535
Query: 402 TGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPK 461
K EKADV+SFG++ +E+LTGK PF + + K++ +I G RP+ PS P
Sbjct: 1536 -------KYCEKADVFSFGVVMWEVLTGKEPFAECNFM--KVSLDILEGGRPIIPSDCPH 1586
Query: 462 YLVNLTKKCWHTNPSQRPSFSSICRILRYIKK 493
L KKCWH +RP+ + + + L I +
Sbjct: 1587 EFAKLIKKCWHAKAHKRPTMTEVVQQLMLITE 1618
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P41241|CSK_MOUSE Tyrosine-protein kinase CSK OS=Mus musculus GN=Csk PE=1 SV=2 | Back alignment and function description |
|---|
Score = 99.8 bits (247), Expect = 8e-20, Method: Compositional matrix adjust.
Identities = 76/245 (31%), Positives = 113/245 (46%), Gaps = 33/245 (13%)
Query: 250 ESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNS 308
++ AE S M L H N+VQ L G EEK ++V E M+K L Y+R SR R+
Sbjct: 231 QAFLAEASVMTQLRHSNLVQ-LLGVIVEEKGGLYIVTEYMAKGSLVDYLR----SRGRSV 285
Query: 309 FSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTART 368
++ L + ME+L H +L N+ + ++ KVS FGL
Sbjct: 286 LGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV-----AKVSDFGL----- 335
Query: 369 YASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT 428
T AS T P W APE L E+ K S K+DV+SFG+L +E+ +
Sbjct: 336 -----TKEASSTQDTGKLPVKWTAPEALREK---------KFSTKSDVWSFGILLWEIYS 381
Query: 429 -GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRI 487
G+VP+ L+ + + G + P G P + + K CWH + + RP+F +
Sbjct: 382 FGRVPYPRIPLK--DVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAATRPTFLQLREQ 439
Query: 488 LRYIK 492
L +IK
Sbjct: 440 LEHIK 444
|
Non-receptor tyrosine-protein kinase that plays an important role in the regulation of cell growth, differentiation, migration and immune response. Phosphorylates tyrosine residues located in the C-terminal tails of Src-family kinases (SFKs) including LCK, SRC, HCK, FYN, LYN or YES1. Upon tail phosphorylation, Src-family members engage in intramolecular interactions between the phosphotyrosine tail and the SH2 domain that result in an inactive conformation. To inhibit SFKs, CSK is recruited to the plasma membrane via binding to transmembrane proteins or adapter proteins located near the plasma membrane. Suppresses signaling by various surface receptors, including T-cell receptor (TCR) and B-cell receptor (BCR) by phosphorylating and maintaining inactive several positive effectors such as FYN or LCK. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|P32577|CSK_RAT Tyrosine-protein kinase CSK OS=Rattus norvegicus GN=Csk PE=1 SV=1 | Back alignment and function description |
|---|
Score = 99.4 bits (246), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 75/245 (30%), Positives = 114/245 (46%), Gaps = 33/245 (13%)
Query: 250 ESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNS 308
++ AE S M L H N+VQ L G EEK ++V E M+K L Y+R SR R+
Sbjct: 231 QAFLAEASVMTQLRHSNLVQ-LLGVIVEEKGGLYIVTEYMAKGSLVDYLR----SRGRSV 285
Query: 309 FSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTART 368
++ L + ME+L H +L N+ + ++ KVS FGL
Sbjct: 286 LGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV-----AKVSDFGL----- 335
Query: 369 YASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT 428
T AS T P W APE L E+ K S K+DV+SFG+L +E+ +
Sbjct: 336 -----TKEASSTQDTGKLPVKWTAPEALREK---------KFSTKSDVWSFGILLWEIYS 381
Query: 429 -GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRI 487
G+VP+ L+ + + G + P G P + ++ K CWH + + RP+F +
Sbjct: 382 FGRVPYPRIPLK--DVVPRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQ 439
Query: 488 LRYIK 492
L +I+
Sbjct: 440 LEHIR 444
|
Non-receptor tyrosine-protein kinase that plays an important role in the regulation of cell growth, differentiation, migration and immune response. Phosphorylates tyrosine residues located in the C-terminal tails of Src-family kinases (SFKs) including LCK, SRC, HCK, FYN, LYN or YES1. Upon tail phosphorylation, Src-family members engage in intramolecular interactions between the phosphotyrosine tail and the SH2 domain that result in an inactive conformation. To inhibit SFKs, CSK is recruited to the plasma membrane via binding to transmembrane proteins or adapter proteins located near the plasma membrane. Suppresses signaling by various surface receptors, including T-cell receptor (TCR) and B-cell receptor (BCR) by phosphorylating and maintaining inactive several positive effectors such as FYN or LCK. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|Q54U31|SHKD_DICDI Dual specificity protein kinase shkD OS=Dictyostelium discoideum GN=shkD PE=3 SV=1 | Back alignment and function description |
|---|
Score = 99.4 bits (246), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 78/246 (31%), Positives = 112/246 (45%), Gaps = 29/246 (11%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRN 307
EL S E+ M + HPN+V +L G C + K +V EL DL + R +
Sbjct: 315 ELTSFRHEVKIMSKIFHPNVVLFL-GACTQSGK-MQIVTELCQTDLEKLLH---NDRTKK 369
Query: 308 SFSLPVVVDIMLQIARGMEFLHA-QKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366
FSL + + A GM +LH +I H +L +N+ + VKV+ FG S
Sbjct: 370 EFSLFRRMQMAKDAALGMNWLHGITRIVHNDLKTANLLVDIN-----LRVKVTDFGFSQI 424
Query: 367 RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFEL 426
+ Q++ A +W APEV+ + +EKADVYSFG++ +E+
Sbjct: 425 KEGEEF-------QDKAAKGTPLWMAPEVMM---------GNPYNEKADVYSFGIILWEI 468
Query: 427 LTGKVPFEDGHLQGDKMTKNI-RAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSIC 485
LT + P+ H D I ERP P+ + L +L + CW NP RPSFS I
Sbjct: 469 LTKEAPYSH-HKDYDIFFNAICNEKERPPIPADTLPSLRHLIQTCWDHNPQNRPSFSEIL 527
Query: 486 RILRYI 491
L I
Sbjct: 528 FRLNEI 533
|
Required for proper chemotaxis and phagocytosis; proper spatiotemporal control of F-actin levels in chemotaxing cells. Negative regulator of the PI3K (phosphatidylinositol 3 kinase) pathway. Predominantly phosphorylates serines and threonines and tyrosines at a lower level. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0VBZ0|CSK_BOVIN Tyrosine-protein kinase CSK OS=Bos taurus GN=CSK PE=2 SV=1 | Back alignment and function description |
|---|
Score = 99.4 bits (246), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 77/245 (31%), Positives = 112/245 (45%), Gaps = 33/245 (13%)
Query: 250 ESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNS 308
++ AE S M L H N+VQ L G EEK ++V E M+K L Y+R SR R+
Sbjct: 231 QAFLAEASVMTQLRHSNLVQ-LLGVIVEEKSGLYIVTEYMAKGSLVDYLR----SRGRSV 285
Query: 309 FSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTART 368
++ L + ME+L H +L N+ + ++ KVS FGL
Sbjct: 286 LGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV-----AKVSDFGL----- 335
Query: 369 YASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT 428
T AS T P W APE L E+ K S K+DV+SFG+L +E+ +
Sbjct: 336 -----TKEASSTQDTGKLPVKWTAPEALREK---------KFSTKSDVWSFGILLWEIYS 381
Query: 429 -GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRI 487
G+VP+ L+ + + G + P G P + + K CWH + + RPSF +
Sbjct: 382 FGRVPYPRIPLK--DVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAATRPSFLQLREQ 439
Query: 488 LRYIK 492
L IK
Sbjct: 440 LERIK 444
|
Non-receptor tyrosine-protein kinase that plays an important role in the regulation of cell growth, differentiation, migration and immune response. Phosphorylates tyrosine residues located in the C-terminal tails of Src-family kinases (SFKs) including LCK, SRC, HCK, FYN, LYN or YES1. Upon tail phosphorylation, Src-family members engage in intramolecular interactions between the phosphotyrosine tail and the SH2 domain that result in an inactive conformation. To inhibit SFKs, CSK is recruited to the plasma membrane via binding to transmembrane proteins or adapter proteins located near the plasma membrane. Suppresses signaling by various surface receptors, including T-cell receptor (TCR) and B-cell receptor (BCR) by phosphorylating and maintaining inactive several positive effectors such as FYN or LCK. Bos taurus (taxid: 9913) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|Q3U1V8|M3K9_MOUSE Mitogen-activated protein kinase kinase kinase 9 OS=Mus musculus GN=Map3k9 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 99.0 bits (245), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 87/276 (31%), Positives = 130/276 (47%), Gaps = 47/276 (17%)
Query: 235 WLGDSFVL---RHFYGE-----LESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVM 286
W GD + RH E +E++ E L HPNI+ L G C +E LVM
Sbjct: 156 WAGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA-LRGVCLKEPN-LCLVM 213
Query: 287 ELMSKDLSCYMRETFGSRRRNSFSLP--VVVDIMLQIARGMEFLHAQKIY---HGELNPS 341
E + R +R + +P ++V+ +QIARGM +LH + I H +L S
Sbjct: 214 E--------FARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSS 265
Query: 342 NIYLKARSMEGYFH---VKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAE 398
NI + + G +K++ FGL AR + R T +A Y W APEV+
Sbjct: 266 NILILQKVENGDLSNKILKITDFGL--AREW-HRTT------KMSAAGTYAWMAPEVI-- 314
Query: 399 QEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPL-FPS 457
S S+ +DV+S+G+L +ELLTG+VPF + G + + + L PS
Sbjct: 315 -------RASMFSKGSDVWSYGVLLWELLTGEVPFRG--IDGLAVAYGVAMNKLALPIPS 365
Query: 458 GSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKK 493
P+ L + CW+ +P RPSF+SI L I++
Sbjct: 366 TCPEPFAKLMEDCWNPDPHSRPSFTSILDQLTTIEE 401
|
Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. Plays an important role in the cascades of cellular responses evoked by changes in the environment. Once activated, acts as an upstream activator of the MKK/JNK signal transduction cascade through the phosphorylation of MAP2K4/MKK4 and MAP2K7/MKK7 which in turn activate the JNKs. The MKK/JNK signaling pathway regulates stress response via activator protein-1 (JUN) and GATA4 transcription factors. Plays also a role in mitochondrial death signaling pathway, including the release cytochrome c, leading to apoptosis. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 811 | ||||||
| 255537715 | 714 | serine-threonine protein kinase, putativ | 0.770 | 0.875 | 0.644 | 0.0 | |
| 297840045 | 715 | kinase family protein [Arabidopsis lyrat | 0.747 | 0.847 | 0.624 | 0.0 | |
| 18408017 | 717 | protein kinase-like protein [Arabidopsis | 0.821 | 0.928 | 0.587 | 0.0 | |
| 15238163 | 711 | protein kinase-like protein [Arabidopsis | 0.744 | 0.849 | 0.612 | 0.0 | |
| 297801388 | 715 | kinase family protein [Arabidopsis lyrat | 0.747 | 0.847 | 0.616 | 0.0 | |
| 449452416 | 711 | PREDICTED: uncharacterized protein LOC10 | 0.750 | 0.856 | 0.613 | 0.0 | |
| 224072120 | 591 | predicted protein [Populus trichocarpa] | 0.700 | 0.961 | 0.630 | 0.0 | |
| 359489706 | 685 | PREDICTED: mitogen-activated protein kin | 0.732 | 0.867 | 0.605 | 0.0 | |
| 357481473 | 893 | Integrin-linked protein kinase [Medicago | 0.742 | 0.674 | 0.575 | 0.0 | |
| 12323479 | 636 | phytochrome, putative; 80131-78152 [Arab | 0.748 | 0.954 | 0.578 | 0.0 |
| >gi|255537715|ref|XP_002509924.1| serine-threonine protein kinase, putative [Ricinus communis] gi|223549823|gb|EEF51311.1| serine-threonine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 854 bits (2206), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 423/656 (64%), Positives = 511/656 (77%), Gaps = 31/656 (4%)
Query: 1 MEQFRQVGEVLGSLKALMVLKDDIQINQRQCCLLLDIFTLAFSTVAEEIRLFLKSEEKNT 60
MEQFRQ+GE LGSLKALMVL+DDIQIN+RQCCLLL+IFT AF T+AEEI+ LK +EKNT
Sbjct: 1 MEQFRQIGEALGSLKALMVLQDDIQINRRQCCLLLNIFTSAFDTIAEEIKQNLKLDEKNT 60
Query: 61 KWRALEQPLRELQKVFREGEHYVKQCLDYKDWWGKAISLHQNKDCVEFHIHNLLCYFPAV 120
KW+ LE+PL+EL +VF+EGE YV++CLD KDWWGKA+ LHQNKD +EFHIHNL+ YFPAV
Sbjct: 61 KWKPLEEPLKELYRVFKEGELYVRRCLDSKDWWGKAVVLHQNKDSIEFHIHNLVSYFPAV 120
Query: 121 IEAIEAAGEISGLDPDEMQRRRVAFARKYDREWNDPKLFQLRFGKEYLIPREVCNEFESA 180
IEAIE AGEISGLD DEMQ++RV +KYDR W+D KLFQ RFGK+YL+ RE+CN+ E+A
Sbjct: 121 IEAIETAGEISGLDQDEMQKKRVMLFKKYDRSWHDQKLFQWRFGKQYLVSREICNQIETA 180
Query: 181 YKEDKWLLIDALKEKKRLGSVVLTKNEQRLVDMLLKKL---------------------- 218
KED WLL+ A+KEK + GS LTKNEQRL D+L KKL
Sbjct: 181 VKEDGWLLVGAIKEKMKAGS--LTKNEQRLGDLLQKKLNGQLLINGKLPPSSILLGAEDY 238
Query: 219 MVRRRLGASSQFKEIQWLGDSFVLRHFYGELESLNAEISTMLSLSHPNIVQYLCGFCDEE 278
VRRRLG SQ+KEIQWLG+SF LRHF+ ++E LN+EIS +LSLSHPNIVQYLCGF DEE
Sbjct: 239 QVRRRLGGGSQYKEIQWLGESFALRHFFEDIEPLNSEISVLLSLSHPNIVQYLCGFYDEE 298
Query: 279 KKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGEL 338
KKE FLVMELMSKDL YM+E SRR+ F LP+VVDIMLQ+ARGMEFLH++KIY G+L
Sbjct: 299 KKECFLVMELMSKDLYAYMKENSSSRRQVLFPLPIVVDIMLQVARGMEFLHSRKIYVGDL 358
Query: 339 NPSNIYLKAR-SMEGYFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLA 397
NP+NI+LK R S EGYFHVKVSGFGL+ +SR+ S NQ A +P IW+APEVLA
Sbjct: 359 NPTNIFLKPRKSTEGYFHVKVSGFGLTYIENPSSRH----SSSNQNAFDPCIWHAPEVLA 414
Query: 398 EQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPS 457
E+E TGS ST K SEKADVYSFGMLCF+LLTGK+PFEDGHLQGD+M KNIRAGERPLFPS
Sbjct: 415 EREQTGSPSTRKHSEKADVYSFGMLCFQLLTGKLPFEDGHLQGDQMAKNIRAGERPLFPS 474
Query: 458 GSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKKFMANNPDIARSEFQSPLADYCDIE 517
SPKYLVNLTKKCWHT+P+ RPSFSSI R+LRYIKK++ NP + QSP DY ++E
Sbjct: 475 LSPKYLVNLTKKCWHTDPNYRPSFSSISRVLRYIKKYLVMNPVDGQLVMQSPPVDYSELE 534
Query: 518 AGFVRKFVGEGCPDVAPVSQIPFQMFAYKIAEKEKANSSNKGKHWELGSDVASTCKDEVF 577
AGF++++ GE +A VSQIPFQMF Y+I+EKE+ + S + K E S+ AS DE
Sbjct: 535 AGFLKRYPGEMNGGLASVSQIPFQMFVYRISEKERTSLSFRFKQSE-TSEAASNGWDENI 593
Query: 578 SVGDEGMVPVTETRSVCSDVKSVTFDMRSVYSEAFGKKVSNFDTRSVRSESPNKKM 633
SV ++ +VP ++ RS+ SD+K+V FD+ S+Y E K+ + D RSVRSE P+KK+
Sbjct: 594 SVVEDPVVPASDARSISSDMKTVCFDLSSIYIENPDGKIPS-DLRSVRSEPPDKKI 648
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297840045|ref|XP_002887904.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297333745|gb|EFH64163.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 811 bits (2096), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 403/645 (62%), Positives = 488/645 (75%), Gaps = 39/645 (6%)
Query: 1 MEQFRQVGEVLGSLKALMVLKDDIQINQRQCCLLLDIFTLAFSTVAEEIRLFLKSEEKNT 60
MEQFRQ+GEVLGSL ALMVL+DDI INQRQCCLLLDIF+LAF+TVAEEIR LK EEK+T
Sbjct: 1 MEQFRQIGEVLGSLNALMVLQDDILINQRQCCLLLDIFSLAFNTVAEEIRHHLKLEEKHT 60
Query: 61 KWRALEQPLRELQKVFREGEHYVKQCLDYKDWWGKAISLHQNKDCVEFHIHNLLCYFPAV 120
KWRALEQPLREL +VF+EGE YV+ C+ KDWWGK I+ HQNKDCVEFHIHNLLCYF AV
Sbjct: 61 KWRALEQPLRELYRVFKEGEMYVRNCMSNKDWWGKVINFHQNKDCVEFHIHNLLCYFSAV 120
Query: 121 IEAIEAAGEISGLDPDEMQRRRVAFARKYDREWNDPKLFQLRFGKEYLIPREVCNEFESA 180
IEAIE AGEISGLDP EM+RRRV F+RKYDREWNDPKLFQ R+GK+YL+PR++C FE +
Sbjct: 121 IEAIETAGEISGLDPAEMERRRVVFSRKYDREWNDPKLFQWRYGKQYLVPRDICIRFEHS 180
Query: 181 YKEDKWLLIDALKEKKRLGSVVLTKNEQRLVDMLLKKL---------------------- 218
++ED+W L++AL+EK++ S + K E+RL D LLKKL
Sbjct: 181 WREDRWNLVEALQEKRKSKSDEIGKTEKRLADFLLKKLTGLEQFNGKLFPSSILVGSKDY 240
Query: 219 MVRRRLGASSQFKEIQWLGDSFVLRHFYGELESLNAEISTMLSLSHPNIVQYLCGFCDEE 278
VRRRLG Q+KEIQWLGDSFVLRHF+G+LE LNAEIS++LSL H NI+QYLCGF DEE
Sbjct: 241 QVRRRLGGGGQYKEIQWLGDSFVLRHFFGDLEPLNAEISSLLSLCHSNILQYLCGFYDEE 300
Query: 279 KKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGEL 338
+KE LVMELM KDL YM+E G RRR FS+PVV+DIMLQIARGME+LH+ +I+HG+L
Sbjct: 301 RKECSLVMELMHKDLKSYMKENCGPRRRYLFSVPVVIDIMLQIARGMEYLHSNEIFHGDL 360
Query: 339 NPSNIYLKARS-MEGYFHVKVSGFGLSTAR--TYASRNTPPASPQNQTAPNPYIWYAPEV 395
NP NI LK RS EGYFH K+SGFGL++ + +++ ++ P T P+P IWYAPEV
Sbjct: 361 NPMNILLKERSHTEGYFHAKISGFGLTSVKNQSFSRASSRP------TTPDPVIWYAPEV 414
Query: 396 LA--EQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERP 453
LA EQ+ G+ SK + KADVYSF M+CFEL+TGKVPFED HLQG+KM KNIR GERP
Sbjct: 415 LAEMEQDLKGTAPRSKFTHKADVYSFAMVCFELITGKVPFEDDHLQGEKMAKNIRTGERP 474
Query: 454 LFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKKFMANNPDIARSEFQSPLADY 513
LFP SPKYLV+L K+CWH+ PSQRP+FSSICRILRYIKKF+ NPD + Q+PL D
Sbjct: 475 LFPFPSPKYLVSLIKRCWHSEPSQRPTFSSICRILRYIKKFLVVNPDHGHLQIQNPLVDC 534
Query: 514 CDIEAGFVRKFVGEGCPDVAPVSQIPFQMFAYKIAEKEKANSS-NKGKHWELGSDVASTC 572
D+EA F++KF E V+QIPFQ+++Y+IAEKEK + + NK ++ E G V+
Sbjct: 535 WDLEARFLKKFSMESGSHAGSVTQIPFQLYSYRIAEKEKMSPNFNKEENSETGESVS--- 591
Query: 573 KDEVFSVGDEGMVPVTETRSVCSDVKSVTFDMRSVYSEAFGKKVS 617
+ V V D +P+ T+S+C D S D+RSVYSEA KK S
Sbjct: 592 -EGVSVVEDPPTMPMY-TKSLCLDAISEYSDIRSVYSEAPIKKTS 634
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|18408017|ref|NP_564829.1| protein kinase-like protein [Arabidopsis thaliana] gi|79320679|ref|NP_001031229.1| protein kinase-like protein [Arabidopsis thaliana] gi|15983374|gb|AAL11555.1|AF424561_1 At1g64300/F15H21_13 [Arabidopsis thaliana] gi|22655480|gb|AAM98332.1| At1g64300/F15H21_13 [Arabidopsis thaliana] gi|332196102|gb|AEE34223.1| protein kinase-like protein [Arabidopsis thaliana] gi|332196103|gb|AEE34224.1| protein kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 805 bits (2080), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 421/716 (58%), Positives = 509/716 (71%), Gaps = 50/716 (6%)
Query: 1 MEQFRQVGEVLGSLKALMVLKDDIQINQRQCCLLLDIFTLAFSTVAEEIRLFLKSEEKNT 60
MEQFRQ+GEVLGSL ALMVL+DDI INQRQCCLLLDIF+L F+TVAEEIR LK EEK+T
Sbjct: 1 MEQFRQIGEVLGSLNALMVLQDDILINQRQCCLLLDIFSLGFNTVAEEIRHNLKLEEKHT 60
Query: 61 KWRALEQPLRELQKVFREGEHYVKQCLDYKDWWGKAISLHQNKDCVEFHIHNLLCYFPAV 120
KWRALEQPLREL +VF+EGE YV+ C+ KDWWGK I+ HQNKDCVEFHIHNLLCYF AV
Sbjct: 61 KWRALEQPLRELYRVFKEGEMYVRNCMSNKDWWGKVINFHQNKDCVEFHIHNLLCYFSAV 120
Query: 121 IEAIEAAGEISGLDPDEMQRRRVAFARKYDREWNDPKLFQLRFGKEYLIPREVCNEFESA 180
IEAIE AGEISGLDP EM+RRRV F+RKYDREWNDPKLFQ RFGK+YL+PR++C FE +
Sbjct: 121 IEAIETAGEISGLDPSEMERRRVVFSRKYDREWNDPKLFQWRFGKQYLVPRDICLRFEHS 180
Query: 181 YKEDKWLLIDALKEKKRLGSVVLTKNEQRLVDMLLKKL---------------------- 218
++ED+W L++AL+EK++ S + K E+RL D LLKKL
Sbjct: 181 WREDRWNLVEALQEKRKSKSDEIGKTEKRLADFLLKKLTGLEQFNGKLFPSSILVGSKDY 240
Query: 219 MVRRRLGASSQFKEIQWLGDSFVLRHFYGELESLNAEISTMLSLSHPNIVQYLCGFCDEE 278
VRRRLG Q+KEIQWLGDSFVLRHF+G+LE LNAEIS++LSL H NI+QYLCGF DEE
Sbjct: 241 QVRRRLGGGGQYKEIQWLGDSFVLRHFFGDLEPLNAEISSLLSLCHSNILQYLCGFYDEE 300
Query: 279 KKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGEL 338
+KE LVMELM KDL YM+E G RRR FS+PVV+DIMLQIARGME+LH+ +I+HG+L
Sbjct: 301 RKECSLVMELMHKDLKSYMKENCGPRRRYLFSVPVVIDIMLQIARGMEYLHSNEIFHGDL 360
Query: 339 NPSNIYLKARS-MEGYFHVKVSGFGLSTAR--TYASRNTPPASPQNQTAPNPYIWYAPEV 395
NP NI LK RS EGYFH K+SGFGL++ + +++ ++ P T P+P IWYAPEV
Sbjct: 361 NPMNILLKERSHTEGYFHAKISGFGLTSVKNQSFSRASSRP------TTPDPVIWYAPEV 414
Query: 396 LA--EQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERP 453
LA EQ+ G+ SK + KADVYSF M+CFEL+TGKVPFED HLQGDKM KNIR GERP
Sbjct: 415 LAEMEQDLKGTAPRSKFTHKADVYSFAMVCFELITGKVPFEDDHLQGDKMAKNIRTGERP 474
Query: 454 LFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKKFMANNPDIARSEFQSPLADY 513
LFP SPKYLV+L K+CWH+ PSQRP+FSSICRILRYIKKF+ NPD + Q+PL D
Sbjct: 475 LFPFPSPKYLVSLIKRCWHSEPSQRPTFSSICRILRYIKKFLVVNPDHGHLQIQNPLVDC 534
Query: 514 CDIEAGFVRKFVGEGCPDVAPVSQIPFQMFAYKIAEKEKANSSNKGKHWELGSDVASTCK 573
D+EA F++KF E V+QIPFQ+++Y+IAEKEK S N K E SD +
Sbjct: 535 WDLEARFLKKFSMESGSHAGSVTQIPFQLYSYRIAEKEKM-SPNFNK--EENSDAGESVS 591
Query: 574 DEVFSVGDEGMVPVTETRSVCSDVKSVTFDMRSVYSEAFGKKVSNFDTRSVRSESPNKKM 633
+ V V + T+S+C D S D RSVYSEA KK S +S K
Sbjct: 592 ESVSVVEEPPTTMPMYTKSLCLDAISEYSDTRSVYSEAPIKKTSALK----KSGDTIKNR 647
Query: 634 QGSVSRLIQSMVLEKNVSSSDTKP-AVPENSISNSEVKSEVPETNISNSDTKLVVS 688
+ S+S L ++ SS KP + P+ S S +N +N DT+L +S
Sbjct: 648 RNSISGL-------RSPGSSPIKPRSTPKVSSPLSPFGRS--SSNKANKDTRLPLS 694
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15238163|ref|NP_198988.1| protein kinase-like protein [Arabidopsis thaliana] gi|9758531|dbj|BAB08932.1| unnamed protein product [Arabidopsis thaliana] gi|332007334|gb|AED94717.1| protein kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 794 bits (2050), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 393/642 (61%), Positives = 477/642 (74%), Gaps = 38/642 (5%)
Query: 1 MEQFRQVGEVLGSLKALMVLKDDIQINQRQCCLLLDIFTLAFSTVAEEIRLFLKSEEKNT 60
MEQFRQ+GEVLGSL ALMVL+DDI INQRQCCLLL++F+LAF+TVAEEIR LK EEK+T
Sbjct: 1 MEQFRQIGEVLGSLNALMVLQDDILINQRQCCLLLELFSLAFNTVAEEIRQNLKLEEKHT 60
Query: 61 KWRALEQPLRELQKVFREGEHYVKQCLDYKDWWGKAISLHQNKDCVEFHIHNLLCYFPAV 120
KWRALEQPLREL +VF+EGE YVK C+D DWWGK I+LHQNKDCVEFHIHNL CYF AV
Sbjct: 61 KWRALEQPLRELYRVFKEGELYVKHCMDNSDWWGKVINLHQNKDCVEFHIHNLFCYFSAV 120
Query: 121 IEAIEAAGEISGLDPDEMQRRRVAFARKYDREWNDPKLFQLRFGKEYLIPREVCNEFESA 180
+EAIEAAGEISGLDP EM+RRRV F+RKYDREWNDPK+FQ RFGK+YL+ R++C+ FE +
Sbjct: 121 VEAIEAAGEISGLDPSEMERRRVVFSRKYDREWNDPKMFQWRFGKQYLLSRDICSRFEHS 180
Query: 181 YKEDKWLLIDALKEKKRLGSVVLTKNEQRLVDMLLKKL---------------------- 218
++ED+W L++AL+EK++ S + K E+RL D+LLKKL
Sbjct: 181 WREDRWNLVEALQEKRKSDSDDIGKTEKRLADLLLKKLTGLEQFNGKLFPSSILLGSKDY 240
Query: 219 MVRRRLGASSQFKEIQWLGDSFVLRHFYGELESLNAEISTMLSLSHPNIVQYLCGFCDEE 278
V++RL A Q+KEIQWLGDSF LRHF+ +LE L++EIS++L+L H NI+QYLCGF DEE
Sbjct: 241 QVKKRLDADGQYKEIQWLGDSFALRHFFSDLEPLSSEISSLLALCHSNILQYLCGFYDEE 300
Query: 279 KKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGEL 338
+KE FLVMELM KDL YM+E G RRR FS+PVV+DIMLQIARGME+LH I+HG+L
Sbjct: 301 RKECFLVMELMHKDLQSYMKENCGPRRRYLFSIPVVIDIMLQIARGMEYLHGNDIFHGDL 360
Query: 339 NPSNIYLKARS-MEGYFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLA 397
NP NI+LK RS EGYFH K+ GFGLS+ S + P P+P IWYAPEVLA
Sbjct: 361 NPMNIHLKERSHTEGYFHAKICGFGLSSVVKAQSSSKP-------GTPDPVIWYAPEVLA 413
Query: 398 --EQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLF 455
EQ+ G T SK + KADVYSF M+CFEL+TGKVPFED HLQG+ MT NIR GERPLF
Sbjct: 414 EMEQDLNGKTPKSKLTHKADVYSFAMVCFELITGKVPFEDSHLQGEPMTINIRMGERPLF 473
Query: 456 PSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKKFMANNPDIARSEFQSPLADYCD 515
P SPKYLV+L K+CWH+ PSQRP+FSSICRILRYIKKF+ NPD + Q+PL D D
Sbjct: 474 PFPSPKYLVSLIKRCWHSEPSQRPNFSSICRILRYIKKFLVVNPDHGHPQMQTPLVDCWD 533
Query: 516 IEAGFVRKFVGEGCPDVAPVSQIPFQMFAYKIAEKEKANSSNKGKHWELGSDVASTCKDE 575
+EA F+RKF G+ A V+QIPFQ+++Y++ EKEK N ++K S+ S +D
Sbjct: 534 LEARFLRKFPGDAGSHTASVNQIPFQLYSYRVLEKEKMNPNSKESSETSESESVSVVEDP 593
Query: 576 VFSVGDEGMVPVTETRSVCSDVKSVTFDMRSVYSEAFGKKVS 617
M+ +T+S+C D S D RSVYSEA KKVS
Sbjct: 594 -----PNAMI-TRDTKSLCLDTISEYSDTRSVYSEAPMKKVS 629
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297801388|ref|XP_002868578.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297314414|gb|EFH44837.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 786 bits (2031), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 397/644 (61%), Positives = 482/644 (74%), Gaps = 38/644 (5%)
Query: 1 MEQFRQVGEVLGSLKALMVLKDDIQINQRQCCLLLDIFTLAFSTVAEEIRLFLKSEEKNT 60
MEQFRQ+GEVLGSL ALMVL+DDI INQRQCCLLL++F+LAF+TVAEEIR LK EEK+T
Sbjct: 1 MEQFRQIGEVLGSLNALMVLQDDILINQRQCCLLLELFSLAFNTVAEEIRQNLKLEEKHT 60
Query: 61 KWRALEQPLRELQKVFREGEHYVKQCLDYKDWWGKAISLHQNKDCVEFHIHNLLCYFPAV 120
KWRALEQPLREL +VF+EGE YVK C+D DWWGK I+LHQNKDCVEFHIHNL CYF AV
Sbjct: 61 KWRALEQPLRELYRVFKEGELYVKHCMDNSDWWGKVINLHQNKDCVEFHIHNLFCYFSAV 120
Query: 121 IEAIEAAGEISGLDPDEMQRRRVAFARKYDREWNDPKLFQLRFGKEYLIPREVCNEFESA 180
+EAIEAAGEISGLDP EM+RRRV F+RKYDREWNDPKLFQ RFGK+YL+ R++C+ FE +
Sbjct: 121 VEAIEAAGEISGLDPSEMERRRVVFSRKYDREWNDPKLFQWRFGKQYLVSRDICSRFEHS 180
Query: 181 YKEDKWLLIDALKEKKRLGSVVLTKNEQRLVDMLLKKL---------------------- 218
++ED+W L++AL+EK++ S + K E+RL D+LLKKL
Sbjct: 181 WREDRWNLVEALQEKRKSDSDDIGKTEKRLADLLLKKLTGLEQFNGKLFPSSILLGSKDY 240
Query: 219 MVRRRLGASSQFKEIQWLGDSFVLRHFYGELESLNAEISTMLSLSHPNIVQYLCGFCDEE 278
+V+RRL A Q+KEIQWLGDSF +RHF+ +LE L++EIS++LSL H NI+QYLCGF DEE
Sbjct: 241 LVKRRLDADGQYKEIQWLGDSFAVRHFFSDLEPLSSEISSLLSLCHSNILQYLCGFYDEE 300
Query: 279 KKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGEL 338
+KE FLVMELM KDL YM+E G RRR FS+PVV+DIMLQIARGME+LH I+HG+L
Sbjct: 301 RKECFLVMELMHKDLQSYMKENCGPRRRYLFSIPVVIDIMLQIARGMEYLHGNDIFHGDL 360
Query: 339 NPSNIYLKARS-MEGYFHVKVSGFGLST-ARTYASRNTPPASPQNQTAPNPYIWYAPEVL 396
NP NI+LK RS EGYFH K+SGFGLS+ + +SR S P+P IWYAPEVL
Sbjct: 361 NPMNIHLKERSHTEGYFHAKISGFGLSSVVKAQSSR-----SSSKPGTPDPVIWYAPEVL 415
Query: 397 A--EQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPL 454
A EQ+ G T SK + KADVYSF M+CFEL+TGKVPFED HLQG+ M NIR GERPL
Sbjct: 416 AEMEQDLNGKTPKSKLTHKADVYSFAMVCFELITGKVPFEDSHLQGEPMAINIRMGERPL 475
Query: 455 FPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKKFMANNPDIARSEFQSPLADYC 514
FP SPKYLV+L K+CWH+ PSQRP+FSSICRILRYIKKF+ NPD + Q+PL D
Sbjct: 476 FPFPSPKYLVSLIKRCWHSEPSQRPNFSSICRILRYIKKFLVVNPDHGHPQMQTPLVDCW 535
Query: 515 DIEAGFVRKFVGEGCPDVAPVSQIPFQMFAYKIAEKEKANSSNKGKHWELGSDVASTCKD 574
D+EA F+RKF G+ A V+QIPFQ+++Y+++E+EK N ++K S AS +
Sbjct: 536 DLEARFLRKFPGDAGSHTASVNQIPFQLYSYRVSEREKMNPNSK------ESSEASDQSE 589
Query: 575 EVFSVGD-EGMVPVTETRSVCSDVKSVTFDMRSVYSEAFGKKVS 617
V V D + +T+S+C D S D RSVYSEA KKVS
Sbjct: 590 SVSVVEDPPNAIIARDTKSLCLDTISEYSDTRSVYSEAPIKKVS 633
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449452416|ref|XP_004143955.1| PREDICTED: uncharacterized protein LOC101209943 [Cucumis sativus] gi|449501838|ref|XP_004161472.1| PREDICTED: uncharacterized protein LOC101223325 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 785 bits (2026), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 395/644 (61%), Positives = 476/644 (73%), Gaps = 35/644 (5%)
Query: 1 MEQFRQVGEVLGSLKALMVLKDDIQINQRQCCLLLDIFTLAFSTVAEEIRLFLKSEEKNT 60
MEQFR++GEVLGSLKALMVL+DDIQ NQRQCCLL D+F LAF T+A EIR LK EEKNT
Sbjct: 1 MEQFRRIGEVLGSLKALMVLQDDIQFNQRQCCLLHDMFRLAFDTIAGEIRDNLKLEEKNT 60
Query: 61 KWRALEQPLRELQKVFREGEHYVKQCLDYKDWWGKAISLHQNKDCVEFHIHNLLCYFPAV 120
KW+ALEQPLREL +VF+EGE Y+KQC+D KDWW K IS H +KDC+EFH+HNLL FPAV
Sbjct: 61 KWKALEQPLRELHRVFKEGELYIKQCIDGKDWWAKVISFHHSKDCIEFHVHNLLSCFPAV 120
Query: 121 IEAIEAAGEISGLDPDEMQRRRVAFARKYDREWNDPKLFQLRFGKEYLIPREVCNEFESA 180
IEAIE AGEISGLD DEMQ+RR+ RKYD EWND KLF RFGK+YL+PRE+ N +S
Sbjct: 121 IEAIETAGEISGLDQDEMQKRRLVLMRKYDMEWNDLKLFHWRFGKQYLVPREIRNRMQSV 180
Query: 181 YKEDKWLLIDALKEKKRLGSVVLTKNEQRLVDMLLKKL---------------------- 218
+ED+WLL++ALKEK ++KNEQ+L ++L+KKL
Sbjct: 181 LREDRWLLVEALKEKISSPGTAVSKNEQQLGELLIKKLNNSEPSKAKLFPSSILVGTKDY 240
Query: 219 MVRRRLGASSQFKEIQWLGDSFVLRHFYGELESLNAEISTMLSLSHPNIVQYLCGFCDEE 278
VRRRL Q KE+QW G++F +R F E E +E+ +LSL HPNI+QYLCGF DEE
Sbjct: 241 QVRRRLDG-GQSKEVQWFGENFGMRQFTAETEETESEVPILLSLLHPNILQYLCGFLDEE 299
Query: 279 KKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGEL 338
KKE+FLV ELMSKDLS YM++ G+RRR F L V VDIMLQIARGME+LH+Q IYHG+L
Sbjct: 300 KKEYFLVTELMSKDLSSYMKDNNGARRRLLFPLHVSVDIMLQIARGMEYLHSQMIYHGDL 359
Query: 339 NPSNIYLKAR-SMEGYFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLA 397
NPSN+++K R S EG + VKVSGFGLS+ +N+PP + NQ NP+IW+APEV+A
Sbjct: 360 NPSNVFMKPRNSSEGSYLVKVSGFGLSSV-----KNSPPRNSTNQLETNPFIWHAPEVMA 414
Query: 398 EQE--GTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLF 455
EQE G+ S + +EKADVYSFGMLCFELLTGKVPFED HLQG+KM++NIRAGERPLF
Sbjct: 415 EQEQQAPGTVSFFRKTEKADVYSFGMLCFELLTGKVPFEDSHLQGEKMSRNIRAGERPLF 474
Query: 456 PSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKKFMANNP-DIARSEFQSPLADYC 514
P +PKYLV+LTK+CWH++PSQR SFSSICRILR +KKF+A NP + + E Q P DYC
Sbjct: 475 PFPTPKYLVSLTKRCWHSDPSQRLSFSSICRILRQVKKFLAMNPAESNQPELQMPTVDYC 534
Query: 515 DIEAGFVRKFVGEGCPDVAPVSQIPFQMFAYKIAEKEKANSSNKGKHWELGSDVASTCKD 574
D+EAG RKF +G D+ VSQIPFQMFAY++AEKEK N S K K W+ SDV S KD
Sbjct: 535 DVEAGVARKFSSDGVGDLCSVSQIPFQMFAYRLAEKEKTNPS-KIKTWDSASDVVSISKD 593
Query: 575 EVFSVGDEGMVPVTETRSV--CSDVKSVTFDMRSVYSEAFGKKV 616
+ S+ + V V E SD +S DMRSVYSEA KK+
Sbjct: 594 DCASIYRDDTVSVIEDPFTIPASDTRSFYSDMRSVYSEAPSKKM 637
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224072120|ref|XP_002303628.1| predicted protein [Populus trichocarpa] gi|222841060|gb|EEE78607.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 763 bits (1969), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 377/598 (63%), Positives = 455/598 (76%), Gaps = 30/598 (5%)
Query: 1 MEQFRQVGEVLGSLKALMVLKDDIQINQRQCCLLLDIFTLAFSTVAEEIRLFLKSEEKNT 60
MEQFRQ GEVLGSLKALMVL+DDIQINQ+QCCLL++IF LAF T+AEEI+ LK EEKNT
Sbjct: 1 MEQFRQTGEVLGSLKALMVLQDDIQINQKQCCLLVNIFCLAFKTIAEEIKQNLKLEEKNT 60
Query: 61 KWRALEQPLRELQKVFREGEHYVKQCLDYKDWWGKAISLHQNKDCVEFHIHNLLCYFPAV 120
KWR LE+PL+E+ +VF+EGE YV++CLD KDWWGKAISLHQNKD VEFHIHNLL FPAV
Sbjct: 61 KWRPLEEPLKEVYRVFKEGELYVRRCLDNKDWWGKAISLHQNKDSVEFHIHNLLSCFPAV 120
Query: 121 IEAIEAAGEISGLDPDEMQRRRVAFARKYDREWNDPKLFQLRFGKEYLIPREVCNEFESA 180
IEA+E AGEISGLD +EM ++R +KYDR W+DPKLFQ FGK+YL+PRE+C + E A
Sbjct: 121 IEAVEIAGEISGLDQEEMTKKRAMLVKKYDRGWSDPKLFQWNFGKQYLVPREICRQMERA 180
Query: 181 YKEDKWLLIDALKEKKRLGSVVLTKNEQRLVDMLLKKL---------------------- 218
+ED+WLLID +KEK+R ++ K+E RL ++LLKKL
Sbjct: 181 MREDRWLLIDTIKEKRR--ALPPGKSEHRLGELLLKKLNVLAPANGKLPPSSILLEAEDY 238
Query: 219 MVRRRLGASSQFKEIQWLGDSFVLRHFYGELESLNAEISTMLSLSHPNIVQYLCGFCDEE 278
VRRRLG +Q KEIQWLG++F LRHF+ + E LN+EIS +LSLSHPNIVQYLCGF DE
Sbjct: 239 QVRRRLGG-NQHKEIQWLGENFALRHFFHDFEPLNSEISMLLSLSHPNIVQYLCGFYDEN 297
Query: 279 KKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGEL 338
KKE FLVMELM+KD Y++E ++R F LP VVDIMLQIARGMEFLH++KIY G+
Sbjct: 298 KKECFLVMELMTKDFYSYIKENSSPKKRVLFPLPTVVDIMLQIARGMEFLHSRKIYVGDF 357
Query: 339 NPSNIYLKAR-SMEGYFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLA 397
NPSN+ LK R S EGYFHVKVSGFGL++ + ++SR++ P T IW+APEVLA
Sbjct: 358 NPSNVLLKPRKSTEGYFHVKVSGFGLTSVKNHSSRHSSPEPSPVDTC----IWHAPEVLA 413
Query: 398 EQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPS 457
EQE + S+ K +EKADVYSFGMLCF+LLTGK+PFEDGHLQGD+M NIRAGERPLFPS
Sbjct: 414 EQEQARNASSKKYTEKADVYSFGMLCFQLLTGKLPFEDGHLQGDQMINNIRAGERPLFPS 473
Query: 458 GSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKKFMANNPDIARSEFQSPLADYCDIE 517
SPKYLV+LTKKCWHT PS RP+F SICR+LRYIKKF+ NP+ + QSP D+ D+E
Sbjct: 474 LSPKYLVSLTKKCWHTEPSYRPTFLSICRVLRYIKKFLVMNPNDGQPYIQSPPVDFYDLE 533
Query: 518 AGFVRKFVGEGCPDVAPVSQIPFQMFAYKIAEKEKANSSNKGKHWELGSDVASTCKDE 575
AGF++K GE D+ VSQIPFQMF+Y++ EKEK K K+ E S+ AS DE
Sbjct: 534 AGFLKKCQGEVTCDLPSVSQIPFQMFSYRLIEKEKTCVQIKFKNSEAASEAASNGWDE 591
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359489706|ref|XP_002280598.2| PREDICTED: mitogen-activated protein kinase kinase kinase 7-like [Vitis vinifera] gi|147772008|emb|CAN60248.1| hypothetical protein VITISV_039398 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 761 bits (1965), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 378/624 (60%), Positives = 464/624 (74%), Gaps = 30/624 (4%)
Query: 1 MEQFRQVGEVLGSLKALMVLKDDIQINQRQCCLLLDIFTLAFSTVAEEIRLFLKSEEKNT 60
MEQFRQ+GEVLGSLKA MV ++DIQINQRQCCLLLD+ LA+ TVAEE++ L+ +EK+T
Sbjct: 1 MEQFRQMGEVLGSLKAFMVFREDIQINQRQCCLLLDVLDLAYHTVAEEMKQNLRLDEKHT 60
Query: 61 KWRALEQPLRELQKVFREGEHYVKQCLDYKDWWGKAISLHQNKDCVEFHIHNLLCYFPAV 120
KW+ LEQPLREL VF+EGEHYV+QCLD K+WW KAI +QN D VEFHIHNLLC FP V
Sbjct: 61 KWKILEQPLRELHGVFKEGEHYVRQCLDTKEWWAKAIIFYQNTDSVEFHIHNLLCCFPVV 120
Query: 121 IEAIEAAGEISGLDPDEMQRRRVAFARKYDREWNDPKLFQLRFGKEYLIPREVCNEFESA 180
IEAIE AGE SG D DE+Q++RV F+ KY +EW DPKLFQ RFGK+YLI ++ C+ +
Sbjct: 121 IEAIEIAGENSGWDQDEIQKKRVLFSTKYQKEWQDPKLFQWRFGKQYLISKDFCSRVDEV 180
Query: 181 YKEDKWLLIDALKEKKRLGSVVLTKNEQRLVDMLLKKL---------------------- 218
++ED+W+L++ ++ K+ GSV LTK EQRL D+L K L
Sbjct: 181 WREDRWILLNKIQGKRPSGSVSLTKYEQRLRDLLFKNLDVSQPLNGKLLPSSILLGSKDY 240
Query: 219 MVRRRLGASSQFKEIQWLGDSFVLRHFYGELESLNAEISTMLSLSHPNIVQYLCGFCDEE 278
VRRRLG+ SQ+KEI WLG+SF LRHFYGE+E L EIS +LSLSHPNI++ LCGF DEE
Sbjct: 241 QVRRRLGSGSQYKEIMWLGESFALRHFYGEIEPLVPEISQLLSLSHPNIMRLLCGFIDEE 300
Query: 279 KKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGEL 338
K+E FLVMELM KDL +++E G RRR FSLPV VD+MLQ+ARGME+LH++KIYHG+L
Sbjct: 301 KRECFLVMELMYKDLCSHLKEICGPRRRLPFSLPVAVDLMLQVARGMEYLHSKKIYHGDL 360
Query: 339 NPSNIYLKARSM--EGYFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVL 396
NPSNI +KARS+ EGY H KVSGFGLS+ + + +P NQ P+IW+APEVL
Sbjct: 361 NPSNILVKARSISTEGYLHAKVSGFGLSSTKNLNQKTSP-----NQAVNLPFIWHAPEVL 415
Query: 397 AEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFP 456
A+QE G T K +EKADVYSFGM+CFELLTGKVPFED HLQGDKM++NIRAGERPLFP
Sbjct: 416 ADQEQLGKTGNFKYTEKADVYSFGMVCFELLTGKVPFEDSHLQGDKMSRNIRAGERPLFP 475
Query: 457 SGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKKFMANNPDIARSEFQSPLADYCDI 516
S SPKY+ NLTKKCWHT+P+QRPSFSSICRILRY K F+A NPD ++ + PL D+CDI
Sbjct: 476 SNSPKYITNLTKKCWHTDPNQRPSFSSICRILRYTKWFLAMNPDHSQPDAPVPLVDFCDI 535
Query: 517 EAGFVRKFVGEGCPDVAPVSQIPFQMFAYKIAEKEKANSSNKGKHWELGSDVASTCKDEV 576
EAG ++ D P+S IPFQ+F Y+ EKEK ++ K K E GSD STC DE
Sbjct: 536 EAGLLKTIPSWRSSDPLPISDIPFQIFVYRAVEKEKLHAIPKQKSSESGSDGYSTCGDEP 595
Query: 577 FSVGDEGMVPVTETR-SVCSDVKS 599
++ D+ P+TE + SV S+ S
Sbjct: 596 LTIIDDPPPPMTEKKPSVSSETTS 619
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357481473|ref|XP_003611022.1| Integrin-linked protein kinase [Medicago truncatula] gi|355512357|gb|AES93980.1| Integrin-linked protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 757 bits (1955), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 383/665 (57%), Positives = 467/665 (70%), Gaps = 63/665 (9%)
Query: 1 MEQFRQVGEVLGSLKALMVLKDDIQINQRQCCLLLDIFTLAFSTVAEEIRLFLKSEEKNT 60
MEQ R +GEVLGSLKALMVL D+IQINQRQCCLL DIFTLAF T+A+EIR LK E++ T
Sbjct: 1 MEQLRHIGEVLGSLKALMVLSDEIQINQRQCCLLHDIFTLAFDTIADEIRQNLKLEDRTT 60
Query: 61 KWRALEQPLRELQKVFREGEHYVKQCLDYKDWWGKAISLHQNKDCVEFHIHNLLCYFPAV 120
KW+ LE PLREL +VF+EGE Y+K CLD KDW GKA++L QN++CVEFHIHNLLCYFPAV
Sbjct: 61 KWKPLECPLRELSRVFKEGELYIKHCLDSKDWSGKALTLSQNRECVEFHIHNLLCYFPAV 120
Query: 121 IEAIEAAGEISGLDPDEMQRRRVAFARKYDREWNDPKLFQLRFGKEYLIPREVCNEFESA 180
IEAIE AGE+SGLD DE ++++ ARKYD EWNDPKLFQ RFGK+YL+P+E+C + E+A
Sbjct: 121 IEAIENAGEMSGLDQDENSKKKLMLARKYDVEWNDPKLFQWRFGKQYLVPKEICKQLENA 180
Query: 181 YKEDKWLLIDALKEKKRLGSVVLTKNEQRLVDMLLKKLM--------------------- 219
++ED+W LI+AL+EKK + +KN+Q DMLLKKLM
Sbjct: 181 WREDRWRLIEALREKKGSSKLTYSKNDQHFADMLLKKLMNGNSDKTNHKNSNDKVLWPIG 240
Query: 220 ---------VRRRLGASSQFKEIQWLGDSFVLRHFYGELESLNAEISTMLSLSHPNIVQY 270
VRRRLG +FKEIQWLG SF LRHF GE E+ EIS +LSLSHPNI+QY
Sbjct: 241 VLLGSKDYQVRRRLGRGKEFKEIQWLGQSFALRHFLGEREAYENEISNLLSLSHPNILQY 300
Query: 271 LCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHA 330
LCGF DEEKKEF LV ELM+KDL YMRE G RR+ FS+PVVVD+MLQ+ARG+E+LH+
Sbjct: 301 LCGFYDEEKKEFSLVTELMNKDLWTYMRENCGPRRQILFSIPVVVDLMLQMARGIEYLHS 360
Query: 331 QKIYHGELNPSNIYLKAR-SMEGYFHVKVSGFGLSTART----YASRNTPPASPQNQTAP 385
+ IYHG LNP NI L+AR S EGYF KV GFGLS+ ASR++P +P +
Sbjct: 361 KNIYHGNLNPCNILLRARNSQEGYFQAKVVGFGLSSVENGEIYNASRSSPTHNPIGEEI- 419
Query: 386 NPYIWYAPEVLAEQEGTGSTSTS-KCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMT 444
NP IWYAPEVL E E + TS K SEKAD YSFGM+CFELLTGK+PFED HLQG +
Sbjct: 420 NPIIWYAPEVLTELEQMKNAFTSCKYSEKADAYSFGMICFELLTGKIPFEDNHLQGIRTN 479
Query: 445 KNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKKFMAN------- 497
+NI+AGERPLFP SPKYLV+L KKCW T+PSQRPSFSSICRILRYIKKF++
Sbjct: 480 QNIKAGERPLFPYRSPKYLVSLIKKCWQTDPSQRPSFSSICRILRYIKKFLSMNTEYVLI 539
Query: 498 NPDIARSEFQSPLADYCDIEAGFVRKFVGEGCPDVAPVSQIPFQMFAYKIAEKEKANS-- 555
NP++ + E Q+P D CDIE F++ F E +++ VSQIP++MFAYK+ EK K N+
Sbjct: 540 NPELNQLELQNPPVDCCDIEGIFLKSFPMERTYNMSFVSQIPYEMFAYKVVEKGKINNQN 599
Query: 556 ---------SNKGKHWELGSDVASTCKDE------VFSVGDEGMVP--VTETRSVCSDVK 598
NKG E DVA+ +E VF D ++ VT +S+ D +
Sbjct: 600 MSNITIPTIDNKGSESEPTKDVATVRSEESDDQSTVFEDIDASIIKDLVTYPKSISGDTQ 659
Query: 599 SVTFD 603
S+ +D
Sbjct: 660 SIFYD 664
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|12323479|gb|AAG51718.1|AC066689_17 phytochrome, putative; 80131-78152 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 747 bits (1929), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 385/666 (57%), Positives = 465/666 (69%), Gaps = 59/666 (8%)
Query: 1 MEQFRQVGEVLGSLKALMVLKDDIQINQRQCCLLLDIFTLAFSTVAEEIRLFLKSEEKNT 60
MEQFRQ+GEVLGSL AL F+TVAEEIR LK EEK+T
Sbjct: 1 MEQFRQIGEVLGSLNAL-----------------------GFNTVAEEIRHNLKLEEKHT 37
Query: 61 KWRALEQPLRELQKVFREGEHYVKQCLDYKDWWGKAISLHQNKDCVEFHIHNLLCYFPAV 120
KWRALEQPLREL +VF+EGE YV+ C+ KDWWGK I+ HQNKDCVEFHIHNLLCYF AV
Sbjct: 38 KWRALEQPLRELYRVFKEGEMYVRNCMSNKDWWGKVINFHQNKDCVEFHIHNLLCYFSAV 97
Query: 121 IEAIEAAGEISGLDPDEMQRRRVAFARKYDREWNDPKLFQLRFGKEYLIPREVCNEFESA 180
IEAIE AGEISGLDP EM+RRRV F+RKYDREWNDPKLFQ RFGK+YL+PR++C FE +
Sbjct: 98 IEAIETAGEISGLDPSEMERRRVVFSRKYDREWNDPKLFQWRFGKQYLVPRDICLRFEHS 157
Query: 181 YKEDKWLLIDALKEKKRLGSVVLTKNEQRLVDMLLKKL---------------------- 218
++ED+W L++AL+EK++ S + K E+RL D LLKKL
Sbjct: 158 WREDRWNLVEALQEKRKSKSDEIGKTEKRLADFLLKKLTGLEQFNGKLFPSSILVGSKDY 217
Query: 219 MVRRRLGASSQFKEIQWLGDSFVLRHFYGELESLNAEISTMLSLSHPNIVQYLCGFCDEE 278
VRRRLG Q+KEIQWLGDSFVLRHF+G+LE LNAEIS++LSL H NI+QYLCGF DEE
Sbjct: 218 QVRRRLGGGGQYKEIQWLGDSFVLRHFFGDLEPLNAEISSLLSLCHSNILQYLCGFYDEE 277
Query: 279 KKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGEL 338
+KE LVMELM KDL YM+E G RRR FS+PVV+DIMLQIARGME+LH+ +I+HG+L
Sbjct: 278 RKECSLVMELMHKDLKSYMKENCGPRRRYLFSVPVVIDIMLQIARGMEYLHSNEIFHGDL 337
Query: 339 NPSNIYLKARS-MEGYFHVKVSGFGLSTAR--TYASRNTPPASPQNQTAPNPYIWYAPEV 395
NP NI LK RS EGYFH K+SGFGL++ + +++ ++ P T P+P IWYAPEV
Sbjct: 338 NPMNILLKERSHTEGYFHAKISGFGLTSVKNQSFSRASSRP------TTPDPVIWYAPEV 391
Query: 396 LA--EQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERP 453
LA EQ+ G+ SK + KADVYSF M+CFEL+TGKVPFED HLQGDKM KNIR GERP
Sbjct: 392 LAEMEQDLKGTAPRSKFTHKADVYSFAMVCFELITGKVPFEDDHLQGDKMAKNIRTGERP 451
Query: 454 LFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKKFMANNPDIARSEFQSPLADY 513
LFP SPKYLV+L K+CWH+ PSQRP+FSSICRILRYIKKF+ NPD + Q+PL D
Sbjct: 452 LFPFPSPKYLVSLIKRCWHSEPSQRPTFSSICRILRYIKKFLVVNPDHGHLQIQNPLVDC 511
Query: 514 CDIEAGFVRKFVGEGCPDVAPVSQIPFQMFAYKIAEKEKANSSNKGKHWELGSDVASTCK 573
D+EA F++KF E V+QIPFQ+++Y+IAEKEK S N K E SD +
Sbjct: 512 WDLEARFLKKFSMESGSHAGSVTQIPFQLYSYRIAEKEKM-SPNFNK--EENSDAGESVS 568
Query: 574 DEVFSVGDEGMVPVTETRSVCSDVKSVTFDMRSVYSEAFGKKVSNFDTRSVRSESPNKKM 633
+ V V + T+S+C D S D RSVYSEA KK S ++ +
Sbjct: 569 ESVSVVEEPPTTMPMYTKSLCLDAISEYSDTRSVYSEAPIKKTSALKKSGDTIKNRRNSI 628
Query: 634 QGSVSR 639
G +S+
Sbjct: 629 SGQISQ 634
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 811 | ||||||
| TAIR|locus:2014255 | 717 | AT1G64300 [Arabidopsis thalian | 0.546 | 0.617 | 0.550 | 3e-203 | |
| TAIR|locus:2175065 | 711 | AT5G41730 [Arabidopsis thalian | 0.467 | 0.533 | 0.584 | 2.5e-199 | |
| TAIR|locus:2025356 | 470 | AT1G01450 [Arabidopsis thalian | 0.452 | 0.780 | 0.551 | 3.5e-107 | |
| ZFIN|ZDB-GENE-070705-132 | 675 | ripk1l "receptor (TNFRSF)-inte | 0.283 | 0.340 | 0.329 | 2.8e-20 | |
| TAIR|locus:2154573 | 525 | AT5G58950 [Arabidopsis thalian | 0.112 | 0.173 | 0.345 | 3.8e-17 | |
| TAIR|locus:2102802 | 475 | AT3G46930 [Arabidopsis thalian | 0.124 | 0.212 | 0.327 | 5.3e-17 | |
| TAIR|locus:2180992 | 333 | AT5G01850 [Arabidopsis thalian | 0.218 | 0.531 | 0.331 | 5.8e-17 | |
| UNIPROTKB|P41239 | 450 | CSK "Tyrosine-protein kinase C | 0.134 | 0.242 | 0.338 | 4.8e-16 | |
| TAIR|locus:2084193 | 411 | AT3G01490 [Arabidopsis thalian | 0.199 | 0.394 | 0.336 | 6.5e-16 | |
| WB|WBGene00005077 | 533 | src-1 [Caenorhabditis elegans | 0.260 | 0.395 | 0.302 | 6.7e-16 |
| TAIR|locus:2014255 AT1G64300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1181 (420.8 bits), Expect = 3.0e-203, Sum P(2) = 3.0e-203
Identities = 258/469 (55%), Positives = 315/469 (67%)
Query: 225 GASSQFKEIQWLGDSFVLRHFYGELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFL 284
G Q+KEIQWLGDSFVLRHF+G+LE LNAEIS++LSL H NI+QYLCGF DEE+KE L
Sbjct: 247 GGGGQYKEIQWLGDSFVLRHFFGDLEPLNAEISSLLSLCHSNILQYLCGFYDEERKECSL 306
Query: 285 VMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIY 344
VMELM KDL YM+E G RRR FS+PVV+DIMLQIARGME+LH+ +I+HG+LNP NI
Sbjct: 307 VMELMHKDLKSYMKENCGPRRRYLFSVPVVIDIMLQIARGMEYLHSNEIFHGDLNPMNIL 366
Query: 345 LKARS-MEGYFHVKVSGFGLSTARTYA-SRNTPPASPQNQTAPNPYIWYAPEVLAEQEGT 402
LK RS EGYFH K+SGFGL++ + + SR AS + T P+P IWYAPEVLAE E
Sbjct: 367 LKERSHTEGYFHAKISGFGLTSVKNQSFSR----ASSR-PTTPDPVIWYAPEVLAEMEQD 421
Query: 403 --GSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSP 460
G+ SK + KADVYSF M+CFEL+TGKVPFED HLQGDKM KNIR GERPLFP SP
Sbjct: 422 LKGTAPRSKFTHKADVYSFAMVCFELITGKVPFEDDHLQGDKMAKNIRTGERPLFPFPSP 481
Query: 461 KYLVNLTKKCWHTNPSQRPSFSSICRILRYIKKFMANNPDIARSEFQSPLADYCDIEAGF 520
KYLV+L K+CWH+ PSQRP+FSSICRILRYIKKF+ NPD + Q+PL D D+EA F
Sbjct: 482 KYLVSLIKRCWHSEPSQRPTFSSICRILRYIKKFLVVNPDHGHLQIQNPLVDCWDLEARF 541
Query: 521 VRKFVGEGCPDVAPVSQIPFQMFAYKIAEKEKANSSNKGKHWELGSDVASTCKDEVFSVG 580
++KF E V+QIPFQ+++Y+IAEKEK S N K E SD + + V V
Sbjct: 542 LKKFSMESGSHAGSVTQIPFQLYSYRIAEKEKM-SPNFNK--EENSDAGESVSESVSVVE 598
Query: 581 DEGMVPVTETRSVCSDVKSVTFDMRSVYSEAFGKKVSNFDTRSVRSESPNKKMQGSVSRL 640
+ T+S+C D S D RSVYSEA KK S +S K + S+S L
Sbjct: 599 EPPTTMPMYTKSLCLDAISEYSDTRSVYSEAPIKKTSALK----KSGDTIKNRRNSISGL 654
Query: 641 IQSMVLEKNVSSSDTKP-AVPENSISNSEVKSEVPETNISNSDTKLVVS 688
++ SS KP + P+ S S +N +N DT+L +S
Sbjct: 655 -------RSPGSSPIKPRSTPKVSSPLSPFGRS--SSNKANKDTRLPLS 694
|
|
| TAIR|locus:2175065 AT5G41730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1149 (409.5 bits), Expect = 2.5e-199, Sum P(2) = 2.5e-199
Identities = 231/395 (58%), Positives = 282/395 (71%)
Query: 226 ASSQFKEIQWLGDSFVLRHFYGELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLV 285
A Q+KEIQWLGDSF LRHF+ +LE L++EIS++L+L H NI+QYLCGF DEE+KE FLV
Sbjct: 248 ADGQYKEIQWLGDSFALRHFFSDLEPLSSEISSLLALCHSNILQYLCGFYDEERKECFLV 307
Query: 286 MELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYL 345
MELM KDL YM+E G RRR FS+PVV+DIMLQIARGME+LH I+HG+LNP NI+L
Sbjct: 308 MELMHKDLQSYMKENCGPRRRYLFSIPVVIDIMLQIARGMEYLHGNDIFHGDLNPMNIHL 367
Query: 346 KARS-MEGYFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEG--T 402
K RS EGYFH K+ GFGLS+ A ++ P +P +P IWYAPEVLAE E
Sbjct: 368 KERSHTEGYFHAKICGFGLSSV-VKAQSSSKPGTP------DPVIWYAPEVLAEMEQDLN 420
Query: 403 GSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKY 462
G T SK + KADVYSF M+CFEL+TGKVPFED HLQG+ MT NIR GERPLFP SPKY
Sbjct: 421 GKTPKSKLTHKADVYSFAMVCFELITGKVPFEDSHLQGEPMTINIRMGERPLFPFPSPKY 480
Query: 463 LVNLTKKCWHTNPSQRPSFSSICRILRYIKKFMANNPDIARSEFQSPLADYCDIEAGFVR 522
LV+L K+CWH+ PSQRP+FSSICRILRYIKKF+ NPD + Q+PL D D+EA F+R
Sbjct: 481 LVSLIKRCWHSEPSQRPNFSSICRILRYIKKFLVVNPDHGHPQMQTPLVDCWDLEARFLR 540
Query: 523 KFVGEGCPDVAPVSQIPFQMFAYKIAEKEKANSSNKGKHWELGSDVASTCKDEVFSVGDE 582
KF G+ A V+QIPFQ+++Y++ EKEK N ++K S+ S +D
Sbjct: 541 KFPGDAGSHTASVNQIPFQLYSYRVLEKEKMNPNSKESSETSESESVSVVEDP-----PN 595
Query: 583 GMVPVTETRSVCSDVKSVTFDMRSVYSEAFGKKVS 617
M+ +T+S+C D S D RSVYSEA KKVS
Sbjct: 596 AMI-TRDTKSLCLDTISEYSDTRSVYSEAPMKKVS 629
|
|
| TAIR|locus:2025356 AT1G01450 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1060 (378.2 bits), Expect = 3.5e-107, P = 3.5e-107
Identities = 209/379 (55%), Positives = 275/379 (72%)
Query: 225 GASSQFKEIQWLGDSFVLRHFYGELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFL 284
G SQ+KEI WLG+SF LRHF+G++++L +I+ +LSLSHPNIV YLCGF DEEKKE FL
Sbjct: 37 GNGSQYKEITWLGESFALRHFFGDIDALLPQITPLLSLSHPNIVYYLCGFTDEEKKECFL 96
Query: 285 VMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIY 344
VMELM K L +++E G R++N+ SLPV VD+MLQIA GME+LH+++IYHGELNPSNI
Sbjct: 97 VMELMRKTLGMHIKEVCGPRKKNTLSLPVAVDLMLQIALGMEYLHSKRIYHGELNPSNIL 156
Query: 345 LKARSME---GYFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEG 401
+K RS + GY K+ GFGL++ + ++S++ S QN+ P +IWY+PEVL EQE
Sbjct: 157 VKPRSNQSGDGYLLGKIFGFGLNSVKGFSSKSASLTS-QNENFP--FIWYSPEVLEEQEQ 213
Query: 402 TGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPK 461
+G+ + K S+K+DVYSFGM+ FELLTGKVPFED HLQGDKM++NIRAGERPLFP SPK
Sbjct: 214 SGTAGSLKYSDKSDVYSFGMVSFELLTGKVPFEDSHLQGDKMSRNIRAGERPLFPFNSPK 273
Query: 462 YLVNLTKKCWHTNPSQRPSFSSICRILRYIKKFMANNPDIARSEFQ----SPLADYCDIE 517
++ NLTK+CWH +P+QRP+FSSI RILRYIK+F+A NP+ S Q +P DYC+IE
Sbjct: 274 FITNLTKRCWHADPNQRPTFSSISRILRYIKRFLALNPECYSSSQQDPSIAPTVDYCEIE 333
Query: 518 AGFVRKFVGEGCPDVAPVSQIPFQMFAYKIAEKEKA-NSSNKGKHWELGSDVASTCKDEV 576
++K E ++ VSQ+PFQMFAY++ E+ K N + E GS+ AS +DE
Sbjct: 334 TKLLQKLSWEST-ELTKVSQVPFQMFAYRVVERAKTCEKDNLREPSESGSEWASCSEDEG 392
Query: 577 FSVGDEGMVPVTETRSVCS 595
+ DE + E R CS
Sbjct: 393 GAGSDEQLSYAKERRLSCS 411
|
|
| ZFIN|ZDB-GENE-070705-132 ripk1l "receptor (TNFRSF)-interacting serine-threonine kinase 1, like" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 273 (101.2 bits), Expect = 2.8e-20, P = 2.8e-20
Identities = 85/258 (32%), Positives = 133/258 (51%)
Query: 250 ESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSF 309
+SL E S M L+H +V+ L G E+ ++ LVMEL+ K M ET
Sbjct: 71 QSLLEEGSLMSRLNHQRVVKLL-GVILEDG-DYSLVMELIPKGNLLTMLETV-------- 120
Query: 310 SLPVVVD--IMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTAR 367
++P+ V I+L+I GM +L ++ H +L P NI + FH+K++ GL+T+
Sbjct: 121 TVPISVKGRIILEILEGMVYLTKNQVIHKDLKPENILVDKN-----FHIKIADLGLATSE 175
Query: 368 TYASRNTPPASPQNQTAPNPYIWYAPEVLAEQ--EGTGSTSTSKCSEKADVYSFGMLCFE 425
+ S+ T S + +A L E S T + SEK+DVYSF ++ +
Sbjct: 176 VW-SKLTKEESRRQSRLGKKTSAHAAGTLCYMAPEHLKSIHT-RSSEKSDVYSFAIVLWV 233
Query: 426 LLTGKVPFEDGHLQGDKMTKNIRAGERP---LFPSGSPKYLVNLTKKCWHTNPSQRPSFS 482
+LTG+ P+E+ + D++ + GERP L P +P + +L K CWH +P QRPSF+
Sbjct: 234 ILTGREPYENARSE-DQICHCVCQGERPDEALIPPNTPTDITDLMKSCWHQDPLQRPSFT 292
Query: 483 SIC--RILRYIKKFMANN 498
C R L + K+ +A N
Sbjct: 293 D-CYNRFLPFYKEKLAAN 309
|
|
| TAIR|locus:2154573 AT5G58950 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 148 (57.2 bits), Expect = 3.8e-17, Sum P(2) = 3.8e-17
Identities = 37/107 (34%), Positives = 58/107 (54%)
Query: 385 PNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGH-LQGD-- 441
P Y W APE++ +++ G KADVYSFG++ +E++ G +P+ED + +Q
Sbjct: 370 PGTYRWMAPEMI-KRKPHG--------RKADVYSFGLVLWEMVAGAIPYEDMNPIQAAFA 420
Query: 442 KMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRIL 488
+ KNIR P P P + L ++CW P +RP F I ++L
Sbjct: 421 VVHKNIR----PAIPGDCPVAMKALIEQCWSVAPDKRPEFWQIVKVL 463
|
|
| TAIR|locus:2102802 AT3G46930 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 151 (58.2 bits), Expect = 5.3e-17, Sum P(2) = 5.3e-17
Identities = 36/110 (32%), Positives = 57/110 (51%)
Query: 388 YIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNI 447
Y W APEVL ++ G KC DVYSFG+L +E++ G +P+E+ I
Sbjct: 324 YRWMAPEVL-KRIPHGR----KC----DVYSFGLLLWEMVAGALPYEEMKFAEQIAYAVI 374
Query: 448 RAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKKFMAN 497
RP+ P+ P + L ++CW + +RP F I ++L + KK + +
Sbjct: 375 YKKIRPVIPTDCPAAMKELIERCWSSQTDKRPEFWQIVKVLEHFKKSLTS 424
|
|
| TAIR|locus:2180992 AT5G01850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 231 (86.4 bits), Expect = 5.8e-17, P = 5.8e-17
Identities = 64/193 (33%), Positives = 93/193 (48%)
Query: 297 MRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHV 356
+R+ S R LP+ + L IAR + LHA I H +L P N+ L E + V
Sbjct: 102 LRKYLTSIRPQLLHLPLALSFALDIARALHCLHANGIIHRDLKPDNLLLT----ENHKSV 157
Query: 357 KVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADV 416
K++ FGL+ + T +T Y W APE+ + + K DV
Sbjct: 158 KLADFGLAREESVTEMMTA------ETGT--YRWMAPELYSTVT-LRQGEKKHYNNKVDV 208
Query: 417 YSFGMLCFELLTGKVPFED-GHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNP 475
YSFG++ +ELLT ++PFE +LQ + ERP+ P G L + + CW +P
Sbjct: 209 YSFGIVLWELLTNRMPFEGMSNLQAAYAAAFKQ--ERPVMPEGISPSLAFIVQSCWVEDP 266
Query: 476 SQRPSFSSICRIL 488
+ RPSFS I R+L
Sbjct: 267 NMRPSFSQIIRLL 279
|
|
| UNIPROTKB|P41239 CSK "Tyrosine-protein kinase CSK" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 151 (58.2 bits), Expect = 4.8e-16, Sum P(2) = 4.8e-16
Identities = 41/121 (33%), Positives = 60/121 (49%)
Query: 374 TPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVP 432
T AS T P W APE L E+ K S K+DV+SFG+L +E+ + G+VP
Sbjct: 336 TKEASSTQDTGKLPVKWTAPEALREK---------KFSTKSDVWSFGILLWEIYSFGRVP 386
Query: 433 FEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIK 492
+ L+ + + G + P G P + + KKCW +P RPSF + L +IK
Sbjct: 387 YPRIPLKD--VVPRVEKGYKMDPPDGCPAIVYEVMKKCWTLDPGHRPSFHQLREQLVHIK 444
Query: 493 K 493
+
Sbjct: 445 E 445
|
|
| TAIR|locus:2084193 AT3G01490 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 228 (85.3 bits), Expect = 6.5e-16, P = 6.5e-16
Identities = 64/190 (33%), Positives = 96/190 (50%)
Query: 305 RRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYL-KARSMEGYFHVKVSGFGL 363
RR + VV+ + L +ARG+ +LH+QKI H ++ N+ L K+R++ K++ FG+
Sbjct: 221 RRRKLAFKVVIQLSLDLARGLSYLHSQKIVHRDVKTENMLLDKSRTL------KIADFGV 274
Query: 364 STARTYASRNTPPASPQNQTAPNPYIWY-APEVLAEQEGTGSTSTSKCSEKADVYSFGML 422
AR AS +P + T + Y APEVL GS KC DVYSFG+
Sbjct: 275 --ARLEAS------NPNDMTGETGTLGYMAPEVL-----NGSPYNRKC----DVYSFGIC 317
Query: 423 CFELLTGKVPFEDGHLQGDKMTKNI-RAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSF 481
+E+ +P+ D L ++T + R RP P P L N+ K+CW NP +RP
Sbjct: 318 LWEIYCCDMPYPD--LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPEKRPEM 375
Query: 482 SSICRILRYI 491
+ +L I
Sbjct: 376 EEVVAMLEAI 385
|
|
| WB|WBGene00005077 src-1 [Caenorhabditis elegans (taxid:6239)] | Back alignment and assigned GO terms |
|---|
Score = 231 (86.4 bits), Expect = 6.7e-16, P = 6.7e-16
Identities = 72/238 (30%), Positives = 117/238 (49%)
Query: 250 ESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELM-SKDLSCYMRETFGSRRRNS 308
E+ E M HPN+V+ L C E+ F+++ E M + L Y+R T GS +
Sbjct: 300 EAFLQEAQIMKQCDHPNLVK-LYAVCTREEP-FYIITEYMINGSLLQYLR-TDGS----T 352
Query: 309 FSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTART 368
+ +VD+ QIA GM +L +K+ H +L N+ L + G VKV+ FGL AR
Sbjct: 353 LGIQALVDMAAQIANGMMYLEERKLVHRDLAARNV-LVGDKISGVPVVKVADFGL--ARK 409
Query: 369 YASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT 428
+ A A P W APE + + + K+DV+S+G+L +E++T
Sbjct: 410 LMEEDIYEA---RTGAKFPIKWTAPE---------AATCGNFTVKSDVWSYGILLYEIMT 457
Query: 429 -GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVN-LTKKCWHTNPSQRPSFSSI 484
G+VP+ H + ++ + + G R P G P+ + + KCW P +RP+F ++
Sbjct: 458 KGQVPYPGMHNR--EVVEQVELGYRMPMPRGCPEQIYEEVLLKCWDKTPDRRPTFDTL 513
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 3rd Layer | 2.7.11 | LOW CONFIDENCE prediction! |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | fgenesh2_kg.2__52__AT1G64300.2 | annotation not avaliable (715 aa) | |||||||||
(Arabidopsis lyrata) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 811 | |||
| pfam06760 | 217 | pfam06760, DUF1221, Protein of unknown function (D | 1e-115 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 7e-47 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-46 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-45 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-45 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-41 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-39 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-35 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 7e-33 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-32 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-26 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-26 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-26 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-26 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-26 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-25 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 7e-25 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-24 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-24 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-24 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 8e-24 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-23 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-23 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 8e-23 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-22 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-22 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-22 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-21 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-21 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-21 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-21 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-21 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-21 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 8e-21 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-20 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-20 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 6e-20 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 6e-20 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 8e-20 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 8e-20 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-19 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-19 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-19 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-19 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 5e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 8e-19 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 9e-19 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-18 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-18 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-18 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-17 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-17 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-17 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-17 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-17 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-17 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-17 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-17 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-17 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 6e-17 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 8e-17 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-16 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-16 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-16 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-16 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-16 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-16 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-16 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-16 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-16 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-16 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 8e-16 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-15 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-15 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-15 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-15 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-15 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-15 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-15 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 6e-15 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 6e-15 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 9e-15 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-14 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-14 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-14 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-14 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-14 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-14 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-14 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-14 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-14 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-14 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-14 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 7e-14 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 7e-14 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-13 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-13 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-13 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-13 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-13 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-13 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-13 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-13 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-13 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-13 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-13 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 6e-13 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 6e-13 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 6e-13 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 6e-13 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-12 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-12 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-12 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-12 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-12 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-12 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-12 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-12 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 7e-12 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-11 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-11 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-11 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-11 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-11 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-11 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-11 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 7e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 7e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 8e-11 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 9e-11 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 9e-11 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 9e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-10 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-10 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-10 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-10 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-10 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-10 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-10 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-10 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-10 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-10 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 9e-10 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 9e-10 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 9e-10 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-09 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-09 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-09 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-09 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-09 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-09 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-09 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-09 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-09 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-09 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-09 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-09 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-09 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-09 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-09 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-09 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-09 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-09 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 6e-09 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 6e-09 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 7e-09 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 8e-09 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 9e-09 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 9e-09 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-08 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-08 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-08 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-08 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-08 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-08 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-08 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-08 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-08 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-08 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 5e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-08 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 6e-08 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 8e-08 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 9e-08 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 9e-08 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-07 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-07 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-07 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-07 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-07 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-07 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-07 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-07 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-07 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-07 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-07 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-07 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-07 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-07 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 4e-07 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 5e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 5e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 7e-07 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 8e-07 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-06 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-06 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-06 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-06 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-06 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-06 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-06 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-06 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-06 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 4e-06 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 8e-06 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-05 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-05 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-05 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-05 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-05 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-05 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-05 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 5e-05 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-05 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-05 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 5e-05 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 6e-05 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 8e-05 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 8e-05 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 9e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-04 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-04 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-04 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-04 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-04 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-04 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-04 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-04 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-04 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-04 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-04 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-04 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 4e-04 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-04 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-04 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 6e-04 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 0.001 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 0.001 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 0.002 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 0.002 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 0.003 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 0.004 |
| >gnl|CDD|191604 pfam06760, DUF1221, Protein of unknown function (DUF1221) | Back alignment and domain information |
|---|
Score = 347 bits (891), Expect = e-115
Identities = 125/200 (62%), Positives = 154/200 (77%)
Query: 21 KDDIQINQRQCCLLLDIFTLAFSTVAEEIRLFLKSEEKNTKWRALEQPLRELQKVFREGE 80
KDDIQINQRQCCLLLD F LA+ VA E+R L+ +EK+TKW+ LEQPLREL +VFREGE
Sbjct: 1 KDDIQINQRQCCLLLDAFALAYEAVAGEMRANLRFDEKHTKWKILEQPLRELHRVFREGE 60
Query: 81 HYVKQCLDYKDWWGKAISLHQNKDCVEFHIHNLLCYFPAVIEAIEAAGEISGLDPDEMQR 140
YV+QCLD K WW KAI+ H N DCVEFHIHNLL P V+EAIE AGE+SG DPDE+ R
Sbjct: 61 AYVRQCLDPKGWWAKAIAFHHNTDCVEFHIHNLLWCVPVVVEAIETAGEVSGSDPDELAR 120
Query: 141 RRVAFARKYDREWNDPKLFQLRFGKEYLIPREVCNEFESAYKEDKWLLIDALKEKKRLGS 200
+R+ +RKYD++W DPKLFQ RFGK+YL+ R++C + A+KED+W+L L+EKK GS
Sbjct: 121 KRLVLSRKYDKDWLDPKLFQWRFGKQYLVTRDLCARMDMAWKEDRWILSQELQEKKGSGS 180
Query: 201 VVLTKNEQRLVDMLLKKLMV 220
L+K+E RL D+L K L
Sbjct: 181 SKLSKHEHRLADLLAKHLDG 200
|
This is a family of plant proteins, most of which are hypothetical and of unknown function. All members contain the pfam00069 domain, suggesting that they may possess kinase activity. Length = 217 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 7e-47
Identities = 73/243 (30%), Positives = 113/243 (46%), Gaps = 30/243 (12%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRR 306
E E E S M LSHPNIV+ L G C + + ++V E M DL ++R +
Sbjct: 44 EREEFLEEASIMKKLSHPNIVRLL-GVC-TQGEPLYIVTEYMPGGDLLDFLR-----KHG 96
Query: 307 NSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366
+L ++ + LQIA+GME+L ++ H +L N + VK+S FGLS
Sbjct: 97 EKLTLKDLLQMALQIAKGMEYLESKNFVHRDLAARNCLVTEN-----LVVKISDFGLS-- 149
Query: 367 RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFEL 426
R + + P W APE L + K + K+DV+SFG+L +E+
Sbjct: 150 RDIYEDDY---YRKRGGGKLPIKWMAPESLKD---------GKFTSKSDVWSFGVLLWEI 197
Query: 427 LT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSIC 485
T G+ P+ + +++ + + G R P P L L +CW +P RP+FS +
Sbjct: 198 FTLGEQPYPG--MSNEEVLELLEDGYRLPRPENCPDELYELMLQCWAYDPEDRPTFSELV 255
Query: 486 RIL 488
L
Sbjct: 256 EDL 258
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 166 bits (424), Expect = 1e-46
Identities = 75/243 (30%), Positives = 114/243 (46%), Gaps = 32/243 (13%)
Query: 254 AEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRE---TFGSRRRNSF 309
E M L HPN+V+ L G C E++ +LV+E M DL Y+R+ F S +++
Sbjct: 45 KEARVMKKLGHPNVVR-LLGVC-TEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTL 102
Query: 310 SLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTY 369
SL ++ +QIA+GME+L ++K H +L N + VK+S FGLS
Sbjct: 103 SLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGED-----LVVKISDFGLS----- 152
Query: 370 ASRNTPPASPQNQT--APNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELL 427
R+ + P W APE L + + K+DV+SFG+L +E+
Sbjct: 153 --RDVYDDDYYRKKTGGKLPIRWMAPESLKDG---------IFTSKSDVWSFGVLLWEIF 201
Query: 428 T-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486
T G P+ L +++ + +R G R P P L L CW +P RP+FS +
Sbjct: 202 TLGATPYPG--LSNEEVLEYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVE 259
Query: 487 ILR 489
L
Sbjct: 260 RLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 163 bits (415), Expect = 2e-45
Identities = 76/244 (31%), Positives = 116/244 (47%), Gaps = 33/244 (13%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRR 306
++E E M L HPN+V+ L G C E++ ++VME M DL Y+R+ R
Sbjct: 44 QIEEFLREARIMRKLDHPNVVKLL-GVC-TEEEPLYIVMEYMEGGDLLSYLRK-----NR 96
Query: 307 NSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366
SL ++ LQIARGME+L ++ H +L N + VK+S FGLS
Sbjct: 97 PKLSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGEN-----LVVKISDFGLS-- 149
Query: 367 RTYASRNTPPASPQNQTAPN-PYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFE 425
R+ + P W APE L K + K+DV+SFG+L +E
Sbjct: 150 -----RDLYDDDYYRKRGGKLPIRWMAPESL---------KEGKFTSKSDVWSFGVLLWE 195
Query: 426 LLT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSI 484
+ T G+ P+ + +++ + ++ G R P P L +L +CW +P RP+FS +
Sbjct: 196 IFTLGEQPYPG--MSNEEVLEYLKNGYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSEL 253
Query: 485 CRIL 488
IL
Sbjct: 254 VEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 4e-45
Identities = 77/244 (31%), Positives = 112/244 (45%), Gaps = 32/244 (13%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRR 306
++E E M L HPNIV+ L G C E++ +VME M DL Y+R+ R
Sbjct: 44 QIEEFLREARIMRKLDHPNIVKLL-GVC-TEEEPLMIVMEYMPGGDLLDYLRK----NRP 97
Query: 307 NSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366
SL ++ LQIARGME+L ++ H +L N + VK+S FGLS
Sbjct: 98 KELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGEN-----LVVKISDFGLS-- 150
Query: 367 RTYASRNTPPASPQNQTAPN-PYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFE 425
R+ P W APE L K + K+DV+SFG+L +E
Sbjct: 151 -----RDLYDDDYYKVKGGKLPIRWMAPESL---------KEGKFTSKSDVWSFGVLLWE 196
Query: 426 LLT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSI 484
+ T G+ P+ + ++ + ++ G R P P L L +CW +P RP+FS +
Sbjct: 197 IFTLGEEPYPG--MSNAEVLEYLKKGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSEL 254
Query: 485 CRIL 488
IL
Sbjct: 255 VEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 6e-41
Identities = 66/248 (26%), Positives = 105/248 (42%), Gaps = 38/248 (15%)
Query: 242 LRHFYGELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRET 300
+ + E + EI + L HPNIV+ F E++ + +LVME DL ++
Sbjct: 34 KKKIKKDRERILREIKILKKLKHPNIVRLYDVF--EDEDKLYLVMEYCEGGDLFDLLK-- 89
Query: 301 FGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSG 360
+R S + QI +E+LH++ I H +L P NI L HVK++
Sbjct: 90 ----KRGRLSEDEARFYLRQILSALEYLHSKGIVHRDLKPENILLDEDG-----HVKLAD 140
Query: 361 FGLSTA-RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSF 419
FGL+ T +P+ + APEVL + + D++S
Sbjct: 141 FGLARQLDPGEKLTTFVGTPE---------YMAPEVLLGK---------GYGKAVDIWSL 182
Query: 420 GMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKY---LVNLTKKCWHTNPS 476
G++ +ELLTGK PF G Q ++ K I +P FP +L +K +P
Sbjct: 183 GVILYELLTGKPPF-PGDDQLLELFKKIGKP-KPPFPPPEWDISPEAKDLIRKLLVKDPE 240
Query: 477 QRPSFSSI 484
+R +
Sbjct: 241 KRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 1e-39
Identities = 81/247 (32%), Positives = 110/247 (44%), Gaps = 41/247 (16%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRR 306
+ ++ EI + LSHPNIV+ + F E+K +LVME DL Y+ R
Sbjct: 41 KDQTARREIRILRRLSHPNIVRLIDAF--EDKDHLYLVMEYCEGGDLFDYLS------RG 92
Query: 307 NSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366
S I LQI RG+E+LH+ I H +L P NI L VK++ FGL+
Sbjct: 93 GPLSEDEAKKIALQILRGLEYLHSNGIIHRDLKPENILLDENG-----VVKIADFGLAKK 147
Query: 367 RT--YASRNTPPASPQNQTAPNPYIWY-APEVLAEQEGTGSTSTSKCSEKADVYSFGMLC 423
+S T +P WY APEVL G G K DV+S G++
Sbjct: 148 LLKSSSSLTTFVGTP----------WYMAPEVLLGGNGYGP--------KVDVWSLGVIL 189
Query: 424 FELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVN-----LTKKCWHTNPSQR 478
+ELLTGK PF G D++ R PL + L KKC + +PS+R
Sbjct: 190 YELLTGKPPF-SGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKR 248
Query: 479 PSFSSIC 485
P+ I
Sbjct: 249 PTAEEIL 255
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 133 bits (338), Expect = 1e-35
Identities = 63/250 (25%), Positives = 96/250 (38%), Gaps = 61/250 (24%)
Query: 240 FVLRHFYGELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMR 298
LE L EI + L+HPNIV+ G E++ +LVME L ++
Sbjct: 26 IKKEDSSSLLEELLREIEILKKLNHPNIVKLY-GVF-EDENHLYLVMEYCEGGSLKDLLK 83
Query: 299 ETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKV 358
S ++ I+LQI G+E+LH+ I H +L P NI L + + VK+
Sbjct: 84 -----ENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDN----GKVKL 134
Query: 359 SGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYS 418
+ FGLS + + T + APEVL + SEK+D++S
Sbjct: 135 ADFGLS---KLLTSDKSLLKTIVGT----PAYMAPEVLLGKG--------YYSEKSDIWS 179
Query: 419 FGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQR 478
G++ +EL L +L +K +P +R
Sbjct: 180 LGVILYEL----------------------------------PELKDLIRKMLQKDPEKR 205
Query: 479 PSFSSICRIL 488
PS I L
Sbjct: 206 PSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 7e-33
Identities = 68/234 (29%), Positives = 103/234 (44%), Gaps = 26/234 (11%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMS-KDLSCYMRETFGSRRR 306
ELE+L EI + SL HPNIV+Y DEEK + +E +S LS + + FG
Sbjct: 42 ELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLS-SLLKKFG---- 96
Query: 307 NSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366
PV+ QI G+ +LH+ I H ++ +NI + VK++ FG A
Sbjct: 97 -KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVD-----SDGVVKLADFG--CA 148
Query: 367 RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFEL 426
+ T + + P W APEV+ E G AD++S G E+
Sbjct: 149 KRLGDIETGEGTGSVRGTPY---WMAPEVI-RGEEYGR--------AADIWSLGCTVIEM 196
Query: 427 LTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPS 480
TGK P+ + + K +GE P P + + +KC +P +RP+
Sbjct: 197 ATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPT 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 5e-32
Identities = 75/253 (29%), Positives = 114/253 (45%), Gaps = 47/253 (18%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEE-KKEFFLVME-LMSKDLSCYMRETFGSRRRNSFSLP 312
EI + +L H NIV+Y G C++ + L+ME L S L Y++ R+ +L
Sbjct: 56 EIEILRTLDHENIVKYK-GVCEKPGGRSLRLIMEYLPSGSLRDYLQRH-----RDQINLK 109
Query: 313 VVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA----RT 368
++ QI +GM++L +Q+ H +L NI + E VK+S FGL+ +
Sbjct: 110 RLLLFSSQICKGMDYLGSQRYIHRDLAARNILV-----ESEDLVKISDFGLAKVLPEDKD 164
Query: 369 YASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT 428
Y P SP WYAPE L TSK S +DV+SFG+ +EL T
Sbjct: 165 YYYVKEPGESP--------IFWYAPECL---------RTSKFSSASDVWSFGVTLYELFT 207
Query: 429 ----GKVP---------FEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNP 475
+ P G + ++ + ++ GER P P + +L K CW P
Sbjct: 208 YGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEP 267
Query: 476 SQRPSFSSICRIL 488
RPSF+ + I+
Sbjct: 268 QDRPSFADLILIV 280
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 82/277 (29%), Positives = 129/277 (46%), Gaps = 48/277 (17%)
Query: 222 RRLGASSQFKEI---QWLGDSFV----LRHFYGELESLNAEISTMLSLSHPNIVQYLCGF 274
R+LGA QF E+ W G + V L+ E+ E M L H +VQ L
Sbjct: 12 RKLGAG-QFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQ-LYAV 69
Query: 275 CDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKI 333
C EE+ ++V E MSK L +++ G + R LP +VD+ QIA GM +L ++
Sbjct: 70 CSEEEP-IYIVTEYMSKGSLLDFLKSGEGKKLR----LPQLVDMAAQIAEGMAYLESRNY 124
Query: 334 YHGELNPSNIYLKARSMEGYFHVKVSGFGLSTART-----YASRNTPPASPQNQTAPNPY 388
H +L NI + + K++ FGL AR Y +R + A P
Sbjct: 125 IHRDLAARNILVGENLV-----CKIADFGL--ARLIEDDEYTAR---------EGAKFPI 168
Query: 389 IWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGDKMTKNI 447
W APE + + + + K+DV+SFG+L E++T G+VP+ ++ + +
Sbjct: 169 KWTAPE---------AANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT--NREVLEQV 217
Query: 448 RAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSI 484
G R P P+ L +L +CW +P +RP+F +
Sbjct: 218 ERGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYL 254
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 1e-26
Identities = 77/240 (32%), Positives = 113/240 (47%), Gaps = 33/240 (13%)
Query: 254 AEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFSLP 312
AE S M L H N+VQ L G EEK ++V E M+K L Y+R SR R+
Sbjct: 48 AEASVMTQLRHSNLVQLL-GVIVEEKGGLYIVTEYMAKGSLVDYLR----SRGRSVLGGD 102
Query: 313 VVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASR 372
++ L + ME+L A H +L N+ + ++ KVS FGL
Sbjct: 103 CLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNV-----AKVSDFGL--------- 148
Query: 373 NTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKV 431
T AS T P W APE L E+ K S K+DV+SFG+L +E+ + G+V
Sbjct: 149 -TKEASSTQDTGKLPVKWTAPEALREK---------KFSTKSDVWSFGILLWEIYSFGRV 198
Query: 432 PFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYI 491
P+ L+ + + G + P G P + ++ K+CWH + + RPSF + L +I
Sbjct: 199 PYPRIPLK--DVVPRVEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 70/239 (29%), Positives = 107/239 (44%), Gaps = 33/239 (13%)
Query: 254 AEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKD-LSCYMRETFGSRRRNSFSLP 312
E S M L HP IV+ L G C E LVMEL L Y+++ R +
Sbjct: 45 REASVMAQLDHPCIVR-LIGVCKGEP--LMLVMELAPLGPLLKYLKK------RREIPVS 95
Query: 313 VVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASR 372
+ ++ Q+A GM +L ++ H +L N+ L R K+S FG+S A S
Sbjct: 96 DLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRH-----QAKISDFGMSRALGAGSD 150
Query: 373 NTPPASPQNQTAPN-PYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GK 430
+ TA P WYAPE + K S K+DV+S+G+ +E + G
Sbjct: 151 YY-----RATTAGRWPLKWYAPE---------CINYGKFSSKSDVWSYGVTLWEAFSYGA 196
Query: 431 VPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILR 489
P+ G ++G ++ + +GER P P+ + ++ CW P RP+FS + R
Sbjct: 197 KPY--GEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFR 253
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 69/242 (28%), Positives = 113/242 (46%), Gaps = 30/242 (12%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELM-SKDLSCYMRETFGSRRR 306
E E E+ + L+HPNI++Y F EEK + +VME DLS +++ +
Sbjct: 42 EREDALNEVKILKKLNHPNIIKYYESF--EEKGKLCIVMEYADGGDLSQKIKKQKKEGK- 98
Query: 307 NSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366
F ++D +Q+ +++LH++KI H ++ P NI+L + VK+ FG+S
Sbjct: 99 -PFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSN-----GLVKLGDFGIS-- 150
Query: 367 RTYASRNTPPASPQNQTAPNPYIWY-APEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFE 425
+ +S A T PY Y +PE+ + + K+D++S G + +E
Sbjct: 151 KVLSS-TVDLAKTVVGT---PY--YLSPELCQNK---------PYNYKSDIWSLGCVLYE 195
Query: 426 LLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSIC 485
L T K PFE +L + I G+ P PS L NL +P +RPS + I
Sbjct: 196 LCTLKHPFEGENLLE--LALKILKGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQIL 253
Query: 486 RI 487
+
Sbjct: 254 QS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 72/238 (30%), Positives = 111/238 (46%), Gaps = 36/238 (15%)
Query: 247 GELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRR 305
++ AE S M +L HPN+VQ L G + ++V E M+K L Y+R SR
Sbjct: 42 TAAQAFLAEASVMTTLRHPNLVQ-LLGVV-LQGNPLYIVTEYMAKGSLVDYLR----SRG 95
Query: 306 RNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365
R +L + L + GME+L + H +L N+ + + KVS FGL+
Sbjct: 96 RAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLV-----AKVSDFGLAK 150
Query: 366 ARTYASRNTPPASPQNQTAPN-PYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCF 424
+ Q Q + P W APE L E K S K+DV+SFG+L +
Sbjct: 151 E-----------ASQGQDSGKLPVKWTAPEALRE---------KKFSTKSDVWSFGILLW 190
Query: 425 ELLT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSF 481
E+ + G+VP+ L+ + ++ G R P G P + + K CW +P++RP+F
Sbjct: 191 EIYSFGRVPYPRIPLK--DVVPHVEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTF 246
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 65/240 (27%), Positives = 105/240 (43%), Gaps = 42/240 (17%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMS----KDLSCYMRETFGS 303
+ E + EI + HPNIV+Y + +K E ++VME S KDL ++ T +
Sbjct: 40 KKEKIINEIQILKKCKHPNIVKYYGSY--LKKDELWIVMEFCSGGSLKDL---LKSTNQT 94
Query: 304 RRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGL 363
+ + + ++ +G+E+LH+ I H ++ +NI L + +G VK+ FGL
Sbjct: 95 -----LTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILL---TSDG--EVKLIDFGL 144
Query: 364 STARTYA-SRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGML 422
S + +RNT +P W APEV+ + KAD++S G+
Sbjct: 145 SAQLSDTKARNTMVGTPY---------WMAPEVINGKP---------YDYKADIWSLGIT 186
Query: 423 CFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGS--PKYLVNLTKKCWHTNPSQRPS 480
EL GK P+ + L K I P + + KKC NP +RP+
Sbjct: 187 AIELAEGKPPYSE--LPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPT 244
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 82/246 (33%), Positives = 115/246 (46%), Gaps = 44/246 (17%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRR 306
E+E E + M + HPN+VQ L G C E F+++ E M+ +L Y+RE
Sbjct: 45 EVEEFLKEAAVMKEIKHPNLVQ-LLGVCTREPP-FYIITEFMTYGNLLDYLREC------ 96
Query: 307 NSFSLPVVVDIML--QIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS 364
N + VV + + QI+ ME+L + H +L N + + VKV+ FGLS
Sbjct: 97 NRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL-----VKVADFGLS 151
Query: 365 ---TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGM 421
T TY T A A P W APE LA +K S K+DV++FG+
Sbjct: 152 RLMTGDTY----TAHAG-----AKFPIKWTAPESLA---------YNKFSIKSDVWAFGV 193
Query: 422 LCFELLT-GKVPFEDGHLQG--DKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQR 478
L +E+ T G P+ L + + K R ERP G P + L + CW NPS R
Sbjct: 194 LLWEIATYGMSPYPGIDLSQVYELLEKGYRM-ERP---EGCPPKVYELMRACWQWNPSDR 249
Query: 479 PSFSSI 484
PSF+ I
Sbjct: 250 PSFAEI 255
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 70/236 (29%), Positives = 109/236 (46%), Gaps = 31/236 (13%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKD-LSCYMRETFGSRRRNSFSLPV 313
E M+ LSHPN+VQ L G C +++ F+V E M+ L Y+RE R+
Sbjct: 49 EAKVMMKLSHPNLVQ-LYGVC-TKQRPIFIVTEYMANGCLLNYLRE-----RKGKLGTEW 101
Query: 314 VVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRN 373
++D+ + ME+L + H +L N + VKVS FGL+ Y +
Sbjct: 102 LLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGED-----NVVKVSDFGLAR---YVLDD 153
Query: 374 TPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVP 432
+S Q P W PEV S+ S K+DV+SFG+L +E+ + GK+P
Sbjct: 154 QYTSS---QGTKFPVKWAPPEVF---------DYSRFSSKSDVWSFGVLMWEVFSEGKMP 201
Query: 433 FEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRIL 488
+E ++ +++ AG R P +P + + CWH P RP+F + L
Sbjct: 202 YER--FSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 4e-24
Identities = 64/244 (26%), Positives = 106/244 (43%), Gaps = 40/244 (16%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRR- 306
L+S+ EI + +L HPNIV+Y+ G E ++++E GS R+
Sbjct: 42 ALKSIMQEIDLLKNLKHPNIVKYI-GSI-ETSDSLYIILEYAE----------NGSLRQI 89
Query: 307 ----NSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFG 362
F +V + Q+ +G+ +LH Q + H ++ +NI +G VK++ FG
Sbjct: 90 IKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTK---DG--VVKLADFG 144
Query: 363 LSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGML 422
++T S++ PY W APEV+ E G S +D++S G
Sbjct: 145 VATKLNDVSKDD------ASVVGTPY-WMAPEVI-EMSG--------ASTASDIWSLGCT 188
Query: 423 CFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFS 482
ELLTG P+ D L I + P P G L + +C+ +P+ RP+
Sbjct: 189 VIELLTGNPPYYD--LNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAK 246
Query: 483 SICR 486
+ +
Sbjct: 247 QLLK 250
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 77/239 (32%), Positives = 108/239 (45%), Gaps = 35/239 (14%)
Query: 259 MLSLSHPNIVQYLCGFC-DEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDI 317
M SHPN++ L G C E ++ + DL ++R S N P V D+
Sbjct: 50 MKDFSHPNVLS-LLGICLPSEGSPLVVLPYMKHGDLRNFIR----SETHN----PTVKDL 100
Query: 318 M---LQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNT 374
+ LQ+A+GME+L ++K H +L N L F VKV+ FGL AR +
Sbjct: 101 IGFGLQVAKGMEYLASKKFVHRDLAARNCMLDES-----FTVKVADFGL--ARDIYDKEY 153
Query: 375 PPASPQNQTAPN-PYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVP 432
S N T P W A E S T K + K+DV+SFG+L +EL+T G P
Sbjct: 154 --YSVHNHTGAKLPVKWMALE---------SLQTQKFTTKSDVWSFGVLLWELMTRGAPP 202
Query: 433 FEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYI 491
+ D + +T + G R L P P L + CWH P RP+FS + + I
Sbjct: 203 YPD--VDSFDITVYLLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 8e-24
Identities = 66/240 (27%), Positives = 103/240 (42%), Gaps = 41/240 (17%)
Query: 249 LESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRN 307
+ E+ + L H +++ L C + +++ ELM K L ++R G
Sbjct: 46 QQDFQKEVQALKRLRHKHLIS-LFAVCSVGEP-VYIITELMEKGSLLAFLRSPEG----Q 99
Query: 308 SFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTAR 367
+ ++D+ Q+A GM +L Q H +L NI + E KV+ FGL AR
Sbjct: 100 VLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVG----EDLV-CKVADFGL--AR 152
Query: 368 -----TYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGML 422
Y S + PY W APE + S K+DV+SFG+L
Sbjct: 153 LIKEDVYLSSDKKI----------PYKWTAPEAASHG---------TFSTKSDVWSFGIL 193
Query: 423 CFELLT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSF 481
+E+ T G+VP+ G + + I AG R P+ P+ + + +CW P RPSF
Sbjct: 194 LYEMFTYGQVPYP-GMNNHEVYDQ-ITAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSF 251
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 4e-23
Identities = 80/283 (28%), Positives = 131/283 (46%), Gaps = 48/283 (16%)
Query: 216 KKLMVRRRLGASSQFKEI---QWLGDSFV----LRHFYGELESLNAEISTMLSLSHPNIV 268
+ + R+LGA QF E+ W + V L+ + + AE M L HP ++
Sbjct: 6 TSIQLLRKLGAG-QFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLI 64
Query: 269 QYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEF 327
Q L C E+ ++V ELM L Y++ G + LP ++D+ Q+A GM +
Sbjct: 65 Q-LYAVCTLEEP-IYIVTELMKYGSLLEYLQGGAGR----ALKLPQLIDMAAQVASGMAY 118
Query: 328 LHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTART-----YASRNTPPASPQNQ 382
L AQ H +L N+ + ++ KV+ FGL AR Y +R +
Sbjct: 119 LEAQNYIHRDLAARNVLVGENNI-----CKVADFGL--ARVIKEDIYEAR---------E 162
Query: 383 TAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGD 441
A P W APE + ++ S K+DV+SFG+L E++T G++P+ +
Sbjct: 163 GAKFPIKWTAPE---------AALYNRFSIKSDVWSFGILLTEIVTYGRMPYPG--MTNA 211
Query: 442 KMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSI 484
++ + + G R P G PK L ++ CW +P RP+F ++
Sbjct: 212 EVLQQVDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETL 254
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.7 bits (247), Expect = 5e-23
Identities = 60/236 (25%), Positives = 102/236 (43%), Gaps = 37/236 (15%)
Query: 246 YGELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSR 304
E+E E + + ++HP IV+ F EEK +LV+E +L ++
Sbjct: 34 RKEVEHTLTERNILSRINHPFIVKLHYAFQTEEK--LYLVLEYAPGGELFSHLS------ 85
Query: 305 RRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS 364
+ FS +I +E+LH+ I + +L P NI L A +G H+K++ FGL+
Sbjct: 86 KEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDA---DG--HIKLTDFGLA 140
Query: 365 T--ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGML 422
+ + NT +P+ Y+ APEVL + + D +S G+L
Sbjct: 141 KELSSEGSRTNTFCGTPE-------YL--APEVLLGKG---------YGKAVDWWSLGVL 182
Query: 423 CFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQR 478
+E+LTGK PF + ++ + I FP +L +P++R
Sbjct: 183 LYEMLTGKPPFYAEDRK--EIYEKILKDP-LRFPEFLSPEARDLISGLLQKDPTKR 235
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 8e-23
Identities = 64/238 (26%), Positives = 102/238 (42%), Gaps = 40/238 (16%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMR---ETFGSRRRNSFSL 311
E + M SL H N+++ L G +V EL + + F +
Sbjct: 46 EAAIMHSLDHENLIR-LYGVVLTHP--LMMVTEL------APLGSLLDRLRKDALGHFLI 96
Query: 312 PVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYAS 371
+ D +QIA GM +L +++ H +L NI L + VK+ FGL
Sbjct: 97 STLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDK-----VKIGDFGLM------- 144
Query: 372 RNTPPASPQNQTAPN---PYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT 428
R P + P+ W APE L T S +DV+ FG+ +E+ T
Sbjct: 145 RALPQNEDHYVMEEHLKVPFAWCAPESL---------RTRTFSHASDVWMFGVTLWEMFT 195
Query: 429 -GKVPFEDGHLQGDKMTKNI-RAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSI 484
G+ P+ L G ++ K I + GER P P+ + N+ +CW NP+ RP+F+++
Sbjct: 196 YGEEPWA--GLSGSQILKKIDKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAAL 251
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.6 bits (244), Expect = 2e-22
Identities = 58/182 (31%), Positives = 88/182 (48%), Gaps = 33/182 (18%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVV 314
EIS + L HPNIV+ L E K +LV E DL Y+ +R S ++
Sbjct: 48 EISLLKELKHPNIVKLLDVIHTERK--LYLVFEYCDMDLKKYLD-----KRPGPLSPNLI 100
Query: 315 VDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNT 374
IM Q+ RG+ + H+ +I H +L P NI + + +G +K++ FGL+ A R
Sbjct: 101 KSIMYQLLRGLAYCHSHRILHRDLKPQNILI---NRDGV--LKLADFGLARAFGIPLR-- 153
Query: 375 PPASPQNQTAPNPYIWY-APEVLAEQEGTGST--STSKCSEKADVYSFGMLCFELLTGKV 431
+ + T +WY APE+L GS ST+ D++S G + E++TGK
Sbjct: 154 -TYTHEVVT-----LWYRAPEIL-----LGSKHYSTA-----VDIWSVGCIFAEMITGKP 197
Query: 432 PF 433
F
Sbjct: 198 LF 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 4e-22
Identities = 61/246 (24%), Positives = 102/246 (41%), Gaps = 43/246 (17%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCY--MRETFGSRR 305
++ L E+ M +HPN+V+Y F E +LVM +S S M+ ++
Sbjct: 42 SVDELRKEVQAMSQCNHPNVVKYYTSFV--VGDELWLVMPYLSGG-SLLDIMKSSY---P 95
Query: 306 RNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS- 364
R ++ ++ ++ +G+E+LH+ H ++ NI L VK++ FG+S
Sbjct: 96 RGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDG-----SVKIADFGVSA 150
Query: 365 -----TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSF 419
RT R T +P W APEV+ + G KAD++SF
Sbjct: 151 SLADGGDRTRKVRKTFVGTP---------CWMAPEVMEQVHGYD--------FKADIWSF 193
Query: 420 GMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSP-----KYLVNLTKKCWHTN 474
G+ EL TG P+ K+ + P +G+ K + C +
Sbjct: 194 GITAIELATGAAPYS--KYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKD 251
Query: 475 PSQRPS 480
PS+RP+
Sbjct: 252 PSKRPT 257
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 98.7 bits (244), Expect = 6e-22
Identities = 67/246 (27%), Positives = 102/246 (41%), Gaps = 30/246 (12%)
Query: 248 ELESLNAEISTMLSLSHP-NIVQYLCGFCDEEKKEFFLVMELMS-KDLSCYMRETFGSRR 305
E+E EI + SL+HP NIV+ F +++ +LVME + L +++ R
Sbjct: 40 EVERFLREIQILASLNHPPNIVKLYDFF--QDEGSLYLVMEYVDGGSLEDLLKK---IGR 94
Query: 306 RNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365
+ S + I+ QI +E+LH++ I H ++ P NI L VK+ FGL
Sbjct: 95 KGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRV----VKLIDFGL-- 148
Query: 366 ARTYASRNTPPASPQNQTAPNPYIWY-APEVLAEQEGTGSTSTSKCSEKADVYSFGMLCF 424
A+ + + P + Y APEVL S + S +D++S G+ +
Sbjct: 149 AKLLPDPGSTSSIPALPSTSVGTPGYMAPEVL------LGLSLAYASSSSDIWSLGITLY 202
Query: 425 ELLTGKVPF--EDGHLQGDKMTKNIRAGERPLFPSGSPKY--------LVNLTKKCWHTN 474
ELLTG PF E + K I P S +L KK +
Sbjct: 203 ELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKD 262
Query: 475 PSQRPS 480
P R S
Sbjct: 263 PKNRLS 268
|
Length = 384 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 95.3 bits (238), Expect = 1e-21
Identities = 57/250 (22%), Positives = 102/250 (40%), Gaps = 46/250 (18%)
Query: 258 TMLSLS-HPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFSLPVVV 315
+ L+ HP I++ F DEE + V+E +L Y+R + S
Sbjct: 54 VLTRLNGHPGIIKLYYTFQDEEN--LYFVLEYAPNGELLQYIR------KYGSLDEKCTR 105
Query: 316 DIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTP 375
+I +E+LH++ I H +L P NI L H+K++ FG TA+ ++P
Sbjct: 106 FYAAEILLALEYLHSKGIIHRDLKPENILLDKD-----MHIKITDFG--TAKVLDPNSSP 158
Query: 376 PASPQNQTAPNPYIWY---------------APEVLAEQEGTGSTSTSKCSEKADVYSFG 420
++ + T + I +PE+L E+ + +D+++ G
Sbjct: 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEK---------PAGKSSDLWALG 209
Query: 421 MLCFELLTGKVPFEDGHLQGDKMT-KNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRP 479
+ +++LTGK PF + +T + I E FP P +L +K +P R
Sbjct: 210 CIIYQMLTGKPPFRGS---NEYLTFQKILKLE-YSFPPNFPPDAKDLIEKLLVLDPQDRL 265
Query: 480 SFSSICRILR 489
+ L+
Sbjct: 266 GVNEGYDELK 275
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 2e-21
Identities = 74/263 (28%), Positives = 111/263 (42%), Gaps = 57/263 (21%)
Query: 250 ESLNAEISTMLSLSHPNIVQYLCGFCDEE-KKEFFLVMELMSKDLSCYMRETFGSRR--- 305
EI+ + +L H NIV+Y G C E+ K L+ME + GS R
Sbjct: 51 SGWKKEINILKTLYHENIVKYK-GCCSEQGGKGLQLIMEYVP----------LGSLRDYL 99
Query: 306 -RNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS 364
++ +L ++ QI GM +LH+Q H +L N+ L + VK+ FGL+
Sbjct: 100 PKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRL-----VKIGDFGLA 154
Query: 365 TA-----RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSF 419
A Y R + +P WYA E L E +K S +DV+SF
Sbjct: 155 KAVPEGHEYYRVR---------EDGDSPVFWYAVECLKE---------NKFSYASDVWSF 196
Query: 420 GMLCFELLTGKVP-------FED------GHLQGDKMTKNIRAGERPLFPSGSPKYLVNL 466
G+ +ELLT FE+ G + ++ + + G R P P+ + L
Sbjct: 197 GVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYIL 256
Query: 467 TKKCWHTNPSQRPSFSSICRILR 489
K CW T RP+F S+ IL+
Sbjct: 257 MKNCWETEAKFRPTFRSLIPILK 279
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 3e-21
Identities = 72/238 (30%), Positives = 108/238 (45%), Gaps = 30/238 (12%)
Query: 253 NAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMS-KDLSCYMRETFGSRRRNS--- 308
E+ LSH N+V+ L G C E + ++++E DL ++R T +
Sbjct: 56 RRELDMFRKLSHKNVVR-LLGLC-REAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPP 113
Query: 309 FSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTART 368
S V + QIA GM+ L + H +L N + ++ VKVS LS
Sbjct: 114 LSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQ-----REVKVSLLSLSKD-V 167
Query: 369 YASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT 428
Y S +N P W APE + E + S K+DV+SFG+L +E+ T
Sbjct: 168 YNSEYYKL---RNALIP--LRWLAPEAVQEDD---------FSTKSDVWSFGVLMWEVFT 213
Query: 429 -GKVPFEDGHLQGDKMTKNIRAGERPL-FPSGSPKYLVNLTKKCWHTNPSQRPSFSSI 484
G++PF L +++ ++AG+ L P G P L L +CW NP RPSFS +
Sbjct: 214 QGELPFYG--LSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSEL 269
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.5 bits (236), Expect = 3e-21
Identities = 50/180 (27%), Positives = 80/180 (44%), Gaps = 26/180 (14%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVV 314
EI + L HPNIV+ + K ++V E M DL+ + F+ +
Sbjct: 48 EIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLD-----SPEVKFTESQI 102
Query: 315 VDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNT 374
M Q+ G+++LH+ I H ++ SNI + +K++ FGL AR Y RN+
Sbjct: 103 KCYMKQLLEGLQYLHSNGILHRDIKGSNILINND-----GVLKLADFGL--ARPYTKRNS 155
Query: 375 PPASPQNQTAPNPYIWY-APEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPF 433
+ + T +WY PE+L G+T + D++S G + EL GK F
Sbjct: 156 ADYTNRVIT-----LWYRPPELL-----LGATRY---GPEVDMWSVGCILAELFLGKPIF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 4e-21
Identities = 61/252 (24%), Positives = 101/252 (40%), Gaps = 49/252 (19%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRR 306
E + L +E++ + L HPNIV+Y D + ++VME DL+ +++ + R
Sbjct: 42 EKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKC--KKER 99
Query: 307 NSFSLPVVVDIMLQIARGMEFLH-----AQKIYHGELNPSNIYLKARSMEGYFHVKVSGF 361
+ I+ Q+ + H + H +L P+NI+L A + +VK+ F
Sbjct: 100 KYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANN-----NVKLGDF 154
Query: 362 GLS--------TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEK 413
GL+ A+TY PY +PE L EK
Sbjct: 155 GLAKILGHDSSFAKTYVG--------------TPYYM-SPEQLNHM---------SYDEK 190
Query: 414 ADVYSFGMLCFELLTGKVPFE-DGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWH 472
+D++S G L +EL PF LQ + I+ G+ P L + K +
Sbjct: 191 SDIWSLGCLIYELCALSPPFTARNQLQ---LASKIKEGKFRRIPYRYSSELNEVIKSMLN 247
Query: 473 TNPSQRPSFSSI 484
+P +RPS +
Sbjct: 248 VDPDKRPSTEEL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 5e-21
Identities = 69/230 (30%), Positives = 109/230 (47%), Gaps = 35/230 (15%)
Query: 254 AEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFSLP 312
E + M L H N+V+ L ++VMELMSK +L ++R +R R S+
Sbjct: 48 EETAVMTKLHHKNLVRLLGVIL---HNGLYIVMELMSKGNLVNFLR----TRGRALVSVI 100
Query: 313 VVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASR 372
++ L +A GME+L ++K+ H +L NI + + KVS FGL+ +
Sbjct: 101 QLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGV-----AKVSDFGLARVGSMGVD 155
Query: 373 NTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKV 431
N+ P W APE L + K S K+DV+S+G+L +E+ + G+
Sbjct: 156 NSKL----------PVKWTAPEALKHK---------KFSSKSDVWSYGVLLWEVFSYGRA 196
Query: 432 PFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSF 481
P+ L+ ++ + + G R P G P + L CW T P +RPSF
Sbjct: 197 PYPKMSLK--EVKECVEKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSF 244
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 8e-21
Identities = 70/242 (28%), Positives = 119/242 (49%), Gaps = 31/242 (12%)
Query: 250 ESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMS-KDLSCYMRETFGSRRRNS 308
+ L E + M L +P IV+ + G C+ E + LVMEL L+ ++++ +N
Sbjct: 41 DELLREANVMQQLDNPYIVRMI-GICEAES--WMLVMELAELGPLNKFLQKNKHVTEKN- 96
Query: 309 FSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTART 368
+ +++ Q++ GM++L H +L N+ L + + K+S FGLS A
Sbjct: 97 -----ITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQH-----YAKISDFGLSKALG 146
Query: 369 YASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT 428
A N A + P WYAPE + + K S K+DV+SFG+L +E +
Sbjct: 147 -ADENYYKAKTHGKW---PVKWYAPECM---------NYYKFSSKSDVWSFGVLMWEAFS 193
Query: 429 -GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRI 487
G+ P++ ++G+++T+ I +GER P P + +L K CW +RP F+ +
Sbjct: 194 YGQKPYKG--MKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELR 251
Query: 488 LR 489
LR
Sbjct: 252 LR 253
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 1e-20
Identities = 71/237 (29%), Positives = 111/237 (46%), Gaps = 33/237 (13%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKD-LSCYMRETFGSRRRNSFSLPV 313
E M+ LSHP +VQ L G C ++K ++V E M L Y+R+ R+ S +
Sbjct: 49 EAKVMMKLSHPKLVQ-LYGVCTQQKP-LYIVTEFMENGCLLNYLRQ-----RQGKLSKDM 101
Query: 314 VVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRN 373
++ + + GME+L H +L N + + + VKVS FG++ Y +
Sbjct: 102 LLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGV-----VKVSDFGMTR---YVLDD 153
Query: 374 TPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVP 432
+S A P W PEV + SK S K+DV+SFG+L +E+ T GK+P
Sbjct: 154 EYTSS---SGAKFPVKWSPPEVF---------NFSKYSSKSDVWSFGVLMWEVFTEGKMP 201
Query: 433 FED-GHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRIL 488
FE + + +M I G R P + + + CWH P RP+F+ + R +
Sbjct: 202 FEKKSNYEVVEM---ISRGFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 3e-20
Identities = 79/263 (30%), Positives = 115/263 (43%), Gaps = 41/263 (15%)
Query: 235 WLGDSFV----LRHFYGELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMS 290
WL V +R E E M+ LSHP +VQ L G C E+ LV E M
Sbjct: 25 WLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQ-LYGVC-TERSPICLVFEFME 82
Query: 291 KD-LSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARS 349
LS Y+R +R FS ++ + L + GM +L + + H +L N +
Sbjct: 83 HGCLSDYLRA-----QRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQ 137
Query: 350 MEGYFHVKVSGFGLST---ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTS 406
+ VKVS FG++ Y S + P W +PEV S
Sbjct: 138 V-----VKVSDFGMTRFVLDDQYTS---------STGTKFPVKWSSPEVF---------S 174
Query: 407 TSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVN 465
SK S K+DV+SFG+L +E+ + GK P+E+ ++ + I AG R P + + +
Sbjct: 175 FSKYSSKSDVWSFGVLMWEVFSEGKTPYEN--RSNSEVVETINAGFRLYKPRLASQSVYE 232
Query: 466 LTKKCWHTNPSQRPSFSSICRIL 488
L + CW P RPSFS + L
Sbjct: 233 LMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 6e-20
Identities = 67/275 (24%), Positives = 110/275 (40%), Gaps = 68/275 (24%)
Query: 241 VLRHFYGELESLNA--EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMR 298
+ F E A EI + L+HPNI++ L F K + +LV E M DL ++
Sbjct: 32 IKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVF--RHKGDLYLVFEFMDTDLYKLIK 89
Query: 299 ETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKV 358
R+ ++ + Q+ +G+ F H+ I H +L P N+ + + +K+
Sbjct: 90 -----DRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGV-----LKL 139
Query: 359 SGFGLSTARTYASRNTPPASPQNQTAPNPYI---WY-APEVLAEQEGTGSTSTSKCSEKA 414
+ FGL AR++ S P Y+ WY APE+L +G
Sbjct: 140 ADFGL--ARSFGSPVRP---------YTHYVVTRWYRAPELLLGDKGYS--------TPV 180
Query: 415 DVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERP--------------------- 453
D++S G + ELL+ P G + D++ K R P
Sbjct: 181 DIWSVGCIFAELLSR-RPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPK 239
Query: 454 --------LFPSGSPKYLVNLTKKCWHTNPSQRPS 480
LFP+ SP+ L +L + H +P +R +
Sbjct: 240 KAGMPLPKLFPNASPQAL-DLLSQMLHYDPHKRIT 273
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 6e-20
Identities = 78/260 (30%), Positives = 112/260 (43%), Gaps = 54/260 (20%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFC-DEEKKEFFLVME-LMSKDLSCYMRETFGSRR 305
L EI + SL H NIV+Y G C ++ LVME L L Y+ +
Sbjct: 48 HLRDFEREIEILKSLQHDNIVKYK-GVCYSAGRRNLRLVMEYLPYGSLRDYL-----QKH 101
Query: 306 RNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365
R ++ QI +GME+L +++ H +L NI + E VK+ FGL+
Sbjct: 102 RERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILV-----ESENRVKIGDFGLTK 156
Query: 366 ARTYASRNTPPASPQN-------QTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYS 418
PQ+ + +P WYAPE L E SK S +DV+S
Sbjct: 157 VL-----------PQDKEYYKVREPGESPIFWYAPESLTE---------SKFSVASDVWS 196
Query: 419 FGMLCFELLT-----GKVPFEDGHLQG-DKMTKNI--------RAGERPLFPSGSPKYLV 464
FG++ +EL T P E + G DK + I + R P G P +
Sbjct: 197 FGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIY 256
Query: 465 NLTKKCWHTNPSQRPSFSSI 484
+ K+CW+ +PSQRPSFS +
Sbjct: 257 AIMKECWNNDPSQRPSFSEL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 8e-20
Identities = 62/243 (25%), Positives = 95/243 (39%), Gaps = 58/243 (23%)
Query: 199 GSVVLTKNEQRLVDMLLKKLMVRRRLGASSQFKEIQWLGDSFVLRHFYGELESLNAEIST 258
G V K+ + + LKK+ +RR G + + LR EI
Sbjct: 14 GIVFKAKDRETGETVALKKVALRRLEG---------GIPNQ-ALR-----------EIKA 52
Query: 259 MLSLSHPNIVQ----YLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVV 314
+ + HP +V+ + G F LVME M DLS +R+ V
Sbjct: 53 LQACQHPYVVKLLDVFPHGSG------FVLVMEYMPSDLSEVLRD-----EERPLPEAQV 101
Query: 315 VDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNT 374
M + +G+ ++HA I H +L P+N+ + A +K++ FGL AR ++
Sbjct: 102 KSYMRMLLKGVAYMHANGIMHRDLKPANLLISADG-----VLKIADFGL--ARLFSEEEP 154
Query: 375 PPASPQNQTAPNPYIWY-APEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPF 433
S Q T WY APE+L K D+++ G + ELL G P
Sbjct: 155 RLYSHQVATR-----WYRAPELLYGAR--------KYDPGVDLWAVGCIFAELLNG-SPL 200
Query: 434 EDG 436
G
Sbjct: 201 FPG 203
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 8e-20
Identities = 64/237 (27%), Positives = 102/237 (43%), Gaps = 31/237 (13%)
Query: 249 LESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMS-KDLSCYMRETFGSRRRN 307
+++N EI + S++HPNI+ Y F D K +VME DLS + + ++R
Sbjct: 44 EDAVN-EIRILASVNHPNIISYKEAFLDGNK--LCIVMEYAPFGDLSKAISK--RKKKRK 98
Query: 308 SFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTAR 367
+ I +Q+ RG++ LH QKI H +L +NI L + VK+ G+S
Sbjct: 99 LIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILL----VANDL-VKIGDLGISKVL 153
Query: 368 TYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELL 427
T +P + APEV + S K+D++S G L +E+
Sbjct: 154 KKNMAKTQIGTP---------HYMAPEVWKGR---------PYSYKSDIWSLGCLLYEMA 195
Query: 428 TGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSI 484
T PFE +Q + ++ G+ P P + L N + P RP+ I
Sbjct: 196 TFAPPFEARSMQ--DLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 1e-19
Identities = 73/259 (28%), Positives = 119/259 (45%), Gaps = 54/259 (20%)
Query: 248 ELESLNAEISTMLSL-SHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRR 305
+L L +E+ M + H NI+ L G C +E ++V+E + +L ++R +RR
Sbjct: 58 DLSDLVSEMEMMKMIGKHKNIIN-LLGVCTQEGP-LYVVVEYAAHGNLRDFLR----ARR 111
Query: 306 ----RNSFSLPVV-------VDIM---LQIARGMEFLHAQKIYHGELNPSNIYLKARSME 351
S P D++ Q+ARGMEFL ++K H +L N+ + E
Sbjct: 112 PPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT----E 167
Query: 352 GYFHVKVSGFGLSTAR-----TYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTS 406
+ +K++ FGL AR Y + T P W APE L ++ T +
Sbjct: 168 DHV-MKIADFGL--ARDIHHIDYYRKTT--------NGRLPVKWMAPEALFDRVYTHQS- 215
Query: 407 TSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVN 465
DV+SFG+L +E+ T G P+ ++ ++ K ++ G R P + L +
Sbjct: 216 --------DVWSFGVLLWEIFTLGGSPYPGIPVE--ELFKLLKEGYRMEKPQNCTQELYH 265
Query: 466 LTKKCWHTNPSQRPSFSSI 484
L + CWH PSQRP+F +
Sbjct: 266 LMRDCWHEVPSQRPTFKQL 284
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 70/238 (29%), Positives = 108/238 (45%), Gaps = 47/238 (19%)
Query: 252 LNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFS 310
L EI+ + L HPNIVQYL +E+ FL EL+ L+ +++ +G SF
Sbjct: 49 LEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL--ELVPGGSLAKLLKK-YG-----SFP 100
Query: 311 LPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS------ 364
PV+ QI G+E+LH + H ++ +NI + + VK++ FG++
Sbjct: 101 EPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGV-----VKLADFGMAKQVVEF 155
Query: 365 -TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLC 423
A+++ +PY W APEV+A+Q G G AD++S G
Sbjct: 156 SFAKSFKG--------------SPY-WMAPEVIAQQGGYGL--------AADIWSLGCTV 192
Query: 424 FELLTGKVPFEDGHLQGDKMTKNI-RAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPS 480
E+ TGK P+ L+G I R+ E P P + KC +PS RP+
Sbjct: 193 LEMATGKPPW--SQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPT 248
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 3e-19
Identities = 68/246 (27%), Positives = 104/246 (42%), Gaps = 30/246 (12%)
Query: 249 LESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRN 307
+E LN E S M + ++V+ L G + +VMELM+K DL Y+R N
Sbjct: 54 IEFLN-EASVMKEFNCHHVVRLL-GVVSTGQPTL-VVMELMAKGDLKSYLRSRRPEAENN 110
Query: 308 SFSLPVVVDIML----QIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGL 363
P + + +IA GM +L A+K H +L N + VK+ FG+
Sbjct: 111 PGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVA-----EDLTVKIGDFGM 165
Query: 364 STARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLC 423
T Y + P W APE S + K+DV+SFG++
Sbjct: 166 -TRDIYETDYYRKGG----KGLLPVRWMAPE---------SLKDGVFTTKSDVWSFGVVL 211
Query: 424 FELLT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFS 482
+E+ T + P++ L +++ K + G P P L+ L + CW NP RP+F
Sbjct: 212 WEMATLAEQPYQG--LSNEEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFL 269
Query: 483 SICRIL 488
I L
Sbjct: 270 EIVSSL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 3e-19
Identities = 66/236 (27%), Positives = 108/236 (45%), Gaps = 32/236 (13%)
Query: 249 LESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNS 308
L++L EI+ + L H NIVQYL D + FL E + + +G +
Sbjct: 50 LDALAREIALLKELQHENIVQYLGSSLDADHLNIFL--EYVPGGSVAALLNNYG-----A 102
Query: 309 FSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTART 368
F +V + + QI +G+ +LH + I H ++ +NI + + +K+S FG+S
Sbjct: 103 FEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKG-----GIKISDFGISKKLE 157
Query: 369 YASRNTP--PASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFEL 426
S +T A P Q + W APEV+ + T KAD++S G L E+
Sbjct: 158 ANSLSTKTNGARPSLQGS---VFWMAPEVVKQTSYT---------RKADIWSLGCLVVEM 205
Query: 427 LTGKVPFEDGHLQGDKMTKNIRAGE--RPLFPSGSPKYLVNLTKKCWHTNPSQRPS 480
LTGK PF D ++ + GE P PS ++ +K + + ++RP+
Sbjct: 206 LTGKHPFPD----CTQLQAIFKIGENASPEIPSNISSEAIDFLEKTFEIDHNKRPT 257
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 5e-19
Identities = 74/286 (25%), Positives = 130/286 (45%), Gaps = 51/286 (17%)
Query: 218 LMVRRRLGASSQFKEIQWLGDSFVLRHFYGELESLN----------AEISTMLSLSHPNI 267
L + ++LGA QF E+ W+G + H ++SL AE + M L HP +
Sbjct: 8 LKLVKKLGAG-QFGEV-WMG--YYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRL 63
Query: 268 VQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGME 326
V+ + ++ +++ E M L +++ G + ++ ++D+ QIA GM
Sbjct: 64 VRL---YAVVTQEPIYIITEYMENGSLVDFLKTPEGIK----LTINKLIDMAAQIAEGMA 116
Query: 327 FLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS---TARTYASRNTPPASPQNQT 383
F+ + H +L +NI + K++ FGL+ Y +R +
Sbjct: 117 FIERKNYIHRDLRAANILVSET-----LCCKIADFGLARLIEDNEYTAR---------EG 162
Query: 384 APNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGDK 442
A P W APE A GT + K+DV+SFG+L E++T G++P+ + +
Sbjct: 163 AKFPIKWTAPE--AINYGTFTI-------KSDVWSFGILLTEIVTYGRIPYPG--MTNPE 211
Query: 443 MTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRIL 488
+ +N+ G R P P+ L L + CW P +RP+F + +L
Sbjct: 212 VIQNLERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVL 257
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 8e-19
Identities = 61/242 (25%), Positives = 105/242 (43%), Gaps = 39/242 (16%)
Query: 247 GELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELM-SKDLSCYMRETFGSRR 305
G + ++ E + L+HP +V F DEE +LV++L+ DL + +
Sbjct: 42 GSVRNVLNERRILQELNHPFLVNLWYSFQDEEN--MYLVVDLLLGGDLR------YHLSQ 93
Query: 306 RNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365
+ FS V + +I +E+LH++ I H ++ P NI L + HV ++ F ++T
Sbjct: 94 KVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQG-----HVHITDFNIAT 148
Query: 366 ARTYASRNTPPA-SPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCF 424
T + T + +P Y+ APEVL Q S D +S G+ +
Sbjct: 149 KVTPDTLTTSTSGTP-------GYM--APEVLCRQ---------GYSVAVDWWSLGVTAY 190
Query: 425 ELLTGKVPFEDGHLQGDKMTKNIRAGE---RPLFPSGSPKYLVNLTKKCWHTNPSQRPSF 481
E L GK P+ GH + + IRA + L+P+ ++ K +P +R
Sbjct: 191 ECLRGKRPYR-GHSR--TIRDQIRAKQETADVLYPATWSTEAIDAINKLLERDPQKRLGD 247
Query: 482 SS 483
+
Sbjct: 248 NL 249
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 9e-19
Identities = 64/232 (27%), Positives = 106/232 (45%), Gaps = 31/232 (13%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKD-LSCYMRETFGSRRRNSFSLPV 313
E M+ LSH +VQ L G C +++ ++V E MS L Y+RE F
Sbjct: 49 EAKVMMKLSHEKLVQ-LYGVCTKQRP-IYIVTEYMSNGCLLNYLREH-----GKRFQPSQ 101
Query: 314 VVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRN 373
++++ + GM +L +++ H +L N + + VKVS FGLS Y +
Sbjct: 102 LLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGC-----VKVSDFGLSR---YVLDD 153
Query: 374 TPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVP 432
+S + P W PEVL SK S K+DV++FG+L +E+ + GK+P
Sbjct: 154 EYTSS---VGSKFPVRWSPPEVLL---------YSKFSSKSDVWAFGVLMWEVYSLGKMP 201
Query: 433 FEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSI 484
+E + + + G R P + + + + CWH +RP+F +
Sbjct: 202 YE--RFNNSETVEKVSQGLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQL 251
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 1e-18
Identities = 74/247 (29%), Positives = 116/247 (46%), Gaps = 27/247 (10%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELM-SKDLSCYMR----ETFG 302
E + E M + +HPNIV+ L G C + ++ ++MELM DL Y+R E FG
Sbjct: 42 EKKEFLKEAHLMSNFNHPNIVKLL-GVCLLNEPQY-IIMELMEGGDLLSYLRDARVERFG 99
Query: 303 SRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFG 362
+L ++DI L +A+G +L H +L N + + + VK+ FG
Sbjct: 100 P---PLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFG 156
Query: 363 LSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGML 422
L AR + + P W APE L + K + ++DV+SFG+L
Sbjct: 157 L--ARDIYKSDYYRKEGEGLL---PVRWMAPESLLD---------GKFTTQSDVWSFGVL 202
Query: 423 CFELLT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSF 481
+E+LT G+ P+ L ++ +++ AG R P P + L CW +PS+RP+F
Sbjct: 203 MWEILTLGQQPYPA--LNNQEVLQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTF 260
Query: 482 SSICRIL 488
I IL
Sbjct: 261 DRIQEIL 267
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 1e-18
Identities = 64/247 (25%), Positives = 101/247 (40%), Gaps = 33/247 (13%)
Query: 250 ESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNS 308
+ + E + P +V+ F KK +LVME + DL+ + E GS
Sbjct: 38 DQVLTERDILSQAQSPYVVKLYYSFQG--KKNLYLVMEYLPGGDLASLL-ENVGS----- 89
Query: 309 FSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTART 368
V + +I +E+LH+ I H +L P NI + + G H+K++ FGLS
Sbjct: 90 LDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDS---NG--HLKLTDFGLSKVGL 144
Query: 369 YASRNTPPASPQ--NQTAPNP-YIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFE 425
+ + + P YI APEV+ Q SK D +S G + +E
Sbjct: 145 VRRQINLNDDEKEDKRIVGTPDYI--APEVILGQ------GHSKT---VDWWSLGCILYE 193
Query: 426 LLTGKVPFEDGHLQGDKMTKNIRAG--ERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSS 483
L G PF + ++ +NI G E P S + ++L K +P +R S
Sbjct: 194 FLVGIPPFHGETPE--EIFQNILNGKIEWPEDVEVSDEA-IDLISKLLVPDPEKRLGAKS 250
Query: 484 ICRILRY 490
I I +
Sbjct: 251 IEEIKNH 257
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 64/245 (26%), Positives = 105/245 (42%), Gaps = 32/245 (13%)
Query: 250 ESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNS 308
E E M HP+IV+ L G E ++VMEL +L Y++ + S
Sbjct: 52 EKFLQEAYIMRQFDHPHIVK-LIGVITENP--VWIVMELAPLGELRSYLQ-----VNKYS 103
Query: 309 FSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTART 368
L ++ Q++ + +L +++ H ++ N+ + + VK+ FGLS
Sbjct: 104 LDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDC-----VKLGDFGLSRYLE 158
Query: 369 YASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT 428
S AS P W APE S + + + +DV+ FG+ +E+L
Sbjct: 159 DESYYK--AS----KGKLPIKWMAPE---------SINFRRFTSASDVWMFGVCMWEILM 203
Query: 429 -GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRI 487
G PF+ ++ + + I GER P P L +L KCW +PS+RP F+ +
Sbjct: 204 LGVKPFQG--VKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ 261
Query: 488 LRYIK 492
L I
Sbjct: 262 LSDIL 266
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 62/232 (26%), Positives = 109/232 (46%), Gaps = 30/232 (12%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFSLPV 313
E + HPNIV+ L G C +K+ ++VMEL+ L ++R +++N ++
Sbjct: 42 EAEILKQYDHPNIVK-LIGVC-VQKQPIYIVMELVPGGSLLTFLR-----KKKNRLTVKK 94
Query: 314 VVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRN 373
++ + L A GME+L ++ H +L N + ++ +K+S FG+S R
Sbjct: 95 LLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNV-----LKISDFGMS--REEEGGI 147
Query: 374 TPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVP 432
+ Q P W APE L + + + ++DV+S+G+L +E + G P
Sbjct: 148 YTVSDGLKQI---PIKWTAPEAL---------NYGRYTSESDVWSYGILLWETFSLGDTP 195
Query: 433 FEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSI 484
+ + + + I +G R P P+ + L +CW +P RPSFS I
Sbjct: 196 YPG--MSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEI 245
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 1e-17
Identities = 66/247 (26%), Positives = 103/247 (41%), Gaps = 51/247 (20%)
Query: 249 LESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRE----TFGS- 303
+++L +EI T+ L H NIVQYL GF E E + LS ++ + GS
Sbjct: 52 VKALRSEIETLKDLDHLNIVQYL-GF---ETTE---------EYLSIFLEYVPGGSIGSC 98
Query: 304 -RRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFG 362
R F +V Q+ G+ +LH++ I H +L N+ + A + K+S FG
Sbjct: 99 LRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGI-----CKISDFG 153
Query: 363 LS--TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFG 420
+S + Y + QN + W APEV+ + + S K D++S G
Sbjct: 154 ISKKSDDIYDND-------QNMSMQGSVFWMAPEVI-------HSYSQGYSAKVDIWSLG 199
Query: 421 MLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTK-------KCWHT 473
+ E+ G+ P+ D M K P P P +NL+ C+
Sbjct: 200 CVVLEMFAGRRPWSDEEAIA-AMFKLGNKRSAPPIP---PDVSMNLSPVALDFLNACFTI 255
Query: 474 NPSQRPS 480
NP RP+
Sbjct: 256 NPDNRPT 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 1e-17
Identities = 67/248 (27%), Positives = 110/248 (44%), Gaps = 39/248 (15%)
Query: 252 LNAEISTMLSLSHPNIVQYLCGFCDEEK-KEFFLVMELM-SKDLSCYMRETFGSRRRNSF 309
L EI + +L H NIV+Y G C E+ L+ME + S L Y+ R +N
Sbjct: 53 LKKEIEILRNLYHENIVKYK-GICTEDGGNGIKLIMEFLPSGSLKEYL-----PRNKNKI 106
Query: 310 SLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTY 369
+L + +QI +GM++L +++ H +L N+ +++ VK+ FGL T
Sbjct: 107 NLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ-----VKIGDFGL----TK 157
Query: 370 ASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT- 428
A +P WYAPE L + SK +DV+SFG+ +ELLT
Sbjct: 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQ---------SKFYIASDVWSFGVTLYELLTY 208
Query: 429 ------------GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPS 476
+ G + ++ + + G+R P P+ + L +KCW PS
Sbjct: 209 CDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPS 268
Query: 477 QRPSFSSI 484
+R +F ++
Sbjct: 269 KRTTFQNL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 1e-17
Identities = 61/237 (25%), Positives = 98/237 (41%), Gaps = 49/237 (20%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK----DL----SCYMRETFGSRRR 306
EI M HPNIV Y + + E ++VME M D+ M E +
Sbjct: 65 EILIMKDCKHPNIVDYYDSYLVGD--ELWVVMEYMDGGSLTDIITQNFVRMNEPQIAY-- 120
Query: 307 NSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366
+ ++ +G+E+LH+Q + H ++ NI L S +G VK++ FG
Sbjct: 121 ----------VCREVLQGLEYLHSQNVIHRDIKSDNILL---SKDG--SVKLADFG---- 161
Query: 367 RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFEL 426
+A++ T S +N PY W APEV+ ++ K D++S G++C E+
Sbjct: 162 --FAAQLTKEKSKRNSVVGTPY-WMAPEVIKRKD---------YGPKVDIWSLGIMCIEM 209
Query: 427 LTGKVP-FEDGHLQGDKMTKNIRAGERPLF--PSGSPKYLVNLTKKCWHTNPSQRPS 480
G+ P + L + I P P + KC +P +RPS
Sbjct: 210 AEGEPPYLREPPL---RALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPS 263
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 1e-17
Identities = 63/245 (25%), Positives = 108/245 (44%), Gaps = 38/245 (15%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFSLPV 313
E + LSH NI+ L C E+ + F++ M+ +L ++++ N +L
Sbjct: 58 ESCLLYGLSHQNILPILH-VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALST 116
Query: 314 --VVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYAS 371
+V + +QIA GM +LH + + H ++ N + VK++ LS
Sbjct: 117 QQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEEL-----QVKITDNALS------- 164
Query: 372 RNTPPAS------PQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFE 425
R+ P +N+ P W A E L + S +DV+SFG+L +E
Sbjct: 165 RDLFPMDYHCLGDNENR----PVKWMALESLVN---------KEYSSASDVWSFGVLLWE 211
Query: 426 LLT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSI 484
L+T G+ P+ + + +M ++ G R P P L + CW +P +RPSFS +
Sbjct: 212 LMTLGQTPYVE--IDPFEMAAYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQL 269
Query: 485 CRILR 489
+ L
Sbjct: 270 VQCLT 274
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 1e-17
Identities = 68/228 (29%), Positives = 112/228 (49%), Gaps = 30/228 (13%)
Query: 263 SHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQI 321
SHPNIV+ L G C +K+ ++VMEL+ D ++R T G R + + ++ ++
Sbjct: 51 SHPNIVR-LIGVC-TQKQPIYIVMELVQGGDFLTFLR-TEGPRLK----VKELIQMVENA 103
Query: 322 ARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTPPASPQN 381
A GME+L ++ H +L N + +++ +K+S FG+S R
Sbjct: 104 AAGMEYLESKHCIHRDLAARNCLVTEKNV-----LKISDFGMS--REEEDGVYASTGGMK 156
Query: 382 QTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQG 440
Q P W APE L + + S ++DV+SFG+L +E + G VP+ + L
Sbjct: 157 QI---PVKWTAPEAL---------NYGRYSSESDVWSFGILLWEAFSLGAVPYAN--LSN 202
Query: 441 DKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRIL 488
+ + I G R P P + L ++CW +P QRPSFS++ + L
Sbjct: 203 QQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 2e-17
Identities = 60/233 (25%), Positives = 102/233 (43%), Gaps = 39/233 (16%)
Query: 212 DMLLKKLMVRRRLGASSQFKEIQWLGDSFVLRHFYGELE---SLNAEISTMLSLSHPNIV 268
D L K++ A + K I+ D R G + E+ M + H NI+
Sbjct: 30 DTLTGKIV------AIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIM 83
Query: 269 QYLCGFCDEEKKEFF-LVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEF 327
+ + + +F LVM++M+ DL ++ + R + V I+LQI G+
Sbjct: 84 GLVDVYV---EGDFINLVMDIMASDL----KKVVDRKIR--LTESQVKCILLQILNGLNV 134
Query: 328 LHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYA------SRNTPPASPQN 381
LH H +L+P+NI++ ++ + K++ FGL+ Y S++ +
Sbjct: 135 LHKWYFMHRDLSPANIFINSKGI-----CKIADFGLARRYGYPPYSDTLSKDETMQRREE 189
Query: 382 QTAPNPYIWY-APEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPF 433
T+ +WY APE+L G+ K D++S G + ELLTGK F
Sbjct: 190 MTSKVVTLWYRAPELL-----MGAE---KYHFAVDMWSVGCIFAELLTGKPLF 234
|
Length = 335 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.6 bits (205), Expect = 3e-17
Identities = 67/256 (26%), Positives = 102/256 (39%), Gaps = 64/256 (25%)
Query: 263 SHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIA 322
HPNIV+ F E E + V E M +L M+ R+ FS V+ I+ QI
Sbjct: 56 EHPNIVKLKEVF--RENDELYFVFEYMEGNLYQLMK----DRKGKPFSESVIRSIIYQIL 109
Query: 323 RGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTPPASPQNQ 382
+G+ +H +H +L P N+ + G VK++ FGL AR R+ PP +
Sbjct: 110 QGLAHIHKHGFFHRDLKPENLLVS-----GPEVVKIADFGL--AR--EIRSRPPYT---- 156
Query: 383 TAPNPYI---WY-APEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPF----E 434
Y+ WY APE+L STS S D+++ G + EL T + F E
Sbjct: 157 ----DYVSTRWYRAPEILLR-----STSYSS---PVDIWALGCIMAELYTLRPLFPGSSE 204
Query: 435 DGHLQ------------------------GDKMTKNIRAGERPLFPSGSPKYLVNLTKKC 470
L G + + L P+ SP+ ++L K
Sbjct: 205 IDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPE-AIDLIKDM 263
Query: 471 WHTNPSQRPSFSSICR 486
+P +RP+ S +
Sbjct: 264 LRWDPKKRPTASQALQ 279
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 5e-17
Identities = 66/239 (27%), Positives = 105/239 (43%), Gaps = 34/239 (14%)
Query: 254 AEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFSLP 312
E S M HPNI+ L G + + ++ E M L ++RE G F++
Sbjct: 54 TEASIMGQFDHPNII-RLEGVV-TKSRPVMIITEYMENGSLDKFLRENDGK-----FTVG 106
Query: 313 VVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASR 372
+V ++ IA GM++L H +L NI + + + KVS FGLS R
Sbjct: 107 QLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLV-----CKVSDFGLS-------R 154
Query: 373 NTPPASPQNQTAPN--PYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-G 429
+ T P W APE +A + K + +DV+SFG++ +E+++ G
Sbjct: 155 RLEDSEATYTTKGGKIPIRWTAPEAIAYR---------KFTSASDVWSFGIVMWEVMSYG 205
Query: 430 KVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRIL 488
+ P+ D + + K + G R P P L L CW + ++RP+FS I L
Sbjct: 206 ERPYWD--MSNQDVIKAVEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 6e-17
Identities = 70/262 (26%), Positives = 119/262 (45%), Gaps = 46/262 (17%)
Query: 248 ELESLNAEISTM-LSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRR- 305
+L L +E+ M L H NI+ L G C +E ++++E +K +RE +RR
Sbjct: 60 DLADLISEMELMKLIGKHKNIINLL-GVCTQEGP-LYVIVEYAAKG---NLREFLRARRP 114
Query: 306 -------------RNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEG 352
S +V Q+ARGME+L +++ H +L N+ + ++
Sbjct: 115 PGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNV-- 172
Query: 353 YFHVKVSGFGLSTARTYASRNTPPASPQNQTAPN--PYIWYAPEVLAEQEGTGSTSTSKC 410
+K++ FGL+ R +T+ P W APE L ++ T
Sbjct: 173 ---MKIADFGLA-------RGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYT-------- 214
Query: 411 SEKADVYSFGMLCFELLT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKK 469
++DV+SFG+L +E+ T G P+ + +++ K +R G R PS L L ++
Sbjct: 215 -HQSDVWSFGILMWEIFTLGGSPYPG--IPVEELFKLLREGHRMDKPSNCTHELYMLMRE 271
Query: 470 CWHTNPSQRPSFSSICRILRYI 491
CWH P+QRP+F + L +
Sbjct: 272 CWHAVPTQRPTFKQLVEALDKV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 8e-17
Identities = 73/280 (26%), Positives = 126/280 (45%), Gaps = 46/280 (16%)
Query: 222 RRLGASSQFKEIQWLG--------DSFVLRHFYGELESLNAEISTMLSLSHPNIVQYLCG 273
++LGA QF E+ W+G L+ +++ E + M +L H +V+
Sbjct: 12 KKLGAG-QFGEV-WMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAV 69
Query: 274 FCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQK 332
EE +++ E M+K L +++ G + LP ++D QIA GM ++ +
Sbjct: 70 VTKEEP--IYIITEYMAKGSLLDFLKSDEGGK----VLLPKLIDFSAQIAEGMAYIERKN 123
Query: 333 IYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA---RTYASRNTPPASPQNQTAPNPYI 389
H +L +N+ + M K++ FGL+ Y +R + A P
Sbjct: 124 YIHRDLRAANVLVSESLM-----CKIADFGLARVIEDNEYTAR---------EGAKFPIK 169
Query: 390 WYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGDKMTKNIR 448
W APE + GS + K+DV+SFG+L +E++T GK+P+ G D M+ ++
Sbjct: 170 WTAPEAI----NFGSFTI-----KSDVWSFGILLYEIVTYGKIPYP-GMSNSDVMSA-LQ 218
Query: 449 AGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRIL 488
G R P L ++ K CW +RP+F + +L
Sbjct: 219 RGYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVL 258
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 1e-16
Identities = 70/255 (27%), Positives = 105/255 (41%), Gaps = 51/255 (20%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKK-----EF--------FLVMELMSKDLSCYMRETF 301
E M L HPNIV L G C +E+ E+ FLV D+ E+
Sbjct: 58 EAELMSDLQHPNIVCLL-GVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGA---ESG 113
Query: 302 GSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGF 361
++S + I +QIA GME+L + H +L N + EG VK+S F
Sbjct: 114 DETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVG----EG-LTVKISDF 168
Query: 362 GLS----TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVY 417
GLS +A Y + P W PE + K + ++D++
Sbjct: 169 GLSRDIYSADYYR---------VQSKSLLPVRWMPPE---------AILYGKFTTESDIW 210
Query: 418 SFGMLCFELLT-GKVPFEDGHLQGDKMTKNIRAGERPLF--PSGSPKYLVNLTKKCWHTN 474
SFG++ +E+ + G P+ G + + IR R L P P + L +CW+
Sbjct: 211 SFGVVLWEIFSYGLQPYY-GFSNQEVIEM-IR--SRQLLPCPEDCPARVYALMIECWNEI 266
Query: 475 PSQRPSFSSICRILR 489
P++RP F I LR
Sbjct: 267 PARRPRFKDIHTRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 63/244 (25%), Positives = 115/244 (47%), Gaps = 37/244 (15%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFSLPV 313
EI + L HPN+++YL F + E +V+EL DLS M + F ++R
Sbjct: 52 EIDLLKQLDHPNVIKYLASFIEN--NELNIVLELADAGDLS-RMIKHFKKQKR-LIPERT 107
Query: 314 VVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRN 373
+ +Q+ +E +H+++I H ++ P+N+++ A + VK+ GL R ++S+
Sbjct: 108 IWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGV-----VKLGDLGL--GRFFSSKT 160
Query: 374 TPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPF 433
T S PY + +PE + E + K+D++S G L +E+ + PF
Sbjct: 161 TAAHS----LVGTPY-YMSPERIHEN---------GYNFKSDIWSLGCLLYEMAALQSPF 206
Query: 434 EDGHLQGDKMT-----KNIRAGERPLFPSGS-PKYLVNLTKKCWHTNPSQRPSFSSICRI 487
GDKM K I + P P+ + L +L +C + +P +RP S + ++
Sbjct: 207 Y-----GDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQV 261
Query: 488 LRYI 491
+ +
Sbjct: 262 AKEM 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 1e-16
Identities = 80/294 (27%), Positives = 132/294 (44%), Gaps = 52/294 (17%)
Query: 216 KKLMVRRRLGASSQFKEI---QWLGDSFV----LRHFYGELESLNAEISTMLSLSHPNIV 268
+ L + ++LG + QF E+ W G++ V L+ ES E M L H +V
Sbjct: 6 ESLQLIKKLG-NGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLV 64
Query: 269 QYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEF 327
Q L EE ++V E MSK L ++++ G + LP +VD+ Q+A GM +
Sbjct: 65 Q-LYAVVSEEP--IYIVTEYMSKGSLLDFLKDGEG----RALKLPNLVDMAAQVAAGMAY 117
Query: 328 LHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA---RTYASRNTPPASPQNQTA 384
+ H +L +NI + + K++ FGL+ Y +R Q A
Sbjct: 118 IERMNYIHRDLRSANILVGDGLV-----CKIADFGLARLIEDNEYTAR---------QGA 163
Query: 385 PNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGDKM 443
P W APE + + + K+DV+SFG+L EL+T G+VP+ + ++
Sbjct: 164 KFPIKWTAPE---------AALYGRFTIKSDVWSFGILLTELVTKGRVPYPG--MNNREV 212
Query: 444 TKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKKFMAN 497
+ + G R P P L L +CW +P +RP+F Y++ F+ +
Sbjct: 213 LEQVERGYRMPCPQDCPISLHELMLQCWKKDPEERPTF-------EYLQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 67/271 (24%), Positives = 122/271 (45%), Gaps = 46/271 (16%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRET------- 300
EL L +E + + ++HP++++ L G C ++ +V L ++RE+
Sbjct: 46 ELRDLLSEFNLLKQVNHPHVIK-LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSY 104
Query: 301 -FGSRRRNSFSL------PVVVDIML----QIARGMEFLHAQKIYHGELNPSNIYL-KAR 348
RNS L + + ++ QI+RGM++L K+ H +L N+ + + R
Sbjct: 105 LGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGR 164
Query: 349 SMEGYFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTS 408
M K+S FGLS R ++ + + P W A E L + T
Sbjct: 165 KM------KISDFGLS--RDVYEEDSYVKRSKGRI---PVKWMAIESLFDHIYT------ 207
Query: 409 KCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLT 467
++DV+SFG+L +E++T G P+ + +++ ++ G R P + + NL
Sbjct: 208 ---TQSDVWSFGVLLWEIVTLGGNPYPG--IAPERLFNLLKTGYRMERPENCSEEMYNLM 262
Query: 468 KKCWHTNPSQRPSFSSICRILRYIKKFMANN 498
CW P +RP+F+ I + L +K M +
Sbjct: 263 LTCWKQEPDKRPTFADISKEL---EKMMVKS 290
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 67/249 (26%), Positives = 111/249 (44%), Gaps = 35/249 (14%)
Query: 244 HFYGELESLNAEISTMLSLSHPNIVQYLCGFC--DEEKKEF---FLVMELMSK-DLSCYM 297
H Y E+E +E + M HPN+++ L G C ++ +++ M DL ++
Sbjct: 40 HTYSEIEEFLSEAACMKDFDHPNVMK-LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFL 98
Query: 298 RETFGSR-RRNSFSLPV--VVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYF 354
SR LP+ ++ M+ IA GME+L + H +L N L+
Sbjct: 99 ---LYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLRED-----M 150
Query: 355 HVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKA 414
V V+ FGLS + S + Q + A P W A E LA++ T K+
Sbjct: 151 TVCVADFGLS--KKIYSGDY---YRQGRIAKMPVKWIAIESLADRVYT---------SKS 196
Query: 415 DVYSFGMLCFELLT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHT 473
DV++FG+ +E+ T G+ P+ ++ ++ +R G R P L +L CW
Sbjct: 197 DVWAFGVTMWEIATRGQTPYPG--VENHEIYDYLRHGNRLKQPEDCLDELYDLMYSCWRA 254
Query: 474 NPSQRPSFS 482
+P RP+F+
Sbjct: 255 DPKDRPTFT 263
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 63/257 (24%), Positives = 109/257 (42%), Gaps = 46/257 (17%)
Query: 247 GELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRE-----T 300
E E+ + LS PNI + L G C + ++ME M DL+ ++++ +
Sbjct: 61 NAREDFLKEVKILSRLSDPNIARLL-GVCTVDPP-LCMIMEYMENGDLNQFLQKHVAETS 118
Query: 301 FGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSG 360
+ S S ++ + QIA GM +L + H +L N L ++ + +K++
Sbjct: 119 GLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC-LVGKN----YTIKIAD 173
Query: 361 FGLS----TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADV 416
FG+S ++ Y + P P W A E S K + K+DV
Sbjct: 174 FGMSRNLYSSDYYRVQGRAPL---------PIRWMAWE---------SVLLGKFTTKSDV 215
Query: 417 YSFGMLCFELLT--GKVPFEDGHLQGDKMTKNI-----RAGERPLF--PSGSPKYLVNLT 467
++FG+ +E+LT + P+E HL ++ +N G + P PK + L
Sbjct: 216 WAFGVTLWEILTLCREQPYE--HLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELM 273
Query: 468 KKCWHTNPSQRPSFSSI 484
+CW + RP+F I
Sbjct: 274 LECWRRDEEDRPTFREI 290
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 2e-16
Identities = 65/204 (31%), Positives = 88/204 (43%), Gaps = 52/204 (25%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKE---------FFLVMELMSKDLSCYMRETFGSRR 305
EI+ +L L HPNIV KE ++VME + DL M ET
Sbjct: 54 EINILLKLQHPNIVTV---------KEVVVGSNLDKIYMVMEYVEHDLKSLM-ETM---- 99
Query: 306 RNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365
+ F V +MLQ+ G+ LH I H +L SN+ L R + +K+ FGL
Sbjct: 100 KQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGI-----LKICDFGL-- 152
Query: 366 ARTYASRNTPPASPQNQ---TAPNPYIWY-APEVLAEQEGTGSTSTSKCSEKADVYSFGM 421
AR Y S P P Q T +WY APE+L + S D++S G
Sbjct: 153 AREYGS----PLKPYTQLVVT-----LWYRAPELL--------LGAKEYSTAIDMWSVGC 195
Query: 422 LCFELLTGKVPFEDGHLQGDKMTK 445
+ ELLT K F G + D++ K
Sbjct: 196 IFAELLTKKPLF-PGKSEIDQLNK 218
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 72/253 (28%), Positives = 112/253 (44%), Gaps = 44/253 (17%)
Query: 250 ESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNS 308
E+ E M L H +V L EE ++V E M K L +++E G
Sbjct: 46 EAFLQEAQIMKKLRHDKLVP-LYAVVSEEP--IYIVTEFMGKGSLLDFLKEGDGKY---- 98
Query: 309 FSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA-- 366
LP +VD+ QIA GM ++ H +L +NI + + K++ FGL+
Sbjct: 99 LKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLV-----CKIADFGLARLIE 153
Query: 367 -RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFE 425
Y +R Q A P W APE + + + K+DV+SFG+L E
Sbjct: 154 DNEYTAR---------QGAKFPIKWTAPE---------AALYGRFTIKSDVWSFGILLTE 195
Query: 426 LLT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSI 484
L+T G+VP+ + ++ + + G R P G P+ L L K CW +P +RP+F
Sbjct: 196 LVTKGRVPYPG--MVNREVLEQVERGYRMPCPQGCPESLHELMKLCWKKDPDERPTF--- 250
Query: 485 CRILRYIKKFMAN 497
YI+ F+ +
Sbjct: 251 ----EYIQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 3e-16
Identities = 65/246 (26%), Positives = 114/246 (46%), Gaps = 38/246 (15%)
Query: 250 ESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSF 309
+ + E M L +P IV+ + G C+ E LVME+ S F S +++
Sbjct: 40 DEMMREAEIMHQLDNPYIVR-MIGVCEAEA--LMLVMEMASGG----PLNKFLSGKKDEI 92
Query: 310 SLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA--- 366
++ VV++M Q++ GM++L + H +L N+ L + + K+S FGLS A
Sbjct: 93 TVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQH-----YAKISDFGLSKALGA 147
Query: 367 --RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCF 424
Y +R+ P WYAPE + + K S ++DV+S+G+ +
Sbjct: 148 DDSYYKARSA---------GKWPLKWYAPECI---------NFRKFSSRSDVWSYGITMW 189
Query: 425 ELLT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSS 483
E + G+ P++ ++G ++ I G+R P+ P + L K CW RP+F+
Sbjct: 190 EAFSYGQKPYKK--MKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAK 247
Query: 484 ICRILR 489
+ +R
Sbjct: 248 VEERMR 253
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 79.5 bits (197), Expect = 4e-16
Identities = 67/256 (26%), Positives = 104/256 (40%), Gaps = 62/256 (24%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVV 314
EI + L HPNI+ L F K LV E M DL ++ + + +
Sbjct: 52 EIKLLQELKHPNIIGLLDVFG--HKSNINLVFEFMETDLEKVIK-----DKSIVLTPADI 104
Query: 315 VDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNT 374
ML RG+E+LH+ I H +L P+N+ + + + +K++ FGL AR++ S N
Sbjct: 105 KSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGV-----LKLADFGL--ARSFGSPNR 157
Query: 375 PPASPQNQTAPNPYIWY-APEVL--AEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKV 431
+ Q T WY APE+L A G G D++S G + ELL
Sbjct: 158 -KMTHQVVT-----RWYRAPELLFGARHYGVG----------VDMWSVGCIFAELLLRV- 200
Query: 432 PFEDGHLQGDKMTKNIRA---------------------GERP------LFPSGSPKYLV 464
PF G D++ K A P +FP+ S +
Sbjct: 201 PFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAAS-DDAL 259
Query: 465 NLTKKCWHTNPSQRPS 480
+L ++ NP++R +
Sbjct: 260 DLLQRLLTLNPNKRIT 275
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 8e-16
Identities = 57/238 (23%), Positives = 102/238 (42%), Gaps = 32/238 (13%)
Query: 249 LESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNS 308
++ + E+ + L HPN+V+Y G + +++ ++ ME S T +
Sbjct: 43 IKEIADEMKVLELLKHPNLVKYY-GV-EVHREKVYIFMEYCSGG-------TLEELLEHG 93
Query: 309 FSLP--VVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366
L V+ LQ+ G+ +LH+ I H ++ P+NI+L + +K+ FG A
Sbjct: 94 RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGV-----IKLGDFG--CA 146
Query: 367 RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFEL 426
+ T A P + APEV+ +G G AD++S G + E+
Sbjct: 147 VKLKNNTTTMGEEVQSLAGTP-AYMAPEVITGGKGKGHGRA------ADIWSLGCVVLEM 199
Query: 427 LTGKVPFE--DGHLQGDKMTKNIRAGERPLFPSGSPKYL--VNLTKKCWHTNPSQRPS 480
TGK P+ D Q + ++ AG +P P + +C ++P +RP+
Sbjct: 200 ATGKRPWSELDNEFQ---IMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPT 254
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 1e-15
Identities = 68/239 (28%), Positives = 100/239 (41%), Gaps = 38/239 (15%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMS----KDLSCYMRETFGS 303
E+ +L EI + +L H IVQY C + + + ME M KD ++ +G+
Sbjct: 47 EVNALECEIQLLKNLQHERIVQYYG--CLRDDETLSIFMEYMPGGSVKD---QLK-AYGA 100
Query: 304 RRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGL 363
V QI G+E+LH+ I H ++ +NI R G +VK+ FG
Sbjct: 101 LTET-----VTRKYTRQILEGVEYLHSNMIVHRDIKGANIL---RDSAG--NVKLGDFGA 150
Query: 364 STA-RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGML 422
S +T S T S PY W +PEV++ EG G KADV+S G
Sbjct: 151 SKRLQTICSSGTGMKS----VTGTPY-WMSPEVIS-GEGYG--------RKADVWSVGCT 196
Query: 423 CFELLTGKVPFEDGHLQGDKMTKNIRAGE-RPLFPSGSPKYLVNLTKKCWHTNPSQRPS 480
E+LT K P+ + + I P PS N ++ + N +RPS
Sbjct: 197 VVEMLTEKPPWAE--FEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPS 253
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 71/250 (28%), Positives = 111/250 (44%), Gaps = 41/250 (16%)
Query: 248 ELESLNAEISTMLSL-SHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRR 306
E E+L +E+ M L +H NIV L G C + DL ++R R+R
Sbjct: 81 EREALMSELKIMSHLGNHENIVNLL-GACTIGGPILVITEYCCYGDLLNFLR-----RKR 134
Query: 307 NSF-SLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365
SF +L ++ Q+A+GM FL ++ H +L N+ L G VK+ FGL
Sbjct: 135 ESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLT----HGKI-VKICDFGL-- 187
Query: 366 AR------TYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSF 419
AR Y + A P W APE + T ++DV+S+
Sbjct: 188 ARDIMNDSNYVVKGN---------ARLPVKWMAPESIFNCVYT---------FESDVWSY 229
Query: 420 GMLCFELLT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQR 478
G+L +E+ + G P+ G K K I+ G R P +P + ++ K CW +P +R
Sbjct: 230 GILLWEIFSLGSNPYP-GMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKR 288
Query: 479 PSFSSICRIL 488
P+F I +++
Sbjct: 289 PTFKQIVQLI 298
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 3e-15
Identities = 70/253 (27%), Positives = 109/253 (43%), Gaps = 41/253 (16%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMS-KDLSCYMRE-------------- 299
E + M HPNIV+ L G C K L+ E M+ DL+ ++R
Sbjct: 58 EAALMAEFDHPNIVK-LLGVC-AVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTS 115
Query: 300 --TFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVK 357
S + I Q+A GM +L +K H +L N + VK
Sbjct: 116 SARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVG-----ENMVVK 170
Query: 358 VSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVY 417
++ FGLS R S + AS +N P W PE S ++ + ++DV+
Sbjct: 171 IADFGLS--RNIYSADYYKAS-ENDAIP--IRWMPPE---------SIFYNRYTTESDVW 216
Query: 418 SFGMLCFELLT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPS 476
++G++ +E+ + G P+ + +++ +R G P P L NL + CW PS
Sbjct: 217 AYGVVLWEIFSYGMQPYYG--MAHEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPS 274
Query: 477 QRPSFSSICRILR 489
RPSF+SI RIL+
Sbjct: 275 DRPSFASINRILQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (190), Expect = 3e-15
Identities = 57/235 (24%), Positives = 102/235 (43%), Gaps = 42/235 (17%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMS-KDLSCYMRETFGSRRR 306
++E + E + S+ HP +V F D+ +LVME + +L ++R +
Sbjct: 44 QVEHVLNEKRILQSIRHPFLVNLYGSFQDD--SNLYLVMEYVPGGELFSHLR------KS 95
Query: 307 NSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS-- 364
F PV Q+ +E+LH+ I + +L P N+ L + +G ++K++ FG +
Sbjct: 96 GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDS---DG--YIKITDFGFAKR 150
Query: 365 -TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLC 423
RTY TP Y+ APE++ + G G D ++ G+L
Sbjct: 151 VKGRTYTLCGTPE-----------YL--APEIILSK-GYGKA--------VDWWALGILI 188
Query: 424 FELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQR 478
+E+L G PF D ++ + I G + FPS +L + + ++R
Sbjct: 189 YEMLAGYPPFFD--DNPIQIYEKILEG-KVRFPSFFSPDAKDLIRNLLQVDLTKR 240
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 4e-15
Identities = 64/252 (25%), Positives = 109/252 (43%), Gaps = 45/252 (17%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSC---YMRE---TFGSRRRNS 308
E M S+ HP++V+ L G C + + L+ +LM L C Y+R GS+ +
Sbjct: 59 EAYVMASVDHPHVVR-LLGICLSSQVQ--LITQLMP--LGCLLDYVRNHKDNIGSQYLLN 113
Query: 309 FSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTART 368
+ + QIA+GM +L +++ H +L N+ +K HVK++ FGL A+
Sbjct: 114 WCV--------QIAKGMSYLEEKRLVHRDLAARNVLVKTPQ-----HVKITDFGL--AKL 158
Query: 369 YASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT 428
+ + P W A E + + T K+DV+S+G+ +EL+T
Sbjct: 159 LDVDEKEYHAEGGKV---PIKWMALESILHRIYT---------HKSDVWSYGVTVWELMT 206
Query: 429 -GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRI 487
G P+E + ++ + GER P + + KCW + RP+F +
Sbjct: 207 FGAKPYEG--IPAVEIPDLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINE 264
Query: 488 LRYIKKFMANNP 499
MA +P
Sbjct: 265 FSK----MARDP 272
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.1 bits (188), Expect = 4e-15
Identities = 62/250 (24%), Positives = 99/250 (39%), Gaps = 64/250 (25%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRN 307
E+E + EI + P I +Y F K +++ME SC +
Sbjct: 42 EIEDIQQEIQFLSQCRSPYITKYYGSFLKGSK--LWIIMEYCGGG-SC-----LDLLKPG 93
Query: 308 SFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST-- 365
+ I+ ++ G+E+LH + H ++ +NI L S EG VK++ FG+S
Sbjct: 94 KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILL---SEEG--DVKLADFGVSGQL 148
Query: 366 ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFE 425
T + RNT P+ W APEV+ + S EKAD++S G+ E
Sbjct: 149 TSTMSKRNT--------FVGTPF-WMAPEVIKQ---------SGYDEKADIWSLGITAIE 190
Query: 426 LLTGKVPFEDGH---------------LQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKC 470
L G+ P D H L+G+K +K + + C
Sbjct: 191 LAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFK----------------DFVSLC 234
Query: 471 WHTNPSQRPS 480
+ +P +RPS
Sbjct: 235 LNKDPKERPS 244
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 5e-15
Identities = 71/263 (26%), Positives = 119/263 (45%), Gaps = 36/263 (13%)
Query: 248 ELESLNAEISTMLSLS-HPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRR 305
+L L +E+ M + H NI+ L G C ++ ++++E SK +L Y+R
Sbjct: 63 DLSDLVSEMEMMKMIGKHKNIINLL-GACTQDGP-LYVIVEYASKGNLREYLRARRPPGM 120
Query: 306 RNSFSLPVVVDIML----------QIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFH 355
S+ + V D + Q+ARGME+L +QK H +L N+ + ++
Sbjct: 121 EYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNV----- 175
Query: 356 VKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKAD 415
+K++ FGL AR N + P W APE L ++ T ++D
Sbjct: 176 MKIADFGL--ARDV---NNIDYYKKTTNGRLPVKWMAPEALFDRVYT---------HQSD 221
Query: 416 VYSFGMLCFELLT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTN 474
V+SFG+L +E+ T G P+ + +++ K ++ G R P+ L + + CWH
Sbjct: 222 VWSFGVLMWEIFTLGGSPYPG--IPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAI 279
Query: 475 PSQRPSFSSICRILRYIKKFMAN 497
PS RP+F + L I N
Sbjct: 280 PSHRPTFKQLVEDLDRILTLTTN 302
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 6e-15
Identities = 53/179 (29%), Positives = 86/179 (48%), Gaps = 34/179 (18%)
Query: 255 EISTMLSL---SHPNIVQYL--CGFCDEEKK-EFFLVMELMSKDLSCYMRETFGSRRRNS 308
EI+ + L HPNIV+ L C +++ + LV E + +DL+ Y+ +
Sbjct: 48 EIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKP----G 103
Query: 309 FSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTART 368
+ D+M Q+ RG++FLH+ +I H +L P NI + + +G VK++ FGL AR
Sbjct: 104 LPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILV---TSDG--QVKIADFGL--ARI 156
Query: 369 YASRNTPPASPQNQTAPNPYIWY-APEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFEL 426
Y+ + T +WY APEVL S+ + D++S G + EL
Sbjct: 157 YS--FEMALTSVVVT-----LWYRAPEVL-----LQSSYATPV----DMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 6e-15
Identities = 70/237 (29%), Positives = 105/237 (44%), Gaps = 37/237 (15%)
Query: 250 ESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNS 308
E+ E M L H +VQ L EE ++V E MSK L +++ G R
Sbjct: 46 EAFLQEAQVMKKLRHEKLVQ-LYAVVSEEP--IYIVTEYMSKGSLLDFLKGEMGKYLR-- 100
Query: 309 FSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA-- 366
LP +VD+ QIA GM ++ H +L +NI + + KV+ FGL+
Sbjct: 101 --LPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV-----CKVADFGLARLIE 153
Query: 367 -RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFE 425
Y +R Q A P W APE + + + K+DV+SFG+L E
Sbjct: 154 DNEYTAR---------QGAKFPIKWTAPE---------AALYGRFTIKSDVWSFGILLTE 195
Query: 426 LLT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSF 481
L T G+VP+ + ++ + G R P P+ L +L +CW P +RP+F
Sbjct: 196 LTTKGRVPYPG--MVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTF 250
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 9e-15
Identities = 64/236 (27%), Positives = 106/236 (44%), Gaps = 27/236 (11%)
Query: 254 AEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPV 313
+E S M SH NI++ L G + K + + + L Y+R+ G FS
Sbjct: 55 SEASIMGQFSHHNIIR-LEGVVTKFKPAMIITEYMENGALDKYLRDHDGE-----FSSYQ 108
Query: 314 VVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRN 373
+V ++ IA GM++L H +L NI + + KVS FGLS +
Sbjct: 109 LVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSN-----LECKVSDFGLSRVL----ED 159
Query: 374 TPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVP 432
P + P W APE +A ++ T ++ DV+SFG++ +E+++ G+ P
Sbjct: 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSAS---------DVWSFGIVMWEVMSFGERP 210
Query: 433 FEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRIL 488
+ D + ++ K I G R P P + L +CW + ++RP F I +L
Sbjct: 211 YWD--MSNHEVMKAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLL 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 1e-14
Identities = 62/215 (28%), Positives = 95/215 (44%), Gaps = 48/215 (22%)
Query: 276 DEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYH 335
+E + L +E DL Y SF Q+ARGMEFL ++K H
Sbjct: 162 GDELYKEPLTLE----DLISY-----------SF----------QVARGMEFLASRKCIH 196
Query: 336 GELNPSNIYLKARSMEGYFHVKVSGFGLSTAR-TYASRNTPPASPQNQTAPNPYIWYAPE 394
+L NI L ++ VK+ FGL AR Y P + A P W APE
Sbjct: 197 RDLAARNILLSENNV-----VKICDFGL--ARDIYKD----PDYVRKGDARLPLKWMAPE 245
Query: 395 VLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGDKMTKNIRAGERP 453
+ ++ T ++DV+SFG+L +E+ + G P+ G ++ + ++ G R
Sbjct: 246 SIFDKVYT---------TQSDVWSFGVLLWEIFSLGASPYP-GVQIDEEFCRRLKEGTRM 295
Query: 454 LFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRIL 488
P + + ++ CWH NP RP+FS + IL
Sbjct: 296 RAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 62/235 (26%), Positives = 101/235 (42%), Gaps = 31/235 (13%)
Query: 250 ESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSF 309
E+L EI M L+HP+I++ L C E F L +E M+ ++ +G+ F
Sbjct: 48 EALRKEIRLMARLNHPHIIRMLGATC--EDSHFNLFVEWMAGGSVSHLLSKYGA-----F 100
Query: 310 SLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTY 369
V+++ Q+ RG+ +LH +I H ++ +N+ + + ++++ FG A
Sbjct: 101 KEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQ----RLRIADFG--AAARL 154
Query: 370 ASRNTPPASPQNQTAPNPYIWYAPEVL-AEQEGTGSTSTSKCSEKADVYSFGMLCFELLT 428
A++ T Q Q + APEVL EQ G DV+S G + E+ T
Sbjct: 155 AAKGTGAGEFQGQLL-GTIAFMAPEVLRGEQYGRSC----------DVWSVGCVIIEMAT 203
Query: 429 GKVPFE----DGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRP 479
K P+ HL + K A P P L ++T +C P RP
Sbjct: 204 AKPPWNAEKHSNHLA--LIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRP 256
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 1e-14
Identities = 63/236 (26%), Positives = 107/236 (45%), Gaps = 27/236 (11%)
Query: 254 AEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPV 313
+E S M HPNI+ +L G + K + + + L ++R+ G F++
Sbjct: 54 SEASIMGQFDHPNII-HLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQ-----FTVIQ 107
Query: 314 VVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRN 373
+V ++ IA GM++L H +L NI + + + KVS FGLS +
Sbjct: 108 LVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLV-----CKVSDFGLSRVL----ED 158
Query: 374 TPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVP 432
P A+ + P W APE +A + K + +DV+S+G++ +E+++ G+ P
Sbjct: 159 DPEAAYTTRGGKIPIRWTAPEAIAYR---------KFTSASDVWSYGIVMWEVMSYGERP 209
Query: 433 FEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRIL 488
+ + + + K I G R P P L L CW + ++RP F I IL
Sbjct: 210 YWE--MSNQDVIKAIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSIL 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 63/260 (24%), Positives = 100/260 (38%), Gaps = 52/260 (20%)
Query: 231 KEIQWLGDSFVLRHFYGELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMS 290
K+I GD + L E+ T+ S P +V+ F E E +V+E M
Sbjct: 32 KKIHVDGDEEFRK-------QLLRELKTLRSCESPYVVKCYGAFYKEG--EISIVLEYMD 82
Query: 291 KDLSCYMRETFGS-----RRRNSFSLPVVVDIMLQIARGMEFLHAQ-KIYHGELNPSNIY 344
GS ++ PV+ I QI +G+++LH + I H ++ PSN+
Sbjct: 83 ----------GGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLL 132
Query: 345 LKARSMEGYFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGS 404
+ + +G VK++ FG S+ Q T + +PE +
Sbjct: 133 I---NSKGE--VKIADFG-------ISKVLENTLDQCNTFVGTVTYMSPERI-------- 172
Query: 405 TSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMT--KNIRAGERPLFPSG--SP 460
S AD++S G+ E GK PF Q + I G P P+ SP
Sbjct: 173 -QGESYSYAADIWSLGLTLLECALGKFPFLPP-GQPSFFELMQAICDGPPPSLPAEEFSP 230
Query: 461 KYLVNLTKKCWHTNPSQRPS 480
+ + C +P +RPS
Sbjct: 231 E-FRDFISACLQKDPKKRPS 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 62/213 (29%), Positives = 92/213 (43%), Gaps = 49/213 (23%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVV 314
EI+ +L+L HPNIV+ + FLVME +DL+ + FS V
Sbjct: 56 EITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNM-----PTPFSESQV 110
Query: 315 VDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNT 374
+MLQ+ RG+++LH I H +L SN+ L + +K++ FGL ARTY
Sbjct: 111 KCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKG-----CLKIADFGL--ARTYGLPAK 163
Query: 375 PPASPQNQTAPNPYIWY-APEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPF 433
P +P+ T +WY APE+L G T + D+++ G + ELL K
Sbjct: 164 -PMTPKVVT-----LWYRAPELL-----LGCT---TYTTAIDMWAVGCILAELLAHK--- 206
Query: 434 EDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNL 466
PL P S ++L
Sbjct: 207 -------------------PLLPGKSEIEQLDL 220
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-14
Identities = 63/237 (26%), Positives = 99/237 (41%), Gaps = 38/237 (16%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFSLPV 313
E + L I++Y F D+ K +VME DL ++ G
Sbjct: 49 EARVLAKLDSSYIIRYYESFLDKGK--LNIVMEYAENGDLHKLLKMQRGRP----LPEDQ 102
Query: 314 VVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFG----LSTARTY 369
V +QI G+ LH++KI H ++ N++L A Y +VK+ G LS +
Sbjct: 103 VWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDA-----YDNVKIGDLGVAKLLSDNTNF 157
Query: 370 ASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTG 429
A N PY + +PE+ ++ +EK+DV++ G++ +E TG
Sbjct: 158 A----------NTIVGTPY-YLSPELCEDK---------PYNEKSDVWALGVVLYECCTG 197
Query: 430 KVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486
K PF D + QG + K IR G P + L L +C + QRP + R
Sbjct: 198 KHPF-DANNQGALILKIIR-GVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 3e-14
Identities = 72/268 (26%), Positives = 122/268 (45%), Gaps = 46/268 (17%)
Query: 248 ELESLNAEISTMLSL-SHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRR- 305
+L L +E+ M + H NI+ L G C ++ ++++E SK +RE +RR
Sbjct: 66 DLSDLISEMEMMKMIGKHKNIINLL-GACTQDGP-LYVIVEYASKG---NLREYLRARRP 120
Query: 306 ------RNSFSLPV-------VVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEG 352
N +P +V Q+ARGME+L ++K H +L N+ + ++
Sbjct: 121 PGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV-- 178
Query: 353 YFHVKVSGFGLSTARTYASRNTPPASPQNQTAPN--PYIWYAPEVLAEQEGTGSTSTSKC 410
+K++ FGL+ R+ +T P W APE L ++ T
Sbjct: 179 ---MKIADFGLA-------RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT-------- 220
Query: 411 SEKADVYSFGMLCFELLT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKK 469
++DV+SFG+L +E+ T G P+ + +++ K ++ G R PS L + +
Sbjct: 221 -HQSDVWSFGVLLWEIFTLGGSPYPG--VPVEELFKLLKEGHRMDKPSNCTNELYMMMRD 277
Query: 470 CWHTNPSQRPSFSSICRILRYIKKFMAN 497
CWH PSQRP+F + L I +N
Sbjct: 278 CWHAVPSQRPTFKQLVEDLDRILALTSN 305
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 3e-14
Identities = 65/249 (26%), Positives = 108/249 (43%), Gaps = 30/249 (12%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRR 306
E + L E M +H NIV+ L G E+ F+++ELM+ DL ++RE R
Sbjct: 53 ESDFLM-EALIMSKFNHQNIVR-LIGVS-FERLPRFILLELMAGGDLKSFLREN-RPRPE 108
Query: 307 NSFSLPV--VVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS 364
SL + ++ +A+G ++L H ++ N L + K++ FG++
Sbjct: 109 RPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRV--AKIADFGMA 166
Query: 365 --TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGML 422
R R + A P W PE A +G ++ K DV+SFG+L
Sbjct: 167 RDIYRASYYR-------KGGRAMLPIKWMPPE--AFLDGIFTS-------KTDVWSFGVL 210
Query: 423 CFELLT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSF 481
+E+ + G +P+ Q + M G R P G P + + CW P RP+F
Sbjct: 211 LWEIFSLGYMPYPGRTNQ-EVMEFVTGGG-RLDPPKGCPGPVYRIMTDCWQHTPEDRPNF 268
Query: 482 SSICRILRY 490
++I ++Y
Sbjct: 269 ATILERIQY 277
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 3e-14
Identities = 63/241 (26%), Positives = 98/241 (40%), Gaps = 38/241 (15%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKD-LSCYMRETFGSRRR 306
ELE EI + HPNIV + E K ++++E L M E
Sbjct: 45 ELEDFMVEIDILSECKHPNIVGLYEAYFYENK--LWILIEFCDGGALDSIMLEL-----E 97
Query: 307 NSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST- 365
+ P + + Q+ + FLH+ K+ H +L NI L +++G VK++ FG+S
Sbjct: 98 RGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILL---TLDG--DVKLADFGVSAK 152
Query: 366 -ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSE---KADVYSFGM 421
T R+T +P W APEV+A T K + KAD++S G+
Sbjct: 153 NKSTLQKRDTFIGTPY---------WMAPEVVA-------CETFKDNPYDYKADIWSLGI 196
Query: 422 LCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLF--PSGSPKYLVNLTKKCWHTNPSQRP 479
EL + P + + ++ I E P PS + K C +P RP
Sbjct: 197 TLIELAQMEPPHHELNPM--RVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRP 254
Query: 480 S 480
+
Sbjct: 255 T 255
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (183), Expect = 4e-14
Identities = 65/266 (24%), Positives = 111/266 (41%), Gaps = 72/266 (27%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEF---FLVMELMSKDLSCYMRETFGSRRRNSFSL 311
EI + L H NI+ L ++F ++V ELM DL ++ S +
Sbjct: 49 EIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIK----SPQ------ 98
Query: 312 PVVVD----IMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTAR 367
P+ D + QI RG+++LH+ + H +L PSNI + + +K+ FGL AR
Sbjct: 99 PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNC-----DLKICDFGL--AR 151
Query: 368 TYASRNTPPASPQNQTAPNPYI---WY-APEVLAEQEGTGSTSTSKCSEKADVYSFGMLC 423
+ T Y+ WY APE+L S+S+ ++ D++S G +
Sbjct: 152 ---GVDPDEDEKGFLT---EYVVTRWYRAPELL--------LSSSRYTKAIDIWSVGCIF 197
Query: 424 FELLTGKVPF----------------------EDGHLQGDKMTKNIRA-GERP------L 454
ELLT K F + + +K +++ ++P L
Sbjct: 198 AELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKL 257
Query: 455 FPSGSPKYLVNLTKKCWHTNPSQRPS 480
FP SP+ + +L +K +P +R +
Sbjct: 258 FPGASPEAI-DLLEKMLVFDPKKRIT 282
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 5e-14
Identities = 66/249 (26%), Positives = 117/249 (46%), Gaps = 34/249 (13%)
Query: 248 ELESLNAEISTMLSL-SHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRE------- 299
+L L +E+ M + H NI+ L G C ++ + LV +L Y+R
Sbjct: 60 DLSDLVSEMEMMKMIGKHKNIINLL-GACTQDGPLYVLVEYASKGNLREYLRARRPPGMD 118
Query: 300 -TFGSRR--RNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHV 356
+F + + + +V Q+ARGME+L +QK H +L N+ + ++ +
Sbjct: 119 YSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNV-----M 173
Query: 357 KVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADV 416
K++ FGL AR + + + + P W APE L ++ T ++DV
Sbjct: 174 KIADFGL--ARDVHNIDYYKKTTNGRL---PVKWMAPEALFDRVYT---------HQSDV 219
Query: 417 YSFGMLCFELLT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNP 475
+SFG+L +E+ T G P+ + +++ K ++ G R P+ L + ++CWH P
Sbjct: 220 WSFGVLLWEIFTLGGSPYPG--IPVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVP 277
Query: 476 SQRPSFSSI 484
SQRP+F +
Sbjct: 278 SQRPTFKQL 286
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 5e-14
Identities = 67/251 (26%), Positives = 106/251 (42%), Gaps = 61/251 (24%)
Query: 247 GELESLNAEISTMLSLSHPNIVQYL-CGFCDEEKKEFFLVMELMSKDLSCYMRETFGS-- 303
+L+ + EIS + P IV+Y F + + ++VME GS
Sbjct: 40 EDLQEIIKEISILKQCDSPYIVKYYGSYFKNT---DLWIVMEYCG----------AGSVS 86
Query: 304 ----RRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVS 359
+ + + I+ Q +G+E+LH+ K H ++ NI L + EG K++
Sbjct: 87 DIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILL---NEEG--QAKLA 141
Query: 360 GFGLST--ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVY 417
FG+S T A RNT +P W APEV+ E + KAD++
Sbjct: 142 DFGVSGQLTDTMAKRNTVIGTP---------FWMAPEVIQEI---------GYNNKADIW 183
Query: 418 SFGMLCFELLTGKVPFEDGH-LQGDKMTKNIRAGERPLFPSG-------SPKYLVNLTKK 469
S G+ E+ GK P+ D H ++ M N +P P SP++ + KK
Sbjct: 184 SLGITAIEMAEGKPPYSDIHPMRAIFMIPN-----KP--PPTLSDPEKWSPEF-NDFVKK 235
Query: 470 CWHTNPSQRPS 480
C +P +RPS
Sbjct: 236 CLVKDPEERPS 246
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 7e-14
Identities = 55/185 (29%), Positives = 88/185 (47%), Gaps = 38/185 (20%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVV 314
EIS + L+HPNIV+ L E K +LV E + +DL +M + S LP++
Sbjct: 49 EISLLKELNHPNIVKLLDVIHTENK--LYLVFEFLHQDLKKFMDASPLS----GIPLPLI 102
Query: 315 VDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA-----RTY 369
+ Q+ +G+ F H+ ++ H +L P N+ + EG +K++ FGL+ A RTY
Sbjct: 103 KSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT---EG--AIKLADFGLARAFGVPVRTY 157
Query: 370 ASRNTPPASPQNQTAPNPYIWY-APEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT 428
T +WY APE+L G ST+ D++S G + E++T
Sbjct: 158 -------------THEVVTLWYRAPEILL---GCKYYSTA-----VDIWSLGCIFAEMVT 196
Query: 429 GKVPF 433
+ F
Sbjct: 197 RRALF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 7e-14
Identities = 62/246 (25%), Positives = 117/246 (47%), Gaps = 41/246 (16%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELM-SKDLSCYMRETFGSRRRNSFSLP- 312
EI + L+HPN+++Y F ++ E +V+EL + DLS ++ F ++R +P
Sbjct: 52 EIDLLKQLNHPNVIKYYASFIED--NELNIVLELADAGDLSRMIKH-FKKQKR---LIPE 105
Query: 313 -VVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYAS 371
V +Q+ +E +H++++ H ++ P+N+++ A + VK+ GL R ++S
Sbjct: 106 KTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGV-----VKLGDLGL--GRFFSS 158
Query: 372 RNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKV 431
+ T S PY + +PE + E + + K+D++S G L +E+ +
Sbjct: 159 KTTAAHS----LVGTPY-YMSPERIHE---------NGYNFKSDIWSLGCLLYEMAALQS 204
Query: 432 PFEDGHLQGDKMT-----KNIRAGERPLFPSGS-PKYLVNLTKKCWHTNPSQRPSFSSIC 485
PF GDKM K I + P PS + L L C + +P +RP + +
Sbjct: 205 PF-----YGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVY 259
Query: 486 RILRYI 491
+ + +
Sbjct: 260 DVAKRM 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 73/283 (25%), Positives = 128/283 (45%), Gaps = 45/283 (15%)
Query: 218 LMVRRRLGASSQFKEIQWLGDSF--------VLRHFYGELESLNAEISTMLSLSHPNIVQ 269
L + ++LGA QF E+ W+ ++ +E+ AE + M +L H +V+
Sbjct: 8 LKLEKKLGAG-QFGEV-WMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVK 65
Query: 270 YLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLH 329
K+ +++ E M+K + + S + LP ++D QIA GM F+
Sbjct: 66 LHAVVT---KEPIYIITEFMAKG---SLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 119
Query: 330 AQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA---RTYASRNTPPASPQNQTAPN 386
+ H +L +NI + A + K++ FGL+ Y +R + A
Sbjct: 120 QRNYIHRDLRAANILVSASLV-----CKIADFGLARVIEDNEYTAR---------EGAKF 165
Query: 387 PYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGDKMTK 445
P W APE + GS + K+DV+SFG+L E++T G++P+ + ++ +
Sbjct: 166 PIKWTAPEAI----NFGSFTI-----KSDVWSFGILLMEIVTYGRIPYPG--MSNPEVIR 214
Query: 446 NIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRIL 488
+ G R P P+ L N+ +CW P +RP+F I +L
Sbjct: 215 ALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVL 257
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 63/195 (32%), Positives = 92/195 (47%), Gaps = 28/195 (14%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVV 314
EIS M L H NIV+ L E K LV E M KDL YM +T G R + V
Sbjct: 48 EISLMKELKHENIVR-LHDVIHTENK-LMLVFEYMDKDLKKYM-DTHGVRG--ALDPNTV 102
Query: 315 VDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNT 374
Q+ +G+ F H ++ H +L P N+ + R +K++ FGL AR +
Sbjct: 103 KSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRG-----ELKLADFGL--ARAFG---I 152
Query: 375 PPASPQNQTAPNPYIWY-APEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPF 433
P + N+ +WY AP+VL G+ + STS D++S G + E++TG+ P
Sbjct: 153 PVNTFSNEVVT---LWYRAPDVLL---GSRTYSTS-----IDIWSVGCIMAEMITGR-PL 200
Query: 434 EDGHLQGDKMTKNIR 448
G D++ K R
Sbjct: 201 FPGTNNEDQLLKIFR 215
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 60/240 (25%), Positives = 107/240 (44%), Gaps = 37/240 (15%)
Query: 254 AEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFSLP 312
+E + HPNIV+ L G C +++ ++VMEL+ D ++R ++++
Sbjct: 41 SEARILKQYDHPNIVK-LIGVC-TQRQPIYIVMELVPGGDFLSFLR-----KKKDELKTK 93
Query: 313 VVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTAR---TY 369
+V L A GM +L ++ H +L N + ++ +K+S FG+S Y
Sbjct: 94 QLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNV-----LKISDFGMSRQEDDGIY 148
Query: 370 ASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT- 428
+S S Q P W APE L + + S ++DV+S+G+L +E +
Sbjct: 149 SS------SGLKQI---PIKWTAPEAL---------NYGRYSSESDVWSYGILLWETFSL 190
Query: 429 GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRIL 488
G P+ + + + + G R P P + + ++CW P RP FS + + L
Sbjct: 191 GVCPYPG--MTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-13
Identities = 69/242 (28%), Positives = 105/242 (43%), Gaps = 28/242 (11%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELM-SKDLSCYMRETFGSRRR 306
++ L+ EI+ L H NIVQYL D E F + ME + LS +R +G +
Sbjct: 48 YVQPLHEEIALHSYLKHRNIVQYLG--SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKD 105
Query: 307 NSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366
N ++ QI G+++LH +I H ++ N+ + S G VK+S FG T+
Sbjct: 106 NE---QTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYS--GV--VKISDFG--TS 156
Query: 367 RTYASRNTPPASPQNQTAPNPYIWYAPEVLAE-QEGTGSTSTSKCSEKADVYSFGMLCFE 425
+ A N P +T + APEV+ + G G+ AD++S G E
Sbjct: 157 KRLAGIN-----PCTETFTGTLQYMAPEVIDKGPRGYGAP--------ADIWSLGCTIVE 203
Query: 426 LLTGKVPF-EDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSI 484
+ TGK PF E G Q M K P P N +C+ +P +R S +
Sbjct: 204 MATGKPPFIELGEPQA-AMFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDL 262
Query: 485 CR 486
+
Sbjct: 263 LQ 264
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 50/195 (25%), Positives = 81/195 (41%), Gaps = 31/195 (15%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMS----KDLSCYMRETFGS 303
+L+ L EI T L HPNI+ Y+ F E ++V LM+ +DL ++ F
Sbjct: 42 DLKLLQQEIITSRQLQHPNILPYVTSFIV--DSELYVVSPLMAYGSCEDL---LKTHF-- 94
Query: 304 RRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGL 363
+ I+ + ++++H++ H + S+I L V +SG
Sbjct: 95 --PEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDG-----KVVLSGL-- 145
Query: 364 STARTYAS---RNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFG 420
+ + R + N W +PEVL +Q G EK+D+YS G
Sbjct: 146 RYSVSMIKHGKRQRVVHDFPKSSVKNLP-WLSPEVL-QQNLQGYN------EKSDIYSVG 197
Query: 421 MLCFELLTGKVPFED 435
+ EL G VPF+D
Sbjct: 198 ITACELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 67/248 (27%), Positives = 107/248 (43%), Gaps = 29/248 (11%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFC--DEEKKEF---FLVMELMSK-DLSCYMRETF 301
E+E +E M HPN+++ L G C E + + +++ M DL ++ +
Sbjct: 43 EMEDFLSEAVCMKEFDHPNVMR-LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSR 101
Query: 302 GSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGF 361
++V M IA GME+L ++ H +L N L +V V+ F
Sbjct: 102 LGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNEN-----MNVCVADF 156
Query: 362 GLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGM 421
GLS + Y Q + A P W A E LA++ T K+DV+SFG+
Sbjct: 157 GLSK-KIYNG----DYYRQGRIAKMPVKWIAIESLADRVYT---------TKSDVWSFGV 202
Query: 422 LCFELLT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPS 480
+E+ T G+ P+ ++ ++ +R G R P L +L CW NP RPS
Sbjct: 203 TMWEIATRGQTPYPG--VENSEIYDYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPS 260
Query: 481 FSSICRIL 488
F ++ L
Sbjct: 261 FETLRCEL 268
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 3e-13
Identities = 51/180 (28%), Positives = 85/180 (47%), Gaps = 21/180 (11%)
Query: 306 RNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365
+ +L ++ Q+A+GMEFL ++K H +L NI L ++ VK+ FGL
Sbjct: 173 KKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNV-----VKICDFGL-- 225
Query: 366 ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFE 425
AR P + A P W APE + ++ T ++DV+SFG+L +E
Sbjct: 226 ARDIYK---DPDYVRKGDARLPLKWMAPETIFDRVYT---------IQSDVWSFGVLLWE 273
Query: 426 LLT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSI 484
+ + G P+ + ++ + ++ G R P + + CWH PSQRP+FS +
Sbjct: 274 IFSLGASPYPGVKID-EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSEL 332
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 4e-13
Identities = 48/230 (20%), Positives = 92/230 (40%), Gaps = 28/230 (12%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVV 314
EI + L HPNI+ Y F D+ + ME + + + ++ F +V
Sbjct: 49 EIVILSLLQHPNIIAYYNHFMDD--NTLLIEMEYAN---GGTLYDKIVRQKGQLFEEEMV 103
Query: 315 VDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNT 374
+ + QI + ++H I H ++ NI+L + +K+ FG+S +
Sbjct: 104 LWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGL-----IKLGDFGISKIL-----GS 153
Query: 375 PPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFE 434
+ + PY + +PE+ K + K+D+++ G + +ELLT K F+
Sbjct: 154 EYSMAETVVG-TPY-YMSPELCQGV---------KYNFKSDIWALGCVLYELLTLKRTFD 202
Query: 435 DGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSI 484
+ + I G S L++L +P +RP+ +
Sbjct: 203 ATNPL--NLVVKIVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEV 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 4e-13
Identities = 65/247 (26%), Positives = 116/247 (46%), Gaps = 41/247 (16%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFSLP- 312
EI + L+HPN+++YL F E E +V+EL DLS M + F ++R +P
Sbjct: 52 EIDLLKQLNHPNVIKYLDSFI--EDNELNIVLELADAGDLS-QMIKYFKKQKR---LIPE 105
Query: 313 -VVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYAS 371
V +Q+ +E +H++++ H ++ P+N+++ A + VK+ GL R ++S
Sbjct: 106 RTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGV-----VKLGDLGL--GRFFSS 158
Query: 372 RNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKV 431
+ T S PY + +PE + E + + K+D++S G L +E+ +
Sbjct: 159 KTTAAHS----LVGTPY-YMSPERIHE---------NGYNFKSDIWSLGCLLYEMAALQS 204
Query: 432 PFEDGHLQGDKMT-----KNIRAGERPLFPSGS-PKYLVNLTKKCWHTNPSQRPSFSSIC 485
PF GDKM + I + P P+ + L L C + +P QRP +
Sbjct: 205 PF-----YGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVH 259
Query: 486 RILRYIK 492
+I + +
Sbjct: 260 QIAKQMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 4e-13
Identities = 47/180 (26%), Positives = 78/180 (43%), Gaps = 36/180 (20%)
Query: 254 AEISTMLSLS-HPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLP 312
EI + LS HPNI++ + D + LV ELM +L ++ R+
Sbjct: 46 REIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMDMNLYELIKG-----RKRPLPEK 100
Query: 313 VVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASR 372
V M Q+ + ++ +H I+H ++ P NI +K +K++ FG + R S+
Sbjct: 101 RVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKDD------ILKLADFG--SCRGIYSK 152
Query: 373 NTPPASPQNQTAPNPYI---WY-APEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT 428
PP + YI WY APE L + K D+++ G + FE+L+
Sbjct: 153 --PPYT--------EYISTRWYRAPECL--------LTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 5e-13
Identities = 50/238 (21%), Positives = 90/238 (37%), Gaps = 48/238 (20%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVV 314
E+ + + P IV + F + + + ME M + + ++
Sbjct: 49 ELDILHKCNSPYIVGFYGAFYNN--GDISICMEYMD----GGSLDKILKEVQGRIPERIL 102
Query: 315 VDIMLQIARGMEFLHAQ-KIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST------AR 367
I + + +G+ +LH + KI H ++ PSNI + +R +K+ FG+S A+
Sbjct: 103 GKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRG-----QIKLCDFGVSGQLVNSLAK 157
Query: 368 TYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELL 427
T+ + Y+ APE + + S K+D++S G+ EL
Sbjct: 158 TFV-------------GTSSYM--APERI---------QGNDYSVKSDIWSLGLSLIELA 193
Query: 428 TGKVPFEDGHLQGDKMT----KNIRAGERPLFPSGS-PKYLVNLTKKCWHTNPSQRPS 480
TG+ P+ + I P PSG + C +P +RPS
Sbjct: 194 TGRFPY-PPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPS 250
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.5 bits (177), Expect = 6e-13
Identities = 66/258 (25%), Positives = 116/258 (44%), Gaps = 49/258 (18%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELM-SKDLS-----CYMRETF 301
E L E++ M L H NIV+Y+ F ++ ++ +++ME + DLS CY + F
Sbjct: 55 EKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCY--KMF 112
Query: 302 GSRRRNSFSLPVVVDIMLQIARGMEFLH-------AQKIYHGELNPSNIYL--------- 345
G ++ +VDI Q+ + + H +++ H +L P NI+L
Sbjct: 113 GKIEEHA-----IVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167
Query: 346 ---KARSMEGYFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGT 402
+A ++ G K+ FGL S+N S + PY W +PE+L +
Sbjct: 168 ITAQANNLNGRPIAKIGDFGL-------SKNIGIESMAHSCVGTPYYW-SPELLLHE--- 216
Query: 403 GSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKY 462
T +K+D+++ G + +EL +GK PF + +++ R + P+ G K
Sbjct: 217 ----TKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRGPDLPI--KGKSKE 270
Query: 463 LVNLTKKCWHTNPSQRPS 480
L L K + + +RPS
Sbjct: 271 LNILIKNLLNLSAKERPS 288
|
Length = 1021 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 6e-13
Identities = 67/248 (27%), Positives = 103/248 (41%), Gaps = 36/248 (14%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKK----EF--------FLVMELMSKDLSCYMRETFG 302
E S M L HPNIV L E+ E+ FL+M D+ C E
Sbjct: 57 EASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDED-- 114
Query: 303 SRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFG 362
++S + I +QIA GME+L + H +L NI + + HVK+S G
Sbjct: 115 GTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ-----LHVKISDLG 169
Query: 363 LSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGML 422
LS R S + P++ P W PE + K S +D++SFG++
Sbjct: 170 LS--REIYSADYYRVQPKSLL---PIRWMPPEAIM---------YGKFSSDSDIWSFGVV 215
Query: 423 CFELLT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSF 481
+E+ + G P+ ++ + +R + P + +L +CW PS+RP F
Sbjct: 216 LWEIFSFGLQPYYG--FSNQEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRF 273
Query: 482 SSICRILR 489
I LR
Sbjct: 274 KDIHTRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 6e-13
Identities = 60/249 (24%), Positives = 97/249 (38%), Gaps = 54/249 (21%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMS----KDLSCYMRETFGS 303
+ E + EIS + HPNIV Y + +K ++VME +D+ R
Sbjct: 43 DFEIIQQEISMLKECRHPNIVAYFGSYLRRDK--LWIVMEYCGGGSLQDIYQVTRGP--- 97
Query: 304 RRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGL 363
S + + + +G+ +LH H ++ +NI L VK++ FG+
Sbjct: 98 -----LSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDG-----DVKLADFGV 147
Query: 364 ST--ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGM 421
S T A R + +P W APEV A + G K D+++ G+
Sbjct: 148 SAQLTATIAKRKSFIGTP---------YWMAPEVAAVERKGGYD------GKCDIWALGI 192
Query: 422 LCFELLTGKVPFEDGH----LQGDKMTKNIRAGERPLFPS------GSPKYLVNLTKKCW 471
EL + P D H L ++K+ P P SP + + KKC
Sbjct: 193 TAIELAELQPPMFDLHPMRALF--LISKS---NFPP--PKLKDKEKWSPVF-HDFIKKCL 244
Query: 472 HTNPSQRPS 480
+P +RP+
Sbjct: 245 TKDPKKRPT 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 6e-13
Identities = 50/171 (29%), Positives = 83/171 (48%), Gaps = 21/171 (12%)
Query: 319 LQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTPPAS 378
Q+ARGMEFL ++K H +L NI L ++ VK+ FGL AR P
Sbjct: 181 FQVARGMEFLASRKCIHRDLAARNILLSENNV-----VKICDFGL--ARDIYK---DPDY 230
Query: 379 PQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGH 437
+ +A P W APE + ++ T ++DV+SFG+L +E+ + G P+
Sbjct: 231 VRKGSARLPLKWMAPESIFDKVYT---------TQSDVWSFGVLLWEIFSLGASPYPGVQ 281
Query: 438 LQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRIL 488
+ + + ++ G R P + + + CW +P +RP+FS++ IL
Sbjct: 282 INEE-FCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 57/194 (29%), Positives = 94/194 (48%), Gaps = 25/194 (12%)
Query: 250 ESLNAEISTMLSLS-HPNIVQYLCGFCDEEKK---EFFLVMELMSKDLSCYMRETFGSRR 305
E + AE + + +LS HPN+V++ + ++ K + +LV+EL + + + F +R
Sbjct: 59 EEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGF-LKR 117
Query: 306 RNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365
P++ I+ + G++ LH K H ++ +NI L + EG VK+ FG+S
Sbjct: 118 GERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILL---TTEG--GVKLVDFGVSA 172
Query: 366 --ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLC 423
T RNT +P W APEV+A ++ ST ++C DV+S G+
Sbjct: 173 QLTSTRLRRNTSVGTP---------FWMAPEVIACEQQLDSTYDARC----DVWSLGITA 219
Query: 424 FELLTGKVPFEDGH 437
EL G P D H
Sbjct: 220 IELGDGDPPLADLH 233
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.8 bits (169), Expect = 1e-12
Identities = 67/255 (26%), Positives = 98/255 (38%), Gaps = 58/255 (22%)
Query: 248 ELESLNAEISTMLSLS-HPNIVQYLCGFCDE----EKKEFFLVMELMS----KDLSCYMR 298
E E + E + + S HPNI + F + + +LVMEL DL +R
Sbjct: 45 EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLR 104
Query: 299 ETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKV 358
++ + I+ + RG+ +LH K+ H ++ NI L + VK+
Sbjct: 105 -----KKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILL---TKNA--EVKL 154
Query: 359 SGFGLST--ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADV 416
FG+S T RNT +P W APEV+A E ++ ++ DV
Sbjct: 155 VDFGVSAQLDSTLGRRNTFIGTP---------YWMAPEVIACDEQPDASYDARS----DV 201
Query: 417 YSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLF--PSGSP----------KYLV 464
+S G+ EL GK P D H M R LF P P K
Sbjct: 202 WSLGITAIELADGKPPLCDMH----PM--------RALFKIPRNPPPTLKSPENWSKKFN 249
Query: 465 NLTKKCWHTNPSQRP 479
+ +C N QRP
Sbjct: 250 DFISECLIKNYEQRP 264
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 69.5 bits (171), Expect = 1e-12
Identities = 68/250 (27%), Positives = 102/250 (40%), Gaps = 60/250 (24%)
Query: 264 HPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIAR 323
HPNIV+ L E K+ +LV E M DL +R + IM Q+ +
Sbjct: 66 HPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHKRY-------IMYQLLK 118
Query: 324 GMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTPPASPQNQT 383
++++H+ + H +L PSNI L + VK++ FGL AR+ + P +P
Sbjct: 119 ALKYIHSGNVIHRDLKPSNILLNSDC-----RVKLADFGL--ARSLSELEENPENP---- 167
Query: 384 APNPYI---WY-APEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPF------ 433
Y+ WY APE+L GST +K D++S G + E+L GK F
Sbjct: 168 VLTDYVATRWYRAPEIL-----LGSTRYTK---GVDMWSVGCILGEMLLGKPLFPGTSTL 219
Query: 434 ---------------ED----GHLQGDKMTKNIRAGER----PLFPSGSPKYLVNLTKKC 470
ED M ++ + R L P S L +L KK
Sbjct: 220 NQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDAL-DLLKKL 278
Query: 471 WHTNPSQRPS 480
NP++R +
Sbjct: 279 LVFNPNKRLT 288
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 65/243 (26%), Positives = 110/243 (45%), Gaps = 36/243 (14%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRR 306
E E E++ + ++ HPNIVQY F EE ++VM+ DL Y + ++R
Sbjct: 42 EREESRKEVAVLSNMKHPNIVQYQESF--EENGNLYIVMDYCEGGDL--YKK--INAQRG 95
Query: 307 NSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366
F ++D +QI ++ +H +KI H ++ NI+L +K+ FG+ A
Sbjct: 96 VLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT-----IKLGDFGI--A 148
Query: 367 RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFEL 426
R S PY + +PE+ + + K+D+++ G + +E+
Sbjct: 149 RVLNS----TVELARTCIGTPY-YLSPEICENR---------PYNNKSDIWALGCVLYEM 194
Query: 427 LTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKY---LVNLTKKCWHTNPSQRPSFSS 483
T K FE G+++ + + K IR +P S Y L NL + + NP RPS +S
Sbjct: 195 CTLKHAFEAGNMK-NLVLKIIRGS----YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNS 249
Query: 484 ICR 486
I
Sbjct: 250 ILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 68/249 (27%), Positives = 114/249 (45%), Gaps = 34/249 (13%)
Query: 249 LESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRN 307
+E LN E S M + ++V+ L G + + +VMELM+ DL Y+R N
Sbjct: 54 IEFLN-EASVMKGFTCHHVVRLL-GVVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENN 110
Query: 308 SFSLPVVVDIMLQ----IARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGL 363
P + M+Q IA GM +L+A+K H +L N + F VK+ FG+
Sbjct: 111 PGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHD-----FTVKIGDFGM 165
Query: 364 STARTYASRNTPPASPQNQTAPN--PYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGM 421
+ R+ + P W APE L + G +TS +D++SFG+
Sbjct: 166 T-------RDIYETDYYRKGGKGLLPVRWMAPESLKD----GVFTTS-----SDMWSFGV 209
Query: 422 LCFELLT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPS 480
+ +E+ + + P++ L +++ K + G P P+ + +L + CW NP RP+
Sbjct: 210 VLWEITSLAEQPYQG--LSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPT 267
Query: 481 FSSICRILR 489
F I +L+
Sbjct: 268 FLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 57/210 (27%), Positives = 93/210 (44%), Gaps = 31/210 (14%)
Query: 283 FLVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQ----IARGMEFLHAQKIYHGE 337
++MELM++ DL Y+R N P + M+Q IA GM +L+A K H +
Sbjct: 85 LVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRD 144
Query: 338 LNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTPPASPQNQTAPN--PYIWYAPEV 395
L N + F VK+ FG++ R+ + P W +PE
Sbjct: 145 LAARNCMVAED-----FTVKIGDFGMT-------RDIYETDYYRKGGKGLLPVRWMSPES 192
Query: 396 LAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGDKMTKNIRAGERPL 454
L ++G +T + DV+SFG++ +E+ T + P++ + +++ + + G
Sbjct: 193 L--KDGVFTTYS-------DVWSFGVVLWEIATLAEQPYQG--MSNEQVLRFVMEGGLLD 241
Query: 455 FPSGSPKYLVNLTKKCWHTNPSQRPSFSSI 484
P P L L + CW NP RPSF I
Sbjct: 242 KPDNCPDMLFELMRMCWQYNPKMRPSFLEI 271
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 3e-12
Identities = 50/178 (28%), Positives = 81/178 (45%), Gaps = 24/178 (13%)
Query: 307 NSFSLPV--VVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS 364
F+LP+ +V M+ IA GME+L ++ H +L N L +M V V+ FGLS
Sbjct: 106 EPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCML-NENMT----VCVADFGLS 160
Query: 365 TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCF 424
+ Y+ Q + P W A E LA+ T +DV++FG+ +
Sbjct: 161 K-KIYSG----DYYRQGCASKLPVKWLALESLADNVYT---------THSDVWAFGVTMW 206
Query: 425 ELLT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSF 481
E++T G+ P+ ++ ++ + G R P + + L +CW P RPSF
Sbjct: 207 EIMTRGQTPYAG--VENSEIYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSF 262
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 3e-12
Identities = 66/260 (25%), Positives = 118/260 (45%), Gaps = 44/260 (16%)
Query: 223 RLGASSQFKEIQWLGDSFVLRHFYGELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEF 282
+ + ++ I+ L +L+ +++ + E S ++ LSHP IV +C F D E + +
Sbjct: 38 KHKGTGEYYAIKCLKKREILK--MKQVQHVAQEKSILMELSHPFIVNMMCSFQD-ENRVY 94
Query: 283 FLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSN 342
FL+ ++ +L ++R+ R N + +++L E+LH++ I + +L P N
Sbjct: 95 FLLEFVVGGELFTHLRK--AGRFPNDVAKFYHAELVL----AFEYLHSKDIIYRDLKPEN 148
Query: 343 IYLKARSMEGYFHVKVSGFGLS---TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQ 399
+ L + HVKV+ FG + RT+ TP + APEV+
Sbjct: 149 LLLDNKG-----HVKVTDFGFAKKVPDRTFTLCGTPE-------------YLAPEVI--- 187
Query: 400 EGTGSTSTSKCSEKA-DVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSG 458
SK KA D ++ G+L +E + G PF D ++ + I AG R FP+
Sbjct: 188 -------QSKGHGKAVDWWTMGVLLYEFIAGYPPFFDD--TPFRIYEKILAG-RLKFPNW 237
Query: 459 SPKYLVNLTKKCWHTNPSQR 478
+L K T+ ++R
Sbjct: 238 FDGRARDLVKGLLQTDHTKR 257
|
Length = 329 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 6e-12
Identities = 62/242 (25%), Positives = 98/242 (40%), Gaps = 38/242 (15%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRN 307
E + E + LSHPNI++Y F E K +VME + E R +
Sbjct: 42 ERLAAQNECQVLKLLSHPNIIEYYENFL--EDKALMIVMEYAPGGT---LAEYIQKRCNS 96
Query: 308 SFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS--- 364
++ +QI + +H + I H +L NI L M VK+ FG+S
Sbjct: 97 LLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMV----VKIGDFGISKIL 152
Query: 365 --TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGML 422
++ Y TP YI +PE+ EG ++K+D+++ G +
Sbjct: 153 SSKSKAYTVVGTP-----------CYI--SPELC---EG------KPYNQKSDIWALGCV 190
Query: 423 CFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFS 482
+EL + K FE +L + K + P+ SP L L + +PS+RP S
Sbjct: 191 LYELASLKRAFEAANLPALVL-KIMSGTFAPISDRYSPD-LRQLILSMLNLDPSKRPQLS 248
Query: 483 SI 484
I
Sbjct: 249 QI 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 7e-12
Identities = 67/269 (24%), Positives = 110/269 (40%), Gaps = 61/269 (22%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVV 314
E+ M P IV + F +E + ME M + + G P+
Sbjct: 53 ELQIMHECRSPYIVSFYGAFLNE--NNICMCMEFMDCGSLDRIYKKGG---------PIP 101
Query: 315 VDIMLQIA----RGMEFLH-AQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS----- 364
V+I+ +IA G+ +L+ +I H ++ PSNI + +R +K+ FG+S
Sbjct: 102 VEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRG-----QIKLCDFGVSGELIN 156
Query: 365 -TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLC 423
A T+ +T + +PE + Q G K + K+DV+S G+
Sbjct: 157 SIADTFVGTST---------------YMSPERI--QGG-------KYTVKSDVWSLGISI 192
Query: 424 FELLTGKVPF----EDGHLQGDKMT-----KNIRAGERPLFPSGS-PKYLVNLTKKCWHT 473
EL GK PF D Q D M + I P PS P+ L + C
Sbjct: 193 IELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLK 252
Query: 474 NPSQRPSFSSICRILRYIKKFMANNPDIA 502
+P++RP+ +C + +I+ A+N D+
Sbjct: 253 DPTERPTPQQLCAMPPFIQALRASNVDLQ 281
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 65.7 bits (161), Expect = 1e-11
Identities = 62/236 (26%), Positives = 96/236 (40%), Gaps = 52/236 (22%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELM-SKDLSCYMRETFGSRRRNSFSLPV 313
E + +HP IV+ F D KK +++ME +L +R+ R F
Sbjct: 43 EKEILEECNHPFIVKLYRTFKD--KKYIYMLMEYCLGGELWTILRD------RGLFDEYT 94
Query: 314 VVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGL-----START 368
+ + E+LH + I + +L P N+ L + GY VK+ FG S +T
Sbjct: 95 ARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDS---NGY--VKLVDFGFAKKLKSGQKT 149
Query: 369 YASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT 428
+ TP Y+ APE++ +G + D +S G+L +ELLT
Sbjct: 150 WTFCGTPE-----------YV--APEII-LNKGYDFS--------VDYWSLGILLYELLT 187
Query: 429 GKVPFEDGHLQGDKMT--KNIRAGERPLFPSGSPKYL----VNLTKKCWHTNPSQR 478
G+ PF G D M +I G L P Y+ +L K+ NP +R
Sbjct: 188 GRPPF--GEDDEDPMEIYNDILKGNGKLE---FPNYIDKAAKDLIKQLLRRNPEER 238
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 61/229 (26%), Positives = 99/229 (43%), Gaps = 51/229 (22%)
Query: 260 LSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIM 318
L+ HP + Q C + K F VME ++ DL +++ S R F P
Sbjct: 51 LAGKHPFLTQLHS--CFQTKDRLFFVMEYVNGGDLMFHIQR---SGR---FDEPRARFYA 102
Query: 319 LQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS--------TARTYA 370
+I G++FLH + I + +L N+ L + EG H+K++ FG+ T T+
Sbjct: 103 AEIVLGLQFLHERGIIYRDLKLDNVLLDS---EG--HIKIADFGMCKEGILGGVTTSTFC 157
Query: 371 SRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGK 430
TP YI APE+L+ Q + D ++ G+L +E+L G+
Sbjct: 158 G--TPD-----------YI--APEILSYQPYGPA---------VDWWALGVLLYEMLAGQ 193
Query: 431 VPFE-DGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQR 478
PFE D D++ ++I E +P K ++ K NP +R
Sbjct: 194 SPFEGDDE---DELFQSILEDE-VRYPRWLSKEAKSILKSFLTKNPEKR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 64/239 (26%), Positives = 106/239 (44%), Gaps = 27/239 (11%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRN 307
E E+ E+ + + HPNIV + F +E F+VME D M+ +R
Sbjct: 42 EKEASKKEVILLAKMKHPNIVTFFASF--QENGRLFIVMEYC--DGGDLMKR-INRQRGV 96
Query: 308 SFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTAR 367
FS ++ +QI+ G++ +H +KI H ++ NI+L M K+ FG AR
Sbjct: 97 LFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVA----KLGDFG--IAR 150
Query: 368 TYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELL 427
N PY + +PE+ + + K D++S G + +EL
Sbjct: 151 QL---NDSMELAYT-CVGTPY-YLSPEICQNR---------PYNNKTDIWSLGCVLYELC 196
Query: 428 TGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486
T K PFE +L + K + P+ P+ S + L +L + + +P RPS +SI +
Sbjct: 197 TLKHPFEGNNLH-QLVLKICQGYFAPISPNFS-RDLRSLISQLFKVSPRDRPSITSILK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 55/221 (24%), Positives = 102/221 (46%), Gaps = 31/221 (14%)
Query: 262 LSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGS--RRRNSFSLPVVVDIML 319
L HPNIV+Y F + ++ ++VM+L+ + E F S ++ F+ + +I +
Sbjct: 66 LRHPNIVRYYKTFLENDR--LYIVMDLIE---GAPLGEHFNSLKEKKQRFTEERIWNIFV 120
Query: 320 QIARGMEFLHAQK-IYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTPPAS 378
Q+ + +LH +K I H +L P+NI L V ++ FGL+ + S+ T
Sbjct: 121 QMVLALRYLHKEKRIVHRDLTPNNIMLGEDD-----KVTITDFGLAKQKQPESKLT---- 171
Query: 379 PQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHL 438
+ ++ PE++ + E G EKADV++FG + +++ T + PF ++
Sbjct: 172 ----SVVGTILYSCPEIV-KNEPYG--------EKADVWAFGCILYQMCTLQPPFYSTNM 218
Query: 439 QGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRP 479
TK + A PL + + ++ C + RP
Sbjct: 219 L-SLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARP 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 1e-11
Identities = 61/238 (25%), Positives = 100/238 (42%), Gaps = 33/238 (13%)
Query: 254 AEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKD-LSCYMRETFGSRRRNSFSLP 312
AE T+ H NIV+ L G +V E MS L ++R +
Sbjct: 55 AEALTLGQFDHSNIVR-LEGVI-TRGNTMMIVTEYMSNGALDSFLR-----KHEGQLVAG 107
Query: 313 VVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFG-LSTARTYAS 371
++ ++ +A GM++L H L + + + K+SGF L ++ A
Sbjct: 108 QLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSD-----LVCKISGFRRLQEDKSEAI 162
Query: 372 RNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GK 430
T + +P +W APE + Q S+++ DV+SFG++ +E+++ G+
Sbjct: 163 YTT-------MSGKSPVLWAAPEAI--QYHHFSSAS-------DVWSFGIVMWEVMSYGE 206
Query: 431 VPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRIL 488
P+ D + G + K + G R P P L L CW +RP FS I IL
Sbjct: 207 RPYWD--MSGQDVIKAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSIL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 61/248 (24%), Positives = 102/248 (41%), Gaps = 46/248 (18%)
Query: 253 NAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMS-KDLSCYMRETFGSRRRNSFSL 311
N E + L HP IV++ F E+ F ++ E +DL C + E + S
Sbjct: 50 NQEAQLLSKLDHPAIVKFHASFL--ERDAFCIITEYCEGRDLDCKLEEL--KHTGKTLSE 105
Query: 312 PVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST------ 365
V + +Q+ G+ ++H ++I H +L NI+LK +K+ FG+S
Sbjct: 106 NQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNNL------LKIGDFGVSRLLMGSC 159
Query: 366 --ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLC 423
A T+ PY + +PE L Q G S K+D++S G +
Sbjct: 160 DLATTFTG--------------TPY-YMSPEALKHQ---GYDS------KSDIWSLGCIL 195
Query: 424 FELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSS 483
+E+ FE + + I G P P + L ++ + + +PS RPS +
Sbjct: 196 YEMCCLAHAFEGQNFLS--VVLRIVEGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAE 253
Query: 484 ICRILRYI 491
I R +I
Sbjct: 254 ILRN-PFI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 4e-11
Identities = 60/236 (25%), Positives = 102/236 (43%), Gaps = 25/236 (10%)
Query: 254 AEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPV 313
+E S M HPNI+ L G + + + + + L ++R+ G F++
Sbjct: 54 SEASIMGQFDHPNIIH-LEGVVTKSRPVMIITEFMENGALDSFLRQNDGQ-----FTVIQ 107
Query: 314 VVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRN 373
+V ++ IA GM++L H +L NI + + + KVS FGLS R
Sbjct: 108 LVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLV-----CKVSDFGLS--RFLEDDT 160
Query: 374 TPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVP 432
+ P + P W APE +A ++ T ++ DV+S+G++ +E+++ G+ P
Sbjct: 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSAS---------DVWSYGIVMWEVMSYGERP 211
Query: 433 FEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRIL 488
+ D + + I R P P L L CW + + RP F I L
Sbjct: 212 YWD--MSNQDVINAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTL 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 7e-11
Identities = 47/170 (27%), Positives = 79/170 (46%), Gaps = 21/170 (12%)
Query: 320 QIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTPPASP 379
Q+ARGMEFL ++ H +L N+ L + VK+ FGL+ + S S
Sbjct: 245 QVARGMEFLASKNCVHRDLAARNVLLAQGKI-----VKICDFGLARDIMHDSNYVSKGS- 298
Query: 380 QNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHL 438
P W APE + + T +DV+S+G+L +E+ + G P+ G +
Sbjct: 299 ----TFLPVKWMAPESIFDNLYT---------TLSDVWSYGILLWEIFSLGGTPYP-GMI 344
Query: 439 QGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRIL 488
I++G R P + + + ++ KCW++ P +RPSF + I+
Sbjct: 345 VDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIV 394
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 7e-11
Identities = 53/194 (27%), Positives = 86/194 (44%), Gaps = 25/194 (12%)
Query: 250 ESLNAEISTMLSLS-HPNIVQYLCGFCDEEK---KEFFLVMELMSKDLSCYMRETFGSRR 305
E + AE + + SL HPN+V++ F +K + +LV+EL + + +
Sbjct: 63 EEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGL-LIC 121
Query: 306 RNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365
++ I+ G++ LH +I H ++ +NI L EG VK+ FG+S
Sbjct: 122 GQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTT---EG--GVKLVDFGVSA 176
Query: 366 ARTYA--SRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLC 423
T RNT +P W APEV+A ++ + ++C DV+S G+
Sbjct: 177 QLTSTRLRRNTSVGTP---------FWMAPEVIACEQQYDYSYDARC----DVWSLGITA 223
Query: 424 FELLTGKVPFEDGH 437
EL G P D H
Sbjct: 224 IELGDGDPPLFDMH 237
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 8e-11
Identities = 66/252 (26%), Positives = 100/252 (39%), Gaps = 53/252 (21%)
Query: 248 ELESLNAEISTMLSLSH-PNIVQYLCGFCDE----EKKEFFLVMELM-SKDLSCYMRETF 301
E E + EI+ + SH NI Y F + + +LVME + ++ ++ T
Sbjct: 55 EEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTK 114
Query: 302 GSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGF 361
G N+ + I +I RG+ LHA K+ H ++ N+ L + VK+ F
Sbjct: 115 G----NALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENA-----EVKLVDF 165
Query: 362 GLSTA--RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSF 419
G+S RT RNT +P W APEV+A E +T ++D++S
Sbjct: 166 GVSAQLDRTVGRRNTFIGTP---------YWMAPEVIACDENPDATY----DYRSDIWSL 212
Query: 420 GMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLF--PSGSP---------KYLVNLTK 468
G+ E+ G P D H R LF P P K ++ +
Sbjct: 213 GITAIEMAEGAPPLCDMHPM------------RALFLIPRNPPPKLKSKKWSKKFIDFIE 260
Query: 469 KCWHTNPSQRPS 480
C N RPS
Sbjct: 261 GCLVKNYLSRPS 272
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 9e-11
Identities = 59/233 (25%), Positives = 90/233 (38%), Gaps = 22/233 (9%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRN 307
E E L E+ + SL H NIVQYL G C ++ + ME + + FG
Sbjct: 45 EYEKLQEEVDLLKSLKHVNIVQYL-GTCLDDNT-ISIFMEFVPGGSISSILNRFG----- 97
Query: 308 SFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTAR 367
PV QI G+ +LH + H ++ +N+ L + +K+ FG +
Sbjct: 98 PLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGI-----IKLIDFGCARRL 152
Query: 368 TYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELL 427
+ + ++ PY W APEV+ E G G K+D++S G FE+
Sbjct: 153 AWVGLHGTHSNMLKSMHGTPY-WMAPEVINES-GYG--------RKSDIWSIGCTVFEMA 202
Query: 428 TGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPS 480
TGK P G P P ++ C + +RPS
Sbjct: 203 TGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPS 255
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 9e-11
Identities = 64/237 (27%), Positives = 103/237 (43%), Gaps = 34/237 (14%)
Query: 256 ISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMS-KDLSCYMRETFGSRRRNSFSLPVV 314
S M LSH ++V+ L G C + E +V E + L ++ R +N+ SL
Sbjct: 52 ASLMSQLSHKHLVK-LYGVC--VRDENIMVEEYVKFGPLDVFLH-----REKNNVSLHWK 103
Query: 315 VDIMLQIARGMEFLHAQKIYHGELNPSNIYL-KARSMEGY-FHVKVSGFGLSTARTYASR 372
+D+ Q+A + +L +K+ HG + NI + + EGY +K+S G+ T SR
Sbjct: 104 LDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP--ITVLSR 161
Query: 373 NTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKV 431
P W APE + ++ T AD +SFG E+ + G+
Sbjct: 162 EER-------VERIP--WIAPECI---RNGQASLTI----AADKWSFGTTLLEICSNGEE 205
Query: 432 PFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRIL 488
P + + + R P + L NL +CW +P++RPSF +I R L
Sbjct: 206 PLSTLSSS--EKERFYQDQHRLPMPDCAE--LANLINQCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 9e-11
Identities = 64/250 (25%), Positives = 102/250 (40%), Gaps = 43/250 (17%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRE-----TFGSRRRNS 308
E + + H NIV++ G C E +V E M DL+ ++R F +
Sbjct: 58 EAELLTNFQHENIVKFY-GVCTEGD-PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSP 115
Query: 309 ---FSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGY-FHVKVSGFGLS 364
+L ++ I +QIA GM +L +Q H +L N + GY VK+ FG+S
Sbjct: 116 MGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRN------CLVGYDLVVKIGDFGMS 169
Query: 365 ----TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFG 420
T Y P W PE S K + ++DV+SFG
Sbjct: 170 RDVYTTDYYRVGGH---------TMLPIRWMPPE---------SIMYRKFTTESDVWSFG 211
Query: 421 MLCFELLT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRP 479
++ +E+ T GK P+ L +++ + I G P P + ++ CW +P QR
Sbjct: 212 VVLWEIFTYGKQPWYG--LSNEEVIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRI 269
Query: 480 SFSSICRILR 489
+ I L+
Sbjct: 270 NIKDIHERLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 61/193 (31%), Positives = 87/193 (45%), Gaps = 46/193 (23%)
Query: 264 HPNIVQYLCGFC-----DEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPV--VVD 316
HPNIV+ L C D E K LV E + +DL Y+ + LP + D
Sbjct: 61 HPNIVR-LMDVCATSRTDRETK-VTLVFEHVDQDLRTYLDKVPPP------GLPAETIKD 112
Query: 317 IMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTPP 376
+M Q RG++FLHA I H +L P NI + + VK++ FGL AR Y+
Sbjct: 113 LMRQFLRGLDFLHANCIVHRDLKPENILVTSGG-----QVKLADFGL--ARIYSC----- 160
Query: 377 ASPQNQTAPNPYI---WY-APEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVP 432
Q A P + WY APEVL + S + D++S G + E+ K P
Sbjct: 161 -----QMALTPVVVTLWYRAPEVLLQ---------STYATPVDMWSVGCIFAEMFRRK-P 205
Query: 433 FEDGHLQGDKMTK 445
G+ + D++ K
Sbjct: 206 LFCGNSEADQLGK 218
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 76/267 (28%), Positives = 106/267 (39%), Gaps = 69/267 (25%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK----DLSCYMRETFGSRRRNSFS 310
EI + L H N+V + F KK +LV E + DL Y N
Sbjct: 50 EIRMLKQLRHENLVNLIEVF--RRKKRLYLVFEFVDHTVLDDLEKY---------PNGLD 98
Query: 311 LPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYA 370
V + QI RG+EF H+ I H ++ P NI + S G VK+ FG ART A
Sbjct: 99 ESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILV---SQSGV--VKLCDFGF--ARTLA 151
Query: 371 SRNTPPASPQNQTAPNPYIWY-APEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTG 429
+ P + A WY APE+L G T + D+++ G L E+LTG
Sbjct: 152 A---PGEVYTDYVATR---WYRAPELL-----VGDTKYGR---AVDIWAVGCLVTEMLTG 197
Query: 430 KVPFEDGHLQGDKMTKNIR-------------------AGER--------PL---FPSGS 459
+ P G D++ I+ AG R PL FP S
Sbjct: 198 E-PLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLS 256
Query: 460 PKYLVNLTKKCWHTNPSQRPSFSSICR 486
+++L K+C +P RPS S +
Sbjct: 257 G-LVLDLAKQCLRIDPDDRPSSSQLLH 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 72/263 (27%), Positives = 118/263 (44%), Gaps = 48/263 (18%)
Query: 224 LGASSQFKEIQWLGDSFVLRHFYGELESLNAEISTM-LSLSHPNIVQYLCGFCDEEKKEF 282
L ++QF I+ L VL ++E E + L+ HP + C F + K+
Sbjct: 16 LKGTNQFFAIKALKKDVVLMD--DDVECTMVEKRVLSLAWEHPFLTHLYCTF--QTKENL 71
Query: 283 FLVME-LMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPS 341
F VME L DL +++ + F LP +I G++FLH++ I + +L
Sbjct: 72 FFVMEYLNGGDLMFHIQSC------HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLD 125
Query: 342 NIYLKARSMEGYFHVKVSGFG------LSTARTYASRNTPPASPQNQTAPNPYIWYAPEV 395
NI L +G H+K++ FG L A+T TP YI APE+
Sbjct: 126 NILL---DTDG--HIKIADFGMCKENMLGDAKTCTFCGTPD-----------YI--APEI 167
Query: 396 LAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLF 455
L Q K + D +SFG+L +E+L G+ PF GH + +++ ++IR + P +
Sbjct: 168 LLGQ---------KYNTSVDWWSFGVLLYEMLIGQSPFH-GHDE-EELFQSIRM-DNPCY 215
Query: 456 PSGSPKYLVNLTKKCWHTNPSQR 478
P + ++ K + P +R
Sbjct: 216 PRWLTREAKDILVKLFVREPERR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 1e-10
Identities = 49/172 (28%), Positives = 79/172 (45%), Gaps = 25/172 (14%)
Query: 320 QIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTPPASP 379
Q+A+GM FL ++ H +L NI L + K+ FGL+ S +
Sbjct: 222 QVAKGMSFLASKNCIHRDLAARNILLTHGRI-----TKICDFGLARDIRNDSNYVVKGN- 275
Query: 380 QNQTAPNPYIWYAPEVLAEQEGTGSTSTSKC--SEKADVYSFGMLCFELLT-GKVPFEDG 436
A P W APE S C + ++DV+S+G+L +E+ + G P+ G
Sbjct: 276 ----ARLPVKWMAPE-----------SIFNCVYTFESDVWSYGILLWEIFSLGSSPYP-G 319
Query: 437 HLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRIL 488
K K I+ G R L P +P + ++ K CW +P +RP+F I +++
Sbjct: 320 MPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLI 371
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 2e-10
Identities = 50/184 (27%), Positives = 82/184 (44%), Gaps = 24/184 (13%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSC---YMRETFGSRRRNSFSL 311
EI+ + L H N+V + F + K +L+ + DL + R+ +R S
Sbjct: 52 EIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQA----KRVSIPP 107
Query: 312 PVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYAS 371
+V ++ QI G+ +LH+ + H +L P+NI + E VK+ GL AR +
Sbjct: 108 SMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERG-VVKIGDLGL--ARLF-- 162
Query: 372 RNTPPASPQNQTAPNPYIWY-APEVLAEQEGTGSTSTSKCSEKA-DVYSFGMLCFELLTG 429
N P + IWY APE+L ++ KA D+++ G + ELLT
Sbjct: 163 -NAPLKPLADLDPVVVTIWYRAPELLL---------GARHYTKAIDIWAIGCIFAELLTL 212
Query: 430 KVPF 433
+ F
Sbjct: 213 EPIF 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 57/249 (22%), Positives = 105/249 (42%), Gaps = 34/249 (13%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRN 307
E+E + EI+ + P + +Y + + K +++ME + + + E
Sbjct: 45 EIEDIQQEITVLSQCDSPYVTKYYGSYLKDTK--LWIIMEYLGGGSALDLLEP------G 96
Query: 308 SFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTAR 367
+ I+ +I +G+++LH++K H ++ +N+ L VK++ FG+
Sbjct: 97 PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHG-----EVKLADFGV---- 147
Query: 368 TYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELL 427
A + T +N P+ W APEV+ + S KAD++S G+ EL
Sbjct: 148 --AGQLTDTQIKRNTFVGTPF-WMAPEVIKQ---------SAYDSKADIWSLGITAIELA 195
Query: 428 TGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR- 486
G+ P + H K+ I P K L + C + PS RP+ + +
Sbjct: 196 KGEPPHSELHPM--KVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253
Query: 487 --ILRYIKK 493
I+R+ KK
Sbjct: 254 KFIVRFAKK 262
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 2e-10
Identities = 49/180 (27%), Positives = 83/180 (46%), Gaps = 31/180 (17%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVME-LMSKDLSCYMRETFGSRRRNSFSLPV 313
EI M HPNIV YL + + E ++VME L L+ + ET
Sbjct: 66 EILVMRENKHPNIVNYLDSYLVGD--ELWVVMEYLAGGSLTDVVTET-------CMDEGQ 116
Query: 314 VVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRN 373
+ + + + +EFLH+ ++ H ++ NI L M+G VK++ FG + ++
Sbjct: 117 IAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDG--SVKLTDFG------FCAQI 165
Query: 374 TPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPF 433
TP S ++ PY W APEV+ + K D++S G++ E++ G+ P+
Sbjct: 166 TPEQSKRSTMVGTPY-WMAPEVVTRKA---------YGPKVDIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 56/251 (22%), Positives = 101/251 (40%), Gaps = 38/251 (15%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRN 307
E+E + EI+ + P I +Y + K +++ME + +
Sbjct: 45 EIEDIQQEITVLSQCDSPYITRYYGSYLKGTK--LWIIMEYLGGG------SALDLLKPG 96
Query: 308 SFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS--T 365
+ I+ +I +G+++LH+++ H ++ +N+ L + VK++ FG++
Sbjct: 97 PLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQG-----DVKLADFGVAGQL 151
Query: 366 ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFE 425
T RNT +P W APEV+ + S KAD++S G+ E
Sbjct: 152 TDTQIKRNTFVGTP---------FWMAPEVIKQ---------SAYDFKADIWSLGITAIE 193
Query: 426 LLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSIC 485
L G+ P D H ++ I P K + C + +P RP+ +
Sbjct: 194 LAKGEPPNSDLHPM--RVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELL 251
Query: 486 R---ILRYIKK 493
+ I RY KK
Sbjct: 252 KHKFITRYTKK 262
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 3e-10
Identities = 56/256 (21%), Positives = 91/256 (35%), Gaps = 57/256 (22%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVV 314
E+ + L H NIV F K +LV E + + L + V
Sbjct: 50 EVKVLRQLRHENIVNLKEAF--RRKGRLYLVFEYVERTLLELLEA-----SPGGLPPDAV 102
Query: 315 VDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNT 374
+ Q+ + + + H+ I H ++ P NI + + +K+ FG AR +R
Sbjct: 103 RSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGV-----LKLCDFGF--ARALRARPA 155
Query: 375 PPASPQNQTAPNPYIWY-APEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPF 433
P + T WY APE+L G T+ K DV++ G + ELL G+ F
Sbjct: 156 SPLTDYVATR-----WYRAPELL-----VGDTNYGK---PVDVWAIGCIMAELLDGEPLF 202
Query: 434 E-DGHL----------------QGDKMTKNIR-AGER--------PL---FPSGSPKYLV 464
D + + + N R AG L +P +
Sbjct: 203 PGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPAL 262
Query: 465 NLTKKCWHTNPSQRPS 480
+ K C +P +R +
Sbjct: 263 DFLKACLRMDPKERLT 278
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 4e-10
Identities = 47/194 (24%), Positives = 69/194 (35%), Gaps = 45/194 (23%)
Query: 252 LNAEISTMLSLSHPNIVQYLCGFCDEEKKE---FFLVMELMSKDLSCYMRETFGSRRRNS 308
E + L HPNIV L D + F V E + T
Sbjct: 25 FRRETALCARLYHPNIVALL----DSGEAPPGLLFAVFEYVPG-------RTLREVLAAD 73
Query: 309 FSLPVV--VDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST- 365
+LP +MLQ+ + H Q I H +L P NI + + H KV FG+ T
Sbjct: 74 GALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRP--HAKVLDFGIGTL 131
Query: 366 -------ARTYASRNTPP-ASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVY 417
+R T +P + APE L + T +D+Y
Sbjct: 132 LPGVRDADVATLTRTTEVLGTPT---------YCAPEQLRGEPVTP---------NSDLY 173
Query: 418 SFGMLCFELLTGKV 431
++G++ E LTG+
Sbjct: 174 AWGLIFLECLTGQR 187
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 61.3 bits (148), Expect = 5e-10
Identities = 50/180 (27%), Positives = 85/180 (47%), Gaps = 31/180 (17%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVME-LMSKDLSCYMRETFGSRRRNSFSLPV 313
EI M L +PNIV +L F + E F+VME L L+ + ET +
Sbjct: 66 EILVMKELKNPNIVNFLDSFLVGD--ELFVVMEYLAGGSLTDVVTETCMDEAQ------- 116
Query: 314 VVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRN 373
+ + + + +EFLHA ++ H ++ N+ L M+G VK++ FG + ++
Sbjct: 117 IAAVCRECLQALEFLHANQVIHRDIKSDNVLL---GMDG--SVKLTDFG------FCAQI 165
Query: 374 TPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPF 433
TP S ++ PY W APEV+ + K D++S G++ E++ G+ P+
Sbjct: 166 TPEQSKRSTMVGTPY-WMAPEVVTRK---------AYGPKVDIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 9e-10
Identities = 60/225 (26%), Positives = 102/225 (45%), Gaps = 43/225 (19%)
Query: 260 LSLSHPNIVQYLCGFCDEEKKEFFLVME-LMSKDLSCYMRET--FGSRRRNSFSLPVVVD 316
L+ HP + C F + K+ F VME L DL +++ + F R ++ ++
Sbjct: 51 LAWEHPFLTHLFCTF--QTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIIC- 107
Query: 317 IMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTY--ASRNT 374
G++FLH + I + +L N+ L +G H+K++ FG+ +T
Sbjct: 108 -------GLQFLHKKGIIYRDLKLDNVLL---DKDG--HIKIADFGMCKENMNGEGKAST 155
Query: 375 PPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFE 434
+P YI APE+L Q K +E D +SFG+L +E+L G+ PF
Sbjct: 156 FCGTPD-------YI--APEILKGQ---------KYNESVDWWSFGVLLYEMLIGQSPF- 196
Query: 435 DGHLQG-DKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQR 478
H + D++ +I +RP FP K + K + +P++R
Sbjct: 197 --HGEDEDELFDSILN-DRPHFPRWISKEAKDCLSKLFERDPTKR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 9e-10
Identities = 48/220 (21%), Positives = 95/220 (43%), Gaps = 26/220 (11%)
Query: 286 MELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQ-KIYHGELNPSNIY 344
ME+M L + ++ + ++ I + I + +E+LH++ + H ++ PSN+
Sbjct: 79 MEVMDTSLDKFYKKVYDKGLT--IPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVL 136
Query: 345 LKARSMEGYFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGS 404
+ VK+ FG+S + T A + PY+ APE +
Sbjct: 137 INRNG-----QVKLCDFGISGYLVDSVAKTIDAGCK------PYM--APERI-----NPE 178
Query: 405 TSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSG--SPKY 462
+ K+DV+S G+ EL TG+ P++ ++ K + P P+ SP+
Sbjct: 179 LNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQL-KQVVEEPSPQLPAEKFSPE- 236
Query: 463 LVNLTKKCWHTNPSQRPSFSSICRILRYIKKFMANNPDIA 502
+ KC N +RP++ + + + + ++ N D+A
Sbjct: 237 FQDFVNKCLKKNYKERPNYPELLQ-HPFFELHLSKNTDVA 275
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 9e-10
Identities = 53/192 (27%), Positives = 91/192 (47%), Gaps = 41/192 (21%)
Query: 310 SLPVVVDIML----QIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365
S P+ +D +L Q+A+GM+FL ++ H ++ N+ L + K+ FGL
Sbjct: 206 SWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRV-----AKICDFGL-- 258
Query: 366 AR------TYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKC--SEKADVY 417
AR Y + A P W APE S C + ++DV+
Sbjct: 259 ARDIMNDSNYVVKGN---------ARLPVKWMAPE-----------SIFDCVYTVQSDVW 298
Query: 418 SFGMLCFELLT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPS 476
S+G+L +E+ + GK P+ G L K K ++ G + P +P + ++ K CW+ P+
Sbjct: 299 SYGILLWEIFSLGKSPYP-GILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPT 357
Query: 477 QRPSFSSICRIL 488
+RP+FS I +++
Sbjct: 358 ERPTFSQISQLI 369
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 1e-09
Identities = 44/192 (22%), Positives = 78/192 (40%), Gaps = 40/192 (20%)
Query: 255 EISTMLSLSHPNIVQYLCGFCD------EEKKEFFLVMELMSKDLSCYMRETFGSRRRNS 308
EI + L HPN+V + + ++ ++V M DLS +
Sbjct: 57 EIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLL-----ENPSVK 111
Query: 309 FSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTART 368
+ + MLQ+ G+ +LH I H ++ +NI + + + +K++ FGL AR
Sbjct: 112 LTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGI-----LKIADFGL--ARP 164
Query: 369 YASRNTPPASPQNQTAPN--PYI------WY-APE-VLAEQEGTGSTSTSKCSEKADVYS 418
Y + PP +P+ Y WY PE +L E+ T + D++
Sbjct: 165 Y---DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAV---------DIWG 212
Query: 419 FGMLCFELLTGK 430
G + E+ T +
Sbjct: 213 IGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 62/242 (25%), Positives = 101/242 (41%), Gaps = 39/242 (16%)
Query: 262 LSHPNIV------------QYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRR-RNS 308
L HPNIV + +C FLVM D+ T + +++
Sbjct: 65 LQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVG----STDDDKTVKST 120
Query: 309 FSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTART 368
V I+ QIA GMEFL + + H +L N+ + + +VK+S GL
Sbjct: 121 LEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK-----LNVKISDLGLFR-EV 174
Query: 369 YASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT 428
YA+ + P W +PE + K S +D++S+G++ +E+ +
Sbjct: 175 YAADYYKLMG----NSLLPIRWMSPEAI---------MYGKFSIDSDIWSYGVVLWEVFS 221
Query: 429 -GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRI 487
G P+ G+ D + + IR + P P ++ L +CW+ PS+RP F I
Sbjct: 222 YGLQPY-CGYSNQD-VIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279
Query: 488 LR 489
LR
Sbjct: 280 LR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 63/252 (25%), Positives = 112/252 (44%), Gaps = 45/252 (17%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSC---YMRE---TFGSRRRNS 308
E M S+ +P++ + L G C + L+ +LM C Y+RE GS+
Sbjct: 59 EAYVMASVDNPHVCRLL-GICLTSTVQ--LITQLMP--FGCLLDYVREHKDNIGSQY--- 110
Query: 309 FSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTART 368
+++ +QIA+GM +L +++ H +L N+ +K HVK++ FGL+
Sbjct: 111 -----LLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQ-----HVKITDFGLAKLLG 160
Query: 369 YASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT 428
+ + P W A E + + T ++DV+S+G+ +EL+T
Sbjct: 161 ADEKEY-----HAEGGKVPIKWMALESILHRIYT---------HQSDVWSYGVTVWELMT 206
Query: 429 -GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRI 487
G P+ DG + +++ + GER P + + KCW + RP F + I
Sbjct: 207 FGSKPY-DG-IPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFREL--I 262
Query: 488 LRYIKKFMANNP 499
+ + K MA +P
Sbjct: 263 IEFSK--MARDP 272
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 53/193 (27%), Positives = 85/193 (44%), Gaps = 42/193 (21%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVV 314
EIS + L HPNIV E + +L+ E +S DL Y+ ++ + +V
Sbjct: 49 EISLLKELQHPNIVCLQDVLMQESR--LYLIFEFLSMDLKKYL-DSLPKGQ--YMDAELV 103
Query: 315 VDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA-----RTY 369
+ QI +G+ F H++++ H +L P N+ + + + +K++ FGL+ A R Y
Sbjct: 104 KSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGV-----IKLADFGLARAFGIPVRVY 158
Query: 370 ASRNTPPASPQNQTAPNPYIWY-APEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT 428
T +WY APEVL GS + S D++S G + E+ T
Sbjct: 159 -------------THEVVTLWYRAPEVL-----LGSP---RYSTPVDIWSIGTIFAEMAT 197
Query: 429 GKVPFEDGHLQGD 441
K F GD
Sbjct: 198 KKPLF-----HGD 205
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 56/251 (22%), Positives = 102/251 (40%), Gaps = 38/251 (15%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRN 307
E+E + EI+ + P + +Y + K +++ME + R
Sbjct: 45 EIEDIQQEITVLSQCDSPYVTKYYGSYLKGTK--LWIIMEYLGGG------SALDLLRAG 96
Query: 308 SFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS--T 365
F + ++ +I +G+++LH++K H ++ +N+ L + VK++ FG++
Sbjct: 97 PFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQG-----DVKLADFGVAGQL 151
Query: 366 ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFE 425
T RNT +P W APEV+ + S KAD++S G+ E
Sbjct: 152 TDTQIKRNTFVGTP---------FWMAPEVIQQ---------SAYDSKADIWSLGITAIE 193
Query: 426 LLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSIC 485
L G+ P D H ++ I P K C + +PS RP+ +
Sbjct: 194 LAKGEPPNSDMHPM--RVLFLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELL 251
Query: 486 R---ILRYIKK 493
+ I++ KK
Sbjct: 252 KHKFIVKNAKK 262
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 65/242 (26%), Positives = 99/242 (40%), Gaps = 33/242 (13%)
Query: 248 ELESLNAEISTMLSLSH-PNIVQYLCGFCDEE----KKEFFLVMELM-SKDLSCYMRETF 301
E E + EI+ + SH NI Y F + + +LVME + ++ ++ T
Sbjct: 45 EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK 104
Query: 302 GSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGF 361
G N+ + I +I RG+ LH K+ H ++ N+ L + VK+ F
Sbjct: 105 G----NTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENA-----EVKLVDF 155
Query: 362 GLSTA--RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSF 419
G+S RT RNT +P W APEV+A E +T K+D++S
Sbjct: 156 GVSAQLDRTVGRRNTFIGTP---------YWMAPEVIACDENPDATYDF----KSDLWSL 202
Query: 420 GMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGS-PKYLVNLTKKCWHTNPSQR 478
G+ E+ G P D H + I P S K + + C N SQR
Sbjct: 203 GITAIEMAEGAPPLCDMHPM--RALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQR 260
Query: 479 PS 480
P+
Sbjct: 261 PT 262
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 57/216 (26%), Positives = 88/216 (40%), Gaps = 51/216 (23%)
Query: 250 ESLNAEISTMLSLSHPNIVQ----YLCGFCDEEKKEFFLVMELMS----KDLSCYMRETF 301
E L E+ M HPNIV+ YL G E ++VME + D+ + R
Sbjct: 61 ELLFNEVVIMRDYQHPNIVEMYSSYLVG------DELWVVMEFLEGGALTDIVTHTR--- 111
Query: 302 GSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGF 361
+ + + L + + + FLHAQ + H ++ +I L + VK+S F
Sbjct: 112 -------MNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDG-----RVKLSDF 159
Query: 362 GLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLA-EQEGTGSTSTSKCSEKADVYSFG 420
G S+ P T PY W APEV++ GT + D++S G
Sbjct: 160 GFCAQ---VSKEVPRRKSLVGT---PY-WMAPEVISRLPYGT----------EVDIWSLG 202
Query: 421 MLCFELLTGKVP-FEDGHLQGDKMTKNIRAGERPLF 455
++ E++ G+ P F + LQ K IR P
Sbjct: 203 IMVIEMVDGEPPYFNEPPLQA---MKRIRDNLPPKL 235
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 53/196 (27%), Positives = 91/196 (46%), Gaps = 41/196 (20%)
Query: 250 ESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVME-LMSKDLSCYMRETFGSRRRNS 308
+ ++ E + +SHP I++ D+ + +++ME + +L Y+R + R
Sbjct: 46 QHVHNEKRVLKEVSHPFIIRLFWTEHDQ--RFLYMLMEYVPGGELFSYLR----NSGR-- 97
Query: 309 FSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA-- 366
FS + +I +E+LH+++I + +L P NI L EG H+K++ FG +
Sbjct: 98 FSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILL---DKEG--HIKLTDFGFAKKLR 152
Query: 367 -RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKA-DVYSFGMLCF 424
RT+ TP Y+ APEV+ SK KA D ++ G+L +
Sbjct: 153 DRTWTLCGTPE-----------YL--APEVIQ----------SKGHNKAVDWWALGILIY 189
Query: 425 ELLTGKVPFEDGHLQG 440
E+L G PF D + G
Sbjct: 190 EMLVGYPPFFDDNPFG 205
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 51/180 (28%), Positives = 85/180 (47%), Gaps = 29/180 (16%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVV 314
E+S + L H NIV L EK LV E + KDL Y+ + NS ++ V
Sbjct: 54 EVSLLKDLKHANIVT-LHDIIHTEKS-LTLVFEYLDKDLKQYLDDC-----GNSINMHNV 106
Query: 315 VDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNT 374
+ Q+ RG+ + H +K+ H +L P N+ + R +K++ FGL+ A++
Sbjct: 107 KLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERG-----ELKLADFGLARAKS-----I 156
Query: 375 PPASPQNQTAPNPYIWY-APEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPF 433
P + N+ +WY P++L GST S + D++ G + +E+ TG+ F
Sbjct: 157 PTKTYSNEVVT---LWYRPPDIL-----LGSTDYST---QIDMWGVGCIFYEMSTGRPLF 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 55/187 (29%), Positives = 85/187 (45%), Gaps = 42/187 (22%)
Query: 255 EISTMLSLSHPNIVQYLCGFCD----EEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFS 310
E+ M ++H NI+ L F EE ++ +LVMELM +L C + + R S+
Sbjct: 65 ELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANL-CQVIQMDLDHERMSY- 122
Query: 311 LPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYA 370
++ Q+ G++ LH+ I H +L PSNI +K+ +K+ FGL ART
Sbjct: 123 ------LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-----LKILDFGL--ARTAG 169
Query: 371 SRNTPPASPQNQTAPNPYI---WY-APEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFEL 426
PY+ +Y APEV+ G G E D++S G + E+
Sbjct: 170 ----------TSFMMTPYVVTRYYRAPEVIL---GMGY------KENVDIWSVGCIMGEM 210
Query: 427 LTGKVPF 433
+ G V F
Sbjct: 211 IRGTVLF 217
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 62/254 (24%), Positives = 110/254 (43%), Gaps = 44/254 (17%)
Query: 243 RHFYGELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRET- 300
R F GELE L L HPNI+ L G C E + +L +E +L ++R++
Sbjct: 52 RDFAGELEVL-----CKLG-HHPNIINLL-GAC-EHRGYLYLAIEYAPHGNLLDFLRKSR 103
Query: 301 ---------FGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSME 351
+ ++ S ++ +ARGM++L ++ H +L NI +
Sbjct: 104 VLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN--- 160
Query: 352 GYFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCS 411
+ K++ FGLS + + T P W A E S + S +
Sbjct: 161 --YVAKIADFGLSRGQEVYVKKT--------MGRLPVRWMAIE---------SLNYSVYT 201
Query: 412 EKADVYSFGMLCFELLT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKC 470
+DV+S+G+L +E+++ G P+ + ++ + + G R P + +L ++C
Sbjct: 202 TNSDVWSYGVLLWEIVSLGGTPY--CGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQC 259
Query: 471 WHTNPSQRPSFSSI 484
W P +RPSF+ I
Sbjct: 260 WREKPYERPSFAQI 273
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 3e-09
Identities = 75/306 (24%), Positives = 121/306 (39%), Gaps = 89/306 (29%)
Query: 218 LMVRRRLGASSQFKEIQWLGDSFVLRHFYGELESLNA----EISTMLSLSHPNIVQYLCG 273
++ R + GAS + K I+ G FV++ E+ +N+ EI+ M L HPNIV+ L G
Sbjct: 697 VISRGKKGASYKGKSIK-NGMQFVVK----EINDVNSIPSSEIADMGKLQHPNIVK-LIG 750
Query: 274 FCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLH---A 330
C EK + + + K+LS +R RRR I + IA+ + FLH +
Sbjct: 751 LCRSEKGAYLIHEYIEGKNLSEVLRNLSWERRRK---------IAIGIAKALRFLHCRCS 801
Query: 331 QKIYHGELNPSNIYLKAR-------SMEGYFHVKVSGFGLSTARTYASRNTPPASPQNQT 383
+ G L+P I + + S+ G F S
Sbjct: 802 PAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFISSA------------------ 843
Query: 384 APNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVP----------- 432
+ APE + T +EK+D+Y FG++ ELLTGK P
Sbjct: 844 ------YVAPE---------TRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSI 888
Query: 433 -------FEDGHLQG--DKMTK-NIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFS 482
+ D HL D + ++ + + ++NL C T+P+ RP +
Sbjct: 889 VEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIV------EVMNLALHCTATDPTARPCAN 942
Query: 483 SICRIL 488
+ + L
Sbjct: 943 DVLKTL 948
|
Length = 968 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 3e-09
Identities = 61/242 (25%), Positives = 101/242 (41%), Gaps = 33/242 (13%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRR 306
E ++ E + L HPNIV Y + + E ++VM DL ++E G
Sbjct: 42 ERKAAEQEAQLLSQLKHPNIVAYRESW-EGEDGLLYIVMGFCEGGDLYHKLKEQKGKL-- 98
Query: 307 NSFSLP--VVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS 364
LP VV+ +QIA +++LH + I H +L N++L ++ +KV G+
Sbjct: 99 ----LPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNI-----IKVGDLGI- 148
Query: 365 TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCF 424
AR ++ ++ PY + +PE+ S + K+DV++ G +
Sbjct: 149 -ARVLENQCDMAST----LIGTPY-YMSPELF---------SNKPYNYKSDVWALGCCVY 193
Query: 425 ELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSI 484
E+ T K F + + + I G+ P P L L P +RPS SI
Sbjct: 194 EMATLKHAFNAKDM--NSLVYRIIEGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSI 251
Query: 485 CR 486
R
Sbjct: 252 LR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 3e-09
Identities = 51/180 (28%), Positives = 84/180 (46%), Gaps = 29/180 (16%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVV 314
E+S + L H NIV L +K LV E + KDL YM + N S+ V
Sbjct: 54 EVSLLKDLKHANIVT-LHDIVHTDK-SLTLVFEYLDKDLKQYMDDC-----GNIMSMHNV 106
Query: 315 VDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNT 374
+ QI RG+ + H +K+ H +L P N+ + R +K++ FGL+ A++
Sbjct: 107 KIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERG-----ELKLADFGLARAKS-----V 156
Query: 375 PPASPQNQTAPNPYIWY-APEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPF 433
P + N+ +WY P+VL +S+ S + D++ G + FE+ +G+ F
Sbjct: 157 PTKTYSNEVVT---LWYRPPDVL--------LGSSEYSTQIDMWGVGCIFFEMASGRPLF 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 68/254 (26%), Positives = 107/254 (42%), Gaps = 41/254 (16%)
Query: 255 EISTMLSLSHPNIVQY--LCGFCDEEKKEFFLVMELMSK-DLSCYMRE--------TFGS 303
E + +L H +IV++ +CG D +V E M DL+ ++R G
Sbjct: 57 EAELLTNLQHEHIVKFYGVCGDGDP----LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQ 112
Query: 304 RRRNS--FSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGF 361
R+ L ++ I QIA GM +L +Q H +L N + A + VK+ F
Sbjct: 113 PRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLL-----VKIGDF 167
Query: 362 GLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGM 421
G+S R S + P W PE S K + ++DV+SFG+
Sbjct: 168 GMS--RDVYSTDYYRVGGHTML---PIRWMPPE---------SIMYRKFTTESDVWSFGV 213
Query: 422 LCFELLT-GKVP-FEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRP 479
+ +E+ T GK P F+ + + + R ERP PK + ++ CW P QR
Sbjct: 214 ILWEIFTYGKQPWFQLSNTEVIECITQGRVLERPRV---CPKEVYDIMLGCWQREPQQRL 270
Query: 480 SFSSICRILRYIKK 493
+ I +IL + K
Sbjct: 271 NIKEIYKILHALGK 284
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 42/167 (25%), Positives = 77/167 (46%), Gaps = 22/167 (13%)
Query: 319 LQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTPPAS 378
+QIA+GM +L ++ H +L N+ +K+ + HVK++ FGL AR T +
Sbjct: 116 VQIAKGMSYLEEVRLVHRDLAARNVLVKSPN-----HVKITDFGL--ARLLDIDETEYHA 168
Query: 379 PQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGH 437
+ P W A E + + + + ++DV+S+G+ +EL+T G P++
Sbjct: 169 DGGKV---PIKWMALESILHR---------RFTHQSDVWSYGVTVWELMTFGAKPYDG-- 214
Query: 438 LQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSI 484
+ ++ + GER P + + KCW + RP F +
Sbjct: 215 IPAREIPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFREL 261
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 4e-09
Identities = 41/156 (26%), Positives = 68/156 (43%), Gaps = 35/156 (22%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEE-------KKEFFLVMELMSKDLSCYMRETFGSRRRN 307
EI + L H N+V L C + K F+LV E DL+ + S +
Sbjct: 61 EIKILQLLKHENVVN-LIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLL-----SNKNV 114
Query: 308 SFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTAR 367
F+L + +M + G+ ++H KI H ++ +NI + + +G +K++ FGL AR
Sbjct: 115 KFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILI---TKDGI--LKLADFGL--AR 167
Query: 368 TYASRNTPPASPQNQTAPNPY------IWY-APEVL 396
++ PN Y +WY PE+L
Sbjct: 168 AFSLSKNS--------KPNRYTNRVVTLWYRPPELL 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 5e-09
Identities = 51/185 (27%), Positives = 82/185 (44%), Gaps = 38/185 (20%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVV 314
EIS + L+HPNIV+ L E K +LV E + DL YM S P++
Sbjct: 48 EISLLKELNHPNIVR-LLDVVHSENK-LYLVFEFLDLDLKKYMD----SSPLTGLDPPLI 101
Query: 315 VDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA-----RTY 369
+ Q+ +G+ + H+ ++ H +L P N+ + +K++ FGL+ A RTY
Sbjct: 102 KSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREG-----ALKLADFGLARAFGVPVRTY 156
Query: 370 ASRNTPPASPQNQTAPNPYIWY-APEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT 428
T +WY APE+L G+ ST D++S G + E++
Sbjct: 157 -------------THEVVTLWYRAPEILL---GSRQYSTP-----VDIWSIGCIFAEMVN 195
Query: 429 GKVPF 433
+ F
Sbjct: 196 RRPLF 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 6e-09
Identities = 64/260 (24%), Positives = 119/260 (45%), Gaps = 34/260 (13%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVV 314
E M S+ HP++V+ L G C + LV +LM C + + +++ ++
Sbjct: 59 EALIMASMDHPHLVRLL-GVCLSPTIQ--LVTQLMPH--GCLLD--YVHEHKDNIGSQLL 111
Query: 315 VDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNT 374
++ +QIA+GM +L +++ H +L N+ +K+ + HVK++ FGL AR
Sbjct: 112 LNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPN-----HVKITDFGL--ARLLEGDEK 164
Query: 375 PPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPF 433
+ + P W A E + + K + ++DV+S+G+ +EL+T G P+
Sbjct: 165 EYNADGGKM---PIKWMALECIHYR---------KFTHQSDVWSYGVTIWELMTFGGKPY 212
Query: 434 EDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSIC----RILR 489
DG + ++ + GER P + + KCW + RP F + R+ R
Sbjct: 213 -DG-IPTREIPDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR 270
Query: 490 YIKKFMANNPDIARSEFQSP 509
++++ D R + SP
Sbjct: 271 DPQRYLVIQGD-DRMKLPSP 289
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 6e-09
Identities = 51/184 (27%), Positives = 79/184 (42%), Gaps = 37/184 (20%)
Query: 255 EISTMLSLSHPNIVQYLCGFCD--EEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLP 312
E S + L H NIV D KK LV E + DL YM S+
Sbjct: 53 EASLLKDLKHANIVT----LHDIIHTKKTLTLVFEYLDTDLKQYM-----DDCGGGLSMH 103
Query: 313 VVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASR 372
V + Q+ RG+ + H +++ H +L P N+ + R +K++ FGL+ A++ S+
Sbjct: 104 NVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERG-----ELKLADFGLARAKSVPSK 158
Query: 373 NTPPASPQNQTAPNPYI--WY-APEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTG 429
T N + WY P+VL GST S D++ G + +E+ TG
Sbjct: 159 ----------TYSNEVVTLWYRPPDVL-----LGSTEYSTS---LDMWGVGCIFYEMATG 200
Query: 430 KVPF 433
+ F
Sbjct: 201 RPLF 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 7e-09
Identities = 49/183 (26%), Positives = 79/183 (43%), Gaps = 45/183 (24%)
Query: 312 PVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST------ 365
V+ I + + +G+ +L + KI H ++ PSN+ + R VK+ FG+ST
Sbjct: 95 HVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRG-----QVKLCDFGVSTQLVNSI 149
Query: 366 ARTYASRNTPPASPQNQTAPNPYIWYAPE-VLAEQEGTGSTSTSKCSEKADVYSFGMLCF 424
A+TY N + APE + EQ G S DV+S G+
Sbjct: 150 AKTYVGTNA---------------YMAPERISGEQYGIHS----------DVWSLGISFM 184
Query: 425 ELLTGKVPF-----EDGHLQGDKMTKNIRAGERPLFPSG--SPKYLVNLTKKCWHTNPSQ 477
EL G+ P+ G L ++ + I + P+ P G S K+ V+ +C P +
Sbjct: 185 ELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKF-VHFITQCMRKQPKE 243
Query: 478 RPS 480
RP+
Sbjct: 244 RPA 246
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 8e-09
Identities = 50/186 (26%), Positives = 77/186 (41%), Gaps = 30/186 (16%)
Query: 255 EISTMLSLSH-PNIVQYLCGFCDEE---KKEFFLVMELMSKDLSCYMRETFGSRRRNSFS 310
EIS + LS IV+ L EE K +LV E + DL +M + R
Sbjct: 50 EISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMD---SNGRGPGRP 106
Query: 311 LP--VVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTART 368
LP + M Q+ +G+ H + H +L P N+ + + +K++ GL A +
Sbjct: 107 LPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGL----LKIADLGLGRAFS 162
Query: 369 YASRNTPPASPQNQTAPNPYIWY-APEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELL 427
P S ++ +WY APEVL GST S D++S G + E+
Sbjct: 163 -----IPVKSYTHEIVT---LWYRAPEVL-----LGSTHYST---PVDIWSVGCIFAEMS 206
Query: 428 TGKVPF 433
+ F
Sbjct: 207 RKQPLF 212
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 9e-09
Identities = 36/192 (18%), Positives = 75/192 (39%), Gaps = 30/192 (15%)
Query: 296 YMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQ-KIYHGELNPSNIYLKARSMEGYF 354
Y+RE + S +D+ + +G+ L+ + L + + +
Sbjct: 108 YLREVL--DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFL-----VTENY 160
Query: 355 HVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKA 414
+K+ GL ++PP N +++ ++L + S+ + K
Sbjct: 161 KLKIICHGL-----EKILSSPPFKNVNFMV-----YFSYKML-------NDIFSEYTIKD 203
Query: 415 DVYSFGMLCFELLTGKVPFEDGHLQG--DKMTKNIRAGERPLFPSGSPKYLVNLTKKCWH 472
D+YS G++ +E+ TGK+PFE+ + D + L P P + + + C
Sbjct: 204 DIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKN--NSLKL-PLDCPLEIKCIVEACTS 260
Query: 473 TNPSQRPSFSSI 484
+ +RP+ I
Sbjct: 261 HDSIKRPNIKEI 272
|
Length = 283 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 9e-09
Identities = 57/189 (30%), Positives = 82/189 (43%), Gaps = 25/189 (13%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRN 307
E+ +L EI + +L H IVQY D +K + ME M + +G
Sbjct: 47 EVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYG----- 101
Query: 308 SFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA- 366
+ + V QI GM +LH+ I H ++ +NI R G +VK+ FG S
Sbjct: 102 ALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANIL---RDSAG--NVKLGDFGASKRL 156
Query: 367 RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFEL 426
+T T S PY W +PEV++ EG G KADV+S G E+
Sbjct: 157 QTICMSGTGIRS----VTGTPY-WMSPEVIS-GEGYG--------RKADVWSLGCTVVEM 202
Query: 427 LTGKVPFED 435
LT K P+ +
Sbjct: 203 LTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 61/243 (25%), Positives = 102/243 (41%), Gaps = 40/243 (16%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVME------LMSKDLSCYMRETF 301
+E E + + HPNIV + F E ++VME LM K
Sbjct: 41 AVEDSRKEAVLLAKMKHPNIVAFKESF--EADGHLYIVMEYCDGGDLMQK---------I 89
Query: 302 GSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGF 361
+R F ++ +Q+ G++ +H +++ H ++ NI+L VK+ F
Sbjct: 90 KLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNG-----KVKLGDF 144
Query: 362 GLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGM 421
G +AR S P + PY Y P + E + K+D++S G
Sbjct: 145 G--SARLLTS----PGAYACTYVGTPY--YVPPEIWEN--------MPYNNKSDIWSLGC 188
Query: 422 LCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSF 481
+ +EL T K PF+ + + + K + +PL PS L +L K+ + NP RPS
Sbjct: 189 ILYELCTLKHPFQANSWK-NLILKVCQGSYKPL-PSHYSYELRSLIKQMFKRNPRSRPSA 246
Query: 482 SSI 484
++I
Sbjct: 247 TTI 249
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 48/180 (26%), Positives = 84/180 (46%), Gaps = 31/180 (17%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVME-LMSKDLSCYMRETFGSRRRNSFSLPV 313
EI M +PNIV YL + + E ++VME L L+ + ET +
Sbjct: 67 EILVMRENKNPNIVNYLDSYLVGD--ELWVVMEYLAGGSLTDVVTETCMDEGQ------- 117
Query: 314 VVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRN 373
+ + + + +EFLH+ ++ H ++ NI L M+G VK++ FG + ++
Sbjct: 118 IAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDG--SVKLTDFG------FCAQI 166
Query: 374 TPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPF 433
TP S ++ PY W APEV+ + K D++S G++ E++ G+ P+
Sbjct: 167 TPEQSKRSTMVGTPY-WMAPEVVTRK---------AYGPKVDIWSLGIMAIEMIEGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 51/180 (28%), Positives = 82/180 (45%), Gaps = 29/180 (16%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVV 314
E+S + +L H NIV L E+ LV E + DL Y+ N S+ V
Sbjct: 53 EVSLLKNLKHANIVT-LHDIIHTERC-LTLVFEYLDSDLKQYLDNC-----GNLMSMHNV 105
Query: 315 VDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNT 374
M Q+ RG+ + H +KI H +L P N+ + + +K++ FGL+ A++
Sbjct: 106 KIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKG-----ELKLADFGLARAKS-----V 155
Query: 375 PPASPQNQTAPNPYIWY-APEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPF 433
P + N+ +WY P+VL GST S D++ G + +E+ TG+ F
Sbjct: 156 PTKTYSNEVVT---LWYRPPDVL-----LGSTEYST---PIDMWGVGCILYEMATGRPMF 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 52/180 (28%), Positives = 80/180 (44%), Gaps = 29/180 (16%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVV 314
E S + L H NIV L K+ V E M DL+ YM + G + L
Sbjct: 53 EASLLKGLKHANIV--LLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRL--- 107
Query: 315 VDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNT 374
M Q+ RG+ ++H Q I H +L P N+ + S G +K++ FGL+ A++ S
Sbjct: 108 --FMFQLLRGLAYIHGQHILHRDLKPQNLLI---SYLG--ELKLADFGLARAKSIPS--- 157
Query: 375 PPASPQNQTAPNPYIWY-APEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPF 433
Q ++ +WY P+VL G+T S D++ G + E+L G+ F
Sbjct: 158 -----QTYSSEVVTLWYRPPDVL-----LGATDYSS---ALDIWGAGCIFIEMLQGQPAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 55/231 (23%), Positives = 99/231 (42%), Gaps = 35/231 (15%)
Query: 258 TMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVD 316
M SL H IV+ L G C + LV +L L ++R+ R+S +++
Sbjct: 62 AMGSLDHAYIVRLL-GICPGASLQ--LVTQLSPLGSLLDHVRQ-----HRDSLDPQRLLN 113
Query: 317 IMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTPP 376
+QIA+GM +L ++ H L NI LK+ S+ V+++ FG++ P
Sbjct: 114 WCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSI-----VQIADFGVADL-------LYP 161
Query: 377 ASPQ--NQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPF 433
+ P W A E S + + ++DV+S+G+ +E+++ G P+
Sbjct: 162 DDKKYFYSEHKTPIKWMALE---------SILFGRYTHQSDVWSYGVTVWEMMSYGAEPY 212
Query: 434 EDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSI 484
++ + GER P + + KCW + + RP+F +
Sbjct: 213 AGMRPH--EVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKEL 261
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 59/228 (25%), Positives = 87/228 (38%), Gaps = 34/228 (14%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVV 314
E+ + + HPN ++Y + E +LVME S + + + +
Sbjct: 75 EVKFLQRIKHPNSIEYKGCYLREHTA--WLVMEYCLGSASDLLE--VHKKPLQEVEIAAI 130
Query: 315 VDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNT 374
LQ G+ +LH+ + H ++ NI L VK++ FG ++
Sbjct: 131 THGALQ---GLAYLHSHNMIHRDIKAGNILLTEPG-----QVKLADFGSASI-------- 174
Query: 375 PPASPQNQTAPNPYIWYAPEV-LAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPF 433
ASP N PY W APEV LA EG + K DV+S G+ C EL K P
Sbjct: 175 --ASPANSFVGTPY-WMAPEVILAMDEG-------QYDGKVDVWSLGITCIELAERKPPL 224
Query: 434 EDGHLQGDKMTKNIRAGERPLFPSGS-PKYLVNLTKKCWHTNPSQRPS 480
+ + +I E P S Y N C P RP+
Sbjct: 225 FN--MNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPT 270
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 55/222 (24%), Positives = 103/222 (46%), Gaps = 37/222 (16%)
Query: 260 LSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIM 318
L+ +P + C F + K+ F VME ++ DL ++++ + F L
Sbjct: 51 LAWENPFLTHLYCTF--QTKEHLFFVMEFLNGGDLMFHIQD------KGRFDLYRATFYA 102
Query: 319 LQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASR--NTPP 376
+I G++FLH++ I + +L N+ L + H+K++ FG+ + +T
Sbjct: 103 AEIVCGLQFLHSKGIIYRDLKLDNVML-----DRDGHIKIADFGMCKENVFGDNRASTFC 157
Query: 377 ASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDG 436
+P YI APE+L + T S D +SFG+L +E+L G+ PF
Sbjct: 158 GTPD-------YI--APEILQGLKYTFSV---------DWWSFGVLLYEMLIGQSPFHGD 199
Query: 437 HLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQR 478
D++ ++IR + P +P K ++ +K + +P++R
Sbjct: 200 --DEDELFESIRV-DTPHYPRWITKESKDILEKLFERDPTRR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-08
Identities = 46/170 (27%), Positives = 75/170 (44%), Gaps = 21/170 (12%)
Query: 320 QIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTPPASP 379
Q+A GMEFL ++ H +L N+ + EG VK+ FGL+ S S
Sbjct: 247 QVANGMEFLASKNCVHRDLAARNVLI----CEGKL-VKICDFGLARDIMRDSNYISKGS- 300
Query: 380 QNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHL 438
P W APE S + + +DV+SFG+L +E+ T G P+ + +
Sbjct: 301 ----TFLPLKWMAPE---------SIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM 347
Query: 439 QGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRIL 488
++ I+ G R P+ + + + +KCW RP FS + ++
Sbjct: 348 N-EQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLV 396
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 3e-08
Identities = 49/169 (28%), Positives = 78/169 (46%), Gaps = 44/169 (26%)
Query: 320 QIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS------TARTYASRN 373
++A ++ LH+ I + +L P NI L EG H+K++ FGLS + Y+
Sbjct: 106 ELALALDHLHSLGIIYRDLKPENILLDE---EG--HIKLTDFGLSKESIDHEKKAYSFCG 160
Query: 374 TPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPF 433
T + APEV+ + T S AD +SFG+L FE+LTG +PF
Sbjct: 161 TVE-------------YMAPEVVNRRGHTQS---------ADWWSFGVLMFEMLTGSLPF 198
Query: 434 EDGHLQGDKMTKNIRAGERPLFPSGSPKYLVN----LTKKCWHTNPSQR 478
+ G + + MT ++A G P++L L + + NP+ R
Sbjct: 199 Q-GKDRKETMTMILKA------KLGMPQFLSPEAQSLLRALFKRNPANR 240
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (136), Expect = 3e-08
Identities = 48/178 (26%), Positives = 76/178 (42%), Gaps = 42/178 (23%)
Query: 264 HPNIVQYLCGFC-DEEKKEF---FLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIML 319
H N++ L F ++F +LV LM DL+ ++ ++ S + ++
Sbjct: 73 HENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVK----CQK---LSDDHIQFLVY 125
Query: 320 QIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTPPASP 379
QI RG++++H+ I H +L PSNI + +K+ FGL AR T
Sbjct: 126 QILRGLKYIHSAGIIHRDLKPSNIAVNEDC-----ELKILDFGL--ARHTDDEMT----- 173
Query: 380 QNQTAPNPYI---WY-APEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPF 433
Y+ WY APE++ T D++S G + ELLTGK F
Sbjct: 174 -------GYVATRWYRAPEIMLNWMHYNQT--------VDIWSVGCIMAELLTGKTLF 216
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 78/322 (24%), Positives = 134/322 (41%), Gaps = 71/322 (22%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEF---FLVMELMSKDLSCYMRETFG-SRRRNSFS 310
EI + L HP+IV+ ++EF ++V ELM DL ++ + + F
Sbjct: 49 EIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFF 108
Query: 311 LPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYA 370
L Q+ R ++++H ++H +L P NI A +K+ FGL+ A
Sbjct: 109 L-------YQLLRALKYIHTANVFHRDLKPKNILANADC-----KLKICDFGLARV---A 153
Query: 371 SRNTPPASPQNQTAPNPYI---WY-APEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFEL 426
+TP A Y+ WY APE+ GS SK + D++S G + E+
Sbjct: 154 FNDTPTA-----IFWTDYVATRWYRAPEL------CGSF-FSKYTPAIDIWSIGCIFAEV 201
Query: 427 LTGK--VPFEDGHLQGDKMT--------------KNIRAGERPLFPSGSPKYLVNLTKKC 470
LTGK P ++ Q D +T +N +A R S K V ++K
Sbjct: 202 LTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKA--RRYLSSMRKKQPVPFSQKF 259
Query: 471 WHTNPSQRPSFSSICRILRYIKKFMANNPDIARSEFQSPLAD-YCDIEAGFVRKFVGEGC 529
+ +P LR +++ +A +P R + LAD Y A R+
Sbjct: 260 PNADPLA----------LRLLERLLAFDPK-DRPTAEEALADPYFKGLAKVERE------ 302
Query: 530 PDVAPVSQIPFQMFAYKIAEKE 551
P P++++ F+ ++ +++
Sbjct: 303 PSAQPITKLEFEFERRRLTKED 324
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 4e-08
Identities = 61/236 (25%), Positives = 88/236 (37%), Gaps = 50/236 (21%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSR------RRNS 308
E+ + L HPN ++Y + E +LVME C GS +
Sbjct: 65 EVRFLQQLRHPNTIEYKGCYLREHTA--WLVMEY------C-----LGSASDILEVHKKP 111
Query: 309 FSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTART 368
+ I +G+ +LH+ + H ++ NI L VK++ FG ++
Sbjct: 112 LQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGT-----VKLADFGSASL-- 164
Query: 369 YASRNTPPASPQNQTAPNPYIWYAPEV-LAEQEGTGSTSTSKCSEKADVYSFGMLCFELL 427
SP N PY W APEV LA EG + K DV+S G+ C EL
Sbjct: 165 --------VSPANSFVGTPY-WMAPEVILAMDEG-------QYDGKVDVWSLGITCIELA 208
Query: 428 TGKVPFEDGHLQGDKMTK--NIRAGERP-LFPSGSPKYLVNLTKKCWHTNPSQRPS 480
K P + M+ +I + P L + Y N C P RPS
Sbjct: 209 ERKPPL----FNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPS 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 53/191 (27%), Positives = 87/191 (45%), Gaps = 36/191 (18%)
Query: 261 SLSHPNIVQYLCGFC-----DEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVV 315
+ HPN+V+ L C D E K LV E + +DL+ Y+ + +
Sbjct: 60 TFEHPNVVR-LFDVCTVSRTDRETK-LTLVFEHVDQDLTTYLDKV----PEPGVPTETIK 113
Query: 316 DIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTP 375
D+M Q+ RG++FLH+ ++ H +L P NI + + +K++ FGL AR Y+ +
Sbjct: 114 DMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG-----QIKLADFGL--ARIYSFQMA- 165
Query: 376 PASPQNQTAPNPYIWY-APEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFE 434
T+ +WY APEVL + S + D++S G + E+ K P
Sbjct: 166 ------LTSVVVTLWYRAPEVLLQ---------SSYATPVDLWSVGCIFAEMFRRK-PLF 209
Query: 435 DGHLQGDKMTK 445
G D++ K
Sbjct: 210 RGSSDVDQLGK 220
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 5e-08
Identities = 55/189 (29%), Positives = 83/189 (43%), Gaps = 25/189 (13%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRN 307
E+ +L EI + +L H IVQY D ++ + ME M +++G+ N
Sbjct: 47 EVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTEN 106
Query: 308 SFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA- 366
V QI G+ +LH+ I H ++ +NI R G +VK+ FG S
Sbjct: 107 -----VTRKYTRQILEGVSYLHSNMIVHRDIKGANIL---RDSVG--NVKLGDFGASKRL 156
Query: 367 RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFEL 426
+T T S PY W +PEV++ EG G KAD++S G E+
Sbjct: 157 QTICLSGTGMKS----VTGTPY-WMSPEVIS-GEGYG--------RKADIWSVGCTVVEM 202
Query: 427 LTGKVPFED 435
LT K P+ +
Sbjct: 203 LTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 5e-08
Identities = 62/241 (25%), Positives = 103/241 (42%), Gaps = 47/241 (19%)
Query: 220 VRRRLGASSQFKEIQWLGDSFVLRHFYGELESLNA--EISTMLSLSHPNIVQYLCGFCDE 277
+ RR GA K++ R F EL + A E+ + + H N++ L F +
Sbjct: 35 LDRRTGAKVAIKKLY--------RPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPD 86
Query: 278 EK----KEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKI 333
+F+LVM M DL M+ S R F ++ Q+ +G++++HA I
Sbjct: 87 LSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQF-------LVYQMLKGLKYIHAAGI 139
Query: 334 YHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWY-A 392
H +L P N+ + +K+ FGL AR S T + WY A
Sbjct: 140 IHRDLKPGNLAVNEDC-----ELKILDFGL--ARQTDSEMTGYVVTR---------WYRA 183
Query: 393 PEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGER 452
PEV+ + ++ D++S G + E+LTGK F+ GH D++ + ++
Sbjct: 184 PEVI--------LNWMHYTQTVDIWSVGCIMAEMLTGKPLFK-GHDHLDQLMEIMKVTGT 234
Query: 453 P 453
P
Sbjct: 235 P 235
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 6e-08
Identities = 56/198 (28%), Positives = 78/198 (39%), Gaps = 50/198 (25%)
Query: 248 ELESLNAE---ISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGS 303
E+ESL E T S HP +V F E+ F VME + DL ++ S
Sbjct: 42 EVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCF--VMEYAAGGDLMMHIHTDVFS 99
Query: 304 RRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGL 363
R F VV G+++LH KI + +L N+ L EG VK++ FGL
Sbjct: 100 EPRAVFYAACVV-------LGLQYLHENKIVYRDLKLDNLLLDT---EG--FVKIADFGL 147
Query: 364 --------STARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKAD 415
T+ TP + APEVL E T + D
Sbjct: 148 CKEGMGFGDRTSTFCG--TPE-------------FLAPEVLTETSYTRAV---------D 183
Query: 416 VYSFGMLCFELLTGKVPF 433
+ G+L +E+L G+ PF
Sbjct: 184 WWGLGVLIYEMLVGESPF 201
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 8e-08
Identities = 56/189 (29%), Positives = 84/189 (44%), Gaps = 25/189 (13%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRN 307
E+ +L EI + +L H IVQY D E+K+ + +E M + +G+ N
Sbjct: 47 EVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTEN 106
Query: 308 SFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST-A 366
V QI +G+ +LH+ I H ++ +NI R G +VK+ FG S
Sbjct: 107 -----VTRRYTRQILQGVSYLHSNMIVHRDIKGANIL---RDSAG--NVKLGDFGASKRI 156
Query: 367 RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFEL 426
+T T S PY W +PEV++ EG G KADV+S E+
Sbjct: 157 QTICMSGTGIKS----VTGTPY-WMSPEVIS-GEGYG--------RKADVWSVACTVVEM 202
Query: 427 LTGKVPFED 435
LT K P+ +
Sbjct: 203 LTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 9e-08
Identities = 47/180 (26%), Positives = 84/180 (46%), Gaps = 31/180 (17%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVME-LMSKDLSCYMRETFGSRRRNSFSLPV 313
EI M +PNIV YL + + E ++VME L L+ + ET +
Sbjct: 66 EILVMRENKNPNIVNYLDSYLVGD--ELWVVMEYLAGGSLTDVVTETCMDEGQ------- 116
Query: 314 VVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRN 373
+ + + + ++FLH+ ++ H ++ NI L M+G VK++ FG + ++
Sbjct: 117 IAAVCRECLQALDFLHSNQVIHRDIKSDNILL---GMDG--SVKLTDFG------FCAQI 165
Query: 374 TPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPF 433
TP S ++ PY W APEV+ + K D++S G++ E++ G+ P+
Sbjct: 166 TPEQSKRSTMVGTPY-WMAPEVVTRK---------AYGPKVDIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 9e-08
Identities = 59/255 (23%), Positives = 108/255 (42%), Gaps = 29/255 (11%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELM-SKDLSCYMRETFGSRRR 306
ELE EI + + +HP IV+ L F + K ++++E + M E
Sbjct: 52 ELEDYMVEIEILATCNHPYIVKLLGAFYWDGK--LWIMIEFCPGGAVDAIMLEL-----D 104
Query: 307 NSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366
+ P + I Q+ +++LH+ KI H +L N+ L +++G +K++ FG+S
Sbjct: 105 RGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLL---TLDG--DIKLADFGVS-- 157
Query: 367 RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFEL 426
++N ++ PY W APEV+ + + + KAD++S G+ E+
Sbjct: 158 ----AKNVKTLQRRDSFIGTPY-WMAPEVVMCE----TMKDTPYDYKADIWSLGITLIEM 208
Query: 427 LTGKVPFEDGHLQGDKMTKNIRAGERPLF--PSGSPKYLVNLTKKCWHTNPSQRPSFSSI 484
+ P + L ++ I E P PS + K +P RPS + +
Sbjct: 209 AQIEPPHHE--LNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQL 266
Query: 485 CRILRYIKKFMANNP 499
++ +N P
Sbjct: 267 LE-HPFVSSVTSNRP 280
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 1e-07
Identities = 48/195 (24%), Positives = 78/195 (40%), Gaps = 53/195 (27%)
Query: 255 EISTMLSLSHPNIVQYLCGFCD-------EEKKEFFLVMELMSKDLSCYMRETFGSRRRN 307
EI + H NI+ G D E + ++V ELM DL ++
Sbjct: 53 EIKILRRFKHENII----GILDIIRPPSFESFNDVYIVQELMETDLYKLIK--------- 99
Query: 308 SFSLPVVVD----IMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGL 363
+ + D + QI RG++++H+ + H +L PSN+ L +K+ FGL
Sbjct: 100 --TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNC-----DLKICDFGL 152
Query: 364 STARTYASRNTPPASPQNQTAPNPYI---WY-APEVLAEQEGTGSTSTSKCSEKA-DVYS 418
+R P Y+ WY APE++ SK KA D++S
Sbjct: 153 -------ARIADPEHDHTGFL-TEYVATRWYRAPEIML---------NSKGYTKAIDIWS 195
Query: 419 FGMLCFELLTGKVPF 433
G + E+L+ + F
Sbjct: 196 VGCILAEMLSNRPLF 210
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 65/261 (24%), Positives = 110/261 (42%), Gaps = 54/261 (20%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYM-------RETFGSRRR 306
E+ + L PNI++ L G C +E ++ E M DL+ ++ +E G+
Sbjct: 69 EVKILSRLKDPNIIRLL-GVCVDEDP-LCMITEYMENGDLNQFLSSHHLDDKEENGNDAV 126
Query: 307 N------SFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSG 360
+ S ++ + LQIA GM++L + H +L N + +K++
Sbjct: 127 PPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVG-----ENLTIKIAD 181
Query: 361 FGLSTARTYASRNTPPASPQ--NQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYS 418
FG+S RN A P W A E + K + +DV++
Sbjct: 182 FGMS-------RNLYAGDYYRIQGRAVLPIRWMAWECIL---------MGKFTTASDVWA 225
Query: 419 FGMLCFELLT--GKVPFEDGHLQGDKMTKNIRAGE------RPLF---PSGSPKYLVNLT 467
FG+ +E+L + P+ G L +++ +N AGE R ++ P P+ L L
Sbjct: 226 FGVTLWEILMLCKEQPY--GELTDEQVIEN--AGEFFRDQGRQVYLFRPPPCPQGLYELM 281
Query: 468 KKCWHTNPSQRPSFSSICRIL 488
+CW + +RPSFS I L
Sbjct: 282 LQCWSRDCRERPSFSDIHAFL 302
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 49/180 (27%), Positives = 78/180 (43%), Gaps = 29/180 (16%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVV 314
E S + L H NIV L K+ LV E + DL YM + G + L
Sbjct: 53 EASLLKGLKHANIV--LLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKL--- 107
Query: 315 VDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNT 374
+ Q+ RG+ ++H + I H +L P N+ + +K++ FGL+ A++
Sbjct: 108 --FLFQLLRGLSYIHQRYILHRDLKPQNLLISDTG-----ELKLADFGLARAKS-----V 155
Query: 375 PPASPQNQTAPNPYIWY-APEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPF 433
P + N+ +WY P+VL GST S C D++ G + E++ G F
Sbjct: 156 PSHTYSNEVVT---LWYRPPDVL-----LGSTEYSTC---LDMWGVGCIFVEMIQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 62/241 (25%), Positives = 102/241 (42%), Gaps = 30/241 (12%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKD-LSCYMRETFGSRRR 306
ELE EI + S HPNIV+ L F E ++++E + + M E
Sbjct: 45 ELEDYMVEIDILASCDHPNIVKLLDAFYYE--NNLWILIEFCAGGAVDAVMLEL-----E 97
Query: 307 NSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366
+ P + + Q + +LH KI H +L NI +++G +K++ FG+S
Sbjct: 98 RPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILF---TLDG--DIKLADFGVS-- 150
Query: 367 RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSE-KADVYSFGMLCFE 425
++NT ++ PY W APEV+ + TS + + KADV+S G+ E
Sbjct: 151 ----AKNTRTIQRRDSFIGTPY-WMAPEVVMCE-----TSKDRPYDYKADVWSLGITLIE 200
Query: 426 LLTGKVPFEDGHLQGDKMTKNIRAGERPLF--PSGSPKYLVNLTKKCWHTNPSQRPSFSS 483
+ + P + L ++ I E P PS + KKC N R + +
Sbjct: 201 MAQIEPPHHE--LNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQ 258
Query: 484 I 484
+
Sbjct: 259 L 259
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 53/189 (28%), Positives = 79/189 (41%), Gaps = 34/189 (17%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDE--------EKKEFFLVMELMSKDLSCYMRETFGSRRR 306
EI + L+H NIV D+ +K F+LV E M DL +
Sbjct: 56 EIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGL----- 110
Query: 307 NSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366
FS + M Q+ G+ + H + H ++ SNI L + +K++ FGL A
Sbjct: 111 VHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKG-----QIKLADFGL--A 163
Query: 367 RTYASRNTPPASPQNQTAPNPYIWY-APEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFE 425
R Y S + P + + T +WY PE+L +E G DV+S G + E
Sbjct: 164 RLYNSEESRPYTNKVIT-----LWYRPPELLLGEERYGPA--------IDVWSCGCILGE 210
Query: 426 LLTGKVPFE 434
L T K F+
Sbjct: 211 LFTKKPIFQ 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 44/210 (20%), Positives = 82/210 (39%), Gaps = 58/210 (27%)
Query: 255 EISTMLSLSHPNIVQYLCGFC--DEEKKEFFLVMELMSKDLS--CYMRETFGSRRRNSFS 310
E+ + H NI+ + K+ ++VM+LM DL + + F
Sbjct: 54 ELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYF- 112
Query: 311 LPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYA 370
+ Q+ RG++++H+ + H +L PSN+ + +++ FG+ AR +
Sbjct: 113 -------LYQLLRGLKYIHSANVIHRDLKPSNLLVN-----EDCELRIGDFGM--ARGLS 158
Query: 371 SRNTPPASPQNQTAPNPYI---WY-APEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFEL 426
S + +++ Y+ WY APE+L S + + D++S G + E+
Sbjct: 159 S-----SPTEHKYFMTEYVATRWYRAPELL--------LSLPEYTTAIDMWSVGCIFAEM 205
Query: 427 LTGKVPFEDGHLQGDKMTKNIRAGERPLFP 456
L G R LFP
Sbjct: 206 L----------------------GRRQLFP 213
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 3e-07
Identities = 56/205 (27%), Positives = 95/205 (46%), Gaps = 38/205 (18%)
Query: 317 IMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTPP 376
+ +Q+ + +H++ + H ++ +NI L + + VK+ FG S + YA T
Sbjct: 148 LFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGL-----VKLGDFGFS--KMYA--ATVS 198
Query: 377 ASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKC--SEKADVYSFGMLCFELLTGKVPFE 434
PY + APE+ + S+KAD++S G+L +ELLT K PF
Sbjct: 199 DDVGRTFCGTPY-YVAPEIW-----------RRKPYSKKADMFSLGVLLYELLTLKRPF- 245
Query: 435 DGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSS-----ICRILR 489
DG + M K + PL PS SP+ + + ++P +RPS S IC++
Sbjct: 246 DGENMEEVMHKTLAGRYDPLPPSISPE-MQEIVTALLSSDPKRRPSSSKLLNMPICKL-- 302
Query: 490 YIKKFMANNPDIARSE--FQSPLAD 512
F++ +I +++ F PL D
Sbjct: 303 ----FISGLLEIVQTQPGFSGPLRD 323
|
Length = 496 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 61/228 (26%), Positives = 88/228 (38%), Gaps = 34/228 (14%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVV 314
E+ + L HPN +QY + E +LVME S + + + V
Sbjct: 65 EVRFLQKLRHPNTIQYRGCYLREHTA--WLVMEYCLGSASDLLE--VHKKPLQEVEIAAV 120
Query: 315 VDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNT 374
LQ G+ +LH+ + H ++ NI L + VK+ FG ++
Sbjct: 121 THGALQ---GLAYLHSHNMIHRDVKAGNILLSEPGL-----VKLGDFGSASI-------- 164
Query: 375 PPASPQNQTAPNPYIWYAPEV-LAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPF 433
+P N PY W APEV LA EG + K DV+S G+ C EL K P
Sbjct: 165 --MAPANXFVGTPY-WMAPEVILAMDEG-------QYDGKVDVWSLGITCIELAERKPPL 214
Query: 434 EDGHLQGDKMTKNIRAGERPLFPSGS-PKYLVNLTKKCWHTNPSQRPS 480
+ + +I E P SG +Y N C P RP+
Sbjct: 215 FN--MNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPT 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 3e-07
Identities = 58/254 (22%), Positives = 89/254 (35%), Gaps = 56/254 (22%)
Query: 254 AEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRR---NSFS 310
E + +L HP + F + + LVM+ C E F +R S
Sbjct: 50 TEQEILATLDHPFLPTLYASF--QTETYLCLVMDY------CPGGELFRLLQRQPGKCLS 101
Query: 311 LPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS------ 364
V ++ +E+LH I + +L P NI L H+ +S F LS
Sbjct: 102 EEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESG-----HIMLSDFDLSKQSDVE 156
Query: 365 TARTYASRNTPPASPQNQTAPNP------------------YIWYAPEVLAEQEGTGSTS 406
+ + P+ YI APEV++ G G S
Sbjct: 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYI--APEVIS---GDGHGS 211
Query: 407 TSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPS--GSPKYLV 464
D ++ G+L +E+L G PF+ G D+ NI E FP
Sbjct: 212 A------VDWWTLGILLYEMLYGTTPFK-GS-NRDETFSNILKKE-VTFPGSPPVSSSAR 262
Query: 465 NLTKKCWHTNPSQR 478
+L +K +PS+R
Sbjct: 263 DLIRKLLVKDPSKR 276
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 54/188 (28%), Positives = 84/188 (44%), Gaps = 42/188 (22%)
Query: 255 EISTMLSLSHPNIVQYLCGFCD----EEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFS 310
E+ + ++H NI+ L F EE ++ +LVMELM +L C + R S+
Sbjct: 70 ELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANL-CQVIHMELDHERMSY- 127
Query: 311 LPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYA 370
++ Q+ G++ LH+ I H +L PSNI +K+ +K+ FGL ART A
Sbjct: 128 ------LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-----LKILDFGL--ART-A 173
Query: 371 SRNTPPASPQNQTAPNPYI----WYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFEL 426
N PY+ + APEV+ E D++S G + EL
Sbjct: 174 CTN---------FMMTPYVVTRYYRAPEVILGM---------GYKENVDIWSVGCIMGEL 215
Query: 427 LTGKVPFE 434
+ G V F+
Sbjct: 216 VKGSVIFQ 223
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 51/189 (26%), Positives = 76/189 (40%), Gaps = 42/189 (22%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELM---SKDLSCYMRETFGSRRRNSFSL 311
E+ S P IV+Y F DE + ME S D S Y + +R
Sbjct: 49 ELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLD-SIYKKV---KKRGGRIGE 104
Query: 312 PVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVK-----VSG-FGLST 365
V+ I + +G+ +LH++KI H ++ PSNI L + +G VK VSG S
Sbjct: 105 KVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILL---TRKG--QVKLCDFGVSGELVNSL 159
Query: 366 ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFE 425
A T+ T + Y+ APE + G + DV+S G+ E
Sbjct: 160 AGTF-------------TGTSFYM--APERI-----QGKPYSITS----DVWSLGLTLLE 195
Query: 426 LLTGKVPFE 434
+ + PF
Sbjct: 196 VAQNRFPFP 204
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 47/190 (24%), Positives = 73/190 (38%), Gaps = 30/190 (15%)
Query: 247 GELESLNAEISTMLSLSH-PNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRR 305
GE +LN + +L IV F E K + LVM LM+ Y G
Sbjct: 36 GEQMALNEKK--ILEKVSSRFIVSLAYAF--ETKDDLCLVMTLMNGGDLKYHIYNVGEP- 90
Query: 306 RNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365
F + QI G+E LH ++I + +L P N+ L + + +V++S GL+
Sbjct: 91 --GFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLL-----DDHGNVRISDLGLAV 143
Query: 366 ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFE 425
A P + APEVL + S D ++ G +E
Sbjct: 144 -------ELKGGKKIKGRAGTPG-YMAPEVLQGEVYDFS---------VDWFALGCTLYE 186
Query: 426 LLTGKVPFED 435
++ G+ PF
Sbjct: 187 MIAGRSPFRQ 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 3e-07
Identities = 59/252 (23%), Positives = 102/252 (40%), Gaps = 37/252 (14%)
Query: 237 GDSFVLRHFYGELE-----SLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK 291
G + L+ YG E + EI + ++HPN+V+ C + E +++E M
Sbjct: 99 GRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVK--CHDMFDHNGEIQVLLEFMDG 156
Query: 292 DLSCYMRETFGS-RRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSM 350
GS + + D+ QI G+ +LH + I H ++ PSN+ + +
Sbjct: 157 ----------GSLEGTHIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAK- 205
Query: 351 EGYFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKC 410
+VK++ FG+S R A P S A + +PE + G+
Sbjct: 206 ----NVKIADFGVS--RILAQTMDPCNSSVGTIA-----YMSPERINTDLNHGAYD---- 250
Query: 411 SEKADVYSFGMLCFELLTGKVPFEDGHLQGD--KMTKNIRAGERPLFPSGSPKYLVNLTK 468
D++S G+ E G+ PF G QGD + I + P P+ + + +
Sbjct: 251 GYAGDIWSLGVSILEFYLGRFPFGVGR-QGDWASLMCAICMSQPPEAPATASREFRHFIS 309
Query: 469 KCWHTNPSQRPS 480
C P++R S
Sbjct: 310 CCLQREPAKRWS 321
|
Length = 353 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 60/242 (24%), Positives = 97/242 (40%), Gaps = 36/242 (14%)
Query: 254 AEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMR---------ETFGS 303
AE+ T+L H +IV++ G C E + +V E M DL+ ++R
Sbjct: 58 AELLTVLQ--HQHIVRFY-GVC-TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGED 113
Query: 304 RRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGL 363
+L ++ I QIA GM +L + H +L N + + VK+ FG+
Sbjct: 114 VAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLV-----VKIGDFGM 168
Query: 364 STARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLC 423
S R S + + P W PE S K + ++D++SFG++
Sbjct: 169 S--RDIYSTDYYRVGGRTML---PIRWMPPE---------SILYRKFTTESDIWSFGVVL 214
Query: 424 FELLT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFS 482
+E+ T GK P+ L + + I G P P + + + CW P QR
Sbjct: 215 WEIFTYGKQPWY--QLSNTEAIECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIK 272
Query: 483 SI 484
I
Sbjct: 273 DI 274
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 60/254 (23%), Positives = 107/254 (42%), Gaps = 44/254 (17%)
Query: 243 RHFYGELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMS-KDLSCYMRET- 300
R F GELE L ++ HPNI+ L G C E + ++ +E +L ++R++
Sbjct: 47 RDFAGELEVL-CKLG-----HHPNIIN-LLGAC-ENRGYLYIAIEYAPYGNLLDFLRKSR 98
Query: 301 -------FGSRRRNSFSLPV--VVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSME 351
F + +L ++ +A GM++L ++ H +L N+ +
Sbjct: 99 VLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGEN--- 155
Query: 352 GYFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCS 411
K++ FGLS + T P W A E S + S +
Sbjct: 156 --LASKIADFGLSRGEEVYVKKT--------MGRLPVRWMAIE---------SLNYSVYT 196
Query: 412 EKADVYSFGMLCFELLT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKC 470
K+DV+SFG+L +E+++ G P+ + ++ + + G R P + L ++C
Sbjct: 197 TKSDVWSFGVLLWEIVSLGGTPY--CGMTCAELYEKLPQGYRMEKPRNCDDEVYELMRQC 254
Query: 471 WHTNPSQRPSFSSI 484
W P +RP F+ I
Sbjct: 255 WRDRPYERPPFAQI 268
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 4e-07
Identities = 54/201 (26%), Positives = 91/201 (45%), Gaps = 22/201 (10%)
Query: 240 FVLRHFYGELESLNA--EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYM 297
+ L+ G S++A EI+ + L HPN++ F ++ +L+ + DL +
Sbjct: 31 YALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHII 90
Query: 298 RETFGSR-RRNSFSLP--VVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYF 354
+ S+ + LP +V ++ QI G+ +LHA + H +L P+NI + E
Sbjct: 91 KFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPE-RG 149
Query: 355 HVKVSGFGLSTARTYASRNTPPASPQNQTAPNPY-IWY-APEVLAEQEGTGSTSTSKCSE 412
VK++ G AR + S P P P WY APE+L G+ +K
Sbjct: 150 RVKIADMGF--ARLFNS----PLKPLADLDPVVVTFWYRAPELL-----LGARHYTKA-- 196
Query: 413 KADVYSFGMLCFELLTGKVPF 433
D+++ G + ELLT + F
Sbjct: 197 -IDIWAIGCIFAELLTSEPIF 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 61/203 (30%), Positives = 92/203 (45%), Gaps = 38/203 (18%)
Query: 247 GELESLNAEISTMLSLSH----PNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETF 301
GE +LN I MLSL P IV F +K F +++LM+ DL ++ +
Sbjct: 37 GETLALNERI--MLSLVSTGDCPFIVCMSYAFHTPDKLSF--ILDLMNGGDLHYHLSQ-- 90
Query: 302 GSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGF 361
FS + +I G+E +H + + + +L P+NI L + + HV++S
Sbjct: 91 ----HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILL-----DEHGHVRISDL 141
Query: 362 GLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGM 421
GL+ S+ P AS + Y+ APEVL Q+G S+ AD +S G
Sbjct: 142 GLACD---FSKKKPHAS----VGTHGYM--APEVL--QKGVAYDSS------ADWFSLGC 184
Query: 422 LCFELLTGKVPFEDGHLQGDKMT 444
+ F+LL G PF H DK
Sbjct: 185 MLFKLLRGHSPFR-QHKTKDKHE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 60/234 (25%), Positives = 98/234 (41%), Gaps = 34/234 (14%)
Query: 257 STMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMS-KDLSCYMRETFGSRRRNSFSLPVVV 315
S M +SH +IV L G C + E +V E + L +M R+ + + P
Sbjct: 56 SMMRQVSHKHIV-LLYGVCVRDV-ENIMVEEFVEFGPLDLFMH-----RKSDVLTTPWKF 108
Query: 316 DIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYF--HVKVSGFGLSTARTYASRN 373
+ Q+A + +L + + HG + NI L ++G +K+S G+ T SR
Sbjct: 109 KVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPI--TVLSR- 165
Query: 374 TPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFEL-LTGKVP 432
Q W APE + + + S AD +SFG +E+ G++P
Sbjct: 166 --------QECVERIPWIAPECVED--------SKNLSIAADKWSFGTTLWEICYNGEIP 209
Query: 433 FEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486
+D L K + + + S K L +L C + +P+QRP F +I R
Sbjct: 210 LKDKTL----AEKERFYEGQCMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMR 259
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 5e-07
Identities = 55/202 (27%), Positives = 91/202 (45%), Gaps = 42/202 (20%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRET--FGSRRRNSFSLP 312
EIS + + H NIV+ L EK+ +LV E + DL +M + F R
Sbjct: 51 EISLLKEMQHGNIVR-LQDVVHSEKR-LYLVFEYLDLDLKKHMDSSPDFAKNPR------ 102
Query: 313 VVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA-----R 367
++ + QI RG+ + H+ ++ H +L P N+ + R+ +K++ FGL+ A R
Sbjct: 103 LIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNA----LKLADFGLARAFGIPVR 158
Query: 368 TYASRNTPPASPQNQTAPNPYIWY-APEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFEL 426
T+ T +WY APE+L G+ ST D++S G + E+
Sbjct: 159 TF-------------THEVVTLWYRAPEILL---GSRHYSTP-----VDIWSVGCIFAEM 197
Query: 427 LTGKVPFEDGHLQGDKMTKNIR 448
+ K P G + D++ K R
Sbjct: 198 VNQK-PLFPGDSEIDELFKIFR 218
|
Length = 294 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 5e-07
Identities = 54/201 (26%), Positives = 91/201 (45%), Gaps = 22/201 (10%)
Query: 240 FVLRHFYGELESLNA--EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYM 297
+ L+ G S++A EI+ + L HPN++ F ++ +L+ + DL +
Sbjct: 31 YALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHII 90
Query: 298 RETFGSR-RRNSFSLP--VVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYF 354
+ S+ + LP +V ++ QI G+ +LHA + H +L P+NI + E
Sbjct: 91 KFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPE-RG 149
Query: 355 HVKVSGFGLSTARTYASRNTPPASPQNQTAPNPY-IWY-APEVLAEQEGTGSTSTSKCSE 412
VK++ G AR + S P P P WY APE+L G+ +K
Sbjct: 150 RVKIADMGF--ARLFNS----PLKPLADLDPVVVTFWYRAPELL-----LGARHYTKA-- 196
Query: 413 KADVYSFGMLCFELLTGKVPF 433
D+++ G + ELLT + F
Sbjct: 197 -IDIWAIGCIFAELLTSEPIF 216
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 7e-07
Identities = 55/231 (23%), Positives = 88/231 (38%), Gaps = 72/231 (31%)
Query: 216 KKLMVRRRLGASSQFKEIQWLGDSFVLRHFYGELESLNAEISTMLSLSHPNIVQYLCGFC 275
KK++ +R L +E++ +LRHF G H NI
Sbjct: 41 KKILAKRAL------RELK------LLRHFRG----------------HKNIT----CLY 68
Query: 276 DEEK------KEFFLVMELMSKDLSCYMR--ETFGSRRRNSFSLPVVVDIMLQIARGMEF 327
D + E +L ELM DL +R + SF + QI G+++
Sbjct: 69 DMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSF--------IYQILCGLKY 120
Query: 328 LHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNP 387
+H+ + H +L P N+ + A +K+ FGL +R +N
Sbjct: 121 IHSANVLHRDLKPGNLLVNADC-----ELKICDFGL-------ARGFSENPGENAGFMTE 168
Query: 388 YI---WY-APEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFE 434
Y+ WY APE++ S ++ DV+S G + ELL K F+
Sbjct: 169 YVATRWYRAPEIM--------LSFQSYTKAIDVWSVGCILAELLGRKPVFK 211
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 8e-07
Identities = 58/212 (27%), Positives = 94/212 (44%), Gaps = 45/212 (21%)
Query: 275 CDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIY 334
C + + VME ++ Y + G F P V +IA G+ FLH++ I
Sbjct: 69 CFQTMDRLYFVMEYVNGGDLMYHIQQVGK-----FKEPHAVFYAAEIAIGLFFLHSKGII 123
Query: 335 HGELNPSNIYLKARSMEGYFHVKVSGFGL--------STARTYASRNTPPASPQNQTAPN 386
+ +L N+ L A EG H+K++ FG+ T RT+ TP
Sbjct: 124 YRDLKLDNVMLDA---EG--HIKIADFGMCKENIFGGKTTRTFCG--TPD---------- 166
Query: 387 PYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKN 446
YI APE++A Q S D ++FG+L +E+L G+ PF DG + D++ ++
Sbjct: 167 -YI--APEIIAYQPYGKSV---------DWWAFGVLLYEMLAGQPPF-DGEDE-DELFQS 212
Query: 447 IRAGERPLFPSGSPKYLVNLTKKCWHTNPSQR 478
I +P K V++ K +P++R
Sbjct: 213 IME-HNVSYPKSLSKEAVSICKGLLTKHPAKR 243
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 62/253 (24%), Positives = 103/253 (40%), Gaps = 32/253 (12%)
Query: 250 ESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRE-------TF 301
+ + E + +L H +IV++ G C E +V E M DL+ ++R
Sbjct: 52 KDFHREAELLTNLQHEHIVKFY-GVC-VEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMA 109
Query: 302 GSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGF 361
R + ++ I QIA GM +L +Q H +L N + + VK+ F
Sbjct: 110 EGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL-----VKIGDF 164
Query: 362 GLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGM 421
G+S R S + P W PE S K + ++DV+S G+
Sbjct: 165 GMS--RDVYSTDYYRVGGHTML---PIRWMPPE---------SIMYRKFTTESDVWSLGV 210
Query: 422 LCFELLT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPS 480
+ +E+ T GK P+ L +++ + I G P PK + +L CW P R +
Sbjct: 211 VLWEIFTYGKQPWY--QLSNNEVIECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLN 268
Query: 481 FSSICRILRYIKK 493
I +L+ + K
Sbjct: 269 IKEIHSLLQNLAK 281
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-06
Identities = 68/260 (26%), Positives = 117/260 (45%), Gaps = 32/260 (12%)
Query: 254 AEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFSLP 312
+E+ + + H IV++ F ++K L+ME S DL+ +++ + F
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDK--LLLIMEYGSGGDLNKQIKQRL--KEHLPFQEY 169
Query: 313 VVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASR 372
V + QI ++ +H++K+ H +L +NI+L + +K+ FG S + S
Sbjct: 170 EVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGI-----IKLGDFGFSKQYS-DSV 223
Query: 373 NTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVP 432
+ AS T PY + APE+ + + S+KAD++S G++ +ELLT P
Sbjct: 224 SLDVASSFCGT---PY-YLAPELWERK---------RYSKKADMWSLGVILYELLTLHRP 270
Query: 433 FEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSI--CRILRY 490
F+ G Q + M + + P FP + L NP+ RP+ + L+Y
Sbjct: 271 FK-GPSQREIMQQVLYGKYDP-FPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328
Query: 491 IKKFMANNPDIAR-SEFQSP 509
+ DI R SE SP
Sbjct: 329 VANLFQ---DIVRHSETISP 345
|
Length = 478 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 2e-06
Identities = 59/253 (23%), Positives = 108/253 (42%), Gaps = 42/253 (16%)
Query: 243 RHFYGELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRET-- 300
R F GELE L ++ HPNI+ L G C+ + + +L ++R++
Sbjct: 40 RDFAGELEVL-CKLG-----HHPNIINLL-GACEHRGYLYLAIEYAPHGNLLDFLRKSRV 92
Query: 301 ------FGSRRRNSFSLPV--VVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEG 352
F + +L ++ +ARGM++L ++ H +L NI +
Sbjct: 93 LETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN---- 148
Query: 353 YFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSE 412
+ K++ FGLS + + T P W A E S + S +
Sbjct: 149 -YVAKIADFGLSRGQEVYVKKT--------MGRLPVRWMAIE---------SLNYSVYTT 190
Query: 413 KADVYSFGMLCFELLT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCW 471
+DV+S+G+L +E+++ G P+ + ++ + + G R P + +L ++CW
Sbjct: 191 NSDVWSYGVLLWEIVSLGGTPY--CGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCW 248
Query: 472 HTNPSQRPSFSSI 484
P +RPSF+ I
Sbjct: 249 REKPYERPSFAQI 261
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 57/234 (24%), Positives = 89/234 (38%), Gaps = 34/234 (14%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVV 314
E+ + L HPN ++Y + E +LVME S + + + +
Sbjct: 71 EVKFLQQLKHPNTIEYKGCYLKEHTA--WLVMEYCLGSASDLLE--VHKKPLQEVEIAAI 126
Query: 315 VDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNT 374
LQ G+ +LH+ + H ++ NI L VK++ FG ++
Sbjct: 127 THGALQ---GLAYLHSHNMIHRDIKAGNILLTEPG-----QVKLADFGSASK-------- 170
Query: 375 PPASPQNQTAPNPYIWYAPEV-LAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPF 433
+SP N PY W APEV LA EG + K DV+S G+ C EL K P
Sbjct: 171 --SSPANSFVGTPY-WMAPEVILAMDEG-------QYDGKVDVWSLGITCIELAERKPPL 220
Query: 434 EDGHLQGDKMTKNIRAGERPLFPSGS-PKYLVNLTKKCWHTNPSQRPSFSSICR 486
+ + +I + P S C P +RP+ + + R
Sbjct: 221 FN--MNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLR 272
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 50/179 (27%), Positives = 73/179 (40%), Gaps = 29/179 (16%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVV 314
EI + L H NIV+ L +KK LV E +DL Y G +V
Sbjct: 49 EICLLKELKHKNIVR-LYDVLHSDKK-LTLVFEYCDQDLKKYFDSCNGDIDP-----EIV 101
Query: 315 VDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNT 374
M Q+ +G+ F H+ + H +L P N+ + +K++ FGL AR +
Sbjct: 102 KSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNG-----ELKLADFGL--ARAFG---I 151
Query: 375 PPASPQNQTAPNPYIWY-APEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVP 432
P +A +WY P+VL G STS D++S G + EL P
Sbjct: 152 PVRC---YSAEVVTLWYRPPDVLF---GAKLYSTS-----IDMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 40/134 (29%), Positives = 58/134 (43%), Gaps = 23/134 (17%)
Query: 325 MEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTPPASPQNQTA 384
+E LH I + +L P NI L A H+ + FGLS A ++ T T
Sbjct: 109 LEHLHKYDIVYRDLKPENILLDATG-----HIALCDFGLSKANLTDNKTT-------NTF 156
Query: 385 PNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMT 444
+ APEVL +++G + D +S G+L FE+ G PF Q +M
Sbjct: 157 CGTTEYLAPEVLLDEKGYT--------KHVDFWSLGVLVFEMCCGWSPFYAEDTQ--QMY 206
Query: 445 KNIRAGERPLFPSG 458
+NI G + FP
Sbjct: 207 RNIAFG-KVRFPKN 219
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 47/210 (22%)
Query: 247 GELESLNAEISTMLSLSH----PNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRE-- 299
GE +LN I MLSL P IV F +K F +++LM+ DL ++ +
Sbjct: 37 GETLALNERI--MLSLVSTGDCPFIVCMTYAFHTPDKLCF--ILDLMNGGDLHYHLSQHG 92
Query: 300 TFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVS 359
F + ++ +++ G+E +H + + + +L P+NI L + + HV++S
Sbjct: 93 VFSEKEMRFYATEIIL--------GLEHMHNRFVVYRDLKPANILL-----DEHGHVRIS 139
Query: 360 GFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSF 419
GL+ S+ P AS + APEVL Q+GT S+ AD +S
Sbjct: 140 DLGLACD---FSKKKPHASVGTHG------YMAPEVL--QKGTAYDSS------ADWFSL 182
Query: 420 GMLCFELLTGKVPF-----EDGHLQGDKMT 444
G + F+LL G PF +D H + D+MT
Sbjct: 183 GCMLFKLLRGHSPFRQHKTKDKH-EIDRMT 211
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 62/252 (24%), Positives = 112/252 (44%), Gaps = 41/252 (16%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYM--RETFGSRRRNSFSL 311
EI M L +PNI++ L C + ++ E M DL+ ++ RE S ++ ++
Sbjct: 67 EIKIMSRLKNPNIIRLLG-VCVSDDP-LCMITEYMENGDLNQFLSQREIE-STFTHANNI 123
Query: 312 PVV-----VDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366
P V + + +QIA GM++L + H +L N + ++ +K++ FG+S
Sbjct: 124 PSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV-----GNHYTIKIADFGMS-- 176
Query: 367 RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFEL 426
R S + + A P W A E S K + +DV++FG+ +E+
Sbjct: 177 RNLYSGDYYRIQGR---AVLPIRWMAWE---------SILLGKFTTASDVWAFGVTLWEM 224
Query: 427 --LTGKVPFEDGHLQGDKMTKN----IRAGERPLFPSGSP---KYLVNLTKKCWHTNPSQ 477
L + P+ L +++ +N R R ++ S +P + L +CW +
Sbjct: 225 FTLCKEQPYS--LLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKD 282
Query: 478 RPSFSSICRILR 489
RP+F+ I LR
Sbjct: 283 RPTFNKIHHFLR 294
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 72/292 (24%), Positives = 113/292 (38%), Gaps = 60/292 (20%)
Query: 275 CDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIY 334
C + + VME ++ Y + G F P V +IA G+ FLH++ I
Sbjct: 69 CFQTMDRLYFVMEYVNGGDLMYQIQQVGR-----FKEPHAVFYAAEIAIGLFFLHSKGII 123
Query: 335 HGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTPP--ASPQNQTAPNPYIWYA 392
+ +L N+ L + EG H+K++ FG+ + T +P YI A
Sbjct: 124 YRDLKLDNVMLDS---EG--HIKIADFGMCKENMWDGVTTKTFCGTPD-------YI--A 169
Query: 393 PEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFE---DGHLQGDKMTKNIRA 449
PE++A Q S D ++FG+L +E+L G+ PFE + L M N+
Sbjct: 170 PEIIAYQPYGKSV---------DWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA- 219
Query: 450 GERPLFPSGSPKYLVNLTKKCWHTNPSQR----PSFSSICR---ILRYIKKFMANNPDIA 502
+P K V + K +P +R P + RYI + +
Sbjct: 220 -----YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI-----DWEKLE 269
Query: 503 RSEFQSPLADY-CDIEAGFVRKFVGEGCPDVAP--------VSQIPFQMFAY 545
R E Q P C +A KF P + P + Q F+ F+Y
Sbjct: 270 RKEVQPPYKPKACGRDAENFDKFFTRHPPVLTPPDQEVIMNLDQSEFEGFSY 321
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 3e-06
Identities = 55/234 (23%), Positives = 96/234 (41%), Gaps = 45/234 (19%)
Query: 260 LSLSH--PNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDI 317
+ SH P IV+ C + F+ MELMS +C + R + ++ +
Sbjct: 67 VLKSHDCPYIVK--CYGYFITDSDVFICMELMS---TCL--DKLLKRIQGPIPEDILGKM 119
Query: 318 MLQIARGMEFL-HAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGL------STARTYA 370
+ I + + +L + H ++ PSNI L A +VK+ FG+ S A+T +
Sbjct: 120 TVAIVKALHYLKEKHGVIHRDVKPSNILLDASG-----NVKLCDFGISGRLVDSKAKTRS 174
Query: 371 SRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGK 430
+ +P+ P+P K +ADV+S G+ EL TG+
Sbjct: 175 AGCAAYMAPERIDPPDP-------------------NPKYDIRADVWSLGISLVELATGQ 215
Query: 431 VPFEDGHLQGDKMTKNIRAGERPLFPSG---SPKYLVNLTKKCWHTNPSQRPSF 481
P+++ + + +TK I E P P SP + + C + +RP +
Sbjct: 216 FPYKNCKTEFEVLTK-ILQEEPPSLPPNEGFSPDF-CSFVDLCLTKDHRKRPKY 267
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 3e-06
Identities = 50/183 (27%), Positives = 83/183 (45%), Gaps = 34/183 (18%)
Query: 255 EISTMLSLSHPNIVQYLCGFCD----EEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFS 310
E+ M ++H NI+ L F EE ++ ++VMELM +L C + + R S+
Sbjct: 73 ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANL-CQVIQMELDHERMSY- 130
Query: 311 LPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYA 370
++ Q+ G++ LH+ I H +L PSNI +K+ +K+ FGL+ +
Sbjct: 131 ------LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-----LKILDFGLARTAGTS 179
Query: 371 SRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGK 430
TP + + APEV+ G G E D++S G + E++ G
Sbjct: 180 FMMTPYVVTR--------YYRAPEVIL---GMGY------KENVDIWSVGCIMGEMIKGG 222
Query: 431 VPF 433
V F
Sbjct: 223 VLF 225
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 4e-06
Identities = 53/187 (28%), Positives = 85/187 (45%), Gaps = 42/187 (22%)
Query: 255 EISTMLSLSHPNIVQYLCGFCD----EEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFS 310
E+ M ++H NI+ L F EE ++ +LVMELM +L C + + R S+
Sbjct: 66 ELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANL-CQVIQMELDHERMSY- 123
Query: 311 LPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYA 370
++ Q+ G++ LH+ I H +L PSNI +K+ +K+ FGL ART
Sbjct: 124 ------LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-----LKILDFGL--ARTAG 170
Query: 371 SRNTPPASPQNQTAPNPYI----WYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFEL 426
+ PY+ + APEV+ G G E D++S G + E+
Sbjct: 171 T----------SFMMTPYVVTRYYRAPEVIL---GMGY------KENVDIWSVGCIMGEM 211
Query: 427 LTGKVPF 433
+ K+ F
Sbjct: 212 VRHKILF 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 4e-06
Identities = 50/190 (26%), Positives = 78/190 (41%), Gaps = 32/190 (16%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELM-SKDLSCYMRETFGSRRRNSFSLPV 313
E M + P +VQ C F D+ K ++VME M DL M + F
Sbjct: 93 ERDIMAFANSPWVVQLFCAFQDD--KYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAE 150
Query: 314 VVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFG--LSTARTYAS 371
VV ++ +H+ + H ++ P N+ L + + H+K++ FG + T
Sbjct: 151 VV-------LALDAIHSMGLIHRDVKPDNMLL-----DKHGHLKLADFGTCMKMDETGMV 198
Query: 372 R-NTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGK 430
R +T +P + +PEVL Q G G + D +S G+ FE+L G
Sbjct: 199 RCDTAVGTPD---------YISPEVLKSQGGDGYYG-----RECDWWSVGVFLFEMLVGD 244
Query: 431 VPFEDGHLQG 440
PF L G
Sbjct: 245 TPFYADSLVG 254
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 4e-06
Identities = 57/190 (30%), Positives = 84/190 (44%), Gaps = 30/190 (15%)
Query: 305 RRNSFSLPVVVDIML--QIARGMEFLHAQKIYHGELNPSNIYLKARSM-EGYF-HVKVSG 360
R+ +PV I + Q+A + +L + + HG + NI L + EG +K+S
Sbjct: 108 RKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSD 167
Query: 361 FGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFG 420
G+S T SR + + P W APE + G S ST+ AD +SFG
Sbjct: 168 PGVSF--TALSR-------EERVERIP--WIAPECV---PGGNSLSTA-----ADKWSFG 208
Query: 421 MLCFEL-LTGKVPFEDGHLQGDKMTKNIRAGERPL-FPSGSPKYLVNLTKKCWHTNPSQR 478
E+ G+VP L+ ++ R E+ P S K L L +C P+QR
Sbjct: 209 TTLLEICFDGEVP-----LKERTPSEKERFYEKKHRLPEPSCKELATLISQCLTYEPTQR 263
Query: 479 PSFSSICRIL 488
PSF +I R L
Sbjct: 264 PSFRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 8e-06
Identities = 35/133 (26%), Positives = 53/133 (39%), Gaps = 31/133 (23%)
Query: 320 QIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASR--NTPPA 377
++ G+E LH + I H ++ P N+ + H+K++ FGLS + TP
Sbjct: 105 EVVLGVEDLHQRGIIHRDIKPENLLIDQTG-----HLKLTDFGLSRNGLENKKFVGTPD- 158
Query: 378 SPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGH 437
Y+ APE + G G S D +S G + FE L G PF
Sbjct: 159 ----------YL--APETI---LGVGDDKMS------DWWSLGCVIFEFLFGYPPFHAE- 196
Query: 438 LQGDKMTKNIRAG 450
D + NI +
Sbjct: 197 -TPDAVFDNILSR 208
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 63/230 (27%), Positives = 92/230 (40%), Gaps = 41/230 (17%)
Query: 254 AEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPV 313
AE + + ++ HP IV + F K +L++E +S E F R +
Sbjct: 49 AERNILEAVKHPFIVDLIYAFQTGGK--LYLILEYLSGG------ELFMHLEREGIFMED 100
Query: 314 VVDIML-QIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASR 372
L +I+ +E LH Q I + +L P NI L A+ HVK++ FGL +
Sbjct: 101 TACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQG-----HVKLTDFGLCKESIHEGT 155
Query: 373 NTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVP 432
T T + APE+L S + D +S G L +++LTG P
Sbjct: 156 VT-------HTFCGTIEYMAPEIL---------MRSGHGKAVDWWSLGALMYDMLTGAPP 199
Query: 433 FEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVN----LTKKCWHTNPSQR 478
F + + K I G+ L P YL L KK NPS R
Sbjct: 200 FTAENRK--KTIDKILKGKLNL-----PPYLTPEARDLLKKLLKRNPSSR 242
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 59/237 (24%), Positives = 97/237 (40%), Gaps = 32/237 (13%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELM-SKDLSCYMRETFGSRRRNSFSLPV 313
E + + P I Q F D K +LVME DL + +R + F +
Sbjct: 51 ERDILSISNSPWIPQLQYAFQD--KDNLYLVMEYQPGGDLLSLL-----NRYEDQFDEDM 103
Query: 314 VVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRN 373
+ ++ + +H H ++ P N+ + + H+K++ FG S AR A++
Sbjct: 104 AQFYLAELVLAIHSVHQMGYVHRDIKPENVLI-----DRTGHIKLADFG-SAARLTANKM 157
Query: 374 TPPASPQNQTAPNPYIWYAPEVLAEQEGTG-STSTSKCSEKADVYSFGMLCFELLTGKVP 432
P YI APEVL G G T +C D +S G++ +E++ G+ P
Sbjct: 158 VNSKLP---VGTPDYI--APEVLTTMNGDGKGTYGVEC----DWWSLGVIAYEMIYGRSP 208
Query: 433 FEDGHLQGDKMTKNIRAGERPL-FPSGSPKY---LVNLTKKCWHTNPSQRPSFSSIC 485
F +G K NI +R L FP PK ++L + +R + +C
Sbjct: 209 FHEGTSA--KTYNNIMNFQRFLKFPE-DPKVSSDFLDLIQSLL-CGQKERLGYEGLC 261
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 46/203 (22%), Positives = 83/203 (40%), Gaps = 46/203 (22%)
Query: 256 ISTML--SLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRE-------TFGSRRR 306
I ML +++HP++++ + L+S ++C + T+ ++R
Sbjct: 106 IEAMLLQNVNHPSVIR--------------MKDTLVSGAITCMVLPHYSSDLYTYLTKRS 151
Query: 307 NSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366
+ + I QI G+ +LHAQ+I H ++ NI++ V + G
Sbjct: 152 RPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVD-----QVCIGDLG---- 202
Query: 367 RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFEL 426
A++ P +P APEVLA K + KAD++S G++ FE+
Sbjct: 203 ---AAQ-FPVVAPAFLGLAGTVETNAPEVLAR---------DKYNSKADIWSAGIVLFEM 249
Query: 427 LT-GKVPFEDGHLQGDKMTKNIR 448
L FED ++ K+
Sbjct: 250 LAYPSTIFEDPPSTPEEYVKSCH 272
|
Length = 357 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 44/179 (24%), Positives = 74/179 (41%), Gaps = 31/179 (17%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVV 314
E+ + L H NI+ L ++ + V EL+ DL R F +
Sbjct: 59 ELKLLKHLRHENIIS-LSDIFISPLEDIYFVTELLGTDLH---RLLTSRPLEKQF----I 110
Query: 315 VDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNT 374
+ QI RG++++H+ + H +L PSNI + +K+ FGL AR + T
Sbjct: 111 QYFLYQILRGLKYVHSAGVVHRDLKPSNILINENC-----DLKICDFGL--ARIQDPQMT 163
Query: 375 PPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPF 433
S + + APE++ + K + D++S G + E+L GK F
Sbjct: 164 GYVSTR--------YYRAPEIM--------LTWQKYDVEVDIWSAGCIFAEMLEGKPLF 206
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 61/228 (26%), Positives = 95/228 (41%), Gaps = 49/228 (21%)
Query: 260 LSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIM 318
L+ HP + C F + K F VME ++ DL F +R F P
Sbjct: 51 LAAKHPFLTALHCCF--QTKDRLFFVMEYVNGGDL------MFQIQRSRKFDEPRSRFYA 102
Query: 319 LQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGL--------STARTYA 370
++ + FLH + + +L NI L A EG H K++ FG+ T T+
Sbjct: 103 AEVTLALMFLHRHGVIYRDLKLDNILLDA---EG--HCKLADFGMCKEGILNGVTTTTFC 157
Query: 371 SRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGK 430
TP YI APE+L E E S D ++ G+L +E++ G+
Sbjct: 158 G--TPD-----------YI--APEILQELEYGPSV---------DWWALGVLMYEMMAGQ 193
Query: 431 VPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQR 478
PFE + D + ++I + L+P K V++ K NP++R
Sbjct: 194 PPFEADN--EDDLFESI-LHDDVLYPVWLSKEAVSILKAFMTKNPNKR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 62/238 (26%), Positives = 103/238 (43%), Gaps = 30/238 (12%)
Query: 262 LSHPNIVQYLCGFCDEEKKEFFLVMELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQ 320
L HPNI+Q L G C E + LV E DL Y+ + RRNS L ++ + +
Sbjct: 52 LQHPNILQCL-GQC-VEAIPYLLVFEYCELGDLKSYLSQE-QWHRRNSQLL-LLQRMACE 107
Query: 321 IARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTPPASPQ 380
IA G+ +H H +L N +L VKV +G+ +R +
Sbjct: 108 IAAGVTHMHKHNFLHSDLALRNCFLT-----SDLTVKVGDYGIGPSRYKEDYIE---TED 159
Query: 381 NQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELL-TGKVPFEDGHLQ 439
++ P W APE++ E G T++ ++ ++V++ G+ +EL P+ HL
Sbjct: 160 DKCV--PLRWLAPELVGEFH--GGLITAEQTKPSNVWALGVTLWELFENAAQPYS--HLS 213
Query: 440 G-DKMTKNIRAGERPLF------PSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRY 490
+ + I+ + LF P Y V + CW +P +R + + R+L Y
Sbjct: 214 DREVLNHVIKDQQVKLFKPQLELPYSERWYEV--LQFCW-LSPEKRATAEEVHRLLTY 268
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 56/212 (26%), Positives = 93/212 (43%), Gaps = 45/212 (21%)
Query: 275 CDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIY 334
C + + VME ++ Y + G F P V +I+ G+ FLH + I
Sbjct: 69 CFQTVDRLYFVMEYVNGGDLMYHIQQVGK-----FKEPQAVFYAAEISVGLFFLHRRGII 123
Query: 335 HGELNPSNIYLKARSMEGYFHVKVSGFGLS--------TARTYASRNTPPASPQNQTAPN 386
+ +L N+ L + EG H+K++ FG+ T RT+ TP
Sbjct: 124 YRDLKLDNVMLDS---EG--HIKIADFGMCKEHMVDGVTTRTFCG--TPD---------- 166
Query: 387 PYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKN 446
YI APE++A Q S D +++G+L +E+L G+ PF DG + D++ ++
Sbjct: 167 -YI--APEIIAYQPYGKSV---------DWWAYGVLLYEMLAGQPPF-DGEDE-DELFQS 212
Query: 447 IRAGERPLFPSGSPKYLVNLTKKCWHTNPSQR 478
I +P K V++ K +PS+R
Sbjct: 213 IME-HNVSYPKSLSKEAVSICKGLMTKHPSKR 243
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 49/182 (26%), Positives = 78/182 (42%), Gaps = 37/182 (20%)
Query: 264 HPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIML--QI 321
+P +V C F E K+ +VME + C + +N +LPV + M +
Sbjct: 60 NPFVVSMFCSF--ETKRHLCMVMEYVEGG-DC------ATLLKNIGALPVDMARMYFAET 110
Query: 322 ARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS-------TARTYA---S 371
+E+LH I H +L P N+ + + H+K++ FGLS T Y
Sbjct: 111 VLALEYLHNYGIVHRDLKPDNLLITSMG-----HIKLTDFGLSKIGLMSLTTNLYEGHIE 165
Query: 372 RNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKV 431
++T + YI APEV+ Q G G + D ++ G++ +E L G V
Sbjct: 166 KDTREFLDKQVCGTPEYI--APEVILRQ-GYG--------KPVDWWAMGIILYEFLVGCV 214
Query: 432 PF 433
PF
Sbjct: 215 PF 216
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 3e-05
Identities = 52/203 (25%), Positives = 93/203 (45%), Gaps = 40/203 (19%)
Query: 250 ESLNAEISTMLSLSHPNIVQ----YLCGFCDEEKKEFFLVME-LMSKDLSCYMRETFGSR 304
E L E+ M H N+V+ YL G +E +++ME L L+ + +T
Sbjct: 63 ELLFNEVVIMRDYQHQNVVEMYKSYLVG------EELWVLMEFLQGGALTDIVSQT---- 112
Query: 305 RRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS 364
R N + V + +LQ + +LH+Q + H ++ +I L +++G VK+S FG
Sbjct: 113 RLNEEQIATVCESVLQ---ALCYLHSQGVIHRDIKSDSILL---TLDG--RVKLSDFGFC 164
Query: 365 TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCF 424
S++ P + PY W APEV++ + + D++S G++
Sbjct: 165 AQ---ISKDVPK---RKSLVGTPY-WMAPEVISR---------TPYGTEVDIWSLGIMVI 208
Query: 425 ELLTGKVP-FEDGHLQGDKMTKN 446
E++ G+ P F D +Q K ++
Sbjct: 209 EMVDGEPPYFSDSPVQAMKRLRD 231
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 3e-05
Identities = 48/176 (27%), Positives = 75/176 (42%), Gaps = 23/176 (13%)
Query: 306 RNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365
R F+ V + +I ++ LH I + ++ NI L + EG HV ++ FGLS
Sbjct: 99 REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDS---EG--HVVLTDFGLS- 152
Query: 366 ARTYASRNTPPASPQNQTAPNPYIWY-APEVLAEQEGTGSTSTSKCSEKADVYSFGMLCF 424
+ + + A T I Y APEV+ GS K D +S G+L F
Sbjct: 153 -KEFLAEEEERAYSFCGT-----IEYMAPEVIR----GGSGGHDKA---VDWWSLGVLTF 199
Query: 425 ELLTGKVPF--EDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQR 478
ELLTG PF + ++++ I +P FP + +K +P +R
Sbjct: 200 ELLTGASPFTVDGEQNSQSEISRRILK-SKPPFPKTMSAEARDFIQKLLEKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 5e-05
Identities = 60/274 (21%), Positives = 105/274 (38%), Gaps = 66/274 (24%)
Query: 247 GELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRR 306
G+ E + +++HP+I+Q F K L++ DL CY+ + +R
Sbjct: 125 GQRGGTATEAHILRAINHPSIIQLKGTFT--YNKFTCLILPRYKTDLYCYL-----AAKR 177
Query: 307 NSFSLPV--VVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS 364
N + + ++ I + R +++LH +I H ++ NI++ V + FG
Sbjct: 178 N---IAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPG-----DVCLGDFG-- 227
Query: 365 TARTYASRNTPPASPQNQTAPNPYIWY------APEVLAEQEGTGSTSTSKCSEKADVYS 418
A + P + A Y W APE+LA D++S
Sbjct: 228 -AACF---------PVDINANKYYGWAGTIATNAPELLAR---------DPYGPAVDIWS 268
Query: 419 FGMLCFELLTGKVP-FE----DGHLQGDKMTKNI--RAG----ERPLFPSGSPKYLVNLT 467
G++ FE+ T FE DG D+ K I R+G E P+ + +
Sbjct: 269 AGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGL 328
Query: 468 KKCWHTNPSQRPSFSS-----------ICRILRY 490
K P RP +++ IC++L +
Sbjct: 329 AKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAF 362
|
Length = 391 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 5e-05
Identities = 47/184 (25%), Positives = 78/184 (42%), Gaps = 36/184 (19%)
Query: 255 EISTMLSLSHPNIVQYLCGFCD----EEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFS 310
E+ + + H N++ L F EE + +LV LM DL+ ++ + F
Sbjct: 66 ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF- 124
Query: 311 LPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYA 370
++ QI RG++++H+ I H +L PSN+ + +K+ FGL AR
Sbjct: 125 ------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-----ELKILDFGL--ARHTD 171
Query: 371 SRNTPPASPQNQTAPNPYIWY-APEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTG 429
T + + WY APE++ T D++S G + ELLTG
Sbjct: 172 DEMTGYVATR---------WYRAPEIMLNWMHYNQT--------VDIWSVGCIMAELLTG 214
Query: 430 KVPF 433
+ F
Sbjct: 215 RTLF 218
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 5e-05
Identities = 33/120 (27%), Positives = 58/120 (48%), Gaps = 22/120 (18%)
Query: 317 IMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTPP 376
I+ ++ ++++H + H ++ +NI + + G +VK+ FG++ A N
Sbjct: 106 IIREVLVALKYIHKVGVIHRDIKAANILV---TNTG--NVKLCDFGVA-----ALLNQ-- 153
Query: 377 ASPQNQT-APNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFED 435
S + T PY W APEV+ EG KAD++S G+ +E+ TG P+ D
Sbjct: 154 NSSKRSTFVGTPY-WMAPEVI--TEG------KYYDTKADIWSLGITIYEMATGNPPYSD 204
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 5e-05
Identities = 58/243 (23%), Positives = 99/243 (40%), Gaps = 39/243 (16%)
Query: 262 LSHPNIVQYLCGFCDEEKKEFFLVMELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQ 320
L+HPN++Q L G C E + LV+E DL Y+R G + + V+ + +
Sbjct: 52 LNHPNVLQCL-GQC-IESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKD-VLQRMACE 108
Query: 321 IARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTAR---TYASRNTPPA 377
+A G+ +LH H +L N L A VK+ +GL+ + Y A
Sbjct: 109 VASGLLWLHQADFIHSDLALRNCQLTAD-----LSVKIGDYGLALEQYPEDYYITKDCHA 163
Query: 378 SPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDG 436
P W APE++ + ++K++++S G+ +EL T P+ D
Sbjct: 164 VPLR--------WLAPELVEIRGQ--DLLPKDQTKKSNIWSLGVTMWELFTAADQPYPD- 212
Query: 437 HLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKK---------CWHTNPSQRPSFSSICRI 487
+ + +R + L PK ++L CW +P RP+ + +
Sbjct: 213 LSDEQVLKQVVREQDIKL-----PKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHEL 266
Query: 488 LRY 490
L Y
Sbjct: 267 LTY 269
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 6e-05
Identities = 50/190 (26%), Positives = 80/190 (42%), Gaps = 45/190 (23%)
Query: 255 EISTMLSLSHPNIVQY---LCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSL 311
EI + L H N++ + E + ++V ELM DL +R S
Sbjct: 54 EIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRS----------SQ 103
Query: 312 PVVVD----IMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTAR 367
+ D + Q+ RG++++H+ + H +L PSN+ L A +K+ FGL AR
Sbjct: 104 TLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANC-----DLKICDFGL--AR 156
Query: 368 TYASRNTPPASPQNQTAPNPYI---WY-APEVLAEQEGTGSTSTSKCSEKADVYSFGMLC 423
T + + Y+ WY APE+L + S+ + DV+S G +
Sbjct: 157 T---------TSEKGDFMTEYVVTRWYRAPELL--------LNCSEYTTAIDVWSVGCIF 199
Query: 424 FELLTGKVPF 433
ELL K F
Sbjct: 200 AELLGRKPLF 209
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 8e-05
Identities = 35/163 (21%), Positives = 68/163 (41%), Gaps = 39/163 (23%)
Query: 283 FLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSN 342
++V E M DL+ + + S M Q+ RG++++H+ + H +L P+N
Sbjct: 92 YIVQEYMETDLANVLEQ-------GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPAN 144
Query: 343 IYLKARSMEGYFHVKVSGFGLS-------TARTYASRNTPPASPQNQTAPNPYIWY-APE 394
+++ + +K+ FGL+ + + Y S WY +P
Sbjct: 145 VFINTEDLV----LKIGDFGLARIVDPHYSHKGYLSEGLVTK------------WYRSPR 188
Query: 395 VLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGH 437
+L S + ++ D+++ G + E+LTGK F H
Sbjct: 189 LL--------LSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAH 223
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 8e-05
Identities = 49/178 (27%), Positives = 77/178 (43%), Gaps = 34/178 (19%)
Query: 260 LSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIM 318
L+ +HP + Q C C + F VME ++ DL ++++ SRR F
Sbjct: 51 LARNHPFLTQLYC--CFQTPDRLFFVMEFVNGGDLMFHIQK---SRR---FDEARARFYA 102
Query: 319 LQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTPP-- 376
+I + FLH + I + +L N+ L EG H K++ FG+ + + T
Sbjct: 103 AEITSALMFLHDKGIIYRDLKLDNVLL---DHEG--HCKLADFGMCKEGIFNGKTTSTFC 157
Query: 377 ASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFE 434
+P YI APE+L E S D ++ G+L +E+L G PFE
Sbjct: 158 GTPD-------YI--APEILQEMLYGPSV---------DWWAMGVLLYEMLCGHAPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 9e-05
Identities = 50/190 (26%), Positives = 80/190 (42%), Gaps = 29/190 (15%)
Query: 252 LNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMS----KDLSCYMRETFGSRRRN 307
L E+ +HPNIV Y F + E ++V M+ KDL C + +
Sbjct: 46 LQGELHVSKLFNHPNIVPYRATFIAD--NELWVVTSFMAYGSAKDLIC-------THFMD 96
Query: 308 SFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGF--GLST 365
S + I+ + + ++++H H + S+I + S++G V +SG LS
Sbjct: 97 GMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI---SVDG--KVYLSGLRSNLSM 151
Query: 366 ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFE 425
P+ P W +PEVL +Q G + K+D+YS G+ E
Sbjct: 152 INHGQRLRVVHDFPKYSVKVLP--WLSPEVL-QQNLQGYDA------KSDIYSVGITACE 202
Query: 426 LLTGKVPFED 435
L G VPF+D
Sbjct: 203 LANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 56/216 (25%), Positives = 82/216 (37%), Gaps = 62/216 (28%)
Query: 316 DIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFG--LSTARTYASRN 373
+I+ RG+ +LH H + S+I + S +G V +SG S R
Sbjct: 105 NILFGALRGLNYLHQNGYIHRNIKASHILI---SGDGL--VSLSGLSHLYSLVRNGQKAK 159
Query: 374 TPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPF 433
PQ T+ P W +PE+L Q+ G K+D+YS G+ EL TG+VPF
Sbjct: 160 VVYDFPQFSTSVLP--WLSPELL-RQDLYGYNV------KSDIYSVGITACELATGRVPF 210
Query: 434 EDGHL----------------------QGDKMTKNIRAG--------------------E 451
+D + KN ++G E
Sbjct: 211 QDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSE 270
Query: 452 RPLFPSG---SPKYLVNLTKKCWHTNPSQRPSFSSI 484
R PS SP + NL + C +P +RPS SS+
Sbjct: 271 RLRTPSSKTFSPAFQ-NLVELCLQQDPEKRPSASSL 305
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 60/251 (23%), Positives = 101/251 (40%), Gaps = 42/251 (16%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYM-----RETFGSRRRNS 308
EI M L PNI++ L + ++ E M DL+ ++ +E +
Sbjct: 69 EIKIMSRLKDPNIIRLLAVCITSDP--LCMITEYMENGDLNQFLSRHEPQEAAEKADVVT 126
Query: 309 FSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTART 368
S ++ + QIA GM++L + H +L N + + +K++ FG+S
Sbjct: 127 ISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKN-----YTIKIADFGMS---- 177
Query: 369 YASRNTPPASPQ--NQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFEL 426
RN A P W + E S K + +DV++FG+ +E+
Sbjct: 178 ---RNLYSGDYYRIQGRAVLPIRWMSWE---------SILLGKFTTASDVWAFGVTLWEI 225
Query: 427 LT--GKVPFEDGHLQGDKMTKN----IRAGERPLF---PSGSPKYLVNLTKKCWHTNPSQ 477
LT + P+ L +++ +N R R ++ P+ P L L CW N +
Sbjct: 226 LTLCKEQPY--SQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKE 283
Query: 478 RPSFSSICRIL 488
RPSF I L
Sbjct: 284 RPSFQEIHATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 1e-04
Identities = 40/156 (25%), Positives = 69/156 (44%), Gaps = 27/156 (17%)
Query: 280 KEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELN 339
+E ++V ELM DL + S V + QI RG+++LH+ I H ++
Sbjct: 77 EEIYVVTELMQSDLHKIIV------SPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIK 130
Query: 340 PSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWY-APEVLAE 398
P N+ + + + +K+ FGL +R P ++ T +Y APE+L
Sbjct: 131 PGNLLVNSNCV-----LKICDFGL-------ARVEEPDESKHMTQEVVTQYYRAPEIL-- 176
Query: 399 QEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFE 434
GS + D++S G + ELL ++ F+
Sbjct: 177 ---MGSRHY---TSAVDIWSVGCIFAELLGRRILFQ 206
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 59/253 (23%), Positives = 97/253 (38%), Gaps = 53/253 (20%)
Query: 250 ESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMS-KDLSCYMRETFGSRRRNS 308
ES S M LSH ++V G C E +V E + L Y++ + +N
Sbjct: 44 ESFFEAASMMSQLSHKHLV-LNYGVC-VCGDESIMVQEYVKFGSLDTYLK-----KNKNL 96
Query: 309 FSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYL---KARSMEGYFHVKVSGFGLST 365
++ +++ Q+A + FL + + HG + N+ L + R +K+S G+S
Sbjct: 97 INISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156
Query: 366 A---RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGML 422
+ P W PE + + S AD +SFG
Sbjct: 157 TVLPKEILLERIP--------------WVPPECIENPQ--------NLSLAADKWSFGTT 194
Query: 423 CFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSG-----SPKY--LVNLTKKCWHTNP 475
+E+ +G GDK + + ++ F +PK+ L NL +C P
Sbjct: 195 LWEIFSG----------GDKPLSALDSQKKLQFYEDRHQLPAPKWTELANLINQCMDYEP 244
Query: 476 SQRPSFSSICRIL 488
RPSF +I R L
Sbjct: 245 DFRPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 53/186 (28%), Positives = 79/186 (42%), Gaps = 42/186 (22%)
Query: 305 RRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS 364
+R++FS V +I +E LH I + ++ NI L + EG HV ++ FGLS
Sbjct: 98 QRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDS---EG--HVVLTDFGLS 152
Query: 365 TA-------RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVY 417
RTY+ T + APE++ + G G D +
Sbjct: 153 KEFLSEEKERTYSFCGTIE-------------YMAPEIIRGKGGHGKA--------VDWW 191
Query: 418 SFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGER-----PLFPSGSPKYLVNLTKKCWH 472
S G+L FELLTG PF L+G++ T++ R P FPS +L K
Sbjct: 192 SLGILIFELLTGASPFT---LEGERNTQS-EVSRRILKCDPPFPSFIGPEAQDLLHKLLR 247
Query: 473 TNPSQR 478
+P +R
Sbjct: 248 KDPKKR 253
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 46/189 (24%), Positives = 77/189 (40%), Gaps = 39/189 (20%)
Query: 250 ESLNAEISTMLSLSHPNIV----QYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRR 305
E L E+ M H N+V YL G E ++VME + + + R
Sbjct: 64 ELLFNEVVIMRDYHHENVVDMYNSYLVG------DELWVVMEFLEGGA---LTDIVTHTR 114
Query: 306 RNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365
N + V L + R + +LH Q + H ++ +I L + +K+S FG
Sbjct: 115 MNEEQIATVC---LSVLRALSYLHNQGVIHRDIKSDSILLTSDG-----RIKLSDFGFCA 166
Query: 366 ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQE-GTGSTSTSKCSEKADVYSFGMLCF 424
S+ P + PY W APEV++ GT + D++S G++
Sbjct: 167 Q---VSKEVPK---RKSLVGTPY-WMAPEVISRLPYGT----------EVDIWSLGIMVI 209
Query: 425 ELLTGKVPF 433
E++ G+ P+
Sbjct: 210 EMIDGEPPY 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 57/264 (21%), Positives = 105/264 (39%), Gaps = 57/264 (21%)
Query: 258 TMLSLSHPNIVQYL--------CGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSF 309
M S P IV++ C C MELM L + + + +
Sbjct: 56 VMRSSDCPYIVKFYGALFREGDCWIC----------MELMDISLDKFYKYVYEVLKSV-I 104
Query: 310 SLPVVVDIMLQIARGMEFLHAQ-KIYHGELNPSNIYLKARSMEGYFHVKVSGFGL----- 363
++ I + + + +L + KI H ++ PSNI L ++K+ FG+
Sbjct: 105 PEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNG-----NIKLCDFGISGQLV 159
Query: 364 -STARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGML 422
S A+T PY+ APE + ++ ++DV+S G+
Sbjct: 160 DSIAKT------------RDAGCRPYM--APERID------PSARDGYDVRSDVWSLGIT 199
Query: 423 CFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKY----LVNLTKKCWHTNPSQR 478
+E+ TGK P+ + D++T+ ++ G+ P+ + + VN C + S+R
Sbjct: 200 LYEVATGKFPYPKWNSVFDQLTQVVK-GDPPILSNSEEREFSPSFVNFINLCLIKDESKR 258
Query: 479 PSFSSICRILRYIKKFMANNPDIA 502
P + + +IK + N D+A
Sbjct: 259 PKYKELLE-HPFIKDYEERNVDVA 281
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 59/264 (22%), Positives = 102/264 (38%), Gaps = 46/264 (17%)
Query: 231 KEIQWLGDSFVLRHFYGELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMS 290
KEI+ D EL+ L+ +S P IV + F E ++ ME M
Sbjct: 32 KEIRLELDESKFNQIIMELDILHKAVS-------PYIVDFYGAFFIE--GAVYMCMEYM- 81
Query: 291 KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQ-KIYHGELNPSNIYLKARS 349
D + G V+ I + +G++FL + I H ++ P+N+ +
Sbjct: 82 -DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNG 140
Query: 350 MEGYFHVKVSGFGLS--TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTST 407
VK+ FG+S + A N S + APE + + G
Sbjct: 141 -----QVKLCDFGVSGNLVASLAKTNIGCQS-----------YMAPERI---KSGGPNQN 181
Query: 408 SKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRA-------GERPLFPSGSP 460
+ ++DV+S G+ E+ G+ P+ + NI A G+ P PSG
Sbjct: 182 PTYTVQSDVWSLGLSILEMALGRYPYPP------ETYANIFAQLSAIVDGDPPTLPSGYS 235
Query: 461 KYLVNLTKKCWHTNPSQRPSFSSI 484
+ KC + P++RP+++ +
Sbjct: 236 DDAQDFVAKCLNKIPNRRPTYAQL 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 50/202 (24%), Positives = 87/202 (43%), Gaps = 45/202 (22%)
Query: 243 RHFYGELESLNA--EISTMLSLSHPNIVQYLCGFCD----EEKKEFFLVMELMSKDLSCY 296
R F E+ + A E++ + + H N++ L F +E ++F+LVM M DL
Sbjct: 50 RPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKI 109
Query: 297 MRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHV 356
M + V ++ Q+ G++++H+ I H +L P N+ + +
Sbjct: 110 MGHPLSEDK--------VQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDC-----EL 156
Query: 357 KVSGFGLSTARTYASRNTPPASPQNQTAPNPYI---WY-APEVLAEQEGTGSTSTSKCSE 412
K+ FGL AR + T Y+ WY APEV+ + ++
Sbjct: 157 KILDFGL--ARHADAEMT------------GYVVTRWYRAPEVI--------LNWMHYNQ 194
Query: 413 KADVYSFGMLCFELLTGKVPFE 434
D++S G + E+LTGK F+
Sbjct: 195 TVDIWSVGCIMAEMLTGKTLFK 216
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 48/202 (23%), Positives = 86/202 (42%), Gaps = 38/202 (18%)
Query: 250 ESLNAEISTMLSLSHPNIVQ----YLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRR 305
E L E+ M H N+V+ YL G E ++VME + + + R
Sbjct: 62 ELLFNEVVIMRDYQHENVVEMYNSYLVG------DELWVVMEFLEGGA---LTDIVTHTR 112
Query: 306 RNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365
N + V L + + + LHAQ + H ++ +I L + +G VK+S FG
Sbjct: 113 MNEEQIAAVC---LAVLKALSVLHAQGVIHRDIKSDSILL---THDG--RVKLSDFG--- 161
Query: 366 ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFE 425
+ ++ + + PY W APE++ S + D++S G++ E
Sbjct: 162 ---FCAQVSKEVPRRKSLVGTPY-WMAPELI---------SRLPYGPEVDIWSLGIMVIE 208
Query: 426 LLTGKVP-FEDGHLQGDKMTKN 446
++ G+ P F + L+ KM ++
Sbjct: 209 MVDGEPPYFNEPPLKAMKMIRD 230
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 3e-04
Identities = 44/175 (25%), Positives = 70/175 (40%), Gaps = 29/175 (16%)
Query: 262 LSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQI 321
++ P IV F E K LVM LM+ Y G R + V+ QI
Sbjct: 50 VNSPFIVNLAYAF--ESKTHLCLVMSLMNGGDLKYHIYNVGER---GLEMERVIHYSAQI 104
Query: 322 ARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTPPASPQN 381
G+ LH+ I + ++ P N+ L + + ++S GL+
Sbjct: 105 TCGILHLHSMDIVYRDMKPENVLLDDQG-----NCRLSDLGLAV-------ELKDGKTIT 152
Query: 382 QTA-PNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFED 435
Q A N Y+ APE+L E+ S D ++ G +E++ G+ PF+D
Sbjct: 153 QRAGTNGYM--APEILKEE----PYSYP-----VDWFAMGCSIYEMVAGRTPFKD 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 3e-04
Identities = 36/107 (33%), Positives = 46/107 (42%), Gaps = 26/107 (24%)
Query: 328 LHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTAR-TYASRNTPPASPQNQTAPN 386
LH H +L P N + A H+K++ FGLS TYA N+ SP
Sbjct: 117 LHELGYIHRDLKPENFLIDASG-----HIKLTDFGLSKGIVTYA--NSVVGSPD------ 163
Query: 387 PYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPF 433
Y+ APEVL G G T D +S G + +E L G PF
Sbjct: 164 -YM--APEVL---RGKGYDFT------VDYWSLGCMLYEFLCGFPPF 198
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 4e-04
Identities = 54/259 (20%), Positives = 102/259 (39%), Gaps = 56/259 (21%)
Query: 253 NAEISTMLSLSHPNIV-----QYLCGFCDEEKKEFF-LVMELMSKDLSCYMRETFGSRRR 306
N E+ M +L+H NI+ Y F EK F +VME + + + YM+ +R
Sbjct: 107 NRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMK--HYARNN 164
Query: 307 NSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366
++ L +V Q+ R + ++H++ I H +L P N+ + + +K+ FG +
Sbjct: 165 HALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHT----LKLCDFGSAKN 220
Query: 367 RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFEL 426
R+ + + APE++ G+T+ + D++S G + E+
Sbjct: 221 LLAGQRSVSYICSR--------FYRAPELM-----LGATNYTT---HIDLWSLGCIIAEM 264
Query: 427 LTGKVPFEDGHLQGDKMTKNIRAGERP---------------------------LFPSGS 459
+ G P G D++ + I+ P +FP G+
Sbjct: 265 ILG-YPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGT 323
Query: 460 PKYLVNLTKKCWHTNPSQR 478
P +N + P +R
Sbjct: 324 PDDAINFISQFLKYEPLKR 342
|
Length = 440 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 4e-04
Identities = 44/178 (24%), Positives = 68/178 (38%), Gaps = 33/178 (18%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLP-- 312
EI + L HPN+V + F K++ LV E + +N +P
Sbjct: 50 EIRMLKQLKHPNLVNLIEVF--RRKRKLHLVFEYCDHTV-------LNELEKNPRGVPEH 100
Query: 313 VVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASR 372
++ I+ Q + + F H H ++ P NI + + +K+ FG AR
Sbjct: 101 LIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQ-----IKLCDFGF--ARIL--- 150
Query: 373 NTPPASPQNQTAPNPYIWY-APEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTG 429
P + A WY APE+L G DV++ G + ELLTG
Sbjct: 151 TGPGDDYTDYVATR---WYRAPELLVGDTQYGPP--------VDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 4e-04
Identities = 43/171 (25%), Positives = 72/171 (42%), Gaps = 32/171 (18%)
Query: 267 IVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGM 325
IV F + K + LVM +M+ DL ++ F P QI G+
Sbjct: 55 IVSLAYAF--QTKTDLCLVMTIMNGGDLRYHIYNV--DEENPGFPEPRACFYTAQIISGL 110
Query: 326 EFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTPPASPQNQT-- 383
E LH ++I + +L P N+ L +G +V++S GL+ Q++T
Sbjct: 111 EHLHQRRIIYRDLKPENVLLDN---DG--NVRISDLGLAVEL---------KDGQSKTKG 156
Query: 384 -APNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPF 433
A P + APE+L +E S D ++ G+ +E++ + PF
Sbjct: 157 YAGTPG-FMAPELLQGEEYDFSV---------DYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 6e-04
Identities = 46/184 (25%), Positives = 76/184 (41%), Gaps = 36/184 (19%)
Query: 255 EISTMLSLSHPNIVQYLCGFCD----EEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFS 310
E+ + + H N++ L F E E +LV LM DL+ ++ S F
Sbjct: 64 ELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQF- 122
Query: 311 LPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYA 370
++ Q+ RG++++H+ I H +L PSN+ + +++ FGL AR
Sbjct: 123 ------LIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDC-----ELRILDFGL--ARQAD 169
Query: 371 SRNTPPASPQNQTAPNPYIWY-APEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTG 429
T + + WY APE++ T D++S G + ELL G
Sbjct: 170 DEMTGYVATR---------WYRAPEIMLNWMHYNQT--------VDIWSVGCIMAELLKG 212
Query: 430 KVPF 433
K F
Sbjct: 213 KALF 216
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 33/118 (27%), Positives = 53/118 (44%), Gaps = 28/118 (23%)
Query: 320 QIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTPPASP 379
+I G+E LH ++I + +L P NI L + Y H+++S GL+ P
Sbjct: 110 EITCGLEDLHRERIVYRDLKPENILL-----DDYGHIRISDLGLAV-----------EIP 153
Query: 380 QNQTAPNPY--IWY-APEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFE 434
+ +T + Y APEV+ + T S D + G L +E++ GK PF
Sbjct: 154 EGETIRGRVGTVGYMAPEVVKNERYTFS---------PDWWGLGCLIYEMIEGKSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.001
Identities = 28/114 (24%), Positives = 39/114 (34%), Gaps = 34/114 (29%)
Query: 319 LQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTPPAS 378
LQ + LH Q NI L + +G G +T P
Sbjct: 24 LQCLGALRELHRQAKSG------NILL---TWDGLLK----LDGSVAFKTPEQSRPDPY- 69
Query: 379 PQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVP 432
+ APEV+ Q T EKAD+YS G+ +E L ++P
Sbjct: 70 -----------FMAPEVIQGQSYT---------EKADIYSLGITLYEALDYELP 103
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 44/192 (22%), Positives = 75/192 (39%), Gaps = 29/192 (15%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRN 307
+ + EI M H NIV Y + +K ++ ME + G
Sbjct: 49 DFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDK--LWICMEFCGGGSLQDIYHVTG----- 101
Query: 308 SFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST-- 365
S + + + +G+ +LH++ H ++ +NI L HVK++ FG+S
Sbjct: 102 PLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNG-----HVKLADFGVSAQI 156
Query: 366 ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFE 425
T A R + +P W APEV A + G ++ D+++ G+ E
Sbjct: 157 TATIAKRKSFIGTP---------YWMAPEVAAVERKGGY------NQLCDIWAVGITAIE 201
Query: 426 LLTGKVPFEDGH 437
L + P D H
Sbjct: 202 LAELQPPMFDLH 213
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 62/249 (24%), Positives = 96/249 (38%), Gaps = 43/249 (17%)
Query: 216 KKLMVRRRLGASSQFKEIQWLGDSFVLRHFYGELESLNAEISTML-SLSHPNIVQYLCGF 274
K L+ +R+L + ++ L VL E + + AE + +L ++ HP +V F
Sbjct: 10 KVLLAKRKL--DGKCYAVKVLQKKIVLNR--KEQKHIMAERNVLLKNVKHPFLVGLHYSF 65
Query: 275 CDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIY 334
EK F L D F +R SF P +IA + +LH+ I
Sbjct: 66 QTTEKLYFVL-------DFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIV 118
Query: 335 HGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTPP--ASPQNQTAPNPYIWYA 392
+ +L P NI L ++ HV ++ FGL S T +P+ + A
Sbjct: 119 YRDLKPENILLDSQG-----HVVLTDFGLCKEGIAQSDTTTTFCGTPE---------YLA 164
Query: 393 PEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPF--EDGHLQGDKMTKNIRAG 450
PEV+ +Q D + G + +E+L G PF D +M NI
Sbjct: 165 PEVIRKQ---------PYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA----EMYDNILHK 211
Query: 451 ERPLFPSGS 459
L P S
Sbjct: 212 PLVLRPGAS 220
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.003
Identities = 53/237 (22%), Positives = 82/237 (34%), Gaps = 90/237 (37%)
Query: 247 GELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVME----------LMSKDL--- 293
++ + AE + +P +V+ F DE +L+ME LM KD
Sbjct: 43 EQVAHVRAERDILAEADNPWVVKLYYSFQDENY--LYLIMEYLPGGDMMTLLMKKDTFTE 100
Query: 294 ---SCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSM 350
Y+ ET +L I + +H H ++ P N+ L A+
Sbjct: 101 EETRFYIAET-----------------ILAI----DSIHKLGYIHRDIKPDNLLLDAKG- 138
Query: 351 EGYFHVKVSGFGLSTA-----RTYASRNTP----------PASPQNQTA----------- 384
H+K+S FGL T RT R + P +
Sbjct: 139 ----HIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRA 194
Query: 385 --------PNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPF 433
P+ YI APEV Q G ++ D +S G++ +E+L G PF
Sbjct: 195 LAYSTVGTPD-YI--APEVFL-QTGYN--------KECDWWSLGVIMYEMLVGYPPF 239
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.004
Identities = 31/118 (26%), Positives = 54/118 (45%), Gaps = 28/118 (23%)
Query: 320 QIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTPPASP 379
+I G+E LH ++I + +L P NI L + + H+++S GL+ P
Sbjct: 110 EICCGLEDLHQERIVYRDLKPENILL-----DDHGHIRISDLGLAV-----------HVP 153
Query: 380 QNQTAP---NPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFE 434
+ QT + APEV+ + T S D ++ G L +E++ G+ PF+
Sbjct: 154 EGQTIKGRVGTVGYMAPEVVKNERYTFS---------PDWWALGCLLYEMIAGQSPFQ 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 811 | |||
| PF06760 | 217 | DUF1221: Protein of unknown function (DUF1221); In | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.98 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.98 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.98 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.98 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.98 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.98 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.98 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.95 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.93 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.93 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.92 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.84 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.84 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.83 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.81 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.8 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.77 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.75 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.74 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.74 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.73 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.72 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.69 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.68 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.67 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.66 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.62 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.58 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.53 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.52 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.49 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.49 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.43 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.42 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.34 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.32 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.2 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.11 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.11 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.09 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.05 | |
| KOG4171 | 671 | consensus Adenylate/guanylate kinase [Nucleotide t | 99.05 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.04 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.04 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.01 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.01 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.83 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.83 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.79 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.79 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.79 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.68 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.67 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.58 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.49 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.35 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.25 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.24 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.02 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.94 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.84 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.81 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.46 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.44 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.43 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.41 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.37 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.23 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.22 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.18 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.0 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.9 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 96.89 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.8 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.76 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 96.67 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 96.58 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.58 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.4 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.09 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.93 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 95.86 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.81 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 95.74 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.56 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 95.1 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.08 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 94.74 | |
| PF05659 | 147 | RPW8: Arabidopsis broad-spectrum mildew resistance | 94.42 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 93.57 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 93.44 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 93.06 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 93.05 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 92.6 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 92.34 | |
| PLN02236 | 344 | choline kinase | 92.21 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 90.99 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 90.29 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 89.24 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 88.32 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 87.34 |
| >PF06760 DUF1221: Protein of unknown function (DUF1221); InterPro: IPR010632 This is a group of plant proteins, most of which are hypothetical and of unknown function | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-57 Score=436.17 Aligned_cols=199 Identities=71% Similarity=1.180 Sum_probs=195.4
Q ss_pred hHHHhhcHHHHHHHHHHHHHHHHHHHHHHHHhhhcccccCCchHHHHHHHHHHHHHHHHHHHHHHhcCchhHHHHHHhhc
Q 003542 21 KDDIQINQRQCCLLLDIFTLAFSTVAEEIRLFLKSEEKNTKWRALEQPLRELQKVFREGEHYVKQCLDYKDWWGKAISLH 100 (811)
Q Consensus 21 ~~~~~~n~~qc~~l~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~el~~~l~~a~~~i~~c~~~~~~~~~~~~~~ 100 (811)
.+++|||+||||+|+|.|++||.+|+++|+++|+|+||++||+.||+||+|||+++++|+.||++|+++++||+|++.++
T Consensus 1 ~ddiqIN~RQC~LL~d~f~~A~~~va~eir~nLrfeEk~tKWr~LE~PLREl~rvfregE~YvR~CLd~k~WWaka~~~~ 80 (217)
T PF06760_consen 1 QDDIQINPRQCCLLADIFALAFDTVAEEIRQNLRFEEKNTKWRPLEQPLRELHRVFREGEGYVRHCLDPKDWWAKAIALH 80 (217)
T ss_pred CcccccCHHHHHHHHHHHHHHHHHHHHHHHHhhchHhhcCcccccchhHHHHHHHHhhhHHHHHHccCchhHHHHHHHHH
Confidence 37899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccchhhccccccchhhHHHHHHHhhhhcCCCHHHHHHHHHHHHhhhccccCChhhHHHhhcCcccchhhhHHHhhhh
Q 003542 101 QNKDCVEFHIHNLLCYFPAVIEAIEAAGEISGLDPDEMQRRRVAFARKYDREWNDPKLFQLRFGKEYLIPREVCNEFESA 180 (811)
Q Consensus 101 ~~~~~~~f~~~n~~~~~~~~~e~l~~~~e~s~~~q~e~~~~~~~~~~~~~~~~~d~~~f~~~~~k~~~~~~~~~~~~~~~ 180 (811)
+|+||||||+|||+|||++|+|+|++|+|+||+||+|++++|++++++|+++|.||++|||+|||+|++++++|.+++.+
T Consensus 81 ~n~dcVE~hiHnlL~c~~vviEAIE~AgE~sG~D~dE~~rkRl~~a~kYdk~~~dpklFqw~fGKqYLvs~e~c~R~d~a 160 (217)
T PF06760_consen 81 QNTDCVEFHIHNLLWCFPVVIEAIETAGEISGSDQDEMARKRLVLARKYDKEWLDPKLFQWRFGKQYLVSRELCARMDTA 160 (217)
T ss_pred cCcchHHHHHHHHHHHHHHHHHHHHHHhhccCCCHHHHHHHHHHHHHhhhhhccchHHHHHHhhhhheeHHHHHHHHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hhhhhHHHHHHHhhcccccceEeeechhhHHHHHhcceE
Q 003542 181 YKEDKWLLIDALKEKKRLGSVVLTKNEQRLVDMLLKKLM 219 (811)
Q Consensus 181 ~~ed~~~l~~~l~~~~~~g~v~l~~~e~~~~~~l~k~~~ 219 (811)
|+||+|++++.|.|+++.|+..++++++.+++++.+...
T Consensus 161 WkEDRW~L~~~l~Ekk~~~s~~ltK~E~rLaDlL~k~l~ 199 (217)
T PF06760_consen 161 WKEDRWLLSQLLDEKKGSGSPPLTKNEHRLADLLLKPLN 199 (217)
T ss_pred HHHHHHHHHHHHHHhccCCCCCCchhHHHHHHHHHhhcc
Confidence 999999999999999999988999999999999998763
|
All members contain the IPR000719 from INTERPRO domain, suggesting that they may possess kinase activity. |
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=384.91 Aligned_cols=250 Identities=25% Similarity=0.420 Sum_probs=217.2
Q ss_pred hcceEEeeeecccc---eEEEE-EEcCCEEEEEEecc-----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEE
Q 003542 215 LKKLMVRRRLGASS---QFKEI-QWLGDSFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLV 285 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v-~~~g~~VAVK~~~~-----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLV 285 (811)
..+++.++.||.|. ||++. +++++.+|+|.+.. -.+++.+|+++++..+|||||.+|++|+.+.. .++|+
T Consensus 78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~-~isI~ 156 (364)
T KOG0581|consen 78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE-EISIC 156 (364)
T ss_pred HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc-eEEee
Confidence 34567777888875 89887 56899999999943 35678999999999999999999999986544 69999
Q ss_pred EecCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEeccCCCCcceEEEeeccc
Q 003542 286 MELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHA-QKIYHGELNPSNIYLKARSMEGYFHVKVSGFGL 363 (811)
Q Consensus 286 mEy~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs-~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGl 363 (811)
||||+ |+|..+++.. +.+++...-.++.+|++||.|||+ ++||||||||+||||+..| .|||||||.
T Consensus 157 mEYMDgGSLd~~~k~~------g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskG-----eVKicDFGV 225 (364)
T KOG0581|consen 157 MEYMDGGSLDDILKRV------GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKG-----EVKICDFGV 225 (364)
T ss_pred hhhcCCCCHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCC-----CEEeccccc
Confidence 99999 5888888765 679999999999999999999996 8999999999999999998 899999999
Q ss_pred cccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCC---ccch
Q 003542 364 STARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDG---HLQG 440 (811)
Q Consensus 364 A~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~---~~~~ 440 (811)
++.+... ...+.+||..|||||.+.+. .|+.++||||||++++|+++|+.||... ....
T Consensus 226 S~~lvnS---------~a~tfvGT~~YMsPERi~g~---------~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~ 287 (364)
T KOG0581|consen 226 SGILVNS---------IANTFVGTSAYMSPERISGE---------SYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDI 287 (364)
T ss_pred cHHhhhh---------hcccccccccccChhhhcCC---------cCCcccceecccHHHHHHhhCCCCCCCcCCCCCCH
Confidence 9877543 34688999999999999865 7889999999999999999999999764 2344
Q ss_pred HHHHHHHHhCCCCCCCCC-ChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHHHHHh
Q 003542 441 DKMTKNIRAGERPLFPSG-SPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKKFM 495 (811)
Q Consensus 441 ~~i~~~i~~~~~~~~p~~-~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~k~l 495 (811)
-++...|..+..|.+|.. +++++++||..||+.||.+||++.+++. +.+|+++.
T Consensus 288 ~~Ll~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~-Hpfi~~~~ 342 (364)
T KOG0581|consen 288 FELLCAIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ-HPFIKKFE 342 (364)
T ss_pred HHHHHHHhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc-CHHHhhcc
Confidence 567788888899999987 9999999999999999999999999987 66666654
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=388.13 Aligned_cols=247 Identities=23% Similarity=0.347 Sum_probs=206.5
Q ss_pred HhcceEEeeeecccceEEEEE-----EcCCEEEEEEeccc-----------HHHHHHHHHHHHhCCCCccceeeeeEEcc
Q 003542 214 LLKKLMVRRRLGASSQFKEIQ-----WLGDSFVLRHFYGE-----------LESLNAEISTMLSLSHPNIVQYLCGFCDE 277 (811)
Q Consensus 214 l~k~~~i~~~lG~G~vyk~v~-----~~g~~VAVK~~~~~-----------~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e 277 (811)
..+.|.+.+.||.| .|+.++ .+|+.||||++.+. ...+.+|++||++|+|||||++++.| +
T Consensus 170 ~~d~yii~~~LGsG-afg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f--~ 246 (475)
T KOG0615|consen 170 FNDYYIISKTLGSG-AFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFF--E 246 (475)
T ss_pred hcceeEeeeeecCC-ceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeee--e
Confidence 34678888999999 566663 48999999999531 23467999999999999999999888 5
Q ss_pred CCCeEEEEEecCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceE
Q 003542 278 EKKEFFLVMELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHV 356 (811)
Q Consensus 278 ~~~~~yLVmEy~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~v 356 (811)
.....||||||++ |+|++++..+ ..+.+..-..++.|++.|+.|||++||+||||||+|||+..+. ..+.+
T Consensus 247 ~~ds~YmVlE~v~GGeLfd~vv~n------k~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~--e~~ll 318 (475)
T KOG0615|consen 247 VPDSSYMVLEYVEGGELFDKVVAN------KYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDA--EDCLL 318 (475)
T ss_pred cCCceEEEEEEecCccHHHHHHhc------cccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCC--cceEE
Confidence 5667899999999 5999999875 6788888899999999999999999999999999999998763 44599
Q ss_pred EEeeccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCC
Q 003542 357 KVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDG 436 (811)
Q Consensus 357 KL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~ 436 (811)
||+|||+|+..... ....+.+||+.|.|||++.... ...+..++||||+|||||-+++|.+||.+.
T Consensus 319 KItDFGlAK~~g~~--------sfm~TlCGTpsYvAPEVl~~kg------~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~ 384 (475)
T KOG0615|consen 319 KITDFGLAKVSGEG--------SFMKTLCGTPSYVAPEVLASKG------VEYYPSKVDIWSLGCVLFVCLSGYPPFSEE 384 (475)
T ss_pred Eecccchhhccccc--------eehhhhcCCccccChhheecCC------eecccchheeeeccceEEEEeccCCCcccc
Confidence 99999999987533 2446889999999999998762 234456999999999999999999999875
Q ss_pred ccchHHHHHHHHhCCCCCCC---CCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 437 HLQGDKMTKNIRAGERPLFP---SGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 437 ~~~~~~i~~~i~~~~~~~~p---~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
..+ ..+.+.|..|.....| ..++++..+||.+||..||++|||++++++
T Consensus 385 ~~~-~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 385 YTD-PSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred cCC-ccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 433 3356777777755444 467889999999999999999999999987
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=396.03 Aligned_cols=243 Identities=28% Similarity=0.466 Sum_probs=210.9
Q ss_pred cceEEeeeecccc---eEEEEE-EcCCEEEEEEecc-------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEE
Q 003542 216 KKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG-------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFL 284 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~-------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yL 284 (811)
++|...+.||+|+ +|.+.. -+|+.||+|++.+ ..+.+.+||+|.++|+|||||++|+.| ++.+++||
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~F--EDs~nVYi 95 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFF--EDSNNVYI 95 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEe--ecCCceEE
Confidence 5799999999998 787775 6999999999953 568899999999999999999999888 77889999
Q ss_pred EEecCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccc
Q 003542 285 VMELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGL 363 (811)
Q Consensus 285 VmEy~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGl 363 (811)
|+|+|. ++|..+++. +..++|.+++.++.||+.||.|||+++|+|||||..|+|++.+- +|||+||||
T Consensus 96 vLELC~~~sL~el~Kr------rk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~-----~VKIgDFGL 164 (592)
T KOG0575|consen 96 VLELCHRGSLMELLKR------RKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENM-----NVKIGDFGL 164 (592)
T ss_pred EEEecCCccHHHHHHh------cCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcC-----cEEecccce
Confidence 999999 688877764 37899999999999999999999999999999999999996653 999999999
Q ss_pred cccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHH
Q 003542 364 STARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKM 443 (811)
Q Consensus 364 A~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i 443 (811)
|....... ....+.+|||.|+|||++... .+++.+||||+|||||.||+|++||+..... +.
T Consensus 165 At~le~~~-------Erk~TlCGTPNYIAPEVl~k~---------gHsfEvDiWSlGcvmYtLL~G~PPFetk~vk--et 226 (592)
T KOG0575|consen 165 ATQLEYDG-------ERKKTLCGTPNYIAPEVLNKS---------GHSFEVDIWSLGCVMYTLLVGRPPFETKTVK--ET 226 (592)
T ss_pred eeeecCcc-------cccceecCCCcccChhHhccC---------CCCCchhhhhhhhHHHhhhhCCCCcccchHH--HH
Confidence 98886542 244688999999999999743 6889999999999999999999999875433 45
Q ss_pred HHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHH
Q 003542 444 TKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYI 491 (811)
Q Consensus 444 ~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i 491 (811)
+..|.... -.+|...+.+.++||.++|..||.+|||+++|+. .+++
T Consensus 227 y~~Ik~~~-Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~-h~Ff 272 (592)
T KOG0575|consen 227 YNKIKLNE-YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD-HPFF 272 (592)
T ss_pred HHHHHhcC-cccccccCHHHHHHHHHHhcCCcccCCCHHHHhc-CHhh
Confidence 56666544 3468899999999999999999999999999987 4444
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=381.82 Aligned_cols=254 Identities=34% Similarity=0.605 Sum_probs=210.8
Q ss_pred eEEeeeecccc---eEEEEEEcCCE-EEEEEeccc------HHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEe
Q 003542 218 LMVRRRLGASS---QFKEIQWLGDS-FVLRHFYGE------LESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVME 287 (811)
Q Consensus 218 ~~i~~~lG~G~---vyk~v~~~g~~-VAVK~~~~~------~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmE 287 (811)
+.+...+|.|+ ||+ ..|.|+. ||||++... .+.|.+|+.+|.+++|||||+|++++ .+....++||||
T Consensus 43 l~~~~~iG~G~~g~V~~-~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~-~~~~~~~~iVtE 120 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYK-GKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGAC-TSPPGSLCIVTE 120 (362)
T ss_pred hhhhhhcccCCceeEEE-EEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEE-cCCCCceEEEEE
Confidence 34444466664 665 4688888 999999642 46899999999999999999998555 333336899999
Q ss_pred cCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-ceeccCCCCcEEEeccCCCCcceEEEeeccccc
Q 003542 288 LMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQK-IYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365 (811)
Q Consensus 288 y~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~g-IVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~ 365 (811)
|++ |+|..++... ....+++..++.++.||++||.|||+++ ||||||||+|||++.++ .++||+|||+++
T Consensus 121 y~~~GsL~~~l~~~----~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~----~~~KI~DFGlsr 192 (362)
T KOG0192|consen 121 YMPGGSLSVLLHKK----RKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKG----KTLKIADFGLSR 192 (362)
T ss_pred eCCCCcHHHHHhhc----ccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCC----CEEEECCCccce
Confidence 999 6888888763 2378999999999999999999999999 99999999999997663 389999999998
Q ss_pred cccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHH
Q 003542 366 ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTK 445 (811)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~ 445 (811)
...... .......||+.|||||++.+. ...|+.|+|||||||+||||+||+.||.+... ......
T Consensus 193 ~~~~~~-------~~~~~~~GT~~wMAPEv~~~~-------~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~~~~~ 257 (362)
T KOG0192|consen 193 EKVISK-------TSMTSVAGTYRWMAPEVLRGE-------KSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQVASA 257 (362)
T ss_pred eecccc-------ccccCCCCCccccChhhhcCC-------CCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HHHHHH
Confidence 765431 122347899999999999842 23799999999999999999999999998765 444555
Q ss_pred HHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHHHHHhh
Q 003542 446 NIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKKFMA 496 (811)
Q Consensus 446 ~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~k~l~ 496 (811)
.+..+.++.+|..+++.+..|+.+||+.||..||++.+|+..|+.+.....
T Consensus 258 v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 258 VVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred HHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 666888999999999999999999999999999999999999998877443
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-44 Score=367.78 Aligned_cols=245 Identities=26% Similarity=0.408 Sum_probs=211.4
Q ss_pred hcceEEeeeecccc---eEEEE-EEcCCEEEEEEec------ccHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEE
Q 003542 215 LKKLMVRRRLGASS---QFKEI-QWLGDSFVLRHFY------GELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFL 284 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v-~~~g~~VAVK~~~------~~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yL 284 (811)
+..|++.++||+|+ +|++. .++|..||.|.+. +..+....|+.+|++|+|||||++|+.-+.++..-++|
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 35678888899986 88877 6799999999984 35678899999999999999999997444555556899
Q ss_pred EEecCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHh--CC--ceeccCCCCcEEEeccCCCCcceEEEe
Q 003542 285 VMELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHA--QK--IYHGELNPSNIYLKARSMEGYFHVKVS 359 (811)
Q Consensus 285 VmEy~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs--~g--IVHRDLKPsNILI~~~g~d~~~~vKL~ 359 (811)
|||||. |||...++... +.+..+++..+|.++.|+++||+++|+ .. |+||||||.||+++.+| .+||+
T Consensus 98 vmE~c~~GDLsqmIk~~K--~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~g-----vvKLG 170 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFK--KQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANG-----VVKLG 170 (375)
T ss_pred HHHhhcccCHHHHHHHHH--hccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCC-----ceeec
Confidence 999999 79999887653 334679999999999999999999999 44 89999999999999988 99999
Q ss_pred eccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccc
Q 003542 360 GFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQ 439 (811)
Q Consensus 360 DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~ 439 (811)
||||++.+... .....+.+|||.||+||.+.+. .|++++||||+||++|||+.-++||.+.+
T Consensus 171 DfGL~r~l~s~-------~tfA~S~VGTPyYMSPE~i~~~---------~Y~~kSDiWslGCllyEMcaL~~PF~g~n-- 232 (375)
T KOG0591|consen 171 DFGLGRFLSSK-------TTFAHSLVGTPYYMSPERIHES---------GYNFKSDIWSLGCLLYEMCALQSPFYGDN-- 232 (375)
T ss_pred cchhHhHhcch-------hHHHHhhcCCCcccCHHHHhcC---------CCCcchhHHHHHHHHHHHHhcCCCccccc--
Confidence 99999988654 2345688999999999999864 89999999999999999999999999874
Q ss_pred hHHHHHHHHhCCCCCCC-CCChHHHHHHHhhhccCCCCCCCCHHHH
Q 003542 440 GDKMTKNIRAGERPLFP-SGSPKYLVNLTKKCWHTNPSQRPSFSSI 484 (811)
Q Consensus 440 ~~~i~~~i~~~~~~~~p-~~~~~~l~~LI~~cL~~DP~~RPS~~eI 484 (811)
-..+.+.|..+..++.| ...+.++..||..|+..||..||+...+
T Consensus 233 ~~~L~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~ 278 (375)
T KOG0591|consen 233 LLSLCKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPY 278 (375)
T ss_pred HHHHHHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchH
Confidence 45678899999988888 7789999999999999999999995444
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=373.25 Aligned_cols=244 Identities=29% Similarity=0.463 Sum_probs=205.7
Q ss_pred hcceEEeeeecccc---eEEEE-EEcCCEEEEEEecc------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEE
Q 003542 215 LKKLMVRRRLGASS---QFKEI-QWLGDSFVLRHFYG------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFL 284 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v-~~~g~~VAVK~~~~------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yL 284 (811)
..+|.+.++||.|+ ||++. +.++..||||.+.. ..+.+..||.+|+.++|||||++++++ +..+.+||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~--~~~~~i~l 86 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCI--EDDDFIYL 86 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEE--ecCCeEEE
Confidence 35788999999996 77777 45889999999953 356789999999999999999999777 56678999
Q ss_pred EEecCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecc-CCCCcceEEEeecc
Q 003542 285 VMELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKAR-SMEGYFHVKVSGFG 362 (811)
Q Consensus 285 VmEy~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~-g~d~~~~vKL~DFG 362 (811)
|||||. |||.+||+.. +.+++..++.++.||+.||++||+++||||||||+||||+.. +.+....+||+|||
T Consensus 87 VMEyC~gGDLs~yi~~~------~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFG 160 (429)
T KOG0595|consen 87 VMEYCNGGDLSDYIRRR------GRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFG 160 (429)
T ss_pred EEEeCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccc
Confidence 999999 6999999875 689999999999999999999999999999999999999886 22222689999999
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHH
Q 003542 363 LSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDK 442 (811)
Q Consensus 363 lA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~ 442 (811)
+|+.+.... ...+.+|++.|||||++..+ +|+.|+|+||+|+|+|+|++|+.||...+.. +
T Consensus 161 fAR~L~~~~--------~a~tlcGSplYMAPEV~~~~---------~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~--e 221 (429)
T KOG0595|consen 161 FARFLQPGS--------MAETLCGSPLYMAPEVIMSQ---------QYDAKADLWSIGTILYQCLTGKPPFDAETPK--E 221 (429)
T ss_pred hhhhCCchh--------HHHHhhCCccccCHHHHHhc---------cccchhhHHHHHHHHHHHHhCCCCccccCHH--H
Confidence 999886432 34578899999999999754 8999999999999999999999999876543 4
Q ss_pred HHHHHHhCC--CCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHH
Q 003542 443 MTKNIRAGE--RPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSIC 485 (811)
Q Consensus 443 i~~~i~~~~--~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl 485 (811)
+...+..+. .+.++...+..+.+|+...+..+|.+|.++.+-.
T Consensus 222 L~~~~~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~ 266 (429)
T KOG0595|consen 222 LLLYIKKGNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFF 266 (429)
T ss_pred HHHHHhccccccCchhhhccCchhhhhhHHHhcCccccCchHHhh
Confidence 455555544 3455666777788999999999999999987654
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=381.53 Aligned_cols=324 Identities=20% Similarity=0.325 Sum_probs=233.3
Q ss_pred cCCCHHHHHHHHHHHHhhhccccCChhhHHHhhcCcccchhhhHHHhhhhhhhhhHHHHHHHhhcccccceEeeechhhH
Q 003542 131 SGLDPDEMQRRRVAFARKYDREWNDPKLFQLRFGKEYLIPREVCNEFESAYKEDKWLLIDALKEKKRLGSVVLTKNEQRL 210 (811)
Q Consensus 131 s~~~q~e~~~~~~~~~~~~~~~~~d~~~f~~~~~k~~~~~~~~~~~~~~~~~ed~~~l~~~l~~~~~~g~v~l~~~e~~~ 210 (811)
+...++.....+++++++|...+.-.. ++...+-.+.+.+... ....+.+..+.+.+..+.. .+.+...
T Consensus 67 s~~T~~k~~~~k~~ien~Y~~~~~~~~---~R~er~~~le~~l~~~--~~s~~~~~~~~~~~~~kEt------e~lR~~R 135 (550)
T KOG0605|consen 67 SNKTKRKVAAAKQYIENHYSSQIKYLN---ERKERRKELEEKLASE--DVSEEEQNELLKSLLSKET------EYLRLRR 135 (550)
T ss_pred CchhHHHHHHHHHHHHHHHHHHHHHHH---HHHHHHHHHHHHHhhc--cccHHHHHHHHHHHhhHHH------HHHHhcc
Confidence 344455555778889999987633322 2222221112111111 1122233333333333221 1222222
Q ss_pred HHHHhcceEEeeeecccceEEEEE-----EcCCEEEEEEecc-------cHHHHHHHHHHHHhCCCCccceeeeeEEccC
Q 003542 211 VDMLLKKLMVRRRLGASSQFKEIQ-----WLGDSFVLRHFYG-------ELESLNAEISTMLSLSHPNIVQYLCGFCDEE 278 (811)
Q Consensus 211 ~~~l~k~~~i~~~lG~G~vyk~v~-----~~g~~VAVK~~~~-------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~ 278 (811)
..+-.++|++++.||+| .|++|+ -+|..||+|++++ +.+.++.|-.+|...++|+||++|++| ++
T Consensus 136 ~r~~~~DFe~Lk~IgkG-AfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF--QD 212 (550)
T KOG0605|consen 136 TRLSLDDFELLKVIGKG-AFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSF--QD 212 (550)
T ss_pred ccCCcccchhheeeccc-cceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe--cC
Confidence 34456799999999999 566663 3899999999963 678899999999999999999999999 66
Q ss_pred CCeEEEEEecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEE
Q 003542 279 KKEFFLVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVK 357 (811)
Q Consensus 279 ~~~~yLVmEy~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vK 357 (811)
..++||||||++| |+..+|... ..|++..+..|+.+++.|+..||+.|+|||||||+|+|||..| |+|
T Consensus 213 ~~~LYLiMEylPGGD~mTLL~~~------~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~G-----HiK 281 (550)
T KOG0605|consen 213 KEYLYLIMEYLPGGDMMTLLMRK------DTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKG-----HIK 281 (550)
T ss_pred CCeeEEEEEecCCccHHHHHHhc------CcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCC-----CEe
Confidence 7789999999995 899888864 7899999999999999999999999999999999999999998 999
Q ss_pred EeeccccccccccCC-------------------CCCC---------------------CCCCCCCCCCCCccCChhHhh
Q 003542 358 VSGFGLSTARTYASR-------------------NTPP---------------------ASPQNQTAPNPYIWYAPEVLA 397 (811)
Q Consensus 358 L~DFGlA~~~~~~~~-------------------~~~~---------------------~~~~~~~~~GT~~Y~APEvl~ 397 (811)
|+|||||..+..... .... ......+.+|||.|||||++.
T Consensus 282 LSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll 361 (550)
T KOG0605|consen 282 LSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLL 361 (550)
T ss_pred eccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHh
Confidence 999999954322000 0000 001234678999999999999
Q ss_pred hhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHHHHh-CCCCCCC--CCChHHHHHHHhhhccCC
Q 003542 398 EQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRA-GERPLFP--SGSPKYLVNLTKKCWHTN 474 (811)
Q Consensus 398 ~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i~~-~~~~~~p--~~~~~~l~~LI~~cL~~D 474 (811)
+. .|+..+|+|||||||||||.|.+||.+.+.. +..+.|.. .....+| ..++++.++||.+||. |
T Consensus 362 ~k---------gY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~--~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d 429 (550)
T KOG0605|consen 362 GK---------GYGKECDWWSLGCIMYEMLVGYPPFCSETPQ--ETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-D 429 (550)
T ss_pred cC---------CCCccccHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-C
Confidence 75 6889999999999999999999999986544 33444433 3233344 4567899999999999 9
Q ss_pred CCCCCC---HHHHHHHHHHHH
Q 003542 475 PSQRPS---FSSICRILRYIK 492 (811)
Q Consensus 475 P~~RPS---~~eIl~~L~~i~ 492 (811)
|.+|.. ++||.+ +.+++
T Consensus 430 ~~~RLG~~G~~EIK~-HPfF~ 449 (550)
T KOG0605|consen 430 PENRLGSKGAEEIKK-HPFFK 449 (550)
T ss_pred HHHhcCcccHHHHhc-CCccc
Confidence 999986 556554 44443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=368.70 Aligned_cols=234 Identities=26% Similarity=0.429 Sum_probs=204.5
Q ss_pred hcceEEeeeecccc---eEEEE-EEcCCEEEEEEecc-------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEE
Q 003542 215 LKKLMVRRRLGASS---QFKEI-QWLGDSFVLRHFYG-------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFF 283 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v-~~~g~~VAVK~~~~-------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~y 283 (811)
...|++++.||+|+ ||.+. .-+++.||+|++++ +.+...+|..||.+++||+||+++++| ++...+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF--Qt~~kLy 101 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF--QTEEKLY 101 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec--ccCCeEE
Confidence 46899999999996 55544 34899999999953 567899999999999999999999999 6677799
Q ss_pred EEEecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecc
Q 003542 284 LVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFG 362 (811)
Q Consensus 284 LVmEy~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFG 362 (811)
||+||+.| .|..+|... ..|++..+..|+.+|+.||.|||++|||||||||+|||++.+| +++|+|||
T Consensus 102 lVld~~~GGeLf~hL~~e------g~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~G-----Hi~LtDFg 170 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQRE------GRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQG-----HIKLTDFG 170 (357)
T ss_pred EEEeccCCccHHHHHHhc------CCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCC-----cEEEeccc
Confidence 99999995 899988754 7899999999999999999999999999999999999999998 99999999
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHH
Q 003542 363 LSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDK 442 (811)
Q Consensus 363 lA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~ 442 (811)
||+...... ....+.+||+.|||||++.+. .|+.++|+||||+++|||++|.+||.+.+. ..
T Consensus 171 L~k~~~~~~-------~~t~tfcGT~eYmAPEil~~~---------gy~~~vDWWsLGillYeML~G~pPF~~~~~--~~ 232 (357)
T KOG0598|consen 171 LCKEDLKDG-------DATRTFCGTPEYMAPEILLGK---------GYDKAVDWWSLGILLYEMLTGKPPFYAEDV--KK 232 (357)
T ss_pred cchhcccCC-------CccccccCCccccChHHHhcC---------CCCcccchHhHHHHHHHHhhCCCCCcCccH--HH
Confidence 998654432 234568999999999999865 789999999999999999999999987543 45
Q ss_pred HHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCC
Q 003542 443 MTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRP 479 (811)
Q Consensus 443 i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RP 479 (811)
+.+.|..+..+..|...+.+.++|+.++|..||.+|.
T Consensus 233 ~~~~I~~~k~~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 233 MYDKILKGKLPLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred HHHHHhcCcCCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 6778887776777777999999999999999999996
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=378.84 Aligned_cols=247 Identities=31% Similarity=0.556 Sum_probs=211.3
Q ss_pred ceEEeeeecccceEEEE---EEcCC-EEEEEEecc---cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEecC
Q 003542 217 KLMVRRRLGASSQFKEI---QWLGD-SFVLRHFYG---ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELM 289 (811)
Q Consensus 217 ~~~i~~~lG~G~vyk~v---~~~g~-~VAVK~~~~---~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~ 289 (811)
.+.+++.||+| .|+++ .|+|. .||+|.++. ..+.|.+|+++|++|+|+|||++++++. ....+|||||||
T Consensus 207 ~l~l~~~LG~G-~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~--~~~piyIVtE~m 283 (468)
T KOG0197|consen 207 ELKLIRELGSG-QFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCT--KQEPIYIVTEYM 283 (468)
T ss_pred HHHHHHHhcCC-ccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEe--cCCceEEEEEec
Confidence 45667889999 78777 57777 999999975 4578999999999999999999996553 233699999999
Q ss_pred C-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccccccc
Q 003542 290 S-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTART 368 (811)
Q Consensus 290 ~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~ 368 (811)
+ |+|.+||+.. .+..+...+.+.++.|||+||+||+++++|||||-..||||+.+. .+||+|||||+...
T Consensus 284 ~~GsLl~yLr~~----~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~-----~vKIsDFGLAr~~~ 354 (468)
T KOG0197|consen 284 PKGSLLDYLRTR----EGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDL-----VVKISDFGLARLIG 354 (468)
T ss_pred ccCcHHHHhhhc----CCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCc-----eEEEcccccccccC
Confidence 9 8999999872 346788999999999999999999999999999999999998876 99999999999544
Q ss_pred ccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CCCCCCCCccchHHHHHHH
Q 003542 369 YASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGDKMTKNI 447 (811)
Q Consensus 369 ~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~~PF~~~~~~~~~i~~~i 447 (811)
.... .......-+..|.|||.+.. +.++.+||||||||+||||+| |+.||.+. ...+..+.+
T Consensus 355 d~~Y------~~~~~~kfPIkWtAPEa~~~---------~~FS~kSDVWSFGVlL~E~fT~G~~py~~m--sn~ev~~~l 417 (468)
T KOG0197|consen 355 DDEY------TASEGGKFPIKWTAPEALNY---------GKFSSKSDVWSFGVLLWELFTYGRVPYPGM--SNEEVLELL 417 (468)
T ss_pred CCce------eecCCCCCCceecCHHHHhh---------CCcccccceeehhhhHHHHhccCCCCCCCC--CHHHHHHHH
Confidence 3321 12234456778999999974 489999999999999999999 99999875 455778999
Q ss_pred HhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHHH
Q 003542 448 RAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIK 492 (811)
Q Consensus 448 ~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~ 492 (811)
..|.+.+.|..||+++.+|+..||+.+|++||||+.+...|+.+.
T Consensus 418 e~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~ 462 (468)
T KOG0197|consen 418 ERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF 462 (468)
T ss_pred hccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence 999999999999999999999999999999999998877776654
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=373.93 Aligned_cols=252 Identities=23% Similarity=0.416 Sum_probs=211.8
Q ss_pred hcceEEeeeecccc---eEEEE-EEcCCEEEEEEecc-------cHHHHHHHHHHHHhC-CCCccceeeeeEEccCCCeE
Q 003542 215 LKKLMVRRRLGASS---QFKEI-QWLGDSFVLRHFYG-------ELESLNAEISTMLSL-SHPNIVQYLCGFCDEEKKEF 282 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v-~~~g~~VAVK~~~~-------~~~~~~~Ei~iL~~L-~HPNIVkl~~~~~~e~~~~~ 282 (811)
.++|.+++.||.|+ ||.+. .-+++.||||++.+ ..+-+.+|-.+|.+| .||.|+++|..|.+ ...+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD--~~sL 149 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQD--EESL 149 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeec--ccce
Confidence 36899999999996 66655 34899999999954 346688999999999 89999999988855 4459
Q ss_pred EEEEecCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeec
Q 003542 283 FLVMELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGF 361 (811)
Q Consensus 283 yLVmEy~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DF 361 (811)
|+|+||++ |+|+++|... +.|++..++.|+.||+.||+|||++|||||||||+|||++.++ ++||+||
T Consensus 150 YFvLe~A~nGdll~~i~K~------Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dm-----hikITDF 218 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKY------GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDG-----HIKITDF 218 (604)
T ss_pred EEEEEecCCCcHHHHHHHh------CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCC-----cEEEeec
Confidence 99999999 7999999976 8899999999999999999999999999999999999998887 9999999
Q ss_pred cccccccccCCCCC----C--CCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCC
Q 003542 362 GLSTARTYASRNTP----P--ASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFED 435 (811)
Q Consensus 362 GlA~~~~~~~~~~~----~--~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~ 435 (811)
|.|+.+........ . ......+.+||..|.+||+|... ..++.+|||+||||||+|+.|.+||.+
T Consensus 219 GsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~---------~~~~~sDiWAlGCilyQmlaG~PPFra 289 (604)
T KOG0592|consen 219 GSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDS---------PAGPSSDLWALGCILYQMLAGQPPFRA 289 (604)
T ss_pred cccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCC---------CCCcccchHHHHHHHHHHhcCCCCCcc
Confidence 99998865543211 1 11112568999999999999753 778999999999999999999999987
Q ss_pred CccchHHHHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHHH
Q 003542 436 GHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIK 492 (811)
Q Consensus 436 ~~~~~~~i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~ 492 (811)
.+ +..+++.|..-. -.+|...++.+.+||+++|..||.+|++.++|.+ +.++.
T Consensus 290 ~N--eyliFqkI~~l~-y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~-HpFF~ 342 (604)
T KOG0592|consen 290 AN--EYLIFQKIQALD-YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA-HPFFE 342 (604)
T ss_pred cc--HHHHHHHHHHhc-ccCCCCCCHHHHHHHHHHHccCccccccHHHHhh-Ccccc
Confidence 54 445667766643 3478899999999999999999999999998876 44444
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=344.50 Aligned_cols=251 Identities=21% Similarity=0.356 Sum_probs=202.0
Q ss_pred cceEEeeeecccceEEEE-----EEcCCEEEEEEeccc------HHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEE
Q 003542 216 KKLMVRRRLGASSQFKEI-----QWLGDSFVLRHFYGE------LESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFL 284 (811)
Q Consensus 216 k~~~i~~~lG~G~vyk~v-----~~~g~~VAVK~~~~~------~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yL 284 (811)
.+|+.+.++|+|+ |+++ +-+|+.||||+|... .+...+||++|++|+|||+|.++++| ..+..++|
T Consensus 2 ekYE~LgkvGEGS-YGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVF--rrkrklhL 78 (396)
T KOG0593|consen 2 EKYEKLGKVGEGS-YGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVF--RRKRKLHL 78 (396)
T ss_pred cHHhhhhccccCc-ceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHH--HhcceeEE
Confidence 4688889999994 5555 348999999999642 34579999999999999999999999 66778999
Q ss_pred EEecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccc
Q 003542 285 VMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS 364 (811)
Q Consensus 285 VmEy~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA 364 (811)
|+|||+.++++.|... ...++...+..|++|++.|+.|+|++++|||||||+||||+.+| .+||||||+|
T Consensus 79 VFE~~dhTvL~eLe~~-----p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~g-----vvKLCDFGFA 148 (396)
T KOG0593|consen 79 VFEYCDHTVLHELERY-----PNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNG-----VVKLCDFGFA 148 (396)
T ss_pred EeeecchHHHHHHHhc-----cCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCC-----cEEeccchhh
Confidence 9999999888888764 26789999999999999999999999999999999999999998 9999999999
Q ss_pred ccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHH
Q 003542 365 TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMT 444 (811)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~ 444 (811)
+.+.... ...+..+.|.+|.|||.+.+. ..|+..+||||+||++.||++|.+.|.+.+.-. ++.
T Consensus 149 R~L~~pg-------d~YTDYVATRWYRaPELLvGD--------tqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiD-QLy 212 (396)
T KOG0593|consen 149 RTLSAPG-------DNYTDYVATRWYRAPELLVGD--------TQYGKPVDIWAIGCVFAELLTGEPLWPGRSDID-QLY 212 (396)
T ss_pred HhhcCCc-------chhhhhhhhhhccChhhhccc--------CcCCCcccchhhhHHHHHHhcCCcCCCCcchHH-HHH
Confidence 9876432 233567889999999999874 478999999999999999999999998865432 222
Q ss_pred HHHH-hCC------------------CCCCC----------CCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHHHHHh
Q 003542 445 KNIR-AGE------------------RPLFP----------SGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKKFM 495 (811)
Q Consensus 445 ~~i~-~~~------------------~~~~p----------~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~k~l 495 (811)
.... -|. ..+-| ...+.-+.+|++.||..||.+|++.++++. ..++..+.
T Consensus 213 ~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~-H~yFd~~~ 291 (396)
T KOG0593|consen 213 LIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH-HPYFDGFI 291 (396)
T ss_pred HHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc-ChHHHHHH
Confidence 1111 111 10111 123345889999999999999999999987 55555554
Q ss_pred h
Q 003542 496 A 496 (811)
Q Consensus 496 ~ 496 (811)
.
T Consensus 292 e 292 (396)
T KOG0593|consen 292 E 292 (396)
T ss_pred H
Confidence 3
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=364.20 Aligned_cols=249 Identities=22% Similarity=0.393 Sum_probs=201.2
Q ss_pred HhcceEEeeeecccc---eEEEE-EEcCCEEEEEEeccc---HHH--HHHHHHHHHhCC-CCccceeeeeEEccCCCeEE
Q 003542 214 LLKKLMVRRRLGASS---QFKEI-QWLGDSFVLRHFYGE---LES--LNAEISTMLSLS-HPNIVQYLCGFCDEEKKEFF 283 (811)
Q Consensus 214 l~k~~~i~~~lG~G~---vyk~v-~~~g~~VAVK~~~~~---~~~--~~~Ei~iL~~L~-HPNIVkl~~~~~~e~~~~~y 283 (811)
+.++|.++++||.|+ ||.+. ..+|+.||||.+++. .++ -.||+..|++|+ |||||++++++.+.+. .+|
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~-~L~ 86 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDR-ILY 86 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCc-eEe
Confidence 456788888888885 66655 458899999999753 233 378999999998 9999999998865443 899
Q ss_pred EEEecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccc
Q 003542 284 LVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGL 363 (811)
Q Consensus 284 LVmEy~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGl 363 (811)
+|||||+.+|++.++.. +..|++..+..|+.||++||+|+|.+|+.||||||+||||.... .+||+|||+
T Consensus 87 fVfE~Md~NLYqLmK~R-----~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~-----~iKiaDFGL 156 (538)
T KOG0661|consen 87 FVFEFMDCNLYQLMKDR-----NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGND-----VIKIADFGL 156 (538)
T ss_pred eeHHhhhhhHHHHHhhc-----CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccc-----eeEeccccc
Confidence 99999999999999863 47899999999999999999999999999999999999997543 899999999
Q ss_pred cccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHH
Q 003542 364 STARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKM 443 (811)
Q Consensus 364 A~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i 443 (811)
|+..... ...+..+.|.+|+|||+|.. .+.|+.+.||||+|||++|+.+-++.|.|.+.- +++
T Consensus 157 ARev~Sk--------pPYTeYVSTRWYRAPEvLLr--------s~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~-Dqi 219 (538)
T KOG0661|consen 157 AREVRSK--------PPYTEYVSTRWYRAPEVLLR--------SGYYSSPVDMWAVGCIMAELYSLRPLFPGASEI-DQI 219 (538)
T ss_pred ccccccC--------CCcchhhhcccccchHHhhh--------ccccCCchHHHHHHHHHHHHHHhcccCCCCcHH-HHH
Confidence 9877543 23457789999999999986 468999999999999999999999999886432 223
Q ss_pred HHHHHh-C-------------------CCCCC--------CCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHH
Q 003542 444 TKNIRA-G-------------------ERPLF--------PSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYI 491 (811)
Q Consensus 444 ~~~i~~-~-------------------~~~~~--------p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i 491 (811)
.+...- | ..|.+ -..++.++.+||.+|+..||.+|||++++++ +.++
T Consensus 220 ~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~-~pff 294 (538)
T KOG0661|consen 220 YKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQ-HPFF 294 (538)
T ss_pred HHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhc-Cccc
Confidence 221110 1 01111 1236788999999999999999999999987 4443
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=367.35 Aligned_cols=246 Identities=23% Similarity=0.396 Sum_probs=209.7
Q ss_pred cceEEeeeecccceEEEE----EEcCCEEEEEEeccc-------HHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEE
Q 003542 216 KKLMVRRRLGASSQFKEI----QWLGDSFVLRHFYGE-------LESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFL 284 (811)
Q Consensus 216 k~~~i~~~lG~G~vyk~v----~~~g~~VAVK~~~~~-------~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yL 284 (811)
.-|++++.||.|+.-.+. ..+|+..|||++.+. ...+.+||-||+-+.||||+++|++| +++.++|+
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVw--e~~~~lyl 89 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVW--ENKQHLYL 89 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeee--ccCceEEE
Confidence 458888899999622211 359999999999654 67799999999999999999999999 67788999
Q ss_pred EEecCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccc
Q 003542 285 VMELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGL 363 (811)
Q Consensus 285 VmEy~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGl 363 (811)
|.||++ |.|++||... ++|++.++++++.||+.|+.|+|..+|+||||||+|+|++..+ .+||+|||+
T Consensus 90 vlEyv~gGELFdylv~k------G~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~-----nIKIADFGM 158 (786)
T KOG0588|consen 90 VLEYVPGGELFDYLVRK------GPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKN-----NIKIADFGM 158 (786)
T ss_pred EEEecCCchhHHHHHhh------CCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhccc-----CEeeeccce
Confidence 999999 5899999875 8999999999999999999999999999999999999998876 799999999
Q ss_pred cccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHH
Q 003542 364 STARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKM 443 (811)
Q Consensus 364 A~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i 443 (811)
|.....+ ....+.+|++.|.|||++.|..|+ +.++||||.|||||.||||++||++++. ..+
T Consensus 159 AsLe~~g--------klLeTSCGSPHYA~PEIV~G~pYd--------G~~sDVWSCGVILfALLtG~LPFdDdNi--r~L 220 (786)
T KOG0588|consen 159 ASLEVPG--------KLLETSCGSPHYAAPEIVSGRPYD--------GRPSDVWSCGVILFALLTGKLPFDDDNI--RVL 220 (786)
T ss_pred eecccCC--------ccccccCCCcccCCchhhcCCCCC--------CCccccchhHHHHHHHHhCCCCCCCccH--HHH
Confidence 9765443 234577899999999999988655 4689999999999999999999986543 345
Q ss_pred HHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHHHHH
Q 003542 444 TKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKKF 494 (811)
Q Consensus 444 ~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~k~ 494 (811)
...+..|.. .+|..++.++++||.+||..||++|.|.++|+++ .++..+
T Consensus 221 LlKV~~G~f-~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH-P~l~g~ 269 (786)
T KOG0588|consen 221 LLKVQRGVF-EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH-PFLSGY 269 (786)
T ss_pred HHHHHcCcc-cCCCcCCHHHHHHHHHHhccCccccccHHHHhhC-chhhcC
Confidence 566666653 3678999999999999999999999999999984 444443
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=351.93 Aligned_cols=249 Identities=26% Similarity=0.423 Sum_probs=198.9
Q ss_pred ceEEeeeecccc---eEEEEEE-cCCEEEEEEeccc----HHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEec
Q 003542 217 KLMVRRRLGASS---QFKEIQW-LGDSFVLRHFYGE----LESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMEL 288 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v~~-~g~~VAVK~~~~~----~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy 288 (811)
++...+.||+|+ ||.+... +|..+|||.+.-. .+.+.+|+.+|.+|+|||||++++.....+...++|+|||
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy 97 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY 97 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence 466667788874 4444433 4899999999654 6779999999999999999999965332222369999999
Q ss_pred CC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEec-cCCCCcceEEEeecccccc
Q 003542 289 MS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKA-RSMEGYFHVKVSGFGLSTA 366 (811)
Q Consensus 289 ~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~-~g~d~~~~vKL~DFGlA~~ 366 (811)
++ |+|.+++... . ..|++..++.+.+||++||.|||++||+||||||+|||++. ++ .+||+|||+++.
T Consensus 98 ~~~GsL~~~~~~~----g-~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~-----~~KlaDFG~a~~ 167 (313)
T KOG0198|consen 98 APGGSLSDLIKRY----G-GKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNG-----DVKLADFGLAKK 167 (313)
T ss_pred cCCCcHHHHHHHc----C-CCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCC-----eEEeccCccccc
Confidence 99 5999998864 1 26999999999999999999999999999999999999988 45 899999999987
Q ss_pred ccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHH
Q 003542 367 RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKN 446 (811)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~ 446 (811)
...... .........||+.|||||++... .....++|||||||++.||+||++||.........+...
T Consensus 168 ~~~~~~----~~~~~~~~~Gtp~~maPEvi~~g--------~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~i 235 (313)
T KOG0198|consen 168 LESKGT----KSDSELSVQGTPNYMAPEVIRNG--------EVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLI 235 (313)
T ss_pred cccccc----cccccccccCCccccCchhhcCC--------CcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHH
Confidence 764111 01223467899999999999741 122358999999999999999999998642223334445
Q ss_pred HHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHH
Q 003542 447 IRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRI 487 (811)
Q Consensus 447 i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~ 487 (811)
......|.+|..++++.++++.+|+..||.+|||+++++.+
T Consensus 236 g~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~h 276 (313)
T KOG0198|consen 236 GREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEH 276 (313)
T ss_pred hccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhC
Confidence 55555678899999999999999999999999999999874
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=358.55 Aligned_cols=248 Identities=27% Similarity=0.411 Sum_probs=205.2
Q ss_pred HhcceEEeeeecccc---eEEEE-EEcCCEEEEEEeccc---------HHHHHHHHHHHHhCC-CCccceeeeeEEccCC
Q 003542 214 LLKKLMVRRRLGASS---QFKEI-QWLGDSFVLRHFYGE---------LESLNAEISTMLSLS-HPNIVQYLCGFCDEEK 279 (811)
Q Consensus 214 l~k~~~i~~~lG~G~---vyk~v-~~~g~~VAVK~~~~~---------~~~~~~Ei~iL~~L~-HPNIVkl~~~~~~e~~ 279 (811)
..++|.+.+.||.|+ |+.+. ..+|+.||+|++..+ .+.+.+|+.+|+.++ ||||+++++++. ..
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~--t~ 92 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFA--TP 92 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEe--cC
Confidence 457899999999995 55543 448899999977542 345678999999998 999999998884 44
Q ss_pred CeEEEEEecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecc-CCCCcceEE
Q 003542 280 KEFFLVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKAR-SMEGYFHVK 357 (811)
Q Consensus 280 ~~~yLVmEy~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~-g~d~~~~vK 357 (811)
..+|+|||||.| +|++++.+. +++.+..+..+++||++|++|||++||+||||||+|||++.+ + .+|
T Consensus 93 ~~~~ivmEy~~gGdL~~~i~~~------g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~-----~~K 161 (370)
T KOG0583|consen 93 TKIYIVMEYCSGGDLFDYIVNK------GRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEG-----NLK 161 (370)
T ss_pred CeEEEEEEecCCccHHHHHHHc------CCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCC-----CEE
Confidence 559999999995 999999874 789999999999999999999999999999999999999887 5 899
Q ss_pred EeeccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCC-CcccceecchhHHHHHhhCCCCCCCC
Q 003542 358 VSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKC-SEKADVYSFGMLCFELLTGKVPFEDG 436 (811)
Q Consensus 358 L~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~-s~ksDIWSLGvILyELltG~~PF~~~ 436 (811)
|+|||++...... .....+.+||+.|+|||++.+.. .| +.++||||+||+||.|++|+.||.+.
T Consensus 162 l~DFG~s~~~~~~-------~~~l~t~cGsp~Y~aPEvl~~~~--------~Y~g~~aDvWS~GViLy~ml~G~~PF~d~ 226 (370)
T KOG0583|consen 162 LSDFGLSAISPGE-------DGLLKTFCGSPAYAAPEVLSGKG--------TYSGKAADVWSLGVILYVLLCGRLPFDDS 226 (370)
T ss_pred EeccccccccCCC-------CCcccCCCCCcccCCHHHhCCCC--------CcCCchhhhhhhHHHHHHHHhCCCCCCCc
Confidence 9999999876311 22446789999999999998753 13 47899999999999999999999874
Q ss_pred ccchHHHHHHHHhCCCCCCCCCC-hHHHHHHHhhhccCCCCCCCCHHHHHHHHHHHHH
Q 003542 437 HLQGDKMTKNIRAGERPLFPSGS-PKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKK 493 (811)
Q Consensus 437 ~~~~~~i~~~i~~~~~~~~p~~~-~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~k 493 (811)
.. ..+...+..+ ...+|..+ ++++..|+.+||..||.+|+++.+|+ ...+++.
T Consensus 227 ~~--~~l~~ki~~~-~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~~ 280 (370)
T KOG0583|consen 227 NV--PNLYRKIRKG-EFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQK 280 (370)
T ss_pred cH--HHHHHHHhcC-CccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh-hChhhcc
Confidence 32 3444555544 34567777 99999999999999999999999998 4655554
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=356.07 Aligned_cols=247 Identities=22% Similarity=0.334 Sum_probs=202.0
Q ss_pred hcceEEeeeecccc---eEEEE-EEcCCEEEEEEecc------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEE
Q 003542 215 LKKLMVRRRLGASS---QFKEI-QWLGDSFVLRHFYG------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFL 284 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v-~~~g~~VAVK~~~~------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yL 284 (811)
...|+.+++||+|+ ||++. ..+|+.||+|++.- -.....+||.||++|+||||+++.+..+......+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 35678888999997 88888 45999999999842 2345689999999999999999997776655678999
Q ss_pred EEecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccc
Q 003542 285 VMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS 364 (811)
Q Consensus 285 VmEy~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA 364 (811)
|+|||+.||.-++.. ..-.|++.++..|+.||+.||+|||++||+|||||.+||||+.+| .+||+|||||
T Consensus 196 VFeYMdhDL~GLl~~-----p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G-----~LKiaDFGLA 265 (560)
T KOG0600|consen 196 VFEYMDHDLSGLLSS-----PGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNG-----VLKIADFGLA 265 (560)
T ss_pred EEecccchhhhhhcC-----CCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCC-----CEEeccccce
Confidence 999999999887764 235799999999999999999999999999999999999999998 8999999999
Q ss_pred ccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHH
Q 003542 365 TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMT 444 (811)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~ 444 (811)
+.+..... ...+..+-|.+|.|||+|+|. ..|+.++|+||.||||.||++|++.|.+.+.. +++.
T Consensus 266 r~y~~~~~------~~~T~rVvTLWYRpPELLLG~--------t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEv-eQl~ 330 (560)
T KOG0600|consen 266 RFYTPSGS------APYTSRVVTLWYRPPELLLGA--------TSYGTAVDLWSVGCILAELFLGKPILQGRTEV-EQLH 330 (560)
T ss_pred eeccCCCC------cccccceEEeeccChHHhcCC--------cccccceeehhhhHHHHHHHcCCCCcCCccHH-HHHH
Confidence 98765542 234677899999999999974 48999999999999999999999999886432 2222
Q ss_pred HHHHh-CCC-----C--CCC-------------------CCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 445 KNIRA-GER-----P--LFP-------------------SGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 445 ~~i~~-~~~-----~--~~p-------------------~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
..... |.+ + .+| ...+....+|+..+|..||.+|.|+.+++.
T Consensus 331 kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 331 KIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred HHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 11111 110 0 011 134667899999999999999999999976
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=346.82 Aligned_cols=256 Identities=24% Similarity=0.420 Sum_probs=208.7
Q ss_pred HhcceEEeeeecccc---eEEEE-EEcCCEEEEEEec-----ccHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEE
Q 003542 214 LLKKLMVRRRLGASS---QFKEI-QWLGDSFVLRHFY-----GELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFL 284 (811)
Q Consensus 214 l~k~~~i~~~lG~G~---vyk~v-~~~g~~VAVK~~~-----~~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yL 284 (811)
-.+.|++...||.|. ||.+. ..+++.||||++. .+.+.+.+|+..|+.++||||++++..|.. +..+|+
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv--~~~LWv 101 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVV--DSELWV 101 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEe--cceeEE
Confidence 357899999999995 78877 5588999999994 357899999999999999999999999965 456999
Q ss_pred EEecCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccc
Q 003542 285 VMELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGL 363 (811)
Q Consensus 285 VmEy~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGl 363 (811)
||.||. |++.+.++..+. ..|++..+..|++++++||.|||.+|.||||||+.||||+.+| .|||+|||.
T Consensus 102 VmpfMa~GS~ldIik~~~~----~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG-----~VkLadFgv 172 (516)
T KOG0582|consen 102 VMPFMAGGSLLDIIKTYYP----DGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDG-----TVKLADFGV 172 (516)
T ss_pred eehhhcCCcHHHHHHHHcc----ccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCC-----cEEEcCcee
Confidence 999999 699999988643 5699999999999999999999999999999999999999998 899999999
Q ss_pred cccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHH
Q 003542 364 STARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKM 443 (811)
Q Consensus 364 A~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i 443 (811)
+..+..... ...... ...+||+.|||||++..+ -..|+.|+||||||++..||++|..||.... ..++
T Consensus 173 sa~l~~~G~--R~~~rf-~tfvgtp~wmAPEvl~q~-------~~GYdfKaDIwSfGITA~ELA~G~aPf~k~p--Pmkv 240 (516)
T KOG0582|consen 173 SASLFDSGD--RQVTRF-NTFVGTPCWMAPEVLMQQ-------LHGYDFKADIWSFGITACELAHGHAPFSKYP--PMKV 240 (516)
T ss_pred eeeecccCc--eeeEee-ccccCcccccChHHhhhc-------ccCccchhhhhhhhHHHHHHhcCCCCcccCC--hHHH
Confidence 876655331 111111 677999999999997654 4479999999999999999999999998643 3333
Q ss_pred HHHHHhCCCCC-----CC----CCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHHHH
Q 003542 444 TKNIRAGERPL-----FP----SGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKK 493 (811)
Q Consensus 444 ~~~i~~~~~~~-----~p----~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~k 493 (811)
.-.-..+..|. ++ ...+..++++|..||..||.+|||++++++ ..+++.
T Consensus 241 Ll~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk-h~FFk~ 298 (516)
T KOG0582|consen 241 LLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK-HAFFKK 298 (516)
T ss_pred HHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc-cHHHhh
Confidence 33333344331 11 134556899999999999999999999988 444443
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=357.44 Aligned_cols=246 Identities=24% Similarity=0.425 Sum_probs=209.7
Q ss_pred cceEEeeeecccc---eEEEE-EEcCCEEEEEEecc------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEE
Q 003542 216 KKLMVRRRLGASS---QFKEI-QWLGDSFVLRHFYG------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLV 285 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v-~~~g~~VAVK~~~~------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLV 285 (811)
.+|.+...||+|+ |||+. +++.+.||+|.+.+ +...+.+|++|++.|+|||||.++++| +...++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esf--Et~~~~~vV 79 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESF--ETSAHLWVV 79 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhh--cccceEEEE
Confidence 3566667788876 89988 56899999999953 567799999999999999999999988 788899999
Q ss_pred EecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccc
Q 003542 286 MELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365 (811)
Q Consensus 286 mEy~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~ 365 (811)
+|||.|+|..+|... ..++++.+..++.|++.||.|||+.+|+|||+||.|||+...+ ++|+||||+|+
T Consensus 80 te~a~g~L~~il~~d------~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~-----~~KlcdFg~Ar 148 (808)
T KOG0597|consen 80 TEYAVGDLFTILEQD------GKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGG-----TLKLCDFGLAR 148 (808)
T ss_pred ehhhhhhHHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCC-----ceeechhhhhh
Confidence 999999999999864 7899999999999999999999999999999999999998887 99999999998
Q ss_pred cccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHH
Q 003542 366 ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTK 445 (811)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~ 445 (811)
.+.... .......|||.|||||++.++ .|+..+|+||+|||+||+++|++||..... .++.+
T Consensus 149 ~m~~~t-------~vltsikGtPlYmAPElv~e~---------pyd~~sDlWslGcilYE~~~G~PPF~a~si--~~Lv~ 210 (808)
T KOG0597|consen 149 AMSTNT-------SVLTSIKGTPLYMAPELVEEQ---------PYDHTSDLWSLGCILYELYVGQPPFYARSI--TQLVK 210 (808)
T ss_pred hcccCc-------eeeeeccCcccccCHHHHcCC---------CccchhhHHHHHHHHHHHhcCCCCchHHHH--HHHHH
Confidence 775532 234567899999999999865 788999999999999999999999986432 23334
Q ss_pred HHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHHHHH
Q 003542 446 NIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKKF 494 (811)
Q Consensus 446 ~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~k~ 494 (811)
.|.. ..+..|...+..+..|++.+|..||.+|.+..+++. +.+++..
T Consensus 211 ~I~~-d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~-HpF~k~~ 257 (808)
T KOG0597|consen 211 SILK-DPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG-HPFWKGK 257 (808)
T ss_pred HHhc-CCCCCcccccHHHHHHHHHHhhcChhhcccHHHHhc-ChHHhhh
Confidence 4433 344567788899999999999999999999999987 4555543
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=335.46 Aligned_cols=230 Identities=25% Similarity=0.448 Sum_probs=202.9
Q ss_pred HHhcceEEeeeecccceEEEE-----EEcCCEEEEEEecc-------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCC
Q 003542 213 MLLKKLMVRRRLGASSQFKEI-----QWLGDSFVLRHFYG-------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKK 280 (811)
Q Consensus 213 ~l~k~~~i~~~lG~G~vyk~v-----~~~g~~VAVK~~~~-------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~ 280 (811)
+.+++|++++.||.|+ |+.+ +.+|..||+|++.. +.++..+|..+|+.+.||+++++++.| .+..
T Consensus 41 ~~l~dfe~~~tlGtGS-FGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~--~d~~ 117 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGS-FGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTF--KDNS 117 (355)
T ss_pred cchhhhhheeeeccCc-cceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEee--ccCC
Confidence 3457899999999995 5555 23889999999964 568899999999999999999999777 4567
Q ss_pred eEEEEEecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEe
Q 003542 281 EFFLVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVS 359 (811)
Q Consensus 281 ~~yLVmEy~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~ 359 (811)
.+||||||.+| .|..+|+.. ++|++..++.|+.||+.||+|||+.+|++|||||+|||+|.+| ++||+
T Consensus 118 ~lymvmeyv~GGElFS~Lrk~------~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G-----~iKit 186 (355)
T KOG0616|consen 118 NLYMVMEYVPGGELFSYLRKS------GRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNG-----HIKIT 186 (355)
T ss_pred eEEEEEeccCCccHHHHHHhc------CCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCC-----cEEEE
Confidence 89999999995 899999875 7899999999999999999999999999999999999999998 99999
Q ss_pred eccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccc
Q 003542 360 GFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQ 439 (811)
Q Consensus 360 DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~ 439 (811)
|||+|+.... ...+.+|||.|+|||++... .|+.++|+|||||++|||+.|.+||.+.+.
T Consensus 187 DFGFAK~v~~----------rT~TlCGTPeYLAPEii~sk---------~ynkavDWWalGVLIYEMlaG~pPF~~~~~- 246 (355)
T KOG0616|consen 187 DFGFAKRVSG----------RTWTLCGTPEYLAPEIIQSK---------GYNKAVDWWALGVLIYEMLAGYPPFYDDNP- 246 (355)
T ss_pred eccceEEecC----------cEEEecCCccccChHHhhcC---------CCCcchhHHHHHHHHHHHHcCCCCCcCCCh-
Confidence 9999987643 34578999999999999854 788999999999999999999999987654
Q ss_pred hHHHHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCC
Q 003542 440 GDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQR 478 (811)
Q Consensus 440 ~~~i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~R 478 (811)
..+.+.|..+. ..+|...+.++++|+..+|+.|-.+|
T Consensus 247 -~~iY~KI~~~~-v~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 247 -IQIYEKILEGK-VKFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred -HHHHHHHHhCc-ccCCcccCHHHHHHHHHHHhhhhHhh
Confidence 67778887765 45888999999999999999999999
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=360.18 Aligned_cols=249 Identities=27% Similarity=0.462 Sum_probs=200.2
Q ss_pred hcceEEeeeeccc---ceEEEEEEcCCEEEEEEecccHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEecCC-
Q 003542 215 LKKLMVRRRLGAS---SQFKEIQWLGDSFVLRHFYGELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMS- 290 (811)
Q Consensus 215 ~k~~~i~~~lG~G---~vyk~v~~~g~~VAVK~~~~~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~~- 290 (811)
+..+.-+..||.| .||.+ +..++.||||+++. .-..+|+.|++|+||||+.|.+++ .....||||||||.
T Consensus 123 Fe~IsELeWlGSGaQGAVF~G-rl~netVAVKKV~e---lkETdIKHLRkLkH~NII~FkGVC--tqsPcyCIiMEfCa~ 196 (904)
T KOG4721|consen 123 FEEISELEWLGSGAQGAVFLG-RLHNETVAVKKVRE---LKETDIKHLRKLKHPNIITFKGVC--TQSPCYCIIMEFCAQ 196 (904)
T ss_pred HHHhhhhhhhccCcccceeee-eccCceehhHHHhh---hhhhhHHHHHhccCcceeeEeeee--cCCceeEEeeecccc
Confidence 3333444556665 37763 57889999999854 234589999999999999998555 34568999999999
Q ss_pred CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccccccccc
Q 003542 291 KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYA 370 (811)
Q Consensus 291 g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~ 370 (811)
|-|...|+.. ..+.......|..+||.||.|||.+.|||||||.-||||..+. .|||+|||-++.....
T Consensus 197 GqL~~VLka~------~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d-----~VKIsDFGTS~e~~~~ 265 (904)
T KOG4721|consen 197 GQLYEVLKAG------RPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDD-----VVKISDFGTSKELSDK 265 (904)
T ss_pred ccHHHHHhcc------CccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccc-----eEEeccccchHhhhhh
Confidence 7899999864 6788899999999999999999999999999999999999886 8999999999876543
Q ss_pred CCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHHHHhC
Q 003542 371 SRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAG 450 (811)
Q Consensus 371 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i~~~ 450 (811)
. ....+.||..|||||++..+ .++.|+|||||||||||||||..||.+...... +...-...
T Consensus 266 S--------TkMSFaGTVaWMAPEvIrne---------PcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI-IwGVGsNs 327 (904)
T KOG4721|consen 266 S--------TKMSFAGTVAWMAPEVIRNE---------PCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI-IWGVGSNS 327 (904)
T ss_pred h--------hhhhhhhhHhhhCHHHhhcC---------CcccccceehhHHHHHHHHhcCCCccccchhee-EEeccCCc
Confidence 2 33578899999999999865 789999999999999999999999986432211 11111112
Q ss_pred CCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHHHHHhhcC
Q 003542 451 ERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKKFMANN 498 (811)
Q Consensus 451 ~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~k~l~~~ 498 (811)
...+.|..||+-++-||++||...|..||+|.+|+.+|+-....+...
T Consensus 328 L~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pell~~ 375 (904)
T KOG4721|consen 328 LHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPELLST 375 (904)
T ss_pred ccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHHhcc
Confidence 245678999999999999999999999999999999887665544433
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=350.56 Aligned_cols=252 Identities=25% Similarity=0.394 Sum_probs=199.2
Q ss_pred HhcceEEeeeecccceEEEEEE-----cCCEEEEEEecc------------------cHHHHHHHHHHHHhCCCCcccee
Q 003542 214 LLKKLMVRRRLGASSQFKEIQW-----LGDSFVLRHFYG------------------ELESLNAEISTMLSLSHPNIVQY 270 (811)
Q Consensus 214 l~k~~~i~~~lG~G~vyk~v~~-----~g~~VAVK~~~~------------------~~~~~~~Ei~iL~~L~HPNIVkl 270 (811)
.+..|++++.||.| .|+.++. +|+.||||++.+ ..+.+.+||.||++|+|||||++
T Consensus 95 ~lNqy~l~~eiG~G-~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 95 QLNQYELIKEIGSG-QYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred ehhheehhhhhcCC-ccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 35789999999999 6777743 789999999942 24789999999999999999999
Q ss_pred eeeEEccCCCeEEEEEecCCCCHHHHHHHhhCCCCCCC-CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccC
Q 003542 271 LCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNS-FSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARS 349 (811)
Q Consensus 271 ~~~~~~e~~~~~yLVmEy~~g~L~~~L~~~~~~~~~~~-ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g 349 (811)
+++.-+.....+|||+|||..+-..+.- .... +++.+++.|+++++.||+|||.+|||||||||+|+||+.+|
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p------~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCP------PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDG 247 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCC------CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCC
Confidence 9888666678899999999943222221 1234 89999999999999999999999999999999999999988
Q ss_pred CCCcceEEEeeccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhC
Q 003542 350 MEGYFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTG 429 (811)
Q Consensus 350 ~d~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG 429 (811)
++||+|||.+........... .......+|||.|+|||.+.+.. .....+.+.||||+||+||.|+.|
T Consensus 248 -----~VKIsDFGVs~~~~~~~~~~~--d~~L~~tvGTPAF~APE~c~~~~-----~~~~~g~a~DiWalGVTLYCllfG 315 (576)
T KOG0585|consen 248 -----TVKISDFGVSNEFPQGSDEGS--DDQLSRTVGTPAFFAPELCSGGN-----SFSYSGFALDIWALGVTLYCLLFG 315 (576)
T ss_pred -----cEEeeccceeeecccCCcccc--HHHHhhcCCCccccchHhhcCCC-----CccccchhhhhhhhhhhHHHhhhc
Confidence 999999999976643321100 11223478999999999998632 123457899999999999999999
Q ss_pred CCCCCCCccchHHHHHHHHhCCCCCCCC--CChHHHHHHHhhhccCCCCCCCCHHHHHHH
Q 003542 430 KVPFEDGHLQGDKMTKNIRAGERPLFPS--GSPKYLVNLTKKCWHTNPSQRPSFSSICRI 487 (811)
Q Consensus 430 ~~PF~~~~~~~~~i~~~i~~~~~~~~p~--~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~ 487 (811)
+.||.+.. ..+++..|... +..+|. ...+.+++||.+||..||.+|.+..+|..+
T Consensus 316 ~~PF~~~~--~~~l~~KIvn~-pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~H 372 (576)
T KOG0585|consen 316 QLPFFDDF--ELELFDKIVND-PLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLH 372 (576)
T ss_pred cCCcccch--HHHHHHHHhcC-cccCCCcccccHHHHHHHHHHhhcChhheeehhhheec
Confidence 99998753 23445555443 333453 367889999999999999999999988653
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=344.26 Aligned_cols=257 Identities=23% Similarity=0.470 Sum_probs=202.7
Q ss_pred hcceEEeeeecccc---eEEEEE------EcCCEEEEEEecc-----cHHHHHHHHHHHHhC-CCCccceeeeeEEccCC
Q 003542 215 LKKLMVRRRLGASS---QFKEIQ------WLGDSFVLRHFYG-----ELESLNAEISTMLSL-SHPNIVQYLCGFCDEEK 279 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~------~~g~~VAVK~~~~-----~~~~~~~Ei~iL~~L-~HPNIVkl~~~~~~e~~ 279 (811)
.++|++.+.||.|+ ||++.. ..+..||||++.. ....+.+|+.+|..+ +||||+++++.+. ...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~-~~~ 84 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACT-KPN 84 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEec-CCC
Confidence 35789999999986 777653 2456899999963 245689999999999 8999999996653 344
Q ss_pred CeEEEEEecCC-CCHHHHHHHhhCC-------------------------------------------------------
Q 003542 280 KEFFLVMELMS-KDLSCYMRETFGS------------------------------------------------------- 303 (811)
Q Consensus 280 ~~~yLVmEy~~-g~L~~~L~~~~~~------------------------------------------------------- 303 (811)
..+|+|||||+ |+|.+++......
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 56899999999 5999988753110
Q ss_pred -CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccccccCCCCCCCCCCCC
Q 003542 304 -RRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTPPASPQNQ 382 (811)
Q Consensus 304 -~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~ 382 (811)
.....+++..+..++.||+.||.|||+.||+||||||+|||++.++ .+||+|||+++....... .....
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~-----~~kl~DfG~a~~~~~~~~-----~~~~~ 234 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENN-----VVKICDFGLARDIYKDPD-----YVRKG 234 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCC-----cEEEeecccccccccCcc-----hhccc
Confidence 0123578889999999999999999999999999999999998776 899999999976532211 11122
Q ss_pred CCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CCCCCCCCccchHHHHHHHHhCCCCCCCCCChH
Q 003542 383 TAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPK 461 (811)
Q Consensus 383 ~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~~PF~~~~~~~~~i~~~i~~~~~~~~p~~~~~ 461 (811)
...+++.|+|||++.+. .++.++|||||||+||||++ |..||.+.... ..+...+..+..+..+..+++
T Consensus 235 ~~~~~~~y~aPE~~~~~---------~~~~~sDiwslG~il~el~~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 304 (338)
T cd05102 235 SARLPLKWMAPESIFDK---------VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN-EEFCQRLKDGTRMRAPENATP 304 (338)
T ss_pred CCCCCccccCcHHhhcC---------CCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc-HHHHHHHhcCCCCCCCCCCCH
Confidence 34567789999999643 67899999999999999997 99999875433 334455556666666778899
Q ss_pred HHHHHHhhhccCCCCCCCCHHHHHHHHHHHH
Q 003542 462 YLVNLTKKCWHTNPSQRPSFSSICRILRYIK 492 (811)
Q Consensus 462 ~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~ 492 (811)
.+.+|+.+||+.||.+|||+.+|++.|+.+.
T Consensus 305 ~l~~li~~cl~~dp~~RPs~~el~~~l~~~~ 335 (338)
T cd05102 305 EIYRIMLACWQGDPKERPTFSALVEILGDLL 335 (338)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 9999999999999999999999998887654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=354.94 Aligned_cols=242 Identities=24% Similarity=0.406 Sum_probs=202.1
Q ss_pred ceEEeeeecccc---eEEEEE-EcCCEEEEEEecc----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEec
Q 003542 217 KLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMEL 288 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy 288 (811)
.|....+||+|. ||-+.. .+++.||||.+.- ..+-+.+|+.+|+.++|+|||.|++.|... +.+|+||||
T Consensus 274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~--deLWVVMEy 351 (550)
T KOG0578|consen 274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVG--DELWVVMEY 351 (550)
T ss_pred hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhccc--ceeEEEEee
Confidence 566666777764 888774 4888999999942 456689999999999999999999998643 569999999
Q ss_pred CCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccc
Q 003542 289 MSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTAR 367 (811)
Q Consensus 289 ~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~ 367 (811)
|+| +|.+.+.. ..+++.++..++++++.||+|||.+||+|||||.+|||++.+| .+||+|||+|..+
T Consensus 352 m~ggsLTDvVt~-------~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g-----~vKltDFGFcaqi 419 (550)
T KOG0578|consen 352 MEGGSLTDVVTK-------TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDG-----SVKLTDFGFCAQI 419 (550)
T ss_pred cCCCchhhhhhc-------ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCC-----cEEEeeeeeeecc
Confidence 995 77776665 4699999999999999999999999999999999999999988 8999999999877
Q ss_pred cccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHHH
Q 003542 368 TYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNI 447 (811)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i 447 (811)
.... ....+.+||+.|||||++... .|++++||||||++++||+-|.+||..... ......|
T Consensus 420 ~~~~-------~KR~TmVGTPYWMAPEVvtrk---------~YG~KVDIWSLGIMaIEMveGEPPYlnE~P--lrAlyLI 481 (550)
T KOG0578|consen 420 SEEQ-------SKRSTMVGTPYWMAPEVVTRK---------PYGPKVDIWSLGIMAIEMVEGEPPYLNENP--LRALYLI 481 (550)
T ss_pred cccc-------CccccccCCCCccchhhhhhc---------ccCccccchhhhhHHHHHhcCCCCccCCCh--HHHHHHH
Confidence 6542 244678999999999999754 789999999999999999999999975432 2233445
Q ss_pred HhCCCC--CCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHH
Q 003542 448 RAGERP--LFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYI 491 (811)
Q Consensus 448 ~~~~~~--~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i 491 (811)
.....| ..+...++.+++|+.+||..|+.+|+++.++|+ +.+|
T Consensus 482 a~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~-HpFl 526 (550)
T KOG0578|consen 482 ATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE-HPFL 526 (550)
T ss_pred hhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc-Chhh
Confidence 444444 356788999999999999999999999999987 4444
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=334.29 Aligned_cols=244 Identities=18% Similarity=0.309 Sum_probs=198.9
Q ss_pred EEeeeecccceEEEEEEcCCEEEEEEeccc-------HHHHHHHHHHHHhCCCCccceeeeeEEc--cCCCeEEEEEecC
Q 003542 219 MVRRRLGASSQFKEIQWLGDSFVLRHFYGE-------LESLNAEISTMLSLSHPNIVQYLCGFCD--EEKKEFFLVMELM 289 (811)
Q Consensus 219 ~i~~~lG~G~vyk~v~~~g~~VAVK~~~~~-------~~~~~~Ei~iL~~L~HPNIVkl~~~~~~--e~~~~~yLVmEy~ 289 (811)
..++..|.|.+|++. ++|+.||||.+... .+.+.+|+.+|.+++||||+++++.+.+ +....+++|||||
T Consensus 26 ~~i~~g~~~~v~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGI-FNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEE-ECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 445555666688865 58999999999531 4667899999999999999999977754 3445789999999
Q ss_pred CC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcEEEeccCCCCcceEEEeeccccccc
Q 003542 290 SK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQ-KIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTAR 367 (811)
Q Consensus 290 ~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~-gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~ 367 (811)
+| +|.+++.+. ..+++...+.++.|++.||.|||+. +++||||||+|||++.++ .+||+|||+++..
T Consensus 105 ~~g~L~~~l~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~-----~~kl~dfg~~~~~ 173 (283)
T PHA02988 105 TRGYLREVLDKE------KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENY-----KLKIICHGLEKIL 173 (283)
T ss_pred CCCcHHHHHhhC------CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCC-----cEEEcccchHhhh
Confidence 95 899988753 5688999999999999999999984 899999999999998876 8999999998765
Q ss_pred cccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHHH
Q 003542 368 TYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNI 447 (811)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i 447 (811)
... .....|+..|+|||++.+. ...++.++|||||||++|||++|..||.+... ..+...+
T Consensus 174 ~~~----------~~~~~~~~~y~aPE~~~~~-------~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~--~~~~~~i 234 (283)
T PHA02988 174 SSP----------PFKNVNFMVYFSYKMLNDI-------FSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT--KEIYDLI 234 (283)
T ss_pred ccc----------cccccCcccccCHHHhhhc-------cccccchhhhhHHHHHHHHHHHCCCCCCCCCH--HHHHHHH
Confidence 321 1234678899999999752 23688999999999999999999999986532 3334444
Q ss_pred -HhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHHHH
Q 003542 448 -RAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKK 493 (811)
Q Consensus 448 -~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~k 493 (811)
..+.++.+|..+++.+.+|+.+||+.||.+|||+.+++..|+.++.
T Consensus 235 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 235 INKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred HhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 3445566677889999999999999999999999999998887653
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=334.89 Aligned_cols=254 Identities=21% Similarity=0.366 Sum_probs=203.9
Q ss_pred cceEEeeeecccceEEEE-----EEcCCEEEEEEecc------cHHHHHHHHHHHHhCCCCccceeeeeEEc---cCCCe
Q 003542 216 KKLMVRRRLGASSQFKEI-----QWLGDSFVLRHFYG------ELESLNAEISTMLSLSHPNIVQYLCGFCD---EEKKE 281 (811)
Q Consensus 216 k~~~i~~~lG~G~vyk~v-----~~~g~~VAVK~~~~------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~---e~~~~ 281 (811)
..|..++.||.| +|+.+ ..+|+.||||++.+ ..++..+|+++|+.++|+||+.+++.+.. +.-+.
T Consensus 22 ~~y~~~~~iG~G-AyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 22 RYYVLIEPIGRG-AYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred ceecccccccCc-ceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 456668899999 57655 34899999999963 45778999999999999999999988864 23467
Q ss_pred EEEEEecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeec
Q 003542 282 FFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGF 361 (811)
Q Consensus 282 ~yLVmEy~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DF 361 (811)
+|+|+|+|+.||...++.. ..++...+..+++||++||.|+|+.+++||||||+|+|++.+. .+||+||
T Consensus 101 vYiV~elMetDL~~iik~~------~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c-----~lKI~DF 169 (359)
T KOG0660|consen 101 VYLVFELMETDLHQIIKSQ------QDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADC-----DLKICDF 169 (359)
T ss_pred eEEehhHHhhHHHHHHHcC------ccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCC-----CEEeccc
Confidence 8999999999999988863 4599999999999999999999999999999999999998876 7899999
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccch-
Q 003542 362 GLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQG- 440 (811)
Q Consensus 362 GlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~- 440 (811)
|+|+....... ....+..+.|.+|.|||++.. ...|+.+.||||+||||.||++|++.|.+.+.-.
T Consensus 170 GLAR~~~~~~~-----~~~mTeYVaTRWYRAPElll~--------~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Q 236 (359)
T KOG0660|consen 170 GLARYLDKFFE-----DGFMTEYVATRWYRAPELLLN--------SSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQ 236 (359)
T ss_pred cceeeccccCc-----ccchhcceeeeeecCHHHHhc--------cccccchhhhhhhhHHHHHHHcCCCCCCCCchHHH
Confidence 99998754311 223357788999999999974 5689999999999999999999999998753211
Q ss_pred ------------HHHH---------HHHHh-CCCCCCC-----CCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHHHH
Q 003542 441 ------------DKMT---------KNIRA-GERPLFP-----SGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKK 493 (811)
Q Consensus 441 ------------~~i~---------~~i~~-~~~~~~p-----~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~k 493 (811)
.+.. ..+.. ...+..| ...++...+|+.+||..||.+|+|+++++. ..++..
T Consensus 237 l~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~-hPYl~~ 315 (359)
T KOG0660|consen 237 LQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA-HPYLAP 315 (359)
T ss_pred HHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc-Chhhhh
Confidence 1111 11111 1112111 356778999999999999999999999998 677777
Q ss_pred Hh
Q 003542 494 FM 495 (811)
Q Consensus 494 ~l 495 (811)
+.
T Consensus 316 ~h 317 (359)
T KOG0660|consen 316 YH 317 (359)
T ss_pred hc
Confidence 65
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=335.29 Aligned_cols=255 Identities=22% Similarity=0.345 Sum_probs=203.1
Q ss_pred ceEEeeeecccc---eEEEEEE-cCCEEEEEEecccHHHHHHHHHHHHhCCCCccceeeeeEEccCCC---eEEEEEecC
Q 003542 217 KLMVRRRLGASS---QFKEIQW-LGDSFVLRHFYGELESLNAEISTMLSLSHPNIVQYLCGFCDEEKK---EFFLVMELM 289 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v~~-~g~~VAVK~~~~~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~---~~yLVmEy~ 289 (811)
.|.-.+.+|.|+ ||+++.. +++.||||+...+..--.+|+.+|+.++|||||++...|...... +..+|||||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleym 104 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYM 104 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhc
Confidence 456667778775 7777743 679999999987777778899999999999999999777644333 456899999
Q ss_pred CCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccccc
Q 003542 290 SKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTY 369 (811)
Q Consensus 290 ~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~ 369 (811)
+.+|..+++.... .+..++.-.+.-|..||++||.|||+.||+||||||.|+|+|.+.. .+||||||.|+.+..
T Consensus 105 P~tL~~~~r~~~~--~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg----~LKicDFGSAK~L~~ 178 (364)
T KOG0658|consen 105 PETLYRVIRHYTR--ANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTG----VLKICDFGSAKVLVK 178 (364)
T ss_pred hHHHHHHHHHHhh--cCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCC----eEEeccCCcceeecc
Confidence 9999999987432 2366888899999999999999999999999999999999998742 899999999998876
Q ss_pred cCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHHHHh
Q 003542 370 ASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRA 449 (811)
Q Consensus 370 ~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i~~ 449 (811)
.. .+.+...|..|.|||.+.| ...|+.+.||||.|||+.||+-|++.|.+.+.. +++...+.-
T Consensus 179 ~e--------pniSYicSRyYRaPELifg--------a~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~-dQL~eIik~ 241 (364)
T KOG0658|consen 179 GE--------PNISYICSRYYRAPELIFG--------ATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSV-DQLVEIIKV 241 (364)
T ss_pred CC--------CceeEEEeccccCHHHHcC--------ccccCceeEEhhhhHHHHHHhcCCcccCCCCHH-HHHHHHHHH
Confidence 54 2346678899999999986 458999999999999999999999999885432 222111111
Q ss_pred -CC----------C-------C---------CCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHHHHHh
Q 003542 450 -GE----------R-------P---------LFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKKFM 495 (811)
Q Consensus 450 -~~----------~-------~---------~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~k~l 495 (811)
|. . + .+....++++.+|+.++|.++|.+|.++.+++. +.++....
T Consensus 242 lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~-h~fFdelr 313 (364)
T KOG0658|consen 242 LGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA-HPFFDELR 313 (364)
T ss_pred hCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc-chhhHHhh
Confidence 10 0 0 023456788999999999999999999999987 55555443
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=357.63 Aligned_cols=248 Identities=23% Similarity=0.377 Sum_probs=207.9
Q ss_pred HHHhcceEEeeeecccceEEEE-----EEcCCEEEEEEecc-------cHHHHHHHHHHHHhC-CCCccceeeeeEEccC
Q 003542 212 DMLLKKLMVRRRLGASSQFKEI-----QWLGDSFVLRHFYG-------ELESLNAEISTMLSL-SHPNIVQYLCGFCDEE 278 (811)
Q Consensus 212 ~~l~k~~~i~~~lG~G~vyk~v-----~~~g~~VAVK~~~~-------~~~~~~~Ei~iL~~L-~HPNIVkl~~~~~~e~ 278 (811)
.+-+++|.+++.||+|+ |+.+ +-+++.||||.+++ +.+....|.+|+... +||.++.+|..| ++
T Consensus 364 ~~~l~~F~~l~vLGkGs-FGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f--QT 440 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGS-FGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCF--QT 440 (694)
T ss_pred cccccceEEEEEeccCc-CceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccc--cc
Confidence 34467899999999995 4444 33889999999964 578899999999888 599999999888 67
Q ss_pred CCeEEEEEecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEE
Q 003542 279 KKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKV 358 (811)
Q Consensus 279 ~~~~yLVmEy~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL 358 (811)
+.++|+||||+.|+...++. ....|++..+..|+..|+.||.|||++||||||||.+|||+|.+| ++||
T Consensus 441 ~~~l~fvmey~~Ggdm~~~~------~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eG-----h~ki 509 (694)
T KOG0694|consen 441 KEHLFFVMEYVAGGDLMHHI------HTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEG-----HVKI 509 (694)
T ss_pred CCeEEEEEEecCCCcEEEEE------ecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccC-----cEEe
Confidence 78899999999964322222 226899999999999999999999999999999999999999998 9999
Q ss_pred eeccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCcc
Q 003542 359 SGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHL 438 (811)
Q Consensus 359 ~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~ 438 (811)
+||||++..... .....+.+|||.|||||++.+. .|+.++|+|||||+|||||.|..||.+.
T Consensus 510 ADFGlcKe~m~~-------g~~TsTfCGTpey~aPEil~e~---------~Yt~aVDWW~lGVLlyeML~Gq~PF~gd-- 571 (694)
T KOG0694|consen 510 ADFGLCKEGMGQ-------GDRTSTFCGTPEFLAPEVLTEQ---------SYTRAVDWWGLGVLLYEMLVGESPFPGD-- 571 (694)
T ss_pred cccccccccCCC-------CCccccccCChhhcChhhhccC---------cccchhhHHHHHHHHHHHHcCCCCCCCC--
Confidence 999999865422 2345688999999999999865 7899999999999999999999999975
Q ss_pred chHHHHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCH----HHHHHHHHHHH
Q 003542 439 QGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSF----SSICRILRYIK 492 (811)
Q Consensus 439 ~~~~i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~----~eIl~~L~~i~ 492 (811)
++++++..|... .+.+|..++.+..+|++++|..+|++|... ++.++...+++
T Consensus 572 dEee~FdsI~~d-~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr 628 (694)
T KOG0694|consen 572 DEEEVFDSIVND-EVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFR 628 (694)
T ss_pred CHHHHHHHHhcC-CCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccc
Confidence 455677777654 466899999999999999999999999987 55555455544
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=317.70 Aligned_cols=249 Identities=23% Similarity=0.354 Sum_probs=200.6
Q ss_pred cceEEeeeecccc---eEEEE-EEcCCEEEEEEecc------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEE
Q 003542 216 KKLMVRRRLGASS---QFKEI-QWLGDSFVLRHFYG------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLV 285 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v-~~~g~~VAVK~~~~------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLV 285 (811)
++|..++++|+|+ ||++. ..+|+.||||+++- -.-...+||+.|+.++||||+.++++| .....+.||
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F--~~~~~l~lV 79 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVF--PHKSNLSLV 79 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhc--cCCCceEEE
Confidence 3567778899995 66666 45999999999952 134578999999999999999999999 455669999
Q ss_pred EecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccc
Q 003542 286 MELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365 (811)
Q Consensus 286 mEy~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~ 365 (811)
+|||+.||...+++. ...++...+..|+.++++||+|||.+.|+||||||.|+||+.+| .+||+|||+|+
T Consensus 80 fEfm~tdLe~vIkd~-----~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g-----~lKiADFGLAr 149 (318)
T KOG0659|consen 80 FEFMPTDLEVVIKDK-----NIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDG-----QLKIADFGLAR 149 (318)
T ss_pred EEeccccHHHHhccc-----ccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCC-----cEEeecccchh
Confidence 999999999999864 36789999999999999999999999999999999999999988 89999999999
Q ss_pred cccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHH
Q 003542 366 ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTK 445 (811)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~ 445 (811)
.+..... .....+-|.+|.|||.+.| ...|+..+||||.|||+.||+.|.+-|.+.+.- +++..
T Consensus 150 ~f~~p~~-------~~~~~V~TRWYRAPELLfG--------sr~Yg~~VDmWavGCI~AELllr~P~fpG~sDi-dQL~~ 213 (318)
T KOG0659|consen 150 FFGSPNR-------IQTHQVVTRWYRAPELLFG--------SRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDI-DQLSK 213 (318)
T ss_pred ccCCCCc-------ccccceeeeeccChHHhcc--------chhcCCcchhhhHHHHHHHHHccCCCCCCCchH-HHHHH
Confidence 8865532 1223478999999999986 458999999999999999999999888876432 33322
Q ss_pred HHHh-CCCC--C---------------C--------CCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHHHH
Q 003542 446 NIRA-GERP--L---------------F--------PSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKK 493 (811)
Q Consensus 446 ~i~~-~~~~--~---------------~--------p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~k 493 (811)
.... |.+. . + -...+.++.+|+.+||.+||.+|+++.++++ .+++..
T Consensus 214 If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~-~~yf~~ 286 (318)
T KOG0659|consen 214 IFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALK-HPYFKS 286 (318)
T ss_pred HHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhc-chhhhc
Confidence 2221 1100 0 0 1234566899999999999999999999988 445443
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=336.82 Aligned_cols=237 Identities=24% Similarity=0.415 Sum_probs=196.3
Q ss_pred hcceEEeeeecccc---eEEEEE-EcCCEEEEEEecc-------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEE
Q 003542 215 LKKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG-------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFF 283 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~-------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~y 283 (811)
..+|++.+.||.|+ ||.+.. .+|+.||||.+.. ..+.+.+|+.+|++++||||+++++.+. +.+.+|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~~~ 94 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQ--DENRVY 94 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEE--cCCEEE
Confidence 46899999999986 676653 3789999999853 3456889999999999999999998774 456799
Q ss_pred EEEecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecc
Q 003542 284 LVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFG 362 (811)
Q Consensus 284 LVmEy~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFG 362 (811)
+|||||.| +|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 95 lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~-----~~kl~Dfg 163 (329)
T PTZ00263 95 FLLEFVVGGELFTHLRKA------GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKG-----HVKVTDFG 163 (329)
T ss_pred EEEcCCCCChHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCC-----CEEEeecc
Confidence 99999985 898888753 5689999999999999999999999999999999999998876 89999999
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHH
Q 003542 363 LSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDK 442 (811)
Q Consensus 363 lA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~ 442 (811)
++...... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.. ...
T Consensus 164 ~~~~~~~~----------~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~elltg~~pf~~~~--~~~ 222 (329)
T PTZ00263 164 FAKKVPDR----------TFTLCGTPEYLAPEVIQSK---------GHGKAVDWWTMGVLLYEFIAGYPPFFDDT--PFR 222 (329)
T ss_pred CceEcCCC----------cceecCChhhcCHHHHcCC---------CCCCcceeechHHHHHHHHcCCCCCCCCC--HHH
Confidence 98765321 1245689999999999753 57889999999999999999999997643 233
Q ss_pred HHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCC-----HHHHHH
Q 003542 443 MTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPS-----FSSICR 486 (811)
Q Consensus 443 i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS-----~~eIl~ 486 (811)
....+..+ ...+|...+..+.+||.+||..||.+||+ +.+++.
T Consensus 223 ~~~~i~~~-~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 223 IYEKILAG-RLKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred HHHHHhcC-CcCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 44555544 34567778889999999999999999997 566654
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=334.52 Aligned_cols=240 Identities=25% Similarity=0.417 Sum_probs=205.5
Q ss_pred HhcceEEeeeecccceEEEEE-----EcCCEEEEEEecc-------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCe
Q 003542 214 LLKKLMVRRRLGASSQFKEIQ-----WLGDSFVLRHFYG-------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKE 281 (811)
Q Consensus 214 l~k~~~i~~~lG~G~vyk~v~-----~~g~~VAVK~~~~-------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~ 281 (811)
+..+|++.+.||.| .|+.+. ..|+.||||.+++ ++-.+.+||+||..|+||||+.+|++| ++.+.
T Consensus 51 lkHRyE~~etLGkG-TYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVF--ENkdK 127 (668)
T KOG0611|consen 51 LKHRYEITETLGKG-TYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVF--ENKDK 127 (668)
T ss_pred hhhHHHHHHHhcCC-cccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhh--cCCce
Confidence 34578999999999 466663 4799999999964 355689999999999999999999999 77788
Q ss_pred EEEEEecCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEee
Q 003542 282 FFLVMELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSG 360 (811)
Q Consensus 282 ~yLVmEy~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~D 360 (811)
+.|||||.. |.|++|+.+. +.|++.+++++++||++|+.|+|+++++|||||.+|||+|.++ ++||+|
T Consensus 128 IvivMEYaS~GeLYDYiSer------~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~-----NiKIAD 196 (668)
T KOG0611|consen 128 IVIVMEYASGGELYDYISER------GSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNN-----NIKIAD 196 (668)
T ss_pred EEEEEEecCCccHHHHHHHh------ccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCC-----Ceeeec
Confidence 999999999 6999999875 7899999999999999999999999999999999999999887 899999
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccch
Q 003542 361 FGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQG 440 (811)
Q Consensus 361 FGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~ 440 (811)
|||+..+.... ...+.+|++.|.+||++.|..|. ++.+|-|||||+||.|+.|..||++.+ .
T Consensus 197 FGLSNly~~~k--------fLqTFCGSPLYASPEIvNG~PY~--------GPEVDsWsLGvLLYtLVyGtMPFDG~D--h 258 (668)
T KOG0611|consen 197 FGLSNLYADKK--------FLQTFCGSPLYASPEIVNGTPYK--------GPEVDSWSLGVLLYTLVYGTMPFDGRD--H 258 (668)
T ss_pred cchhhhhcccc--------HHHHhcCCcccCCccccCCCCCC--------CCccchhhHHHHHHHHhhcccccCCch--H
Confidence 99997765432 34578999999999999986544 468999999999999999999998853 3
Q ss_pred HHHHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHH
Q 003542 441 DKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRI 487 (811)
Q Consensus 441 ~~i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~ 487 (811)
..+.+.|..|.. +.+..|....-||+.||..+|.+|.|+.+|..+
T Consensus 259 k~lvrQIs~GaY--rEP~~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 259 KRLVRQISRGAY--REPETPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred HHHHHHhhcccc--cCCCCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 455666766653 234456678999999999999999999999874
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=327.14 Aligned_cols=246 Identities=24% Similarity=0.326 Sum_probs=200.2
Q ss_pred hcceEEeeeecccc---eEEEE-EEcCCEEEEEEecccH------HHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEE
Q 003542 215 LKKLMVRRRLGASS---QFKEI-QWLGDSFVLRHFYGEL------ESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFL 284 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v-~~~g~~VAVK~~~~~~------~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yL 284 (811)
.+.|+.+.+|++|+ ||++. ..+++.||+|+++-+. -...+||.+|.+++|||||.+-++....+-+.+||
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 35788889999996 66655 4589999999996432 23589999999999999999998887777778999
Q ss_pred EEecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccc
Q 003542 285 VMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS 364 (811)
Q Consensus 285 VmEy~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA 364 (811)
|||||+.||...+... ..+|...++..++.|+++||+|||.+.|+||||||+|+|+...| .+||+|||+|
T Consensus 155 VMe~~EhDLksl~d~m-----~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G-----~lKiaDFGLA 224 (419)
T KOG0663|consen 155 VMEYVEHDLKSLMETM-----KQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKG-----ILKIADFGLA 224 (419)
T ss_pred eHHHHHhhHHHHHHhc-----cCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCC-----cEEecccchh
Confidence 9999999999988753 36899999999999999999999999999999999999999998 8999999999
Q ss_pred ccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHH
Q 003542 365 TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMT 444 (811)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~ 444 (811)
+.+.... ...+..+-|.+|.|||++.+ ...|+.+.|+||+|||+.||+++++.|.+.... +++.
T Consensus 225 R~ygsp~-------k~~T~lVVTLWYRaPELLLG--------~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~-dQl~ 288 (419)
T KOG0663|consen 225 REYGSPL-------KPYTPLVVTLWYRAPELLLG--------AKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEI-DQLD 288 (419)
T ss_pred hhhcCCc-------ccCcceEEEeeecCHHHhcC--------CcccCcchhhhhHHHHHHHHHhcCCCCCCCchH-HHHH
Confidence 9876542 23456778999999999997 458999999999999999999999999876432 2222
Q ss_pred HHHHh-CCC-------------------CC---------CCCC-ChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 445 KNIRA-GER-------------------PL---------FPSG-SPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 445 ~~i~~-~~~-------------------~~---------~p~~-~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
+.... |.+ +. |+.. .++.-.+|+..+|.+||.+|.|+++.++
T Consensus 289 ~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 289 KIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred HHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 21111 110 00 1111 3466789999999999999999999987
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=320.86 Aligned_cols=255 Identities=23% Similarity=0.318 Sum_probs=211.6
Q ss_pred hcceEEeeeecccc---eEEEE-EEcCCEEEEEEecc------------cHHHHHHHHHHHHhC-CCCccceeeeeEEcc
Q 003542 215 LKKLMVRRRLGASS---QFKEI-QWLGDSFVLRHFYG------------ELESLNAEISTMLSL-SHPNIVQYLCGFCDE 277 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v-~~~g~~VAVK~~~~------------~~~~~~~Ei~iL~~L-~HPNIVkl~~~~~~e 277 (811)
..+|...+.+|+|. +-+.+ ..+|..+|+|++.- -.+.-.+|+.||+++ .||||+++.+.| +
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y--e 93 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY--E 93 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec--c
Confidence 45677777888884 22222 45899999999831 135668899999999 699999999888 6
Q ss_pred CCCeEEEEEecCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceE
Q 003542 278 EKKEFFLVMELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHV 356 (811)
Q Consensus 278 ~~~~~yLVmEy~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~v 356 (811)
....+++|+|+|+ |.|++||.+. -.+++.....|++|++.|++|||.++||||||||+|||++++- ++
T Consensus 94 s~sF~FlVFdl~prGELFDyLts~------VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~-----~i 162 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTSK------VTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNM-----NI 162 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhhh------eeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeecccc-----ce
Confidence 7778999999999 7999999875 7899999999999999999999999999999999999997664 99
Q ss_pred EEeeccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCC
Q 003542 357 KVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDG 436 (811)
Q Consensus 357 KL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~ 436 (811)
||+|||+|..+..+. .....+|||+|+|||.+....+.. ...|+..+|+||+|+|||.|+.|.+||..
T Consensus 163 ~isDFGFa~~l~~Ge--------kLrelCGTPgYLAPEtikC~m~e~---~pGYs~EVD~Wa~GVImyTLLaGcpPFwH- 230 (411)
T KOG0599|consen 163 KISDFGFACQLEPGE--------KLRELCGTPGYLAPETIKCSMYEN---HPGYSKEVDEWACGVIMYTLLAGCPPFWH- 230 (411)
T ss_pred EEeccceeeccCCch--------hHHHhcCCCcccChhheeeecccC---CCCccchhhHHHHHHHHHHHHcCCCchhH-
Confidence 999999998876543 345788999999999999887664 45899999999999999999999999974
Q ss_pred ccchHHHHHHHHhCCCCCC---CCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHHHHHhh
Q 003542 437 HLQGDKMTKNIRAGERPLF---PSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKKFMA 496 (811)
Q Consensus 437 ~~~~~~i~~~i~~~~~~~~---p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~k~l~ 496 (811)
..+..+.+.|..|....- ..+.+...++||.+||+.||.+|.|+++++. ++++.....
T Consensus 231 -RkQmlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~La-Hpff~q~~~ 291 (411)
T KOG0599|consen 231 -RKQMLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA-HPFFIQIAQ 291 (411)
T ss_pred -HHHHHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc-ChHHHHHHH
Confidence 345567788888764322 2466778999999999999999999999998 455554443
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=331.79 Aligned_cols=235 Identities=23% Similarity=0.364 Sum_probs=194.5
Q ss_pred ceEEeeeecccc---eEEEEEE-cCCEEEEEEecc-------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEE
Q 003542 217 KLMVRRRLGASS---QFKEIQW-LGDSFVLRHFYG-------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLV 285 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v~~-~g~~VAVK~~~~-------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLV 285 (811)
+|++.+.||.|+ ||++... +|+.||||++.. ..+.+.+|+.+|+.++||||+++++.+ .+...+|+|
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~--~~~~~~~lv 79 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTE--HDQRFLYML 79 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhh--ccCCeEEEE
Confidence 688888999986 7776643 789999999852 245688999999999999999998766 455689999
Q ss_pred EecCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccc
Q 003542 286 MELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS 364 (811)
Q Consensus 286 mEy~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA 364 (811)
|||++ |+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 80 ~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~-----~~kl~Dfg~~ 148 (291)
T cd05612 80 MEYVPGGELFSYLRNS------GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEG-----HIKLTDFGFA 148 (291)
T ss_pred EeCCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC-----CEEEEecCcc
Confidence 99998 5899988753 5689999999999999999999999999999999999998776 8999999998
Q ss_pred ccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHH
Q 003542 365 TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMT 444 (811)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~ 444 (811)
...... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+... ....
T Consensus 149 ~~~~~~----------~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwSlG~il~~l~~g~~pf~~~~~--~~~~ 207 (291)
T cd05612 149 KKLRDR----------TWTLCGTPEYLAPEVIQSK---------GHNKAVDWWALGILIYEMLVGYPPFFDDNP--FGIY 207 (291)
T ss_pred hhccCC----------cccccCChhhcCHHHHcCC---------CCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHH
Confidence 765321 1235689999999998753 578899999999999999999999986532 3344
Q ss_pred HHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCC-----HHHHHH
Q 003542 445 KNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPS-----FSSICR 486 (811)
Q Consensus 445 ~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS-----~~eIl~ 486 (811)
..+..+ ...+|...+..+.+||.+||..||.+||+ ++++++
T Consensus 208 ~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 208 EKILAG-KLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred HHHHhC-CcCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 455444 34467777889999999999999999995 888876
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=347.57 Aligned_cols=255 Identities=19% Similarity=0.342 Sum_probs=197.7
Q ss_pred cceEEeeeecccc---eEEEEE-EcCCEEEEEEecccHHHHHHHHHHHHhCCCCccceeeeeEEcc------CCCeEEEE
Q 003542 216 KKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYGELESLNAEISTMLSLSHPNIVQYLCGFCDE------EKKEFFLV 285 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e------~~~~~yLV 285 (811)
++|.+.+.||+|+ ||++.. .+++.||||++........+|+.+|+.++||||+++++.|... ....+++|
T Consensus 66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lv 145 (440)
T PTZ00036 66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVV 145 (440)
T ss_pred CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEE
Confidence 5799999999986 777664 3789999999976666677899999999999999998766432 12357899
Q ss_pred EecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccc
Q 003542 286 MELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365 (811)
Q Consensus 286 mEy~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~ 365 (811)
||||+++|..++.... .....+++..++.++.||+.||.|||++||+||||||+|||++.++. .+||+|||+|+
T Consensus 146 mE~~~~~l~~~~~~~~--~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~----~vkL~DFGla~ 219 (440)
T PTZ00036 146 MEFIPQTVHKYMKHYA--RNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTH----TLKLCDFGSAK 219 (440)
T ss_pred EecCCccHHHHHHHHh--hcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCC----ceeeeccccch
Confidence 9999999988876532 12357899999999999999999999999999999999999976541 69999999997
Q ss_pred cccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHH
Q 003542 366 ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTK 445 (811)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~ 445 (811)
...... ......||+.|+|||++.+. ..|+.++|||||||++|||++|.+||.+..... .+..
T Consensus 220 ~~~~~~--------~~~~~~~t~~y~aPE~~~~~--------~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~-~~~~ 282 (440)
T PTZ00036 220 NLLAGQ--------RSVSYICSRFYRAPELMLGA--------TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD-QLVR 282 (440)
T ss_pred hccCCC--------CcccCCCCcCccCHHHhcCC--------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHH
Confidence 654321 12345689999999998642 368899999999999999999999998754321 1211
Q ss_pred HHHh-CC--------------------------CCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHHHHH
Q 003542 446 NIRA-GE--------------------------RPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKKF 494 (811)
Q Consensus 446 ~i~~-~~--------------------------~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~k~ 494 (811)
.+.. +. ...+|...++++.+||.+||..||.+|||+.+++. ..++...
T Consensus 283 i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~-hp~f~~~ 357 (440)
T PTZ00036 283 IIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA-DPFFDDL 357 (440)
T ss_pred HHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC-ChhHHhh
Confidence 1110 00 01134456788999999999999999999999987 4555543
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=334.88 Aligned_cols=231 Identities=20% Similarity=0.309 Sum_probs=187.7
Q ss_pred eccc---ceEEEEE-EcCCEEEEEEecc-------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEecCCC-
Q 003542 224 LGAS---SQFKEIQ-WLGDSFVLRHFYG-------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK- 291 (811)
Q Consensus 224 lG~G---~vyk~v~-~~g~~VAVK~~~~-------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~~g- 291 (811)
||+| .||.+.. .+|+.||||++.. ....+.+|+.+|+.++||||+++++.+ +....+||||||++|
T Consensus 3 lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~--~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSF--QTHDRLCFVMEYANGG 80 (323)
T ss_pred eeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEE--EcCCEEEEEEeCCCCC
Confidence 4555 4777663 4889999999863 235678899999999999999998777 455689999999995
Q ss_pred CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccccccC
Q 003542 292 DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYAS 371 (811)
Q Consensus 292 ~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~~ 371 (811)
+|..++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus 81 ~L~~~l~~~------~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~-----~~kl~DfG~a~~~~~~~ 149 (323)
T cd05571 81 ELFFHLSRE------RVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDG-----HIKITDFGLCKEGISDG 149 (323)
T ss_pred cHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCC-----CEEEeeCCCCcccccCC
Confidence 888888653 5789999999999999999999999999999999999998876 89999999987532211
Q ss_pred CCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHHHHhCC
Q 003542 372 RNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGE 451 (811)
Q Consensus 372 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i~~~~ 451 (811)
.......||+.|+|||++.+. .++.++|||||||++|||++|..||.+... ..+...+..+
T Consensus 150 -------~~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwSlG~il~elltg~~Pf~~~~~--~~~~~~~~~~- 210 (323)
T cd05571 150 -------ATMKTFCGTPEYLAPEVLEDN---------DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--EKLFELILME- 210 (323)
T ss_pred -------CcccceecCccccChhhhcCC---------CCCccccCcccchhhhhhhcCCCCCCCCCH--HHHHHHHHcC-
Confidence 122345689999999999643 678999999999999999999999976432 2333444333
Q ss_pred CCCCCCCChHHHHHHHhhhccCCCCCCC-----CHHHHHH
Q 003542 452 RPLFPSGSPKYLVNLTKKCWHTNPSQRP-----SFSSICR 486 (811)
Q Consensus 452 ~~~~p~~~~~~l~~LI~~cL~~DP~~RP-----S~~eIl~ 486 (811)
...+|...++++.+||.+||..||.+|| ++.++++
T Consensus 211 ~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 211 EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 3456778899999999999999999999 7888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=329.61 Aligned_cols=244 Identities=22% Similarity=0.297 Sum_probs=190.2
Q ss_pred cceEEeeeecccc---eEEEEE-EcCCEEEEEEecc-----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEE
Q 003542 216 KKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVM 286 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~-----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVm 286 (811)
.+|++.+.||.|+ ||.+.. .+|+.||||++.. ....+.+|+.+++.++||||+++++.+. +...+|+||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~~lv~ 82 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIH--TKETLTLVF 82 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEe--cCCeEEEEE
Confidence 5789999999985 666553 3789999999853 2346788999999999999999997774 456799999
Q ss_pred ecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccccc
Q 003542 287 ELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366 (811)
Q Consensus 287 Ey~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~ 366 (811)
||++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 83 e~~~~~l~~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~-----~~kl~Dfg~~~~ 152 (303)
T cd07869 83 EYVHTDLCQYMDKH-----PGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTG-----ELKLADFGLARA 152 (303)
T ss_pred ECCCcCHHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-----CEEECCCCccee
Confidence 99999999888753 25688999999999999999999999999999999999998876 899999999875
Q ss_pred ccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHH
Q 003542 367 RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKN 446 (811)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~ 446 (811)
..... .......+|+.|+|||++.+. ..++.++|||||||++|+|++|..||.+.......+...
T Consensus 153 ~~~~~-------~~~~~~~~~~~y~aPE~~~~~--------~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~ 217 (303)
T cd07869 153 KSVPS-------HTYSNEVVTLWYRPPDVLLGS--------TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERI 217 (303)
T ss_pred ccCCC-------ccCCCCcccCCCCChHHHcCC--------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHH
Confidence 43221 112345688999999998642 357889999999999999999999998654332222211
Q ss_pred HHhCCCC------------C---------CC---------CCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 447 IRAGERP------------L---------FP---------SGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 447 i~~~~~~------------~---------~p---------~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
......+ . .+ ...+..+.+|+.+||+.||.+|||+.++++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 218 FLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred HHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 1110000 0 00 023456889999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=332.87 Aligned_cols=253 Identities=21% Similarity=0.350 Sum_probs=192.8
Q ss_pred ceEEeeeecccc---eEEEEE-EcCCEEEEEEecc------cHHHHHHHHHHHHhCCCCccceeeeeEEccC---CCeEE
Q 003542 217 KLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG------ELESLNAEISTMLSLSHPNIVQYLCGFCDEE---KKEFF 283 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~---~~~~y 283 (811)
+|++.+.||.|+ ||.+.. .+|+.||||.+.. ....+.+|+.+|+.++||||+++++.+.... ...+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 588889999886 777663 4789999999853 2356889999999999999999987665322 23589
Q ss_pred EEEecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccc
Q 003542 284 LVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGL 363 (811)
Q Consensus 284 LVmEy~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGl 363 (811)
+|||||+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 81 lv~e~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~-----~~kL~Dfg~ 149 (338)
T cd07859 81 VVFELMESDLHQVIKAN------DDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADC-----KLKICDFGL 149 (338)
T ss_pred EEEecCCCCHHHHHHhc------ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-----cEEEccCcc
Confidence 99999999999888753 5689999999999999999999999999999999999998876 899999999
Q ss_pred cccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchH--
Q 003542 364 STARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGD-- 441 (811)
Q Consensus 364 A~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~-- 441 (811)
++........ ........||+.|+|||++.+. ...++.++|||||||++|+|++|++||.+......
T Consensus 150 ~~~~~~~~~~----~~~~~~~~~t~~y~aPE~~~~~-------~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~ 218 (338)
T cd07859 150 ARVAFNDTPT----AIFWTDYVATRWYRAPELCGSF-------FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLD 218 (338)
T ss_pred ccccccccCc----cccccCCCCCCCcCCHHHHhcc-------ccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHH
Confidence 9754322111 1112345789999999998642 23678899999999999999999999976432110
Q ss_pred -----------HHHH------------HHHhCCCCCC---CCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHHH
Q 003542 442 -----------KMTK------------NIRAGERPLF---PSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIK 492 (811)
Q Consensus 442 -----------~i~~------------~i~~~~~~~~---p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~ 492 (811)
.... .+.......+ ....++.+.++|.+||..||.+|||++++++ ..+++
T Consensus 219 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~-hp~f~ 294 (338)
T cd07859 219 LITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA-DPYFK 294 (338)
T ss_pred HHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc-Cchhh
Confidence 0000 0011111111 1245677899999999999999999999987 34443
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=325.66 Aligned_cols=243 Identities=23% Similarity=0.353 Sum_probs=190.5
Q ss_pred cceEEeeeecccc---eEEEEE-EcCCEEEEEEecc-----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEE
Q 003542 216 KKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVM 286 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~-----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVm 286 (811)
.+|++.+.||.|+ ||++.. .+++.||+|.+.. ....+.+|+.+++.++||||+++++.+. ....+|+||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~~lv~ 82 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIH--TERCLTLVF 82 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEc--CCCeEEEEE
Confidence 5789999999986 777663 3789999999852 2356789999999999999999997773 456799999
Q ss_pred ecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccccc
Q 003542 287 ELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366 (811)
Q Consensus 287 Ey~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~ 366 (811)
||++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 83 e~~~~~l~~~l~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~-----~~kl~DfG~~~~ 152 (288)
T cd07871 83 EYLDSDLKQYLDNC-----GNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKG-----ELKLADFGLARA 152 (288)
T ss_pred eCCCcCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC-----CEEECcCcceee
Confidence 99999999888653 24578899999999999999999999999999999999998876 899999999875
Q ss_pred ccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHH
Q 003542 367 RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKN 446 (811)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~ 446 (811)
..... .......+++.|+|||++.+ ...++.++|||||||++|+|++|++||.+...... +...
T Consensus 153 ~~~~~-------~~~~~~~~~~~y~aPE~~~~--------~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~-~~~~ 216 (288)
T cd07871 153 KSVPT-------KTYSNEVVTLWYRPPDVLLG--------STEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEE-LHLI 216 (288)
T ss_pred ccCCC-------ccccCceecccccChHHhcC--------CcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHH
Confidence 43221 11234567899999999864 23678899999999999999999999976543221 1111
Q ss_pred HHh-CCC----------------CCC-----------CCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 447 IRA-GER----------------PLF-----------PSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 447 i~~-~~~----------------~~~-----------p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
... +.. ..+ ....+.++.+||.+||..||.+|||++++++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 217 FRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred HHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 100 000 001 1235677899999999999999999999976
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=318.33 Aligned_cols=242 Identities=22% Similarity=0.330 Sum_probs=202.3
Q ss_pred cceEEeeeecccc---eEEEE-EEcCCEEEEEEec------ccHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEE
Q 003542 216 KKLMVRRRLGASS---QFKEI-QWLGDSFVLRHFY------GELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLV 285 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v-~~~g~~VAVK~~~------~~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLV 285 (811)
+.|++.+.||+|. |++.+ ..+|+.||+|++. ...+.+.+|+.|.+.|+|||||++.+.+ .+....|||
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti--~~~~~~ylv 88 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI--QEESFHYLV 88 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhh--cccceeEEE
Confidence 5677777888884 33333 3589999999884 2578899999999999999999999887 556678999
Q ss_pred EecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccc
Q 003542 286 MELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS 364 (811)
Q Consensus 286 mEy~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA 364 (811)
+|+|.| +|...|... ..+++..+-++++||+.||.|+|.+||||||+||+|+|+..... ..-+||+|||+|
T Consensus 89 Fe~m~G~dl~~eIV~R------~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~--~A~vKL~~FGvA 160 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR------EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAK--GAAVKLADFGLA 160 (355)
T ss_pred EecccchHHHHHHHHH------HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccC--CCceeecccceE
Confidence 999996 787777654 56899999999999999999999999999999999999977642 237999999999
Q ss_pred ccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHH
Q 003542 365 TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMT 444 (811)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~ 444 (811)
...... ......+|||.|||||++... +|+..+|||+.|||||-|+.|.+||.+.+ ...++
T Consensus 161 i~l~~g--------~~~~G~~GtP~fmaPEvvrkd---------py~kpvDiW~cGViLfiLL~G~~PF~~~~--~~rly 221 (355)
T KOG0033|consen 161 IEVNDG--------EAWHGFAGTPGYLSPEVLKKD---------PYSKPVDIWACGVILYILLVGYPPFWDED--QHRLY 221 (355)
T ss_pred EEeCCc--------cccccccCCCcccCHHHhhcC---------CCCCcchhhhhhHHHHHHHhCCCCCCCcc--HHHHH
Confidence 887632 244678999999999999854 78899999999999999999999998743 44667
Q ss_pred HHHHhCCCC---CCCCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 445 KNIRAGERP---LFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 445 ~~i~~~~~~---~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
+.|..+... +.-...+++.++|+++||..||.+|+|+.|.++
T Consensus 222 e~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 222 EQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred HHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 788776532 233567889999999999999999999999987
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=322.64 Aligned_cols=240 Identities=18% Similarity=0.298 Sum_probs=190.1
Q ss_pred eEEeeeecccc---eEEEE-EEcCCEEEEEEecc-------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEE
Q 003542 218 LMVRRRLGASS---QFKEI-QWLGDSFVLRHFYG-------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVM 286 (811)
Q Consensus 218 ~~i~~~lG~G~---vyk~v-~~~g~~VAVK~~~~-------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVm 286 (811)
|++.+.||+|+ ||++. ..+|+.||||.+.. ....+.+|+.+|..++|+||+++++.+ .+.+.+|+||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~--~~~~~~~lv~ 79 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAY--ETKDALCLVL 79 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEE--ccCCeEEEEE
Confidence 66777788775 77766 34899999999853 123578899999999999999998777 4456799999
Q ss_pred ecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccc
Q 003542 287 ELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365 (811)
Q Consensus 287 Ey~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~ 365 (811)
|||++ +|..++... ....+++..+..++.||+.||.|||+.||+||||||+|||++.++ .+||+|||++.
T Consensus 80 e~~~~g~L~~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~-----~~kl~Dfg~~~ 150 (285)
T cd05631 80 TIMNGGDLKFHIYNM----GNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRG-----HIRISDLGLAV 150 (285)
T ss_pred EecCCCcHHHHHHhh----CCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCC-----CEEEeeCCCcE
Confidence 99995 787777542 124689999999999999999999999999999999999998776 89999999987
Q ss_pred cccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccch--HHH
Q 003542 366 ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQG--DKM 443 (811)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~--~~i 443 (811)
...... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||....... ..+
T Consensus 151 ~~~~~~--------~~~~~~g~~~y~aPE~~~~~---------~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~ 213 (285)
T cd05631 151 QIPEGE--------TVRGRVGTVGYMAPEVINNE---------KYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEV 213 (285)
T ss_pred EcCCCC--------eecCCCCCCCccCHhhhcCC---------CCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHH
Confidence 643221 12345689999999999743 67889999999999999999999998654321 122
Q ss_pred HHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCC-----HHHHHH
Q 003542 444 TKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPS-----FSSICR 486 (811)
Q Consensus 444 ~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS-----~~eIl~ 486 (811)
...+ ......++...+..+.+||.+||..||.+||+ ++++++
T Consensus 214 ~~~~-~~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 214 DRRV-KEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred HHHh-hcccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 2222 22233466778899999999999999999997 778776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=322.58 Aligned_cols=241 Identities=20% Similarity=0.302 Sum_probs=188.9
Q ss_pred ceEEeeeecccc---eEEEEE-EcCCEEEEEEecc------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEE
Q 003542 217 KLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVM 286 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVm 286 (811)
+|++.+.||+|+ ||++.. .+++.||||++.. ..+.+.+|+.+++.++||||+++++.+ .....+|+||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~~~~~~~lv~ 79 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAF--RRRGKLYLVF 79 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhE--ecCCEEEEEE
Confidence 688999999986 777654 3688999999853 245688999999999999999999777 4456799999
Q ss_pred ecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccccc
Q 003542 287 ELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366 (811)
Q Consensus 287 Ey~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~ 366 (811)
||+++++...+... ...+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+||+|||++..
T Consensus 80 e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~-----~~kl~Dfg~~~~ 149 (287)
T cd07848 80 EYVEKNMLELLEEM-----PNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHND-----VLKLCDFGFARN 149 (287)
T ss_pred ecCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-----cEEEeeccCccc
Confidence 99998777766542 25689999999999999999999999999999999999998776 899999999976
Q ss_pred ccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHH
Q 003542 367 RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKN 446 (811)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~ 446 (811)
...... .......||+.|+|||++.+. .++.++|||||||++|+|++|++||.+...... ...
T Consensus 150 ~~~~~~------~~~~~~~~~~~y~aPE~~~~~---------~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~-~~~- 212 (287)
T cd07848 150 LSEGSN------ANYTEYVATRWYRSPELLLGA---------PYGKAVDMWSVGCILGELSDGQPLFPGESEIDQ-LFT- 212 (287)
T ss_pred cccccc------ccccccccccccCCcHHHcCC---------CCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHH-HHH-
Confidence 533211 112245688999999999643 578899999999999999999999986542221 111
Q ss_pred HHh--CC-------------------CCC----------CCCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 447 IRA--GE-------------------RPL----------FPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 447 i~~--~~-------------------~~~----------~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
+.. +. .+. ....++..+.+||.+||+.||.+|||++++++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 213 IQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred HHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 100 00 000 01135677999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=354.78 Aligned_cols=254 Identities=27% Similarity=0.456 Sum_probs=209.3
Q ss_pred cceEEeeeecccc---eEEEEEE------cCCEEEEEEecc-----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCe
Q 003542 216 KKLMVRRRLGASS---QFKEIQW------LGDSFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKE 281 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~~------~g~~VAVK~~~~-----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~ 281 (811)
.+.++++.||+|. ||++... ....||||.++. ...+|++|+++|..|+|||||+|++++ .+++.
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC--~~~~P 563 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVC--REGDP 563 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEE--ccCCe
Confidence 4678889999994 4444422 345799999974 457899999999999999999999666 34567
Q ss_pred EEEEEecCC-CCHHHHHHHhhCCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCC
Q 003542 282 FFLVMELMS-KDLSCYMRETFGSR--------RRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEG 352 (811)
Q Consensus 282 ~yLVmEy~~-g~L~~~L~~~~~~~--------~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~ 352 (811)
+|+|+|||. |||.+||+...... ...+++..+.+.|+.|||.||.||-++.+|||||-..|+||..+
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~---- 639 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGEN---- 639 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccc----
Confidence 999999999 89999998753211 12348889999999999999999999999999999999999554
Q ss_pred cceEEEeeccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CCC
Q 003542 353 YFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKV 431 (811)
Q Consensus 353 ~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~~ 431 (811)
+.|||+||||++..=.... ........-+..|||||.+. +++||.+||||||||+|||+++ |+.
T Consensus 640 -l~VKIsDfGLsRdiYssDY-----Yk~~~~t~lPIRWMppEsIl---------y~kFTteSDVWs~GVvLWEIFsyG~Q 704 (774)
T KOG1026|consen 640 -LVVKISDFGLSRDIYSSDY-----YKVRGNTLLPIRWMPPESIL---------YGKFTTESDVWSFGVVLWEIFSYGKQ 704 (774)
T ss_pred -eEEEecccccchhhhhhhh-----hcccCCceeeeecCCHHHhh---------cCcccchhhhhhhhhhhhhhhccccC
Confidence 4999999999976532221 11112344578899999998 4589999999999999999998 999
Q ss_pred CCCCCccchHHHHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHHH
Q 003542 432 PFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIK 492 (811)
Q Consensus 432 PF~~~~~~~~~i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~ 492 (811)
||.+. ..++..+.+..|.....|.+||.++.+|+..||+.+|.+||+|.+|...|....
T Consensus 705 Py~gl--Sn~EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~ 763 (774)
T KOG1026|consen 705 PYYGL--SNQEVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWA 763 (774)
T ss_pred ccccc--chHHHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHH
Confidence 99985 455778999999888899999999999999999999999999999988776543
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=317.38 Aligned_cols=247 Identities=24% Similarity=0.413 Sum_probs=198.5
Q ss_pred hcceEEeeeecccc---eEEEEE----EcCCEEEEEEeccc-----HHHHHHHHHHHHhCCCCccceeeeeEEccCCCeE
Q 003542 215 LKKLMVRRRLGASS---QFKEIQ----WLGDSFVLRHFYGE-----LESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEF 282 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~----~~g~~VAVK~~~~~-----~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~ 282 (811)
.++|++.+.||+|+ ||++.. ..+..||+|.+... ...+.+|+.+|.+++||||+++++.+. ....+
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~ 81 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVIT--RGNTM 81 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEe--cCCCc
Confidence 35789999999986 676653 24668999998642 356889999999999999999997764 45679
Q ss_pred EEEEecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeec
Q 003542 283 FLVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGF 361 (811)
Q Consensus 283 yLVmEy~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DF 361 (811)
|+||||+++ +|.+++... ...+++..++.++.||+.||+|||+.|++||||||+|||++.++ .++|+||
T Consensus 82 ~lv~e~~~~~~L~~~l~~~-----~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~-----~~~l~df 151 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKH-----EGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDL-----VCKISGF 151 (266)
T ss_pred EEEEEeCCCCcHHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCC-----cEEECCC
Confidence 999999995 788777642 24689999999999999999999999999999999999998766 8999999
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CCCCCCCCccch
Q 003542 362 GLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQG 440 (811)
Q Consensus 362 GlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~~PF~~~~~~~ 440 (811)
|.+....... ........++..|+|||++.+. .++.++|||||||++||+++ |..||.+.. .
T Consensus 152 g~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~~l~ell~~g~~p~~~~~--~ 214 (266)
T cd05064 152 RRLQEDKSEA------IYTTMSGKSPVLWAAPEAIQYH---------HFSSASDVWSFGIVMWEVMSYGERPYWDMS--G 214 (266)
T ss_pred cccccccccc------hhcccCCCCceeecCHHHHhhC---------CccchhHHHHHHHHHHHHhcCCCCCcCcCC--H
Confidence 9875432211 0111233456789999998643 67889999999999999775 999997643 3
Q ss_pred HHHHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHH
Q 003542 441 DKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRY 490 (811)
Q Consensus 441 ~~i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~ 490 (811)
..+...+..+..++.|..++..+.+++.+||+.+|.+||++.+|.+.|..
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 215 QDVIKAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred HHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 34556666666666788899999999999999999999999999887754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=338.72 Aligned_cols=251 Identities=26% Similarity=0.412 Sum_probs=212.9
Q ss_pred hcceEEeeeecccceEEEE-----EEcCCEEEEEEecc------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEE
Q 003542 215 LKKLMVRRRLGASSQFKEI-----QWLGDSFVLRHFYG------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFF 283 (811)
Q Consensus 215 ~k~~~i~~~lG~G~vyk~v-----~~~g~~VAVK~~~~------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~y 283 (811)
++.|..++.+|+| .|+.. ...+..|++|.+.- .......|+.+++++.|||||.+++.|. +++..++
T Consensus 3 m~~Ye~~~~iG~G-afG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~-~~~~~l~ 80 (426)
T KOG0589|consen 3 MDNYEVLRQVGRG-AFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFE-EDGQLLC 80 (426)
T ss_pred cchhhhhhhcCcc-ccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchh-cCCceEE
Confidence 3678889999999 56655 23678999999842 4457899999999999999999999995 3344599
Q ss_pred EEEecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecc
Q 003542 284 LVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFG 362 (811)
Q Consensus 284 LVmEy~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFG 362 (811)
|||+||+| +|.+.|... +...|+++.+..|+.||+.|+.|||+++|+|||||+.||+++.++ .|||+|||
T Consensus 81 Ivm~Y~eGg~l~~~i~~~----k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~-----~VkLgDfG 151 (426)
T KOG0589|consen 81 IVMEYCEGGDLAQLIKEQ----KGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDK-----KVKLGDFG 151 (426)
T ss_pred EEEeecCCCCHHHHHHHH----hhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccC-----ceeecchh
Confidence 99999995 888888764 246799999999999999999999999999999999999999887 78999999
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHH
Q 003542 363 LSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDK 442 (811)
Q Consensus 363 lA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~ 442 (811)
+|+.+.... ....+.+||+.|++||++.+. +|+.|+|||||||++|||++-+++|.+.+.. .
T Consensus 152 laK~l~~~~-------~~a~tvvGTp~YmcPEil~d~---------pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~--~ 213 (426)
T KOG0589|consen 152 LAKILNPED-------SLASTVVGTPYYMCPEILSDI---------PYNEKSDIWSLGCCLYEMCTLKPAFKASNMS--E 213 (426)
T ss_pred hhhhcCCch-------hhhheecCCCcccCHHHhCCC---------CCCccCcchhhcchHHHHHhcccccCccchH--H
Confidence 999876542 234578999999999999865 8999999999999999999999999986654 4
Q ss_pred HHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHHHHHh
Q 003542 443 MTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKKFM 495 (811)
Q Consensus 443 i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~k~l 495 (811)
+...|..+...+.|...+.+++.||..||..+|..||++.+++.. ..+.+.+
T Consensus 214 Li~ki~~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~-P~l~~~~ 265 (426)
T KOG0589|consen 214 LILKINRGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR-PHLLRYL 265 (426)
T ss_pred HHHHHhhccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC-hhhhhHH
Confidence 455666666677889999999999999999999999999999986 4454444
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=331.57 Aligned_cols=238 Identities=21% Similarity=0.294 Sum_probs=195.4
Q ss_pred HhcceEEeeeecccc---eEEEEEE-c-CCEEEEEEecc-------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCe
Q 003542 214 LLKKLMVRRRLGASS---QFKEIQW-L-GDSFVLRHFYG-------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKE 281 (811)
Q Consensus 214 l~k~~~i~~~lG~G~---vyk~v~~-~-g~~VAVK~~~~-------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~ 281 (811)
..++|++.+.||.|+ ||++... . +..||+|.+.. ..+.+.+|+.+|..++||||+++++.+. +...
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~--~~~~ 105 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFK--DESY 105 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEE--eCCE
Confidence 346799999999986 6776533 2 36899999842 3456889999999999999999998774 4567
Q ss_pred EEEEEecCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEee
Q 003542 282 FFLVMELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSG 360 (811)
Q Consensus 282 ~yLVmEy~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~D 360 (811)
+|+|||||+ |+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++ .+||+|
T Consensus 106 ~~lv~Ey~~~g~L~~~i~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~-----~ikL~D 174 (340)
T PTZ00426 106 LYLVLEFVIGGEFFTFLRRN------KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDG-----FIKMTD 174 (340)
T ss_pred EEEEEeCCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCC-----CEEEec
Confidence 999999998 5898888753 5689999999999999999999999999999999999998776 899999
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccch
Q 003542 361 FGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQG 440 (811)
Q Consensus 361 FGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~ 440 (811)
||++...... .....||+.|+|||++.+. .++.++|||||||++|||++|..||.+...
T Consensus 175 FG~a~~~~~~----------~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-- 233 (340)
T PTZ00426 175 FGFAKVVDTR----------TYTLCGTPEYIAPEILLNV---------GHGKAADWWTLGIFIYEILVGCPPFYANEP-- 233 (340)
T ss_pred CCCCeecCCC----------cceecCChhhcCHHHHhCC---------CCCccccccchhhHHHHHhcCCCCCCCCCH--
Confidence 9998765321 1345789999999999753 578899999999999999999999986432
Q ss_pred HHHHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCC-----CHHHHHH
Q 003542 441 DKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRP-----SFSSICR 486 (811)
Q Consensus 441 ~~i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RP-----S~~eIl~ 486 (811)
......+..+. ..+|...++.+.++|.+||+.||.+|+ +++++++
T Consensus 234 ~~~~~~i~~~~-~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 234 LLIYQKILEGI-IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred HHHHHHHhcCC-CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 23344554443 346777888999999999999999995 7888876
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=328.49 Aligned_cols=227 Identities=21% Similarity=0.354 Sum_probs=183.6
Q ss_pred cccceEEEEEE-cCCEEEEEEecc-------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEecCCC-CHHH
Q 003542 225 GASSQFKEIQW-LGDSFVLRHFYG-------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSC 295 (811)
Q Consensus 225 G~G~vyk~v~~-~g~~VAVK~~~~-------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~~g-~L~~ 295 (811)
|.|.||++... +++.||+|.+.. ....+.+|+.+|.+++||||+++++.+ .+...+|+|||||+| +|.+
T Consensus 5 ~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~~~~~~~lv~e~~~~g~L~~ 82 (312)
T cd05585 5 SFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSF--QSPEKLYLVLAFINGGELFH 82 (312)
T ss_pred CCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEE--ecCCeEEEEEcCCCCCcHHH
Confidence 33447876643 688999999853 345678899999999999999998777 445679999999995 8988
Q ss_pred HHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccccccCCCCC
Q 003542 296 YMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTP 375 (811)
Q Consensus 296 ~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~~~~~~ 375 (811)
++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus 83 ~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~-----~~kl~Dfg~~~~~~~~~---- 147 (312)
T cd05585 83 HLQRE------GRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQG-----HIALCDFGLCKLNMKDD---- 147 (312)
T ss_pred HHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCC-----cEEEEECcccccCccCC----
Confidence 88753 5689999999999999999999999999999999999998776 89999999987532221
Q ss_pred CCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHHHHhCCCCCC
Q 003542 376 PASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLF 455 (811)
Q Consensus 376 ~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i~~~~~~~~ 455 (811)
.......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+... ..+...+... ...+
T Consensus 148 ---~~~~~~~gt~~y~aPE~~~~~---------~~~~~~DvwslGvil~el~tg~~pf~~~~~--~~~~~~~~~~-~~~~ 212 (312)
T cd05585 148 ---DKTNTFCGTPEYLAPELLLGH---------GYTKAVDWWTLGVLLYEMLTGLPPFYDENV--NEMYRKILQE-PLRF 212 (312)
T ss_pred ---CccccccCCcccCCHHHHcCC---------CCCCccceechhHHHHHHHhCCCCcCCCCH--HHHHHHHHcC-CCCC
Confidence 122345689999999999743 678999999999999999999999986543 2334444433 3456
Q ss_pred CCCChHHHHHHHhhhccCCCCCCCCHHH
Q 003542 456 PSGSPKYLVNLTKKCWHTNPSQRPSFSS 483 (811)
Q Consensus 456 p~~~~~~l~~LI~~cL~~DP~~RPS~~e 483 (811)
|...++.+.+||.+||..||.+||++..
T Consensus 213 ~~~~~~~~~~li~~~L~~dp~~R~~~~~ 240 (312)
T cd05585 213 PDGFDRDAKDLLIGLLSRDPTRRLGYNG 240 (312)
T ss_pred CCcCCHHHHHHHHHHcCCCHHHcCCCCC
Confidence 7788999999999999999999986433
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=335.85 Aligned_cols=255 Identities=24% Similarity=0.431 Sum_probs=199.6
Q ss_pred hcceEEeeeecccc---eEEEEEE------cCCEEEEEEecc-----cHHHHHHHHHHHHhC-CCCccceeeeeEEccCC
Q 003542 215 LKKLMVRRRLGASS---QFKEIQW------LGDSFVLRHFYG-----ELESLNAEISTMLSL-SHPNIVQYLCGFCDEEK 279 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~~------~g~~VAVK~~~~-----~~~~~~~Ei~iL~~L-~HPNIVkl~~~~~~e~~ 279 (811)
.++|++.+.||+|+ ||++... .+..||||.+.. ....+.+|+.+|+.+ +||||+++++.+ ...
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~--~~~ 114 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGAC--THG 114 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEe--cCC
Confidence 45789999999986 6665522 235799999964 245688999999999 899999999776 345
Q ss_pred CeEEEEEecCC-CCHHHHHHHhhC--------------------------------------------------------
Q 003542 280 KEFFLVMELMS-KDLSCYMRETFG-------------------------------------------------------- 302 (811)
Q Consensus 280 ~~~yLVmEy~~-g~L~~~L~~~~~-------------------------------------------------------- 302 (811)
+.+|+|||||+ |+|.+++.....
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 67999999999 599999865311
Q ss_pred --------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccccccCCCC
Q 003542 303 --------SRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNT 374 (811)
Q Consensus 303 --------~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~~~~~ 374 (811)
......+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++........
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~-----~~kL~DfGla~~~~~~~~-- 267 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGR-----VAKICDFGLARDIMNDSN-- 267 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCC-----eEEEeeceeeeeccCCcc--
Confidence 00123578899999999999999999999999999999999998765 899999999876533211
Q ss_pred CCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CCCCCCCCccchHHHHHHHHhCCCC
Q 003542 375 PPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGDKMTKNIRAGERP 453 (811)
Q Consensus 375 ~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~~PF~~~~~~~~~i~~~i~~~~~~ 453 (811)
........+++.|+|||++.+. .++.++|||||||++|+|++ |+.||...... ..+...+..+..+
T Consensus 268 ---~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~-~~~~~~~~~~~~~ 334 (374)
T cd05106 268 ---YVVKGNARLPVKWMAPESIFDC---------VYTVQSDVWSYGILLWEIFSLGKSPYPGILVN-SKFYKMVKRGYQM 334 (374)
T ss_pred ---eeeccCCCCccceeCHHHhcCC---------CCCccccHHHHHHHHHHHHhCCCCCCcccccc-HHHHHHHHcccCc
Confidence 1111233456779999998643 68899999999999999997 99999865432 2344445555555
Q ss_pred CCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHH
Q 003542 454 LFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYI 491 (811)
Q Consensus 454 ~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i 491 (811)
..+...++++.++|.+||+.||.+|||+.+|++.|+.+
T Consensus 335 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 335 SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 56677789999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=338.60 Aligned_cols=245 Identities=23% Similarity=0.418 Sum_probs=206.0
Q ss_pred ceEEeeeecccc---eEEEE-EEcCCEEEEEEec-----ccHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEe
Q 003542 217 KLMVRRRLGASS---QFKEI-QWLGDSFVLRHFY-----GELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVME 287 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v-~~~g~~VAVK~~~-----~~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmE 287 (811)
.|.....||+|+ ||++. ..+++.||+|++. .+.+++++|+.+|.+++|+||.++|+.|.. +..++|+||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~--g~~LwiiMe 91 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLK--GTKLWIIME 91 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheee--cccHHHHHH
Confidence 345556677775 88877 5689999999994 367889999999999999999999988864 445999999
Q ss_pred cCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccccc
Q 003542 288 LMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366 (811)
Q Consensus 288 y~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~ 366 (811)
||.| ++.+.|... ..+.+..+..++++++.||.|||.++.+|||||+.|||+...| .+||+|||.+..
T Consensus 92 y~~gGsv~~lL~~~------~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g-----~vkl~DfgVa~q 160 (467)
T KOG0201|consen 92 YCGGGSVLDLLKSG------NILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESG-----DVKLADFGVAGQ 160 (467)
T ss_pred HhcCcchhhhhccC------CCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccC-----cEEEEecceeee
Confidence 9995 777777542 4558889999999999999999999999999999999999887 899999999987
Q ss_pred ccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHH
Q 003542 367 RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKN 446 (811)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~ 446 (811)
..... ....+.+||+.|||||++.+. .|+.++||||||++.+||++|.+||.+.+.. .....
T Consensus 161 l~~~~-------~rr~tfvGTPfwMAPEVI~~~---------~Y~~KADIWSLGITaiEla~GePP~s~~hPm--rvlfl 222 (467)
T KOG0201|consen 161 LTNTV-------KRRKTFVGTPFWMAPEVIKQS---------GYDTKADIWSLGITAIELAKGEPPHSKLHPM--RVLFL 222 (467)
T ss_pred eechh-------hccccccccccccchhhhccc---------cccchhhhhhhhHHHHHHhcCCCCCcccCcc--eEEEe
Confidence 76543 233688999999999999854 7899999999999999999999999887653 23344
Q ss_pred HHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHHHH
Q 003542 447 IRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKK 493 (811)
Q Consensus 447 i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~k 493 (811)
|-+..+|.+...+++.+++|+..||..||+.||++.++++ .++|++
T Consensus 223 Ipk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK-h~FIk~ 268 (467)
T KOG0201|consen 223 IPKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK-HKFIKR 268 (467)
T ss_pred ccCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhh-hHHHHh
Confidence 5556666667788999999999999999999999999998 666665
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=328.57 Aligned_cols=238 Identities=21% Similarity=0.321 Sum_probs=193.2
Q ss_pred cceEEeeeecccc---eEEEEEE-cCCEEEEEEecc-------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEE
Q 003542 216 KKLMVRRRLGASS---QFKEIQW-LGDSFVLRHFYG-------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFL 284 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~~-~g~~VAVK~~~~-------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yL 284 (811)
++|++.+.||.|+ ||++... +|+.||||++.. ....+.+|+.+|..++||||+++++.+ .....+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~--~~~~~~~l 78 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAF--QDDEYLYL 78 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEE--EcCCEEEE
Confidence 3688999999986 7776643 689999999953 345688999999999999999999777 45668999
Q ss_pred EEecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccc
Q 003542 285 VMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGL 363 (811)
Q Consensus 285 VmEy~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGl 363 (811)
|||||+| +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 79 v~e~~~g~~L~~~l~~~------~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~-----~~kL~Dfg~ 147 (333)
T cd05600 79 AMEYVPGGDFRTLLNNL------GVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASG-----HIKLTDFGL 147 (333)
T ss_pred EEeCCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC-----CEEEEeCcC
Confidence 9999985 899888653 5689999999999999999999999999999999999998876 899999999
Q ss_pred cccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHH
Q 003542 364 STARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKM 443 (811)
Q Consensus 364 A~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i 443 (811)
+..... ......||+.|+|||++.+. .++.++|||||||++|||++|..||...... ..
T Consensus 148 a~~~~~----------~~~~~~gt~~y~aPE~~~~~---------~~~~~~DvwslG~il~ell~g~~pf~~~~~~--~~ 206 (333)
T cd05600 148 SKGIVT----------YANSVVGSPDYMAPEVLRGK---------GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPN--ET 206 (333)
T ss_pred Cccccc----------ccCCcccCccccChhHhcCC---------CCCCccceecchHHHhhhhhCCCCCCCCCHH--HH
Confidence 875432 12355789999999999743 6789999999999999999999999865432 22
Q ss_pred HHHHHhCC----CCCCC---CCChHHHHHHHhhhccCCCCCCCCHHHHHHH
Q 003542 444 TKNIRAGE----RPLFP---SGSPKYLVNLTKKCWHTNPSQRPSFSSICRI 487 (811)
Q Consensus 444 ~~~i~~~~----~~~~p---~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~ 487 (811)
...+.... .+... ..++.++.+||.+||..+|.+||++.+++++
T Consensus 207 ~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 207 WENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred HHHHHhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 23332211 11111 2457889999999999999999999999873
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=312.61 Aligned_cols=248 Identities=22% Similarity=0.443 Sum_probs=201.3
Q ss_pred hcceEEeeeecccc---eEEEEEEcCCEEEEEEecc---cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEec
Q 003542 215 LKKLMVRRRLGASS---QFKEIQWLGDSFVLRHFYG---ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMEL 288 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~~~g~~VAVK~~~~---~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy 288 (811)
.++|++.++||.|+ +|++....+..||+|.+.. ..+.+.+|+.+++.++||||+++++.+ ......|+||||
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~lv~e~ 82 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVV--TKEEPIYIITEY 82 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEE--cCCCCcEEEEec
Confidence 36789999999986 8887766788999999864 356789999999999999999998766 345668999999
Q ss_pred CC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccc
Q 003542 289 MS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTAR 367 (811)
Q Consensus 289 ~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~ 367 (811)
++ ++|.+++... ....+++..++.++.|++.||.|||+.+++||||||+||+++.++ .++|+|||++...
T Consensus 83 ~~~~~L~~~l~~~----~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~-----~~~l~dfg~~~~~ 153 (261)
T cd05072 83 MAKGSLLDFLKSD----EGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESL-----MCKIADFGLARVI 153 (261)
T ss_pred CCCCcHHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCC-----cEEECCCccceec
Confidence 98 5999988753 224688899999999999999999999999999999999998776 8999999999765
Q ss_pred cccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CCCCCCCCccchHHHHHH
Q 003542 368 TYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGDKMTKN 446 (811)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~~PF~~~~~~~~~i~~~ 446 (811)
..... .......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.. .......
T Consensus 154 ~~~~~------~~~~~~~~~~~y~aPE~~~~---------~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~--~~~~~~~ 216 (261)
T cd05072 154 EDNEY------TAREGAKFPIKWTAPEAINF---------GSFTIKSDVWSFGILLYEIVTYGKIPYPGMS--NSDVMSA 216 (261)
T ss_pred CCCce------eccCCCccceecCCHHHhcc---------CCCChhhhhhhhHHHHHHHHccCCCCCCCCC--HHHHHHH
Confidence 43211 11123345678999999864 257889999999999999998 999997643 2234455
Q ss_pred HHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHH
Q 003542 447 IRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRY 490 (811)
Q Consensus 447 i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~ 490 (811)
+..+...+.+..++.++.+++.+||..+|.+||+++++.+.|+.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 217 LQRGYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred HHcCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 55555555556788899999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=326.57 Aligned_cols=242 Identities=22% Similarity=0.322 Sum_probs=192.1
Q ss_pred ceEEeeeecccc---eEEEEE----EcCCEEEEEEecc--------cHHHHHHHHHHHHhC-CCCccceeeeeEEccCCC
Q 003542 217 KLMVRRRLGASS---QFKEIQ----WLGDSFVLRHFYG--------ELESLNAEISTMLSL-SHPNIVQYLCGFCDEEKK 280 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v~----~~g~~VAVK~~~~--------~~~~~~~Ei~iL~~L-~HPNIVkl~~~~~~e~~~ 280 (811)
+|++.+.||+|+ ||.+.. .+|+.||+|++.. ..+.+..|+.+|..+ +||||+++++.+ +...
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~--~~~~ 78 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF--QTEA 78 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE--ecCC
Confidence 478888999986 665543 2688999999853 235678899999999 599999998777 4556
Q ss_pred eEEEEEecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEe
Q 003542 281 EFFLVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVS 359 (811)
Q Consensus 281 ~~yLVmEy~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~ 359 (811)
.+|+|||||+| +|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+
T Consensus 79 ~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~-----~~kl~ 147 (332)
T cd05614 79 KLHLILDYVSGGEMFTHLYQR------DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEG-----HVVLT 147 (332)
T ss_pred EEEEEEeCCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCC-----CEEEe
Confidence 79999999995 898888753 5689999999999999999999999999999999999998876 89999
Q ss_pred eccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCcc-
Q 003542 360 GFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHL- 438 (811)
Q Consensus 360 DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~- 438 (811)
|||++........ .......||+.|+|||++.+. ..++.++|||||||++|||++|..||.....
T Consensus 148 DfG~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~--------~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 213 (332)
T cd05614 148 DFGLSKEFLSEEK------ERTYSFCGTIEYMAPEIIRGK--------GGHGKAVDWWSLGILIFELLTGASPFTLEGER 213 (332)
T ss_pred eCcCCccccccCC------CccccccCCccccCHHHhcCC--------CCCCCccccccchhhhhhhhcCCCCCCCCCCC
Confidence 9999876433211 112345689999999999742 2467899999999999999999999964322
Q ss_pred -chHHHHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCC-----CHHHHHH
Q 003542 439 -QGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRP-----SFSSICR 486 (811)
Q Consensus 439 -~~~~i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RP-----S~~eIl~ 486 (811)
....+...+.. ..+.++...++.+.+++.+||..||.+|| +++++++
T Consensus 214 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 214 NTQSEVSRRILK-CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred CCHHHHHHHHhc-CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 22233333333 34556778899999999999999999999 6667765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=311.49 Aligned_cols=244 Identities=27% Similarity=0.470 Sum_probs=197.9
Q ss_pred cceEEeeeecccc---eEEEEEEcCCEEEEEEecc---cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEecC
Q 003542 216 KKLMVRRRLGASS---QFKEIQWLGDSFVLRHFYG---ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELM 289 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~~~g~~VAVK~~~~---~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~ 289 (811)
++|++.+.||+|+ +|.+....+..+|+|.+.. ....+.+|+.+|+.++||||+++++.+ .....+|+||||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~iv~e~~ 81 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVC--TQQKPLYIVTEFM 81 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEE--ccCCCEEEEEEcC
Confidence 4688888899986 7776555677999999864 346789999999999999999999766 4456799999999
Q ss_pred C-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccccccc
Q 003542 290 S-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTART 368 (811)
Q Consensus 290 ~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~ 368 (811)
+ |+|.+++... ...+++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+|||++....
T Consensus 82 ~~~~L~~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~-----~~kl~d~g~~~~~~ 151 (256)
T cd05114 82 ENGCLLNYLRQR-----QGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTG-----VVKVSDFGMTRYVL 151 (256)
T ss_pred CCCcHHHHHHhC-----ccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCC-----eEEECCCCCccccC
Confidence 8 5898888642 14588999999999999999999999999999999999998766 89999999987543
Q ss_pred ccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CCCCCCCCccchHHHHHHH
Q 003542 369 YASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGDKMTKNI 447 (811)
Q Consensus 369 ~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~~PF~~~~~~~~~i~~~i 447 (811)
.... .......++..|+|||++.+. .++.++||||||+++|+|++ |+.||.... .......+
T Consensus 152 ~~~~------~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~s~G~~l~el~~~g~~p~~~~~--~~~~~~~i 214 (256)
T cd05114 152 DDEY------TSSSGAKFPVKWSPPEVFNFS---------KYSSKSDVWSFGVLMWEVFTEGKMPFEKKS--NYEVVEMI 214 (256)
T ss_pred CCce------eccCCCCCchhhCChhhcccC---------ccchhhhhHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHH
Confidence 2211 111233456679999998643 57889999999999999999 999997643 23445566
Q ss_pred HhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHH
Q 003542 448 RAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRIL 488 (811)
Q Consensus 448 ~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L 488 (811)
..+..+..|...+..+.+|+.+||..+|.+||++.++++.|
T Consensus 215 ~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 215 SRGFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred HCCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 66666666777888999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=330.23 Aligned_cols=246 Identities=22% Similarity=0.363 Sum_probs=194.6
Q ss_pred cceEEeeeecccc---eEEEEEE-cCCEEEEEEecc-------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEE
Q 003542 216 KKLMVRRRLGASS---QFKEIQW-LGDSFVLRHFYG-------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFL 284 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~~-~g~~VAVK~~~~-------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yL 284 (811)
++|.+.+.||.|+ ||++... +|+.||||++.. ....+.+|+.+|..++||||+++++.+ .+...+|+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~--~~~~~~~l 78 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSF--QDEEHLYL 78 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhe--ecCCeEEE
Confidence 3688889999886 6766533 799999999853 345688999999999999999999777 45668999
Q ss_pred EEecCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccc
Q 003542 285 VMELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGL 363 (811)
Q Consensus 285 VmEy~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGl 363 (811)
|||||+ ++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+||+|||+
T Consensus 79 v~e~~~~~~L~~~l~~~------~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~-----~~kL~Dfg~ 147 (350)
T cd05573 79 VMEYMPGGDLMNLLIRK------DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADG-----HIKLADFGL 147 (350)
T ss_pred EEcCCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC-----CEEeecCCC
Confidence 999998 4899988753 5789999999999999999999999999999999999998876 899999999
Q ss_pred cccccccCCC----------------------CCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchh
Q 003542 364 STARTYASRN----------------------TPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGM 421 (811)
Q Consensus 364 A~~~~~~~~~----------------------~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGv 421 (811)
+......... ............||+.|+|||++.+. .++.++|||||||
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwSlG~ 218 (350)
T cd05573 148 CKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT---------PYGLECDWWSLGV 218 (350)
T ss_pred CccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCC---------CCCCceeeEecch
Confidence 8765433200 00000122345789999999999753 6789999999999
Q ss_pred HHHHHhhCCCCCCCCccchHHHHHHHHh-CCCCCCCC--CChHHHHHHHhhhccCCCCCCCC-HHHHHH
Q 003542 422 LCFELLTGKVPFEDGHLQGDKMTKNIRA-GERPLFPS--GSPKYLVNLTKKCWHTNPSQRPS-FSSICR 486 (811)
Q Consensus 422 ILyELltG~~PF~~~~~~~~~i~~~i~~-~~~~~~p~--~~~~~l~~LI~~cL~~DP~~RPS-~~eIl~ 486 (811)
++|+|++|+.||...... .....+.. .....+|. .+++.+.+||.+||. ||.+||+ +.++++
T Consensus 219 il~ell~g~~Pf~~~~~~--~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~ 284 (350)
T cd05573 219 ILYEMLYGFPPFYSDTLQ--ETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKS 284 (350)
T ss_pred hhhhhccCCCCCCCCCHH--HHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence 999999999999875422 22333333 12222332 358999999999997 9999999 999976
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=313.00 Aligned_cols=249 Identities=29% Similarity=0.508 Sum_probs=201.4
Q ss_pred hcceEEeeeecccc---eEEEEE-EcCCEEEEEEeccc---HHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEe
Q 003542 215 LKKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYGE---LESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVME 287 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~~---~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmE 287 (811)
..+|.+.+.||.|+ +|+++. ..++.||+|.+... ...+.+|+.+++.++||||+++++.+. ....+++|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e 82 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT--REPPFYIITE 82 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEc--CCCCcEEEEE
Confidence 35688889999885 677663 36889999998643 457899999999999999999997663 3456899999
Q ss_pred cCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccccc
Q 003542 288 LMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366 (811)
Q Consensus 288 y~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~ 366 (811)
|++ ++|.+++... ....+++..++.++.|++.||.|||++|++||||||+|||++.++ .+||+|||++..
T Consensus 83 ~~~~~~L~~~~~~~----~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~-----~~kl~df~~~~~ 153 (263)
T cd05052 83 FMTYGNLLDYLREC----NRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-----LVKVADFGLSRL 153 (263)
T ss_pred eCCCCcHHHHHHhC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCC-----cEEeCCCccccc
Confidence 998 5899888653 224688999999999999999999999999999999999998776 899999999876
Q ss_pred ccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CCCCCCCCccchHHHHH
Q 003542 367 RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGDKMTK 445 (811)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~~PF~~~~~~~~~i~~ 445 (811)
...... .......++..|+|||.+.+. .++.++|||||||++|||++ |..||.+... .....
T Consensus 154 ~~~~~~------~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--~~~~~ 216 (263)
T cd05052 154 MTGDTY------TAHAGAKFPIKWTAPESLAYN---------KFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQVYE 216 (263)
T ss_pred ccccee------eccCCCCCccccCCHHHhccC---------CCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHH
Confidence 543211 111223346679999998643 67889999999999999998 9999976432 34455
Q ss_pred HHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHH
Q 003542 446 NIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYI 491 (811)
Q Consensus 446 ~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i 491 (811)
.+..+..+..+..++..+.++|.+||..||++||++.++++.|+.+
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 217 LLEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 5666666677888999999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=328.80 Aligned_cols=231 Identities=22% Similarity=0.336 Sum_probs=186.5
Q ss_pred eccc---ceEEEE-EEcCCEEEEEEecc-------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEecCCC-
Q 003542 224 LGAS---SQFKEI-QWLGDSFVLRHFYG-------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK- 291 (811)
Q Consensus 224 lG~G---~vyk~v-~~~g~~VAVK~~~~-------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~~g- 291 (811)
||+| .||.+. ..+|+.||||++.. ....+.+|+.+|+.++||||+++++.+ .....+||||||+++
T Consensus 3 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~--~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSF--QTKDRLCFVMEYVNGG 80 (328)
T ss_pred eeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE--EcCCEEEEEEeCCCCC
Confidence 4555 477765 34789999999953 345678899999999999999998777 455679999999995
Q ss_pred CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccccccC
Q 003542 292 DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYAS 371 (811)
Q Consensus 292 ~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~~ 371 (811)
+|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus 81 ~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~-----~~kL~DfG~~~~~~~~~ 149 (328)
T cd05593 81 ELFFHLSRE------RVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDG-----HIKITDFGLCKEGITDA 149 (328)
T ss_pred CHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCC-----cEEEecCcCCccCCCcc
Confidence 888777643 5689999999999999999999999999999999999998776 89999999987532211
Q ss_pred CCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHHHHhCC
Q 003542 372 RNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGE 451 (811)
Q Consensus 372 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i~~~~ 451 (811)
.......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+... ......+.. .
T Consensus 150 -------~~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslGvil~elltG~~Pf~~~~~--~~~~~~~~~-~ 210 (328)
T cd05593 150 -------ATMKTFCGTPEYLAPEVLEDN---------DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--EKLFELILM-E 210 (328)
T ss_pred -------cccccccCCcCccChhhhcCC---------CCCccCCccccchHHHHHhhCCCCCCCCCH--HHHHHHhcc-C
Confidence 112345689999999999643 678999999999999999999999976432 233333333 3
Q ss_pred CCCCCCCChHHHHHHHhhhccCCCCCCC-----CHHHHHH
Q 003542 452 RPLFPSGSPKYLVNLTKKCWHTNPSQRP-----SFSSICR 486 (811)
Q Consensus 452 ~~~~p~~~~~~l~~LI~~cL~~DP~~RP-----S~~eIl~ 486 (811)
...+|...+.++.+||.+||..||.+|| ++.++++
T Consensus 211 ~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 211 DIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred CccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence 3456778899999999999999999997 7888876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=331.47 Aligned_cols=246 Identities=19% Similarity=0.322 Sum_probs=191.2
Q ss_pred cceEEeeeecccc---eEEEEE-EcCCEEEEEEecc-------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEE
Q 003542 216 KKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG-------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFL 284 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~-------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yL 284 (811)
++|++++.||.|+ ||.+.. .+|+.||||++.. ....+.+|+.+|..++||||+++++.+ .+...+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~--~~~~~~~l 78 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSF--QDENYLYL 78 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE--EcCCeEEE
Confidence 3688899999986 666553 3789999999953 235578899999999999999999777 45668999
Q ss_pred EEecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccc
Q 003542 285 VMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGL 363 (811)
Q Consensus 285 VmEy~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGl 363 (811)
|||||+| +|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 79 v~E~~~~g~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~-----~~kl~Dfg~ 147 (364)
T cd05599 79 IMEYLPGGDMMTLLMKK------DTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKG-----HIKLSDFGL 147 (364)
T ss_pred EECCCCCcHHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC-----CEEEeeccc
Confidence 9999984 888888753 5689999999999999999999999999999999999998877 899999999
Q ss_pred cccccccCCCCCC-------------------------------CCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCc
Q 003542 364 STARTYASRNTPP-------------------------------ASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSE 412 (811)
Q Consensus 364 A~~~~~~~~~~~~-------------------------------~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ 412 (811)
+............ .........||+.|+|||++.+. .++.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~ 218 (364)
T cd05599 148 CTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT---------GYNK 218 (364)
T ss_pred ceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCC---------CCCC
Confidence 8754322110000 00011234699999999998643 6789
Q ss_pred ccceecchhHHHHHhhCCCCCCCCccchHHHHHHHHhC-CCCCCCC--CChHHHHHHHhhhccCCCCCCCC---HHHHHH
Q 003542 413 KADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAG-ERPLFPS--GSPKYLVNLTKKCWHTNPSQRPS---FSSICR 486 (811)
Q Consensus 413 ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i~~~-~~~~~p~--~~~~~l~~LI~~cL~~DP~~RPS---~~eIl~ 486 (811)
++|||||||++|||++|..||.+.... .....+... ....+|. .+++.+.+||.+|+. +|.+|++ +.+++.
T Consensus 219 ~~DiwSlG~il~el~~G~~Pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 219 ECDWWSLGVIMYEMLVGYPPFCSDNPQ--ETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred eeeeecchhHHHHhhcCCCCCCCCCHH--HHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 999999999999999999999865432 233333332 2223333 457889999999996 9999998 887765
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=316.10 Aligned_cols=252 Identities=25% Similarity=0.400 Sum_probs=201.0
Q ss_pred cceEEeeeecccc---eEEEEEEc------CCEEEEEEecc-----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCe
Q 003542 216 KKLMVRRRLGASS---QFKEIQWL------GDSFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKE 281 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~~~------g~~VAVK~~~~-----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~ 281 (811)
.+|++.+.||+|+ ||++.... +..||+|.+.. ....+.+|+.+|..++||||+++++.+. ....
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~--~~~~ 82 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCT--KEQP 82 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEc--CCCc
Confidence 4678888888875 77766432 25799999963 2356889999999999999999997663 3456
Q ss_pred EEEEEecCC-CCHHHHHHHhhCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCC
Q 003542 282 FFLVMELMS-KDLSCYMRETFGS----------RRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSM 350 (811)
Q Consensus 282 ~yLVmEy~~-g~L~~~L~~~~~~----------~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~ 350 (811)
.|++|||++ ++|.+++...... .....+++..++.++.||+.||.|||++|++||||||+|||++.++
T Consensus 83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~- 161 (283)
T cd05048 83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGL- 161 (283)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCC-
Confidence 899999998 5999998764211 0114578899999999999999999999999999999999998776
Q ss_pred CCcceEEEeeccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-C
Q 003542 351 EGYFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-G 429 (811)
Q Consensus 351 d~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G 429 (811)
.++|+|||++........ ........+++.|+|||.+.+ ..++.++|||||||++|||++ |
T Consensus 162 ----~~~L~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~---------~~~~~~sDv~slG~il~el~~~g 223 (283)
T cd05048 162 ----TVKISDFGLSRDIYSADY-----YRVQSKSLLPVRWMPPEAILY---------GKFTTESDIWSFGVVLWEIFSYG 223 (283)
T ss_pred ----cEEECCCcceeecccccc-----ccccCCCcccccccCHHHhcc---------CcCchhhhHHHHHHHHHHHHcCC
Confidence 899999999875432211 111223456788999999864 367889999999999999998 9
Q ss_pred CCCCCCCccchHHHHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHH
Q 003542 430 KVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRY 490 (811)
Q Consensus 430 ~~PF~~~~~~~~~i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~ 490 (811)
..||.+... ..+...+..+..+..+..++..+.+|+.+||+.||.+||++.+|++.|..
T Consensus 224 ~~p~~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 224 LQPYYGFSN--QEVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred CCCCCCCCH--HHHHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 999986543 34556677777677788899999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=343.67 Aligned_cols=246 Identities=21% Similarity=0.331 Sum_probs=200.2
Q ss_pred cceEEeeeecccc---eEEEEEE-c-CCEEEEEEecc----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEE
Q 003542 216 KKLMVRRRLGASS---QFKEIQW-L-GDSFVLRHFYG----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVM 286 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~~-~-g~~VAVK~~~~----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVm 286 (811)
..|.+.+.||+|+ +|.+... + +..||+|.+.. ....+.+|+.+|+.++|||||++++.+. ..+.+||||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~--~~~~~~lv~ 144 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFK--SDDKLLLIM 144 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE--ECCEEEEEE
Confidence 3488888888885 7776643 3 67899998732 2356788999999999999999998774 456799999
Q ss_pred ecCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccc
Q 003542 287 ELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365 (811)
Q Consensus 287 Ey~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~ 365 (811)
|||+ |+|.+++..... ...++++..+..++.||+.||.|||+++|+||||||+|||++.++ .+||+|||+++
T Consensus 145 E~~~gg~L~~~l~~~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~-----~~kL~DFgla~ 217 (478)
T PTZ00267 145 EYGSGGDLNKQIKQRLK--EHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTG-----IIKLGDFGFSK 217 (478)
T ss_pred ECCCCCCHHHHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCC-----cEEEEeCcCce
Confidence 9998 599988875422 235689999999999999999999999999999999999998776 89999999998
Q ss_pred cccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHH
Q 003542 366 ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTK 445 (811)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~ 445 (811)
....... ........||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.. ...+..
T Consensus 218 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~---------~~~~~~Dv~slG~~l~el~tg~~Pf~~~~--~~~~~~ 281 (478)
T PTZ00267 218 QYSDSVS-----LDVASSFCGTPYYLAPELWERK---------RYSKKADMWSLGVILYELLTLHRPFKGPS--QREIMQ 281 (478)
T ss_pred ecCCccc-----cccccccCCCccccCHhHhCCC---------CCCcHHhHHHHHHHHHHHHhCCCCCCCCC--HHHHHH
Confidence 6543211 1122355689999999998643 68899999999999999999999997643 334555
Q ss_pred HHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 446 NIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 446 ~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
.+..+....+|..++..+.+||.+||..||.+||++.+++.
T Consensus 282 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 282 QVLYGKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred HHHhCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 66666666677788899999999999999999999999976
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=333.00 Aligned_cols=254 Identities=26% Similarity=0.449 Sum_probs=199.5
Q ss_pred hcceEEeeeecccc---eEEEEEE------cCCEEEEEEecc-----cHHHHHHHHHHHHhC-CCCccceeeeeEEccCC
Q 003542 215 LKKLMVRRRLGASS---QFKEIQW------LGDSFVLRHFYG-----ELESLNAEISTMLSL-SHPNIVQYLCGFCDEEK 279 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~~------~g~~VAVK~~~~-----~~~~~~~Ei~iL~~L-~HPNIVkl~~~~~~e~~ 279 (811)
..+|++.+.||.|+ ||++..+ ++..||||++.. ..+.+.+|+.+|..+ +||||+++++.+ ...
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~--~~~ 111 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGAC--TVG 111 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeee--ccC
Confidence 34788999999986 6666432 356899999853 345688999999999 899999999776 345
Q ss_pred CeEEEEEecCC-CCHHHHHHHhhCC-------------------------------------------------------
Q 003542 280 KEFFLVMELMS-KDLSCYMRETFGS------------------------------------------------------- 303 (811)
Q Consensus 280 ~~~yLVmEy~~-g~L~~~L~~~~~~------------------------------------------------------- 303 (811)
...|+|||||+ |+|.+++......
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 57899999999 5999998753210
Q ss_pred --------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccccc
Q 003542 304 --------------RRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTY 369 (811)
Q Consensus 304 --------------~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~ 369 (811)
.....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~-----~~kl~DfG~a~~~~~ 266 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGR-----ITKICDFGLARDIRN 266 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCC-----cEEEecCccceeccC
Confidence 0112578889999999999999999999999999999999998765 899999999976543
Q ss_pred cCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CCCCCCCCccchHHHHHHHH
Q 003542 370 ASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGDKMTKNIR 448 (811)
Q Consensus 370 ~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~~PF~~~~~~~~~i~~~i~ 448 (811)
... ........++..|+|||++.+. .++.++|||||||++|||++ |..||...... ..+.+.+.
T Consensus 267 ~~~-----~~~~~~~~~~~~y~aPE~~~~~---------~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~-~~~~~~~~ 331 (375)
T cd05104 267 DSN-----YVVKGNARLPVKWMAPESIFNC---------VYTFESDVWSYGILLWEIFSLGSSPYPGMPVD-SKFYKMIK 331 (375)
T ss_pred ccc-----ccccCCCCCCcceeChhHhcCC---------CCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch-HHHHHHHH
Confidence 221 0111233456779999999643 67899999999999999998 89999764322 34455566
Q ss_pred hCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHH
Q 003542 449 AGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRY 490 (811)
Q Consensus 449 ~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~ 490 (811)
.+..+..|...+.++.+||.+||+.||++||++.+|++.|+.
T Consensus 332 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 332 EGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred hCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 665666667778899999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=314.75 Aligned_cols=252 Identities=28% Similarity=0.427 Sum_probs=193.8
Q ss_pred cce-EEeeeecccc---eEEEE-----EEcCCEEEEEEecc-----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCe
Q 003542 216 KKL-MVRRRLGASS---QFKEI-----QWLGDSFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKE 281 (811)
Q Consensus 216 k~~-~i~~~lG~G~---vyk~v-----~~~g~~VAVK~~~~-----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~ 281 (811)
++| ++.+.||+|+ ||.+. ..++..||+|.+.. ....+.+|+.+|+.++||||+++++.+.......
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 344 7888888885 43322 12678999999864 2456889999999999999999997665444567
Q ss_pred EEEEEecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEee
Q 003542 282 FFLVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSG 360 (811)
Q Consensus 282 ~yLVmEy~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~D 360 (811)
+|+||||+++ +|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++ .++|+|
T Consensus 83 ~~lv~e~~~~~~l~~~~~~-------~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~-----~~~l~d 150 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPK-------HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDR-----LVKIGD 150 (283)
T ss_pred EEEEecCCCCCCHHHHHHH-------cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCC-----cEEEee
Confidence 8999999995 88888864 4589999999999999999999999999999999999998765 899999
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccch
Q 003542 361 FGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQG 440 (811)
Q Consensus 361 FGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~ 440 (811)
||++......... ........++..|+|||++.+. .++.++||||||+++|+|++|..||.......
T Consensus 151 fg~~~~~~~~~~~----~~~~~~~~~~~~~~~PE~~~~~---------~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~ 217 (283)
T cd05080 151 FGLAKAVPEGHEY----YRVREDGDSPVFWYAVECLKEN---------KFSYASDVWSFGVTLYELLTHCDSKQSPPKKF 217 (283)
T ss_pred cccccccCCcchh----hccCCCCCCCceeeCHhHhccc---------CCCcccccHHHHHHHHHHHhCCCCCCCCcchh
Confidence 9998765432110 0111223456679999998643 67889999999999999999999986432111
Q ss_pred -------------HHHHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHHH
Q 003542 441 -------------DKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIK 492 (811)
Q Consensus 441 -------------~~i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~ 492 (811)
......+..+..+..+..++..+.+++.+||+.+|++|||+++++..|+.+.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 218 EEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 1111222233344456778899999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=317.26 Aligned_cols=243 Identities=23% Similarity=0.368 Sum_probs=187.7
Q ss_pred cceEEeeeecccc---eEEEEEE--cCCEEEEEEecc------cHHHHHHHHHHHHhC---CCCccceeeeeEEc---cC
Q 003542 216 KKLMVRRRLGASS---QFKEIQW--LGDSFVLRHFYG------ELESLNAEISTMLSL---SHPNIVQYLCGFCD---EE 278 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~~--~g~~VAVK~~~~------~~~~~~~Ei~iL~~L---~HPNIVkl~~~~~~---e~ 278 (811)
++|++.+.||+|+ ||++... .|..||||.+.. ....+.+|+.+++.+ +||||+++++.+.. ..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 3688888999986 7776542 468899999852 234567788888776 69999999976642 23
Q ss_pred CCeEEEEEecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEE
Q 003542 279 KKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKV 358 (811)
Q Consensus 279 ~~~~yLVmEy~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL 358 (811)
...+++||||++++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||
T Consensus 81 ~~~~~lv~e~~~~~l~~~~~~~----~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~-----~~kl 151 (290)
T cd07862 81 ETKLTLVFEHVDQDLTTYLDKV----PEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG-----QIKL 151 (290)
T ss_pred CCcEEEEEccCCCCHHHHHHhC----CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCC-----CEEE
Confidence 4568999999999999988753 224589999999999999999999999999999999999998876 8999
Q ss_pred eeccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCcc
Q 003542 359 SGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHL 438 (811)
Q Consensus 359 ~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~ 438 (811)
+|||++...... .......||+.|+|||++.+. .++.++|||||||++|||++|.+||.+...
T Consensus 152 ~Dfg~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~---------~~~~~~DiwslG~il~el~~g~~~f~~~~~ 214 (290)
T cd07862 152 ADFGLARIYSFQ--------MALTSVVVTLWYRAPEVLLQS---------SYATPVDLWSVGCIFAEMFRRKPLFRGSSD 214 (290)
T ss_pred ccccceEeccCC--------cccccccccccccChHHHhCC---------CCCCccchHHHHHHHHHHHcCCCCcCCCCH
Confidence 999998765322 122345689999999999643 678899999999999999999999987543
Q ss_pred chHHHHHHHHhCCCC--------------------------CCCCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 439 QGDKMTKNIRAGERP--------------------------LFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 439 ~~~~i~~~i~~~~~~--------------------------~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
. ..+ ..+...... ......++.+.+|+.+||+.||++|||+.++++
T Consensus 215 ~-~~~-~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 215 V-DQL-GKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred H-HHH-HHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 2 122 222111000 011245677899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=327.79 Aligned_cols=230 Identities=18% Similarity=0.293 Sum_probs=184.7
Q ss_pred cccceEEEE-EEcCCEEEEEEecc-------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEecCCC-CHHH
Q 003542 225 GASSQFKEI-QWLGDSFVLRHFYG-------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSC 295 (811)
Q Consensus 225 G~G~vyk~v-~~~g~~VAVK~~~~-------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~~g-~L~~ 295 (811)
|.|.||.+. ..+|..||+|.+.. ....+.+|+.+|+.++||||+++++.|. ....+||||||+++ +|..
T Consensus 7 ~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~--~~~~~~lv~E~~~~~~L~~ 84 (323)
T cd05595 7 TFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ--THDRLCFVMEYANGGELFF 84 (323)
T ss_pred CCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEe--cCCEEEEEEeCCCCCcHHH
Confidence 334477766 34789999999853 2355778999999999999999987774 45679999999995 8887
Q ss_pred HHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccccccCCCCC
Q 003542 296 YMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTP 375 (811)
Q Consensus 296 ~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~~~~~~ 375 (811)
++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus 85 ~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-----~~kL~Dfg~~~~~~~~~---- 149 (323)
T cd05595 85 HLSRE------RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG-----HIKITDFGLCKEGISDG---- 149 (323)
T ss_pred HHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCC-----CEEecccHHhccccCCC----
Confidence 77643 5789999999999999999999999999999999999998876 89999999986432211
Q ss_pred CCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHHHHhCCCCCC
Q 003542 376 PASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLF 455 (811)
Q Consensus 376 ~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i~~~~~~~~ 455 (811)
.......||+.|+|||++.+. .++.++|||||||++|+|++|+.||..... ......+... ...+
T Consensus 150 ---~~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwSlGvil~ell~g~~Pf~~~~~--~~~~~~~~~~-~~~~ 214 (323)
T cd05595 150 ---ATMKTFCGTPEYLAPEVLEDN---------DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--ERLFELILME-EIRF 214 (323)
T ss_pred ---CccccccCCcCcCCcccccCC---------CCCchhchhhhHHHHHHHHhCCCCCCCCCH--HHHHHHHhcC-CCCC
Confidence 112345689999999998643 678899999999999999999999976432 2333333332 3346
Q ss_pred CCCChHHHHHHHhhhccCCCCCCC-----CHHHHHH
Q 003542 456 PSGSPKYLVNLTKKCWHTNPSQRP-----SFSSICR 486 (811)
Q Consensus 456 p~~~~~~l~~LI~~cL~~DP~~RP-----S~~eIl~ 486 (811)
|..+++.+.+||.+||..||.+|| ++.++++
T Consensus 215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 778899999999999999999998 7888776
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=324.68 Aligned_cols=246 Identities=21% Similarity=0.341 Sum_probs=193.1
Q ss_pred hcceEEeeeecccc---eEEEEE-EcCCEEEEEEeccc-----HHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEE
Q 003542 215 LKKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYGE-----LESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLV 285 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~~-----~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLV 285 (811)
..+|++++.||+|+ ||++.. .+|..||+|.+..+ ...+.+|+++|++++||||+++++.+. ....+|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv 81 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY--SDGEISIC 81 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE--ECCEEEEE
Confidence 46899999999986 666553 37889999998532 356899999999999999999998774 34579999
Q ss_pred EecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcEEEeccCCCCcceEEEeeccc
Q 003542 286 MELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQ-KIYHGELNPSNIYLKARSMEGYFHVKVSGFGL 363 (811)
Q Consensus 286 mEy~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~-gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGl 363 (811)
|||+++ +|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++ .+||+|||+
T Consensus 82 ~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~-----~~kl~Dfg~ 150 (331)
T cd06649 82 MEHMDGGSLDQVLKEA------KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRG-----EIKLCDFGV 150 (331)
T ss_pred eecCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCC-----cEEEccCcc
Confidence 999995 898888753 5689999999999999999999986 699999999999998876 899999999
Q ss_pred cccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchH--
Q 003542 364 STARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGD-- 441 (811)
Q Consensus 364 A~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~-- 441 (811)
+...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||........
T Consensus 151 ~~~~~~~---------~~~~~~g~~~y~aPE~~~~~---------~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~ 212 (331)
T cd06649 151 SGQLIDS---------MANSFVGTRSYMSPERLQGT---------HYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEA 212 (331)
T ss_pred ccccccc---------ccccCCCCcCcCCHhHhcCC---------CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 8755322 12345689999999999743 678899999999999999999999965322110
Q ss_pred ------------------------------------------HHHHHHHhCCCCCCC-CCChHHHHHHHhhhccCCCCCC
Q 003542 442 ------------------------------------------KMTKNIRAGERPLFP-SGSPKYLVNLTKKCWHTNPSQR 478 (811)
Q Consensus 442 ------------------------------------------~i~~~i~~~~~~~~p-~~~~~~l~~LI~~cL~~DP~~R 478 (811)
.+...+.....+..+ ...++++.+||.+||..||++|
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~R 292 (331)
T cd06649 213 IFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAER 292 (331)
T ss_pred HhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccC
Confidence 011111222222222 2457789999999999999999
Q ss_pred CCHHHHHHHHHHHH
Q 003542 479 PSFSSICRILRYIK 492 (811)
Q Consensus 479 PS~~eIl~~L~~i~ 492 (811)
||+.+|+++ .+++
T Consensus 293 pt~~ell~h-~~~~ 305 (331)
T cd06649 293 ADLKMLMNH-TFIK 305 (331)
T ss_pred CCHHHHhcC-hHHh
Confidence 999999874 3444
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=314.74 Aligned_cols=251 Identities=24% Similarity=0.407 Sum_probs=199.4
Q ss_pred cceEEeeeecccc---eEEEEEE------cCCEEEEEEecc-----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCe
Q 003542 216 KKLMVRRRLGASS---QFKEIQW------LGDSFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKE 281 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~~------~g~~VAVK~~~~-----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~ 281 (811)
++|.+.+.||+|+ ||++... .+..||||.+.. ..+.+.+|+++|+.++||||+++++.+. ....
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~ 82 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCT--EGDP 82 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEe--cCCC
Confidence 4567777788875 7766543 347899999864 2467899999999999999999997774 3467
Q ss_pred EEEEEecCC-CCHHHHHHHhhC--------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCC
Q 003542 282 FFLVMELMS-KDLSCYMRETFG--------SRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEG 352 (811)
Q Consensus 282 ~yLVmEy~~-g~L~~~L~~~~~--------~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~ 352 (811)
.|+||||++ ++|.+++..... ......+++..+..++.||+.||.|||++|++||||||+|||++.++
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~--- 159 (280)
T cd05049 83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDL--- 159 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCC---
Confidence 999999998 599999876421 11234588999999999999999999999999999999999998876
Q ss_pred cceEEEeeccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CCC
Q 003542 353 YFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKV 431 (811)
Q Consensus 353 ~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~~ 431 (811)
.+||+|||++........ ........+++.|+|||++.+. .++.++|||||||++|+|++ |..
T Consensus 160 --~~kl~d~g~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~e~~~~g~~ 223 (280)
T cd05049 160 --VVKIGDFGMSRDVYTTDY-----YRVGGHTMLPIRWMPPESIMYR---------KFTTESDVWSFGVVLWEIFTYGKQ 223 (280)
T ss_pred --eEEECCcccceecccCcc-----eecCCCCcccceecChhhhccC---------CcchhhhHHHHHHHHHHHHhcCCC
Confidence 899999999865422211 0112234467889999998743 67889999999999999998 999
Q ss_pred CCCCCccchHHHHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHH
Q 003542 432 PFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILR 489 (811)
Q Consensus 432 PF~~~~~~~~~i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~ 489 (811)
||.+.. .......+..+..+..+..++..+.+++.+||..||.+||++.++++.|+
T Consensus 224 p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 224 PWYGLS--NEEVIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred CCCCCC--HHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 997643 23445556666666667788999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=308.36 Aligned_cols=252 Identities=22% Similarity=0.444 Sum_probs=205.1
Q ss_pred cceEEeeeecccc---eEEEEEE-cCCEEEEEEecc-------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEE
Q 003542 216 KKLMVRRRLGASS---QFKEIQW-LGDSFVLRHFYG-------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFL 284 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~~-~g~~VAVK~~~~-------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yL 284 (811)
++|++.+.||.|+ +|++... +|+.||+|.+.. ..+.+.+|+.++++++|+||+++++.+. ..+.+++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~--~~~~~~l 79 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFI--ENNELNI 79 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeee--cCCeEEE
Confidence 4788999999986 7776644 899999998842 3567899999999999999999998774 3467899
Q ss_pred EEecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccc
Q 003542 285 VMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGL 363 (811)
Q Consensus 285 VmEy~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGl 363 (811)
||||+++ +|..++.... .....+++..++.++.||+.||.|||+.|++||||+|+||+++.++ .++|+|||+
T Consensus 80 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~-----~~~l~d~~~ 152 (267)
T cd08224 80 VLELADAGDLSRMIKHFK--KQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATG-----VVKLGDLGL 152 (267)
T ss_pred EEecCCCCCHHHHHHHhc--ccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCC-----cEEEeccce
Confidence 9999995 9988886532 2235689999999999999999999999999999999999998776 899999999
Q ss_pred cccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHH
Q 003542 364 STARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKM 443 (811)
Q Consensus 364 A~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i 443 (811)
+........ ......++..|+|||.+.+. .++.++||||||+++|+|++|..||..........
T Consensus 153 ~~~~~~~~~-------~~~~~~~~~~y~apE~~~~~---------~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~ 216 (267)
T cd08224 153 GRFFSSKTT-------AAHSLVGTPYYMSPERIHEN---------GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL 216 (267)
T ss_pred eeeccCCCc-------ccceecCCccccCHHHhccC---------CCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHH
Confidence 876533211 11234578889999998643 57889999999999999999999997655444445
Q ss_pred HHHHHhCCCCCCCC-CChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHHH
Q 003542 444 TKNIRAGERPLFPS-GSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIK 492 (811)
Q Consensus 444 ~~~i~~~~~~~~p~-~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~ 492 (811)
...+..+..+..|. ..+..+.++|.+||..+|.+||++.+|++.|..+.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 217 CKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred HhhhhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 55555555555554 67888999999999999999999999999887653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=331.35 Aligned_cols=245 Identities=21% Similarity=0.324 Sum_probs=188.8
Q ss_pred ceEEeeeecccc---eEEEE-EEcCCEEEEEEecc-------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEE
Q 003542 217 KLMVRRRLGASS---QFKEI-QWLGDSFVLRHFYG-------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLV 285 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v-~~~g~~VAVK~~~~-------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLV 285 (811)
+|.+++.||.|+ ||.+. ..+|+.||||++.. ....+.+|+.+|+.++||||+++++.+ .+...+|||
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~--~~~~~~~lv 79 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSF--QDAQYLYLI 79 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEE--EcCCeeEEE
Confidence 688889999885 66655 34889999999843 245688999999999999999999877 456689999
Q ss_pred EecCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccc
Q 003542 286 MELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS 364 (811)
Q Consensus 286 mEy~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA 364 (811)
||||+ |+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++ .+||+|||++
T Consensus 80 ~E~~~gg~L~~~l~~~------~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~-----~~kl~DfGla 148 (377)
T cd05629 80 MEFLPGGDLMTMLIKY------DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGG-----HIKLSDFGLS 148 (377)
T ss_pred EeCCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCC-----CEEEeecccc
Confidence 99998 5898888753 5689999999999999999999999999999999999998776 8999999998
Q ss_pred ccccccCCCC---------CCC-------------------------------CCCCCCCCCCCccCChhHhhhhcCCCC
Q 003542 365 TARTYASRNT---------PPA-------------------------------SPQNQTAPNPYIWYAPEVLAEQEGTGS 404 (811)
Q Consensus 365 ~~~~~~~~~~---------~~~-------------------------------~~~~~~~~GT~~Y~APEvl~~~~~~~~ 404 (811)
+......... ... ........||+.|+|||++.+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----- 223 (377)
T cd05629 149 TGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ----- 223 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccC-----
Confidence 6432110000 000 0001135699999999999643
Q ss_pred CCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHHHHh-CCCCCCCC--CChHHHHHHHhhhccCCCCCC---
Q 003542 405 TSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRA-GERPLFPS--GSPKYLVNLTKKCWHTNPSQR--- 478 (811)
Q Consensus 405 ~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i~~-~~~~~~p~--~~~~~l~~LI~~cL~~DP~~R--- 478 (811)
.++.++|||||||++|||++|.+||.+... ......+.. .....+|. ..+.++.+||.+||. +|.+|
T Consensus 224 ----~~~~~~DiwSlGvil~elltG~~Pf~~~~~--~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r 296 (377)
T cd05629 224 ----GYGQECDWWSLGAIMFECLIGWPPFCSENS--HETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGR 296 (377)
T ss_pred ----CCCCceeeEecchhhhhhhcCCCCCCCCCH--HHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCC
Confidence 678999999999999999999999976542 223333333 22233443 467889999999997 77765
Q ss_pred CCHHHHHH
Q 003542 479 PSFSSICR 486 (811)
Q Consensus 479 PS~~eIl~ 486 (811)
+++.+++.
T Consensus 297 ~~~~~~l~ 304 (377)
T cd05629 297 GGAHEIKS 304 (377)
T ss_pred CCHHHHhc
Confidence 58888876
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=330.03 Aligned_cols=246 Identities=20% Similarity=0.269 Sum_probs=196.0
Q ss_pred hcceEEeeeecccc---eEEEEE-EcCCEEEEEEecc-------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEE
Q 003542 215 LKKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG-------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFF 283 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~-------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~y 283 (811)
.++|++.+.||.|+ ||++.. .+|+.||+|.+.. ....+.+|+.+|+.++||||+++++.+ .+...+|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~--~~~~~~~ 119 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAF--QDDKYLY 119 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEE--ecCCEEE
Confidence 46799999999986 666553 3789999999853 234578899999999999999999776 4566899
Q ss_pred EEEecCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecc
Q 003542 284 LVMELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFG 362 (811)
Q Consensus 284 LVmEy~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFG 362 (811)
+|||||+ |+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 120 lv~Ey~~gg~L~~~l~~-------~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~-----~~kL~DfG 187 (370)
T cd05596 120 MVMEYMPGGDLVNLMSN-------YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG-----HLKLADFG 187 (370)
T ss_pred EEEcCCCCCcHHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCC-----CEEEEecc
Confidence 9999998 588888764 4588899999999999999999999999999999999998876 89999999
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHH
Q 003542 363 LSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDK 442 (811)
Q Consensus 363 lA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~ 442 (811)
++....... ........||+.|+|||++.+... ...++.++|||||||++|||++|..||.+.... .
T Consensus 188 ~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~-----~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--~ 254 (370)
T cd05596 188 TCMKMDANG------MVRCDTAVGTPDYISPEVLKSQGG-----DGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--G 254 (370)
T ss_pred ceeeccCCC------cccCCCCCCCcCeECHHHhccCCC-----CCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH--H
Confidence 987653321 111234579999999999975321 235789999999999999999999999875432 3
Q ss_pred HHHHHHhCC-CCCCCC--CChHHHHHHHhhhccCCCCC--CCCHHHHHHH
Q 003542 443 MTKNIRAGE-RPLFPS--GSPKYLVNLTKKCWHTNPSQ--RPSFSSICRI 487 (811)
Q Consensus 443 i~~~i~~~~-~~~~p~--~~~~~l~~LI~~cL~~DP~~--RPS~~eIl~~ 487 (811)
....+.... ...+|. ..+..+.+||.+||..+|.+ |+++++++.+
T Consensus 255 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 255 TYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred HHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 334444332 233443 56889999999999999988 9999999773
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=323.98 Aligned_cols=232 Identities=26% Similarity=0.387 Sum_probs=185.8
Q ss_pred eeccc---ceEEEEE----EcCCEEEEEEecc--------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEe
Q 003542 223 RLGAS---SQFKEIQ----WLGDSFVLRHFYG--------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVME 287 (811)
Q Consensus 223 ~lG~G---~vyk~v~----~~g~~VAVK~~~~--------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmE 287 (811)
.||+| .||.+.. ..|+.||||.+.. ....+.+|+.+|+.++||||+++++.+. ..+.+|+|||
T Consensus 3 ~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~--~~~~~~lv~e 80 (323)
T cd05584 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQ--TGGKLYLILE 80 (323)
T ss_pred eeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEe--cCCeEEEEEe
Confidence 45555 3777653 2678999999853 2345788999999999999999998774 4567999999
Q ss_pred cCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccccc
Q 003542 288 LMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366 (811)
Q Consensus 288 y~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~ 366 (811)
|++| +|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 81 ~~~~~~L~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~-----~~kl~Dfg~~~~ 149 (323)
T cd05584 81 YLSGGELFMHLERE------GIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQG-----HVKLTDFGLCKE 149 (323)
T ss_pred CCCCchHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-----CEEEeeCcCCee
Confidence 9995 888888653 5688899999999999999999999999999999999998876 899999999865
Q ss_pred ccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHH
Q 003542 367 RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKN 446 (811)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~ 446 (811)
..... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+... ......
T Consensus 150 ~~~~~-------~~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~ell~G~~pf~~~~~--~~~~~~ 211 (323)
T cd05584 150 SIHEG-------TVTHTFCGTIEYMAPEILMRS---------GHGKAVDWWSLGALMYDMLTGAPPFTAENR--KKTIDK 211 (323)
T ss_pred cccCC-------CcccccCCCccccChhhccCC---------CCCCcceecccHHHHHHHhcCCCCCCCCCH--HHHHHH
Confidence 32221 122345689999999998643 567899999999999999999999986543 233344
Q ss_pred HHhCCCCCCCCCChHHHHHHHhhhccCCCCCCC-----CHHHHHH
Q 003542 447 IRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRP-----SFSSICR 486 (811)
Q Consensus 447 i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RP-----S~~eIl~ 486 (811)
+..+ ...+|..+++.+.+||.+||..||.+|| ++.+++.
T Consensus 212 ~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 212 ILKG-KLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred HHcC-CCCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 4443 3346777889999999999999999999 7777765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=330.55 Aligned_cols=247 Identities=18% Similarity=0.277 Sum_probs=188.8
Q ss_pred ceEEeeeecccc---eEEEEE-EcCCEEEEEEecc-------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEE
Q 003542 217 KLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG-------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLV 285 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~-------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLV 285 (811)
.|++++.||+|+ ||++.. .+++.||||++.. ....+.+|+.+|+.++||||+++++.+. +...+|+|
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~--~~~~~~lv 79 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQ--DKDNLYFV 79 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEe--cCCEEEEE
Confidence 478888899986 777653 4788999999953 2456889999999999999999997774 45679999
Q ss_pred EecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccc
Q 003542 286 MELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS 364 (811)
Q Consensus 286 mEy~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA 364 (811)
||||+| +|.+++... ..+++..+..++.||+.||.|||+.||+||||||+||||+.++ ++||+|||++
T Consensus 80 ~E~~~gg~L~~~l~~~------~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~-----~~kL~DFGl~ 148 (381)
T cd05626 80 MDYIPGGDMMSLLIRM------EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDG-----HIKLTDFGLC 148 (381)
T ss_pred EecCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCC-----CEEEeeCcCC
Confidence 999985 898888753 5689999999999999999999999999999999999998776 8999999998
Q ss_pred ccccccCCCCC----------------------------------------CCCCCCCCCCCCCccCChhHhhhhcCCCC
Q 003542 365 TARTYASRNTP----------------------------------------PASPQNQTAPNPYIWYAPEVLAEQEGTGS 404 (811)
Q Consensus 365 ~~~~~~~~~~~----------------------------------------~~~~~~~~~~GT~~Y~APEvl~~~~~~~~ 404 (811)
........... ..........||+.|+|||++.+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----- 223 (381)
T cd05626 149 TGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK----- 223 (381)
T ss_pred cccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCC-----
Confidence 64321100000 000011245799999999999743
Q ss_pred CCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHHHHhCCCCCCC--CCChHHHHHHHhhhc--cCCCCCCCC
Q 003542 405 TSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFP--SGSPKYLVNLTKKCW--HTNPSQRPS 480 (811)
Q Consensus 405 ~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i~~~~~~~~p--~~~~~~l~~LI~~cL--~~DP~~RPS 480 (811)
.++.++|||||||++|||++|..||....... .....+.......+| ..+++++.+||.+|+ ..+|..||+
T Consensus 224 ----~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~ 298 (381)
T cd05626 224 ----GYTQLCDWWSVGVILFEMLVGQPPFLAPTPTE-TQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNG 298 (381)
T ss_pred ----CCCCccceeehhhHHHHHHhCCCCCcCCCHHH-HHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCC
Confidence 67889999999999999999999998654322 122222222222233 356888999999954 556666999
Q ss_pred HHHHHH
Q 003542 481 FSSICR 486 (811)
Q Consensus 481 ~~eIl~ 486 (811)
+.+++.
T Consensus 299 ~~~~l~ 304 (381)
T cd05626 299 ADDIKA 304 (381)
T ss_pred HHHHhc
Confidence 999976
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=335.31 Aligned_cols=241 Identities=20% Similarity=0.309 Sum_probs=187.6
Q ss_pred cceEEeeeecccc---eEEEE-EEcCCEEEEEEecccHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEecCCC
Q 003542 216 KKLMVRRRLGASS---QFKEI-QWLGDSFVLRHFYGELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK 291 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v-~~~g~~VAVK~~~~~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~~g 291 (811)
.+|++++.||.|+ ||.+. ..+++.||||... ...+.+|+.+|++|+||||+++++.|. .....++|||++.+
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--~~~~~~E~~il~~l~HpnIv~~~~~~~--~~~~~~lv~e~~~~ 167 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--RGGTATEAHILRAINHPSIIQLKGTFT--YNKFTCLILPRYKT 167 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--hhhhHHHHHHHHhCCCCCCCCEeEEEE--ECCeeEEEEecCCC
Confidence 5799999999986 66665 3478999999764 346789999999999999999998774 45678999999999
Q ss_pred CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccccccC
Q 003542 292 DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYAS 371 (811)
Q Consensus 292 ~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~~ 371 (811)
+|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus 168 ~L~~~l~~~------~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~-----~vkL~DFG~a~~~~~~~ 236 (391)
T PHA03212 168 DLYCYLAAK------RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPG-----DVCLGDFGAACFPVDIN 236 (391)
T ss_pred CHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCC-----CEEEEeCCccccccccc
Confidence 999888753 5688999999999999999999999999999999999998776 89999999986533221
Q ss_pred CCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCcc------chHHHHH
Q 003542 372 RNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHL------QGDKMTK 445 (811)
Q Consensus 372 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~------~~~~i~~ 445 (811)
........||+.|+|||++.+. .++.++|||||||++|||++|..||..... ....+..
T Consensus 237 ------~~~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~ 301 (391)
T PHA03212 237 ------ANKYYGWAGTIATNAPELLARD---------PYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKL 301 (391)
T ss_pred ------ccccccccCccCCCChhhhcCC---------CCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHH
Confidence 1122345799999999999643 678999999999999999999988753211 0011110
Q ss_pred HHHh-CC--------------------------CC-CCC-----CCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 446 NIRA-GE--------------------------RP-LFP-----SGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 446 ~i~~-~~--------------------------~~-~~p-----~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
.+.. +. .+ ..+ ...+.++.+||.+||+.||.+|||+.++++
T Consensus 302 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 302 IIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000 00 00 000 124567899999999999999999999987
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=311.62 Aligned_cols=251 Identities=21% Similarity=0.408 Sum_probs=200.5
Q ss_pred cceEEeeeecccc---eEEEEE-EcCCEEEEEEecc-------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEE
Q 003542 216 KKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG-------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFL 284 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~-------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yL 284 (811)
.+|++.+.||.|+ +|++.. .+|+.||||.+.. ....+.+|+.+++.++||||+++++.+. ..+.+|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~~ 79 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFI--EDNELNI 79 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEE--ECCeEEE
Confidence 4688899999986 777663 4889999998742 2356889999999999999999998774 3467899
Q ss_pred EEecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccc
Q 003542 285 VMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGL 363 (811)
Q Consensus 285 VmEy~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGl 363 (811)
||||+++ +|.+++.... .....+++..+..++.||+.||.|||++|++||||||+|||++.++ .++|+|||+
T Consensus 80 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~-----~~~l~d~g~ 152 (267)
T cd08228 80 VLELADAGDLSQMIKYFK--KQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATG-----VVKLGDLGL 152 (267)
T ss_pred EEEecCCCcHHHHHHHhh--hccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCC-----CEEECcccc
Confidence 9999995 8888776431 1224588999999999999999999999999999999999998776 799999999
Q ss_pred cccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHH
Q 003542 364 STARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKM 443 (811)
Q Consensus 364 A~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i 443 (811)
+........ ......|++.|+|||.+.+. .++.++|+||||+++|+|++|..||.........+
T Consensus 153 ~~~~~~~~~-------~~~~~~~~~~~~aPE~~~~~---------~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~ 216 (267)
T cd08228 153 GRFFSSKTT-------AAHSLVGTPYYMSPERIHEN---------GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSL 216 (267)
T ss_pred ceeccchhH-------HHhcCCCCccccChhhhccC---------CCCchhhHHHHHHHHHHHhcCCCCCccccccHHHH
Confidence 876543211 11234678889999998743 56789999999999999999999997655444445
Q ss_pred HHHHHhCCCCCCC-CCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHH
Q 003542 444 TKNIRAGERPLFP-SGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYI 491 (811)
Q Consensus 444 ~~~i~~~~~~~~p-~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i 491 (811)
...+.....+..+ ...+..+.+++.+||..+|.+||++.++++.++.+
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 217 CQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred HHHHhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 5555554443333 45778899999999999999999999999988765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=323.74 Aligned_cols=236 Identities=23% Similarity=0.368 Sum_probs=186.7
Q ss_pred eEEeeeecccc---eEEEEE-EcCCEEEEEEecc-------cHHHHHHHHHHH---HhCCCCccceeeeeEEccCCCeEE
Q 003542 218 LMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG-------ELESLNAEISTM---LSLSHPNIVQYLCGFCDEEKKEFF 283 (811)
Q Consensus 218 ~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~-------~~~~~~~Ei~iL---~~L~HPNIVkl~~~~~~e~~~~~y 283 (811)
|.+.+.||+|+ ||.+.. .+|+.||||.+.. ..+.+.+|++++ ..++||||+++++.+ .....+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~--~~~~~~~ 78 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACF--QTEDHVC 78 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEE--EcCCEEE
Confidence 56778888885 676553 3789999999953 245677777665 456899999999777 4566899
Q ss_pred EEEecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecc
Q 003542 284 LVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFG 362 (811)
Q Consensus 284 LVmEy~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFG 362 (811)
+|||||+| +|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 79 lv~E~~~~~~L~~~~~~-------~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~-----~~kL~Dfg 146 (324)
T cd05589 79 FVMEYAAGGDLMMHIHT-------DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEG-----FVKIADFG 146 (324)
T ss_pred EEEcCCCCCcHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCC-----cEEeCccc
Confidence 99999995 77766643 5689999999999999999999999999999999999998877 89999999
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHH
Q 003542 363 LSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDK 442 (811)
Q Consensus 363 lA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~ 442 (811)
++....... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+... ..
T Consensus 147 ~~~~~~~~~-------~~~~~~~g~~~y~aPE~~~~~---------~~~~~~DiwslG~il~el~~G~~pf~~~~~--~~ 208 (324)
T cd05589 147 LCKEGMGFG-------DRTSTFCGTPEFLAPEVLTET---------SYTRAVDWWGLGVLIYEMLVGESPFPGDDE--EE 208 (324)
T ss_pred CCccCCCCC-------CcccccccCccccCHhHhcCC---------CCCcccchhhHHHHHHHHHhCCCCCCCCCH--HH
Confidence 986432211 122345789999999998753 678899999999999999999999986532 23
Q ss_pred HHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCC-----HHHHHH
Q 003542 443 MTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPS-----FSSICR 486 (811)
Q Consensus 443 i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS-----~~eIl~ 486 (811)
....+..+ .+.+|..++..+.++|.+||..||.+||+ +.++++
T Consensus 209 ~~~~i~~~-~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 209 VFDSIVND-EVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred HHHHHHhC-CCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 34444443 34467788999999999999999999994 555543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=317.90 Aligned_cols=252 Identities=22% Similarity=0.348 Sum_probs=190.4
Q ss_pred hcceEEeeeecccc---eEEEEEE-----------------cCCEEEEEEecc-----cHHHHHHHHHHHHhCCCCccce
Q 003542 215 LKKLMVRRRLGASS---QFKEIQW-----------------LGDSFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQ 269 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~~-----------------~g~~VAVK~~~~-----~~~~~~~Ei~iL~~L~HPNIVk 269 (811)
..+|.+.+.||+|+ ||.+... .+..||+|.+.. ....+.+|+.+|.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 35788888999986 6665421 234799999864 2456899999999999999999
Q ss_pred eeeeEEccCCCeEEEEEecCC-CCHHHHHHHhhCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 003542 270 YLCGFCDEEKKEFFLVMELMS-KDLSCYMRETFGS-------------RRRNSFSLPVVVDIMLQIARGMEFLHAQKIYH 335 (811)
Q Consensus 270 l~~~~~~e~~~~~yLVmEy~~-g~L~~~L~~~~~~-------------~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVH 335 (811)
+++.+.. ...+|+||||++ |+|.+++...... .....+++..++.++.||+.||.|||+.||+|
T Consensus 84 ~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH 161 (304)
T cd05096 84 LLGVCVD--EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVH 161 (304)
T ss_pred EEEEEec--CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 9977743 456899999998 5899988653211 11134788899999999999999999999999
Q ss_pred ccCCCCcEEEeccCCCCcceEEEeeccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccc
Q 003542 336 GELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKAD 415 (811)
Q Consensus 336 RDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksD 415 (811)
|||||+|||++.++ .+||+|||+++....... ........++..|+|||++.+. .++.++|
T Consensus 162 ~dlkp~Nill~~~~-----~~kl~DfG~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~D 222 (304)
T cd05096 162 RDLATRNCLVGENL-----TIKIADFGMSRNLYAGDY-----YRIQGRAVLPIRWMAWECILMG---------KFTTASD 222 (304)
T ss_pred cCcchhheEEcCCc-----cEEECCCccceecccCce-----eEecCcCCCCccccCHHHHhcC---------CCCchhh
Confidence 99999999998776 899999999875432211 0112234567889999998643 6788999
Q ss_pred eecchhHHHHHhh--CCCCCCCCccchHHHHHHHH----hC---CCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 416 VYSFGMLCFELLT--GKVPFEDGHLQGDKMTKNIR----AG---ERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 416 IWSLGvILyELlt--G~~PF~~~~~~~~~i~~~i~----~~---~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
|||||+++|+|++ +..||...... .....+. .. .....+..++..+.+|+.+||..||.+|||+.+|.+
T Consensus 223 v~slG~~l~el~~~~~~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 223 VWAFGVTLWEILMLCKEQPYGELTDE--QVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred hHHHHHHHHHHHHccCCCCCCcCCHH--HHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 9999999999987 66788754322 2222211 11 122345678899999999999999999999999987
Q ss_pred HHH
Q 003542 487 ILR 489 (811)
Q Consensus 487 ~L~ 489 (811)
.|+
T Consensus 301 ~l~ 303 (304)
T cd05096 301 FLT 303 (304)
T ss_pred HHh
Confidence 664
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=337.95 Aligned_cols=251 Identities=27% Similarity=0.530 Sum_probs=199.7
Q ss_pred hcceEEeeeecccc---eEEEEEEcCCEEEEEEec------ccHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEE
Q 003542 215 LKKLMVRRRLGASS---QFKEIQWLGDSFVLRHFY------GELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLV 285 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~~~g~~VAVK~~~------~~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLV 285 (811)
...+.+..+||+|. ||++ +|.| .||||+++ ...+.|++|+.+|++-+|.||+-|.+++ -. ..+.||
T Consensus 391 ~~ev~l~~rIGsGsFGtV~Rg-~whG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~-~~--p~~AIi 465 (678)
T KOG0193|consen 391 PEEVLLGERIGSGSFGTVYRG-RWHG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGAC-MN--PPLAII 465 (678)
T ss_pred HHHhhccceeccccccceeec-cccc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhh-cC--Cceeee
Confidence 34567788999984 5542 4555 59999995 2578899999999999999999988555 22 235999
Q ss_pred EecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccc
Q 003542 286 MELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS 364 (811)
Q Consensus 286 mEy~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA 364 (811)
+-+|+| +|+.+|+.. +..|.....+.|+.||++||.|||.++|||||||..||++.+++ .|||+||||+
T Consensus 466 TqwCeGsSLY~hlHv~-----etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~-----kVkIgDFGLa 535 (678)
T KOG0193|consen 466 TQWCEGSSLYTHLHVQ-----ETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDL-----KVKIGDFGLA 535 (678)
T ss_pred ehhccCchhhhhccch-----hhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCC-----cEEEecccce
Confidence 999998 899998753 36799999999999999999999999999999999999998876 8999999999
Q ss_pred ccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHH
Q 003542 365 TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMT 444 (811)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~ 444 (811)
........ ........|...|||||++..+. ...|++.+||||||+++|||++|..||..... +++.
T Consensus 536 tvk~~w~g-----~~q~~qp~gsilwmAPEvIRmqd------~nPfS~qSDVYaFGiV~YELltg~lPysi~~~--dqIi 602 (678)
T KOG0193|consen 536 TVKTRWSG-----EQQLEQPHGSLLWMAPEVIRMQD------DNPFSFQSDVYAFGIVWYELLTGELPYSIQNR--DQII 602 (678)
T ss_pred eeeeeecc-----ccccCCCccchhhhcHHHHhhcc------cCCCCcccchhhhhHHHHHHHhCcCCcCCCCh--hheE
Confidence 76544421 22334556888899999999653 45899999999999999999999999984332 2333
Q ss_pred HHHHhCCC----CCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHHHH
Q 003542 445 KNIRAGER----PLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKK 493 (811)
Q Consensus 445 ~~i~~~~~----~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~k 493 (811)
-.+-.|.. .....++++++++|+..||.+++++||.|.+|+..|+.+.+
T Consensus 603 fmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 603 FMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred EEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 33333321 12236889999999999999999999999999887765544
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=327.20 Aligned_cols=249 Identities=24% Similarity=0.357 Sum_probs=191.9
Q ss_pred HHhcceEEeeeecccc---eEEEE-EEcCCEEEEEEecc------cHHHHHHHHHHHHhCCCCccceeeeeEEccC----
Q 003542 213 MLLKKLMVRRRLGASS---QFKEI-QWLGDSFVLRHFYG------ELESLNAEISTMLSLSHPNIVQYLCGFCDEE---- 278 (811)
Q Consensus 213 ~l~k~~~i~~~lG~G~---vyk~v-~~~g~~VAVK~~~~------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~---- 278 (811)
.+.++|++.+.||.|+ ||.+. ..+|..||||.+.. ....+.+|+.+++.++||||+++++.+....
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 3468999999999996 66655 34789999999853 3456789999999999999999997774322
Q ss_pred CCeEEEEEecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEE
Q 003542 279 KKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKV 358 (811)
Q Consensus 279 ~~~~yLVmEy~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL 358 (811)
...+|+||||++++|...+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||
T Consensus 98 ~~~~~lv~e~~~~~l~~~~~--------~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~-----~~kl 164 (359)
T cd07876 98 FQDVYLVMELMDANLCQVIH--------MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-----TLKI 164 (359)
T ss_pred cceeEEEEeCCCcCHHHHHh--------ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC-----CEEE
Confidence 23579999999998887764 3478899999999999999999999999999999999998876 8999
Q ss_pred eeccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCcc
Q 003542 359 SGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHL 438 (811)
Q Consensus 359 ~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~ 438 (811)
+|||++....... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+...
T Consensus 165 ~Dfg~a~~~~~~~--------~~~~~~~t~~y~aPE~~~~~---------~~~~~~DiwSlG~il~el~tg~~pf~~~~~ 227 (359)
T cd07876 165 LDFGLARTACTNF--------MMTPYVVTRYYRAPEVILGM---------GYKENVDIWSVGCIMGELVKGSVIFQGTDH 227 (359)
T ss_pred ecCCCccccccCc--------cCCCCcccCCCCCchhccCC---------CCCcchhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999986543211 12345689999999999753 678899999999999999999999976432
Q ss_pred chHHHHH---------------------HHHhCCCCCC--------------------CCCChHHHHHHHhhhccCCCCC
Q 003542 439 QGDKMTK---------------------NIRAGERPLF--------------------PSGSPKYLVNLTKKCWHTNPSQ 477 (811)
Q Consensus 439 ~~~~i~~---------------------~i~~~~~~~~--------------------p~~~~~~l~~LI~~cL~~DP~~ 477 (811)
.. .+.. .... ..+.+ +...++.+.+||.+||..||.+
T Consensus 228 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~ 305 (359)
T cd07876 228 ID-QWNKVIEQLGTPSAEFMNRLQPTVRNYVE-NRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDK 305 (359)
T ss_pred HH-HHHHHHHhcCCCcHHHHHHHHHHHHHHHh-hCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCccc
Confidence 11 1000 0000 00100 1123567899999999999999
Q ss_pred CCCHHHHHHHHHHHHHH
Q 003542 478 RPSFSSICRILRYIKKF 494 (811)
Q Consensus 478 RPS~~eIl~~L~~i~k~ 494 (811)
|||+.+++. ..++..+
T Consensus 306 R~t~~e~l~-hp~~~~~ 321 (359)
T cd07876 306 RISVDEALR-HPYITVW 321 (359)
T ss_pred CCCHHHHhc-Cchhhhh
Confidence 999999987 3444443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=344.47 Aligned_cols=250 Identities=22% Similarity=0.347 Sum_probs=202.9
Q ss_pred hcceEEeeeecccc---eEEEE-EEcCCEEEEEEecc------cHHHHHHHHHHHHhCCCCccceeeeeEEccCC-----
Q 003542 215 LKKLMVRRRLGASS---QFKEI-QWLGDSFVLRHFYG------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEK----- 279 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v-~~~g~~VAVK~~~~------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~----- 279 (811)
.++|.+.+.||.|+ ||++. ..+|+.||||.+.. ....+.+|+.+|..++|+||++++..+...+.
T Consensus 31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~ 110 (496)
T PTZ00283 31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPEN 110 (496)
T ss_pred CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCccc
Confidence 46899999999986 66665 34799999999842 34568899999999999999998866643221
Q ss_pred -CeEEEEEecCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEE
Q 003542 280 -KEFFLVMELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVK 357 (811)
Q Consensus 280 -~~~yLVmEy~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vK 357 (811)
..+++||||++ |+|.+++..... ....+++..+..++.|++.||.|||+.+|+||||||+|||++.++ .+|
T Consensus 111 ~~~i~lV~Ey~~~gsL~~~l~~~~~--~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~-----~vk 183 (496)
T PTZ00283 111 VLMIALVLDYANAGDLRQEIKSRAK--TNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNG-----LVK 183 (496)
T ss_pred ceEEEEEEeCCCCCcHHHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCC-----CEE
Confidence 24789999999 599998876421 235689999999999999999999999999999999999998876 899
Q ss_pred EeeccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCc
Q 003542 358 VSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGH 437 (811)
Q Consensus 358 L~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~ 437 (811)
|+|||+++....... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||.+..
T Consensus 184 L~DFGls~~~~~~~~-----~~~~~~~~Gt~~Y~aPE~~~~~---------~~s~k~DVwSlGvilyeLltG~~Pf~~~~ 249 (496)
T PTZ00283 184 LGDFGFSKMYAATVS-----DDVGRTFCGTPYYVAPEIWRRK---------PYSKKADMFSLGVLLYELLTLKRPFDGEN 249 (496)
T ss_pred EEecccCeecccccc-----ccccccccCCcceeCHHHhCCC---------CCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 999999976543211 1122356789999999999743 68899999999999999999999998653
Q ss_pred cchHHHHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHH
Q 003542 438 LQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRI 487 (811)
Q Consensus 438 ~~~~~i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~ 487 (811)
. ..+...+..+....+|..+++.+.+|+.+||..||.+||++.+++.+
T Consensus 250 ~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 250 M--EEVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred H--HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 2 34445555666666788899999999999999999999999999874
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=330.85 Aligned_cols=245 Identities=16% Similarity=0.265 Sum_probs=189.3
Q ss_pred ceEEeeeecccc---eEEEEE-EcCCEEEEEEecc-------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEE
Q 003542 217 KLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG-------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLV 285 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~-------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLV 285 (811)
+|++++.||+|+ ||++.. .+|+.||||.+.. ....+.+|+.+|+.++||||+++++.+ ++.+.+|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~--~~~~~~~lv 79 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSF--QDKDNLYFV 79 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEE--EcCCEEEEE
Confidence 688999999996 666553 3789999999853 345688999999999999999999777 456689999
Q ss_pred EecCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccc
Q 003542 286 MELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS 364 (811)
Q Consensus 286 mEy~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA 364 (811)
||||+ |+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|
T Consensus 80 ~E~~~~g~L~~~i~~~------~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~-----~ikL~DFG~a 148 (376)
T cd05598 80 MDYIPGGDMMSLLIRL------GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDG-----HIKLTDFGLC 148 (376)
T ss_pred EeCCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCC-----CEEEEeCCCC
Confidence 99998 5899988753 5689999999999999999999999999999999999998776 8999999998
Q ss_pred ccccccCCCC------------------------------------CCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCC
Q 003542 365 TARTYASRNT------------------------------------PPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTS 408 (811)
Q Consensus 365 ~~~~~~~~~~------------------------------------~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~ 408 (811)
..+....... ...........||+.|+|||++.+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------- 219 (376)
T cd05598 149 TGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT--------- 219 (376)
T ss_pred ccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCC---------
Confidence 5432110000 0000011235799999999999743
Q ss_pred CCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHHHHhC-CCCCC--CCCChHHHHHHHhhhccCCCCCCC---CHH
Q 003542 409 KCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAG-ERPLF--PSGSPKYLVNLTKKCWHTNPSQRP---SFS 482 (811)
Q Consensus 409 ~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i~~~-~~~~~--p~~~~~~l~~LI~~cL~~DP~~RP---S~~ 482 (811)
.++.++|||||||++|||++|+.||.+.... .....+... ....+ ...+++.+.++|.+|+ .+|.+|+ ++.
T Consensus 220 ~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ 296 (376)
T cd05598 220 GYTQLCDWWSVGVILYEMLVGQPPFLADTPA--ETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGAD 296 (376)
T ss_pred CCCcceeeeeccceeeehhhCCCCCCCCCHH--HHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHH
Confidence 6788999999999999999999999875432 222222221 12222 2357888999999977 5999999 888
Q ss_pred HHHH
Q 003542 483 SICR 486 (811)
Q Consensus 483 eIl~ 486 (811)
+++.
T Consensus 297 ell~ 300 (376)
T cd05598 297 EIKA 300 (376)
T ss_pred HHhC
Confidence 8875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=309.72 Aligned_cols=248 Identities=27% Similarity=0.482 Sum_probs=200.3
Q ss_pred hcceEEeeeecccc---eEEEEEEcCCEEEEEEecc---cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEec
Q 003542 215 LKKLMVRRRLGASS---QFKEIQWLGDSFVLRHFYG---ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMEL 288 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~~~g~~VAVK~~~~---~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy 288 (811)
.++|++.+.||.|+ +|++....++.||||.+.. ..+.+.+|+.++++++||||+++++.+ ...+.+|+||||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~lv~e~ 82 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVC--TLEEPIYIVTEL 82 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEE--ecCCCeeeeeec
Confidence 35688999999886 8887766778899999964 346789999999999999999998766 345568999999
Q ss_pred CC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccc
Q 003542 289 MS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTAR 367 (811)
Q Consensus 289 ~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~ 367 (811)
++ ++|.+++.... ...+++..+..++.|++.||.|||+.|++||||||+||+++.++ .+||+|||++...
T Consensus 83 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~-----~~~l~dfg~~~~~ 153 (261)
T cd05068 83 MKYGSLLEYLQGGA----GRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENN-----ICKVADFGLARVI 153 (261)
T ss_pred ccCCcHHHHHhccC----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCC-----CEEECCcceEEEc
Confidence 96 69999887531 24689999999999999999999999999999999999998876 8999999999876
Q ss_pred cccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CCCCCCCCccchHHHHHH
Q 003542 368 TYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGDKMTKN 446 (811)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~~PF~~~~~~~~~i~~~ 446 (811)
..... ........+..|+|||++.+. .++.++||||||+++|+|++ |+.||.+.. .......
T Consensus 154 ~~~~~------~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~~l~el~t~g~~p~~~~~--~~~~~~~ 216 (261)
T cd05068 154 KEDIY------EAREGAKFPIKWTAPEAALYN---------RFSIKSDVWSFGILLTEIVTYGRMPYPGMT--NAEVLQQ 216 (261)
T ss_pred cCCcc------cccCCCcCceeccCccccccC---------CCCchhhHHHHHHHHHHHHhcCCCCCCCCC--HHHHHHH
Confidence 42211 111122334679999988643 67889999999999999999 999997643 2334455
Q ss_pred HHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHH
Q 003542 447 IRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRY 490 (811)
Q Consensus 447 i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~ 490 (811)
+........+..++..+.+++.+||..+|.+||++.++...|+.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 217 VDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred HHcCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 55554555667788999999999999999999999999987764
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=321.17 Aligned_cols=254 Identities=23% Similarity=0.362 Sum_probs=200.1
Q ss_pred hcceEEeeeecccc---eEEEEEE-cCCEEEEEEecc-------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEE
Q 003542 215 LKKLMVRRRLGASS---QFKEIQW-LGDSFVLRHFYG-------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFF 283 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~~-~g~~VAVK~~~~-------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~y 283 (811)
+..|+++++||.|. ||.+... ++..+|+|++.+ ...+++.|-+||+.++||.++.+|..| +..+..|
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f--et~~~~c 153 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASF--ETDKYSC 153 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhee--eccceeE
Confidence 35677788899885 7775533 558999999964 356788899999999999999999888 6778899
Q ss_pred EEEecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecc
Q 003542 284 LVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFG 362 (811)
Q Consensus 284 LVmEy~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFG 362 (811)
+|||||+| +|...++. +....|++..++.|+.+++.||+|||-.|||+|||||+||||..+| +|.|+||.
T Consensus 154 l~meyCpGGdL~~Lrqk----Qp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredG-----HIMLsDFD 224 (459)
T KOG0610|consen 154 LVMEYCPGGDLHSLRQK----QPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDG-----HIMLSDFD 224 (459)
T ss_pred EEEecCCCccHHHHHhh----CCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCC-----cEEeeecc
Confidence 99999995 77766654 3447899999999999999999999999999999999999999998 99999999
Q ss_pred ccccccccC-------------------------------CCC------------------CCCCCCCCCCCCCCccCCh
Q 003542 363 LSTARTYAS-------------------------------RNT------------------PPASPQNQTAPNPYIWYAP 393 (811)
Q Consensus 363 lA~~~~~~~-------------------------------~~~------------------~~~~~~~~~~~GT~~Y~AP 393 (811)
|+....... ... .+......+.+||-.|+||
T Consensus 225 LS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAP 304 (459)
T KOG0610|consen 225 LSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAP 304 (459)
T ss_pred ccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccc
Confidence 975331100 000 0111234567899999999
Q ss_pred hHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHHHHhCCCCCCCC--CChHHHHHHHhhhc
Q 003542 394 EVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPS--GSPKYLVNLTKKCW 471 (811)
Q Consensus 394 Evl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i~~~~~~~~p~--~~~~~l~~LI~~cL 471 (811)
|++.|. ..+.++|+|+|||++|||+.|..||.+.+.. +.+.+|... .+.+|. ..+..+++||+++|
T Consensus 305 EvI~G~---------GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~--~Tl~NIv~~-~l~Fp~~~~vs~~akDLIr~LL 372 (459)
T KOG0610|consen 305 EVIRGE---------GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNK--ETLRNIVGQ-PLKFPEEPEVSSAAKDLIRKLL 372 (459)
T ss_pred eeeecC---------CCCchhhHHHHHHHHHHHHhCCCCcCCCCch--hhHHHHhcC-CCcCCCCCcchhHHHHHHHHHh
Confidence 999875 5678999999999999999999999986543 334444433 233442 45678999999999
Q ss_pred cCCCCCCCC----HHHHHHHHHHHH
Q 003542 472 HTNPSQRPS----FSSICRILRYIK 492 (811)
Q Consensus 472 ~~DP~~RPS----~~eIl~~L~~i~ 492 (811)
..||.+|.. +.+|.+ +.+++
T Consensus 373 vKdP~kRlg~~rGA~eIK~-HpFF~ 396 (459)
T KOG0610|consen 373 VKDPSKRLGSKRGAAEIKR-HPFFE 396 (459)
T ss_pred ccChhhhhccccchHHhhc-Ccccc
Confidence 999999998 888765 44444
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=322.17 Aligned_cols=230 Identities=25% Similarity=0.449 Sum_probs=184.6
Q ss_pred eccc---ceEEEEE-EcCCEEEEEEecc-------cHHHHHHHHHHHHhC-CCCccceeeeeEEccCCCeEEEEEecCCC
Q 003542 224 LGAS---SQFKEIQ-WLGDSFVLRHFYG-------ELESLNAEISTMLSL-SHPNIVQYLCGFCDEEKKEFFLVMELMSK 291 (811)
Q Consensus 224 lG~G---~vyk~v~-~~g~~VAVK~~~~-------~~~~~~~Ei~iL~~L-~HPNIVkl~~~~~~e~~~~~yLVmEy~~g 291 (811)
||+| .||.+.. .+|+.||||.+.. ....+..|..++..+ +||||+++++.+ .+.+.+|+|||||.|
T Consensus 3 lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~--~~~~~~~lv~E~~~~ 80 (316)
T cd05620 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTF--QTKEHLFFVMEFLNG 80 (316)
T ss_pred eeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEE--EeCCEEEEEECCCCC
Confidence 4555 4777663 3789999999953 345577888888765 899999999777 456689999999995
Q ss_pred -CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccccccccc
Q 003542 292 -DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYA 370 (811)
Q Consensus 292 -~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~ 370 (811)
+|..++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++......
T Consensus 81 g~L~~~i~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~-----~~kl~Dfg~~~~~~~~ 149 (316)
T cd05620 81 GDLMFHIQDK------GRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDG-----HIKIADFGMCKENVFG 149 (316)
T ss_pred CcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC-----CEEeCccCCCeecccC
Confidence 888888653 5689999999999999999999999999999999999998876 8999999998643221
Q ss_pred CCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHHHHhC
Q 003542 371 SRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAG 450 (811)
Q Consensus 371 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i~~~ 450 (811)
. .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+... ..+...+...
T Consensus 150 ~-------~~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslGvil~el~~g~~Pf~~~~~--~~~~~~~~~~ 211 (316)
T cd05620 150 D-------NRASTFCGTPDYIAPEILQGL---------KYTFSVDWWSFGVLLYEMLIGQSPFHGDDE--DELFESIRVD 211 (316)
T ss_pred C-------CceeccCCCcCccCHHHHcCC---------CCCcccchhhhHHHHHHHHhCCCCCCCCCH--HHHHHHHHhC
Confidence 1 122345689999999999753 678899999999999999999999976532 3444444433
Q ss_pred CCCCCCCCChHHHHHHHhhhccCCCCCCCCHH-HHH
Q 003542 451 ERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFS-SIC 485 (811)
Q Consensus 451 ~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~-eIl 485 (811)
.+.+|..++.++.+||.+||+.||.+||++. +++
T Consensus 212 -~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 212 -TPHYPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred -CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 3556777889999999999999999999985 444
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=307.25 Aligned_cols=253 Identities=25% Similarity=0.432 Sum_probs=197.9
Q ss_pred eEEeeeecccc---eEEEEEE----cCCEEEEEEecc------cHHHHHHHHHHHHhCCCCccceeeeeEEccCC----C
Q 003542 218 LMVRRRLGASS---QFKEIQW----LGDSFVLRHFYG------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEK----K 280 (811)
Q Consensus 218 ~~i~~~lG~G~---vyk~v~~----~g~~VAVK~~~~------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~----~ 280 (811)
|++.+.||+|+ ||.+... .+..||||.+.. ....+.+|+.+|+.++||||+++++.+..... .
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 34566777775 6766543 236899999863 24578999999999999999999865543221 3
Q ss_pred eEEEEEecCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEe
Q 003542 281 EFFLVMELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVS 359 (811)
Q Consensus 281 ~~yLVmEy~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~ 359 (811)
..++||||++ |+|..++...........+++..+..++.|++.||.|||+.+++||||||+||+++.++ .+||+
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~-----~~kl~ 155 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDM-----TVCVA 155 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCC-----eEEEC
Confidence 4799999999 58988886543222335689999999999999999999999999999999999998776 89999
Q ss_pred eccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CCCCCCCCcc
Q 003542 360 GFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHL 438 (811)
Q Consensus 360 DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~~PF~~~~~ 438 (811)
|||+++........ .......++..|+|||++.+. .++.++|||||||++|||++ |.+||.+..
T Consensus 156 dfg~~~~~~~~~~~-----~~~~~~~~~~~~~~pe~~~~~---------~~~~~~Dv~SlG~il~el~~~g~~p~~~~~- 220 (273)
T cd05035 156 DFGLSKKIYSGDYY-----RQGRIAKMPVKWIAIESLADR---------VYTSKSDVWAFGVTMWEIATRGQTPYPGVE- 220 (273)
T ss_pred Cccceeeccccccc-----cccccccCCccccCHhhcccC---------CCCcccchHHHHHHHHHHHhCCCCCCCCCC-
Confidence 99998765433211 011123356779999998543 67889999999999999999 999997643
Q ss_pred chHHHHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHH
Q 003542 439 QGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYI 491 (811)
Q Consensus 439 ~~~~i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i 491 (811)
.......+..+..+..+..++..+.+++.+||+.||.+||++.++++.|..+
T Consensus 221 -~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 221 -NHEIYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred -HHHHHHHHHcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 3345566666666677888999999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=324.36 Aligned_cols=230 Identities=20% Similarity=0.307 Sum_probs=184.7
Q ss_pred cccceEEEE-EEcCCEEEEEEecc-------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEecCCC-CHHH
Q 003542 225 GASSQFKEI-QWLGDSFVLRHFYG-------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSC 295 (811)
Q Consensus 225 G~G~vyk~v-~~~g~~VAVK~~~~-------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~~g-~L~~ 295 (811)
+.|.||.+. ..+|+.||+|.+.. ....+..|+.++..++||||+++++.+ .....+||||||+++ +|..
T Consensus 7 ~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~--~~~~~~~lv~E~~~~~~L~~ 84 (325)
T cd05594 7 TFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF--QTHDRLCFVMEYANGGELFF 84 (325)
T ss_pred CCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEE--EcCCEEEEEEeCCCCCcHHH
Confidence 334477765 34889999999963 235678899999999999999998777 445679999999995 7877
Q ss_pred HHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEeccCCCCcceEEEeeccccccccccCCCC
Q 003542 296 YMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHA-QKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNT 374 (811)
Q Consensus 296 ~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs-~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~~~~~ 374 (811)
++... ..+++..+..++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||++.......
T Consensus 85 ~l~~~------~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~-----~~kL~Dfg~~~~~~~~~--- 150 (325)
T cd05594 85 HLSRE------RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG-----HIKITDFGLCKEGIKDG--- 150 (325)
T ss_pred HHHhc------CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCC-----CEEEecCCCCeecCCCC---
Confidence 77643 568999999999999999999997 7999999999999998876 89999999986532211
Q ss_pred CCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHHHHhCCCCC
Q 003542 375 PPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPL 454 (811)
Q Consensus 375 ~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i~~~~~~~ 454 (811)
.......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+... ......+.. ....
T Consensus 151 ----~~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~el~tG~~Pf~~~~~--~~~~~~i~~-~~~~ 214 (325)
T cd05594 151 ----ATMKTFCGTPEYLAPEVLEDN---------DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--EKLFELILM-EEIR 214 (325)
T ss_pred ----cccccccCCcccCCHHHHccC---------CCCCccccccccceeeeeccCCCCCCCCCH--HHHHHHHhc-CCCC
Confidence 112245689999999999643 678899999999999999999999976432 233333333 3345
Q ss_pred CCCCChHHHHHHHhhhccCCCCCCC-----CHHHHHH
Q 003542 455 FPSGSPKYLVNLTKKCWHTNPSQRP-----SFSSICR 486 (811)
Q Consensus 455 ~p~~~~~~l~~LI~~cL~~DP~~RP-----S~~eIl~ 486 (811)
+|...++++.+||.+||+.||.+|+ ++.++++
T Consensus 215 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 215 FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 6778899999999999999999997 8888876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=313.35 Aligned_cols=255 Identities=24% Similarity=0.402 Sum_probs=202.1
Q ss_pred cceEEeeeecccc---eEEEEEE------cCCEEEEEEecc----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeE
Q 003542 216 KKLMVRRRLGASS---QFKEIQW------LGDSFVLRHFYG----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEF 282 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~~------~g~~VAVK~~~~----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~ 282 (811)
.+|.+.+.+|.|+ +|.+... ++..+|+|.+.. ....+.+|+.+|++++||||+++++.+. ....+
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~ 82 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCV--EGDPL 82 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe--cCCcc
Confidence 4688888999986 6665532 345699999864 3456899999999999999999997663 45678
Q ss_pred EEEEecCC-CCHHHHHHHhhC-------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcc
Q 003542 283 FLVMELMS-KDLSCYMRETFG-------SRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYF 354 (811)
Q Consensus 283 yLVmEy~~-g~L~~~L~~~~~-------~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~ 354 (811)
|+||||++ ++|.+++..... ......+++..++.++.||+.||+|||++|++||||||+|||++.++
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~----- 157 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL----- 157 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC-----
Confidence 99999998 589998875421 01123589999999999999999999999999999999999998776
Q ss_pred eEEEeeccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CCCCC
Q 003542 355 HVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPF 433 (811)
Q Consensus 355 ~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~~PF 433 (811)
.+||+|||++........ ........++..|+|||++.+. .++.++|||||||++|+|++ |.+||
T Consensus 158 ~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~---------~~~~~sDiwslG~il~~l~t~g~~p~ 223 (288)
T cd05093 158 LVKIGDFGMSRDVYSTDY-----YRVGGHTMLPIRWMPPESIMYR---------KFTTESDVWSLGVVLWEIFTYGKQPW 223 (288)
T ss_pred cEEeccCCccccccCCce-----eecCCCCCccccccCHHHhccC---------CCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 899999999875432211 1111234457789999998643 67889999999999999998 99999
Q ss_pred CCCccchHHHHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHHHH
Q 003542 434 EDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKK 493 (811)
Q Consensus 434 ~~~~~~~~~i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~k 493 (811)
..... ......+..+.....+..++..+.+|+.+||+.||.+|||+.+++..|+.+.+
T Consensus 224 ~~~~~--~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 224 YQLSN--NEVIECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred CCCCH--HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 76542 33455666666556667788899999999999999999999999998877764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=327.29 Aligned_cols=245 Identities=18% Similarity=0.305 Sum_probs=188.8
Q ss_pred ceEEeeeecccc---eEEEEE-EcCCEEEEEEecc-------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEE
Q 003542 217 KLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG-------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLV 285 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~-------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLV 285 (811)
+|++++.||+|+ ||.+.. .+|+.||||++.. ....+.+|+.++..++||||+++++.+ ++...+|||
T Consensus 2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~--~~~~~~~lv 79 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSF--QDKLNLYLI 79 (363)
T ss_pred CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEE--ecCCeEEEE
Confidence 688889999985 666553 3789999999953 235678899999999999999999777 455679999
Q ss_pred EecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccc
Q 003542 286 MELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS 364 (811)
Q Consensus 286 mEy~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA 364 (811)
||||+| +|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 80 ~E~~~gg~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~-----~vkL~DFGla 148 (363)
T cd05628 80 MEFLPGGDMMTLLMKK------DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKG-----HVKLSDFGLC 148 (363)
T ss_pred EcCCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCC-----CEEEeeccCc
Confidence 999985 898888753 6789999999999999999999999999999999999998876 8999999998
Q ss_pred ccccccCCCCC----------------------------CCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccce
Q 003542 365 TARTYASRNTP----------------------------PASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADV 416 (811)
Q Consensus 365 ~~~~~~~~~~~----------------------------~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDI 416 (811)
+.......... ..........||+.|+|||++.+. .++.++||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~---------~~~~~~Dv 219 (363)
T cd05628 149 TGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT---------GYNKLCDW 219 (363)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCC---------CCCCchhh
Confidence 75432110000 000011245799999999999753 67889999
Q ss_pred ecchhHHHHHhhCCCCCCCCccchHHHHHHHHhC-CCCCCCC--CChHHHHHHHhhhccCCCC---CCCCHHHHHH
Q 003542 417 YSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAG-ERPLFPS--GSPKYLVNLTKKCWHTNPS---QRPSFSSICR 486 (811)
Q Consensus 417 WSLGvILyELltG~~PF~~~~~~~~~i~~~i~~~-~~~~~p~--~~~~~l~~LI~~cL~~DP~---~RPS~~eIl~ 486 (811)
|||||++|||++|..||.+... ......+... ....+|. ..++++.+||.+|+. +|. .||++++|++
T Consensus 220 wSlGvil~ell~G~~Pf~~~~~--~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~ 292 (363)
T cd05628 220 WSLGVIMYEMLIGYPPFCSETP--QETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKT 292 (363)
T ss_pred hhhHHHHHHHHhCCCCCCCCCH--HHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhC
Confidence 9999999999999999986542 2334444432 2233443 357789999998764 444 4689998865
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=322.98 Aligned_cols=228 Identities=19% Similarity=0.320 Sum_probs=180.8
Q ss_pred eccc---ceEEEEE-EcCCEEEEEEecc-------cHHHHHHHHHHHHhC-CCCccceeeeeEEccCCCeEEEEEecCCC
Q 003542 224 LGAS---SQFKEIQ-WLGDSFVLRHFYG-------ELESLNAEISTMLSL-SHPNIVQYLCGFCDEEKKEFFLVMELMSK 291 (811)
Q Consensus 224 lG~G---~vyk~v~-~~g~~VAVK~~~~-------~~~~~~~Ei~iL~~L-~HPNIVkl~~~~~~e~~~~~yLVmEy~~g 291 (811)
||+| .||.+.. .+|+.||||++.. ....+..|+.++..+ +||||+++++.+ .+...+|||||||+|
T Consensus 3 lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~--~~~~~~~lv~e~~~~ 80 (329)
T cd05588 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCF--QTESRLFFVIEFVSG 80 (329)
T ss_pred EeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEE--EcCCEEEEEEeCCCC
Confidence 4555 4777663 3789999999963 235578999999999 799999999777 445679999999995
Q ss_pred -CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccccccccc
Q 003542 292 -DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYA 370 (811)
Q Consensus 292 -~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~ 370 (811)
+|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 81 g~L~~~~~~~------~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~-----~~kL~Dfg~~~~~~~~ 149 (329)
T cd05588 81 GDLMFHMQRQ------RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEG-----HIKLTDYGMCKEGIRP 149 (329)
T ss_pred CCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC-----CEEECcCccccccccC
Confidence 888877653 5799999999999999999999999999999999999998876 8999999998643211
Q ss_pred CCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCcc-------chHHH
Q 003542 371 SRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHL-------QGDKM 443 (811)
Q Consensus 371 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~-------~~~~i 443 (811)
........||+.|+|||++.+. .++.++|||||||++|+|++|+.||..... .....
T Consensus 150 -------~~~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~ 213 (329)
T cd05588 150 -------GDTTSTFCGTPNYIAPEILRGE---------DYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYL 213 (329)
T ss_pred -------CCccccccCCccccCHHHHcCC---------CCCCccceechHHHHHHHHHCCCCcccccccccccccchHHH
Confidence 1122345789999999999753 678899999999999999999999963211 11122
Q ss_pred HHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCH
Q 003542 444 TKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSF 481 (811)
Q Consensus 444 ~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~ 481 (811)
.+.+. .....+|..++..+.+||.+||..||.+||++
T Consensus 214 ~~~~~-~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~ 250 (329)
T cd05588 214 FQVIL-EKQIRIPRSLSVKASSVLKGFLNKDPKERLGC 250 (329)
T ss_pred HHHHH-cCCCCCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 23333 33445677888999999999999999999983
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=329.11 Aligned_cols=243 Identities=22% Similarity=0.400 Sum_probs=188.9
Q ss_pred cceEEeeeecccc---eEEEEEE-cCCEEEEEEeccc-----HHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEE
Q 003542 216 KKLMVRRRLGASS---QFKEIQW-LGDSFVLRHFYGE-----LESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVM 286 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~~-~g~~VAVK~~~~~-----~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVm 286 (811)
.+|+.++.||.|+ ||++... +|+.||||.+... ...+.+|+.+|+.++||||+++++.+ +..+.+|+||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~~~~~~~lv~ 151 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF--DHNGEIQVLL 151 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEe--ccCCeEEEEE
Confidence 4566677788875 7776633 7899999998532 45688999999999999999999776 4566799999
Q ss_pred ecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccc
Q 003542 287 ELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365 (811)
Q Consensus 287 Ey~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~ 365 (811)
|||.+ +|... ...++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 152 e~~~~~~L~~~----------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~-----~~kL~DfG~~~ 216 (353)
T PLN00034 152 EFMDGGSLEGT----------HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAK-----NVKIADFGVSR 216 (353)
T ss_pred ecCCCCccccc----------ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC-----CEEEcccccce
Confidence 99996 55321 3356778889999999999999999999999999999998776 89999999987
Q ss_pred cccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccc-hHHHH
Q 003542 366 ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQ-GDKMT 444 (811)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~-~~~i~ 444 (811)
...... .......||..|+|||++...... ....+.++|||||||++|||++|+.||...... .....
T Consensus 217 ~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~----~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~ 285 (353)
T PLN00034 217 ILAQTM-------DPCNSSVGTIAYMSPERINTDLNH----GAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLM 285 (353)
T ss_pred eccccc-------ccccccccCccccCcccccccccc----CcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHH
Confidence 654321 112345789999999998542111 123457899999999999999999999743222 12223
Q ss_pred HHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 445 KNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 445 ~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
..+.....+..+..++.++.+||.+||..||.+||++.++++
T Consensus 286 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 286 CAICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred HHHhccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 333344455567788899999999999999999999999987
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=318.92 Aligned_cols=252 Identities=19% Similarity=0.303 Sum_probs=185.7
Q ss_pred eeecccc---eEEEEEE---cCCEEEEEEeccc--HHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEecCCCCH
Q 003542 222 RRLGASS---QFKEIQW---LGDSFVLRHFYGE--LESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDL 293 (811)
Q Consensus 222 ~~lG~G~---vyk~v~~---~g~~VAVK~~~~~--~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~~g~L 293 (811)
.+||+|+ ||++... .++.||+|.+... ...+.+|+.+|++++||||+++++.+.......+|+||||++++|
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~l 86 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDL 86 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCCCH
Confidence 4577774 7777643 5678999999642 456789999999999999999998887666678999999999999
Q ss_pred HHHHHHhhCC---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccccccccc
Q 003542 294 SCYMRETFGS---RRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYA 370 (811)
Q Consensus 294 ~~~L~~~~~~---~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~ 370 (811)
..++...... .....+++..+..++.||+.||.|||++||+||||||+|||+...+ +....+||+|||++......
T Consensus 87 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~-~~~~~~kl~DfG~a~~~~~~ 165 (317)
T cd07868 87 WHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEG-PERGRVKIADMGFARLFNSP 165 (317)
T ss_pred HHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCC-CCcCcEEEeecCceeccCCC
Confidence 8887643211 1223589999999999999999999999999999999999996442 22238999999999765432
Q ss_pred CCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccch--------HH
Q 003542 371 SRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQG--------DK 442 (811)
Q Consensus 371 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~--------~~ 442 (811)
... ........||+.|+|||++.+. ..++.++|||||||++|+|++|++||....... ..
T Consensus 166 ~~~----~~~~~~~~~t~~y~aPE~~~~~--------~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~ 233 (317)
T cd07868 166 LKP----LADLDPVVVTFWYRAPELLLGA--------RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 233 (317)
T ss_pred Ccc----ccccCCccccccccCCHHHcCC--------CCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHH
Confidence 110 1122356789999999999752 357889999999999999999999996432210 01
Q ss_pred HHHHHHhCC-C-----------C------------C------------CCCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 443 MTKNIRAGE-R-----------P------------L------------FPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 443 i~~~i~~~~-~-----------~------------~------------~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
+...+.... . + . .....+..+.+||.+||..||.+|||++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~ 313 (317)
T cd07868 234 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 313 (317)
T ss_pred HHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhc
Confidence 100000000 0 0 0 00112346889999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=328.81 Aligned_cols=245 Identities=17% Similarity=0.284 Sum_probs=188.3
Q ss_pred ceEEeeeecccc---eEEEEE-EcCCEEEEEEecc-------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEE
Q 003542 217 KLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG-------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLV 285 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~-------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLV 285 (811)
.|++++.||+|+ ||++.. .+++.||||.+.. ....+.+|+.+|++++||||+++++.+. +...+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~--~~~~~~lv 79 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQ--DKDNLYFV 79 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEE--eCCEEEEE
Confidence 478889999986 676653 4788999999853 2456889999999999999999998874 45689999
Q ss_pred EecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccc
Q 003542 286 MELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS 364 (811)
Q Consensus 286 mEy~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA 364 (811)
||||+| +|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 80 ~E~~~gg~L~~~l~~~------~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g-----~~kL~DFGla 148 (382)
T cd05625 80 MDYIPGGDMMSLLIRM------GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDG-----HIKLTDFGLC 148 (382)
T ss_pred EeCCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-----CEEEeECCCC
Confidence 999985 888888653 5689999999999999999999999999999999999998877 8999999997
Q ss_pred ccccccCCCC----------------------------------------CCCCCCCCCCCCCCccCChhHhhhhcCCCC
Q 003542 365 TARTYASRNT----------------------------------------PPASPQNQTAPNPYIWYAPEVLAEQEGTGS 404 (811)
Q Consensus 365 ~~~~~~~~~~----------------------------------------~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~ 404 (811)
.......... ...........||+.|+|||++.+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----- 223 (382)
T cd05625 149 TGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT----- 223 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC-----
Confidence 5432110000 0000011235799999999999743
Q ss_pred CCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHHHHh-CCCCCCC--CCChHHHHHHHhhhccCCCCCCCC-
Q 003542 405 TSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRA-GERPLFP--SGSPKYLVNLTKKCWHTNPSQRPS- 480 (811)
Q Consensus 405 ~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i~~-~~~~~~p--~~~~~~l~~LI~~cL~~DP~~RPS- 480 (811)
.++.++|||||||++|||++|++||.+.... .....+.. .....+| ...++++.++|.+|+ .+|.+|++
T Consensus 224 ----~~~~~~DiwSlGvil~elltG~~Pf~~~~~~--~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~ 296 (382)
T cd05625 224 ----GYTQLCDWWSVGVILYEMLVGQPPFLAQTPL--ETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGK 296 (382)
T ss_pred ----CCCCeeeEEechHHHHHHHhCCCCCCCCCHH--HHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCC
Confidence 6788999999999999999999999865432 22222222 2222233 356788999999976 59999997
Q ss_pred --HHHHHH
Q 003542 481 --FSSICR 486 (811)
Q Consensus 481 --~~eIl~ 486 (811)
+.+++.
T Consensus 297 ~~~~ei~~ 304 (382)
T cd05625 297 NGADEIKA 304 (382)
T ss_pred CCHHHHhc
Confidence 777764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=307.52 Aligned_cols=244 Identities=25% Similarity=0.434 Sum_probs=196.1
Q ss_pred cceEEeeeecccc---eEEEEEEcCCEEEEEEecc---cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEecC
Q 003542 216 KKLMVRRRLGASS---QFKEIQWLGDSFVLRHFYG---ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELM 289 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~~~g~~VAVK~~~~---~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~ 289 (811)
++|.+.+.||+|+ +|.+....+..+|||.+.. ..+.+.+|+.++.+++||||+++++.+. ....+|+||||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~ 81 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCT--KQRPIYIVTEYM 81 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEc--cCCCcEEEEEcC
Confidence 5688899999985 6665444555799999864 2467899999999999999999997663 445689999999
Q ss_pred C-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccccccc
Q 003542 290 S-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTART 368 (811)
Q Consensus 290 ~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~ 368 (811)
. ++|.+++... ...+++..++.++.||+.||.|||+.|++|+||||+|||++.++ .+||+|||+++...
T Consensus 82 ~~~~l~~~i~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~-----~~kl~d~g~~~~~~ 151 (256)
T cd05113 82 SNGCLLNYLREH-----GKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQG-----CVKVSDFGLSRYVL 151 (256)
T ss_pred CCCcHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCC-----CEEECCCccceecC
Confidence 8 5888888653 13689999999999999999999999999999999999998766 89999999987553
Q ss_pred ccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CCCCCCCCccchHHHHHHH
Q 003542 369 YASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGDKMTKNI 447 (811)
Q Consensus 369 ~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~~PF~~~~~~~~~i~~~i 447 (811)
.... .......++..|+|||++.+. .++.++|||||||++|+|++ |..||.... .......+
T Consensus 152 ~~~~------~~~~~~~~~~~y~~pe~~~~~---------~~~~~~Di~slG~~l~~l~~~g~~p~~~~~--~~~~~~~~ 214 (256)
T cd05113 152 DDEY------TSSVGSKFPVRWSPPEVLLYS---------KFSSKSDVWAFGVLMWEVYSLGKMPYERFN--NSETVEKV 214 (256)
T ss_pred CCce------eecCCCccChhhCCHHHHhcC---------cccchhHHHHHHHHHHHHhcCCCCCcCcCC--HHHHHHHH
Confidence 3211 111233456789999999642 67889999999999999998 999997543 23345556
Q ss_pred HhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHH
Q 003542 448 RAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRIL 488 (811)
Q Consensus 448 ~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L 488 (811)
..+..+..+...+..+.+++.+||..+|.+||++.+|+..|
T Consensus 215 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 215 SQGLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSI 255 (256)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence 66666656677788999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=322.81 Aligned_cols=226 Identities=23% Similarity=0.384 Sum_probs=183.0
Q ss_pred eccc---ceEEEEE-EcCCEEEEEEecc-------cHHHHHHHHHHHHhC-CCCccceeeeeEEccCCCeEEEEEecCCC
Q 003542 224 LGAS---SQFKEIQ-WLGDSFVLRHFYG-------ELESLNAEISTMLSL-SHPNIVQYLCGFCDEEKKEFFLVMELMSK 291 (811)
Q Consensus 224 lG~G---~vyk~v~-~~g~~VAVK~~~~-------~~~~~~~Ei~iL~~L-~HPNIVkl~~~~~~e~~~~~yLVmEy~~g 291 (811)
||+| .||++.. .+|+.||||++.. ....+..|+.++..+ +||||+++++.+ .....+|||||||+|
T Consensus 3 lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~--~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCF--QTPDRLFFVMEFVNG 80 (320)
T ss_pred eeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEE--EcCCEEEEEEcCCCC
Confidence 4555 4787664 3789999999853 345677899999877 699999999777 455679999999995
Q ss_pred -CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccccccccc
Q 003542 292 -DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYA 370 (811)
Q Consensus 292 -~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~ 370 (811)
+|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++......
T Consensus 81 g~L~~~i~~~------~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~-----~~kL~DfG~~~~~~~~ 149 (320)
T cd05590 81 GDLMFHIQKS------RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEG-----HCKLADFGMCKEGIFN 149 (320)
T ss_pred chHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCC-----cEEEeeCCCCeecCcC
Confidence 888877653 5689999999999999999999999999999999999998876 8999999998753221
Q ss_pred CCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHHHHhC
Q 003542 371 SRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAG 450 (811)
Q Consensus 371 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i~~~ 450 (811)
. .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+... ..+...+..+
T Consensus 150 ~-------~~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~el~~g~~Pf~~~~~--~~~~~~i~~~ 211 (320)
T cd05590 150 G-------KTTSTFCGTPDYIAPEILQEM---------LYGPSVDWWAMGVLLYEMLCGHAPFEAENE--DDLFEAILND 211 (320)
T ss_pred C-------CcccccccCccccCHHHHcCC---------CCCCccchhhhHHHHHHHhhCCCCCCCCCH--HHHHHHHhcC
Confidence 1 122345689999999999643 678899999999999999999999986542 3344445443
Q ss_pred CCCCCCCCChHHHHHHHhhhccCCCCCCCCH
Q 003542 451 ERPLFPSGSPKYLVNLTKKCWHTNPSQRPSF 481 (811)
Q Consensus 451 ~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~ 481 (811)
...+|...+.++.+||.+||..||.+||++
T Consensus 212 -~~~~~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 212 -EVVYPTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred -CCCCCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 344677788999999999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=322.35 Aligned_cols=233 Identities=23% Similarity=0.390 Sum_probs=187.4
Q ss_pred ceEEeeeecccc---eEEEEEE-cCCEEEEEEecc-------cHHHHHHHHHHHHhCCCC-ccceeeeeEEccCCCeEEE
Q 003542 217 KLMVRRRLGASS---QFKEIQW-LGDSFVLRHFYG-------ELESLNAEISTMLSLSHP-NIVQYLCGFCDEEKKEFFL 284 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v~~-~g~~VAVK~~~~-------~~~~~~~Ei~iL~~L~HP-NIVkl~~~~~~e~~~~~yL 284 (811)
+|++++.||.|+ ||++... +++.||||++.. ..+.+..|+.++..++|+ +|+++++.+ .+.+.+|+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~--~~~~~~~l 78 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF--QTMDRLYF 78 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEE--EcCCEEEE
Confidence 478888899885 7776533 678999999853 345678899999999765 577877666 34567999
Q ss_pred EEecCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccc
Q 003542 285 VMELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGL 363 (811)
Q Consensus 285 VmEy~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGl 363 (811)
|||||+ |+|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 79 v~E~~~~g~L~~~~~~~------~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~-----~~kL~Dfg~ 147 (324)
T cd05587 79 VMEYVNGGDLMYHIQQV------GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEG-----HIKIADFGM 147 (324)
T ss_pred EEcCCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCC-----CEEEeecCc
Confidence 999998 5888888653 5689999999999999999999999999999999999998876 899999999
Q ss_pred cccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHH
Q 003542 364 STARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKM 443 (811)
Q Consensus 364 A~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i 443 (811)
+....... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.. ....
T Consensus 148 ~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslGvil~elltG~~pf~~~~--~~~~ 209 (324)
T cd05587 148 CKENIFGG-------KTTRTFCGTPDYIAPEIIAYQ---------PYGKSVDWWAFGVLLYEMLAGQPPFDGED--EDEL 209 (324)
T ss_pred ceecCCCC-------CceeeecCCccccChhhhcCC---------CCCcccchhhhHHHHHHHHhCCCCCCCCC--HHHH
Confidence 86432211 112345689999999999753 57889999999999999999999998653 2334
Q ss_pred HHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCH
Q 003542 444 TKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSF 481 (811)
Q Consensus 444 ~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~ 481 (811)
...+... ...+|...+..+.+++.+||..||.+|++.
T Consensus 210 ~~~i~~~-~~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 210 FQSIMEH-NVSYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred HHHHHcC-CCCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 4444443 345677889999999999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=305.91 Aligned_cols=244 Identities=30% Similarity=0.541 Sum_probs=199.0
Q ss_pred hcceEEeeeecccc---eEEEEEEcCCEEEEEEecc--cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEecC
Q 003542 215 LKKLMVRRRLGASS---QFKEIQWLGDSFVLRHFYG--ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELM 289 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~~~g~~VAVK~~~~--~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~ 289 (811)
.++|++.+.||.|+ +|++ ...|..||+|.+.. ..+.+.+|+.++++++||||+++++.+. ......|+||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~-~~~~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~~lv~e~~ 82 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLG-DYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV-EEKGGLYIVTEYM 82 (256)
T ss_pred HHhCeeeeeecccCCCeEEEE-EEcCCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEE-cCCCceEEEEECC
Confidence 35788889999886 6664 45789999999964 3467899999999999999999986654 3445689999999
Q ss_pred C-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccccccc
Q 003542 290 S-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTART 368 (811)
Q Consensus 290 ~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~ 368 (811)
+ ++|.+++.+. ....+++..++.++.||+.||.|||++|++||||||+||+++.++ .+||+|||++....
T Consensus 83 ~~~~L~~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~-----~~kl~dfg~~~~~~ 153 (256)
T cd05082 83 AKGSLVDYLRSR----GRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDN-----VAKVSDFGLTKEAS 153 (256)
T ss_pred CCCcHHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCC-----cEEecCCccceecc
Confidence 8 5999988753 224588999999999999999999999999999999999998876 89999999987543
Q ss_pred ccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CCCCCCCCccchHHHHHHH
Q 003542 369 YASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGDKMTKNI 447 (811)
Q Consensus 369 ~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~~PF~~~~~~~~~i~~~i 447 (811)
... ....++..|+|||++.+. .++.++|||||||++|+|++ |+.||..... ......+
T Consensus 154 ~~~----------~~~~~~~~y~aPE~~~~~---------~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~--~~~~~~~ 212 (256)
T cd05082 154 STQ----------DTGKLPVKWTAPEALREK---------KFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPRV 212 (256)
T ss_pred ccC----------CCCccceeecCHHHHccC---------CCCchhhhHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHH
Confidence 221 123345679999998643 57889999999999999997 9999976432 3344555
Q ss_pred HhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHH
Q 003542 448 RAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRY 490 (811)
Q Consensus 448 ~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~ 490 (811)
..+..+..+..+++.+.+++.+||..+|.+|||+.++++.|+.
T Consensus 213 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 213 EKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 5565666677889999999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=321.83 Aligned_cols=229 Identities=25% Similarity=0.429 Sum_probs=183.1
Q ss_pred eccc---ceEEEEE-EcCCEEEEEEecc-------cHHHHHHHHHHHHhC-CCCccceeeeeEEccCCCeEEEEEecCCC
Q 003542 224 LGAS---SQFKEIQ-WLGDSFVLRHFYG-------ELESLNAEISTMLSL-SHPNIVQYLCGFCDEEKKEFFLVMELMSK 291 (811)
Q Consensus 224 lG~G---~vyk~v~-~~g~~VAVK~~~~-------~~~~~~~Ei~iL~~L-~HPNIVkl~~~~~~e~~~~~yLVmEy~~g 291 (811)
||+| .||++.. .+++.||||.+.. ..+.+..|..++..+ +||||+++++.+ .....+|+||||++|
T Consensus 3 lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~--~~~~~~~lv~e~~~g 80 (316)
T cd05592 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTF--QTKEHLFFVMEYLNG 80 (316)
T ss_pred eeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEE--EcCCEEEEEEcCCCC
Confidence 4555 4777663 3688999999853 234566777777755 899999999777 445689999999984
Q ss_pred -CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccccccccc
Q 003542 292 -DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYA 370 (811)
Q Consensus 292 -~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~ 370 (811)
+|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++......
T Consensus 81 g~L~~~~~~~------~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~-----~~kL~Dfg~a~~~~~~ 149 (316)
T cd05592 81 GDLMFHIQSS------GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDG-----HIKIADFGMCKENMNG 149 (316)
T ss_pred CcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCC-----CEEEccCcCCeECCCC
Confidence 888887653 5689999999999999999999999999999999999998776 8999999998754322
Q ss_pred CCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHHHHhC
Q 003542 371 SRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAG 450 (811)
Q Consensus 371 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i~~~ 450 (811)
. .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+... ..+...+..
T Consensus 150 ~-------~~~~~~~gt~~y~aPE~~~~~---------~~~~~~DvwslG~il~ell~G~~Pf~~~~~--~~~~~~i~~- 210 (316)
T cd05592 150 E-------GKASTFCGTPDYIAPEILKGQ---------KYNESVDWWSFGVLLYEMLIGQSPFHGEDE--DELFDSILN- 210 (316)
T ss_pred C-------CccccccCCccccCHHHHcCC---------CCCCcccchhHHHHHHHHHhCCCCCCCCCH--HHHHHHHHc-
Confidence 1 122345689999999999743 678899999999999999999999986543 333444433
Q ss_pred CCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHH
Q 003542 451 ERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSI 484 (811)
Q Consensus 451 ~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eI 484 (811)
..+.+|..++.++.+||.+||..||.+||++.+.
T Consensus 211 ~~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~ 244 (316)
T cd05592 211 DRPHFPRWISKEAKDCLSKLFERDPTKRLGVDGD 244 (316)
T ss_pred CCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHH
Confidence 4556778889999999999999999999997543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=307.21 Aligned_cols=246 Identities=25% Similarity=0.466 Sum_probs=200.7
Q ss_pred hcceEEeeeecccc---eEEEEEEcCCEEEEEEecc---cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEec
Q 003542 215 LKKLMVRRRLGASS---QFKEIQWLGDSFVLRHFYG---ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMEL 288 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~~~g~~VAVK~~~~---~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy 288 (811)
.+.|++.++||.|+ +|++...+++.||+|.+.. ....+.+|+.+++.++||||+++++.+. ...+|+||||
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~---~~~~~~v~e~ 81 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT---QEPIYIITEY 81 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc---cCCcEEEEEc
Confidence 46789999999986 7877766889999999964 3467899999999999999999986552 3458999999
Q ss_pred CC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccc
Q 003542 289 MS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTAR 367 (811)
Q Consensus 289 ~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~ 367 (811)
+. ++|.+++... ....+++..+..++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++...
T Consensus 82 ~~~~~L~~~~~~~----~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~-----~~~l~dfg~~~~~ 152 (260)
T cd05067 82 MENGSLVDFLKTP----EGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETL-----CCKIADFGLARLI 152 (260)
T ss_pred CCCCCHHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCC-----CEEEccCcceeec
Confidence 98 5899888653 224688999999999999999999999999999999999998776 8999999998765
Q ss_pred cccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CCCCCCCCccchHHHHHH
Q 003542 368 TYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGDKMTKN 446 (811)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~~PF~~~~~~~~~i~~~ 446 (811)
..... .......++..|+|||++.. ..++.++||||||+++|+|++ |++||.+... ......
T Consensus 153 ~~~~~------~~~~~~~~~~~y~~pe~~~~---------~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~ 215 (260)
T cd05067 153 EDNEY------TAREGAKFPIKWTAPEAINY---------GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN--PEVIQN 215 (260)
T ss_pred CCCCc------ccccCCcccccccCHHHhcc---------CCcCcccchHHHHHHHHHHHhCCCCCCCCCCh--HHHHHH
Confidence 42211 11123345678999999864 357889999999999999999 9999976532 334455
Q ss_pred HHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHH
Q 003542 447 IRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILR 489 (811)
Q Consensus 447 i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~ 489 (811)
+..+.....+...+.++.+++.+||..+|.+||++++++..|+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 258 (260)
T cd05067 216 LERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLE 258 (260)
T ss_pred HHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhh
Confidence 5555555667778899999999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=307.17 Aligned_cols=244 Identities=27% Similarity=0.466 Sum_probs=196.2
Q ss_pred cceEEeeeecccc---eEEEEEEcCCEEEEEEecc---cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEecC
Q 003542 216 KKLMVRRRLGASS---QFKEIQWLGDSFVLRHFYG---ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELM 289 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~~~g~~VAVK~~~~---~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~ 289 (811)
.+|++.+.||.|+ ||.+....+..+|+|.+.. ....+.+|+.+++.++||||+++++.+ ......|+||||+
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~--~~~~~~~lv~e~~ 81 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC--TKQRPIFIVTEYM 81 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEE--cCCCceEEEEecC
Confidence 4577788888885 7776555667899999864 345788999999999999999998766 4456789999999
Q ss_pred CC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccccccc
Q 003542 290 SK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTART 368 (811)
Q Consensus 290 ~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~ 368 (811)
+| +|.+++... ...+++..++.++.||+.||.|||+.|++||||||+||+++.++ .+||+|||++....
T Consensus 82 ~~~~L~~~l~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~-----~~kl~dfg~~~~~~ 151 (256)
T cd05059 82 ANGCLLNYLRER-----KGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDN-----VVKVSDFGLARYVL 151 (256)
T ss_pred CCCCHHHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCC-----cEEECCcccceecc
Confidence 85 899988753 13689999999999999999999999999999999999998876 89999999987553
Q ss_pred ccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CCCCCCCCccchHHHHHHH
Q 003542 369 YASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGDKMTKNI 447 (811)
Q Consensus 369 ~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~~PF~~~~~~~~~i~~~i 447 (811)
.... .......++..|+|||.+.+. .++.++||||||+++|+|++ |..||..... ......+
T Consensus 152 ~~~~------~~~~~~~~~~~y~~Pe~~~~~---------~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~~~ 214 (256)
T cd05059 152 DDQY------TSSQGTKFPVKWAPPEVFDYS---------RFSSKSDVWSFGVLMWEVFSEGKMPYERFSN--SEVVESV 214 (256)
T ss_pred cccc------cccCCCCCCccccCHHHhccC---------CCCchhhHHHHHHHHHHHhccCCCCCCCCCH--HHHHHHH
Confidence 2210 111122345679999998743 67889999999999999999 8999976432 3344556
Q ss_pred HhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHH
Q 003542 448 RAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRIL 488 (811)
Q Consensus 448 ~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L 488 (811)
..+.....+..++..+.+++.+||..+|.+|||+.++++.|
T Consensus 215 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 215 SAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 66656666778899999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=316.79 Aligned_cols=249 Identities=22% Similarity=0.424 Sum_probs=198.3
Q ss_pred cceEEeeeecccc---eEEEEEE-cCC----EEEEEEecc-----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeE
Q 003542 216 KKLMVRRRLGASS---QFKEIQW-LGD----SFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEF 282 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~~-~g~----~VAVK~~~~-----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~ 282 (811)
.+|++.+.||+|+ ||++... .|+ .||+|.+.. ....+.+|+.+++.++||||+++++.+.. ...
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~---~~~ 83 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT---STV 83 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC---CCc
Confidence 5788999999886 7777633 444 489999853 24678899999999999999999965532 246
Q ss_pred EEEEecCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeec
Q 003542 283 FLVMELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGF 361 (811)
Q Consensus 283 yLVmEy~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DF 361 (811)
++|+||++ |+|.+++... ...+++..++.++.||+.||+|||+.||+||||||+|||++.++ .+||+||
T Consensus 84 ~~v~e~~~~g~l~~~l~~~-----~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~-----~~kl~Df 153 (316)
T cd05108 84 QLITQLMPFGCLLDYVREH-----KDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQ-----HVKITDF 153 (316)
T ss_pred eeeeecCCCCCHHHHHHhc-----cccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCC-----cEEEccc
Confidence 89999998 6899988763 24588899999999999999999999999999999999998766 8999999
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CCCCCCCCccch
Q 003542 362 GLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQG 440 (811)
Q Consensus 362 GlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~~PF~~~~~~~ 440 (811)
|+++........ .......++..|+|||++.+. .++.++|||||||++|||++ |..||.+...
T Consensus 154 G~a~~~~~~~~~-----~~~~~~~~~~~y~apE~~~~~---------~~~~~~Di~slGv~l~el~t~g~~p~~~~~~-- 217 (316)
T cd05108 154 GLAKLLGADEKE-----YHAEGGKVPIKWMALESILHR---------IYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-- 217 (316)
T ss_pred cccccccCCCcc-----eeccCCccceeecChHHhccC---------CCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--
Confidence 999876433211 111223346789999998643 67899999999999999997 9999976432
Q ss_pred HHHHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHHHH
Q 003542 441 DKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKK 493 (811)
Q Consensus 441 ~~i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~k 493 (811)
..+...+..+...+.+..++..+.+++.+||..+|.+||++.+++..+..+.+
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 218 SEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred HHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 33445555566666677888899999999999999999999999988766543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=326.08 Aligned_cols=245 Identities=21% Similarity=0.304 Sum_probs=192.7
Q ss_pred hcceEEeeeecccc---eEEEEE-EcCCEEEEEEecc-------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEE
Q 003542 215 LKKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG-------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFF 283 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~-------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~y 283 (811)
.++|++.+.||+|+ ||.+.. .+++.||+|.+.. ....+.+|+.+++.++||||+++++.+ .+...+|
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~--~~~~~~~ 119 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAF--QDDKYLY 119 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE--EcCCEEE
Confidence 35799999999986 666553 3688999999853 234578999999999999999999777 4566899
Q ss_pred EEEecCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecc
Q 003542 284 LVMELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFG 362 (811)
Q Consensus 284 LVmEy~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFG 362 (811)
+|||||+ |+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 120 lv~Ey~~gg~L~~~l~~-------~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~-----~~kL~DFG 187 (370)
T cd05621 120 MVMEYMPGGDLVNLMSN-------YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHG-----HLKLADFG 187 (370)
T ss_pred EEEcCCCCCcHHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCC-----CEEEEecc
Confidence 9999998 589888864 4588999999999999999999999999999999999998776 89999999
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHH
Q 003542 363 LSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDK 442 (811)
Q Consensus 363 lA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~ 442 (811)
++....... ........||+.|+|||++.+... ...++.++|||||||++|+|++|..||.+.... .
T Consensus 188 ~a~~~~~~~------~~~~~~~~gt~~Y~aPE~~~~~~~-----~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~--~ 254 (370)
T cd05621 188 TCMKMDETG------MVRCDTAVGTPDYISPEVLKSQGG-----DGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV--G 254 (370)
T ss_pred cceecccCC------ceecccCCCCcccCCHHHHhccCC-----CCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH--H
Confidence 997653221 111235679999999999975421 224788999999999999999999999865432 2
Q ss_pred HHHHHHhC-CCCCCCC--CChHHHHHHHhhhccCCCCC--CCCHHHHHH
Q 003542 443 MTKNIRAG-ERPLFPS--GSPKYLVNLTKKCWHTNPSQ--RPSFSSICR 486 (811)
Q Consensus 443 i~~~i~~~-~~~~~p~--~~~~~l~~LI~~cL~~DP~~--RPS~~eIl~ 486 (811)
....+... ....+|. ..+..+.+++..||..++.+ |+++.++++
T Consensus 255 ~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~ 303 (370)
T cd05621 255 TYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQ 303 (370)
T ss_pred HHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhc
Confidence 33344332 2333444 45888999999999855543 889999877
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=322.86 Aligned_cols=247 Identities=20% Similarity=0.351 Sum_probs=194.1
Q ss_pred cceEEeeeecccc---eEEEEE-EcCCEEEEEEecc-------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEE
Q 003542 216 KKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG-------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFL 284 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~-------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yL 284 (811)
++|++.+.||.|+ ||++.. .+|+.||||.+.. ....+.+|+.+++.++||||+++++.+ .+...+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~--~~~~~~~l 78 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAF--QDKDNLYL 78 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEE--ecCCeEEE
Confidence 3688899999986 666553 4789999999963 235688999999999999999998776 44567999
Q ss_pred EEecCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccc
Q 003542 285 VMELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGL 363 (811)
Q Consensus 285 VmEy~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGl 363 (811)
|||||+ |+|.+++... ...+++..+..++.||+.||.|||+.||+||||||+|||++.++ .+||+|||+
T Consensus 79 v~e~~~~~~L~~~l~~~-----~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~-----~~kL~Dfg~ 148 (330)
T cd05601 79 VMEYQPGGDLLSLLNRY-----EDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTG-----HIKLADFGS 148 (330)
T ss_pred EECCCCCCCHHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCC-----CEEeccCCC
Confidence 999998 5899888753 24689999999999999999999999999999999999998876 899999999
Q ss_pred cccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHH
Q 003542 364 STARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKM 443 (811)
Q Consensus 364 A~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i 443 (811)
+........ .......||+.|+|||++...... ....++.++|||||||++|+|++|..||...... ..
T Consensus 149 a~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~---~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~--~~ 217 (330)
T cd05601 149 AARLTANKM------VNSKLPVGTPDYIAPEVLTTMNGD---GKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA--KT 217 (330)
T ss_pred CeECCCCCc------eeeecccCCccccCHHHhcccccc---ccCCCCCcceeecccceeeeeccCCCCCCCCCHH--HH
Confidence 976543221 112234689999999998743211 1336789999999999999999999999765422 22
Q ss_pred HHHHHhCC-CCCCC--CCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 444 TKNIRAGE-RPLFP--SGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 444 ~~~i~~~~-~~~~p--~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
...+.... ...+| ...+..+.+||..||. +|.+||++.+++.
T Consensus 218 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 218 YNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred HHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 33333322 22233 3568889999999998 9999999999875
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=320.15 Aligned_cols=231 Identities=23% Similarity=0.392 Sum_probs=185.2
Q ss_pred ecccc---eEEEEEE-cCCEEEEEEecc-------cHHHHHHHHHHHHhC-CCCccceeeeeEEccCCCeEEEEEecCCC
Q 003542 224 LGASS---QFKEIQW-LGDSFVLRHFYG-------ELESLNAEISTMLSL-SHPNIVQYLCGFCDEEKKEFFLVMELMSK 291 (811)
Q Consensus 224 lG~G~---vyk~v~~-~g~~VAVK~~~~-------~~~~~~~Ei~iL~~L-~HPNIVkl~~~~~~e~~~~~yLVmEy~~g 291 (811)
||+|+ ||++... +|+.||||++.. ....+..|+.++..+ +||||+++++.+ .....+|||||||++
T Consensus 3 lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~--~~~~~~~lv~E~~~~ 80 (321)
T cd05591 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCF--QTKDRLFFVMEYVNG 80 (321)
T ss_pred cccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEE--EcCCeEEEEEeCCCC
Confidence 55553 7776643 678999999863 234577899999876 799999999777 445679999999995
Q ss_pred -CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccccccccc
Q 003542 292 -DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYA 370 (811)
Q Consensus 292 -~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~ 370 (811)
+|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++......
T Consensus 81 ~~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~-----~~kL~Dfg~~~~~~~~ 149 (321)
T cd05591 81 GDLMFQIQRS------RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEG-----HCKLADFGMCKEGILN 149 (321)
T ss_pred CcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC-----CEEEeecccceecccC
Confidence 888887653 5689999999999999999999999999999999999998876 8999999998753222
Q ss_pred CCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHHHHhC
Q 003542 371 SRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAG 450 (811)
Q Consensus 371 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i~~~ 450 (811)
. .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.... .......+..+
T Consensus 150 ~-------~~~~~~~gt~~y~aPE~~~~~---------~~~~~~DvwslG~il~el~tg~~Pf~~~~--~~~~~~~i~~~ 211 (321)
T cd05591 150 G-------VTTTTFCGTPDYIAPEILQEL---------EYGPSVDWWALGVLMYEMMAGQPPFEADN--EDDLFESILHD 211 (321)
T ss_pred C-------ccccccccCccccCHHHHcCC---------CCCCccceechhHHHHHHhcCCCCCCCCC--HHHHHHHHHcC
Confidence 1 122345689999999998643 67889999999999999999999998654 23344455443
Q ss_pred CCCCCCCCChHHHHHHHhhhccCCCCCCC-------CHHHHHH
Q 003542 451 ERPLFPSGSPKYLVNLTKKCWHTNPSQRP-------SFSSICR 486 (811)
Q Consensus 451 ~~~~~p~~~~~~l~~LI~~cL~~DP~~RP-------S~~eIl~ 486 (811)
. ..+|..++.++.+||.+||..||.+|| ++.++++
T Consensus 212 ~-~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 212 D-VLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred C-CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 3 345677889999999999999999999 6677654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=332.45 Aligned_cols=233 Identities=21% Similarity=0.383 Sum_probs=194.0
Q ss_pred eecccc---eEEEE-EEcCCEEEEEEec-------ccHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEecCCC
Q 003542 223 RLGASS---QFKEI-QWLGDSFVLRHFY-------GELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK 291 (811)
Q Consensus 223 ~lG~G~---vyk~v-~~~g~~VAVK~~~-------~~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~~g 291 (811)
.||.|+ ||-+. ..+.+.||||++. ....++.+|+..|.+|.|||+|.|-++|.- ....|||||||-|
T Consensus 33 EIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLr--e~TaWLVMEYClG 110 (948)
T KOG0577|consen 33 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLR--EHTAWLVMEYCLG 110 (948)
T ss_pred HhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeec--cchHHHHHHHHhc
Confidence 345552 55544 3478899999994 135789999999999999999999877753 3458999999999
Q ss_pred CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccccccC
Q 003542 292 DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYAS 371 (811)
Q Consensus 292 ~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~~ 371 (811)
+-.+.+.-. +.++.+.++..|..+.+.||.|||+++.||||||..|||++..| .|||+|||.|....
T Consensus 111 SAsDlleVh-----kKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g-----~VKLaDFGSAsi~~--- 177 (948)
T KOG0577|consen 111 SASDLLEVH-----KKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPG-----LVKLADFGSASIMA--- 177 (948)
T ss_pred cHHHHHHHH-----hccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCC-----eeeeccccchhhcC---
Confidence 766655432 26899999999999999999999999999999999999999888 99999999987653
Q ss_pred CCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHHHHhCC
Q 003542 372 RNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGE 451 (811)
Q Consensus 372 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i~~~~ 451 (811)
...+++|||.|||||++..- .-+.|+-++|||||||++.||+-.++|+... ........|....
T Consensus 178 --------PAnsFvGTPywMAPEVILAM------DEGqYdgkvDvWSLGITCIELAERkPPlFnM--NAMSALYHIAQNe 241 (948)
T KOG0577|consen 178 --------PANSFVGTPYWMAPEVILAM------DEGQYDGKVDVWSLGITCIELAERKPPLFNM--NAMSALYHIAQNE 241 (948)
T ss_pred --------chhcccCCccccchhHheec------cccccCCccceeeccchhhhhhhcCCCccCc--hHHHHHHHHHhcC
Confidence 33578999999999999854 3568999999999999999999999998753 3444566777777
Q ss_pred CCCCC-CCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 452 RPLFP-SGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 452 ~~~~p-~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
.|.++ ..++.+++.|+..||..-|.+|||.+++++
T Consensus 242 sPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 242 SPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred CCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 77665 467889999999999999999999999987
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=303.31 Aligned_cols=241 Identities=24% Similarity=0.398 Sum_probs=197.9
Q ss_pred ceEEeeeecccc---eEEEEE-EcCCEEEEEEecc------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEE
Q 003542 217 KLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVM 286 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVm 286 (811)
+|.+.+.||.|+ +|++.. .+|+.||+|.+.. ....+.+|+.+++.++||||+++++.+. +.+.+|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~ 78 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFL--DKGKLNIVM 78 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeec--cCCEEEEEE
Confidence 367778888875 777663 3789999999842 4567899999999999999999997774 456799999
Q ss_pred ecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccc
Q 003542 287 ELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365 (811)
Q Consensus 287 Ey~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~ 365 (811)
||++| +|.+++... ....+++..++.++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++.
T Consensus 79 e~~~~~~L~~~l~~~----~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~-----~~~l~df~~~~ 149 (256)
T cd08529 79 EYAENGDLHKLLKMQ----RGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYD-----NVKIGDLGVAK 149 (256)
T ss_pred EeCCCCcHHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCC-----CEEEcccccce
Confidence 99985 999988763 125688999999999999999999999999999999999998776 89999999987
Q ss_pred cccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHH
Q 003542 366 ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTK 445 (811)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~ 445 (811)
....... ......|++.|+|||++.+. .++.++||||||+++|+|++|+.||.... ......
T Consensus 150 ~~~~~~~-------~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~ 211 (256)
T cd08529 150 LLSDNTN-------FANTIVGTPYYLSPELCEDK---------PYNEKSDVWALGVVLYECCTGKHPFDANN--QGALIL 211 (256)
T ss_pred eccCccc-------hhhccccCccccCHHHhcCC---------CCCCccchHHHHHHHHHHHhCCCCCCCCC--HHHHHH
Confidence 6543211 12234578889999998743 57789999999999999999999997654 334445
Q ss_pred HHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 446 NIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 446 ~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
.+..+..+..+...+..+.+++.+||+.+|++||++.++++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 212 KIIRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred HHHcCCCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 55666666677778889999999999999999999999976
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=306.21 Aligned_cols=238 Identities=28% Similarity=0.482 Sum_probs=190.7
Q ss_pred eccc---ceEEEEE---EcCCEEEEEEecc------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEecCC-
Q 003542 224 LGAS---SQFKEIQ---WLGDSFVLRHFYG------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMS- 290 (811)
Q Consensus 224 lG~G---~vyk~v~---~~g~~VAVK~~~~------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~~- 290 (811)
||+| .||++.. .++..||+|++.. ..+.+.+|+.+++.++||||+++++.+ + ...+++||||++
T Consensus 3 lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~-~~~~~lv~e~~~~ 79 (257)
T cd05116 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGIC--E-AESWMLVMELAEL 79 (257)
T ss_pred CCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEE--c-CCCcEEEEecCCC
Confidence 4555 3787652 2678999999853 245789999999999999999998654 2 345799999999
Q ss_pred CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccccccccc
Q 003542 291 KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYA 370 (811)
Q Consensus 291 g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~ 370 (811)
++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++......
T Consensus 80 ~~L~~~l~~~------~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~-----~~kl~Dfg~~~~~~~~ 148 (257)
T cd05116 80 GPLNKFLQKN------KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQH-----YAKISDFGLSKALGAD 148 (257)
T ss_pred CcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCC-----eEEECCCccccccCCC
Confidence 5898888643 5689999999999999999999999999999999999998765 8999999998765432
Q ss_pred CCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CCCCCCCCccchHHHHHHHHh
Q 003542 371 SRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGDKMTKNIRA 449 (811)
Q Consensus 371 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~~PF~~~~~~~~~i~~~i~~ 449 (811)
... ........++..|+|||.+.. ..++.++|||||||++|||++ |..||.+.. ...+...+..
T Consensus 149 ~~~----~~~~~~~~~~~~y~aPE~~~~---------~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--~~~~~~~i~~ 213 (257)
T cd05116 149 ENY----YKAKTHGKWPVKWYAPECMNY---------YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMK--GNEVTQMIES 213 (257)
T ss_pred CCe----eeecCCCCCCccccCHhHhcc---------CCcCchhHHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHC
Confidence 210 011122334678999999853 367789999999999999998 999997643 3345566777
Q ss_pred CCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHH
Q 003542 450 GERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRY 490 (811)
Q Consensus 450 ~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~ 490 (811)
+..+..|..+++++.+||.+||+.||.+||++++|...|+.
T Consensus 214 ~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 214 GERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 77777888899999999999999999999999999887754
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=306.27 Aligned_cols=246 Identities=27% Similarity=0.465 Sum_probs=198.6
Q ss_pred hcceEEeeeecccc---eEEEEEEcCCEEEEEEecc---cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEec
Q 003542 215 LKKLMVRRRLGASS---QFKEIQWLGDSFVLRHFYG---ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMEL 288 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~~~g~~VAVK~~~~---~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy 288 (811)
.++|++.+.||+|+ +|++....+..||+|.+.. ..+.+.+|+.++++++||||+++++.+ .. ...|+||||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~--~~-~~~~lv~e~ 81 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVV--SE-EPIYIVTEY 81 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEE--CC-CCcEEEEEe
Confidence 35678888888886 7877666778899999964 356799999999999999999998654 22 347999999
Q ss_pred CCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccc
Q 003542 289 MSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTAR 367 (811)
Q Consensus 289 ~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~ 367 (811)
+++ +|.+++... ....+++..+..++.|++.||.|||+.+++||||||+||+++.++ .++|+|||++...
T Consensus 82 ~~~~~L~~~~~~~----~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~-----~~~l~dfg~~~~~ 152 (260)
T cd05070 82 MSKGSLLDFLKDG----EGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGL-----VCKIADFGLARLI 152 (260)
T ss_pred cCCCcHHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCc-----eEEeCCceeeeec
Confidence 984 899988753 124589999999999999999999999999999999999998776 8999999999765
Q ss_pred cccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CCCCCCCCccchHHHHHH
Q 003542 368 TYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGDKMTKN 446 (811)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~~PF~~~~~~~~~i~~~ 446 (811)
..... .......++..|+|||++.+ ..++.++||||||+++|+|++ |.+||.+.. .......
T Consensus 153 ~~~~~------~~~~~~~~~~~y~aPE~~~~---------~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~--~~~~~~~ 215 (260)
T cd05070 153 EDNEY------TARQGAKFPIKWTAPEAALY---------GRFTIKSDVWSFGILLTELVTKGRVPYPGMN--NREVLEQ 215 (260)
T ss_pred cCccc------ccccCCCCCccccChHHHhc---------CCCcchhhhHHHHHHHHHHHhcCCCCCCCCC--HHHHHHH
Confidence 43211 11123345677999999864 367889999999999999999 999997643 3344555
Q ss_pred HHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHH
Q 003542 447 IRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILR 489 (811)
Q Consensus 447 i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~ 489 (811)
+..+..+..+...+..+.+|+.+||..+|.+|||+.++.+.|+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 258 (260)
T cd05070 216 VERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLE 258 (260)
T ss_pred HHcCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHh
Confidence 6555566677788899999999999999999999999987765
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=328.17 Aligned_cols=245 Identities=21% Similarity=0.320 Sum_probs=189.7
Q ss_pred ceEEeeeecccc---eEEEEE-EcCCEEEEEEecc------cHHHHHHHHHHHHhCCCCccceeeeeEEccCC---CeEE
Q 003542 217 KLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEK---KEFF 283 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~---~~~y 283 (811)
+|++.+.||.|+ ||++.. .+|+.||||.+.. ....+.+|+.+|+.++||||+++++.+..... ..+|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 367778888875 777663 4789999999853 23568899999999999999999977743221 2689
Q ss_pred EEEecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccc
Q 003542 284 LVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGL 363 (811)
Q Consensus 284 LVmEy~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGl 363 (811)
+||||+.++|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 81 lv~e~~~~~l~~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~-----~~kL~Dfg~ 149 (372)
T cd07853 81 VVTELMQSDLHKIIVSP------QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNC-----VLKICDFGL 149 (372)
T ss_pred EEeeccccCHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCC-----CEEeccccc
Confidence 99999999988887642 5789999999999999999999999999999999999998876 899999999
Q ss_pred cccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHH
Q 003542 364 STARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKM 443 (811)
Q Consensus 364 A~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i 443 (811)
+....... ........+|+.|+|||++.+. ..++.++|||||||++|||++|+.||.+..... .+
T Consensus 150 a~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~--------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~ 214 (372)
T cd07853 150 ARVEEPDE------SKHMTQEVVTQYYRAPEILMGS--------RHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ-QL 214 (372)
T ss_pred eeecccCc------cccCCCCCcCCCcCCHHHHcCC--------CCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH-HH
Confidence 97653321 1122344678899999998752 357889999999999999999999997654221 11
Q ss_pred HH----------------------HHHh-CCCC-------CCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHH
Q 003542 444 TK----------------------NIRA-GERP-------LFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRI 487 (811)
Q Consensus 444 ~~----------------------~i~~-~~~~-------~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~ 487 (811)
.. .+.. ...+ ......++++.+||.+||..||.+|||+.+++.+
T Consensus 215 ~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 215 DLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00 0111 1111 1223457789999999999999999999999873
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=321.64 Aligned_cols=229 Identities=23% Similarity=0.368 Sum_probs=184.0
Q ss_pred eeccc---ceEEEEE----EcCCEEEEEEecc------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEecC
Q 003542 223 RLGAS---SQFKEIQ----WLGDSFVLRHFYG------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELM 289 (811)
Q Consensus 223 ~lG~G---~vyk~v~----~~g~~VAVK~~~~------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~ 289 (811)
.||+| .||.+.. .+|+.||+|++.. ....+..|+.+|++++||||+++++.+. +...+|+|||||
T Consensus 3 ~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~~lv~e~~ 80 (318)
T cd05582 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQ--TEGKLYLILDFL 80 (318)
T ss_pred eeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEE--cCCEEEEEEcCC
Confidence 45555 3776553 3688999999963 2345778999999999999999997774 456799999999
Q ss_pred C-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccccccc
Q 003542 290 S-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTART 368 (811)
Q Consensus 290 ~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~ 368 (811)
+ |+|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+||+|||++....
T Consensus 81 ~~~~L~~~l~~~------~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-----~~kL~Dfg~~~~~~ 149 (318)
T cd05582 81 RGGDLFTRLSKE------VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEG-----HIKLTDFGLSKESI 149 (318)
T ss_pred CCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCC-----cEEEeeccCCcccC
Confidence 8 5898888653 5689999999999999999999999999999999999998776 89999999987543
Q ss_pred ccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHHHH
Q 003542 369 YASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIR 448 (811)
Q Consensus 369 ~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i~ 448 (811)
... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||..... ......+.
T Consensus 150 ~~~-------~~~~~~~g~~~y~aPE~~~~~---------~~~~~~DiwslG~il~el~tg~~p~~~~~~--~~~~~~i~ 211 (318)
T cd05582 150 DHE-------KKAYSFCGTVEYMAPEVVNRR---------GHTQSADWWSFGVLMFEMLTGSLPFQGKDR--KETMTMIL 211 (318)
T ss_pred CCC-------CceecccCChhhcCHHHHcCC---------CCCCccceeccceEeeeeccCCCCCCCCCH--HHHHHHHH
Confidence 221 122345789999999999743 567899999999999999999999976432 23333443
Q ss_pred hCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHH
Q 003542 449 AGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSS 483 (811)
Q Consensus 449 ~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~e 483 (811)
.. ...+|...++.+.+||.+||+.||.+||++.+
T Consensus 212 ~~-~~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 212 KA-KLGMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred cC-CCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 33 33467778899999999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=309.93 Aligned_cols=252 Identities=25% Similarity=0.420 Sum_probs=197.1
Q ss_pred hcceEEeeeecccc---eEEEEE------EcCCEEEEEEecc-----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCC
Q 003542 215 LKKLMVRRRLGASS---QFKEIQ------WLGDSFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKK 280 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~------~~g~~VAVK~~~~-----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~ 280 (811)
.++|++.+.||+|+ +|.+.. ..+..||||.+.. ....+.+|+.+++.++||||+++++.+ ....
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~--~~~~ 82 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV--SQGQ 82 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE--cCCC
Confidence 46789999999986 665542 1356799999853 235688999999999999999999766 4456
Q ss_pred eEEEEEecCC-CCHHHHHHHhhCCC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcce
Q 003542 281 EFFLVMELMS-KDLSCYMRETFGSR----RRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFH 355 (811)
Q Consensus 281 ~~yLVmEy~~-g~L~~~L~~~~~~~----~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~ 355 (811)
..++||||++ ++|.+++....... ....+++..+..++.|++.||.|||+.|++||||||+|||++.++ .
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~-----~ 157 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF-----T 157 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCC-----C
Confidence 7899999999 58999887532110 123467888999999999999999999999999999999998766 8
Q ss_pred EEEeeccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CCCCCC
Q 003542 356 VKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFE 434 (811)
Q Consensus 356 vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~~PF~ 434 (811)
++|+|||++......... .......+++.|+|||++.+. .++.++|||||||++|||++ |..||.
T Consensus 158 ~~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~~l~el~~~~~~p~~ 223 (277)
T cd05062 158 VKIGDFGMTRDIYETDYY-----RKGGKGLLPVRWMSPESLKDG---------VFTTYSDVWSFGVVLWEIATLAEQPYQ 223 (277)
T ss_pred EEECCCCCccccCCccee-----ecCCCCccCHhhcChhHhhcC---------CcCchhHHHHHHHHHHHHHcCCCCCCC
Confidence 999999998754322110 011223457789999998643 67889999999999999999 789997
Q ss_pred CCccchHHHHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHH
Q 003542 435 DGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILR 489 (811)
Q Consensus 435 ~~~~~~~~i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~ 489 (811)
+.. .......+..+..+..+..++..+.+++.+||+.||.+|||+.++++.|+
T Consensus 224 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 224 GMS--NEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred CCC--HHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 643 23445555555555667788999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=308.32 Aligned_cols=246 Identities=25% Similarity=0.489 Sum_probs=200.9
Q ss_pred cceEEeeeecccc---eEEEEEEcCCEEEEEEecc----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEec
Q 003542 216 KKLMVRRRLGASS---QFKEIQWLGDSFVLRHFYG----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMEL 288 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~~~g~~VAVK~~~~----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy 288 (811)
.+|++.+.||.|+ +|.+....+..+|+|.+.. ....+.+|+.+++.++||||+++++.+ .+...+|+||||
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~--~~~~~~~lv~e~ 83 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVC--SVGEPVYIITEL 83 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeE--ecCCCeEEEEee
Confidence 4566777777775 8887766789999999964 346789999999999999999998766 345678999999
Q ss_pred CCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccc
Q 003542 289 MSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTAR 367 (811)
Q Consensus 289 ~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~ 367 (811)
+++ +|.+++... ....+++..+..++.||+.||.|||++|++||||||+||+++.++ .+||+|||++...
T Consensus 84 ~~~~~L~~~~~~~----~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~-----~~kl~d~g~~~~~ 154 (261)
T cd05148 84 MEKGSLLAFLRSP----EGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDL-----VCKVADFGLARLI 154 (261)
T ss_pred cccCCHHHHHhcC----CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCc-----eEEEccccchhhc
Confidence 995 999988753 225689999999999999999999999999999999999998776 8999999998765
Q ss_pred cccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CCCCCCCCccchHHHHHH
Q 003542 368 TYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGDKMTKN 446 (811)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~~PF~~~~~~~~~i~~~ 446 (811)
..... ......++..|+|||++.+. .++.++||||||+++|+|++ |+.||.... .......
T Consensus 155 ~~~~~-------~~~~~~~~~~~~~PE~~~~~---------~~~~~~DiwslG~~l~~l~~~g~~p~~~~~--~~~~~~~ 216 (261)
T cd05148 155 KEDVY-------LSSDKKIPYKWTAPEAASHG---------TFSTKSDVWSFGILLYEMFTYGQVPYPGMN--NHEVYDQ 216 (261)
T ss_pred CCccc-------cccCCCCceEecCHHHHccC---------CCCchhhHHHHHHHHHHHHcCCCCCCCcCC--HHHHHHH
Confidence 33211 11234467789999998643 67789999999999999998 899997643 3344555
Q ss_pred HHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHH
Q 003542 447 IRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRY 490 (811)
Q Consensus 447 i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~ 490 (811)
+..+..+..+..+++.+.+++.+||..||.+|||+.+|++.|+.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 217 ITAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred HHhCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 55666666778889999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=321.19 Aligned_cols=228 Identities=18% Similarity=0.298 Sum_probs=180.1
Q ss_pred eccc---ceEEEEE-EcCCEEEEEEecc-------cHHHHHHHHHHHHhC-CCCccceeeeeEEccCCCeEEEEEecCCC
Q 003542 224 LGAS---SQFKEIQ-WLGDSFVLRHFYG-------ELESLNAEISTMLSL-SHPNIVQYLCGFCDEEKKEFFLVMELMSK 291 (811)
Q Consensus 224 lG~G---~vyk~v~-~~g~~VAVK~~~~-------~~~~~~~Ei~iL~~L-~HPNIVkl~~~~~~e~~~~~yLVmEy~~g 291 (811)
||+| .||++.. .+++.||+|++.. ....+..|+.++.++ +||||+++++.+. ....+|+|||||++
T Consensus 3 lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~--~~~~~~lv~E~~~~ 80 (329)
T cd05618 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ--TESRLFFVIEYVNG 80 (329)
T ss_pred eeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEE--eCCEEEEEEeCCCC
Confidence 4555 4777663 4788999999963 235578899998887 8999999998774 45679999999995
Q ss_pred -CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccccccccc
Q 003542 292 -DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYA 370 (811)
Q Consensus 292 -~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~ 370 (811)
+|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 81 ~~L~~~~~~~------~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~-----~~kL~DfG~~~~~~~~ 149 (329)
T cd05618 81 GDLMFHMQRQ------RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG-----HIKLTDYGMCKEGLRP 149 (329)
T ss_pred CCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCC-----CEEEeeCCccccccCC
Confidence 888777653 5789999999999999999999999999999999999998876 8999999998653221
Q ss_pred CCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCcc-------chHHH
Q 003542 371 SRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHL-------QGDKM 443 (811)
Q Consensus 371 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~-------~~~~i 443 (811)
. .......||+.|+|||++.+. .++.++|||||||++|+|++|..||..... ....+
T Consensus 150 ~-------~~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~ 213 (329)
T cd05618 150 G-------DTTSTFCGTPNYIAPEILRGE---------DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL 213 (329)
T ss_pred C-------CccccccCCccccCHHHHcCC---------CCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHH
Confidence 1 122345789999999999753 678899999999999999999999953111 11122
Q ss_pred HHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCH
Q 003542 444 TKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSF 481 (811)
Q Consensus 444 ~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~ 481 (811)
...+. .....+|...+..+.+||.+||..||.+||++
T Consensus 214 ~~~i~-~~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 214 FQVIL-EKQIRIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred HHHHh-cCCCCCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 22232 33445778888999999999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=310.80 Aligned_cols=255 Identities=24% Similarity=0.415 Sum_probs=202.6
Q ss_pred cceEEeeeecccc---eEEEEEE------cCCEEEEEEeccc----HHHHHHHHHHHHhCCCCccceeeeeEEccCCCeE
Q 003542 216 KKLMVRRRLGASS---QFKEIQW------LGDSFVLRHFYGE----LESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEF 282 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~~------~g~~VAVK~~~~~----~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~ 282 (811)
.+|.+.+.||+|+ +|.+... ++..+|+|.+... .+.+.+|+.++++++||||+++++.+ .....+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~ 82 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVC--GDGDPL 82 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEE--ccCCce
Confidence 4688888888885 7765532 3456999998642 35789999999999999999999766 345678
Q ss_pred EEEEecCC-CCHHHHHHHhhC----------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCC
Q 003542 283 FLVMELMS-KDLSCYMRETFG----------SRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSME 351 (811)
Q Consensus 283 yLVmEy~~-g~L~~~L~~~~~----------~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d 351 (811)
++||||++ ++|.+++..... ......+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~-- 160 (291)
T cd05094 83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL-- 160 (291)
T ss_pred EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC--
Confidence 99999998 599999875321 01123588999999999999999999999999999999999998776
Q ss_pred CcceEEEeeccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CC
Q 003542 352 GYFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GK 430 (811)
Q Consensus 352 ~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~ 430 (811)
.++|+|||++........ ........++..|+|||++.+. .++.++||||||+++|+|++ |.
T Consensus 161 ---~~~l~dfg~a~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~el~t~g~ 223 (291)
T cd05094 161 ---LVKIGDFGMSRDVYSTDY-----YRVGGHTMLPIRWMPPESIMYR---------KFTTESDVWSFGVILWEIFTYGK 223 (291)
T ss_pred ---cEEECCCCcccccCCCce-----eecCCCCCcceeecChHHhccC---------CCCchhhHHHHHHHHHHHHhCCC
Confidence 899999999875433211 1112344567889999998643 67889999999999999998 99
Q ss_pred CCCCCCccchHHHHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHHHH
Q 003542 431 VPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKK 493 (811)
Q Consensus 431 ~PF~~~~~~~~~i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~k 493 (811)
.||..... ......+..+..+..+..++..+.+++.+||+.||.+||++.++++.|..+.+
T Consensus 224 ~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 224 QPWFQLSN--TEVIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred CCCCCCCH--HHHHHHHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 99976432 33445566666656667788999999999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=305.42 Aligned_cols=241 Identities=24% Similarity=0.396 Sum_probs=196.9
Q ss_pred ceEEeeeecccc---eEEEE-EEcCCEEEEEEecc-----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEe
Q 003542 217 KLMVRRRLGASS---QFKEI-QWLGDSFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVME 287 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v-~~~g~~VAVK~~~~-----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmE 287 (811)
+|++.+.||.|+ +|.+. ..++..||+|.+.. ..+.+.+|+.+++.++||||+++++.+ ++...+|+|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF--EADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEE--EECCEEEEEEe
Confidence 478889999985 55544 34789999999842 356788999999999999999999877 45568999999
Q ss_pred cCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccccc
Q 003542 288 LMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366 (811)
Q Consensus 288 y~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~ 366 (811)
|++ ++|.+++... ....+++..++.++.||+.||.|||++||+|+||||+||+++.++ .++|+|||++..
T Consensus 79 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~-----~~~l~dfg~~~~ 149 (255)
T cd08219 79 YCDGGDLMQKIKLQ----RGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNG-----KVKLGDFGSARL 149 (255)
T ss_pred eCCCCcHHHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCC-----cEEEcccCccee
Confidence 998 5888888653 224688999999999999999999999999999999999998776 899999999876
Q ss_pred ccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHH
Q 003542 367 RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKN 446 (811)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~ 446 (811)
..... .......|++.|+|||++.+. .++.++|+||||+++|+|++|..||..... ......
T Consensus 150 ~~~~~-------~~~~~~~~~~~~~aPE~~~~~---------~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~--~~~~~~ 211 (255)
T cd08219 150 LTSPG-------AYACTYVGTPYYVPPEIWENM---------PYNNKSDIWSLGCILYELCTLKHPFQANSW--KNLILK 211 (255)
T ss_pred ecccc-------cccccccCCccccCHHHHccC---------CcCchhhhhhhchhheehhhccCCCCCCCH--HHHHHH
Confidence 53321 112245688899999998643 578899999999999999999999976432 233445
Q ss_pred HHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 447 IRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 447 i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
+..+.....+..++..+.+||.+||+.||.+||++.+|+.
T Consensus 212 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 251 (255)
T cd08219 212 VCQGSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILS 251 (255)
T ss_pred HhcCCCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhh
Confidence 5566666677778889999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=323.82 Aligned_cols=240 Identities=21% Similarity=0.365 Sum_probs=201.1
Q ss_pred cceEEeeeecccceEEEEE-----EcCCEEEEEEecc------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEE
Q 003542 216 KKLMVRRRLGASSQFKEIQ-----WLGDSFVLRHFYG------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFL 284 (811)
Q Consensus 216 k~~~i~~~lG~G~vyk~v~-----~~g~~VAVK~~~~------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yL 284 (811)
.-|.+.+.||+| -|-+++ .+|+.||||++.+ ....+..|++.|+-++|||||++|+++ +....+||
T Consensus 18 GLYDLekTlG~G-HFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEVi--DTQTKlyL 94 (864)
T KOG4717|consen 18 GLYDLEKTLGRG-HFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVI--DTQTKLYL 94 (864)
T ss_pred eeehhhhhhcCC-ceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehh--cccceEEE
Confidence 457777889999 566663 5999999999964 246789999999999999999999877 45556999
Q ss_pred EEecCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccc
Q 003542 285 VMELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGL 363 (811)
Q Consensus 285 VmEy~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGl 363 (811)
|+|+-. |+|++||.++ ...+.+..+..|+.||+.|+.|+|+..+|||||||+|+++...-. .|||+|||+
T Consensus 95 iLELGD~GDl~DyImKH-----e~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlG----lVKLTDFGF 165 (864)
T KOG4717|consen 95 ILELGDGGDLFDYIMKH-----EEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLG----LVKLTDFGF 165 (864)
T ss_pred EEEecCCchHHHHHHhh-----hccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecC----ceEeeeccc
Confidence 999998 5999999875 367999999999999999999999999999999999999876532 899999999
Q ss_pred cccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHH
Q 003542 364 STARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKM 443 (811)
Q Consensus 364 A~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i 443 (811)
+..+..+ ....+.+|+..|-|||++.|..|+ .+++||||||||||.|++|++||+..+..+ .
T Consensus 166 SNkf~PG--------~kL~TsCGSLAYSAPEILLGDsYD--------APAVDiWSLGVILyMLVCGq~PFqeANDSE--T 227 (864)
T KOG4717|consen 166 SNKFQPG--------KKLTTSCGSLAYSAPEILLGDSYD--------APAVDIWSLGVILYMLVCGQPPFQEANDSE--T 227 (864)
T ss_pred cccCCCc--------chhhcccchhhccCchhhhcCccC--------CcchhhhHHHHHHHHHHhCCCccccccchh--h
Confidence 9766543 244678899999999999987443 478999999999999999999998765443 2
Q ss_pred HHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 444 TKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 444 ~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
...|... ....|...+.+.++||..||..||.+|.+.++|..
T Consensus 228 LTmImDC-KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 228 LTMIMDC-KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred hhhhhcc-cccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 3344433 33468889999999999999999999999999876
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=318.50 Aligned_cols=231 Identities=26% Similarity=0.442 Sum_probs=184.0
Q ss_pred eeccc---ceEEEEE-EcCCEEEEEEecc-------cHHHHHHHHHHHHhC-CCCccceeeeeEEccCCCeEEEEEecCC
Q 003542 223 RLGAS---SQFKEIQ-WLGDSFVLRHFYG-------ELESLNAEISTMLSL-SHPNIVQYLCGFCDEEKKEFFLVMELMS 290 (811)
Q Consensus 223 ~lG~G---~vyk~v~-~~g~~VAVK~~~~-------~~~~~~~Ei~iL~~L-~HPNIVkl~~~~~~e~~~~~yLVmEy~~ 290 (811)
.||+| .||++.. .+++.||||.+.. ....+..|..++..+ +||||+++++.+. +...+||||||++
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~--~~~~~~lv~ey~~ 79 (316)
T cd05619 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQ--TKENLFFVMEYLN 79 (316)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEE--eCCEEEEEEeCCC
Confidence 34555 4777663 3678999999854 234567788888765 8999999997774 4567999999998
Q ss_pred -CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccccc
Q 003542 291 -KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTY 369 (811)
Q Consensus 291 -g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~ 369 (811)
|+|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 80 ~g~L~~~l~~~------~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~-----~~kl~Dfg~~~~~~~ 148 (316)
T cd05619 80 GGDLMFHIQSC------HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDG-----HIKIADFGMCKENML 148 (316)
T ss_pred CCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCC-----CEEEccCCcceECCC
Confidence 5898888753 5689999999999999999999999999999999999998876 899999999864322
Q ss_pred cCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHHHHh
Q 003542 370 ASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRA 449 (811)
Q Consensus 370 ~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i~~ 449 (811)
.. .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.. ...+.+.+..
T Consensus 149 ~~-------~~~~~~~gt~~y~aPE~~~~~---------~~~~~~DvwslG~il~el~~G~~pf~~~~--~~~~~~~i~~ 210 (316)
T cd05619 149 GD-------AKTCTFCGTPDYIAPEILLGQ---------KYNTSVDWWSFGVLLYEMLIGQSPFHGHD--EEELFQSIRM 210 (316)
T ss_pred CC-------CceeeecCCccccCHHHHcCC---------CCCchhhhhhHHHHHHHHHhCCCCCCCCC--HHHHHHHHHh
Confidence 11 112345689999999999743 67889999999999999999999998653 2344444444
Q ss_pred CCCCCCCCCChHHHHHHHhhhccCCCCCCCCHH-HHH
Q 003542 450 GERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFS-SIC 485 (811)
Q Consensus 450 ~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~-eIl 485 (811)
. .+.+|..++..+.+||.+||..||.+||++. +++
T Consensus 211 ~-~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 211 D-NPCYPRWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred C-CCCCCccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 3 3456777888999999999999999999997 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=316.44 Aligned_cols=243 Identities=24% Similarity=0.374 Sum_probs=190.1
Q ss_pred cceEEeeeecccc---eEEEEE-EcCCEEEEEEecc-----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEE
Q 003542 216 KKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVM 286 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~-----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVm 286 (811)
.+|.+.+.||.|+ ||++.. .+++.||+|.+.. ....+.+|+.+++.++||||+++++.+. ..+.+|+||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~ 83 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVH--TDKSLTLVF 83 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEe--eCCeEEEEE
Confidence 5799999999986 777653 4788999999853 2346788999999999999999997774 456799999
Q ss_pred ecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccccc
Q 003542 287 ELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366 (811)
Q Consensus 287 Ey~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~ 366 (811)
||++++|..++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 84 e~~~~~l~~~~~~~-----~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~-----~~kl~Dfg~~~~ 153 (309)
T cd07872 84 EYLDKDLKQYMDDC-----GNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERG-----ELKLADFGLARA 153 (309)
T ss_pred eCCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-----CEEECcccccee
Confidence 99999999888653 24578899999999999999999999999999999999998776 899999999875
Q ss_pred ccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHH
Q 003542 367 RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKN 446 (811)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~ 446 (811)
..... .......+|+.|+|||++.+ ...++.++|||||||++|+|++|++||.+...... +...
T Consensus 154 ~~~~~-------~~~~~~~~~~~y~aPE~~~~--------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-~~~~ 217 (309)
T cd07872 154 KSVPT-------KTYSNEVVTLWYRPPDVLLG--------SSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDE-LHLI 217 (309)
T ss_pred cCCCc-------cccccccccccccCCHHHhC--------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHH
Confidence 43221 11223467889999999864 23578899999999999999999999976543211 1111
Q ss_pred HHh-C-------------------CCCC--------CCCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 447 IRA-G-------------------ERPL--------FPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 447 i~~-~-------------------~~~~--------~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
... + ..+. ....+++++.+||.+||..||.+|||+.++++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 218 FRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred HHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 000 0 0000 01245778999999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=307.38 Aligned_cols=250 Identities=25% Similarity=0.403 Sum_probs=193.9
Q ss_pred Eeeeecccc---eEEEEEE-cCC--EEEEEEecc------cHHHHHHHHHHHHhCCCCccceeeeeEEcc----CCCeEE
Q 003542 220 VRRRLGASS---QFKEIQW-LGD--SFVLRHFYG------ELESLNAEISTMLSLSHPNIVQYLCGFCDE----EKKEFF 283 (811)
Q Consensus 220 i~~~lG~G~---vyk~v~~-~g~--~VAVK~~~~------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e----~~~~~y 283 (811)
+.+.||.|+ ||++... .+. .||+|.+.. ..+.+.+|+.+|+.++||||+++++.+... .....+
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence 456677775 7776543 333 699998842 356788999999999999999998654321 123578
Q ss_pred EEEecCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecc
Q 003542 284 LVMELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFG 362 (811)
Q Consensus 284 LVmEy~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFG 362 (811)
+||||++ |+|..++...........+++..+..++.||+.||.|||+++|+||||||+|||++.++ .+||+|||
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-----~~kl~Dfg 157 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENM-----NVCVADFG 157 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCC-----CEEECCCC
Confidence 9999999 58888875432222234589999999999999999999999999999999999998766 89999999
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CCCCCCCCccchH
Q 003542 363 LSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGD 441 (811)
Q Consensus 363 lA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~~PF~~~~~~~~ 441 (811)
+++....... ........+++.|+|||++.+. .++.++||||||+++|+|++ |..||.+.. ..
T Consensus 158 ~~~~~~~~~~-----~~~~~~~~~~~~~~~pe~~~~~---------~~~~~~Di~slG~il~el~~~g~~p~~~~~--~~ 221 (272)
T cd05075 158 LSKKIYNGDY-----YRQGRIAKMPVKWIAIESLADR---------VYTTKSDVWSFGVTMWEIATRGQTPYPGVE--NS 221 (272)
T ss_pred cccccCcccc-----eecCCcccCCcccCCHHHccCC---------CcChHHHHHHHHHHHHHHHcCCCCCCCCCC--HH
Confidence 9976543211 0111233456789999998643 67889999999999999999 899997643 33
Q ss_pred HHHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHH
Q 003542 442 KMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRY 490 (811)
Q Consensus 442 ~i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~ 490 (811)
.+...+..+..+..+..++..+.++|.+||+.||.+|||+.+|++.|+.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~ 270 (272)
T cd05075 222 EIYDYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK 270 (272)
T ss_pred HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 4556666666666677888999999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=326.32 Aligned_cols=250 Identities=27% Similarity=0.476 Sum_probs=188.7
Q ss_pred cceEEeeeeccc---ceEEEEEEcCCEEEEEEecc---c-HHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEec
Q 003542 216 KKLMVRRRLGAS---SQFKEIQWLGDSFVLRHFYG---E-LESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMEL 288 (811)
Q Consensus 216 k~~~i~~~lG~G---~vyk~v~~~g~~VAVK~~~~---~-~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy 288 (811)
++|.-...||+| .||++...+|..||||++.. . ...|.+|+.+|.+++|||+|+++ +||.+...+.+||+||
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~Ll-GyC~e~~~~~~LVYEy 153 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLL-GYCLEGGEHRLLVYEY 153 (361)
T ss_pred hCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEE-EEEecCCceEEEEEEc
Confidence 566644555555 49999988999999999854 2 45699999999999999999999 5554443368999999
Q ss_pred CC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCCCcEEEeccCCCCcceEEEeecccc
Q 003542 289 MS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQK---IYHGELNPSNIYLKARSMEGYFHVKVSGFGLS 364 (811)
Q Consensus 289 ~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~g---IVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA 364 (811)
|+ |+|.++|.... . ..++|..+..|+.++|+||+|||... ||||||||+|||+|.+. .+||+|||+|
T Consensus 154 m~nGsL~d~L~~~~---~-~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~-----~aKlsDFGLa 224 (361)
T KOG1187|consen 154 MPNGSLEDHLHGKK---G-EPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDF-----NAKLSDFGLA 224 (361)
T ss_pred cCCCCHHHHhCCCC---C-CCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCC-----CEEccCccCc
Confidence 99 79999987531 1 18899999999999999999999864 99999999999997654 9999999999
Q ss_pred ccccc-cCCCCCCCCCCCCCC-CCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchH-
Q 003542 365 TARTY-ASRNTPPASPQNQTA-PNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGD- 441 (811)
Q Consensus 365 ~~~~~-~~~~~~~~~~~~~~~-~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~- 441 (811)
+.... .. ..... .||..|+|||++. .+..+.++|||||||+|.||+||+.|.+.......
T Consensus 225 ~~~~~~~~--------~~~~~~~gt~gY~~PEy~~---------~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~ 287 (361)
T KOG1187|consen 225 KLGPEGDT--------SVSTTVMGTFGYLAPEYAS---------TGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGEL 287 (361)
T ss_pred ccCCcccc--------ceeeecCCCCccCChhhhc---------cCCcCcccccccchHHHHHHHhCCcccCCCCCcccc
Confidence 65432 11 11112 7999999999996 34789999999999999999999988875321111
Q ss_pred ---HH-HHHHHhCC-----CCCCC-CCCh-----HHHHHHHhhhccCCCCCCCCHHHHHHHHHHHH
Q 003542 442 ---KM-TKNIRAGE-----RPLFP-SGSP-----KYLVNLTKKCWHTNPSQRPSFSSICRILRYIK 492 (811)
Q Consensus 442 ---~i-~~~i~~~~-----~~~~p-~~~~-----~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~ 492 (811)
.+ ...+..+. .+.+. ...+ ..+..+..+|++.+|.+||++.++++.|+.+.
T Consensus 288 ~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 288 SLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred cHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 11 11222221 11111 1222 23678899999999999999999988875443
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=319.80 Aligned_cols=233 Identities=23% Similarity=0.382 Sum_probs=187.8
Q ss_pred ceEEeeeecccc---eEEEEEE-cCCEEEEEEecc-------cHHHHHHHHHHHHhC-CCCccceeeeeEEccCCCeEEE
Q 003542 217 KLMVRRRLGASS---QFKEIQW-LGDSFVLRHFYG-------ELESLNAEISTMLSL-SHPNIVQYLCGFCDEEKKEFFL 284 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v~~-~g~~VAVK~~~~-------~~~~~~~Ei~iL~~L-~HPNIVkl~~~~~~e~~~~~yL 284 (811)
+|.+.+.||+|+ ||++... +++.||||.+.. ....+..|..++..+ +||+|+++++.+ ++.+.+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~--~~~~~~~l 78 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCF--QTMDRLYF 78 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEE--ecCCEEEE
Confidence 477888888885 6766533 678999999863 234567788888887 589999988666 44567999
Q ss_pred EEecCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccc
Q 003542 285 VMELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGL 363 (811)
Q Consensus 285 VmEy~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGl 363 (811)
||||++ |+|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 79 v~E~~~~g~L~~~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~-----~~kL~DfG~ 147 (323)
T cd05616 79 VMEYVNGGDLMYQIQQV------GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEG-----HIKIADFGM 147 (323)
T ss_pred EEcCCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCC-----cEEEccCCC
Confidence 999998 5888888653 5689999999999999999999999999999999999998876 899999999
Q ss_pred cccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHH
Q 003542 364 STARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKM 443 (811)
Q Consensus 364 A~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i 443 (811)
++...... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+... ..+
T Consensus 148 ~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwSlGvil~elltg~~Pf~~~~~--~~~ 209 (323)
T cd05616 148 CKENMWDG-------VTTKTFCGTPDYIAPEIIAYQ---------PYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--DEL 209 (323)
T ss_pred ceecCCCC-------CccccCCCChhhcCHHHhcCC---------CCCCccchhchhHHHHHHHhCCCCCCCCCH--HHH
Confidence 87543211 122345689999999999743 678999999999999999999999986542 344
Q ss_pred HHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCH
Q 003542 444 TKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSF 481 (811)
Q Consensus 444 ~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~ 481 (811)
...+... ...+|...+.++.+|+.+||+.||.+|++.
T Consensus 210 ~~~i~~~-~~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 210 FQSIMEH-NVAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred HHHHHhC-CCCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 4455443 344677889999999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=308.75 Aligned_cols=252 Identities=25% Similarity=0.432 Sum_probs=199.4
Q ss_pred hcceEEeeeecccc---eEEEEEE-----cCCEEEEEEecc-----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCe
Q 003542 215 LKKLMVRRRLGASS---QFKEIQW-----LGDSFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKE 281 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~~-----~g~~VAVK~~~~-----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~ 281 (811)
+..|++.+.||+|+ ||++... .+..||+|.+.. ....+.+|+.+++.++||||+++++.+. ....
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~ 81 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVT--QEQP 81 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEe--cCCc
Confidence 35688889999886 7877632 557899999963 2356889999999999999999997764 3456
Q ss_pred EEEEEecCC-CCHHHHHHHhhC-----------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccC
Q 003542 282 FFLVMELMS-KDLSCYMRETFG-----------SRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARS 349 (811)
Q Consensus 282 ~yLVmEy~~-g~L~~~L~~~~~-----------~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g 349 (811)
.|+||||++ ++|.+++..... ......+++..+..++.||+.||.|||++|++||||||+|||++.++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQL 161 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCC
Confidence 899999999 589988864311 00123578889999999999999999999999999999999998765
Q ss_pred CCCcceEEEeeccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-
Q 003542 350 MEGYFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT- 428 (811)
Q Consensus 350 ~d~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt- 428 (811)
.+||+|||+++....... ........++..|+|||++.+. .++.++||||||+++|||++
T Consensus 162 -----~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Dv~slG~il~el~~~ 222 (283)
T cd05090 162 -----HVKISDLGLSREIYSADY-----YRVQPKSLLPIRWMPPEAIMYG---------KFSSDSDIWSFGVVLWEIFSF 222 (283)
T ss_pred -----cEEeccccccccccCCcc-----eecccCCCccceecChHHhccC---------CCCchhhhHHHHHHHHHHHcC
Confidence 899999999976533211 1112234456789999998642 57889999999999999998
Q ss_pred CCCCCCCCccchHHHHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHH
Q 003542 429 GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILR 489 (811)
Q Consensus 429 G~~PF~~~~~~~~~i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~ 489 (811)
|..||.+.. ...+...+.....+..+..+++.+.+++.+||+.||.+||++.+|++.|.
T Consensus 223 g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 281 (283)
T cd05090 223 GLQPYYGFS--NQEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR 281 (283)
T ss_pred CCCCCCCCC--HHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhh
Confidence 999997643 23445556666656677888999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=312.57 Aligned_cols=242 Identities=19% Similarity=0.289 Sum_probs=190.4
Q ss_pred ceEEeeeecccc---eEEEEE-EcCCEEEEEEeccc-------HHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEE
Q 003542 217 KLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYGE-------LESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLV 285 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~~-------~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLV 285 (811)
.|++.+.||+|+ ||++.. .+++.||||.+... ...+.+|+.+++.++||||+++++.+ .....+|+|
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~~~~~~~lv 78 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY--ETKDALCLV 78 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeee--cCCCeEEEE
Confidence 367778888875 666553 47899999998531 24567899999999999999998776 445679999
Q ss_pred EecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccc
Q 003542 286 MELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS 364 (811)
Q Consensus 286 mEy~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA 364 (811)
||||+| +|..++... ....+++..+..++.|++.||.|||+.||+||||||+||+++.++ .++|+|||++
T Consensus 79 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~-----~~~l~Dfg~~ 149 (285)
T cd05605 79 LTLMNGGDLKFHIYNM----GNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYG-----HIRISDLGLA 149 (285)
T ss_pred EeccCCCcHHHHHHhc----CcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCC-----CEEEeeCCCc
Confidence 999984 887777542 124689999999999999999999999999999999999998776 8999999998
Q ss_pred ccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccch--HH
Q 003542 365 TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQG--DK 442 (811)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~--~~ 442 (811)
....... ......|++.|+|||++.+. .++.++|||||||++|+|++|..||.+..... ..
T Consensus 150 ~~~~~~~--------~~~~~~~~~~y~aPE~~~~~---------~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~ 212 (285)
T cd05605 150 VEIPEGE--------TIRGRVGTVGYMAPEVVKNE---------RYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREE 212 (285)
T ss_pred eecCCCC--------ccccccCCCCccCcHHhcCC---------CCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHH
Confidence 7643221 11244688999999998643 67889999999999999999999998643321 12
Q ss_pred HHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCC-----CHHHHHHH
Q 003542 443 MTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRP-----SFSSICRI 487 (811)
Q Consensus 443 i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RP-----S~~eIl~~ 487 (811)
+...+. .....++...+..+.+||.+||..||.+|| ++++++.+
T Consensus 213 ~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 213 VERRVK-EDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred HHHHhh-hcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 222222 233445667888999999999999999999 78888663
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=311.84 Aligned_cols=243 Identities=34% Similarity=0.604 Sum_probs=191.7
Q ss_pred EEeeeecccc---eEEEEEE-----cCCEEEEEEecc-----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEE
Q 003542 219 MVRRRLGASS---QFKEIQW-----LGDSFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLV 285 (811)
Q Consensus 219 ~i~~~lG~G~---vyk~v~~-----~g~~VAVK~~~~-----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLV 285 (811)
.+.+.||.|. ||++... .+..|+||.+.. ..+.+.+|+++|++++||||+++++.+. ....+++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~--~~~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCI--ENEPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEE--SSSSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccc--cccccccc
Confidence 4567788885 6665544 367899999953 3578999999999999999999996664 33458999
Q ss_pred EecCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccc
Q 003542 286 MELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS 364 (811)
Q Consensus 286 mEy~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA 364 (811)
||||+ |+|.++|... ....+++..++.|+.||+.||.|||+++++||||+++|||++.++ .+||+|||++
T Consensus 80 ~e~~~~g~L~~~L~~~----~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~-----~~Kl~~f~~~ 150 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSK----NKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNG-----QVKLSDFGLS 150 (259)
T ss_dssp EE--TTEBHHHHHHHT----CTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTT-----EEEEESTTTG
T ss_pred cccccccccccccccc----ccccccccccccccccccccccccccccccccccccccccccccc-----cccccccccc
Confidence 99999 5999999874 235789999999999999999999999999999999999998876 9999999999
Q ss_pred ccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CCCCCCCCccchHHH
Q 003542 365 TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGDKM 443 (811)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~~PF~~~~~~~~~i 443 (811)
........ ........+...|+|||.+.+. .++.++||||||+++|||++ |+.||.+. ....+
T Consensus 151 ~~~~~~~~-----~~~~~~~~~~~~~~aPE~~~~~---------~~~~ksDVysfG~~l~ei~~~~~~p~~~~--~~~~~ 214 (259)
T PF07714_consen 151 RPISEKSK-----YKNDSSQQLPLRYLAPEVLKDG---------EYTKKSDVYSFGMLLYEILTLGKFPFSDY--DNEEI 214 (259)
T ss_dssp EETTTSSS-----EEESTTSESGGGGS-HHHHHHS---------EESHHHHHHHHHHHHHHHHTTSSGTTTTS--CHHHH
T ss_pred cccccccc-----cccccccccccccccccccccc---------ccccccccccccccccccccccccccccc--ccccc
Confidence 76622111 1112334567789999999864 57899999999999999999 78999765 34455
Q ss_pred HHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHH
Q 003542 444 TKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRIL 488 (811)
Q Consensus 444 ~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L 488 (811)
...+..+.++..+..++..+.++|.+||+.||.+||++.+|++.|
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 215 IEKLKQGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHHHHTTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred cccccccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 667777777778888999999999999999999999999998765
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=324.29 Aligned_cols=247 Identities=23% Similarity=0.336 Sum_probs=190.5
Q ss_pred HhcceEEeeeecccc---eEEEE-EEcCCEEEEEEecc------cHHHHHHHHHHHHhCCCCccceeeeeEEccC----C
Q 003542 214 LLKKLMVRRRLGASS---QFKEI-QWLGDSFVLRHFYG------ELESLNAEISTMLSLSHPNIVQYLCGFCDEE----K 279 (811)
Q Consensus 214 l~k~~~i~~~lG~G~---vyk~v-~~~g~~VAVK~~~~------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~----~ 279 (811)
+.++|++.+.||+|+ ||.+. ...++.||||.+.. ....+.+|+.+++.++||||+++++.+.... .
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 467899999999986 66655 34789999999853 2456788999999999999999998775322 2
Q ss_pred CeEEEEEecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEe
Q 003542 280 KEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVS 359 (811)
Q Consensus 280 ~~~yLVmEy~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~ 359 (811)
..+|+||||++++|..++. ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+
T Consensus 95 ~~~~lv~e~~~~~l~~~~~--------~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~-----~~kl~ 161 (355)
T cd07874 95 QDVYLVMELMDANLCQVIQ--------MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-----TLKIL 161 (355)
T ss_pred ceeEEEhhhhcccHHHHHh--------hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCC-----CEEEe
Confidence 4579999999999887775 3478899999999999999999999999999999999998776 89999
Q ss_pred eccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccc
Q 003542 360 GFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQ 439 (811)
Q Consensus 360 DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~ 439 (811)
|||+++...... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+....
T Consensus 162 Dfg~~~~~~~~~--------~~~~~~~t~~y~aPE~~~~~---------~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 224 (355)
T cd07874 162 DFGLARTAGTSF--------MMTPYVVTRYYRAPEVILGM---------GYKENVDIWSVGCIMGEMVRHKILFPGRDYI 224 (355)
T ss_pred eCcccccCCCcc--------ccCCccccCCccCHHHHcCC---------CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999997543221 12345689999999999753 6788999999999999999999999764322
Q ss_pred hHHHHHHHHh--------------------CCCC--------------------CCCCCChHHHHHHHhhhccCCCCCCC
Q 003542 440 GDKMTKNIRA--------------------GERP--------------------LFPSGSPKYLVNLTKKCWHTNPSQRP 479 (811)
Q Consensus 440 ~~~i~~~i~~--------------------~~~~--------------------~~p~~~~~~l~~LI~~cL~~DP~~RP 479 (811)
. .+...+.. ...+ ..+...+..+.+||.+||..||.+||
T Consensus 225 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rp 303 (355)
T cd07874 225 D-QWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 303 (355)
T ss_pred H-HHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcC
Confidence 1 11100000 0000 00112345689999999999999999
Q ss_pred CHHHHHHHHHHHH
Q 003542 480 SFSSICRILRYIK 492 (811)
Q Consensus 480 S~~eIl~~L~~i~ 492 (811)
|+.+++++ .++.
T Consensus 304 s~~ell~h-p~~~ 315 (355)
T cd07874 304 SVDEALQH-PYIN 315 (355)
T ss_pred CHHHHhcC-cchh
Confidence 99999873 3443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=307.96 Aligned_cols=251 Identities=21% Similarity=0.423 Sum_probs=199.4
Q ss_pred cceEEeeeecccc---eEEEE-EEcCCEEEEEEecc-------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEE
Q 003542 216 KKLMVRRRLGASS---QFKEI-QWLGDSFVLRHFYG-------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFL 284 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v-~~~g~~VAVK~~~~-------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yL 284 (811)
.+|++.+.||.|+ +|++. ..+|..||||.+.. ....+.+|+.+++.++||||+++++.+. ..+.+++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~--~~~~~~~ 79 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI--EDNELNI 79 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeE--eCCeEEE
Confidence 3566677777764 77766 35899999998742 3457889999999999999999997775 3457899
Q ss_pred EEecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccc
Q 003542 285 VMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGL 363 (811)
Q Consensus 285 VmEy~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGl 363 (811)
+|||+++ +|.+++.... .....+++..++.++.||+.||.|||++|++|+||||+||+++.++ .++|+|||+
T Consensus 80 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~-----~~~l~dfg~ 152 (267)
T cd08229 80 VLELADAGDLSRMIKHFK--KQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG-----VVKLGDLGL 152 (267)
T ss_pred EEEecCCCCHHHHHHHhh--ccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-----CEEECcchh
Confidence 9999995 8888886432 1235689999999999999999999999999999999999998776 899999999
Q ss_pred cccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHH
Q 003542 364 STARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKM 443 (811)
Q Consensus 364 A~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i 443 (811)
+....... .......++..|+|||++.+. .++.++||||||+++|+|++|..||.+........
T Consensus 153 ~~~~~~~~-------~~~~~~~~~~~~~ape~~~~~---------~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~ 216 (267)
T cd08229 153 GRFFSSKT-------TAAHSLVGTPYYMSPERIHEN---------GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL 216 (267)
T ss_pred hhccccCC-------cccccccCCcCccCHHHhcCC---------CccchhhHHHHHHHHHHHHhCCCCcccccchHHHH
Confidence 87653321 112244688899999998643 57789999999999999999999997655444444
Q ss_pred HHHHHhCCCCCCC-CCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHH
Q 003542 444 TKNIRAGERPLFP-SGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYI 491 (811)
Q Consensus 444 ~~~i~~~~~~~~p-~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i 491 (811)
...+.....+..+ ...++.+.+++.+||..||.+|||+.+|++.++.+
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 217 CKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred hhhhhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 4555544433333 45788899999999999999999999999887664
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=328.71 Aligned_cols=253 Identities=22% Similarity=0.318 Sum_probs=199.9
Q ss_pred hcceEEeeeecccc---eEEEEEEcCCEEEEEEec------ccHHHHHHHHHHHHhC-CCCccceeeeeEEccCCCeEEE
Q 003542 215 LKKLMVRRRLGASS---QFKEIQWLGDSFVLRHFY------GELESLNAEISTMLSL-SHPNIVQYLCGFCDEEKKEFFL 284 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~~~g~~VAVK~~~------~~~~~~~~Ei~iL~~L-~HPNIVkl~~~~~~e~~~~~yL 284 (811)
.+.|+++++||.|| ||++..-+.+.||+|++. ....-|.+|+..|.+| .|.+||++|++-.. .+++||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~--d~~lYm 437 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT--DGYLYM 437 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc--CceEEE
Confidence 35789999999998 999777777889999874 2357799999999999 59999999977643 568999
Q ss_pred EEecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccc
Q 003542 285 VMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS 364 (811)
Q Consensus 285 VmEy~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA 364 (811)
||||-+.||..+|.+.. ...+.-.++.|..||+.|+.++|.+||||.||||.|+|+-.. .+||+|||+|
T Consensus 438 vmE~Gd~DL~kiL~k~~-----~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVkG------~LKLIDFGIA 506 (677)
T KOG0596|consen 438 VMECGDIDLNKILKKKK-----SIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVKG------RLKLIDFGIA 506 (677)
T ss_pred EeecccccHHHHHHhcc-----CCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEee------eEEeeeechh
Confidence 99998899999998741 223333889999999999999999999999999999999654 8999999999
Q ss_pred ccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCC--CCCCCCcccceecchhHHHHHhhCCCCCCCCccchHH
Q 003542 365 TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGST--STSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDK 442 (811)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~--~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~ 442 (811)
..+..... .-.....+||+.||+||.+.....+... +.-+.+.++||||||||||+|+.|++||.........
T Consensus 507 ~aI~~DTT-----sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aK 581 (677)
T KOG0596|consen 507 NAIQPDTT-----SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAK 581 (677)
T ss_pred cccCcccc-----ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHH
Confidence 88765543 2234577899999999999865443211 1335788999999999999999999999753212122
Q ss_pred HHHHHHh-CCCCCCCCCChHH-HHHHHhhhccCCCCCCCCHHHHHH
Q 003542 443 MTKNIRA-GERPLFPSGSPKY-LVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 443 i~~~i~~-~~~~~~p~~~~~~-l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
+ ..|.. +....||...+.+ +.++++.||..||.+||++.++|.
T Consensus 582 l-~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 582 L-HAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred H-HhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 2 22222 2334566655555 999999999999999999999976
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=316.82 Aligned_cols=246 Identities=30% Similarity=0.509 Sum_probs=208.4
Q ss_pred ceEEeeeecccceEEEE-----EEcCCEEEEEEecc---cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEec
Q 003542 217 KLMVRRRLGASSQFKEI-----QWLGDSFVLRHFYG---ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMEL 288 (811)
Q Consensus 217 ~~~i~~~lG~G~vyk~v-----~~~g~~VAVK~~~~---~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy 288 (811)
++.+..+||.| +|+++ +...-.||||.++. +.+.|.+|+.+|+.++|||+|++++++.. ...+|||+||
T Consensus 268 dItMkhKLGGG-QYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~--EpPFYIiTEf 344 (1157)
T KOG4278|consen 268 DITMKHKLGGG-QYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTH--EPPFYIITEF 344 (1157)
T ss_pred heeeeeccCCC-cccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhcc--CCCeEEEEec
Confidence 45677889988 45554 23567899999986 57899999999999999999999976643 3459999999
Q ss_pred CC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccc
Q 003542 289 MS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTAR 367 (811)
Q Consensus 289 ~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~ 367 (811)
|. |+|++||++.. +..++--..+.++.||.+||+||..+++|||||-..|+||..+. .||++||||++.+
T Consensus 345 M~yGNLLdYLRecn----r~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnh-----iVKvADFGLsRlM 415 (1157)
T KOG4278|consen 345 MCYGNLLDYLRECN----RSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-----IVKVADFGLSRLM 415 (1157)
T ss_pred ccCccHHHHHHHhc----hhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccc-----eEEeeccchhhhh
Confidence 98 89999999862 24566667788999999999999999999999999999997765 8999999999988
Q ss_pred cccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CCCCCCCCccchHHHHHH
Q 003542 368 TYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGDKMTKN 446 (811)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~~PF~~~~~~~~~i~~~ 446 (811)
..... ........++.|.|||-|.. ..++.|+|||+|||+||||+| |-.||.+.... +++..
T Consensus 416 tgDTY------TAHAGAKFPIKWTAPEsLAy---------NtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS--qVY~L 478 (1157)
T KOG4278|consen 416 TGDTY------TAHAGAKFPIKWTAPESLAY---------NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYGL 478 (1157)
T ss_pred cCCce------ecccCccCcccccCcccccc---------cccccchhhHHHHHHHHHHHhcCCCCCCCccHH--HHHHH
Confidence 76542 22334556788999999963 478899999999999999998 99999986544 66788
Q ss_pred HHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHH
Q 003542 447 IRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYI 491 (811)
Q Consensus 447 i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i 491 (811)
+..+.+..-|..||+.+.+|++.||+..|.+||+|.+|...++.+
T Consensus 479 LEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm 523 (1157)
T KOG4278|consen 479 LEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM 523 (1157)
T ss_pred HhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence 888999999999999999999999999999999999998877654
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=307.60 Aligned_cols=253 Identities=26% Similarity=0.467 Sum_probs=200.1
Q ss_pred cceEEeeeecccc---eEEEEEE------cCCEEEEEEecc-----cHHHHHHHHHHHHhC-CCCccceeeeeEEccCCC
Q 003542 216 KKLMVRRRLGASS---QFKEIQW------LGDSFVLRHFYG-----ELESLNAEISTMLSL-SHPNIVQYLCGFCDEEKK 280 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~~------~g~~VAVK~~~~-----~~~~~~~Ei~iL~~L-~HPNIVkl~~~~~~e~~~ 280 (811)
.+|++.+.||+|+ ||++... ....+|+|.+.. ....+.+|+.++.++ +||||+++++.+ ....
T Consensus 12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~--~~~~ 89 (293)
T cd05053 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC--TQEG 89 (293)
T ss_pred hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE--cCCC
Confidence 5688888899885 6765532 236899999864 235688999999999 899999999766 3455
Q ss_pred eEEEEEecCC-CCHHHHHHHhhC----------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccC
Q 003542 281 EFFLVMELMS-KDLSCYMRETFG----------SRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARS 349 (811)
Q Consensus 281 ~~yLVmEy~~-g~L~~~L~~~~~----------~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g 349 (811)
.+|+||||++ |+|..++..... ......+++..++.++.||+.||.|||+.+|+||||||+|||++.++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~ 169 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDH 169 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCC
Confidence 7999999998 599998875310 01235688999999999999999999999999999999999998776
Q ss_pred CCCcceEEEeeccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-
Q 003542 350 MEGYFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT- 428 (811)
Q Consensus 350 ~d~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt- 428 (811)
.+||+|||+++........ .......++..|+|||++.+. .++.++|||||||++|+|++
T Consensus 170 -----~~kL~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~el~~~ 230 (293)
T cd05053 170 -----VMKIADFGLARDIHHIDYY-----RKTTNGRLPVKWMAPEALFDR---------VYTHQSDVWSFGVLLWEIFTL 230 (293)
T ss_pred -----eEEeCccccccccccccce-----eccCCCCCCccccCHHHhccC---------CcCcccceeehhhHHHHHhcC
Confidence 8999999999765432210 111223356779999998643 67889999999999999997
Q ss_pred CCCCCCCCccchHHHHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHH
Q 003542 429 GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYI 491 (811)
Q Consensus 429 G~~PF~~~~~~~~~i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i 491 (811)
|..||.+.. ...+...+..+..+..+..++..+.+|+.+||..||.+|||+.++++.|..+
T Consensus 231 g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 231 GGSPYPGIP--VEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred CCCCCCCCC--HHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 999997643 3345566666666667778889999999999999999999999999888764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=306.20 Aligned_cols=252 Identities=26% Similarity=0.436 Sum_probs=200.6
Q ss_pred hcceEEeeeecccc---eEEEEEE------cCCEEEEEEecc-----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCC
Q 003542 215 LKKLMVRRRLGASS---QFKEIQW------LGDSFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKK 280 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~~------~g~~VAVK~~~~-----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~ 280 (811)
.++|.+.+.||.|+ ||++... .+..||+|.+.. ....+.+|+.+|+.++||||+++++.+. ...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~ 82 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVS--TGQ 82 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEc--CCC
Confidence 46789999999986 6665532 236899999853 2356889999999999999999997774 446
Q ss_pred eEEEEEecCC-CCHHHHHHHhhCCC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcce
Q 003542 281 EFFLVMELMS-KDLSCYMRETFGSR----RRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFH 355 (811)
Q Consensus 281 ~~yLVmEy~~-g~L~~~L~~~~~~~----~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~ 355 (811)
..|+||||++ ++|.+++....... ....+++..++.++.||+.||.|||+.+++||||||+|||++.++ .
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~-----~ 157 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDL-----T 157 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCC-----C
Confidence 7899999998 59999987642211 123578889999999999999999999999999999999998876 8
Q ss_pred EEEeeccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CCCCCC
Q 003542 356 VKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFE 434 (811)
Q Consensus 356 vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~~PF~ 434 (811)
+||+|||+++....... ........++..|+|||.+.+ ..++.++|||||||++|||++ |..||.
T Consensus 158 ~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~---------~~~~~~~Di~slG~il~el~t~g~~p~~ 223 (277)
T cd05032 158 VKIGDFGMTRDIYETDY-----YRKGGKGLLPVRWMAPESLKD---------GVFTTKSDVWSFGVVLWEMATLAEQPYQ 223 (277)
T ss_pred EEECCcccchhhccCcc-----cccCCCCCccccccCHHHHhc---------CCCCcccchHHHHHHHHHhhccCCCCCc
Confidence 99999999876543221 111223456788999999864 367889999999999999998 999997
Q ss_pred CCccchHHHHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHH
Q 003542 435 DGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILR 489 (811)
Q Consensus 435 ~~~~~~~~i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~ 489 (811)
+.. .......+..+..+..|..++..+.+++.+||..+|.+|||+.+++..|+
T Consensus 224 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 224 GLS--NEEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred cCC--HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 643 33445566666666778888999999999999999999999999988663
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=313.91 Aligned_cols=248 Identities=25% Similarity=0.360 Sum_probs=195.2
Q ss_pred cceEEeeeecccc---eEEEE-EEcCCEEEEEEeccc------HHHHHHHHHHHHhCCCCc-cceeeeeEEccC----CC
Q 003542 216 KKLMVRRRLGASS---QFKEI-QWLGDSFVLRHFYGE------LESLNAEISTMLSLSHPN-IVQYLCGFCDEE----KK 280 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v-~~~g~~VAVK~~~~~------~~~~~~Ei~iL~~L~HPN-IVkl~~~~~~e~----~~ 280 (811)
..|..++++|+|+ ||++. +.+|+.||+|++.-+ -....+|+.+|+.|+|+| ||.+++.+...+ ..
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 3455566788886 88877 569999999999532 345799999999999999 999998876433 13
Q ss_pred eEEEEEecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEee
Q 003542 281 EFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSG 360 (811)
Q Consensus 281 ~~yLVmEy~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~D 360 (811)
.+++|+||+..+|..|+....... ..++...+..+++||+.||+|||+++|+||||||.||||+.+| .+||+|
T Consensus 91 ~l~lvfe~~d~DL~~ymd~~~~~~--~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G-----~lKlaD 163 (323)
T KOG0594|consen 91 KLYLVFEFLDRDLKKYMDSLPKKP--QGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSG-----VLKLAD 163 (323)
T ss_pred eEEEEEEeecccHHHHHHhccccc--cCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCC-----cEeeec
Confidence 789999999999999998752111 3577789999999999999999999999999999999999987 899999
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccch
Q 003542 361 FGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQG 440 (811)
Q Consensus 361 FGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~ 440 (811)
||+|+...... ......++|.+|.|||++.+. ..|+...||||+|||++||+++++.|.+....
T Consensus 164 FGlAra~~ip~-------~~yt~evvTlWYRaPEvLlGs--------~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~- 227 (323)
T KOG0594|consen 164 FGLARAFSIPM-------RTYTPEVVTLWYRAPEVLLGS--------TSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEI- 227 (323)
T ss_pred cchHHHhcCCc-------ccccccEEEeeccCHHHhcCC--------CcCCCCcchHhHHHHHHHHHhCCCCCCCCcHH-
Confidence 99998664332 224567899999999999974 46999999999999999999999999886542
Q ss_pred HHHHHHHHh-CCC---------------CCCCC------------CChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 441 DKMTKNIRA-GER---------------PLFPS------------GSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 441 ~~i~~~i~~-~~~---------------~~~p~------------~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
+++...... |.+ +.++. ...+...+++.+||.++|.+|.|+..++.
T Consensus 228 ~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~ 301 (323)
T KOG0594|consen 228 DQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALT 301 (323)
T ss_pred HHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhc
Confidence 222222211 111 01111 11236899999999999999999999987
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=318.44 Aligned_cols=230 Identities=23% Similarity=0.364 Sum_probs=185.1
Q ss_pred cccceEEEEEE-cCCEEEEEEecc-------cHHHHHHHHHHHHhC-CCCccceeeeeEEccCCCeEEEEEecCCC-CHH
Q 003542 225 GASSQFKEIQW-LGDSFVLRHFYG-------ELESLNAEISTMLSL-SHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLS 294 (811)
Q Consensus 225 G~G~vyk~v~~-~g~~VAVK~~~~-------~~~~~~~Ei~iL~~L-~HPNIVkl~~~~~~e~~~~~yLVmEy~~g-~L~ 294 (811)
|.|.||++... +++.||||.+.. ....+..|+.++..+ +||||+++++.+ +..+.+|+|||||+| +|.
T Consensus 7 ~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~--~~~~~~~lv~e~~~~~~L~ 84 (318)
T cd05570 7 SFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCF--QTKDRLFFVMEYVNGGDLM 84 (318)
T ss_pred CCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEE--EcCCEEEEEEcCCCCCCHH
Confidence 33447776643 688999999963 345678899999888 799999999777 455689999999985 888
Q ss_pred HHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccccccCCCC
Q 003542 295 CYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNT 374 (811)
Q Consensus 295 ~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~~~~~ 374 (811)
.++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++ .+||+|||++.......
T Consensus 85 ~~~~~~------~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~-----~~kl~Dfg~~~~~~~~~--- 150 (318)
T cd05570 85 FHIQRS------GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEG-----HIKIADFGMCKEGILGG--- 150 (318)
T ss_pred HHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCC-----cEEecccCCCeecCcCC---
Confidence 877653 5799999999999999999999999999999999999998876 89999999986432211
Q ss_pred CCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHHHHhCCCCC
Q 003542 375 PPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPL 454 (811)
Q Consensus 375 ~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i~~~~~~~ 454 (811)
.......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.. ...+...+... ...
T Consensus 151 ----~~~~~~~g~~~y~aPE~~~~~---------~~~~~~DiwslGvil~~l~~G~~pf~~~~--~~~~~~~i~~~-~~~ 214 (318)
T cd05570 151 ----VTTSTFCGTPDYIAPEILSYQ---------PYGPAVDWWALGVLLYEMLAGQSPFEGDD--EDELFQSILED-EVR 214 (318)
T ss_pred ----CcccceecCccccCHHHhcCC---------CCCcchhhhhHHHHHHHHhhCCCCCCCCC--HHHHHHHHHcC-CCC
Confidence 112344689999999999743 67889999999999999999999997643 23334444433 345
Q ss_pred CCCCChHHHHHHHhhhccCCCCCCCCH-----HHHHH
Q 003542 455 FPSGSPKYLVNLTKKCWHTNPSQRPSF-----SSICR 486 (811)
Q Consensus 455 ~p~~~~~~l~~LI~~cL~~DP~~RPS~-----~eIl~ 486 (811)
+|..++..+.+||.+||..||.+||++ .+++.
T Consensus 215 ~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 215 YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 677889999999999999999999999 77765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=306.46 Aligned_cols=254 Identities=23% Similarity=0.433 Sum_probs=198.7
Q ss_pred cceEEeeeecccc---eEEEEEE------cCCEEEEEEecc-----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCe
Q 003542 216 KKLMVRRRLGASS---QFKEIQW------LGDSFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKE 281 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~~------~g~~VAVK~~~~-----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~ 281 (811)
++|.+.+.||+|+ +|++... .+..||+|.+.. ....+.+|+.+++.++||||+++++.+. +...
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~ 83 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSF--ERLP 83 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEc--cCCC
Confidence 5688889999886 7877643 467899999853 2356899999999999999999997664 3456
Q ss_pred EEEEEecCC-CCHHHHHHHhhCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEe
Q 003542 282 FFLVMELMS-KDLSCYMRETFGS-RRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVS 359 (811)
Q Consensus 282 ~yLVmEy~~-g~L~~~L~~~~~~-~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~ 359 (811)
.|+||||++ ++|.+++...... .....+++..++.++.||+.||.|||+++++||||||+|||++.++. ...+||+
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~--~~~~kl~ 161 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGP--GRVAKIA 161 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCC--CcceEec
Confidence 899999998 5999988764211 11235899999999999999999999999999999999999987642 2379999
Q ss_pred eccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CCCCCCCCcc
Q 003542 360 GFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHL 438 (811)
Q Consensus 360 DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~~PF~~~~~ 438 (811)
|||+++....... .........+..|+|||++.+ ..++.++|||||||++|+|++ |..||.+...
T Consensus 162 dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~---------~~~~~~~DiwslG~il~el~~~g~~pf~~~~~ 227 (277)
T cd05036 162 DFGMARDIYRASY-----YRKGGRAMLPIKWMPPEAFLD---------GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN 227 (277)
T ss_pred cCccccccCCccc-----eecCCCCCccHhhCCHHHHhc---------CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 9999976532211 001112234567999999964 368899999999999999997 9999986433
Q ss_pred chHHHHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHH
Q 003542 439 QGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILR 489 (811)
Q Consensus 439 ~~~~i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~ 489 (811)
..+...+.....+..|..++..+.+++.+||+.+|.+||++.++++.|.
T Consensus 228 --~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 228 --QEVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred --HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 2344555555556667788999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=304.24 Aligned_cols=246 Identities=27% Similarity=0.434 Sum_probs=197.6
Q ss_pred cceEEeeeecccc---eEEEEEEcCCEEEEEEecc---cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEecC
Q 003542 216 KKLMVRRRLGASS---QFKEIQWLGDSFVLRHFYG---ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELM 289 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~~~g~~VAVK~~~~---~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~ 289 (811)
.+|.+.++||.|+ ||++....+..||+|.+.. ..+.+.+|+.+++.++||||+++++.+ .+ ...|+||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~--~~-~~~~lv~e~~ 82 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV--SE-EPIYIVTEYM 82 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEE--CC-CCcEEEEEcC
Confidence 5689999999986 7877655556899999964 246789999999999999999998655 22 3579999999
Q ss_pred C-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccccccc
Q 003542 290 S-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTART 368 (811)
Q Consensus 290 ~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~ 368 (811)
+ |+|.+++... ....+++..+..++.|++.||.|||+.+++||||||+||+++.++ .++|+|||++....
T Consensus 83 ~~~~L~~~~~~~----~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~-----~~~L~dfg~~~~~~ 153 (262)
T cd05071 83 SKGSLLDFLKGE----MGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL-----VCKVADFGLARLIE 153 (262)
T ss_pred CCCcHHHHHhhc----cccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCC-----cEEeccCCceeecc
Confidence 9 5999988753 124578999999999999999999999999999999999998776 89999999997654
Q ss_pred ccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CCCCCCCCccchHHHHHHH
Q 003542 369 YASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGDKMTKNI 447 (811)
Q Consensus 369 ~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~~PF~~~~~~~~~i~~~i 447 (811)
.... .......++..|+|||++.+ ..++.++||||||+++|+|++ |..||.+... ......+
T Consensus 154 ~~~~------~~~~~~~~~~~y~~PE~~~~---------~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~--~~~~~~~ 216 (262)
T cd05071 154 DNEY------TARQGAKFPIKWTAPEAALY---------GRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQV 216 (262)
T ss_pred cccc------ccccCCcccceecCHhHhcc---------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh--HHHHHHH
Confidence 3221 11123446778999998863 367899999999999999999 8999976532 2334445
Q ss_pred HhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHH
Q 003542 448 RAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRY 490 (811)
Q Consensus 448 ~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~ 490 (811)
..+.....+..++..+.+|+.+||+.||.+||++.+++..|+.
T Consensus 217 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 217 ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred hcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 5554455566788999999999999999999999999887754
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=330.48 Aligned_cols=251 Identities=30% Similarity=0.514 Sum_probs=205.6
Q ss_pred cceEEeeeecccc---eEEEEEEc--C---CEEEEEEecc-------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCC
Q 003542 216 KKLMVRRRLGASS---QFKEIQWL--G---DSFVLRHFYG-------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKK 280 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~~~--g---~~VAVK~~~~-------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~ 280 (811)
.+..+.++||+|. ||++.+.. + ..||||..+. ....|.+|+++|++++|||||++|++.+.+.
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~-- 234 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE-- 234 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC--
Confidence 4556678999994 55554332 2 2389999874 3578999999999999999999997665544
Q ss_pred eEEEEEecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEe
Q 003542 281 EFFLVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVS 359 (811)
Q Consensus 281 ~~yLVmEy~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~ 359 (811)
.+|||||+|.| +|.+||++. ...++..+...++.+++.||+|||+++++||||-..|+|++.++ .+||+
T Consensus 235 Pl~ivmEl~~gGsL~~~L~k~-----~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~-----~vKIS 304 (474)
T KOG0194|consen 235 PLMLVMELCNGGSLDDYLKKN-----KKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKG-----VVKIS 304 (474)
T ss_pred ccEEEEEecCCCcHHHHHHhC-----CCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCC-----eEEeC
Confidence 59999999995 999999975 13599999999999999999999999999999999999998876 78999
Q ss_pred eccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CCCCCCCCcc
Q 003542 360 GFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHL 438 (811)
Q Consensus 360 DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~~PF~~~~~ 438 (811)
||||++....... ......-+..|+|||.+. .+.|++++|||||||++||+++ |..||.+...
T Consensus 305 DFGLs~~~~~~~~-------~~~~~klPirWLAPEtl~---------~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~ 368 (474)
T KOG0194|consen 305 DFGLSRAGSQYVM-------KKFLKKLPIRWLAPETLN---------TGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN 368 (474)
T ss_pred ccccccCCcceee-------ccccccCcceecChhhhc---------cCccccccchhheeeeEEeeeccCCCCCCCCCH
Confidence 9999876541110 111224567899999996 4589999999999999999999 8999987543
Q ss_pred chHHHHHHH-HhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHHHHHhh
Q 003542 439 QGDKMTKNI-RAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKKFMA 496 (811)
Q Consensus 439 ~~~~i~~~i-~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~k~l~ 496 (811)
.++...| ..+.+...|...|..+..++.+||..+|++||++.++.+.++.+.....
T Consensus 369 --~~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 369 --YEVKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred --HHHHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 3555666 6688888899999999999999999999999999999999988876543
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=326.80 Aligned_cols=254 Identities=24% Similarity=0.448 Sum_probs=200.0
Q ss_pred cceEEeeeecccc---eEEEEEE------cCCEEEEEEecc-----cHHHHHHHHHHHHhCC-CCccceeeeeEEccCCC
Q 003542 216 KKLMVRRRLGASS---QFKEIQW------LGDSFVLRHFYG-----ELESLNAEISTMLSLS-HPNIVQYLCGFCDEEKK 280 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~~------~g~~VAVK~~~~-----~~~~~~~Ei~iL~~L~-HPNIVkl~~~~~~e~~~ 280 (811)
.+|.+.+.||.|+ ||++... .+..||||++.. ..+.+.+|+.+|+++. ||||+++++.+ .+..
T Consensus 37 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~--~~~~ 114 (400)
T cd05105 37 DGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC--TKSG 114 (400)
T ss_pred cceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE--ccCC
Confidence 5788888999886 7776532 234699999953 2467899999999996 99999999776 4456
Q ss_pred eEEEEEecCC-CCHHHHHHHhhCC--------------------------------------------------------
Q 003542 281 EFFLVMELMS-KDLSCYMRETFGS-------------------------------------------------------- 303 (811)
Q Consensus 281 ~~yLVmEy~~-g~L~~~L~~~~~~-------------------------------------------------------- 303 (811)
.+|||||||+ |+|.++|......
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 7999999999 5999988653210
Q ss_pred ----------------------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccC
Q 003542 304 ----------------------------------RRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARS 349 (811)
Q Consensus 304 ----------------------------------~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g 349 (811)
.....+++..++.++.||+.||.|||+.+|+||||||+|||++.++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~ 274 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGK 274 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCC
Confidence 0113478888999999999999999999999999999999998765
Q ss_pred CCCcceEEEeeccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-
Q 003542 350 MEGYFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT- 428 (811)
Q Consensus 350 ~d~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt- 428 (811)
.+||+|||++........ ........+++.|+|||++.+. .++.++|||||||++|+|++
T Consensus 275 -----~~kL~DfGla~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~DiwSlGvil~ellt~ 335 (400)
T cd05105 275 -----IVKICDFGLARDIMHDSN-----YVSKGSTFLPVKWMAPESIFDN---------LYTTLSDVWSYGILLWEIFSL 335 (400)
T ss_pred -----EEEEEeCCcceecccccc-----ccccCCcCCCcceEChhhhcCC---------CCCchhhHHHHHHHHHHHHHC
Confidence 899999999876533211 1112334567889999998643 67889999999999999997
Q ss_pred CCCCCCCCccchHHHHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHH
Q 003542 429 GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYI 491 (811)
Q Consensus 429 G~~PF~~~~~~~~~i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i 491 (811)
|..||...... ..+...+..+..+..+..++..+.+++.+||..||++||++.+|.+.|..+
T Consensus 336 g~~P~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l 397 (400)
T cd05105 336 GGTPYPGMIVD-STFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397 (400)
T ss_pred CCCCCcccchh-HHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence 99999764322 233445555556666778899999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=324.15 Aligned_cols=247 Identities=23% Similarity=0.340 Sum_probs=190.8
Q ss_pred HhcceEEeeeecccc---eEEEE-EEcCCEEEEEEecc------cHHHHHHHHHHHHhCCCCccceeeeeEEcc----CC
Q 003542 214 LLKKLMVRRRLGASS---QFKEI-QWLGDSFVLRHFYG------ELESLNAEISTMLSLSHPNIVQYLCGFCDE----EK 279 (811)
Q Consensus 214 l~k~~~i~~~lG~G~---vyk~v-~~~g~~VAVK~~~~------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e----~~ 279 (811)
+.++|++.+.||+|+ ||++. ...++.||||++.. ....+.+|+.+++.++||||+++++.+... ..
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 467899999999996 66655 34789999999853 245688999999999999999999776432 22
Q ss_pred CeEEEEEecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEe
Q 003542 280 KEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVS 359 (811)
Q Consensus 280 ~~~yLVmEy~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~ 359 (811)
..+|+||||++++|..++. ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+
T Consensus 102 ~~~~lv~e~~~~~l~~~~~--------~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-----~~kL~ 168 (364)
T cd07875 102 QDVYIVMELMDANLCQVIQ--------MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-----TLKIL 168 (364)
T ss_pred CeEEEEEeCCCCCHHHHHH--------hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCC-----cEEEE
Confidence 4689999999999888775 3478889999999999999999999999999999999998776 89999
Q ss_pred eccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccc
Q 003542 360 GFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQ 439 (811)
Q Consensus 360 DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~ 439 (811)
|||+++...... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+....
T Consensus 169 DfG~a~~~~~~~--------~~~~~~~t~~y~aPE~~~~~---------~~~~~~DiwSlG~il~ell~g~~pf~~~~~~ 231 (364)
T cd07875 169 DFGLARTAGTSF--------MMTPYVVTRYYRAPEVILGM---------GYKENVDIWSVGCIMGEMIKGGVLFPGTDHI 231 (364)
T ss_pred eCCCccccCCCC--------cccCCcccCCcCCHHHHhCC---------CCCchhhHHhHHHHHHHHHhCCCCCCCCCHH
Confidence 999997543221 12345689999999999753 6788999999999999999999999764321
Q ss_pred hHHHHHHHHh--------------------CCCCCC--------------------CCCChHHHHHHHhhhccCCCCCCC
Q 003542 440 GDKMTKNIRA--------------------GERPLF--------------------PSGSPKYLVNLTKKCWHTNPSQRP 479 (811)
Q Consensus 440 ~~~i~~~i~~--------------------~~~~~~--------------------p~~~~~~l~~LI~~cL~~DP~~RP 479 (811)
. .+...+.. ..++.+ ....+..+.+||.+||..||.+||
T Consensus 232 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~ 310 (364)
T cd07875 232 D-QWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRI 310 (364)
T ss_pred H-HHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCC
Confidence 1 11111100 000100 011235689999999999999999
Q ss_pred CHHHHHHHHHHHH
Q 003542 480 SFSSICRILRYIK 492 (811)
Q Consensus 480 S~~eIl~~L~~i~ 492 (811)
|+.++++ ..++.
T Consensus 311 t~~e~L~-hp~~~ 322 (364)
T cd07875 311 SVDEALQ-HPYIN 322 (364)
T ss_pred CHHHHhc-Ccccc
Confidence 9999987 34444
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=304.91 Aligned_cols=245 Identities=23% Similarity=0.355 Sum_probs=195.5
Q ss_pred cceEEeeeecccc---eEEEEE-EcCCEEEEEEecc---------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeE
Q 003542 216 KKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG---------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEF 282 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~---------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~ 282 (811)
+.|.+.+.||.|+ +|.+.. .+|+.||+|.+.. ....+.+|+.++++++||||+++++.+. +...+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~ 79 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLR--DDETL 79 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEc--cCCeE
Confidence 3577888888885 677663 4789999999842 2356889999999999999999997773 45589
Q ss_pred EEEEecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeec
Q 003542 283 FLVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGF 361 (811)
Q Consensus 283 yLVmEy~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DF 361 (811)
|+||||++| +|.+++... ..+++..+..++.|++.||.|||+.||+||||+|+||+++.++ .++|+||
T Consensus 80 ~~v~e~~~~~~l~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~-----~~~l~df 148 (263)
T cd06625 80 SIFMEYMPGGSVKDQLKAY------GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAG-----NVKLGDF 148 (263)
T ss_pred EEEEEECCCCcHHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-----CEEEeec
Confidence 999999985 888888753 5688999999999999999999999999999999999998776 8999999
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchH
Q 003542 362 GLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGD 441 (811)
Q Consensus 362 GlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~ 441 (811)
|++......... ........++..|+|||++.+. .++.++||||||+++|+|++|+.||...... .
T Consensus 149 g~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~ 214 (263)
T cd06625 149 GASKRLQTICSS----GTGMKSVTGTPYWMSPEVISGE---------GYGRKADVWSVGCTVVEMLTEKPPWAEFEAM-A 214 (263)
T ss_pred ccceeccccccc----cccccCCCcCccccCcceeccC---------CCCchhhhHHHHHHHHHHHhCCCCccccchH-H
Confidence 998765332110 0111234577889999999753 5788999999999999999999999764322 2
Q ss_pred HHHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHH
Q 003542 442 KMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRI 487 (811)
Q Consensus 442 ~i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~ 487 (811)
...........+.++...+..+.++|.+||..+|.+||++.+++.+
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 215 AIFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred HHHHHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 2223333334455777889999999999999999999999999763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=320.27 Aligned_cols=246 Identities=21% Similarity=0.353 Sum_probs=191.3
Q ss_pred hcceEEeeeecccc---eEEEEEE-cCCEEEEEEeccc-----HHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEE
Q 003542 215 LKKLMVRRRLGASS---QFKEIQW-LGDSFVLRHFYGE-----LESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLV 285 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~~-~g~~VAVK~~~~~-----~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLV 285 (811)
..+|++.+.||.|+ ||.+... +|..+|+|.+... ...+.+|+++|+.++||||+++++.+. +.+.+|+|
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv 81 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY--SDGEISIC 81 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEE--ECCEEEEE
Confidence 46789999999986 6665533 7889999988532 356899999999999999999998774 45679999
Q ss_pred EecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcEEEeccCCCCcceEEEeeccc
Q 003542 286 MELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQ-KIYHGELNPSNIYLKARSMEGYFHVKVSGFGL 363 (811)
Q Consensus 286 mEy~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~-gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGl 363 (811)
|||+++ +|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++ .+||+|||+
T Consensus 82 ~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~-----~~kL~Dfg~ 150 (333)
T cd06650 82 MEHMDGGSLDQVLKKA------GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-----EIKLCDFGV 150 (333)
T ss_pred EecCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCC-----CEEEeeCCc
Confidence 999985 899988753 5688999999999999999999985 799999999999998776 799999999
Q ss_pred cccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHH-
Q 003542 364 STARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDK- 442 (811)
Q Consensus 364 A~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~- 442 (811)
+...... ......||..|+|||++.+. .++.++|||||||++|+|++|+.||.........
T Consensus 151 ~~~~~~~---------~~~~~~~~~~y~aPE~~~~~---------~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~ 212 (333)
T cd06650 151 SGQLIDS---------MANSFVGTRSYMSPERLQGT---------HYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELEL 212 (333)
T ss_pred chhhhhh---------ccccCCCCccccCHHHhcCC---------CCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHH
Confidence 8654322 11234688999999999643 5788999999999999999999999753321110
Q ss_pred -----------------------------------------HHHHHHhCCCCCCCC-CChHHHHHHHhhhccCCCCCCCC
Q 003542 443 -----------------------------------------MTKNIRAGERPLFPS-GSPKYLVNLTKKCWHTNPSQRPS 480 (811)
Q Consensus 443 -----------------------------------------i~~~i~~~~~~~~p~-~~~~~l~~LI~~cL~~DP~~RPS 480 (811)
+...+.....+..+. ..+.++.+||.+||+.||.+|||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt 292 (333)
T cd06650 213 MFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERAD 292 (333)
T ss_pred HhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcC
Confidence 011111222222222 35678999999999999999999
Q ss_pred HHHHHHHHHHHH
Q 003542 481 FSSICRILRYIK 492 (811)
Q Consensus 481 ~~eIl~~L~~i~ 492 (811)
+.+++. ..+|+
T Consensus 293 ~~ell~-h~~~~ 303 (333)
T cd06650 293 LKQLMV-HAFIK 303 (333)
T ss_pred HHHHhh-CHHHh
Confidence 999986 34443
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=300.42 Aligned_cols=246 Identities=24% Similarity=0.394 Sum_probs=207.4
Q ss_pred hcceEEeeeecccc---eEEEE-EEcCCEEEEEEecc-------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEE
Q 003542 215 LKKLMVRRRLGASS---QFKEI-QWLGDSFVLRHFYG-------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFF 283 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v-~~~g~~VAVK~~~~-------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~y 283 (811)
..+|++.+.||+|. ||.+. ..++..||+|++.+ -...+.+|++|-+.|+||||+++|+.|.+ ....|
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd--~~riy 98 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHD--SKRIY 98 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheec--cceeE
Confidence 46788999999873 55554 44788999999864 23668999999999999999999988854 45699
Q ss_pred EEEecCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecc
Q 003542 284 LVMELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFG 362 (811)
Q Consensus 284 LVmEy~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFG 362 (811)
|++||.+ |.|+..|.+. ....|++..++.|+.|++.||.|+|..+++||||||+|+|++..+ .+||+|||
T Consensus 99 LilEya~~gel~k~L~~~----~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~-----~lkiAdfG 169 (281)
T KOG0580|consen 99 LILEYAPRGELYKDLQEG----RMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAG-----ELKIADFG 169 (281)
T ss_pred EEEEecCCchHHHHHHhc----ccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCC-----CeeccCCC
Confidence 9999999 7899999853 336799999999999999999999999999999999999999887 89999999
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHH
Q 003542 363 LSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDK 442 (811)
Q Consensus 363 lA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~ 442 (811)
-+...... ...+.+||..|.+||+..+. .++..+|+|++|+++||++.|.+||+... ..+
T Consensus 170 wsV~~p~~---------kR~tlcgt~dyl~pEmv~~~---------~hd~~Vd~w~lgvl~yeflvg~ppFes~~--~~e 229 (281)
T KOG0580|consen 170 WSVHAPSN---------KRKTLCGTLDYLPPEMVEGR---------GHDKFVDLWSLGVLCYEFLVGLPPFESQS--HSE 229 (281)
T ss_pred ceeecCCC---------CceeeecccccCCHhhcCCC---------CccchhhHHHHHHHHHHHHhcCCchhhhh--hHH
Confidence 98665422 33577899999999999865 67899999999999999999999998765 455
Q ss_pred HHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHHHH
Q 003542 443 MTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKK 493 (811)
Q Consensus 443 i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~k 493 (811)
.++.|.... ..+|..++..+.++|.+|+..+|.+|.+..+++. +.+|.+
T Consensus 230 tYkrI~k~~-~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~-hpwI~a 278 (281)
T KOG0580|consen 230 TYKRIRKVD-LKFPSTISGGAADLISRLLVKNPIERLALTEVMD-HPWIVA 278 (281)
T ss_pred HHHHHHHcc-ccCCcccChhHHHHHHHHhccCccccccHHHHhh-hHHHHh
Confidence 666666543 4478899999999999999999999999999987 555543
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=320.22 Aligned_cols=256 Identities=25% Similarity=0.495 Sum_probs=200.2
Q ss_pred cceEEeeeecccc---eEEEEEE------cCCEEEEEEecc-----cHHHHHHHHHHHHhC-CCCccceeeeeEEccCCC
Q 003542 216 KKLMVRRRLGASS---QFKEIQW------LGDSFVLRHFYG-----ELESLNAEISTMLSL-SHPNIVQYLCGFCDEEKK 280 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~~------~g~~VAVK~~~~-----~~~~~~~Ei~iL~~L-~HPNIVkl~~~~~~e~~~ 280 (811)
++|++.+.||.|+ ||.+... +++.||+|++.. ..+.+..|+.++.++ +||||+++++.+. ....
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~-~~~~ 85 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACT-KPGG 85 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEe-cCCC
Confidence 4688888888886 7766422 357899999863 245678899999999 8999999997654 3445
Q ss_pred eEEEEEecCCC-CHHHHHHHhhCC-------------------------------------------------------C
Q 003542 281 EFFLVMELMSK-DLSCYMRETFGS-------------------------------------------------------R 304 (811)
Q Consensus 281 ~~yLVmEy~~g-~L~~~L~~~~~~-------------------------------------------------------~ 304 (811)
.++++|||+++ +|.+++...... .
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 78999999995 898888643110 0
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccccccCCCCCCCCCCCCCC
Q 003542 305 RRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTPPASPQNQTA 384 (811)
Q Consensus 305 ~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~ 384 (811)
....+++..+..++.||+.||.|||++||+||||||+|||++.++ .++|+|||++........ .......
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~-----~vkL~DfG~a~~~~~~~~-----~~~~~~~ 235 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENN-----VVKICDFGLARDIYKDPD-----YVRKGDA 235 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCC-----cEEEeccccchhcccCcc-----hhhccCC
Confidence 013688999999999999999999999999999999999998766 899999999976533211 1112234
Q ss_pred CCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CCCCCCCCccchHHHHHHHHhCCCCCCCCCChHHH
Q 003542 385 PNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYL 463 (811)
Q Consensus 385 ~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~~PF~~~~~~~~~i~~~i~~~~~~~~p~~~~~~l 463 (811)
.++..|+|||++.+. .++.++|||||||++|||++ |..||.+.... +.+...+..+..+..+...++.+
T Consensus 236 ~~~~~y~aPE~~~~~---------~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 305 (337)
T cd05054 236 RLPLKWMAPESIFDK---------VYTTQSDVWSFGVLLWEIFSLGASPYPGVQID-EEFCRRLKEGTRMRAPEYATPEI 305 (337)
T ss_pred CCCccccCcHHhcCC---------CCCccccHHHHHHHHHHHHHcCCCCCCCCCcc-HHHHHHHhccCCCCCCccCCHHH
Confidence 567789999998643 68899999999999999998 99999764332 23444555555666677788899
Q ss_pred HHHHhhhccCCCCCCCCHHHHHHHHHHHH
Q 003542 464 VNLTKKCWHTNPSQRPSFSSICRILRYIK 492 (811)
Q Consensus 464 ~~LI~~cL~~DP~~RPS~~eIl~~L~~i~ 492 (811)
.+++.+||+.+|++||++.+++++|..+-
T Consensus 306 ~~l~~~cl~~~p~~RPs~~ell~~l~~~~ 334 (337)
T cd05054 306 YSIMLDCWHNNPEDRPTFSELVEILGDLL 334 (337)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 99999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=310.08 Aligned_cols=236 Identities=19% Similarity=0.307 Sum_probs=184.1
Q ss_pred cccceEEEE-EEcCCEEEEEEecc-------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEecCCC-CHHH
Q 003542 225 GASSQFKEI-QWLGDSFVLRHFYG-------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSC 295 (811)
Q Consensus 225 G~G~vyk~v-~~~g~~VAVK~~~~-------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~~g-~L~~ 295 (811)
|.|.||.+. ..+|+.||+|.+.. ..+.+..|+.+|+.++||||+++++.+ .....+|+|||||+| +|..
T Consensus 5 ~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~--~~~~~~~lv~e~~~~g~L~~ 82 (280)
T cd05608 5 GFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAF--QTKTDLCLVMTIMNGGDLRY 82 (280)
T ss_pred CceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEE--cCCCeEEEEEeCCCCCCHHH
Confidence 344478766 34889999999853 235577899999999999999998766 445679999999985 8877
Q ss_pred HHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccccccCCCCC
Q 003542 296 YMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTP 375 (811)
Q Consensus 296 ~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~~~~~~ 375 (811)
++.... .....+++..++.++.||+.||.|||++||+||||||+|||++.++ .++|+|||++.......
T Consensus 83 ~~~~~~--~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~-----~~~l~dfg~~~~~~~~~---- 151 (280)
T cd05608 83 HIYNVD--EENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDG-----NVRISDLGLAVELKDGQ---- 151 (280)
T ss_pred HHHhcc--ccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-----CEEEeeCccceecCCCC----
Confidence 775421 1235689999999999999999999999999999999999998776 79999999987653321
Q ss_pred CCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccc--hHHHHHHHHhCCCC
Q 003542 376 PASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQ--GDKMTKNIRAGERP 453 (811)
Q Consensus 376 ~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~--~~~i~~~i~~~~~~ 453 (811)
.......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...... .......+.. ...
T Consensus 152 ---~~~~~~~g~~~y~aPE~~~~~---------~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~-~~~ 218 (280)
T cd05608 152 ---SKTKGYAGTPGFMAPELLQGE---------EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILN-DSV 218 (280)
T ss_pred ---ccccccCCCcCccCHHHhcCC---------CCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcc-cCC
Confidence 112345689999999999743 6788999999999999999999999764322 1122222222 223
Q ss_pred CCCCCChHHHHHHHhhhccCCCCCCC-----CHHHHHH
Q 003542 454 LFPSGSPKYLVNLTKKCWHTNPSQRP-----SFSSICR 486 (811)
Q Consensus 454 ~~p~~~~~~l~~LI~~cL~~DP~~RP-----S~~eIl~ 486 (811)
.++...+..+.+++.+||+.||.+|| +++++++
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 219 TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 45667889999999999999999999 6677776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=303.23 Aligned_cols=248 Identities=25% Similarity=0.446 Sum_probs=198.9
Q ss_pred cceEEeeeecccc---eEEEEEE----cCCEEEEEEecc-----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEE
Q 003542 216 KKLMVRRRLGASS---QFKEIQW----LGDSFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFF 283 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~~----~g~~VAVK~~~~-----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~y 283 (811)
.+|.+.+.||.|+ ||++... ....||||.+.. ....+.+|+.+++.++||||+++++.+. ....+|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~ 81 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVT--KSRPVM 81 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEe--cCCceE
Confidence 4688888888886 7776542 245899999853 2456889999999999999999997663 455689
Q ss_pred EEEecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecc
Q 003542 284 LVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFG 362 (811)
Q Consensus 284 LVmEy~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFG 362 (811)
+||||+++ +|.+++... ...+++..++.++.|++.||.|||+++|+||||||+|||++.++ .++|+|||
T Consensus 82 iv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~-----~~~l~dfg 151 (266)
T cd05033 82 IITEYMENGSLDKFLREN-----DGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNL-----VCKVSDFG 151 (266)
T ss_pred EEEEcCCCCCHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC-----CEEECccc
Confidence 99999985 899888653 24689999999999999999999999999999999999998776 89999999
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CCCCCCCCccchH
Q 003542 363 LSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGD 441 (811)
Q Consensus 363 lA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~~PF~~~~~~~~ 441 (811)
++........ ........++..|+|||.+.+. .++.++||||||+++|+|++ |..||.... ..
T Consensus 152 ~~~~~~~~~~-----~~~~~~~~~~~~y~~Pe~~~~~---------~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~--~~ 215 (266)
T cd05033 152 LSRRLEDSEA-----TYTTKGGKIPIRWTAPEAIAYR---------KFTSASDVWSFGIVMWEVMSYGERPYWDMS--NQ 215 (266)
T ss_pred hhhccccccc-----ceeccCCCCCccccChhhhccC---------CCccccchHHHHHHHHHHHccCCCCCCCCC--HH
Confidence 9987642111 1111223456789999998643 67889999999999999998 999997543 33
Q ss_pred HHHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHH
Q 003542 442 KMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYI 491 (811)
Q Consensus 442 ~i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i 491 (811)
.....+..+...+.+..+++.+.+|+.+||+.+|.+||++.+|++.|..+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 216 DVIKAVEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 44556666655566778899999999999999999999999999888653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=302.08 Aligned_cols=236 Identities=26% Similarity=0.466 Sum_probs=186.9
Q ss_pred ccceEEEEE-EcCCEEEEEEecc-----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEecCCC-CHHHHHH
Q 003542 226 ASSQFKEIQ-WLGDSFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMR 298 (811)
Q Consensus 226 ~G~vyk~v~-~~g~~VAVK~~~~-----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~~g-~L~~~L~ 298 (811)
.|.||++.. .+|+.||+|.+.. ....+.+|+++++.++||||+++++.+. ....+|+||||+++ +|.+++.
T Consensus 8 ~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~~~ 85 (252)
T cd05084 8 FGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT--QKQPIYIVMELVQGGDFLTFLR 85 (252)
T ss_pred CccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEc--CCCCeEEEEeeccCCcHHHHHH
Confidence 344888774 4899999998753 2456899999999999999999997663 45578999999985 8988886
Q ss_pred HhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccccccCCCCCCCC
Q 003542 299 ETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTPPAS 378 (811)
Q Consensus 299 ~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~~~~~~~~~ 378 (811)
.. ...+++..++.++.|++.||.|||++|++||||||+|||++.++ .+||+|||++........ .
T Consensus 86 ~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~-----~~kl~dfg~~~~~~~~~~-----~ 150 (252)
T cd05084 86 TE-----GPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKN-----VLKISDFGMSREEEDGVY-----A 150 (252)
T ss_pred hC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCC-----cEEECccccCcccccccc-----c
Confidence 42 24588999999999999999999999999999999999998776 899999999875432110 0
Q ss_pred CCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CCCCCCCCccchHHHHHHHHhCCCCCCCC
Q 003542 379 PQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGDKMTKNIRAGERPLFPS 457 (811)
Q Consensus 379 ~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~~PF~~~~~~~~~i~~~i~~~~~~~~p~ 457 (811)
.......++..|+|||.+.+ ..++.++||||||+++|+|++ |..||..... ......+........+.
T Consensus 151 ~~~~~~~~~~~y~aPE~~~~---------~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~--~~~~~~~~~~~~~~~~~ 219 (252)
T cd05084 151 STGGMKQIPVKWTAPEALNY---------GRYSSESDVWSFGILLWEAFSLGAVPYANLSN--QQTREAIEQGVRLPCPE 219 (252)
T ss_pred ccCCCCCCceeecCchhhcC---------CCCChHHHHHHHHHHHHHHHhCCCCCccccCH--HHHHHHHHcCCCCCCcc
Confidence 00111223456999999864 357889999999999999998 9999975432 23344555555566777
Q ss_pred CChHHHHHHHhhhccCCCCCCCCHHHHHHHHH
Q 003542 458 GSPKYLVNLTKKCWHTNPSQRPSFSSICRILR 489 (811)
Q Consensus 458 ~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~ 489 (811)
.++..+.+|+.+||..+|++|||+.++++.|.
T Consensus 220 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 88999999999999999999999999988663
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=318.00 Aligned_cols=230 Identities=20% Similarity=0.282 Sum_probs=181.8
Q ss_pred eecccc---eEEEEE-EcCCEEEEEEecc-------cHHHHHHHHHHHHhC-CCCccceeeeeEEccCCCeEEEEEecCC
Q 003542 223 RLGASS---QFKEIQ-WLGDSFVLRHFYG-------ELESLNAEISTMLSL-SHPNIVQYLCGFCDEEKKEFFLVMELMS 290 (811)
Q Consensus 223 ~lG~G~---vyk~v~-~~g~~VAVK~~~~-------~~~~~~~Ei~iL~~L-~HPNIVkl~~~~~~e~~~~~yLVmEy~~ 290 (811)
.||+|+ ||.+.. .+++.||+|++.. ..+.+.+|+.++.++ +||||+++++.+ ++...+|+|||||+
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~--~~~~~~~lv~e~~~ 79 (327)
T cd05617 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCF--QTTSRLFLVIEYVN 79 (327)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEE--EeCCEEEEEEeCCC
Confidence 355553 776653 4778999999963 235578999999998 699999999777 44567999999998
Q ss_pred C-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccccc
Q 003542 291 K-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTY 369 (811)
Q Consensus 291 g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~ 369 (811)
| +|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 80 ~~~L~~~~~~~------~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~-----~~kl~Dfg~~~~~~~ 148 (327)
T cd05617 80 GGDLMFHMQRQ------RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADG-----HIKLTDYGMCKEGLG 148 (327)
T ss_pred CCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCC-----CEEEeccccceeccC
Confidence 5 888877643 5799999999999999999999999999999999999998876 899999999864322
Q ss_pred cCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCcc-----chHHHH
Q 003542 370 ASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHL-----QGDKMT 444 (811)
Q Consensus 370 ~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~-----~~~~i~ 444 (811)
.. .......||+.|+|||++.+. .++.++|||||||++|+|++|..||..... ......
T Consensus 149 ~~-------~~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~ 212 (327)
T cd05617 149 PG-------DTTSTFCGTPNYIAPEILRGE---------EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLF 212 (327)
T ss_pred CC-------CceecccCCcccCCHHHHCCC---------CCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHH
Confidence 11 122345689999999999743 678899999999999999999999964221 112223
Q ss_pred HHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHH
Q 003542 445 KNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFS 482 (811)
Q Consensus 445 ~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~ 482 (811)
..+. .....+|...+..+.++|.+||..||.+|+++.
T Consensus 213 ~~~~-~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 213 QVIL-EKPIRIPRFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred HHHH-hCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 3333 334457778889999999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=309.27 Aligned_cols=250 Identities=24% Similarity=0.410 Sum_probs=195.8
Q ss_pred ceEEeeeecccc---eEEEEEE------cCCEEEEEEeccc-----HHHHHHHHHHHHhCCCCccceeeeeEEccCCCeE
Q 003542 217 KLMVRRRLGASS---QFKEIQW------LGDSFVLRHFYGE-----LESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEF 282 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v~~------~g~~VAVK~~~~~-----~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~ 282 (811)
+|.+.+.||.|+ ||++... .+..||||.+... .+.+.+|+.++..++||||+++++.+. .....
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~--~~~~~ 83 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVT--KEQPL 83 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCCce
Confidence 355556667664 7776643 2478999999642 356889999999999999999997663 44568
Q ss_pred EEEEecCC-CCHHHHHHHhhC----------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCC
Q 003542 283 FLVMELMS-KDLSCYMRETFG----------SRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSME 351 (811)
Q Consensus 283 yLVmEy~~-g~L~~~L~~~~~----------~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d 351 (811)
++++||+. ++|.+++..... ......+++..+..++.|++.||.|||++||+||||||+|||++.++
T Consensus 84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~-- 161 (283)
T cd05091 84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKL-- 161 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCC--
Confidence 99999998 588888853210 01123588889999999999999999999999999999999998765
Q ss_pred CcceEEEeeccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CC
Q 003542 352 GYFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GK 430 (811)
Q Consensus 352 ~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~ 430 (811)
.+||+|||+++....... ........+++.|+|||++.+. .++.++|||||||++|||++ |.
T Consensus 162 ---~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Dv~slG~~l~el~~~g~ 224 (283)
T cd05091 162 ---NVKISDLGLFREVYAADY-----YKLMGNSLLPIRWMSPEAIMYG---------KFSIDSDIWSYGVVLWEVFSYGL 224 (283)
T ss_pred ---ceEecccccccccccchh-----eeeccCccCCccccCHHHHhcC---------CCCcchhHHHHHHHHHHHHcCCC
Confidence 799999999876533211 1112234467789999998642 57889999999999999998 88
Q ss_pred CCCCCCccchHHHHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHH
Q 003542 431 VPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILR 489 (811)
Q Consensus 431 ~PF~~~~~~~~~i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~ 489 (811)
.||.+.. ...+...+..+.....+..++.++.+|+.+||+.+|.+||++.+|+..|+
T Consensus 225 ~p~~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~ 281 (283)
T cd05091 225 QPYCGYS--NQDVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281 (283)
T ss_pred CCCCCCC--HHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence 8997643 33456667777666778899999999999999999999999999988774
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=347.20 Aligned_cols=261 Identities=26% Similarity=0.444 Sum_probs=210.6
Q ss_pred hcceEEeeeecccc---eEEEEEE--cCC----EEEEEEecc-----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCC
Q 003542 215 LKKLMVRRRLGASS---QFKEIQW--LGD----SFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKK 280 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~~--~g~----~VAVK~~~~-----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~ 280 (811)
.+..++.+.||+|. ||.+... .|. .||||.+.. +...|.+|..+|++++|||||++++...+ ..
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~--~~ 768 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD--SG 768 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC--CC
Confidence 45778889999984 4544432 333 499999964 56889999999999999999999976654 45
Q ss_pred eEEEEEecCC-CCHHHHHHHhhCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEE
Q 003542 281 EFFLVMELMS-KDLSCYMRETFGS-RRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKV 358 (811)
Q Consensus 281 ~~yLVmEy~~-g~L~~~L~~~~~~-~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL 358 (811)
..+|++|||+ |||..||++.... -....++....+.++.|||+|+.||+++++|||||-..|+|++... .|||
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r-----~VKI 843 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERR-----VVKI 843 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccC-----cEEE
Confidence 6899999999 5999999985221 1235688999999999999999999999999999999999997764 9999
Q ss_pred eeccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CCCCCCCCc
Q 003542 359 SGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGH 437 (811)
Q Consensus 359 ~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~~PF~~~~ 437 (811)
+|||||+..-..... .......-+..|||||.+.. +.++.|+|||||||+|||++| |..||.+.+
T Consensus 844 aDFGlArDiy~~~yy-----r~~~~a~lPvkWm~PEsl~d---------~iFtskSDvWsFGVllWEifslG~~PY~~~~ 909 (1025)
T KOG1095|consen 844 ADFGLARDIYDKDYY-----RKHGEAMLPVKWMPPESLKD---------GIFTSKSDVWSFGVLLWEIFSLGATPYPSRS 909 (1025)
T ss_pred cccchhHhhhhchhe-----eccCccccceecCCHHHHhh---------cccccccchhhhHHHHHHHHhCCCCCCCCcc
Confidence 999999844322211 01111244578999999984 489999999999999999999 999998653
Q ss_pred cchHHHHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHHHHHhhcC
Q 003542 438 LQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKKFMANN 498 (811)
Q Consensus 438 ~~~~~i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~k~l~~~ 498 (811)
..++...+..+.+...|..||..+.+|+.+||+.+|++||+|..|++.+..+...+...
T Consensus 910 --n~~v~~~~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~ 968 (1025)
T KOG1095|consen 910 --NFEVLLDVLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGT 968 (1025)
T ss_pred --hHHHHHHHHhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccC
Confidence 34555656666688899999999999999999999999999999999888887765443
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=322.54 Aligned_cols=245 Identities=19% Similarity=0.328 Sum_probs=189.0
Q ss_pred ceEEeeeecccc---eEEEEE-EcCCEEEEEEecc-------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEE
Q 003542 217 KLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG-------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLV 285 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~-------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLV 285 (811)
+|++++.||+|+ ||.+.. .+|+.||||++.. ....+.+|+.++..++||||+++++.+ ++...+|||
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~--~~~~~~~lv 79 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSF--QDKRNLYLI 79 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE--EcCCEEEEE
Confidence 578888899885 666553 3789999999853 345688899999999999999999877 456689999
Q ss_pred EecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccc
Q 003542 286 MELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS 364 (811)
Q Consensus 286 mEy~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA 364 (811)
||||+| +|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 80 ~E~~~gg~L~~~l~~~------~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~-----~vkL~DfG~~ 148 (360)
T cd05627 80 MEFLPGGDMMTLLMKK------DTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKG-----HVKLSDFGLC 148 (360)
T ss_pred EeCCCCccHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCC-----CEEEeeccCC
Confidence 999995 898888753 5789999999999999999999999999999999999998876 8999999998
Q ss_pred ccccccCCCCC----------------------------CCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccce
Q 003542 365 TARTYASRNTP----------------------------PASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADV 416 (811)
Q Consensus 365 ~~~~~~~~~~~----------------------------~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDI 416 (811)
........... ..........||+.|+|||++.+. .++.++||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~---------~~~~~~Di 219 (360)
T cd05627 149 TGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT---------GYNKLCDW 219 (360)
T ss_pred cccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCC---------CCCCccee
Confidence 75432110000 000011245799999999999753 67889999
Q ss_pred ecchhHHHHHhhCCCCCCCCccchHHHHHHHHhC-CCCCCCC--CChHHHHHHHhhhccCCCCCCCC---HHHHHH
Q 003542 417 YSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAG-ERPLFPS--GSPKYLVNLTKKCWHTNPSQRPS---FSSICR 486 (811)
Q Consensus 417 WSLGvILyELltG~~PF~~~~~~~~~i~~~i~~~-~~~~~p~--~~~~~l~~LI~~cL~~DP~~RPS---~~eIl~ 486 (811)
|||||++|||++|+.||.+.... .....+... ....+|. ..++.+.+||.+|+. ||.+|++ +.+++.
T Consensus 220 wSlGvilyel~tG~~Pf~~~~~~--~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 220 WSLGVIMYEMLIGYPPFCSETPQ--ETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKS 292 (360)
T ss_pred ccccceeeecccCCCCCCCCCHH--HHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhc
Confidence 99999999999999999865432 333344332 2223343 367889999999874 9999985 556554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=302.52 Aligned_cols=239 Identities=27% Similarity=0.475 Sum_probs=189.7
Q ss_pred eccc---ceEEEEEE---cCCEEEEEEeccc-----HHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEecCC-C
Q 003542 224 LGAS---SQFKEIQW---LGDSFVLRHFYGE-----LESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMS-K 291 (811)
Q Consensus 224 lG~G---~vyk~v~~---~g~~VAVK~~~~~-----~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~~-g 291 (811)
||.| .||.+... .+..||+|.+... .+.+.+|+.++++++||||+++++.+ + ...+++||||++ +
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~--~-~~~~~lv~e~~~~~ 79 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVC--E-AEALMLVMEMASGG 79 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEE--c-CCCeEEEEEeCCCC
Confidence 4555 37776532 3457999998542 35688999999999999999998654 2 346899999998 4
Q ss_pred CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccccccC
Q 003542 292 DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYAS 371 (811)
Q Consensus 292 ~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~~ 371 (811)
+|.+++... ...+++..++.++.||+.||.|||++|++||||||+|||++.++ .+||+|||++.......
T Consensus 80 ~L~~~l~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~-----~~kl~dfg~~~~~~~~~ 149 (257)
T cd05115 80 PLNKFLSGK-----KDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQH-----YAKISDFGLSKALGADD 149 (257)
T ss_pred CHHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCC-----cEEeccCCccccccCCc
Confidence 888887642 25689999999999999999999999999999999999998765 89999999987553322
Q ss_pred CCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CCCCCCCCccchHHHHHHHHhC
Q 003542 372 RNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGDKMTKNIRAG 450 (811)
Q Consensus 372 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~~PF~~~~~~~~~i~~~i~~~ 450 (811)
.. ........++..|+|||++... .++.++||||||+++|++++ |..||.+.. .......+..+
T Consensus 150 ~~----~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~~l~el~~~g~~p~~~~~--~~~~~~~~~~~ 214 (257)
T cd05115 150 SY----YKARSAGKWPLKWYAPECINFR---------KFSSRSDVWSYGITMWEAFSYGQKPYKKMK--GPEVMSFIEQG 214 (257)
T ss_pred cc----eeccCCCCCCcccCCHHHHccC---------CCCchhhHHHHHHHHHHHhcCCCCCcCcCC--HHHHHHHHHCC
Confidence 11 0111123345789999998643 57889999999999999996 999997653 23445666677
Q ss_pred CCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHH
Q 003542 451 ERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRY 490 (811)
Q Consensus 451 ~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~ 490 (811)
..+..+..+++++.++|.+||..+|++||++.+|.+.|+.
T Consensus 215 ~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~ 254 (257)
T cd05115 215 KRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRT 254 (257)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence 7777888899999999999999999999999999887764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=304.89 Aligned_cols=257 Identities=24% Similarity=0.397 Sum_probs=203.6
Q ss_pred hcceEEeeeecccc---eEEEEEEc-----CCEEEEEEecc-----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCe
Q 003542 215 LKKLMVRRRLGASS---QFKEIQWL-----GDSFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKE 281 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~~~-----g~~VAVK~~~~-----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~ 281 (811)
.++|++.+.||+|+ ||++.... +..||+|.+.. ....+.+|+.+|+.++||||+++++.+. .....
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~-~~~~~ 83 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCI-EDGEP 83 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCCCC
Confidence 35788888999886 77777554 68899999864 2466889999999999999999986543 34567
Q ss_pred EEEEEecCC-CCHHHHHHHhhCCC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEE
Q 003542 282 FFLVMELMS-KDLSCYMRETFGSR--RRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKV 358 (811)
Q Consensus 282 ~yLVmEy~~-g~L~~~L~~~~~~~--~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL 358 (811)
.++++||++ ++|.+++....... ....+++..++.++.||+.||.|||+.+++||||||+||+++.++ .+||
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~-----~~kl 158 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEEL-----QVKI 158 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCC-----cEEE
Confidence 899999998 68999887642110 114689999999999999999999999999999999999998765 8999
Q ss_pred eeccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CCCCCCCCc
Q 003542 359 SGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGH 437 (811)
Q Consensus 359 ~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~~PF~~~~ 437 (811)
+|||+++........ .......++..|+|||++.+. .++.++||||||+++|++++ |+.||....
T Consensus 159 ~d~g~~~~~~~~~~~-----~~~~~~~~~~~y~apE~~~~~---------~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 224 (280)
T cd05043 159 TDNALSRDLFPMDYH-----CLGDNENRPVKWMALESLVNK---------EYSSASDVWSFGVLLWELMTLGQTPYVEID 224 (280)
T ss_pred CCCCCcccccCCceE-----EeCCCCCcchhccCHHHHhcC---------CCCchhhHHHhHHHHHHHhcCCCCCcCcCC
Confidence 999999755332110 011233456779999998643 57899999999999999999 999997643
Q ss_pred cchHHHHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHHHH
Q 003542 438 LQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKK 493 (811)
Q Consensus 438 ~~~~~i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~k 493 (811)
...+...+..+.....+..+++.+.+++.+||..||++|||+.+++..|..+.+
T Consensus 225 --~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 225 --PFEMAAYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred --HHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 234445555555555566788999999999999999999999999999887764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=317.64 Aligned_cols=226 Identities=21% Similarity=0.313 Sum_probs=179.0
Q ss_pred cccceEEEEE-EcCCEEEEEEecc-------cHHHHHHHHH-HHHhCCCCccceeeeeEEccCCCeEEEEEecCCC-CHH
Q 003542 225 GASSQFKEIQ-WLGDSFVLRHFYG-------ELESLNAEIS-TMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLS 294 (811)
Q Consensus 225 G~G~vyk~v~-~~g~~VAVK~~~~-------~~~~~~~Ei~-iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~~g-~L~ 294 (811)
|.|.||++.. .+|+.||||++.. ....+..|.. +++.++||||+++++.+ .+...+|+|||||+| +|.
T Consensus 7 ~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~--~~~~~~~lv~e~~~~g~L~ 84 (323)
T cd05575 7 SFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSF--QTADKLYFVLDYVNGGELF 84 (323)
T ss_pred CCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEE--EeCCEEEEEEcCCCCCCHH
Confidence 3344887764 3789999999853 2244555655 45778999999999777 445679999999995 888
Q ss_pred HHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccccccCCCC
Q 003542 295 CYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNT 374 (811)
Q Consensus 295 ~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~~~~~ 374 (811)
.++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus 85 ~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~-----~~kl~Dfg~~~~~~~~~--- 150 (323)
T cd05575 85 FHLQRE------RSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQG-----HVVLTDFGLCKEGIEHS--- 150 (323)
T ss_pred HHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCC-----cEEEeccCCCcccccCC---
Confidence 888653 5789999999999999999999999999999999999998876 89999999986532211
Q ss_pred CCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHHHHhCCCCC
Q 003542 375 PPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPL 454 (811)
Q Consensus 375 ~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i~~~~~~~ 454 (811)
.......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+... ..+...+..+. ..
T Consensus 151 ----~~~~~~~gt~~y~aPE~~~~~---------~~~~~~DvwslG~il~ell~g~~pf~~~~~--~~~~~~i~~~~-~~ 214 (323)
T cd05575 151 ----KTTSTFCGTPEYLAPEVLRKQ---------PYDRTVDWWCLGAVLYEMLYGLPPFYSRDT--AEMYDNILNKP-LR 214 (323)
T ss_pred ----CccccccCChhhcChhhhcCC---------CCCccccccccchhhhhhhcCCCCCCCCCH--HHHHHHHHcCC-CC
Confidence 122345689999999998643 678899999999999999999999986432 33444444433 33
Q ss_pred CCCCChHHHHHHHhhhccCCCCCCCCHH
Q 003542 455 FPSGSPKYLVNLTKKCWHTNPSQRPSFS 482 (811)
Q Consensus 455 ~p~~~~~~l~~LI~~cL~~DP~~RPS~~ 482 (811)
.+...+..+.++|.+||+.||.+||++.
T Consensus 215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 215 LKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 5566788999999999999999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=306.01 Aligned_cols=249 Identities=23% Similarity=0.390 Sum_probs=197.2
Q ss_pred cceEEeeeecccc---eEEEEEE-cCC----EEEEEEecc-----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeE
Q 003542 216 KKLMVRRRLGASS---QFKEIQW-LGD----SFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEF 282 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~~-~g~----~VAVK~~~~-----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~ 282 (811)
.+|++.+.||.|+ +|++... +|+ .||+|.+.. ....+..|+.++.+++||||+++++.+ . ...+
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~-~--~~~~ 83 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGIC-P--GASL 83 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEE-C--CCcc
Confidence 5678888888886 7776643 454 488888843 235677888899999999999998654 2 2357
Q ss_pred EEEEecCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeec
Q 003542 283 FLVMELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGF 361 (811)
Q Consensus 283 yLVmEy~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DF 361 (811)
+++|||++ |+|.+++... ...+++..+..++.||+.||.|||+++++||||||+|||++.++ .+||+||
T Consensus 84 ~~i~e~~~~gsL~~~l~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~-----~~kl~Df 153 (279)
T cd05111 84 QLVTQLSPLGSLLDHVRQH-----RDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDS-----IVQIADF 153 (279)
T ss_pred EEEEEeCCCCcHHHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCC-----cEEEcCC
Confidence 89999998 6999998753 24689999999999999999999999999999999999998765 8999999
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CCCCCCCCccch
Q 003542 362 GLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQG 440 (811)
Q Consensus 362 GlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~~PF~~~~~~~ 440 (811)
|+++....... ........++..|+|||.+.+ ..++.++||||||+++|||++ |..||.+...
T Consensus 154 g~~~~~~~~~~-----~~~~~~~~~~~~y~~pE~~~~---------~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-- 217 (279)
T cd05111 154 GVADLLYPDDK-----KYFYSEHKTPIKWMALESILF---------GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP-- 217 (279)
T ss_pred ccceeccCCCc-----ccccCCCCCcccccCHHHhcc---------CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH--
Confidence 99976533221 111223456778999999864 368899999999999999998 9999976533
Q ss_pred HHHHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHHHH
Q 003542 441 DKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKK 493 (811)
Q Consensus 441 ~~i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~k 493 (811)
..+...+..+..+..+..++..+.+++.+||..||.+|||+.++++.|..+.+
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 218 HEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred HHHHHHHHCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 33445566666666677788899999999999999999999999887766543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=328.11 Aligned_cols=245 Identities=27% Similarity=0.501 Sum_probs=206.6
Q ss_pred EEeeeecccc---eEEEEEE---cCC--EEEEEEecc-----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEE
Q 003542 219 MVRRRLGASS---QFKEIQW---LGD--SFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLV 285 (811)
Q Consensus 219 ~i~~~lG~G~---vyk~v~~---~g~--~VAVK~~~~-----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLV 285 (811)
.+.+.||.|. ||+++.. .|+ .||||..+. ..+.|..|.-+|++++|||||++++.+. + ...|||
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~-e--~P~Wiv 468 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCV-E--QPMWIV 468 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeee-c--cceeEE
Confidence 4456788874 7777743 333 589999875 4688999999999999999999996553 3 348999
Q ss_pred EecCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccc
Q 003542 286 MELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS 364 (811)
Q Consensus 286 mEy~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA 364 (811)
||+++ |.|..||..+ ...++......|+.||+.||.|||+.++|||||-..|||+.... .|||+|||++
T Consensus 469 mEL~~~GELr~yLq~n-----k~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~-----CVKLaDFGLS 538 (974)
T KOG4257|consen 469 MELAPLGELREYLQQN-----KDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQ-----CVKLADFGLS 538 (974)
T ss_pred EecccchhHHHHHHhc-----cccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcc-----eeeecccchh
Confidence 99999 8999999864 36789999999999999999999999999999999999998776 9999999999
Q ss_pred ccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CCCCCCCCccchHHH
Q 003542 365 TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGDKM 443 (811)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~~PF~~~~~~~~~i 443 (811)
+........ ......-+..|||||.+.. ..++.++|||.|||.+||++. |..||.+.... ..
T Consensus 539 R~~ed~~yY------kaS~~kLPIKWmaPESINf---------RrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs--DV 601 (974)
T KOG4257|consen 539 RYLEDDAYY------KASRGKLPIKWMAPESINF---------RRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS--DV 601 (974)
T ss_pred hhccccchh------hccccccceeecCccccch---------hcccchhhHHHHHHHHHHHHHhcCCcccccccc--ce
Confidence 988766432 2223445678999999864 488999999999999999997 99999875433 34
Q ss_pred HHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHHHH
Q 003542 444 TKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKK 493 (811)
Q Consensus 444 ~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~k 493 (811)
...+..|.+++.|++||+.+..|+.+||++||.+||.|.+|...|..+..
T Consensus 602 I~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 602 IGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred EEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 56788899999999999999999999999999999999999998887765
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=301.86 Aligned_cols=245 Identities=28% Similarity=0.462 Sum_probs=196.5
Q ss_pred cceEEeeeecccc---eEEEEEEcCCEEEEEEecc---cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEecC
Q 003542 216 KKLMVRRRLGASS---QFKEIQWLGDSFVLRHFYG---ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELM 289 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~~~g~~VAVK~~~~---~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~ 289 (811)
.+|.+...||.|+ +|++....+..+|+|.+.. ..+.+.+|+.+++.++||||+++++.+ . ....|+||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~--~-~~~~~~v~e~~ 82 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVV--S-EEPIYIVTEFM 82 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEE--c-CCCcEEEEEcC
Confidence 5688888999886 7776655666899999864 236788999999999999999998654 2 24579999999
Q ss_pred CC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccccccc
Q 003542 290 SK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTART 368 (811)
Q Consensus 290 ~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~ 368 (811)
++ +|.+++... ....+++..+..++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++....
T Consensus 83 ~~~~L~~~~~~~----~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~-----~~~l~dfg~~~~~~ 153 (260)
T cd05069 83 GKGSLLDFLKEG----DGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNL-----VCKIADFGLARLIE 153 (260)
T ss_pred CCCCHHHHHhhC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCC-----eEEECCCccceEcc
Confidence 95 899988753 124578999999999999999999999999999999999998776 89999999997653
Q ss_pred ccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CCCCCCCCccchHHHHHHH
Q 003542 369 YASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGDKMTKNI 447 (811)
Q Consensus 369 ~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~~PF~~~~~~~~~i~~~i 447 (811)
.... .......++..|+|||.+.+ ..++.++||||||+++|+|++ |..||.+... ......+
T Consensus 154 ~~~~------~~~~~~~~~~~y~~Pe~~~~---------~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~~ 216 (260)
T cd05069 154 DNEY------TARQGAKFPIKWTAPEAALY---------GRFTIKSDVWSFGILLTELVTKGRVPYPGMVN--REVLEQV 216 (260)
T ss_pred CCcc------cccCCCccchhhCCHHHhcc---------CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHH
Confidence 3211 11123346678999998864 367889999999999999999 9999986432 2344455
Q ss_pred HhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHH
Q 003542 448 RAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILR 489 (811)
Q Consensus 448 ~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~ 489 (811)
..+..+..+...+..+.+++.+||..||.+||+++++++.|+
T Consensus 217 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 258 (260)
T cd05069 217 ERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLE 258 (260)
T ss_pred HcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHh
Confidence 555555566778899999999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=326.50 Aligned_cols=246 Identities=21% Similarity=0.322 Sum_probs=191.4
Q ss_pred HhcceEEeeeecccc---eEEEEEE---cCCEEEEEEecccHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEe
Q 003542 214 LLKKLMVRRRLGASS---QFKEIQW---LGDSFVLRHFYGELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVME 287 (811)
Q Consensus 214 l~k~~~i~~~lG~G~---vyk~v~~---~g~~VAVK~~~~~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmE 287 (811)
+..+|.+++.||.|+ ||.+... .+..||+|.+... ..+.+|+.+|++++||||+++++.+. ....+|+|||
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-~~~~~E~~il~~l~h~~iv~~~~~~~--~~~~~~lv~e 166 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-KTPGREIDILKTISHRAIINLIHAYR--WKSTVCMVMP 166 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-ccHHHHHHHHHhcCCCCccceeeeEe--eCCEEEEEeh
Confidence 346799999999995 6665432 4578999998653 34678999999999999999997774 4567999999
Q ss_pred cCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccc
Q 003542 288 LMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTAR 367 (811)
Q Consensus 288 y~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~ 367 (811)
|+.++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .++|+|||++...
T Consensus 167 ~~~~~l~~~l~~~------~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~-----~~~l~DfG~a~~~ 235 (392)
T PHA03207 167 KYKCDLFTYVDRS------GPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPE-----NAVLGDFGAACKL 235 (392)
T ss_pred hcCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCC-----CEEEccCcccccc
Confidence 9999999988432 6789999999999999999999999999999999999998876 8999999998765
Q ss_pred cccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccch--HHHHH
Q 003542 368 TYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQG--DKMTK 445 (811)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~--~~i~~ 445 (811)
..... ........||+.|+|||++.+. .++.++|||||||++|||++|..||.+..... ..+..
T Consensus 236 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~~---------~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~ 301 (392)
T PHA03207 236 DAHPD-----TPQCYGWSGTLETNSPELLALD---------PYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRS 301 (392)
T ss_pred Ccccc-----cccccccccccCccCHhHhcCC---------CCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHH
Confidence 43221 1122356799999999999643 67889999999999999999999997643211 11111
Q ss_pred HHH-------------------------hCCCCCC--C-----CCChHHHHHHHhhhccCCCCCCCCHHHHHHH
Q 003542 446 NIR-------------------------AGERPLF--P-----SGSPKYLVNLTKKCWHTNPSQRPSFSSICRI 487 (811)
Q Consensus 446 ~i~-------------------------~~~~~~~--p-----~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~ 487 (811)
.+. ...++.+ + ...+.++.++|.+||..||.+||++.+++.+
T Consensus 302 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 302 IIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 111 0011111 1 1345678899999999999999999999873
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=307.86 Aligned_cols=253 Identities=23% Similarity=0.462 Sum_probs=197.3
Q ss_pred ceEEeeeecccc---eEEEEEE------cCCEEEEEEecc-----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeE
Q 003542 217 KLMVRRRLGASS---QFKEIQW------LGDSFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEF 282 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v~~------~g~~VAVK~~~~-----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~ 282 (811)
+|++.+.||+|+ +|++... ....+|+|.+.. ....+.+|+.+++.++||||+++++.+. .....
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACS--QDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEe--cCCCc
Confidence 466777788875 7776632 235799998853 2457889999999999999999997663 44568
Q ss_pred EEEEecCC-CCHHHHHHHhhC------------------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcE
Q 003542 283 FLVMELMS-KDLSCYMRETFG------------------SRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNI 343 (811)
Q Consensus 283 yLVmEy~~-g~L~~~L~~~~~------------------~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNI 343 (811)
|+||||+. ++|.+++..... ......+++..++.++.|++.||.|||+.+++||||||+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 99999999 589988865311 01123588999999999999999999999999999999999
Q ss_pred EEeccCCCCcceEEEeeccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHH
Q 003542 344 YLKARSMEGYFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLC 423 (811)
Q Consensus 344 LI~~~g~d~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvIL 423 (811)
|++.++ .+||+|||++........ ........++..|+|||++.+. .++.++||||||+++
T Consensus 159 ll~~~~-----~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~apE~~~~~---------~~~~~~Di~slG~~l 219 (290)
T cd05045 159 LVAEGR-----KMKISDFGLSRDVYEEDS-----YVKRSKGRIPVKWMAIESLFDH---------IYTTQSDVWSFGVLL 219 (290)
T ss_pred EEcCCC-----cEEeccccccccccCccc-----hhcccCCCCCccccCHHHHccC---------CcchHhHHHHHHHHH
Confidence 998765 899999999875432211 0011233456789999998643 678899999999999
Q ss_pred HHHhh-CCCCCCCCccchHHHHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHHH
Q 003542 424 FELLT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIK 492 (811)
Q Consensus 424 yELlt-G~~PF~~~~~~~~~i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~ 492 (811)
|+|++ |..||.+.. ...+...+..+.....+..++..+.+++.+||+.+|.+||++.++++.|+.+.
T Consensus 220 ~el~t~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 220 WEIVTLGGNPYPGIA--PERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred HHHHhcCCCCCCCCC--HHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 99998 999997643 33445555555556667788899999999999999999999999998887653
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=321.54 Aligned_cols=247 Identities=21% Similarity=0.292 Sum_probs=193.1
Q ss_pred hcceEEeeeecccc---eEEEEE-EcCCEEEEEEecc-------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEE
Q 003542 215 LKKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG-------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFF 283 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~-------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~y 283 (811)
.++|++.+.||+|+ ||.+.. .+++.||+|.+.. ....+.+|+.+++.++||||+++++.+ .+...+|
T Consensus 42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~--~~~~~~~ 119 (371)
T cd05622 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF--QDDRYLY 119 (371)
T ss_pred hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE--EcCCEEE
Confidence 46899999999986 666553 3788999999853 234578899999999999999999777 4567899
Q ss_pred EEEecCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecc
Q 003542 284 LVMELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFG 362 (811)
Q Consensus 284 LVmEy~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFG 362 (811)
+|||||+ |+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 120 lv~Ey~~gg~L~~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~-----~ikL~DfG 187 (371)
T cd05622 120 MVMEYMPGGDLVNLMSN-------YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG-----HLKLADFG 187 (371)
T ss_pred EEEcCCCCCcHHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCC-----CEEEEeCC
Confidence 9999998 488888764 4588899999999999999999999999999999999998776 89999999
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHH
Q 003542 363 LSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDK 442 (811)
Q Consensus 363 lA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~ 442 (811)
++....... ........||+.|+|||++.+... ...++.++|||||||++|||++|..||.+.... .
T Consensus 188 ~a~~~~~~~------~~~~~~~~gt~~y~aPE~l~~~~~-----~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--~ 254 (371)
T cd05622 188 TCMKMNKEG------MVRCDTAVGTPDYISPEVLKSQGG-----DGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--G 254 (371)
T ss_pred ceeEcCcCC------cccccCcccCccccCHHHHhccCC-----CccCCCccceeehhHHHHHHHhCCCCCCCCCHH--H
Confidence 997654321 112235679999999999975421 234789999999999999999999999875432 3
Q ss_pred HHHHHHhCC-CCCCC--CCChHHHHHHHhhhccCCCCC--CCCHHHHHHHH
Q 003542 443 MTKNIRAGE-RPLFP--SGSPKYLVNLTKKCWHTNPSQ--RPSFSSICRIL 488 (811)
Q Consensus 443 i~~~i~~~~-~~~~p--~~~~~~l~~LI~~cL~~DP~~--RPS~~eIl~~L 488 (811)
....+.... ...+| ...+..+.+||..||..++.+ |+++.+|+++.
T Consensus 255 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 255 TYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred HHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 344444332 22333 357888999999999844433 77888887643
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=305.41 Aligned_cols=253 Identities=28% Similarity=0.463 Sum_probs=194.2
Q ss_pred cceEEeeeecccc---eEEEEE-----EcCCEEEEEEecc----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEE
Q 003542 216 KKLMVRRRLGASS---QFKEIQ-----WLGDSFVLRHFYG----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFF 283 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~-----~~g~~VAVK~~~~----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~y 283 (811)
+.|++.+.||.|+ +|.+.. .++..||||.+.. ....+.+|+.+|+.++||||+++++.+...+...+|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4678888899885 666542 2678999999864 345789999999999999999998766555556789
Q ss_pred EEEecCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecc
Q 003542 284 LVMELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFG 362 (811)
Q Consensus 284 LVmEy~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFG 362 (811)
+||||++ ++|.+++... ...+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 84 lv~e~~~~~~L~~~l~~~-----~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~-----~~~l~dfg 153 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH-----RERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESEN-----RVKIGDFG 153 (284)
T ss_pred EEEEecCCCCHHHHHHhc-----CcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCC-----eEEECCCc
Confidence 9999998 5999988653 24589999999999999999999999999999999999998776 89999999
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccc---
Q 003542 363 LSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQ--- 439 (811)
Q Consensus 363 lA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~--- 439 (811)
++......... ........++..|+|||++.+. .++.++||||||+++|||++|..|+......
T Consensus 154 ~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~ 220 (284)
T cd05081 154 LTKVLPQDKEY----YKVREPGESPIFWYAPESLTES---------KFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMR 220 (284)
T ss_pred ccccccCCCcc----eeecCCCCCceEeeCHHHhccC---------CcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhh
Confidence 99765432210 0011122344569999998643 5788999999999999999987776432110
Q ss_pred -----------hHHHHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHH
Q 003542 440 -----------GDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYI 491 (811)
Q Consensus 440 -----------~~~i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i 491 (811)
...+...+........+..++..+.+|+.+||..+|++|||+.+|++.|+.+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 221 MMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred hcccccccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 0111222333344445667888999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=322.51 Aligned_cols=246 Identities=24% Similarity=0.343 Sum_probs=204.3
Q ss_pred HHhcceEEeeeecccc---eEEEEEE-cCCEEEEEEecc-------cHHHHHHHHHHHHhCC-CCccceeeeeEEccCCC
Q 003542 213 MLLKKLMVRRRLGASS---QFKEIQW-LGDSFVLRHFYG-------ELESLNAEISTMLSLS-HPNIVQYLCGFCDEEKK 280 (811)
Q Consensus 213 ~l~k~~~i~~~lG~G~---vyk~v~~-~g~~VAVK~~~~-------~~~~~~~Ei~iL~~L~-HPNIVkl~~~~~~e~~~ 280 (811)
.....|++.+.||+|. +|.+... +|+.||+|.+.+ ..+.+.+|+.+|+++. |||||.+++.| ++..
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~--e~~~ 109 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAF--EDPD 109 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEE--EcCC
Confidence 3456899999999995 5555533 699999999954 2368999999999998 99999999888 5667
Q ss_pred eEEEEEecCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEe
Q 003542 281 EFFLVMELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVS 359 (811)
Q Consensus 281 ~~yLVmEy~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~ 359 (811)
.+|||||+|. |.|++.+... .+++..+..++.||+.|+.|||+.||+||||||+|+|+.... ++...+|++
T Consensus 110 ~~~lvmEL~~GGeLfd~i~~~-------~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~-~~~~~ik~~ 181 (382)
T KOG0032|consen 110 SVYLVMELCEGGELFDRIVKK-------HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKD-EGSGRIKLI 181 (382)
T ss_pred eEEEEEEecCCchHHHHHHHc-------cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeecccc-CCCCcEEEe
Confidence 8999999999 5899998863 399999999999999999999999999999999999998764 223479999
Q ss_pred eccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccc
Q 003542 360 GFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQ 439 (811)
Q Consensus 360 DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~ 439 (811)
|||++...... ......+||+.|+|||++... .|+..+||||+|+++|.|++|.+||.+....
T Consensus 182 DFGla~~~~~~--------~~~~~~~Gtp~y~APEvl~~~---------~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~ 244 (382)
T KOG0032|consen 182 DFGLAKFIKPG--------ERLHTIVGTPEYVAPEVLGGR---------PYGDEVDVWSIGVILYILLSGVPPFWGETEF 244 (382)
T ss_pred eCCCceEccCC--------ceEeeecCCccccCchhhcCC---------CCCcccchhHHHHHHHHHhhCCCCCcCCChh
Confidence 99999877542 134578899999999999743 7899999999999999999999999986533
Q ss_pred hHHHHHHHHhCCCC---CCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHH
Q 003542 440 GDKMTKNIRAGERP---LFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRI 487 (811)
Q Consensus 440 ~~~i~~~i~~~~~~---~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~ 487 (811)
.....+..+... ......+..++++|..||..||.+|+|+.+++++
T Consensus 245 --~~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 245 --EIFLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred --HHHHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 334456555432 1224568889999999999999999999999883
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=306.52 Aligned_cols=244 Identities=21% Similarity=0.303 Sum_probs=189.1
Q ss_pred ceEEeeeecccc---eEEEEE-EcCCEEEEEEecc------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEE
Q 003542 217 KLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVM 286 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVm 286 (811)
+|++.+.||.|+ +|++.. .+|..||||.+.. ....+.+|+.+++.++||||+++++.+. +...+|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~~v~ 78 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLM--QESRLYLIF 78 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEe--eCCeEEEEE
Confidence 477888888885 777664 3789999999852 2356889999999999999999998774 456799999
Q ss_pred ecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccccc
Q 003542 287 ELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366 (811)
Q Consensus 287 Ey~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~ 366 (811)
||++++|.+++.... ....+++..++.++.||+.||.|||+.|++||||||+|||++.++ .++|+|||++..
T Consensus 79 e~~~~~l~~~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~-----~~~l~dfg~~~~ 150 (285)
T cd07861 79 EFLSMDLKKYLDSLP---KGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKG-----VIKLADFGLARA 150 (285)
T ss_pred ecCCCCHHHHHhcCC---CCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCC-----cEEECcccceee
Confidence 999999988886531 225689999999999999999999999999999999999998876 899999999875
Q ss_pred ccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHH
Q 003542 367 RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKN 446 (811)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~ 446 (811)
..... .......+++.|+|||++.+. ..++.++|||||||++|+|++|++||.+...... ....
T Consensus 151 ~~~~~-------~~~~~~~~~~~y~aPE~~~~~--------~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~-~~~~ 214 (285)
T cd07861 151 FGIPV-------RVYTHEVVTLWYRAPEVLLGS--------PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ-LFRI 214 (285)
T ss_pred cCCCc-------ccccCCcccccccChHHhcCC--------CCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHH
Confidence 43221 112234568889999998642 2567899999999999999999999976432211 1111
Q ss_pred HHhCC---------------------------CCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 447 IRAGE---------------------------RPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 447 i~~~~---------------------------~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
..... .......+++++.++|.+||..||.+|||+.+|+.
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 215 FRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 10000 00012346778899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=308.51 Aligned_cols=257 Identities=25% Similarity=0.458 Sum_probs=203.2
Q ss_pred hcceEEeeeecccc---eEEEEEE--------cCCEEEEEEecc-----cHHHHHHHHHHHHhC-CCCccceeeeeEEcc
Q 003542 215 LKKLMVRRRLGASS---QFKEIQW--------LGDSFVLRHFYG-----ELESLNAEISTMLSL-SHPNIVQYLCGFCDE 277 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~~--------~g~~VAVK~~~~-----~~~~~~~Ei~iL~~L-~HPNIVkl~~~~~~e 277 (811)
..+|.+.+.||.|+ ||.+... .+..||+|.+.. ....+.+|+.+++.+ +||||+++++.+.
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~-- 91 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT-- 91 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe--
Confidence 46788888999886 6655421 345799999853 346689999999999 8999999997764
Q ss_pred CCCeEEEEEecCC-CCHHHHHHHhhCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEe
Q 003542 278 EKKEFFLVMELMS-KDLSCYMRETFGS----------RRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLK 346 (811)
Q Consensus 278 ~~~~~yLVmEy~~-g~L~~~L~~~~~~----------~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~ 346 (811)
....+|+||||++ |+|.+++...... .....+++..+..++.||+.||.|||++|++||||||+|||++
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~ 171 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT 171 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEc
Confidence 4457899999998 5999998764211 0123578889999999999999999999999999999999998
Q ss_pred ccCCCCcceEEEeeccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHH
Q 003542 347 ARSMEGYFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFEL 426 (811)
Q Consensus 347 ~~g~d~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyEL 426 (811)
.++ .+||+|||+++....... ........+++.|+|||++.+. .++.++||||||+++|+|
T Consensus 172 ~~~-----~~kl~D~g~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~~l~el 232 (304)
T cd05101 172 ENN-----VMKIADFGLARDVNNIDY-----YKKTTNGRLPVKWMAPEALFDR---------VYTHQSDVWSFGVLMWEI 232 (304)
T ss_pred CCC-----cEEECCCccceecccccc-----cccccCCCCCceeeCchhhccC---------CCCchhhHHHHHHHHHHH
Confidence 776 899999999976543221 1111233456789999998643 678899999999999999
Q ss_pred hh-CCCCCCCCccchHHHHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHHHHH
Q 003542 427 LT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKKF 494 (811)
Q Consensus 427 lt-G~~PF~~~~~~~~~i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~k~ 494 (811)
++ |..||.+.. ...+...+..+.....+..++..+.+|+.+||..+|.+||++.++++.|..+...
T Consensus 233 ~~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 233 FTLGGSPYPGIP--VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred HcCCCCCcccCC--HHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 98 889997643 3445566666666666778899999999999999999999999999988876654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=301.47 Aligned_cols=247 Identities=28% Similarity=0.473 Sum_probs=200.1
Q ss_pred hcceEEeeeecccc---eEEEEEEcCCEEEEEEecc---cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEec
Q 003542 215 LKKLMVRRRLGASS---QFKEIQWLGDSFVLRHFYG---ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMEL 288 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~~~g~~VAVK~~~~---~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy 288 (811)
..+|.+.+.||.|+ +|++....+..||||.+.. ..+.+.+|+.++++++||||+++++.+ .....+++||||
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~~v~e~ 82 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVC--SEEEPIYIVTEY 82 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeee--ecCCceEEEEec
Confidence 46789999999885 7776655678899999964 356799999999999999999999766 344568999999
Q ss_pred CCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccc
Q 003542 289 MSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTAR 367 (811)
Q Consensus 289 ~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~ 367 (811)
+++ +|.+++... ....+++..+..++.||+.||.|||++|++||||||+||+++.++ .++|+|||++...
T Consensus 83 ~~~~~L~~~i~~~----~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~-----~~~l~d~g~~~~~ 153 (261)
T cd05034 83 MSKGSLLDFLKSG----EGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENL-----VCKIADFGLARLI 153 (261)
T ss_pred cCCCCHHHHHhcc----ccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCC-----CEEECccccceec
Confidence 985 899988753 124689999999999999999999999999999999999998876 8999999998765
Q ss_pred cccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CCCCCCCCccchHHHHHH
Q 003542 368 TYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGDKMTKN 446 (811)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~~PF~~~~~~~~~i~~~ 446 (811)
..... .......++..|+|||.+.+. .++.++||||||+++|+|++ |+.||.+.. .......
T Consensus 154 ~~~~~------~~~~~~~~~~~y~~PE~~~~~---------~~~~~~Di~slG~il~~l~t~g~~p~~~~~--~~~~~~~ 216 (261)
T cd05034 154 EDDEY------TAREGAKFPIKWTAPEAANYG---------RFTIKSDVWSFGILLTEIVTYGRVPYPGMT--NREVLEQ 216 (261)
T ss_pred cchhh------hhhhccCCCccccCHHHhccC---------CcCchhHHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHH
Confidence 43210 111123345679999998643 57889999999999999998 999997643 2344455
Q ss_pred HHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHH
Q 003542 447 IRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILR 489 (811)
Q Consensus 447 i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~ 489 (811)
+..+.....+...+..+.+++.+||..+|.+||++.++...|+
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~ 259 (261)
T cd05034 217 VERGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLE 259 (261)
T ss_pred HHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHh
Confidence 5555555667778899999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=306.86 Aligned_cols=243 Identities=23% Similarity=0.303 Sum_probs=185.9
Q ss_pred ceEEeeeecccc---eEEEEEE-cCCEEEEEEecc------cHHHHHHHHHHHHhC---CCCccceeeeeEEcc---CCC
Q 003542 217 KLMVRRRLGASS---QFKEIQW-LGDSFVLRHFYG------ELESLNAEISTMLSL---SHPNIVQYLCGFCDE---EKK 280 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v~~-~g~~VAVK~~~~------~~~~~~~Ei~iL~~L---~HPNIVkl~~~~~~e---~~~ 280 (811)
+|++.+.||+|+ ||++... +|+.||+|.+.. ....+.+|+.+++.+ +||||+++++.+... ...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 478888899886 7776543 789999999853 123567788887766 799999999776432 235
Q ss_pred eEEEEEecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEee
Q 003542 281 EFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSG 360 (811)
Q Consensus 281 ~~yLVmEy~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~D 360 (811)
.+++||||+.++|.+++... ....+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~-----~~kl~d 151 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKV----PPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG-----QVKLAD 151 (288)
T ss_pred eEEEEEcccccCHHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-----CEEECc
Confidence 68999999999998888753 224589999999999999999999999999999999999998876 899999
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccch
Q 003542 361 FGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQG 440 (811)
Q Consensus 361 FGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~ 440 (811)
||++....... ......||..|+|||++.+. .++.++|||||||++|+|++|.+||.+.....
T Consensus 152 fg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~---------~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~ 214 (288)
T cd07863 152 FGLARIYSCQM--------ALTPVVVTLWYRAPEVLLQS---------TYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD 214 (288)
T ss_pred cCccccccCcc--------cCCCccccccccCchHhhCC---------CCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH
Confidence 99987653221 12245678899999999643 67899999999999999999999997643221
Q ss_pred HHHHHHHHh-CC--C-----------C-----------CCCCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 441 DKMTKNIRA-GE--R-----------P-----------LFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 441 ~~i~~~i~~-~~--~-----------~-----------~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
.+...+.. +. . . .....++..+.+||.+||+.||.+|||+.+++.
T Consensus 215 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 215 -QLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred -HHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 11111110 00 0 0 011245677899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=304.14 Aligned_cols=249 Identities=23% Similarity=0.402 Sum_probs=197.8
Q ss_pred hcceEEeeeecccc---eEEEEE-EcCC----EEEEEEecc-----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCe
Q 003542 215 LKKLMVRRRLGASS---QFKEIQ-WLGD----SFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKE 281 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~-~~g~----~VAVK~~~~-----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~ 281 (811)
..+|++.+.||.|+ +|++.. .+|. .||+|.+.. ....+.+|+.++..++||||+++++.+.. ..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---~~ 82 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT---ST 82 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC---CC
Confidence 35788899999986 777663 3554 489999853 24568899999999999999999865532 34
Q ss_pred EEEEEecCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEee
Q 003542 282 FFLVMELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSG 360 (811)
Q Consensus 282 ~yLVmEy~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~D 360 (811)
.+++|||++ |+|.+++.+. ...+++..++.++.||+.||.|||+++|+||||||+|||++.++ .+||+|
T Consensus 83 ~~l~~~~~~~g~l~~~l~~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~-----~~kL~d 152 (279)
T cd05109 83 VQLVTQLMPYGCLLDYVREN-----KDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPN-----HVKITD 152 (279)
T ss_pred cEEEEEcCCCCCHHHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCC-----cEEECC
Confidence 789999998 6899888753 24689999999999999999999999999999999999997765 799999
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CCCCCCCCccc
Q 003542 361 FGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQ 439 (811)
Q Consensus 361 FGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~~PF~~~~~~ 439 (811)
||+++....... ........+++.|+|||.+.+. .++.++|||||||++|||++ |..||....
T Consensus 153 fG~~~~~~~~~~-----~~~~~~~~~~~~y~~PE~~~~~---------~~~~~~Di~slG~~l~el~t~g~~p~~~~~-- 216 (279)
T cd05109 153 FGLARLLDIDET-----EYHADGGKVPIKWMALESILHR---------RFTHQSDVWSYGVTVWELMTFGAKPYDGIP-- 216 (279)
T ss_pred CCceeecccccc-----eeecCCCccchhhCCHHHhccC---------CCCchhHHHHHHHHHHHHHcCCCCCCCCCC--
Confidence 999976643221 0111223456779999998643 67889999999999999998 999997543
Q ss_pred hHHHHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHHH
Q 003542 440 GDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIK 492 (811)
Q Consensus 440 ~~~i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~ 492 (811)
...+...+..+..+..+..++..+.+++.+||..||++||++.++++.|..+.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 217 AREIPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred HHHHHHHHHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 23344556666666667788899999999999999999999999998776554
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=298.74 Aligned_cols=242 Identities=24% Similarity=0.388 Sum_probs=196.0
Q ss_pred ceEEeeeecccc---eEEEEE-EcCCEEEEEEecc------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEE
Q 003542 217 KLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVM 286 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVm 286 (811)
.|++.+.||.|+ +|.+.. .+++.||+|.+.. ..+.+.+|+.++++++||||+++++.+. .....+|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWE-GEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeec-CCCCEEEEEe
Confidence 478888999886 676663 3678999999842 3456889999999999999999987663 2345689999
Q ss_pred ecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccc
Q 003542 287 ELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365 (811)
Q Consensus 287 Ey~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~ 365 (811)
||+++ +|.+++... ....+++..++.++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++.
T Consensus 80 e~~~~~~l~~~l~~~----~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~-----~~~l~df~~~~ 150 (257)
T cd08223 80 GFCEGGDLYHKLKEQ----KGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTN-----IIKVGDLGIAR 150 (257)
T ss_pred cccCCCcHHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCC-----cEEEecccceE
Confidence 99984 898888753 224689999999999999999999999999999999999998776 89999999987
Q ss_pred cccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHH
Q 003542 366 ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTK 445 (811)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~ 445 (811)
...... .......+++.|+|||++.+. .++.++||||||+++|+|++|..||..... .....
T Consensus 151 ~~~~~~-------~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Dv~slG~il~~l~~g~~~~~~~~~--~~~~~ 212 (257)
T cd08223 151 VLENQC-------DMASTLIGTPYYMSPELFSNK---------PYNYKSDVWALGCCVYEMATLKHAFNAKDM--NSLVY 212 (257)
T ss_pred EecccC-------CccccccCCcCccChhHhcCC---------CCCchhhhHHHHHHHHHHHcCCCCCCCCCH--HHHHH
Confidence 653321 112345678899999998643 677899999999999999999999976432 23334
Q ss_pred HHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 446 NIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 446 ~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
.+..+..+..+...++.+.+++.+||+.||.+||++.++++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 213 RIIEGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred HHHhcCCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 45555555667788899999999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=299.91 Aligned_cols=248 Identities=25% Similarity=0.472 Sum_probs=199.6
Q ss_pred HhcceEEeeeecccc---eEEEEEEcCCEEEEEEecc---cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEe
Q 003542 214 LLKKLMVRRRLGASS---QFKEIQWLGDSFVLRHFYG---ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVME 287 (811)
Q Consensus 214 l~k~~~i~~~lG~G~---vyk~v~~~g~~VAVK~~~~---~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmE 287 (811)
..++|++.+.||+|+ +|.+....+..+|+|.+.. ..+.+.+|+.+++.++|+||+++++.+.. ..+|++||
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~v~e 80 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK---EPIYIITE 80 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC---CCeEEEEE
Confidence 357899999999996 7776655777899999864 34678999999999999999999866643 56899999
Q ss_pred cCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccccc
Q 003542 288 LMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366 (811)
Q Consensus 288 y~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~ 366 (811)
|++ ++|.+++... ....+++..+..++.|++.||.|||+.|++||||||+||+++.++ .+||+|||++..
T Consensus 81 ~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~-----~~~l~d~~~~~~ 151 (260)
T cd05073 81 FMAKGSLLDFLKSD----EGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL-----VCKIADFGLARV 151 (260)
T ss_pred eCCCCcHHHHHHhC----CccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCC-----cEEECCCcceee
Confidence 998 5999988753 224578889999999999999999999999999999999998776 899999999876
Q ss_pred ccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CCCCCCCCccchHHHHH
Q 003542 367 RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGDKMTK 445 (811)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~~PF~~~~~~~~~i~~ 445 (811)
...... .......++..|+|||++.. ..++.++|+||||+++|++++ |..||.+... ..+..
T Consensus 152 ~~~~~~------~~~~~~~~~~~y~~PE~~~~---------~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~--~~~~~ 214 (260)
T cd05073 152 IEDNEY------TAREGAKFPIKWTAPEAINF---------GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--PEVIR 214 (260)
T ss_pred ccCCCc------ccccCCcccccccCHhHhcc---------CCcCccccchHHHHHHHHHHhcCCCCCCCCCH--HHHHH
Confidence 543211 11123345677999999864 257889999999999999998 9999976432 23445
Q ss_pred HHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHH
Q 003542 446 NIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRY 490 (811)
Q Consensus 446 ~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~ 490 (811)
.+..+.....+...+..+.+++.+||+.+|.+||++.++++.|+.
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 215 ALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred HHhCCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 555555555566788899999999999999999999999887753
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=308.62 Aligned_cols=257 Identities=26% Similarity=0.457 Sum_probs=201.6
Q ss_pred hcceEEeeeecccc---eEEEEEE--------cCCEEEEEEecc-----cHHHHHHHHHHHHhC-CCCccceeeeeEEcc
Q 003542 215 LKKLMVRRRLGASS---QFKEIQW--------LGDSFVLRHFYG-----ELESLNAEISTMLSL-SHPNIVQYLCGFCDE 277 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~~--------~g~~VAVK~~~~-----~~~~~~~Ei~iL~~L-~HPNIVkl~~~~~~e 277 (811)
..+|.+.+.||+|+ ||.+... .+..||+|.+.. ....+.+|+.+++.+ +||||+++++.+.
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~-- 94 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT-- 94 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe--
Confidence 35789999999985 5554321 235799999964 235688899999999 7999999997763
Q ss_pred CCCeEEEEEecCC-CCHHHHHHHhhCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEe
Q 003542 278 EKKEFFLVMELMS-KDLSCYMRETFGS----------RRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLK 346 (811)
Q Consensus 278 ~~~~~yLVmEy~~-g~L~~~L~~~~~~----------~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~ 346 (811)
....+|+||||++ |+|.+++...... .....+++..++.++.||+.||.|||+.|++||||||+|||++
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~ 174 (307)
T cd05098 95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 174 (307)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEc
Confidence 4457899999999 5999999764211 0123588899999999999999999999999999999999998
Q ss_pred ccCCCCcceEEEeeccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHH
Q 003542 347 ARSMEGYFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFEL 426 (811)
Q Consensus 347 ~~g~d~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyEL 426 (811)
.++ .+||+|||++........ ........+++.|+|||++.+. .++.++|||||||++|+|
T Consensus 175 ~~~-----~~kL~dfg~a~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~DvwslG~~l~el 235 (307)
T cd05098 175 EDN-----VMKIADFGLARDIHHIDY-----YKKTTNGRLPVKWMAPEALFDR---------IYTHQSDVWSFGVLLWEI 235 (307)
T ss_pred CCC-----cEEECCCcccccccccch-----hhccccCCCccceeChHHhccC---------CCCcHHHHHHHHHHHHHH
Confidence 776 899999999875532211 0011122345679999998643 578899999999999999
Q ss_pred hh-CCCCCCCCccchHHHHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHHHHH
Q 003542 427 LT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKKF 494 (811)
Q Consensus 427 lt-G~~PF~~~~~~~~~i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~k~ 494 (811)
++ |..||.+.. ...+...+..+.....+..++.++.+|+.+||..+|.+||++.++++.|..+...
T Consensus 236 ~~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 236 FTLGGSPYPGVP--VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred HcCCCCCCCcCC--HHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 98 899997643 3445566666666667778899999999999999999999999999988877654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=300.54 Aligned_cols=240 Identities=27% Similarity=0.478 Sum_probs=191.0
Q ss_pred eecccc---eEEEEEE-c---CCEEEEEEecc-----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEecCC
Q 003542 223 RLGASS---QFKEIQW-L---GDSFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMS 290 (811)
Q Consensus 223 ~lG~G~---vyk~v~~-~---g~~VAVK~~~~-----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~~ 290 (811)
.||+|+ ||++... . +..||+|.+.. ..+.+.+|+.+++.++||||+++++.+ + ...+++||||++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~--~-~~~~~~v~e~~~ 78 (257)
T cd05060 2 ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVC--K-GEPLMLVMELAP 78 (257)
T ss_pred ccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEE--c-CCceEEEEEeCC
Confidence 355553 7776532 2 26899999863 235688999999999999999998654 2 345899999998
Q ss_pred -CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccccc
Q 003542 291 -KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTY 369 (811)
Q Consensus 291 -g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~ 369 (811)
++|.+++... ..+++..+..++.|++.||.|||..+++||||||+|||++.++ .+||+|||++.....
T Consensus 79 ~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~-----~~kl~df~~~~~~~~ 147 (257)
T cd05060 79 LGPLLKYLKKR------REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRH-----QAKISDFGMSRALGA 147 (257)
T ss_pred CCcHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCC-----cEEeccccccceeec
Confidence 5899998753 4689999999999999999999999999999999999998876 899999999876643
Q ss_pred cCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CCCCCCCCccchHHHHHHHH
Q 003542 370 ASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGDKMTKNIR 448 (811)
Q Consensus 370 ~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~~PF~~~~~~~~~i~~~i~ 448 (811)
.... ........++..|+|||.+.+ ..++.++||||||+++|+|++ |.+||.... ...+...+.
T Consensus 148 ~~~~----~~~~~~~~~~~~y~aPE~~~~---------~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~--~~~~~~~~~ 212 (257)
T cd05060 148 GSDY----YRATTAGRWPLKWYAPECINY---------GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK--GAEVIAMLE 212 (257)
T ss_pred CCcc----cccccCccccccccCHHHhcC---------CCCCccchHHHHHHHHHHHHcCCCCCcccCC--HHHHHHHHH
Confidence 3211 111112234567999999864 367889999999999999998 999997643 334556666
Q ss_pred hCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHH
Q 003542 449 AGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYI 491 (811)
Q Consensus 449 ~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i 491 (811)
.+.....+..++..+.++|.+||..+|.+||++.++++.|+.+
T Consensus 213 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 213 SGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 6666667778899999999999999999999999999888654
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=307.77 Aligned_cols=257 Identities=25% Similarity=0.470 Sum_probs=201.7
Q ss_pred cceEEeeeecccc---eEEEEEE--------cCCEEEEEEecc-----cHHHHHHHHHHHHhC-CCCccceeeeeEEccC
Q 003542 216 KKLMVRRRLGASS---QFKEIQW--------LGDSFVLRHFYG-----ELESLNAEISTMLSL-SHPNIVQYLCGFCDEE 278 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~~--------~g~~VAVK~~~~-----~~~~~~~Ei~iL~~L-~HPNIVkl~~~~~~e~ 278 (811)
.+|.+.+.||+|+ ||.+... .+..||+|.+.. ....+..|+.+++.+ +||||+++++.+. .
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~--~ 89 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT--Q 89 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc--c
Confidence 5788899999986 6665421 245799999863 245688999999999 6999999997663 4
Q ss_pred CCeEEEEEecCC-CCHHHHHHHhhCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEec
Q 003542 279 KKEFFLVMELMS-KDLSCYMRETFGS----------RRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKA 347 (811)
Q Consensus 279 ~~~~yLVmEy~~-g~L~~~L~~~~~~----------~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~ 347 (811)
...+|+||||++ |+|.+++...... .....+++..+..++.||+.||.|||++|++||||||+|||++.
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~ 169 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTE 169 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcC
Confidence 457899999998 5999999764210 11245888999999999999999999999999999999999987
Q ss_pred cCCCCcceEEEeeccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHh
Q 003542 348 RSMEGYFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELL 427 (811)
Q Consensus 348 ~g~d~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELl 427 (811)
++ .+||+|||+++........ .......++..|+|||++.+. .++.++||||||+++|+|+
T Consensus 170 ~~-----~~kL~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~---------~~~~~~DiwslG~~l~el~ 230 (314)
T cd05099 170 DN-----VMKIADFGLARGVHDIDYY-----KKTSNGRLPVKWMAPEALFDR---------VYTHQSDVWSFGILMWEIF 230 (314)
T ss_pred CC-----cEEEccccccccccccccc-----cccccCCCCccccCHHHHccC---------CcCccchhhHHHHHHHHHH
Confidence 76 8999999999765432110 111122345679999998643 6788999999999999999
Q ss_pred h-CCCCCCCCccchHHHHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHHHHHh
Q 003542 428 T-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKKFM 495 (811)
Q Consensus 428 t-G~~PF~~~~~~~~~i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~k~l 495 (811)
+ |..||.+.. ...+...+..+.....+..++..+.+|+.+||..+|.+||++.++++.|..+....
T Consensus 231 ~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 231 TLGGSPYPGIP--VEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred hCCCCCCCCCC--HHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 9 899997643 33455566666656667788899999999999999999999999999888776543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=307.36 Aligned_cols=252 Identities=21% Similarity=0.412 Sum_probs=196.7
Q ss_pred cceEEeeeecccc---eEEEEEE-cCC--EEEEEEecc-----cHHHHHHHHHHHHhC-CCCccceeeeeEEccCCCeEE
Q 003542 216 KKLMVRRRLGASS---QFKEIQW-LGD--SFVLRHFYG-----ELESLNAEISTMLSL-SHPNIVQYLCGFCDEEKKEFF 283 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~~-~g~--~VAVK~~~~-----~~~~~~~Ei~iL~~L-~HPNIVkl~~~~~~e~~~~~y 283 (811)
++|++.+.||.|+ +|++... +|. .+|+|.++. ..+.+.+|+.++.++ +||||+++++.+ .....+|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~--~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGAC--ENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEE--ccCCcce
Confidence 4688888899886 6766543 333 478888863 235688999999999 799999999766 3455689
Q ss_pred EEEecCC-CCHHHHHHHhhCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCC
Q 003542 284 LVMELMS-KDLSCYMRETFGS----------RRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEG 352 (811)
Q Consensus 284 LVmEy~~-g~L~~~L~~~~~~----------~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~ 352 (811)
+||||++ ++|.+++...... .....+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~--- 156 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENL--- 156 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCC---
Confidence 9999998 5999998753211 0113588999999999999999999999999999999999998765
Q ss_pred cceEEEeeccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CCC
Q 003542 353 YFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKV 431 (811)
Q Consensus 353 ~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~~ 431 (811)
.+||+|||++....... .......+..|+|||++.+. .++.++|||||||++|||++ |..
T Consensus 157 --~~kl~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~---------~~~~~~DvwSlG~il~el~t~g~~ 217 (297)
T cd05089 157 --ASKIADFGLSRGEEVYV--------KKTMGRLPVRWMAIESLNYS---------VYTTKSDVWSFGVLLWEIVSLGGT 217 (297)
T ss_pred --eEEECCcCCCcccccee--------ccCCCCcCccccCchhhccC---------CCCchhhHHHHHHHHHHHHcCCCC
Confidence 89999999986432110 11122335579999998643 67889999999999999997 999
Q ss_pred CCCCCccchHHHHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHHHH
Q 003542 432 PFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKK 493 (811)
Q Consensus 432 PF~~~~~~~~~i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~k 493 (811)
||.+... ......+..+..+..+..++..+.+|+.+||..+|.+||+++++++.|..+..
T Consensus 218 pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~ 277 (297)
T cd05089 218 PYCGMTC--AELYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277 (297)
T ss_pred CCCCCCH--HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 9976543 33445555555556677888999999999999999999999999988876654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=309.72 Aligned_cols=241 Identities=22% Similarity=0.392 Sum_probs=192.9
Q ss_pred hcceEEeeeecccc---eEEEEE-EcCCEEEEEEecc----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEE
Q 003542 215 LKKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVM 286 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVm 286 (811)
.++|++.+.||.|+ +|+++. .+|+.||+|.+.. ..+.+.+|+.+++.++||||+++++.+. ....+|+||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~--~~~~~~lv~ 96 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL--VGDELWVVM 96 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEE--eCCEEEEee
Confidence 36899999999985 777663 4789999999853 3467889999999999999999998774 356799999
Q ss_pred ecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccc
Q 003542 287 ELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365 (811)
Q Consensus 287 Ey~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~ 365 (811)
||++| +|.+++.+ ..+++..+..++.|++.||.|||+.||+||||||+|||++.++ .++|+|||++.
T Consensus 97 e~~~~~~L~~~~~~-------~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~-----~~kl~dfg~~~ 164 (296)
T cd06654 97 EYLAGGSLTDVVTE-------TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-----SVKLTDFGFCA 164 (296)
T ss_pred cccCCCCHHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC-----CEEECccccch
Confidence 99985 88888764 4578899999999999999999999999999999999998776 89999999987
Q ss_pred cccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHH
Q 003542 366 ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTK 445 (811)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~ 445 (811)
...... .......+++.|+|||.+.+. .++.++|||||||++|+|++|+.||....... ....
T Consensus 165 ~~~~~~-------~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~-~~~~ 227 (296)
T cd06654 165 QITPEQ-------SKRSTMVGTPYWMAPEVVTRK---------AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-ALYL 227 (296)
T ss_pred hccccc-------cccCcccCCccccCHHHHcCC---------CCCccchHHHHHHHHHHHHhCCCCCCCCCHHH-hHHH
Confidence 543221 112234688899999998643 56789999999999999999999997654322 2222
Q ss_pred HHHhCC-CCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 446 NIRAGE-RPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 446 ~i~~~~-~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
....+. ....+...+..+.+||.+||..+|.+||++.+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 228 IATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred HhcCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 222221 12235567788999999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=307.17 Aligned_cols=234 Identities=19% Similarity=0.288 Sum_probs=181.1
Q ss_pred ecccceEEEE-EEcCCEEEEEEecc-------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEecCCC-CHH
Q 003542 224 LGASSQFKEI-QWLGDSFVLRHFYG-------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLS 294 (811)
Q Consensus 224 lG~G~vyk~v-~~~g~~VAVK~~~~-------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~~g-~L~ 294 (811)
.|.|.||++. ..+|+.||+|.+.. ....+..|+++|++++||||+++++.+ +....+|+||||++| +|.
T Consensus 4 G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~--~~~~~~~lv~e~~~g~~L~ 81 (277)
T cd05607 4 GGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAF--ESKTHLCLVMSLMNGGDLK 81 (277)
T ss_pred CCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEE--ecCCeEEEEEecCCCCCHH
Confidence 3444588766 34799999999853 123456799999999999999998777 455679999999985 888
Q ss_pred HHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccccccCCCC
Q 003542 295 CYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNT 374 (811)
Q Consensus 295 ~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~~~~~ 374 (811)
.++... ....+++..+..++.||+.||.|||+.||+||||||+|||++.++ .++|+|||++.......
T Consensus 82 ~~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~-----~~~l~Dfg~~~~~~~~~--- 149 (277)
T cd05607 82 YHIYNV----GERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQG-----NCRLSDLGLAVELKDGK--- 149 (277)
T ss_pred HHHHhc----cccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCC-----CEEEeeceeeeecCCCc---
Confidence 777543 224588999999999999999999999999999999999998776 89999999987653221
Q ss_pred CCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccc--hHHHHHHHHhCCC
Q 003542 375 PPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQ--GDKMTKNIRAGER 452 (811)
Q Consensus 375 ~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~--~~~i~~~i~~~~~ 452 (811)
......|+..|+|||++.+. .++.++|||||||++|+|++|..||...... ...+.........
T Consensus 150 -----~~~~~~~~~~y~aPE~~~~~---------~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 215 (277)
T cd05607 150 -----TITQRAGTNGYMAPEILKEE---------PYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEV 215 (277)
T ss_pred -----eeeccCCCCCccCHHHHccC---------CCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccc
Confidence 11234688899999998643 5889999999999999999999999754321 1222222222222
Q ss_pred CCCCCCChHHHHHHHhhhccCCCCCCCCHHHHH
Q 003542 453 PLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSIC 485 (811)
Q Consensus 453 ~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl 485 (811)
.......+.++.+|+.+||+.||.+||++.+++
T Consensus 216 ~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~ 248 (277)
T cd05607 216 KFEHQNFTEESKDICRLFLAKKPEDRLGSREKN 248 (277)
T ss_pred ccccccCCHHHHHHHHHHhccCHhhCCCCccch
Confidence 222346788899999999999999999996654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=347.44 Aligned_cols=256 Identities=24% Similarity=0.412 Sum_probs=200.2
Q ss_pred HHHhcceEEeeeecccc---eEEEEE-EcCCEEEEEEecc------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCe
Q 003542 212 DMLLKKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKE 281 (811)
Q Consensus 212 ~~l~k~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~ 281 (811)
+....+|.+++.||.|+ ||.+.. ..+..||+|.+.. ....+..|+.+|.+|+|||||++++.|.......
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 34567899999999996 666553 3678999999852 3467899999999999999999998887666678
Q ss_pred EEEEEecCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-------CceeccCCCCcEEEeccC----
Q 003542 282 FFLVMELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQ-------KIYHGELNPSNIYLKARS---- 349 (811)
Q Consensus 282 ~yLVmEy~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~-------gIVHRDLKPsNILI~~~g---- 349 (811)
+|||||||+ ++|.++|..... ....+++..++.|+.||+.||.|||+. +||||||||+||||+...
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~--~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYK--MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 999999999 599998876422 125699999999999999999999984 499999999999996531
Q ss_pred --------CCCcceEEEeeccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchh
Q 003542 350 --------MEGYFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGM 421 (811)
Q Consensus 350 --------~d~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGv 421 (811)
.++...+||+|||++....... ......||+.|+|||++.+. ...++.++|||||||
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--------~~~s~vGTp~YmAPEvL~ge-------~~~~s~KSDVWSLG~ 231 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGIES--------MAHSCVGTPYYWSPELLLHE-------TKSYDDKSDMWALGC 231 (1021)
T ss_pred cccccccccCCCCceEEccCCccccccccc--------cccccCCCccccCHHHHhcc-------CCCCCchhHHHHHHH
Confidence 1223369999999997653321 12345789999999999753 235789999999999
Q ss_pred HHHHHhhCCCCCCCCccchHHHHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 422 LCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 422 ILyELltG~~PF~~~~~~~~~i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
|||+|++|..||...... ..+...+..+... .....+.++.+||..||..+|.+||++.+++.
T Consensus 232 ILYELLTGk~PF~~~~~~-~qli~~lk~~p~l-pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 232 IIYELCSGKTPFHKANNF-SQLISELKRGPDL-PIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred HHHHHHHCCCCCCcCCcH-HHHHHHHhcCCCC-CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 999999999999764322 2333333333221 12356788999999999999999999999986
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=306.47 Aligned_cols=245 Identities=20% Similarity=0.313 Sum_probs=190.9
Q ss_pred hcceEEeeeecccc---eEEEEE-EcCCEEEEEEecc----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEE
Q 003542 215 LKKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVM 286 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVm 286 (811)
.++|++.+.||.|+ ||++.. .+|+.||+|++.. ....+.+|+.++++++||||+++++.+. ....+|+||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~--~~~~~~iv~ 85 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL--SREKLWICM 85 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEE--eCCEEEEEE
Confidence 35788999999885 777663 4788999999853 3456889999999999999999997774 446789999
Q ss_pred ecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccc
Q 003542 287 ELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365 (811)
Q Consensus 287 Ey~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~ 365 (811)
||+++ +|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++ .++|+|||++.
T Consensus 86 e~~~~~~L~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~-----~~~l~dfg~~~ 154 (267)
T cd06646 86 EYCGGGSLQDIYHVT------GPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNG-----DVKLADFGVAA 154 (267)
T ss_pred eCCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC-----CEEECcCccce
Confidence 99995 888877643 5689999999999999999999999999999999999998776 79999999987
Q ss_pred cccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHH
Q 003542 366 ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTK 445 (811)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~ 445 (811)
...... .......|++.|+|||.+.... ...++.++|||||||++|+|++|..||........ . .
T Consensus 155 ~~~~~~-------~~~~~~~~~~~y~~PE~~~~~~------~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~-~-~ 219 (267)
T cd06646 155 KITATI-------AKRKSFIGTPYWMAPEVAAVEK------NGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-L-F 219 (267)
T ss_pred eecccc-------cccCccccCccccCHhHccccc------CCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh-h-e
Confidence 653221 1122446788999999985431 23577899999999999999999999965432211 1 1
Q ss_pred HHHh-CCCCC---CCCCChHHHHHHHhhhccCCCCCCCCHHHHHHH
Q 003542 446 NIRA-GERPL---FPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRI 487 (811)
Q Consensus 446 ~i~~-~~~~~---~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~ 487 (811)
.+.. ...+. .+...+..+.+||.+||..+|++||++++|++.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 220 LMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred eeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 1111 11111 123457889999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=317.78 Aligned_cols=232 Identities=22% Similarity=0.318 Sum_probs=180.6
Q ss_pred cccceEEEEE-EcCCEEEEEEecc-------cHHHHHHHHHHHHhC---CCCccceeeeeEEccCCCeEEEEEecCCC-C
Q 003542 225 GASSQFKEIQ-WLGDSFVLRHFYG-------ELESLNAEISTMLSL---SHPNIVQYLCGFCDEEKKEFFLVMELMSK-D 292 (811)
Q Consensus 225 G~G~vyk~v~-~~g~~VAVK~~~~-------~~~~~~~Ei~iL~~L---~HPNIVkl~~~~~~e~~~~~yLVmEy~~g-~ 292 (811)
|.|.||.+.. .+|+.||||++.. ....+..|..++..+ +||||+++++.+ ++...+|+||||+++ +
T Consensus 5 ~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~--~~~~~~~lv~e~~~~g~ 82 (330)
T cd05586 5 TFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSF--QTDSDLYLVTDYMSGGE 82 (330)
T ss_pred CceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEE--ecCCeEEEEEcCCCCCh
Confidence 3444787663 4789999999853 223455677777665 699999999777 455679999999984 8
Q ss_pred HHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccccccCC
Q 003542 293 LSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASR 372 (811)
Q Consensus 293 L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~~~ 372 (811)
|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus 83 L~~~l~~~------~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~-----~~kl~Dfg~a~~~~~~~- 150 (330)
T cd05586 83 LFWHLQKE------GRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATG-----HIALCDFGLSKANLTDN- 150 (330)
T ss_pred HHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC-----CEEEecCCcCcCCCCCC-
Confidence 88887653 5689999999999999999999999999999999999998876 89999999986532211
Q ss_pred CCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHHHHhCCC
Q 003542 373 NTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGER 452 (811)
Q Consensus 373 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i~~~~~ 452 (811)
.......||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+... ..+...+..+..
T Consensus 151 ------~~~~~~~gt~~y~aPE~~~~~--------~~~~~~~DvwslGvil~elltG~~Pf~~~~~--~~~~~~i~~~~~ 214 (330)
T cd05586 151 ------KTTNTFCGTTEYLAPEVLLDE--------KGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT--QQMYRNIAFGKV 214 (330)
T ss_pred ------CCccCccCCccccCHHHHcCC--------CCCCCccceeccccEEEEeccCCCCCCCCCH--HHHHHHHHcCCC
Confidence 122345689999999998642 2478899999999999999999999986532 344455554443
Q ss_pred CCCCCCChHHHHHHHhhhccCCCCCCC----CHHHHHH
Q 003542 453 PLFPSGSPKYLVNLTKKCWHTNPSQRP----SFSSICR 486 (811)
Q Consensus 453 ~~~p~~~~~~l~~LI~~cL~~DP~~RP----S~~eIl~ 486 (811)
.......++.+.+||.+||..||.+|| ++.++++
T Consensus 215 ~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 215 RFPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CCCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 322345688899999999999999998 4566554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=314.32 Aligned_cols=239 Identities=25% Similarity=0.449 Sum_probs=199.7
Q ss_pred eEEeeeecccc---eEEEE-EEcCCEEEEEEec--ccHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEecCC-
Q 003542 218 LMVRRRLGASS---QFKEI-QWLGDSFVLRHFY--GELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMS- 290 (811)
Q Consensus 218 ~~i~~~lG~G~---vyk~v-~~~g~~VAVK~~~--~~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~~- 290 (811)
|.++++||+|+ ||+++ +-.|+.+|||.+. .+++.+.+||.||++++.|+||+||+.|+.. ..+|||||||+
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~--sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKH--SDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccC--CceEeehhhcCC
Confidence 44556677774 66666 5599999999985 5789999999999999999999999888643 35999999999
Q ss_pred CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccccccccc
Q 003542 291 KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYA 370 (811)
Q Consensus 291 g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~ 370 (811)
|+..+.++- ++.++++.++..+++..+.||+|||...-+|||||..|||++.+| +.||+|||.|..++..
T Consensus 113 GSiSDI~R~-----R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G-----~AKLADFGVAGQLTDT 182 (502)
T KOG0574|consen 113 GSISDIMRA-----RRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDG-----IAKLADFGVAGQLTDT 182 (502)
T ss_pred CcHHHHHHH-----hcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccc-----hhhhhhccccchhhhh
Confidence 788888775 347899999999999999999999999999999999999999988 9999999999877654
Q ss_pred CCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHHHHhC
Q 003542 371 SRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAG 450 (811)
Q Consensus 371 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i~~~ 450 (811)
....++..||+.|||||++... .|+.++||||||++..||+-|++||.+.+.... .-.|-..
T Consensus 183 -------MAKRNTVIGTPFWMAPEVI~EI---------GY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA--IFMIPT~ 244 (502)
T KOG0574|consen 183 -------MAKRNTVIGTPFWMAPEVIEEI---------GYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA--IFMIPTK 244 (502)
T ss_pred -------HHhhCccccCcccccHHHHHHh---------ccchhhhHhhhcchhhhhhcCCCCcccccccce--eEeccCC
Confidence 2334578899999999999865 688999999999999999999999987664321 1122223
Q ss_pred CCCCC--CCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 451 ERPLF--PSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 451 ~~~~~--p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
.+|.| |+.++.++.+++++||...|++|-|+-++++
T Consensus 245 PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 245 PPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred CCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 33333 4667888999999999999999999988876
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=307.73 Aligned_cols=252 Identities=22% Similarity=0.417 Sum_probs=195.9
Q ss_pred hcceEEeeeecccc---eEEEEE-EcCC--EEEEEEecc-----cHHHHHHHHHHHHhC-CCCccceeeeeEEccCCCeE
Q 003542 215 LKKLMVRRRLGASS---QFKEIQ-WLGD--SFVLRHFYG-----ELESLNAEISTMLSL-SHPNIVQYLCGFCDEEKKEF 282 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~-~~g~--~VAVK~~~~-----~~~~~~~Ei~iL~~L-~HPNIVkl~~~~~~e~~~~~ 282 (811)
..+|++.+.||+|+ ||++.. .+|. .+|+|.+.. ....+.+|+.++.++ +||||+++++.+ .....+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~--~~~~~~ 83 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC--EHRGYL 83 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEE--CCCCCc
Confidence 35788999999986 777663 3454 468888753 235688999999999 899999999776 445679
Q ss_pred EEEEecCC-CCHHHHHHHhhCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCC
Q 003542 283 FLVMELMS-KDLSCYMRETFGS----------RRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSME 351 (811)
Q Consensus 283 yLVmEy~~-g~L~~~L~~~~~~----------~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d 351 (811)
|+||||++ ++|.+++...... .....+++..++.++.||+.||.|||++|++||||||+|||++.++
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~-- 161 (303)
T cd05088 84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY-- 161 (303)
T ss_pred eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC--
Confidence 99999998 5899998754210 1123588999999999999999999999999999999999998776
Q ss_pred CcceEEEeeccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CC
Q 003542 352 GYFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GK 430 (811)
Q Consensus 352 ~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~ 430 (811)
.+||+|||++....... ......++..|+|||++.+. .++.++|||||||++|+|++ |.
T Consensus 162 ---~~kl~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~ellt~g~ 221 (303)
T cd05088 162 ---VAKIADFGLSRGQEVYV--------KKTMGRLPVRWMAIESLNYS---------VYTTNSDVWSYGVLLWEIVSLGG 221 (303)
T ss_pred ---cEEeCccccCcccchhh--------hcccCCCcccccCHHHHhcc---------CCcccccchhhhhHHHHHHhcCC
Confidence 89999999986432111 11122346679999988643 57889999999999999998 99
Q ss_pred CCCCCCccchHHHHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHHH
Q 003542 431 VPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIK 492 (811)
Q Consensus 431 ~PF~~~~~~~~~i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~ 492 (811)
.||.+... ......+..+.....+...+..+.+|+.+||+.+|.+||++++++..|..+.
T Consensus 222 ~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~ 281 (303)
T cd05088 222 TPYCGMTC--AELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 281 (303)
T ss_pred CCcccCCh--HHHHHHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 99975432 2344445444444556677889999999999999999999999988876654
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=300.51 Aligned_cols=248 Identities=25% Similarity=0.436 Sum_probs=196.6
Q ss_pred cceEEeeeecccc---eEEEEEE-c---CCEEEEEEecc-----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEE
Q 003542 216 KKLMVRRRLGASS---QFKEIQW-L---GDSFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFF 283 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~~-~---g~~VAVK~~~~-----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~y 283 (811)
.+|++.+.||.|+ +|++... . +..+|+|.+.. ....+.+|+.++++++||||+++++.+. ....+|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~ 81 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT--KSKPVM 81 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe--cCCccE
Confidence 4688888999985 7776643 2 23799999853 2467899999999999999999987663 455789
Q ss_pred EEEecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecc
Q 003542 284 LVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFG 362 (811)
Q Consensus 284 LVmEy~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFG 362 (811)
+||||+++ +|.+++... ...+++..+..++.|++.||.|||+.|++||||||+|||++.++ .++|+|||
T Consensus 82 lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~-----~~~l~dfg 151 (267)
T cd05066 82 IVTEYMENGSLDAFLRKH-----DGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNL-----VCKVSDFG 151 (267)
T ss_pred EEEEcCCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCC-----eEEeCCCC
Confidence 99999985 898888653 24689999999999999999999999999999999999998766 89999999
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CCCCCCCCccchH
Q 003542 363 LSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGD 441 (811)
Q Consensus 363 lA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~~PF~~~~~~~~ 441 (811)
++......... ........++..|+|||.+.+. .++.++|+||||+++|++++ |..||.+... .
T Consensus 152 ~~~~~~~~~~~----~~~~~~~~~~~~y~~pe~~~~~---------~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~--~ 216 (267)
T cd05066 152 LSRVLEDDPEA----AYTTRGGKIPIRWTAPEAIAYR---------KFTSASDVWSYGIVMWEVMSYGERPYWEMSN--Q 216 (267)
T ss_pred cccccccccce----eeecCCCccceeecCHhHhccC---------ccCchhhhHHHHHHHHHHhcCCCCCcccCCH--H
Confidence 99765432110 0111122345679999999643 67889999999999999886 9999976432 2
Q ss_pred HHHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHH
Q 003542 442 KMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRY 490 (811)
Q Consensus 442 ~i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~ 490 (811)
.....+..+...+.+..+++.+.+++.+||+.+|.+||++.++++.|..
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 265 (267)
T cd05066 217 DVIKAIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK 265 (267)
T ss_pred HHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence 3445555555555667788999999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=299.70 Aligned_cols=242 Identities=29% Similarity=0.534 Sum_probs=197.9
Q ss_pred cceEEeeeecccc---eEEEEEEcCCEEEEEEeccc---HHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEecC
Q 003542 216 KKLMVRRRLGASS---QFKEIQWLGDSFVLRHFYGE---LESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELM 289 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~~~g~~VAVK~~~~~---~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~ 289 (811)
++|++.+.+|.|+ ||++. ..|+.||||.+... .+.+.+|+.+++.++||||+++++.+.+ ....|+||||+
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~-~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~e~~ 82 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGD-YRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ--GNPLYIVTEYM 82 (256)
T ss_pred hhccceeeeecCCCceEEEEE-ecCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcC--CCCeEEEEEec
Confidence 5678888888885 67654 56899999999754 4578999999999999999999977643 56789999999
Q ss_pred C-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccccccc
Q 003542 290 S-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTART 368 (811)
Q Consensus 290 ~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~ 368 (811)
+ ++|.+++... ....+++..+..++.|++.||.|||++|++||||||+||+++.++ .+||+|||++....
T Consensus 83 ~~~~L~~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~-----~~~l~d~g~~~~~~ 153 (256)
T cd05039 83 AKGSLVDYLRSR----GRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDL-----VAKVSDFGLAKEAS 153 (256)
T ss_pred CCCcHHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCC-----CEEEcccccccccc
Confidence 9 5999988763 113689999999999999999999999999999999999998776 89999999987653
Q ss_pred ccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CCCCCCCCccchHHHHHHH
Q 003542 369 YASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGDKMTKNI 447 (811)
Q Consensus 369 ~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~~PF~~~~~~~~~i~~~i 447 (811)
... ....++..|+|||++.. ..++.++||||||+++|+|++ |..||.... ...+...+
T Consensus 154 ~~~----------~~~~~~~~~~ape~~~~---------~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--~~~~~~~~ 212 (256)
T cd05039 154 QGQ----------DSGKLPVKWTAPEALRE---------KKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--LKDVVPHV 212 (256)
T ss_pred ccc----------ccCCCcccccCchhhcC---------CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC--HHHHHHHH
Confidence 211 12234567999999863 357789999999999999997 999997643 23444555
Q ss_pred HhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHH
Q 003542 448 RAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRY 490 (811)
Q Consensus 448 ~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~ 490 (811)
..+.....+..+++.+.++|.+||..+|.+||++.++++.|..
T Consensus 213 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 213 EKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred hcCCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 5555556677788999999999999999999999999987753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=315.91 Aligned_cols=228 Identities=19% Similarity=0.289 Sum_probs=178.5
Q ss_pred cccceEEEEEE-cCCEEEEEEecc-------cHHHHHHHHH-HHHhCCCCccceeeeeEEccCCCeEEEEEecCCC-CHH
Q 003542 225 GASSQFKEIQW-LGDSFVLRHFYG-------ELESLNAEIS-TMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLS 294 (811)
Q Consensus 225 G~G~vyk~v~~-~g~~VAVK~~~~-------~~~~~~~Ei~-iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~~g-~L~ 294 (811)
|.|.||++... +++.||+|++.. ....+..|.. +++.++||||+++++.+ ...+.+|+|||||+| +|.
T Consensus 7 ~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~--~~~~~~~lv~e~~~~~~L~ 84 (325)
T cd05602 7 SFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF--QTADKLYFVLDYINGGELF 84 (325)
T ss_pred CCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEE--EcCCeEEEEEeCCCCCcHH
Confidence 33448877643 678999999853 1234444544 46778999999999777 445679999999995 888
Q ss_pred HHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccccccCCCC
Q 003542 295 CYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNT 374 (811)
Q Consensus 295 ~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~~~~~ 374 (811)
.++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus 85 ~~~~~~------~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~-----~~kl~DfG~a~~~~~~~--- 150 (325)
T cd05602 85 YHLQRE------RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG-----HIVLTDFGLCKENIEHN--- 150 (325)
T ss_pred HHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC-----CEEEccCCCCcccccCC---
Confidence 887653 5688899999999999999999999999999999999998776 89999999987532211
Q ss_pred CCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHHHHhCCCCC
Q 003542 375 PPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPL 454 (811)
Q Consensus 375 ~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i~~~~~~~ 454 (811)
.......||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+... ..+...+... ...
T Consensus 151 ----~~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~el~~g~~pf~~~~~--~~~~~~i~~~-~~~ 214 (325)
T cd05602 151 ----GTTSTFCGTPEYLAPEVLHKQ---------PYDRTVDWWCLGAVLYEMLYGLPPFYSRNT--AEMYDNILNK-PLQ 214 (325)
T ss_pred ----CCcccccCCccccCHHHHcCC---------CCCCccccccccHHHHHHhcCCCCCCCCCH--HHHHHHHHhC-CcC
Confidence 122345689999999999753 678899999999999999999999986432 2334444433 233
Q ss_pred CCCCChHHHHHHHhhhccCCCCCCCCHHHH
Q 003542 455 FPSGSPKYLVNLTKKCWHTNPSQRPSFSSI 484 (811)
Q Consensus 455 ~p~~~~~~l~~LI~~cL~~DP~~RPS~~eI 484 (811)
++...+..+.++|.+||+.||.+||++.+.
T Consensus 215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~ 244 (325)
T cd05602 215 LKPNITNSARHLLEGLLQKDRTKRLGAKDD 244 (325)
T ss_pred CCCCCCHHHHHHHHHHcccCHHHCCCCCCC
Confidence 556788899999999999999999998754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=304.48 Aligned_cols=252 Identities=26% Similarity=0.439 Sum_probs=192.7
Q ss_pred ceEEeeeecccc---eEEEE-----EEcCCEEEEEEecc-----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEE
Q 003542 217 KLMVRRRLGASS---QFKEI-----QWLGDSFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFF 283 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v-----~~~g~~VAVK~~~~-----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~y 283 (811)
.|++++.||+|+ +|.+. ..++..||+|.+.. ....+.+|+.+++.++||||+++++.+...+...++
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 357777888885 55543 13578999999863 246789999999999999999998766544346789
Q ss_pred EEEecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecc
Q 003542 284 LVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFG 362 (811)
Q Consensus 284 LVmEy~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFG 362 (811)
+||||++| +|.+++... ...+++..+..++.||+.||.|||++|++||||||+|||++.++ .++|+|||
T Consensus 85 lv~e~~~g~~L~~~l~~~-----~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~-----~~~l~dfg 154 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRN-----KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH-----QVKIGDFG 154 (284)
T ss_pred EEEEccCCCCHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCC-----CEEECCCc
Confidence 99999984 898888643 13589999999999999999999999999999999999998776 79999999
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCcc----
Q 003542 363 LSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHL---- 438 (811)
Q Consensus 363 lA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~---- 438 (811)
++......... ........++..|+|||++.+. .++.++||||||+++|+|+++..|+.....
T Consensus 155 ~~~~~~~~~~~----~~~~~~~~~~~~y~apE~~~~~---------~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~ 221 (284)
T cd05079 155 LTKAIETDKEY----YTVKDDLDSPVFWYAPECLIQS---------KFYIASDVWSFGVTLYELLTYCDSESSPMTLFLK 221 (284)
T ss_pred cccccccCccc----eeecCCCCCCccccCHHHhccC---------CCCccccchhhhhhhhhhhcCCCCCccccchhhh
Confidence 98765432210 0111234567789999998643 578899999999999999998776532110
Q ss_pred ---------chHHHHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHH
Q 003542 439 ---------QGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYI 491 (811)
Q Consensus 439 ---------~~~~i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i 491 (811)
........+..+.....+..++..+.+|+.+||+.+|.+||++.++++.++.+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 222 MIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred hcccccccccHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 11112223334444455667889999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=314.06 Aligned_cols=227 Identities=22% Similarity=0.356 Sum_probs=179.2
Q ss_pred eccc---ceEEEEE-EcCCEEEEEEecc-------cHHHHHHHHH-HHHhCCCCccceeeeeEEccCCCeEEEEEecCCC
Q 003542 224 LGAS---SQFKEIQ-WLGDSFVLRHFYG-------ELESLNAEIS-TMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK 291 (811)
Q Consensus 224 lG~G---~vyk~v~-~~g~~VAVK~~~~-------~~~~~~~Ei~-iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~~g 291 (811)
||+| .||++.. .+|+.||+|++.. ....+..|+. +++.++||||+++++.+ .+.+.+|+|||||+|
T Consensus 3 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~--~~~~~~~lv~e~~~~ 80 (321)
T cd05603 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSF--QTAEKLYFVLDYVNG 80 (321)
T ss_pred eeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEE--EcCCEEEEEEcCCCC
Confidence 4555 4887764 4789999999853 2334555654 57888999999998777 445679999999995
Q ss_pred -CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccccccccc
Q 003542 292 -DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYA 370 (811)
Q Consensus 292 -~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~ 370 (811)
+|..++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++ .+||+|||++......
T Consensus 81 ~~L~~~l~~~------~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~-----~~kl~Dfg~~~~~~~~ 149 (321)
T cd05603 81 GELFFHLQRE------RCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQG-----HVVLTDFGLCKEGVEP 149 (321)
T ss_pred CCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC-----CEEEccCCCCccCCCC
Confidence 887777642 5688999999999999999999999999999999999998877 8999999998643221
Q ss_pred CCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHHHHhC
Q 003542 371 SRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAG 450 (811)
Q Consensus 371 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i~~~ 450 (811)
. .......||+.|+|||++.+. .++.++|||||||++|||++|..||.+.+. ..+...+...
T Consensus 150 ~-------~~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslG~il~el~~g~~pf~~~~~--~~~~~~i~~~ 211 (321)
T cd05603 150 E-------ETTSTFCGTPEYLAPEVLRKE---------PYDRTVDWWCLGAVLYEMLYGLPPFYSRDV--SQMYDNILHK 211 (321)
T ss_pred C-------CccccccCCcccCCHHHhcCC---------CCCCcCcccccchhhhhhhcCCCCCCCCCH--HHHHHHHhcC
Confidence 1 122345689999999998643 678899999999999999999999987542 2344444433
Q ss_pred CCCCCCCCChHHHHHHHhhhccCCCCCCCCHH
Q 003542 451 ERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFS 482 (811)
Q Consensus 451 ~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~ 482 (811)
...+|...+..+.++|.+||+.||.+||++.
T Consensus 212 -~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 212 -PLQLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred -CCCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 3456677888999999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=313.73 Aligned_cols=233 Identities=22% Similarity=0.368 Sum_probs=186.0
Q ss_pred eEEeeeecccc---eEEEEE-EcCCEEEEEEecc-------cHHHHHHHHHHHHhCC-CCccceeeeeEEccCCCeEEEE
Q 003542 218 LMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG-------ELESLNAEISTMLSLS-HPNIVQYLCGFCDEEKKEFFLV 285 (811)
Q Consensus 218 ~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~-------~~~~~~~Ei~iL~~L~-HPNIVkl~~~~~~e~~~~~yLV 285 (811)
|++.+.||+|+ ||.+.. .+|+.||||++.. ..+.+..|+.++..+. ||+|+++++.+ .+.+.+|+|
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~--~~~~~~~lv 79 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCF--QTVDRLYFV 79 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEE--ecCCEEEEE
Confidence 56777788875 776653 3789999999853 2355788999998885 57788888666 445679999
Q ss_pred EecCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccc
Q 003542 286 MELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS 364 (811)
Q Consensus 286 mEy~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA 364 (811)
|||++ |+|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 80 ~Ey~~~g~L~~~i~~~------~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~-----~ikL~Dfg~~ 148 (323)
T cd05615 80 MEYVNGGDLMYHIQQV------GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEG-----HIKIADFGMC 148 (323)
T ss_pred EcCCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC-----CEEEeccccc
Confidence 99998 5888888653 5699999999999999999999999999999999999998876 8999999998
Q ss_pred ccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHH
Q 003542 365 TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMT 444 (811)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~ 444 (811)
....... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+... ..+.
T Consensus 149 ~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwslGvil~elltG~~pf~~~~~--~~~~ 210 (323)
T cd05615 149 KEHMVDG-------VTTRTFCGTPDYIAPEIIAYQ---------PYGKSVDWWAYGVLLYEMLAGQPPFDGEDE--DELF 210 (323)
T ss_pred cccCCCC-------ccccCccCCccccCHHHHcCC---------CCCCccchhhhHHHHHHHHhCCCCCCCCCH--HHHH
Confidence 7532211 112345689999999999643 678899999999999999999999986532 3344
Q ss_pred HHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHH
Q 003542 445 KNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFS 482 (811)
Q Consensus 445 ~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~ 482 (811)
+.+.... ..+|...+..+.+++.+||+.+|.+|++..
T Consensus 211 ~~i~~~~-~~~p~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 211 QSIMEHN-VSYPKSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred HHHHhCC-CCCCccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 4444433 346778889999999999999999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=296.23 Aligned_cols=235 Identities=23% Similarity=0.454 Sum_probs=188.6
Q ss_pred cccceEEEEEEcCCEEEEEEeccc-----HHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEecCC-CCHHHHHH
Q 003542 225 GASSQFKEIQWLGDSFVLRHFYGE-----LESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMS-KDLSCYMR 298 (811)
Q Consensus 225 G~G~vyk~v~~~g~~VAVK~~~~~-----~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~~-g~L~~~L~ 298 (811)
|.|.||++....+..||+|.+... ...+.+|+.+++.++||||+++++.+. .....++||||++ ++|.+++.
T Consensus 7 ~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~~~ 84 (250)
T cd05085 7 NFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT--QRQPIYIVMELVPGGDFLSFLR 84 (250)
T ss_pred CCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEe--cCCccEEEEECCCCCcHHHHHH
Confidence 344489887778899999998642 346889999999999999999997663 3456899999998 58888876
Q ss_pred HhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccccccCCCCCCCC
Q 003542 299 ETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTPPAS 378 (811)
Q Consensus 299 ~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~~~~~~~~~ 378 (811)
.. ...+++..++.++.|++.||.|||++|++||||||+||+++.++ .+||+|||++........
T Consensus 85 ~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~-----~~~l~d~g~~~~~~~~~~------ 148 (250)
T cd05085 85 KK-----KDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENN-----VLKISDFGMSRQEDDGIY------ 148 (250)
T ss_pred hc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCC-----eEEECCCccceecccccc------
Confidence 42 24578999999999999999999999999999999999998776 899999999865432211
Q ss_pred CCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CCCCCCCCccchHHHHHHHHhCCCCCCCC
Q 003542 379 PQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGDKMTKNIRAGERPLFPS 457 (811)
Q Consensus 379 ~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~~PF~~~~~~~~~i~~~i~~~~~~~~p~ 457 (811)
.......++..|+|||++.. ..++.++||||||+++|++++ |..||.+... ......+..+.+...+.
T Consensus 149 ~~~~~~~~~~~y~aPE~~~~---------~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~ 217 (250)
T cd05085 149 SSSGLKQIPIKWTAPEALNY---------GRYSSESDVWSYGILLWETFSLGVCPYPGMTN--QQAREQVEKGYRMSCPQ 217 (250)
T ss_pred ccCCCCCCcccccCHHHhcc---------CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH--HHHHHHHHcCCCCCCCC
Confidence 11112334567999999864 367889999999999999998 9999976533 23445555565666677
Q ss_pred CChHHHHHHHhhhccCCCCCCCCHHHHHHHH
Q 003542 458 GSPKYLVNLTKKCWHTNPSQRPSFSSICRIL 488 (811)
Q Consensus 458 ~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L 488 (811)
.++..+.+++.+||..+|.+||++.++++.|
T Consensus 218 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l 248 (250)
T cd05085 218 KCPDDVYKVMQRCWDYKPENRPKFSELQKEL 248 (250)
T ss_pred CCCHHHHHHHHHHcccCcccCCCHHHHHHHh
Confidence 8889999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=309.72 Aligned_cols=252 Identities=19% Similarity=0.304 Sum_probs=184.8
Q ss_pred eeecccc---eEEEEEE---cCCEEEEEEeccc--HHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEecCCCCH
Q 003542 222 RRLGASS---QFKEIQW---LGDSFVLRHFYGE--LESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDL 293 (811)
Q Consensus 222 ~~lG~G~---vyk~v~~---~g~~VAVK~~~~~--~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~~g~L 293 (811)
.+||+|+ ||++... .+..||+|.+... ...+.+|+.+|+.++||||+++++.+.......+|+||||++++|
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~l 86 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDL 86 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCCcH
Confidence 3566664 8887643 4578999998642 356889999999999999999998776666678999999999999
Q ss_pred HHHHHHhhCC---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccccccccc
Q 003542 294 SCYMRETFGS---RRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYA 370 (811)
Q Consensus 294 ~~~L~~~~~~---~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~ 370 (811)
.+++...... .....+++..++.++.||+.||.|||+.||+||||||+|||+..++ +....+||+|||+++.....
T Consensus 87 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~-~~~~~~kl~DfG~a~~~~~~ 165 (317)
T cd07867 87 WHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEG-PERGRVKIADMGFARLFNSP 165 (317)
T ss_pred HHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCC-CCCCcEEEeeccceeccCCC
Confidence 8888643211 1223588999999999999999999999999999999999995443 22238999999999765432
Q ss_pred CCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccch--------HH
Q 003542 371 SRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQG--------DK 442 (811)
Q Consensus 371 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~--------~~ 442 (811)
... ........||+.|+|||++.+. ..++.++|||||||++|||+||.+||....... ..
T Consensus 166 ~~~----~~~~~~~~~t~~y~aPE~~~~~--------~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~ 233 (317)
T cd07867 166 LKP----LADLDPVVVTFWYRAPELLLGA--------RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQ 233 (317)
T ss_pred ccc----ccccCcceecccccCcHHhcCC--------CccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHH
Confidence 211 1122345689999999998642 357889999999999999999999996432110 00
Q ss_pred HHHHHHhCC------------CC------------------------CCCCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 443 MTKNIRAGE------------RP------------------------LFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 443 i~~~i~~~~------------~~------------------------~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
+...+.... .+ ......+..+.+|+.+||..||.+|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~ 313 (317)
T cd07867 234 LDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ 313 (317)
T ss_pred HHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence 100000000 00 001122345889999999999999999999976
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=298.50 Aligned_cols=245 Identities=25% Similarity=0.388 Sum_probs=202.7
Q ss_pred ceEEeeeecccc---eEEEE-EEcCCEEEEEEecc------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEE
Q 003542 217 KLMVRRRLGASS---QFKEI-QWLGDSFVLRHFYG------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVM 286 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v-~~~g~~VAVK~~~~------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVm 286 (811)
+|++.+.||.|+ +|++. ..+|..||+|.+.. ..+.+..|+.+++.++||||+++++.+.......+|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 477888888875 77765 34789999999852 345688999999999999999999877665667789999
Q ss_pred ecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHH-----hCCceeccCCCCcEEEeccCCCCcceEEEee
Q 003542 287 ELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLH-----AQKIYHGELNPSNIYLKARSMEGYFHVKVSG 360 (811)
Q Consensus 287 Ey~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLH-----s~gIVHRDLKPsNILI~~~g~d~~~~vKL~D 360 (811)
||+++ +|.+++.... .....+++..++.++.||+.||.||| +.+++||||+|+||+++.++ .+||+|
T Consensus 81 e~~~~~~L~~~l~~~~--~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~-----~~kl~d 153 (265)
T cd08217 81 EYCEGGDLAQLIQKCK--KERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANN-----NVKLGD 153 (265)
T ss_pred hhccCCCHHHHHHHHh--hcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCC-----CEEEec
Confidence 99984 8999887642 12357899999999999999999999 88999999999999998876 899999
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccch
Q 003542 361 FGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQG 440 (811)
Q Consensus 361 FGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~ 440 (811)
||++........ ......+++.|+|||++.+. .++.++|+||||+++|+|++|..||.... .
T Consensus 154 ~g~~~~~~~~~~-------~~~~~~~~~~~~~pE~~~~~---------~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~ 215 (265)
T cd08217 154 FGLAKILGHDSS-------FAKTYVGTPYYMSPEQLNHM---------SYDEKSDIWSLGCLIYELCALSPPFTARN--Q 215 (265)
T ss_pred ccccccccCCcc-------cccccccCCCccChhhhcCC---------CCCchhHHHHHHHHHHHHHHCCCcccCcC--H
Confidence 999887643321 12234688899999998643 57889999999999999999999998654 4
Q ss_pred HHHHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 441 DKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 441 ~~i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
..+.+.+..+..+.++...+..+.+++.+||..+|.+||++.+|++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 216 LQLASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred HHHHHHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 4556667777666778888899999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=304.86 Aligned_cols=252 Identities=22% Similarity=0.366 Sum_probs=197.0
Q ss_pred hcceEEeeeecccc---eEEEEEE------cCCEEEEEEecc----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCe
Q 003542 215 LKKLMVRRRLGASS---QFKEIQW------LGDSFVLRHFYG----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKE 281 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~~------~g~~VAVK~~~~----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~ 281 (811)
.++|.+.++||+|+ ||.+... .+..+|+|.+.. ....+.+|+++++.++||||+++++.+. ....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~ 81 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCT--EGRP 81 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEe--cCCc
Confidence 35677788888875 6765422 456899999864 3567999999999999999999987663 4456
Q ss_pred EEEEEecCC-CCHHHHHHHhhCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCC
Q 003542 282 FFLVMELMS-KDLSCYMRETFGS---------RRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSME 351 (811)
Q Consensus 282 ~yLVmEy~~-g~L~~~L~~~~~~---------~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d 351 (811)
+|+||||++ ++|.+++...... .....+++..++.++.||+.||.|||+.|++||||||+|||++.++
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~-- 159 (280)
T cd05092 82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL-- 159 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC--
Confidence 899999998 5899988753210 0113578999999999999999999999999999999999998765
Q ss_pred CcceEEEeeccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CC
Q 003542 352 GYFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GK 430 (811)
Q Consensus 352 ~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~ 430 (811)
.+||+|||++........ ........+++.|+|||++.+. .++.++|||||||++|+|++ |.
T Consensus 160 ---~~kL~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~el~~~g~ 222 (280)
T cd05092 160 ---VVKIGDFGMSRDIYSTDY-----YRVGGRTMLPIRWMPPESILYR---------KFTTESDIWSFGVVLWEIFTYGK 222 (280)
T ss_pred ---CEEECCCCceeEcCCCce-----eecCCCccccccccCHHHhccC---------CcCchhhHHHHHHHHHHHHcCCC
Confidence 899999999875432211 0111233456789999998743 67899999999999999998 99
Q ss_pred CCCCCCccchHHHHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHH
Q 003542 431 VPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILR 489 (811)
Q Consensus 431 ~PF~~~~~~~~~i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~ 489 (811)
+||..... ......+..+.....+..+++.+.+|+.+||..||.+||++.+|++.|.
T Consensus 223 ~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 223 QPWYQLSN--TEAIECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred CCCccCCH--HHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 99976432 2334555556556667788899999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=308.41 Aligned_cols=243 Identities=22% Similarity=0.349 Sum_probs=190.5
Q ss_pred hcceEEeeeecccc---eEEEEE-EcCCEEEEEEecc-----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEE
Q 003542 215 LKKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLV 285 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~-----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLV 285 (811)
.++|++.+.||.|+ ||++.. .+++.||+|.+.. ....+.+|+.+++.++||||+++++.+. ....+|+|
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~--~~~~~~lv 82 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH--TEKSLTLV 82 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEe--cCCeEEEE
Confidence 35799999999986 676653 3789999999852 2346789999999999999999998874 45679999
Q ss_pred EecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccc
Q 003542 286 MELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365 (811)
Q Consensus 286 mEy~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~ 365 (811)
|||++++|..++... ...+++..+..++.||+.||.|||+.||+||||||+|||++.++ .+||+|||++.
T Consensus 83 ~e~~~~~l~~~l~~~-----~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~-----~~kl~dfg~~~ 152 (301)
T cd07873 83 FEYLDKDLKQYLDDC-----GNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERG-----ELKLADFGLAR 152 (301)
T ss_pred EeccccCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCC-----cEEECcCcchh
Confidence 999999999888653 24688999999999999999999999999999999999998876 89999999987
Q ss_pred cccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHH
Q 003542 366 ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTK 445 (811)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~ 445 (811)
...... .......+++.|+|||++.+. ..++.++|||||||++|+|++|++||....... .+ .
T Consensus 153 ~~~~~~-------~~~~~~~~~~~y~~PE~~~~~--------~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~-~~-~ 215 (301)
T cd07873 153 AKSIPT-------KTYSNEVVTLWYRPPDILLGS--------TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE-QL-H 215 (301)
T ss_pred ccCCCC-------CcccccceeecccCcHHHhCC--------CCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HH-H
Confidence 543221 111234568889999998642 257789999999999999999999997654321 11 1
Q ss_pred HHHhC---------------------CCCC--------CCCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 446 NIRAG---------------------ERPL--------FPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 446 ~i~~~---------------------~~~~--------~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
.+... ..+. ....+++.+.+||.+||..||.+|||+++++.
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 216 FIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred HHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 11000 0000 11245778899999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=298.98 Aligned_cols=249 Identities=27% Similarity=0.464 Sum_probs=197.1
Q ss_pred cceEEeeeecccc---eEEEEEE-cCC---EEEEEEecc-----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEE
Q 003542 216 KKLMVRRRLGASS---QFKEIQW-LGD---SFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFF 283 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~~-~g~---~VAVK~~~~-----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~y 283 (811)
.+|...+.||+|+ +|++... ++. .+|+|.+.. ..+.+..|+.++++++||||+++++.+. .....|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~ 82 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVT--KFKPAM 82 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEc--cCCCcE
Confidence 4677778888875 7877644 343 799999853 2456889999999999999999997764 445689
Q ss_pred EEEecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecc
Q 003542 284 LVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFG 362 (811)
Q Consensus 284 LVmEy~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFG 362 (811)
+||||+++ +|.+++... ...+++..+..++.|++.||.|||+.|++||||||+||+++.++ .+||+|||
T Consensus 83 lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~-----~~kl~dfg 152 (268)
T cd05063 83 IITEYMENGALDKYLRDH-----DGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNL-----ECKVSDFG 152 (268)
T ss_pred EEEEcCCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCC-----cEEECCCc
Confidence 99999995 888888652 24689999999999999999999999999999999999998765 89999999
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CCCCCCCCccchH
Q 003542 363 LSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGD 441 (811)
Q Consensus 363 lA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~~PF~~~~~~~~ 441 (811)
++......... .........++.|+|||++.+. .++.++|||||||++|||++ |..||.... ..
T Consensus 153 ~~~~~~~~~~~----~~~~~~~~~~~~y~~PE~~~~~---------~~~~~~Dv~slG~il~ell~~g~~p~~~~~--~~ 217 (268)
T cd05063 153 LSRVLEDDPEG----TYTTSGGKIPIRWTAPEAIAYR---------KFTSASDVWSFGIVMWEVMSFGERPYWDMS--NH 217 (268)
T ss_pred cceeccccccc----ceeccCCCcCceecCHHHhhcC---------CcChHhHHHHHHHHHHHHHhCCCCCCCcCC--HH
Confidence 98765432211 1111122335679999998643 67889999999999999997 999997643 23
Q ss_pred HHHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHH
Q 003542 442 KMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYI 491 (811)
Q Consensus 442 ~i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i 491 (811)
.+...+..+...+.+..++..+.+++.+||..+|.+||++.+|++.|..+
T Consensus 218 ~~~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 218 EVMKAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 45566666555556677889999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=296.35 Aligned_cols=244 Identities=29% Similarity=0.504 Sum_probs=197.0
Q ss_pred cceEEeeeecccc---eEEEEEEcCCEEEEEEecc---cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEecC
Q 003542 216 KKLMVRRRLGASS---QFKEIQWLGDSFVLRHFYG---ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELM 289 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~~~g~~VAVK~~~~---~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~ 289 (811)
.+|++.+.||.|+ +|++....+..+|+|.+.. ....+.+|++++++++||||+++++.+ .....+|+||||+
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~--~~~~~~~~v~e~~ 81 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVC--TERSPICLVFEFM 81 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEE--ccCCceEEEEEcC
Confidence 3678888888885 7877665688999999864 246789999999999999999999776 4455789999999
Q ss_pred CC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccccccc
Q 003542 290 SK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTART 368 (811)
Q Consensus 290 ~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~ 368 (811)
++ +|.+++... ...+++..++.++.|++.||.|||+.+++||||||+||+++.++ .++|+|||++....
T Consensus 82 ~~~~L~~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~-----~~~l~d~g~~~~~~ 151 (256)
T cd05112 82 EHGCLSDYLRAQ-----RGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQ-----VVKVSDFGMTRFVL 151 (256)
T ss_pred CCCcHHHHHHhC-----ccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCC-----eEEECCCcceeecc
Confidence 95 888887642 24588999999999999999999999999999999999998766 89999999987543
Q ss_pred ccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CCCCCCCCccchHHHHHHH
Q 003542 369 YASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGDKMTKNI 447 (811)
Q Consensus 369 ~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~~PF~~~~~~~~~i~~~i 447 (811)
... ........++..|+|||++.+. .++.++||||||+++|+|++ |..||.... ...+...+
T Consensus 152 ~~~------~~~~~~~~~~~~~~aPe~~~~~---------~~~~~~Dv~slG~~l~el~~~g~~p~~~~~--~~~~~~~~ 214 (256)
T cd05112 152 DDQ------YTSSTGTKFPVKWSSPEVFSFS---------KYSSKSDVWSFGVLMWEVFSEGKTPYENRS--NSEVVETI 214 (256)
T ss_pred cCc------ccccCCCccchhhcCHhHhccC---------CcChHHHHHHHHHHHHHHHcCCCCCCCcCC--HHHHHHHH
Confidence 221 1111233456789999998643 67889999999999999998 999997543 23455566
Q ss_pred HhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHH
Q 003542 448 RAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRIL 488 (811)
Q Consensus 448 ~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L 488 (811)
..+.....+...+..+.+|+.+||+.+|.+||++.++++.|
T Consensus 215 ~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 215 NAGFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred hCCCCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 66555556667789999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=306.69 Aligned_cols=242 Identities=23% Similarity=0.311 Sum_probs=187.5
Q ss_pred ceEEeeeecccc---eEEEEE-EcCCEEEEEEecc------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEE
Q 003542 217 KLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVM 286 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVm 286 (811)
+|++.+.||.|+ +|++.. .+|+.||+|.+.. ....+.+|+.+++.++||||+++++.+. +...+|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~--~~~~~~lv~ 78 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLH--SDKKLTLVF 78 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhc--cCCceEEEE
Confidence 477888888885 777653 3789999999853 1356788999999999999999998874 456799999
Q ss_pred ecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccccc
Q 003542 287 ELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366 (811)
Q Consensus 287 Ey~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~ 366 (811)
||++++|.+++... ...+++..++.++.||+.||.|||+.||+||||||+||+++.++ .+||+|||++..
T Consensus 79 e~~~~~l~~~~~~~-----~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~-----~~~l~dfg~~~~ 148 (284)
T cd07839 79 EYCDQDLKKYFDSC-----NGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNG-----ELKLADFGLARA 148 (284)
T ss_pred ecCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCC-----cEEECccchhhc
Confidence 99999998888653 25689999999999999999999999999999999999998876 899999999875
Q ss_pred ccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHH
Q 003542 367 RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKN 446 (811)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~ 446 (811)
..... .......+++.|+|||++.+. ..++.++|||||||++|+|++|..||.........+ ..
T Consensus 149 ~~~~~-------~~~~~~~~~~~y~aPE~~~~~--------~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~-~~ 212 (284)
T cd07839 149 FGIPV-------RCYSAEVVTLWYRPPDVLFGA--------KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL-KR 212 (284)
T ss_pred cCCCC-------CCcCCCccccCCcChHHHhCC--------cccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHH-HH
Confidence 53221 112234578889999998642 256889999999999999999988864433222211 11
Q ss_pred HHhC-------------------CCCCC---------CCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 447 IRAG-------------------ERPLF---------PSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 447 i~~~-------------------~~~~~---------p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
+... ..+.+ ....++.+.+||.+||..||.+|||+++++.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 213 IFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred HHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 1110 00001 1235678899999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=302.03 Aligned_cols=244 Identities=24% Similarity=0.363 Sum_probs=192.5
Q ss_pred ceEEeeeecccc---eEEEEE-EcCCEEEEEEecc---------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEE
Q 003542 217 KLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG---------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFF 283 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~---------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~y 283 (811)
+|+..+.||.|+ +|++.. .+|..||+|.+.. ....+.+|+.+++.++||||+++++.+.......++
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 577778888885 677664 3789999998842 235688999999999999999999776554456789
Q ss_pred EEEecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecc
Q 003542 284 LVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFG 362 (811)
Q Consensus 284 LVmEy~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFG 362 (811)
++|||+++ +|.+++... ..+++..++.++.||+.||.|||+.+|+||||+|+||+++.++ .+||+|||
T Consensus 83 l~~e~~~~~~L~~~l~~~------~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~-----~~~l~dfg 151 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAY------GALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAG-----NVKLGDFG 151 (266)
T ss_pred EEEeCCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC-----CEEEccCC
Confidence 99999985 898888753 4688999999999999999999999999999999999998765 89999999
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHH
Q 003542 363 LSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDK 442 (811)
Q Consensus 363 lA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~ 442 (811)
++......... ........++..|+|||++.+. .++.++|||||||++|+|++|+.||...... ..
T Consensus 152 ~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~-~~ 217 (266)
T cd06651 152 ASKRLQTICMS----GTGIRSVTGTPYWMSPEVISGE---------GYGRKADVWSLGCTVVEMLTEKPPWAEYEAM-AA 217 (266)
T ss_pred Ccccccccccc----CCccccCCccccccCHHHhCCC---------CCCchhhhHHHHHHHHHHHHCCCCccccchH-HH
Confidence 98755322110 1111234578899999998643 5788999999999999999999999765322 22
Q ss_pred HHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 443 MTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 443 i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
+.........+.+|...++.+.+++ +||..+|.+||++.+|++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 218 IFKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred HHHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 3333333445566777788899999 688899999999999976
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=303.55 Aligned_cols=253 Identities=23% Similarity=0.397 Sum_probs=195.0
Q ss_pred hcceEEeeeecccc---eEEEEE-EcCCEEEEEEecc---cHHHHHHHHHHHHhC-CCCccceeeeeEEc---cCCCeEE
Q 003542 215 LKKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG---ELESLNAEISTMLSL-SHPNIVQYLCGFCD---EEKKEFF 283 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~---~~~~~~~Ei~iL~~L-~HPNIVkl~~~~~~---e~~~~~y 283 (811)
..+|++.+.||+|+ +|++.. .+|+.||+|.+.. ....+.+|+.+++.+ +||||+++++.+.. +....+|
T Consensus 17 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~ 96 (286)
T cd06638 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLW 96 (286)
T ss_pred ccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEE
Confidence 46899999999986 776653 4788999999854 235688999999999 79999999976642 2345789
Q ss_pred EEEecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecc
Q 003542 284 LVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFG 362 (811)
Q Consensus 284 LVmEy~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFG 362 (811)
+||||++| +|.+++..... ....+++..+..++.|++.||.|||+.+++||||||+||+++.++ .+||+|||
T Consensus 97 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~-----~~kl~dfg 169 (286)
T cd06638 97 LVLELCNGGSVTDLVKGFLK--RGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEG-----GVKLVDFG 169 (286)
T ss_pred EEEeecCCCCHHHHHHHhhc--cCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCC-----CEEEccCC
Confidence 99999985 88887764321 225688999999999999999999999999999999999998876 79999999
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHH
Q 003542 363 LSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDK 442 (811)
Q Consensus 363 lA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~ 442 (811)
++....... .......|++.|+|||++..... ....++.++|||||||++|+|++|+.||....... .
T Consensus 170 ~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~----~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~-~ 237 (286)
T cd06638 170 VSAQLTSTR-------LRRNTSVGTPFWMAPEVIACEQQ----LDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR-A 237 (286)
T ss_pred ceeecccCC-------CccccccCCCcccChhhhchhhh----ccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH-H
Confidence 987653321 11234468899999999864311 12357889999999999999999999997653221 1
Q ss_pred HHHHHHhCCCC--CCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHH
Q 003542 443 MTKNIRAGERP--LFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRI 487 (811)
Q Consensus 443 i~~~i~~~~~~--~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~ 487 (811)
+ ..+.....+ ..+..++..+.+||.+||+.||.+|||+.+|++.
T Consensus 238 ~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 238 L-FKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred H-hhccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 1 122222211 2344567889999999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=299.06 Aligned_cols=248 Identities=25% Similarity=0.460 Sum_probs=198.4
Q ss_pred cceEEeeeecccc---eEEEEEEc----CCEEEEEEecc-----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEE
Q 003542 216 KKLMVRRRLGASS---QFKEIQWL----GDSFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFF 283 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~~~----g~~VAVK~~~~-----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~y 283 (811)
++|.+.+.||.|+ +|++.... ...||||.+.. ..+.+.+|+.+++.++||||+++++.+. + ...|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~--~-~~~~ 82 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVIT--E-NPVW 82 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEc--C-CCcE
Confidence 4678888888885 77766443 24799999863 2457899999999999999999986653 2 3478
Q ss_pred EEEecCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecc
Q 003542 284 LVMELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFG 362 (811)
Q Consensus 284 LVmEy~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFG 362 (811)
+||||++ ++|.+++... ...+++..++.++.|++.||.|||+.|++||||||+|||++.++ .++|+|||
T Consensus 83 lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~-----~~~l~d~g 152 (270)
T cd05056 83 IVMELAPLGELRSYLQVN-----KYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPD-----CVKLGDFG 152 (270)
T ss_pred EEEEcCCCCcHHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCC-----CeEEccCc
Confidence 9999998 5899988753 24589999999999999999999999999999999999998876 89999999
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CCCCCCCCccchH
Q 003542 363 LSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGD 441 (811)
Q Consensus 363 lA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~~PF~~~~~~~~ 441 (811)
++........ .......++..|+|||.+... .++.++||||||+++|+|++ |..||.+... .
T Consensus 153 ~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~el~~~g~~pf~~~~~--~ 215 (270)
T cd05056 153 LSRYLEDESY------YKASKGKLPIKWMAPESINFR---------RFTSASDVWMFGVCMWEILMLGVKPFQGVKN--N 215 (270)
T ss_pred eeeecccccc------eecCCCCccccccChhhhccC---------CCCchhhhHHHHHHHHHHHHcCCCCCCCCCH--H
Confidence 9876543311 111123345679999998643 57889999999999999996 9999976543 2
Q ss_pred HHHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHHHH
Q 003542 442 KMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKK 493 (811)
Q Consensus 442 ~i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~k 493 (811)
.....+..+.....+..++..+.++|.+||..+|.+|||+.+++..|..+..
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 216 DVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 3345566666667778889999999999999999999999999998877653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=308.14 Aligned_cols=251 Identities=26% Similarity=0.458 Sum_probs=197.5
Q ss_pred HhcceEEeeeecccc---eEEEEEE------cCCEEEEEEecc-----cHHHHHHHHHHHHhC-CCCccceeeeeEEccC
Q 003542 214 LLKKLMVRRRLGASS---QFKEIQW------LGDSFVLRHFYG-----ELESLNAEISTMLSL-SHPNIVQYLCGFCDEE 278 (811)
Q Consensus 214 l~k~~~i~~~lG~G~---vyk~v~~------~g~~VAVK~~~~-----~~~~~~~Ei~iL~~L-~HPNIVkl~~~~~~e~ 278 (811)
...+|.+.+.||+|+ +|.+..+ .+..||||.+.. ..+.+.+|+.+++++ +||||+++++.+. .
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~--~ 110 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACT--I 110 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEe--c
Confidence 345789999999985 5655432 345799999864 235688999999999 7999999997764 3
Q ss_pred CCeEEEEEecCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEE
Q 003542 279 KKEFFLVMELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVK 357 (811)
Q Consensus 279 ~~~~yLVmEy~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vK 357 (811)
.+.+|+||||+. |+|.+++... ....+++..+..++.||+.||.|||+++|+|+||||+|||++.++ .++
T Consensus 111 ~~~~~lv~e~~~~~~L~~~i~~~----~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~-----~~~ 181 (302)
T cd05055 111 GGPILVITEYCCYGDLLNFLRRK----RESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGK-----IVK 181 (302)
T ss_pred CCceEEEEEcCCCCcHHHHHHhC----CCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCC-----eEE
Confidence 456899999998 5899988753 123489999999999999999999999999999999999998765 899
Q ss_pred EeeccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CCCCCCCC
Q 003542 358 VSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDG 436 (811)
Q Consensus 358 L~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~~PF~~~ 436 (811)
|+|||++........ ........++..|+|||++.+. .++.++|||||||++|+|++ |..||.+.
T Consensus 182 l~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~DiwslGvil~el~t~g~~p~~~~ 247 (302)
T cd05055 182 ICDFGLARDIMNDSN-----YVVKGNARLPVKWMAPESIFNC---------VYTFESDVWSYGILLWEIFSLGSNPYPGM 247 (302)
T ss_pred ECCCcccccccCCCc-----eeecCCCCcccccCCHhhhccC---------CCCcHhHHHHHHHHHHHHHhCCCCCcCCC
Confidence 999999875533211 0111233467789999998643 57889999999999999998 99999765
Q ss_pred ccchHHHHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHH
Q 003542 437 HLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRY 490 (811)
Q Consensus 437 ~~~~~~i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~ 490 (811)
... ..+...+..+..+..+...++.+.+|+.+||..+|++||++.+++..|..
T Consensus 248 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 248 PVD-SKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred Cch-HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 432 23334444455555566778899999999999999999999999987764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=314.63 Aligned_cols=257 Identities=25% Similarity=0.466 Sum_probs=199.7
Q ss_pred hcceEEeeeecccc---eEEEEE------EcCCEEEEEEecc-----cHHHHHHHHHHHHhC-CCCccceeeeeEEccCC
Q 003542 215 LKKLMVRRRLGASS---QFKEIQ------WLGDSFVLRHFYG-----ELESLNAEISTMLSL-SHPNIVQYLCGFCDEEK 279 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~------~~g~~VAVK~~~~-----~~~~~~~Ei~iL~~L-~HPNIVkl~~~~~~e~~ 279 (811)
.++|++.+.||.|+ ||++.. ..++.||||.+.. ....+.+|+.+|.++ +||||+++++.+. ...
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~-~~~ 84 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT-KPG 84 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceee-cCC
Confidence 35788999999986 777652 3578999999963 245688999999999 6899999986554 344
Q ss_pred CeEEEEEecCC-CCHHHHHHHhhCCC------------------------------------------------------
Q 003542 280 KEFFLVMELMS-KDLSCYMRETFGSR------------------------------------------------------ 304 (811)
Q Consensus 280 ~~~yLVmEy~~-g~L~~~L~~~~~~~------------------------------------------------------ 304 (811)
..+++|||||+ |+|.+++.......
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 57899999999 58999886531100
Q ss_pred -------CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccccccCCCCCCC
Q 003542 305 -------RRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTPPA 377 (811)
Q Consensus 305 -------~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~~~~~~~~ 377 (811)
....+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++........
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~-----~~kl~dfg~~~~~~~~~~----- 234 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENN-----VVKICDFGLARDIYKDPD----- 234 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCC-----cEEEEecccccccccCcc-----
Confidence 012468888999999999999999999999999999999998766 899999999876532211
Q ss_pred CCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CCCCCCCCccchHHHHHHHHhCCCCCCC
Q 003542 378 SPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGDKMTKNIRAGERPLFP 456 (811)
Q Consensus 378 ~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~~PF~~~~~~~~~i~~~i~~~~~~~~p 456 (811)
........+++.|+|||++.+. .++.++||||||+++|+|++ |..||...... ..+...+..+..+..|
T Consensus 235 ~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~ 304 (343)
T cd05103 235 YVRKGDARLPLKWMAPETIFDR---------VYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-EEFCRRLKEGTRMRAP 304 (343)
T ss_pred hhhcCCCCCCcceECcHHhcCC---------CCCchhhHHHHHHHHHHHHHCCCCCCCCcccc-HHHHHHHhccCCCCCC
Confidence 0111233456779999998643 67889999999999999997 99999765433 2344455555566666
Q ss_pred CCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHHH
Q 003542 457 SGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIK 492 (811)
Q Consensus 457 ~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~ 492 (811)
...++.+.+++.+||+.||.+||++.+|++.|..+.
T Consensus 305 ~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~ 340 (343)
T cd05103 305 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 340 (343)
T ss_pred CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 677888999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=338.40 Aligned_cols=256 Identities=22% Similarity=0.335 Sum_probs=199.9
Q ss_pred ceEEeeeecccc---eEEEEEEcC-CEEEEEEecc----cHHHHHHHHHHHHhCC-CCccceeeeeEEc----cC-CCeE
Q 003542 217 KLMVRRRLGASS---QFKEIQWLG-DSFVLRHFYG----ELESLNAEISTMLSLS-HPNIVQYLCGFCD----EE-KKEF 282 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v~~~g-~~VAVK~~~~----~~~~~~~Ei~iL~~L~-HPNIVkl~~~~~~----e~-~~~~ 282 (811)
++++.+.|.+|| ||.+....+ ..||+|++.. ....+.+||.+|++|+ |+|||.|++.... .. ..++
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev 117 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV 117 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence 578888899887 888776655 9999999853 4677899999999996 9999999983321 11 2468
Q ss_pred EEEEecCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCcEEEeccCCCCcceEEEe
Q 003542 283 FLVMELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQK--IYHGELNPSNIYLKARSMEGYFHVKVS 359 (811)
Q Consensus 283 yLVmEy~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~g--IVHRDLKPsNILI~~~g~d~~~~vKL~ 359 (811)
+|.||||. |+|.+++..+.. ..|++.+++.|+.|+++|+.+||... |||||||-+||||..+| +.|||
T Consensus 118 llLmEyC~gg~Lvd~mn~Rlq----~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g-----~~KLC 188 (738)
T KOG1989|consen 118 LLLMEYCKGGSLVDFMNTRLQ----TRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADG-----NYKLC 188 (738)
T ss_pred EeehhhccCCcHHHHHHHHHh----ccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCC-----CEEeC
Confidence 99999999 699999987643 45999999999999999999999997 99999999999999887 89999
Q ss_pred eccccccccccCCCCCC--CCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCc
Q 003542 360 GFGLSTARTYASRNTPP--ASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGH 437 (811)
Q Consensus 360 DFGlA~~~~~~~~~~~~--~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~ 437 (811)
|||.+............ .....-....|+.|+|||++.-. .....++|+|||+|||+||-|++...||++..
T Consensus 189 DFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDly------sg~pI~eKsDIWALGclLYkLCy~t~PFe~sg 262 (738)
T KOG1989|consen 189 DFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLY------SGLPIGEKSDIWALGCLLYKLCYFTTPFEESG 262 (738)
T ss_pred cccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhh------cCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc
Confidence 99998654332210000 00011234578999999999753 24578999999999999999999999998652
Q ss_pred cchHHHHHHHHhCCCC-CCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHHHH
Q 003542 438 LQGDKMTKNIRAGERP-LFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKK 493 (811)
Q Consensus 438 ~~~~~i~~~i~~~~~~-~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~k 493 (811)
. -.|..+... +....++..+.+||..||+.||.+||++-+++..+-.|..
T Consensus 263 ~------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~ 313 (738)
T KOG1989|consen 263 K------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN 313 (738)
T ss_pred c------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence 2 123333322 1124678889999999999999999999999876655543
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=300.58 Aligned_cols=244 Identities=25% Similarity=0.398 Sum_probs=192.3
Q ss_pred eEEeeeecccc---eEEEEEEcCCEEEEEEecc----------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEE
Q 003542 218 LMVRRRLGASS---QFKEIQWLGDSFVLRHFYG----------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFL 284 (811)
Q Consensus 218 ~~i~~~lG~G~---vyk~v~~~g~~VAVK~~~~----------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yL 284 (811)
|.+.+.||.|+ +|++...+|+.+|||.+.. ....+.+|+.+|+.++|+||+++++.+. +...+|+
T Consensus 2 ~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~l 79 (265)
T cd06631 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCL--DDNTISI 79 (265)
T ss_pred ccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEee--cCCeEEE
Confidence 56677788775 7776666899999998842 1356889999999999999999997764 4468999
Q ss_pred EEecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccc
Q 003542 285 VMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGL 363 (811)
Q Consensus 285 VmEy~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGl 363 (811)
||||++| +|.+++... ..+++..+..++.|++.||.|||+.+|+|+||+|+||+++.++ .++|+|||+
T Consensus 80 v~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~-----~~~l~dfg~ 148 (265)
T cd06631 80 FMEFVPGGSISSILNRF------GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNG-----IIKLIDFGC 148 (265)
T ss_pred EEecCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCC-----eEEeccchh
Confidence 9999985 888888653 5688999999999999999999999999999999999998776 899999999
Q ss_pred cccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHH
Q 003542 364 STARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKM 443 (811)
Q Consensus 364 A~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i 443 (811)
+........... .........|+..|+|||++.+. .++.++||||||+++|+|++|..||........ .
T Consensus 149 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~pe~~~~~---------~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~-~ 217 (265)
T cd06631 149 ARRLAWVGLHGT-HSNMLKSMHGTPYWMAPEVINES---------GYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA-M 217 (265)
T ss_pred hHhhhhcccccc-ccccccccCCCccccChhhhcCC---------CCcchhhHHHHHHHHHHHHhCCCccccCChHHH-H
Confidence 876532211100 01112345688999999998643 577899999999999999999999976432221 1
Q ss_pred HHHHHh--CCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 444 TKNIRA--GERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 444 ~~~i~~--~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
..+.. ...+..+...+..+.++|.+||..+|.+||++.+++.
T Consensus 218 -~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 218 -FYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred -HHhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 12222 3345567778899999999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=317.18 Aligned_cols=240 Identities=22% Similarity=0.346 Sum_probs=187.3
Q ss_pred hcceEEeeeecccc---eEEEEE-EcCCEEEEEEecc------cHHHHHHHHHHHHhCCCCccceeeeeEEccC----CC
Q 003542 215 LKKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG------ELESLNAEISTMLSLSHPNIVQYLCGFCDEE----KK 280 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~----~~ 280 (811)
.++|++++.||.|+ ||++.. .+++.||||.+.. ....+.+|+.+|+.++||||+++++.+.... ..
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 46788888899886 777663 4788999999864 2355778999999999999999997764321 24
Q ss_pred eEEEEEecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEee
Q 003542 281 EFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSG 360 (811)
Q Consensus 281 ~~yLVmEy~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~D 360 (811)
.+|++||++.++|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|
T Consensus 94 ~~~~~~~~~~~~l~~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~-----~~kl~D 161 (343)
T cd07878 94 EVYLVTNLMGADLNNIVKC-------QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDC-----ELRILD 161 (343)
T ss_pred cEEEEeecCCCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCC-----CEEEcC
Confidence 5799999998898877653 5699999999999999999999999999999999999998876 899999
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccch
Q 003542 361 FGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQG 440 (811)
Q Consensus 361 FGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~ 440 (811)
||++...... .....||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+.....
T Consensus 162 fg~~~~~~~~----------~~~~~~t~~y~aPE~~~~--------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 223 (343)
T cd07878 162 FGLARQADDE----------MTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID 223 (343)
T ss_pred CccceecCCC----------cCCccccccccCchHhcC--------CccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH
Confidence 9998764321 124568999999999864 2367889999999999999999999997643211
Q ss_pred HHHHHHHHh--C--------------------CCCCCC--------CCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 441 DKMTKNIRA--G--------------------ERPLFP--------SGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 441 ~~i~~~i~~--~--------------------~~~~~p--------~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
. ...+.. + ..+..+ ...++.+.+||.+||..||.+|||+.+++.
T Consensus 224 -~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 224 -Q-LKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred -H-HHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1 111100 0 000011 134556889999999999999999999987
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=311.70 Aligned_cols=247 Identities=16% Similarity=0.293 Sum_probs=189.3
Q ss_pred cceEEeeeecccc---eEEEEE-EcCCEEEEEEecc-------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEE
Q 003542 216 KKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG-------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFL 284 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~-------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yL 284 (811)
++|++.+.||.|+ ||.+.. .+++.||||++.. ..+.+.+|+.++..++||||+++++.+ ++...+|+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~--~~~~~~~l 78 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAF--QDENNLYL 78 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEE--ecCCeEEE
Confidence 3688999999986 566553 3789999999853 345588999999999999999999777 45568999
Q ss_pred EEecCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccc
Q 003542 285 VMELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGL 363 (811)
Q Consensus 285 VmEy~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGl 363 (811)
||||++ |+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 79 v~e~~~g~~L~~~l~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~-----~~kl~Dfg~ 148 (331)
T cd05597 79 VMDYYVGGDLLTLLSKF-----EDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNG-----HIRLADFGS 148 (331)
T ss_pred EEecCCCCcHHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCC-----CEEEEECCc
Confidence 999998 5899888652 25689999999999999999999999999999999999998776 899999999
Q ss_pred cccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHH
Q 003542 364 STARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKM 443 (811)
Q Consensus 364 A~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i 443 (811)
+........ .......||+.|+|||++..... ....++.++|||||||++|+|++|+.||.+.... +.
T Consensus 149 ~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~----~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~--~~ 216 (331)
T cd05597 149 CLRLLADGT------VQSNVAVGTPDYISPEILQAMED----GKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV--ET 216 (331)
T ss_pred eeecCCCCC------ccccceeccccccCHHHHhhccc----cccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH--HH
Confidence 865533211 11123468999999999974311 1235788999999999999999999999765432 22
Q ss_pred HHHHHhC-CCCCCC---CCChHHHHHHHhhhccCCCCC--CCCHHHHHH
Q 003542 444 TKNIRAG-ERPLFP---SGSPKYLVNLTKKCWHTNPSQ--RPSFSSICR 486 (811)
Q Consensus 444 ~~~i~~~-~~~~~p---~~~~~~l~~LI~~cL~~DP~~--RPS~~eIl~ 486 (811)
...+... ....++ ..+++.+.++|.+||..++.. |+++.+++.
T Consensus 217 ~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~ 265 (331)
T cd05597 217 YGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKD 265 (331)
T ss_pred HHHHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence 2333322 112222 346888999999988654443 788888876
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=315.19 Aligned_cols=228 Identities=21% Similarity=0.353 Sum_probs=179.3
Q ss_pred eccc---ceEEEEE-EcCCEEEEEEecc-------cHHHHHHHHH-HHHhCCCCccceeeeeEEccCCCeEEEEEecCCC
Q 003542 224 LGAS---SQFKEIQ-WLGDSFVLRHFYG-------ELESLNAEIS-TMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK 291 (811)
Q Consensus 224 lG~G---~vyk~v~-~~g~~VAVK~~~~-------~~~~~~~Ei~-iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~~g 291 (811)
||.| .||.+.. .+|+.||||++.. ....+..|.. +++.++||||+++++.+ ...+.+|+||||++|
T Consensus 3 lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~--~~~~~~~lv~e~~~~ 80 (325)
T cd05604 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSF--QTTEKLYFVLDFVNG 80 (325)
T ss_pred eeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEE--ecCCEEEEEEcCCCC
Confidence 4555 4777663 4789999999853 2344556655 46778999999999777 445679999999995
Q ss_pred -CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccccccccc
Q 003542 292 -DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYA 370 (811)
Q Consensus 292 -~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~ 370 (811)
+|..++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++ .+||+|||++......
T Consensus 81 ~~L~~~l~~~------~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~-----~~kL~DfG~~~~~~~~ 149 (325)
T cd05604 81 GELFFHLQRE------RSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQG-----HVVLTDFGLCKEGIAQ 149 (325)
T ss_pred CCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC-----CEEEeecCCcccCCCC
Confidence 787777643 5789999999999999999999999999999999999998876 8999999998643221
Q ss_pred CCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHHHHhC
Q 003542 371 SRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAG 450 (811)
Q Consensus 371 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i~~~ 450 (811)
. .......||+.|+|||++.+. .++.++|||||||++|+|++|..||..... ..+...+...
T Consensus 150 ~-------~~~~~~~gt~~y~aPE~~~~~---------~~~~~~DvwslG~il~el~~G~~pf~~~~~--~~~~~~~~~~ 211 (325)
T cd05604 150 S-------DTTTTFCGTPEYLAPEVIRKQ---------PYDNTVDWWCLGAVLYEMLYGLPPFYCRDV--AEMYDNILHK 211 (325)
T ss_pred C-------CCcccccCChhhCCHHHHcCC---------CCCCcCccccccceehhhhcCCCCCCCCCH--HHHHHHHHcC
Confidence 1 122345689999999999743 678899999999999999999999986532 2344444443
Q ss_pred CCCCCCCCChHHHHHHHhhhccCCCCCCCCHHH
Q 003542 451 ERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSS 483 (811)
Q Consensus 451 ~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~e 483 (811)
. ..++...+..+.++|.+||..+|.+||++.+
T Consensus 212 ~-~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 212 P-LVLRPGASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred C-ccCCCCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence 3 2344567888999999999999999998753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=337.32 Aligned_cols=356 Identities=23% Similarity=0.335 Sum_probs=274.7
Q ss_pred HHhCCCCccceeeeeEEccCCCeEEEEEecCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCc-eec
Q 003542 259 MLSLSHPNIVQYLCGFCDEEKKEFFLVMELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKI-YHG 336 (811)
Q Consensus 259 L~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gI-VHR 336 (811)
|+.+.|.|+.+|++...+. ..+++|.+||. |+|.+.+.. ....+++.....++++|+.||.|||...| +|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~--~~~~~i~~~c~rGsl~D~i~~-----~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg 73 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG--PEMIVIWEYCSRGSLLDILSN-----EDIKLDYFFILSFIRDISKGLAYLHNSPIGYHG 73 (484)
T ss_pred CcccchhhhhhheeeEecC--CceEEEEeeecCccHHhHHhc-----cccCccHHHHHHHHHHHHHHHHHHhcCcceeee
Confidence 4578999999999777543 67999999999 799998875 23568888899999999999999999877 999
Q ss_pred cCCCCcEEEeccCCCCcceEEEeeccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccce
Q 003542 337 ELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADV 416 (811)
Q Consensus 337 DLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDI 416 (811)
.|++.|++++ .+|.+||+|||+......... ........-...|.|||.+.+...... ....+.++||
T Consensus 74 ~l~s~nClvd-----~~w~lklt~~Gl~~~~~~~~~-----~~~~~~~~~~~lw~aPellr~~~~~~~--~~~~~~~gdi 141 (484)
T KOG1023|consen 74 ALKSSNCLVD-----SRWVLKLTDFGLNSLLEETAE-----PEAHHPIRKALLWTAPELLRGALSQSL--ESALTQKGDI 141 (484)
T ss_pred eeccccceee-----eeEEEEechhhhccccccccc-----ccccchhHHHHhccCHHHhcccccccc--cccccccCCe
Confidence 9999999994 556999999999876643110 011112224456999999986422210 1235788999
Q ss_pred ecchhHHHHHhhCCCCCCCCccch--HHHHHHHHh-CCCCCCCC-----CChHHHHHHHhhhccCCCCCCCCHHHHHHHH
Q 003542 417 YSFGMLCFELLTGKVPFEDGHLQG--DKMTKNIRA-GERPLFPS-----GSPKYLVNLTKKCWHTNPSQRPSFSSICRIL 488 (811)
Q Consensus 417 WSLGvILyELltG~~PF~~~~~~~--~~i~~~i~~-~~~~~~p~-----~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L 488 (811)
||||+|++|+++...||....... .++...+.. +..+..|. ..++++..++.+||..+|.+||+++.|...+
T Consensus 142 Ys~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~ 221 (484)
T KOG1023|consen 142 YSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKL 221 (484)
T ss_pred ehHHHHHHHHHhccCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhh
Confidence 999999999999999998643332 345555555 33333332 3455799999999999999999999998877
Q ss_pred HHHHHHhhcCCccccccCCCCccccchhhhHHHhhhhcCCCCCCCcCCcchhhHHhhhhHHHhhhccCccCcccccCCCC
Q 003542 489 RYIKKFMANNPDIARSEFQSPLADYCDIEAGFVRKFVGEGCPDVAPVSQIPFQMFAYKIAEKEKANSSNKGKHWELGSDV 568 (811)
Q Consensus 489 ~~i~k~l~~~p~~~~~~~~~p~~~~~~~e~~~l~~~~~e~~~~~~k~~~ll~qml~~~vaEeek~g~~~~f~~~d~~s~~ 568 (811)
+.+.+...... ...+.+...+..|.+..+..+++++.+...++.+.+.++.+|+|..|++++|.|.. ++++++
T Consensus 222 ~~~~~~~~~~~-nl~D~m~~~le~Y~~nLe~~v~eRt~~l~~e~~k~d~LL~~mLP~~VA~~lk~G~~-----v~pe~~- 294 (484)
T KOG1023|consen 222 LTINKGGSSKG-NLMDSLFRMLESYADNLEKLVDERTAELEEEKKKTDTLLGQMLPKSVAESLKLGKT-----VDPESF- 294 (484)
T ss_pred hhhcccccccc-hhHHHHHHHHHHHHhhhHHHHHHHHHHHHHHHHHHHHHHHHhcCHHHhhHhhcCCc-----CCcccc-
Confidence 76655321100 11122333445566666666777666666788999999999999999999999999 999999
Q ss_pred CCCCCCcccccccCCCCCCccccccCCCchhHhhhhccccccccCccccCCcccccccCCCcccch-hhH-------HHH
Q 003542 569 ASTCKDEVFSVGDEGMVPVTETRSVCSDVKSVTFDMRSVYSEAFGKKVSNFDTRSVRSESPNKKMQ-GSV-------SRL 640 (811)
Q Consensus 569 ~~~~~de~~~~~sd~~~~~~t~~s~~st~~~v~~~~~~~~~~~~~~~i~~~d~~kv~~~~~~~~~~-~~~-------~~~ 640 (811)
+.++.+|||+++| |++++.++|+|||.++|++ |+.||.+|+.||+||||+-.-+.-+. |+. .+.
T Consensus 295 -----~~vti~fsDiv~f--T~l~~~~~P~~vv~~lNdl-yt~Fd~ii~~~d~yKVetiGDaYmvvSglp~~n~~~H~~e 366 (484)
T KOG1023|consen 295 -----DSVTIYFSDIVGF--TVLSSNSTPIQVVTLLNDL-YTTFDRIIDKHDVYKVETIGDAYMVVSGLPIRNGYRHARE 366 (484)
T ss_pred -----CceeeeeHHHHHH--HHHHhcCCCceeeeeccch-HHhhhhcccccCCeeEeccCcceeecccCceecHhHHHHH
Confidence 9999999999999 9999999999999999999 99999999999999999988776544 543 567
Q ss_pred HHHhhhhc
Q 003542 641 IQSMVLEK 648 (811)
Q Consensus 641 ~~~~~~~~ 648 (811)
|-+|-|+.
T Consensus 367 ia~msl~~ 374 (484)
T KOG1023|consen 367 IASMALGL 374 (484)
T ss_pred HHHHHHHH
Confidence 77887774
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=297.67 Aligned_cols=250 Identities=24% Similarity=0.418 Sum_probs=195.4
Q ss_pred cceEEeeeecccc---eEEEEEE-cC---CEEEEEEecc-----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEE
Q 003542 216 KKLMVRRRLGASS---QFKEIQW-LG---DSFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFF 283 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~~-~g---~~VAVK~~~~-----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~y 283 (811)
..|++.+.||.|+ +|++... +| ..||||.+.. ....|..|+.+++.++||||+++++.+ .+...++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~--~~~~~~~ 81 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV--TKSRPVM 81 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEE--CCCCceE
Confidence 4578888899886 7876643 33 3699999863 245789999999999999999998766 4456789
Q ss_pred EEEecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecc
Q 003542 284 LVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFG 362 (811)
Q Consensus 284 LVmEy~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFG 362 (811)
+||||+++ +|.+++... ...+++..++.++.|++.||.|||++|++||||||+||+++.++ .+||+|||
T Consensus 82 lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~-----~~kl~dfg 151 (269)
T cd05065 82 IITEFMENGALDSFLRQN-----DGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNL-----VCKVSDFG 151 (269)
T ss_pred EEEecCCCCcHHHHHhhC-----CCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCC-----cEEECCCc
Confidence 99999985 888887642 24689999999999999999999999999999999999997765 89999999
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CCCCCCCCccchH
Q 003542 363 LSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGD 441 (811)
Q Consensus 363 lA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~~PF~~~~~~~~ 441 (811)
++........... .........+..|+|||.+.+ ..++.++|||||||++|||++ |..||..... .
T Consensus 152 ~~~~~~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~---------~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~--~ 218 (269)
T cd05065 152 LSRFLEDDTSDPT--YTSSLGGKIPIRWTAPEAIAY---------RKFTSASDVWSYGIVMWEVMSYGERPYWDMSN--Q 218 (269)
T ss_pred cccccccCccccc--cccccCCCcceeecCHhHhcc---------CcccchhhhhhhHHHHHHHhcCCCCCCCCCCH--H
Confidence 9875543221100 001111122457999999864 367889999999999999886 9999976432 3
Q ss_pred HHHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHH
Q 003542 442 KMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRY 490 (811)
Q Consensus 442 ~i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~ 490 (811)
.....+......+.+..++..+.+++.+||..+|.+||++.+|+..|+.
T Consensus 219 ~~~~~i~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 267 (269)
T cd05065 219 DVINAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK 267 (269)
T ss_pred HHHHHHHcCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 3445555555555667888999999999999999999999999887764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=295.08 Aligned_cols=242 Identities=30% Similarity=0.502 Sum_probs=196.2
Q ss_pred eccc---ceEEEEEEc----CCEEEEEEeccc-----HHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEecCC-
Q 003542 224 LGAS---SQFKEIQWL----GDSFVLRHFYGE-----LESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMS- 290 (811)
Q Consensus 224 lG~G---~vyk~v~~~----g~~VAVK~~~~~-----~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~~- 290 (811)
||.| .+|++.... +..||+|.+... ...+.+|+.++..++||||+++++.+. ....+++||||++
T Consensus 3 ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~lv~e~~~~ 80 (262)
T cd00192 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCT--EEEPLYLVLEYMEG 80 (262)
T ss_pred cccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeec--CCCceEEEEEeccC
Confidence 4554 477766543 889999999642 577899999999999999999997664 3667999999997
Q ss_pred CCHHHHHHHhhCC---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccc
Q 003542 291 KDLSCYMRETFGS---RRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTAR 367 (811)
Q Consensus 291 g~L~~~L~~~~~~---~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~ 367 (811)
++|.+++...... .....+++..++.++.|++.||.|||++|++||||+|+||+++.++ .+||+|||.+...
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~-----~~~l~dfg~~~~~ 155 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDL-----VVKISDFGLSRDV 155 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCC-----cEEEccccccccc
Confidence 6999988763100 0125689999999999999999999999999999999999998876 8999999999766
Q ss_pred cccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CCCCCCCCccchHHHHHH
Q 003542 368 TYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGDKMTKN 446 (811)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~~PF~~~~~~~~~i~~~ 446 (811)
..... ........++..|+|||.+... .++.++||||||+++|+|++ |..||... ....+...
T Consensus 156 ~~~~~-----~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~~l~~~g~~p~~~~--~~~~~~~~ 219 (262)
T cd00192 156 YDDDY-----YRKKTGGKLPIRWMAPESLKDG---------IFTSKSDVWSFGVLLWEIFTLGATPYPGL--SNEEVLEY 219 (262)
T ss_pred ccccc-----cccccCCCcCccccCHHHhccC---------CcchhhccHHHHHHHHHHHhcCCCCCCCC--CHHHHHHH
Confidence 44321 1122345578889999998642 67889999999999999999 69999875 33455666
Q ss_pred HHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHH
Q 003542 447 IRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRIL 488 (811)
Q Consensus 447 i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L 488 (811)
+..+.....+..++.++.+++.+||..+|.+|||+.++++.|
T Consensus 220 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l 261 (262)
T cd00192 220 LRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261 (262)
T ss_pred HHcCCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 666666777888899999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=302.95 Aligned_cols=251 Identities=27% Similarity=0.430 Sum_probs=197.0
Q ss_pred cceEEeeeecccc---eEEEEEE------cCCEEEEEEeccc-----HHHHHHHHHHHHhCCCCccceeeeeEEccCCCe
Q 003542 216 KKLMVRRRLGASS---QFKEIQW------LGDSFVLRHFYGE-----LESLNAEISTMLSLSHPNIVQYLCGFCDEEKKE 281 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~~------~g~~VAVK~~~~~-----~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~ 281 (811)
.+|++.+.||.|+ +|++... .+..||+|.+... ...+.+|+.++++++||||+++++.+. ....
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~--~~~~ 82 (288)
T cd05050 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCA--VGKP 82 (288)
T ss_pred HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEc--CCCc
Confidence 5688888888885 7765532 4678999998642 456889999999999999999997663 4456
Q ss_pred EEEEEecCC-CCHHHHHHHhhCC----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEE
Q 003542 282 FFLVMELMS-KDLSCYMRETFGS----------------RRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIY 344 (811)
Q Consensus 282 ~yLVmEy~~-g~L~~~L~~~~~~----------------~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNIL 344 (811)
+|+||||++ ++|.+++...... .....+++..++.++.||+.||.|||+++++||||||+|||
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil 162 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCL 162 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheE
Confidence 899999999 5999998753210 11134788899999999999999999999999999999999
Q ss_pred EeccCCCCcceEEEeeccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHH
Q 003542 345 LKARSMEGYFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCF 424 (811)
Q Consensus 345 I~~~g~d~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILy 424 (811)
++.++ .++|+|||++........ ........++..|+|||.+.+. .++.++|||||||++|
T Consensus 163 ~~~~~-----~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Dv~slG~il~ 223 (288)
T cd05050 163 VGENM-----VVKIADFGLSRNIYSADY-----YKASENDAIPIRWMPPESIFYN---------RYTTESDVWAYGVVLW 223 (288)
T ss_pred ecCCC-----ceEECccccceecccCcc-----ccccCCCccChhhcCHHHHhcC---------CCCchhHHHHHHHHHH
Confidence 98776 899999999875432211 0111223346679999998643 6889999999999999
Q ss_pred HHhh-CCCCCCCCccchHHHHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHH
Q 003542 425 ELLT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILR 489 (811)
Q Consensus 425 ELlt-G~~PF~~~~~~~~~i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~ 489 (811)
+|++ |..||.+... .+....+..+.....+..++..+.+||.+||..||.+|||+.++++.|+
T Consensus 224 el~~~~~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 224 EIFSYGMQPYYGMAH--EEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred HHHhCCCCCCCCCCH--HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 9997 8889976432 3445556666555567778899999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=303.02 Aligned_cols=243 Identities=21% Similarity=0.349 Sum_probs=187.0
Q ss_pred ceEEeeeecccc---eEEEEE-EcCCEEEEEEecc----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEec
Q 003542 217 KLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMEL 288 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy 288 (811)
+|.+.+.||.|+ +|++.. .+++.||+|.+.. ....+.+|+.+++.++||||+++++.+. ....+|+||||
T Consensus 10 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~--~~~~~~lv~e~ 87 (267)
T cd06645 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL--RRDKLWICMEF 87 (267)
T ss_pred HHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEE--eCCEEEEEEec
Confidence 455666677764 676653 3688999999853 3456788999999999999999998774 45679999999
Q ss_pred CCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccc
Q 003542 289 MSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTAR 367 (811)
Q Consensus 289 ~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~ 367 (811)
+++ +|.+++... ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++ .++|+|||++...
T Consensus 88 ~~~~~L~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~-----~~~l~dfg~~~~~ 156 (267)
T cd06645 88 CGGGSLQDIYHVT------GPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNG-----HVKLADFGVSAQI 156 (267)
T ss_pred cCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-----CEEECcceeeeEc
Confidence 995 888887653 5789999999999999999999999999999999999998776 8999999998755
Q ss_pred cccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHHH
Q 003542 368 TYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNI 447 (811)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i 447 (811)
.... .......|+..|+|||++... ....++.++|||||||++|+|++|..||........ .....
T Consensus 157 ~~~~-------~~~~~~~~~~~y~aPE~~~~~------~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~-~~~~~ 222 (267)
T cd06645 157 TATI-------AKRKSFIGTPYWMAPEVAAVE------RKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LFLMT 222 (267)
T ss_pred cCcc-------cccccccCcccccChhhhccc------cCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh-HHhhh
Confidence 3221 112345688999999998532 123578899999999999999999999975432211 11111
Q ss_pred HhCCCC-CC--CCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 448 RAGERP-LF--PSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 448 ~~~~~~-~~--p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
.....+ .. ...++..+.++|.+||..+|++||++++|+.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 223 KSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred ccCCCCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 111111 11 1246678999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=306.23 Aligned_cols=244 Identities=23% Similarity=0.414 Sum_probs=194.8
Q ss_pred cceEEeeeecccc---eEEEE-EEcCCEEEEEEecc----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEe
Q 003542 216 KKLMVRRRLGASS---QFKEI-QWLGDSFVLRHFYG----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVME 287 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v-~~~g~~VAVK~~~~----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmE 287 (811)
++|++.+.||.|+ +|+++ ..+|+.||||.+.. ..+.+.+|+.+++.++||||+++++.+. ....+|+|||
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e 96 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL--VGDELFVVME 96 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEe--cCceEEEEEE
Confidence 5689999999885 77766 35889999999853 3567889999999999999999997774 4567999999
Q ss_pred cCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccccc
Q 003542 288 LMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366 (811)
Q Consensus 288 y~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~ 366 (811)
|+++ +|..++.. ..+++..+..++.|++.||.|||+.|++||||||+||+++.++ .+||+|||++..
T Consensus 97 ~~~~~~L~~~~~~-------~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~-----~~kl~dfg~~~~ 164 (296)
T cd06655 97 YLAGGSLTDVVTE-------TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDG-----SVKLTDFGFCAQ 164 (296)
T ss_pred ecCCCcHHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-----CEEEccCccchh
Confidence 9985 77777653 4689999999999999999999999999999999999998776 899999999876
Q ss_pred ccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHH
Q 003542 367 RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKN 446 (811)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~ 446 (811)
...... ......++..|+|||.+.+. .++.++|||||||++|+|++|+.||.+...... + ..
T Consensus 165 ~~~~~~-------~~~~~~~~~~y~aPE~~~~~---------~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~-~-~~ 226 (296)
T cd06655 165 ITPEQS-------KRSTMVGTPYWMAPEVVTRK---------AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-L-YL 226 (296)
T ss_pred cccccc-------cCCCcCCCccccCcchhcCC---------CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-H-HH
Confidence 543211 11234678899999998643 577899999999999999999999977543222 2 22
Q ss_pred HHhCCC--CCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHHH
Q 003542 447 IRAGER--PLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIK 492 (811)
Q Consensus 447 i~~~~~--~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~ 492 (811)
+..... ...+..+++.+.+||.+||..||.+||++.+|+. .+++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~-~~~~~ 273 (296)
T cd06655 227 IATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ-HPFLK 273 (296)
T ss_pred HHhcCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh-ChHhh
Confidence 222222 2345667888999999999999999999999986 44443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=302.06 Aligned_cols=253 Identities=25% Similarity=0.423 Sum_probs=196.9
Q ss_pred hcceEEeeeecccc---eEEEEEE------cCCEEEEEEecc-----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCC
Q 003542 215 LKKLMVRRRLGASS---QFKEIQW------LGDSFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKK 280 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~~------~g~~VAVK~~~~-----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~ 280 (811)
.++|++.+.||+|+ ||++... .+..||+|.+.. ....+.+|+.+++.++||||+++++.+. +..
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~ 82 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVS--KGQ 82 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc--CCC
Confidence 46799999999986 6765422 245899999853 2345788999999999999999997763 445
Q ss_pred eEEEEEecCC-CCHHHHHHHhhCC----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcce
Q 003542 281 EFFLVMELMS-KDLSCYMRETFGS----RRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFH 355 (811)
Q Consensus 281 ~~yLVmEy~~-g~L~~~L~~~~~~----~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~ 355 (811)
..|+||||++ |+|.+++...... .....+++..+..++.||+.||.|||+++|+||||||+|||++.++ .
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~-----~ 157 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDF-----T 157 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCC-----c
Confidence 6899999998 5999999763211 1123456778899999999999999999999999999999998766 8
Q ss_pred EEEeeccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CCCCCC
Q 003542 356 VKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFE 434 (811)
Q Consensus 356 vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~~PF~ 434 (811)
++|+|||+++....... ........++..|+|||.+.+. .++.++|||||||++|||++ |..||.
T Consensus 158 ~~L~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~~pE~~~~~---------~~~~~~DvwslG~~l~el~~~~~~p~~ 223 (288)
T cd05061 158 VKIGDFGMTRDIYETDY-----YRKGGKGLLPVRWMAPESLKDG---------VFTTSSDMWSFGVVLWEITSLAEQPYQ 223 (288)
T ss_pred EEECcCCcccccccccc-----ccccCCCcccccccCHHHhccC---------CCChHhHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999875432211 0111223456779999998643 67889999999999999998 889997
Q ss_pred CCccchHHHHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHH
Q 003542 435 DGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRY 490 (811)
Q Consensus 435 ~~~~~~~~i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~ 490 (811)
+.. ...+...+..+..+..+..+++.+.+++.+||+.||.+|||+.++++.|..
T Consensus 224 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~ 277 (288)
T cd05061 224 GLS--NEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD 277 (288)
T ss_pred CCC--HHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 643 334555566665666677888999999999999999999999999876654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=298.64 Aligned_cols=244 Identities=25% Similarity=0.447 Sum_probs=192.6
Q ss_pred eEEeeeecccc---eEEEEE-EcCCEEEEEEecc-------------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCC
Q 003542 218 LMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG-------------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKK 280 (811)
Q Consensus 218 ~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~-------------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~ 280 (811)
|.+...||.|+ +|.+.. .+++.||+|.+.. ..+.+.+|+.++++++||||+++++.+. +..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~ 79 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSL--DAD 79 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE--eCC
Confidence 55666777775 777663 4688999998842 1256889999999999999999997764 345
Q ss_pred eEEEEEecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEe
Q 003542 281 EFFLVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVS 359 (811)
Q Consensus 281 ~~yLVmEy~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~ 359 (811)
.+++||||+++ +|.+++... ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++ .++|+
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~------~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~-----~~~l~ 148 (267)
T cd06628 80 HLNIFLEYVPGGSVAALLNNY------GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKG-----GIKIS 148 (267)
T ss_pred ccEEEEEecCCCCHHHHHHhc------cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCC-----CEEec
Confidence 78999999985 888888753 5688999999999999999999999999999999999998766 89999
Q ss_pred eccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccc
Q 003542 360 GFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQ 439 (811)
Q Consensus 360 DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~ 439 (811)
|||+++........... ........|+..|+|||.+.+. .++.++|||||||++|+|++|..||.+....
T Consensus 149 dfg~~~~~~~~~~~~~~-~~~~~~~~~~~~y~~pe~~~~~---------~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 218 (267)
T cd06628 149 DFGISKKLEANSLSTKT-NGARPSLQGSVFWMAPEVVKQT---------SYTRKADIWSLGCLVVEMLTGKHPFPDCTQL 218 (267)
T ss_pred ccCCCcccccccccCCc-cccccccCCCcCccChhHhccC---------CCCchhhhHHHHHHHHHHhhCCCCCCCccHH
Confidence 99998766532111000 1111234578899999998643 5678999999999999999999999864322
Q ss_pred hHHHHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 440 GDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 440 ~~~i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
.....+.....+..+...+..+.++|.+||+.||.+||++.+|++
T Consensus 219 --~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 219 --QAIFKIGENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred --HHHHHHhccCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 222333445556677788999999999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=303.65 Aligned_cols=244 Identities=23% Similarity=0.350 Sum_probs=188.0
Q ss_pred eEEeeeecccc---eEEEEEE-cCCEEEEEEecc----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEecC
Q 003542 218 LMVRRRLGASS---QFKEIQW-LGDSFVLRHFYG----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELM 289 (811)
Q Consensus 218 ~~i~~~lG~G~---vyk~v~~-~g~~VAVK~~~~----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~ 289 (811)
|++.+.||.|+ +|++... ++..+|+|.+.. ..+.+.+|+.+++.++||||+++++.+. ....+|+||||+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~--~~~~~~~v~e~~ 84 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY--YENNLWILIEFC 84 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEe--eCCEEEEEEEec
Confidence 45556677764 6665533 678899999853 3567889999999999999999997774 356799999999
Q ss_pred CC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccccccc
Q 003542 290 SK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTART 368 (811)
Q Consensus 290 ~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~ 368 (811)
++ +|..++... ...+++..+..++.||+.||.|||+.|++||||||+|||++.++ .+||+|||++....
T Consensus 85 ~~~~l~~~~~~~-----~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~-----~~kl~dfg~~~~~~ 154 (282)
T cd06643 85 AGGAVDAVMLEL-----ERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDG-----DIKLADFGVSAKNT 154 (282)
T ss_pred CCCcHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCC-----CEEEcccccccccc
Confidence 95 666666532 25689999999999999999999999999999999999998776 89999999986543
Q ss_pred ccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHHHH
Q 003542 369 YASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIR 448 (811)
Q Consensus 369 ~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i~ 448 (811)
... .......++..|+|||++...... ...++.++|||||||++|+|++|.+||...... .....+.
T Consensus 155 ~~~-------~~~~~~~~~~~y~aPE~~~~~~~~----~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~~~~~ 221 (282)
T cd06643 155 RTI-------QRRDSFIGTPYWMAPEVVMCETSK----DRPYDYKADVWSLGITLIEMAQIEPPHHELNPM--RVLLKIA 221 (282)
T ss_pred ccc-------cccccccccccccCHhhccccCCC----CCCCCccchhhhHHHHHHHHccCCCCccccCHH--HHHHHHh
Confidence 221 112345688899999998632111 235788999999999999999999999764422 2222233
Q ss_pred hCCC--CCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 449 AGER--PLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 449 ~~~~--~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
.... ...+..++..+.+||.+||+.||.+||++.++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 222 KSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred hcCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 2222 2345567889999999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=304.49 Aligned_cols=242 Identities=19% Similarity=0.262 Sum_probs=188.5
Q ss_pred eEEeeeecccc---eEEEE-EEcCCEEEEEEeccc-------HHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEE
Q 003542 218 LMVRRRLGASS---QFKEI-QWLGDSFVLRHFYGE-------LESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVM 286 (811)
Q Consensus 218 ~~i~~~lG~G~---vyk~v-~~~g~~VAVK~~~~~-------~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVm 286 (811)
|++.+.||+|+ ||.+. ..+++.||||.+... ...+.+|+.+++.++|+||+.+++.+. +...+|+||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~--~~~~~~lv~ 79 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYE--TKDALCLVL 79 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEe--cCCEEEEEE
Confidence 55666777764 66655 347899999998531 245778999999999999999987773 456799999
Q ss_pred ecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccc
Q 003542 287 ELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365 (811)
Q Consensus 287 Ey~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~ 365 (811)
||++| +|.+++... ....+++..+..++.|++.||.|||+.||+||||||+||+++.++ .++|+|||++.
T Consensus 80 e~~~g~~L~~~l~~~----~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~-----~~~l~Dfg~~~ 150 (285)
T cd05630 80 TLMNGGDLKFHIYHM----GEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHG-----HIRISDLGLAV 150 (285)
T ss_pred EecCCCcHHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCC-----CEEEeecccee
Confidence 99985 888887543 124589999999999999999999999999999999999998776 89999999986
Q ss_pred cccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccch-HHHH
Q 003542 366 ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQG-DKMT 444 (811)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~-~~i~ 444 (811)
...... ......|+..|+|||++.+. .++.++||||||+++|+|++|..||....... ....
T Consensus 151 ~~~~~~--------~~~~~~g~~~y~aPE~~~~~---------~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~ 213 (285)
T cd05630 151 HVPEGQ--------TIKGRVGTVGYMAPEVVKNE---------RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV 213 (285)
T ss_pred ecCCCc--------cccCCCCCccccChHHHcCC---------CCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHH
Confidence 543221 11244689999999999643 67889999999999999999999997643221 1111
Q ss_pred HHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCC-----HHHHHHH
Q 003542 445 KNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPS-----FSSICRI 487 (811)
Q Consensus 445 ~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS-----~~eIl~~ 487 (811)
..+.......++..+++.+.+|+.+||+.||.+||| +.+++++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 214 ERLVKEVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred HhhhhhhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 222222233456678889999999999999999999 8888773
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=300.50 Aligned_cols=249 Identities=24% Similarity=0.373 Sum_probs=191.2
Q ss_pred ceEEeeeecccc---eEEEEE-EcCCEEEEEEecc---cHHHHHHHHHHHHhC-CCCccceeeeeEEccC----CCeEEE
Q 003542 217 KLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG---ELESLNAEISTMLSL-SHPNIVQYLCGFCDEE----KKEFFL 284 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~---~~~~~~~Ei~iL~~L-~HPNIVkl~~~~~~e~----~~~~yL 284 (811)
.|++.+.||.|+ +|++.. .+++.||+|.+.. ....+..|+.++..+ +||||+++++.+.... ...+|+
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~i 86 (272)
T cd06637 7 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWL 86 (272)
T ss_pred hhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEE
Confidence 455666677764 777653 3788999999853 356789999999999 7999999998776432 246899
Q ss_pred EEecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccc
Q 003542 285 VMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGL 363 (811)
Q Consensus 285 VmEy~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGl 363 (811)
||||+++ +|.+++... ....+++..+..++.|++.||.|||+++|+||||||+||+++.++ .++|+|||+
T Consensus 87 v~e~~~~~~L~~~l~~~----~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~-----~~~l~Dfg~ 157 (272)
T cd06637 87 VMEFCGAGSVTDLIKNT----KGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENA-----EVKLVDFGV 157 (272)
T ss_pred EEEcCCCCcHHHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCC-----CEEEccCCC
Confidence 9999995 888888753 224689999999999999999999999999999999999998776 899999999
Q ss_pred cccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHH
Q 003542 364 STARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKM 443 (811)
Q Consensus 364 A~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i 443 (811)
+....... .......|++.|+|||++.+... ....++.++|||||||++|+|++|..||........ .
T Consensus 158 ~~~~~~~~-------~~~~~~~g~~~y~aPE~~~~~~~----~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~-~ 225 (272)
T cd06637 158 SAQLDRTV-------GRRNTFIGTPYWMAPEVIACDEN----PDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA-L 225 (272)
T ss_pred ceeccccc-------ccCCcccccccccCHhHhccccC----cCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHH-H
Confidence 87653321 12234568889999999864321 123678899999999999999999999975432221 1
Q ss_pred HHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 444 TKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 444 ~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
............+..++..+.+|+.+||..||.+|||+.++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 226 FLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred HHHhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 1111222222334567889999999999999999999999876
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=300.33 Aligned_cols=247 Identities=20% Similarity=0.395 Sum_probs=191.0
Q ss_pred ceEEeeeecccc---eEEEEE-EcCCEEEEEEeccc-----HHHHHHHHHH-HHhCCCCccceeeeeEEccCCCeEEEEE
Q 003542 217 KLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYGE-----LESLNAEIST-MLSLSHPNIVQYLCGFCDEEKKEFFLVM 286 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~~-----~~~~~~Ei~i-L~~L~HPNIVkl~~~~~~e~~~~~yLVm 286 (811)
+|++.+.||.|+ ||++.. .+|+.||||.+... ...+..|+.+ ++.++||||+++++.+. ....+|+||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~--~~~~~~lv~ 79 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALF--REGDVWICM 79 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEe--cCCcEEEEh
Confidence 688888899886 777663 37999999998532 3455667665 56668999999997774 445699999
Q ss_pred ecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcEEEeccCCCCcceEEEeeccccc
Q 003542 287 ELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQ-KIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365 (811)
Q Consensus 287 Ey~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~-gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~ 365 (811)
||++|+|.+++..... ....+++..++.++.||+.||.|||++ +++||||||+|||++.++ .+||+|||++.
T Consensus 80 e~~~~~l~~~l~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~-----~~kl~dfg~~~ 152 (283)
T cd06617 80 EVMDTSLDKFYKKVYD--KGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNG-----QVKLCDFGISG 152 (283)
T ss_pred hhhcccHHHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC-----CEEEeeccccc
Confidence 9999999888876432 225789999999999999999999997 999999999999998876 89999999987
Q ss_pred cccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHH
Q 003542 366 ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTK 445 (811)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~ 445 (811)
...... ......++..|+|||++.+.. ....++.++|+|||||++|+|++|..||.........+ .
T Consensus 153 ~~~~~~--------~~~~~~~~~~y~aPE~~~~~~-----~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~-~ 218 (283)
T cd06617 153 YLVDSV--------AKTIDAGCKPYMAPERINPEL-----NQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQL-K 218 (283)
T ss_pred cccccc--------ccccccCCccccChhhcCCcc-----cccccCccccchhhHHHHHHHHhCCCCCCccccCHHHH-H
Confidence 543211 112345788899999986431 12357889999999999999999999997533222222 2
Q ss_pred HHHhCCCCCCC-CCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 446 NIRAGERPLFP-SGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 446 ~i~~~~~~~~p-~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
.+..+..+.++ ..++.++.++|.+||..+|.+||++.+++.
T Consensus 219 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 219 QVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred HHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 33334334444 356889999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=309.26 Aligned_cols=247 Identities=16% Similarity=0.288 Sum_probs=189.7
Q ss_pred cceEEeeeecccc---eEEEEE-EcCCEEEEEEecc-------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEE
Q 003542 216 KKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG-------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFL 284 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~-------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yL 284 (811)
++|++.+.||+|+ ||++.. .+++.||+|.+.. ....+..|+.++..++||||+++++.+ ++...+|+
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~--~~~~~~~l 78 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAF--QDENNLYL 78 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEE--ecCCEEEE
Confidence 3688899999986 565543 3678999999853 234578899999999999999999777 45567999
Q ss_pred EEecCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccc
Q 003542 285 VMELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGL 363 (811)
Q Consensus 285 VmEy~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGl 363 (811)
||||++ |+|.+++... ...+++..+..++.||+.||.|||+.||+||||||+|||++.++ .+||+|||+
T Consensus 79 v~ey~~~g~L~~~l~~~-----~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~-----~~kL~DfG~ 148 (332)
T cd05623 79 VMDYYVGGDLLTLLSKF-----EDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNG-----HIRLADFGS 148 (332)
T ss_pred EEeccCCCcHHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCC-----CEEEeecch
Confidence 999998 5899998753 24689999999999999999999999999999999999998776 899999999
Q ss_pred cccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHH
Q 003542 364 STARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKM 443 (811)
Q Consensus 364 A~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i 443 (811)
+....... ........||+.|+|||++..... ....++.++|||||||++|||++|+.||..... ...
T Consensus 149 a~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~----~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~--~~~ 216 (332)
T cd05623 149 CLKLMEDG------TVQSSVAVGTPDYISPEILQAMED----GKGKYGPECDWWSLGVCMYEMLYGETPFYAESL--VET 216 (332)
T ss_pred heecccCC------cceecccccCccccCHHHHhcccc----CCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH--HHH
Confidence 86543221 111224568999999999974211 123678899999999999999999999986532 233
Q ss_pred HHHHHhCC-CCCCC---CCChHHHHHHHhhhccCCCCC--CCCHHHHHH
Q 003542 444 TKNIRAGE-RPLFP---SGSPKYLVNLTKKCWHTNPSQ--RPSFSSICR 486 (811)
Q Consensus 444 ~~~i~~~~-~~~~p---~~~~~~l~~LI~~cL~~DP~~--RPS~~eIl~ 486 (811)
...+.... ...+| ..+++.+.+||.+||..++.. |+++.++++
T Consensus 217 ~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~ 265 (332)
T cd05623 217 YGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQ 265 (332)
T ss_pred HHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhC
Confidence 33443322 22233 457889999999999765544 688888875
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=295.70 Aligned_cols=240 Identities=30% Similarity=0.554 Sum_probs=194.8
Q ss_pred cceEEeeeecccc---eEEEEEEcCCEEEEEEecc--cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEecCC
Q 003542 216 KKLMVRRRLGASS---QFKEIQWLGDSFVLRHFYG--ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMS 290 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~~~g~~VAVK~~~~--~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~~ 290 (811)
++|++.+.||+|+ +|.+ ...++.||+|.+.. ..+.+.+|+.+++.++||||+++++.+.. ..+|+||||+.
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~-~~~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---~~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQG-EYTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH---NGLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEec-ccCCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcC---CCcEEEEECCC
Confidence 5788899999985 6653 46889999999864 34678999999999999999999976642 23799999999
Q ss_pred -CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccccc
Q 003542 291 -KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTY 369 (811)
Q Consensus 291 -g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~ 369 (811)
++|.+++... ....+++..++.++.|++.||.|||+.|++||||||+||+++.++ .+||+|||++.....
T Consensus 82 ~~~L~~~l~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~-----~~kl~Dfg~~~~~~~ 152 (254)
T cd05083 82 KGNLVNFLRTR----GRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDG-----VAKVSDFGLARVGSM 152 (254)
T ss_pred CCCHHHHHHhc----CcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCC-----cEEECCCccceeccc
Confidence 5999988753 224588999999999999999999999999999999999998776 899999999865422
Q ss_pred cCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CCCCCCCCccchHHHHHHHH
Q 003542 370 ASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGDKMTKNIR 448 (811)
Q Consensus 370 ~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~~PF~~~~~~~~~i~~~i~ 448 (811)
.. .....+..|+|||.+.+ ..++.++|+||||+++|+|++ |.+||..... ......+.
T Consensus 153 ~~----------~~~~~~~~y~~pe~~~~---------~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~ 211 (254)
T cd05083 153 GV----------DNSKLPVKWTAPEALKH---------KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL--KEVKECVE 211 (254)
T ss_pred cC----------CCCCCCceecCHHHhcc---------CCcCchhhHHHHHHHHHHHHhCCCCCCccCCH--HHHHHHHh
Confidence 11 12234567999999864 367889999999999999997 9999976543 33445555
Q ss_pred hCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHH
Q 003542 449 AGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILR 489 (811)
Q Consensus 449 ~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~ 489 (811)
.+..+..+..++..+.+++.+||+.+|.+||++++++..|+
T Consensus 212 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 212 KGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred CCCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence 56555556778899999999999999999999999988664
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=325.79 Aligned_cols=239 Identities=26% Similarity=0.384 Sum_probs=200.6
Q ss_pred eecccc---eEEEE-EEcCCEEEEEEecc----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEecCCC-CH
Q 003542 223 RLGASS---QFKEI-QWLGDSFVLRHFYG----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DL 293 (811)
Q Consensus 223 ~lG~G~---vyk~v-~~~g~~VAVK~~~~----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~~g-~L 293 (811)
.||+|+ ||-+. +.+...+|||-+.. ..+.+..||.+.++|+|.|||+|++.+ .+++++-|.||-++| +|
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~--senGf~kIFMEqVPGGSL 659 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSV--SENGFFKIFMEQVPGGSL 659 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhcc--CCCCeEEEEeecCCCCcH
Confidence 467774 44444 33666899999953 467799999999999999999999775 456688999999995 89
Q ss_pred HHHHHHhhCCCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccccccC
Q 003542 294 SCYMRETFGSRRRNSF--SLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYAS 371 (811)
Q Consensus 294 ~~~L~~~~~~~~~~~l--s~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~~ 371 (811)
.+.|+... +++ .+..+-.|..||++||.|||.+.|||||||-+|+||+.-.. .+||+|||-++.+....
T Consensus 660 SsLLrskW-----GPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySG----vlKISDFGTsKRLAgin 730 (1226)
T KOG4279|consen 660 SSLLRSKW-----GPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSG----VLKISDFGTSKRLAGIN 730 (1226)
T ss_pred HHHHHhcc-----CCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccc----eEEecccccchhhccCC
Confidence 99998754 345 77889999999999999999999999999999999976432 89999999998876543
Q ss_pred CCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHHHHhCC
Q 003542 372 RNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGE 451 (811)
Q Consensus 372 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i~~~~ 451 (811)
+...+..||..|||||++... ...|+.++|||||||++.||+||++||.........+++.-.-..
T Consensus 731 -------P~TETFTGTLQYMAPEvIDqG-------~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKv 796 (1226)
T KOG4279|consen 731 -------PCTETFTGTLQYMAPEVIDQG-------PRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKV 796 (1226)
T ss_pred -------ccccccccchhhhChHhhccC-------CcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceec
Confidence 234577899999999999753 457999999999999999999999999876666666666655667
Q ss_pred CCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 452 RPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 452 ~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
.|++|...+.+.+.+|.+|+..||.+||++.+++.
T Consensus 797 HP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 797 HPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 78899999999999999999999999999999875
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=327.56 Aligned_cols=250 Identities=17% Similarity=0.260 Sum_probs=186.9
Q ss_pred hcceEEeeeecccc---eEEEEE-EcCCEEEEEEecc---cHHHHHHHHHHHHhCCC------CccceeeeeEEccCCCe
Q 003542 215 LKKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG---ELESLNAEISTMLSLSH------PNIVQYLCGFCDEEKKE 281 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~---~~~~~~~Ei~iL~~L~H------PNIVkl~~~~~~e~~~~ 281 (811)
..+|++.+.||.|+ ||++.. ..++.||||++.. ....+..|+.++..++| ++|+++++.|. .+..+
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~-~~~~~ 206 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ-NETGH 206 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE-cCCce
Confidence 46899999999986 777664 4688999999964 23456778888887755 45888876654 34567
Q ss_pred EEEEEecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEeccCC----------
Q 003542 282 FFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHA-QKIYHGELNPSNIYLKARSM---------- 350 (811)
Q Consensus 282 ~yLVmEy~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs-~gIVHRDLKPsNILI~~~g~---------- 350 (811)
+|||||++.++|.+++... ..+++..+..|+.||+.||.|||+ .||+||||||+|||++.++.
T Consensus 207 ~~iv~~~~g~~l~~~l~~~------~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~ 280 (467)
T PTZ00284 207 MCIVMPKYGPCLLDWIMKH------GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRAL 280 (467)
T ss_pred EEEEEeccCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccccc
Confidence 9999999999999988753 579999999999999999999998 59999999999999986541
Q ss_pred -CCcceEEEeeccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhC
Q 003542 351 -EGYFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTG 429 (811)
Q Consensus 351 -d~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG 429 (811)
.....+||+|||++..... ......||+.|+|||++.+. .|+.++|||||||++|||++|
T Consensus 281 ~~~~~~vkl~DfG~~~~~~~----------~~~~~~gt~~Y~APE~~~~~---------~~~~~~DiwSlGvil~elltG 341 (467)
T PTZ00284 281 PPDPCRVRICDLGGCCDERH----------SRTAIVSTRHYRSPEVVLGL---------GWMYSTDMWSMGCIIYELYTG 341 (467)
T ss_pred CCCCceEEECCCCccccCcc----------ccccccCCccccCcHHhhcC---------CCCcHHHHHHHHHHHHHHHhC
Confidence 0123599999998753211 22356789999999999754 688999999999999999999
Q ss_pred CCCCCCCccchHHHHHHHHh--CC------------------------CCCC-C--------------CCChHHHHHHHh
Q 003542 430 KVPFEDGHLQGDKMTKNIRA--GE------------------------RPLF-P--------------SGSPKYLVNLTK 468 (811)
Q Consensus 430 ~~PF~~~~~~~~~i~~~i~~--~~------------------------~~~~-p--------------~~~~~~l~~LI~ 468 (811)
++||.+..... ....+.. +. .+.. + ....+.+.+||.
T Consensus 342 ~~pf~~~~~~~--~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~ 419 (467)
T PTZ00284 342 KLLYDTHDNLE--HLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIY 419 (467)
T ss_pred CCCCCCCChHH--HHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHH
Confidence 99997643211 1111110 00 0000 0 011345779999
Q ss_pred hhccCCCCCCCCHHHHHHHHHHHHH
Q 003542 469 KCWHTNPSQRPSFSSICRILRYIKK 493 (811)
Q Consensus 469 ~cL~~DP~~RPS~~eIl~~L~~i~k 493 (811)
+||..||.+|||+.++++ +.+|.+
T Consensus 420 ~mL~~dP~~R~ta~e~L~-Hp~~~~ 443 (467)
T PTZ00284 420 GLLHYDRQKRLNARQMTT-HPYVLK 443 (467)
T ss_pred HhCCcChhhCCCHHHHhc-Cccccc
Confidence 999999999999999987 444444
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=296.50 Aligned_cols=244 Identities=23% Similarity=0.385 Sum_probs=191.4
Q ss_pred cceEEeeeecccc---eEEEEE-EcCCEEEEEEecc----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEe
Q 003542 216 KKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVME 287 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmE 287 (811)
++|++.+.+|.|+ +|.+.. .+++.+|+|.+.. ..+.+.+|+.++++++||||+++++.+. ....+|++||
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~--~~~~~~l~~e 80 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL--RRDKLWIVME 80 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEE--eCCEEEEEEe
Confidence 5788999999985 666553 3678999999853 3577899999999999999999997773 4567999999
Q ss_pred cCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccccc
Q 003542 288 LMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366 (811)
Q Consensus 288 y~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~ 366 (811)
|+++ +|.+++... ...+++..+..++.|++.||.|||+++++||||+|+||+++.++ .+||+|||++..
T Consensus 81 ~~~~~~l~~~~~~~-----~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~-----~~~l~d~g~~~~ 150 (262)
T cd06613 81 YCGGGSLQDIYQVT-----RGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDG-----DVKLADFGVSAQ 150 (262)
T ss_pred CCCCCcHHHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCC-----CEEECccccchh
Confidence 9996 788777652 25689999999999999999999999999999999999998776 799999999876
Q ss_pred ccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHH
Q 003542 367 RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKN 446 (811)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~ 446 (811)
..... .......++..|+|||.+.+.. ...++.++||||||+++|+|++|.+||.+...... . ..
T Consensus 151 ~~~~~-------~~~~~~~~~~~y~~Pe~~~~~~------~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~-~-~~ 215 (262)
T cd06613 151 LTATI-------AKRKSFIGTPYWMAPEVAAVER------KGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA-L-FL 215 (262)
T ss_pred hhhhh-------hccccccCCccccCchhhcccc------cCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-H-HH
Confidence 54321 1122456788899999986431 12677899999999999999999999986543322 1 11
Q ss_pred HHhC-CCC---CCCCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 447 IRAG-ERP---LFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 447 i~~~-~~~---~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
+... ..+ ..+...+..+.+++.+||..+|..||++.+|+.
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 216 ISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred HHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 2222 111 123345678999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=294.04 Aligned_cols=241 Identities=24% Similarity=0.361 Sum_probs=195.6
Q ss_pred ceEEeeeecccc---eEEEEE-EcCCEEEEEEecc------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEE
Q 003542 217 KLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVM 286 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVm 286 (811)
+|++.+.||.|+ +|.+.. .+++.||||.+.. ....+.+|+.+|+.++||||+++++.+. ....+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~lv~ 78 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFL--EDKALMIVM 78 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEe--cCCEEEEEE
Confidence 578889999885 565542 4788999999843 3567899999999999999999997774 456799999
Q ss_pred ecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccc
Q 003542 287 ELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365 (811)
Q Consensus 287 Ey~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~ 365 (811)
||+++ +|.+++... ....+++..+..++.|++.||.|||++|++||||+|+||+++.++. .+||+|||++.
T Consensus 79 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~----~~~l~d~~~~~ 150 (256)
T cd08220 79 EYAPGGTLAEYIQKR----CNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKM----VVKIGDFGISK 150 (256)
T ss_pred ecCCCCCHHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC----EEEEccCCCce
Confidence 99985 899988763 1245899999999999999999999999999999999999975531 78999999987
Q ss_pred cccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHH
Q 003542 366 ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTK 445 (811)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~ 445 (811)
...... ......++..|+|||.+.+. .++.++||||||+++|+|++|..||...... ....
T Consensus 151 ~~~~~~--------~~~~~~~~~~y~aPE~~~~~---------~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~--~~~~ 211 (256)
T cd08220 151 ILSSKS--------KAYTVVGTPCYISPELCEGK---------PYNQKSDIWALGCVLYELASLKRAFEAANLP--ALVL 211 (256)
T ss_pred ecCCCc--------cccccccCCcccCchhccCC---------CCCcccchHHHHHHHHHHHhCCCCcccCchH--HHHH
Confidence 654321 11234678899999998643 5778999999999999999999999765432 3344
Q ss_pred HHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 446 NIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 446 ~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
.+..+.....+..++..+.+++.+||..+|.+|||+.+++.
T Consensus 212 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 212 KIMSGTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred HHHhcCCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 44555555567778899999999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=294.78 Aligned_cols=238 Identities=26% Similarity=0.454 Sum_probs=187.6
Q ss_pred cccceEEEEEEc--C--CEEEEEEecc-----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEecCC-CCHH
Q 003542 225 GASSQFKEIQWL--G--DSFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMS-KDLS 294 (811)
Q Consensus 225 G~G~vyk~v~~~--g--~~VAVK~~~~-----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~~-g~L~ 294 (811)
|.|.+|++.... + ..||||.+.. ..+.+.+|+.++++++||||+++++.+.. ..+++||||++ ++|.
T Consensus 7 ~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~e~~~~~~L~ 83 (257)
T cd05040 7 SFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT---HPLMMVTELAPLGSLL 83 (257)
T ss_pred CcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC---CeEEEEEEecCCCcHH
Confidence 334488876432 3 3699999964 24578999999999999999999977743 67899999998 5999
Q ss_pred HHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccccccCCCC
Q 003542 295 CYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNT 374 (811)
Q Consensus 295 ~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~~~~~ 374 (811)
+++.... ...+++..++.++.|++.||.|||++|++||||||+||+++.++ .+||+|||++.........
T Consensus 84 ~~l~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~-----~~kl~dfg~~~~~~~~~~~- 153 (257)
T cd05040 84 DRLRKDA----LGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDD-----KVKIGDFGLMRALPQNEDH- 153 (257)
T ss_pred HHHHhcc----cccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCC-----EEEeccccccccccccccc-
Confidence 9987641 14689999999999999999999999999999999999998876 8999999999876432211
Q ss_pred CCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CCCCCCCCccchHHHHHHHH-hCCC
Q 003542 375 PPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGDKMTKNIR-AGER 452 (811)
Q Consensus 375 ~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~~PF~~~~~~~~~i~~~i~-~~~~ 452 (811)
........++..|+|||++.+. .++.++|||||||++|+|++ |..||...... .+...+. ....
T Consensus 154 ---~~~~~~~~~~~~y~~pE~~~~~---------~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~~~~~~ 219 (257)
T cd05040 154 ---YVMEEHLKVPFAWCAPESLRTR---------TFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS--QILKKIDKEGER 219 (257)
T ss_pred ---eecccCCCCCceecCHHHhccc---------CcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHhcCCc
Confidence 1111234567889999998643 67889999999999999998 99999754322 2333333 3334
Q ss_pred CCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHH
Q 003542 453 PLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILR 489 (811)
Q Consensus 453 ~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~ 489 (811)
...+...+..+.+++.+||..+|.+||++.+++..|.
T Consensus 220 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 220 LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 4456677889999999999999999999999988663
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=344.99 Aligned_cols=245 Identities=20% Similarity=0.319 Sum_probs=204.4
Q ss_pred hcceEEeeeecccceEEEEE-----EcCCEEEEEEecc-------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeE
Q 003542 215 LKKLMVRRRLGASSQFKEIQ-----WLGDSFVLRHFYG-------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEF 282 (811)
Q Consensus 215 ~k~~~i~~~lG~G~vyk~v~-----~~g~~VAVK~~~~-------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~ 282 (811)
..+|.+++.||+| .|+++. .+++.||+|++++ +..-|..|-.+|..-+.+.|+.++++| ++..++
T Consensus 74 ~~DfeilKvIGrG-aFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF--QD~~~L 150 (1317)
T KOG0612|consen 74 AEDFEILKVIGRG-AFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAF--QDERYL 150 (1317)
T ss_pred HHhhHHHHHhccc-ccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh--cCccce
Confidence 3578899999999 677772 3789999999964 456689999999999999999999999 667789
Q ss_pred EEEEecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeec
Q 003542 283 FLVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGF 361 (811)
Q Consensus 283 yLVmEy~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DF 361 (811)
|+|||||+| ||...|-+. ..+++..+++|+..|+.||.-||+.|+|||||||+|||||..| ++||+||
T Consensus 151 YlVMdY~pGGDlltLlSk~------~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~G-----HikLADF 219 (1317)
T KOG0612|consen 151 YLVMDYMPGGDLLTLLSKF------DRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSG-----HIKLADF 219 (1317)
T ss_pred EEEEecccCchHHHHHhhc------CCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccC-----cEeeccc
Confidence 999999995 898888754 4799999999999999999999999999999999999999998 9999999
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchH
Q 003542 362 GLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGD 441 (811)
Q Consensus 362 GlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~ 441 (811)
|.|..+.... .......+|||.|++||+|.....+ .+.|+..+|+||+||++|||++|..||+..+..
T Consensus 220 GsClkm~~dG------~V~s~~aVGTPDYISPEvLqs~~~~----~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslv-- 287 (1317)
T KOG0612|consen 220 GSCLKMDADG------TVRSSVAVGTPDYISPEVLQSQGDG----KGEYGRECDWWSLGVFMYEMLYGETPFYADSLV-- 287 (1317)
T ss_pred hhHHhcCCCC------cEEeccccCCCCccCHHHHHhhcCC----ccccCCccchhhhHHHHHHHHcCCCcchHHHHH--
Confidence 9997776443 2345678999999999999876432 468999999999999999999999999876543
Q ss_pred HHHHHHHh-CCCCCCC--CCChHHHHHHHhhhccCCCCCCCC---HHHHHH
Q 003542 442 KMTKNIRA-GERPLFP--SGSPKYLVNLTKKCWHTNPSQRPS---FSSICR 486 (811)
Q Consensus 442 ~i~~~i~~-~~~~~~p--~~~~~~l~~LI~~cL~~DP~~RPS---~~eIl~ 486 (811)
+.+..|.. .....|| ...++++++||.+.+. +|..|.. +++|..
T Consensus 288 eTY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 288 ETYGKIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN 337 (1317)
T ss_pred HHHHHHhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence 22333433 3344566 5689999999999885 8889888 888765
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=297.45 Aligned_cols=245 Identities=22% Similarity=0.347 Sum_probs=191.2
Q ss_pred cceEEeeeecccc---eEEEEE-EcCCEEEEEEecc---------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeE
Q 003542 216 KKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG---------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEF 282 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~---------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~ 282 (811)
.+|.+.+.||+|+ +|.+.. .+|..||||.+.. ....+.+|+.++++++||||+++++.+.+.....+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4688888888885 666553 3689999998741 24578899999999999999999977654445678
Q ss_pred EEEEecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeec
Q 003542 283 FLVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGF 361 (811)
Q Consensus 283 yLVmEy~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DF 361 (811)
|+||||+++ +|.+++... ..+++..+..++.|++.||.|||+.+++|+||||+|||++.++ .++|+||
T Consensus 82 ~~v~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~-----~~~l~Df 150 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY------GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVG-----NVKLGDF 150 (265)
T ss_pred EEEEEecCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCC-----CEEECcC
Confidence 999999985 898888753 4578899999999999999999999999999999999998776 8999999
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchH
Q 003542 362 GLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGD 441 (811)
Q Consensus 362 GlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~ 441 (811)
|++......... ........|+..|+|||++.+. .++.++||||||+++|+|++|+.||...... .
T Consensus 151 g~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-~ 216 (265)
T cd06652 151 GASKRLQTICLS----GTGMKSVTGTPYWMSPEVISGE---------GYGRKADIWSVGCTVVEMLTEKPPWAEFEAM-A 216 (265)
T ss_pred cccccccccccc----ccccccCCCCccccChhhhcCC---------CCCcchhHHHHHHHHHHHhhCCCCCCccchH-H
Confidence 998765322110 1112234588899999998643 5678999999999999999999999764322 2
Q ss_pred HHHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 442 KMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 442 ~i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
...........+..|...+..+.++|.+||. +|.+||++++|+.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 217 AIFKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred HHHHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 2222222233445566677889999999995 9999999999876
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=306.98 Aligned_cols=255 Identities=25% Similarity=0.456 Sum_probs=200.2
Q ss_pred cceEEeeeecccc---eEEEEEE--------cCCEEEEEEecc-----cHHHHHHHHHHHHhC-CCCccceeeeeEEccC
Q 003542 216 KKLMVRRRLGASS---QFKEIQW--------LGDSFVLRHFYG-----ELESLNAEISTMLSL-SHPNIVQYLCGFCDEE 278 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~~--------~g~~VAVK~~~~-----~~~~~~~Ei~iL~~L-~HPNIVkl~~~~~~e~ 278 (811)
.+|.+.+.||+|+ +|.+... .+..||+|.+.. ....+.+|+.+++++ +||||+++++.+. .
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~--~ 89 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT--Q 89 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc--c
Confidence 5788999999986 6665432 123799999863 246789999999999 7999999997663 3
Q ss_pred CCeEEEEEecCC-CCHHHHHHHhhCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEec
Q 003542 279 KKEFFLVMELMS-KDLSCYMRETFGS----------RRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKA 347 (811)
Q Consensus 279 ~~~~yLVmEy~~-g~L~~~L~~~~~~----------~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~ 347 (811)
...+|++|||++ |+|.+++...... .....+++..+..++.||+.||.|||++|++||||||+|||++.
T Consensus 90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~ 169 (334)
T cd05100 90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTE 169 (334)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcC
Confidence 456899999998 5999998763210 11235788899999999999999999999999999999999987
Q ss_pred cCCCCcceEEEeeccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHh
Q 003542 348 RSMEGYFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELL 427 (811)
Q Consensus 348 ~g~d~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELl 427 (811)
++ .+||+|||+++....... ........++..|+|||++.+. .++.++||||||+++|||+
T Consensus 170 ~~-----~~kL~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~el~ 230 (334)
T cd05100 170 DN-----VMKIADFGLARDVHNIDY-----YKKTTNGRLPVKWMAPEALFDR---------VYTHQSDVWSFGVLLWEIF 230 (334)
T ss_pred CC-----cEEECCcccceecccccc-----cccccCCCcCceEcCHHHhccC---------CcCchhhhHHHHHHHHHHH
Confidence 76 899999999876543211 0111223345679999999643 6788999999999999999
Q ss_pred h-CCCCCCCCccchHHHHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHHHH
Q 003542 428 T-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKK 493 (811)
Q Consensus 428 t-G~~PF~~~~~~~~~i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~k 493 (811)
+ |..||.+.. ...+...+..+..+..+..++..+.+|+.+||+.+|.+||++.+++..|..+..
T Consensus 231 ~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 231 TLGGSPYPGIP--VEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred hcCCCCCCCCC--HHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 8 899997643 334555666666666777888899999999999999999999999998877654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=294.10 Aligned_cols=242 Identities=21% Similarity=0.304 Sum_probs=195.7
Q ss_pred ceEEeeeecccc---eEEEE-EEcCCEEEEEEecc------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEE
Q 003542 217 KLMVRRRLGASS---QFKEI-QWLGDSFVLRHFYG------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVM 286 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v-~~~g~~VAVK~~~~------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVm 286 (811)
+|++++.||.|+ +|... ..+|+.+|+|.+.. ....+.+|+.+|++++|+||+++++.+. +...+++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~--~~~~~~~~~ 78 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFM--DDNTLLIEM 78 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEe--cCCeEEEEE
Confidence 478899999984 23322 34789999998742 3456889999999999999999998774 456799999
Q ss_pred ecCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccc
Q 003542 287 ELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365 (811)
Q Consensus 287 Ey~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~ 365 (811)
|||+ ++|.+++... ....+++..+..++.|++.||.|||+.|++||||+|+||+++.++ .+||+|||++.
T Consensus 79 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~-----~~kl~d~~~~~ 149 (256)
T cd08221 79 EYANGGTLYDKIVRQ----KGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAG-----LIKLGDFGISK 149 (256)
T ss_pred EecCCCcHHHHHHhc----cccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCC-----CEEECcCcceE
Confidence 9998 4899888753 135689999999999999999999999999999999999998776 89999999987
Q ss_pred cccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHH
Q 003542 366 ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTK 445 (811)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~ 445 (811)
....... ......+++.|+|||++.+. .++.++||||||+++|+|++|..||..... .....
T Consensus 150 ~~~~~~~-------~~~~~~~~~~y~ape~~~~~---------~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~--~~~~~ 211 (256)
T cd08221 150 ILGSEYS-------MAETVVGTPYYMSPELCQGV---------KYNFKSDIWALGCVLYELLTLKRTFDATNP--LNLVV 211 (256)
T ss_pred Ecccccc-------cccccCCCccccCHhhcCCC---------CCCCcchhHHHHHHHHHHHHCCCCCCCCCH--HHHHH
Confidence 6533221 12345688999999998643 567899999999999999999999976432 23344
Q ss_pred HHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHH
Q 003542 446 NIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRI 487 (811)
Q Consensus 446 ~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~ 487 (811)
.+..+.....+...+.++.++|.+||..+|.+||++.++++.
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 212 KIVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred HHHcCCCCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 555555555566788899999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=301.13 Aligned_cols=252 Identities=24% Similarity=0.361 Sum_probs=190.6
Q ss_pred hcceEEeeeecccc---eEEEEEE-----------------cCCEEEEEEecc-----cHHHHHHHHHHHHhCCCCccce
Q 003542 215 LKKLMVRRRLGASS---QFKEIQW-----------------LGDSFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQ 269 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~~-----------------~g~~VAVK~~~~-----~~~~~~~Ei~iL~~L~HPNIVk 269 (811)
.++|++.+.||+|+ +|.+... .+..||+|.+.. ..+.+.+|+++|.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 35678888888885 5544321 235689999864 3467889999999999999999
Q ss_pred eeeeEEccCCCeEEEEEecCC-CCHHHHHHHhhCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcE
Q 003542 270 YLCGFCDEEKKEFFLVMELMS-KDLSCYMRETFGS-----RRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNI 343 (811)
Q Consensus 270 l~~~~~~e~~~~~yLVmEy~~-g~L~~~L~~~~~~-----~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNI 343 (811)
+++.+. ....+++||||+. ++|..++...... .....+++..++.++.|++.||.|||++|++||||||+||
T Consensus 84 ~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni 161 (296)
T cd05051 84 LLGVCT--VDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC 161 (296)
T ss_pred EEEEEe--cCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence 997664 3467899999998 5899988764211 0113689999999999999999999999999999999999
Q ss_pred EEeccCCCCcceEEEeeccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHH
Q 003542 344 YLKARSMEGYFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLC 423 (811)
Q Consensus 344 LI~~~g~d~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvIL 423 (811)
+++.++ .++|+|||++........ ........+++.|+|||++.+. .++.++|||||||++
T Consensus 162 li~~~~-----~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Dv~slG~~l 222 (296)
T cd05051 162 LVGKNY-----TIKIADFGMSRNLYSSDY-----YRVQGRAPLPIRWMAWESVLLG---------KFTTKSDVWAFGVTL 222 (296)
T ss_pred eecCCC-----ceEEccccceeecccCcc-----eeecCcCCCCceecCHHHhhcC---------CCCccchhhhhHHHH
Confidence 998775 899999999875432211 1112244567789999998643 678999999999999
Q ss_pred HHHhh--CCCCCCCCccchHHHHHHHHhC-----C--CCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHH
Q 003542 424 FELLT--GKVPFEDGHLQGDKMTKNIRAG-----E--RPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILR 489 (811)
Q Consensus 424 yELlt--G~~PF~~~~~~~~~i~~~i~~~-----~--~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~ 489 (811)
|+|++ |..||..... ......+... . ....+..++.++.+|+.+||+.||.+|||+.+|++.|.
T Consensus 223 ~el~~~~~~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 223 WEILTLCREQPYEHLTD--QQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HHHHhcCCCCCCCCcCh--HHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 99998 7788865432 2222322221 1 12234566789999999999999999999999987663
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=306.43 Aligned_cols=241 Identities=21% Similarity=0.388 Sum_probs=192.8
Q ss_pred hcceEEeeeecccc---eEEEEE-EcCCEEEEEEecc----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEE
Q 003542 215 LKKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVM 286 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVm 286 (811)
.++|.+.+.||.|+ +|++.. .+|+.||+|.+.. ..+.+.+|+.+++.++||||+++++.+. ....+|+||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~--~~~~~~lv~ 95 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL--VGDELWVVM 95 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEe--cCCEEEEee
Confidence 36899999999985 777663 4799999999853 3466889999999999999999998774 456799999
Q ss_pred ecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccc
Q 003542 287 ELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365 (811)
Q Consensus 287 Ey~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~ 365 (811)
||+++ +|.+++.+ ..+++..+..++.|++.||.|||+.|++||||||+|||++.++ .++|+|||++.
T Consensus 96 e~~~~~~L~~~~~~-------~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~-----~~~l~Dfg~~~ 163 (297)
T cd06656 96 EYLAGGSLTDVVTE-------TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDG-----SVKLTDFGFCA 163 (297)
T ss_pred cccCCCCHHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-----CEEECcCccce
Confidence 99985 88888764 4578899999999999999999999999999999999998776 89999999987
Q ss_pred cccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHH
Q 003542 366 ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTK 445 (811)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~ 445 (811)
....... ......+++.|+|||.+.+. .++.++|||||||++|+|++|..||........ ...
T Consensus 164 ~~~~~~~-------~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~-~~~ 226 (297)
T cd06656 164 QITPEQS-------KRSTMVGTPYWMAPEVVTRK---------AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LYL 226 (297)
T ss_pred EccCCcc-------CcCcccCCccccCHHHHcCC---------CCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh-eee
Confidence 5433211 12234678899999998643 577899999999999999999999976443211 111
Q ss_pred HHHhCC-CCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 446 NIRAGE-RPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 446 ~i~~~~-~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
....+. ....+...+..+.+|+.+||..+|.+||++.++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 227 IATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred eccCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111111 12245567788999999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=329.05 Aligned_cols=250 Identities=25% Similarity=0.445 Sum_probs=209.7
Q ss_pred ceEEeeeecccc---eEEEEEE-c---CCEEEEEEecc-----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEE
Q 003542 217 KLMVRRRLGASS---QFKEIQW-L---GDSFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFL 284 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v~~-~---g~~VAVK~~~~-----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yL 284 (811)
...+.+.||.|. |+++.+. . ...||||.++. +..+|+.|+.||-+++||||+++.++. ...+.+.|
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVV--Tks~PvMI 707 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVV--TKSKPVMI 707 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEE--ecCceeEE
Confidence 456777889884 4443322 2 34799999973 567899999999999999999998666 34567999
Q ss_pred EEecCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccc
Q 003542 285 VMELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGL 363 (811)
Q Consensus 285 VmEy~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGl 363 (811)
|+|||+ |+|..||+++ ++.|+..+..-+++.|+.||.||-+.|+|||||-..||||+.+ +.+|++||||
T Consensus 708 iTEyMENGsLDsFLR~~-----DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsn-----LvCKVsDFGL 777 (996)
T KOG0196|consen 708 ITEYMENGSLDSFLRQN-----DGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSN-----LVCKVSDFGL 777 (996)
T ss_pred EhhhhhCCcHHHHHhhc-----CCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccc-----eEEEeccccc
Confidence 999999 7999999975 3669999999999999999999999999999999999999655 4999999999
Q ss_pred cccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CCCCCCCCccchHH
Q 003542 364 STARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGDK 442 (811)
Q Consensus 364 A~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~~PF~~~~~~~~~ 442 (811)
++.+..... .........-+..|.|||.+... +++.++|||||||+|||.++ |..||.+. .+.+
T Consensus 778 SRvledd~~----~~ytt~GGKIPiRWTAPEAIa~R---------KFTsASDVWSyGIVmWEVmSyGERPYWdm--SNQd 842 (996)
T KOG0196|consen 778 SRVLEDDPE----AAYTTLGGKIPIRWTAPEAIAYR---------KFTSASDVWSYGIVMWEVMSYGERPYWDM--SNQD 842 (996)
T ss_pred eeecccCCC----ccccccCCccceeecChhHhhhc---------ccCchhhccccceEEEEecccCCCccccc--chHH
Confidence 997765531 12222233446789999999754 89999999999999999887 99999874 4557
Q ss_pred HHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHHHH
Q 003542 443 MTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKK 493 (811)
Q Consensus 443 i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~k 493 (811)
..+.|..+.+.+.|.+||..|.+|+..||++|-.+||.|.+|+..|..+-+
T Consensus 843 VIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr 893 (996)
T KOG0196|consen 843 VIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR 893 (996)
T ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence 789999999999999999999999999999999999999999998877654
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=318.13 Aligned_cols=255 Identities=24% Similarity=0.424 Sum_probs=199.1
Q ss_pred hcceEEeeeecccc---eEEEEEE------cCCEEEEEEeccc-----HHHHHHHHHHHHhCC-CCccceeeeeEEccCC
Q 003542 215 LKKLMVRRRLGASS---QFKEIQW------LGDSFVLRHFYGE-----LESLNAEISTMLSLS-HPNIVQYLCGFCDEEK 279 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~~------~g~~VAVK~~~~~-----~~~~~~Ei~iL~~L~-HPNIVkl~~~~~~e~~ 279 (811)
.++|.+.+.||+|+ ||++... .+..||||++... .+.+.+|+.+|.++. ||||+++++.+. ..
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~--~~ 113 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT--KG 113 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc--cC
Confidence 35678888899986 6665432 3458999999642 346889999999997 999999997763 44
Q ss_pred CeEEEEEecCC-CCHHHHHHHhhCC-------------------------------------------------------
Q 003542 280 KEFFLVMELMS-KDLSCYMRETFGS------------------------------------------------------- 303 (811)
Q Consensus 280 ~~~yLVmEy~~-g~L~~~L~~~~~~------------------------------------------------------- 303 (811)
..+|||||||+ |+|.+++......
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 57899999999 5999998753110
Q ss_pred -------------------------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEe
Q 003542 304 -------------------------------------RRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLK 346 (811)
Q Consensus 304 -------------------------------------~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~ 346 (811)
.....+++..++.++.||+.||.|||+.+++||||||+|||++
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~ 273 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLIC 273 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEe
Confidence 0113467788899999999999999999999999999999998
Q ss_pred ccCCCCcceEEEeeccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHH
Q 003542 347 ARSMEGYFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFEL 426 (811)
Q Consensus 347 ~~g~d~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyEL 426 (811)
.++ .+||+|||+++....... ........+++.|+|||++.+. .++.++||||||+++|||
T Consensus 274 ~~~-----~~kL~DfGla~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~DvwslGvil~e~ 334 (401)
T cd05107 274 EGK-----LVKICDFGLARDIMRDSN-----YISKGSTFLPLKWMAPESIFNN---------LYTTLSDVWSFGILLWEI 334 (401)
T ss_pred CCC-----EEEEEecCcceecccccc-----cccCCCcCCCCceeChHHhcCC---------CCCcHhHHHHHHHHHHHH
Confidence 765 899999999875432211 0112234567889999998642 578899999999999999
Q ss_pred hh-CCCCCCCCccchHHHHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHH
Q 003542 427 LT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYI 491 (811)
Q Consensus 427 lt-G~~PF~~~~~~~~~i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i 491 (811)
++ |..||..... .......+..+.++..|..++.++.+|+.+||..+|.+||++.+|++.|+.+
T Consensus 335 l~~g~~P~~~~~~-~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 335 FTLGGTPYPELPM-NEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred HHcCCCCCCCCCc-hHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 98 8999975432 2333445555666667778899999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=297.03 Aligned_cols=249 Identities=24% Similarity=0.436 Sum_probs=199.6
Q ss_pred cceEEeeeecccc---eEEEEEE-cCC----EEEEEEecc-----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeE
Q 003542 216 KKLMVRRRLGASS---QFKEIQW-LGD----SFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEF 282 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~~-~g~----~VAVK~~~~-----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~ 282 (811)
.+|++.+.||.|+ +|++... +|+ .||+|.+.. ....+.+|+.+|+.++||||+++++.+.. ...
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~ 83 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS---SQV 83 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec---Cce
Confidence 5788888898886 7776633 343 699999854 24578899999999999999999966532 568
Q ss_pred EEEEecCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeec
Q 003542 283 FLVMELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGF 361 (811)
Q Consensus 283 yLVmEy~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DF 361 (811)
++||||++ |+|.+++... ...+++..+..++.||+.||.|||+.+++||||||+|||++.++ .+||+||
T Consensus 84 ~~v~e~~~~g~L~~~l~~~-----~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~-----~~kL~df 153 (279)
T cd05057 84 QLITQLMPLGCLLDYVRNH-----KDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQ-----HVKITDF 153 (279)
T ss_pred EEEEecCCCCcHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCC-----eEEECCC
Confidence 99999998 5899988753 24589999999999999999999999999999999999998766 8999999
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CCCCCCCCccch
Q 003542 362 GLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQG 440 (811)
Q Consensus 362 GlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~~PF~~~~~~~ 440 (811)
|+++........ .......++..|+|||.+.. ..++.++||||||+++||+++ |..||.+.. .
T Consensus 154 g~~~~~~~~~~~-----~~~~~~~~~~~y~~PE~~~~---------~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--~ 217 (279)
T cd05057 154 GLAKLLDVDEKE-----YHAEGGKVPIKWMALESILH---------RIYTHKSDVWSYGVTVWELMTFGAKPYEGIP--A 217 (279)
T ss_pred cccccccCcccc-----eecCCCcccccccCHHHhhc---------CCcCchhhHHHHHHHHHHHhcCCCCCCCCCC--H
Confidence 999766432211 11112334567999999863 367889999999999999998 999998754 3
Q ss_pred HHHHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHHHH
Q 003542 441 DKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKK 493 (811)
Q Consensus 441 ~~i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~k 493 (811)
..+...+..+.....|..++..+.+++.+||..||.+||++.++++.|..+.+
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 218 VEIPDLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred HHHHHHHhCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 34556666666666677788899999999999999999999999888876543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=294.82 Aligned_cols=241 Identities=26% Similarity=0.452 Sum_probs=196.0
Q ss_pred ceEEeeeecccc---eEEEE-EEcCCEEEEEEecc------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEE
Q 003542 217 KLMVRRRLGASS---QFKEI-QWLGDSFVLRHFYG------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVM 286 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v-~~~g~~VAVK~~~~------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVm 286 (811)
+|++.+.||.|+ +|.+. ..+|+.||+|.+.. ....+.+|+.++++++||||+++++.+ .+....|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~--~~~~~~~lv~ 78 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESF--EENGNLYIVM 78 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeee--cCCCeEEEEE
Confidence 578899999985 45444 23789999999842 345789999999999999999999777 4567899999
Q ss_pred ecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccc
Q 003542 287 ELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365 (811)
Q Consensus 287 Ey~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~ 365 (811)
||+.+ +|.+++... ....+++..++.++.|++.||.|||+.+++|+||+|+|||++.++ .++|+|||++.
T Consensus 79 e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~-----~~~l~d~~~~~ 149 (256)
T cd08218 79 DYCEGGDLYKKINAQ----RGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDG-----TIKLGDFGIAR 149 (256)
T ss_pred ecCCCCcHHHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC-----CEEEeecccee
Confidence 99985 898888753 124578999999999999999999999999999999999998776 79999999987
Q ss_pred cccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHH
Q 003542 366 ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTK 445 (811)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~ 445 (811)
....... ......|++.|+|||++.+. .++.++|+|||||++|+|++|..||..... .....
T Consensus 150 ~~~~~~~-------~~~~~~~~~~~~~pe~~~~~---------~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~--~~~~~ 211 (256)
T cd08218 150 VLNSTVE-------LARTCIGTPYYLSPEICENR---------PYNNKSDIWALGCVLYEMCTLKHAFEAGNM--KNLVL 211 (256)
T ss_pred ecCcchh-------hhhhccCCccccCHHHhCCC---------CCCCccchhHHHHHHHHHHcCCCCccCCCH--HHHHH
Confidence 6533211 11234578889999998643 577899999999999999999999976432 33445
Q ss_pred HHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 446 NIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 446 ~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
.+..+..+..+...+..+.++|.+||+.+|.+||++.++++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 212 KIIRGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred HHhcCCCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 55566666677788999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=302.20 Aligned_cols=246 Identities=24% Similarity=0.369 Sum_probs=193.8
Q ss_pred cceEEeeeecccc---eEEEEE-EcCCEEEEEEecc----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEe
Q 003542 216 KKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVME 287 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmE 287 (811)
.+|++.+.||.|+ +|++.. .++..||+|.+.. ..+.+.+|+.++++++||||+++++.+. ....+|+|||
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e 82 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF--YENKLWILIE 82 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEe--cCCeEEEEee
Confidence 3466667777765 777664 3689999999853 3467889999999999999999998774 4567999999
Q ss_pred cCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccccc
Q 003542 288 LMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366 (811)
Q Consensus 288 y~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~ 366 (811)
|+++ +|..++... ...+++..++.++.|++.||.|||+.||+||||||+||+++.++ .++|+|||++..
T Consensus 83 ~~~~~~L~~~~~~~-----~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~-----~~~l~d~g~~~~ 152 (280)
T cd06611 83 FCDGGALDSIMLEL-----ERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDG-----DVKLADFGVSAK 152 (280)
T ss_pred ccCCCcHHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCC-----CEEEccCccchh
Confidence 9996 888877653 24689999999999999999999999999999999999998776 899999998765
Q ss_pred ccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHH
Q 003542 367 RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKN 446 (811)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~ 446 (811)
..... .......+++.|+|||++...... ...++.++||||||+++|+|++|..||..... ......
T Consensus 153 ~~~~~-------~~~~~~~~~~~y~~PE~~~~~~~~----~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~--~~~~~~ 219 (280)
T cd06611 153 NKSTL-------QKRDTFIGTPYWMAPEVVACETFK----DNPYDYKADIWSLGITLIELAQMEPPHHELNP--MRVLLK 219 (280)
T ss_pred hcccc-------cccceeecchhhcCHHHHhhcccC----CCCCCccccHHHHHHHHHHHHhCCCCcccCCH--HHHHHH
Confidence 43221 112244688899999998743211 23578899999999999999999999976432 233344
Q ss_pred HHhCCCCC--CCCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 447 IRAGERPL--FPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 447 i~~~~~~~--~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
+..+..+. .+..++..+.++|.+||..+|.+||++.++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 220 ILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred HhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 44444332 34567889999999999999999999999977
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=295.89 Aligned_cols=263 Identities=22% Similarity=0.318 Sum_probs=200.5
Q ss_pred hcceEEeeeecccc---eEEEE-EEcCCEEEEEEec----ccHHHHHHHHHHHHhCCCCccceeeeeEEcc---CCCeEE
Q 003542 215 LKKLMVRRRLGASS---QFKEI-QWLGDSFVLRHFY----GELESLNAEISTMLSLSHPNIVQYLCGFCDE---EKKEFF 283 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v-~~~g~~VAVK~~~----~~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e---~~~~~y 283 (811)
.++|.+.+.+|.|+ ||-+. ..++..||+|++. .+.+..++|++..++++||||+++++....+ .....|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 37899999999998 44433 4588999999983 4678899999999999999999998655422 335789
Q ss_pred EEEecCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCcEEEeccCCCCcceEEEee
Q 003542 284 LVMELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQK--IYHGELNPSNIYLKARSMEGYFHVKVSG 360 (811)
Q Consensus 284 LVmEy~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~g--IVHRDLKPsNILI~~~g~d~~~~vKL~D 360 (811)
|+++|.. |+|.+.+.... .....+++.+++.|+.+|++||++||+.. +.||||||.|||+...+ .++|.|
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k--~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~-----~~vl~D 172 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLK--IKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSG-----LPVLMD 172 (302)
T ss_pred EEeehhccccHHHHHHHHh--hcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCC-----ceEEEe
Confidence 9999998 78999998753 23357899999999999999999999998 99999999999998765 899999
Q ss_pred ccccccccccCCCCCC--CCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCcc
Q 003542 361 FGLSTARTYASRNTPP--ASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHL 438 (811)
Q Consensus 361 FGlA~~~~~~~~~~~~--~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~ 438 (811)
||.+......-.+... ..........|..|.|||.+.-+ .....+.++|||||||+||.|+.|..||+....
T Consensus 173 ~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk------~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~ 246 (302)
T KOG2345|consen 173 LGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVK------SHCTITERTDIWSLGCTLYAMMFGESPFERIYQ 246 (302)
T ss_pred ccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecc------cCcccccccchhhhhHHHHHHHHcCCcchHHhh
Confidence 9998654322111000 00111234578889999999866 344688999999999999999999999964322
Q ss_pred chHHHHHHHHhCCCCCCC--CCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHH
Q 003542 439 QGDKMTKNIRAGERPLFP--SGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYI 491 (811)
Q Consensus 439 ~~~~i~~~i~~~~~~~~p--~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i 491 (811)
....+.-.+..+. ..+| ...++.+.+||+.||+.||.+||++.+++..+..+
T Consensus 247 ~GgSlaLAv~n~q-~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 247 QGGSLALAVQNAQ-ISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred cCCeEEEeeeccc-cccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 2222212222211 1122 34788899999999999999999999998877543
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=309.38 Aligned_cols=247 Identities=21% Similarity=0.338 Sum_probs=181.6
Q ss_pred Eeeeecccc-----eEEEE-EEcCCEEEEEEeccc------HHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEe
Q 003542 220 VRRRLGASS-----QFKEI-QWLGDSFVLRHFYGE------LESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVME 287 (811)
Q Consensus 220 i~~~lG~G~-----vyk~v-~~~g~~VAVK~~~~~------~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmE 287 (811)
+++.||+|. ||.+. ..+|+.||+|.+... ...+.+|+.+++.++||||+++++.+. ..+.+|+|||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~--~~~~~~lv~e 79 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFI--ADNELWVVTS 79 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE--ECCEEEEEEe
Confidence 345677772 55544 348899999999632 345788999999999999999997774 4467999999
Q ss_pred cCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccccc
Q 003542 288 LMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366 (811)
Q Consensus 288 y~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~ 366 (811)
||+ |+|.+++.... ...+++..++.++.||+.||.|||+++|+||||||+|||++.++ .++++|||.+..
T Consensus 80 ~~~~~~l~~~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~-----~~~l~~~~~~~~ 150 (327)
T cd08227 80 FMAYGSAKDLICTHF----MDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDG-----KVYLSGLRSNLS 150 (327)
T ss_pred ccCCCcHHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCC-----cEEEcccchhhc
Confidence 999 58888886531 24589999999999999999999999999999999999998876 899999987544
Q ss_pred ccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHH
Q 003542 367 RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKN 446 (811)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~ 446 (811)
...................++..|+|||++.+. ...++.++|||||||++|||++|..||........ ...
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~ 221 (327)
T cd08227 151 MINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQN-------LQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLE 221 (327)
T ss_pred cccccccccccccccccccceecccChHHhhcc-------cCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH--HHH
Confidence 322111000001112234567789999999742 23578999999999999999999999975432211 111
Q ss_pred HHhCCCC---------------------------------------------CCCCCChHHHHHHHhhhccCCCCCCCCH
Q 003542 447 IRAGERP---------------------------------------------LFPSGSPKYLVNLTKKCWHTNPSQRPSF 481 (811)
Q Consensus 447 i~~~~~~---------------------------------------------~~p~~~~~~l~~LI~~cL~~DP~~RPS~ 481 (811)
...+..+ ......++.+.+|+.+||..||.+|||+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~ 301 (327)
T cd08227 222 KLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSA 301 (327)
T ss_pred HhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCH
Confidence 1111000 0111245678999999999999999999
Q ss_pred HHHHH
Q 003542 482 SSICR 486 (811)
Q Consensus 482 ~eIl~ 486 (811)
+++++
T Consensus 302 ~ell~ 306 (327)
T cd08227 302 STLLN 306 (327)
T ss_pred HHHhc
Confidence 99987
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=322.99 Aligned_cols=198 Identities=28% Similarity=0.378 Sum_probs=167.2
Q ss_pred HHHhcceEEeeeecccc---eEEEE-EEcCCEEEEEEecccH---HHHHHHHHHHHhCC-C-----CccceeeeeEEccC
Q 003542 212 DMLLKKLMVRRRLGASS---QFKEI-QWLGDSFVLRHFYGEL---ESLNAEISTMLSLS-H-----PNIVQYLCGFCDEE 278 (811)
Q Consensus 212 ~~l~k~~~i~~~lG~G~---vyk~v-~~~g~~VAVK~~~~~~---~~~~~Ei~iL~~L~-H-----PNIVkl~~~~~~e~ 278 (811)
+.+..+|++.+.||+|+ |.++. ..+++.||||++++.. .....|+.+|..|+ | -|||++++.|. .
T Consensus 182 d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~--f 259 (586)
T KOG0667|consen 182 DHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFY--F 259 (586)
T ss_pred ceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccc--c
Confidence 34556999999999996 55544 3479999999998754 44577999999996 4 48999999995 4
Q ss_pred CCeEEEEEecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEE
Q 003542 279 KKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKV 358 (811)
Q Consensus 279 ~~~~yLVmEy~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL 358 (811)
.+++|||+|+++.+|+++|+.+ .-.+|+...++.++.||+.||.+||+.||||+||||+||||...+ ...|||
T Consensus 260 r~HlciVfELL~~NLYellK~n----~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~---r~~vKV 332 (586)
T KOG0667|consen 260 RNHLCIVFELLSTNLYELLKNN----KFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPK---RSRIKV 332 (586)
T ss_pred ccceeeeehhhhhhHHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCC---cCceeE
Confidence 6789999999999999999975 336799999999999999999999999999999999999997654 238999
Q ss_pred eeccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCc
Q 003542 359 SGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGH 437 (811)
Q Consensus 359 ~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~ 437 (811)
+|||.|...... .....-+..|.|||++.|. .|+.+.||||||||+.||++|.+.|.+.+
T Consensus 333 IDFGSSc~~~q~----------vytYiQSRfYRAPEVILGl---------pY~~~IDmWSLGCIlAEL~tG~PLfpG~n 392 (586)
T KOG0667|consen 333 IDFGSSCFESQR----------VYTYIQSRFYRAPEVILGL---------PYDTAIDMWSLGCILAELFTGEPLFPGDN 392 (586)
T ss_pred EecccccccCCc----------ceeeeeccccccchhhccC---------CCCCccceeehhhhHHhHhcCccccCCCC
Confidence 999999876432 2366678889999999975 88999999999999999999998887653
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=300.42 Aligned_cols=238 Identities=23% Similarity=0.413 Sum_probs=194.4
Q ss_pred ceEEeeeecccc---eEEEEE-EcCCEEEEEEecc-----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEe
Q 003542 217 KLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVME 287 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~-----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmE 287 (811)
+|++.+.||.|+ +|++.. .+|+.||+|.+.. ....+.+|+.+++.++||||+++++.+.+ ...+|+|||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~e 79 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLK--GSKLWIIME 79 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEE--CCeEEEEEE
Confidence 466677777775 777663 3789999999853 24568899999999999999999977743 467999999
Q ss_pred cCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccccc
Q 003542 288 LMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366 (811)
Q Consensus 288 y~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~ 366 (811)
|+++ +|.+++.. ..+++..++.++.|++.||.|||+.+++||||+|+||+++.++ .++|+|||++..
T Consensus 80 ~~~~~~L~~~~~~-------~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~-----~~~l~d~g~~~~ 147 (274)
T cd06609 80 YCGGGSCLDLLKP-------GKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEG-----DVKLADFGVSGQ 147 (274)
T ss_pred eeCCCcHHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC-----CEEEccccccee
Confidence 9995 88888764 3789999999999999999999999999999999999998876 899999999977
Q ss_pred ccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHH
Q 003542 367 RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKN 446 (811)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~ 446 (811)
..... .......+++.|+|||++.+. .++.++||||||+++|+|++|..||.... .......
T Consensus 148 ~~~~~-------~~~~~~~~~~~y~~PE~~~~~---------~~~~~sDv~slG~il~~l~tg~~p~~~~~--~~~~~~~ 209 (274)
T cd06609 148 LTSTM-------SKRNTFVGTPFWMAPEVIKQS---------GYDEKADIWSLGITAIELAKGEPPLSDLH--PMRVLFL 209 (274)
T ss_pred ecccc-------cccccccCCccccChhhhccC---------CCCchhhHHHHHHHHHHHHhCCCCcccCc--hHHHHHH
Confidence 65432 122345678889999999753 58899999999999999999999997644 2233444
Q ss_pred HHhCCCCCCCCC-ChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 447 IRAGERPLFPSG-SPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 447 i~~~~~~~~p~~-~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
+.....+..+.. ++..+.+++.+||..+|.+||++++++.
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 210 IPKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred hhhcCCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 555555555555 7889999999999999999999999987
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=296.27 Aligned_cols=251 Identities=24% Similarity=0.395 Sum_probs=194.4
Q ss_pred cceEEeeeecccc---eEEEEE-EcCCEEEEEEecc---cHHHHHHHHHHHHhC-CCCccceeeeeEEccC----CCeEE
Q 003542 216 KKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG---ELESLNAEISTMLSL-SHPNIVQYLCGFCDEE----KKEFF 283 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~---~~~~~~~Ei~iL~~L-~HPNIVkl~~~~~~e~----~~~~y 283 (811)
++|++.+.||.|+ +|.+.. .+++.||+|.+.. ..+.+.+|+.+++++ +||||+++++.+.... ...+|
T Consensus 6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 85 (275)
T cd06608 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLW 85 (275)
T ss_pred hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEE
Confidence 5788999999885 676654 3678999999863 346789999999999 7999999998775422 45689
Q ss_pred EEEecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecc
Q 003542 284 LVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFG 362 (811)
Q Consensus 284 LVmEy~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFG 362 (811)
+||||+++ +|.+++.... .....+++..+..++.|++.||.|||+.+++||||+|+||+++.++ .++|+|||
T Consensus 86 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~-----~~~l~d~~ 158 (275)
T cd06608 86 LVMELCGGGSVTDLVKGLR--KKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNA-----EVKLVDFG 158 (275)
T ss_pred EEEEcCCCCcHHHHHHHHh--hcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCC-----eEEECCCc
Confidence 99999995 8888776532 1135789999999999999999999999999999999999998776 89999999
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHH
Q 003542 363 LSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDK 442 (811)
Q Consensus 363 lA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~ 442 (811)
++....... .......|+..|+|||++...... ...++.++||||||++||+|++|..||...... ..
T Consensus 159 ~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~----~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~ 226 (275)
T cd06608 159 VSAQLDSTL-------GRRNTFIGTPYWMAPEVIACDEQP----DASYDARSDVWSLGITAIELADGKPPLCDMHPM-RA 226 (275)
T ss_pred cceecccch-------hhhcCccccccccCHhHhcccccc----cCCccccccHHHhHHHHHHHHhCCCCccccchH-HH
Confidence 987553321 112345688899999998643211 336788999999999999999999999754322 22
Q ss_pred HHHHHHhCCCCCC--CCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 443 MTKNIRAGERPLF--PSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 443 i~~~i~~~~~~~~--p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
...+.....+.. +..++..+.+||.+||..||.+|||+.++++
T Consensus 227 -~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 227 -LFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred -HHHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 222333322222 2346778999999999999999999999976
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=309.01 Aligned_cols=246 Identities=16% Similarity=0.281 Sum_probs=188.6
Q ss_pred ceEEeeeecccc---eEEEEE-EcCCEEEEEEecc-------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEE
Q 003542 217 KLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG-------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLV 285 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~-------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLV 285 (811)
+|++.+.||+|+ ||.+.. .+++.||+|.+.. ....+.+|+.++..++||||+++++.+ ++.+.+|||
T Consensus 2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~--~~~~~~~lv 79 (331)
T cd05624 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAF--QDENYLYLV 79 (331)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEE--EcCCEEEEE
Confidence 688899999986 666553 3788999999853 234578899999999999999999777 456789999
Q ss_pred EecCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccc
Q 003542 286 MELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS 364 (811)
Q Consensus 286 mEy~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA 364 (811)
|||++ |+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 80 ~Ey~~gg~L~~~l~~~-----~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~-----~~kl~DfG~a 149 (331)
T cd05624 80 MDYYVGGDLLTLLSKF-----EDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNG-----HIRLADFGSC 149 (331)
T ss_pred EeCCCCCcHHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCC-----CEEEEeccce
Confidence 99998 5899988753 24689999999999999999999999999999999999998776 8999999998
Q ss_pred ccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHH
Q 003542 365 TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMT 444 (811)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~ 444 (811)
........ .......||+.|+|||++.+.... ...++.++|||||||++|+|++|+.||...... ...
T Consensus 150 ~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~----~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~--~~~ 217 (331)
T cd05624 150 LKMNQDGT------VQSSVAVGTPDYISPEILQAMEDG----MGKYGPECDWWSLGVCMYEMLYGETPFYAESLV--ETY 217 (331)
T ss_pred eeccCCCc------eeeccccCCcccCCHHHHhccccC----CCCCCCcccEEeeehhhhhhhhCCCCccCCCHH--HHH
Confidence 76543211 111235689999999998753111 135788999999999999999999999765432 223
Q ss_pred HHHHh-CCCCCCC---CCChHHHHHHHhhhccCCCCC--CCCHHHHHH
Q 003542 445 KNIRA-GERPLFP---SGSPKYLVNLTKKCWHTNPSQ--RPSFSSICR 486 (811)
Q Consensus 445 ~~i~~-~~~~~~p---~~~~~~l~~LI~~cL~~DP~~--RPS~~eIl~ 486 (811)
..+.. ..+..+| ...++.+.+||.+||..++.+ |++++++++
T Consensus 218 ~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 218 GKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred HHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 33333 2222333 346788999999999866544 457777654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=295.31 Aligned_cols=241 Identities=27% Similarity=0.451 Sum_probs=190.8
Q ss_pred cceEEeeeecccc---eEEEEEE-cCCEEEEEEecc--cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEecC
Q 003542 216 KKLMVRRRLGASS---QFKEIQW-LGDSFVLRHFYG--ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELM 289 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~~-~g~~VAVK~~~~--~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~ 289 (811)
++|++.+.||.|+ +|++... +++.||+|.+.. ..+.+.+|+.+++.++||||+++++.+. ....+|++|||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~--~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYF--KNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeee--cCCcEEEEEecC
Confidence 4577777788875 6666544 478999999864 3578999999999999999999997774 346799999999
Q ss_pred CC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccccccc
Q 003542 290 SK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTART 368 (811)
Q Consensus 290 ~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~ 368 (811)
++ +|.+++... ...+++..+..++.|++.||.|||+.+++||||+|+||+++.++ .++|+|||++....
T Consensus 81 ~~~~L~~~l~~~-----~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~-----~~~l~dfg~~~~~~ 150 (256)
T cd06612 81 GAGSVSDIMKIT-----NKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEG-----QAKLADFGVSGQLT 150 (256)
T ss_pred CCCcHHHHHHhC-----ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCC-----cEEEcccccchhcc
Confidence 95 888887642 25689999999999999999999999999999999999998776 89999999987654
Q ss_pred ccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHHHH
Q 003542 369 YASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIR 448 (811)
Q Consensus 369 ~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i~ 448 (811)
.... ......++..|+|||++.+. .++.++||||||+++|+|++|+.||........ ...+.
T Consensus 151 ~~~~-------~~~~~~~~~~y~~PE~~~~~---------~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~--~~~~~ 212 (256)
T cd06612 151 DTMA-------KRNTVIGTPFWMAPEVIQEI---------GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA--IFMIP 212 (256)
T ss_pred cCcc-------ccccccCCccccCHHHHhcC---------CCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh--hhhhc
Confidence 3221 12234578889999998643 678899999999999999999999976432211 11121
Q ss_pred hCCCC--CCCCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 449 AGERP--LFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 449 ~~~~~--~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
....+ ..+..++..+.++|.+||+.||.+|||+.+++.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 213 NKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred cCCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 11111 223456778999999999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=293.71 Aligned_cols=243 Identities=28% Similarity=0.434 Sum_probs=186.4
Q ss_pred cccceEEEEEE----cCCEEEEEEecc-----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEecCC-CCHH
Q 003542 225 GASSQFKEIQW----LGDSFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMS-KDLS 294 (811)
Q Consensus 225 G~G~vyk~v~~----~g~~VAVK~~~~-----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~~-g~L~ 294 (811)
|.|.+|++... .+..||||.+.. ..+.+.+|+.+++.++||||+++++.+. ......|+||||+. ++|.
T Consensus 7 ~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~~lv~e~~~~~~L~ 85 (262)
T cd05058 7 HFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICL-PSEGSPLVVLPYMKHGDLR 85 (262)
T ss_pred CCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEee-cCCCCcEEEEecCCCCCHH
Confidence 33448877643 235799999843 3467889999999999999999986443 33456789999998 5999
Q ss_pred HHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccccccCCCC
Q 003542 295 CYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNT 374 (811)
Q Consensus 295 ~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~~~~~ 374 (811)
+++... ...+++..+..++.||+.||.|||+.+++||||||+|||++.++ .+||+|||++..........
T Consensus 86 ~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~-----~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 86 NFIRSE-----THNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESF-----TVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred HHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCC-----cEEECCccccccccCCccee
Confidence 988652 13467778889999999999999999999999999999998766 89999999987543221100
Q ss_pred CCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CCCCCCCCccchHHHHHHHHhCCCC
Q 003542 375 PPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGDKMTKNIRAGERP 453 (811)
Q Consensus 375 ~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~~PF~~~~~~~~~i~~~i~~~~~~ 453 (811)
........++..|+|||.+.+. .++.++|||||||++|||++ |.+||.... ...+...+..+..+
T Consensus 156 ---~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~~l~el~~~~~~~~~~~~--~~~~~~~~~~~~~~ 221 (262)
T cd05058 156 ---VHNHTGAKLPVKWMALESLQTQ---------KFTTKSDVWSFGVLLWELMTRGAPPYPDVD--SFDITVYLLQGRRL 221 (262)
T ss_pred ---ecccccCcCCccccChhHhccC---------ccchHHHHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHHhcCCCC
Confidence 0111233457789999998643 67889999999999999999 566776432 33344555556556
Q ss_pred CCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHHH
Q 003542 454 LFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIK 492 (811)
Q Consensus 454 ~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~ 492 (811)
..+...+..+.+++.+||..+|++||++.+++..|+.+.
T Consensus 222 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 222 LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 666778889999999999999999999999998887653
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=302.98 Aligned_cols=256 Identities=20% Similarity=0.325 Sum_probs=192.4
Q ss_pred ceEEeeeecccc---eEEEEEE---cCCEEEEEEeccc-------HHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEE
Q 003542 217 KLMVRRRLGASS---QFKEIQW---LGDSFVLRHFYGE-------LESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFF 283 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v~~---~g~~VAVK~~~~~-------~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~y 283 (811)
+|.+.+.||.|+ +|++... .|..||||.+... ...+.+|+.+++.++||||+++++.+.+.....+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 477888888885 7776643 5799999999652 35678999999999999999999888655447899
Q ss_pred EEEecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccc
Q 003542 284 LVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGL 363 (811)
Q Consensus 284 LVmEy~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGl 363 (811)
+||||++++|.+++...... ....+++..++.++.||+.||.|||+.+|+||||||+|||++.++ +....+||+|||+
T Consensus 81 lv~e~~~~~l~~~~~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~-~~~~~~kl~Dfg~ 158 (316)
T cd07842 81 LLFDYAEHDLWQIIKFHRQA-KRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEG-PERGVVKIGDLGL 158 (316)
T ss_pred EEEeCCCcCHHHHHHhhccC-CCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCC-CccceEEECCCcc
Confidence 99999999988887654221 124689999999999999999999999999999999999998832 2223899999999
Q ss_pred cccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccch---
Q 003542 364 STARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQG--- 440 (811)
Q Consensus 364 A~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~--- 440 (811)
+......... ........+++.|+|||++.+. ..++.++||||||+++|+|++|++||.+.....
T Consensus 159 ~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~--------~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~ 226 (316)
T cd07842 159 ARLFNAPLKP----LADLDPVVVTIWYRAPELLLGA--------RHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKS 226 (316)
T ss_pred ccccCCCccc----ccccCCccccccccCHHHHhCC--------CCCCcHHHHHHHHHHHHHHHhcCCCCcCCccccccc
Confidence 8765433211 1122345678889999998642 357889999999999999999999997543321
Q ss_pred -----HHHHHHHH------------------------hCCCCCCC-----------CCChHHHHHHHhhhccCCCCCCCC
Q 003542 441 -----DKMTKNIR------------------------AGERPLFP-----------SGSPKYLVNLTKKCWHTNPSQRPS 480 (811)
Q Consensus 441 -----~~i~~~i~------------------------~~~~~~~p-----------~~~~~~l~~LI~~cL~~DP~~RPS 480 (811)
..+...+. ......++ ...+..+.+++.+||..||.+|||
T Consensus 227 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps 306 (316)
T cd07842 227 NPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRIT 306 (316)
T ss_pred chhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcC
Confidence 00000000 00011111 144567899999999999999999
Q ss_pred HHHHHH
Q 003542 481 FSSICR 486 (811)
Q Consensus 481 ~~eIl~ 486 (811)
+.+++.
T Consensus 307 ~~eil~ 312 (316)
T cd07842 307 AEEALE 312 (316)
T ss_pred HHHHhc
Confidence 999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=318.85 Aligned_cols=233 Identities=22% Similarity=0.361 Sum_probs=189.1
Q ss_pred eEEEEEE-cCCEEEEEEec----ccHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEecCCCCHH-HHHHHhhC
Q 003542 229 QFKEIQW-LGDSFVLRHFY----GELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLS-CYMRETFG 302 (811)
Q Consensus 229 vyk~v~~-~g~~VAVK~~~----~~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~~g~L~-~~L~~~~~ 302 (811)
||+++.. ++-.-|-|++. .+++++.-||.||..++||+||++++.|+.+. .++|+.|||+|+-. ..+.+.
T Consensus 48 VyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~en--kLwiliEFC~GGAVDaimlEL-- 123 (1187)
T KOG0579|consen 48 VYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFEN--KLWILIEFCGGGAVDAIMLEL-- 123 (1187)
T ss_pred hhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccC--ceEEEEeecCCchHhHHHHHh--
Confidence 6666633 44445667774 36789999999999999999999999887654 49999999997544 444442
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccccccCCCCCCCCCCCC
Q 003542 303 SRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTPPASPQNQ 382 (811)
Q Consensus 303 ~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~ 382 (811)
...|.+.++..+++|++.||.|||+++|||||||..|||++-+| .++|+|||.+...... .....
T Consensus 124 ---~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldG-----dirLADFGVSAKn~~t-------~qkRD 188 (1187)
T KOG0579|consen 124 ---GRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDG-----DIRLADFGVSAKNKST-------RQKRD 188 (1187)
T ss_pred ---ccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecC-----cEeeecccccccchhH-------Hhhhc
Confidence 36899999999999999999999999999999999999999998 8999999997543322 12335
Q ss_pred CCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHHHHhCCCCC--CCCCCh
Q 003542 383 TAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPL--FPSGSP 460 (811)
Q Consensus 383 ~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i~~~~~~~--~p~~~~ 460 (811)
++.|||.|||||+....... ..+|+.++||||||++|.||+-+.+|....+ ...+.-.|....+|. .|..++
T Consensus 189 sFIGTPYWMAPEVvmCET~K----D~PYDykaDiWSlGITLIEMAqiEPPHheln--pMRVllKiaKSePPTLlqPS~Ws 262 (1187)
T KOG0579|consen 189 SFIGTPYWMAPEVVMCETFK----DQPYDYKADIWSLGITLIEMAQIEPPHHELN--PMRVLLKIAKSEPPTLLQPSHWS 262 (1187)
T ss_pred cccCCcccccchheeecccc----CCCchhhhhHHhhhhHHHHHhccCCCccccc--hHHHHHHHhhcCCCcccCcchhh
Confidence 78999999999999876432 3479999999999999999999999987644 334445555555554 367888
Q ss_pred HHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 461 KYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 461 ~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
..+.+++.+||..||..||++.++++
T Consensus 263 ~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 263 RSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred hHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 99999999999999999999999987
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=294.68 Aligned_cols=252 Identities=23% Similarity=0.395 Sum_probs=192.5
Q ss_pred EEeeeecccc---eEEEEEE----cCCEEEEEEecc------cHHHHHHHHHHHHhCCCCccceeeeeEEccCC----Ce
Q 003542 219 MVRRRLGASS---QFKEIQW----LGDSFVLRHFYG------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEK----KE 281 (811)
Q Consensus 219 ~i~~~lG~G~---vyk~v~~----~g~~VAVK~~~~------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~----~~ 281 (811)
.+.+.||+|+ +|++... +|..||||.+.. ..+.+.+|+.+|+.++||||+++++.+..... ..
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 81 (273)
T cd05074 2 TLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPI 81 (273)
T ss_pred cchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccc
Confidence 4455566664 8877643 468999999864 24568899999999999999999976654322 23
Q ss_pred EEEEEecCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEee
Q 003542 282 FFLVMELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSG 360 (811)
Q Consensus 282 ~yLVmEy~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~D 360 (811)
.++++||+. |+|..++...........+++..++.++.||+.||.|||+.||+||||||+||+++.++ .+||+|
T Consensus 82 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~-----~~kl~d 156 (273)
T cd05074 82 PMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENM-----TVCVAD 156 (273)
T ss_pred eEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCC-----CEEECc
Confidence 478999998 58888775432222223578899999999999999999999999999999999997665 899999
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CCCCCCCCccc
Q 003542 361 FGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQ 439 (811)
Q Consensus 361 FGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~~PF~~~~~~ 439 (811)
||++........ ........+++.|++||.+... .++.++||||||+++|+|++ |.+||.+..
T Consensus 157 fg~~~~~~~~~~-----~~~~~~~~~~~~~~~pe~~~~~---------~~~~~sDi~slG~il~el~~~g~~p~~~~~-- 220 (273)
T cd05074 157 FGLSKKIYSGDY-----YRQGCASKLPVKWLALESLADN---------VYTTHSDVWAFGVTMWEIMTRGQTPYAGVE-- 220 (273)
T ss_pred ccccccccCCcc-----eecCCCccCchhhcCHhHHhcC---------ccchhhhhHHHHHHHHHHhhCCCCCCCCCC--
Confidence 999876532211 0111233456779999998643 57789999999999999999 899997643
Q ss_pred hHHHHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHH
Q 003542 440 GDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYI 491 (811)
Q Consensus 440 ~~~i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i 491 (811)
.......+..+.....+...+..+.+++.+||+.+|.+||++.+++..|+.+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 221 NSEIYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred HHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 2334455555555555667888999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=323.80 Aligned_cols=244 Identities=19% Similarity=0.252 Sum_probs=187.5
Q ss_pred hcceEEeeeecccc---eEEEEEE-cCCEEEEEEecccHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEecCC
Q 003542 215 LKKLMVRRRLGASS---QFKEIQW-LGDSFVLRHFYGELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMS 290 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~~-~g~~VAVK~~~~~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~~ 290 (811)
...|.+.+.||.|+ ||++... .++.||||... ...+.+|+++|++|+|||||++++.+. .....|||||++.
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~--~~~~~~E~~iL~~L~HpnIv~l~~~~~--~~~~~~lv~e~~~ 243 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW--YASSVHEARLLRRLSHPAVLALLDVRV--VGGLTCLVLPKYR 243 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc--ccCHHHHHHHHHHCCCCCCCcEEEEEE--ECCEEEEEEEccC
Confidence 35799999999986 7776643 68899999743 345678999999999999999997664 3467899999999
Q ss_pred CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccccccccc
Q 003542 291 KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYA 370 (811)
Q Consensus 291 g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~ 370 (811)
++|..++... ...+++..++.|+.||+.||.|||++||+||||||+||||+.++ .+||+|||+++.....
T Consensus 244 ~~L~~~l~~~-----~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~-----~vkL~DFGla~~~~~~ 313 (461)
T PHA03211 244 SDLYTYLGAR-----LRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPE-----DICLGDFGAACFARGS 313 (461)
T ss_pred CCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCC-----CEEEcccCCceecccc
Confidence 9999988653 24689999999999999999999999999999999999998776 7999999999765332
Q ss_pred CCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCcc------chHHHH
Q 003542 371 SRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHL------QGDKMT 444 (811)
Q Consensus 371 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~------~~~~i~ 444 (811)
.. ........||+.|+|||++.+. .++.++|||||||+||||++|..|+..... ....+.
T Consensus 314 ~~-----~~~~~~~~GT~~Y~APE~~~~~---------~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~ 379 (461)
T PHA03211 314 WS-----TPFHYGIAGTVDTNAPEVLAGD---------PYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQIL 379 (461)
T ss_pred cc-----cccccccCCCcCCcCHHHHcCC---------CCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHH
Confidence 11 1112345699999999999753 678999999999999999998766533211 112222
Q ss_pred HHHHhCCC--CCCC-------------------------------CCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 445 KNIRAGER--PLFP-------------------------------SGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 445 ~~i~~~~~--~~~p-------------------------------~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
+.+..... ..++ ...+..+.+||.+||..||.+|||+.++++
T Consensus 380 ~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~ 454 (461)
T PHA03211 380 RIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR 454 (461)
T ss_pred HHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence 22222110 0010 023456899999999999999999999987
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=295.96 Aligned_cols=234 Identities=29% Similarity=0.511 Sum_probs=185.0
Q ss_pred CEEEEEEecc-----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEecCC-CCHHHHHHHhhCCC-CCCCCC
Q 003542 238 DSFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMS-KDLSCYMRETFGSR-RRNSFS 310 (811)
Q Consensus 238 ~~VAVK~~~~-----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~~-g~L~~~L~~~~~~~-~~~~ls 310 (811)
..||||.+.. ....+.+|+.+|+.++||||+++++.+. .....|+||||++ ++|.+++....... ....++
T Consensus 27 ~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~ 104 (269)
T cd05044 27 IRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCL--LNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLT 104 (269)
T ss_pred eeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeec--CCCCeEEEEeccCCCcHHHHHHHhhhcccCCcccc
Confidence 5799998853 3567889999999999999999997663 4456899999998 59999997643222 234578
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccccccCCCCCCCCCCCCCCCCCCcc
Q 003542 311 LPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIW 390 (811)
Q Consensus 311 ~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y 390 (811)
+..+..++.||+.||.|||+.+++|+||||+||+++.++.+....++|+|||++........ ........++..|
T Consensus 105 ~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~~y 179 (269)
T cd05044 105 LKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDY-----YRKEGEGLLPVRW 179 (269)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccccccccc-----cccCcccCCCccc
Confidence 89999999999999999999999999999999999876533445799999999875532211 0111233456789
Q ss_pred CChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CCCCCCCCccchHHHHHHHHhCCCCCCCCCChHHHHHHHhh
Q 003542 391 YAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKK 469 (811)
Q Consensus 391 ~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~~PF~~~~~~~~~i~~~i~~~~~~~~p~~~~~~l~~LI~~ 469 (811)
+|||++.+ ..++.++|||||||++|+|++ |..||.... .......+..+.....+...+..+.++|.+
T Consensus 180 ~aPE~~~~---------~~~~~~~Dv~slG~il~ellt~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 248 (269)
T cd05044 180 MAPESLLD---------GKFTTQSDVWSFGVLMWEILTLGQQPYPALN--NQEVLQHVTAGGRLQKPENCPDKIYQLMTN 248 (269)
T ss_pred cCHHHHcc---------CCcccchhHHHHHHHHHHHHHcCCCCCcccC--HHHHHHHHhcCCccCCcccchHHHHHHHHH
Confidence 99999864 367899999999999999998 999997543 233445555555556677888999999999
Q ss_pred hccCCCCCCCCHHHHHHHHH
Q 003542 470 CWHTNPSQRPSFSSICRILR 489 (811)
Q Consensus 470 cL~~DP~~RPS~~eIl~~L~ 489 (811)
||..+|.+||++.+|++.|.
T Consensus 249 ~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 249 CWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred HcCCCcccCCCHHHHHHHHh
Confidence 99999999999999988764
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=291.45 Aligned_cols=237 Identities=25% Similarity=0.463 Sum_probs=188.9
Q ss_pred cccceEEEEEEcCCEEEEEEecc-----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEecCCC-CHHHHHH
Q 003542 225 GASSQFKEIQWLGDSFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMR 298 (811)
Q Consensus 225 G~G~vyk~v~~~g~~VAVK~~~~-----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~~g-~L~~~L~ 298 (811)
|.|.+|++....++.||+|.+.. ....+.+|++++++++||||+++++.+. .....|+||||++| +|.+++.
T Consensus 7 ~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~~v~e~~~~~~l~~~l~ 84 (251)
T cd05041 7 NFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV--QKQPIYIVMELVPGGSLLTFLR 84 (251)
T ss_pred CCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEe--cCCCeEEEEEcCCCCcHHHHHH
Confidence 34448887766699999999853 3457899999999999999999987663 44568999999985 8988886
Q ss_pred HhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccccccCCCCCCCC
Q 003542 299 ETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTPPAS 378 (811)
Q Consensus 299 ~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~~~~~~~~~ 378 (811)
.. ...+++..+..++.+++.||.|||+++++||||||+|||++.++ .++|+|||++........ .
T Consensus 85 ~~-----~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~-----~~~l~d~g~~~~~~~~~~-----~ 149 (251)
T cd05041 85 KK-----KNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENN-----VLKISDFGMSREEEGGIY-----T 149 (251)
T ss_pred hc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCC-----cEEEeeccccccccCCcc-----e
Confidence 53 24578899999999999999999999999999999999998776 899999999875532211 0
Q ss_pred CCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CCCCCCCCccchHHHHHHHHhCCCCCCCC
Q 003542 379 PQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGDKMTKNIRAGERPLFPS 457 (811)
Q Consensus 379 ~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~~PF~~~~~~~~~i~~~i~~~~~~~~p~ 457 (811)
.......++..|+|||.+.+ ..++.++||||||+++|+|++ |..||..... ......+........+.
T Consensus 150 ~~~~~~~~~~~y~~PE~~~~---------~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~--~~~~~~~~~~~~~~~~~ 218 (251)
T cd05041 150 VSDGLKQIPIKWTAPEALNY---------GRYTSESDVWSYGILLWETFSLGDTPYPGMSN--QQTRERIESGYRMPAPQ 218 (251)
T ss_pred eccccCcceeccCChHhhcc---------CCCCcchhHHHHHHHHHHHHhccCCCCccCCH--HHHHHHHhcCCCCCCCc
Confidence 01112234567999999864 267889999999999999999 8999976432 33445555555555677
Q ss_pred CChHHHHHHHhhhccCCCCCCCCHHHHHHHHH
Q 003542 458 GSPKYLVNLTKKCWHTNPSQRPSFSSICRILR 489 (811)
Q Consensus 458 ~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~ 489 (811)
..+.++.+++.+||..+|.+||++.++++.|+
T Consensus 219 ~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 219 LCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred cCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 88899999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=301.24 Aligned_cols=252 Identities=23% Similarity=0.345 Sum_probs=189.0
Q ss_pred hcceEEeeeecccc---eEEEEEE-----------------cCCEEEEEEeccc-----HHHHHHHHHHHHhCCCCccce
Q 003542 215 LKKLMVRRRLGASS---QFKEIQW-----------------LGDSFVLRHFYGE-----LESLNAEISTMLSLSHPNIVQ 269 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~~-----------------~g~~VAVK~~~~~-----~~~~~~Ei~iL~~L~HPNIVk 269 (811)
.++|++.+.||+|+ +|.+... .+..||+|.+... ...+.+|+.+|+.++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 35788888999886 5543211 2346999999642 357899999999999999999
Q ss_pred eeeeEEccCCCeEEEEEecCC-CCHHHHHHHhhCCC-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcE
Q 003542 270 YLCGFCDEEKKEFFLVMELMS-KDLSCYMRETFGSR-----RRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNI 343 (811)
Q Consensus 270 l~~~~~~e~~~~~yLVmEy~~-g~L~~~L~~~~~~~-----~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNI 343 (811)
+++.+. ....+|+||||++ ++|.+++....... ....+++..+..++.||+.||.|||+.|++||||||+||
T Consensus 84 ~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 84 LLAVCI--TSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred EEEEEe--cCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 997764 3456899999998 59999887642111 113477889999999999999999999999999999999
Q ss_pred EEeccCCCCcceEEEeeccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHH
Q 003542 344 YLKARSMEGYFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLC 423 (811)
Q Consensus 344 LI~~~g~d~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvIL 423 (811)
|++.++ .++|+|||++........ ........+++.|+|||+..+ ..++.++|||||||++
T Consensus 162 li~~~~-----~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~~~~~pe~~~~---------~~~~~~~DiwSlG~~l 222 (296)
T cd05095 162 LVGKNY-----TIKIADFGMSRNLYSGDY-----YRIQGRAVLPIRWMSWESILL---------GKFTTASDVWAFGVTL 222 (296)
T ss_pred EEcCCC-----CEEeccCcccccccCCcc-----eeccCcCcCccccCCHHHHhc---------CCccchhhhhHHHHHH
Confidence 998765 899999999875432211 011122344678999998764 3678899999999999
Q ss_pred HHHhh--CCCCCCCCccchHHHHHHH----H---hCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHH
Q 003542 424 FELLT--GKVPFEDGHLQGDKMTKNI----R---AGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILR 489 (811)
Q Consensus 424 yELlt--G~~PF~~~~~~~~~i~~~i----~---~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~ 489 (811)
|||++ |..||...... ...... . .....+.+..+++.+.+|+.+||..||.+||++.+|++.|.
T Consensus 223 ~el~~~~~~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 223 WEILTLCKEQPYSQLSDE--QVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHHHHhCCCCCccccChH--HHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 99998 77898754322 111111 1 11112334567889999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=296.54 Aligned_cols=241 Identities=22% Similarity=0.411 Sum_probs=186.2
Q ss_pred cccceEEEEEE-cCC--EEEEEEecc-----cHHHHHHHHHHHHhC-CCCccceeeeeEEccCCCeEEEEEecCC-CCHH
Q 003542 225 GASSQFKEIQW-LGD--SFVLRHFYG-----ELESLNAEISTMLSL-SHPNIVQYLCGFCDEEKKEFFLVMELMS-KDLS 294 (811)
Q Consensus 225 G~G~vyk~v~~-~g~--~VAVK~~~~-----~~~~~~~Ei~iL~~L-~HPNIVkl~~~~~~e~~~~~yLVmEy~~-g~L~ 294 (811)
|.|.||++... +|. .+|+|.+.. ....+.+|+.++.++ +||||+++++.+. ....+|+||||++ |+|.
T Consensus 7 ~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~--~~~~~~lv~e~~~~~~L~ 84 (270)
T cd05047 7 NFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE--HRGYLYLAIEYAPHGNLL 84 (270)
T ss_pred CCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEe--cCCCceEEEEeCCCCcHH
Confidence 34447876643 343 578998863 235788999999999 8999999997763 4456899999998 5999
Q ss_pred HHHHHhhCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccc
Q 003542 295 CYMRETFGS----------RRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS 364 (811)
Q Consensus 295 ~~L~~~~~~----------~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA 364 (811)
+++...... .....+++..++.++.|++.||+|||+.|++||||||+|||++.++ .+||+|||++
T Consensus 85 ~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~-----~~kl~dfgl~ 159 (270)
T cd05047 85 DFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY-----VAKIADFGLS 159 (270)
T ss_pred HHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCC-----eEEECCCCCc
Confidence 998764210 1113578999999999999999999999999999999999998776 8999999998
Q ss_pred ccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CCCCCCCCccchHHH
Q 003542 365 TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGDKM 443 (811)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~~PF~~~~~~~~~i 443 (811)
....... .......+..|+|||++... .++.++||||||+++|||++ |..||.+... ...
T Consensus 160 ~~~~~~~--------~~~~~~~~~~y~apE~~~~~---------~~~~~~Di~slG~il~el~~~g~~pf~~~~~--~~~ 220 (270)
T cd05047 160 RGQEVYV--------KKTMGRLPVRWMAIESLNYS---------VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--AEL 220 (270)
T ss_pred cccchhh--------hccCCCCccccCChHHHccC---------CCCchhhHHHHHHHHHHHHcCCCCCccccCH--HHH
Confidence 5322110 11122345679999998643 67889999999999999997 9999976432 334
Q ss_pred HHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHH
Q 003542 444 TKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYI 491 (811)
Q Consensus 444 ~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i 491 (811)
...+..+.....+..++..+.+|+.+||..||.+|||+.+++..|..+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 221 YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred HHHHhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 455555555556667888999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=302.29 Aligned_cols=243 Identities=21% Similarity=0.434 Sum_probs=191.5
Q ss_pred EEeeeecccc---eEEEEE-EcCCEEEEEEecc-----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEecC
Q 003542 219 MVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELM 289 (811)
Q Consensus 219 ~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~-----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~ 289 (811)
+..+.||.|+ +|+++. .+|..||+|.+.. ..+.+.+|+.++++++||||+++++.+. ....+|+||||+
T Consensus 7 ~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~ 84 (277)
T cd06642 7 TKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYL--KGTKLWIIMEYL 84 (277)
T ss_pred HHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccc--cCCceEEEEEcc
Confidence 3344455553 888764 4688999999852 2456899999999999999999998774 456799999999
Q ss_pred CC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccccccc
Q 003542 290 SK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTART 368 (811)
Q Consensus 290 ~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~ 368 (811)
++ +|.+++.. ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++ .++|+|||++....
T Consensus 85 ~~~~L~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~-----~~~l~dfg~~~~~~ 152 (277)
T cd06642 85 GGGSALDLLKP-------GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQG-----DVKLADFGVAGQLT 152 (277)
T ss_pred CCCcHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCC-----CEEEcccccccccc
Confidence 95 78777653 5688999999999999999999999999999999999998776 79999999987654
Q ss_pred ccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHHHH
Q 003542 369 YASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIR 448 (811)
Q Consensus 369 ~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i~ 448 (811)
... .......++..|+|||++.+. .++.++|||||||++|+|++|..||..... ......+.
T Consensus 153 ~~~-------~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Dv~slG~il~el~tg~~p~~~~~~--~~~~~~~~ 214 (277)
T cd06642 153 DTQ-------IKRNTFVGTPFWMAPEVIKQS---------AYDFKADIWSLGITAIELAKGEPPNSDLHP--MRVLFLIP 214 (277)
T ss_pred Ccc-------hhhhcccCcccccCHHHhCcC---------CCchhhhHHHHHHHHHHHHhCCCCCcccch--hhHHhhhh
Confidence 321 111234578889999998643 578899999999999999999999975432 22233344
Q ss_pred hCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHHHHH
Q 003542 449 AGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKKF 494 (811)
Q Consensus 449 ~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~k~ 494 (811)
.+..+..+...+..+.++|.+||..+|.+||++.+++.+ ..+.++
T Consensus 215 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~-~~~~~~ 259 (277)
T cd06642 215 KNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH-KFITRY 259 (277)
T ss_pred cCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh-HHHHHH
Confidence 444455566778889999999999999999999999984 444443
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=295.30 Aligned_cols=239 Identities=22% Similarity=0.362 Sum_probs=193.8
Q ss_pred ceEEeeeecccc---eEEEEEE-cCCEEEEEEecc-------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEE
Q 003542 217 KLMVRRRLGASS---QFKEIQW-LGDSFVLRHFYG-------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLV 285 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v~~-~g~~VAVK~~~~-------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLV 285 (811)
.|++.+.||.|+ +|.+... +|+.||+|.+.. ..+.+.+|+.++++++||||+++++.+ .+...+|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~lv 78 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSF--QDEENMYLV 78 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhh--cCCCeEEEE
Confidence 478888999886 7776643 689999999853 356789999999999999999998777 456789999
Q ss_pred EecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccc
Q 003542 286 MELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS 364 (811)
Q Consensus 286 mEy~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA 364 (811)
|||+.| +|..++... ..+++..+..++.||+.||.|||+++++|+||+|+||+++.++ .++|+|||++
T Consensus 79 ~e~~~~~~L~~~l~~~------~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~-----~~~l~d~~~~ 147 (258)
T cd05578 79 VDLLLGGDLRYHLSQK------VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQG-----HVHITDFNIA 147 (258)
T ss_pred EeCCCCCCHHHHHHhc------CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCC-----CEEEeecccc
Confidence 999985 888888653 5789999999999999999999999999999999999998876 8999999998
Q ss_pred ccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHH
Q 003542 365 TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMT 444 (811)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~ 444 (811)
....... ......|+..|+|||++... .++.++|+||||+++|+|++|..||...........
T Consensus 148 ~~~~~~~--------~~~~~~~~~~y~~PE~~~~~---------~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 210 (258)
T cd05578 148 TKVTPDT--------LTTSTSGTPGYMAPEVLCRQ---------GYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQI 210 (258)
T ss_pred cccCCCc--------cccccCCChhhcCHHHHccc---------CCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHH
Confidence 7553321 12345578889999998643 478899999999999999999999986543222222
Q ss_pred HHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCH--HHHH
Q 003542 445 KNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSF--SSIC 485 (811)
Q Consensus 445 ~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~--~eIl 485 (811)
........+..|...+..+.++|.+||..||.+||++ .+++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 211 RAKQETADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred HHHhccccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 2222224556777888999999999999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=302.05 Aligned_cols=246 Identities=22% Similarity=0.351 Sum_probs=191.1
Q ss_pred cceEEeeeecccc---eEEEEE-EcCCEEEEEEecc----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEe
Q 003542 216 KKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVME 287 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmE 287 (811)
+.|++++.||.|+ +|++.. .+|..||+|.+.. ..+.+.+|+.+++.++||||+++++.+. ....+|+|||
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e 89 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY--WDGKLWIMIE 89 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEE--eCCeEEEEEe
Confidence 4688888888885 676653 3689999999853 3466889999999999999999998774 3457999999
Q ss_pred cCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccccc
Q 003542 288 LMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366 (811)
Q Consensus 288 y~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~ 366 (811)
|++| +|..++.+. ...+++..+..++.||+.||.|||+.|++||||||+||+++.++ .++|+|||++..
T Consensus 90 ~~~~~~l~~~~~~~-----~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~-----~~kl~dfg~~~~ 159 (292)
T cd06644 90 FCPGGAVDAIMLEL-----DRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDG-----DIKLADFGVSAK 159 (292)
T ss_pred cCCCCcHHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCC-----CEEEccCcccee
Confidence 9996 676666542 24689999999999999999999999999999999999998766 899999999865
Q ss_pred ccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHH
Q 003542 367 RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKN 446 (811)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~ 446 (811)
..... .......+++.|+|||++.+.... ...++.++|||||||++|+|++|.+||...... .....
T Consensus 160 ~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~----~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--~~~~~ 226 (292)
T cd06644 160 NVKTL-------QRRDSFIGTPYWMAPEVVMCETMK----DTPYDYKADIWSLGITLIEMAQIEPPHHELNPM--RVLLK 226 (292)
T ss_pred ccccc-------cccceecCCccccCceeecccccc----CCCCCchhhhHhHHHHHHHHhcCCCCCccccHH--HHHHH
Confidence 32221 112244578889999998643111 235788999999999999999999999764422 22223
Q ss_pred HHhCCCC--CCCCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 447 IRAGERP--LFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 447 i~~~~~~--~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
+.....+ ..+..++..+.+||.+||..||.+||++.++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 227 IAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred HhcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 3333322 234567788999999999999999999999976
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=299.75 Aligned_cols=240 Identities=19% Similarity=0.283 Sum_probs=186.7
Q ss_pred eEEeeeecccc---eEEEEE-EcCCEEEEEEeccc-------HHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEE
Q 003542 218 LMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYGE-------LESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVM 286 (811)
Q Consensus 218 ~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~~-------~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVm 286 (811)
|+..+.||.|+ +|.+.. .+|+.||+|.+... ...+.+|+.+|+.++|+||+++++.+. ..+.+|+||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~--~~~~~~lv~ 79 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYE--TKDALCLVL 79 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEe--cCCEEEEEE
Confidence 55566677764 666553 37899999998531 245788999999999999999987774 456799999
Q ss_pred ecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccc
Q 003542 287 ELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365 (811)
Q Consensus 287 Ey~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~ 365 (811)
||+.+ +|..++... ....+++..+..++.|++.||.|||+.||+||||||+||+++.++ .++|+|||++.
T Consensus 80 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~-----~~kl~Dfg~~~ 150 (285)
T cd05632 80 TIMNGGDLKFHIYNM----GNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYG-----HIRISDLGLAV 150 (285)
T ss_pred EeccCccHHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCC-----CEEEecCCcce
Confidence 99995 787777643 124699999999999999999999999999999999999998765 89999999986
Q ss_pred cccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccch--HHH
Q 003542 366 ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQG--DKM 443 (811)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~--~~i 443 (811)
...... ......|+..|+|||++.+. .++.++|+|||||++|+|++|..||.+..... ..+
T Consensus 151 ~~~~~~--------~~~~~~g~~~~~aPE~~~~~---------~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~ 213 (285)
T cd05632 151 KIPEGE--------SIRGRVGTVGYMAPEVLNNQ---------RYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEV 213 (285)
T ss_pred ecCCCC--------cccCCCCCcCccChHHhcCC---------CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 543211 12345689999999999643 67889999999999999999999998643221 112
Q ss_pred HHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCC-----HHHHHH
Q 003542 444 TKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPS-----FSSICR 486 (811)
Q Consensus 444 ~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS-----~~eIl~ 486 (811)
...+... ...++...+..+.+|+..||..||.+||+ +.+++.
T Consensus 214 ~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 214 DRRVLET-EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred HHhhhcc-ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 2222222 23456678888999999999999999999 666665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=299.85 Aligned_cols=235 Identities=23% Similarity=0.378 Sum_probs=193.0
Q ss_pred ceEEeeeecccc---eEEEEE-EcCCEEEEEEecc-------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEE
Q 003542 217 KLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG-------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLV 285 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~-------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLV 285 (811)
+|++.+.||.|+ +|.+.. .+++.||+|.+.. ..+.+.+|+++|++++||||+++++.+. ....+|+|
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~~v 79 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQ--DDSNLYLV 79 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEE--cCCeEEEE
Confidence 688888999886 666553 3789999999853 3466889999999999999999998774 45679999
Q ss_pred EecCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccc
Q 003542 286 MELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS 364 (811)
Q Consensus 286 mEy~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA 364 (811)
|||++ ++|.+++... ..+++..+..++.||+.||.|||+.|++||||+|+|||++.++ .+||+|||++
T Consensus 80 ~e~~~~~~L~~~~~~~------~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~-----~~kl~dfg~~ 148 (290)
T cd05580 80 MEYVPGGELFSHLRKS------GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDG-----YIKITDFGFA 148 (290)
T ss_pred EecCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCC-----CEEEeeCCCc
Confidence 99996 6899988753 5789999999999999999999999999999999999998876 8999999998
Q ss_pred ccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHH
Q 003542 365 TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMT 444 (811)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~ 444 (811)
...... .....+++.|+|||.+.+. .++.++||||||+++|+|++|..||.... .....
T Consensus 149 ~~~~~~----------~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~ 207 (290)
T cd05580 149 KRVKGR----------TYTLCGTPEYLAPEIILSK---------GYGKAVDWWALGILIYEMLAGYPPFFDDN--PIQIY 207 (290)
T ss_pred cccCCC----------CCCCCCCccccChhhhcCC---------CCCccccHHHHHHHHHHHHhCCCCCCCCC--HHHHH
Confidence 765322 2244678899999998643 56789999999999999999999997644 22333
Q ss_pred HHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCC-----CHHHHHH
Q 003542 445 KNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRP-----SFSSICR 486 (811)
Q Consensus 445 ~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RP-----S~~eIl~ 486 (811)
+.+..+ ...+|...+..+.++|.+||..||.+|+ ++.+++.
T Consensus 208 ~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 208 EKILEG-KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred HHHhcC-CccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 444433 3456777889999999999999999999 7777765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=299.96 Aligned_cols=248 Identities=20% Similarity=0.398 Sum_probs=194.2
Q ss_pred ceEEeeeecccc---eEEEEEE-cCCEEEEEEecc-----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEe
Q 003542 217 KLMVRRRLGASS---QFKEIQW-LGDSFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVME 287 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v~~-~g~~VAVK~~~~-----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmE 287 (811)
+|++++.||.|+ +|++... +|..||+|.+.. ....+.+|+.++++++||||+++++.+. ..+.+|+|||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~lv~e 79 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFF--IEGAVYMCME 79 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhhee--cCCeEEEEEe
Confidence 467777888875 6665533 789999998853 2457889999999999999999998774 4567999999
Q ss_pred cCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEeccCCCCcceEEEeeccccc
Q 003542 288 LMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHA-QKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365 (811)
Q Consensus 288 y~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs-~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~ 365 (811)
|++| +|..++... .....+++..+..++.||+.||.|||+ .+|+||||||+||+++.++ .+||+|||++.
T Consensus 80 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~-----~~~l~dfg~~~ 151 (286)
T cd06622 80 YMDAGSLDKLYAGG---VATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNG-----QVKLCDFGVSG 151 (286)
T ss_pred ecCCCCHHHHHHhc---cccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCC-----CEEEeecCCcc
Confidence 9996 787777642 112478999999999999999999997 5999999999999998866 89999999986
Q ss_pred cccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchH-HHH
Q 003542 366 ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGD-KMT 444 (811)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~-~i~ 444 (811)
..... ......+++.|+|||++.+.... ....++.++|||||||++|+|++|..||........ ...
T Consensus 152 ~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~---~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~ 219 (286)
T cd06622 152 NLVAS---------LAKTNIGCQSYMAPERIKSGGPN---QNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQL 219 (286)
T ss_pred cccCC---------ccccCCCccCccCcchhcCCCCC---ccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHH
Confidence 55322 11234578889999998653211 123568899999999999999999999975432211 122
Q ss_pred HHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 445 KNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 445 ~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
..+..+..+..+..++.++.+||.+||..+|.+||++.+++.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 220 SAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred HHHhhcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 334445556677778999999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=296.58 Aligned_cols=243 Identities=21% Similarity=0.324 Sum_probs=186.6
Q ss_pred cceEEeeeecccc---eEEEEEE-cCCEEEEEEecc------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEE
Q 003542 216 KKLMVRRRLGASS---QFKEIQW-LGDSFVLRHFYG------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLV 285 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~~-~g~~VAVK~~~~------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLV 285 (811)
++|++.+.||.|+ +|++... +|+.||+|.+.. ..+.+.+|+.++++++||||+++++.+ .....+|+|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~--~~~~~~~~v 78 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVF--RRKRKLHLV 78 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEE--eeCCEEEEE
Confidence 3688889999885 7776643 689999999842 235578999999999999999999777 445679999
Q ss_pred EecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccc
Q 003542 286 MELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365 (811)
Q Consensus 286 mEy~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~ 365 (811)
|||+++++...+... ...+++..++.++.||+.||.|||+.|++||||||+||+++.++ .++|+|||++.
T Consensus 79 ~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~-----~~~l~dfg~~~ 148 (286)
T cd07847 79 FEYCDHTVLNELEKN-----PRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQG-----QIKLCDFGFAR 148 (286)
T ss_pred EeccCccHHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCC-----cEEECccccce
Confidence 999998655554431 24689999999999999999999999999999999999998776 89999999997
Q ss_pred cccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHH
Q 003542 366 ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTK 445 (811)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~ 445 (811)
....... ......++..|+|||++.+. ..++.++||||||+++|+|++|.+||.+...... ...
T Consensus 149 ~~~~~~~-------~~~~~~~~~~~~aPE~~~~~--------~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~-~~~ 212 (286)
T cd07847 149 ILTGPGD-------DYTDYVATRWYRAPELLVGD--------TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ-LYL 212 (286)
T ss_pred ecCCCcc-------cccCcccccccCCHHHHhCC--------CCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHH-HHH
Confidence 6543221 11234577889999998642 3578899999999999999999999986543221 111
Q ss_pred HHHh-C------------------C-CCC---------CCCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 446 NIRA-G------------------E-RPL---------FPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 446 ~i~~-~------------------~-~~~---------~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
.... + . .+. .....+..+.+|+.+||..+|++||++.+++.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 213 IRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred HHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 1000 0 0 000 01235677899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=298.51 Aligned_cols=245 Identities=24% Similarity=0.370 Sum_probs=187.7
Q ss_pred hcceEEeeeecccc---eEEEEEE-cCCEEEEEEecc-----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEE
Q 003542 215 LKKLMVRRRLGASS---QFKEIQW-LGDSFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLV 285 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~~-~g~~VAVK~~~~-----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLV 285 (811)
.++|++.+.||.|+ +|++... +|+.||||.+.. ....+.+|+.+++.++||||+++++.+ .+....|+|
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~--~~~~~~~lv 81 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII--HTKKTLTLV 81 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEE--ecCCeEEEE
Confidence 36789999999985 7776643 789999999853 234567899999999999999999777 345689999
Q ss_pred EecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccc
Q 003542 286 MELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365 (811)
Q Consensus 286 mEy~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~ 365 (811)
|||+.++|.+++... ...+++..+..++.||+.||.|||+.||+||||||+|||++.++ .+||+|||++.
T Consensus 82 ~e~~~~~L~~~~~~~-----~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~-----~~kl~dfg~~~ 151 (291)
T cd07844 82 FEYLDTDLKQYMDDC-----GGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERG-----ELKLADFGLAR 151 (291)
T ss_pred EecCCCCHHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCC-----CEEECcccccc
Confidence 999999999888653 24688999999999999999999999999999999999998876 89999999986
Q ss_pred cccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHH
Q 003542 366 ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTK 445 (811)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~ 445 (811)
....... ......++..|+|||++.+. ..++.++||||||+++|+|++|..||.+.......+..
T Consensus 152 ~~~~~~~-------~~~~~~~~~~~~aPE~~~~~--------~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~ 216 (291)
T cd07844 152 AKSVPSK-------TYSNEVVTLWYRPPDVLLGS--------TEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHK 216 (291)
T ss_pred ccCCCCc-------cccccccccccCCcHHhhcC--------cccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHH
Confidence 5432111 11223467889999998642 35778999999999999999999999765422221111
Q ss_pred HHHhCCC--------------------CCC--------CCCCh--HHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 446 NIRAGER--------------------PLF--------PSGSP--KYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 446 ~i~~~~~--------------------~~~--------p~~~~--~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
....-.. ... ..... ..+.+++.+||+.+|.+|||+.+++.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 217 IFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred HHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 1100000 000 01122 67889999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=299.97 Aligned_cols=235 Identities=20% Similarity=0.384 Sum_probs=185.2
Q ss_pred ceEEeeeecccc---eEEEE-EEcCCEEEEEEecc-----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEe
Q 003542 217 KLMVRRRLGASS---QFKEI-QWLGDSFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVME 287 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v-~~~g~~VAVK~~~~-----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmE 287 (811)
+|++.+.||+|+ +|++. ..+++.||+|.+.. ....+.+|+.++++++||||+++++.+. ..+.+++|||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e 79 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFF--VENRISICTE 79 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEE--ECCEEEEEEe
Confidence 567778888875 78776 35889999999853 2356889999999999999999998774 3567899999
Q ss_pred cCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccccc
Q 003542 288 LMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366 (811)
Q Consensus 288 y~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~ 366 (811)
|+++ +|..+ ..+++..+..++.|++.||.|||+.||+|+||||+|||++.++ .++|+|||++..
T Consensus 80 ~~~~~~l~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~-----~~~l~dfg~~~~ 144 (279)
T cd06619 80 FMDGGSLDVY----------RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRG-----QVKLCDFGVSTQ 144 (279)
T ss_pred cCCCCChHHh----------hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCC-----CEEEeeCCccee
Confidence 9996 54322 3468889999999999999999999999999999999998876 899999999875
Q ss_pred ccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccc-----hH
Q 003542 367 RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQ-----GD 441 (811)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~-----~~ 441 (811)
.... ......||..|+|||++.+. .++.++||||||+++|+|++|..||...... ..
T Consensus 145 ~~~~---------~~~~~~~~~~y~aPE~~~~~---------~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~ 206 (279)
T cd06619 145 LVNS---------IAKTYVGTNAYMAPERISGE---------QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPL 206 (279)
T ss_pred cccc---------cccCCCCChhhcCceeecCC---------CCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchH
Confidence 5322 12345688999999998743 5788999999999999999999999643211 11
Q ss_pred HHHHHHHhCCCCCC-CCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 442 KMTKNIRAGERPLF-PSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 442 ~i~~~i~~~~~~~~-p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
.....+.....+.. ....++.+.++|.+||+.+|.+||++.++++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~ 252 (279)
T cd06619 207 QLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMD 252 (279)
T ss_pred HHHHHHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 22233333333332 2346778999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=296.64 Aligned_cols=253 Identities=27% Similarity=0.459 Sum_probs=196.0
Q ss_pred cceEEeeeecccc---eEEEEEE-----cCCEEEEEEeccc-----HHHHHHHHHHHHhCCCCccceeeeeEEccCCCeE
Q 003542 216 KKLMVRRRLGASS---QFKEIQW-----LGDSFVLRHFYGE-----LESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEF 282 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~~-----~g~~VAVK~~~~~-----~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~ 282 (811)
+.|++.+.||+|+ +|++... ++..||||.+... ...+.+|+.+++.++||||+++++.+.......+
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 3566777788875 6665532 3689999999632 5679999999999999999999876654446678
Q ss_pred EEEEecCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeec
Q 003542 283 FLVMELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGF 361 (811)
Q Consensus 283 yLVmEy~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DF 361 (811)
++||||++ ++|.+++... ...+++..+..++.|++.||.|||+.|++||||||+||+++.++ .++|+||
T Consensus 84 ~lv~e~~~~~~l~~~l~~~-----~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~-----~~~l~df 153 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH-----RDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESED-----LVKISDF 153 (284)
T ss_pred EEEEecCCCCCHHHHHHhC-----ccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCC-----CEEEccc
Confidence 99999998 5999988753 13589999999999999999999999999999999999998775 8999999
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccch-
Q 003542 362 GLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQG- 440 (811)
Q Consensus 362 GlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~- 440 (811)
|++......... ........++..|+|||.+.+. .++.++||||||+++|+|++|..||.......
T Consensus 154 g~~~~~~~~~~~----~~~~~~~~~~~~~~~Pe~~~~~---------~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~ 220 (284)
T cd05038 154 GLAKVLPEDKDY----YYVKEPGESPIFWYAPECLRTS---------KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFL 220 (284)
T ss_pred ccccccccCCcc----eeccCCCCCcccccCcHHHccC---------CCCcccchHHHhhhhheeeccCCCcccccchhc
Confidence 999766422110 0011123445669999998642 67889999999999999999999986532211
Q ss_pred ------------HHHHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHH
Q 003542 441 ------------DKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYI 491 (811)
Q Consensus 441 ------------~~i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i 491 (811)
..+...+........+..++..+.+|+.+||..+|.+||++.+|++.|..+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 221 RMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred cccccccccccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 122233334444445667788999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=297.89 Aligned_cols=246 Identities=24% Similarity=0.400 Sum_probs=195.5
Q ss_pred cceEEe-eeecccc---eEEEE-EEcCCEEEEEEecccHHHHHHHHHHHHhC-CCCccceeeeeEEc--cCCCeEEEEEe
Q 003542 216 KKLMVR-RRLGASS---QFKEI-QWLGDSFVLRHFYGELESLNAEISTMLSL-SHPNIVQYLCGFCD--EEKKEFFLVME 287 (811)
Q Consensus 216 k~~~i~-~~lG~G~---vyk~v-~~~g~~VAVK~~~~~~~~~~~Ei~iL~~L-~HPNIVkl~~~~~~--e~~~~~yLVmE 287 (811)
.+|.+- ..||-|- |.... +.+|+.||+|++.. ....++|+++.-.. .|||||.++++|-. ...+.+.+|||
T Consensus 61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE 139 (400)
T KOG0604|consen 61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVME 139 (400)
T ss_pred hhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeee
Confidence 345443 2466653 44444 56999999999864 34578899887766 69999999988742 34567899999
Q ss_pred cCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccccc
Q 003542 288 LMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366 (811)
Q Consensus 288 y~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~ 366 (811)
.|+| .|+..+.+. ....|++.++..|+.||..|+.|||+.+|.||||||+|+|....+. +..+||+|||+|+.
T Consensus 140 ~meGGeLfsriq~~----g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~--na~lKLtDfGFAK~ 213 (400)
T KOG0604|consen 140 CMEGGELFSRIQDR----GDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSP--NAPLKLTDFGFAKE 213 (400)
T ss_pred cccchHHHHHHHHc----ccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCC--CcceEecccccccc
Confidence 9995 898888874 4467999999999999999999999999999999999999987753 34899999999986
Q ss_pred ccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccc--hHHHH
Q 003542 367 RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQ--GDKMT 444 (811)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~--~~~i~ 444 (811)
-... ....+.+.|+.|.|||++-.+ +|+..+|+||+|||+|-|++|.+||...+-. ...+.
T Consensus 214 t~~~--------~~L~TPc~TPyYvaPevlg~e---------KydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk 276 (400)
T KOG0604|consen 214 TQEP--------GDLMTPCFTPYYVAPEVLGPE---------KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK 276 (400)
T ss_pred cCCC--------ccccCCcccccccCHHHhCch---------hcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHH
Confidence 5432 123466789999999999643 7899999999999999999999999865432 13456
Q ss_pred HHHHhCCCCCCC----CCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 445 KNIRAGERPLFP----SGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 445 ~~i~~~~~~~~p----~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
..|..|... || ...++..+++|+.+|..+|.+|.|+.+++.
T Consensus 277 ~rI~~gqy~-FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 277 RRIRTGQYE-FPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred hHhhccCcc-CCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 667776543 33 245778999999999999999999999987
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=303.07 Aligned_cols=245 Identities=23% Similarity=0.301 Sum_probs=191.0
Q ss_pred hcceEEeeeecccc---eEEEEE-EcCCEEEEEEeccc------HHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEE
Q 003542 215 LKKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYGE------LESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFL 284 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~~------~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yL 284 (811)
..+|++.+.||.|+ +|++.. .+|+.||+|.+... ...+.+|+.++++++||||+++++.+.......+|+
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 46799999999986 666663 37899999998521 234678999999999999999998776555567899
Q ss_pred EEecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccc
Q 003542 285 VMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS 364 (811)
Q Consensus 285 VmEy~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA 364 (811)
||||++++|.+++... ...+++..++.++.||+.||.|||+.|++||||||+||+++.++ .+||+|||++
T Consensus 86 v~e~~~~~l~~~l~~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~-----~~kL~dfg~~ 155 (309)
T cd07845 86 VMEYCEQDLASLLDNM-----PTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKG-----CLKIADFGLA 155 (309)
T ss_pred EEecCCCCHHHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-----CEEECcccee
Confidence 9999999998888653 25689999999999999999999999999999999999998876 8999999998
Q ss_pred ccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHH
Q 003542 365 TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMT 444 (811)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~ 444 (811)
....... .......++..|+|||++.+. ..++.++|||||||++|+|++|.+||.+..... ..
T Consensus 156 ~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~--------~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~--~~ 218 (309)
T cd07845 156 RTYGLPA-------KPMTPKVVTLWYRAPELLLGC--------TTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE--QL 218 (309)
T ss_pred eecCCcc-------CCCCcccccccccChhhhcCC--------CCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--HH
Confidence 7654321 111233457789999998642 357889999999999999999999997654321 12
Q ss_pred HHHHhCCC------------------CCCC-----------CCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 445 KNIRAGER------------------PLFP-----------SGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 445 ~~i~~~~~------------------~~~p-----------~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
..+..... ...+ ...++.+.+||.+||..||.+|||+.+++.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 219 DLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred HHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 22211000 0000 124677899999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=301.41 Aligned_cols=251 Identities=22% Similarity=0.349 Sum_probs=187.1
Q ss_pred cceEEeeeecccc---eEEEEE-------------EcC--CEEEEEEecc-----cHHHHHHHHHHHHhCCCCccceeee
Q 003542 216 KKLMVRRRLGASS---QFKEIQ-------------WLG--DSFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQYLC 272 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~-------------~~g--~~VAVK~~~~-----~~~~~~~Ei~iL~~L~HPNIVkl~~ 272 (811)
.+|++.+.||+|+ ||.+.. +++ ..||+|.+.. ....+.+|+++|++++||||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 4678888888885 454331 122 3589999864 2356889999999999999999997
Q ss_pred eEEccCCCeEEEEEecCCC-CHHHHHHHhhCC------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE
Q 003542 273 GFCDEEKKEFFLVMELMSK-DLSCYMRETFGS------RRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYL 345 (811)
Q Consensus 273 ~~~~e~~~~~yLVmEy~~g-~L~~~L~~~~~~------~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI 345 (811)
.+. .....|+||||+.+ +|.+++...... .....+++..++.++.|++.||.|||++|++||||||+|||+
T Consensus 85 ~~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill 162 (295)
T cd05097 85 VCV--SDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV 162 (295)
T ss_pred EEc--CCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEE
Confidence 764 45578999999995 898888653110 011246888999999999999999999999999999999999
Q ss_pred eccCCCCcceEEEeeccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHH
Q 003542 346 KARSMEGYFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFE 425 (811)
Q Consensus 346 ~~~g~d~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyE 425 (811)
+.++ .+||+|||++........ ........++..|+|||++.+. .++.++|||||||++|+
T Consensus 163 ~~~~-----~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~DvwSlG~~l~e 223 (295)
T cd05097 163 GNHY-----TIKIADFGMSRNLYSGDY-----YRIQGRAVLPIRWMAWESILLG---------KFTTASDVWAFGVTLWE 223 (295)
T ss_pred cCCC-----cEEecccccccccccCcc-----eeccCcCcCceeecChhhhccC---------CcCchhhHHHHHHHHHH
Confidence 8765 799999999875432211 1112234457789999998643 67899999999999999
Q ss_pred Hhh--CCCCCCCCccchHHHHHHHH----h---CCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHH
Q 003542 426 LLT--GKVPFEDGHLQGDKMTKNIR----A---GERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILR 489 (811)
Q Consensus 426 Llt--G~~PF~~~~~~~~~i~~~i~----~---~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~ 489 (811)
|++ |..||...... .....+. . ......+...++.+.+|+.+||+.||.+||++.+|++.|.
T Consensus 224 l~~~~~~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 224 MFTLCKEQPYSLLSDE--QVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHcCCCCCCcccChH--HHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 988 67788754322 2222211 1 1112235567889999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=308.28 Aligned_cols=255 Identities=18% Similarity=0.287 Sum_probs=192.2
Q ss_pred hcceEEeeeecccc---eEEEE-EEcCCEEEEEEecc-----cHHHHHHHHHHHHhCCCCccceeeeeEEcc---CCCeE
Q 003542 215 LKKLMVRRRLGASS---QFKEI-QWLGDSFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQYLCGFCDE---EKKEF 282 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v-~~~g~~VAVK~~~~-----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e---~~~~~ 282 (811)
.++|++.+.||.|+ +|.+. ..+|+.||||.+.. ....+.+|+.++++++||||+++++.+... .....
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 36899999999986 77765 34789999999852 245678899999999999999998665422 22468
Q ss_pred EEEEecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecc
Q 003542 283 FLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFG 362 (811)
Q Consensus 283 yLVmEy~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFG 362 (811)
|+||||++++|..++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+||+|||
T Consensus 84 ~lv~e~~~~~l~~~~~~-------~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~-----~~kl~dfg 151 (336)
T cd07849 84 YIVQELMETDLYKLIKT-------QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNC-----DLKICDFG 151 (336)
T ss_pred EEEehhcccCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCC-----CEEECccc
Confidence 99999999998887754 5689999999999999999999999999999999999998876 89999999
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchH-
Q 003542 363 LSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGD- 441 (811)
Q Consensus 363 lA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~- 441 (811)
++......... ........||+.|+|||++.+ ...++.++|||||||++|+|++|++||.+......
T Consensus 152 ~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~ 219 (336)
T cd07849 152 LARIADPEHDH----TGFLTEYVATRWYRAPEIMLN--------SKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQL 219 (336)
T ss_pred ceeeccccccc----cCCcCCcCcCCCccChHHhhC--------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 98765432211 112234568899999998753 23578899999999999999999999976432110
Q ss_pred ------------HHHHHHHh---------CC-CCC-----CCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHHHHH
Q 003542 442 ------------KMTKNIRA---------GE-RPL-----FPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKKF 494 (811)
Q Consensus 442 ------------~i~~~i~~---------~~-~~~-----~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~k~ 494 (811)
+....+.. .. .+. .....+.++.++|.+||+.||.+|||+.++++ +.+++..
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~-hp~~~~~ 298 (336)
T cd07849 220 NLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALA-HPYLEQY 298 (336)
T ss_pred HHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhc-Ccccccc
Confidence 00000000 00 000 01234677999999999999999999999987 3444443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=290.23 Aligned_cols=241 Identities=31% Similarity=0.548 Sum_probs=193.5
Q ss_pred EEeeeecccc---eEEEEEE-c----CCEEEEEEecc-----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEE
Q 003542 219 MVRRRLGASS---QFKEIQW-L----GDSFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLV 285 (811)
Q Consensus 219 ~i~~~lG~G~---vyk~v~~-~----g~~VAVK~~~~-----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLV 285 (811)
++.+.||.|+ +|.+... . +..||+|.+.. ..+.+..|+.++..++||||+++++.+. +.+.+|++
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~~i 79 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCT--EEEPLMIV 79 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEc--CCCeeEEE
Confidence 3556677764 7776643 2 48899999963 3567899999999999999999997774 34679999
Q ss_pred EecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccc
Q 003542 286 MELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS 364 (811)
Q Consensus 286 mEy~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA 364 (811)
|||+++ +|.+++.... ...+++..+..++.|++.||.|||+.+++||||||+||+++.++ .++|+|||++
T Consensus 80 ~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~-----~~~l~dfg~~ 150 (258)
T smart00219 80 MEYMEGGDLLDYLRKNR----PKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENL-----VVKISDFGLS 150 (258)
T ss_pred EeccCCCCHHHHHHhhh----hccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCC-----eEEEcccCCc
Confidence 999985 8988887531 11289999999999999999999999999999999999998876 8999999998
Q ss_pred ccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CCCCCCCCccchHHH
Q 003542 365 TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGDKM 443 (811)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~~PF~~~~~~~~~i 443 (811)
......... ......+++.|+|||.+.+ ..++.++||||||+++|+|++ |.+||... ....+
T Consensus 151 ~~~~~~~~~------~~~~~~~~~~y~~Pe~~~~---------~~~~~~~Di~slG~i~~~l~~~g~~p~~~~--~~~~~ 213 (258)
T smart00219 151 RDLYDDDYY------KKKGGKLPIRWMAPESLKD---------GKFTSKSDVWSFGVLLWEIFTLGESPYPGM--SNEEV 213 (258)
T ss_pred eeccccccc------ccccCCCcccccChHHhcc---------CCCCcchhHHHHHHHHHHHHhCCCCCCCCC--CHHHH
Confidence 765433110 1112336788999999853 367899999999999999998 88999763 33445
Q ss_pred HHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHH
Q 003542 444 TKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRI 487 (811)
Q Consensus 444 ~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~ 487 (811)
.+.+..+..+..+...+.++.+++.+||..||.+|||+.++++.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 257 (258)
T smart00219 214 LEYLKKGYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEI 257 (258)
T ss_pred HHHHhcCCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhh
Confidence 56666666666777889999999999999999999999999764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=291.23 Aligned_cols=239 Identities=28% Similarity=0.450 Sum_probs=191.5
Q ss_pred eEEeeeecccc---eEEEEEE-cCCEEEEEEecc---------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEE
Q 003542 218 LMVRRRLGASS---QFKEIQW-LGDSFVLRHFYG---------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFL 284 (811)
Q Consensus 218 ~~i~~~lG~G~---vyk~v~~-~g~~VAVK~~~~---------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yL 284 (811)
|+..+.||.|+ +|+++.. +++.||+|.+.. ..+.+.+|+.+++.++||||+++++.+ .....+|+
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~--~~~~~~~l 79 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTE--REEDNLYI 79 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeE--ecCCeEEE
Confidence 45556667664 8887755 899999999842 235689999999999999999999766 44567999
Q ss_pred EEecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccc
Q 003542 285 VMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGL 363 (811)
Q Consensus 285 VmEy~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGl 363 (811)
||||+++ +|.+++... ..+++..+..++.||+.||.|||+.|++|+||+|+||+++.++ .+||+|||+
T Consensus 80 v~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~-----~~kl~d~~~ 148 (258)
T cd06632 80 FLELVPGGSLAKLLKKY------GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNG-----VVKLADFGM 148 (258)
T ss_pred EEEecCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-----CEEEccCcc
Confidence 9999985 898888753 4588999999999999999999999999999999999998776 899999999
Q ss_pred cccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHH
Q 003542 364 STARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKM 443 (811)
Q Consensus 364 A~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i 443 (811)
+....... ......++..|+|||.+... ..++.++|+||||+++|+|++|..||.... .....
T Consensus 149 ~~~~~~~~--------~~~~~~~~~~y~~pe~~~~~--------~~~~~~~D~~slG~~l~~l~~g~~pf~~~~-~~~~~ 211 (258)
T cd06632 149 AKQVVEFS--------FAKSFKGSPYWMAPEVIAQQ--------GGYGLAADIWSLGCTVLEMATGKPPWSQLE-GVAAV 211 (258)
T ss_pred ceeccccc--------cccccCCCcceeCHHHhcCC--------CCCCchhhhHHHHHHHHHHHhCCCCcccCc-HHHHH
Confidence 87653321 12345678889999998642 137889999999999999999999997654 22222
Q ss_pred HHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 444 TKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 444 ~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
.........+.++..+++.+.+++.+||..+|.+||++.+++.
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 212 FKIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred HHHHhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 2222224455567778899999999999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=293.56 Aligned_cols=245 Identities=22% Similarity=0.394 Sum_probs=191.7
Q ss_pred eEEeeeecccc---eEEEE-EEcCCEEEEEEecc----------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEE
Q 003542 218 LMVRRRLGASS---QFKEI-QWLGDSFVLRHFYG----------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFF 283 (811)
Q Consensus 218 ~~i~~~lG~G~---vyk~v-~~~g~~VAVK~~~~----------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~y 283 (811)
|+..+.||+|+ +|.+. ..+|+.||+|.+.. ..+.+.+|+.+|+.++||||+++++.+ .+.+.++
T Consensus 2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~--~~~~~~~ 79 (268)
T cd06630 2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGAT--CEDSHFN 79 (268)
T ss_pred ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhcee--ccCCeEE
Confidence 66677788885 66554 35789999999852 246789999999999999999999877 4456799
Q ss_pred EEEecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecc
Q 003542 284 LVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFG 362 (811)
Q Consensus 284 LVmEy~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFG 362 (811)
+||||++| +|.+++... ..+++..++.++.||+.||.|||++|++||||+|+||+++.++. .+||+|||
T Consensus 80 ~v~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~----~~~l~dfg 149 (268)
T cd06630 80 LFVEWMAGGSVSHLLSKY------GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQ----RLRIADFG 149 (268)
T ss_pred EEEeccCCCcHHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC----EEEEcccc
Confidence 99999995 888888753 56899999999999999999999999999999999999976542 69999999
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccch-H
Q 003542 363 LSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQG-D 441 (811)
Q Consensus 363 lA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~-~ 441 (811)
++.......... ........++..|+|||++.+. .++.++||||||+++|+|++|..||....... .
T Consensus 150 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~PE~~~~~---------~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~ 217 (268)
T cd06630 150 AAARLAAKGTGA---GEFQGQLLGTIAFMAPEVLRGE---------QYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL 217 (268)
T ss_pred cccccccccccC---CccccccccccceeCHhHhccC---------CCCcccchHHHHHHHHHHHhCCCCCCCCCCcchH
Confidence 987664431110 1112234678899999998643 56789999999999999999999997543221 1
Q ss_pred HHHHHH-HhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 442 KMTKNI-RAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 442 ~i~~~i-~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
.....+ .....+..+...++.+.+++.+||..+|.+||++.++++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 218 ALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred HHHHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 111111 223345566678889999999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=293.44 Aligned_cols=241 Identities=24% Similarity=0.332 Sum_probs=186.4
Q ss_pred eeeecccceEEEEEE-cCCEEEEEEecc----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEecCCC-CHH
Q 003542 221 RRRLGASSQFKEIQW-LGDSFVLRHFYG----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLS 294 (811)
Q Consensus 221 ~~~lG~G~vyk~v~~-~g~~VAVK~~~~----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~~g-~L~ 294 (811)
+...|.|.||++... ++..||+|.+.. ..+.+.+|+.+++.++||||+++++.+ .....+|+||||+++ +|.
T Consensus 16 lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~--~~~~~~~lv~e~~~~~~L~ 93 (268)
T cd06624 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD--SENGFFKIFMEQVPGGSLS 93 (268)
T ss_pred EecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeee--ccCCEEEEEEecCCCCCHH
Confidence 333344448887643 678899999853 356789999999999999999999766 345679999999985 899
Q ss_pred HHHHHhhCCCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccccccCC
Q 003542 295 CYMRETFGSRRRNSF--SLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASR 372 (811)
Q Consensus 295 ~~L~~~~~~~~~~~l--s~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~~~ 372 (811)
+++.... ..+ ++..+..++.||+.||.|||+.||+||||||+||+++.+.. .++|+|||++.......
T Consensus 94 ~~l~~~~-----~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~----~~~l~dfg~~~~~~~~~- 163 (268)
T cd06624 94 ALLRSKW-----GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSG----VVKISDFGTSKRLAGIN- 163 (268)
T ss_pred HHHHHhc-----ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCC----eEEEecchhheecccCC-
Confidence 9887531 234 77888999999999999999999999999999999975321 79999999986543221
Q ss_pred CCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHHHHhCCC
Q 003542 373 NTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGER 452 (811)
Q Consensus 373 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i~~~~~ 452 (811)
.......|+..|+|||++... ...++.++||||||+++|+|++|..||...................
T Consensus 164 ------~~~~~~~~~~~~~aPE~~~~~-------~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 230 (268)
T cd06624 164 ------PCTETFTGTLQYMAPEVIDKG-------PRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIH 230 (268)
T ss_pred ------CccccCCCCccccChhhhccc-------cccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccC
Confidence 111234578899999998642 2247789999999999999999999997543332222222223344
Q ss_pred CCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 453 PLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 453 ~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
+.+|...++++.+++.+||+.+|.+|||+.+++.
T Consensus 231 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 231 PEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred CCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 5567788899999999999999999999999876
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=293.37 Aligned_cols=249 Identities=24% Similarity=0.358 Sum_probs=180.7
Q ss_pred eccc---ceEEEEEE---cCCEEEEEEecc-----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEecCC-C
Q 003542 224 LGAS---SQFKEIQW---LGDSFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMS-K 291 (811)
Q Consensus 224 lG~G---~vyk~v~~---~g~~VAVK~~~~-----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~~-g 291 (811)
||+| .||++... .+..+|+|.+.. ....+.+|+.+++.++||||+++++.+ .+...+|+||||++ |
T Consensus 3 lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~~~~~~~lv~e~~~~g 80 (269)
T cd05087 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQC--TEVTPYLLVMEFCPLG 80 (269)
T ss_pred ccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEE--cCCCCcEEEEECCCCC
Confidence 4555 37877543 345799999853 234688899999999999999998766 34556899999999 5
Q ss_pred CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccccccC
Q 003542 292 DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYAS 371 (811)
Q Consensus 292 ~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~~ 371 (811)
+|.+++...... ....+++..+..++.|++.||.|||+.+++||||||+||+++.++ .+||+|||++.......
T Consensus 81 ~L~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~-----~~kL~dfg~~~~~~~~~ 154 (269)
T cd05087 81 DLKGYLRSCRKA-ELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADL-----TVKIGDYGLSHNKYKED 154 (269)
T ss_pred cHHHHHHHhhhc-ccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCC-----cEEECCccccccccCcc
Confidence 899988754211 123466778889999999999999999999999999999998765 89999999986432221
Q ss_pred CCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CCCCCCCCccchHHHHHHHHhC
Q 003542 372 RNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGDKMTKNIRAG 450 (811)
Q Consensus 372 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~~PF~~~~~~~~~i~~~i~~~ 450 (811)
. ........++..|+|||++.+.... .....++.++||||||+++|||++ |..||....... .....+...
T Consensus 155 ~-----~~~~~~~~~~~~y~aPE~~~~~~~~--~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~-~~~~~~~~~ 226 (269)
T cd05087 155 Y-----YVTPDQLWVPLRWIAPELVDEVHGN--LLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ-VLTYTVREQ 226 (269)
T ss_pred e-----eecCCCcCCcccccCHhHhcccccc--ccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH-HHHHHhhcc
Confidence 1 0111234567889999998643110 001246889999999999999996 999997643322 222222211
Q ss_pred C----CCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHH
Q 003542 451 E----RPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILR 489 (811)
Q Consensus 451 ~----~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~ 489 (811)
. .+......++.+.+++..|| .+|.+|||+++|+..|.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 227 QLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred cCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1 12223356778999999999 68999999999987663
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=298.91 Aligned_cols=243 Identities=22% Similarity=0.375 Sum_probs=188.0
Q ss_pred ceEEeeeecccc---eEEEEE-EcCCEEEEEEecc------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEE
Q 003542 217 KLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVM 286 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVm 286 (811)
+|++++.||.|+ +|++.. .+|+.||||.+.. ....+.+|++++++++||||+++++.+ .+...+|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~--~~~~~~~~v~ 78 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI--HTENKLYLVF 78 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhc--ccCCcEEEEe
Confidence 367788888875 777663 3789999999853 235688999999999999999999777 4456799999
Q ss_pred ecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccccc
Q 003542 287 ELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366 (811)
Q Consensus 287 Ey~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~ 366 (811)
||+.++|..++... ....+++..++.++.||+.||.|||+.+++||||+|+||+++.++ .+||+|||++..
T Consensus 79 e~~~~~l~~~~~~~----~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~-----~~~l~dfg~~~~ 149 (284)
T cd07860 79 EFLHQDLKKFMDAS----PLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEG-----AIKLADFGLARA 149 (284)
T ss_pred eccccCHHHHHHhC----CCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-----CEEEeeccchhh
Confidence 99998988888653 235689999999999999999999999999999999999998876 899999999875
Q ss_pred ccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHH
Q 003542 367 RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKN 446 (811)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~ 446 (811)
..... .......+++.|+|||++.+. ..++.++||||||+++|+|+||+.||.+..... ...+.
T Consensus 150 ~~~~~-------~~~~~~~~~~~y~aPE~~~~~--------~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~-~~~~~ 213 (284)
T cd07860 150 FGVPV-------RTYTHEVVTLWYRAPEILLGC--------KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRI 213 (284)
T ss_pred cccCc-------cccccccccccccCCeEEecC--------CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHH
Confidence 53221 111234567889999988642 246788999999999999999999997654221 22221
Q ss_pred HHhCCCC---------------------------CCCCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 447 IRAGERP---------------------------LFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 447 i~~~~~~---------------------------~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
+.....+ ......++.+.++|.+||..||.+||++.+++.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 214 FRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 1111000 011235677899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=300.93 Aligned_cols=241 Identities=21% Similarity=0.356 Sum_probs=188.0
Q ss_pred ceEEeeeecccc---eEEEEE-EcCCEEEEEEeccc-----HHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEe
Q 003542 217 KLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYGE-----LESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVME 287 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~~-----~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmE 287 (811)
+|++.+.||.|+ ||++.. .+|..+|+|.+... ...+.+|++++.+++||||+++++.+. ..+.+|+|||
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e 79 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFY--SDGEISICME 79 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe--eCCEEEEEee
Confidence 588999999986 666553 37889999998532 355889999999999999999998774 4568999999
Q ss_pred cCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEeccCCCCcceEEEeeccccc
Q 003542 288 LMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHA-QKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365 (811)
Q Consensus 288 y~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs-~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~ 365 (811)
|++| +|.+++... ..+++..+..++.||+.||.|||+ .+++||||||+|||++.++ .+||+|||++.
T Consensus 80 y~~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~-----~~~l~dfg~~~ 148 (308)
T cd06615 80 HMDGGSLDQVLKKA------GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRG-----EIKLCDFGVSG 148 (308)
T ss_pred ccCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCC-----cEEEccCCCcc
Confidence 9985 898888753 568999999999999999999998 5899999999999998776 79999999986
Q ss_pred cccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHH---
Q 003542 366 ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDK--- 442 (811)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~--- 442 (811)
..... ......++..|+|||++.+. .++.++||||||+++|+|++|..||.........
T Consensus 149 ~~~~~---------~~~~~~~~~~~~aPE~~~~~---------~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~ 210 (308)
T cd06615 149 QLIDS---------MANSFVGTRSYMSPERLQGT---------HYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMF 210 (308)
T ss_pred ccccc---------ccccCCCCcCccChhHhcCC---------CCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhh
Confidence 54221 12345688899999998643 5778999999999999999999999643211100
Q ss_pred -------------------------------HHHHHHhCCCCCCCC-CChHHHHHHHhhhccCCCCCCCCHHHHHHHH
Q 003542 443 -------------------------------MTKNIRAGERPLFPS-GSPKYLVNLTKKCWHTNPSQRPSFSSICRIL 488 (811)
Q Consensus 443 -------------------------------i~~~i~~~~~~~~p~-~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L 488 (811)
....+.....+..|. ..+.++.+|+.+||..||++||++.+++...
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 211 GRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred cCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 001111111222222 3567899999999999999999999998743
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-33 Score=296.45 Aligned_cols=245 Identities=22% Similarity=0.317 Sum_probs=188.6
Q ss_pred cceEEeeeecccc---eEEEEE-EcCCEEEEEEecc------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEE
Q 003542 216 KKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLV 285 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLV 285 (811)
++|++.+.||.|. +|++.. .+|+.||+|.+.. ....+.+|+.+++.++||||+++++.+. ....+|+|
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv 79 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVH--SEKRLYLV 79 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEe--cCCeEEEE
Confidence 5788999999885 777663 4789999999853 2356889999999999999999997774 45679999
Q ss_pred EecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccc
Q 003542 286 MELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365 (811)
Q Consensus 286 mEy~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~ 365 (811)
|||++++|..++... ....+++..+..++.||+.||.|||+++++||||+|+||+++.++. .+||+|||++.
T Consensus 80 ~e~~~~~l~~~~~~~----~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~----~~kl~dfg~~~ 151 (294)
T PLN00009 80 FEYLDLDLKKHMDSS----PDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN----ALKLADFGLAR 151 (294)
T ss_pred EecccccHHHHHHhC----CCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCC----EEEEccccccc
Confidence 999999988887643 1234678889999999999999999999999999999999985432 79999999986
Q ss_pred cccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHH
Q 003542 366 ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTK 445 (811)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~ 445 (811)
...... .......+++.|+|||++.+ ...++.++||||||+++|+|++|.+||...... ..+.+
T Consensus 152 ~~~~~~-------~~~~~~~~~~~y~~PE~~~~--------~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~-~~~~~ 215 (294)
T PLN00009 152 AFGIPV-------RTFTHEVVTLWYRAPEILLG--------SRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI-DELFK 215 (294)
T ss_pred ccCCCc-------cccccCceeecccCHHHHhC--------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHH
Confidence 543221 11123456888999999864 235788999999999999999999999764322 22222
Q ss_pred HHHh-CC------------------CCC--------CCCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 446 NIRA-GE------------------RPL--------FPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 446 ~i~~-~~------------------~~~--------~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
.... +. .+. .....++.+.+++.+||+.+|.+||++.+++.
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 216 IFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred HHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1110 00 000 11245677899999999999999999999987
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=300.67 Aligned_cols=248 Identities=24% Similarity=0.427 Sum_probs=195.4
Q ss_pred cceEEeeeecccc---eEEEEEE-cCC----EEEEEEeccc-----HHHHHHHHHHHHhCCCCccceeeeeEEccCCCeE
Q 003542 216 KKLMVRRRLGASS---QFKEIQW-LGD----SFVLRHFYGE-----LESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEF 282 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~~-~g~----~VAVK~~~~~-----~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~ 282 (811)
.+|+..+.||.|+ +|++... +|. .||+|.+... ...+.+|+.+++.++||||+++++.+.. ...
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~---~~~ 83 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS---PTI 83 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC---CCc
Confidence 4677778888886 7876643 454 5799988642 3368899999999999999999965532 246
Q ss_pred EEEEecCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeec
Q 003542 283 FLVMELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGF 361 (811)
Q Consensus 283 yLVmEy~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DF 361 (811)
+++|||++ |+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+||
T Consensus 84 ~~v~e~~~~g~l~~~~~~~-----~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~-----~~kL~Df 153 (303)
T cd05110 84 QLVTQLMPHGCLLDYVHEH-----KDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPN-----HVKITDF 153 (303)
T ss_pred eeeehhcCCCCHHHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCC-----ceEEccc
Confidence 79999999 6899888753 24588999999999999999999999999999999999997765 7999999
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CCCCCCCCccch
Q 003542 362 GLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQG 440 (811)
Q Consensus 362 GlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~~PF~~~~~~~ 440 (811)
|++........ ........++..|+|||++.+. .++.++||||||+++|||++ |..||.+.. .
T Consensus 154 g~~~~~~~~~~-----~~~~~~~~~~~~y~~PE~~~~~---------~~~~~~DiwslG~~l~el~t~g~~p~~~~~--~ 217 (303)
T cd05110 154 GLARLLEGDEK-----EYNADGGKMPIKWMALECIHYR---------KFTHQSDVWSYGVTIWELMTFGGKPYDGIP--T 217 (303)
T ss_pred cccccccCccc-----ccccCCCccccccCCHHHhccC---------CCChHHHHHHHHHHHHHHHhCCCCCCCCCC--H
Confidence 99976543221 1111234456789999998643 67899999999999999997 999997643 2
Q ss_pred HHHHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHHH
Q 003542 441 DKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIK 492 (811)
Q Consensus 441 ~~i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~ 492 (811)
......+..+..+..+..++..+.+++.+||..+|++||++.++++.|..+.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~ 269 (303)
T cd05110 218 REIPDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA 269 (303)
T ss_pred HHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 3344455555555566778889999999999999999999999999887764
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=297.75 Aligned_cols=239 Identities=23% Similarity=0.429 Sum_probs=192.1
Q ss_pred ceEEeeeecccc---eEEEEE-EcCCEEEEEEecc-----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEe
Q 003542 217 KLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVME 287 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~-----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmE 287 (811)
.|+..+.||.|+ +|.+.. .++..||||.+.. ....+.+|+.+++.++||||+++++.+. +...+|+|||
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e 82 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL--KGTKLWIIME 82 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE--ECCEEEEEEe
Confidence 355566677765 777663 4688999999853 3467889999999999999999998774 4568999999
Q ss_pred cCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccccc
Q 003542 288 LMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366 (811)
Q Consensus 288 y~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~ 366 (811)
|++| +|.+++.. ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++ .++|+|||++..
T Consensus 83 ~~~~~~L~~~i~~-------~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~-----~~~l~dfg~~~~ 150 (277)
T cd06640 83 YLGGGSALDLLRA-------GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQG-----DVKLADFGVAGQ 150 (277)
T ss_pred cCCCCcHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCC-----CEEEccccccee
Confidence 9985 88887753 4688899999999999999999999999999999999998776 899999999876
Q ss_pred ccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHH
Q 003542 367 RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKN 446 (811)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~ 446 (811)
...... ......++..|+|||++.+. .++.++|+||||+++|+|++|..||...... .....
T Consensus 151 ~~~~~~-------~~~~~~~~~~y~apE~~~~~---------~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--~~~~~ 212 (277)
T cd06640 151 LTDTQI-------KRNTFVGTPFWMAPEVIQQS---------AYDSKADIWSLGITAIELAKGEPPNSDMHPM--RVLFL 212 (277)
T ss_pred ccCCcc-------ccccccCcccccCHhHhccC---------CCccHHHHHHHHHHHHHHHHCCCCCCCcChH--hHhhh
Confidence 543211 11234578889999998643 5788999999999999999999999764322 22333
Q ss_pred HHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHH
Q 003542 447 IRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRI 487 (811)
Q Consensus 447 i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~ 487 (811)
+.....+..+..++..+.+++.+||..+|.+||++.+++..
T Consensus 213 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 213 IPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred hhcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 44444555666788899999999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=318.13 Aligned_cols=240 Identities=25% Similarity=0.403 Sum_probs=200.7
Q ss_pred hcceEEeeeecccceEEEEE-----EcCCEEEEEEecc------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEE
Q 003542 215 LKKLMVRRRLGASSQFKEIQ-----WLGDSFVLRHFYG------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFF 283 (811)
Q Consensus 215 ~k~~~i~~~lG~G~vyk~v~-----~~g~~VAVK~~~~------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~y 283 (811)
...|.+.+.||.| .|..++ .+|..||||.+.+ ....+.+|+++|+.|+|||||++|.+. +....+|
T Consensus 55 vg~y~i~~tig~g-~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~--~t~~~ly 131 (596)
T KOG0586|consen 55 VGLYVIIKTIGKG-NFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVI--ETEATLY 131 (596)
T ss_pred ccceeeeeeeccc-eeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeee--eecceeE
Confidence 3579999999999 566563 3899999999964 345689999999999999999999776 5567899
Q ss_pred EEEecCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecc
Q 003542 284 LVMELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFG 362 (811)
Q Consensus 284 LVmEy~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFG 362 (811)
+||||+. |.+.+||... ....+..+..++.|+++|++|||+++|+|||||.+|||++.+- ++||+|||
T Consensus 132 lV~eya~~ge~~~yl~~~------gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~m-----nikIaDfg 200 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLVKH------GRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENM-----NIKIADFG 200 (596)
T ss_pred EEEEeccCchhHHHHHhc------ccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhccccccc-----ceeeeccc
Confidence 9999998 5899999875 6677789999999999999999999999999999999997664 79999999
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHH
Q 003542 363 LSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDK 442 (811)
Q Consensus 363 lA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~ 442 (811)
++..+.... ...+.+|++.|.|||++.+.. ..++++|+||+|++||-|+.|.+||++.....
T Consensus 201 fS~~~~~~~--------~lqt~cgsppyAaPEl~~g~~--------y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~-- 262 (596)
T KOG0586|consen 201 FSTFFDYGL--------MLQTFCGSPPYAAPELFNGKK--------YDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE-- 262 (596)
T ss_pred cceeecccc--------cccccCCCCCccChHhhcCcc--------cCCcceehhhhhhhheeeeecccccCCccccc--
Confidence 999887543 345788999999999999864 34578999999999999999999999865442
Q ss_pred HHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHH
Q 003542 443 MTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRI 487 (811)
Q Consensus 443 i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~ 487 (811)
+...+..+. ..+|..++.+..+||+++|..+|.+|++.++|.+.
T Consensus 263 Lr~rvl~gk-~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 263 LRPRVLRGK-YRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred ccchheeee-ecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 222222221 22566677789999999999999999999999873
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=313.10 Aligned_cols=240 Identities=25% Similarity=0.309 Sum_probs=183.0
Q ss_pred cceEEeeeecccc---eEEEEEE-cCCEEEEEEecccHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEecCCC
Q 003542 216 KKLMVRRRLGASS---QFKEIQW-LGDSFVLRHFYGELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK 291 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~~-~g~~VAVK~~~~~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~~g 291 (811)
..|.+++.||.|+ ||++... +++.||+|..... ....|+.+|++++||||+++++.+. .....|+||||+.+
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~~~ 141 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--TTLIEAMLLQNVNHPSVIRMKDTLV--SGAITCMVLPHYSS 141 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--ccHHHHHHHHhCCCCCCcChhheEE--eCCeeEEEEEccCC
Confidence 4799999999986 7766533 6779999986432 3467999999999999999997774 45678999999999
Q ss_pred CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccccccC
Q 003542 292 DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYAS 371 (811)
Q Consensus 292 ~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~~ 371 (811)
+|..++... ...+++..++.|+.||+.||.|||++||+||||||+|||++..+ .+||+|||++......
T Consensus 142 ~l~~~l~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~-----~~kl~DfG~a~~~~~~- 210 (357)
T PHA03209 142 DLYTYLTKR-----SRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVD-----QVCIGDLGAAQFPVVA- 210 (357)
T ss_pred cHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-----CEEEecCccccccccC-
Confidence 999988753 25689999999999999999999999999999999999998776 8999999998643221
Q ss_pred CCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCC-CCCCccch--------HH
Q 003542 372 RNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVP-FEDGHLQG--------DK 442 (811)
Q Consensus 372 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~P-F~~~~~~~--------~~ 442 (811)
.......||+.|+|||++.+. .++.++|||||||++|||+++..| |....... ..
T Consensus 211 -------~~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~ 274 (357)
T PHA03209 211 -------PAFLGLAGTVETNAPEVLARD---------KYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSH 274 (357)
T ss_pred -------cccccccccccccCCeecCCC---------CCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHH
Confidence 112345689999999998643 678999999999999999985444 44321110 11
Q ss_pred HHHHHHh-CC-CCCCC------------------------------CCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 443 MTKNIRA-GE-RPLFP------------------------------SGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 443 i~~~i~~-~~-~~~~p------------------------------~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
+...+.. +. ...++ ...+..+.+||.+||+.||.+|||+.++++
T Consensus 275 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~ 350 (357)
T PHA03209 275 LLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN 350 (357)
T ss_pred HHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc
Confidence 1111111 00 00111 134556778999999999999999999987
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=333.74 Aligned_cols=264 Identities=16% Similarity=0.265 Sum_probs=192.6
Q ss_pred cceEEeeeecccc---eEEEEE-EcCCEEEEEEeccc-------HHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEE
Q 003542 216 KKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYGE-------LESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFL 284 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~~-------~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yL 284 (811)
++|++.+.||+|+ ||++.. .+|+.||||++... .+.+.+|+.+++.++||||+++++.+ .+.+..|+
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~--~d~~~lyL 79 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSIC--SDGDPVYY 79 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEE--eeCCEEEE
Confidence 5799999999986 777663 36899999998532 35689999999999999999999766 44567999
Q ss_pred EEecCCC-CHHHHHHHhhCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEE
Q 003542 285 VMELMSK-DLSCYMRETFGS-----RRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKV 358 (811)
Q Consensus 285 VmEy~~g-~L~~~L~~~~~~-----~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL 358 (811)
||||++| +|.+++...... .....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||
T Consensus 80 VMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg-----~vKL 154 (932)
T PRK13184 80 TMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFG-----EVVI 154 (932)
T ss_pred EEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCC-----CEEE
Confidence 9999995 898888653211 1123456778899999999999999999999999999999998876 8999
Q ss_pred eeccccccccccCCCC-----------CCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHh
Q 003542 359 SGFGLSTARTYASRNT-----------PPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELL 427 (811)
Q Consensus 359 ~DFGlA~~~~~~~~~~-----------~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELl 427 (811)
+|||++.......... ...........||+.|+|||++.+. .++.++|||||||++|||+
T Consensus 155 iDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~---------~~S~kSDIWSLGVILyELL 225 (932)
T PRK13184 155 LDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGV---------PASESTDIYALGVILYQML 225 (932)
T ss_pred EecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCC---------CCCcHhHHHHHHHHHHHHH
Confidence 9999998662211000 0001112235799999999998743 6789999999999999999
Q ss_pred hCCCCCCCCccchHHHHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHH-HHHHHHHHHHHHhhcC
Q 003542 428 TGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFS-SICRILRYIKKFMANN 498 (811)
Q Consensus 428 tG~~PF~~~~~~~~~i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~-eIl~~L~~i~k~l~~~ 498 (811)
+|..||.............+...........+++.+.+++.+||..||.+||+.. ++++. +..++...
T Consensus 226 TG~~PF~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~---Le~~lq~~ 294 (932)
T PRK13184 226 TLSFPYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQD---LEPHLQGS 294 (932)
T ss_pred HCCCCCCCcchhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHH---HHHHHhcC
Confidence 9999997643221111111111111111235778899999999999999997654 44443 44444433
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=290.09 Aligned_cols=241 Identities=25% Similarity=0.428 Sum_probs=197.9
Q ss_pred ceEEeeeecccc---eEEEEEE-cCCEEEEEEeccc-----HHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEe
Q 003542 217 KLMVRRRLGASS---QFKEIQW-LGDSFVLRHFYGE-----LESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVME 287 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v~~-~g~~VAVK~~~~~-----~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmE 287 (811)
+|++.+.||.|+ +|++... +|+.||||.+... ...+.+|+.++..++||||+++++.+. ....+|+|||
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~lv~e 79 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFY--KEGEISIVLE 79 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc--cCCeEEEEEE
Confidence 577788888875 7777644 6999999998642 567999999999999999999997763 4567999999
Q ss_pred cCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEeccCCCCcceEEEeeccccc
Q 003542 288 LMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHA-QKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365 (811)
Q Consensus 288 y~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs-~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~ 365 (811)
|++ ++|.+++... ..+++..++.++.||+.||.|||+ .+++||||+|+||+++.++ .++|+|||++.
T Consensus 80 ~~~~~~L~~~l~~~------~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~-----~~~l~df~~~~ 148 (264)
T cd06623 80 YMDGGSLADLLKKV------GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKG-----EVKIADFGISK 148 (264)
T ss_pred ecCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCC-----CEEEccCccce
Confidence 999 5899888753 678999999999999999999999 9999999999999998876 89999999987
Q ss_pred cccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCcc-chHHHH
Q 003542 366 ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHL-QGDKMT 444 (811)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~-~~~~i~ 444 (811)
....... ......++..|+|||.+... .++.++|+||||+++|+|++|..||..... ......
T Consensus 149 ~~~~~~~-------~~~~~~~~~~y~~pE~~~~~---------~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~ 212 (264)
T cd06623 149 VLENTLD-------QCNTFVGTVTYMSPERIQGE---------SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELM 212 (264)
T ss_pred ecccCCC-------cccceeecccccCHhhhCCC---------CCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHH
Confidence 6543321 11244578889999998642 678899999999999999999999976531 223344
Q ss_pred HHHHhCCCCCCCCC-ChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 445 KNIRAGERPLFPSG-SPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 445 ~~i~~~~~~~~p~~-~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
..+.....+..+.. ++..+.++|.+||..+|.+||++.++++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 213 QAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred HHHhcCCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 55555555556666 8889999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=296.69 Aligned_cols=241 Identities=28% Similarity=0.442 Sum_probs=186.9
Q ss_pred eEEeeeecccc---eEEEEEE-cCCEEEEEEeccc------HHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEe
Q 003542 218 LMVRRRLGASS---QFKEIQW-LGDSFVLRHFYGE------LESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVME 287 (811)
Q Consensus 218 ~~i~~~lG~G~---vyk~v~~-~g~~VAVK~~~~~------~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmE 287 (811)
|++.+.||+|+ ||++... +++.||+|.+... .....+|+.++++++||||+++++.+.. ...+++|||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~~v~~ 78 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD--DNYLYIVME 78 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE--SSEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc--ccccccccc
Confidence 67888888885 6766543 5668999999642 1233559999999999999999977743 567999999
Q ss_pred cCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccccc
Q 003542 288 LMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366 (811)
Q Consensus 288 y~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~ 366 (811)
|+.+ +|.+++... ..+++..++.++.||+.||.|||+.||+|+||||+||+++.++ .++|+|||++..
T Consensus 79 ~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~-----~~~l~Dfg~~~~ 147 (260)
T PF00069_consen 79 YCPGGSLQDYLQKN------KPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENG-----EVKLIDFGSSVK 147 (260)
T ss_dssp EETTEBHHHHHHHH------SSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTS-----EEEESSGTTTEE
T ss_pred cccccccccccccc------ccccccccccccccccccccccccccccccccccccccccccc-----cccccccccccc
Confidence 9997 999999843 6789999999999999999999999999999999999998776 899999999875
Q ss_pred ccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCcc-chHHHHH
Q 003542 367 RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHL-QGDKMTK 445 (811)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~-~~~~i~~ 445 (811)
.... ........++..|+|||++.. ...++.++||||||+++|+|++|..||..... .......
T Consensus 148 ~~~~-------~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~ 212 (260)
T PF00069_consen 148 LSEN-------NENFNPFVGTPEYMAPEVLQQ--------GKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIE 212 (260)
T ss_dssp STST-------TSEBSSSSSSGGGSCHHHHTT--------TSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHH
T ss_pred cccc-------ccccccccccccccccccccc--------cccccccccccccccccccccccccccccccchhhhhhhh
Confidence 4111 112345678899999999861 23678999999999999999999999987521 1111121
Q ss_pred HHHhCCC---CCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 446 NIRAGER---PLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 446 ~i~~~~~---~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
....... .......+..+.++|.+||+.||.+||++.++++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 213 KILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred hcccccccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111110 0011223478999999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=292.26 Aligned_cols=244 Identities=23% Similarity=0.364 Sum_probs=194.6
Q ss_pred ceEEeeeecccc---eEEEEE-EcCCEEEEEEecc---------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEE
Q 003542 217 KLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG---------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFF 283 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~---------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~y 283 (811)
+|.+.+.||+|+ +|.+.. .+|..||+|.+.. ....+.+|+.++++++||||+++++.+.+.....++
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (264)
T cd06653 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLS 82 (264)
T ss_pred ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEE
Confidence 688888999885 666653 4789999998731 235788999999999999999999777555556789
Q ss_pred EEEecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecc
Q 003542 284 LVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFG 362 (811)
Q Consensus 284 LVmEy~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFG 362 (811)
+||||+++ +|.+++... ..+++..+..++.||+.||.|||+.|++|+||||+||+++.++ .++|+|||
T Consensus 83 ~v~e~~~~~~L~~~~~~~------~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~-----~~~l~dfg 151 (264)
T cd06653 83 IFVEYMPGGSIKDQLKAY------GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAG-----NVKLGDFG 151 (264)
T ss_pred EEEEeCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC-----CEEECccc
Confidence 99999985 888888753 4588999999999999999999999999999999999998766 79999999
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHH
Q 003542 363 LSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDK 442 (811)
Q Consensus 363 lA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~ 442 (811)
++......... ........++..|+|||++.+. .++.++|+|||||++|+|++|..||...... ..
T Consensus 152 ~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~ 217 (264)
T cd06653 152 ASKRIQTICMS----GTGIKSVTGTPYWMSPEVISGE---------GYGRKADVWSVACTVVEMLTEKPPWAEYEAM-AA 217 (264)
T ss_pred ccccccccccc----CccccccCCcccccCHhhhcCC---------CCCccccHHHHHHHHHHHHhCCCCCCccCHH-HH
Confidence 98765332110 1111234588899999998643 5678999999999999999999999764322 23
Q ss_pred HHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 443 MTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 443 i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
+.+.......+.+|...++.+.++|.+||. +|..||++.+++.
T Consensus 218 ~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 218 IFKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred HHHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 333333444566788888999999999999 5799999998865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=296.59 Aligned_cols=250 Identities=23% Similarity=0.367 Sum_probs=191.6
Q ss_pred cceEEeeeecccc---eEEEEE-EcCCEEEEEEecc---cHHHHHHHHHHHHhC-CCCccceeeeeEEcc----CCCeEE
Q 003542 216 KKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG---ELESLNAEISTMLSL-SHPNIVQYLCGFCDE----EKKEFF 283 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~---~~~~~~~Ei~iL~~L-~HPNIVkl~~~~~~e----~~~~~y 283 (811)
..|++.+.+|.|+ +|.+.. ..++.||+|.+.. ....+..|+.+++++ +||||+++++.+... ....+|
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 95 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLW 95 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEE
Confidence 5677788888885 666553 3788999999853 345788999999999 799999999776532 245789
Q ss_pred EEEecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecc
Q 003542 284 LVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFG 362 (811)
Q Consensus 284 LVmEy~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFG 362 (811)
++|||+++ +|.+++... ....+++..+..++.||+.||.|||+.||+||||+|+||+++.++ .++|+|||
T Consensus 96 iv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~-----~~~l~dfg 166 (282)
T cd06636 96 LVMEFCGAGSVTDLVKNT----KGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENA-----EVKLVDFG 166 (282)
T ss_pred EEEEeCCCCcHHHHHHHc----cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-----CEEEeeCc
Confidence 99999995 888887653 224588889999999999999999999999999999999998776 79999999
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHH
Q 003542 363 LSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDK 442 (811)
Q Consensus 363 lA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~ 442 (811)
++....... .......|+..|+|||++..... ....++.++|||||||++|+|++|..||...... ..
T Consensus 167 ~~~~~~~~~-------~~~~~~~~~~~y~aPE~l~~~~~----~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~-~~ 234 (282)
T cd06636 167 VSAQLDRTV-------GRRNTFIGTPYWMAPEVIACDEN----PDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM-RA 234 (282)
T ss_pred chhhhhccc-------cCCCcccccccccCHhhcCcccC----cCcCCCcccchhHHHHHHHHHHhCCCCccccCHH-hh
Confidence 987553221 11234568889999999864211 1336788999999999999999999999764322 21
Q ss_pred HHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 443 MTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 443 i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
.............+..++..+.+||.+||..||.+||++.+|++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 235 LFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred hhhHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 21111111222233467889999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=294.27 Aligned_cols=240 Identities=21% Similarity=0.314 Sum_probs=185.2
Q ss_pred eEEeeeecccc---eEEEE-EEcCCEEEEEEeccc-----HHHHHHHHHHHHhCC-CCccceeeeeEEccCCCeEEEEEe
Q 003542 218 LMVRRRLGASS---QFKEI-QWLGDSFVLRHFYGE-----LESLNAEISTMLSLS-HPNIVQYLCGFCDEEKKEFFLVME 287 (811)
Q Consensus 218 ~~i~~~lG~G~---vyk~v-~~~g~~VAVK~~~~~-----~~~~~~Ei~iL~~L~-HPNIVkl~~~~~~e~~~~~yLVmE 287 (811)
|++.+.+|.|+ +|++. ..+++.||+|.+... .....+|+.++.++. ||||+++++.+.+...+.+++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 45677788875 77766 347899999998642 233457999999995 999999998776544467999999
Q ss_pred cCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccc
Q 003542 288 LMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTAR 367 (811)
Q Consensus 288 y~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~ 367 (811)
|++++|.+++... ...+++..++.++.||+.||.|||+.|++||||+|+||+++. + .+||+|||++...
T Consensus 81 ~~~~~l~~~l~~~-----~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~-----~~kl~dfg~~~~~ 149 (282)
T cd07831 81 LMDMNLYELIKGR-----KRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-D-----ILKLADFGSCRGI 149 (282)
T ss_pred cCCccHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-C-----CeEEEeccccccc
Confidence 9999999888753 246899999999999999999999999999999999999987 5 8999999998765
Q ss_pred cccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHHH
Q 003542 368 TYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNI 447 (811)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i 447 (811)
.... ......++..|+|||++.. ...++.++|||||||++|||++|.+||.+.+... ....+
T Consensus 150 ~~~~--------~~~~~~~~~~y~aPE~~~~--------~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~--~~~~~ 211 (282)
T cd07831 150 YSKP--------PYTEYISTRWYRAPECLLT--------DGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD--QIAKI 211 (282)
T ss_pred ccCC--------CcCCCCCCcccCChhHhhc--------CCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH--HHHHH
Confidence 3321 1123457888999998753 2356789999999999999999999997643221 11111
Q ss_pred Hh---------------CC--CCCC-----------CCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 448 RA---------------GE--RPLF-----------PSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 448 ~~---------------~~--~~~~-----------p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
.. .. ...+ ....+..+.+||.+||..+|.+||++.+++.
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 212 HDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred HHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 10 00 0001 1245788999999999999999999999976
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=300.33 Aligned_cols=249 Identities=18% Similarity=0.340 Sum_probs=190.5
Q ss_pred ceEEeeeecccc---eEEEE-EEcCCEEEEEEecc-------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEE
Q 003542 217 KLMVRRRLGASS---QFKEI-QWLGDSFVLRHFYG-------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLV 285 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v-~~~g~~VAVK~~~~-------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLV 285 (811)
+|++.+.||.|+ +|++. ...++.||+|.+.. ....+.+|+.+++.++||||+++++.+ .....+|+|
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~--~~~~~~~lv 79 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSF--ETKRHLCMV 79 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE--ecCCEEEEE
Confidence 578888888885 66655 34778999999853 245678999999999999999999777 345679999
Q ss_pred EecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccc
Q 003542 286 MELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS 364 (811)
Q Consensus 286 mEy~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA 364 (811)
|||++| +|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++
T Consensus 80 ~e~~~g~~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~-----~~~l~dfg~~ 148 (305)
T cd05609 80 MEYVEGGDCATLLKNI------GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMG-----HIKLTDFGLS 148 (305)
T ss_pred EecCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCC-----CEEEeeCCCc
Confidence 999995 888888653 5689999999999999999999999999999999999998776 8999999998
Q ss_pred ccccccCCCC--------CCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCC
Q 003542 365 TARTYASRNT--------PPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDG 436 (811)
Q Consensus 365 ~~~~~~~~~~--------~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~ 436 (811)
+......... ...........++..|+|||.+.+. .++.++||||||+++|+|++|..||.+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Di~slG~vl~el~~g~~pf~~~ 219 (305)
T cd05609 149 KIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQ---------GYGKPVDWWAMGIILYEFLVGCVPFFGD 219 (305)
T ss_pred cccCcCccccccccccccchhhccccCCccCccccCchhccCC---------CCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 6421110000 0000011234578889999998643 5788999999999999999999999764
Q ss_pred ccchHHHHHHHHhCCC--CCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHH
Q 003542 437 HLQGDKMTKNIRAGER--PLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILR 489 (811)
Q Consensus 437 ~~~~~~i~~~i~~~~~--~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~ 489 (811)
.. ..+...+..+.. +..+..++.++.++|.+||+.||.+||++.++.+.|.
T Consensus 220 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 220 TP--EELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred CH--HHHHHHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence 32 334444443322 2222357888999999999999999999766655443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=294.48 Aligned_cols=246 Identities=24% Similarity=0.344 Sum_probs=193.0
Q ss_pred ceEEeeeecccc---eEEEEE-EcCCEEEEEEecc-----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEe
Q 003542 217 KLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVME 287 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~-----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmE 287 (811)
+|...+.||.|+ +|.+.. .+++.||+|.+.. ....+.+|+++++.++||||+++++.+..+....+|+|||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 81 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME 81 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence 578889999885 676664 3789999999863 2456899999999999999999997776666668999999
Q ss_pred cCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccccc
Q 003542 288 LMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366 (811)
Q Consensus 288 y~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~ 366 (811)
|++| +|.+++..... ....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++ .++|+|||++..
T Consensus 82 ~~~~~~L~~~l~~~~~--~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~-----~~~l~dfg~~~~ 154 (287)
T cd06621 82 YCEGGSLDSIYKKVKK--RGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKG-----QVKLCDFGVSGE 154 (287)
T ss_pred ecCCCCHHHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCC-----eEEEeecccccc
Confidence 9985 88887764321 235688999999999999999999999999999999999998776 899999999865
Q ss_pred ccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCcc---chHHH
Q 003542 367 RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHL---QGDKM 443 (811)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~---~~~~i 443 (811)
..... .....++..|+|||.+.+. .++.++||||||+++|+|++|..||..... ...+.
T Consensus 155 ~~~~~---------~~~~~~~~~y~~pE~~~~~---------~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 216 (287)
T cd06621 155 LVNSL---------AGTFTGTSFYMAPERIQGK---------PYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIEL 216 (287)
T ss_pred ccccc---------cccccCCccccCHHHhcCC---------CCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHH
Confidence 43221 1234567889999998643 678899999999999999999999976521 12223
Q ss_pred HHHHHhCCCCCCC------CCChHHHHHHHhhhccCCCCCCCCHHHHHHH
Q 003542 444 TKNIRAGERPLFP------SGSPKYLVNLTKKCWHTNPSQRPSFSSICRI 487 (811)
Q Consensus 444 ~~~i~~~~~~~~p------~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~ 487 (811)
...+.....+..+ ...++.+.++|.+||..+|.+|||+.++++.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 217 LSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred HHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 3333332222222 2345789999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=300.31 Aligned_cols=246 Identities=23% Similarity=0.412 Sum_probs=191.8
Q ss_pred cceEEeeeecccc---eEEEEE-EcCCEEEEEEecc-----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEE
Q 003542 216 KKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVM 286 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~-----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVm 286 (811)
.+|++.+.||+|+ +|++.. .+|+.||+|++.. ....+.+|+++++.++||||+++++.+. ....+|+||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~ 82 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFL--NENNICMCM 82 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEe--cCCEEEEEE
Confidence 4567777788875 666553 3688999998743 2467889999999999999999998774 346799999
Q ss_pred ecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEeccCCCCcceEEEeecccc
Q 003542 287 ELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHA-QKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS 364 (811)
Q Consensus 287 Ey~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs-~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA 364 (811)
||+++ +|..++... ..+++..+..++.+++.||.|||+ .+++||||+|+||+++.++ .++|+|||++
T Consensus 83 e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~-----~~~l~d~gl~ 151 (284)
T cd06620 83 EFMDCGSLDRIYKKG------GPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRG-----QIKLCDFGVS 151 (284)
T ss_pred ecCCCCCHHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCC-----cEEEccCCcc
Confidence 99995 787777653 568999999999999999999997 5899999999999998776 8999999998
Q ss_pred ccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccc-----
Q 003542 365 TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQ----- 439 (811)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~----- 439 (811)
...... ......|+..|+|||++.+. .++.++|||||||++|+|++|..||......
T Consensus 152 ~~~~~~---------~~~~~~~~~~~~aPE~~~~~---------~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~ 213 (284)
T cd06620 152 GELINS---------IADTFVGTSTYMSPERIQGG---------KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQD 213 (284)
T ss_pred cchhhh---------ccCccccCcccCCHHHHccC---------CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhh
Confidence 654221 11245688999999998642 6788999999999999999999999754321
Q ss_pred -h---HHHHHHHHhCCCCCCCC-CChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHHH
Q 003542 440 -G---DKMTKNIRAGERPLFPS-GSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIK 492 (811)
Q Consensus 440 -~---~~i~~~i~~~~~~~~p~-~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~ 492 (811)
. ......+.....+.++. .++..+.+|+.+||..||.+||++.+++++...++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 214 DPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred hhhHHHHHHHHHhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 0 11222233333333333 37788999999999999999999999988654443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=291.71 Aligned_cols=248 Identities=22% Similarity=0.377 Sum_probs=181.4
Q ss_pred ecccc---eEEEEEEc---CCEEEEEEecc-----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEecCC-C
Q 003542 224 LGASS---QFKEIQWL---GDSFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMS-K 291 (811)
Q Consensus 224 lG~G~---vyk~v~~~---g~~VAVK~~~~-----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~~-g 291 (811)
||+|+ ||++..+. ...+|+|.+.. ....+.+|+.+++.++||||+++++.+ .....+|+||||++ |
T Consensus 3 lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~--~~~~~~~lv~e~~~~g 80 (269)
T cd05042 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQC--IESIPYLLVLEFCPLG 80 (269)
T ss_pred CCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEE--CCCCceEEEEEeCCCC
Confidence 55553 77765443 34788998753 234678999999999999999999766 34567999999999 5
Q ss_pred CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccccccC
Q 003542 292 DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYAS 371 (811)
Q Consensus 292 ~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~~ 371 (811)
+|.+++...... ....+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus 81 ~L~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~-----~~kl~dfg~~~~~~~~~ 154 (269)
T cd05042 81 DLKNYLRSNRGM-VAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADL-----SVKIGDYGLALEQYPED 154 (269)
T ss_pred cHHHHHHhcccc-ccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCC-----cEEEeccccccccccch
Confidence 999988764211 113356788899999999999999999999999999999998876 89999999986532221
Q ss_pred CCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CCCCCCCCccchHHHHHHHHhC
Q 003542 372 RNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGDKMTKNIRAG 450 (811)
Q Consensus 372 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~~PF~~~~~~~~~i~~~i~~~ 450 (811)
. ........+++.|+|||++....... ....++.++|||||||++|||++ |..||...... ..+...+...
T Consensus 155 ~-----~~~~~~~~~~~~y~aPE~~~~~~~~~--~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-~~~~~~~~~~ 226 (269)
T cd05042 155 Y-----YITKDCHAVPLRWLAPELVEIRGQDL--LPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE-QVLKQVVREQ 226 (269)
T ss_pred h-----eeccCCCCCcccccCHHHHhhccccc--cccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH-HHHHHHhhcc
Confidence 0 01112344667899999987532110 12357889999999999999999 88898754322 2222223322
Q ss_pred C----CCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHH
Q 003542 451 E----RPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRIL 488 (811)
Q Consensus 451 ~----~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L 488 (811)
. .+..+..++..+.+++..|| .||.+||++++|++.|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 227 DIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred CccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 2 12334567888999999999 5999999999998865
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=305.01 Aligned_cols=251 Identities=24% Similarity=0.354 Sum_probs=192.8
Q ss_pred HhcceEEeeeecccc---eEEEEE-EcCCEEEEEEecc------cHHHHHHHHHHHHhCCCCccceeeeeEEccC----C
Q 003542 214 LLKKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG------ELESLNAEISTMLSLSHPNIVQYLCGFCDEE----K 279 (811)
Q Consensus 214 l~k~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~----~ 279 (811)
+.++|++.+.||.|+ ||.+.. .+|+.||||.+.. ....+.+|+.+++.++||||+++++.|.... .
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 467899999999986 666553 4889999999853 2356778999999999999999997775322 2
Q ss_pred CeEEEEEecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEe
Q 003542 280 KEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVS 359 (811)
Q Consensus 280 ~~~yLVmEy~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~ 359 (811)
..+|+||||+.++|..++.. .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+
T Consensus 94 ~~~~lv~e~~~~~l~~~~~~--------~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~-----~~kL~ 160 (353)
T cd07850 94 QDVYLVMELMDANLCQVIQM--------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-----TLKIL 160 (353)
T ss_pred CcEEEEEeccCCCHHHHHhh--------cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC-----CEEEc
Confidence 35799999999998887753 388899999999999999999999999999999999998876 89999
Q ss_pred eccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccc
Q 003542 360 GFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQ 439 (811)
Q Consensus 360 DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~ 439 (811)
|||++....... ......++..|+|||++.+. .++.++|||||||++|+|++|+.||......
T Consensus 161 Dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~---------~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~ 223 (353)
T cd07850 161 DFGLARTAGTSF--------MMTPYVVTRYYRAPEVILGM---------GYKENVDIWSVGCIMGEMIRGTVLFPGTDHI 223 (353)
T ss_pred cCccceeCCCCC--------CCCCCcccccccCHHHHhCC---------CCCCchhhHhHHHHHHHHHHCCCCCCCCCHH
Confidence 999997653321 12234578899999999753 6788999999999999999999999754321
Q ss_pred hHHHHHHHHh--------------------CCCCC--------------C-------CCCChHHHHHHHhhhccCCCCCC
Q 003542 440 GDKMTKNIRA--------------------GERPL--------------F-------PSGSPKYLVNLTKKCWHTNPSQR 478 (811)
Q Consensus 440 ~~~i~~~i~~--------------------~~~~~--------------~-------p~~~~~~l~~LI~~cL~~DP~~R 478 (811)
......+.. ...+. + +...++.+.+||.+||..||.+|
T Consensus 224 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 302 (353)
T cd07850 224 -DQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKR 302 (353)
T ss_pred -HHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhC
Confidence 111000000 00000 0 11345668999999999999999
Q ss_pred CCHHHHHHHHHHHHHHhh
Q 003542 479 PSFSSICRILRYIKKFMA 496 (811)
Q Consensus 479 PS~~eIl~~L~~i~k~l~ 496 (811)
||+.+++. ..++..|..
T Consensus 303 ~t~~eiL~-~~~~~~~~~ 319 (353)
T cd07850 303 ISVDDALQ-HPYINVWYD 319 (353)
T ss_pred cCHHHHhc-ChhHhhccC
Confidence 99999997 556665543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=295.65 Aligned_cols=252 Identities=23% Similarity=0.367 Sum_probs=193.6
Q ss_pred hcceEEeeeecccc---eEEEEE-EcCCEEEEEEecc---cHHHHHHHHHHHHhC-CCCccceeeeeEEccC---CCeEE
Q 003542 215 LKKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG---ELESLNAEISTMLSL-SHPNIVQYLCGFCDEE---KKEFF 283 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~---~~~~~~~Ei~iL~~L-~HPNIVkl~~~~~~e~---~~~~y 283 (811)
..+|++.+.||.|+ +|++.. .+|+.+|+|.+.. ....+.+|+.++.++ +||||+++++.+...+ ...+|
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~ 100 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLW 100 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeE
Confidence 46799999999985 676653 4788999999853 346678999999999 8999999997775332 24689
Q ss_pred EEEecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecc
Q 003542 284 LVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFG 362 (811)
Q Consensus 284 LVmEy~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFG 362 (811)
+||||++| +|.+++..... ....+++..++.++.|++.||.|||+.+++||||||+||+++.++ .+||+|||
T Consensus 101 lv~ey~~~~sL~~~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~-----~~kl~dfg 173 (291)
T cd06639 101 LVLELCNGGSVTELVKGLLI--CGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEG-----GVKLVDFG 173 (291)
T ss_pred EEEEECCCCcHHHHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCC-----CEEEeecc
Confidence 99999985 88887764321 225689999999999999999999999999999999999998776 79999999
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHH
Q 003542 363 LSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDK 442 (811)
Q Consensus 363 lA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~ 442 (811)
++........ ......|+..|+|||++..... ....++.++|||||||++|+|++|++||...... ..
T Consensus 174 ~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~----~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~-~~ 241 (291)
T cd06639 174 VSAQLTSTRL-------RRNTSVGTPFWMAPEVIACEQQ----YDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV-KT 241 (291)
T ss_pred cchhcccccc-------cccCccCCccccChhhhcCCCC----cccccCCccchHHHHHHHHHHhhCCCCCCCCcHH-HH
Confidence 9876543211 1123467888999999864311 0124688999999999999999999999764322 11
Q ss_pred HHHHHHhCCCC--CCCCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 443 MTKNIRAGERP--LFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 443 i~~~i~~~~~~--~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
+ ..+.....+ ..+...+..+.+||.+||+.+|++||++.+|+.
T Consensus 242 ~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 242 L-FKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred H-HHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 2 223223222 224456678999999999999999999999976
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=288.86 Aligned_cols=242 Identities=25% Similarity=0.436 Sum_probs=193.2
Q ss_pred ceEEeeeecccc---eEEEEE-EcCCEEEEEEecc------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEE
Q 003542 217 KLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVM 286 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVm 286 (811)
+|++.+.||.|+ +|++.. .+|..||+|.+.. +.+.+.+|+.+++.++||||+++++.+ .....+|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~--~~~~~~~lv~ 78 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASF--QENGRLFIVM 78 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhhee--ccCCeEEEEE
Confidence 477888888875 777664 3688999999842 446788999999999999999999766 4456799999
Q ss_pred ecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccc
Q 003542 287 ELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365 (811)
Q Consensus 287 Ey~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~ 365 (811)
||+++ +|.+++... ....+++..+..++.|++.||.|||+.+++|+||||+||+++.++. .+||+|||.+.
T Consensus 79 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~----~~~l~d~~~~~ 150 (257)
T cd08225 79 EYCDGGDLMKRINRQ----RGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGM----VAKLGDFGIAR 150 (257)
T ss_pred ecCCCCcHHHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCC----eEEecccccch
Confidence 99985 898888653 1245799999999999999999999999999999999999977642 68999999987
Q ss_pred cccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHH
Q 003542 366 ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTK 445 (811)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~ 445 (811)
...... .......|++.|+|||++.+ ..++.++|+||||+++|+|++|..||...... ....
T Consensus 151 ~~~~~~-------~~~~~~~~~~~~~ape~~~~---------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~ 212 (257)
T cd08225 151 QLNDSM-------ELAYTCVGTPYYLSPEICQN---------RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH--QLVL 212 (257)
T ss_pred hccCCc-------ccccccCCCccccCHHHHcC---------CCCCchhhHHHHHHHHHHHHhCCCCCCCccHH--HHHH
Confidence 654321 11123458889999999863 25788999999999999999999999764322 2233
Q ss_pred HHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 446 NIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 446 ~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
.+..+..+..+...+..+.++|.+||..+|++|||+.++++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 213 KICQGYFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred HHhcccCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 34444444455567888999999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-33 Score=296.08 Aligned_cols=244 Identities=25% Similarity=0.346 Sum_probs=187.1
Q ss_pred cceEEeeeecccc---eEEEEE-EcCCEEEEEEecc-----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEE
Q 003542 216 KKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVM 286 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~-----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVm 286 (811)
++|.+.+.||.|+ ||.+.. .+|..||+|.+.. ....+.+|+.+++.++|+||+++++.+. .....|+||
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~--~~~~~~lv~ 82 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIH--TKETLTFVF 82 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEe--cCCeEEEEE
Confidence 5789999999985 677653 4789999999853 2246789999999999999999997774 456789999
Q ss_pred ecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccccc
Q 003542 287 ELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366 (811)
Q Consensus 287 Ey~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~ 366 (811)
||+.++|..++... ...+++..+..++.||+.||.|||+.||+||||||+|||++.++ .++|+|||+++.
T Consensus 83 e~~~~~l~~~~~~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~-----~~~l~Dfg~~~~ 152 (291)
T cd07870 83 EYMHTDLAQYMIQH-----PGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLG-----ELKLADFGLARA 152 (291)
T ss_pred ecccCCHHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCC-----cEEEeccccccc
Confidence 99999988887642 24578888999999999999999999999999999999998776 899999999865
Q ss_pred ccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHH
Q 003542 367 RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKN 446 (811)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~ 446 (811)
...... ......+++.|+|||++.+. ..++.++||||||+++|+|++|..||.+.....+.+.+.
T Consensus 153 ~~~~~~-------~~~~~~~~~~y~aPE~~~~~--------~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~ 217 (291)
T cd07870 153 KSIPSQ-------TYSSEVVTLWYRPPDVLLGA--------TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKI 217 (291)
T ss_pred cCCCCC-------CCCCccccccccCCceeecC--------CCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHH
Confidence 432211 11234568889999998642 246788999999999999999999997654332222221
Q ss_pred HHh-CC---------------CCC-C----C---------CCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 447 IRA-GE---------------RPL-F----P---------SGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 447 i~~-~~---------------~~~-~----p---------~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
+.. +. .+. + + ...+..+.+++.+||..||.+|||+.+++.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 218 WTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred HHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 110 00 000 0 0 012457899999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=294.70 Aligned_cols=240 Identities=23% Similarity=0.410 Sum_probs=191.9
Q ss_pred ceEEeeeecccc---eEEEEEE-cCCEEEEEEecc-----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEe
Q 003542 217 KLMVRRRLGASS---QFKEIQW-LGDSFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVME 287 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v~~-~g~~VAVK~~~~-----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmE 287 (811)
+|++.+.||.|+ +|++... +++.||+|.+.. ....+.+|+.+++.++||||+++++.+.. ...+|+|||
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~e 79 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYN--NGDISICME 79 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeec--CCEEEEEEE
Confidence 456667777774 7776543 689999999853 23568899999999999999999977743 467999999
Q ss_pred cCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEeccCCCCcceEEEeeccccc
Q 003542 288 LMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHA-QKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365 (811)
Q Consensus 288 y~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs-~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~ 365 (811)
|++ ++|.+++... ...+++..+..++.|++.||.|||+ .|++||||||+||+++.++ .++|+|||++.
T Consensus 80 ~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~-----~~~l~d~g~~~ 149 (265)
T cd06605 80 YMDGGSLDKILKEV-----QGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRG-----QIKLCDFGVSG 149 (265)
T ss_pred ecCCCcHHHHHHHc-----cCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCC-----CEEEeecccch
Confidence 999 5898888753 1568999999999999999999999 9999999999999998876 89999999986
Q ss_pred cccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCcc---chHH
Q 003542 366 ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHL---QGDK 442 (811)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~---~~~~ 442 (811)
....... ....++..|+|||.+.+. .++.++||||||+++|+|++|..||..... ....
T Consensus 150 ~~~~~~~---------~~~~~~~~y~~PE~~~~~---------~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 211 (265)
T cd06605 150 QLVNSLA---------KTFVGTSSYMAPERIQGN---------DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFE 211 (265)
T ss_pred hhHHHHh---------hcccCChhccCHHHHcCC---------CCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHH
Confidence 5532211 125678889999998643 678899999999999999999999975421 1122
Q ss_pred HHHHHHhCCCCCCCCC-ChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 443 MTKNIRAGERPLFPSG-SPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 443 i~~~i~~~~~~~~p~~-~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
..+.+.....+..+.. .+..+.++|.+||..||.+|||+.+++.
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 212 LLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred HHHHHhcCCCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 3334444445555554 7888999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=288.58 Aligned_cols=247 Identities=21% Similarity=0.415 Sum_probs=194.9
Q ss_pred ceEEeeeecccc---eEEEEE-EcCCEEEEEEecc------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEE
Q 003542 217 KLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVM 286 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVm 286 (811)
+|++.+.||.|+ +|++.. .+++.||+|.+.. ....+.+|+.+++.++||||+++++.+ .....+++|+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~--~~~~~~~lv~ 78 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVE--VHREKVYIFM 78 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeE--ecCCEEEEEE
Confidence 477888899886 777664 3789999999853 356789999999999999999999765 4456799999
Q ss_pred ecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccc
Q 003542 287 ELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365 (811)
Q Consensus 287 Ey~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~ 365 (811)
||+++ +|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .+||+|||++.
T Consensus 79 e~~~~~~L~~~~~~~------~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~-----~~kl~d~g~~~ 147 (264)
T cd06626 79 EYCSGGTLEELLEHG------RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNG-----VIKLGDFGCAV 147 (264)
T ss_pred ecCCCCcHHHHHhhc------CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-----CEEEccccccc
Confidence 99995 888887642 4578899999999999999999999999999999999998876 89999999987
Q ss_pred cccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHH
Q 003542 366 ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTK 445 (811)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~ 445 (811)
......... ........++..|+|||++.+.. ...++.++||||||+++|+|++|..||...... .....
T Consensus 148 ~~~~~~~~~---~~~~~~~~~~~~~~~PE~~~~~~------~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-~~~~~ 217 (264)
T cd06626 148 KLKNNTTTM---GEEVQSLAGTPAYMAPEVITGGK------GKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-FQIMF 217 (264)
T ss_pred ccCCCCCcc---cccccCCcCCcCccChhhccCCC------CCCCCcccchHHHHHHHHHHHhCCCCccCCcch-HHHHH
Confidence 764432110 11012356788999999987531 124788999999999999999999999764322 22233
Q ss_pred HHHhCCCCCCCCCC--hHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 446 NIRAGERPLFPSGS--PKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 446 ~i~~~~~~~~p~~~--~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
.+..+..+.+|... +..+.++|.+||+.+|.+||++.+++.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 218 HVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred HHhcCCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 33444455555544 888999999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=290.67 Aligned_cols=244 Identities=24% Similarity=0.422 Sum_probs=189.4
Q ss_pred ceEEeeeecccc---eEEEEE-EcCCEEEEEEecc--------------cHHHHHHHHHHHHhCCCCccceeeeeEEccC
Q 003542 217 KLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG--------------ELESLNAEISTMLSLSHPNIVQYLCGFCDEE 278 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~--------------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~ 278 (811)
+|.+.+.||.|+ +|++.. .+|+.||+|.+.. ..+.+.+|+.+++.++||||+++++.+ ..
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~ 79 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFE--TT 79 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEe--cc
Confidence 467777888886 777763 4789999998742 124678899999999999999999665 44
Q ss_pred CCeEEEEEecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEE
Q 003542 279 KKEFFLVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVK 357 (811)
Q Consensus 279 ~~~~yLVmEy~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vK 357 (811)
...+++||||+++ +|.+++... ..+++..+..++.||+.||.|||+++++||||+|+||+++.++ .++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~------~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~-----~~~ 148 (272)
T cd06629 80 EEYLSIFLEYVPGGSIGSCLRTY------GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADG-----ICK 148 (272)
T ss_pred CCceEEEEecCCCCcHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCC-----eEE
Confidence 5679999999985 898888753 5689999999999999999999999999999999999998776 899
Q ss_pred EeeccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCc
Q 003542 358 VSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGH 437 (811)
Q Consensus 358 L~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~ 437 (811)
|+|||++........ ........|+..|+|||++... ...++.++|+||||+++|++++|..||....
T Consensus 149 l~d~~~~~~~~~~~~-----~~~~~~~~~~~~y~~PE~~~~~-------~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 216 (272)
T cd06629 149 ISDFGISKKSDDIYD-----NDQNMSMQGSVFWMAPEVIHSY-------SQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE 216 (272)
T ss_pred Eeecccccccccccc-----ccccccccCCccccCHHHhccc-------cCCCCccchhHHHHHHHHHHHhCCCCCcCcc
Confidence 999999875432211 1112344578899999998753 1247889999999999999999999996533
Q ss_pred cchHHHHHHHHhCCCCCCCC----CChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 438 LQGDKMTKNIRAGERPLFPS----GSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 438 ~~~~~i~~~i~~~~~~~~p~----~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
.. ............+.++. .++..+.++|.+||..+|.+||++.++++
T Consensus 217 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 217 AI-AAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred hH-HHHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 22 12222222222233332 45788999999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=299.94 Aligned_cols=241 Identities=22% Similarity=0.378 Sum_probs=190.7
Q ss_pred cceEEeeeecccc---eEEEEE-EcCCEEEEEEecc-------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEE
Q 003542 216 KKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG-------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFL 284 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~-------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yL 284 (811)
+.|.+.+.||.|+ +|.+.. .+|+.||+|.+.. ....+.+|+.+++.++||||+++++.+. +....|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~--~~~~~~l 92 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYL--REHTAWL 92 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEE--eCCeEEE
Confidence 4577777888875 777664 3789999999842 2356889999999999999999997774 3456899
Q ss_pred EEecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccc
Q 003542 285 VMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS 364 (811)
Q Consensus 285 VmEy~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA 364 (811)
||||+.|+|.+++... ...+++..+..++.||+.||.|||+.|++||||+|+||+++.++ .++|+|||++
T Consensus 93 v~e~~~g~l~~~~~~~-----~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~-----~~kL~dfg~~ 162 (307)
T cd06607 93 VMEYCLGSASDILEVH-----KKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPG-----TVKLADFGSA 162 (307)
T ss_pred EHHhhCCCHHHHHHHc-----ccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCC-----CEEEeecCcc
Confidence 9999999988877642 24689999999999999999999999999999999999998876 8999999998
Q ss_pred ccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHH
Q 003542 365 TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMT 444 (811)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~ 444 (811)
...... ....+++.|+|||++.+. ....++.++||||||+++|+|++|..||.+..... ..
T Consensus 163 ~~~~~~-----------~~~~~~~~y~aPE~~~~~------~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~--~~ 223 (307)
T cd06607 163 SLVSPA-----------NSFVGTPYWMAPEVILAM------DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--AL 223 (307)
T ss_pred eecCCC-----------CCccCCccccCceeeecc------CCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH--HH
Confidence 654221 234577889999998532 12357889999999999999999999997643221 22
Q ss_pred HHHHhCCCCCC-CCCChHHHHHHHhhhccCCCCCCCCHHHHHHH
Q 003542 445 KNIRAGERPLF-PSGSPKYLVNLTKKCWHTNPSQRPSFSSICRI 487 (811)
Q Consensus 445 ~~i~~~~~~~~-p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~ 487 (811)
..+.....+.. +..++..+.++|.+||..+|.+||++.+|+.+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 224 YHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred HHHhcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 22333333333 34567889999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=294.05 Aligned_cols=244 Identities=24% Similarity=0.338 Sum_probs=189.9
Q ss_pred ceEEeeeecccc---eEEEEE-EcCCEEEEEEecc------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEE
Q 003542 217 KLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVM 286 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVm 286 (811)
+|++.+.||.|+ +|++.. .+|+.||+|.+.. ....+.+|+.++++++||||+++++.+. ....+|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~~v~ 78 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFP--HGSGFVLVM 78 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEe--cCCeeEEEe
Confidence 478888999886 777664 3789999999853 2467899999999999999999998774 456799999
Q ss_pred ecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccccc
Q 003542 287 ELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366 (811)
Q Consensus 287 Ey~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~ 366 (811)
||+.++|.+++... ...+++..++.++.||+.||.|||+.|++|+||||+||+++.++ .++|+|||++..
T Consensus 79 e~~~~~L~~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~-----~~~l~dfg~~~~ 148 (286)
T cd07832 79 EYMPSDLSEVLRDE-----ERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADG-----VLKIADFGLARL 148 (286)
T ss_pred cccCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCC-----cEEEeeeeeccc
Confidence 99966999988753 15689999999999999999999999999999999999998876 899999999876
Q ss_pred ccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHH
Q 003542 367 RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKN 446 (811)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~ 446 (811)
...... .......++..|+|||++.+. ..++.++||||||+++|+|++|.+||.+... .......
T Consensus 149 ~~~~~~------~~~~~~~~~~~y~aPE~~~~~--------~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~-~~~~~~~ 213 (286)
T cd07832 149 FSEEEP------RLYSHQVATRWYRAPELLYGA--------RKYDPGVDLWAVGCIFAELLNGSPLFPGEND-IEQLAIV 213 (286)
T ss_pred ccCCCC------CccccccCcccccCceeeecc--------ccCCchhHHHHHHHHHHHHHcCCcCcCCCCH-HHHHHHH
Confidence 543321 112245688899999998642 3568899999999999999999888865432 1111111
Q ss_pred HHhCCCC----------------------------CCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHH
Q 003542 447 IRAGERP----------------------------LFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRI 487 (811)
Q Consensus 447 i~~~~~~----------------------------~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~ 487 (811)
+.....+ ......+..+.+||.+||..+|.+||++++++.+
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 214 FRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred HHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 1100000 0112456789999999999999999999999763
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=292.06 Aligned_cols=250 Identities=28% Similarity=0.452 Sum_probs=192.7
Q ss_pred cceEEeeeecccc---eEEEEEE------cCCEEEEEEecc-----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCe
Q 003542 216 KKLMVRRRLGASS---QFKEIQW------LGDSFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKE 281 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~~------~g~~VAVK~~~~-----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~ 281 (811)
++|++++.||.|+ +|.+... ..+.||+|.+.. ..+.+.+|+.++++++||||+++++.+ .+...
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~~~~~ 82 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLC--REAEP 82 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEE--CCCCc
Confidence 5688888899885 6655432 346799999853 245789999999999999999999665 34557
Q ss_pred EEEEEecCC-CCHHHHHHHhhCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEE
Q 003542 282 FFLVMELMS-KDLSCYMRETFGSR---RRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVK 357 (811)
Q Consensus 282 ~yLVmEy~~-g~L~~~L~~~~~~~---~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vK 357 (811)
.|+||||++ ++|.+++....... ....+++..+..++.||+.||.|||+.+|+||||||+|||++.++ .++
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~-----~~~ 157 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQR-----EVK 157 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCC-----cEE
Confidence 899999999 59999887542110 012689999999999999999999999999999999999998876 899
Q ss_pred EeeccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CCCCCCCC
Q 003542 358 VSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDG 436 (811)
Q Consensus 358 L~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~~PF~~~ 436 (811)
|+|||++....... ........++..|+|||.+.+. .++.++||||||+++|+|++ |..||.+.
T Consensus 158 l~~~~~~~~~~~~~------~~~~~~~~~~~~y~~PE~~~~~---------~~~~~~Di~slG~~l~~l~~~~~~p~~~~ 222 (275)
T cd05046 158 VSLLSLSKDVYNSE------YYKLRNALIPLRWLAPEAVQED---------DFSTKSDVWSFGVLMWEVFTQGELPFYGL 222 (275)
T ss_pred EcccccccccCccc------ccccCCceeEEeecChhhhccC---------CCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 99999986543221 1112234567779999998643 56789999999999999998 88999754
Q ss_pred ccchHHHHHHHHhCC-CCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHH
Q 003542 437 HLQGDKMTKNIRAGE-RPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILR 489 (811)
Q Consensus 437 ~~~~~~i~~~i~~~~-~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~ 489 (811)
.. ..+...+..+. ....+..++..+.+++.+||..+|.+||++.+++..|.
T Consensus 223 ~~--~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 223 SD--EEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred ch--HHHHHHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 32 23334443332 22345678889999999999999999999999988663
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=294.70 Aligned_cols=248 Identities=20% Similarity=0.247 Sum_probs=187.6
Q ss_pred ceEEeeeecccc---eEEEEE-EcCCEEEEEEecc------cHHHHHHHHHHHHhCC-CCccceeeeeEEccCC---CeE
Q 003542 217 KLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG------ELESLNAEISTMLSLS-HPNIVQYLCGFCDEEK---KEF 282 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~------~~~~~~~Ei~iL~~L~-HPNIVkl~~~~~~e~~---~~~ 282 (811)
+|++.+.||.|+ +|++.. .+|+.||||.+.. ....+.+|+.+++.+. ||||+++++.+...+. ..+
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~ 81 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL 81 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence 688888898875 777664 3789999999853 2356888999999995 6999999976643221 247
Q ss_pred EEEEecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEec-cCCCCcceEEEeec
Q 003542 283 FLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKA-RSMEGYFHVKVSGF 361 (811)
Q Consensus 283 yLVmEy~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~-~g~d~~~~vKL~DF 361 (811)
|+||||++++|.+++...... ....+++..++.++.||+.||.|||++||+||||+|+||+++. ++ .+||+||
T Consensus 82 ~lv~e~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~-----~~kl~df 155 (295)
T cd07837 82 YLVFEYLDSDLKKFMDSNGRG-PGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKG-----LLKIADL 155 (295)
T ss_pred EEEeeccCcCHHHHHHHhccc-CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCC-----eEEEeec
Confidence 999999999999988764221 1246899999999999999999999999999999999999987 44 8999999
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchH
Q 003542 362 GLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGD 441 (811)
Q Consensus 362 GlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~ 441 (811)
|++....... .......+++.|+|||++.+. ..++.++||||||+++|+|++|..||.+.....
T Consensus 156 g~~~~~~~~~-------~~~~~~~~~~~~~aPE~~~~~--------~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~- 219 (295)
T cd07837 156 GLGRAFSIPV-------KSYTHEIVTLWYRAPEVLLGS--------THYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ- 219 (295)
T ss_pred ccceecCCCc-------cccCCcccccCCCChHHhhCC--------CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH-
Confidence 9987553221 111233567889999998642 357889999999999999999999997643221
Q ss_pred HHHHHHHhCC------------------CCC--------CCCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 442 KMTKNIRAGE------------------RPL--------FPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 442 ~i~~~i~~~~------------------~~~--------~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
........-. .+. .....+..+.+||.+||..||.+||++.+++.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 220 QLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred HHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 1111111000 000 01246778999999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=292.16 Aligned_cols=221 Identities=24% Similarity=0.378 Sum_probs=168.3
Q ss_pred CEEEEEEecc----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEecCCC-CHHHHHHHhhCCCCCCCCCHH
Q 003542 238 DSFVLRHFYG----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFSLP 312 (811)
Q Consensus 238 ~~VAVK~~~~----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~~g-~L~~~L~~~~~~~~~~~ls~~ 312 (811)
..||+|.+.. ....+..|+.++..++||||+++++.+. .....++||||+++ +|..++... ...+++.
T Consensus 33 ~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~--~~~~~~lv~e~~~~~~l~~~~~~~-----~~~~~~~ 105 (262)
T cd05077 33 IKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCV--RDVENIMVEEFVEFGPLDLFMHRK-----SDVLTTP 105 (262)
T ss_pred eeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEe--cCCCCEEEEecccCCCHHHHHHhc-----CCCCCHH
Confidence 3689998854 2346788999999999999999997664 34567999999995 666665432 2568999
Q ss_pred HHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCC--CCcceEEEeeccccccccccCCCCCCCCCCCCCCCCCCcc
Q 003542 313 VVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSM--EGYFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIW 390 (811)
Q Consensus 313 ~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~--d~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y 390 (811)
.++.++.||+.||.|||+++|+||||||+|||++.++. .....++++|||++..... .....++..|
T Consensus 106 ~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~-----------~~~~~~~~~y 174 (262)
T cd05077 106 WKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLS-----------RQECVERIPW 174 (262)
T ss_pred HHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccC-----------cccccccccc
Confidence 99999999999999999999999999999999986552 1223489999999865421 1234577889
Q ss_pred CChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHh-hCCCCCCCCccchHHHHHHHHhCCCCCCCCCChHHHHHHHhh
Q 003542 391 YAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELL-TGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKK 469 (811)
Q Consensus 391 ~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELl-tG~~PF~~~~~~~~~i~~~i~~~~~~~~p~~~~~~l~~LI~~ 469 (811)
+|||++.. ...++.++|||||||++|+|+ +|..||........ .....+.. ......+.++.+||.+
T Consensus 175 ~aPE~~~~--------~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~---~~~~~~~~-~~~~~~~~~~~~li~~ 242 (262)
T cd05077 175 IAPECVED--------SKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK---ERFYEGQC-MLVTPSCKELADLMTH 242 (262)
T ss_pred cChhhhcC--------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH---HHHHhcCc-cCCCCChHHHHHHHHH
Confidence 99998863 236788999999999999998 58999875432211 11122221 2233446779999999
Q ss_pred hccCCCCCCCCHHHHHHHH
Q 003542 470 CWHTNPSQRPSFSSICRIL 488 (811)
Q Consensus 470 cL~~DP~~RPS~~eIl~~L 488 (811)
||+.||.+||++.+|++.+
T Consensus 243 cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 243 CMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred HcCCChhhCcCHHHHHHhc
Confidence 9999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=292.89 Aligned_cols=244 Identities=25% Similarity=0.366 Sum_probs=188.9
Q ss_pred ceEEeeeecccc---eEEEEEE-cCCEEEEEEecc-----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEe
Q 003542 217 KLMVRRRLGASS---QFKEIQW-LGDSFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVME 287 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v~~-~g~~VAVK~~~~-----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmE 287 (811)
+|++.+.||.|+ +|++... +|..||||.+.. ....+.+|+.++++++||||+++++.+.+ ...+|||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHT--ENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEee--CCcEEEEEe
Confidence 478888899885 7776643 789999999853 24667889999999999999999987743 456899999
Q ss_pred cCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccc
Q 003542 288 LMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTAR 367 (811)
Q Consensus 288 y~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~ 367 (811)
|++++|.+++.... ....+++..+..++.||+.||.|||+.|++||||||+||+++.++ .++|+|||++...
T Consensus 79 ~~~~~l~~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~-----~~~l~d~g~~~~~ 150 (284)
T cd07836 79 YMDKDLKKYMDTHG---VRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRG-----ELKLADFGLARAF 150 (284)
T ss_pred cCCccHHHHHHhcC---CCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCC-----cEEEeecchhhhh
Confidence 99999998887532 124689999999999999999999999999999999999998776 8999999998754
Q ss_pred cccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHHH
Q 003542 368 TYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNI 447 (811)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i 447 (811)
.... .......++..|++||++.+. ..++.++||||||+++|+|++|..||.+..... .....+
T Consensus 151 ~~~~-------~~~~~~~~~~~y~~PE~~~~~--------~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~ 214 (284)
T cd07836 151 GIPV-------NTFSNEVVTLWYRAPDVLLGS--------RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED-QLLKIF 214 (284)
T ss_pred cCCc-------cccccccccccccChHHhcCC--------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHH
Confidence 3221 111234568889999998642 356789999999999999999999998654321 111111
Q ss_pred HhCC----------------CCCC-----------CCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 448 RAGE----------------RPLF-----------PSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 448 ~~~~----------------~~~~-----------p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
.... ...+ ....+..+.+++.+||+.||.+||++.++++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 215 RIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred HHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1000 0001 1234677899999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=297.33 Aligned_cols=248 Identities=22% Similarity=0.328 Sum_probs=192.0
Q ss_pred cceEEeeeecccc---eEEEEEE-cCCEEEEEEecc-------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEE
Q 003542 216 KKLMVRRRLGASS---QFKEIQW-LGDSFVLRHFYG-------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFL 284 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~~-~g~~VAVK~~~~-------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yL 284 (811)
++|++.+.||.|+ +|.+... +++.||||.+.. ....+..|+.+++.++||||+++++.+ .....+|+
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~--~~~~~~~l 78 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASF--QTETYLCL 78 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeee--ecCCEEEE
Confidence 3688888999885 7776644 589999999853 335688999999999999999999776 45567999
Q ss_pred EEecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccc
Q 003542 285 VMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGL 363 (811)
Q Consensus 285 VmEy~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGl 363 (811)
||||+.| +|.+++... ....+++..+..++.||+.||.|||+.|++||||||+||+++.++ .++|+|||+
T Consensus 79 v~e~~~~~~L~~~~~~~----~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~-----~~~l~dfg~ 149 (316)
T cd05574 79 VMDYCPGGELFRLLQRQ----PGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESG-----HIMLSDFDL 149 (316)
T ss_pred EEEecCCCCHHHHHHhC----CCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCC-----CEEEeecch
Confidence 9999985 888887642 225689999999999999999999999999999999999998876 899999999
Q ss_pred cccccccCCCCC----------------------CCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchh
Q 003542 364 STARTYASRNTP----------------------PASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGM 421 (811)
Q Consensus 364 A~~~~~~~~~~~----------------------~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGv 421 (811)
+........... ..........||..|+|||++.+. .++.++||||||+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~---------~~~~~~Di~slG~ 220 (316)
T cd05574 150 SKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD---------GHGSAVDWWTLGI 220 (316)
T ss_pred hhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC---------CCCchHHHHHHHH
Confidence 875433211000 000111234688999999999643 5788999999999
Q ss_pred HHHHHhhCCCCCCCCccchHHHHHHHHhCCCCCCCC--CChHHHHHHHhhhccCCCCCCCC----HHHHHH
Q 003542 422 LCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPS--GSPKYLVNLTKKCWHTNPSQRPS----FSSICR 486 (811)
Q Consensus 422 ILyELltG~~PF~~~~~~~~~i~~~i~~~~~~~~p~--~~~~~l~~LI~~cL~~DP~~RPS----~~eIl~ 486 (811)
++|+|++|..||.+.... .....+... ...++. ..+..+.++|.+||..||.+||+ +.+++.
T Consensus 221 ll~~l~~g~~pf~~~~~~--~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 221 LLYEMLYGTTPFKGSNRD--ETFSNILKK-EVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HHHHHhhCCCCCCCCchH--HHHHHHhcC-CccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 999999999999765432 222223222 222332 36889999999999999999999 888776
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=302.00 Aligned_cols=260 Identities=23% Similarity=0.351 Sum_probs=209.0
Q ss_pred HHhcceEEeeeecccc---eEEEE-EEcCCEEEEEEec--c---------cHHHHHHHHHHHHhCCCCccceeeeeEEcc
Q 003542 213 MLLKKLMVRRRLGASS---QFKEI-QWLGDSFVLRHFY--G---------ELESLNAEISTMLSLSHPNIVQYLCGFCDE 277 (811)
Q Consensus 213 ~l~k~~~i~~~lG~G~---vyk~v-~~~g~~VAVK~~~--~---------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e 277 (811)
.+.++|-++..||+|+ ||++. +...+.||||+-. + -.+...+|.+|.+.|+||.||++|+.|..
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl- 538 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL- 538 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee-
Confidence 4567888889999997 88877 4467789999852 1 24667899999999999999999988864
Q ss_pred CCCeEEEEEecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC--CceeccCCCCcEEEeccCCCCcc
Q 003542 278 EKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQ--KIYHGELNPSNIYLKARSMEGYF 354 (811)
Q Consensus 278 ~~~~~yLVmEy~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~--gIVHRDLKPsNILI~~~g~d~~~ 354 (811)
+.+.+|-|+|||+| +|.-||+.. ..+++.+++.|+.||+.||.||... .|||-||||.|||+......+
T Consensus 539 DtdsFCTVLEYceGNDLDFYLKQh------klmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacG-- 610 (775)
T KOG1151|consen 539 DTDSFCTVLEYCEGNDLDFYLKQH------KLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACG-- 610 (775)
T ss_pred ccccceeeeeecCCCchhHHHHhh------hhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccc--
Confidence 44679999999998 888888765 6789999999999999999999986 499999999999997654333
Q ss_pred eEEEeeccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCC
Q 003542 355 HVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFE 434 (811)
Q Consensus 355 ~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~ 434 (811)
.+||+||||++.++....+...+........||++|++||.+.-.. ...+.+.++||||+|||+|.++.|+.||.
T Consensus 611 eIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgk-----ePPKIsnKVDVWSvGVIFyQClYGrKPFG 685 (775)
T KOG1151|consen 611 EIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGK-----EPPKISNKVDVWSVGVIFYQCLYGRKPFG 685 (775)
T ss_pred eeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCC-----CCCccccceeeEeeehhhhhhhccCCCCC
Confidence 7999999999999887766555555667788999999999986432 13478999999999999999999999997
Q ss_pred CCccchHHHHHH-HHhCCCCCCC--CCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 435 DGHLQGDKMTKN-IRAGERPLFP--SGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 435 ~~~~~~~~i~~~-i~~~~~~~~p--~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
......+.+..+ |.......|| +..+.+..++|++||++.-++|..+.++..
T Consensus 686 hnqsQQdILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 686 HNQSQQDILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred CchhHHHHHhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 654444333322 3333333444 356778999999999999999988877654
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=303.47 Aligned_cols=259 Identities=26% Similarity=0.412 Sum_probs=196.5
Q ss_pred HhcceEEeeeecccc---eEEEEEE-cCCEEEEEEecc------cHHHHHHHHHHHHhC-CCCccceeeeeEEccCCCeE
Q 003542 214 LLKKLMVRRRLGASS---QFKEIQW-LGDSFVLRHFYG------ELESLNAEISTMLSL-SHPNIVQYLCGFCDEEKKEF 282 (811)
Q Consensus 214 l~k~~~i~~~lG~G~---vyk~v~~-~g~~VAVK~~~~------~~~~~~~Ei~iL~~L-~HPNIVkl~~~~~~e~~~~~ 282 (811)
+.++|++.+.||.|+ +|++... +|+.||||.+.. ....+.+|+.+++++ +||||+++++.+...+...+
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 346777888888875 7776643 688999998842 345678899999999 99999999977755555678
Q ss_pred EEEEecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecc
Q 003542 283 FLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFG 362 (811)
Q Consensus 283 yLVmEy~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFG 362 (811)
|+||||++++|..++.. ..+++..+..++.||+.||.|||+.||+||||||+||+++.++ .+||+|||
T Consensus 85 ~lv~e~~~~~L~~~~~~-------~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~-----~~kl~d~g 152 (337)
T cd07852 85 YLVFEYMETDLHAVIRA-------NILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDC-----RVKLADFG 152 (337)
T ss_pred EEEecccccCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-----cEEEeecc
Confidence 99999999999888764 3678889999999999999999999999999999999998877 89999999
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHH
Q 003542 363 LSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDK 442 (811)
Q Consensus 363 lA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~ 442 (811)
++.......... .........||..|+|||++.+ ...++.++||||||+++|+|++|+.||.+..... .
T Consensus 153 ~~~~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~-~ 221 (337)
T cd07852 153 LARSLSELEENP--ENPVLTDYVATRWYRAPEILLG--------STRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN-Q 221 (337)
T ss_pred chhccccccccc--cCcchhcccccccccCceeeec--------cccccccchHHHHHHHHHHHHhCCCCCCCCChHH-H
Confidence 997664332110 0112234568899999998864 2357789999999999999999999997543221 1
Q ss_pred HHHHHHh--------------------------CCCC---CCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHHHH
Q 003542 443 MTKNIRA--------------------------GERP---LFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKK 493 (811)
Q Consensus 443 i~~~i~~--------------------------~~~~---~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~k 493 (811)
....+.. .... .....++.++.++|.+||+.||.+|||+.++++ ..++..
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~-~~~~~~ 300 (337)
T cd07852 222 LEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALE-HPYVAQ 300 (337)
T ss_pred HHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhh-Chhhhh
Confidence 1110000 0000 111236788999999999999999999999997 555665
Q ss_pred Hhh
Q 003542 494 FMA 496 (811)
Q Consensus 494 ~l~ 496 (811)
+..
T Consensus 301 ~~~ 303 (337)
T cd07852 301 FHN 303 (337)
T ss_pred hcc
Confidence 533
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=296.44 Aligned_cols=242 Identities=23% Similarity=0.311 Sum_probs=186.8
Q ss_pred ceEEeeeecccc---eEEEEE-EcCCEEEEEEeccc---------HHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEE
Q 003542 217 KLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYGE---------LESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFF 283 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~~---------~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~y 283 (811)
+|++++.||.|+ +|++.. .+|+.||||.+... ...+..|+.+++.++||||+++++.+.+ ...+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~ 78 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH--KSNIN 78 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec--CCEEE
Confidence 477778888875 777664 37899999999532 2356789999999999999999977743 56799
Q ss_pred EEEecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccc
Q 003542 284 LVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGL 363 (811)
Q Consensus 284 LVmEy~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGl 363 (811)
+||||+.++|.+++... ...+++..++.++.||+.||.|||++|++||||+|+|||++.++ .++|+|||+
T Consensus 79 lv~e~~~~~L~~~i~~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~-----~~~l~dfg~ 148 (298)
T cd07841 79 LVFEFMETDLEKVIKDK-----SIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDG-----VLKLADFGL 148 (298)
T ss_pred EEEcccCCCHHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCC-----CEEEcccee
Confidence 99999977999988653 13689999999999999999999999999999999999998876 899999999
Q ss_pred cccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHH
Q 003542 364 STARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKM 443 (811)
Q Consensus 364 A~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i 443 (811)
+........ ......+++.|+|||.+.+ ...++.++|||||||++|+|++|.+||.+.... ..+
T Consensus 149 ~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~--------~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~-~~~ 212 (298)
T cd07841 149 ARSFGSPNR-------KMTHQVVTRWYRAPELLFG--------ARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI-DQL 212 (298)
T ss_pred eeeccCCCc-------cccccccceeeeCHHHHhC--------CCCCCcHHHHHHHHHHHHHHHcCCccccCCccH-HHH
Confidence 976543321 1123356788999999853 235788999999999999999998888754322 111
Q ss_pred HHHHHhCC---------------------CCC-----CCCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 444 TKNIRAGE---------------------RPL-----FPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 444 ~~~i~~~~---------------------~~~-----~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
........ .+. .....+..+.++|.+||..||.+|||+.+++.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 213 GKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred HHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 11111000 000 11234677899999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=302.23 Aligned_cols=247 Identities=21% Similarity=0.299 Sum_probs=190.3
Q ss_pred hcceEEeeeecccc---eEEEE-EEcCCEEEEEEecc------cHHHHHHHHHHHHhCCCCccceeeeeEEccC---CCe
Q 003542 215 LKKLMVRRRLGASS---QFKEI-QWLGDSFVLRHFYG------ELESLNAEISTMLSLSHPNIVQYLCGFCDEE---KKE 281 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v-~~~g~~VAVK~~~~------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~---~~~ 281 (811)
..+|.+.+.||.|+ +|.+. ..+|+.||||.+.. ....+.+|+.+++.++||||+++++.+.... ...
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 45799999999985 66665 34789999999853 2456788999999999999999987664322 135
Q ss_pred EEEEEecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeec
Q 003542 282 FFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGF 361 (811)
Q Consensus 282 ~yLVmEy~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DF 361 (811)
+|+||||+.++|.+++... ..+++..+..++.||+.||.|||+++++||||||+||+++.++ .+||+||
T Consensus 84 ~~lv~e~~~~~L~~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~-----~~kL~Df 152 (337)
T cd07858 84 VYIVYELMDTDLHQIIRSS------QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANC-----DLKICDF 152 (337)
T ss_pred EEEEEeCCCCCHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC-----CEEECcC
Confidence 8999999999998888643 5699999999999999999999999999999999999998776 8999999
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchH
Q 003542 362 GLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGD 441 (811)
Q Consensus 362 GlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~ 441 (811)
|++....... .......++..|+|||.+.+. ..++.++|||||||++|+|++|++||.+......
T Consensus 153 g~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~--------~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 217 (337)
T cd07858 153 GLARTTSEKG-------DFMTEYVVTRWYRAPELLLNC--------SEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQ 217 (337)
T ss_pred ccccccCCCc-------ccccccccccCccChHHHhcC--------CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHH
Confidence 9987653321 112244578889999998642 2478899999999999999999999975432110
Q ss_pred H----------------------HHHHHHh---CCCC---CCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHH
Q 003542 442 K----------------------MTKNIRA---GERP---LFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRI 487 (811)
Q Consensus 442 ~----------------------i~~~i~~---~~~~---~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~ 487 (811)
. ....+.. ...+ .....+++.+.+||.+||+.+|.+|||+.+++++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 218 LKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred HHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 0 0000000 0000 0123567889999999999999999999999884
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=287.08 Aligned_cols=248 Identities=23% Similarity=0.437 Sum_probs=194.4
Q ss_pred cceEEeeeecccc---eEEEEE-EcCCEEEEEEecc-----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEE
Q 003542 216 KKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVM 286 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~-----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVm 286 (811)
++|++.+.||.|+ +|++.. .++..+|+|.+.. ....+.+|+.+|+.++||||+++++.+. ....+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFV--VGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEe--eCCEEEEEE
Confidence 3688889999886 777663 3788999999853 3567899999999999999999997663 456799999
Q ss_pred ecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccc
Q 003542 287 ELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365 (811)
Q Consensus 287 Ey~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~ 365 (811)
||++| +|.+++..... ...+++..+..++.||+.||.|||+.|++||||+|+||+++.++ .++|+|||++.
T Consensus 79 e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~-----~~~l~df~~~~ 150 (267)
T cd06610 79 PYLSGGSLLDIMKSSYP---RGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDG-----SVKIADFGVSA 150 (267)
T ss_pred eccCCCcHHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCC-----CEEEcccchHH
Confidence 99985 88888875421 24689999999999999999999999999999999999998776 89999999987
Q ss_pred cccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHH
Q 003542 366 ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTK 445 (811)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~ 445 (811)
......... ........|+..|+|||++... ..++.++|+||||+++|+|++|+.||...... ....
T Consensus 151 ~~~~~~~~~---~~~~~~~~~~~~y~~Pe~~~~~--------~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~--~~~~ 217 (267)
T cd06610 151 SLADGGDRT---RKVRKTFVGTPCWMAPEVMEQV--------HGYDFKADIWSFGITAIELATGAAPYSKYPPM--KVLM 217 (267)
T ss_pred HhccCcccc---ccccccccCChhhcChHHHccc--------cCcCcccchHhHhHHHHHHHhCCCCccccChh--hhHH
Confidence 665432210 0122345688999999998642 25788999999999999999999999764332 2222
Q ss_pred HHHhCCCCCCC-----CCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 446 NIRAGERPLFP-----SGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 446 ~i~~~~~~~~p-----~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
.+.....+.++ ...++.+.+++.+||..||.+||++.+|+.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 218 LTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred HHhcCCCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 23333322222 245788999999999999999999999976
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=292.29 Aligned_cols=238 Identities=20% Similarity=0.399 Sum_probs=188.1
Q ss_pred eEEeeeecccc---eEEEEE-EcCCEEEEEEecc-----cHHHHHHHHHHHHhCC---CCccceeeeeEEccCCCeEEEE
Q 003542 218 LMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG-----ELESLNAEISTMLSLS---HPNIVQYLCGFCDEEKKEFFLV 285 (811)
Q Consensus 218 ~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~-----~~~~~~~Ei~iL~~L~---HPNIVkl~~~~~~e~~~~~yLV 285 (811)
|++.+.||.|+ +|++.. .+|+.||+|.+.. ..+.+.+|+.+++.++ ||||+++++.+. ....+|+|
T Consensus 3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~--~~~~~~lv 80 (277)
T cd06917 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL--KGPRLWII 80 (277)
T ss_pred hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee--eCCEEEEE
Confidence 55566677764 787763 5789999999842 3567889999999996 999999997763 45679999
Q ss_pred EecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccc
Q 003542 286 MELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS 364 (811)
Q Consensus 286 mEy~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA 364 (811)
|||++| +|.+++.. ..+++..++.++.|++.||.|||+.||+||||+|+||+++.++ .++|+|||++
T Consensus 81 ~e~~~~~~L~~~~~~-------~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~-----~~~l~dfg~~ 148 (277)
T cd06917 81 MEYAEGGSVRTLMKA-------GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTG-----NVKLCDFGVA 148 (277)
T ss_pred EecCCCCcHHHHHHc-------cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCC-----CEEEccCCce
Confidence 999985 88887753 4688999999999999999999999999999999999998876 8999999998
Q ss_pred ccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHH
Q 003542 365 TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMT 444 (811)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~ 444 (811)
....... .......|+..|+|||.+.+ ...++.++|+||||+++|+|++|..||.+.... ...
T Consensus 149 ~~~~~~~-------~~~~~~~~~~~y~aPE~~~~--------~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--~~~ 211 (277)
T cd06917 149 ALLNQNS-------SKRSTFVGTPYWMAPEVITE--------GKYYDTKADIWSLGITIYEMATGNPPYSDVDAF--RAM 211 (277)
T ss_pred eecCCCc-------cccccccCCcceeCHHHhcc--------CCccccchhHHHHHHHHHHHHhCCCCCCCCChh--hhh
Confidence 7654332 11223468889999999863 225678999999999999999999999764322 112
Q ss_pred HHHHhCCCCCCCC-CChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 445 KNIRAGERPLFPS-GSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 445 ~~i~~~~~~~~p~-~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
..+.....+.++. ..+.++.+++.+||..||.+||++.+++.
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 212 MLIPKSKPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred hccccCCCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 2222222333433 37788999999999999999999999987
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=298.96 Aligned_cols=230 Identities=20% Similarity=0.373 Sum_probs=181.3
Q ss_pred cccceEEEEE-EcCCEEEEEEecc----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEecCCC-CHHHHHH
Q 003542 225 GASSQFKEIQ-WLGDSFVLRHFYG----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMR 298 (811)
Q Consensus 225 G~G~vyk~v~-~~g~~VAVK~~~~----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~~g-~L~~~L~ 298 (811)
|.|.+|++.. .++..||||.+.. ..+.+.+|+.+++.++||||+++++.+. ..+..|+||||+++ +|.+++.
T Consensus 34 ~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~--~~~~~~lv~e~~~~~~L~~~~~ 111 (292)
T cd06658 34 STGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL--VGDELWVVMEFLEGGALTDIVT 111 (292)
T ss_pred CCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHhee--cCCeEEEEEeCCCCCcHHHHHh
Confidence 3344777663 4789999999853 3456889999999999999999998774 45679999999996 7777664
Q ss_pred HhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccccccCCCCCCCC
Q 003542 299 ETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTPPAS 378 (811)
Q Consensus 299 ~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~~~~~~~~~ 378 (811)
. ..+++..++.++.||+.||.|||++||+||||||+||+++.++ .++|+|||++.......
T Consensus 112 ~-------~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~-----~~kL~dfg~~~~~~~~~------- 172 (292)
T cd06658 112 H-------TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDG-----RIKLSDFGFCAQVSKEV------- 172 (292)
T ss_pred c-------CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC-----CEEEccCcchhhccccc-------
Confidence 3 4588999999999999999999999999999999999998776 89999999986543221
Q ss_pred CCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHHHHhCCCCCC--C
Q 003542 379 PQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLF--P 456 (811)
Q Consensus 379 ~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i~~~~~~~~--p 456 (811)
.......|+..|+|||++.+. .++.++||||||+++|||++|..||...... .....+.....+.. .
T Consensus 173 ~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~ 241 (292)
T cd06658 173 PKRKSLVGTPYWMAPEVISRL---------PYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL--QAMRRIRDNLPPRVKDS 241 (292)
T ss_pred ccCceeecCccccCHHHHccC---------CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhcCCCccccc
Confidence 112345688899999998643 5788999999999999999999999764322 22233333222222 2
Q ss_pred CCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 457 SGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 457 ~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
...+..+.+++.+||..||.+|||+.++++
T Consensus 242 ~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 271 (292)
T cd06658 242 HKVSSVLRGFLDLMLVREPSQRATAQELLQ 271 (292)
T ss_pred cccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 356778999999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=295.59 Aligned_cols=244 Identities=25% Similarity=0.319 Sum_probs=189.0
Q ss_pred cceEEeeeecccc---eEEEEEE-cCCEEEEEEeccc------HHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEE
Q 003542 216 KKLMVRRRLGASS---QFKEIQW-LGDSFVLRHFYGE------LESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLV 285 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~~-~g~~VAVK~~~~~------~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLV 285 (811)
++|++.+.||.|+ +|++... +++.||+|.+... ...+.+|+.++++++||||+++++.+...+...+|||
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 4677777888875 6776533 6889999999531 2356789999999999999999977765544789999
Q ss_pred EecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccc
Q 003542 286 MELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365 (811)
Q Consensus 286 mEy~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~ 365 (811)
|||++++|.+++... ...+++..++.++.||+.||.|||+.|++||||||+|||++.++ .++|+|||++.
T Consensus 85 ~e~~~~~L~~~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~-----~~~l~d~g~~~ 154 (293)
T cd07843 85 MEYVEHDLKSLMETM-----KQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRG-----ILKICDFGLAR 154 (293)
T ss_pred ehhcCcCHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCC-----cEEEeecCcee
Confidence 999999998887653 13689999999999999999999999999999999999998876 89999999987
Q ss_pred cccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHH
Q 003542 366 ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTK 445 (811)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~ 445 (811)
...... .......+++.|+|||.+.+. ..++.++||||||+++|+|++|.+||....... . ..
T Consensus 155 ~~~~~~-------~~~~~~~~~~~~~aPE~~~~~--------~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~-~-~~ 217 (293)
T cd07843 155 EYGSPL-------KPYTQLVVTLWYRAPELLLGA--------KEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID-Q-LN 217 (293)
T ss_pred eccCCc-------cccccccccccccCchhhcCC--------ccccchhhHHHHHHHHHHHHhCCCCCCCCChHH-H-HH
Confidence 654321 111234567889999998642 246789999999999999999999997643221 1 11
Q ss_pred HHHhC------------------------------CCCCCCCC-ChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 446 NIRAG------------------------------ERPLFPSG-SPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 446 ~i~~~------------------------------~~~~~p~~-~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
.+... ....++.. .++.+.+||.+||+.||++|||+.+++.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 218 KIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred HHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 11100 00112222 5778999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=293.38 Aligned_cols=238 Identities=22% Similarity=0.429 Sum_probs=191.3
Q ss_pred eEEeeeecccc---eEEEEE-EcCCEEEEEEecc-----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEec
Q 003542 218 LMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMEL 288 (811)
Q Consensus 218 ~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~-----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy 288 (811)
|++.+.||.|+ ||++.. .++..||||.+.. ....+.+|+.++.+++||||+++++.+. ++..+|+||||
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~ 83 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL--KDTKLWIIMEY 83 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEE--eCCeEEEEEEe
Confidence 44555666654 888763 4789999999752 2456889999999999999999997774 45679999999
Q ss_pred CCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccc
Q 003542 289 MSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTAR 367 (811)
Q Consensus 289 ~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~ 367 (811)
+++ +|..++.. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++...
T Consensus 84 ~~~~~l~~~i~~-------~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~-----~~~l~dfg~~~~~ 151 (277)
T cd06641 84 LGGGSALDLLEP-------GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHG-----EVKLADFGVAGQL 151 (277)
T ss_pred CCCCcHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCC-----CEEEeecccceec
Confidence 995 78877753 4688999999999999999999999999999999999998776 7999999998765
Q ss_pred cccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHHH
Q 003542 368 TYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNI 447 (811)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i 447 (811)
..... ......++..|+|||.+.+. .++.++|+|||||++|+|++|..||.... .......+
T Consensus 152 ~~~~~-------~~~~~~~~~~y~~PE~~~~~---------~~~~~~Dv~slG~~l~~l~~g~~p~~~~~--~~~~~~~~ 213 (277)
T cd06641 152 TDTQI-------KRNTFVGTPFWMAPEVIKQS---------AYDSKADIWSLGITAIELAKGEPPHSELH--PMKVLFLI 213 (277)
T ss_pred ccchh-------hhccccCCccccChhhhccC---------CCCchhhHHHHHHHHHHHHcCCCCCCccc--hHHHHHHH
Confidence 33211 11234578889999998642 56789999999999999999999997543 22333444
Q ss_pred HhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHH
Q 003542 448 RAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRI 487 (811)
Q Consensus 448 ~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~ 487 (811)
..+..+.++..++..+.+++.+||..+|.+||++.+++.+
T Consensus 214 ~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 214 PKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred hcCCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 4555556677788999999999999999999999999883
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=317.13 Aligned_cols=236 Identities=25% Similarity=0.445 Sum_probs=197.7
Q ss_pred Eeeeecccc---eEEEE-EEcCCEEEEEEe------c--ccHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEe
Q 003542 220 VRRRLGASS---QFKEI-QWLGDSFVLRHF------Y--GELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVME 287 (811)
Q Consensus 220 i~~~lG~G~---vyk~v-~~~g~~VAVK~~------~--~~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmE 287 (811)
....||+|+ ||++. ..+|-.||=-.+ + ...++|..|+.+|+.|+|||||+||++|.+..++.+-+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 344689995 66655 335555553222 1 24589999999999999999999999999888888999999
Q ss_pred cCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCcEEEeccCCCCcceEEEeecccc
Q 003542 288 LMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQK--IYHGELNPSNIYLKARSMEGYFHVKVSGFGLS 364 (811)
Q Consensus 288 y~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~g--IVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA 364 (811)
++. |+|..|+++. ..++...+..|++||++||.|||++. |+|||||-+||+|+.+.. .|||+|+|||
T Consensus 124 L~TSGtLr~Y~kk~------~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G----~VKIGDLGLA 193 (632)
T KOG0584|consen 124 LFTSGTLREYRKKH------RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLG----EVKIGDLGLA 193 (632)
T ss_pred cccCCcHHHHHHHh------ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcC----ceeecchhHH
Confidence 998 8999999986 67888999999999999999999985 999999999999976542 8999999999
Q ss_pred ccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHH
Q 003542 365 TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMT 444 (811)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~ 444 (811)
...... ......|||.|||||++.. .|+..+||||||+.|+||+|+..||..+. ...+++
T Consensus 194 tl~r~s---------~aksvIGTPEFMAPEmYEE----------~YnE~VDVYaFGMCmLEMvT~eYPYsEC~-n~AQIY 253 (632)
T KOG0584|consen 194 TLLRKS---------HAKSVIGTPEFMAPEMYEE----------NYNELVDVYAFGMCMLEMVTSEYPYSECT-NPAQIY 253 (632)
T ss_pred HHhhcc---------ccceeccCccccChHHHhh----------hcchhhhhhhhhHHHHHHHhccCChhhhC-CHHHHH
Confidence 877543 2345789999999999974 79999999999999999999999998765 445778
Q ss_pred HHHHhCCCCC-CCCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 445 KNIRAGERPL-FPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 445 ~~i~~~~~~~-~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
+.+..|..|. +..--.+++++||.+||.. ...|||+.++|.
T Consensus 254 KKV~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 254 KKVTSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred HHHHcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 8888887663 3344577899999999999 999999999987
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=301.36 Aligned_cols=255 Identities=16% Similarity=0.289 Sum_probs=193.5
Q ss_pred cceEEeeeecccc---eEEEEE-EcCCEEEEEEecc------cHHHHHHHHHHHHhCCCCccceeeeeEEc--cCCCeEE
Q 003542 216 KKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG------ELESLNAEISTMLSLSHPNIVQYLCGFCD--EEKKEFF 283 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~--e~~~~~y 283 (811)
.+|++.+.||.|+ +|.+.. .+|+.||+|.+.. ....+.+|+.+|+.++||||+++++.+.. .....+|
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 6788889999886 676663 4799999999853 24567889999999999999999876642 2335789
Q ss_pred EEEecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccc
Q 003542 284 LVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGL 363 (811)
Q Consensus 284 LVmEy~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGl 363 (811)
+||||+.++|..++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||+
T Consensus 85 lv~e~~~~~l~~~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~-----~~kl~dfg~ 153 (334)
T cd07855 85 VVMDLMESDLHHIIHSD------QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDC-----ELRIGDFGM 153 (334)
T ss_pred EEEehhhhhHHHHhccC------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-----cEEeccccc
Confidence 99999999988877542 5589999999999999999999999999999999999998876 899999999
Q ss_pred cccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHH-
Q 003542 364 STARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDK- 442 (811)
Q Consensus 364 A~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~- 442 (811)
+......... .........++..|+|||++.+ ...++.++||||||+++|+|++|++||.+.......
T Consensus 154 ~~~~~~~~~~---~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~ 222 (334)
T cd07855 154 ARGLSSSPTE---HKYFMTEYVATRWYRAPELLLS--------LPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLK 222 (334)
T ss_pred ceeecccCcC---CCcccccccccccccChHHhcC--------CcccccccchHHHHHHHHHHHcCCCccCCCChHHHHH
Confidence 8765433211 0111234568889999999864 235789999999999999999999999764321100
Q ss_pred ---------------------HHHHHHh-CCCCCC-----CCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHHHH
Q 003542 443 ---------------------MTKNIRA-GERPLF-----PSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKK 493 (811)
Q Consensus 443 ---------------------i~~~i~~-~~~~~~-----p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~k 493 (811)
....+.. ...... ....+.++.++|.+||+.+|.+||++.+++. ..++..
T Consensus 223 ~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~-~~~~~~ 299 (334)
T cd07855 223 LILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ-HPFLAQ 299 (334)
T ss_pred HHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh-Chhhhh
Confidence 0000000 011111 1345788999999999999999999999987 344443
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=296.11 Aligned_cols=247 Identities=20% Similarity=0.382 Sum_probs=185.2
Q ss_pred ceEEeeeecccc---eEEEEE-EcCCEEEEEEecc-----cHHHHHHHHHHHHhCC-CCccceeeeeEEccCCCeEEEEE
Q 003542 217 KLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG-----ELESLNAEISTMLSLS-HPNIVQYLCGFCDEEKKEFFLVM 286 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~-----~~~~~~~Ei~iL~~L~-HPNIVkl~~~~~~e~~~~~yLVm 286 (811)
+|+..+.||.|+ ||++.. .+|+.||+|.+.. ....+.+|+.++.++. ||||+++++.+.. ....+++|
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~--~~~~~~~~ 82 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR--EGDCWICM 82 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec--CCcEEEEE
Confidence 344455667764 666553 3789999999853 3456889999999996 9999999977743 45689999
Q ss_pred ecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcEEEeccCCCCcceEEEeeccccc
Q 003542 287 ELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQ-KIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365 (811)
Q Consensus 287 Ey~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~-gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~ 365 (811)
||+++++.++...... .....+++..+..++.|++.||+|||+. +++||||||+|||++.++ .+||+|||++.
T Consensus 83 e~~~~~l~~l~~~~~~-~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~-----~~kl~dfg~~~ 156 (288)
T cd06616 83 ELMDISLDKFYKYVYE-VLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNG-----NIKLCDFGISG 156 (288)
T ss_pred ecccCCHHHHHHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCC-----cEEEeecchhH
Confidence 9999876554432111 1225689999999999999999999985 999999999999998776 89999999987
Q ss_pred cccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHH
Q 003542 366 ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTK 445 (811)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~ 445 (811)
...... ......|++.|+|||++.+.. ...++.++|||||||++|+|++|++||......... ..
T Consensus 157 ~~~~~~--------~~~~~~~~~~y~aPE~~~~~~------~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~ 221 (288)
T cd06616 157 QLVDSI--------AKTRDAGCRPYMAPERIDPSA------RDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQ-LT 221 (288)
T ss_pred HhccCC--------ccccccCccCccCHHHhcccc------ccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHH-Hh
Confidence 553221 112345788899999986431 136788999999999999999999999764321111 12
Q ss_pred HHHhCCCCCCC----CCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 446 NIRAGERPLFP----SGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 446 ~i~~~~~~~~p----~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
.+..+..+..+ ..++..+.+||.+||..||.+|||+.+|+.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 222 QVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred hhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 22223222222 246788999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=292.52 Aligned_cols=249 Identities=22% Similarity=0.371 Sum_probs=200.6
Q ss_pred eeecccceEEEE-----EEcCCEEEEEEecc----cHHHHHHHHHHHHhC-CCCccceeeeeEEccCCCeEEEEEecCCC
Q 003542 222 RRLGASSQFKEI-----QWLGDSFVLRHFYG----ELESLNAEISTMLSL-SHPNIVQYLCGFCDEEKKEFFLVMELMSK 291 (811)
Q Consensus 222 ~~lG~G~vyk~v-----~~~g~~VAVK~~~~----~~~~~~~Ei~iL~~L-~HPNIVkl~~~~~~e~~~~~yLVmEy~~g 291 (811)
+.||.| .|..+ ..+|..||||++.+ ...++.+|++++.+. .|+||+++++.| ++...+|||||-|.|
T Consensus 84 e~LGeG-AyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefF--Edd~~FYLVfEKm~G 160 (463)
T KOG0607|consen 84 ELLGEG-AYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFF--EDDTRFYLVFEKMRG 160 (463)
T ss_pred HHhcCc-cceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHh--cccceEEEEEecccC
Confidence 357888 45444 46999999999965 467899999999999 599999999888 566779999999985
Q ss_pred -CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccccccccc
Q 003542 292 -DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYA 370 (811)
Q Consensus 292 -~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~ 370 (811)
.|+.+|.+. ..|++.++..+..+|+.||.|||.+||.||||||+|||....+ .-.-||||||.|.......
T Consensus 161 GplLshI~~~------~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn--~vsPvKiCDfDLgSg~k~~ 232 (463)
T KOG0607|consen 161 GPLLSHIQKR------KHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPN--KVSPVKICDFDLGSGIKLN 232 (463)
T ss_pred chHHHHHHHh------hhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCC--CcCceeeeccccccccccC
Confidence 899999875 7799999999999999999999999999999999999986543 2336999999998665444
Q ss_pred CCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCcc------------
Q 003542 371 SRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHL------------ 438 (811)
Q Consensus 371 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~------------ 438 (811)
..-.+...+...+.+|+..|||||+..--.. ....|+.++|.||||||||-||+|++||.+...
T Consensus 233 ~~~spastP~L~tPvGSAEfMAPEVVd~fv~----qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr 308 (463)
T KOG0607|consen 233 NDCSPASTPELLTPVGSAEFMAPEVVDVFVD----QATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCR 308 (463)
T ss_pred CCCCCCCCccccCcccchhhcchhHHhhhcc----ccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccH
Confidence 3333333445567889999999999753211 134799999999999999999999999975321
Q ss_pred -chHHHHHHHHhCCCCCCCC----CChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 439 -QGDKMTKNIRAGERPLFPS----GSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 439 -~~~~i~~~i~~~~~~~~p~----~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
-+..+++.|..|... ||. .++.+.++||..+|..|+.+|.++.+++.
T Consensus 309 ~CQ~~LFesIQEGkYe-FPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 309 VCQNKLFESIQEGKYE-FPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHHHHHHHHHhccCCc-CChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 134567778877643 443 46788999999999999999999988866
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=292.92 Aligned_cols=235 Identities=25% Similarity=0.354 Sum_probs=179.2
Q ss_pred eccc---ceEEEEEE--------cCCEEEEEEecc----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEec
Q 003542 224 LGAS---SQFKEIQW--------LGDSFVLRHFYG----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMEL 288 (811)
Q Consensus 224 lG~G---~vyk~v~~--------~g~~VAVK~~~~----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy 288 (811)
||.| .||++... ....||+|.+.. ..+.+..|+.+++.++||||+++++.+.. ....++||||
T Consensus 3 lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~--~~~~~lv~e~ 80 (258)
T cd05078 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVC--GDESIMVQEY 80 (258)
T ss_pred CCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEe--CCCcEEEEec
Confidence 4554 37876632 234589998854 24568899999999999999999977743 4568999999
Q ss_pred CCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCC---CCcceEEEeecccc
Q 003542 289 MSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSM---EGYFHVKVSGFGLS 364 (811)
Q Consensus 289 ~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~---d~~~~vKL~DFGlA 364 (811)
+++ +|..++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++. .....++++|||++
T Consensus 81 ~~~g~L~~~l~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKN-----KNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccc
Confidence 995 888888653 236889999999999999999999999999999999999987652 12235899999987
Q ss_pred ccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhC-CCCCCCCccchHHH
Q 003542 365 TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTG-KVPFEDGHLQGDKM 443 (811)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG-~~PF~~~~~~~~~i 443 (811)
..... .....+++.|+|||++.+ ...++.++||||||+++|+|++| .+||....... .
T Consensus 156 ~~~~~-----------~~~~~~~~~y~aPE~~~~--------~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~--~ 214 (258)
T cd05078 156 ITVLP-----------KEILLERIPWVPPECIEN--------PQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK--K 214 (258)
T ss_pred cccCC-----------chhccccCCccCchhccC--------CCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH--H
Confidence 54321 123457788999999864 22578899999999999999998 46665432221 1
Q ss_pred HHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHH
Q 003542 444 TKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRIL 488 (811)
Q Consensus 444 ~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L 488 (811)
.. + ......+|...+.++.+|+.+||+.||.+|||+++|++.|
T Consensus 215 ~~-~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 215 LQ-F-YEDRHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred HH-H-HHccccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 11 1 1223446666778899999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=293.79 Aligned_cols=242 Identities=21% Similarity=0.361 Sum_probs=186.4
Q ss_pred eEEeeeecccc---eEEEEE-EcCCEEEEEEecc------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEe
Q 003542 218 LMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVME 287 (811)
Q Consensus 218 ~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmE 287 (811)
|++.+.||.|+ +|++.. .+|..||+|++.. ....+.+|+.+++.++||||+++++.+. +....|+|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~--~~~~~~iv~e 78 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVH--SENKLYLVFE 78 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheec--cCCeEEEEEe
Confidence 45667777775 777663 4899999999852 2356889999999999999999997774 4567999999
Q ss_pred cCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccc
Q 003542 288 LMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTAR 367 (811)
Q Consensus 288 y~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~ 367 (811)
|++++|.+++... ....+++..++.++.||+.||.|||+++++||||+|+||+++.++ .++|+|||++...
T Consensus 79 ~~~~~l~~~~~~~----~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~-----~~~l~df~~~~~~ 149 (283)
T cd07835 79 FLDLDLKKYMDSS----PLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREG-----ALKLADFGLARAF 149 (283)
T ss_pred ccCcCHHHHHhhC----CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCC-----cEEEeeccccccc
Confidence 9998999888753 113689999999999999999999999999999999999998866 8999999998654
Q ss_pred cccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHHH
Q 003542 368 TYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNI 447 (811)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i 447 (811)
..... ......++..|+|||++.+. ..++.++||||||+++|+|++|++||....... ......
T Consensus 150 ~~~~~-------~~~~~~~~~~~~aPE~~~~~--------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~ 213 (283)
T cd07835 150 GVPVR-------TYTHEVVTLWYRAPEILLGS--------RQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID-QLFRIF 213 (283)
T ss_pred CCCcc-------ccCccccccCCCCCceeecC--------cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHH
Confidence 32211 11233568889999988642 256789999999999999999999997654321 111111
Q ss_pred HhC------------------------CC---CCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 448 RAG------------------------ER---PLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 448 ~~~------------------------~~---~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
... .. .......+..+.++|.+||+.||.+||++.+++.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 214 RTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred HHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 100 00 0112345678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=295.74 Aligned_cols=255 Identities=14% Similarity=0.231 Sum_probs=183.6
Q ss_pred HHHhcceEEeeeecccc---eEEEEEEc----CCEEEEEEecccHH---------------HHHHHHHHHHhCCCCccce
Q 003542 212 DMLLKKLMVRRRLGASS---QFKEIQWL----GDSFVLRHFYGELE---------------SLNAEISTMLSLSHPNIVQ 269 (811)
Q Consensus 212 ~~l~k~~~i~~~lG~G~---vyk~v~~~----g~~VAVK~~~~~~~---------------~~~~Ei~iL~~L~HPNIVk 269 (811)
+...++|++.+.||+|+ ||++.... +..+|+|......+ ....+...+..++|+||++
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~ 87 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK 87 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence 34457899999999986 77766433 45677776431111 1223334456678999999
Q ss_pred eeeeEEccCC--CeEEEEEecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEec
Q 003542 270 YLCGFCDEEK--KEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKA 347 (811)
Q Consensus 270 l~~~~~~e~~--~~~yLVmEy~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~ 347 (811)
+++....... ...+++||++..++.+.+... ..+++..+..++.||+.||.|||+.+|+||||||+|||++.
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~ 161 (294)
T PHA02882 88 YYGCGSFKRCRMYYRFILLEKLVENTKEIFKRI------KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDG 161 (294)
T ss_pred EEEeeeEecCCceEEEEEEehhccCHHHHHHhh------ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC
Confidence 9865432222 244789999887777666542 34678889999999999999999999999999999999987
Q ss_pred cCCCCcceEEEeeccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHh
Q 003542 348 RSMEGYFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELL 427 (811)
Q Consensus 348 ~g~d~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELl 427 (811)
++ .++|+|||+|+....................||+.|+|||++.+. .++.++|||||||++|||+
T Consensus 162 ~~-----~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~---------~~~~~~DiwSlG~~l~el~ 227 (294)
T PHA02882 162 NN-----RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGA---------CVTRRGDLESLGYCMLKWA 227 (294)
T ss_pred CC-----cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCC---------CCCcHHHHHHHHHHHHHHH
Confidence 65 899999999987643221111111122345699999999998743 6789999999999999999
Q ss_pred hCCCCCCCCccchHH-------HHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHH
Q 003542 428 TGKVPFEDGHLQGDK-------MTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRIL 488 (811)
Q Consensus 428 tG~~PF~~~~~~~~~-------i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L 488 (811)
+|.+||.+....... +...+..+. .....+++.+.+++..||..+|.+||++.+|++.+
T Consensus 228 ~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 228 GIKLPWKGFGHNGNLIHAAKCDFIKRLHEGK--IKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred hCCCCCCccccchHHHHHhHHHHHHHhhhhh--hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 999999865322211 112222221 12346788999999999999999999999998754
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=288.61 Aligned_cols=231 Identities=23% Similarity=0.319 Sum_probs=187.6
Q ss_pred ccceEEEEEE-cCCEEEEEEecc-------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEecCC-CCHHHH
Q 003542 226 ASSQFKEIQW-LGDSFVLRHFYG-------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMS-KDLSCY 296 (811)
Q Consensus 226 ~G~vyk~v~~-~g~~VAVK~~~~-------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~~-g~L~~~ 296 (811)
.|.+|++... +++.||+|.+.. ..+.+.+|+.+++.++||||+++++.+. ++..+|+||||++ ++|.++
T Consensus 6 ~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~ 83 (262)
T cd05572 6 FGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFK--DKKYIYMLMEYCLGGELWTI 83 (262)
T ss_pred ceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEE--cCCccEEEEecCCCCcHHHH
Confidence 3447877643 589999999853 2366899999999999999999998774 4567999999998 589998
Q ss_pred HHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccccccCCCCCC
Q 003542 297 MRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTPP 376 (811)
Q Consensus 297 L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~~~~~~~ 376 (811)
+... ..+++..+..++.||+.||.|||+.+++|+||+|+||+++.++ .++|+|||++.......
T Consensus 84 l~~~------~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~-----~~~l~df~~~~~~~~~~----- 147 (262)
T cd05572 84 LRDR------GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNG-----YVKLVDFGFAKKLKSGQ----- 147 (262)
T ss_pred Hhhc------CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCC-----CEEEeeCCcccccCccc-----
Confidence 8753 4589999999999999999999999999999999999998876 89999999987654321
Q ss_pred CCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHHHHh-CCCCCC
Q 003542 377 ASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRA-GERPLF 455 (811)
Q Consensus 377 ~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i~~-~~~~~~ 455 (811)
......++..|+|||.+.+. .++.++|+||||+++|+|++|..||.....+.......+.. ...+.+
T Consensus 148 ---~~~~~~~~~~~~~PE~~~~~---------~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 215 (262)
T cd05572 148 ---KTWTFCGTPEYVAPEIILNK---------GYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEF 215 (262)
T ss_pred ---ccccccCCcCccChhHhcCC---------CCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCC
Confidence 11234678889999998643 57889999999999999999999997655333344444443 345566
Q ss_pred CCCChHHHHHHHhhhccCCCCCCCC-----HHHHHH
Q 003542 456 PSGSPKYLVNLTKKCWHTNPSQRPS-----FSSICR 486 (811)
Q Consensus 456 p~~~~~~l~~LI~~cL~~DP~~RPS-----~~eIl~ 486 (811)
|...++.+.++|.+||..+|.+||+ +.++++
T Consensus 216 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 216 PNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 7777889999999999999999999 788776
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=299.34 Aligned_cols=233 Identities=18% Similarity=0.357 Sum_probs=183.7
Q ss_pred eeccc---ceEEEEE-EcCCEEEEEEecc----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEecCCC-CH
Q 003542 223 RLGAS---SQFKEIQ-WLGDSFVLRHFYG----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DL 293 (811)
Q Consensus 223 ~lG~G---~vyk~v~-~~g~~VAVK~~~~----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~~g-~L 293 (811)
.||.| .+|++.. .+++.||+|.+.. ..+.+.+|+.++..++||||+++++.+. ....+|+||||+++ +|
T Consensus 28 ~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~--~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL--VGEELWVLMEFLQGGAL 105 (297)
T ss_pred hcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhhee--eCCeEEEEEecCCCCCH
Confidence 34555 4777663 4789999999842 3467889999999999999999997774 45679999999995 77
Q ss_pred HHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccccccCCC
Q 003542 294 SCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRN 373 (811)
Q Consensus 294 ~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~~~~ 373 (811)
..++.. ..+++..++.++.||+.||.|||+.|++||||||+||+++.++ .+||+|||++.......
T Consensus 106 ~~~~~~-------~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~-----~~kL~dfg~~~~~~~~~-- 171 (297)
T cd06659 106 TDIVSQ-------TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDG-----RVKLSDFGFCAQISKDV-- 171 (297)
T ss_pred HHHHhh-------cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCC-----cEEEeechhHhhccccc--
Confidence 776543 4689999999999999999999999999999999999998876 89999999986543221
Q ss_pred CCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHHHHhCCCC
Q 003542 374 TPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERP 453 (811)
Q Consensus 374 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i~~~~~~ 453 (811)
.......|+..|+|||++.+. .++.++|||||||++|+|++|+.||...... .....+.....+
T Consensus 172 -----~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~~~~ 235 (297)
T cd06659 172 -----PKRKSLVGTPYWMAPEVISRT---------PYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV--QAMKRLRDSPPP 235 (297)
T ss_pred -----ccccceecCccccCHHHHccC---------CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHhccCCC
Confidence 112345688999999999643 5788999999999999999999999754322 222333322221
Q ss_pred --CCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHH
Q 003542 454 --LFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRI 487 (811)
Q Consensus 454 --~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~ 487 (811)
..+...+..+.++|.+||..+|.+||++.+++.+
T Consensus 236 ~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 236 KLKNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 1234567889999999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=292.89 Aligned_cols=251 Identities=19% Similarity=0.287 Sum_probs=187.6
Q ss_pred hcceEEeeeecccc---eEEEEE-EcCCEEEEEEecc------cHHHHHHHHHHHHhCCCCccceeeeeEEccC------
Q 003542 215 LKKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG------ELESLNAEISTMLSLSHPNIVQYLCGFCDEE------ 278 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~------ 278 (811)
.++|++.+.||.|+ +|++.. .+|+.||||.+.. ....+.+|+.++++++||||+++++.+....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 35799999999986 666653 3789999999842 1235678999999999999999997654322
Q ss_pred CCeEEEEEecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEE
Q 003542 279 KKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKV 358 (811)
Q Consensus 279 ~~~~yLVmEy~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL 358 (811)
...+|+||||++++|..++... ...+++..++.++.||+.||.|||++|++|+||||+||+++.++ .+||
T Consensus 91 ~~~~~lv~e~~~~~l~~~l~~~-----~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~-----~~kl 160 (310)
T cd07865 91 KGSFYLVFEFCEHDLAGLLSNK-----NVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDG-----ILKL 160 (310)
T ss_pred CceEEEEEcCCCcCHHHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCC-----cEEE
Confidence 2457999999999988887642 24689999999999999999999999999999999999998776 8999
Q ss_pred eeccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCcc
Q 003542 359 SGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHL 438 (811)
Q Consensus 359 ~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~ 438 (811)
+|||++.......... ........++..|+|||++.+. ..++.++||||||+++|+|++|.+||.+...
T Consensus 161 ~dfg~~~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~--------~~~~~~~Di~slG~~l~el~t~~~~~~~~~~ 229 (310)
T cd07865 161 ADFGLARAFSLSKNSK---PNRYTNRVVTLWYRPPELLLGE--------RDYGPPIDMWGAGCIMAEMWTRSPIMQGNTE 229 (310)
T ss_pred CcCCCcccccCCcccC---CCCccCcccCccccCcHHhcCC--------cccCchhhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999997654332110 1112244578889999998642 2467899999999999999999999976542
Q ss_pred chHH-HHHHHHhCCCC---------------CC-------------CCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 439 QGDK-MTKNIRAGERP---------------LF-------------PSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 439 ~~~~-i~~~i~~~~~~---------------~~-------------p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
.... ....+.....+ .+ +...+..+.+||.+||..||.+|||++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 230 QHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred HHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 2110 01111100000 00 1112456789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=311.60 Aligned_cols=255 Identities=24% Similarity=0.374 Sum_probs=201.2
Q ss_pred hhHHHHHhcceEEeeeecccceEEEEEE---c-CCEEEEEEecc-----cHHHHHHHHHHHHhCCCCccceeeeeEEccC
Q 003542 208 QRLVDMLLKKLMVRRRLGASSQFKEIQW---L-GDSFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQYLCGFCDEE 278 (811)
Q Consensus 208 ~~~~~~l~k~~~i~~~lG~G~vyk~v~~---~-g~~VAVK~~~~-----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~ 278 (811)
..+.++-.+.+.+.++||+| +|+++.. . +..||||.++. ...+|.+||++|.+|+|||||++++++..+
T Consensus 530 ~al~EfPRs~L~~~ekiGeG-qFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~D- 607 (807)
T KOG1094|consen 530 PALVEFPRSRLRFKEKIGEG-QFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQD- 607 (807)
T ss_pred cchhhcchhheehhhhhcCc-ccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecC-
Confidence 34455566788999999999 8999943 4 48999999964 357899999999999999999999776543
Q ss_pred CCeEEEEEecCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEE
Q 003542 279 KKEFFLVMELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVK 357 (811)
Q Consensus 279 ~~~~yLVmEy~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vK 357 (811)
+.+++|||||+ |+|.+|+..+.. ..+.-.....|+.||++||+||.+.++|||||.+.|||++.+. ++|
T Consensus 608 -ePicmI~EYmEnGDLnqFl~ahea----pt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~-----~iK 677 (807)
T KOG1094|consen 608 -DPLCMITEYMENGDLNQFLSAHEL----PTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEF-----TIK 677 (807)
T ss_pred -CchHHHHHHHhcCcHHHHHHhccC----cccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcc-----cEE
Confidence 45899999999 899999987522 1234455677999999999999999999999999999996554 999
Q ss_pred EeeccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh--CCCCCCC
Q 003542 358 VSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT--GKVPFED 435 (811)
Q Consensus 358 L~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt--G~~PF~~ 435 (811)
|+|||+++.+-.... .......+-+..|||||.+.. ++++.++|+|+||+++||+++ ...||..
T Consensus 678 iadfgmsR~lysg~y-----y~vqgr~vlpiRwmawEsill---------gkFttaSDvWafgvTlwE~~~~C~e~Py~~ 743 (807)
T KOG1094|consen 678 IADFGMSRNLYSGDY-----YRVQGRAVLPIRWMAWESILL---------GKFTTASDVWAFGVTLWEVFMLCREQPYSQ 743 (807)
T ss_pred ecCcccccccccCCc-----eeeecceeeeeeehhHHHHHh---------ccccchhhhhhhHHHHHHHHHHHhhCchhh
Confidence 999999985533321 112234556788999999974 489999999999999999876 7889986
Q ss_pred CccchHHHHHHHHh----CC---CCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHH
Q 003542 436 GHLQGDKMTKNIRA----GE---RPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRY 490 (811)
Q Consensus 436 ~~~~~~~i~~~i~~----~~---~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~ 490 (811)
.+.+ +..++... +. -+..|..||..+.+++.+||..|..+||+|+++...|..
T Consensus 744 lt~e--~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~ 803 (807)
T KOG1094|consen 744 LTDE--QVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQE 803 (807)
T ss_pred hhHH--HHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence 5433 22222211 11 234578899999999999999999999999999876653
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=291.21 Aligned_cols=244 Identities=20% Similarity=0.331 Sum_probs=189.0
Q ss_pred cceEEeeeecccc---eEEEEEE-cCCEEEEEEecc------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEE
Q 003542 216 KKLMVRRRLGASS---QFKEIQW-LGDSFVLRHFYG------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLV 285 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~~-~g~~VAVK~~~~------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLV 285 (811)
++|++.+.||.|+ +|++... +++.||||.+.. ..+.+.+|+++++.++||||+++++.+. ..+.+|+|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~iv 78 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFR--RKGRLYLV 78 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEE--ECCEEEEE
Confidence 3688999999985 6766543 688999999853 2467899999999999999999998774 35679999
Q ss_pred EecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccc
Q 003542 286 MELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365 (811)
Q Consensus 286 mEy~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~ 365 (811)
|||+++++...+... ...+++..+..++.||+.||.|||+.+++||||+|+||+++.++ .+||+|||++.
T Consensus 79 ~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~-----~~kl~d~g~~~ 148 (288)
T cd07833 79 FEYVERTLLELLEAS-----PGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESG-----VLKLCDFGFAR 148 (288)
T ss_pred EecCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-----CEEEEeeeccc
Confidence 999998766655432 25589999999999999999999999999999999999998776 89999999987
Q ss_pred cccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHH
Q 003542 366 ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTK 445 (811)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~ 445 (811)
....... .......++..|+|||++.+. ..++.++||||||+++|+|++|.+||.+...... +..
T Consensus 149 ~~~~~~~------~~~~~~~~~~~~~~PE~~~~~--------~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~-~~~ 213 (288)
T cd07833 149 ALRARPA------SPLTDYVATRWYRAPELLVGD--------TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQ-LYL 213 (288)
T ss_pred ccCCCcc------ccccCcccccCCcCCchhcCC--------CCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHH
Confidence 6544321 112245678889999998642 2678899999999999999999999976432211 111
Q ss_pred HHH-h------------------CCC-----------CCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 446 NIR-A------------------GER-----------PLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 446 ~i~-~------------------~~~-----------~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
... . +.. ..++..++..+.+||.+||..+|.+||+++++++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 214 IQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred HHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 000 0 000 0123345788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=314.88 Aligned_cols=245 Identities=28% Similarity=0.522 Sum_probs=205.2
Q ss_pred cceEEeeeecccceEEEE---EE---cCC--EEEEEEecc-----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeE
Q 003542 216 KKLMVRRRLGASSQFKEI---QW---LGD--SFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEF 282 (811)
Q Consensus 216 k~~~i~~~lG~G~vyk~v---~~---~g~--~VAVK~~~~-----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~ 282 (811)
+++.+.+.||.| .|+++ .| .|+ .||||.+.. ...+|.+|+.+|.+|+|||++++|+...+ ...
T Consensus 110 e~i~l~e~LG~G-sFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~---qp~ 185 (1039)
T KOG0199|consen 110 EQIKLYELLGEG-SFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD---QPA 185 (1039)
T ss_pred HHHHHHHHhcCc-ceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc---chh
Confidence 344556678998 56666 34 333 699999963 56889999999999999999999977754 457
Q ss_pred EEEEecCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeec
Q 003542 283 FLVMELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGF 361 (811)
Q Consensus 283 yLVmEy~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DF 361 (811)
.+|||+++ |+|++.|++. .+..|.......|+.||+.||.||.++++|||||-..|+|+.... .|||+||
T Consensus 186 mMV~ELaplGSLldrLrka----~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllaspr-----tVKI~DF 256 (1039)
T KOG0199|consen 186 MMVFELAPLGSLLDRLRKA----KKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPR-----TVKICDF 256 (1039)
T ss_pred hHHhhhcccchHHHHHhhc----cccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccc-----eeeeecc
Confidence 89999999 7999999872 346788999999999999999999999999999999999997755 8999999
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CCCCCCCCccch
Q 003542 362 GLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQG 440 (811)
Q Consensus 362 GlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~~PF~~~~~~~ 440 (811)
||.+.+....... .......-.+.|.|||.+.. ..++.++|||+|||++|||++ |..||.+. ..
T Consensus 257 GLmRaLg~ned~Y----vm~p~rkvPfAWCaPEsLrh---------~kFShaSDvWmyGVTiWEMFtyGEePW~G~--~g 321 (1039)
T KOG0199|consen 257 GLMRALGENEDMY----VMAPQRKVPFAWCAPESLRH---------RKFSHASDVWMYGVTIWEMFTYGEEPWVGC--RG 321 (1039)
T ss_pred cceeccCCCCcce----EecCCCcCcccccCHhHhcc---------ccccccchhhhhhhhHHhhhccCCCCCCCC--CH
Confidence 9998876554321 11223445677999999974 489999999999999999998 99999986 45
Q ss_pred HHHHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHH
Q 003542 441 DKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRIL 488 (811)
Q Consensus 441 ~~i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L 488 (811)
.++.+.|..+.+...|..|++++.+++..||..+|.+||+|..|.+.+
T Consensus 322 ~qIL~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 322 IQILKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred HHHHHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 678899999999999999999999999999999999999999997533
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=297.06 Aligned_cols=239 Identities=23% Similarity=0.420 Sum_probs=190.1
Q ss_pred cceEEeeeecccc---eEEEEE-EcCCEEEEEEecc----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEe
Q 003542 216 KKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVME 287 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmE 287 (811)
++|.+.+.||.|+ +|++.. .++..||+|.+.. ..+.+.+|+.+++.++||||+++++.+. .....|+|||
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~--~~~~~~lv~e 96 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL--VGDELWVVME 96 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheee--eCCcEEEEEe
Confidence 6788999999886 777663 4788999999853 3466889999999999999999998774 3456899999
Q ss_pred cCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccccc
Q 003542 288 LMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366 (811)
Q Consensus 288 y~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~ 366 (811)
|+++ +|.+++.+ ..+++..+..++.|++.||.|||++|++||||+|+||+++.++ .++|+|||++..
T Consensus 97 ~~~~~~L~~~~~~-------~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~-----~~kL~dfg~~~~ 164 (293)
T cd06647 97 YLAGGSLTDVVTE-------TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-----SVKLTDFGFCAQ 164 (293)
T ss_pred cCCCCcHHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCC-----CEEEccCcceec
Confidence 9985 88888764 4578899999999999999999999999999999999998776 899999999865
Q ss_pred ccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHH
Q 003542 367 RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKN 446 (811)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~ 446 (811)
...... ......+++.|+|||.+.+. .++.++||||||+++|++++|+.||....... .. ..
T Consensus 165 ~~~~~~-------~~~~~~~~~~y~~PE~~~~~---------~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~-~~-~~ 226 (293)
T cd06647 165 ITPEQS-------KRSTMVGTPYWMAPEVVTRK---------AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-AL-YL 226 (293)
T ss_pred cccccc-------ccccccCChhhcCchhhccC---------CCCchhhHHHHHHHHHHHHhCCCCCCCCChhh-he-ee
Confidence 543211 12234688889999998642 57889999999999999999999997643221 11 11
Q ss_pred HHhCCCCCC--CCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 447 IRAGERPLF--PSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 447 i~~~~~~~~--p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
+.....+.+ +...+..+.++|.+||..+|.+||++.+++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 268 (293)
T cd06647 227 IATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 268 (293)
T ss_pred hhcCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 222222222 3345778999999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=292.43 Aligned_cols=243 Identities=26% Similarity=0.392 Sum_probs=186.0
Q ss_pred cceEEeeeecccc---eEEEEEE-cCCEEEEEEecc------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEE
Q 003542 216 KKLMVRRRLGASS---QFKEIQW-LGDSFVLRHFYG------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLV 285 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~~-~g~~VAVK~~~~------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLV 285 (811)
++|++.+.||.|+ +|++... +|+.||+|.+.. ..+.+.+|+++|+.++||||+++++.+ .....+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~lv 78 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVF--RRKKRLYLV 78 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhc--ccCCeEEEE
Confidence 3688899999986 7776643 689999999843 235688999999999999999999777 456679999
Q ss_pred EecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccc
Q 003542 286 MELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365 (811)
Q Consensus 286 mEy~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~ 365 (811)
|||+++++...+... ...+++..+..++.||+.||.|||+.|++||||+|+||+++.++ .++|+|||++.
T Consensus 79 ~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~-----~~~l~dfg~~~ 148 (286)
T cd07846 79 FEFVDHTVLDDLEKY-----PNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSG-----VVKLCDFGFAR 148 (286)
T ss_pred EecCCccHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC-----cEEEEeeeeee
Confidence 999997544444321 14589999999999999999999999999999999999998776 89999999987
Q ss_pred cccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHH
Q 003542 366 ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTK 445 (811)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~ 445 (811)
....... ......++..|+|||++.+. ..++.++||||||+++|+|++|.+||...... .....
T Consensus 149 ~~~~~~~-------~~~~~~~~~~y~aPE~~~~~--------~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~-~~~~~ 212 (286)
T cd07846 149 TLAAPGE-------VYTDYVATRWYRAPELLVGD--------TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI-DQLYH 212 (286)
T ss_pred eccCCcc-------ccCcccceeeccCcHHhccc--------cccCchHhHHHHHHHHHHHHcCCCCCCCCchH-HHHHH
Confidence 6533221 12234578889999998642 35678999999999999999999999754321 11111
Q ss_pred HHH-------------------hCC-CCC---------CCCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 446 NIR-------------------AGE-RPL---------FPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 446 ~i~-------------------~~~-~~~---------~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
... .+. .+. ....++..+.+|+.+||..+|.+||++.++++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 213 IIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred HHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 110 000 000 12345778999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=291.88 Aligned_cols=221 Identities=24% Similarity=0.338 Sum_probs=170.0
Q ss_pred CEEEEEEeccc----HHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEecCCC-CHHHHHHHhhCCCCCCCCCHH
Q 003542 238 DSFVLRHFYGE----LESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFSLP 312 (811)
Q Consensus 238 ~~VAVK~~~~~----~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~~g-~L~~~L~~~~~~~~~~~ls~~ 312 (811)
..||+|.+... ...+.+|+.+++.++||||+++++.+. +....|+|||||++ +|..++... ...+++.
T Consensus 45 ~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~~~~~~--~~~~~~lv~ey~~~g~L~~~l~~~-----~~~~~~~ 117 (274)
T cd05076 45 LRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCV--RGSENIMVEEFVEHGPLDVCLRKE-----KGRVPVA 117 (274)
T ss_pred eeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeEEEEEE--eCCceEEEEecCCCCcHHHHHHhc-----CCCCCHH
Confidence 46899998642 346788999999999999999997653 34568999999995 777776542 2568899
Q ss_pred HHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCC--CCcceEEEeeccccccccccCCCCCCCCCCCCCCCCCCcc
Q 003542 313 VVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSM--EGYFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIW 390 (811)
Q Consensus 313 ~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~--d~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y 390 (811)
.+..++.||+.||.|||+++|+||||||+|||++..+. .....+||+|||++...... ....++..|
T Consensus 118 ~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~-----------~~~~~~~~~ 186 (274)
T cd05076 118 WKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR-----------EERVERIPW 186 (274)
T ss_pred HHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCccceeeecCCccccccccc-----------cccccCCcc
Confidence 99999999999999999999999999999999986542 12235899999987543211 123467789
Q ss_pred CChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHh-hCCCCCCCCccchHHHHHHHHhCCCCCCCCCChHHHHHHHhh
Q 003542 391 YAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELL-TGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKK 469 (811)
Q Consensus 391 ~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELl-tG~~PF~~~~~~~~~i~~~i~~~~~~~~p~~~~~~l~~LI~~ 469 (811)
+|||.+.+ ...++.++||||||+++|||+ +|..||....... ....... ....+...++.+.++|.+
T Consensus 187 ~aPe~~~~--------~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~--~~~~~~~~~~~~~~li~~ 254 (274)
T cd05076 187 IAPECVPG--------GNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE--KERFYEK--KHRLPEPSCKELATLISQ 254 (274)
T ss_pred cCchhhcC--------CCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH--HHHHHHh--ccCCCCCCChHHHHHHHH
Confidence 99999864 235789999999999999995 6999997654322 1122222 223444556779999999
Q ss_pred hccCCCCCCCCHHHHHHHH
Q 003542 470 CWHTNPSQRPSFSSICRIL 488 (811)
Q Consensus 470 cL~~DP~~RPS~~eIl~~L 488 (811)
||+.+|.+||++.+|++.|
T Consensus 255 cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 255 CLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HcccChhhCcCHHHHHHhh
Confidence 9999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=297.34 Aligned_cols=238 Identities=22% Similarity=0.396 Sum_probs=178.9
Q ss_pred EcCCEEEEEEecc------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEecCC-CCHHHHHHHhhCCCCCC
Q 003542 235 WLGDSFVLRHFYG------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMS-KDLSCYMRETFGSRRRN 307 (811)
Q Consensus 235 ~~g~~VAVK~~~~------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~~-g~L~~~L~~~~~~~~~~ 307 (811)
.+|+.||||.+.. ....+.+|+.+|+.++||||+++++.+. +...+|++|||++ ++|.+++.... ..
T Consensus 23 ~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~--~~~~~~~~~e~~~~~~l~~~l~~~~----~~ 96 (314)
T cd08216 23 PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFI--VDSELYVVSPLMAYGSCEDLLKTHF----PE 96 (314)
T ss_pred CCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheee--cCCeEEEEEeccCCCCHHHHHHHhc----cc
Confidence 3799999999853 3467899999999999999999998774 4557899999999 58888887542 24
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccccccCCCCCCCCCCCCCCCCC
Q 003542 308 SFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNP 387 (811)
Q Consensus 308 ~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT 387 (811)
.+++..+..++.|++.||.|||+++|+||||||+|||++.++ .+||+|||.+.....................++
T Consensus 97 ~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~-----~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (314)
T cd08216 97 GLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDG-----KVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKN 171 (314)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCC-----ceEEecCccceeecccccccccccccccccccc
Confidence 588999999999999999999999999999999999998776 899999999875543221111111122344577
Q ss_pred CccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHHHHhCCC---------------
Q 003542 388 YIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGER--------------- 452 (811)
Q Consensus 388 ~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i~~~~~--------------- 452 (811)
..|+|||++... ...++.++|||||||++|+|++|..||........ ....+.....
T Consensus 172 ~~y~aPE~~~~~-------~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (314)
T cd08216 172 LPWLSPEVLQQN-------LQGYNEKSDIYSVGITACELANGHVPFKDMPATQM-LLEKVRGTVPCLLDKSTYPLYEDSM 243 (314)
T ss_pred ccccCHHHhcCC-------CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhccCccccccCchhhhcCCc
Confidence 889999999642 23578899999999999999999999976432221 1111111000
Q ss_pred -----------------CCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHHH
Q 003542 453 -----------------PLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIK 492 (811)
Q Consensus 453 -----------------~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~ 492 (811)
...+...+.++.+|+.+||..||++|||+.++++ ...++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~-~p~~~ 299 (314)
T cd08216 244 SQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN-HSFFK 299 (314)
T ss_pred CcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc-CchHh
Confidence 0011122456889999999999999999999988 44444
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=296.54 Aligned_cols=242 Identities=20% Similarity=0.364 Sum_probs=189.9
Q ss_pred eEEeeeecccc---eEEEEE-EcCCEEEEEEecc-------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEE
Q 003542 218 LMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG-------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVM 286 (811)
Q Consensus 218 ~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~-------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVm 286 (811)
|...+.||+|+ +|++.. .+|..||+|.+.. ....+.+|+.+++.++||||+++++.+. +....|+||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~ 104 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYL--REHTAWLVM 104 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEe--eCCeEEEEE
Confidence 55566677764 777663 3788999999852 2346889999999999999999997664 345689999
Q ss_pred ecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccccc
Q 003542 287 ELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366 (811)
Q Consensus 287 Ey~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~ 366 (811)
||+.|+|.+++... ...+++..+..++.||+.||.|||+.||+||||+|+||+++.++ .++|+|||++..
T Consensus 105 e~~~g~l~~~~~~~-----~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~-----~~kl~dfg~~~~ 174 (317)
T cd06635 105 EYCLGSASDLLEVH-----KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPG-----QVKLADFGSASI 174 (317)
T ss_pred eCCCCCHHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCC-----CEEEecCCCccc
Confidence 99999988877542 25689999999999999999999999999999999999998776 899999998764
Q ss_pred ccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHH
Q 003542 367 RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKN 446 (811)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~ 446 (811)
... .....|++.|+|||++... ....++.++|||||||++|+|++|..||..... ......
T Consensus 175 ~~~-----------~~~~~~~~~y~aPE~~~~~------~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--~~~~~~ 235 (317)
T cd06635 175 ASP-----------ANSFVGTPYWMAPEVILAM------DEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--MSALYH 235 (317)
T ss_pred cCC-----------cccccCCccccChhhhhcC------CCCCCCccccHHHHHHHHHHHHhCCCCCCCccH--HHHHHH
Confidence 322 1234578889999998532 123578899999999999999999999976432 222333
Q ss_pred HHhCCC-CCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHH
Q 003542 447 IRAGER-PLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRY 490 (811)
Q Consensus 447 i~~~~~-~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~ 490 (811)
+..... ...+...++.+.+|+.+||+.+|.+||++.++++++..
T Consensus 236 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 236 IAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred HHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 333333 33345677889999999999999999999999886544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=341.06 Aligned_cols=247 Identities=19% Similarity=0.344 Sum_probs=204.0
Q ss_pred ceEEeeeecccc---eEEEE-EEcCCEEEEEEecc------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEE
Q 003542 217 KLMVRRRLGASS---QFKEI-QWLGDSFVLRHFYG------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVM 286 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v-~~~g~~VAVK~~~~------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVm 286 (811)
+++-...||.|. ||-++ .-+|+..|+|-++- ....+.+|..+|..|+|||+|++|++-.+. ..++|.|
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHR--ekv~IFM 1313 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHR--EKVYIFM 1313 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecH--HHHHHHH
Confidence 667777888885 66666 34899999999852 346678999999999999999999766543 4589999
Q ss_pred ecCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccc
Q 003542 287 ELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365 (811)
Q Consensus 287 Ey~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~ 365 (811)
|||. |+|.+.+... ...++.....|..|++.|+.|||++|||||||||.||+++.+| .+|++|||.|.
T Consensus 1314 EyC~~GsLa~ll~~g------ri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g-----~iK~~DFGsa~ 1382 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHG------RIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNG-----LIKYGDFGSAV 1382 (1509)
T ss_pred HHhccCcHHHHHHhc------chhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCC-----cEEeeccccee
Confidence 9999 5787776542 4577788888999999999999999999999999999999988 89999999998
Q ss_pred cccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHH
Q 003542 366 ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTK 445 (811)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~ 445 (811)
......... ........||+.|||||++.+.. .....-+.||||||||+.||+||+.||...+ .+-.+..
T Consensus 1383 ki~~~~~~~---~~el~~~~GT~~YMAPEvit~t~------~kG~~~A~DiWslGCVVlEM~tGkrPW~~~d-ne~aIMy 1452 (1509)
T KOG4645|consen 1383 KIKNNAQTM---PGELQSMMGTPMYMAPEVITGTK------GKGHGGAADIWSLGCVVLEMATGKRPWAELD-NEWAIMY 1452 (1509)
T ss_pred EecCchhcC---CHHHHhhcCCchhcCchhhcccc------cCCCCcchhhhcccceEEEeecCCCchhhcc-chhHHHh
Confidence 765542111 12234778999999999998753 2244568999999999999999999997643 3445667
Q ss_pred HHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 446 NIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 446 ~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
.+..|..|.+|...+.+-.++|.+||..||.+|.++.+|++
T Consensus 1453 ~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1453 HVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred HHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 88889999999999999999999999999999999998876
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-32 Score=281.13 Aligned_cols=244 Identities=27% Similarity=0.435 Sum_probs=195.3
Q ss_pred eEEeeeecccc---eEEEEEE-cCCEEEEEEecc------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEe
Q 003542 218 LMVRRRLGASS---QFKEIQW-LGDSFVLRHFYG------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVME 287 (811)
Q Consensus 218 ~~i~~~lG~G~---vyk~v~~-~g~~VAVK~~~~------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmE 287 (811)
|.+.+.||+|+ +|++... +|..|++|.+.. ..+.+.+|+.++++++||||+++++.+.......+++|||
T Consensus 2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 81 (260)
T cd06606 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLE 81 (260)
T ss_pred ceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEE
Confidence 55666677664 7887754 789999999853 2567899999999999999999997774432267999999
Q ss_pred cCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccccc
Q 003542 288 LMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366 (811)
Q Consensus 288 y~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~ 366 (811)
|++ ++|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||.+..
T Consensus 82 ~~~~~~L~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~-----~~~l~d~~~~~~ 150 (260)
T cd06606 82 YVSGGSLSSLLKKF------GKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDG-----VVKLADFGCAKR 150 (260)
T ss_pred ecCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCC-----CEEEcccccEEe
Confidence 997 5898888753 4789999999999999999999999999999999999998866 899999999876
Q ss_pred ccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHH
Q 003542 367 RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKN 446 (811)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~ 446 (811)
....... .......++..|+|||.+.+. .++.++||||||+++|+|++|..||.............
T Consensus 151 ~~~~~~~-----~~~~~~~~~~~y~~pE~~~~~---------~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 216 (260)
T cd06606 151 LGDIETG-----EGTGSVRGTPYWMAPEVIRGE---------EYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKI 216 (260)
T ss_pred ccccccc-----ccccCCCCCccccCHhhhcCC---------CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhc
Confidence 6543210 012345678889999998643 47889999999999999999999998755222222222
Q ss_pred HHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 447 IRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 447 i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
......+..+...+..+.++|.+||..+|.+||++.+++.
T Consensus 217 ~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 217 GSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred cccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 2223445567788999999999999999999999999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-32 Score=281.42 Aligned_cols=243 Identities=28% Similarity=0.456 Sum_probs=198.2
Q ss_pred ceEEeeeecccc---eEEEEE-EcCCEEEEEEecc------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEE
Q 003542 217 KLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVM 286 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVm 286 (811)
+|.+.+.||.|+ +|.+.. .++..||+|.+.. ....+.+|+++++.++|||++++++.+.. ...+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~--~~~~~lv~ 78 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEE--KGKLCIVM 78 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEec--CCEEEEEE
Confidence 477788888875 666553 3689999999853 34668999999999999999999988754 46799999
Q ss_pred ecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccc
Q 003542 287 ELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365 (811)
Q Consensus 287 Ey~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~ 365 (811)
||+++ +|.+++..... ....+++..+..++.+++.||.|||+.|++|+||+|+||+++.++ .++|+|||++.
T Consensus 79 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~-----~~~l~d~~~~~ 151 (258)
T cd08215 79 EYADGGDLSQKIKKQKK--EGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNG-----LVKLGDFGISK 151 (258)
T ss_pred EecCCCcHHHHHHHhhc--cCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCC-----cEEECCcccee
Confidence 99995 89988876421 236789999999999999999999999999999999999998766 89999999987
Q ss_pred cccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHH
Q 003542 366 ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTK 445 (811)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~ 445 (811)
...... .......|++.|+|||.+.+. .++.++|+||||+++|+|++|..||.... ...+..
T Consensus 152 ~~~~~~-------~~~~~~~~~~~y~~pe~~~~~---------~~~~~~Dv~slG~~~~~l~~g~~p~~~~~--~~~~~~ 213 (258)
T cd08215 152 VLSSTV-------DLAKTVVGTPYYLSPELCQNK---------PYNYKSDIWSLGCVLYELCTLKHPFEGEN--LLELAL 213 (258)
T ss_pred ecccCc-------ceecceeeeecccChhHhccC---------CCCccccHHHHHHHHHHHHcCCCCCCCCc--HHHHHH
Confidence 654332 112344678889999998643 57789999999999999999999997643 234445
Q ss_pred HHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 446 NIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 446 ~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
.+.....+..+..++..+.+++.+||..+|.+||++.+++.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 214 KILKGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 55555566677788999999999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-32 Score=287.07 Aligned_cols=247 Identities=21% Similarity=0.396 Sum_probs=179.5
Q ss_pred eccc---ceEEEEEEcCC---EEEEEEecc-----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEecCC-C
Q 003542 224 LGAS---SQFKEIQWLGD---SFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMS-K 291 (811)
Q Consensus 224 lG~G---~vyk~v~~~g~---~VAVK~~~~-----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~~-g 291 (811)
||+| .||++...++. .+++|.+.. ..+.+.+|+.+++.++||||+++++.+. ....+|+|||||+ |
T Consensus 3 lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~--~~~~~~lv~e~~~~~ 80 (268)
T cd05086 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCV--EAIPYLLVFEYCELG 80 (268)
T ss_pred CCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEec--CCCccEEEEecCCCC
Confidence 4555 47776554443 466776642 3467899999999999999999997763 4557899999999 5
Q ss_pred CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccccccC
Q 003542 292 DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYAS 371 (811)
Q Consensus 292 ~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~~ 371 (811)
+|.+++..... ....+++..+..++.||+.||.|||+.+++||||||+|||++.++ .++|+|||++.......
T Consensus 81 ~L~~~l~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~-----~~~l~Dfg~~~~~~~~~ 153 (268)
T cd05086 81 DLKSYLSQEQW--HRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDL-----TVKVGDYGIGPSRYKED 153 (268)
T ss_pred cHHHHHHhhhc--ccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCc-----cEEecccccccccCcch
Confidence 99999876421 123467778889999999999999999999999999999998776 89999999975432111
Q ss_pred CCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CCCCCCCCccchHHHHHHHHhC
Q 003542 372 RNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGDKMTKNIRAG 450 (811)
Q Consensus 372 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~~PF~~~~~~~~~i~~~i~~~ 450 (811)
. ........++..|+|||++....+.. ....++.++||||||+++|||++ |..||...... ..+...+...
T Consensus 154 ~-----~~~~~~~~~~~~y~aPE~~~~~~~~~--~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-~~~~~~~~~~ 225 (268)
T cd05086 154 Y-----IETEDDKCVPLRWLAPELVGEFHGGL--ITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR-EVLNHVIKDQ 225 (268)
T ss_pred h-----hhcccCCcCcccccCchhcccccCcc--ccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHhhc
Confidence 0 01122456788899999986432111 12356889999999999999997 67788654322 2222222222
Q ss_pred C----CCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHH
Q 003542 451 E----RPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRIL 488 (811)
Q Consensus 451 ~----~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L 488 (811)
. .+..+...++.+.+++..|| .+|.+||++++|++.|
T Consensus 226 ~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l 266 (268)
T cd05086 226 QVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLL 266 (268)
T ss_pred ccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence 1 23344556788999999999 6899999999998866
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=291.82 Aligned_cols=232 Identities=20% Similarity=0.288 Sum_probs=177.5
Q ss_pred cccceEEEEE-EcCCEEEEEEeccc-------HHHHHHHHHHHHh---CCCCccceeeeeEEccCCCeEEEEEecCCC-C
Q 003542 225 GASSQFKEIQ-WLGDSFVLRHFYGE-------LESLNAEISTMLS---LSHPNIVQYLCGFCDEEKKEFFLVMELMSK-D 292 (811)
Q Consensus 225 G~G~vyk~v~-~~g~~VAVK~~~~~-------~~~~~~Ei~iL~~---L~HPNIVkl~~~~~~e~~~~~yLVmEy~~g-~ 292 (811)
+.|.||++.. .+|+.||+|.+... ...+.+|..++.. .+||||+.+++.+. ..+.+|+||||++| +
T Consensus 6 ~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~--~~~~~~lv~e~~~~~~ 83 (279)
T cd05633 6 GFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFH--TPDKLCFILDLMNGGD 83 (279)
T ss_pred CCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEe--cCCeEEEEEecCCCCC
Confidence 3344787664 36899999988431 1234455444433 47999999987774 44579999999995 8
Q ss_pred HHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccccccCC
Q 003542 293 LSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASR 372 (811)
Q Consensus 293 L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~~~ 372 (811)
|..++... ..+++..+..++.|++.||.|||+.+|+||||||+|||++.++ .++|+|||++......
T Consensus 84 L~~~i~~~------~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~-----~~~l~dfg~~~~~~~~-- 150 (279)
T cd05633 84 LHYHLSQH------GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHG-----HVRISDLGLACDFSKK-- 150 (279)
T ss_pred HHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCC-----CEEEccCCcceecccc--
Confidence 88887653 5699999999999999999999999999999999999998776 8999999998654321
Q ss_pred CCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHHHHhCCC
Q 003542 373 NTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGER 452 (811)
Q Consensus 373 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i~~~~~ 452 (811)
......|+..|+|||.+.. ...++.++|||||||++|+|++|..||...................
T Consensus 151 -------~~~~~~~~~~y~aPE~~~~--------~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 215 (279)
T cd05633 151 -------KPHASVGTHGYMAPEVLQK--------GTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVN 215 (279)
T ss_pred -------CccCcCCCcCccCHHHhcC--------CCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCC
Confidence 1123468899999999853 1257889999999999999999999997643332222222222334
Q ss_pred CCCCCCChHHHHHHHhhhccCCCCCCC-----CHHHHHH
Q 003542 453 PLFPSGSPKYLVNLTKKCWHTNPSQRP-----SFSSICR 486 (811)
Q Consensus 453 ~~~p~~~~~~l~~LI~~cL~~DP~~RP-----S~~eIl~ 486 (811)
..++...+..+.++|.+||..||.+|| ++.++++
T Consensus 216 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~ 254 (279)
T cd05633 216 VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE 254 (279)
T ss_pred cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence 456777889999999999999999999 5888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-32 Score=283.80 Aligned_cols=236 Identities=24% Similarity=0.381 Sum_probs=178.7
Q ss_pred eecccc---eEEEEEEc-C----------CEEEEEEeccc---HHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEE
Q 003542 223 RLGASS---QFKEIQWL-G----------DSFVLRHFYGE---LESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLV 285 (811)
Q Consensus 223 ~lG~G~---vyk~v~~~-g----------~~VAVK~~~~~---~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLV 285 (811)
.||+|+ ||++.... + ..+|+|.+... ...+.+|+.+|+.++||||+++++.+.. ...++|
T Consensus 2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~lv 78 (259)
T cd05037 2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR---DENIMV 78 (259)
T ss_pred cccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec---CCcEEE
Confidence 345553 77776543 2 25888887532 5678999999999999999999976643 457999
Q ss_pred EecCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCC--CcceEEEeecc
Q 003542 286 MELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSME--GYFHVKVSGFG 362 (811)
Q Consensus 286 mEy~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d--~~~~vKL~DFG 362 (811)
|||++ |+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.. ....+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHRE-----KNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCC
Confidence 99999 5888888753 1268999999999999999999999999999999999999876511 22369999999
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CCCCCCCCccchH
Q 003542 363 LSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGD 441 (811)
Q Consensus 363 lA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~~PF~~~~~~~~ 441 (811)
++...... ....++..|+|||++.+. ...++.++||||||+++|+|++ |..||......
T Consensus 154 ~a~~~~~~-----------~~~~~~~~y~aPE~~~~~-------~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~-- 213 (259)
T cd05037 154 IPITVLSR-----------EERVERIPWIAPECIRNG-------QASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS-- 213 (259)
T ss_pred cccccccc-----------cccccCCCccChhhhcCC-------CCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch--
Confidence 98764321 133456679999998753 1367889999999999999999 68888765422
Q ss_pred HHHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHH
Q 003542 442 KMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRIL 488 (811)
Q Consensus 442 ~i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L 488 (811)
......... ...+......+.++|.+||..+|.+||++.++++.|
T Consensus 214 ~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 214 EKERFYQDQ--HRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred hHHHHHhcC--CCCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 111222221 122333347899999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=292.17 Aligned_cols=248 Identities=23% Similarity=0.291 Sum_probs=190.3
Q ss_pred HHhcceEEeeeecccc---eEEEEEE-cCCEEEEEEecc------cHHHHHHHHHHHHhCCCCccceeeeeEEccC----
Q 003542 213 MLLKKLMVRRRLGASS---QFKEIQW-LGDSFVLRHFYG------ELESLNAEISTMLSLSHPNIVQYLCGFCDEE---- 278 (811)
Q Consensus 213 ~l~k~~~i~~~lG~G~---vyk~v~~-~g~~VAVK~~~~------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~---- 278 (811)
....+|++.+.||.|+ +|++... +|+.||+|.+.. ....+.+|+.+++.++||||+++++.+....
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 3456788899999885 7776643 689999999953 2346788999999999999999997765332
Q ss_pred ----CCeEEEEEecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcc
Q 003542 279 ----KKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYF 354 (811)
Q Consensus 279 ----~~~~yLVmEy~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~ 354 (811)
...+|+||||++++|..++... ...+++..++.++.||+.||.|||+.||+||||||+||+++.++
T Consensus 84 ~~~~~~~~~lv~e~~~~~l~~~l~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~----- 153 (302)
T cd07864 84 FKKDKGAFYLVFEYMDHDLMGLLESG-----LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKG----- 153 (302)
T ss_pred ccccCCcEEEEEcccCccHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-----
Confidence 2378999999999888877642 24689999999999999999999999999999999999998776
Q ss_pred eEEEeeccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCC
Q 003542 355 HVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFE 434 (811)
Q Consensus 355 ~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~ 434 (811)
.+||+|||++........ .......++..|+|||.+.+. ..++.++|||||||++|+|++|++||.
T Consensus 154 ~~kl~dfg~~~~~~~~~~------~~~~~~~~~~~y~~PE~~~~~--------~~~~~~~Di~slG~~~~el~~g~~~~~ 219 (302)
T cd07864 154 QIKLADFGLARLYNSEES------RPYTNKVITLWYRPPELLLGE--------ERYGPAIDVWSCGCILGELFTKKPIFQ 219 (302)
T ss_pred cEEeCcccccccccCCcc------cccccceeccCccChHHhcCC--------CCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence 899999999876543321 111223457789999998632 246789999999999999999999997
Q ss_pred CCccchHHHHHHHHh---CCCC--------------------------CCCCCChHHHHHHHhhhccCCCCCCCCHHHHH
Q 003542 435 DGHLQGDKMTKNIRA---GERP--------------------------LFPSGSPKYLVNLTKKCWHTNPSQRPSFSSIC 485 (811)
Q Consensus 435 ~~~~~~~~i~~~i~~---~~~~--------------------------~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl 485 (811)
...... . ...+.. ...+ ......+..+.+++.+||..||.+||++.+++
T Consensus 220 ~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il 297 (302)
T cd07864 220 ANQELA-Q-LELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEAL 297 (302)
T ss_pred CCChHH-H-HHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 543221 1 111111 1100 00123578899999999999999999999987
Q ss_pred H
Q 003542 486 R 486 (811)
Q Consensus 486 ~ 486 (811)
.
T Consensus 298 ~ 298 (302)
T cd07864 298 N 298 (302)
T ss_pred c
Confidence 5
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=294.32 Aligned_cols=236 Identities=20% Similarity=0.317 Sum_probs=198.2
Q ss_pred HHhcceEEeeeecccceEEEE----EEcCCEEEEEEecc-------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCe
Q 003542 213 MLLKKLMVRRRLGASSQFKEI----QWLGDSFVLRHFYG-------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKE 281 (811)
Q Consensus 213 ~l~k~~~i~~~lG~G~vyk~v----~~~g~~VAVK~~~~-------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~ 281 (811)
+-+.+|..++.||+|+.-+++ +-+|+.||+|++++ +..+-..|-++|+..+||.+..+-+.| +..++
T Consensus 165 vTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF--Qt~dr 242 (516)
T KOG0690|consen 165 VTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF--QTQDR 242 (516)
T ss_pred eccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh--ccCce
Confidence 345688899999999633333 23899999999975 356667888999999999999988788 66778
Q ss_pred EEEEEecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEee
Q 003542 282 FFLVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSG 360 (811)
Q Consensus 282 ~yLVmEy~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~D 360 (811)
+|+||||..| .|+-+|... ..|++..++.|...|++||.|||+++||+||||.+|+|+|.+| ++||+|
T Consensus 243 lCFVMeyanGGeLf~HLsre------r~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDG-----HIKitD 311 (516)
T KOG0690|consen 243 LCFVMEYANGGELFFHLSRE------RVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDG-----HIKITD 311 (516)
T ss_pred EEEEEEEccCceEeeehhhh------hcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCC-----ceEeee
Confidence 9999999995 787777543 7899999999999999999999999999999999999999998 999999
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccch
Q 003542 361 FGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQG 440 (811)
Q Consensus 361 FGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~ 440 (811)
|||++..-.. .....+.+|||.|+|||++... .|+.++|+|.+||+||||++|+.||... +.
T Consensus 312 FGLCKE~I~~-------g~t~kTFCGTPEYLAPEVleDn---------DYgraVDWWG~GVVMYEMmCGRLPFyn~--dh 373 (516)
T KOG0690|consen 312 FGLCKEEIKY-------GDTTKTFCGTPEYLAPEVLEDN---------DYGRAVDWWGVGVVMYEMMCGRLPFYNK--DH 373 (516)
T ss_pred cccchhcccc-------cceeccccCChhhcCchhhccc---------cccceeehhhhhHHHHHHHhccCccccc--ch
Confidence 9999764332 2344678999999999999854 7889999999999999999999999864 34
Q ss_pred HHHHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCC
Q 003542 441 DKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPS 480 (811)
Q Consensus 441 ~~i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS 480 (811)
+.++..|... ...||..++++.+.|+..+|..||.+|..
T Consensus 374 ~kLFeLIl~e-d~kFPr~ls~eAktLLsGLL~kdP~kRLG 412 (516)
T KOG0690|consen 374 EKLFELILME-DLKFPRTLSPEAKTLLSGLLKKDPKKRLG 412 (516)
T ss_pred hHHHHHHHhh-hccCCccCCHHHHHHHHHHhhcChHhhcC
Confidence 4555655543 34589999999999999999999999973
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=295.88 Aligned_cols=238 Identities=21% Similarity=0.294 Sum_probs=196.0
Q ss_pred cceEEeeeecccceEEEE-EEcCCEEEEEEecc-------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEe
Q 003542 216 KKLMVRRRLGASSQFKEI-QWLGDSFVLRHFYG-------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVME 287 (811)
Q Consensus 216 k~~~i~~~lG~G~vyk~v-~~~g~~VAVK~~~~-------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmE 287 (811)
..|.++++.|.|.||.+. .-+|+-||+|++.+ ......+|-.||.+++.+.||.+-++| ++++.+|+||.
T Consensus 188 ~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAf--eTkd~LClVLt 265 (591)
T KOG0986|consen 188 RVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAF--ETKDALCLVLT 265 (591)
T ss_pred eeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeee--cCCCceEEEEE
Confidence 457777777777788877 45999999999843 234568899999999999999998777 77888999999
Q ss_pred cCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccccc
Q 003542 288 LMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366 (811)
Q Consensus 288 y~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~ 366 (811)
.|.| ||.-+|.+. ....|++..++.|+.+|+.||++||..+||+|||||+|||+|+.| ++.|+|+|||..
T Consensus 266 lMNGGDLkfHiyn~----g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~G-----hvRISDLGLAve 336 (591)
T KOG0986|consen 266 LMNGGDLKFHIYNH----GNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHG-----HVRISDLGLAVE 336 (591)
T ss_pred eecCCceeEEeecc----CCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCC-----CeEeeccceEEe
Confidence 9995 777666654 225899999999999999999999999999999999999999988 999999999987
Q ss_pred ccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccc--hHHHH
Q 003542 367 RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQ--GDKMT 444 (811)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~--~~~i~ 444 (811)
+.... .....+||.+|||||++.+. .|+...|+|||||+||||+.|+.||...... .+++-
T Consensus 337 i~~g~--------~~~~rvGT~GYMAPEvl~ne---------~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvd 399 (591)
T KOG0986|consen 337 IPEGK--------PIRGRVGTVGYMAPEVLQNE---------VYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVD 399 (591)
T ss_pred cCCCC--------ccccccCcccccCHHHHcCC---------cccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHH
Confidence 75543 33566999999999999854 6899999999999999999999999753221 22333
Q ss_pred HHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHH
Q 003542 445 KNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFS 482 (811)
Q Consensus 445 ~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~ 482 (811)
+.+. .....++...++++++|.+.+|..||.+|....
T Consensus 400 rr~~-~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 400 RRTL-EDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred HHHh-cchhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 3332 334557889999999999999999999997543
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=319.87 Aligned_cols=255 Identities=20% Similarity=0.239 Sum_probs=181.9
Q ss_pred hHHHHHhcceEEeeeecccc---eEEEEEE--cCCEEEEE------------------Eecc---cHHHHHHHHHHHHhC
Q 003542 209 RLVDMLLKKLMVRRRLGASS---QFKEIQW--LGDSFVLR------------------HFYG---ELESLNAEISTMLSL 262 (811)
Q Consensus 209 ~~~~~l~k~~~i~~~lG~G~---vyk~v~~--~g~~VAVK------------------~~~~---~~~~~~~Ei~iL~~L 262 (811)
...+.+..+|++++.||+|+ ||.+... .+..+++| .+.. ....+.+|+.+|+++
T Consensus 141 ~~~~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l 220 (501)
T PHA03210 141 KHDDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRL 220 (501)
T ss_pred ccchhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhC
Confidence 33445668999999999996 5654321 22222222 1111 235688999999999
Q ss_pred CCCccceeeeeEEccCCCeEEEEEecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCc
Q 003542 263 SHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSN 342 (811)
Q Consensus 263 ~HPNIVkl~~~~~~e~~~~~yLVmEy~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsN 342 (811)
+||||+++++.+. .....|+|||++.++|..++...... .........+..|+.||+.||.|||++||+||||||+|
T Consensus 221 ~HpnIv~l~~~~~--~~~~~~lv~e~~~~~l~~~l~~~~~~-~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~N 297 (501)
T PHA03210 221 NHENILKIEEILR--SEANTYMITQKYDFDLYSFMYDEAFD-WKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLEN 297 (501)
T ss_pred CCCCcCcEeEEEE--ECCeeEEEEeccccCHHHHHhhcccc-ccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 9999999997773 45678999999999998888653211 11234466788899999999999999999999999999
Q ss_pred EEEeccCCCCcceEEEeeccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhH
Q 003542 343 IYLKARSMEGYFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGML 422 (811)
Q Consensus 343 ILI~~~g~d~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvI 422 (811)
||++.++ .+||+|||++..+.... ........||+.|+|||++.+. .++.++|||||||+
T Consensus 298 ILl~~~~-----~vkL~DFGla~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwSlGvi 357 (501)
T PHA03210 298 IFLNCDG-----KIVLGDFGTAMPFEKER------EAFDYGWVGTVATNSPEILAGD---------GYCEITDIWSCGLI 357 (501)
T ss_pred EEECCCC-----CEEEEeCCCceecCccc------ccccccccCCcCCCCchhhcCC---------CCCcHHHHHHHHHH
Confidence 9998876 89999999997664321 1122346789999999999753 67899999999999
Q ss_pred HHHHhhCCCC-CCCCccc-hHHHHHHHHhCC--CCCC----------------------------CCCChHHHHHHHhhh
Q 003542 423 CFELLTGKVP-FEDGHLQ-GDKMTKNIRAGE--RPLF----------------------------PSGSPKYLVNLTKKC 470 (811)
Q Consensus 423 LyELltG~~P-F~~~~~~-~~~i~~~i~~~~--~~~~----------------------------p~~~~~~l~~LI~~c 470 (811)
+|||++|..+ |...... ...+.+.+.... ...+ ....+..+.++|.+|
T Consensus 358 l~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~km 437 (501)
T PHA03210 358 LLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKM 437 (501)
T ss_pred HHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHH
Confidence 9999998754 4332211 122222111100 0000 012455678889999
Q ss_pred ccCCCCCCCCHHHHHH
Q 003542 471 WHTNPSQRPSFSSICR 486 (811)
Q Consensus 471 L~~DP~~RPS~~eIl~ 486 (811)
|..||.+|||+.+++.
T Consensus 438 L~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 438 LTFDWHLRPGAAELLA 453 (501)
T ss_pred hccCcccCcCHHHHhh
Confidence 9999999999999987
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-32 Score=282.07 Aligned_cols=241 Identities=29% Similarity=0.423 Sum_probs=196.5
Q ss_pred ceEEeeeecccc---eEEEE-EEcCCEEEEEEecc------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEE
Q 003542 217 KLMVRRRLGASS---QFKEI-QWLGDSFVLRHFYG------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVM 286 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v-~~~g~~VAVK~~~~------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVm 286 (811)
+|++.+.||.|+ +|++. ..+|+.||+|.+.. ....+.+|+.+++.++||||+++++.++. ...+|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~ 78 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLD--GNKLCIVM 78 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhcc--CCEEEEEe
Confidence 477888888875 66654 33788999999853 24567889999999999999999987753 46799999
Q ss_pred ecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccc
Q 003542 287 ELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365 (811)
Q Consensus 287 Ey~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~ 365 (811)
||+++ +|..++.... .....+++..++.++.|++.||.|||+.|++||||+|+||+++.++ .+||+|||++.
T Consensus 79 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~-----~~kl~d~g~~~ 151 (256)
T cd08530 79 EYAPFGDLSKAISKRK--KKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVAND-----LVKIGDLGISK 151 (256)
T ss_pred hhcCCCCHHHHHHHHH--hhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCC-----cEEEeeccchh
Confidence 99985 8998887632 1235689999999999999999999999999999999999998866 89999999987
Q ss_pred cccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHH
Q 003542 366 ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTK 445 (811)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~ 445 (811)
..... ......+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||..... ..+..
T Consensus 152 ~~~~~---------~~~~~~~~~~~~~Pe~~~~~---------~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--~~~~~ 211 (256)
T cd08530 152 VLKKN---------MAKTQIGTPHYMAPEVWKGR---------PYSYKSDIWSLGCLLYEMATFAPPFEARSM--QDLRY 211 (256)
T ss_pred hhccC---------CcccccCCccccCHHHHCCC---------CCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHH
Confidence 65432 11234578889999998643 677899999999999999999999976542 34445
Q ss_pred HHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 446 NIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 446 ~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
.+..+..+..+...+.++.+++.+||..+|.+||++.+++.
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 212 KVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred HHhcCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 55556656666778899999999999999999999999876
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-32 Score=290.06 Aligned_cols=238 Identities=21% Similarity=0.369 Sum_probs=186.5
Q ss_pred ceEEeeeecccceEEEEE-EcCCEEEEEEecc----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEecCCC
Q 003542 217 KLMVRRRLGASSQFKEIQ-WLGDSFVLRHFYG----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK 291 (811)
Q Consensus 217 ~~~i~~~lG~G~vyk~v~-~~g~~VAVK~~~~----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~~g 291 (811)
.+..++..+.|.+|++.. .+++.||+|.+.. ..+.+.+|+.+++.++||||+++++.+. .....|+||||++|
T Consensus 23 ~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~--~~~~~~~v~e~~~~ 100 (285)
T cd06648 23 NFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL--VGDELWVVMEFLEG 100 (285)
T ss_pred cceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEE--cCCeEEEEEeccCC
Confidence 344444444445887763 4788999999842 3456889999999999999999998774 45678999999985
Q ss_pred -CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccccccccc
Q 003542 292 -DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYA 370 (811)
Q Consensus 292 -~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~ 370 (811)
+|.+++.. ..+++..+..++.|++.||.|||++|++||||+|+||+++.++ .++|+|||++......
T Consensus 101 ~~L~~~~~~-------~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~-----~~~l~d~g~~~~~~~~ 168 (285)
T cd06648 101 GALTDIVTH-------TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDG-----RVKLSDFGFCAQVSKE 168 (285)
T ss_pred CCHHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCC-----cEEEcccccchhhccC
Confidence 88888764 4588999999999999999999999999999999999998776 8999999987654322
Q ss_pred CCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHHHHhC
Q 003542 371 SRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAG 450 (811)
Q Consensus 371 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i~~~ 450 (811)
. .......|++.|+|||.+.+. .++.++||||||+++|+|++|..||..... ......+...
T Consensus 169 ~-------~~~~~~~~~~~y~aPE~~~~~---------~~~~~~Dv~slGv~l~ell~g~~p~~~~~~--~~~~~~~~~~ 230 (285)
T cd06648 169 V-------PRRKSLVGTPYWMAPEVISRL---------PYGTEVDIWSLGIMVIEMVDGEPPYFNEPP--LQAMKRIRDN 230 (285)
T ss_pred C-------cccccccCCccccCHHHhcCC---------CCCCcccHHHHHHHHHHHHhCCCCCcCCCH--HHHHHHHHhc
Confidence 1 112234688899999998642 578899999999999999999999976432 2233344444
Q ss_pred CCCCC--CCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 451 ERPLF--PSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 451 ~~~~~--p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
..+.. +...+..+.+++.+||..+|.+||++.++++
T Consensus 231 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 231 LPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred CCCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 33222 2336788999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-32 Score=280.32 Aligned_cols=239 Identities=24% Similarity=0.469 Sum_probs=194.6
Q ss_pred ceEEeeeecccc---eEEEEE-EcCCEEEEEEecc------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEE
Q 003542 217 KLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVM 286 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVm 286 (811)
+|++.+.||.|+ +|++.. ..++.||+|.+.. ..+.+.+|++++.+++||||+++++.+. +...+|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~~v~ 78 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIE--TSDSLYIIL 78 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEE--eCCEEEEEE
Confidence 477888888875 777653 3788999999853 3467899999999999999999987664 346799999
Q ss_pred ecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccc
Q 003542 287 ELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365 (811)
Q Consensus 287 Ey~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~ 365 (811)
||+++ +|.+++... ..+++..++.++.|++.||.|||+.||+||||+|+||+++.++ .++|+|||++.
T Consensus 79 e~~~~~~L~~~~~~~------~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~-----~~~l~d~~~~~ 147 (254)
T cd06627 79 EYAENGSLRQIIKKF------GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDG-----VVKLADFGVAT 147 (254)
T ss_pred ecCCCCcHHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCC-----CEEEeccccce
Confidence 99995 888887653 5789999999999999999999999999999999999998765 89999999997
Q ss_pred cccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHH
Q 003542 366 ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTK 445 (811)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~ 445 (811)
....... ......++..|+|||.+.+. .++.++||||||+++|+|++|..||..... .....
T Consensus 148 ~~~~~~~-------~~~~~~~~~~y~~pe~~~~~---------~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~--~~~~~ 209 (254)
T cd06627 148 KLNDVSK-------DDASVVGTPYWMAPEVIEMS---------GASTASDIWSLGCTVIELLTGNPPYYDLNP--MAALF 209 (254)
T ss_pred ecCCCcc-------cccccccchhhcCHhhhcCC---------CCCcchhHHHHHHHHHHHHhCCCCCCCccH--HHHHH
Confidence 6644321 12344678889999998643 477899999999999999999999976442 22222
Q ss_pred HHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 446 NIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 446 ~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
.......+.++...+..+.+++.+||..+|++||++.+++.
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 210 RIVQDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred HHhccCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 33344555677788899999999999999999999999875
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-32 Score=291.26 Aligned_cols=253 Identities=19% Similarity=0.293 Sum_probs=189.2
Q ss_pred hcceEEeeeecccc---eEEEEE-EcCCEEEEEEecc------cHHHHHHHHHHHHhCCCCccceeeeeEEccC------
Q 003542 215 LKKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG------ELESLNAEISTMLSLSHPNIVQYLCGFCDEE------ 278 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~------ 278 (811)
.++|++.+.||.|+ +|.+.. .+|+.||||.+.. ....+.+|+.+++.++||||+++++.+....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 46899999999986 676653 3789999999842 1345789999999999999999987665322
Q ss_pred CCeEEEEEecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEE
Q 003542 279 KKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKV 358 (811)
Q Consensus 279 ~~~~yLVmEy~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL 358 (811)
...+|+||||+.++|...+... ...+++..+..++.||++||.|||++||+||||||+|||++.++ .++|
T Consensus 87 ~~~~~lv~~~~~~~l~~~~~~~-----~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~-----~~~l 156 (311)
T cd07866 87 RGSVYMVTPYMDHDLSGLLENP-----SVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQG-----ILKI 156 (311)
T ss_pred CceEEEEEecCCcCHHHHHhcc-----ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-----CEEE
Confidence 2357999999999888877642 24689999999999999999999999999999999999998876 8999
Q ss_pred eeccccccccccCCCCCC----CCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCC
Q 003542 359 SGFGLSTARTYASRNTPP----ASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFE 434 (811)
Q Consensus 359 ~DFGlA~~~~~~~~~~~~----~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~ 434 (811)
+|||++............ .........+++.|+|||++.+. ..++.++|||||||++|+|++|++||.
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--------~~~~~~~Dv~slG~il~el~~g~~~~~ 228 (311)
T cd07866 157 ADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGE--------RRYTTAVDIWGIGCVFAEMFTRRPILQ 228 (311)
T ss_pred CcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCC--------CccCchhHhHHHHHHHHHHHhCCCCCC
Confidence 999999765433211110 01112334678889999998642 357889999999999999999999997
Q ss_pred CCccchHHHHHHHHhCCC---------------------CCCC-------CCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 435 DGHLQGDKMTKNIRAGER---------------------PLFP-------SGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 435 ~~~~~~~~i~~~i~~~~~---------------------~~~p-------~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
+..... ........... ...+ ....+.+.++|.+||..||.+|||+.+++.
T Consensus 229 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 229 GKSDID-QLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred CCCHHH-HHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 644321 11111110000 0000 123356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=288.93 Aligned_cols=233 Identities=21% Similarity=0.304 Sum_probs=183.0
Q ss_pred cccceEEEE-EEcCCEEEEEEecc-------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEecCCC-CHHH
Q 003542 225 GASSQFKEI-QWLGDSFVLRHFYG-------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSC 295 (811)
Q Consensus 225 G~G~vyk~v-~~~g~~VAVK~~~~-------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~~g-~L~~ 295 (811)
|.|.||.+. ..+|+.||+|.+.. ....+..|+.+|+.++||||+++++.+ +..+.+|+||||+++ +|.+
T Consensus 5 ~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~--~~~~~~~lv~e~~~~~~L~~ 82 (277)
T cd05577 5 GFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAF--ETKDDLCLVMTLMNGGDLKY 82 (277)
T ss_pred CceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEE--ecCCeEEEEEecCCCCcHHH
Confidence 445588766 34789999999853 234567899999999999999998777 445679999999995 8988
Q ss_pred HHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccccccCCCCC
Q 003542 296 YMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTP 375 (811)
Q Consensus 296 ~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~~~~~~ 375 (811)
++... ....+++..+..++.|++.||.|||+.|++||||+|+||+++.++ .++|+|||++.......
T Consensus 83 ~l~~~----~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~-----~~~l~dfg~~~~~~~~~---- 149 (277)
T cd05577 83 HIYNV----GEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHG-----NVRISDLGLAVELKGGK---- 149 (277)
T ss_pred HHHHc----CcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC-----CEEEccCcchhhhccCC----
Confidence 88754 114689999999999999999999999999999999999998876 89999999987543211
Q ss_pred CCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCcc--chHHHHHHHHhCCCC
Q 003542 376 PASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHL--QGDKMTKNIRAGERP 453 (811)
Q Consensus 376 ~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~--~~~~i~~~i~~~~~~ 453 (811)
......++..|+|||++.+. .++.++||||||+++|+|++|+.||..... ....+...+. ....
T Consensus 150 ----~~~~~~~~~~y~~PE~~~~~---------~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~ 215 (277)
T cd05577 150 ----KIKGRAGTPGYMAPEVLQGE---------VYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTL-EMAV 215 (277)
T ss_pred ----ccccccCCCCcCCHHHhcCC---------CCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccc-cccc
Confidence 11244577889999998643 478899999999999999999999976432 1122222222 2233
Q ss_pred CCCCCChHHHHHHHhhhccCCCCCCC-----CHHHHHH
Q 003542 454 LFPSGSPKYLVNLTKKCWHTNPSQRP-----SFSSICR 486 (811)
Q Consensus 454 ~~p~~~~~~l~~LI~~cL~~DP~~RP-----S~~eIl~ 486 (811)
.++...++.+.++|.+||+.||.+|| ++.+++.
T Consensus 216 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 216 EYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred cCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 45667789999999999999999999 6666765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-32 Score=288.46 Aligned_cols=243 Identities=19% Similarity=0.314 Sum_probs=189.8
Q ss_pred ceEEeeeecccc---eEEEEE----EcCCEEEEEEecc--------cHHHHHHHHHHHHhC-CCCccceeeeeEEccCCC
Q 003542 217 KLMVRRRLGASS---QFKEIQ----WLGDSFVLRHFYG--------ELESLNAEISTMLSL-SHPNIVQYLCGFCDEEKK 280 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v~----~~g~~VAVK~~~~--------~~~~~~~Ei~iL~~L-~HPNIVkl~~~~~~e~~~ 280 (811)
+|++.+.||.|+ +|.+.. .+|..||+|.+.. ..+.+.+|+.+|.++ +||||+++++.+ +...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~--~~~~ 78 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF--QTDT 78 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe--ecCC
Confidence 367888888885 666553 2789999999853 235678899999999 699999998776 4456
Q ss_pred eEEEEEecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEe
Q 003542 281 EFFLVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVS 359 (811)
Q Consensus 281 ~~yLVmEy~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~ 359 (811)
.+|+||||+++ +|.+++... ..+++..+..++.||+.||.|||+.|++||||+|+|||++.++ .+||+
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~------~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~-----~~kl~ 147 (290)
T cd05613 79 KLHLILDYINGGELFTHLSQR------ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNG-----HVVLT 147 (290)
T ss_pred eEEEEEecCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCC-----CEEEe
Confidence 78999999995 899988753 5688999999999999999999999999999999999998776 89999
Q ss_pred eccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCcc-
Q 003542 360 GFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHL- 438 (811)
Q Consensus 360 DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~- 438 (811)
|||++........ .......|+..|+|||.+.+. ...++.++||||||+++|+|++|..||.....
T Consensus 148 dfg~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~-------~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~ 214 (290)
T cd05613 148 DFGLSKEFHEDEV------ERAYSFCGTIEYMAPDIVRGG-------DGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK 214 (290)
T ss_pred eCccceecccccc------cccccccCCcccCChhhccCC-------CCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc
Confidence 9999876533211 112245688899999998642 22467899999999999999999999964321
Q ss_pred -chHHHHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCC-----CHHHHHH
Q 003542 439 -QGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRP-----SFSSICR 486 (811)
Q Consensus 439 -~~~~i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RP-----S~~eIl~ 486 (811)
....+...+... .+.++..++..+.+++.+||..||.+|| ++.+++.
T Consensus 215 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 215 NSQAEISRRILKS-EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred ccHHHHHHHhhcc-CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 122233333332 3446777888999999999999999997 6666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-32 Score=297.75 Aligned_cols=250 Identities=20% Similarity=0.343 Sum_probs=192.1
Q ss_pred HhcceEEeeeecccc---eEEEE-EEcCCEEEEEEecc------cHHHHHHHHHHHHhCCCCccceeeeeEEccCC----
Q 003542 214 LLKKLMVRRRLGASS---QFKEI-QWLGDSFVLRHFYG------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEK---- 279 (811)
Q Consensus 214 l~k~~~i~~~lG~G~---vyk~v-~~~g~~VAVK~~~~------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~---- 279 (811)
+.++|++.+.||.|+ ||++. ..+|..||||.+.. ....+.+|+.+|+.++||||+++++.+.....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 456899999999986 66665 34789999999853 13467899999999999999999977753221
Q ss_pred CeEEEEEecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEe
Q 003542 280 KEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVS 359 (811)
Q Consensus 280 ~~~yLVmEy~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~ 359 (811)
..+|+||||++++|..++.. ..+++..+..++.||+.||.|||+.||+||||||+||+++.++ .++|+
T Consensus 93 ~~~~lv~e~~~~~l~~~~~~-------~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~-----~~kl~ 160 (343)
T cd07880 93 HDFYLVMPFMGTDLGKLMKH-------EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDC-----ELKIL 160 (343)
T ss_pred ceEEEEEecCCCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-----CEEEe
Confidence 35699999998888877753 4689999999999999999999999999999999999998776 89999
Q ss_pred eccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccc
Q 003542 360 GFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQ 439 (811)
Q Consensus 360 DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~ 439 (811)
|||++...... .....+++.|+|||++.+ ...++.++|+||||+++|+|++|..||.+....
T Consensus 161 dfg~~~~~~~~----------~~~~~~~~~y~aPE~~~~--------~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~ 222 (343)
T cd07880 161 DFGLARQTDSE----------MTGYVVTRWYRAPEVILN--------WMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL 222 (343)
T ss_pred ecccccccccC----------ccccccCCcccCHHHHhC--------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99998754321 123457888999999864 225788999999999999999999999764321
Q ss_pred hHHHHHHHHhC----------------------CC-------CCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHH
Q 003542 440 GDKMTKNIRAG----------------------ER-------PLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRY 490 (811)
Q Consensus 440 ~~~i~~~i~~~----------------------~~-------~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~ 490 (811)
. .....+... .. .......+..+.++|.+||+.||.+|||+.+++. ..+
T Consensus 223 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~-~~~ 300 (343)
T cd07880 223 D-QLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA-HPY 300 (343)
T ss_pred H-HHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc-Ccc
Confidence 1 111111000 00 0012356777999999999999999999999986 455
Q ss_pred HHHHh
Q 003542 491 IKKFM 495 (811)
Q Consensus 491 i~k~l 495 (811)
++.+.
T Consensus 301 ~~~~~ 305 (343)
T cd07880 301 FEEFH 305 (343)
T ss_pred Hhhhc
Confidence 55543
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-32 Score=288.70 Aligned_cols=241 Identities=24% Similarity=0.454 Sum_probs=190.8
Q ss_pred cceEEeeeecccc---eEEEEEE-cCCEEEEEEeccc---HHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEec
Q 003542 216 KKLMVRRRLGASS---QFKEIQW-LGDSFVLRHFYGE---LESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMEL 288 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~~-~g~~VAVK~~~~~---~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy 288 (811)
+.|++.+.+|.|+ +|.+... .+..||+|.+... .+.+.+|+.+++.++||||+++++.+.. ....|+||||
T Consensus 19 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~ 96 (286)
T cd06614 19 ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLV--GDELWVVMEY 96 (286)
T ss_pred ccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEE--CCEEEEEEec
Confidence 4566666777765 7776643 6899999999642 5678999999999999999999987754 4679999999
Q ss_pred CC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccc
Q 003542 289 MS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTAR 367 (811)
Q Consensus 289 ~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~ 367 (811)
++ ++|.+++.... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++...
T Consensus 97 ~~~~~L~~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~-----~~~l~d~~~~~~~ 166 (286)
T cd06614 97 MDGGSLTDIITQNF-----VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDG-----SVKLADFGFAAQL 166 (286)
T ss_pred cCCCcHHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCC-----CEEECccchhhhh
Confidence 99 59999987641 3789999999999999999999999999999999999998776 8999999998654
Q ss_pred cccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHHH
Q 003542 368 TYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNI 447 (811)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i 447 (811)
..... ......++..|+|||++.+. .++.++|+||||+++|+|++|..||...... .....+
T Consensus 167 ~~~~~-------~~~~~~~~~~y~~PE~~~~~---------~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~--~~~~~~ 228 (286)
T cd06614 167 TKEKS-------KRNSVVGTPYWMAPEVIKRK---------DYGPKVDIWSLGIMCIEMAEGEPPYLREPPL--RALFLI 228 (286)
T ss_pred ccchh-------hhccccCCcccCCHhHhcCC---------CCCCccccHHHHHHHHHHHhCCCCCCCCCHH--HHHHHH
Confidence 33211 11234577889999998643 5788999999999999999999999764322 222233
Q ss_pred HhCCCCCC--CCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 448 RAGERPLF--PSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 448 ~~~~~~~~--p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
.....+.. +..++..+.++|.+||+.+|.+||++.+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 229 TTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred HhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 33332222 2337889999999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-32 Score=287.51 Aligned_cols=232 Identities=20% Similarity=0.283 Sum_probs=178.5
Q ss_pred cccceEEEEE-EcCCEEEEEEeccc-------HHHHHHHHH---HHHhCCCCccceeeeeEEccCCCeEEEEEecCCC-C
Q 003542 225 GASSQFKEIQ-WLGDSFVLRHFYGE-------LESLNAEIS---TMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-D 292 (811)
Q Consensus 225 G~G~vyk~v~-~~g~~VAVK~~~~~-------~~~~~~Ei~---iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~~g-~ 292 (811)
+.|.||++.. .+|+.||+|.+... ...+..|.. .++...||||+++++.+ .....+|+||||+.| +
T Consensus 6 ~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~--~~~~~~~~v~e~~~g~~ 83 (278)
T cd05606 6 GFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF--HTPDKLSFILDLMNGGD 83 (278)
T ss_pred CCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeee--ecCCEEEEEEecCCCCc
Confidence 3344887664 47899999998531 122344443 44445899999998777 345679999999995 7
Q ss_pred HHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccccccCC
Q 003542 293 LSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASR 372 (811)
Q Consensus 293 L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~~~ 372 (811)
|..++... ..+++..+..++.|++.||.|||+.+|+||||||+||+++.++ .++|+|||++......
T Consensus 84 L~~~l~~~------~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~-----~~kl~dfg~~~~~~~~-- 150 (278)
T cd05606 84 LHYHLSQH------GVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG-----HVRISDLGLACDFSKK-- 150 (278)
T ss_pred HHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCC-----CEEEccCcCccccCcc--
Confidence 87777542 5689999999999999999999999999999999999998776 8999999998654322
Q ss_pred CCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHHHHhCCC
Q 003542 373 NTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGER 452 (811)
Q Consensus 373 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i~~~~~ 452 (811)
......|+..|+|||++.+. ..++.++||||||+++|+|++|..||.+.................
T Consensus 151 -------~~~~~~~~~~y~aPE~~~~~--------~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 215 (278)
T cd05606 151 -------KPHASVGTHGYMAPEVLQKG--------VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA 215 (278)
T ss_pred -------CCcCcCCCcCCcCcHHhcCC--------CCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccC
Confidence 11244688999999998632 257889999999999999999999997653322222222233344
Q ss_pred CCCCCCChHHHHHHHhhhccCCCCCCC-----CHHHHHH
Q 003542 453 PLFPSGSPKYLVNLTKKCWHTNPSQRP-----SFSSICR 486 (811)
Q Consensus 453 ~~~p~~~~~~l~~LI~~cL~~DP~~RP-----S~~eIl~ 486 (811)
+.+|...+..+.+++.+||..+|.+|| ++.++++
T Consensus 216 ~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 216 VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 556777889999999999999999999 9999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=326.96 Aligned_cols=248 Identities=25% Similarity=0.420 Sum_probs=185.1
Q ss_pred eEEeeeecccceEEEE-EEcCCEEEEEEecc-----cHHHHHHHHHHHHhCCCCccceeeeeEEccC-------------
Q 003542 218 LMVRRRLGASSQFKEI-QWLGDSFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQYLCGFCDEE------------- 278 (811)
Q Consensus 218 ~~i~~~lG~G~vyk~v-~~~g~~VAVK~~~~-----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~------------- 278 (811)
+++++++|.|.||++. +.+|+.||||++.- ....+.+|+.+|++|+|||||+||..|....
T Consensus 484 L~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~ 563 (1351)
T KOG1035|consen 484 LELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDS 563 (1351)
T ss_pred HHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccch
Confidence 3444555555588877 67999999999952 3566899999999999999999985332100
Q ss_pred --------------------------------------------------------------------------------
Q 003542 279 -------------------------------------------------------------------------------- 278 (811)
Q Consensus 279 -------------------------------------------------------------------------------- 278 (811)
T Consensus 564 ~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d 643 (1351)
T KOG1035|consen 564 ESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILD 643 (1351)
T ss_pred hhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccC
Confidence
Q ss_pred ----------------C--------CeEEEEEecCCCCHHHHHHHhhCCCCCCCC--CHHHHHHHHHHHHHHHHHHHhCC
Q 003542 279 ----------------K--------KEFFLVMELMSKDLSCYMRETFGSRRRNSF--SLPVVVDIMLQIARGMEFLHAQK 332 (811)
Q Consensus 279 ----------------~--------~~~yLVmEy~~g~L~~~L~~~~~~~~~~~l--s~~~i~~i~~QIa~gL~yLHs~g 332 (811)
. ..+||-||||+.+|..++... +.+ ....+|+++++|+.||.|+|++|
T Consensus 644 ~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~------N~~~~~~d~~wrLFreIlEGLaYIH~~g 717 (1351)
T KOG1035|consen 644 DTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRR------NHFNSQRDEAWRLFREILEGLAYIHDQG 717 (1351)
T ss_pred cchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHh------cccchhhHHHHHHHHHHHHHHHHHHhCc
Confidence 0 246899999998766666543 223 46789999999999999999999
Q ss_pred ceeccCCCCcEEEeccCCCCcceEEEeecccccccc----cc-------CCCCCCCCCCCCCCCCCCccCChhHhhhhcC
Q 003542 333 IYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTART----YA-------SRNTPPASPQNQTAPNPYIWYAPEVLAEQEG 401 (811)
Q Consensus 333 IVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~----~~-------~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~ 401 (811)
||||||||.||+++.++ .|||+|||+|+... .. ...........+..+||..|+|||++.+.
T Consensus 718 iIHRDLKP~NIFLd~~~-----~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~-- 790 (1351)
T KOG1035|consen 718 IIHRDLKPRNIFLDSRN-----SVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT-- 790 (1351)
T ss_pred eeeccCCcceeEEcCCC-----CeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc--
Confidence 99999999999999776 89999999998722 10 00011111234678899999999999764
Q ss_pred CCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHHHHhCCCCCC---CCCChHHHHHHHhhhccCCCCCC
Q 003542 402 TGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLF---PSGSPKYLVNLTKKCWHTNPSQR 478 (811)
Q Consensus 402 ~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i~~~~~~~~---p~~~~~~l~~LI~~cL~~DP~~R 478 (811)
....|+.|+|+|||||||+||+. ||.. .+....+...++.+..|.. ....-+.-..+|+.|++.||++|
T Consensus 791 ----~~~~Yn~KiDmYSLGIVlFEM~y---PF~T-sMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kR 862 (1351)
T KOG1035|consen 791 ----SSNKYNSKIDMYSLGIVLFEMLY---PFGT-SMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKR 862 (1351)
T ss_pred ----ccccccchhhhHHHHHHHHHHhc---cCCc-hHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccC
Confidence 12479999999999999999985 5653 3344444555665554433 22233446899999999999999
Q ss_pred CCHHHHHH
Q 003542 479 PSFSSICR 486 (811)
Q Consensus 479 PS~~eIl~ 486 (811)
||+.++|.
T Consensus 863 PtA~eLL~ 870 (1351)
T KOG1035|consen 863 PTATELLN 870 (1351)
T ss_pred CCHHHHhh
Confidence 99999875
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-32 Score=286.46 Aligned_cols=243 Identities=22% Similarity=0.326 Sum_probs=187.6
Q ss_pred eEEeeeecccc---eEEEEEE-cCCEEEEEEeccc------HHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEe
Q 003542 218 LMVRRRLGASS---QFKEIQW-LGDSFVLRHFYGE------LESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVME 287 (811)
Q Consensus 218 ~~i~~~lG~G~---vyk~v~~-~g~~VAVK~~~~~------~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmE 287 (811)
|++.+.||.|+ +|++... +|+.||+|.+... ...+.+|+.+++.++||||+++++.+........|+|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 56777788875 7776644 5899999999642 356889999999999999999997775432367999999
Q ss_pred cCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccc
Q 003542 288 LMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTAR 367 (811)
Q Consensus 288 y~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~ 367 (811)
|++++|..++... ...+++..++.++.||+.||.|||+.|++|+||+|+||+++.++ .++|+|||++...
T Consensus 81 ~~~~~l~~~~~~~-----~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~-----~~~l~d~g~~~~~ 150 (287)
T cd07840 81 YMDHDLTGLLDSP-----EVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDG-----VLKLADFGLARPY 150 (287)
T ss_pred cccccHHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCC-----CEEEccccceeec
Confidence 9999988887642 14689999999999999999999999999999999999998876 8999999998766
Q ss_pred cccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHHH
Q 003542 368 TYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNI 447 (811)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i 447 (811)
..... .......++..|+|||.+.+. ..++.++||||||+++|+|++|+.||...... .. ...+
T Consensus 151 ~~~~~------~~~~~~~~~~~y~~PE~~~~~--------~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~-~~-~~~~ 214 (287)
T cd07840 151 TKRNS------ADYTNRVITLWYRPPELLLGA--------TRYGPEVDMWSVGCILAELFLGKPIFQGSTEL-EQ-LEKI 214 (287)
T ss_pred cCCCc------ccccccccccccCCceeeEcc--------ccCChHHHHHHHHHHHHHHHhCCCCCCCCChH-HH-HHHH
Confidence 44321 112234567889999987642 25788999999999999999999999765422 11 1111
Q ss_pred HhCC-CC-----------------------------CCCCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 448 RAGE-RP-----------------------------LFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 448 ~~~~-~~-----------------------------~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
.... .+ .+...++..+.+++.+||..+|.+||++.+++.
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 215 FELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred HHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 1100 00 011123778999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-32 Score=297.33 Aligned_cols=253 Identities=20% Similarity=0.324 Sum_probs=189.6
Q ss_pred hcceEEeeeecccc---eEEEEE-EcCCEEEEEEecc----cHHHHHHHHHHHHhCCCCccceeeeeEEccC--------
Q 003542 215 LKKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG----ELESLNAEISTMLSLSHPNIVQYLCGFCDEE-------- 278 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~-------- 278 (811)
..+|.+.+.||.|+ +|++.. .+|+.||+|.+.. ..+.+.+|+.+|+.++||||+++++.+....
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 36899999999986 666653 3789999999843 3567889999999999999999986654321
Q ss_pred ----CCeEEEEEecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcc
Q 003542 279 ----KKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYF 354 (811)
Q Consensus 279 ----~~~~yLVmEy~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~ 354 (811)
...+|+||||++++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||+++..+.
T Consensus 84 ~~~~~~~~~lv~e~~~~~L~~~~~~-------~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~---- 152 (342)
T cd07854 84 SLTELNSVYIVQEYMETDLANVLEQ-------GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDL---- 152 (342)
T ss_pred cccccceEEEEeecccccHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCc----
Confidence 135799999999998887753 46899999999999999999999999999999999999975431
Q ss_pred eEEEeeccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCC
Q 003542 355 HVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFE 434 (811)
Q Consensus 355 ~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~ 434 (811)
.+||+|||++......... ........++..|+|||++.+ ...++.++|||||||++|+|++|+.||.
T Consensus 153 ~~kl~dfg~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~~DiwSlGvil~el~~g~~pf~ 220 (342)
T cd07854 153 VLKIGDFGLARIVDPHYSH----KGYLSEGLVTKWYRSPRLLLS--------PNNYTKAIDMWAAGCIFAEMLTGKPLFA 220 (342)
T ss_pred eEEECCcccceecCCcccc----ccccccccccccccCHHHHhC--------ccccCchhhHHHHHHHHHHHHhCCCCCC
Confidence 7999999998765322111 111123357888999998753 2257789999999999999999999997
Q ss_pred CCccchHHHHHHHH-----------------------hCCCCC-----CCCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 435 DGHLQGDKMTKNIR-----------------------AGERPL-----FPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 435 ~~~~~~~~i~~~i~-----------------------~~~~~~-----~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
+...... ....+. ....+. +....+.++.+||.+||..||.+|||+.+++.
T Consensus 221 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 221 GAHELEQ-MQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred CCCHHHH-HHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 6432211 111100 000000 11246677899999999999999999999987
Q ss_pred HHHHHH
Q 003542 487 ILRYIK 492 (811)
Q Consensus 487 ~L~~i~ 492 (811)
..+++
T Consensus 300 -h~~~~ 304 (342)
T cd07854 300 -HPYMS 304 (342)
T ss_pred -CCccc
Confidence 33443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-31 Score=276.44 Aligned_cols=238 Identities=25% Similarity=0.453 Sum_probs=189.6
Q ss_pred eEEeeeecccc---eEEEEEE-cCCEEEEEEecc----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEecC
Q 003542 218 LMVRRRLGASS---QFKEIQW-LGDSFVLRHFYG----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELM 289 (811)
Q Consensus 218 ~~i~~~lG~G~---vyk~v~~-~g~~VAVK~~~~----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~ 289 (811)
|.+.+.||.|+ +|++... +|+.||+|.+.. ....+.+|+.+++.++||||+++++.+.. ....+++|||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~l~~e~~ 79 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLK--KDELWIVMEFC 79 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEec--CCeEEEEEecC
Confidence 66777788774 7776643 689999999964 34679999999999999999999977743 46789999999
Q ss_pred C-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccccccc
Q 003542 290 S-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTART 368 (811)
Q Consensus 290 ~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~ 368 (811)
+ ++|.+++... ...+++..+..++.|++.||.|||+.|++||||+|+||+++.++ .++|+|||++....
T Consensus 80 ~~~~L~~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~-----~~~l~d~~~~~~~~ 149 (253)
T cd05122 80 SGGSLKDLLKST-----NQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDG-----EVKLIDFGLSAQLS 149 (253)
T ss_pred CCCcHHHHHhhc-----CCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCC-----eEEEeecccccccc
Confidence 9 5888877652 14689999999999999999999999999999999999998776 89999999987654
Q ss_pred ccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHHHH
Q 003542 369 YASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIR 448 (811)
Q Consensus 369 ~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i~ 448 (811)
.... .....++..|+|||.+.+. .++.++||||||+++|+|++|..||........ .....
T Consensus 150 ~~~~--------~~~~~~~~~~~~PE~~~~~---------~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~~~ 210 (253)
T cd05122 150 DTKA--------RNTMVGTPYWMAPEVINGK---------PYDYKADIWSLGITAIELAEGKPPYSELPPMKA--LFKIA 210 (253)
T ss_pred cccc--------ccceecCCcccCHHHHcCC---------CCCccccHHHHHHHHHHHHhCCCCCCCCchHHH--HHHHH
Confidence 3210 2345678889999998643 478899999999999999999999976532222 12222
Q ss_pred hCCCCCCCCC--ChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 449 AGERPLFPSG--SPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 449 ~~~~~~~p~~--~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
....+..+.. ++..+.++|.+||..||.+|||+.++++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 211 TNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred hcCCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 2333333333 3788999999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=283.77 Aligned_cols=244 Identities=22% Similarity=0.437 Sum_probs=189.1
Q ss_pred eEEeeeecccc---eEEEEEE--cCCEEEEEEecc--------------cHHHHHHHHHHHHh-CCCCccceeeeeEEcc
Q 003542 218 LMVRRRLGASS---QFKEIQW--LGDSFVLRHFYG--------------ELESLNAEISTMLS-LSHPNIVQYLCGFCDE 277 (811)
Q Consensus 218 ~~i~~~lG~G~---vyk~v~~--~g~~VAVK~~~~--------------~~~~~~~Ei~iL~~-L~HPNIVkl~~~~~~e 277 (811)
|++.+.||.|+ +|++... .++.+|+|.+.. ....+..|+.++.+ ++||||+++++.+ .
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~--~ 79 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTF--L 79 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeE--c
Confidence 56677788875 7776644 368899998741 23457788988875 6999999999776 3
Q ss_pred CCCeEEEEEecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEeccCCCCcce
Q 003542 278 EKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHA-QKIYHGELNPSNIYLKARSMEGYFH 355 (811)
Q Consensus 278 ~~~~~yLVmEy~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs-~gIVHRDLKPsNILI~~~g~d~~~~ 355 (811)
....+|+||||++| +|.+++.... .....+++..++.++.|++.||.|||+ .+++||||+|+|||++.++ .
T Consensus 80 ~~~~~~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~-----~ 152 (269)
T cd08528 80 ENDRLYIVMDLIEGAPLGEHFNSLK--EKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDD-----K 152 (269)
T ss_pred cCCeEEEEEecCCCCcHHHHHHHHH--hccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCC-----c
Confidence 45679999999995 8888875432 122568999999999999999999996 6899999999999998776 8
Q ss_pred EEEeeccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCC
Q 003542 356 VKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFED 435 (811)
Q Consensus 356 vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~ 435 (811)
++|+|||++....... ......|+..|+|||++.+. .++.++||||||+++|+|++|..||..
T Consensus 153 ~~l~dfg~~~~~~~~~--------~~~~~~~~~~~~~Pe~~~~~---------~~~~~~Dv~slG~ll~~l~~g~~p~~~ 215 (269)
T cd08528 153 VTITDFGLAKQKQPES--------KLTSVVGTILYSCPEIVKNE---------PYGEKADVWAFGCILYQMCTLQPPFYS 215 (269)
T ss_pred EEEecccceeeccccc--------ccccccCcccCcChhhhcCC---------CCchHHHHHHHHHHHHHHHhCCCcccc
Confidence 9999999987654321 12345678889999999642 578899999999999999999999975
Q ss_pred CccchHHHHHHHHhCCCCCCC-CCChHHHHHHHhhhccCCCCCCCCHHHHHHHHH
Q 003542 436 GHLQGDKMTKNIRAGERPLFP-SGSPKYLVNLTKKCWHTNPSQRPSFSSICRILR 489 (811)
Q Consensus 436 ~~~~~~~i~~~i~~~~~~~~p-~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~ 489 (811)
... ......+..+...+.+ ...++.+.++|.+||..||.+||++.++..++.
T Consensus 216 ~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 216 TNM--LSLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred cCH--HHHHHHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 432 2233344443333333 366788999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=303.08 Aligned_cols=252 Identities=18% Similarity=0.297 Sum_probs=194.6
Q ss_pred echhhHHHHHhcceEEeeeecccceEEEEEE-----cCCEEEEEEecc-------cHHHHHHHHHHHHhCCCCccceeee
Q 003542 205 KNEQRLVDMLLKKLMVRRRLGASSQFKEIQW-----LGDSFVLRHFYG-------ELESLNAEISTMLSLSHPNIVQYLC 272 (811)
Q Consensus 205 ~~e~~~~~~l~k~~~i~~~lG~G~vyk~v~~-----~g~~VAVK~~~~-------~~~~~~~Ei~iL~~L~HPNIVkl~~ 272 (811)
+.+....++-..-|..++.||-| .|+++-. +...||+|.+.+ +...+..|..||..-+++.||++|+
T Consensus 618 YiRLkRaKMdKSmFvkik~iGvG-AFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyy 696 (1034)
T KOG0608|consen 618 YIRLKRAKMDKSMFVKIKTIGVG-AFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYY 696 (1034)
T ss_pred HHHHHHhhccccceEEEeeeccc-ccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEE
Confidence 33444444444567888899999 6777732 566799999843 5678899999999999999999998
Q ss_pred eEEccCCCeEEEEEecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCC
Q 003542 273 GFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSME 351 (811)
Q Consensus 273 ~~~~e~~~~~yLVmEy~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d 351 (811)
.| ++++.+|+||+|++| |+..+|... +.|++..++.|+.++..|+++.|..|+|||||||+|||||.+|
T Consensus 697 SF--QDkdnLYFVMdYIPGGDmMSLLIrm------gIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdG-- 766 (1034)
T KOG0608|consen 697 SF--QDKDNLYFVMDYIPGGDMMSLLIRM------GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDG-- 766 (1034)
T ss_pred Ee--ccCCceEEEEeccCCccHHHHHHHh------ccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCC--
Confidence 88 567789999999995 899988865 7899999999999999999999999999999999999999998
Q ss_pred CcceEEEeeccccccccccCCCCCC-----------------------------------CCCCCCCCCCCCccCChhHh
Q 003542 352 GYFHVKVSGFGLSTARTYASRNTPP-----------------------------------ASPQNQTAPNPYIWYAPEVL 396 (811)
Q Consensus 352 ~~~~vKL~DFGlA~~~~~~~~~~~~-----------------------------------~~~~~~~~~GT~~Y~APEvl 396 (811)
++||+|||||.-+......... ........+||+.|+|||++
T Consensus 767 ---HIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl 843 (1034)
T KOG0608|consen 767 ---HIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVL 843 (1034)
T ss_pred ---ceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHh
Confidence 9999999999654322110000 00123467899999999999
Q ss_pred hhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHH-HHHHHhCCCCCCCCCChHHHHHHHhhhccCCC
Q 003542 397 AEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKM-TKNIRAGERPLFPSGSPKYLVNLTKKCWHTNP 475 (811)
Q Consensus 397 ~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i-~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP 475 (811)
... .|+.-||+||.|||||||+.|++||.+....+.+. ..++.......+..+++++..+||.++. .++
T Consensus 844 ~r~---------g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sa 913 (1034)
T KOG0608|consen 844 ART---------GYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSA 913 (1034)
T ss_pred ccc---------CccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cCh
Confidence 753 78899999999999999999999998765443221 1122222233344678888899888765 367
Q ss_pred CCCCC
Q 003542 476 SQRPS 480 (811)
Q Consensus 476 ~~RPS 480 (811)
+.|..
T Consensus 914 d~RLG 918 (1034)
T KOG0608|consen 914 DSRLG 918 (1034)
T ss_pred hhhhc
Confidence 77754
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=291.49 Aligned_cols=239 Identities=21% Similarity=0.357 Sum_probs=186.5
Q ss_pred eEEeeeeccc---ceEEEEE-EcCCEEEEEEecc-------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEE
Q 003542 218 LMVRRRLGAS---SQFKEIQ-WLGDSFVLRHFYG-------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVM 286 (811)
Q Consensus 218 ~~i~~~lG~G---~vyk~v~-~~g~~VAVK~~~~-------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVm 286 (811)
|...+.||.| .+|++.. .+++.||+|.+.. ....+.+|+.+++.++|||++++++.+. .....|+||
T Consensus 17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~ 94 (308)
T cd06634 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL--REHTAWLVM 94 (308)
T ss_pred HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEE--cCCeeEEEE
Confidence 4444455655 3777663 4788999999842 2356788999999999999999997764 346789999
Q ss_pred ecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccccc
Q 003542 287 ELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366 (811)
Q Consensus 287 Ey~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~ 366 (811)
||+.|+|.+++... ...+++..+..++.|++.||.|||+.+++||||+|+|||++.++ .++|+|||++..
T Consensus 95 e~~~~~l~~~~~~~-----~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~-----~~kl~dfg~~~~ 164 (308)
T cd06634 95 EYCLGSASDLLEVH-----KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG-----LVKLGDFGSASI 164 (308)
T ss_pred EccCCCHHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCC-----cEEECCccccee
Confidence 99999888877542 24588999999999999999999999999999999999998776 899999999865
Q ss_pred ccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHH
Q 003542 367 RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKN 446 (811)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~ 446 (811)
.... ....+++.|+|||++.+. ....++.++|||||||++|+|++|..||..... ......
T Consensus 165 ~~~~-----------~~~~~~~~y~aPE~~~~~------~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~ 225 (308)
T cd06634 165 MAPA-----------NXFVGTPYWMAPEVILAM------DEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--MSALYH 225 (308)
T ss_pred ecCc-----------ccccCCccccCHHHHhhc------ccCCCCcccchHHHHHHHHHHHcCCCCCccccH--HHHHHH
Confidence 4321 234578889999998642 123577899999999999999999999976432 222233
Q ss_pred HHhCCCCC-CCCCChHHHHHHHhhhccCCCCCCCCHHHHHHH
Q 003542 447 IRAGERPL-FPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRI 487 (811)
Q Consensus 447 i~~~~~~~-~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~ 487 (811)
+..+..+. .+...+..+.+||.+||..+|.+||++.+++..
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 226 IAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred HhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 33333333 244678889999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.7e-32 Score=295.09 Aligned_cols=240 Identities=22% Similarity=0.339 Sum_probs=177.2
Q ss_pred eEEEEE-EcCCEEEEEEecc------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEecCCC-CHHHHHHHh
Q 003542 229 QFKEIQ-WLGDSFVLRHFYG------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRET 300 (811)
Q Consensus 229 vyk~v~-~~g~~VAVK~~~~------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~~g-~L~~~L~~~ 300 (811)
||.+.. .+|+.||+|++.. ..+.+.+|+.+++.++||||+++++.|. ....+|+||||+.+ +|.+++...
T Consensus 16 v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~--~~~~~~~v~e~~~~~~l~~~l~~~ 93 (328)
T cd08226 16 VYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFT--TGSWLWVISPFMAYGSANSLLKTY 93 (328)
T ss_pred EEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEe--cCCceEEEEecccCCCHHHHHHhh
Confidence 777653 4899999999852 2467899999999999999999998884 45578999999994 888888764
Q ss_pred hCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccccccCCCCCCCCCC
Q 003542 301 FGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTPPASPQ 380 (811)
Q Consensus 301 ~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 380 (811)
. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++ .++++|||.+................
T Consensus 94 ~----~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (328)
T cd08226 94 F----PEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDG-----LVSLSGLSHLYSLVRNGQKAKVVYDF 164 (328)
T ss_pred c----ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCC-----cEEEechHHHhhhhccCccccccccc
Confidence 2 24588999999999999999999999999999999999998776 89999998654322211100000011
Q ss_pred CCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHHHHhCC---------
Q 003542 381 NQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGE--------- 451 (811)
Q Consensus 381 ~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i~~~~--------- 451 (811)
.....++..|+|||++.+. ...++.++|||||||++|+|++|.+||.+...... ....+....
T Consensus 165 ~~~~~~~~~y~aPE~~~~~-------~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 236 (328)
T cd08226 165 PQFSTSVLPWLSPELLRQD-------LYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM-LLQKLKGPPYSPLDITTF 236 (328)
T ss_pred cccccCccCccChhhhcCC-------CCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH-HHHHhcCCCCCCcccccc
Confidence 1123356679999999753 23578899999999999999999999976432211 111111000
Q ss_pred ------------------------------------CCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHH
Q 003542 452 ------------------------------------RPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRI 487 (811)
Q Consensus 452 ------------------------------------~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~ 487 (811)
....+..++..+.+|+.+||..||.+|||+.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred chhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 001112355678999999999999999999999873
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=290.36 Aligned_cols=238 Identities=20% Similarity=0.373 Sum_probs=185.7
Q ss_pred eEEeeeecccc---eEEEEE-EcCCEEEEEEecc-------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEE
Q 003542 218 LMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG-------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVM 286 (811)
Q Consensus 218 ~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~-------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVm 286 (811)
|...+.||.|+ +|++.. .+|..||+|.+.. ....+.+|+.+++.++||||+++++.+. +....|+||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~ 100 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYL--KEHTAWLVM 100 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEE--eCCEEEEEE
Confidence 44445566664 777663 4789999999852 2356889999999999999999997774 456789999
Q ss_pred ecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccccc
Q 003542 287 ELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366 (811)
Q Consensus 287 Ey~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~ 366 (811)
||+.|+|.+++... ...+++..++.++.||+.||.|||+.|++||||+|+||+++.++ .+||+|||++..
T Consensus 101 e~~~~~l~~~l~~~-----~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~-----~~kL~dfg~~~~ 170 (313)
T cd06633 101 EYCLGSASDLLEVH-----KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPG-----QVKLADFGSASK 170 (313)
T ss_pred ecCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCC-----CEEEeecCCCcc
Confidence 99999988887642 24689999999999999999999999999999999999998776 899999998753
Q ss_pred ccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHH
Q 003542 367 RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKN 446 (811)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~ 446 (811)
.. ......|+..|+|||++... ....++.++||||||+++|+|++|..||...... .. ...
T Consensus 171 ~~-----------~~~~~~~~~~y~aPE~~~~~------~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~-~~-~~~ 231 (313)
T cd06633 171 SS-----------PANSFVGTPYWMAPEVILAM------DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SA-LYH 231 (313)
T ss_pred cC-----------CCCCccccccccChhhcccc------CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-HH-HHH
Confidence 21 11245678889999998532 1235788999999999999999999999764322 12 222
Q ss_pred HHhCCCCC-CCCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 447 IRAGERPL-FPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 447 i~~~~~~~-~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
+.....+. ....++..+.+|+.+||+.+|.+||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 232 IAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred HHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 22222222 23456678999999999999999999999986
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-32 Score=311.26 Aligned_cols=258 Identities=21% Similarity=0.275 Sum_probs=196.5
Q ss_pred eEEeeeecccc---eEEEE-EEcCCEEEEEEecc-----cHHHHHHHHHHHHhCCCCccceeeeeEEccC----CCeEEE
Q 003542 218 LMVRRRLGASS---QFKEI-QWLGDSFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQYLCGFCDEE----KKEFFL 284 (811)
Q Consensus 218 ~~i~~~lG~G~---vyk~v-~~~g~~VAVK~~~~-----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~----~~~~yL 284 (811)
|...+.||+|+ ||+.. +.+|+.||||.++. ..+...+|+++|++|+|||||++++.--... .....+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 45556677775 77777 66999999999964 5788999999999999999999985542222 234589
Q ss_pred EEecCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccc
Q 003542 285 VMELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGL 363 (811)
Q Consensus 285 VmEy~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGl 363 (811)
|||||. |+|...|.+ +.....|++.+++.++.+++.||.|||.+||+||||||.||++.... ++....||+|||.
T Consensus 95 vmEyC~gGsL~~~L~~---PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Ge-dgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNS---PENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGE-DGQSIYKLTDFGA 170 (732)
T ss_pred EEeecCCCcHHHHhcC---cccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecC-CCceEEeeecccc
Confidence 999999 599988875 34457899999999999999999999999999999999999997765 6677899999999
Q ss_pred cccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccc--hH
Q 003542 364 STARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQ--GD 441 (811)
Q Consensus 364 A~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~--~~ 441 (811)
|+..+... ...+.+||..|++||++..+ ..|+..+|.|||||++|+++||..||...... ..
T Consensus 171 Arel~d~s--------~~~S~vGT~~YLhPel~E~q--------~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~ 234 (732)
T KOG4250|consen 171 ARELDDNS--------LFTSLVGTEEYLHPELYERQ--------KKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNK 234 (732)
T ss_pred cccCCCCC--------eeeeecCchhhcChHHHhhc--------cCcCceeehhhhhhHHHHHhccCCCCCcCCCccccc
Confidence 99876653 44688999999999999852 37889999999999999999999999643222 11
Q ss_pred HHHHHHHhCCC--------------------CCCCCCCh----HHHHHHHhhhccCCCCCCC--CHHHHHHHHHHHHHHh
Q 003542 442 KMTKNIRAGER--------------------PLFPSGSP----KYLVNLTKKCWHTNPSQRP--SFSSICRILRYIKKFM 495 (811)
Q Consensus 442 ~i~~~i~~~~~--------------------~~~p~~~~----~~l~~LI~~cL~~DP~~RP--S~~eIl~~L~~i~k~l 495 (811)
++...+....+ .++|...+ ..+..++..+|..+|.+|. .+.+....+..|.+..
T Consensus 235 ~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~ 314 (732)
T KOG4250|consen 235 EIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLK 314 (732)
T ss_pred hhhhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhh
Confidence 12222211110 11122222 2356788888999999998 7777666666655543
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=295.27 Aligned_cols=247 Identities=21% Similarity=0.352 Sum_probs=188.1
Q ss_pred hcceEEeeeecccc---eEEEEE-EcCCEEEEEEecc------cHHHHHHHHHHHHhCCCCccceeeeeEEccC----CC
Q 003542 215 LKKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG------ELESLNAEISTMLSLSHPNIVQYLCGFCDEE----KK 280 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~----~~ 280 (811)
..+|.+.+.||.|+ +|++.. .+|+.||||.+.. ....+.+|+.+++.++||||+++++.+.... ..
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 46888899999885 777663 4799999999853 1345789999999999999999997764321 23
Q ss_pred eEEEEEecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEee
Q 003542 281 EFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSG 360 (811)
Q Consensus 281 ~~yLVmEy~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~D 360 (811)
.+|+||||+..+|..++. ..+++..+..++.|++.||.|||++|++||||||+|||++.++ .+||+|
T Consensus 94 ~~~lv~e~~~~~l~~~~~--------~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~-----~~kL~d 160 (342)
T cd07879 94 DFYLVMPYMQTDLQKIMG--------HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDC-----ELKILD 160 (342)
T ss_pred eEEEEecccccCHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-----CEEEee
Confidence 579999999887766542 4689999999999999999999999999999999999998876 899999
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccch
Q 003542 361 FGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQG 440 (811)
Q Consensus 361 FGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~ 440 (811)
||+++..... .....++..|+|||++.+ ...++.++|||||||++|||++|+.||.+.....
T Consensus 161 fg~~~~~~~~----------~~~~~~~~~y~aPE~~~~--------~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~ 222 (342)
T cd07879 161 FGLARHADAE----------MTGYVVTRWYRAPEVILN--------WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD 222 (342)
T ss_pred CCCCcCCCCC----------CCCceeeecccChhhhcC--------ccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9998654221 123457888999999864 2357889999999999999999999998653221
Q ss_pred HHHHHHHHhC---------------------CCCCC--------CCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHH
Q 003542 441 DKMTKNIRAG---------------------ERPLF--------PSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYI 491 (811)
Q Consensus 441 ~~i~~~i~~~---------------------~~~~~--------p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i 491 (811)
.+...+... ..+.. ....+..+.+||.+||+.||.+||++++++. ..++
T Consensus 223 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~-h~~f 300 (342)
T cd07879 223 -QLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE-HPYF 300 (342)
T ss_pred -HHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc-Ccch
Confidence 111111100 00001 1235667899999999999999999999987 3444
Q ss_pred HHH
Q 003542 492 KKF 494 (811)
Q Consensus 492 ~k~ 494 (811)
...
T Consensus 301 ~~~ 303 (342)
T cd07879 301 DSF 303 (342)
T ss_pred hhc
Confidence 443
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-31 Score=284.84 Aligned_cols=246 Identities=21% Similarity=0.330 Sum_probs=190.9
Q ss_pred ceEEeeeecccc---eEEEEE----EcCCEEEEEEecc--------cHHHHHHHHHHHHhC-CCCccceeeeeEEccCCC
Q 003542 217 KLMVRRRLGASS---QFKEIQ----WLGDSFVLRHFYG--------ELESLNAEISTMLSL-SHPNIVQYLCGFCDEEKK 280 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v~----~~g~~VAVK~~~~--------~~~~~~~Ei~iL~~L-~HPNIVkl~~~~~~e~~~ 280 (811)
+|++.+.||.|+ +|.+.. .+++.||||.+.. ..+.+.+|+.++.++ +||||+++++.+ ....
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~--~~~~ 78 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF--QTDT 78 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee--ecCC
Confidence 367888888875 776653 2678999999853 235678999999999 699999998777 4456
Q ss_pred eEEEEEecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEe
Q 003542 281 EFFLVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVS 359 (811)
Q Consensus 281 ~~yLVmEy~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~ 359 (811)
.+|+||||+++ +|.+++... ..+++..+..++.|++.||.|||+.+++||||+|+||+++.++ .++|+
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~-----~~~l~ 147 (288)
T cd05583 79 KLHLILDYVNGGELFTHLYQR------EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEG-----HVVLT 147 (288)
T ss_pred EEEEEEecCCCCcHHHHHhhc------CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC-----CEEEE
Confidence 78999999985 888888642 5688999999999999999999999999999999999998776 89999
Q ss_pred eccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCcc-
Q 003542 360 GFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHL- 438 (811)
Q Consensus 360 DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~- 438 (811)
|||++........ .......|+..|+|||.+.+. ....+.++||||||+++|+|++|..||.....
T Consensus 148 dfg~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~-------~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~ 214 (288)
T cd05583 148 DFGLSKEFLAEEE------ERAYSFCGTIEYMAPEVIRGG-------SGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ 214 (288)
T ss_pred ECccccccccccc------cccccccCCccccCHHHhcCC-------CCCCcchhhhHHHHHHHHHHHhCCCCcccCccc
Confidence 9999876533211 112234578899999998653 12367899999999999999999999964321
Q ss_pred -chHHHHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHH
Q 003542 439 -QGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILR 489 (811)
Q Consensus 439 -~~~~i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~ 489 (811)
....+.+.+... .+..+...+..+.+++.+||+.||++|||+.++...|.
T Consensus 215 ~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~ 265 (288)
T cd05583 215 NSQSEISRRILKS-KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKN 265 (288)
T ss_pred chHHHHHHHHHcc-CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence 122233333332 34456678889999999999999999999887766543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-32 Score=282.20 Aligned_cols=244 Identities=23% Similarity=0.412 Sum_probs=196.5
Q ss_pred cceEEeeeecccc---eEEEE-EEcCCEEEEEEecc-----cHHHHHHHHHHHHhC-CCCccceeeeeEEccCCCeEEEE
Q 003542 216 KKLMVRRRLGASS---QFKEI-QWLGDSFVLRHFYG-----ELESLNAEISTMLSL-SHPNIVQYLCGFCDEEKKEFFLV 285 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v-~~~g~~VAVK~~~~-----~~~~~~~Ei~iL~~L-~HPNIVkl~~~~~~e~~~~~yLV 285 (811)
++++.+..||.|+ |.+.. +.+|...|||.+.. +.+++...+.++..- +.|+||+.|++|... ..++|.
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n--~dV~Ic 169 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITN--TDVFIC 169 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeC--chHHHH
Confidence 5667778889886 66655 44789999999953 467778888887666 599999999888643 448999
Q ss_pred EecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEeccCCCCcceEEEeecccc
Q 003542 286 MELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHA-QKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS 364 (811)
Q Consensus 286 mEy~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs-~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA 364 (811)
||.|..-+..+++. ...++++..+-++..-++.||.||.. ++|+|||+||+|||+|..| ++||||||++
T Consensus 170 MelMs~C~ekLlkr-----ik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~G-----niKlCDFGIs 239 (391)
T KOG0983|consen 170 MELMSTCAEKLLKR-----IKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG-----NIKLCDFGIS 239 (391)
T ss_pred HHHHHHHHHHHHHH-----hcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCC-----CEEeeccccc
Confidence 99998544444443 23679999999999999999999986 5899999999999999998 8999999999
Q ss_pred ccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHH
Q 003542 365 TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMT 444 (811)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~ 444 (811)
..+.... ......|-+.|||||.+.-. ....|+.++||||||++++||+||+.||.+...+-+.+.
T Consensus 240 GrlvdSk--------AhtrsAGC~~YMaPERidp~------~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~lt 305 (391)
T KOG0983|consen 240 GRLVDSK--------AHTRSAGCAAYMAPERIDPP------DKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLT 305 (391)
T ss_pred ceeeccc--------ccccccCCccccCccccCCC------CCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHH
Confidence 8776543 23455677889999999643 256899999999999999999999999999776655444
Q ss_pred HHHHhCCCCCCCC--CChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 445 KNIRAGERPLFPS--GSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 445 ~~i~~~~~~~~p~--~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
.+....+|.+|. ..++.+.+++..||..|+.+||.+.++++
T Consensus 306 -kvln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 306 -KVLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred -HHHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 444455565553 47899999999999999999999999987
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=292.55 Aligned_cols=251 Identities=21% Similarity=0.334 Sum_probs=193.6
Q ss_pred ceEEeeeecccc---eEEEEEE-cCCEEEEEEecc------cHHHHHHHHHHHHhCCCCccceeeeeEEccC---CCeEE
Q 003542 217 KLMVRRRLGASS---QFKEIQW-LGDSFVLRHFYG------ELESLNAEISTMLSLSHPNIVQYLCGFCDEE---KKEFF 283 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v~~-~g~~VAVK~~~~------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~---~~~~y 283 (811)
+|++.+.||.|+ +|++... +|+.||||.+.. ..+.+.+|+.+++.++||||+++++.+.... ...+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 478888888885 7776643 589999999854 2467899999999999999999997764332 23689
Q ss_pred EEEecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccc
Q 003542 284 LVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGL 363 (811)
Q Consensus 284 LVmEy~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGl 363 (811)
+||||++++|..++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++ .++|+|||+
T Consensus 81 lv~e~~~~~l~~~l~~~------~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~-----~~~L~dfg~ 149 (330)
T cd07834 81 IVTELMETDLHKVIKSP------QPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNC-----DLKICDFGL 149 (330)
T ss_pred EEecchhhhHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-----CEEEcccCc
Confidence 99999999888887642 4799999999999999999999999999999999999998876 899999999
Q ss_pred cccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHH
Q 003542 364 STARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKM 443 (811)
Q Consensus 364 A~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i 443 (811)
+......... ........++..|+|||++.+. ..++.++||||||+++|+|++|.+||.+.... ..
T Consensus 150 ~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~--------~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~--~~ 215 (330)
T cd07834 150 ARGVDPDEDE----KGFLTEYVVTRWYRAPELLLSS--------SRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI--DQ 215 (330)
T ss_pred eEeecccccc----cccccccccccCcCCceeeecc--------cCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH--HH
Confidence 9876543210 0112345678889999998753 26788999999999999999999999765422 11
Q ss_pred HHHHHhC-CCC-----------------------------CCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHHHH
Q 003542 444 TKNIRAG-ERP-----------------------------LFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKK 493 (811)
Q Consensus 444 ~~~i~~~-~~~-----------------------------~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~k 493 (811)
...+... ..+ ......+..+.++|.+||+.+|.+||++.+++. ..++..
T Consensus 216 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~-~~~~~~ 294 (330)
T cd07834 216 LNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA-HPYLAQ 294 (330)
T ss_pred HHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh-CccHHh
Confidence 1111110 000 011235678999999999999999999999987 334444
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.5e-31 Score=289.50 Aligned_cols=255 Identities=19% Similarity=0.279 Sum_probs=190.2
Q ss_pred ceEEeeeecccc---eEEEEEE-c--CCEEEEEEecc------cHHHHHHHHHHHHhC-CCCccceeeeeEEc--cCCCe
Q 003542 217 KLMVRRRLGASS---QFKEIQW-L--GDSFVLRHFYG------ELESLNAEISTMLSL-SHPNIVQYLCGFCD--EEKKE 281 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v~~-~--g~~VAVK~~~~------~~~~~~~Ei~iL~~L-~HPNIVkl~~~~~~--e~~~~ 281 (811)
+|.+.+.||.|+ +|.+... . +..||||.+.. ..+.+.+|+.+++++ +||||+++++.... .....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 477888888885 6665533 3 77999999853 245678899999999 59999999865432 22346
Q ss_pred EEEEEecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeec
Q 003542 282 FFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGF 361 (811)
Q Consensus 282 ~yLVmEy~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DF 361 (811)
+|++|||++++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+||
T Consensus 81 ~~~~~e~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~-----~~kl~Df 149 (332)
T cd07857 81 LYLYEELMEADLHQIIRSG------QPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADC-----ELKICDF 149 (332)
T ss_pred EEEEEecccCCHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCC-----CEEeCcC
Confidence 8999999999999888643 5789999999999999999999999999999999999998876 8999999
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccch-
Q 003542 362 GLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQG- 440 (811)
Q Consensus 362 GlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~- 440 (811)
|++......... .........||..|+|||++.+. ..++.++||||||+++|+|++|.+||.......
T Consensus 150 g~a~~~~~~~~~---~~~~~~~~~g~~~y~aPE~~~~~--------~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~ 218 (332)
T cd07857 150 GLARGFSENPGE---NAGFMTEYVATRWYRAPEIMLSF--------QSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQ 218 (332)
T ss_pred CCceeccccccc---ccccccCcccCccccCcHHHhCC--------CCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHH
Confidence 999765433211 01112345689999999998642 257889999999999999999999997643210
Q ss_pred ------------HHHHHHH---------H---hCCCCCC---CCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHHHH
Q 003542 441 ------------DKMTKNI---------R---AGERPLF---PSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKK 493 (811)
Q Consensus 441 ------------~~i~~~i---------~---~~~~~~~---p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~k 493 (811)
......+ . ......+ ....+..+.+|+.+||+.||.+|||+.+++. ..++.+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~-~~~~~~ 297 (332)
T cd07857 219 LNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE-HPYLAI 297 (332)
T ss_pred HHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc-Chhhhh
Confidence 0000000 0 0000111 1234678999999999999999999999986 455555
Q ss_pred H
Q 003542 494 F 494 (811)
Q Consensus 494 ~ 494 (811)
+
T Consensus 298 ~ 298 (332)
T cd07857 298 W 298 (332)
T ss_pred h
Confidence 5
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=287.22 Aligned_cols=247 Identities=22% Similarity=0.399 Sum_probs=189.6
Q ss_pred hcceEEeeeecccc---eEEEEEE-cCCEEEEEEecc-----cHHHHHHHHHHHHhC-CCCccceeeeeEEccCCCeEEE
Q 003542 215 LKKLMVRRRLGASS---QFKEIQW-LGDSFVLRHFYG-----ELESLNAEISTMLSL-SHPNIVQYLCGFCDEEKKEFFL 284 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~~-~g~~VAVK~~~~-----~~~~~~~Ei~iL~~L-~HPNIVkl~~~~~~e~~~~~yL 284 (811)
.++|++.+.||.|+ +|++... +|+.||||.+.. ....+..|+.++.++ +||||+++++.+. +...+|+
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~--~~~~~~~ 91 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFI--TDSDVFI 91 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeee--cCCeEEE
Confidence 46788899999986 6766544 489999999953 234567788777777 5999999997774 4567999
Q ss_pred EEecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEeccCCCCcceEEEeeccc
Q 003542 285 VMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHA-QKIYHGELNPSNIYLKARSMEGYFHVKVSGFGL 363 (811)
Q Consensus 285 VmEy~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs-~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGl 363 (811)
||||+++.|..++... ...+++..+..++.||+.||.|||+ .||+||||+|+||+++.++ .+||+|||+
T Consensus 92 v~e~~~~~l~~l~~~~-----~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~-----~~kL~dfg~ 161 (296)
T cd06618 92 CMELMSTCLDKLLKRI-----QGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASG-----NVKLCDFGI 161 (296)
T ss_pred EeeccCcCHHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCC-----CEEECcccc
Confidence 9999998877766542 2478999999999999999999997 5999999999999998766 899999999
Q ss_pred cccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHH
Q 003542 364 STARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKM 443 (811)
Q Consensus 364 A~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i 443 (811)
+....... ......++..|+|||.+.+... ...++.++||||||+++|+|++|+.||...... .+.
T Consensus 162 ~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~-----~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~ 227 (296)
T cd06618 162 SGRLVDSK--------AKTRSAGCAAYMAPERIDPPDP-----NPKYDIRADVWSLGISLVELATGQFPYKNCKTE-FEV 227 (296)
T ss_pred chhccCCC--------cccCCCCCccccCHhhcCCCCC-----ccccccchhHHHHHHHHHHHHhCCCCCCcchhH-HHH
Confidence 86553221 1123357788999999865311 235788999999999999999999999753322 222
Q ss_pred HHHHHhCCCCCCCC--CChHHHHHHHhhhccCCCCCCCCHHHHHHH
Q 003542 444 TKNIRAGERPLFPS--GSPKYLVNLTKKCWHTNPSQRPSFSSICRI 487 (811)
Q Consensus 444 ~~~i~~~~~~~~p~--~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~ 487 (811)
...+.....+..+. .++..+.+|+.+||..||.+||++.+++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 228 LTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 33333333333332 468889999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=282.83 Aligned_cols=245 Identities=20% Similarity=0.367 Sum_probs=194.6
Q ss_pred ceEEeeeecccc---eEEEEEE-cCCEEEEEEecc-------cHHHHHHHHHHHHhCC-CCccceeeeeEEccCCCeEEE
Q 003542 217 KLMVRRRLGASS---QFKEIQW-LGDSFVLRHFYG-------ELESLNAEISTMLSLS-HPNIVQYLCGFCDEEKKEFFL 284 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v~~-~g~~VAVK~~~~-------~~~~~~~Ei~iL~~L~-HPNIVkl~~~~~~e~~~~~yL 284 (811)
+|++.+.||.|+ +|++... +|+.||+|++.. ....+.+|+.++.+++ ||||+++++.+ .....+|+
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~--~~~~~~~l 79 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF--QDEENLYF 79 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh--cCCceEEE
Confidence 688888899886 7776643 799999999853 2356889999999998 99999999777 44567999
Q ss_pred EEecCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccc
Q 003542 285 VMELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGL 363 (811)
Q Consensus 285 VmEy~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGl 363 (811)
||||++ ++|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||+
T Consensus 80 v~e~~~~~~L~~~l~~~------~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~-----~~~l~df~~ 148 (280)
T cd05581 80 VLEYAPNGELLQYIRKY------GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDM-----HIKITDFGT 148 (280)
T ss_pred EEcCCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC-----CEEecCCcc
Confidence 999996 6999988763 4799999999999999999999999999999999999998776 899999999
Q ss_pred cccccccCCCCCC-------------CCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCC
Q 003542 364 STARTYASRNTPP-------------ASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGK 430 (811)
Q Consensus 364 A~~~~~~~~~~~~-------------~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~ 430 (811)
+............ .........++..|+|||++... .++.++||||||+++|++++|.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~---------~~~~~~Di~slG~~l~~l~~g~ 219 (280)
T cd05581 149 AKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEK---------PAGKSSDLWALGCIIYQMLTGK 219 (280)
T ss_pred ccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCC---------CCChhhhHHHHHHHHHHHHhCC
Confidence 8765433211000 01122345678899999998643 5788999999999999999999
Q ss_pred CCCCCCccchHHHHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCH----HHHHH
Q 003542 431 VPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSF----SSICR 486 (811)
Q Consensus 431 ~PF~~~~~~~~~i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~----~eIl~ 486 (811)
.||..... ......+.. ....++...++.+.+||.+||..+|.+||++ .+++.
T Consensus 220 ~p~~~~~~--~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 220 PPFRGSNE--YLTFQKILK-LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred CCCCCccH--HHHHHHHHh-cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 99986542 222233332 2334667778999999999999999999999 77765
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=280.80 Aligned_cols=242 Identities=25% Similarity=0.419 Sum_probs=189.4
Q ss_pred ceEEeeeecccc---eEEEEEE-cCCEEEEEEecc---------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEE
Q 003542 217 KLMVRRRLGASS---QFKEIQW-LGDSFVLRHFYG---------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFF 283 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v~~-~g~~VAVK~~~~---------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~y 283 (811)
+|.+.+.||.|+ +|++... .+..+++|.++. ....+..|+.+++.++||||+++++.+. +...++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~ 78 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFL--ERDAFC 78 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHh--cCCceE
Confidence 477888888886 6765532 455566666532 2345778999999999999999997774 445689
Q ss_pred EEEecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecc
Q 003542 284 LVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFG 362 (811)
Q Consensus 284 LVmEy~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFG 362 (811)
+||||+++ +|.+++..... ....+++..++.++.|++.||.|||+.|++|+||+|+||+++.+ .++|+|||
T Consensus 79 lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~~------~~~l~d~g 150 (260)
T cd08222 79 IITEYCEGRDLDCKLEELKH--TGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNN------LLKIGDFG 150 (260)
T ss_pred EEEEeCCCCCHHHHHHHHhh--cccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeecC------CEeecccC
Confidence 99999995 88888765321 23568999999999999999999999999999999999999643 69999999
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHH
Q 003542 363 LSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDK 442 (811)
Q Consensus 363 lA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~ 442 (811)
++....... .......|++.|+|||.+.+. .++.++|+||||+++|+|++|..||.+... ..
T Consensus 151 ~~~~~~~~~-------~~~~~~~~~~~~~~pe~~~~~---------~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--~~ 212 (260)
T cd08222 151 VSRLLMGSC-------DLATTFTGTPYYMSPEALKHQ---------GYDSKSDIWSLGCILYEMCCLAHAFEGQNF--LS 212 (260)
T ss_pred ceeecCCCc-------ccccCCCCCcCccCHHHHccC---------CCCchhhHHHHHHHHHHHHhCCCCCCCccH--HH
Confidence 987653321 112244578889999998643 567889999999999999999999975432 23
Q ss_pred HHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 443 MTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 443 i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
....+..+..+..+..++..+.++|.+||..+|.+||++.++++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 213 VVLRIVEGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred HHHHHHcCCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 33444556666677788899999999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-32 Score=298.98 Aligned_cols=236 Identities=22% Similarity=0.359 Sum_probs=196.3
Q ss_pred eeecccc---eEEEE-EEcCCEEEEEEecc------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEecCCC
Q 003542 222 RRLGASS---QFKEI-QWLGDSFVLRHFYG------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK 291 (811)
Q Consensus 222 ~~lG~G~---vyk~v-~~~g~~VAVK~~~~------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~~g 291 (811)
+.||.|. ||+++ +.+|+.||||++.+ +.+.+++|+.||.+++||.||.+-..| ++...+|+|||-+.|
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~--ET~ervFVVMEKl~G 647 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMF--ETPERVFVVMEKLHG 647 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEee--cCCceEEEEehhhcc
Confidence 4577763 78777 56999999999953 457899999999999999999987555 778889999999999
Q ss_pred CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccccccC
Q 003542 292 DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYAS 371 (811)
Q Consensus 292 ~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~~ 371 (811)
|.++.|... ..+.+++.....++.||+.||.|||.++|+|+||||+|||+... +....+||||||+|+.+....
T Consensus 648 DMLEMILSs----EkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~--~~FPQvKlCDFGfARiIgEks 721 (888)
T KOG4236|consen 648 DMLEMILSS----EKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASA--SPFPQVKLCDFGFARIIGEKS 721 (888)
T ss_pred hHHHHHHHh----hcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccC--CCCCceeeccccceeecchhh
Confidence 988888763 34789999999999999999999999999999999999999876 456699999999999876543
Q ss_pred CCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHHHHhCC
Q 003542 372 RNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGE 451 (811)
Q Consensus 372 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i~~~~ 451 (811)
...+.+||+.|+|||++..+ .|+..-|+||.|||+|--++|..||..+.. +...|....
T Consensus 722 --------FRrsVVGTPAYLaPEVLrnk---------GyNrSLDMWSVGVIiYVsLSGTFPFNEdEd----IndQIQNAa 780 (888)
T KOG4236|consen 722 --------FRRSVVGTPAYLAPEVLRNK---------GYNRSLDMWSVGVIIYVSLSGTFPFNEDED----INDQIQNAA 780 (888)
T ss_pred --------hhhhhcCCccccCHHHHhhc---------cccccccceeeeEEEEEEecccccCCCccc----hhHHhhccc
Confidence 33578999999999999865 678889999999999999999999975432 333444332
Q ss_pred ---CCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 452 ---RPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 452 ---~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
++.....+++...+||..+|+..-.+|.|++..+.
T Consensus 781 FMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 781 FMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred cccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 22222466788999999999999999999888766
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-31 Score=280.03 Aligned_cols=229 Identities=21% Similarity=0.341 Sum_probs=176.0
Q ss_pred eeccc---ceEEEEE-EcCCEEEEEEeccc-------HHHHHHHHHHHH-hCCCCccceeeeeEEccCCCeEEEEEecCC
Q 003542 223 RLGAS---SQFKEIQ-WLGDSFVLRHFYGE-------LESLNAEISTML-SLSHPNIVQYLCGFCDEEKKEFFLVMELMS 290 (811)
Q Consensus 223 ~lG~G---~vyk~v~-~~g~~VAVK~~~~~-------~~~~~~Ei~iL~-~L~HPNIVkl~~~~~~e~~~~~yLVmEy~~ 290 (811)
.||.| .+|++.. .+|+.||||.+... ...+..|..++. .++||||+++++.+ .....+|+||||++
T Consensus 3 ~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~--~~~~~~~lv~e~~~ 80 (260)
T cd05611 3 PISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF--QSKDYLYLVMEYLN 80 (260)
T ss_pred cCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeE--EcCCeEEEEEeccC
Confidence 34555 4787764 47899999998531 123455555544 45899999999777 44567999999998
Q ss_pred C-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccccc
Q 003542 291 K-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTY 369 (811)
Q Consensus 291 g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~ 369 (811)
+ +|.+++... ..+++..+..++.||+.||.|||+.+++||||+|+||+++.++ .++|+|||++.....
T Consensus 81 ~~~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~-----~~~l~dfg~~~~~~~ 149 (260)
T cd05611 81 GGDCASLIKTL------GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTG-----HLKLTDFGLSRNGLE 149 (260)
T ss_pred CCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-----cEEEeecccceeccc
Confidence 5 898888653 5689999999999999999999999999999999999998776 899999999865322
Q ss_pred cCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHHHHh
Q 003542 370 ASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRA 449 (811)
Q Consensus 370 ~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i~~ 449 (811)
.....++..|+|||.+.+. .++.++||||||+++|+|++|..||..... ..+...+..
T Consensus 150 -----------~~~~~~~~~y~~pe~~~~~---------~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~ 207 (260)
T cd05611 150 -----------NKKFVGTPDYLAPETILGV---------GDDKMSDWWSLGCVIFEFLFGYPPFHAETP--DAVFDNILS 207 (260)
T ss_pred -----------cccCCCCcCccChhhhcCC---------CCcchhhhHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHHh
Confidence 1234577889999998753 478899999999999999999999976433 233344433
Q ss_pred CCC---CCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 450 GER---PLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 450 ~~~---~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
+.. ...+..++..+.++|.+||..+|.+||++.++.+
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~ 247 (260)
T cd05611 208 RRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQE 247 (260)
T ss_pred cccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHH
Confidence 321 2233467889999999999999999996654433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=292.66 Aligned_cols=248 Identities=23% Similarity=0.304 Sum_probs=185.9
Q ss_pred cceEE-eeeecccc---eEEEEE-EcCCEEEEEEeccc------------------HHHHHHHHHHHHhCCCCccceeee
Q 003542 216 KKLMV-RRRLGASS---QFKEIQ-WLGDSFVLRHFYGE------------------LESLNAEISTMLSLSHPNIVQYLC 272 (811)
Q Consensus 216 k~~~i-~~~lG~G~---vyk~v~-~~g~~VAVK~~~~~------------------~~~~~~Ei~iL~~L~HPNIVkl~~ 272 (811)
++|.. .+.||.|+ +|++.. ..|+.||||.+... ...+.+|+.+++.++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 45543 35577775 777764 47899999998531 124779999999999999999998
Q ss_pred eEEccCCCeEEEEEecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCC
Q 003542 273 GFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEG 352 (811)
Q Consensus 273 ~~~~e~~~~~yLVmEy~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~ 352 (811)
.+. ....+|+||||+.|+|.+++... ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++
T Consensus 88 ~~~--~~~~~~lv~e~~~~~l~~~l~~~------~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~--- 156 (335)
T PTZ00024 88 VYV--EGDFINLVMDIMASDLKKVVDRK------IRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKG--- 156 (335)
T ss_pred EEe--cCCcEEEEEeccccCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCC---
Confidence 774 44579999999999999888643 5689999999999999999999999999999999999998776
Q ss_pred cceEEEeeccccccccccCCCCC-------CCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHH
Q 003542 353 YFHVKVSGFGLSTARTYASRNTP-------PASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFE 425 (811)
Q Consensus 353 ~~~vKL~DFGlA~~~~~~~~~~~-------~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyE 425 (811)
.++|+|||++........... ..........++..|+|||++.+. ..++.++|||||||++|+
T Consensus 157 --~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--------~~~~~~~Dv~slG~~l~e 226 (335)
T PTZ00024 157 --ICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGA--------EKYHFAVDMWSVGCIFAE 226 (335)
T ss_pred --CEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccC--------CCCCcHHHHHHHHHHHHH
Confidence 899999999876542110000 001111234567889999998642 246889999999999999
Q ss_pred HhhCCCCCCCCccchHHHHHHHHh-CC---CC-----------------------CCCCCChHHHHHHHhhhccCCCCCC
Q 003542 426 LLTGKVPFEDGHLQGDKMTKNIRA-GE---RP-----------------------LFPSGSPKYLVNLTKKCWHTNPSQR 478 (811)
Q Consensus 426 LltG~~PF~~~~~~~~~i~~~i~~-~~---~~-----------------------~~p~~~~~~l~~LI~~cL~~DP~~R 478 (811)
|++|.+||.+.... ..+ ..+.. .. .. ......+..+.++|.+||..+|.+|
T Consensus 227 l~tg~~p~~~~~~~-~~~-~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 304 (335)
T PTZ00024 227 LLTGKPLFPGENEI-DQL-GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLER 304 (335)
T ss_pred HHhCCCCCCCCCHH-HHH-HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhc
Confidence 99999999765432 111 11111 00 00 0012346778999999999999999
Q ss_pred CCHHHHHH
Q 003542 479 PSFSSICR 486 (811)
Q Consensus 479 PS~~eIl~ 486 (811)
|++++++.
T Consensus 305 ~s~~~~l~ 312 (335)
T PTZ00024 305 ISAKEALK 312 (335)
T ss_pred cCHHHHhc
Confidence 99999986
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=295.93 Aligned_cols=247 Identities=21% Similarity=0.335 Sum_probs=190.5
Q ss_pred HhcceEEeeeecccc---eEEEEE-EcCCEEEEEEecc------cHHHHHHHHHHHHhCCCCccceeeeeEEccCC----
Q 003542 214 LLKKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEK---- 279 (811)
Q Consensus 214 l~k~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~---- 279 (811)
+.++|++.+.||.|+ +|.+.. .+++.||||.+.. ....+.+|+.+++.++||||+++++.+...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 346899999999985 666553 3688999999853 23557789999999999999999876643221
Q ss_pred CeEEEEEecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEe
Q 003542 280 KEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVS 359 (811)
Q Consensus 280 ~~~yLVmEy~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~ 359 (811)
..+|+||||++++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||+++.++ .++|+
T Consensus 93 ~~~~lv~e~~~~~L~~~~~~-------~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~-----~~kL~ 160 (343)
T cd07851 93 QDVYLVTHLMGADLNNIVKC-------QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC-----ELKIL 160 (343)
T ss_pred ccEEEEEecCCCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-----CEEEc
Confidence 34899999998899888764 5689999999999999999999999999999999999998876 89999
Q ss_pred eccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccc
Q 003542 360 GFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQ 439 (811)
Q Consensus 360 DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~ 439 (811)
|||++...... .....++..|+|||.+.+. ..++.++|||||||++|+|++|+.||.+....
T Consensus 161 dfg~~~~~~~~----------~~~~~~~~~y~aPE~~~~~--------~~~~~~~DvwslGv~l~elltg~~pf~~~~~~ 222 (343)
T cd07851 161 DFGLARHTDDE----------MTGYVATRWYRAPEIMLNW--------MHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI 222 (343)
T ss_pred ccccccccccc----------ccCCcccccccCHHHHhCC--------CCCCchHhHHHHHHHHHHHHhCCCCCCCCChH
Confidence 99998754321 1234578889999998642 25778999999999999999999999764322
Q ss_pred hHHHHHHHHhCC---------------------------CCC---CCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHH
Q 003542 440 GDKMTKNIRAGE---------------------------RPL---FPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILR 489 (811)
Q Consensus 440 ~~~i~~~i~~~~---------------------------~~~---~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~ 489 (811)
.. ...+.... .+. .....+..+.++|.+||..||.+|||+.+|+. ..
T Consensus 223 -~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~-h~ 299 (343)
T cd07851 223 -DQ-LKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA-HP 299 (343)
T ss_pred -HH-HHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc-CC
Confidence 11 11111100 000 01234778999999999999999999999976 33
Q ss_pred HHHH
Q 003542 490 YIKK 493 (811)
Q Consensus 490 ~i~k 493 (811)
++.+
T Consensus 300 ~~~~ 303 (343)
T cd07851 300 YLAE 303 (343)
T ss_pred Cccc
Confidence 4443
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=287.58 Aligned_cols=239 Identities=19% Similarity=0.326 Sum_probs=184.9
Q ss_pred eeeecccceEEEEE-EcCCEEEEEEecc----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEecCCC-CHH
Q 003542 221 RRRLGASSQFKEIQ-WLGDSFVLRHFYG----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLS 294 (811)
Q Consensus 221 ~~~lG~G~vyk~v~-~~g~~VAVK~~~~----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~~g-~L~ 294 (811)
++..+.|.+|++.. .+|+.||||.+.. ....+.+|+.+++.++||||+++++.+. ..+..|+||||+++ +|.
T Consensus 28 lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL--VGDELWVVMEFLEGGALT 105 (292)
T ss_pred cCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEE--eCCEEEEEEecCCCCcHH
Confidence 33334444777664 4789999999842 3456889999999999999999998774 45679999999996 777
Q ss_pred HHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccccccCCCC
Q 003542 295 CYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNT 374 (811)
Q Consensus 295 ~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~~~~~ 374 (811)
+++.. ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++ .++|+|||++.......
T Consensus 106 ~~~~~-------~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~-----~~~l~dfg~~~~~~~~~--- 170 (292)
T cd06657 106 DIVTH-------TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDG-----RVKLSDFGFCAQVSKEV--- 170 (292)
T ss_pred HHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-----CEEEcccccceeccccc---
Confidence 66542 4588999999999999999999999999999999999998776 89999999876543221
Q ss_pred CCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHHHHhCCCCC
Q 003542 375 PPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPL 454 (811)
Q Consensus 375 ~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i~~~~~~~ 454 (811)
.......|++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+... ......+.....+.
T Consensus 171 ----~~~~~~~~~~~y~~pE~~~~---------~~~~~~~Dv~slGvil~el~tg~~p~~~~~~--~~~~~~~~~~~~~~ 235 (292)
T cd06657 171 ----PRRKSLVGTPYWMAPELISR---------LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMKMIRDNLPPK 235 (292)
T ss_pred ----ccccccccCccccCHHHhcC---------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhhCCcc
Confidence 11234567889999998853 3577899999999999999999999976432 22233333333222
Q ss_pred --CCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHHH
Q 003542 455 --FPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIK 492 (811)
Q Consensus 455 --~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~ 492 (811)
.....+..+.+++.+||..+|.+||++.+++. .+++.
T Consensus 236 ~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~-~~~~~ 274 (292)
T cd06657 236 LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK-HPFLA 274 (292)
T ss_pred cCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhc-ChHHh
Confidence 22456788999999999999999999999987 34433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=292.57 Aligned_cols=250 Identities=20% Similarity=0.327 Sum_probs=190.7
Q ss_pred HhcceEEeeeecccc---eEEEE-EEcCCEEEEEEeccc------HHHHHHHHHHHHhCCCCccceeeeeEEcc----CC
Q 003542 214 LLKKLMVRRRLGASS---QFKEI-QWLGDSFVLRHFYGE------LESLNAEISTMLSLSHPNIVQYLCGFCDE----EK 279 (811)
Q Consensus 214 l~k~~~i~~~lG~G~---vyk~v-~~~g~~VAVK~~~~~------~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e----~~ 279 (811)
+..+|++.+.||+|+ +|.+. ..+|+.||+|++... .+.+.+|+.++.+++||||+++++.+... ..
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 94 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence 347899999999986 66665 347899999998532 35678899999999999999999766432 22
Q ss_pred CeEEEEEecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEe
Q 003542 280 KEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVS 359 (811)
Q Consensus 280 ~~~yLVmEy~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~ 359 (811)
..+|++++++.++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||+++.++ .+||+
T Consensus 95 ~~~~lv~~~~~~~L~~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~-----~~kl~ 162 (345)
T cd07877 95 NDVYLVTHLMGADLNNIVKC-------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-----ELKIL 162 (345)
T ss_pred ccEEEEehhcccCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCC-----CEEEe
Confidence 45789999998888877653 4589999999999999999999999999999999999998876 89999
Q ss_pred eccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccc
Q 003542 360 GFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQ 439 (811)
Q Consensus 360 DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~ 439 (811)
|||++...... .....++..|+|||++.+ ...++.++|||||||++|+|++|+.||......
T Consensus 163 dfg~~~~~~~~----------~~~~~~~~~y~aPE~~~~--------~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~ 224 (345)
T cd07877 163 DFGLARHTDDE----------MTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 224 (345)
T ss_pred ccccccccccc----------ccccccCCCccCHHHHhC--------ccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99998654221 123467888999999864 235788999999999999999999999754321
Q ss_pred hHHHHHHHHh-C-----------------------CCC--C---CCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHH
Q 003542 440 GDKMTKNIRA-G-----------------------ERP--L---FPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRY 490 (811)
Q Consensus 440 ~~~i~~~i~~-~-----------------------~~~--~---~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~ 490 (811)
. .....+.. + ..+ . .....++.+.+||.+||..||.+||++.+++.+ .+
T Consensus 225 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h-~~ 302 (345)
T cd07877 225 D-QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH-AY 302 (345)
T ss_pred H-HHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC-hh
Confidence 1 11110000 0 000 0 012356779999999999999999999999874 45
Q ss_pred HHHHh
Q 003542 491 IKKFM 495 (811)
Q Consensus 491 i~k~l 495 (811)
+.++.
T Consensus 303 f~~~~ 307 (345)
T cd07877 303 FAQYH 307 (345)
T ss_pred hhhcC
Confidence 55443
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=283.03 Aligned_cols=241 Identities=22% Similarity=0.357 Sum_probs=186.4
Q ss_pred eEEeeeecccc---eEEEEE-EcCCEEEEEEecc------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEe
Q 003542 218 LMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVME 287 (811)
Q Consensus 218 ~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmE 287 (811)
|++.+.||.|+ +|++.. .+|+.+|+|.+.. ....+.+|+.+|+.++||||+++++.+. ....+|+|||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~~v~e 78 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFR--HKGDLYLVFE 78 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhc--cCCCEEEEEe
Confidence 34556677765 777664 3789999999853 2356889999999999999999997774 4467999999
Q ss_pred cCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccc
Q 003542 288 LMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTAR 367 (811)
Q Consensus 288 y~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~ 367 (811)
|++++|..++... ...+++..+..++.||+.||.|||+.+|+|+||||+||+++.++ .++|+|||.+...
T Consensus 79 ~~~~~l~~~l~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~-----~~~l~df~~~~~~ 148 (283)
T cd05118 79 FMDTDLYKLIKDR-----QRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEG-----VLKLADFGLARSF 148 (283)
T ss_pred ccCCCHHHHHHhh-----cccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCC-----cEEEeeeeeeEec
Confidence 9999998888753 14789999999999999999999999999999999999998766 8999999998765
Q ss_pred cccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHHH
Q 003542 368 TYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNI 447 (811)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i 447 (811)
.... .......++..|+|||.+.+. ..++.++||||||+++|+|++|+.||...+.. +.+....
T Consensus 149 ~~~~-------~~~~~~~~~~~~~~PE~~~~~--------~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-~~~~~~~ 212 (283)
T cd05118 149 GSPV-------RPYTHYVVTRWYRAPELLLGD--------KGYSTPVDIWSVGCIFAELLSRRPLFPGKSEI-DQLFKIF 212 (283)
T ss_pred CCCc-------ccccCccCcccccCcHHHhcC--------CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHH
Confidence 4332 011234577889999998642 25788999999999999999999999765422 1111111
Q ss_pred HhCCCC----------------------------CCCCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 448 RAGERP----------------------------LFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 448 ~~~~~~----------------------------~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
.....+ ......+.++.++|.+||..||.+||++.+++.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 213 RTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred HHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 110000 011235678999999999999999999999976
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=281.82 Aligned_cols=241 Identities=23% Similarity=0.363 Sum_probs=184.5
Q ss_pred eEEeeeecccc---eEEEEEE-cCCEEEEEEeccc-----HHHHHHHHHHHHhCC-CCccceeeeeEEccCCCeEEEEEe
Q 003542 218 LMVRRRLGASS---QFKEIQW-LGDSFVLRHFYGE-----LESLNAEISTMLSLS-HPNIVQYLCGFCDEEKKEFFLVME 287 (811)
Q Consensus 218 ~~i~~~lG~G~---vyk~v~~-~g~~VAVK~~~~~-----~~~~~~Ei~iL~~L~-HPNIVkl~~~~~~e~~~~~yLVmE 287 (811)
|++.+.||.|+ +|++... +++.||||.+... .....+|+..+++++ ||||+++++.+. .....|+|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~--~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFR--ENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhh--cCCcEEEEEe
Confidence 45667778775 7777643 6789999998542 234567999999998 999999998774 4667999999
Q ss_pred cCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccc
Q 003542 288 LMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTAR 367 (811)
Q Consensus 288 y~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~ 367 (811)
|+.|+|.+++.... ...+++..+..++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||++...
T Consensus 79 ~~~~~l~~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~-----~~~l~d~~~~~~~ 149 (283)
T cd07830 79 YMEGNLYQLMKDRK----GKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPE-----VVKIADFGLAREI 149 (283)
T ss_pred cCCCCHHHHHHhcc----cccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCC-----CEEEeecccceec
Confidence 99889998887531 24689999999999999999999999999999999999998876 8999999998755
Q ss_pred cccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHHH
Q 003542 368 TYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNI 447 (811)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i 447 (811)
.... ......++..|+|||++.. ...++.++|+||||+++|+|++|++||....... ......
T Consensus 150 ~~~~--------~~~~~~~~~~~~aPE~~~~--------~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~-~~~~~~ 212 (283)
T cd07830 150 RSRP--------PYTDYVSTRWYRAPEILLR--------STSYSSPVDIWALGCIMAELYTLRPLFPGSSEID-QLYKIC 212 (283)
T ss_pred cCCC--------CcCCCCCcccccCceeeec--------CcCcCCccchhhHHHHHHHHHhCCCccCCCChHH-HHHHHH
Confidence 3321 1123457888999999863 2357889999999999999999999997643221 111111
Q ss_pred HhCC-----------------C---C--------CCCCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 448 RAGE-----------------R---P--------LFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 448 ~~~~-----------------~---~--------~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
.... . + ......+..+.++|.+||..||.+||++.+++.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 213 SVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred HhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 0000 0 0 001123577999999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-32 Score=283.11 Aligned_cols=257 Identities=21% Similarity=0.332 Sum_probs=198.6
Q ss_pred cceEEeeeecccc---eEEEEEEc-----CCEEEEEEeccc------HHHHHHHHHHHHhCCCCccceeeeeEEccCCCe
Q 003542 216 KKLMVRRRLGASS---QFKEIQWL-----GDSFVLRHFYGE------LESLNAEISTMLSLSHPNIVQYLCGFCDEEKKE 281 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~~~-----g~~VAVK~~~~~------~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~ 281 (811)
..|+.++.||+|+ ||+++..+ ...+|||+|+.+ -....+|+.+++.|+||||+.+..+|... ...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~-d~~ 102 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH-DKK 102 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc-Cce
Confidence 4688999999997 88887432 237999999764 35678999999999999999999888643 568
Q ss_pred EEEEEecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeec
Q 003542 282 FFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGF 361 (811)
Q Consensus 282 ~yLVmEy~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DF 361 (811)
+++++||.+.||...|+-....+. ..++...+..|+.||+.|+.|||++=|+||||||.||||..+| ..+-.|||+||
T Consensus 103 v~l~fdYAEhDL~~II~fHr~~~~-~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdg-perG~VKIaDl 180 (438)
T KOG0666|consen 103 VWLLFDYAEHDLWHIIKFHRASKA-KQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDG-PERGRVKIADL 180 (438)
T ss_pred EEEEehhhhhhHHHHHHHhccchh-ccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccC-CccCeeEeecc
Confidence 999999999999998876544433 5789999999999999999999999999999999999999886 33449999999
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccc--
Q 003542 362 GLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQ-- 439 (811)
Q Consensus 362 GlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~-- 439 (811)
|+++.+...-.. .......+-|.+|.|||.+.| ...||.+.||||.|||+.||++-.+.|.+....
T Consensus 181 GlaR~~~~plkp----l~s~d~VVVTiWYRAPELLLG--------a~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~ 248 (438)
T KOG0666|consen 181 GLARLFNNPLKP----LASLDPVVVTIWYRAPELLLG--------ARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIK 248 (438)
T ss_pred cHHHHhhccccc----cccCCceEEEEEecChHHhcc--------cccccchhhhHHHHHHHHHHHccCccccchhhhcc
Confidence 999987654321 223345678999999999997 458999999999999999999998888653111
Q ss_pred ------hHHHHHHHHh-CCC-----C---CCCC--------------------------CChHHHHHHHhhhccCCCCCC
Q 003542 440 ------GDKMTKNIRA-GER-----P---LFPS--------------------------GSPKYLVNLTKKCWHTNPSQR 478 (811)
Q Consensus 440 ------~~~i~~~i~~-~~~-----~---~~p~--------------------------~~~~~l~~LI~~cL~~DP~~R 478 (811)
.+++.+...- |.+ | .+|+ .-++...+|+.+||.+||.+|
T Consensus 249 ~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kR 328 (438)
T KOG0666|consen 249 TKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKR 328 (438)
T ss_pred cCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhh
Confidence 1111111110 100 0 0010 112337899999999999999
Q ss_pred CCHHHHHHH
Q 003542 479 PSFSSICRI 487 (811)
Q Consensus 479 PS~~eIl~~ 487 (811)
.|++++++.
T Consensus 329 Ita~qAleh 337 (438)
T KOG0666|consen 329 ITAEQALEH 337 (438)
T ss_pred ccHHHHhcc
Confidence 999999873
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=281.20 Aligned_cols=235 Identities=18% Similarity=0.273 Sum_probs=178.4
Q ss_pred cceEEeeee--cccc---eEEEE-EEcCCEEEEEEeccc-HHHHHHHHHHHHhC-CCCccceeeeeEEccCCCeEEEEEe
Q 003542 216 KKLMVRRRL--GASS---QFKEI-QWLGDSFVLRHFYGE-LESLNAEISTMLSL-SHPNIVQYLCGFCDEEKKEFFLVME 287 (811)
Q Consensus 216 k~~~i~~~l--G~G~---vyk~v-~~~g~~VAVK~~~~~-~~~~~~Ei~iL~~L-~HPNIVkl~~~~~~e~~~~~yLVmE 287 (811)
++|.+.+.+ |.|+ ||.+. ..+|..+|+|.+... ... .|+.....+ +||||+++++.+.. .+.+|+|||
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--~e~~~~~~~~~h~~iv~~~~~~~~--~~~~~iv~e 89 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--IEPMVHQLMKDNPNFIKLYYSVTT--LKGHVLIMD 89 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--hhHHHHHHhhcCCCEEEEEEEEec--CCeeEEEEE
Confidence 455555544 7774 66655 347889999998642 111 133333323 79999999988753 457999999
Q ss_pred cCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccccc
Q 003542 288 LMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366 (811)
Q Consensus 288 y~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~ 366 (811)
|++ ++|.+++... ..+++..++.++.||+.||.|||+.|++||||||+||+++.++. .++|+|||++..
T Consensus 90 ~~~~~~L~~~l~~~------~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~----~~~l~dfg~~~~ 159 (267)
T PHA03390 90 YIKDGDLFDLLKKE------GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKD----RIYLCDYGLCKI 159 (267)
T ss_pred cCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCC----eEEEecCcccee
Confidence 998 5999988753 47899999999999999999999999999999999999987642 799999999875
Q ss_pred ccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchH---HH
Q 003542 367 RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGD---KM 443 (811)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~---~i 443 (811)
.... ....++..|+|||++.+. .++.++||||||+++|+|++|..||........ .+
T Consensus 160 ~~~~-----------~~~~~~~~y~aPE~~~~~---------~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~ 219 (267)
T PHA03390 160 IGTP-----------SCYDGTLDYFSPEKIKGH---------NYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESL 219 (267)
T ss_pred cCCC-----------ccCCCCCcccChhhhcCC---------CCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHH
Confidence 5321 133578889999999643 577899999999999999999999975432221 11
Q ss_pred HHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCC-HHHHHH
Q 003542 444 TKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPS-FSSICR 486 (811)
Q Consensus 444 ~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS-~~eIl~ 486 (811)
.... ......+...++.+.++|.+||+.+|.+||+ ++++++
T Consensus 220 ~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 220 LKRQ--QKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred HHhh--cccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 1111 2233445578899999999999999999996 688875
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=281.81 Aligned_cols=242 Identities=25% Similarity=0.346 Sum_probs=182.7
Q ss_pred eEEeeeecccc---eEEEEEE-cCCEEEEEEecc------cHHHHHHHHHHHHhC---CCCccceeeeeEEccCC---Ce
Q 003542 218 LMVRRRLGASS---QFKEIQW-LGDSFVLRHFYG------ELESLNAEISTMLSL---SHPNIVQYLCGFCDEEK---KE 281 (811)
Q Consensus 218 ~~i~~~lG~G~---vyk~v~~-~g~~VAVK~~~~------~~~~~~~Ei~iL~~L---~HPNIVkl~~~~~~e~~---~~ 281 (811)
|++.+.||.|+ +|++... +|+.||+|.+.. ....+.+|+.+++++ +||||+++++.+...+. ..
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 45677777774 7777654 589999999952 124567788887766 59999999987754321 23
Q ss_pred EEEEEecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeec
Q 003542 282 FFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGF 361 (811)
Q Consensus 282 ~yLVmEy~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DF 361 (811)
++++|||+.++|.+++.... ...+++..++.++.||+.||.|||+.+++|+||+|+||+++.++ .+||+||
T Consensus 81 ~~l~~e~~~~~l~~~l~~~~----~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~-----~~~l~df 151 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKCP----KPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDG-----QVKIADF 151 (287)
T ss_pred eEEEehhcccCHHHHHHHcc----CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCC-----CEEEecc
Confidence 89999999999988886531 13589999999999999999999999999999999999998876 8999999
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchH
Q 003542 362 GLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGD 441 (811)
Q Consensus 362 GlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~ 441 (811)
|++....... ......++..|+|||++.+. .++.++|||||||++|+|++|.+||.+.... +
T Consensus 152 g~~~~~~~~~--------~~~~~~~~~~~~~PE~~~~~---------~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~-~ 213 (287)
T cd07838 152 GLARIYSFEM--------ALTSVVVTLWYRAPEVLLQS---------SYATPVDMWSVGCIFAELFRRRPLFRGTSEA-D 213 (287)
T ss_pred CcceeccCCc--------ccccccccccccChHHhccC---------CCCCcchhhhHHHHHHHHHhCCCcccCCChH-H
Confidence 9987654321 11233578889999999643 5778999999999999999999999764422 1
Q ss_pred HHHHHHHhCCC--------------CCC-----------CCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 442 KMTKNIRAGER--------------PLF-----------PSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 442 ~i~~~i~~~~~--------------~~~-----------p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
.+......... ..+ ....+..+.++|.+||+.||.+||++.+++.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 214 QLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred HHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 11111110000 000 0123567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-32 Score=307.01 Aligned_cols=234 Identities=26% Similarity=0.409 Sum_probs=190.4
Q ss_pred hcceEEeeeecccceEEEE-----EEcCCEEEEEEecccHHHHHHHHHHHHhC-CCCccceeeeeEEccCCCeEEEEEec
Q 003542 215 LKKLMVRRRLGASSQFKEI-----QWLGDSFVLRHFYGELESLNAEISTMLSL-SHPNIVQYLCGFCDEEKKEFFLVMEL 288 (811)
Q Consensus 215 ~k~~~i~~~lG~G~vyk~v-----~~~g~~VAVK~~~~~~~~~~~Ei~iL~~L-~HPNIVkl~~~~~~e~~~~~yLVmEy 288 (811)
...|.+...+|.|+ |+++ ..+++.+|+|++.+......+|+.++... +||||+++++.+ .+..+.|+|||+
T Consensus 321 ~~~y~~~~~~~~gs-~s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~--~~~~~~~~v~e~ 397 (612)
T KOG0603|consen 321 TESYEFREELGEGS-FSAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVY--EDGKEIYLVMEL 397 (612)
T ss_pred chhhccccccCCCC-ccceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeeccee--cCCceeeeeehh
Confidence 35788888899993 4444 34889999999987767778899887777 799999999887 677889999999
Q ss_pred CCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEe-ccCCCCcceEEEeecccccc
Q 003542 289 MSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLK-ARSMEGYFHVKVSGFGLSTA 366 (811)
Q Consensus 289 ~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~-~~g~d~~~~vKL~DFGlA~~ 366 (811)
+.| .|.+.+... ..+. ..+..|+.+|+.|+.|||.+|+|||||||+|||++ ..+ +++|+|||.++.
T Consensus 398 l~g~ell~ri~~~------~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g-----~lrltyFG~a~~ 465 (612)
T KOG0603|consen 398 LDGGELLRRIRSK------PEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAG-----HLRLTYFGFWSE 465 (612)
T ss_pred ccccHHHHHHHhc------chhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCC-----cEEEEEechhhh
Confidence 996 555555542 2233 78889999999999999999999999999999995 554 899999999876
Q ss_pred ccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHH
Q 003542 367 RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKN 446 (811)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~ 446 (811)
.... ..+.+-|..|.|||++... .|+++|||||||++||+||+|+.||..... ..++...
T Consensus 466 ~~~~----------~~tp~~t~~y~APEvl~~~---------~yt~acD~WSLGvlLy~ML~G~tp~~~~P~-~~ei~~~ 525 (612)
T KOG0603|consen 466 LERS----------CDTPALTLQYVAPEVLAIQ---------EYTEACDWWSLGVLLYEMLTGRTLFAAHPA-GIEIHTR 525 (612)
T ss_pred Cchh----------hcccchhhcccChhhhccC---------CCCcchhhHHHHHHHHHHHhCCCccccCCc-hHHHHHh
Confidence 5433 1244567889999999844 789999999999999999999999976433 3455555
Q ss_pred HHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 447 IRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 447 i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
+..+ .+....+...++||.+||+.||.+||++.++..
T Consensus 526 i~~~---~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 526 IQMP---KFSECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred hcCC---ccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 5443 345788999999999999999999999999976
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=276.18 Aligned_cols=237 Identities=24% Similarity=0.409 Sum_probs=183.6
Q ss_pred cccceEEEEEE-cCCEEEEEEecc-------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEecCCC-CHHH
Q 003542 225 GASSQFKEIQW-LGDSFVLRHFYG-------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSC 295 (811)
Q Consensus 225 G~G~vyk~v~~-~g~~VAVK~~~~-------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~~g-~L~~ 295 (811)
+.|.+|.+... +|+.||+|.+.. ..+.+.+|++++++++||||+++++.+ .....+|+||||+++ +|.+
T Consensus 5 ~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~--~~~~~~~lv~e~~~~~~L~~ 82 (265)
T cd05579 5 AYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF--QGKKNLYLVMEYLPGGDLAS 82 (265)
T ss_pred CceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhe--ecCcEEEEEEecCCCCcHHH
Confidence 34448887754 599999999853 245789999999999999999998776 456679999999985 8988
Q ss_pred HHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccccccCCCC-
Q 003542 296 YMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNT- 374 (811)
Q Consensus 296 ~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~~~~~- 374 (811)
++... ..+++..++.++.||+.||.|||+.+++||||+|+||+++.++ .++|+|||++..........
T Consensus 83 ~l~~~------~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~-----~~~l~dfg~~~~~~~~~~~~~ 151 (265)
T cd05579 83 LLENV------GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNG-----HLKLTDFGLSKVGLVRRQINL 151 (265)
T ss_pred HHHHc------CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCC-----CEEEEecccchhcccCccccc
Confidence 88753 4689999999999999999999999999999999999998876 89999999987543221100
Q ss_pred CCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHHHHhCCCCC
Q 003542 375 PPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPL 454 (811)
Q Consensus 375 ~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i~~~~~~~ 454 (811)
...........++..|+|||.+... .++.++||||||+++|+|++|..||.... .......+..+. ..
T Consensus 152 ~~~~~~~~~~~~~~~~~~Pe~~~~~---------~~~~~~Dv~slG~~~~~l~~g~~p~~~~~--~~~~~~~~~~~~-~~ 219 (265)
T cd05579 152 NDDEKEDKRIVGTPDYIAPEVILGQ---------GHSKTVDWWSLGCILYEFLVGIPPFHGET--PEEIFQNILNGK-IE 219 (265)
T ss_pred ccccccccCcccCccccCHHHhcCC---------CCCcchhhHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHhcCC-cC
Confidence 0000112344577889999998643 47789999999999999999999997654 233344444433 23
Q ss_pred CCCCC--hHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 455 FPSGS--PKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 455 ~p~~~--~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
.+..+ +..+.+++.+||+.+|.+||++..+.+
T Consensus 220 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~ 253 (265)
T cd05579 220 WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEE 253 (265)
T ss_pred CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHH
Confidence 44444 889999999999999999999944444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=289.35 Aligned_cols=241 Identities=20% Similarity=0.323 Sum_probs=186.7
Q ss_pred hcceEEeeeecccc---eEEEE-EEcCCEEEEEEecc------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEE
Q 003542 215 LKKLMVRRRLGASS---QFKEI-QWLGDSFVLRHFYG------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFL 284 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v-~~~g~~VAVK~~~~------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yL 284 (811)
.++|++.+.||.|+ +|++. ..+|+.||||.+.. ..+.+.+|+.+++.++||||+++++.|.. ....+|+
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~~l 87 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFIS-PLEDIYF 87 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEec-CCCcEEE
Confidence 46799999999885 67665 34899999998742 34678899999999999999999977753 3456899
Q ss_pred EEecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccc
Q 003542 285 VMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS 364 (811)
Q Consensus 285 VmEy~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA 364 (811)
||||++++|..++.. ..+++..+..++.||+.||.|||+.+|+||||+|+|||++.++ .++|+|||++
T Consensus 88 v~e~~~~~L~~~~~~-------~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~-----~~~l~dfg~~ 155 (328)
T cd07856 88 VTELLGTDLHRLLTS-------RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENC-----DLKICDFGLA 155 (328)
T ss_pred EeehhccCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCC-----CEEeCccccc
Confidence 999998898887753 4688888999999999999999999999999999999998776 8999999998
Q ss_pred ccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchH---
Q 003542 365 TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGD--- 441 (811)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~--- 441 (811)
...... .....++..|+|||++.+ ...++.++||||||+++|+|++|..||........
T Consensus 156 ~~~~~~----------~~~~~~~~~y~aPE~~~~--------~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~ 217 (328)
T cd07856 156 RIQDPQ----------MTGYVSTRYYRAPEIMLT--------WQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSI 217 (328)
T ss_pred cccCCC----------cCCCcccccccCceeeec--------cCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 643221 123456788999998753 23578899999999999999999999976432110
Q ss_pred ----------HHHHH---------HHhC-CCCCC-----CCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 442 ----------KMTKN---------IRAG-ERPLF-----PSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 442 ----------~i~~~---------i~~~-~~~~~-----p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
+.... +... ..... ....+..+.++|.+||..+|.+||++++++.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~ 287 (328)
T cd07856 218 ITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA 287 (328)
T ss_pred HHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000 0000 00011 1245678999999999999999999999876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=287.99 Aligned_cols=262 Identities=22% Similarity=0.429 Sum_probs=204.6
Q ss_pred HHhcceEEeeeecccceEEEE---EEcCCEEEEEEecc-cHHHHHHHHHHHHhC--CCCccceeeeeEEccCC--CeEEE
Q 003542 213 MLLKKLMVRRRLGASSQFKEI---QWLGDSFVLRHFYG-ELESLNAEISTMLSL--SHPNIVQYLCGFCDEEK--KEFFL 284 (811)
Q Consensus 213 ~l~k~~~i~~~lG~G~vyk~v---~~~g~~VAVK~~~~-~~~~~~~Ei~iL~~L--~HPNIVkl~~~~~~e~~--~~~yL 284 (811)
.+.+...+.+.+|+| .|+++ +|.|+.||||+|.. +...+.+|.+|.+.+ +|+||+.|+.+-...++ ..+||
T Consensus 208 TiarqI~L~e~IGkG-RyGEVwrG~wrGe~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwL 286 (513)
T KOG2052|consen 208 TIARQIVLQEIIGKG-RFGEVWRGRWRGEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWL 286 (513)
T ss_pred hhhheeEEEEEecCc-cccceeeccccCCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEE
Confidence 456789999999999 79888 68999999999975 677899999999875 99999999854432222 46899
Q ss_pred EEecCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CceeccCCCCcEEEeccCCCCcce
Q 003542 285 VMELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQ--------KIYHGELNPSNIYLKARSMEGYFH 355 (811)
Q Consensus 285 VmEy~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~--------gIVHRDLKPsNILI~~~g~d~~~~ 355 (811)
|++|.+ |+|++||.. ..++....+.++..++.||+|||-. .|.|||||+.||||..++ .
T Consensus 287 vTdYHe~GSL~DyL~r-------~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~-----~ 354 (513)
T KOG2052|consen 287 VTDYHEHGSLYDYLNR-------NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-----T 354 (513)
T ss_pred eeecccCCcHHHHHhh-------ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCC-----c
Confidence 999999 899999986 6799999999999999999999963 399999999999999988 8
Q ss_pred EEEeeccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhC------
Q 003542 356 VKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTG------ 429 (811)
Q Consensus 356 vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG------ 429 (811)
+-|+|+|||.......... -...+..+||-.|||||+|....... ...--..+||||||.|+||++..
T Consensus 355 C~IADLGLAv~h~~~t~~i---di~~N~rVGTKRYMAPEvLdetin~~---~Fesyk~ADIYafgLVlWEiarRc~~ggi 428 (513)
T KOG2052|consen 355 CCIADLGLAVRHDSDTDTI---DIPPNPRVGTKRYMAPEVLDETINMK---HFESYKRADIYAFGLVLWEIARRCESGGI 428 (513)
T ss_pred EEEeeceeeEEecccCCcc---cCCCCCccceeeccChHHhhhhcChh---hhhhhhHHHHHHHHHHHHHHHHHhhcCCE
Confidence 9999999997766553221 22346789999999999997653221 11223468999999999999862
Q ss_pred ----CCCCCCC---ccchHHHHHHHHh-CCCCCCCCCCh-----HHHHHHHhhhccCCCCCCCCHHHHHHHHHHHHH
Q 003542 430 ----KVPFEDG---HLQGDKMTKNIRA-GERPLFPSGSP-----KYLVNLTKKCWHTNPSQRPSFSSICRILRYIKK 493 (811)
Q Consensus 430 ----~~PF~~~---~~~~~~i~~~i~~-~~~~~~p~~~~-----~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~k 493 (811)
++||.+. +.+.+++.+.+.. ..+|.+|..+. ..+.+|++.||..+|.-|.|+-.|.+.|..+.+
T Consensus 429 ~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 429 VEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred ehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 5788753 3334555554433 34566664332 247889999999999999999888887776653
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-32 Score=289.09 Aligned_cols=233 Identities=24% Similarity=0.413 Sum_probs=196.9
Q ss_pred hcceEEeeeecccceEEEEEE-----cCCEEEEEEecc-------cHHHHHHHHHHHHhC-CCCccceeeeeEEccCCCe
Q 003542 215 LKKLMVRRRLGASSQFKEIQW-----LGDSFVLRHFYG-------ELESLNAEISTMLSL-SHPNIVQYLCGFCDEEKKE 281 (811)
Q Consensus 215 ~k~~~i~~~lG~G~vyk~v~~-----~g~~VAVK~~~~-------~~~~~~~Ei~iL~~L-~HPNIVkl~~~~~~e~~~~ 281 (811)
..+|.++..||+|+ |+.++. +.+.||||++++ +.+--..|-++|... +-|.+++++..| ++-+.
T Consensus 348 ~tDFnFl~VlGKGS-FGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScF--QTmDR 424 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGS-FGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCF--QTMDR 424 (683)
T ss_pred ecccceEEEeccCc-cceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHh--hhhhh
Confidence 45889999999995 555533 567899999975 345567788888776 578999998777 56677
Q ss_pred EEEEEecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEee
Q 003542 282 FFLVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSG 360 (811)
Q Consensus 282 ~yLVmEy~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~D 360 (811)
+|+||||+.| +|.-++.+. +.|.+..+..|+.+|+-||-|||++||++||||.+|||++.+| ++||+|
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~------GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eG-----HiKi~D 493 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQV------GKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEG-----HIKIAD 493 (683)
T ss_pred eeeEEEEecCchhhhHHHHh------cccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCC-----ceEeee
Confidence 9999999995 888888776 7899999999999999999999999999999999999999988 999999
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccch
Q 003542 361 FGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQG 440 (811)
Q Consensus 361 FGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~ 440 (811)
||+++.-... .....+.+||+.|+|||++..+ .|+..+|+|||||+||||+.|++||++. ++
T Consensus 494 FGmcKEni~~-------~~TTkTFCGTPdYiAPEIi~Yq---------PYgksvDWWa~GVLLyEmlaGQpPFdGe--DE 555 (683)
T KOG0696|consen 494 FGMCKENIFD-------GVTTKTFCGTPDYIAPEIIAYQ---------PYGKSVDWWAFGVLLYEMLAGQPPFDGE--DE 555 (683)
T ss_pred cccccccccC-------CcceeeecCCCcccccceEEec---------ccccchhHHHHHHHHHHHHcCCCCCCCC--CH
Confidence 9999754332 2244578999999999999754 7889999999999999999999999985 45
Q ss_pred HHHHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCC
Q 003542 441 DKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPS 480 (811)
Q Consensus 441 ~~i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS 480 (811)
+++++.|.... ..+|...+.+..+++...|...|.+|..
T Consensus 556 ~elF~aI~ehn-vsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 556 DELFQAIMEHN-VSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred HHHHHHHHHcc-CcCcccccHHHHHHHHHHhhcCCccccC
Confidence 57777776643 4588999999999999999999999964
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=271.96 Aligned_cols=225 Identities=24% Similarity=0.365 Sum_probs=183.0
Q ss_pred ccceEEEEEE-cCCEEEEEEecc-------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEecCC-CCHHHH
Q 003542 226 ASSQFKEIQW-LGDSFVLRHFYG-------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMS-KDLSCY 296 (811)
Q Consensus 226 ~G~vyk~v~~-~g~~VAVK~~~~-------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~~-g~L~~~ 296 (811)
.|.+|.+... .++.||+|.+.. ....+..|+.+++.++||||+++++.+ +....+|+||||++ ++|.++
T Consensus 6 ~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~~v~e~~~~~~L~~~ 83 (250)
T cd05123 6 FGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAF--QTEEKLYLVLEYAPGGELFSH 83 (250)
T ss_pred ceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHe--ecCCeeEEEEecCCCCcHHHH
Confidence 3347776643 589999999853 345789999999999999999999777 45677999999996 699988
Q ss_pred HHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccccccCCCCCC
Q 003542 297 MRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTPP 376 (811)
Q Consensus 297 L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~~~~~~~ 376 (811)
+... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++ .++|+|||++.......
T Consensus 84 l~~~------~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~-----~~~l~d~~~~~~~~~~~----- 147 (250)
T cd05123 84 LSKE------GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADG-----HIKLTDFGLAKELSSEG----- 147 (250)
T ss_pred HHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCC-----cEEEeecCcceecccCC-----
Confidence 8753 4689999999999999999999999999999999999998876 89999999987654321
Q ss_pred CCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHHHHhCCCCCCC
Q 003542 377 ASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFP 456 (811)
Q Consensus 377 ~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i~~~~~~~~p 456 (811)
.......++..|+|||.+.+. .++.++|+||||+++|+|++|..||..... ......+.. ....++
T Consensus 148 --~~~~~~~~~~~~~~Pe~~~~~---------~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--~~~~~~~~~-~~~~~~ 213 (250)
T cd05123 148 --SRTNTFCGTPEYLAPEVLLGK---------GYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--KEIYEKILK-DPLRFP 213 (250)
T ss_pred --CcccCCcCCccccChHHhCCC---------CCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHhc-CCCCCC
Confidence 112345678889999998643 467899999999999999999999975432 333444443 345577
Q ss_pred CCChHHHHHHHhhhccCCCCCCCCHH
Q 003542 457 SGSPKYLVNLTKKCWHTNPSQRPSFS 482 (811)
Q Consensus 457 ~~~~~~l~~LI~~cL~~DP~~RPS~~ 482 (811)
...+..+.+++.+||..||.+||++.
T Consensus 214 ~~~~~~l~~~i~~~l~~~p~~R~~~~ 239 (250)
T cd05123 214 EFLSPEARDLISGLLQKDPTKRLGSG 239 (250)
T ss_pred CCCCHHHHHHHHHHhcCCHhhCCCcc
Confidence 77889999999999999999999994
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-32 Score=310.29 Aligned_cols=243 Identities=26% Similarity=0.443 Sum_probs=187.0
Q ss_pred eeecccc----eEEEEEEcCCEEEEEEecccH-HHHHHHHHHHHhC-CCCccceeeeeEEccCCCeEEEEEecCCCCHHH
Q 003542 222 RRLGASS----QFKEIQWLGDSFVLRHFYGEL-ESLNAEISTMLSL-SHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSC 295 (811)
Q Consensus 222 ~~lG~G~----vyk~v~~~g~~VAVK~~~~~~-~~~~~Ei~iL~~L-~HPNIVkl~~~~~~e~~~~~yLVmEy~~g~L~~ 295 (811)
+.+|.|+ ||++ .+.|+.||||.+-.+. +...+||..|+.- +|||||++|+.- .+....||+.|+|..+|.+
T Consensus 515 eilG~Gs~Gt~Vf~G-~ye~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E--~d~qF~YIalELC~~sL~d 591 (903)
T KOG1027|consen 515 EILGYGSNGTVVFRG-VYEGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSE--QDRQFLYIALELCACSLQD 591 (903)
T ss_pred HHcccCCCCcEEEEE-eeCCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeec--cCCceEEEEehHhhhhHHH
Confidence 3455554 7774 4789999999997654 4679999999988 599999988443 5667899999999999999
Q ss_pred HHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccccccCCCCC
Q 003542 296 YMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTP 375 (811)
Q Consensus 296 ~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~~~~~~ 375 (811)
++... .. ..........+.++.|+++||++||+.+||||||||.||||+....++...++|+|||+++.+......
T Consensus 592 lie~~-~~-d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS-- 667 (903)
T KOG1027|consen 592 LIESS-GL-DVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSS-- 667 (903)
T ss_pred HHhcc-cc-chhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcch--
Confidence 99763 10 001111145688899999999999999999999999999998865566679999999999988766432
Q ss_pred CCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CCCCCCCCccchHHHHHHHHhCCCCC
Q 003542 376 PASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGDKMTKNIRAGERPL 454 (811)
Q Consensus 376 ~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~~PF~~~~~~~~~i~~~i~~~~~~~ 454 (811)
.....+..||.+|+|||++... .-+.++|||||||++|+.++ |.+||.+.... ..+|..+....
T Consensus 668 --~~r~s~~sGt~GW~APE~L~~~---------~~~~avDiFslGCvfyYvltgG~HpFGd~~~R----~~NIl~~~~~L 732 (903)
T KOG1027|consen 668 --FSRLSGGSGTSGWQAPEQLRED---------RKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER----QANILTGNYTL 732 (903)
T ss_pred --hhcccCCCCcccccCHHHHhcc---------ccCcccchhhcCceEEEEecCCccCCCchHHh----hhhhhcCccce
Confidence 2234577899999999999865 34568999999999999999 59999764322 23444444322
Q ss_pred CCCCC--hHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 455 FPSGS--PKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 455 ~p~~~--~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
..-.. ..+..+||.+|+++||..||++.+++.
T Consensus 733 ~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 733 VHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred eeeccCchHHHHHHHHHhcCCCcccCCCHHHHhC
Confidence 21111 117899999999999999999999975
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-31 Score=277.96 Aligned_cols=241 Identities=26% Similarity=0.384 Sum_probs=184.4
Q ss_pred eEEeeeecccc---eEEEEEE-cCCEEEEEEeccc------HHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEe
Q 003542 218 LMVRRRLGASS---QFKEIQW-LGDSFVLRHFYGE------LESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVME 287 (811)
Q Consensus 218 ~~i~~~lG~G~---vyk~v~~-~g~~VAVK~~~~~------~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmE 287 (811)
|++.+.||.|. +|.+... +++.||+|.+... .+.+..|+.+++.++||||+++++.+. +...+|+|||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~~v~e 78 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIH--TERKLYLVFE 78 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhh--cCCceEEEec
Confidence 34556677764 7776644 6899999998642 356788999999999999999997764 4467999999
Q ss_pred cCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccc
Q 003542 288 LMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTAR 367 (811)
Q Consensus 288 y~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~ 367 (811)
|++++|.+++.... ..+++..+..++.|++.||.|||+.||+||||+|+||+++.++ .++|+|||++...
T Consensus 79 ~~~~~l~~~i~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~-----~~~l~d~g~~~~~ 148 (282)
T cd07829 79 YCDMDLKKYLDKRP-----GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDG-----VLKLADFGLARAF 148 (282)
T ss_pred CcCcCHHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCC-----CEEEecCCccccc
Confidence 99999999887631 4689999999999999999999999999999999999998876 8999999998765
Q ss_pred cccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHHH
Q 003542 368 TYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNI 447 (811)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i 447 (811)
..... ......++..|+|||.+.+. ..++.++|||||||++|+|++|.+||....... .+....
T Consensus 149 ~~~~~-------~~~~~~~~~~~~aPE~~~~~--------~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~-~~~~~~ 212 (282)
T cd07829 149 GIPLR-------TYTHEVVTLWYRAPEILLGS--------KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEID-QLFKIF 212 (282)
T ss_pred CCCcc-------ccCccccCcCcCChHHhcCC--------cCCCccccHHHHHHHHHHHHhCCCCCCCccHHH-HHHHHH
Confidence 43211 11233456789999998642 267889999999999999999999997643221 111100
Q ss_pred H-------------------hCCCCCC--------CCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 448 R-------------------AGERPLF--------PSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 448 ~-------------------~~~~~~~--------p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
. ....+.+ ....+..+.++|.+||..||.+||++.+++.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 213 QILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred HHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0 0000000 0123667999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=307.39 Aligned_cols=252 Identities=24% Similarity=0.477 Sum_probs=202.1
Q ss_pred cceEEeeeecccc---eEEEEEE----c----CCEEEEEEecc-----cHHHHHHHHHHHHhC-CCCccceeeeeEEccC
Q 003542 216 KKLMVRRRLGASS---QFKEIQW----L----GDSFVLRHFYG-----ELESLNAEISTMLSL-SHPNIVQYLCGFCDEE 278 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~~----~----g~~VAVK~~~~-----~~~~~~~Ei~iL~~L-~HPNIVkl~~~~~~e~ 278 (811)
+++.+.+.+|.|. |+++... . ...||||.++. +.+.+..|+++|+.+ .||||+.+++++..
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~-- 373 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ-- 373 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc--
Confidence 3445566788874 4444421 1 45799999964 567899999999999 69999999965533
Q ss_pred CCeEEEEEecCC-CCHHHHHHHhh---CCCCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEec
Q 003542 279 KKEFFLVMELMS-KDLSCYMRETF---GSRRR-------NSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKA 347 (811)
Q Consensus 279 ~~~~yLVmEy~~-g~L~~~L~~~~---~~~~~-------~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~ 347 (811)
+..+++|+|||. |+|..||+... ..... ..++....+.++.||+.||+||++.++|||||-..|||+..
T Consensus 374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~ 453 (609)
T KOG0200|consen 374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITK 453 (609)
T ss_pred CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecC
Confidence 667999999999 79999999864 00000 23888999999999999999999999999999999999987
Q ss_pred cCCCCcceEEEeeccccccccccCCCCCCCCCCCCCCC--CCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHH
Q 003542 348 RSMEGYFHVKVSGFGLSTARTYASRNTPPASPQNQTAP--NPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFE 425 (811)
Q Consensus 348 ~g~d~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~--GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyE 425 (811)
+. .+||+|||+|+........ ...... -+..|||||.+.. ..|+.++|||||||+|||
T Consensus 454 ~~-----~~kIaDFGlar~~~~~~~y------~~~~~~~~LP~kWmApEsl~~---------~~ft~kSDVWSfGI~L~E 513 (609)
T KOG0200|consen 454 NK-----VIKIADFGLARDHYNKDYY------RTKSSAGTLPVKWMAPESLFD---------RVFTSKSDVWSFGILLWE 513 (609)
T ss_pred CC-----EEEEccccceeccCCCCce------EecCCCCccceeecCHHHhcc---------CcccccchhhHHHHHHHH
Confidence 75 8999999999854332211 101112 3456999999974 389999999999999999
Q ss_pred Hhh-CCCCCCCCccchHHHHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHH
Q 003542 426 LLT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRY 490 (811)
Q Consensus 426 Llt-G~~PF~~~~~~~~~i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~ 490 (811)
|++ |..||.+... ...+.+.+..|.+...|..|++++.++++.||+.+|.+||+|.++.+.+..
T Consensus 514 ifsLG~~PYp~~~~-~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~ 578 (609)
T KOG0200|consen 514 IFTLGGTPYPGIPP-TEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK 578 (609)
T ss_pred HhhCCCCCCCCCCc-HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence 999 9999987432 334467899999999999999999999999999999999999999888776
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=309.07 Aligned_cols=138 Identities=19% Similarity=0.403 Sum_probs=118.8
Q ss_pred hcceEEeeeecccc---eEEEEEE-cCCEEEEEEeccc-------HHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEE
Q 003542 215 LKKLMVRRRLGASS---QFKEIQW-LGDSFVLRHFYGE-------LESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFF 283 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~~-~g~~VAVK~~~~~-------~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~y 283 (811)
+++|.+++.||.|+ ||.+... .++.||||++... ...+..|+.++..++||||+++++.+ .....+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~--~~~~~~~ 80 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL--QSANNVY 80 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEE--EECCEEE
Confidence 46799999999986 6665543 6899999999642 36789999999999999999999666 4456799
Q ss_pred EEEecCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecc
Q 003542 284 LVMELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFG 362 (811)
Q Consensus 284 LVmEy~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFG 362 (811)
|||||+. ++|.+++... ..+++..++.|+.||+.||.|||.++|+||||||+||||+.++ .+||+|||
T Consensus 81 lVmEy~~g~~L~~li~~~------~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g-----~vkL~DFG 149 (669)
T cd05610 81 LVMEYLIGGDVKSLLHIY------GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEG-----HIKLTDFG 149 (669)
T ss_pred EEEeCCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCC-----CEEEEeCC
Confidence 9999998 5898888653 5688999999999999999999999999999999999998776 89999999
Q ss_pred ccc
Q 003542 363 LST 365 (811)
Q Consensus 363 lA~ 365 (811)
+++
T Consensus 150 ls~ 152 (669)
T cd05610 150 LSK 152 (669)
T ss_pred CCc
Confidence 986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=286.88 Aligned_cols=257 Identities=22% Similarity=0.371 Sum_probs=197.2
Q ss_pred cceEEeeeecccceEEEE---EEcCCEEEEEEecc-cHHHHHHHHHHHHhC--CCCccceeeeeEE--ccCCCeEEEEEe
Q 003542 216 KKLMVRRRLGASSQFKEI---QWLGDSFVLRHFYG-ELESLNAEISTMLSL--SHPNIVQYLCGFC--DEEKKEFFLVME 287 (811)
Q Consensus 216 k~~~i~~~lG~G~vyk~v---~~~g~~VAVK~~~~-~~~~~~~Ei~iL~~L--~HPNIVkl~~~~~--~e~~~~~yLVmE 287 (811)
+.+++...+|+| .|+.+ .++++.||||+|.. +.+.|.+|-+|.+.. +|+||++|+++-- +.....++||+|
T Consensus 210 ~pl~l~eli~~G-rfg~V~KaqL~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~ 288 (534)
T KOG3653|consen 210 DPLQLLELIGRG-RFGCVWKAQLDNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTE 288 (534)
T ss_pred CchhhHHHhhcC-ccceeehhhccCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEee
Confidence 455666677777 34444 46889999999974 677899999888765 8999999984431 112347999999
Q ss_pred cCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CceeccCCCCcEEEeccCCCCcceEE
Q 003542 288 LMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQ---------KIYHGELNPSNIYLKARSMEGYFHVK 357 (811)
Q Consensus 288 y~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~---------gIVHRDLKPsNILI~~~g~d~~~~vK 357 (811)
|.+ |+|.+||+. ..++|....+++..+++||+|||.. .|+|||||+.||||..+. .+.
T Consensus 289 fh~kGsL~dyL~~-------ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~Dl-----Tcc 356 (534)
T KOG3653|consen 289 FHPKGSLCDYLKA-------NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDL-----TCC 356 (534)
T ss_pred eccCCcHHHHHHh-------ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCC-----cEE
Confidence 999 899999987 6799999999999999999999973 499999999999998887 899
Q ss_pred EeeccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCC-------
Q 003542 358 VSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGK------- 430 (811)
Q Consensus 358 L~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~------- 430 (811)
|+|||||..+..... .......+||..|||||+|.+...-. ....-.+.||||+|.|||||+++.
T Consensus 357 IaDFGLAl~~~p~~~-----~~d~~~qVGT~RYMAPEvLEgainl~---d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~ 428 (534)
T KOG3653|consen 357 IADFGLALRLEPGKP-----QGDTHGQVGTRRYMAPEVLEGAINLQ---DRDAFKRIDVYAMGLVLWEIASRCTDADPGP 428 (534)
T ss_pred eeccceeEEecCCCC-----CcchhhhhhhhhhcCHHHHhhhcccc---cHHHHHHHHHHHHHHHHHHHHhhcccccCCC
Confidence 999999988875432 12233589999999999998753211 011225689999999999999853
Q ss_pred -----CCCC---CCccchHHHHHHH-HhCCCCCCCCCC-----hHHHHHHHhhhccCCCCCCCCHHHHHHHHHHHHH
Q 003542 431 -----VPFE---DGHLQGDKMTKNI-RAGERPLFPSGS-----PKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKK 493 (811)
Q Consensus 431 -----~PF~---~~~~~~~~i~~~i-~~~~~~~~p~~~-----~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~k 493 (811)
.||+ +.+..-+++...+ ++..+|.+|..+ ..-+.+.+..||+.||+.|.|+.-+.+.+..+..
T Consensus 429 vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 429 VPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred CCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence 3443 3344445555544 446677777543 3458999999999999999999999887776654
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=272.03 Aligned_cols=214 Identities=22% Similarity=0.264 Sum_probs=169.4
Q ss_pred ceEEEE-EEcCCEEEEEEecccHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEecCCC-CHHHHHHHhhCCCC
Q 003542 228 SQFKEI-QWLGDSFVLRHFYGELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRR 305 (811)
Q Consensus 228 ~vyk~v-~~~g~~VAVK~~~~~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~~g-~L~~~L~~~~~~~~ 305 (811)
.||.+. ..+|+.||+|.+.... .+.+|...+....||||+++++.+. +...+|+||||++| +|.+++...
T Consensus 8 ~v~~~~~~~~~~~~~~K~i~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~----- 79 (237)
T cd05576 8 KVLLVMDTRTQQTFILKGLRKSS-EYSRERLTIIPHCVPNMVCLHKYIV--SEDSVFLVLQHAEGGKLWSHISKF----- 79 (237)
T ss_pred eEEEEEEccCCcEEEEEeecchh-hhhhHHHHHHhcCCCceeehhhhee--cCCeEEEEEecCCCCCHHHHHHHh-----
Confidence 377766 3588999999996542 3455666666678999999997774 45679999999995 899988764
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccccccCCCCCCCCCCCCCCC
Q 003542 306 RNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTPPASPQNQTAP 385 (811)
Q Consensus 306 ~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~ 385 (811)
..+++..+..++.|++.||.|||+.||+||||||+||+++.++ .++|+|||++...... .....
T Consensus 80 -~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~-----~~~l~df~~~~~~~~~----------~~~~~ 143 (237)
T cd05576 80 -LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRG-----HIQLTYFSRWSEVEDS----------CDGEA 143 (237)
T ss_pred -cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCC-----CEEEecccchhccccc----------cccCC
Confidence 4589999999999999999999999999999999999998876 7999999987654322 12334
Q ss_pred CCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHHHHhCCCCCCCCCChHHHHH
Q 003542 386 NPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVN 465 (811)
Q Consensus 386 GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i~~~~~~~~p~~~~~~l~~ 465 (811)
++..|+|||.+.+ ..++.++||||+|+++|+|++|..||...... +.......+|...++.+.+
T Consensus 144 ~~~~y~aPE~~~~---------~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~ 207 (237)
T cd05576 144 VENMYCAPEVGGI---------SEETEACDWWSLGAILFELLTGKTLVECHPSG-------INTHTTLNIPEWVSEEARS 207 (237)
T ss_pred cCccccCCcccCC---------CCCCchhhHHHHHHHHHHHHHCcchhhcCchh-------cccccccCCcccCCHHHHH
Confidence 5667999998753 25778999999999999999999988642211 1111222356677888999
Q ss_pred HHhhhccCCCCCCCCH
Q 003542 466 LTKKCWHTNPSQRPSF 481 (811)
Q Consensus 466 LI~~cL~~DP~~RPS~ 481 (811)
+|.+||+.||.+||++
T Consensus 208 li~~~l~~dp~~R~~~ 223 (237)
T cd05576 208 LLQQLLQFNPTERLGA 223 (237)
T ss_pred HHHHHccCCHHHhcCC
Confidence 9999999999999996
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=297.95 Aligned_cols=249 Identities=22% Similarity=0.366 Sum_probs=204.2
Q ss_pred cceEEeeeecccc---eEEEE-EEcCCEEEEEEec---ccHHHHHHHHHHHHhC-CCCccceeeeeEEc---cCCCeEEE
Q 003542 216 KKLMVRRRLGASS---QFKEI-QWLGDSFVLRHFY---GELESLNAEISTMLSL-SHPNIVQYLCGFCD---EEKKEFFL 284 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v-~~~g~~VAVK~~~---~~~~~~~~Ei~iL~~L-~HPNIVkl~~~~~~---e~~~~~yL 284 (811)
..|++...+|.|+ ||++. +.+|+..|+|++. ...+.++.|.++|+.+ +|||++.+|+.|.- ..++.+||
T Consensus 19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWL 98 (953)
T KOG0587|consen 19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWL 98 (953)
T ss_pred CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEE
Confidence 5789999999986 66665 5689999999985 3457789999999998 69999999988763 23468999
Q ss_pred EEecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccc
Q 003542 285 VMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGL 363 (811)
Q Consensus 285 VmEy~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGl 363 (811)
|||||.| +.-++++... ...+.|+.+..|++.++.||.+||.+.++|||||-.|||++.++ .|||+|||+
T Consensus 99 VMEfC~gGSVTDLVKn~~----g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~-----~VKLvDFGv 169 (953)
T KOG0587|consen 99 VMEFCGGGSVTDLVKNTK----GNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENA-----EVKLVDFGV 169 (953)
T ss_pred EeeccCCccHHHHHhhhc----ccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccC-----cEEEeeeee
Confidence 9999995 7777776653 47799999999999999999999999999999999999999988 899999999
Q ss_pred cccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHH
Q 003542 364 STARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKM 443 (811)
Q Consensus 364 A~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i 443 (811)
+..++..- ....+..||+.|||||++...... ...|+..+|+||||++..||.-|.+|+.+.+... .
T Consensus 170 SaQldsT~-------grRnT~iGtP~WMAPEViac~e~~----d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr--a 236 (953)
T KOG0587|consen 170 SAQLDSTV-------GRRNTFIGTPYWMAPEVIACDESP----DATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR--A 236 (953)
T ss_pred eeeeeccc-------ccccCcCCCcccccceeeecccCC----CCCcccccchhhccceeehhcCCCCCccCcchhh--h
Confidence 98876653 234678999999999999876443 3478899999999999999999999998765432 1
Q ss_pred HHHHHhCCCCC--CCCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 444 TKNIRAGERPL--FPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 444 ~~~i~~~~~~~--~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
.-.|-...+|. .|..+++++.++|..||..|..+||+..++++
T Consensus 237 LF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 237 LFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred hccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 12222222222 25678889999999999999999999999876
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=293.23 Aligned_cols=242 Identities=24% Similarity=0.349 Sum_probs=203.6
Q ss_pred HHhcceEEeeeecccceEEEE---EEcCCE--EEEEEecc-------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCC
Q 003542 213 MLLKKLMVRRRLGASSQFKEI---QWLGDS--FVLRHFYG-------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKK 280 (811)
Q Consensus 213 ~l~k~~~i~~~lG~G~vyk~v---~~~g~~--VAVK~~~~-------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~ 280 (811)
+.+.+++.+..||-|+ |+.+ ...++. +|+|++++ +.+++..|-+||..++.|.||++|-.| .+.+
T Consensus 417 v~l~dl~~iaTLGvGg-FGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf--rd~k 493 (732)
T KOG0614|consen 417 VKLSDLKRIATLGVGG-FGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF--RDSK 493 (732)
T ss_pred cchhhhhhhhhcccCc-cceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh--ccch
Confidence 3456777777888884 4444 345554 89999864 568899999999999999999999888 5677
Q ss_pred eEEEEEecCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEe
Q 003542 281 EFFLVMELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVS 359 (811)
Q Consensus 281 ~~yLVmEy~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~ 359 (811)
++|++||-|- |.|...|++. +.|+...+..|+..+++|++|||++|||+|||||+|+|++.+| -+||.
T Consensus 494 yvYmLmEaClGGElWTiLrdR------g~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~G-----y~KLV 562 (732)
T KOG0614|consen 494 YVYMLMEACLGGELWTILRDR------GSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRG-----YLKLV 562 (732)
T ss_pred hhhhhHHhhcCchhhhhhhhc------CCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCC-----ceEEe
Confidence 8999999887 5898888764 8899999999999999999999999999999999999999988 89999
Q ss_pred eccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccc
Q 003542 360 GFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQ 439 (811)
Q Consensus 360 DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~ 439 (811)
|||+|+...... ...+.+||+.|.|||++.++ ..+.++|.||||+++|||++|.+||.+.+
T Consensus 563 DFGFAKki~~g~--------KTwTFcGTpEYVAPEIILnK---------GHD~avDyWaLGIli~ELL~G~pPFs~~d-- 623 (732)
T KOG0614|consen 563 DFGFAKKIGSGR--------KTWTFCGTPEYVAPEIILNK---------GHDRAVDYWALGILIYELLTGSPPFSGVD-- 623 (732)
T ss_pred ehhhHHHhccCC--------ceeeecCCcccccchhhhcc---------CcchhhHHHHHHHHHHHHHcCCCCCCCCc--
Confidence 999999876543 44688999999999999865 67789999999999999999999998754
Q ss_pred hHHHHHHHHhCC-CCCCCCCChHHHHHHHhhhccCCCCCCCC-----HHHHHHH
Q 003542 440 GDKMTKNIRAGE-RPLFPSGSPKYLVNLTKKCWHTNPSQRPS-----FSSICRI 487 (811)
Q Consensus 440 ~~~i~~~i~~~~-~~~~p~~~~~~l~~LI~~cL~~DP~~RPS-----~~eIl~~ 487 (811)
....+..|..|. ...+|..++....+||+++...+|.+|.. +.+|.++
T Consensus 624 pmktYn~ILkGid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 624 PMKTYNLILKGIDKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred hHHHHHHHHhhhhhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 345566666654 34578899999999999999999999986 5566553
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-32 Score=275.91 Aligned_cols=259 Identities=20% Similarity=0.404 Sum_probs=197.1
Q ss_pred cceEEeeeecccceEEEE-----EEcCCEEEEEEec-----ccHHHHHHHHHHHHhC-CCCccceeeeeEEccCCCeEEE
Q 003542 216 KKLMVRRRLGASSQFKEI-----QWLGDSFVLRHFY-----GELESLNAEISTMLSL-SHPNIVQYLCGFCDEEKKEFFL 284 (811)
Q Consensus 216 k~~~i~~~lG~G~vyk~v-----~~~g~~VAVK~~~-----~~~~~~~~Ei~iL~~L-~HPNIVkl~~~~~~e~~~~~yL 284 (811)
.+++-++.||.| .|+.+ +..|+..|||++. .+..++..|.++..+- +.||||+||++.+.+. ..||
T Consensus 64 ~~Lqdlg~iG~G-~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EG--dcWi 140 (361)
T KOG1006|consen 64 DNLQDLGEIGNG-AFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEG--DCWI 140 (361)
T ss_pred chHHHHHHhcCC-cchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCC--ceee
Confidence 344555678888 57666 3489999999995 3567888999876655 7999999998876543 4899
Q ss_pred EEecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcEEEeccCCCCcceEEEeeccc
Q 003542 285 VMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQ-KIYHGELNPSNIYLKARSMEGYFHVKVSGFGL 363 (811)
Q Consensus 285 VmEy~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~-gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGl 363 (811)
.||+|.-+|..+.+.... .....+++..+-.|..-.+.||.||-.. +|||||+||+|||++..| .+||||||+
T Consensus 141 CMELMd~SlDklYk~vy~-vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G-----~vKLCDFGI 214 (361)
T KOG1006|consen 141 CMELMDISLDKLYKRVYS-VQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHG-----DVKLCDFGI 214 (361)
T ss_pred eHHHHhhhHHHHHHHHHH-HHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCC-----CEeeecccc
Confidence 999999766544433221 2235789988889999999999999864 899999999999999988 899999999
Q ss_pred cccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHH
Q 003542 364 STARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKM 443 (811)
Q Consensus 364 A~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i 443 (811)
+..+...- ..+...|-..|||||.+... ...|+.++||||||++|||++||..||.+-...-+++
T Consensus 215 cGqLv~Si--------AkT~daGCrpYmAPERi~p~-------~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql 279 (361)
T KOG1006|consen 215 CGQLVDSI--------AKTVDAGCRPYMAPERIDPS-------DKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQL 279 (361)
T ss_pred hHhHHHHH--------HhhhccCCccccChhccCCc-------cCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHH
Confidence 97764432 22345677789999999743 3359999999999999999999999998754433333
Q ss_pred HHHHHhCCCCCCC--C---CChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHHHHHhhcCCc
Q 003542 444 TKNIRAGERPLFP--S---GSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKKFMANNPD 500 (811)
Q Consensus 444 ~~~i~~~~~~~~p--~---~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~k~l~~~p~ 500 (811)
..+..|..|.+. . ..+..+..+|.-||..|-.+||.+.++++ +.+++......++
T Consensus 280 -~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~-~~fyr~y~~~~~~ 339 (361)
T KOG1006|consen 280 -CQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK-FPFYRMYAVEGPD 339 (361)
T ss_pred -HHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhc-CchhhhhhhcCCc
Confidence 344556655432 2 35677999999999999999999999876 5555555444443
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=268.93 Aligned_cols=251 Identities=19% Similarity=0.293 Sum_probs=191.7
Q ss_pred ceEEeeeecccc---eEEEE-EEcCCEEEEEEecc------cHHHHHHHHHHHHhCCCCccceeeeeEEc------cCCC
Q 003542 217 KLMVRRRLGASS---QFKEI-QWLGDSFVLRHFYG------ELESLNAEISTMLSLSHPNIVQYLCGFCD------EEKK 280 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v-~~~g~~VAVK~~~~------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~------e~~~ 280 (811)
+|+-+.++|+|+ ||++. ..+|+.||+|+..- --....+|+++|..|+|+|++.+++.+-. ....
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 455566788885 66655 45788899988631 13557899999999999999998854421 1234
Q ss_pred eEEEEEecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEee
Q 003542 281 EFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSG 360 (811)
Q Consensus 281 ~~yLVmEy~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~D 360 (811)
.+|+||.+|+.||.-.|-+ ....|+..++..++.++..||.|+|...|+|||+||.|+||+.+| .+||+|
T Consensus 98 t~ylVf~~cehDLaGlLsn-----~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dg-----ilklAD 167 (376)
T KOG0669|consen 98 TFYLVFDFCEHDLAGLLSN-----RKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDG-----ILKLAD 167 (376)
T ss_pred eeeeeHHHhhhhHHHHhcC-----ccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCc-----eEEeec
Confidence 6899999999999887754 235789999999999999999999999999999999999999888 999999
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccch
Q 003542 361 FGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQG 440 (811)
Q Consensus 361 FGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~ 440 (811)
||+++.+....... .+..+..+-|.+|.+||.+.|. ..|+++.|||..|||+.||++|.+.|.+.+...
T Consensus 168 FGlar~fs~~~n~~---kprytnrvvTLwYrppEllLG~--------r~yg~~iDiWgAgCimaeMwtrspimqgnteqq 236 (376)
T KOG0669|consen 168 FGLARAFSTSKNVV---KPRYTNRVVTLWYRPPELLLGD--------REYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQ 236 (376)
T ss_pred cccccceecccccC---CCCcccceeeeecCCHHHhhcc--------cccCCcchhHhHHHHHHHHHccCccccCChHHH
Confidence 99998776544321 2223466779999999999974 488999999999999999999999998765433
Q ss_pred HHHHHHHHhCC-------------------CCCCC-------------CCChHHHHHHHhhhccCCCCCCCCHHHHHHHH
Q 003542 441 DKMTKNIRAGE-------------------RPLFP-------------SGSPKYLVNLTKKCWHTNPSQRPSFSSICRIL 488 (811)
Q Consensus 441 ~~i~~~i~~~~-------------------~~~~p-------------~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L 488 (811)
.........|. .+++| ..-.++..+|+.++|..||.+|+++++++.+-
T Consensus 237 ql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~ 316 (376)
T KOG0669|consen 237 QLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD 316 (376)
T ss_pred HHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence 21111111111 01111 11234678999999999999999999998743
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-30 Score=319.01 Aligned_cols=241 Identities=24% Similarity=0.371 Sum_probs=177.3
Q ss_pred cceEEeeeecccc---eEEEEE-EcCCEEEEEEecccHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEecCC-
Q 003542 216 KKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYGELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMS- 290 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~-~~g~~VAVK~~~~~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~~- 290 (811)
..+...+.||+|+ ||++.. .+|..||||.+.........|+.+|++++|||||++++.+. +....|+|||||+
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~~l~HpnIv~~~~~~~--~~~~~~lv~Ey~~~ 767 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCR--SEKGAYLIHEYIEG 767 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccccHHHHHHHhhCCCCCcceEEEEEE--cCCCCEEEEeCCCC
Confidence 3445555666654 888774 58999999999754444566899999999999999997764 3456899999999
Q ss_pred CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCCCcEEEeccCCCCcceEEEeeccccccc
Q 003542 291 KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLH---AQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTAR 367 (811)
Q Consensus 291 g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLH---s~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~ 367 (811)
|+|.+++. .+++..+..++.||+.||+||| +.+|+||||||+||+++.++ ..++. ||.....
T Consensus 768 g~L~~~l~---------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~-----~~~~~-~~~~~~~ 832 (968)
T PLN00113 768 KNLSEVLR---------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKD-----EPHLR-LSLPGLL 832 (968)
T ss_pred CcHHHHHh---------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCC-----ceEEE-ecccccc
Confidence 58888874 2788999999999999999999 56899999999999998664 45543 5554322
Q ss_pred cccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHHH
Q 003542 368 TYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNI 447 (811)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i 447 (811)
.. .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.........+....
T Consensus 833 ~~-----------~~~~~~t~~y~aPE~~~~---------~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~ 892 (968)
T PLN00113 833 CT-----------DTKCFISSAYVAPETRET---------KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWA 892 (968)
T ss_pred cc-----------CCCccccccccCcccccC---------CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHH
Confidence 11 123367889999999864 3688999999999999999999999964322111111111
Q ss_pred HhC---------CCCCC------CCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHHHH
Q 003542 448 RAG---------ERPLF------PSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKK 493 (811)
Q Consensus 448 ~~~---------~~~~~------p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~k 493 (811)
... ..+.. +.....++.+++.+||+.||.+||++.++++.|+.+.+
T Consensus 893 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 893 RYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred HHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 100 00111 11122357789999999999999999999998876654
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-30 Score=291.74 Aligned_cols=243 Identities=27% Similarity=0.460 Sum_probs=202.2
Q ss_pred eeeeccc---ceEEEEEE-cCC----EEEEEEecc-----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEe
Q 003542 221 RRRLGAS---SQFKEIQW-LGD----SFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVME 287 (811)
Q Consensus 221 ~~~lG~G---~vyk~v~~-~g~----~VAVK~~~~-----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmE 287 (811)
.+.||.| +||+++.. .|+ +||||++.. ....+..|+-+|.+|+|||++++++..... .+-||++
T Consensus 701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s---~~qlvtq 777 (1177)
T KOG1025|consen 701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLS---TLQLVTQ 777 (1177)
T ss_pred hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccc---hHHHHHH
Confidence 4456665 48888744 343 799999853 467899999999999999999999555322 3789999
Q ss_pred cCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccccc
Q 003542 288 LMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366 (811)
Q Consensus 288 y~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~ 366 (811)
|++ |.|.+|++.. +..+-....+.|..||++||.|||.++++||||-..||||..-. ++||.|||+++.
T Consensus 778 ~mP~G~LlDyvr~h-----r~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~-----hvkitdfgla~l 847 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREH-----RDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPN-----HVKITDFGLAKL 847 (1177)
T ss_pred hcccchHHHHHHHh-----hccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCC-----eEEEEecchhhc
Confidence 999 7999999975 35677889999999999999999999999999999999998776 999999999998
Q ss_pred ccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CCCCCCCCccchHHHHH
Q 003542 367 RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGDKMTK 445 (811)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~~PF~~~~~~~~~i~~ 445 (811)
....... .......-.+.|||=|.+.. ..|+.++|||||||++||++| |..|+.+. ..+++-.
T Consensus 848 l~~d~~e-----y~~~~gK~pikwmale~i~~---------~~~thqSDVWsfGVtiWElmTFGa~Py~gi--~~~eI~d 911 (1177)
T KOG1025|consen 848 LAPDEKE-----YSAPGGKVPIKWMALESIRI---------RKYTHQSDVWSFGVTIWELMTFGAKPYDGI--PAEEIPD 911 (1177)
T ss_pred cCccccc-----ccccccccCcHHHHHHHhhc---------cCCCchhhhhhhhhhHHHHHhcCCCccCCC--CHHHhhH
Confidence 7665432 22233445677999999874 489999999999999999999 99999875 4557778
Q ss_pred HHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHHH
Q 003542 446 NIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIK 492 (811)
Q Consensus 446 ~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~ 492 (811)
.+..+.+...|+.|+-++..++.+||..|+..||+|+++...+..+.
T Consensus 912 lle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a 958 (1177)
T KOG1025|consen 912 LLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA 958 (1177)
T ss_pred HHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence 88899999999999999999999999999999999999977665543
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=252.17 Aligned_cols=242 Identities=24% Similarity=0.341 Sum_probs=188.5
Q ss_pred eEEeeeecccc---eEEEEEE-cCCEEEEEEecc------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEe
Q 003542 218 LMVRRRLGASS---QFKEIQW-LGDSFVLRHFYG------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVME 287 (811)
Q Consensus 218 ~~i~~~lG~G~---vyk~v~~-~g~~VAVK~~~~------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmE 287 (811)
|...++||+|+ ||++..+ +++.||+|.+.- --....+||-+|+.|+|.|||++++... ..+.+-+|+|
T Consensus 4 ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlh--sdkkltlvfe 81 (292)
T KOG0662|consen 4 YDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH--SDKKLTLVFE 81 (292)
T ss_pred hHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhc--cCceeEEeHH
Confidence 34455678874 6666633 789999999842 2467899999999999999999998874 4456899999
Q ss_pred cCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccc
Q 003542 288 LMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTAR 367 (811)
Q Consensus 288 y~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~ 367 (811)
||..+|..|.... .+.++.+.+..++.|+++||.|+|++++.||||||.|+||+.+| .+||+|||+++.+
T Consensus 82 ~cdqdlkkyfdsl-----ng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ng-----elkladfglaraf 151 (292)
T KOG0662|consen 82 FCDQDLKKYFDSL-----NGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNG-----ELKLADFGLARAF 151 (292)
T ss_pred HhhHHHHHHHHhc-----CCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCC-----cEEecccchhhhc
Confidence 9999998888764 36789999999999999999999999999999999999999998 8999999999877
Q ss_pred cccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CCCCCCCCccchHHHHHH
Q 003542 368 TYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGDKMTKN 446 (811)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~~PF~~~~~~~~~i~~~ 446 (811)
...-. .....+-|.+|.+|.++.+. .-|+...|+||.|||+.|+.. |++.|.+.+.+.......
T Consensus 152 gipvr-------cysaevvtlwyrppdvlfga--------kly~tsidmwsagcifaelanagrplfpg~dvddqlkrif 216 (292)
T KOG0662|consen 152 GIPVR-------CYSAEVVTLWYRPPDVLFGA--------KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIF 216 (292)
T ss_pred CCceE-------eeeceeeeeeccCcceeeee--------ehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHH
Confidence 54321 22345678999999999863 478999999999999999997 888888765443322111
Q ss_pred HHhCCC-----------------CCCCCC---------ChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 447 IRAGER-----------------PLFPSG---------SPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 447 i~~~~~-----------------~~~p~~---------~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
..-|.. |.+|.. ....-++|++++|..+|.+|.+++..++
T Consensus 217 ~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 217 RLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred HHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 111211 111111 1123589999999999999999998876
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-30 Score=276.26 Aligned_cols=252 Identities=22% Similarity=0.307 Sum_probs=192.9
Q ss_pred hHHHHHhcceEEeeeecccceEEEE-----EEcCCEEEEEEecc---cHHHHHHHHHHHHhCC-C-C----ccceeeeeE
Q 003542 209 RLVDMLLKKLMVRRRLGASSQFKEI-----QWLGDSFVLRHFYG---ELESLNAEISTMLSLS-H-P----NIVQYLCGF 274 (811)
Q Consensus 209 ~~~~~l~k~~~i~~~lG~G~vyk~v-----~~~g~~VAVK~~~~---~~~~~~~Ei~iL~~L~-H-P----NIVkl~~~~ 274 (811)
..++.+..+|.+.+.+|+|+ |+.+ ..++..||||++++ -.+...-|+++|.++. + | -+|.+.++|
T Consensus 82 ~~gD~l~~Ry~i~~~lGeGt-FGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF 160 (415)
T KOG0671|consen 82 QVGDILTNRYEIVDLLGEGT-FGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF 160 (415)
T ss_pred EeccccccceehhhhhcCCc-ccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh
Confidence 34566778999999999996 3333 22578999999974 4577888999999993 2 2 366666666
Q ss_pred EccCCCeEEEEEecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCC----
Q 003542 275 CDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSM---- 350 (811)
Q Consensus 275 ~~e~~~~~yLVmEy~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~---- 350 (811)
+-.++.|||+|.++-++.++|.++ .-.+|+...+..++.|++.+++|||+.+++|-||||+|||+.....
T Consensus 161 --dyrghiCivfellG~S~~dFlk~N----~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~ 234 (415)
T KOG0671|consen 161 --DYRGHICIVFELLGLSTFDFLKEN----NYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTY 234 (415)
T ss_pred --hccCceEEEEeccChhHHHHhccC----CccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEe
Confidence 667889999999999999999874 3367999999999999999999999999999999999999864320
Q ss_pred -----------CCcceEEEeeccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecc
Q 003542 351 -----------EGYFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSF 419 (811)
Q Consensus 351 -----------d~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSL 419 (811)
-....|+|+|||.|...... ....+.|..|.|||++++. .++..+||||+
T Consensus 235 ~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~----------hs~iVsTRHYRAPEViLgL---------GwS~pCDvWSi 295 (415)
T KOG0671|consen 235 NPKKKVCFIRPLKSTAIKVIDFGSATFDHEH----------HSTIVSTRHYRAPEVILGL---------GWSQPCDVWSI 295 (415)
T ss_pred ccCCccceeccCCCcceEEEecCCcceeccC----------cceeeeccccCCchheecc---------CcCCccCceee
Confidence 11347999999999765432 2466789999999999975 78899999999
Q ss_pred hhHHHHHhhCCCCCCCCccch-HHHHHHHHhCC-----------------CCCCCC------------------------
Q 003542 420 GMLCFELLTGKVPFEDGHLQG-DKMTKNIRAGE-----------------RPLFPS------------------------ 457 (811)
Q Consensus 420 GvILyELltG~~PF~~~~~~~-~~i~~~i~~~~-----------------~~~~p~------------------------ 457 (811)
||||+|+.+|...|+.....+ -.+.+.|.... +...|.
T Consensus 296 GCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~ 375 (415)
T KOG0671|consen 296 GCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQD 375 (415)
T ss_pred eeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccC
Confidence 999999999999998644221 12222222100 000010
Q ss_pred -CChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 458 -GSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 458 -~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
.....+.+|+++||.+||.+|+|+.|++.
T Consensus 376 d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 376 DLEHVQLFDLLRRMLEFDPARRITLREALS 405 (415)
T ss_pred cHHHhHHHHHHHHHHccCccccccHHHHhc
Confidence 01124899999999999999999999986
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.6e-29 Score=253.88 Aligned_cols=231 Identities=28% Similarity=0.387 Sum_probs=186.0
Q ss_pred cccceEEEEEE-cCCEEEEEEeccc-----HHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEecCCC-CHHHHH
Q 003542 225 GASSQFKEIQW-LGDSFVLRHFYGE-----LESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYM 297 (811)
Q Consensus 225 G~G~vyk~v~~-~g~~VAVK~~~~~-----~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~~g-~L~~~L 297 (811)
|.|.+|++... +|+.||+|++... .+.+.+|+..+++++|+||+++++.+. .....+++|||+++ +|..++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~--~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFE--DEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhhee--eCCEEEEEEeCCCCCCHHHHH
Confidence 34668887754 5899999999642 578999999999999999999987664 34678999999996 999888
Q ss_pred HHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccccccCCCCCCC
Q 003542 298 RETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTPPA 377 (811)
Q Consensus 298 ~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~~~~~~~~ 377 (811)
... ..+++..++.++.+++.+|.|||+.+++|+||+|+||+++.++ .++|+|||++.......
T Consensus 79 ~~~------~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~-----~~~l~d~~~~~~~~~~~------ 141 (244)
T smart00220 79 KKR------GRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDG-----HVKLADFGLARQLDPGG------ 141 (244)
T ss_pred Hhc------cCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCC-----cEEEccccceeeecccc------
Confidence 753 3388999999999999999999999999999999999998776 89999999987654331
Q ss_pred CCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHHHHhCCCCCCCC
Q 003542 378 SPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPS 457 (811)
Q Consensus 378 ~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i~~~~~~~~p~ 457 (811)
......++..|++||.+.+. .++.++||||||+++|+|++|..||.... ....+...+..+.....+.
T Consensus 142 --~~~~~~~~~~~~~pE~~~~~---------~~~~~~Di~slG~~l~~l~~~~~p~~~~~-~~~~~~~~~~~~~~~~~~~ 209 (244)
T smart00220 142 --LLTTFVGTPEYMAPEVLLGK---------GYGKAVDVWSLGVILYELLTGKPPFPGDD-QLLELFKKIGKPKPPFPPP 209 (244)
T ss_pred --ccccccCCcCCCCHHHHccC---------CCCchhhHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHhccCCCCccc
Confidence 12345578889999998632 57789999999999999999999997632 2233344444433332222
Q ss_pred C--ChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 458 G--SPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 458 ~--~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
. ++..+.+++.+||..+|.+||++.++++
T Consensus 210 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 210 EWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred cccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 2 7888999999999999999999999976
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=261.33 Aligned_cols=236 Identities=20% Similarity=0.325 Sum_probs=189.4
Q ss_pred hcceEEeeeecccceEEEE----EEcCCEEEEEEeccc-------HHHHHHHHHHHHhC-CCCccceeeeeEEccCCCeE
Q 003542 215 LKKLMVRRRLGASSQFKEI----QWLGDSFVLRHFYGE-------LESLNAEISTMLSL-SHPNIVQYLCGFCDEEKKEF 282 (811)
Q Consensus 215 ~k~~~i~~~lG~G~vyk~v----~~~g~~VAVK~~~~~-------~~~~~~Ei~iL~~L-~HPNIVkl~~~~~~e~~~~~ 282 (811)
+.+|.+++.||+|+.-++. ..+.+.||+|+++++ .+=++.|-.+..+- +||.+|-++.+| ++...+
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscf--qtesrl 326 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCF--QTESRL 326 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhh--cccceE
Confidence 4689999999999733322 348899999999642 34467788888777 799999999777 555679
Q ss_pred EEEEecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeec
Q 003542 283 FLVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGF 361 (811)
Q Consensus 283 yLVmEy~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DF 361 (811)
++|.||++| +|.-++... ..++++.++.|...|+.||.|||++||++||||.+|+|++..| ++||+|+
T Consensus 327 ffvieyv~ggdlmfhmqrq------rklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeg-----hikltdy 395 (593)
T KOG0695|consen 327 FFVIEYVNGGDLMFHMQRQ------RKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEG-----HIKLTDY 395 (593)
T ss_pred EEEEEEecCcceeeehhhh------hcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCC-----ceeeccc
Confidence 999999995 776666543 6799999999999999999999999999999999999999988 9999999
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCcc---
Q 003542 362 GLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHL--- 438 (811)
Q Consensus 362 GlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~--- 438 (811)
|+++.--.. .....+.+|||.|+|||++.+. .|++.+|+|+||++|+||+.|+.||+-...
T Consensus 396 gmcke~l~~-------gd~tstfcgtpnyiapeilrge---------eygfsvdwwalgvlmfemmagrspfdivgm~n~ 459 (593)
T KOG0695|consen 396 GMCKEGLGP-------GDTTSTFCGTPNYIAPEILRGE---------EYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNP 459 (593)
T ss_pred chhhcCCCC-------CcccccccCCCcccchhhhccc---------ccCceehHHHHHHHHHHHHcCCCCcceecCCCc
Confidence 999754332 3345678999999999999976 788999999999999999999999963211
Q ss_pred ---chHHHHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCC
Q 003542 439 ---QGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPS 480 (811)
Q Consensus 439 ---~~~~i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS 480 (811)
.++-+++.|.. ....+|...+-....+++..|..||.+|..
T Consensus 460 d~ntedylfqvile-kqiriprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 460 DMNTEDYLFQVILE-KQIRIPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred ccchhHHHHHHHhh-hcccccceeehhhHHHHHHhhcCCcHHhcC
Confidence 12223344433 233467777777889999999999999864
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=288.10 Aligned_cols=257 Identities=17% Similarity=0.202 Sum_probs=166.8
Q ss_pred hcceEEeeeecccc---eEEEEEE-c----CCEEEEEEeccc--HHHHHHHHHHHHhCCCCccceeeeeEEc----cCCC
Q 003542 215 LKKLMVRRRLGASS---QFKEIQW-L----GDSFVLRHFYGE--LESLNAEISTMLSLSHPNIVQYLCGFCD----EEKK 280 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~~-~----g~~VAVK~~~~~--~~~~~~Ei~iL~~L~HPNIVkl~~~~~~----e~~~ 280 (811)
.++|++.+.||+|+ ||++... + +..||||++... .+....| .+....+.+++.++..+.. ....
T Consensus 131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (566)
T PLN03225 131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKED 208 (566)
T ss_pred cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHH--HHHhhchhhHHHHHHhhhcccccccCC
Confidence 46899999999986 7877754 4 789999998642 2222222 1222334444444333321 3456
Q ss_pred eEEEEEecCCC-CHHHHHHHhhCC--------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE
Q 003542 281 EFFLVMELMSK-DLSCYMRETFGS--------------RRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYL 345 (811)
Q Consensus 281 ~~yLVmEy~~g-~L~~~L~~~~~~--------------~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI 345 (811)
.++|||||+++ +|.+++...... ..........+..++.||+.||.|||+++|+||||||+|||+
T Consensus 209 ~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl 288 (566)
T PLN03225 209 EYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIF 288 (566)
T ss_pred ceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEEE
Confidence 78999999994 888887642100 000112234567899999999999999999999999999999
Q ss_pred eccCCCCcceEEEeeccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCC-------------CCCCCc
Q 003542 346 KARSMEGYFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTS-------------TSKCSE 412 (811)
Q Consensus 346 ~~~g~d~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~-------------~~~~s~ 412 (811)
+.+.. .+||+|||+|+...... ........+|+.|+|||.+....++.... ...++.
T Consensus 289 ~~~~~----~~KL~DFGlA~~l~~~~------~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~ 358 (566)
T PLN03225 289 SEGSG----SFKIIDLGAAADLRVGI------NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPD 358 (566)
T ss_pred eCCCC----cEEEEeCCCcccccccc------ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCC
Confidence 85321 79999999997654322 11223567889999999876443221110 123566
Q ss_pred ccceecchhHHHHHhhCCCCCCCCccchHHHHHHHHhCC----------CCCCC----------CCChHHHHHHHhhhcc
Q 003542 413 KADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGE----------RPLFP----------SGSPKYLVNLTKKCWH 472 (811)
Q Consensus 413 ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i~~~~----------~~~~p----------~~~~~~l~~LI~~cL~ 472 (811)
++||||||||||||+++..|+.... ..+...+.... .+... ........+||.+||.
T Consensus 359 k~DVwSlGviL~el~~~~~~~~~~~---~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~ 435 (566)
T PLN03225 359 RFDIYSAGLIFLQMAFPNLRSDSNL---IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMR 435 (566)
T ss_pred CcccHHHHHHHHHHHhCcCCCchHH---HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHcc
Confidence 7899999999999999877764321 11111111100 00000 1112335689999999
Q ss_pred CCCCCCCCHHHHHH
Q 003542 473 TNPSQRPSFSSICR 486 (811)
Q Consensus 473 ~DP~~RPS~~eIl~ 486 (811)
.||.+|||+.++++
T Consensus 436 ~dP~kR~ta~e~L~ 449 (566)
T PLN03225 436 FKGRQRISAKAALA 449 (566)
T ss_pred CCcccCCCHHHHhC
Confidence 99999999999987
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=274.77 Aligned_cols=208 Identities=18% Similarity=0.271 Sum_probs=173.8
Q ss_pred eechhhHHHHHhcceEEeeeecccceEEEEE-----EcCCEEEEEEeccc---HHHHHHHHHHHHhCC------CCccce
Q 003542 204 TKNEQRLVDMLLKKLMVRRRLGASSQFKEIQ-----WLGDSFVLRHFYGE---LESLNAEISTMLSLS------HPNIVQ 269 (811)
Q Consensus 204 ~~~e~~~~~~l~k~~~i~~~lG~G~vyk~v~-----~~g~~VAVK~~~~~---~~~~~~Ei~iL~~L~------HPNIVk 269 (811)
.|....+++++-.+|.+....|+| ||..+. ..|+.||||++.+. .+.=++|++||++|. --|+++
T Consensus 420 GYYrv~igE~LD~RY~V~~~~GkG-vFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclr 498 (752)
T KOG0670|consen 420 GYYRVRIGELLDSRYEVQGYTGKG-VFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLR 498 (752)
T ss_pred ceEEEehhhhhcceeEEEeccccc-eeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHH
Confidence 456677888999999999999999 888773 36789999999753 355688999999994 358999
Q ss_pred eeeeEEccCCCeEEEEEecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccC
Q 003542 270 YLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARS 349 (811)
Q Consensus 270 l~~~~~~e~~~~~yLVmEy~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g 349 (811)
|+-.| ...+++|||+|-+.-+|.+.|+.. .....|....+..|+.|+..||..|-..||+|.||||+||||+...
T Consensus 499 l~r~F--~hknHLClVFE~LslNLRevLKKy---G~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k 573 (752)
T KOG0670|consen 499 LFRHF--KHKNHLCLVFEPLSLNLREVLKKY---GRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESK 573 (752)
T ss_pred HHHHh--hhcceeEEEehhhhchHHHHHHHh---CcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCc
Confidence 98778 456789999999999999999875 2336788899999999999999999999999999999999997654
Q ss_pred CCCcceEEEeeccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhC
Q 003542 350 MEGYFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTG 429 (811)
Q Consensus 350 ~d~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG 429 (811)
..+||||||.|....... .+.+.-+..|.|||++.|. .|+...|+||.||+||||.||
T Consensus 574 ----~iLKLCDfGSA~~~~ene---------itPYLVSRFYRaPEIiLG~---------~yd~~iD~WSvgctLYElYtG 631 (752)
T KOG0670|consen 574 ----NILKLCDFGSASFASENE---------ITPYLVSRFYRAPEIILGL---------PYDYPIDTWSVGCTLYELYTG 631 (752)
T ss_pred ----ceeeeccCcccccccccc---------ccHHHHHHhccCcceeecC---------cccCCccceeeceeeEEeecc
Confidence 389999999987654332 2234456679999999975 788899999999999999999
Q ss_pred CCCCCCCccc
Q 003542 430 KVPFEDGHLQ 439 (811)
Q Consensus 430 ~~PF~~~~~~ 439 (811)
+..|.+.+..
T Consensus 632 kIlFpG~TNN 641 (752)
T KOG0670|consen 632 KILFPGRTNN 641 (752)
T ss_pred ceecCCCCcH
Confidence 9999876543
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-29 Score=247.04 Aligned_cols=220 Identities=21% Similarity=0.375 Sum_probs=172.5
Q ss_pred HHhcceEEeeeecccceEEEE-----EEcCCEEEEEEec-----ccHHHHHHHHHHHHhC-CCCccceeeeeEEccCCCe
Q 003542 213 MLLKKLMVRRRLGASSQFKEI-----QWLGDSFVLRHFY-----GELESLNAEISTMLSL-SHPNIVQYLCGFCDEEKKE 281 (811)
Q Consensus 213 ~l~k~~~i~~~lG~G~vyk~v-----~~~g~~VAVK~~~-----~~~~~~~~Ei~iL~~L-~HPNIVkl~~~~~~e~~~~ 281 (811)
+-.+.+..+..||+| .|+.+ ..+|...|+|.+. ++.+++.+|+++..+. .+|.+|+||+.++.+. .
T Consensus 43 V~ad~L~~i~elGrG-ayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg--d 119 (282)
T KOG0984|consen 43 VPADDLVGIEELGRG-AYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG--D 119 (282)
T ss_pred cchhhhhhhhhhcCC-ccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccc--c
Confidence 334566677788999 45544 3589999999995 3567788999987665 7999999998886543 4
Q ss_pred EEEEEecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcEEEeccCCCCcceEEEee
Q 003542 282 FFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQ-KIYHGELNPSNIYLKARSMEGYFHVKVSG 360 (811)
Q Consensus 282 ~yLVmEy~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~-gIVHRDLKPsNILI~~~g~d~~~~vKL~D 360 (811)
++|.||.|.-+|..+.++.+. ....+++..+-+|+..++.||.|||++ .++|||+||+||||+..| ++|+||
T Consensus 120 vwIcME~M~tSldkfy~~v~~--~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~G-----qVKiCD 192 (282)
T KOG0984|consen 120 VWICMELMDTSLDKFYRKVLK--KGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDG-----QVKICD 192 (282)
T ss_pred EEEeHHHhhhhHHHHHHHHHh--cCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCC-----cEEEcc
Confidence 999999999999888877654 346789999999999999999999987 899999999999999998 999999
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccch
Q 003542 361 FGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQG 440 (811)
Q Consensus 361 FGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~ 440 (811)
||++..+...-. .+...|--.|||||.+.... +...|+.++||||||+++.||++++.||......-
T Consensus 193 FGIsG~L~dSiA--------kt~daGCkpYmaPEri~~e~-----n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF 259 (282)
T KOG0984|consen 193 FGISGYLVDSIA--------KTMDAGCKPYMAPERINPEL-----NQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPF 259 (282)
T ss_pred cccceeehhhhH--------HHHhcCCCccCChhhcCccc-----CcccceeehhhhhhhhhhhhhhhccccccccCCHH
Confidence 999987654321 11234556699999997542 24479999999999999999999999998765444
Q ss_pred HHHHHHHHhCCCCCCC
Q 003542 441 DKMTKNIRAGERPLFP 456 (811)
Q Consensus 441 ~~i~~~i~~~~~~~~p 456 (811)
.++ +.+.....|.+|
T Consensus 260 ~qL-kqvVeep~P~Lp 274 (282)
T KOG0984|consen 260 QQL-KQVVEEPSPQLP 274 (282)
T ss_pred HHH-HHHhcCCCCCCc
Confidence 444 344444444444
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.4e-29 Score=249.01 Aligned_cols=244 Identities=17% Similarity=0.245 Sum_probs=191.3
Q ss_pred hcceEEeeeecccc---eEEEE-EEcCCEEEEEEecc-cHHHHHHHHHHHHhCC-CCccceeeeeEEccCCCeEEEEEec
Q 003542 215 LKKLMVRRRLGASS---QFKEI-QWLGDSFVLRHFYG-ELESLNAEISTMLSLS-HPNIVQYLCGFCDEEKKEFFLVMEL 288 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v-~~~g~~VAVK~~~~-~~~~~~~Ei~iL~~L~-HPNIVkl~~~~~~e~~~~~yLVmEy 288 (811)
.++|++.+++|+|. ||.++ ..+.+.++||+++. ..+.+.+|+.||..|. ||||+++++...+...+...||+||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~ 116 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEY 116 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhh
Confidence 35788888889984 55555 34788999999976 5678999999999996 9999999999888888889999999
Q ss_pred CCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccccccc
Q 003542 289 MSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTART 368 (811)
Q Consensus 289 ~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~ 368 (811)
+...-+..|- ..|+...+..++.+++.||.|+|+.||+|||+||.|++|+...- .++|+|+|||.+..
T Consensus 117 v~n~Dfk~ly--------~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~r----kLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 117 VNNTDFKQLY--------PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELR----KLRLIDWGLAEFYH 184 (338)
T ss_pred hccccHHHHh--------hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhc----eeeeeecchHhhcC
Confidence 9973233333 45777899999999999999999999999999999999987642 89999999998765
Q ss_pred ccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHH--
Q 003542 369 YASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKN-- 446 (811)
Q Consensus 369 ~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~-- 446 (811)
... .-...+.+..|--||.+.. ...|+..-|+|||||+|..|+..+.||...+...+++.+.
T Consensus 185 p~~--------eYnVRVASRyfKGPELLVd--------y~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIak 248 (338)
T KOG0668|consen 185 PGK--------EYNVRVASRYFKGPELLVD--------YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAK 248 (338)
T ss_pred CCc--------eeeeeeehhhcCCchheee--------chhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHH
Confidence 432 2235566777889999975 3468889999999999999999999987655544433211
Q ss_pred ----------HHh---------------CCCCC--------CCCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 447 ----------IRA---------------GERPL--------FPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 447 ----------i~~---------------~~~~~--------~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
+.. ..+.. ...-.++++.+|+.++|.+|-.+|+|+.|++.
T Consensus 249 VLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 249 VLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 110 00000 01123578999999999999999999999987
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-28 Score=254.89 Aligned_cols=248 Identities=27% Similarity=0.385 Sum_probs=189.7
Q ss_pred hcceEEeeeecccceEEEE---EEcCCEEEEEEecc------cHHHHHHHHHHHHhCCCCccceeeeeEEccC----CCe
Q 003542 215 LKKLMVRRRLGASSQFKEI---QWLGDSFVLRHFYG------ELESLNAEISTMLSLSHPNIVQYLCGFCDEE----KKE 281 (811)
Q Consensus 215 ~k~~~i~~~lG~G~vyk~v---~~~g~~VAVK~~~~------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~----~~~ 281 (811)
..+|.-+..+|.|..+-+. ...+++||+|++.. ...+..+|..+|..+.|+||++++..|.... -..
T Consensus 16 ~~Ry~nL~p~~~g~~~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQIVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeeecccCCCCceEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 3567777888888742211 45899999999843 3567889999999999999999998776432 246
Q ss_pred EEEEEecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeec
Q 003542 282 FFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGF 361 (811)
Q Consensus 282 ~yLVmEy~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DF 361 (811)
+|+|||||..+|...+.. .++-..+..++.|++.|+.|||+.||+||||||+||++..+. .+||.||
T Consensus 96 ~y~v~e~m~~nl~~vi~~--------elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~-----~lKi~df 162 (369)
T KOG0665|consen 96 VYLVMELMDANLCQVILM--------ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDC-----TLKILDF 162 (369)
T ss_pred HHHHHHhhhhHHHHHHHH--------hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchh-----heeeccc
Confidence 899999999999888873 356678999999999999999999999999999999998876 8999999
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchH
Q 003542 362 GLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGD 441 (811)
Q Consensus 362 GlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~ 441 (811)
|+|...... ...+..+.|..|.|||++.+. .|...+||||+|||+.||++|...|.+... -+
T Consensus 163 g~ar~e~~~--------~~mtpyVvtRyyrapevil~~---------~~ke~vdiwSvGci~gEli~~~Vlf~g~d~-id 224 (369)
T KOG0665|consen 163 GLARTEDTD--------FMMTPYVVTRYYRAPEVILGM---------GYKENVDIWSVGCIMGELILGTVLFPGKDH-ID 224 (369)
T ss_pred hhhcccCcc--------cccCchhheeeccCchheecc---------CCcccchhhhhhhHHHHHhhceEEecCchH-HH
Confidence 999765432 133466788999999999864 488999999999999999999999975321 11
Q ss_pred HHHHHHHhC--------------------CCC---------CCCC-----------CChHHHHHHHhhhccCCCCCCCCH
Q 003542 442 KMTKNIRAG--------------------ERP---------LFPS-----------GSPKYLVNLTKKCWHTNPSQRPSF 481 (811)
Q Consensus 442 ~i~~~i~~~--------------------~~~---------~~p~-----------~~~~~l~~LI~~cL~~DP~~RPS~ 481 (811)
++.+.+..- ..+ .+|. .-...+++|+.+||..||++|.|+
T Consensus 225 Q~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv 304 (369)
T KOG0665|consen 225 QWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISV 304 (369)
T ss_pred HHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccH
Confidence 111111100 000 0111 112347999999999999999999
Q ss_pred HHHHHHHHHHHHH
Q 003542 482 SSICRILRYIKKF 494 (811)
Q Consensus 482 ~eIl~~L~~i~k~ 494 (811)
+++|+ +.+++-|
T Consensus 305 ~daL~-HPY~~vw 316 (369)
T KOG0665|consen 305 DDALR-HPYIKVW 316 (369)
T ss_pred HHHhc-CCeeeee
Confidence 99998 5666533
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-29 Score=255.63 Aligned_cols=245 Identities=24% Similarity=0.377 Sum_probs=187.3
Q ss_pred ceEEeeeecccceEEEEE-----EcCCEEEEEEecc------cHHHHHHHHHHHHhCCCCccceeeeeEEccCC---CeE
Q 003542 217 KLMVRRRLGASSQFKEIQ-----WLGDSFVLRHFYG------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEK---KEF 282 (811)
Q Consensus 217 ~~~i~~~lG~G~vyk~v~-----~~g~~VAVK~~~~------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~---~~~ 282 (811)
+.+..+-||.| .|++++ .+|+.||+|++.. ..+.+.+|+++|.-++|.|++..++....... ..+
T Consensus 54 Di~PDRPIGYG-AFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 54 DIQPDRPIGYG-AFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred cCCCCCccccc-ceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 45667789999 677663 3799999999964 45778999999999999999998876642221 246
Q ss_pred EEEEecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecc
Q 003542 283 FLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFG 362 (811)
Q Consensus 283 yLVmEy~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFG 362 (811)
|+++|+|..||...|..- ..++...+.-+++||++||.|||+.+|.||||||.|+|++.+. .+||||||
T Consensus 133 YV~TELmQSDLHKIIVSP------Q~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNC-----vLKICDFG 201 (449)
T KOG0664|consen 133 YVLTELMQSDLHKIIVSP------QALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNC-----ILKICDFG 201 (449)
T ss_pred HHHHHHHHhhhhheeccC------CCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCc-----eEEecccc
Confidence 889999998887776642 6788899999999999999999999999999999999997775 89999999
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccch--
Q 003542 363 LSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQG-- 440 (811)
Q Consensus 363 lA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~-- 440 (811)
+++..+.... ...+..+-|-.|.|||++.| ...|+.+.||||.|||+.||+..+..|.....-+
T Consensus 202 LARvee~d~~------~hMTqEVVTQYYRAPEiLMG--------aRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL 267 (449)
T KOG0664|consen 202 LARTWDQRDR------LNMTHEVVTQYYRAPELLMG--------ARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQL 267 (449)
T ss_pred cccccchhhh------hhhHHHHHHHHhccHHHhhc--------chhhcCccceehhhHHHHHHHhhhhhhhccChHHHH
Confidence 9987655432 12234566788999999997 4589999999999999999999999987543221
Q ss_pred ------------HHHH--------HHHHhCCC-CCCC--------CCChHHHHHHHhhhccCCCCCCCCHHHHHHH
Q 003542 441 ------------DKMT--------KNIRAGER-PLFP--------SGSPKYLVNLTKKCWHTNPSQRPSFSSICRI 487 (811)
Q Consensus 441 ------------~~i~--------~~i~~~~~-~~~p--------~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~ 487 (811)
+.+. ..++.+.+ |.++ ..-..+...++.+++..||.+|.+..+.+..
T Consensus 268 ~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~ 343 (449)
T KOG0664|consen 268 QMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQH 343 (449)
T ss_pred HHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccc
Confidence 1111 01111111 1111 1223457889999999999999999888764
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4e-27 Score=251.24 Aligned_cols=257 Identities=23% Similarity=0.356 Sum_probs=204.6
Q ss_pred ceEEeeeecccc---eEEEEEE------cCCEEEEEEecc-----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeE
Q 003542 217 KLMVRRRLGASS---QFKEIQW------LGDSFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEF 282 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v~~------~g~~VAVK~~~~-----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~ 282 (811)
++++...+-+|+ +|.+++. +.+.|-+|.++. +...+..|.-.|..+.|||+..+.++. .++....
T Consensus 285 Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~-ie~~~~P 363 (563)
T KOG1024|consen 285 RVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS-IEDYATP 363 (563)
T ss_pred heechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE-eeccCcc
Confidence 444444444443 6666533 234566677654 356688899999999999999998544 4566678
Q ss_pred EEEEecCC-CCHHHHHHHhhC--CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEe
Q 003542 283 FLVMELMS-KDLSCYMRETFG--SRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVS 359 (811)
Q Consensus 283 yLVmEy~~-g~L~~~L~~~~~--~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~ 359 (811)
++++.+++ |+|..||....+ +.....++-.+...++.|++.||+|||++|+||.||-..|++|++. ..+||+
T Consensus 364 ~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~-----LqVklt 438 (563)
T KOG1024|consen 364 FVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQ-----LQVKLT 438 (563)
T ss_pred eEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhh-----eeEEec
Confidence 89999999 899999985432 2233456777889999999999999999999999999999999654 499999
Q ss_pred eccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CCCCCCCCcc
Q 003542 360 GFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHL 438 (811)
Q Consensus 360 DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~~PF~~~~~ 438 (811)
|=.+++.+...... ........+..||+||.+... .|+.++|+||||++||||+| |+.||...
T Consensus 439 DsaLSRDLFP~DYh-----cLGDnEnRPvkWMslEal~n~---------~yssasDvWsfGVllWELmtlg~~PyaeI-- 502 (563)
T KOG1024|consen 439 DSALSRDLFPGDYH-----CLGDNENRPVKWMSLEALQNS---------HYSSASDVWSFGVLLWELMTLGKLPYAEI-- 502 (563)
T ss_pred cchhccccCccccc-----ccCCCCCCcccccCHHHHhhh---------hhcchhhhHHHHHHHHHHHhcCCCCcccc--
Confidence 99999876554321 111233456779999999864 78999999999999999999 99999763
Q ss_pred chHHHHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHHHHHh
Q 003542 439 QGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKKFM 495 (811)
Q Consensus 439 ~~~~i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~k~l 495 (811)
+..++...+..|.+...|.+||+++..++.-||+.+|++||+++++..-|..+...+
T Consensus 503 DPfEm~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ql 559 (563)
T KOG1024|consen 503 DPFEMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQL 559 (563)
T ss_pred CHHHHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence 556788899999999999999999999999999999999999999999888776543
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.5e-26 Score=260.81 Aligned_cols=262 Identities=18% Similarity=0.235 Sum_probs=173.9
Q ss_pred hcceEEeeeecccc---eEEEEE-----------------EcCCEEEEEEeccc----H--------------HHHHHHH
Q 003542 215 LKKLMVRRRLGASS---QFKEIQ-----------------WLGDSFVLRHFYGE----L--------------ESLNAEI 256 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~-----------------~~g~~VAVK~~~~~----~--------------~~~~~Ei 256 (811)
.++|.+.++||+|+ ||++.. ..++.||||++... . +....|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 46899999999986 887653 24568999998531 1 2234577
Q ss_pred HHHHhCCCCcc-----ceeeeeEEcc------CCCeEEEEEecCC-CCHHHHHHHhhCC------------------CCC
Q 003542 257 STMLSLSHPNI-----VQYLCGFCDE------EKKEFFLVMELMS-KDLSCYMRETFGS------------------RRR 306 (811)
Q Consensus 257 ~iL~~L~HPNI-----Vkl~~~~~~e------~~~~~yLVmEy~~-g~L~~~L~~~~~~------------------~~~ 306 (811)
.++.+++|.++ +++++.+... .....||||||++ ++|.+++...... ...
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77778876654 5555433211 2345799999999 5898888642110 011
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccccccCCCCCCCCCCCCCCCC
Q 003542 307 NSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTPPASPQNQTAPN 386 (811)
Q Consensus 307 ~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~G 386 (811)
..+++..+..++.|++.||.|||+.+|+||||||+|||++.++ .+||+|||++........ .......+
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~-----~~kL~DFGla~~~~~~~~------~~~~~g~~ 372 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDG-----QVKIIDFGAAVDMCTGIN------FNPLYGML 372 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCC-----cEEEEeCcCccccccCCc------cCccccCC
Confidence 2356778999999999999999999999999999999998775 899999999865432211 11122345
Q ss_pred CCccCChhHhhhhcCCCCCC-------------CCCCCcccceecchhHHHHHhhCCC-CCCCCccchHHHH------HH
Q 003542 387 PYIWYAPEVLAEQEGTGSTS-------------TSKCSEKADVYSFGMLCFELLTGKV-PFEDGHLQGDKMT------KN 446 (811)
Q Consensus 387 T~~Y~APEvl~~~~~~~~~~-------------~~~~s~ksDIWSLGvILyELltG~~-PF~~~~~~~~~i~------~~ 446 (811)
|+.|+|||++.......... ......+.||||+|||+|+|++|.. ||.+......++. ..
T Consensus 373 tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~ 452 (507)
T PLN03224 373 DPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNR 452 (507)
T ss_pred CcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHH
Confidence 78999999986432110000 0012235799999999999999876 7754221111110 11
Q ss_pred HH--hCCCCCC--CCCChHHHHHHHhhhccCCC---CCCCCHHHHHHH
Q 003542 447 IR--AGERPLF--PSGSPKYLVNLTKKCWHTNP---SQRPSFSSICRI 487 (811)
Q Consensus 447 i~--~~~~~~~--p~~~~~~l~~LI~~cL~~DP---~~RPS~~eIl~~ 487 (811)
+. .+....+ ....++..++|+.+||..+| .+|+|+++++++
T Consensus 453 ~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 453 WRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred HHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 11 1111122 23567789999999999866 689999999873
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.1e-26 Score=255.98 Aligned_cols=244 Identities=21% Similarity=0.368 Sum_probs=196.5
Q ss_pred cceEEeeeecccc---eEEEE-EEcCCEEEEEEec----ccHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEe
Q 003542 216 KKLMVRRRLGASS---QFKEI-QWLGDSFVLRHFY----GELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVME 287 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v-~~~g~~VAVK~~~----~~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmE 287 (811)
.+|+++.++|.|+ |||+. ...++..|+|+++ .+..-++.|+-+++..+|||||.||+.+.. ...++|+||
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr--~dklwicME 92 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLR--RDKLWICME 92 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhh--hcCcEEEEE
Confidence 5789999999996 77766 5689999999996 356778899999999999999999988854 445899999
Q ss_pred cCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccccc
Q 003542 288 LMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366 (811)
Q Consensus 288 y~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~ 366 (811)
||+| +|.+...- ..++++.++....+..+.||+|||+.|-+|||||-.|||++..| .+||+|||.+..
T Consensus 93 ycgggslQdiy~~------TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~g-----DvklaDfgvsaq 161 (829)
T KOG0576|consen 93 YCGGGSLQDIYHV------TGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEG-----DVKLADFGVSAQ 161 (829)
T ss_pred ecCCCcccceeee------cccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccC-----ceeecccCchhh
Confidence 9995 66654332 27899999999999999999999999999999999999999888 899999999876
Q ss_pred ccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHH
Q 003542 367 RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKN 446 (811)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~ 446 (811)
+... ........||+.|||||+..-.. .+.|...+|||++|++..|+.--++|..+.+.....+ -.
T Consensus 162 itat-------i~KrksfiGtpywmapEvaaver------kggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~-Lm 227 (829)
T KOG0576|consen 162 ITAT-------IAKRKSFIGTPYWMAPEVAAVER------KGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALF-LM 227 (829)
T ss_pred hhhh-------hhhhhcccCCccccchhHHHHHh------cccccccccccccccchhhhhhcCCcccccchHHHHH-Hh
Confidence 6443 12335788999999999986542 5579999999999999999999898877655432211 11
Q ss_pred HHhCCCCC---CCCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 447 IRAGERPL---FPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 447 i~~~~~~~---~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
-..+..|+ -+..+++.+-+|++.+|..+|.+||+++.++.
T Consensus 228 TkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 228 TKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred hccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 12222222 23456788999999999999999999998765
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.2e-26 Score=254.02 Aligned_cols=189 Identities=22% Similarity=0.382 Sum_probs=160.7
Q ss_pred cceEEeeeecccceEEEEE-----EcCCEEEEEEeccc------------HHHHHHHHHHHHhCC---CCccceeeeeEE
Q 003542 216 KKLMVRRRLGASSQFKEIQ-----WLGDSFVLRHFYGE------------LESLNAEISTMLSLS---HPNIVQYLCGFC 275 (811)
Q Consensus 216 k~~~i~~~lG~G~vyk~v~-----~~g~~VAVK~~~~~------------~~~~~~Ei~iL~~L~---HPNIVkl~~~~~ 275 (811)
..|..+..+|.| .|+-+. .+...|+||.+.++ +-.+--||.||..|+ |+||+++++.|
T Consensus 561 s~yttlq~lG~G-AyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF- 638 (772)
T KOG1152|consen 561 SDYTTLQPLGEG-AYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF- 638 (772)
T ss_pred ccceeeeecccc-ccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee-
Confidence 458999999999 576663 25678999999653 233567999999996 99999999888
Q ss_pred ccCCCeEEEEEecCC-C-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCc
Q 003542 276 DEEKKEFFLVMELMS-K-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGY 353 (811)
Q Consensus 276 ~e~~~~~yLVmEy~~-g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~ 353 (811)
++.+++||+||--. | +|+++|.-. ..+++.++..|+.||+.|+++||+.||||||||-+|+.++.+|
T Consensus 639 -Eddd~yyl~te~hg~gIDLFd~IE~k------p~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g---- 707 (772)
T KOG1152|consen 639 -EDDDYYYLETEVHGEGIDLFDFIEFK------PRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNG---- 707 (772)
T ss_pred -ecCCeeEEEecCCCCCcchhhhhhcc------CccchHHHHHHHHHHHhccccccccCceecccccccEEEecCC----
Confidence 77788999999876 6 999998743 7899999999999999999999999999999999999999988
Q ss_pred ceEEEeeccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCC
Q 003542 354 FHVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPF 433 (811)
Q Consensus 354 ~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF 433 (811)
.+||+|||.|.....+ .-...+||..|.|||++.|..|. +..-|||++|++||.++....||
T Consensus 708 -~~klidfgsaa~~ksg---------pfd~f~gtv~~aapevl~g~~y~--------gk~qdiwalgillytivykenpy 769 (772)
T KOG1152|consen 708 -FVKLIDFGSAAYTKSG---------PFDVFVGTVDYAAPEVLGGEKYL--------GKPQDIWALGILLYTIVYKENPY 769 (772)
T ss_pred -eEEEeeccchhhhcCC---------CcceeeeeccccchhhhCCCccC--------CCcchhhhhhheeeEEEeccCCC
Confidence 9999999998655433 23477899999999999876433 46789999999999999999998
Q ss_pred CC
Q 003542 434 ED 435 (811)
Q Consensus 434 ~~ 435 (811)
..
T Consensus 770 yn 771 (772)
T KOG1152|consen 770 YN 771 (772)
T ss_pred cC
Confidence 63
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.2e-25 Score=242.69 Aligned_cols=138 Identities=22% Similarity=0.357 Sum_probs=114.1
Q ss_pred echhhHHHHHh-cceEEeeeecccceEEEEE-----EcCCEEEEEEeccc---HHHHHHHHHHHHhCC-----C---Ccc
Q 003542 205 KNEQRLVDMLL-KKLMVRRRLGASSQFKEIQ-----WLGDSFVLRHFYGE---LESLNAEISTMLSLS-----H---PNI 267 (811)
Q Consensus 205 ~~e~~~~~~l~-k~~~i~~~lG~G~vyk~v~-----~~g~~VAVK~~~~~---~~~~~~Ei~iL~~L~-----H---PNI 267 (811)
++...+++... .+|.+.++||-| .|..|+ ...+.||+|+.+.. .+....||++|++++ | .+|
T Consensus 66 YHpV~IGD~F~~gRY~v~rKLGWG-HFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~V 144 (590)
T KOG1290|consen 66 YHPVRIGDVFNGGRYHVQRKLGWG-HFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCV 144 (590)
T ss_pred CceeeccccccCceEEEEEecccc-ccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCcee
Confidence 44555666666 799999999999 566552 26779999999863 467889999999982 3 479
Q ss_pred ceeeeeEEc--cCCCeEEEEEecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcEE
Q 003542 268 VQYLCGFCD--EEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQ-KIYHGELNPSNIY 344 (811)
Q Consensus 268 Vkl~~~~~~--e~~~~~yLVmEy~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~-gIVHRDLKPsNIL 344 (811)
|+|++.|-. ..+.++|+|+|+++.+|+.+|+.. ....++...+..|++||+.||.|||.. ||||-||||+|||
T Consensus 145 V~LlD~FkhsGpNG~HVCMVfEvLGdnLLklI~~s----~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvL 220 (590)
T KOG1290|consen 145 VQLLDHFKHSGPNGQHVCMVFEVLGDNLLKLIKYS----NYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVL 220 (590)
T ss_pred eeeeccceecCCCCcEEEEEehhhhhHHHHHHHHh----CCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceee
Confidence 999988863 455789999999999999999875 236799999999999999999999986 8999999999999
Q ss_pred Eec
Q 003542 345 LKA 347 (811)
Q Consensus 345 I~~ 347 (811)
+..
T Consensus 221 l~~ 223 (590)
T KOG1290|consen 221 LCS 223 (590)
T ss_pred eec
Confidence 854
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-24 Score=214.90 Aligned_cols=200 Identities=33% Similarity=0.502 Sum_probs=165.2
Q ss_pred cceEEEEEE-cCCEEEEEEeccc-----HHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEecCC-CCHHHHHHH
Q 003542 227 SSQFKEIQW-LGDSFVLRHFYGE-----LESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMS-KDLSCYMRE 299 (811)
Q Consensus 227 G~vyk~v~~-~g~~VAVK~~~~~-----~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~~-g~L~~~L~~ 299 (811)
|.+|++... .|+.+++|.+... .+.+.+|+.+++.+.|++|+++++.+. .....+++|||++ ++|.+++..
T Consensus 7 ~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~--~~~~~~~~~e~~~~~~l~~~~~~ 84 (215)
T cd00180 7 GTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFE--DENHLYLVMEYCEGGSLKDLLKE 84 (215)
T ss_pred eEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeee--cCCeEEEEEecCCCCcHHHHHHh
Confidence 347776644 3899999999754 367999999999999999999997664 3467899999999 589888765
Q ss_pred hhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEec-cCCCCcceEEEeeccccccccccCCCCCCCC
Q 003542 300 TFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKA-RSMEGYFHVKVSGFGLSTARTYASRNTPPAS 378 (811)
Q Consensus 300 ~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~-~g~d~~~~vKL~DFGlA~~~~~~~~~~~~~~ 378 (811)
.. ..+++..++.++.+++.+|.|||+.|++|+||+|.||+++. ++ .++|+|||.+........
T Consensus 85 ~~-----~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~-----~~~l~d~~~~~~~~~~~~------ 148 (215)
T cd00180 85 NE-----GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNG-----KVKLADFGLSKLLTSDKS------ 148 (215)
T ss_pred cc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCC-----cEEEecCCceEEccCCcc------
Confidence 21 36889999999999999999999999999999999999987 54 899999999876543311
Q ss_pred CCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHHHHhCCCCCCCCC
Q 003542 379 PQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSG 458 (811)
Q Consensus 379 ~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i~~~~~~~~p~~ 458 (811)
......+...|++||.+... ..++.+.|+|++|+++|+|
T Consensus 149 -~~~~~~~~~~~~~pe~~~~~--------~~~~~~~D~~~lg~~~~~l-------------------------------- 187 (215)
T cd00180 149 -LLKTIVGTPAYMAPEVLLGK--------GYYSEKSDIWSLGVILYEL-------------------------------- 187 (215)
T ss_pred -hhhcccCCCCccChhHhccc--------CCCCchhhhHHHHHHHHHH--------------------------------
Confidence 12234567789999998642 2567899999999999999
Q ss_pred ChHHHHHHHhhhccCCCCCCCCHHHHHHH
Q 003542 459 SPKYLVNLTKKCWHTNPSQRPSFSSICRI 487 (811)
Q Consensus 459 ~~~~l~~LI~~cL~~DP~~RPS~~eIl~~ 487 (811)
..+.+++.+|+..+|.+||++.++++.
T Consensus 188 --~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 --PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred --HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 568999999999999999999998763
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.3e-26 Score=277.24 Aligned_cols=210 Identities=20% Similarity=0.177 Sum_probs=146.4
Q ss_pred HhCCC-CccceeeeeEE----c-cCCCeEEEEEecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 003542 260 LSLSH-PNIVQYLCGFC----D-EEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKI 333 (811)
Q Consensus 260 ~~L~H-PNIVkl~~~~~----~-e~~~~~yLVmEy~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gI 333 (811)
+.++| +||.++++.|- + .....++++|||++++|.++|... ...+++..++.++.||+.||.|||++||
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~-----~~~~~~~~~~~i~~qi~~al~~lH~~gI 101 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNP-----DRSVDAFECFHVFRQIVEIVNAAHSQGI 101 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcc-----cccccHHHHHHHHHHHHHHHHHHHhCCe
Confidence 44566 68888777651 1 112457889999999999998642 2569999999999999999999999999
Q ss_pred eeccCCCCcEEEeccC--------------CCCcceEEEeeccccccccccCCC------C---CCCCCCCCCCCCCCcc
Q 003542 334 YHGELNPSNIYLKARS--------------MEGYFHVKVSGFGLSTARTYASRN------T---PPASPQNQTAPNPYIW 390 (811)
Q Consensus 334 VHRDLKPsNILI~~~g--------------~d~~~~vKL~DFGlA~~~~~~~~~------~---~~~~~~~~~~~GT~~Y 390 (811)
+||||||+||||+..+ .+....+||+|||+++........ . ...........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 9999999999996532 011235777888877643211000 0 0000011234689999
Q ss_pred CChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHHHHhCCCCCCCCCChHHHHHHHhhh
Q 003542 391 YAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKC 470 (811)
Q Consensus 391 ~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i~~~~~~~~p~~~~~~l~~LI~~c 470 (811)
+|||++.+. .|+.++|||||||+||||++|.+||..... ....+.....+............++.+|
T Consensus 182 ~APE~~~~~---------~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (793)
T PLN00181 182 TSPEEDNGS---------SSNCASDVYRLGVLLFELFCPVSSREEKSR----TMSSLRHRVLPPQILLNWPKEASFCLWL 248 (793)
T ss_pred EChhhhccC---------CCCchhhhhhHHHHHHHHhhCCCchhhHHH----HHHHHHHhhcChhhhhcCHHHHHHHHHh
Confidence 999998753 678999999999999999999998864211 1122222222211112234567899999
Q ss_pred ccCCCCCCCCHHHHHHH
Q 003542 471 WHTNPSQRPSFSSICRI 487 (811)
Q Consensus 471 L~~DP~~RPS~~eIl~~ 487 (811)
|..||.+||++.+++++
T Consensus 249 L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 249 LHPEPSCRPSMSELLQS 265 (793)
T ss_pred CCCChhhCcChHHHhhc
Confidence 99999999999999873
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-25 Score=228.95 Aligned_cols=248 Identities=18% Similarity=0.296 Sum_probs=184.9
Q ss_pred hcceEEeeeecccceEEEEEE-----cCCEEEEEEecc---cHHHHHHHHHHHHhC-CCCccceeeeeEEccCCCeEEEE
Q 003542 215 LKKLMVRRRLGASSQFKEIQW-----LGDSFVLRHFYG---ELESLNAEISTMLSL-SHPNIVQYLCGFCDEEKKEFFLV 285 (811)
Q Consensus 215 ~k~~~i~~~lG~G~vyk~v~~-----~g~~VAVK~~~~---~~~~~~~Ei~iL~~L-~HPNIVkl~~~~~~e~~~~~yLV 285 (811)
.+.|.+.+.+|+| .|+-++. ..+.+++|.+.. ...+|.+|...--.| .|.||+.-|++-+ +..+.++++
T Consensus 23 ~d~y~I~k~lgeG-~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaF-qt~d~YvF~ 100 (378)
T KOG1345|consen 23 EDVYTINKQLGEG-RFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAF-QTSDAYVFV 100 (378)
T ss_pred hhhhhHHHHhccc-ceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHh-hcCceEEEe
Confidence 3567788888998 5666633 667899999965 468899999877777 5999999886544 566788999
Q ss_pred EecCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccc
Q 003542 286 MELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS 364 (811)
Q Consensus 286 mEy~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA 364 (811)
|||++ |+|.+-+.. ..+-+.....++.|+++|+.|+|++++||||||.+||||-..+ ...|||||||+.
T Consensus 101 qE~aP~gdL~snv~~-------~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~d---f~rvKlcDFG~t 170 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEA-------AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDAD---FYRVKLCDFGLT 170 (378)
T ss_pred eccCccchhhhhcCc-------ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCC---ccEEEeeecccc
Confidence 99999 787765543 5688888999999999999999999999999999999997643 239999999998
Q ss_pred ccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHH-
Q 003542 365 TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKM- 443 (811)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i- 443 (811)
......- .....+..|.+||++..... ......+.+|||.||+|+|.++||.+||..........
T Consensus 171 ~k~g~tV----------~~~~~~~~y~~pe~~~~~~n----e~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~ 236 (378)
T KOG1345|consen 171 RKVGTTV----------KYLEYVNNYHAPELCDTVVN----EKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYW 236 (378)
T ss_pred cccCcee----------hhhhhhcccCCcHHHhhccc----cceEecccccchheeeeeeeeecCCCcchhhhccCchHH
Confidence 6543221 12234556999998875421 24467889999999999999999999997543332222
Q ss_pred -HHHHHhCCCCCCCC---CChHHHHHHHhhhccCCCCCCCCHHHHHHHH
Q 003542 444 -TKNIRAGERPLFPS---GSPKYLVNLTKKCWHTNPSQRPSFSSICRIL 488 (811)
Q Consensus 444 -~~~i~~~~~~~~p~---~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L 488 (811)
...+..+..+..|. ..++.+..+.++-|..+|++|--.-++.+..
T Consensus 237 ~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 237 EWEQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred HHHHHhcccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 22333344344443 4567788999999999999996555555433
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.4e-24 Score=219.56 Aligned_cols=211 Identities=27% Similarity=0.391 Sum_probs=166.7
Q ss_pred EEeeeecccc---eEEEEEE-cCCEEEEEEecc-----cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEecC
Q 003542 219 MVRRRLGASS---QFKEIQW-LGDSFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELM 289 (811)
Q Consensus 219 ~i~~~lG~G~---vyk~v~~-~g~~VAVK~~~~-----~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~ 289 (811)
.+.+.||.|+ +|++... +++.+|+|.+.. ..+.+.+|+..+..++|+|++++++.+. .....+++|||+
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~--~~~~~~~v~e~~ 79 (225)
T smart00221 2 ELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFE--DPEPLYLVMEYC 79 (225)
T ss_pred ceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeee--cCCceEEEEecc
Confidence 4556666664 7877654 489999999964 4678899999999999999999997663 345689999999
Q ss_pred CC-CHHHHHHHhhCCCCCCC-CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccc
Q 003542 290 SK-DLSCYMRETFGSRRRNS-FSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTAR 367 (811)
Q Consensus 290 ~g-~L~~~L~~~~~~~~~~~-ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~ 367 (811)
++ +|.+++... .. +++..+..++.+++.+|.|||+.+++|+||+|+||+++.++ .++|+|||++...
T Consensus 80 ~~~~L~~~~~~~------~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~-----~~~l~d~g~~~~~ 148 (225)
T smart00221 80 EGGDLFDYLRKK------GGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDG-----LVKLADFGLARFI 148 (225)
T ss_pred CCCCHHHHHHhc------ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-----CEEEeeCceeeEe
Confidence 97 999888753 23 88999999999999999999999999999999999998765 8999999998766
Q ss_pred cccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHHH
Q 003542 368 TYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNI 447 (811)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i 447 (811)
..... .......++..|++||.+. . ...++.++|||+||+++|+|++|+.||.........+.+.+
T Consensus 149 ~~~~~------~~~~~~~~~~~~~~pe~~~-~-------~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~ 214 (225)
T smart00221 149 HRDLA------ALLKTVKGTPFYLAPEVLL-G-------GKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVW 214 (225)
T ss_pred cCccc------ccccceeccCCcCCHhHhc-C-------CCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHH
Confidence 44320 0112445777899999984 1 23667799999999999999999999966344555666777
Q ss_pred HhCCCCCCC
Q 003542 448 RAGERPLFP 456 (811)
Q Consensus 448 ~~~~~~~~p 456 (811)
..+..+..|
T Consensus 215 ~~~~~~~~~ 223 (225)
T smart00221 215 SFGVPLLWE 223 (225)
T ss_pred hcCCccccc
Confidence 776644433
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.7e-25 Score=238.89 Aligned_cols=251 Identities=21% Similarity=0.362 Sum_probs=187.1
Q ss_pred HHhcceEEeeeecccc---eEEEEEE----cCCEEEEEEec--ccHHHHHHHHHHHHhC-CCCccceeeeeEEccCCCeE
Q 003542 213 MLLKKLMVRRRLGASS---QFKEIQW----LGDSFVLRHFY--GELESLNAEISTMLSL-SHPNIVQYLCGFCDEEKKEF 282 (811)
Q Consensus 213 ~l~k~~~i~~~lG~G~---vyk~v~~----~g~~VAVK~~~--~~~~~~~~Ei~iL~~L-~HPNIVkl~~~~~~e~~~~~ 282 (811)
.+.+.|.++.+||.|+ ||++... .++.||+|.+. .....+.+|++.|..+ .|.||+++.+.+ ..++..
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~--rnnd~v 110 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCF--RNNDQV 110 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhh--ccCCee
Confidence 3456788889999996 7777743 56789999995 3568899999999999 599999998766 556779
Q ss_pred EEEEecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeec
Q 003542 283 FLVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGF 361 (811)
Q Consensus 283 yLVmEy~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DF 361 (811)
.+||||++. ...+++. .++...+..|++.++.||.++|++|||||||||+|+|.+.... .-.|+||
T Consensus 111 ~ivlp~~~H~~f~~l~~---------~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~----rg~LvDF 177 (418)
T KOG1167|consen 111 AIVLPYFEHDRFRDLYR---------SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQ----RGVLVDF 177 (418)
T ss_pred EEEecccCccCHHHHHh---------cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccC----CceEEec
Confidence 999999996 5555553 3678899999999999999999999999999999999987643 6789999
Q ss_pred cccccccccC-----------CCCC----------------C----------CCCCCCCCCCCCccCChhHhhhhcCCCC
Q 003542 362 GLSTARTYAS-----------RNTP----------------P----------ASPQNQTAPNPYIWYAPEVLAEQEGTGS 404 (811)
Q Consensus 362 GlA~~~~~~~-----------~~~~----------------~----------~~~~~~~~~GT~~Y~APEvl~~~~~~~~ 404 (811)
|+|...+... .... + .........||++|.|||++..
T Consensus 178 gLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k------ 251 (418)
T KOG1167|consen 178 GLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFR------ 251 (418)
T ss_pred hhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhh------
Confidence 9997211100 0000 0 0012235679999999999985
Q ss_pred CCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHHH------------H-hCC--------------------
Q 003542 405 TSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNI------------R-AGE-------------------- 451 (811)
Q Consensus 405 ~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i------------~-~~~-------------------- 451 (811)
.+..+.++||||.|+|+.-++++..||.....+.+.+.+.+ . .|.
T Consensus 252 --~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~ 329 (418)
T KOG1167|consen 252 --CPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFE 329 (418)
T ss_pred --ccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchh
Confidence 45778999999999999999999999964332221111000 0 000
Q ss_pred -----------CC-----CCCCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 452 -----------RP-----LFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 452 -----------~~-----~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
.+ ...+..+..+.+|+.+||..||.+|.|++++|+
T Consensus 330 s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 330 TLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred ccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 00 001122446899999999999999999999987
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.2e-24 Score=213.03 Aligned_cols=162 Identities=20% Similarity=0.256 Sum_probs=124.7
Q ss_pred CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccccccccc
Q 003542 291 KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYA 370 (811)
Q Consensus 291 g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~ 370 (811)
|+|.+++... ...+++..++.++.||+.||.|||+++ ||+|||++.++ .+|+ ||++......
T Consensus 1 GsL~~~l~~~-----~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~-----~~~~--fG~~~~~~~~ 62 (176)
T smart00750 1 VSLADILEVR-----GRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDG-----LLKL--DGSVAFKTPE 62 (176)
T ss_pred CcHHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCcc-----ceee--ccceEeeccc
Confidence 6788888753 256999999999999999999999998 99999998776 7888 9998765332
Q ss_pred CCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHHHHhC
Q 003542 371 SRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAG 450 (811)
Q Consensus 371 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i~~~ 450 (811)
...||+.|+|||++.+. .++.++|||||||++|||++|..||........ ....+...
T Consensus 63 ------------~~~g~~~y~aPE~~~~~---------~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~-~~~~~~~~ 120 (176)
T smart00750 63 ------------QSRVDPYFMAPEVIQGQ---------SYTEKADIYSLGITLYEALDYELPYNEERELSA-ILEILLNG 120 (176)
T ss_pred ------------cCCCcccccChHHhcCC---------CCcchhhHHHHHHHHHHHHhCCCCccccchhcH-HHHHHHHH
Confidence 12578999999999753 678899999999999999999999975432222 22223222
Q ss_pred CCCCC------CCCChH--HHHHHHhhhccCCCCCCCCHHHHHHHHHHHH
Q 003542 451 ERPLF------PSGSPK--YLVNLTKKCWHTNPSQRPSFSSICRILRYIK 492 (811)
Q Consensus 451 ~~~~~------p~~~~~--~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~ 492 (811)
..... +...+. .+.++|.+||..||.+||++.++++++..+.
T Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 121 MPADDPRDRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred hccCCccccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 22211 122233 5899999999999999999999999776554
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.4e-21 Score=203.03 Aligned_cols=267 Identities=15% Similarity=0.268 Sum_probs=210.8
Q ss_pred HHhcceEEeeeecccceEEEE-----EEcCCEEEEEEe--cccHHHHHHHHHHHHhC-CCCccceeeeeEEccCCCeEEE
Q 003542 213 MLLKKLMVRRRLGASSQFKEI-----QWLGDSFVLRHF--YGELESLNAEISTMLSL-SHPNIVQYLCGFCDEEKKEFFL 284 (811)
Q Consensus 213 ~l~k~~~i~~~lG~G~vyk~v-----~~~g~~VAVK~~--~~~~~~~~~Ei~iL~~L-~HPNIVkl~~~~~~e~~~~~yL 284 (811)
++.-.|.+.++||.| .|++. ++++++||||.- +.+.-.+..|.+..+.| ..++|..+| ++.+++.+-.|
T Consensus 25 ~VG~hyrVGkKIGeG-sFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vY--YFGqeG~~NiL 101 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEG-SFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVY--YFGQEGKYNIL 101 (449)
T ss_pred EecccceeccccccC-cceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCcee--eeccccchhhh
Confidence 344579999999999 46655 568999999986 45677899999999999 579999987 44577777899
Q ss_pred EEecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccc
Q 003542 285 VMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS 364 (811)
Q Consensus 285 VmEy~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA 364 (811)
|||+++.+|.+++ +.++ ..|+..++..++.|++.-++|+|++.+|+|||||+|+||...+....-.+.|+|||+|
T Consensus 102 VidLLGPSLEDLF-D~Cg----R~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA 176 (449)
T KOG1165|consen 102 VIDLLGPSLEDLF-DLCG----RRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA 176 (449)
T ss_pred hhhhhCcCHHHHH-HHhc----CcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccch
Confidence 9999998887755 4443 6799999999999999999999999999999999999998776444448999999999
Q ss_pred ccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchH-HH
Q 003542 365 TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGD-KM 443 (811)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~-~i 443 (811)
+.................+..||..||+-....+. .-+.+.|+=|||.++++.|.|.+||.+...... +-
T Consensus 177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGr---------EQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~k 247 (449)
T KOG1165|consen 177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGR---------EQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEK 247 (449)
T ss_pred hhhcCccccccCccccccccccceeeeEeeccccc---------hhhhhhhHHHhhhhhhhhccCCCccccccCcchHHH
Confidence 98877765555555566788899999999888876 456789999999999999999999988543322 22
Q ss_pred HHHHHhCCCCC----CCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHHHHHhh
Q 003542 444 TKNIRAGERPL----FPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKKFMA 496 (811)
Q Consensus 444 ~~~i~~~~~~~----~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~k~l~ 496 (811)
.+.|-...+.. +....|.++..-+.-.-..+-.+-|+.+-+...+..+-+.+-
T Consensus 248 YeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g 304 (449)
T KOG1165|consen 248 YEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLG 304 (449)
T ss_pred HHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcC
Confidence 33443332221 235678888888888888888899999988877766655443
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.3e-20 Score=201.12 Aligned_cols=263 Identities=18% Similarity=0.240 Sum_probs=191.3
Q ss_pred ceEEeeeecccc---eEEEEEEcC--CEEEEEEeccc----HHHHHHHHHHHHhCCC----CccceeeeeEEccCCCeEE
Q 003542 217 KLMVRRRLGASS---QFKEIQWLG--DSFVLRHFYGE----LESLNAEISTMLSLSH----PNIVQYLCGFCDEEKKEFF 283 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v~~~g--~~VAVK~~~~~----~~~~~~Ei~iL~~L~H----PNIVkl~~~~~~e~~~~~y 283 (811)
+|.+.++||.|+ +|.+..... ..+|+|..... ...+..|+.+|..+.+ +++..+++... ......|
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~-~~~~~~~ 97 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR-STEDFNF 97 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc-CCCceeE
Confidence 799999999985 665554433 47899987542 2268899999999963 58888875552 3456789
Q ss_pred EEEecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccc
Q 003542 284 LVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGL 363 (811)
Q Consensus 284 LVmEy~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGl 363 (811)
|||++++.+|.++..... ...|+..++..++.|++.+|++||+.|++||||||+|+++...+......+.|.|||+
T Consensus 98 iVM~l~G~sL~dl~~~~~----~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 98 IVMSLLGPSLEDLRKRNP----PGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEEeccCccHHHHHHhCC----CCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 999999999998665532 3679999999999999999999999999999999999999765312223799999999
Q ss_pred cccccccCCCC---CCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccch
Q 003542 364 STARTYASRNT---PPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQG 440 (811)
Q Consensus 364 A~~~~~~~~~~---~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~ 440 (811)
++......... ...........||..|.++.+..+. ..+.+.|+||++.++.+++.|..||.......
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~---------e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~ 244 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGI---------EQGRRDDLESLFYMLLELLKGSLPWEALEMTD 244 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCC---------ccCCchhhhhHHHHHHHHhcCCCCCccccccc
Confidence 98433221110 1111112356699999999998865 66789999999999999999999997654321
Q ss_pred H--HHHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHHHH
Q 003542 441 D--KMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKK 493 (811)
Q Consensus 441 ~--~i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~k 493 (811)
. .+...........+....+.++..+...+-..+...+|....+...+.....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~ 299 (322)
T KOG1164|consen 245 LKSKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFD 299 (322)
T ss_pred hHHHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHH
Confidence 1 1111111111111334566778888888888999999999999887665544
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.3e-20 Score=187.49 Aligned_cols=268 Identities=15% Similarity=0.194 Sum_probs=202.3
Q ss_pred HhcceEEeeeecccc---eEEEE-EEcCCEEEEEEecc--cHHHHHHHHHHHHhCCC-CccceeeeeEEccCCCeEEEEE
Q 003542 214 LLKKLMVRRRLGASS---QFKEI-QWLGDSFVLRHFYG--ELESLNAEISTMLSLSH-PNIVQYLCGFCDEEKKEFFLVM 286 (811)
Q Consensus 214 l~k~~~i~~~lG~G~---vyk~v-~~~g~~VAVK~~~~--~~~~~~~Ei~iL~~L~H-PNIVkl~~~~~~e~~~~~yLVm 286 (811)
...+|.++++||.|+ .|.+. ...|+.||||.-.+ ....+..|.++...|+| ..|..+...+ .++.+-.+||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~--~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYG--TEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhc--cccccceeee
Confidence 357899999999996 45544 34899999999865 34568899999999964 5555554222 4556778999
Q ss_pred ecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccccc
Q 003542 287 ELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366 (811)
Q Consensus 287 Ey~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~ 366 (811)
++++.+|.+.+.-. ...|+..+++.++-|++.-++|+|.++++||||||+|+|..-+-.. -.+.|+|||+|+.
T Consensus 91 dLLGPsLEdLfnfC-----~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~--~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 91 DLLGPSLEDLFNFC-----SRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHC--NKLYLIDFGLAKK 163 (341)
T ss_pred eccCccHHHHHHHH-----hhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeecccccc--ceEEEEeccchhh
Confidence 99998888766532 2569999999999999999999999999999999999999654321 1789999999998
Q ss_pred ccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchH-HHHH
Q 003542 367 RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGD-KMTK 445 (811)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~-~i~~ 445 (811)
...................||..|.+-....+. .-+.+.|+-|+|.+|..+..|..||.+...... +-.+
T Consensus 164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~---------eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyE 234 (341)
T KOG1163|consen 164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGI---------EQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYE 234 (341)
T ss_pred hccccccccCccccCCccceeeeehhhhhhhhh---------hhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHH
Confidence 776655444445556678899999998887654 445788999999999999999999987543322 1223
Q ss_pred HHHhCCCC----CCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHHHHHhhcCC
Q 003542 446 NIRAGERP----LFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKKFMANNP 499 (811)
Q Consensus 446 ~i~~~~~~----~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~k~l~~~p 499 (811)
.|...... .+....|.++.-.+.-|-..--++-|+..-+.+.+.-+.+-+....
T Consensus 235 kI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~ 292 (341)
T KOG1163|consen 235 KISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQY 292 (341)
T ss_pred HHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccC
Confidence 33332211 2335778899999999999999999999888877766655444333
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.5e-20 Score=201.67 Aligned_cols=213 Identities=25% Similarity=0.337 Sum_probs=162.0
Q ss_pred CCCccceeeeeEEcc-------------------------CCCeEEEEEecCCCCHHHHHHHhhCCCCCCCCCHHHHHHH
Q 003542 263 SHPNIVQYLCGFCDE-------------------------EKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDI 317 (811)
Q Consensus 263 ~HPNIVkl~~~~~~e-------------------------~~~~~yLVmEy~~g~L~~~L~~~~~~~~~~~ls~~~i~~i 317 (811)
+|||||+++..|+++ ++..+|+||.-+..+|..|+-. ...+......+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~-------~~~s~r~~~~~ 346 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWT-------RHRSYRTGRVI 346 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhc-------CCCchHHHHHH
Confidence 699999999887752 2357899999999999999875 44666778889
Q ss_pred HHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccccccCCCCCCCCCCCCCCCCCCccCChhHhh
Q 003542 318 MLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLA 397 (811)
Q Consensus 318 ~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~ 397 (811)
+.|+++|+.|||++||.|||||++||||.-+. |+-..+.|+|||++-..+......+. ........|.-.-||||+..
T Consensus 347 laQlLEav~hL~~hgvAhRDlKSDNiL~Eldd-D~~P~LVvaDFGCcLAd~~hGlqlpy-~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 347 LAQLLEAVTHLHKHGVAHRDLKSDNILLELDD-DEIPQLVVADFGCCLADDNHGLQLPY-ESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHHccchhhcccccceEEEecC-CCCcEEEEcccceeeecccccccccc-ccccccCCCcceecchhhhh
Confidence 99999999999999999999999999998774 66678999999998554432211111 12223456777899999987
Q ss_pred hhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCC
Q 003542 398 EQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQ 477 (811)
Q Consensus 398 ~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~ 477 (811)
-..+... - .--.++|.|+.|.+.||+++...||+......-. .........|.+|+.+|+.+++|+..+|+.||++
T Consensus 425 a~PGp~a--v-vny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~-~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~psk 500 (598)
T KOG4158|consen 425 AVPGPNA--V-VNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLD-TRTYQESQLPALPSRVPPVARQLVFDLLKRDPSK 500 (598)
T ss_pred cCCCCce--e-eccchhhhhhhhhhHHHHhccCCcccccchheec-hhhhhhhhCCCCcccCChHHHHHHHHHhcCCccc
Confidence 5533321 1 1235799999999999999999999863211111 1234455677889999999999999999999999
Q ss_pred CCCHHHHHHHH
Q 003542 478 RPSFSSICRIL 488 (811)
Q Consensus 478 RPS~~eIl~~L 488 (811)
|++..-....|
T Consensus 501 Rvsp~iAANvl 511 (598)
T KOG4158|consen 501 RVSPNIAANVL 511 (598)
T ss_pred cCCccHHHhHH
Confidence 99987655544
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.8e-19 Score=187.38 Aligned_cols=252 Identities=28% Similarity=0.378 Sum_probs=184.0
Q ss_pred eEEeeeecccc---eEEEEEEcCCEEEEEEecc-------cHHHHHHHHHHHHhCCCC-ccceeeeeEEccCCCeEEEEE
Q 003542 218 LMVRRRLGASS---QFKEIQWLGDSFVLRHFYG-------ELESLNAEISTMLSLSHP-NIVQYLCGFCDEEKKEFFLVM 286 (811)
Q Consensus 218 ~~i~~~lG~G~---vyk~v~~~g~~VAVK~~~~-------~~~~~~~Ei~iL~~L~HP-NIVkl~~~~~~e~~~~~yLVm 286 (811)
|.+...+|.|+ +|.+... ..+|+|.+.. ....+.+|+.++..+.|+ +|+++++.+ ......++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~--~~~~~~~~~~ 77 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFF--QDEGSLYLVM 77 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEE--ecCCEEEEEE
Confidence 56677788775 4433322 7899999853 256799999999999988 799999777 3444589999
Q ss_pred ecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccc
Q 003542 287 ELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365 (811)
Q Consensus 287 Ey~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~ 365 (811)
+|+.+ ++.+++...... ..++......++.|++.++.|+|..+++||||||+||+++..+. .++++|||++.
T Consensus 78 ~~~~~~~l~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~----~~~l~dfg~~~ 150 (384)
T COG0515 78 EYVDGGSLEDLLKKIGRK---GPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGR----VVKLIDFGLAK 150 (384)
T ss_pred ecCCCCcHHHHHHhcccc---cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCC----eEEEeccCcce
Confidence 99996 777555542100 26889999999999999999999999999999999999987642 59999999997
Q ss_pred cccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCcc--chHHH
Q 003542 366 ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHL--QGDKM 443 (811)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~--~~~~i 443 (811)
........... ........||..|+|||.+.+.. ...++...|+||+|++++++++|..||..... .....
T Consensus 151 ~~~~~~~~~~~-~~~~~~~~~t~~~~~pe~~~~~~------~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~ 223 (384)
T COG0515 151 LLPDPGSTSSI-PALPSTSVGTPGYMAPEVLLGLS------LAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQT 223 (384)
T ss_pred ecCCCCccccc-cccccccccccccCCHHHhcCCC------CCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHH
Confidence 55433211000 01235678999999999997520 03678899999999999999999999876543 12333
Q ss_pred HHHHHhCCCC-C---CCCCC----hHHHHHHHhhhccCCCCCCCCHHHHHHH
Q 003542 444 TKNIRAGERP-L---FPSGS----PKYLVNLTKKCWHTNPSQRPSFSSICRI 487 (811)
Q Consensus 444 ~~~i~~~~~~-~---~p~~~----~~~l~~LI~~cL~~DP~~RPS~~eIl~~ 487 (811)
...+.....+ . ..... ...+.+++..++..+|..|.+.......
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 224 LKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred HHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 3444433322 1 11111 2578999999999999999998877653
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.1e-20 Score=205.26 Aligned_cols=179 Identities=17% Similarity=0.115 Sum_probs=127.2
Q ss_pred HHhcceEEeeeecccc---eEEEEEE--cCCEEEEEEeccc---------HHHHHHHHHHHHhCCCCccceeeeeEEccC
Q 003542 213 MLLKKLMVRRRLGASS---QFKEIQW--LGDSFVLRHFYGE---------LESLNAEISTMLSLSHPNIVQYLCGFCDEE 278 (811)
Q Consensus 213 ~l~k~~~i~~~lG~G~---vyk~v~~--~g~~VAVK~~~~~---------~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~ 278 (811)
.+..+|.+.+.||+|+ ||++... +|+.||||++... ...+.+|+++|++++|+||+..+..+
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence 3567899999999986 7776543 5778899986421 45689999999999999999643222
Q ss_pred CCeEEEEEecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccC-CCCcEEEeccCCCCcceE
Q 003542 279 KKEFFLVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGEL-NPSNIYLKARSMEGYFHV 356 (811)
Q Consensus 279 ~~~~yLVmEy~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDL-KPsNILI~~~g~d~~~~v 356 (811)
...|||||||+| +|. .+. ... ...++.|++.||.|||++||+|||| ||+|||++.++ .+
T Consensus 91 -~~~~LVmE~~~G~~L~-~~~---------~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~-----~i 151 (365)
T PRK09188 91 -GKDGLVRGWTEGVPLH-LAR---------PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDG-----EA 151 (365)
T ss_pred -CCcEEEEEccCCCCHH-HhC---------ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCC-----CE
Confidence 247999999997 554 221 011 1467899999999999999999999 99999997665 79
Q ss_pred EEeeccccccccccCCCCCC-CCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCccccee
Q 003542 357 KVSGFGLSTARTYASRNTPP-ASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVY 417 (811)
Q Consensus 357 KL~DFGlA~~~~~~~~~~~~-~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIW 417 (811)
||+|||+|+........... .........+++.|+|||.+....-.. ....+..+|-|
T Consensus 152 kLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~---~~~~~~~~dgW 210 (365)
T PRK09188 152 AVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKI---LARKSLPSRIW 210 (365)
T ss_pred EEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhcc---ccccccccCcE
Confidence 99999999876543211110 011113566888899999997654322 22344556766
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.1e-20 Score=222.49 Aligned_cols=216 Identities=21% Similarity=0.321 Sum_probs=164.2
Q ss_pred HHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 003542 252 LNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQ 331 (811)
Q Consensus 252 ~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~ 331 (811)
+..|+-+-..|.|||++..+..+. +....+-+||||++||+..+... ..+...++-.++.|++.|+.|||+.
T Consensus 368 i~sE~~i~~~l~h~~~~e~l~~~~--~~~~~~~~mE~~~~Dlf~~~~~~------~~~~~~e~~c~fKqL~~Gv~y~h~~ 439 (601)
T KOG0590|consen 368 ITSEFCIGSSLSHPNIIETLDIVQ--EIDGILQSMEYCPYDLFSLVMSN------GKLTPLEADCFFKQLLRGVKYLHSM 439 (601)
T ss_pred hhhheeecccccCCchhhhHHHHh--hcccchhhhhcccHHHHHHHhcc------cccchhhhhHHHHHHHHHHHHHHhc
Confidence 566777778899999988775553 23334455999999999988753 4688899999999999999999999
Q ss_pred CceeccCCCCcEEEeccCCCCcceEEEeeccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCC
Q 003542 332 KIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCS 411 (811)
Q Consensus 332 gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s 411 (811)
||.||||||+|+++..+| .+||+|||.+..+....... ........|+-.|+|||++.+..+. .
T Consensus 440 GiahrdlK~enll~~~~g-----~lki~Dfg~~~vf~~~~e~~---~~~~~g~~gS~pY~apE~~~~~~yd--------p 503 (601)
T KOG0590|consen 440 GLAHRDLKLENLLVTENG-----ILKIIDFGAASVFRYPWEKN---IHESSGIVGSDPYLAPEVLTGKEYD--------P 503 (601)
T ss_pred CceeccCccccEEEecCC-----ceEEeecCcceeeccCcchh---hhhhcCcccCCcCcCcccccccccC--------c
Confidence 999999999999999988 89999999997765443211 1234577899999999999876433 2
Q ss_pred cccceecchhHHHHHhhCCCCCCCCccchHHHHHHHHhCCC------CCCCCCChHHHHHHHhhhccCCCCCCCCHHHHH
Q 003542 412 EKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGER------PLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSIC 485 (811)
Q Consensus 412 ~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i~~~~~------~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl 485 (811)
...||||.|+|+..|++|+.||................... ..+....+...+.+|.+||+.||.+|.|+++|+
T Consensus 504 r~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~ 583 (601)
T KOG0590|consen 504 RAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQIL 583 (601)
T ss_pred chhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHh
Confidence 46899999999999999999997654333221111111111 012245677889999999999999999999998
Q ss_pred HHHHHHH
Q 003542 486 RILRYIK 492 (811)
Q Consensus 486 ~~L~~i~ 492 (811)
+ .++++
T Consensus 584 ~-d~W~~ 589 (601)
T KOG0590|consen 584 N-DEWIR 589 (601)
T ss_pred h-ChHhh
Confidence 7 33333
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.6e-20 Score=190.34 Aligned_cols=229 Identities=26% Similarity=0.387 Sum_probs=178.6
Q ss_pred EEEcCCEEEEEEecc------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEecCC-CCHHHHHHHhhCCCC
Q 003542 233 IQWLGDSFVLRHFYG------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMS-KDLSCYMRETFGSRR 305 (811)
Q Consensus 233 v~~~g~~VAVK~~~~------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~~-g~L~~~L~~~~~~~~ 305 (811)
.+|.|..+++|++.- --.+|..|.-.|+-+.||||+.+++.+ ....++.++..||+ |+|+..|.+..
T Consensus 209 grwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgac--nsppnlv~isq~mp~gslynvlhe~t---- 282 (448)
T KOG0195|consen 209 GRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGAC--NSPPNLVIISQYMPFGSLYNVLHEQT---- 282 (448)
T ss_pred ccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhc--cCCCCceEeeeeccchHHHHHHhcCc----
Confidence 368888899999852 235789999999999999999999766 55677999999999 79999998742
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCcEEEeccCCCCcceEEEeeccccccccccCCCCCCCCCCCCC
Q 003542 306 RNSFSLPVVVDIMLQIARGMEFLHAQK--IYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTPPASPQNQT 383 (811)
Q Consensus 306 ~~~ls~~~i~~i~~QIa~gL~yLHs~g--IVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~ 383 (811)
.-..+-.++..++.+|++||+|||+.. |.---|.+..++|+.+-+ ..+-.+|--++. ....
T Consensus 283 ~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedlt---arismad~kfsf--------------qe~g 345 (448)
T KOG0195|consen 283 SVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLT---ARISMADTKFSF--------------QEVG 345 (448)
T ss_pred cEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhh---hheecccceeee--------------eccc
Confidence 234567889999999999999999975 445568899999976531 133334433221 1123
Q ss_pred CCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHHHHhCCCCCCCCCChHHH
Q 003542 384 APNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYL 463 (811)
Q Consensus 384 ~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i~~~~~~~~p~~~~~~l 463 (811)
..-.+.||+||.+.....+ .--.++|+|||++++|||.|...||.+....+.. .+....|.++.+|+..+..+
T Consensus 346 r~y~pawmspealqrkped------~n~raadmwsfaillwel~trevpfadlspmecg-mkialeglrv~ippgis~hm 418 (448)
T KOG0195|consen 346 RAYSPAWMSPEALQRKPED------LNIRAADMWSFAILLWELNTREVPFADLSPMECG-MKIALEGLRVHIPPGISRHM 418 (448)
T ss_pred cccCcccCCHHHHhcCchh------cchhhhhHHHHHHHHHHhhccccccccCCchhhh-hhhhhccccccCCCCccHHH
Confidence 4456789999999876433 2346799999999999999999999876544332 34556788889999999999
Q ss_pred HHHHhhhccCCCCCCCCHHHHHHHHHHH
Q 003542 464 VNLTKKCWHTNPSQRPSFSSICRILRYI 491 (811)
Q Consensus 464 ~~LI~~cL~~DP~~RPS~~eIl~~L~~i 491 (811)
..|+.-|+..||.+||.|+.|+-+|+.+
T Consensus 419 ~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 419 NKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred HHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 9999999999999999999998888764
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.3e-19 Score=211.66 Aligned_cols=251 Identities=18% Similarity=0.216 Sum_probs=167.9
Q ss_pred ceEEeeeecccceEEEE---EEcCCEEEEEEecc-----cHHH---HHHHHHHHHhCCCCccceeeeeEEccCCCeEEEE
Q 003542 217 KLMVRRRLGASSQFKEI---QWLGDSFVLRHFYG-----ELES---LNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLV 285 (811)
Q Consensus 217 ~~~i~~~lG~G~vyk~v---~~~g~~VAVK~~~~-----~~~~---~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLV 285 (811)
++...+.||.+-.+|.. ...|. |+||+|-+ .... -..|++ ...++|||++.|.... ...+..|||
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~--~t~kAAylv 99 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVL--VTDKAAYLV 99 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHH--HhhHHHHHH
Confidence 67788889998644433 33455 99999943 2333 344555 4556899999987443 555678999
Q ss_pred EecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccc
Q 003542 286 MELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365 (811)
Q Consensus 286 mEy~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~ 365 (811)
-+|...+|++.|-.. .-+...+..-|+.|++.||..+|..||+|||||.+||||+.=+ -+.|+||...+
T Consensus 100 RqyvkhnLyDRlSTR------PFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWN-----W~~LtDFAsFK 168 (1431)
T KOG1240|consen 100 RQYVKHNLYDRLSTR------PFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWN-----WLYLTDFASFK 168 (1431)
T ss_pred HHHHhhhhhhhhccc------hHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeec-----hhhhhcccccC
Confidence 999999999887542 4467777888999999999999999999999999999997755 68899998664
Q ss_pred cccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCC--CCCCCCCCcccceecchhHHHHHhh-CCCCCCCCccchHH
Q 003542 366 ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTG--STSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGDK 442 (811)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~--~~~~~~~s~ksDIWSLGvILyELlt-G~~PF~~~~~~~~~ 442 (811)
..--...+...-...-.+...-..|+|||.+....+.. .......+++-||||+||++.||++ |++||.-. +
T Consensus 169 PtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-----Q 243 (1431)
T KOG1240|consen 169 PTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-----Q 243 (1431)
T ss_pred CccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-----H
Confidence 32111111000000001112223599999997632111 1112237889999999999999998 89999521 1
Q ss_pred HHHHHHhCCC-C--CCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHH
Q 003542 443 MTKNIRAGER-P--LFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRI 487 (811)
Q Consensus 443 i~~~i~~~~~-~--~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~ 487 (811)
+......+.. + .+...-+..++.||..|++.||.+|.++++.++.
T Consensus 244 L~aYr~~~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 244 LLAYRSGNADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHhHhccCccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 1111111000 0 0011123358999999999999999999999875
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.1e-17 Score=174.34 Aligned_cols=169 Identities=13% Similarity=0.161 Sum_probs=123.6
Q ss_pred HHHHHhcceEEeeeecccc---eEEEEEEcCCEEEEEEeccc-------HHH------HHHHHHHHHhCCCCccceeeee
Q 003542 210 LVDMLLKKLMVRRRLGASS---QFKEIQWLGDSFVLRHFYGE-------LES------LNAEISTMLSLSHPNIVQYLCG 273 (811)
Q Consensus 210 ~~~~l~k~~~i~~~lG~G~---vyk~v~~~g~~VAVK~~~~~-------~~~------~~~Ei~iL~~L~HPNIVkl~~~ 273 (811)
..+++..+|.+++.+|.|+ ||. +..++..+|||.+... ... +.+|+..+.++.||+|..+.+.
T Consensus 25 ~~~~l~~~y~~~~~l~~~~f~~v~l-~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~ 103 (232)
T PRK10359 25 FDDFLSYNIKTIKVFRNIDDTKVSL-IDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDF 103 (232)
T ss_pred HHHHhhCceEEEEEecCCCceEEEE-EecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEe
Confidence 3456678999999999876 564 3347789999999631 122 6899999999999999998876
Q ss_pred EEccC------CCeEEEEEecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEe
Q 003542 274 FCDEE------KKEFFLVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLK 346 (811)
Q Consensus 274 ~~~e~------~~~~yLVmEy~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~ 346 (811)
+.... ....+|||||++| +|.++.. +++ ....+|+.+|..||..|++||||||+||+++
T Consensus 104 ~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----------~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~ 169 (232)
T PRK10359 104 YLLAERKTLRYAHTYIMLIEYIEGVELNDMPE----------ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVS 169 (232)
T ss_pred eeecccccccccCCeEEEEEEECCccHHHhhh----------ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEe
Confidence 55432 2357999999998 7766421 222 2456999999999999999999999999997
Q ss_pred ccCCCCcceEEEeeccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHH
Q 003542 347 ARSMEGYFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFEL 426 (811)
Q Consensus 347 ~~g~d~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyEL 426 (811)
.+| ++|+|||......... ....++... .|..++|+||||+++..+
T Consensus 170 ~~g------i~liDfg~~~~~~e~~-------------------a~d~~vler---------~y~~~~di~~lg~~~~~~ 215 (232)
T PRK10359 170 KNG------LRIIDLSGKRCTAQRK-------------------AKDRIDLER---------HYGIKNEIKDLGYYLLIY 215 (232)
T ss_pred CCC------EEEEECCCcccccchh-------------------hHHHHHHHh---------HhcccccccceeEeehHH
Confidence 642 9999999875442211 001133322 456789999999998765
Q ss_pred h
Q 003542 427 L 427 (811)
Q Consensus 427 l 427 (811)
.
T Consensus 216 ~ 216 (232)
T PRK10359 216 K 216 (232)
T ss_pred H
Confidence 3
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=4.3e-19 Score=201.24 Aligned_cols=204 Identities=24% Similarity=0.380 Sum_probs=167.8
Q ss_pred cCCEEEEEEecc------cHHHHHHHHHHHHhCC-CCccceeeeeEEccCCCeEEEEEecCCC-CHHHHHHHhhCCCCCC
Q 003542 236 LGDSFVLRHFYG------ELESLNAEISTMLSLS-HPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRN 307 (811)
Q Consensus 236 ~g~~VAVK~~~~------~~~~~~~Ei~iL~~L~-HPNIVkl~~~~~~e~~~~~yLVmEy~~g-~L~~~L~~~~~~~~~~ 307 (811)
.|.-+|+|.++. .......|..++..++ ||.+|+++..| +.....+++++|..| +|...+.+. .
T Consensus 21 a~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyaf--qt~~kl~l~ld~~rgg~lft~l~~~------~ 92 (612)
T KOG0603|consen 21 AGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAF--QTDGKLYLILDFLRGGDLFTRLSKE------V 92 (612)
T ss_pred ccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeee--ccccchhHhhhhcccchhhhccccC------C
Confidence 566788888753 2235667888899896 99999999777 556679999999985 777766543 6
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccccccCCCCCCCCCCCCCCCCC
Q 003542 308 SFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNP 387 (811)
Q Consensus 308 ~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT 387 (811)
.+.+.....+...++.|++++|+.+|+|||+|++||+++.+| ++++.|||+++...... ..+||
T Consensus 93 ~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~G-----hi~~tdfglske~v~~~-----------~~cgt 156 (612)
T KOG0603|consen 93 MFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEG-----HIKLTDFGLSKEAVKEK-----------IACGT 156 (612)
T ss_pred chHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccC-----ccccCCchhhhHhHhhh-----------hcccc
Confidence 688888999999999999999999999999999999999998 99999999998765432 22789
Q ss_pred CccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHHHHhCCCCCCCCCChHHHHHHH
Q 003542 388 YIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLT 467 (811)
Q Consensus 388 ~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i~~~~~~~~p~~~~~~l~~LI 467 (811)
..|||||++.+ ...++|+||||+++|||++|..||.. +....|.. ..+.+|......+.+++
T Consensus 157 ~eymApEI~~g-----------h~~a~D~ws~gvl~felltg~~pf~~------~~~~~Il~-~~~~~p~~l~~~a~~~~ 218 (612)
T KOG0603|consen 157 YEYRAPEIING-----------HLSAADWWSFGVLAFELLTGTLPFGG------DTMKRILK-AELEMPRELSAEARSLF 218 (612)
T ss_pred hhhhhhHhhhc-----------cCCcccchhhhhhHHHHhhCCCCCch------HHHHHHhh-hccCCchhhhHHHHHHH
Confidence 99999999962 46789999999999999999999976 23344433 23457888888999999
Q ss_pred hhhccCCCCCCCCH
Q 003542 468 KKCWHTNPSQRPSF 481 (811)
Q Consensus 468 ~~cL~~DP~~RPS~ 481 (811)
..++..+|..|.-.
T Consensus 219 ~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 219 RQLFKRNPENRLGA 232 (612)
T ss_pred HHHHhhCHHHHhcc
Confidence 99999999999765
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=4e-18 Score=173.60 Aligned_cols=130 Identities=13% Similarity=0.187 Sum_probs=98.1
Q ss_pred eeecccc---eEEEEEEcCCEEEEEEecccH-------------HHH-----------------HHHHHHHHhCCCCccc
Q 003542 222 RRLGASS---QFKEIQWLGDSFVLRHFYGEL-------------ESL-----------------NAEISTMLSLSHPNIV 268 (811)
Q Consensus 222 ~~lG~G~---vyk~v~~~g~~VAVK~~~~~~-------------~~~-----------------~~Ei~iL~~L~HPNIV 268 (811)
+.||.|+ ||.+...+|+.||||+++... ..| ..|+.+|.++.|+++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 4566665 888886689999999995321 122 3499999999888775
Q ss_pred eeeeeEEccCCCeEEEEEecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCceeccCCCCcEEEe
Q 003542 269 QYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFL-HAQKIYHGELNPSNIYLK 346 (811)
Q Consensus 269 kl~~~~~~e~~~~~yLVmEy~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yL-Hs~gIVHRDLKPsNILI~ 346 (811)
... .+. .. ..+|||||++| ++...+.. ...+++..+..++.|++.+|.|| |+.||+||||||+|||++
T Consensus 83 ~p~-~~~-~~--~~~iVmE~i~g~~l~~~~~~------~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~ 152 (190)
T cd05147 83 CPE-PIL-LK--SHVLVMEFIGDDGWAAPRLK------DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH 152 (190)
T ss_pred CCc-EEE-ec--CCEEEEEEeCCCCCcchhhh------cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE
Confidence 433 221 11 13899999997 44333222 15688999999999999999999 689999999999999997
Q ss_pred ccCCCCcceEEEeeccccccc
Q 003542 347 ARSMEGYFHVKVSGFGLSTAR 367 (811)
Q Consensus 347 ~~g~d~~~~vKL~DFGlA~~~ 367 (811)
. + .++|+|||+|...
T Consensus 153 ~-~-----~v~LiDFG~a~~~ 167 (190)
T cd05147 153 D-G-----KLYIIDVSQSVEH 167 (190)
T ss_pred C-C-----cEEEEEccccccC
Confidence 4 3 7999999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.73 E-value=4.9e-18 Score=181.92 Aligned_cols=238 Identities=20% Similarity=0.303 Sum_probs=142.0
Q ss_pred ceEEeeeecccc---eEEEEEE-cCCEEEEEEec-------ccHHHHHHHHHHHHhCCC-----------CccceeeeeE
Q 003542 217 KLMVRRRLGASS---QFKEIQW-LGDSFVLRHFY-------GELESLNAEISTMLSLSH-----------PNIVQYLCGF 274 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v~~-~g~~VAVK~~~-------~~~~~~~~Ei~iL~~L~H-----------PNIVkl~~~~ 274 (811)
.+...+.||.|+ +|.+... +|+.+|||++. ...+.+.+|.-....+.+ .-++. ++..
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P-~d~~ 91 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVP-LDLL 91 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B----SEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEee-eEEE
Confidence 345556677765 6665543 78999999983 246677777655544322 11122 1211
Q ss_pred Ecc----------CCC-----eEEEEEecCCCCHHHHHHHhhCCCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccC
Q 003542 275 CDE----------EKK-----EFFLVMELMSKDLSCYMRETFGSRRR-NSFSLPVVVDIMLQIARGMEFLHAQKIYHGEL 338 (811)
Q Consensus 275 ~~e----------~~~-----~~yLVmEy~~g~L~~~L~~~~~~~~~-~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDL 338 (811)
..+ +.. ..+++|+-+.+||..++......... ..+.......+..|+++.+++||+.|++|+||
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EEcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 111 011 24789999998888776542221111 12223334566689999999999999999999
Q ss_pred CCCcEEEeccCCCCcceEEEeeccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceec
Q 003542 339 NPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYS 418 (811)
Q Consensus 339 KPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWS 418 (811)
+|+|++++.+| .++|+||+.......... ....+..|.+||........+. ....++.+.|.|+
T Consensus 172 ~~~nfll~~~G-----~v~Lg~F~~~~r~g~~~~----------~~~~~~~~~PPe~~~~~~~~~~-~~~~~t~~~DaW~ 235 (288)
T PF14531_consen 172 KPENFLLDQDG-----GVFLGDFSSLVRAGTRYR----------CSEFPVAFTPPELESCAGQFGQ-NNAPYTFATDAWQ 235 (288)
T ss_dssp SGGGEEE-TTS------EEE--GGGEEETTEEEE----------GGGS-TTTS-HHHHHHHTSCHH-SEEEE-HHHHHHH
T ss_pred ceeeEEEcCCC-----CEEEcChHHHeecCceee----------ccCCCcccCChhhhhhhcccCc-ccceeeeccCHHH
Confidence 99999999998 899999987654432210 1233466999998765311111 2346889999999
Q ss_pred chhHHHHHhhCCCCCCCCccchHHHHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCC
Q 003542 419 FGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQR 478 (811)
Q Consensus 419 LGvILyELltG~~PF~~~~~~~~~i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~R 478 (811)
||+++|.|++|..||........... ...... +.|+.++.||..+|+.||.+|
T Consensus 236 LG~~ly~lWC~~lPf~~~~~~~~~~~------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 236 LGITLYSLWCGRLPFGLSSPEADPEW------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHHHHHSS-STCCCGGGSTSGG------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHHHHHccCCCCCCCccccccc------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99999999999999975432211000 111123 788999999999999999987
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.2e-17 Score=165.77 Aligned_cols=130 Identities=13% Similarity=0.133 Sum_probs=99.5
Q ss_pred eeecccc---eEEEEEEcCCEEEEEEeccc------------------------------HHHHHHHHHHHHhCCCCccc
Q 003542 222 RRLGASS---QFKEIQWLGDSFVLRHFYGE------------------------------LESLNAEISTMLSLSHPNIV 268 (811)
Q Consensus 222 ~~lG~G~---vyk~v~~~g~~VAVK~~~~~------------------------------~~~~~~Ei~iL~~L~HPNIV 268 (811)
+.||.|+ ||.+...+|+.||||++... ...+..|+..+.++.|++|.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (190)
T cd05145 3 GCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVP 82 (190)
T ss_pred ceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 4566665 88887668999999998532 11236789999999999875
Q ss_pred eeeeeEEccCCCeEEEEEecCCCC-HHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEe
Q 003542 269 QYLCGFCDEEKKEFFLVMELMSKD-LSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHA-QKIYHGELNPSNIYLK 346 (811)
Q Consensus 269 kl~~~~~~e~~~~~yLVmEy~~g~-L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs-~gIVHRDLKPsNILI~ 346 (811)
....... . . .||||||++|. +....... ..++...+..++.|++.+|.+||+ .||+||||||+|||++
T Consensus 83 ~p~~~~~-~-~--~~lVmE~~~g~~~~~~~l~~------~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~ 152 (190)
T cd05145 83 VPEPILL-K-K--NVLVMEFIGDDGSPAPRLKD------VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH 152 (190)
T ss_pred CceEEEe-c-C--CEEEEEEecCCCchhhhhhh------ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE
Confidence 4432222 1 1 48999999974 33322221 457788999999999999999999 9999999999999998
Q ss_pred ccCCCCcceEEEeeccccccc
Q 003542 347 ARSMEGYFHVKVSGFGLSTAR 367 (811)
Q Consensus 347 ~~g~d~~~~vKL~DFGlA~~~ 367 (811)
++ .++|+|||++...
T Consensus 153 -~~-----~~~liDFG~a~~~ 167 (190)
T cd05145 153 -DG-----KPYIIDVSQAVEL 167 (190)
T ss_pred -CC-----CEEEEEcccceec
Confidence 44 7999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.69 E-value=2e-17 Score=195.58 Aligned_cols=211 Identities=19% Similarity=0.342 Sum_probs=142.3
Q ss_pred cceEEeeeecccceEEEEE-----EcCCEEEEEEecccHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEecCC
Q 003542 216 KKLMVRRRLGASSQFKEIQ-----WLGDSFVLRHFYGELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMS 290 (811)
Q Consensus 216 k~~~i~~~lG~G~vyk~v~-----~~g~~VAVK~~~~~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~~ 290 (811)
..|..++.+..| .|+++. .+.++||+ +++++.-.+++ |..+- +. .+.|
T Consensus 83 ~df~~Iklisng-Aygavylvrh~~trqrfa~-kiNkq~lilRn------------ilt~a------~n--pfvv----- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNG-AYGAVYLVRHKETRQRFAM-KINKQNLILRN------------ILTFA------GN--PFVV----- 135 (1205)
T ss_pred cccceeEeeccC-CCCceeeeeccccccchhh-cccccchhhhc------------ccccc------CC--ccee-----
Confidence 478888888888 455542 35788999 44433222221 22221 11 2333
Q ss_pred CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccccccccc
Q 003542 291 KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYA 370 (811)
Q Consensus 291 g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~ 370 (811)
||-...++.. +.++. +++.+++|||+.||+|||+||+|.||+.-| ++|++|||+++.....
T Consensus 136 gDc~tllk~~------g~lPv--------dmvla~Eylh~ygivhrdlkpdnllIT~mG-----hiKlTDfgLsk~GLms 196 (1205)
T KOG0606|consen 136 GDCATLLKNI------GPLPV--------DMVLAVEYLHSYGIVHRDLKPDNLLITSMG-----HIKLTDFGLSKKGLMS 196 (1205)
T ss_pred chhhhhcccC------CCCcc--------hhhHHhHhhccCCeecCCCCCCcceeeecc-----cccccchhhhhhhhhh
Confidence 4333333321 34443 237899999999999999999999999988 9999999998754221
Q ss_pred CCCC--------CCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHH
Q 003542 371 SRNT--------PPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDK 442 (811)
Q Consensus 371 ~~~~--------~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~ 442 (811)
.... ..........+||+.|+|||++..+ .|+..+|+|++|+|+||.+.|..||.+... ++
T Consensus 197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrq---------gygkpvdwwamGiIlyeFLVgcvpffGdtp--ee 265 (1205)
T KOG0606|consen 197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQ---------GYGKPVDWWAMGIILYEFLVGCVPFFGDTP--EE 265 (1205)
T ss_pred ccchhhhcchHHHHHHhhhccccCCccccChhhhhhh---------ccCCCccHHHHHHHHHHHheeeeeccCCCH--HH
Confidence 1000 0001123456899999999999865 688899999999999999999999998643 23
Q ss_pred HHHHHHhC--CCCCCCCCChHHHHHHHhhhccCCCCCCCCHHH
Q 003542 443 MTKNIRAG--ERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSS 483 (811)
Q Consensus 443 i~~~i~~~--~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~e 483 (811)
++..+... ..+.-....+++++++|.++|+.+|..|.-...
T Consensus 266 lfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~g 308 (1205)
T KOG0606|consen 266 LFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGG 308 (1205)
T ss_pred HHhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhcccch
Confidence 44333322 222234567889999999999999999965443
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=8.5e-17 Score=164.85 Aligned_cols=184 Identities=14% Similarity=0.055 Sum_probs=125.9
Q ss_pred eeeecccceEEEEEE---cCCEEEEEEeccc--------HHHHHHHHHHHHhCC-CCccceeeeeEEccCCCeEEEEEec
Q 003542 221 RRRLGASSQFKEIQW---LGDSFVLRHFYGE--------LESLNAEISTMLSLS-HPNIVQYLCGFCDEEKKEFFLVMEL 288 (811)
Q Consensus 221 ~~~lG~G~vyk~v~~---~g~~VAVK~~~~~--------~~~~~~Ei~iL~~L~-HPNIVkl~~~~~~e~~~~~yLVmEy 288 (811)
...|++| +|+++.+ .+.+++.+.+... ...+.+|+++|++|. |++|+++++. ...|++|||
T Consensus 7 ~~~l~~~-~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~------~~~~lvmey 79 (218)
T PRK12274 7 NEPLKSD-TFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW------DGRHLDRSY 79 (218)
T ss_pred ceeecCC-CcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE------cCEEEEEee
Confidence 3455666 4555533 6788888887542 125789999999995 5889998742 236999999
Q ss_pred CCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccC-CCCcEEEeccCCCCcceEEEeecccccc
Q 003542 289 MSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGEL-NPSNIYLKARSMEGYFHVKVSGFGLSTA 366 (811)
Q Consensus 289 ~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDL-KPsNILI~~~g~d~~~~vKL~DFGlA~~ 366 (811)
+.| +|...+. . ....++.|++.+|.++|.+||+|||| ||+|||++.++ .++|+|||++..
T Consensus 80 I~G~~L~~~~~------------~-~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g-----~i~LIDFG~A~~ 141 (218)
T PRK12274 80 LAGAAMYQRPP------------R-GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDG-----SPAVIDFQLAVR 141 (218)
T ss_pred ecCccHHhhhh------------h-hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCC-----CEEEEECCCcee
Confidence 998 5543211 0 11357889999999999999999999 79999998766 799999999975
Q ss_pred ccccCCC------CCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCC
Q 003542 367 RTYASRN------TPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDG 436 (811)
Q Consensus 367 ~~~~~~~------~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~ 436 (811)
....... .............++.|++|+.-... ...--...++++.|.-+|.++|+..|+.++
T Consensus 142 ~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l-------~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 142 GNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVL-------KRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred cCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhh-------ccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 4332100 00000001122356778888865432 112225678999999999999999987653
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.3e-16 Score=161.09 Aligned_cols=131 Identities=15% Similarity=0.166 Sum_probs=96.6
Q ss_pred eeecccc---eEEEEEEcCCEEEEEEecc----cHHHHHHHHHHHHhC-----CCCccceeeeeEEccCC-Ce-EEEEEe
Q 003542 222 RRLGASS---QFKEIQWLGDSFVLRHFYG----ELESLNAEISTMLSL-----SHPNIVQYLCGFCDEEK-KE-FFLVME 287 (811)
Q Consensus 222 ~~lG~G~---vyk~v~~~g~~VAVK~~~~----~~~~~~~Ei~iL~~L-----~HPNIVkl~~~~~~e~~-~~-~yLVmE 287 (811)
..||+|+ ||. ...++.. +||++.. ..+.+.+|+.+++.+ +||||+++|+.+....+ +. +.+|||
T Consensus 8 ~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e 85 (210)
T PRK10345 8 SPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIAD 85 (210)
T ss_pred ceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEec
Confidence 4577775 553 2224444 7998753 356799999999999 67999999987754321 34 347999
Q ss_pred cCC---CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccc
Q 003542 288 LMS---KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGM-EFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGL 363 (811)
Q Consensus 288 y~~---g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL-~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGl 363 (811)
|++ ++|.+++.+ ..+++. ..++.|++.++ .|||+++|+||||||+|||++..+ ++...++|+||+.
T Consensus 86 ~~G~~~~tL~~~l~~-------~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~-~~~~~~~LiDg~G 155 (210)
T PRK10345 86 FDGKPSITLTEFAEQ-------CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRIS-ESEVIPVVCDNIG 155 (210)
T ss_pred CCCCcchhHHHHHHc-------ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccC-CCCCcEEEEECCC
Confidence 954 599999964 235555 46688888888 999999999999999999998654 3445899999554
Q ss_pred c
Q 003542 364 S 364 (811)
Q Consensus 364 A 364 (811)
+
T Consensus 156 ~ 156 (210)
T PRK10345 156 E 156 (210)
T ss_pred C
Confidence 3
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.2e-17 Score=183.14 Aligned_cols=175 Identities=29% Similarity=0.506 Sum_probs=133.9
Q ss_pred eEEEEEecCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEe
Q 003542 281 EFFLVMELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVS 359 (811)
Q Consensus 281 ~~yLVmEy~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~ 359 (811)
++||.|++|. .+|.+||... +.....++.....++.|++.|+.| ++.+|||+||.||++..++ .+||.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr---~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~-----q~kIg 398 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRR---RTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDD-----QLKIG 398 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCC---CcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccch-----hhhhh
Confidence 6899999999 5999999743 223456778899999999999999 9999999999999997765 89999
Q ss_pred eccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhh-CCCCCCCCcc
Q 003542 360 GFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHL 438 (811)
Q Consensus 360 DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELlt-G~~PF~~~~~ 438 (811)
|||+.......... .+.........||..||+||.+.++ .|+.++||||||+||+|+++ -..+|+.
T Consensus 399 DFgl~ts~~~~~~~-~~~~a~~t~~~gt~~YmsPEQi~g~---------~y~~kvdIyaLGlil~EL~~~f~T~~er--- 465 (516)
T KOG1033|consen 399 DFGLVTSQDKDETV-APAAASHTQQVGTLLYMSPEQIRGQ---------QYSEKVDIYALGLILAELLIQFSTQFER--- 465 (516)
T ss_pred hhhheeecccCCcc-cchhhhhhhcccccccCCHHHHhhh---------hhhhhcchhhHHHHHHHHHHHhccHHHH---
Confidence 99998766554411 1112334567899999999999976 78999999999999999998 3334432
Q ss_pred chHHHHHHHHhCCCC-CCCCCChHHHHHHHhhhccCCCCCCCCHH
Q 003542 439 QGDKMTKNIRAGERP-LFPSGSPKYLVNLTKKCWHTNPSQRPSFS 482 (811)
Q Consensus 439 ~~~~i~~~i~~~~~~-~~p~~~~~~l~~LI~~cL~~DP~~RPS~~ 482 (811)
......++.+..| .+-.+.|. -..|+.+++...|.+||++.
T Consensus 466 --~~t~~d~r~g~ip~~~~~d~p~-e~~ll~~lls~~p~~RP~~~ 507 (516)
T KOG1033|consen 466 --IATLTDIRDGIIPPEFLQDYPE-EYTLLQQLLSPSPEERPSAI 507 (516)
T ss_pred --HHhhhhhhcCCCChHHhhcCcH-HHHHHHHhcCCCcccCchHH
Confidence 2234455666544 23344444 47899999999999999443
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.4e-15 Score=181.37 Aligned_cols=240 Identities=16% Similarity=0.177 Sum_probs=164.8
Q ss_pred hcceEEeeeecccc---eEEEEEEcCCEEEEEEeccc-HHHHHHHHHHHHhCC---CCccceeeeeEEccCCCeEEEEEe
Q 003542 215 LKKLMVRRRLGASS---QFKEIQWLGDSFVLRHFYGE-LESLNAEISTMLSLS---HPNIVQYLCGFCDEEKKEFFLVME 287 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~~~g~~VAVK~~~~~-~~~~~~Ei~iL~~L~---HPNIVkl~~~~~~e~~~~~yLVmE 287 (811)
..+|.+.+.+|.|+ ||.+...+|+.||||+-+.. .=.|.-=.+++.+|+ -+.|.++..++... +..+||+|
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~--~~S~lv~e 774 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQ--NASVLVSE 774 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccC--Ccceeeee
Confidence 46889999999997 77777778999999997531 111111222333343 23444444333323 34689999
Q ss_pred cCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccC--CCCcceEEEeecccc
Q 003542 288 LMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARS--MEGYFHVKVSGFGLS 364 (811)
Q Consensus 288 y~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g--~d~~~~vKL~DFGlA 364 (811)
|.+ |+|++++... ..+++..+..+..|++.-+++||..+||||||||+|+||...- ..+..-++|+|||.+
T Consensus 775 y~~~Gtlld~~N~~------~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~s 848 (974)
T KOG1166|consen 775 YSPYGTLLDLINTN------KVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRS 848 (974)
T ss_pred ccccccHHHhhccC------CCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccc
Confidence 999 8999988732 6789999999999999999999999999999999999996542 123457999999998
Q ss_pred ccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHH
Q 003542 365 TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMT 444 (811)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~ 444 (811)
..+..-.. ...-....+|-.+-.+|+..|. .++..+|.|.|+.++|-||.|+.-
T Consensus 849 iDm~lfp~-----~~~F~~~~~td~f~C~EM~~gr---------pWtYq~DyfGlAa~~h~mLFG~y~------------ 902 (974)
T KOG1166|consen 849 IDMKLFPD-----GTKFKAVWHTDLFDCIEMREGR---------PWTYQIDYFGLAATVHVMLFGKYM------------ 902 (974)
T ss_pred eeeeEcCC-----CcEEeeeeccccchhHHHhcCC---------CCchhhhhHHHHHHHHHHHHHHHH------------
Confidence 65543322 1223456678889999999865 788999999999999999999642
Q ss_pred HHHHhCCCCC----CCCCChHH-HHHHHhhhccCCCCCCCCHHHHHHHHH
Q 003542 445 KNIRAGERPL----FPSGSPKY-LVNLTKKCWHTNPSQRPSFSSICRILR 489 (811)
Q Consensus 445 ~~i~~~~~~~----~p~~~~~~-l~~LI~~cL~~DP~~RPS~~eIl~~L~ 489 (811)
+ ...|.... ++.....+ ..+++..+|..|-..=|...+|...|+
T Consensus 903 q-~~~g~~~~~~~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~ 951 (974)
T KOG1166|consen 903 E-VKNGSSWMVKTNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELE 951 (974)
T ss_pred H-hcCCcceeccccchhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHH
Confidence 1 12222111 22222223 357788888844444455555544443
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.58 E-value=5.5e-15 Score=155.79 Aligned_cols=132 Identities=14% Similarity=0.154 Sum_probs=99.6
Q ss_pred eEEeeeecccc---eEEEE--EEcCCEEEEEEecccH----------------------------HHHHHHHHHHHhCCC
Q 003542 218 LMVRRRLGASS---QFKEI--QWLGDSFVLRHFYGEL----------------------------ESLNAEISTMLSLSH 264 (811)
Q Consensus 218 ~~i~~~lG~G~---vyk~v--~~~g~~VAVK~~~~~~----------------------------~~~~~Ei~iL~~L~H 264 (811)
|.+.+.||.|+ ||.+. ..+|+.||||.+.... ..+.+|+.++.++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 56677788876 88887 5689999999985311 225689999999975
Q ss_pred C--ccceeeeeEEccCCCeEEEEEecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-ceeccCCC
Q 003542 265 P--NIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQK-IYHGELNP 340 (811)
Q Consensus 265 P--NIVkl~~~~~~e~~~~~yLVmEy~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~g-IVHRDLKP 340 (811)
. .+.+++. + . ..||||||++| +|..++.. ...+....+..++.||+.+|.+||+.| |+||||||
T Consensus 110 ~~i~~p~~~~-~--~---~~~lV~E~~~g~~L~~~~~~------~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp 177 (237)
T smart00090 110 AGVPVPKPIA-W--R---RNVLVMEFIGGDGLPAPRLK------DVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSE 177 (237)
T ss_pred cCCCCCeeeE-e--c---CceEEEEEecCCcccccccc------cCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCCh
Confidence 3 3444442 1 1 24899999998 55443322 134566677899999999999999999 99999999
Q ss_pred CcEEEeccCCCCcceEEEeeccccccc
Q 003542 341 SNIYLKARSMEGYFHVKVSGFGLSTAR 367 (811)
Q Consensus 341 sNILI~~~g~d~~~~vKL~DFGlA~~~ 367 (811)
+||+++ ++ .++|+|||++...
T Consensus 178 ~NIli~-~~-----~i~LiDFg~a~~~ 198 (237)
T smart00090 178 YNILVH-DG-----KVVIIDVSQSVEL 198 (237)
T ss_pred hhEEEE-CC-----CEEEEEChhhhcc
Confidence 999998 44 7999999998643
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.53 E-value=4.8e-14 Score=144.60 Aligned_cols=125 Identities=22% Similarity=0.302 Sum_probs=97.2
Q ss_pred eecccc---eEEEEEEcCCEEEEEEecc------------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEe
Q 003542 223 RLGASS---QFKEIQWLGDSFVLRHFYG------------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVME 287 (811)
Q Consensus 223 ~lG~G~---vyk~v~~~g~~VAVK~~~~------------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmE 287 (811)
.||+|+ ||++. +.|..|++|+... ....+.+|+.++..+.|++|......+.+ ....++|||
T Consensus 3 ~l~~G~~~~vy~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--~~~~~lv~e 79 (211)
T PRK14879 3 LIKRGAEAEIYLGD-FLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD--PENFIIVME 79 (211)
T ss_pred ccccCceEEEEEEe-eCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe--CCCCEEEEE
Confidence 456664 77754 5889999998642 12457889999999999988765433432 345789999
Q ss_pred cCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccccc
Q 003542 288 LMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366 (811)
Q Consensus 288 y~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~ 366 (811)
|++| +|.+++... .. ....++.+++.+|.+||+.|++|||++|.|||++ ++ .++|+|||++..
T Consensus 80 ~~~G~~L~~~~~~~---------~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~-----~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSN---------GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GG-----KIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhc---------cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CC-----CEEEEECCcccC
Confidence 9997 888776531 11 7888999999999999999999999999999998 43 799999998753
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.5e-13 Score=145.15 Aligned_cols=133 Identities=20% Similarity=0.259 Sum_probs=98.5
Q ss_pred ceEEeeeecccceEEEEEEcCCEEEEEEecc-----------------cHHHHHHHHHHHHhCCCCcc--ceeeeeEEcc
Q 003542 217 KLMVRRRLGASSQFKEIQWLGDSFVLRHFYG-----------------ELESLNAEISTMLSLSHPNI--VQYLCGFCDE 277 (811)
Q Consensus 217 ~~~i~~~lG~G~vyk~v~~~g~~VAVK~~~~-----------------~~~~~~~Ei~iL~~L~HPNI--Vkl~~~~~~e 277 (811)
.+.+.+.+|.|++|. +...+..+|||++.. ....+.+|+.++..|.|++| ++.++.....
T Consensus 36 ~~~lg~~~g~gtv~~-v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWF-VQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEE-EEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 455556788998776 445688999998842 12457889999999998775 5555433222
Q ss_pred CCC--eEEEEEecCCC--CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCc
Q 003542 278 EKK--EFFLVMELMSK--DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGY 353 (811)
Q Consensus 278 ~~~--~~yLVmEy~~g--~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~ 353 (811)
... ..+|||||++| +|.+++.. ..++.. .+.+|+.+|.+||+.||+||||||.|||++.++
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-------~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~---- 179 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-------APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDG---- 179 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-------CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCC----
Confidence 221 23599999996 77777643 334443 357899999999999999999999999998765
Q ss_pred ceEEEeecccccc
Q 003542 354 FHVKVSGFGLSTA 366 (811)
Q Consensus 354 ~~vKL~DFGlA~~ 366 (811)
.++|+|||.+..
T Consensus 180 -~v~LIDfg~~~~ 191 (239)
T PRK01723 180 -KFWLIDFDRGEL 191 (239)
T ss_pred -CEEEEECCCccc
Confidence 799999998753
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.4e-13 Score=140.01 Aligned_cols=118 Identities=22% Similarity=0.260 Sum_probs=89.9
Q ss_pred cceEEEEEEcCCEEEEEEecc------------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEecCCC-CH
Q 003542 227 SSQFKEIQWLGDSFVLRHFYG------------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DL 293 (811)
Q Consensus 227 G~vyk~v~~~g~~VAVK~~~~------------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~~g-~L 293 (811)
|.||++. +.|..|++|.+.. ....+.+|++++..+.|+++......+.. ....++||||++| +|
T Consensus 8 ~~vy~~~-~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--~~~~~lv~e~~~g~~l 84 (199)
T TIGR03724 8 AIIYLGD-FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVD--PDNKTIVMEYIEGKPL 84 (199)
T ss_pred EEEEEee-cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEE--CCCCEEEEEEECCccH
Confidence 3378765 7899999999642 12557789999999988765433322322 2346899999996 77
Q ss_pred HHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccccc
Q 003542 294 SCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366 (811)
Q Consensus 294 ~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~ 366 (811)
.+++... . . .++.+++.+|.+||+.|++|||++|.||+++ ++ .++++|||++..
T Consensus 85 ~~~~~~~------~-~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~-----~~~liDfg~a~~ 138 (199)
T TIGR03724 85 KDVIEEG------N-D------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DD-----KLYLIDFGLGKY 138 (199)
T ss_pred HHHHhhc------H-H------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CC-----cEEEEECCCCcC
Confidence 7766431 1 0 7889999999999999999999999999998 44 799999998754
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.3e-13 Score=140.67 Aligned_cols=128 Identities=13% Similarity=0.153 Sum_probs=96.3
Q ss_pred eEEeeeecccc---eEEEEEEcCCEEEEEEeccc--------------------------HHHHHHHHHHHHhCCCCc--
Q 003542 218 LMVRRRLGASS---QFKEIQWLGDSFVLRHFYGE--------------------------LESLNAEISTMLSLSHPN-- 266 (811)
Q Consensus 218 ~~i~~~lG~G~---vyk~v~~~g~~VAVK~~~~~--------------------------~~~~~~Ei~iL~~L~HPN-- 266 (811)
|.+.+.||.|+ +|++...+|+.||||++... ...+..|+.++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 66677788876 78776668999999986421 123678999999998874
Q ss_pred cceeeeeEEccCCCeEEEEEecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE
Q 003542 267 IVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYL 345 (811)
Q Consensus 267 IVkl~~~~~~e~~~~~yLVmEy~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI 345 (811)
++..++ . ...++||||++| +|..... ......++.+|+.++.++|+.||+||||||+||++
T Consensus 97 v~~~~~----~--~~~~lv~e~~~g~~L~~~~~------------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill 158 (198)
T cd05144 97 VPKPID----W--NRHAVVMEYIDGVELYRVRV------------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILV 158 (198)
T ss_pred CCceee----c--CCceEEEEEeCCcchhhccc------------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEE
Confidence 444331 1 235899999997 5543221 03456788999999999999999999999999999
Q ss_pred eccCCCCcceEEEeecccccccc
Q 003542 346 KARSMEGYFHVKVSGFGLSTART 368 (811)
Q Consensus 346 ~~~g~d~~~~vKL~DFGlA~~~~ 368 (811)
+.++ .++|+|||++....
T Consensus 159 ~~~~-----~~~liDfg~~~~~~ 176 (198)
T cd05144 159 DDDE-----KIYIIDWPQMVSTD 176 (198)
T ss_pred cCCC-----cEEEEECCccccCC
Confidence 8765 89999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.43 E-value=6.5e-13 Score=156.02 Aligned_cols=126 Identities=21% Similarity=0.258 Sum_probs=95.4
Q ss_pred eEEeeeecccc---eEEEEEEcCCEEEEEEec-c-----------cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeE
Q 003542 218 LMVRRRLGASS---QFKEIQWLGDSFVLRHFY-G-----------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEF 282 (811)
Q Consensus 218 ~~i~~~lG~G~---vyk~v~~~g~~VAVK~~~-~-----------~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~ 282 (811)
|...+.||+|+ ||++. +.+..+++|+.. . ..+.+.+|++++..++|++|+..+..... ....
T Consensus 335 ~~~~~~iG~G~~g~Vy~~~-~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--~~~~ 411 (535)
T PRK09605 335 KIPDHLIGKGAEADIKKGE-YLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD--PEEK 411 (535)
T ss_pred cCccceeccCCcEEEEEEe-ecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe--CCCC
Confidence 34566788875 77743 556566665531 1 12468899999999999999876533332 3346
Q ss_pred EEEEecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeec
Q 003542 283 FLVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGF 361 (811)
Q Consensus 283 yLVmEy~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DF 361 (811)
++||||++| +|.+++. ....++.+++.+|.|||+.|++||||||+|||++ ++ .++|+||
T Consensus 412 ~lv~E~~~g~~L~~~l~--------------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-~~-----~~~liDF 471 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE--------------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-DD-----RLYLIDF 471 (535)
T ss_pred EEEEEecCCCcHHHHHH--------------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-CC-----cEEEEeC
Confidence 899999996 8877764 2457889999999999999999999999999994 33 7999999
Q ss_pred ccccc
Q 003542 362 GLSTA 366 (811)
Q Consensus 362 GlA~~ 366 (811)
|+++.
T Consensus 472 Gla~~ 476 (535)
T PRK09605 472 GLGKY 476 (535)
T ss_pred ccccc
Confidence 99865
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.42 E-value=2.1e-14 Score=169.44 Aligned_cols=247 Identities=20% Similarity=0.266 Sum_probs=178.7
Q ss_pred ceEEeeeecccceEEEEE------EcCCEEEEEEecc------cHHHHHHHHHHHHhCC-CCccceeeeeEEccCCCeEE
Q 003542 217 KLMVRRRLGASSQFKEIQ------WLGDSFVLRHFYG------ELESLNAEISTMLSLS-HPNIVQYLCGFCDEEKKEFF 283 (811)
Q Consensus 217 ~~~i~~~lG~G~vyk~v~------~~g~~VAVK~~~~------~~~~~~~Ei~iL~~L~-HPNIVkl~~~~~~e~~~~~y 283 (811)
.|.+.+.||.| .|..+. .....+|+|.+.. .......|..+-..+. |+|++++++.. ......+
T Consensus 21 ~~~~~~~ig~g-s~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~--~~~~~~~ 97 (601)
T KOG0590|consen 21 QYKLSRSIGKG-SFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPS--SSPRSYL 97 (601)
T ss_pred ccccccccccc-ccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCcc--CCCcccc
Confidence 46677778888 455442 1334567777642 2344556888888886 99999998666 5566789
Q ss_pred EEEecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCceeccCCCCcEEEeccCCCCcceEEEeec
Q 003542 284 LVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLH-AQKIYHGELNPSNIYLKARSMEGYFHVKVSGF 361 (811)
Q Consensus 284 LVmEy~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLH-s~gIVHRDLKPsNILI~~~g~d~~~~vKL~DF 361 (811)
++++|..| ++...+... .....+...+-.++.|+..++.|+| ..++.||||||+|.+++..+. .++++||
T Consensus 98 ~~~~~s~g~~~f~~i~~~----~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~----~l~~~df 169 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHP----DSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGS----ALKIADF 169 (601)
T ss_pred cccCcccccccccccccC----CccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCC----cccCCCc
Confidence 99999875 676655211 1125677788899999999999999 999999999999999987752 7999999
Q ss_pred cccccccccCCCCCCCCCCCCCCCC-CCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccch
Q 003542 362 GLSTARTYASRNTPPASPQNQTAPN-PYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQG 440 (811)
Q Consensus 362 GlA~~~~~~~~~~~~~~~~~~~~~G-T~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~ 440 (811)
|+|......... ........| ++.|+|||.+.+.. ...+..|+||.|+++.-+++|..||.......
T Consensus 170 ~~At~~~~~~g~----~~~~~~~~g~s~~y~a~E~~~~~~--------~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~ 237 (601)
T KOG0590|consen 170 GLATAYRNKNGA----ERSLKDRCGSSPPYGAPEHLSGKA--------YRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD 237 (601)
T ss_pred hhhccccccCCc----ceeeecccCCCCCCCCcccccchh--------hcCCCcccccccccccccccCCCCcccccccc
Confidence 999877652111 222335566 99999999997642 44678999999999999999999997644333
Q ss_pred HHHHHHHHhCCC--CCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHH
Q 003542 441 DKMTKNIRAGER--PLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 441 ~~i~~~i~~~~~--~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
......+..... ............+++.+++..+|..|.+.+++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 238 GRYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred ccceeecccccccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 222222222111 2233556777899999999999999999988754
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.34 E-value=6.3e-12 Score=119.45 Aligned_cols=125 Identities=19% Similarity=0.196 Sum_probs=96.9
Q ss_pred eeeecccc---eEEEEEEcCCEEEEEEecccH--HHHHHHHHHHHhCCC--CccceeeeeEEccCCCeEEEEEecCCCC-
Q 003542 221 RRRLGASS---QFKEIQWLGDSFVLRHFYGEL--ESLNAEISTMLSLSH--PNIVQYLCGFCDEEKKEFFLVMELMSKD- 292 (811)
Q Consensus 221 ~~~lG~G~---vyk~v~~~g~~VAVK~~~~~~--~~~~~Ei~iL~~L~H--PNIVkl~~~~~~e~~~~~yLVmEy~~g~- 292 (811)
.+.+|.|. +|+.. ..+..+++|.+.... ..+.+|+.++..+.| +++++++..+ +..+..|++|||++|.
T Consensus 3 ~~~i~~g~~~~v~~~~-~~~~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~--~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 3 IKLLKGGLTNRVYLLG-TKDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASG--ESDGWSYLLMEWIEGET 79 (155)
T ss_pred ceecccccccceEEEE-ecCCeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEc--CCCCccEEEEEecCCee
Confidence 35566664 66644 455899999997643 579999999999976 5888887444 3446789999999873
Q ss_pred HHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCCCcEEEeccCCCCcceEEEeecccccc
Q 003542 293 LSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQ---KIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366 (811)
Q Consensus 293 L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~---gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~ 366 (811)
+..+ +......++.+++.+|.+||.. +++|+||+|.|||++..+ .++++|||++..
T Consensus 80 ~~~~-------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~-----~~~l~Df~~~~~ 138 (155)
T cd05120 80 LDEV-------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGK-----ILGIIDWEYAGY 138 (155)
T ss_pred cccC-------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCc-----EEEEEecccccC
Confidence 3221 4456677889999999999985 699999999999998755 899999998753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.32 E-value=5.4e-12 Score=126.87 Aligned_cols=126 Identities=14% Similarity=0.216 Sum_probs=87.0
Q ss_pred eeecccc---eEEEEEEcCCEEEEEEecccH------HHH----------------------HHHHHHHHhCCCCc--cc
Q 003542 222 RRLGASS---QFKEIQWLGDSFVLRHFYGEL------ESL----------------------NAEISTMLSLSHPN--IV 268 (811)
Q Consensus 222 ~~lG~G~---vyk~v~~~g~~VAVK~~~~~~------~~~----------------------~~Ei~iL~~L~HPN--IV 268 (811)
+.||+|+ +|.+...+|+.||||++.... ..+ ..|...+..+.+.. +.
T Consensus 3 ~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~ 82 (187)
T cd05119 3 GPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVP 82 (187)
T ss_pred cccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCC
Confidence 3456554 888776689999999985321 111 35666666664332 44
Q ss_pred eeeeeEEccCCCeEEEEEecCCC-CHH-HHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEE
Q 003542 269 QYLCGFCDEEKKEFFLVMELMSK-DLS-CYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHA-QKIYHGELNPSNIYL 345 (811)
Q Consensus 269 kl~~~~~~e~~~~~yLVmEy~~g-~L~-~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs-~gIVHRDLKPsNILI 345 (811)
+.++ + ...++||||++| ++. ..+... ... ..+..++.+++.++.++|. .||+||||||+||++
T Consensus 83 ~~~~-~-----~~~~lv~e~~~g~~~~~~~l~~~-------~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili 148 (187)
T cd05119 83 KPID-L-----NRHVLVMEFIGGDGIPAPRLKDV-------RLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILV 148 (187)
T ss_pred ceEe-c-----CCCEEEEEEeCCCCccChhhhhh-------hhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEE
Confidence 4431 1 125899999997 321 122211 011 5678899999999999999 999999999999999
Q ss_pred eccCCCCcceEEEeeccccccc
Q 003542 346 KARSMEGYFHVKVSGFGLSTAR 367 (811)
Q Consensus 346 ~~~g~d~~~~vKL~DFGlA~~~ 367 (811)
+ ++ .++|+|||.+...
T Consensus 149 ~-~~-----~~~liDfg~a~~~ 164 (187)
T cd05119 149 D-DG-----KVYIIDVPQAVEI 164 (187)
T ss_pred E-CC-----cEEEEECcccccc
Confidence 8 44 7999999998644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.2e-11 Score=141.12 Aligned_cols=254 Identities=20% Similarity=0.262 Sum_probs=182.6
Q ss_pred hcceEEeeeecc--cc---eEEEE---EEcCCEEEEEEec----c--cHHHHHHHHHHHHhC-CCCccceeeeeEEccCC
Q 003542 215 LKKLMVRRRLGA--SS---QFKEI---QWLGDSFVLRHFY----G--ELESLNAEISTMLSL-SHPNIVQYLCGFCDEEK 279 (811)
Q Consensus 215 ~k~~~i~~~lG~--G~---vyk~v---~~~g~~VAVK~~~----~--~~~~~~~Ei~iL~~L-~HPNIVkl~~~~~~e~~ 279 (811)
...+.+...+|. |. +|... ...+..+|+|.-+ . ....-.+|+...+.+ .|+|.++.+..+ ++.
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~--e~~ 190 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW--EGS 190 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc--ccC
Confidence 345666777777 63 44333 2367789999832 1 233446788877888 499999987777 677
Q ss_pred CeEEEEEecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCceeccCCCCcEEEeccCCCCcce
Q 003542 280 KEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIAR----GMEFLHAQKIYHGELNPSNIYLKARSMEGYFH 355 (811)
Q Consensus 280 ~~~yLVmEy~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~----gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~ 355 (811)
+..|+-+|+|..+|..+.... ..-++...++.++.+..+ ||.++|+.+++|-|+||.||++..++ ..
T Consensus 191 ~~lfiqtE~~~~sl~~~~~~~-----~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~----~s 261 (524)
T KOG0601|consen 191 GILFIQTELCGESLQSYCHTP-----CNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDW----TS 261 (524)
T ss_pred CcceeeeccccchhHHhhhcc-----cccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheeccccc----ce
Confidence 889999999999888887653 244788889999999999 99999999999999999999997763 28
Q ss_pred EEEeeccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCC
Q 003542 356 VKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFED 435 (811)
Q Consensus 356 vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~ 435 (811)
++++|||+...+........ ........|...|++||.+.+ -++...|||++|.++.+..+|..++..
T Consensus 262 ~~~~df~~v~~i~~~~~~~~--~~~~~r~~~~~~Y~~ke~~~~----------l~~~~~di~sl~ev~l~~~l~~~~~~~ 329 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSV--FKVSKRPEGDCIYAAKELLNG----------LATFASDIFSLGEVILEAILGSHLPSV 329 (524)
T ss_pred eecCCcceeEEccCCccccc--eeeeecCCCCceEeChhhhcc----------ccchHhhhcchhhhhHhhHhhcccccC
Confidence 99999999877765442111 111123356677999999865 678999999999999999998776644
Q ss_pred CccchHHHHHHHHhCC-CCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHHHHHHHHh
Q 003542 436 GHLQGDKMTKNIRAGE-RPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKKFM 495 (811)
Q Consensus 436 ~~~~~~~i~~~i~~~~-~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~k~l 495 (811)
..... ...++.+. ...+-...+..+...+.+|++.+|-.|++++.+.. |..|...+
T Consensus 330 g~~~~---W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~-l~~i~s~~ 386 (524)
T KOG0601|consen 330 GKNSS---WSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA-LNVIHSKL 386 (524)
T ss_pred CCCCC---ccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc-cccccchh
Confidence 31111 11112211 11233344556777999999999999999887765 66666443
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.11 E-value=8.4e-10 Score=126.50 Aligned_cols=128 Identities=18% Similarity=0.238 Sum_probs=85.8
Q ss_pred eecccc---eEEEEEEcCCEEEEEEecccH-H-------------------------------------------HHHHH
Q 003542 223 RLGASS---QFKEIQWLGDSFVLRHFYGEL-E-------------------------------------------SLNAE 255 (811)
Q Consensus 223 ~lG~G~---vyk~v~~~g~~VAVK~~~~~~-~-------------------------------------------~~~~E 255 (811)
.||.|+ ||++...+|+.||||+.+... + ++.+|
T Consensus 124 plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~E 203 (437)
T TIGR01982 124 PLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRRE 203 (437)
T ss_pred ceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHHH
Confidence 456654 999998899999999985321 1 24455
Q ss_pred HHHHHhC----C-CCcc--ceeeeeEEccCCCeEEEEEecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHH-HHH
Q 003542 256 ISTMLSL----S-HPNI--VQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIAR-GME 326 (811)
Q Consensus 256 i~iL~~L----~-HPNI--Vkl~~~~~~e~~~~~yLVmEy~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~-gL~ 326 (811)
+..+.++ . +++| .++|..+ ....+|||||++| +|.++..... ..++ ...++.+++. .+.
T Consensus 204 a~n~~~~~~~~~~~~~v~vP~v~~~~----~~~~vLvmE~i~G~~L~~~~~~~~-----~~~~---~~~ia~~~~~~~l~ 271 (437)
T TIGR01982 204 AANASELGENFKNDPGVYVPEVYWDR----TSERVLTMEWIDGIPLSDIAALDE-----AGLD---RKALAENLARSFLN 271 (437)
T ss_pred HHHHHHHHHhcCCCCCEEeCCEehhh----cCCceEEEEeECCcccccHHHHHh-----cCCC---HHHHHHHHHHHHHH
Confidence 5555555 2 3332 2333222 2235899999997 6666554210 1122 2345556655 478
Q ss_pred HHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccc
Q 003542 327 FLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTAR 367 (811)
Q Consensus 327 yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~ 367 (811)
.+|..|++|+|+||.||+++.++ .++|+|||++...
T Consensus 272 ql~~~g~~H~D~hPgNilv~~~g-----~i~liDfG~~~~l 307 (437)
T TIGR01982 272 QVLRDGFFHADLHPGNIFVLKDG-----KIIALDFGIVGRL 307 (437)
T ss_pred HHHhCCceeCCCCcccEEECCCC-----cEEEEeCCCeeEC
Confidence 89999999999999999998776 8999999998654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.11 E-value=6.8e-11 Score=125.70 Aligned_cols=215 Identities=20% Similarity=0.296 Sum_probs=137.9
Q ss_pred HHHHHHHHHHHHhCCCCccceeeeeEEc---cCCCeEEEEEecCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHH
Q 003542 249 LESLNAEISTMLSLSHPNIVQYLCGFCD---EEKKEFFLVMELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARG 324 (811)
Q Consensus 249 ~~~~~~Ei~iL~~L~HPNIVkl~~~~~~---e~~~~~yLVmEy~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~g 324 (811)
.+..+.=+.-|.++.|-|||+++.+|.+ ++.....+++|||. |+|..+|++.. +....+......+|+-||+.|
T Consensus 111 eek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~--~~~~a~~~~~wkkw~tqIlsa 188 (458)
T KOG1266|consen 111 EEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTK--KNQKALFQKAWKKWCTQILSA 188 (458)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHH--HhhhhhhHHHHHHHHHHHHhh
Confidence 3444455566777889999999866643 24456789999999 79999998752 223457777888999999999
Q ss_pred HHHHHhC--CceeccCCCCcEEEeccCCCCcceEEEeeccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCC
Q 003542 325 MEFLHAQ--KIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGT 402 (811)
Q Consensus 325 L~yLHs~--gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~ 402 (811)
|.|||+. -|+|+++..+-|++..+| -+|+.--.... ....... ..........+-+.|.|||.=.
T Consensus 189 l~yLhs~~PpiihgnlTc~tifiq~ng-----LIkig~~ap~s-~h~s~~~--~~~~Ek~~~~~~~g~~a~~sg~----- 255 (458)
T KOG1266|consen 189 LSYLHSCDPPIIHGNLTCDTIFIQHNG-----LIKIGSVAPDS-THPSVNS--TREAEKSVNTSLPGFSAPESGT----- 255 (458)
T ss_pred hhhhhccCCccccCCcchhheeecCCc-----eEEecccCccc-cchhhhh--hhHhhhhccccCCccccCCcCc-----
Confidence 9999997 499999999999998776 56654211110 0000000 0001111233456788888632
Q ss_pred CCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHH
Q 003542 403 GSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFS 482 (811)
Q Consensus 403 ~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~ 482 (811)
....+.++|||+||+...+|..+..--.... ........+..-. +. .....-+++|.+|++.+|..||++.
T Consensus 256 ----~tn~~~a~dIy~fgmcAlemailEiq~tnse-S~~~~ee~ia~~i---~~-len~lqr~~i~kcl~~eP~~rp~ar 326 (458)
T KOG1266|consen 256 ----TTNTTGASDIYKFGMCALEMAILEIQSTNSE-SKVEVEENIANVI---IG-LENGLQRGSITKCLEGEPNGRPDAR 326 (458)
T ss_pred ----ccccccchhhhhhhHHHHHHHHheeccCCCc-ceeehhhhhhhhe---ee-ccCccccCcCcccccCCCCCCcchh
Confidence 2356778999999999999998765321111 1001111111100 00 0111136789999999999999999
Q ss_pred HHHHH
Q 003542 483 SICRI 487 (811)
Q Consensus 483 eIl~~ 487 (811)
.++.+
T Consensus 327 ~llfH 331 (458)
T KOG1266|consen 327 LLLFH 331 (458)
T ss_pred hhhcC
Confidence 87653
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.09 E-value=3.7e-11 Score=143.27 Aligned_cols=211 Identities=21% Similarity=0.325 Sum_probs=157.5
Q ss_pred cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHH
Q 003542 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGME 326 (811)
Q Consensus 248 ~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~ 326 (811)
+.+....+-.++-...||-++..+..+ .-....+|||+|+.| +|...|... ...+.+-+..++..+..+++
T Consensus 847 ~~~s~r~~s~~~i~p~~P~v~~~~~s~--~~rsP~~L~~~~~~~~~~~Skl~~~------~~~saepaRs~i~~~vqs~e 918 (1205)
T KOG0606|consen 847 DYESIRSKSNILITPRSPAVVRSFPSF--PCRSPLPLVGHYLNGGDLPSKLHNS------GCLSAEPARSPILERVQSLE 918 (1205)
T ss_pred cccccCCccCccccCCCCceecccCCC--CCCCCcchhhHHhccCCchhhhhcC------CCcccccccchhHHHHhhhh
Confidence 345555666666666778888876554 334568999999984 888877753 45666777888899999999
Q ss_pred HHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccccccC---------------------C-CCCC--CCCCCC
Q 003542 327 FLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYAS---------------------R-NTPP--ASPQNQ 382 (811)
Q Consensus 327 yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~~---------------------~-~~~~--~~~~~~ 382 (811)
|||...+.|||++|.|+|+...+ +.+++|||......... . .... ......
T Consensus 919 ~L~s~~r~h~~~~p~~~l~~~~g-----h~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 993 (1205)
T KOG0606|consen 919 SLHSSLRKHRDLKPDSLLIAYDG-----HRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKH 993 (1205)
T ss_pred ccccchhhcccccccchhhcccC-----CcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccc
Confidence 99999999999999999998887 89999998432211110 0 0000 001234
Q ss_pred CCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHHHHhCCCC--CCCCCCh
Q 003542 383 TAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERP--LFPSGSP 460 (811)
Q Consensus 383 ~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i~~~~~~--~~p~~~~ 460 (811)
...||+.|.+||.+.+. .....+|+|++|++++|.++|.+||..... ..+++.+..+..+ .-+...+
T Consensus 994 ~~~~t~~~laPe~~lg~---------~hgs~ad~~~~g~~l~e~l~g~pp~na~tp--q~~f~ni~~~~~~~p~g~~~~s 1062 (1205)
T KOG0606|consen 994 AVVGTPDYLAPEILLGR---------RHGSAADWWSSGVCLFEVLTGIPPFNAETP--QQIFENILNRDIPWPEGPEEGS 1062 (1205)
T ss_pred cccCCCcccCCcccccc---------cCCCcchhhhhhhhhhhhhcCCCCCCCcch--hhhhhccccCCCCCCCCccccC
Confidence 56799999999999865 566789999999999999999999987543 3455666655433 3456678
Q ss_pred HHHHHHHhhhccCCCCCCCCHH
Q 003542 461 KYLVNLTKKCWHTNPSQRPSFS 482 (811)
Q Consensus 461 ~~l~~LI~~cL~~DP~~RPS~~ 482 (811)
...++++...+..+|.+|..+.
T Consensus 1063 ~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1063 YEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hhhhhhhhhhhccCchhccCcc
Confidence 8899999999999999998765
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.3e-09 Score=111.46 Aligned_cols=96 Identities=14% Similarity=0.216 Sum_probs=72.2
Q ss_pred HHHHHHHHhCC--CCccceeeeeEEccCCCeEEEEEecCCCC-HHH-HHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 003542 253 NAEISTMLSLS--HPNIVQYLCGFCDEEKKEFFLVMELMSKD-LSC-YMRETFGSRRRNSFSLPVVVDIMLQIARGMEFL 328 (811)
Q Consensus 253 ~~Ei~iL~~L~--HPNIVkl~~~~~~e~~~~~yLVmEy~~g~-L~~-~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yL 328 (811)
.+|++.|.++. .-++.+.++ + . .-+|||||++++ +.. .+++ ..++......+..+++.+|.+|
T Consensus 74 ~kE~r~L~rl~~~Gv~vP~pi~-~--~---~~~lvME~Ig~~~~~~~~Lkd-------~~~~~~~~~~i~~~i~~~l~~l 140 (197)
T cd05146 74 EKEMHNLKRMQKAGIPCPEVVV-L--K---KHVLVMSFIGDDQVPAPKLKD-------AKLNDEEMKNAYYQVLSMMKQL 140 (197)
T ss_pred HHHHHHHHHHHHcCCCCCeEEE-e--c---CCEEEEEEcCCCCccchhhhc-------cccCHHHHHHHHHHHHHHHHHH
Confidence 38999999994 356677663 2 1 248999999863 322 2222 2355566778889999999999
Q ss_pred -HhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccc
Q 003542 329 -HAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTAR 367 (811)
Q Consensus 329 -Hs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~ 367 (811)
|..|++||||++.|||+..+ .+.|+|||.+...
T Consensus 141 ~H~~glVHGDLs~~NIL~~~~------~v~iIDF~qav~~ 174 (197)
T cd05146 141 YKECNLVHADLSEYNMLWHDG------KVWFIDVSQSVEP 174 (197)
T ss_pred HHhCCeecCCCCHHHEEEECC------cEEEEECCCceeC
Confidence 89999999999999999743 6999999987544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG4171 consensus Adenylate/guanylate kinase [Nucleotide transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.05 E-value=2.3e-11 Score=140.15 Aligned_cols=119 Identities=14% Similarity=0.108 Sum_probs=96.0
Q ss_pred hhhhcCCCCCCCcCCcchhhHHhhhhHHHhhhccCccCcccccCCCCCCCCCCcccccccCCCCCCccccccCCCchhHh
Q 003542 522 RKFVGEGCPDVAPVSQIPFQMFAYKIAEKEKANSSNKGKHWELGSDVASTCKDEVFSVGDEGMVPVTETRSVCSDVKSVT 601 (811)
Q Consensus 522 ~~~~~e~~~~~~k~~~ll~qml~~~vaEeek~g~~~~f~~~d~~s~~~~~~~de~~~~~sd~~~~~~t~~s~~st~~~v~ 601 (811)
++...+.+.++.+++.+|++|+|+.+|++++.|.. ++...+ +++++.|+|+++| |.+++..+|+|||
T Consensus 400 e~~~~~Le~EKkkTd~LLy~mlP~~VA~qLr~g~~-----v~a~~f------~~vTilFsdIv~F--t~ic~~ctp~~vV 466 (671)
T KOG4171|consen 400 EKMTRELEEEKKKTDTLLYSMLPRSVAQQLRQGES-----VDAKEF------DDVTILFSDIVGF--TAICSQCTPMQVV 466 (671)
T ss_pred HHHHHHHHHHHhhHHHHHHHhCCHHHHHHHHcCCC-----cCcccc------CceEEEEeccchH--HhHhhccCcHHHH
Confidence 33334434467899999999999999999999997 888888 8999999999999 9999999999999
Q ss_pred hhhccccccccCccccCCcccccccCCCcccch-h----------hHHHH-HHHhhhhcccCCCC
Q 003542 602 FDMRSVYSEAFGKKVSNFDTRSVRSESPNKKMQ-G----------SVSRL-IQSMVLEKNVSSSD 654 (811)
Q Consensus 602 ~~~~~~~~~~~~~~i~~~d~~kv~~~~~~~~~~-~----------~~~~~-~~~~~~~~~~~~~~ 654 (811)
.+||.| |+.||++|+.|||||||+-.-.=-.+ | -+..+ ++-|..-|.|-..+
T Consensus 467 ~~LN~l-yt~fD~~i~~~~VYKVETIGDaYm~vsG~P~~~~~HAe~i~~~AL~Mm~~ak~v~~p~ 530 (671)
T KOG4171|consen 467 NMLNEL-YTRFDRIIDTHDVYKVETIGDAYMVVSGLPDASDYHAEHIADLALGMMEEAKEVVSPV 530 (671)
T ss_pred HHHHHH-HHHHHHhhcccCeEEEeeccchheeecCCCCCChhHHHHHHHHHHHHHHHhhhhcCcC
Confidence 999999 99999999999999999975433222 2 23333 44455566666554
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.3e-09 Score=107.57 Aligned_cols=118 Identities=17% Similarity=0.189 Sum_probs=83.9
Q ss_pred eecccc---eEEEEEEcCCEEEEEEeccc---HHHHHHHHHHHHhCCCCccc-eeeeeEEccCCCeEEEEEecCCC-CHH
Q 003542 223 RLGASS---QFKEIQWLGDSFVLRHFYGE---LESLNAEISTMLSLSHPNIV-QYLCGFCDEEKKEFFLVMELMSK-DLS 294 (811)
Q Consensus 223 ~lG~G~---vyk~v~~~g~~VAVK~~~~~---~~~~~~Ei~iL~~L~HPNIV-kl~~~~~~e~~~~~yLVmEy~~g-~L~ 294 (811)
.++.|. +|.. ...|..|++|..... ...+.+|+.++..+.+.+++ +++ .+. .+ ..++||||++| ++.
T Consensus 5 ~l~~G~~~~vy~~-~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~-~~~-~~--~~~lv~e~i~G~~l~ 79 (170)
T cd05151 5 PLKGGMTNKNYRV-EVANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLY-YFD-PE--TGVLITEFIEGSELL 79 (170)
T ss_pred ecCCcccCceEEE-EECCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceE-EEe-CC--CCeEEEEecCCCccc
Confidence 445553 6763 456889999998653 24578999999999655554 444 332 22 24799999997 432
Q ss_pred HHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCc-----eeccCCCCcEEEeccCCCCcceEEEeeccccc
Q 003542 295 CYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKI-----YHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365 (811)
Q Consensus 295 ~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gI-----VHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~ 365 (811)
.. . .....++.+++.+|..||..++ +|||++|.||+++ ++ .++++|||.+.
T Consensus 80 ~~-----------~---~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~-----~~~liDf~~a~ 135 (170)
T cd05151 80 TE-----------D---FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DG-----RLWLIDWEYAG 135 (170)
T ss_pred cc-----------c---ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CC-----eEEEEeccccc
Confidence 21 0 1113456799999999999885 9999999999998 33 68999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.04 E-value=2.6e-09 Score=123.41 Aligned_cols=162 Identities=21% Similarity=0.298 Sum_probs=120.5
Q ss_pred EEEcCCEEEEEEecc--c--HHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEecCCCCHHHHHHHhhCCCCCCC
Q 003542 233 IQWLGDSFVLRHFYG--E--LESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNS 308 (811)
Q Consensus 233 v~~~g~~VAVK~~~~--~--~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~~g~L~~~L~~~~~~~~~~~ 308 (811)
.+-++.+|.|..++. . .+...+-++.|+.|+||||++|++.+ +..+.+|||+|-+.. |..++.+.
T Consensus 33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~--e~~~~~ylvTErV~P-l~~~lk~l-------- 101 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTT--EEEGTLYLVTERVRP-LETVLKEL-------- 101 (690)
T ss_pred eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhh--cccCceEEEeecccc-HHHHHHHh--------
Confidence 456888999988864 2 35578889999999999999999877 566689999998763 44566542
Q ss_pred CCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEeccCCCCcceEEEeeccccccccccCCCCCCCCCCCCCCCCC
Q 003542 309 FSLPVVVDIMLQIARGMEFLHA-QKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNP 387 (811)
Q Consensus 309 ls~~~i~~i~~QIa~gL~yLHs-~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT 387 (811)
....+.--+.||+.||.|||. .+++|++|.-+.|+|+..| ..||++|.++........ .......-
T Consensus 102 -~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~G-----eWkLggle~v~~~~~~~~-------~~~~~~~~ 168 (690)
T KOG1243|consen 102 -GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESG-----EWKLGGLELVSKASGFNA-------PAKSLYLI 168 (690)
T ss_pred -HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCC-----cEEEeeeEEEeccccCCc-------ccccchhh
Confidence 245667778899999999985 5799999999999999988 899999998754432211 00111112
Q ss_pred CccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhC
Q 003542 388 YIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTG 429 (811)
Q Consensus 388 ~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG 429 (811)
-.|..|+.+.. -+...|.|-|||++++++.|
T Consensus 169 ~s~~~P~~~~~-----------s~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 169 ESFDDPEEIDP-----------SEWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred hcccChhhcCc-----------cccchhhhhHHHHHHHHhCc
Confidence 23666765531 12457999999999999999
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.01 E-value=1.3e-09 Score=126.91 Aligned_cols=142 Identities=16% Similarity=0.214 Sum_probs=84.2
Q ss_pred hcceEEeeeecccc---eEEEEEEc-CCEEEEEEecccH--------------------------------------H--
Q 003542 215 LKKLMVRRRLGASS---QFKEIQWL-GDSFVLRHFYGEL--------------------------------------E-- 250 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~~~-g~~VAVK~~~~~~--------------------------------------~-- 250 (811)
+..|.. +.+|.|+ ||++...+ |+.||||+..... +
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 445555 5677776 88888776 9999999995321 1
Q ss_pred ----HHHHHHHHHHhCC----CCccceeeeeEEccCCCeEEEEEecCCC-CHHHH--HHHhhCCCCCCCCCHHHHHHHHH
Q 003542 251 ----SLNAEISTMLSLS----HPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCY--MRETFGSRRRNSFSLPVVVDIML 319 (811)
Q Consensus 251 ----~~~~Ei~iL~~L~----HPNIVkl~~~~~~e~~~~~yLVmEy~~g-~L~~~--L~~~~~~~~~~~ls~~~i~~i~~ 319 (811)
++.+|+..+.++. +.+.+.+-..+. +-...-+|||||+.| .+.++ +... + .....+....+..++.
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~-d~st~~VLvmE~i~G~~l~d~~~l~~~-g-~d~~~la~~~v~~~~~ 274 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYW-DYCSETVMVMERMYGIPVSDVAALRAA-G-TDMKLLAERGVEVFFT 274 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeec-ccCCCceEEEeeecCccHHhHHHHHhc-C-CCHHHHHHHHHHHHHH
Confidence 1344444444442 332222222221 112235799999997 66553 2211 0 0001233333444444
Q ss_pred HHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccccccc
Q 003542 320 QIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTART 368 (811)
Q Consensus 320 QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~ 368 (811)
|+ +..|++|+|+||.||+++.++ .....++++|||++...+
T Consensus 275 Qi-------f~~GffHaDpHPGNIlv~~~g-~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 275 QV-------FRDGFFHADMHPGNIFVSYDP-PENPRYIALDFGIVGSLN 315 (537)
T ss_pred HH-------HhCCeeeCCCChHHeEEecCC-CCCCeEEEEecceEEECC
Confidence 44 468999999999999998775 223479999999987654
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.01 E-value=3e-10 Score=129.78 Aligned_cols=238 Identities=21% Similarity=0.242 Sum_probs=167.1
Q ss_pred hcceEEeeeecccc---eEEEEE--EcCCEEEEEEecccH------HHHHHHHHHHHhC-CCCccceeeeeEEccCCCeE
Q 003542 215 LKKLMVRRRLGASS---QFKEIQ--WLGDSFVLRHFYGEL------ESLNAEISTMLSL-SHPNIVQYLCGFCDEEKKEF 282 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~--~~g~~VAVK~~~~~~------~~~~~Ei~iL~~L-~HPNIVkl~~~~~~e~~~~~ 282 (811)
..+|..+..||.|. +|++.. .++..|++|.+.+.. ..-..|+.+...+ .|.+++.++..|.. ....
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~--~r~~ 341 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ--LRQG 341 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccc--cccc
Confidence 34678888888886 566552 377899999986532 2224566666666 59999998888853 3446
Q ss_pred EEEEecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeec
Q 003542 283 FLVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGF 361 (811)
Q Consensus 283 yLVmEy~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DF 361 (811)
||--|||.+ ++...+.- ...+++...+.+..|++.++.++|+..++|+|+||+||++..++ +..++.||
T Consensus 342 ~ip~e~~~~~s~~l~~~~------~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~----~~~~~~~~ 411 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSVT------SQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDG----FFSKLGDF 411 (524)
T ss_pred cCchhhhcCcchhhhhHH------HHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccch----hhhhcccc
Confidence 799999985 43333311 14577788999999999999999999999999999999998763 37899999
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCCccC-ChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccch
Q 003542 362 GLSTARTYASRNTPPASPQNQTAPNPYIWY-APEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQG 440 (811)
Q Consensus 362 GlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~-APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~ 440 (811)
|+...+.... ....+.-.++ .+|++.. ...+..+.|+||||..+.+.++|..--....
T Consensus 412 ~~~t~~~~~~----------~~~~~~~r~~p~~~~~~e--------~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~--- 470 (524)
T KOG0601|consen 412 GCWTRLAFSS----------GVFHHIDRLYPIAEILLE--------DYPHLSKADIFSLGLSVDEAITGSPLSESGV--- 470 (524)
T ss_pred ccccccceec----------ccccccccccccchhhcc--------ccccccccccccccccccccccCcccCcccc---
Confidence 9886432211 1122222344 2555543 2367789999999999999999865322111
Q ss_pred HHHHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHH
Q 003542 441 DKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRIL 488 (811)
Q Consensus 441 ~~i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L 488 (811)
....+..+..+..+... .++..+.+.++..++..||.+.++....
T Consensus 471 --~~~~i~~~~~p~~~~~~-~~~q~~~kv~~~~~~~~~~l~~~l~~~~ 515 (524)
T KOG0601|consen 471 --QSLTIRSGDTPNLPGLK-LQLQVLLKVMINPDRKRRPSAVELSLHS 515 (524)
T ss_pred --cceeeecccccCCCchH-HhhhhhhhhhcCCccccchhhhhhcccc
Confidence 12345555555444444 7889999999999999999988776543
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.83 E-value=5.4e-08 Score=109.50 Aligned_cols=214 Identities=16% Similarity=0.211 Sum_probs=149.1
Q ss_pred ceEEEE-EEcCCEEEEEEecccHH----HHHHHHHHHHhCCCCccceeeeeEEcc--CCCeEEEEEecCCC--CHHHHHH
Q 003542 228 SQFKEI-QWLGDSFVLRHFYGELE----SLNAEISTMLSLSHPNIVQYLCGFCDE--EKKEFFLVMELMSK--DLSCYMR 298 (811)
Q Consensus 228 ~vyk~v-~~~g~~VAVK~~~~~~~----~~~~Ei~iL~~L~HPNIVkl~~~~~~e--~~~~~yLVmEy~~g--~L~~~L~ 298 (811)
+.|++. ..+|..|++|++.+... .-..-+++++++.|+|||+|.++|... ....+++|++|+++ +|.++..
T Consensus 291 Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F 370 (655)
T KOG3741|consen 291 TTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYF 370 (655)
T ss_pred eeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHc
Confidence 378877 56999999999955332 233457789999999999999887521 23468999999995 7777654
Q ss_pred HhhCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccccc
Q 003542 299 ETFGS---------RRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTY 369 (811)
Q Consensus 299 ~~~~~---------~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~ 369 (811)
..... ......++..+|.|+.|+..||.++|+.|+.-+-|.|.+||++.+- +++|+..|+.-....
T Consensus 371 ~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~-----RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 371 ANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKM-----RIRISGCGIMDVLQE 445 (655)
T ss_pred cCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcc-----eEEEecccceeeecC
Confidence 43211 1223577899999999999999999999999999999999996553 788888776543322
Q ss_pred cCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHHHHh
Q 003542 370 ASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRA 449 (811)
Q Consensus 370 ~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i~~ 449 (811)
.. + |-+.++ .+-|.=.||.+++.|.||..--.............
T Consensus 446 d~--------------~-------~~le~~------------Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~--- 489 (655)
T KOG3741|consen 446 DP--------------T-------EPLESQ------------QQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTR--- 489 (655)
T ss_pred CC--------------C-------cchhHH------------hhhhHHHHHHHHHHHhhcccccccccchHHHHHHH---
Confidence 11 0 122222 35688899999999999964311111111110111
Q ss_pred CCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHHHHHHH
Q 003542 450 GERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRIL 488 (811)
Q Consensus 450 ~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~eIl~~L 488 (811)
+....+.+++++|.-....++.+ -++.+++.++
T Consensus 490 -----I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 490 -----ITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred -----hhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence 23456778999999999888886 5677776644
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.83 E-value=3.8e-08 Score=98.14 Aligned_cols=127 Identities=18% Similarity=0.267 Sum_probs=93.8
Q ss_pred eEEEEEEcCCEEEEEEecc------------cHHHHHHHHHHHHhCCCCcc--ceeeeeEEccCCCeEEEEEecCCC--C
Q 003542 229 QFKEIQWLGDSFVLRHFYG------------ELESLNAEISTMLSLSHPNI--VQYLCGFCDEEKKEFFLVMELMSK--D 292 (811)
Q Consensus 229 vyk~v~~~g~~VAVK~~~~------------~~~~~~~Ei~iL~~L~HPNI--Vkl~~~~~~e~~~~~yLVmEy~~g--~ 292 (811)
++. ..+.|+.+.||.=.. ...+..+|+++|.++.--.| .++| |++... -.|+|||++| +
T Consensus 23 v~~-~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~--~~D~~~--~~i~ME~~~g~~~ 97 (229)
T KOG3087|consen 23 VPR-GSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLI--FIDTYG--GQIYMEFIDGAST 97 (229)
T ss_pred Eee-eccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEE--EEecCC--CeEEEEeccchhH
Confidence 444 368899988887421 24667899999999853333 3443 554443 4689999998 8
Q ss_pred HHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccccc
Q 003542 293 LSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366 (811)
Q Consensus 293 L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~ 366 (811)
+.+++.+.... .........++.+|-+.+.-||..+|+||||..+||++..++ ..+.+.|+|||++..
T Consensus 98 vk~~i~~~~~~----~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~--~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 98 VKDFILSTMED----ESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDG--NQITPILIDFGLSSV 165 (229)
T ss_pred HHHHHHHHccC----cccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCC--CcCceEEEeecchhc
Confidence 89999876432 222333478899999999999999999999999999998875 344779999999743
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.79 E-value=2.6e-08 Score=101.38 Aligned_cols=120 Identities=18% Similarity=0.245 Sum_probs=81.1
Q ss_pred eEEEEEEcCCEEEEEEecc------------------------------cHHHHHHHHHHHHhCCCC--ccceeeeeEEc
Q 003542 229 QFKEIQWLGDSFVLRHFYG------------------------------ELESLNAEISTMLSLSHP--NIVQYLCGFCD 276 (811)
Q Consensus 229 vyk~v~~~g~~VAVK~~~~------------------------------~~~~~~~Ei~iL~~L~HP--NIVkl~~~~~~ 276 (811)
||.+....|..+|||+.+. ......+|.+.|.++..- ++.+.+ .+
T Consensus 2 Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~-~~-- 78 (188)
T PF01163_consen 2 VYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPY-DY-- 78 (188)
T ss_dssp EEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EE-EE--
T ss_pred EEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEE-EE--
Confidence 6777777899999999831 024568899999999654 566665 23
Q ss_pred cCCCeEEEEEecCC--CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHH-HHhCCceeccCCCCcEEEeccCCCCc
Q 003542 277 EEKKEFFLVMELMS--KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEF-LHAQKIYHGELNPSNIYLKARSMEGY 353 (811)
Q Consensus 277 e~~~~~yLVmEy~~--g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~y-LHs~gIVHRDLKPsNILI~~~g~d~~ 353 (811)
.. -+|||||++ |.....|.+. .++......++.+++..+.. +|..||+||||.+.|||++.+
T Consensus 79 ~~---~~ivME~I~~~G~~~~~l~~~-------~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~----- 143 (188)
T PF01163_consen 79 NR---NVIVMEYIGEDGVPLPRLKDV-------DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG----- 143 (188)
T ss_dssp ET---TEEEEE--EETTEEGGCHHHC-------GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-----
T ss_pred eC---CEEEEEecCCCccchhhHHhc-------cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-----
Confidence 22 279999999 7433444442 22244567788888886666 579999999999999999765
Q ss_pred ceEEEeeccccccc
Q 003542 354 FHVKVSGFGLSTAR 367 (811)
Q Consensus 354 ~~vKL~DFGlA~~~ 367 (811)
.+.|+|||.+...
T Consensus 144 -~~~iIDf~qav~~ 156 (188)
T PF01163_consen 144 -KVYIIDFGQAVDS 156 (188)
T ss_dssp -CEEE--GTTEEET
T ss_pred -eEEEEecCcceec
Confidence 6999999987543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.79 E-value=1.4e-07 Score=101.28 Aligned_cols=132 Identities=15% Similarity=0.171 Sum_probs=92.0
Q ss_pred eEEEEEEcCCEEEEEEeccc-----H----------HHHHHHHHHHHhCC-----CCccceeeeeEEccCCCeEEEEEec
Q 003542 229 QFKEIQWLGDSFVLRHFYGE-----L----------ESLNAEISTMLSLS-----HPNIVQYLCGFCDEEKKEFFLVMEL 288 (811)
Q Consensus 229 vyk~v~~~g~~VAVK~~~~~-----~----------~~~~~Ei~iL~~L~-----HPNIVkl~~~~~~e~~~~~yLVmEy 288 (811)
+++ +.+.|+.|.||..... . ..+.+|...+..|. -|.+|-+...-........+||||+
T Consensus 38 vvr-~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~ 116 (268)
T PRK15123 38 TLR-FELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITED 116 (268)
T ss_pred EEE-EEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEee
Confidence 554 5678889999977431 1 14789999888873 3333332211011112357899999
Q ss_pred CCC--CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEecc--CCCCcceEEEeecccc
Q 003542 289 MSK--DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKAR--SMEGYFHVKVSGFGLS 364 (811)
Q Consensus 289 ~~g--~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~--g~d~~~~vKL~DFGlA 364 (811)
+++ +|.+++.+.. ....+......++.+++..+.-||..||+|+||++.|||++.+ +.++...+.|+||+.+
T Consensus 117 l~~~~sL~~~~~~~~----~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~ 192 (268)
T PRK15123 117 LAPTISLEDYCADWA----TNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRA 192 (268)
T ss_pred CCCCccHHHHHHhhc----ccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcc
Confidence 997 6888875421 1345566778999999999999999999999999999999852 0123348999999987
Q ss_pred c
Q 003542 365 T 365 (811)
Q Consensus 365 ~ 365 (811)
.
T Consensus 193 ~ 193 (268)
T PRK15123 193 Q 193 (268)
T ss_pred c
Confidence 4
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.79 E-value=4.5e-08 Score=98.06 Aligned_cols=119 Identities=22% Similarity=0.298 Sum_probs=83.5
Q ss_pred ecccc---eEEEEEEcCCEEEEEEec-c-----------cHHHHHHHHHHHHhCCCC--ccceeeeeEEccCCCeEEEEE
Q 003542 224 LGASS---QFKEIQWLGDSFVLRHFY-G-----------ELESLNAEISTMLSLSHP--NIVQYLCGFCDEEKKEFFLVM 286 (811)
Q Consensus 224 lG~G~---vyk~v~~~g~~VAVK~~~-~-----------~~~~~~~Ei~iL~~L~HP--NIVkl~~~~~~e~~~~~yLVm 286 (811)
+++|. +|. ..|.|.++.+|.=. + ....-.+|+++|.++.-- ++..+| +++ .....|+|
T Consensus 4 i~~GAEa~i~~-~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~--dvD--~~~~~I~m 78 (204)
T COG3642 4 IKQGAEAIIYL-TDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVY--DVD--PDNGLIVM 78 (204)
T ss_pred hhCCcceeEEe-eeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEE--EEc--CCCCEEEE
Confidence 44554 443 35677777777631 1 135568899999988533 333344 332 33468999
Q ss_pred ecCCCC-HHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccc
Q 003542 287 ELMSKD-LSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365 (811)
Q Consensus 287 Ey~~g~-L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~ 365 (811)
||++|. |.+++... ...++..+-.-+.-||..||+|+||.++||++... .+.++||||+.
T Consensus 79 e~I~G~~lkd~l~~~-------------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~------~i~~IDfGLg~ 139 (204)
T COG3642 79 EYIEGELLKDALEEA-------------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG------RIYFIDFGLGE 139 (204)
T ss_pred EEeCChhHHHHHHhc-------------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC------cEEEEECCccc
Confidence 999994 55566531 24567778888889999999999999999999765 59999999986
Q ss_pred c
Q 003542 366 A 366 (811)
Q Consensus 366 ~ 366 (811)
.
T Consensus 140 ~ 140 (204)
T COG3642 140 F 140 (204)
T ss_pred c
Confidence 4
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.68 E-value=9.3e-08 Score=97.99 Aligned_cols=132 Identities=19% Similarity=0.241 Sum_probs=86.6
Q ss_pred eecccc---eEEEEEEcCCEEEEEEecc-----cHHHHHHHHHHHHhCCC--CccceeeeeEEccCC--CeEEEEEecCC
Q 003542 223 RLGASS---QFKEIQWLGDSFVLRHFYG-----ELESLNAEISTMLSLSH--PNIVQYLCGFCDEEK--KEFFLVMELMS 290 (811)
Q Consensus 223 ~lG~G~---vyk~v~~~g~~VAVK~~~~-----~~~~~~~Ei~iL~~L~H--PNIVkl~~~~~~e~~--~~~yLVmEy~~ 290 (811)
.+|.|. +|+...-+|..+++|.... ....+.+|+.++..+.+ .++.+++. +..... +..++||||++
T Consensus 5 ~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~-~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 5 QLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLA-LCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred ecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEE-ECCCCCccCCceEEEEEeC
Confidence 345553 7876654568999999864 24678999999999965 34566653 322211 25689999999
Q ss_pred C-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------
Q 003542 291 K-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHA--------------------------------------- 330 (811)
Q Consensus 291 g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs--------------------------------------- 330 (811)
| ++...+.. ..++......++.+++.+|.+||+
T Consensus 84 G~~l~~~~~~-------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (223)
T cd05154 84 GRVLRDRLLR-------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPA 156 (223)
T ss_pred CEecCCCCCC-------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHH
Confidence 7 44332210 234555555566666666666663
Q ss_pred -----------------CCceeccCCCCcEEEeccCCCCcceEEEeeccccc
Q 003542 331 -----------------QKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365 (811)
Q Consensus 331 -----------------~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~ 365 (811)
..++|+|++|.|||++.++ ++ .+.|+||+.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~-~~--~~~iID~e~~~ 205 (223)
T cd05154 157 MERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDE-PR--VVAVLDWELAT 205 (223)
T ss_pred HHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCC-Cc--EEEEEeccccc
Confidence 2369999999999998731 01 68999999764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.67 E-value=6.5e-07 Score=98.71 Aligned_cols=214 Identities=15% Similarity=0.192 Sum_probs=143.7
Q ss_pred CeEEEEEecCCC--CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEE
Q 003542 280 KEFFLVMELMSK--DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVK 357 (811)
Q Consensus 280 ~~~yLVmEy~~g--~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vK 357 (811)
...-+.|..+.| ....++.-......-..+.|..++..++.++.+.+-||.+|.+-||+.++|+|+.+++ .|.
T Consensus 83 ~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~-----~V~ 157 (637)
T COG4248 83 KVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDS-----KVV 157 (637)
T ss_pred ceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCc-----eEE
Confidence 347789999886 4444443222122224578999999999999999999999999999999999998876 788
Q ss_pred EeeccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCCCCCCCcccceecchhHHHHHhhC-CCCCCCC
Q 003542 358 VSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTG-KVPFEDG 436 (811)
Q Consensus 358 L~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIWSLGvILyELltG-~~PF~~~ 436 (811)
|.|=..-..... .......+|...|.+||.-.-... ....-+...|.|.||+++|+++.| ++||.+.
T Consensus 158 LVdsDsfqi~~n--------g~~~~cpVg~~eftPPElQ~~~sf----~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 158 LVDSDSFQINAN--------GTLHLCPVGVSEFTPPELQTLPSF----VGFERTANHDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred EEcccceeeccC--------CceEecccCccccCCHHHhccccc----cccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence 887432211111 222345678899999998653222 233456789999999999999986 9999763
Q ss_pred ccch---HHHHHHHHh-----------CCCCC---CC-CCChHHHHHHHhhhccC--CCCCCCCHHHHHHHHHHHHHHhh
Q 003542 437 HLQG---DKMTKNIRA-----------GERPL---FP-SGSPKYLVNLTKKCWHT--NPSQRPSFSSICRILRYIKKFMA 496 (811)
Q Consensus 437 ~~~~---~~i~~~i~~-----------~~~~~---~p-~~~~~~l~~LI~~cL~~--DP~~RPS~~eIl~~L~~i~k~l~ 496 (811)
.... .-....|.. +.++. .| ...++.+..|..+|+.. ++.-|||++..+..|..+...+.
T Consensus 226 ~~~~~ap~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~ 305 (637)
T COG4248 226 PLISDAPNPLETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLK 305 (637)
T ss_pred cccCCCCCcchhhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhh
Confidence 2110 000011111 11111 11 34678899999999975 35689999999999999988877
Q ss_pred cCCccccccCCCCc
Q 003542 497 NNPDIARSEFQSPL 510 (811)
Q Consensus 497 ~~p~~~~~~~~~p~ 510 (811)
......+-..+.+.
T Consensus 306 ~C~v~a~H~y~~hl 319 (637)
T COG4248 306 KCTVSAMHVYPVHL 319 (637)
T ss_pred hhhhcccccccCCC
Confidence 65554433333333
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.58 E-value=5.5e-07 Score=93.03 Aligned_cols=110 Identities=19% Similarity=0.249 Sum_probs=80.7
Q ss_pred HHHHHHHHHHHHhCCC--CccceeeeeEEccC--CCeEEEEEecCCC--CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHH
Q 003542 249 LESLNAEISTMLSLSH--PNIVQYLCGFCDEE--KKEFFLVMELMSK--DLSCYMRETFGSRRRNSFSLPVVVDIMLQIA 322 (811)
Q Consensus 249 ~~~~~~Ei~iL~~L~H--PNIVkl~~~~~~e~--~~~~yLVmEy~~g--~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa 322 (811)
.....+|...+..|.. =.+.+.+....... ....+||||++++ +|.+++... ..++......++.+++
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~------~~~~~~~~~~ll~~l~ 128 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW------EQLDPSQRRELLRALA 128 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh------cccchhhHHHHHHHHH
Confidence 3467889888877732 22333332221111 1346899999997 788888753 2256667888999999
Q ss_pred HHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccccc
Q 003542 323 RGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366 (811)
Q Consensus 323 ~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~ 366 (811)
..+.-||..||+|+|+++.|||++.++ +.+.+.|+||+.+..
T Consensus 129 ~~i~~lH~~gi~H~Dl~~~NILv~~~~--~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 129 RLIAKLHDAGIYHGDLNPSNILVDPDD--GQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHHHHCcCCCCCCCcccEEEeCCC--CceeEEEEcchhcee
Confidence 999999999999999999999998874 445899999997654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.49 E-value=9.3e-08 Score=111.13 Aligned_cols=152 Identities=22% Similarity=0.339 Sum_probs=104.4
Q ss_pred HHHHHHHHHHhC-CceeccCCCCcEEEeccCCCCcceEEEeeccccccccccCCCCC--CCCCCCCCCCCCCccCChhHh
Q 003542 320 QIARGMEFLHAQ-KIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTP--PASPQNQTAPNPYIWYAPEVL 396 (811)
Q Consensus 320 QIa~gL~yLHs~-gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~~~~~~--~~~~~~~~~~GT~~Y~APEvl 396 (811)
+++.||.|+|.. ++||++|.|++|.++..+ ..||+.|+++........... ..........-...|.|||++
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~-----~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~ 181 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANG-----DWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYL 181 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCc-----ceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhh
Confidence 455999999976 799999999999999887 899999998865443221000 000111122234569999999
Q ss_pred hhhcCCCCCCCCCCCcccceecchhHHHHHh-hCCCCCCCCccch-HHHHHHHHhCCCCCCCCCChHHHHHHHhhhccCC
Q 003542 397 AEQEGTGSTSTSKCSEKADVYSFGMLCFELL-TGKVPFEDGHLQG-DKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTN 474 (811)
Q Consensus 397 ~~~~~~~~~~~~~~s~ksDIWSLGvILyELl-tG~~PF~~~~~~~-~~i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~D 474 (811)
.+. ..+.++|+||+|+++|.+. .|+.-+....... ..............+....|.++++=+.+++..+
T Consensus 182 ~~~---------~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~ 252 (700)
T KOG2137|consen 182 LGT---------TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGD 252 (700)
T ss_pred ccc---------cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCC
Confidence 753 6678999999999999999 5666554432111 1111111111122345788999999999999999
Q ss_pred CCCCCCHHHHH
Q 003542 475 PSQRPSFSSIC 485 (811)
Q Consensus 475 P~~RPS~~eIl 485 (811)
+.-||++..+.
T Consensus 253 ~~~rp~~~~l~ 263 (700)
T KOG2137|consen 253 SAVRPTLDLLL 263 (700)
T ss_pred cccCcchhhhh
Confidence 99999777653
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.35 E-value=7.4e-06 Score=84.64 Aligned_cols=130 Identities=15% Similarity=0.154 Sum_probs=94.2
Q ss_pred eEEEEEEcCCEEEEEEecc----------cHHHHHHHHHHHHhCC--CCccceeeeeEE--ccCCCeEEEEEecCCC--C
Q 003542 229 QFKEIQWLGDSFVLRHFYG----------ELESLNAEISTMLSLS--HPNIVQYLCGFC--DEEKKEFFLVMELMSK--D 292 (811)
Q Consensus 229 vyk~v~~~g~~VAVK~~~~----------~~~~~~~Ei~iL~~L~--HPNIVkl~~~~~--~e~~~~~yLVmEy~~g--~ 292 (811)
||. ....|..|-+|.-.+ ....|.+|+..|.+|. .-.+.+...+-. .......+||+|-++| +
T Consensus 34 V~r-~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe~L~g~~~ 112 (216)
T PRK09902 34 VQC-VERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTEDMAGFIS 112 (216)
T ss_pred EEE-EEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEEeCCCCcc
Confidence 666 456677788887642 3467999999999984 223444431111 1122346899999985 8
Q ss_pred HHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccccc
Q 003542 293 LSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366 (811)
Q Consensus 293 L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~ 366 (811)
|.+++.+. ...+.+......++.+++..+.-||+.|+.|+|+.+.|||++..+ .+.++++||.-++.
T Consensus 113 L~~~l~~~----~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g---~~~v~lIDlEk~r~ 179 (216)
T PRK09902 113 IADWYAQH----AVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEG---KAEAGFLDLEKSRR 179 (216)
T ss_pred HHHHHhcC----CcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCC---CeeEEEEEhhccch
Confidence 98887652 113456677789999999999999999999999999999998654 34799999986643
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.25 E-value=1.1e-05 Score=83.86 Aligned_cols=136 Identities=14% Similarity=0.209 Sum_probs=84.4
Q ss_pred HHHHHhcceEEeeeecccc-eEEE-EEEcCCEEEEEEecccH-------------HHHHHHHHHHHhCC---CCccceee
Q 003542 210 LVDMLLKKLMVRRRLGASS-QFKE-IQWLGDSFVLRHFYGEL-------------ESLNAEISTMLSLS---HPNIVQYL 271 (811)
Q Consensus 210 ~~~~l~k~~~i~~~lG~G~-vyk~-v~~~g~~VAVK~~~~~~-------------~~~~~Ei~iL~~L~---HPNIVkl~ 271 (811)
..+++..+|.+++.+-... .|-+ +..+|..+.+|...... ....+++..+..+. --.+..++
T Consensus 25 ~~~i~~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~y 104 (229)
T PF06176_consen 25 GEKILDNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPY 104 (229)
T ss_pred HHHHHhCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccce
Confidence 3445556777777665543 2222 46799999999986421 12234444444442 22333322
Q ss_pred eeEE---ccCCCeEEEEEecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEec
Q 003542 272 CGFC---DEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKA 347 (811)
Q Consensus 272 ~~~~---~e~~~~~yLVmEy~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~ 347 (811)
.+.. ..-....+|||||++| .|.++. .+++ .+...|..+|.-||..|++|+|.+|.|++++.
T Consensus 105 l~~ekk~~~~~~~~~ll~EYIeG~~l~d~~----------~i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~ 170 (229)
T PF06176_consen 105 LAAEKKIFRYTSSYVLLMEYIEGVELNDIE----------DIDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSN 170 (229)
T ss_pred eeeeeeeccceeEEEEEEEEecCeecccch----------hcCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEEC
Confidence 1111 0112345789999998 544332 1222 24456778899999999999999999999986
Q ss_pred cCCCCcceEEEeeccccc
Q 003542 348 RSMEGYFHVKVSGFGLST 365 (811)
Q Consensus 348 ~g~d~~~~vKL~DFGlA~ 365 (811)
+ .++++||+..+
T Consensus 171 ~------~i~iID~~~k~ 182 (229)
T PF06176_consen 171 N------GIRIIDTQGKR 182 (229)
T ss_pred C------cEEEEECcccc
Confidence 5 59999998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.24 E-value=4.6e-06 Score=88.30 Aligned_cols=125 Identities=14% Similarity=0.173 Sum_probs=91.0
Q ss_pred EEeeeecccc---eEEEEEEcCCEEEEEEecc--------------------------cHHHHHHHHHHHHhCCCC--cc
Q 003542 219 MVRRRLGASS---QFKEIQWLGDSFVLRHFYG--------------------------ELESLNAEISTMLSLSHP--NI 267 (811)
Q Consensus 219 ~i~~~lG~G~---vyk~v~~~g~~VAVK~~~~--------------------------~~~~~~~Ei~iL~~L~HP--NI 267 (811)
.+...||-|. ||.+....|.++|||.=.- .....++|.++|..|... .|
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 5567888885 9988888999999998410 134568999999999644 66
Q ss_pred ceeeeeEEccCCCeEEEEEecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEec
Q 003542 268 VQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKA 347 (811)
Q Consensus 268 Vkl~~~~~~e~~~~~yLVmEy~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI~~ 347 (811)
.+-++ + +.-.+||||++|-.+.- .+++....-.++..|+.-+.-+-..||||+|+.+-|||++.
T Consensus 174 P~P~~-~-----nRHaVvMe~ieG~eL~~----------~r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~ 237 (304)
T COG0478 174 PKPIA-W-----NRHAVVMEYIEGVELYR----------LRLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTE 237 (304)
T ss_pred CCccc-c-----ccceeeeehcccceeec----------ccCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEec
Confidence 66652 2 34589999999832111 12234445556666666666666899999999999999999
Q ss_pred cCCCCcceEEEeecccc
Q 003542 348 RSMEGYFHVKVSGFGLS 364 (811)
Q Consensus 348 ~g~d~~~~vKL~DFGlA 364 (811)
+| .+.++||--+
T Consensus 238 dg-----~~~vIDwPQ~ 249 (304)
T COG0478 238 DG-----DIVVIDWPQA 249 (304)
T ss_pred CC-----CEEEEeCccc
Confidence 87 7999999644
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.02 E-value=4e-05 Score=80.52 Aligned_cols=126 Identities=12% Similarity=0.118 Sum_probs=88.5
Q ss_pred eecccc---eEEEEEEcCCEEEEEEecccH----------------------------HHHHHHHHHHHhCC--CCccce
Q 003542 223 RLGASS---QFKEIQWLGDSFVLRHFYGEL----------------------------ESLNAEISTMLSLS--HPNIVQ 269 (811)
Q Consensus 223 ~lG~G~---vyk~v~~~g~~VAVK~~~~~~----------------------------~~~~~Ei~iL~~L~--HPNIVk 269 (811)
.|+.|. ||.+....+..||||++.... .=..+|+..|.++. +-.+.+
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 455554 888888889999999994210 11357888888873 555555
Q ss_pred eeeeEEccCCCeEEEEEecCCCC--HHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEe
Q 003542 270 YLCGFCDEEKKEFFLVMELMSKD--LSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHA-QKIYHGELNPSNIYLK 346 (811)
Q Consensus 270 l~~~~~~e~~~~~yLVmEy~~g~--L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs-~gIVHRDLKPsNILI~ 346 (811)
-+... .-.|||||++.. -.-.|.+ .++...++..+..++++.+.-|-. .++||+||..-|||+.
T Consensus 135 Pi~~~------~nVLvMEfIg~~g~pAP~LkD-------v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~ 201 (268)
T COG1718 135 PIAFR------NNVLVMEFIGDDGLPAPRLKD-------VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH 201 (268)
T ss_pred ceeec------CCeEEEEeccCCCCCCCCccc-------CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE
Confidence 55222 137999999843 1111111 234444688888999999998877 8999999999999998
Q ss_pred ccCCCCcceEEEeeccccccc
Q 003542 347 ARSMEGYFHVKVSGFGLSTAR 367 (811)
Q Consensus 347 ~~g~d~~~~vKL~DFGlA~~~ 367 (811)
++ .+.|+|||-|...
T Consensus 202 -~~-----~p~iID~~QaV~~ 216 (268)
T COG1718 202 -DG-----EPYIIDVSQAVTI 216 (268)
T ss_pred -CC-----eEEEEECcccccc
Confidence 33 7999999987554
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.94 E-value=4.8e-05 Score=88.67 Aligned_cols=122 Identities=11% Similarity=0.252 Sum_probs=78.9
Q ss_pred eEEEEEEcCCEEEEEEeccc--------------------------------------------HHHHHHHHHHHHhC--
Q 003542 229 QFKEIQWLGDSFVLRHFYGE--------------------------------------------LESLNAEISTMLSL-- 262 (811)
Q Consensus 229 vyk~v~~~g~~VAVK~~~~~--------------------------------------------~~~~~~Ei~iL~~L-- 262 (811)
||++++.+|+.||||+.... .-++.+|...+.++
T Consensus 141 VH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~EA~n~~~~~~ 220 (517)
T COG0661 141 VHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRREAANAERFRE 220 (517)
T ss_pred heeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHHHHHHHHHHHH
Confidence 99999999999999998321 01245666666665
Q ss_pred ---CCCcc--ceeeeeEEccCCCeEEEEEecCCC-CHHHH--HHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 003542 263 ---SHPNI--VQYLCGFCDEEKKEFFLVMELMSK-DLSCY--MRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIY 334 (811)
Q Consensus 263 ---~HPNI--Vkl~~~~~~e~~~~~yLVmEy~~g-~L~~~--L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIV 334 (811)
+.|+| .++|-.+ ...-.|+|||++| .+.+. +.+ ..++...+...+.++. +..+-..|++
T Consensus 221 nf~~~~~v~VP~V~we~----t~~~VLtmE~i~Gi~i~d~~~l~~-------~g~d~k~ia~~~~~~f--~~q~~~dgff 287 (517)
T COG0661 221 NFKDDPDVYVPKVYWEY----TTRRVLTMEWIDGIKISDIAALKS-------AGIDRKELAELLVRAF--LRQLLRDGFF 287 (517)
T ss_pred HcCCCCCeEeceeehhc----cCCcEEEEEeeCCEecccHHHHHh-------cCCCHHHHHHHHHHHH--HHHHHhcCcc
Confidence 23433 3333222 2235799999998 55554 332 3444333333222222 2334458999
Q ss_pred eccCCCCcEEEeccCCCCcceEEEeecccccccc
Q 003542 335 HGELNPSNIYLKARSMEGYFHVKVSGFGLSTART 368 (811)
Q Consensus 335 HRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~ 368 (811)
|.|.+|.||+++.+| .+.+.|||+.....
T Consensus 288 HaDpHpGNi~v~~~g-----~i~~lDfGi~g~l~ 316 (517)
T COG0661 288 HADPHPGNILVRSDG-----RIVLLDFGIVGRLD 316 (517)
T ss_pred ccCCCccceEEecCC-----cEEEEcCcceecCC
Confidence 999999999999887 89999999976543
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00011 Score=85.51 Aligned_cols=126 Identities=13% Similarity=0.166 Sum_probs=82.0
Q ss_pred eEEEEEEcCCEEEEEEecccH-----------------------------------------HHHHHHHHHHHh----CC
Q 003542 229 QFKEIQWLGDSFVLRHFYGEL-----------------------------------------ESLNAEISTMLS----LS 263 (811)
Q Consensus 229 vyk~v~~~g~~VAVK~~~~~~-----------------------------------------~~~~~Ei~iL~~----L~ 263 (811)
|+++.+.+|+.||||+-+... =+|.+|++...+ +.
T Consensus 177 VhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~Nae~~~~~f~ 256 (538)
T KOG1235|consen 177 VHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAKNAERFRENFK 256 (538)
T ss_pred eEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHHhHHHHHHHHH
Confidence 999999999999999974210 124455544433 34
Q ss_pred CCc------cceeeeeEEccCCCeEEEEEecCCC---CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 003542 264 HPN------IVQYLCGFCDEEKKEFFLVMELMSK---DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIY 334 (811)
Q Consensus 264 HPN------IVkl~~~~~~e~~~~~yLVmEy~~g---~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIV 334 (811)
|-+ |.++|-.+ ...-.|+||||+| +-.++|.+ ..++...+...+.++.. +-|-..|++
T Consensus 257 ~~~~~~~V~VP~Vy~~~----st~RVLtME~~~G~~i~Dl~~i~~-------~gi~~~~i~~~l~~~~~--~qIf~~Gff 323 (538)
T KOG1235|consen 257 DFSLLTYVLVPKVYWDL----STKRVLTMEYVDGIKINDLDAIDK-------RGISPHDILNKLVEAYL--EQIFKTGFF 323 (538)
T ss_pred hcccccceeCCeehhhc----CcceEEEEEecCCccCCCHHHHHH-------cCCCHHHHHHHHHHHHH--HHHHhcCCc
Confidence 555 66665222 1235899999997 33455655 34555554444433332 223356799
Q ss_pred eccCCCCcEEEeccCCCCcceEEEeecccccccc
Q 003542 335 HGELNPSNIYLKARSMEGYFHVKVSGFGLSTART 368 (811)
Q Consensus 335 HRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~ 368 (811)
|+|-+|.||++..++ .+...+.+.|||+.....
T Consensus 324 HaDPHPGNilv~~~~-~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 324 HADPHPGNILVRPNP-EGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred cCCCCCCcEEEecCC-CCCccEEEEccccccccc
Confidence 999999999998654 344589999999976543
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.00026 Score=72.97 Aligned_cols=126 Identities=18% Similarity=0.262 Sum_probs=87.6
Q ss_pred eeecccc---eEEEEEEcCCEEEEEEeccc--------------------HHHHHHHHHHHHhCC------CCccceeee
Q 003542 222 RRLGASS---QFKEIQWLGDSFVLRHFYGE--------------------LESLNAEISTMLSLS------HPNIVQYLC 272 (811)
Q Consensus 222 ~~lG~G~---vyk~v~~~g~~VAVK~~~~~--------------------~~~~~~Ei~iL~~L~------HPNIVkl~~ 272 (811)
..||.|+ +| .........||++... .....+|+.....+. +.+|.++|+
T Consensus 7 ~~i~~G~~R~cy--~HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G 84 (199)
T PF10707_consen 7 DLIAQGGERDCY--QHPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG 84 (199)
T ss_pred cccccCCCceEE--ECCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence 3567775 33 2456777888988543 377888888777776 889999986
Q ss_pred eEEccCCCeEEEEEecCC---C----CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE
Q 003542 273 GFCDEEKKEFFLVMELMS---K----DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYL 345 (811)
Q Consensus 273 ~~~~e~~~~~yLVmEy~~---g----~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI 345 (811)
.. +++.-.-+|+|.+. | +|.+++.+ ..++. .... .+-.-..||-.++|+.+||+|.||++
T Consensus 85 ~v--eT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-------~~~~~-~~~~---~L~~f~~~l~~~~Iv~~dl~~~NIv~ 151 (199)
T PF10707_consen 85 FV--ETNLGLGLVVELIRDADGNISPTLEDYLKE-------GGLTE-ELRQ---ALDEFKRYLLDHHIVIRDLNPHNIVV 151 (199)
T ss_pred EE--ecCCceEEEEEEEECCCCCcCccHHHHHHc-------CCccH-HHHH---HHHHHHHHHHHcCCeecCCCcccEEE
Confidence 55 45555788888753 3 57777754 44554 3333 33344567888999999999999999
Q ss_pred eccCCCCcceEEEee-ccc
Q 003542 346 KARSMEGYFHVKVSG-FGL 363 (811)
Q Consensus 346 ~~~g~d~~~~vKL~D-FGl 363 (811)
...+ ++...+.|+| ||-
T Consensus 152 ~~~~-~~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 152 QRRD-SGEFRLVLIDGLGE 169 (199)
T ss_pred EecC-CCceEEEEEeCCCC
Confidence 8876 4445788888 553
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.0012 Score=69.26 Aligned_cols=64 Identities=14% Similarity=0.211 Sum_probs=42.8
Q ss_pred eecccc---eEEEEEEcCCEEEEEEecc--cHHHHHHHHHHHHhCCCCcc--ceeeeeEEccCCCeEEEEEecCCC
Q 003542 223 RLGASS---QFKEIQWLGDSFVLRHFYG--ELESLNAEISTMLSLSHPNI--VQYLCGFCDEEKKEFFLVMELMSK 291 (811)
Q Consensus 223 ~lG~G~---vyk~v~~~g~~VAVK~~~~--~~~~~~~Ei~iL~~L~HPNI--Vkl~~~~~~e~~~~~yLVmEy~~g 291 (811)
.+|.|. +|+ ..|..+++|.... ......+|.+++..+..-.+ .+.++.. +....+.+|||+++|
T Consensus 8 ~i~~G~t~~~y~---~~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~--~~~~~~glv~e~i~G 78 (226)
T TIGR02172 8 QTGEGGNGESYT---HKTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLV--EDGGRLGLIYELIVG 78 (226)
T ss_pred eecCCCCcceeE---ecCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEE--ecCCeeeeeeeecCC
Confidence 345553 775 3467788999864 34668999999998853333 4444222 344567899999998
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.0011 Score=69.71 Aligned_cols=63 Identities=8% Similarity=-0.012 Sum_probs=41.8
Q ss_pred eEEEEEEcCCEEEEEEecc-cHHHHHHHHHHHHhCC-CCccceeeeeEEccCCCeEEEEEecCCC-CHH
Q 003542 229 QFKEIQWLGDSFVLRHFYG-ELESLNAEISTMLSLS-HPNIVQYLCGFCDEEKKEFFLVMELMSK-DLS 294 (811)
Q Consensus 229 vyk~v~~~g~~VAVK~~~~-~~~~~~~Ei~iL~~L~-HPNIVkl~~~~~~e~~~~~yLVmEy~~g-~L~ 294 (811)
+|+.. ..+..+.||.... ....+.+|+.++..+. +--+.++++.. ...+..++|||+++| .|.
T Consensus 15 v~~~~-~~~~~~~vk~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~--~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 15 VYRLD-GKNPGLYLKIAPSGPTYELEREAERLRWLAGKLPVPEVIDYG--SDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred EEEEc-CCCCcEEEEecCCCcccchHHHHHHHHHHHhcCCCCeEEEEE--ecCCccEEEEEeeCCccHh
Confidence 66643 3456888998854 2345788999998883 44455666433 233457899999998 443
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.00019 Score=88.16 Aligned_cols=204 Identities=21% Similarity=0.256 Sum_probs=131.1
Q ss_pred HHHHHHHHHHHHhCCCCccceeeeeEEccC-CC-eEEEEEecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHH
Q 003542 249 LESLNAEISTMLSLSHPNIVQYLCGFCDEE-KK-EFFLVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGM 325 (811)
Q Consensus 249 ~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~-~~-~~yLVmEy~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL 325 (811)
......|+..+.++.|+|++.++.+-.... .+ ...+..|+|.+ ++...+... ...+....+.+..++..||
T Consensus 226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v------~~i~~~~~r~~~~~~~~GL 299 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV------GSIPLETLRILHQKLLEGL 299 (1351)
T ss_pred HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc------cccCHHHHHHHHHHHhhhH
Confidence 344566778888899999999884333211 11 12344568886 777766654 6788899999999999999
Q ss_pred HHHHhCCceeccCCCCcEEEeccCCCCcceEEEe--eccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCC
Q 003542 326 EFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVS--GFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTG 403 (811)
Q Consensus 326 ~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~--DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~ 403 (811)
.|+|+....|.-|..+-..-... ++...+.++ ||+.++....... ......+..|.+||.+...
T Consensus 300 ~~~h~~~l~~v~L~~s~~~~~~~--~~e~~~~~sl~~~~ss~~l~d~~~--------~~~~~~~~~~~~~e~~~~~---- 365 (1351)
T KOG1035|consen 300 AYLHSLSLEHVVLSASSSKESTV--DGEGVVAISLSDFDSSKPLPDNEK--------SFSDLLAEIRNADEDLKEN---- 365 (1351)
T ss_pred HHHHHhccceeEEeccccccccc--CccceeecchhhhcccccCCCccc--------chhhcCccccccccccccc----
Confidence 99999966555444441111111 122244444 8888766544321 1223344557888887653
Q ss_pred CCCCCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHHHHhCCCCCCCCCChHHHHHHHhhhccCCCCCCCCHHH
Q 003542 404 STSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSS 483 (811)
Q Consensus 404 ~~~~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i~~~~~~~~p~~~~~~l~~LI~~cL~~DP~~RPS~~e 483 (811)
........|+|.+|..+..+..|..+-...... ....+..+...+.+...+|+..++++|+++.+
T Consensus 366 ---~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~~~------------~~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ 430 (1351)
T KOG1035|consen 366 ---TAKKSRLTDLWCLGLLLLQLSQGEDISEKSAVP------------VSLLDVLSTSELLDALPKCLDEDSEERLSALE 430 (1351)
T ss_pred ---cchhhhhhHHHHHHHHHhhhhhcCcccccccch------------hhhhccccchhhhhhhhhhcchhhhhccchhh
Confidence 233445579999999999998876543211000 01122333336889999999999999999999
Q ss_pred HHHH
Q 003542 484 ICRI 487 (811)
Q Consensus 484 Il~~ 487 (811)
++.+
T Consensus 431 ll~~ 434 (1351)
T KOG1035|consen 431 LLTH 434 (1351)
T ss_pred hhhc
Confidence 9873
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.0027 Score=65.10 Aligned_cols=73 Identities=21% Similarity=0.215 Sum_probs=46.3
Q ss_pred eeecccc---eEEEEEEcCCEEEEEEeccc--HHHHHHHHHHHHhCCCC--ccceeeeeEE-ccCCCeEEEEEecCCC-C
Q 003542 222 RRLGASS---QFKEIQWLGDSFVLRHFYGE--LESLNAEISTMLSLSHP--NIVQYLCGFC-DEEKKEFFLVMELMSK-D 292 (811)
Q Consensus 222 ~~lG~G~---vyk~v~~~g~~VAVK~~~~~--~~~~~~Ei~iL~~L~HP--NIVkl~~~~~-~e~~~~~yLVmEy~~g-~ 292 (811)
+.++.|. +|... ..+..+++|..... ...+.+|..++..|... .+.+++.... .......+++|++++| .
T Consensus 3 ~~l~~G~~n~~~~v~-~~~~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~ 81 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVT-TDDGRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRP 81 (239)
T ss_dssp EEEEESSSSEEEEEE-ETTSEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEE
T ss_pred ccCCCCCeeeEEEEE-ECCcEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecccc
Confidence 4455553 66633 44479999998764 56788999999988422 3556553221 2223457999999998 4
Q ss_pred HHH
Q 003542 293 LSC 295 (811)
Q Consensus 293 L~~ 295 (811)
+..
T Consensus 82 ~~~ 84 (239)
T PF01636_consen 82 LDD 84 (239)
T ss_dssp HHH
T ss_pred ccc
Confidence 544
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.37 E-value=9e-05 Score=85.98 Aligned_cols=196 Identities=19% Similarity=0.230 Sum_probs=127.8
Q ss_pred HHHHHHHHHHHhCCCCc-cceeeeeEEccCCCeEEEEEecCCCC--HHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHH
Q 003542 250 ESLNAEISTMLSLSHPN-IVQYLCGFCDEEKKEFFLVMELMSKD--LSCYMRETFGSRRRNSFSLPVVVDIMLQIARGME 326 (811)
Q Consensus 250 ~~~~~Ei~iL~~L~HPN-IVkl~~~~~~e~~~~~yLVmEy~~g~--L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~ 326 (811)
....-++++|.+++||| .+.+++.+ +...+.+++|++|.++ ...... .....|...+...+.+.-.++|+
T Consensus 278 l~~rl~~eLLdK~n~P~~~v~~~~d~--~~E~~~~i~~~i~s~~rs~~~~~~-----~se~~~~~~~~~~~~r~et~~l~ 350 (829)
T KOG0576|consen 278 LSRRLAIELLDKVNNPNPVVRYLEDY--DGEDYLWIPMRICSTGRSSALEMT-----VSEIALEQYQFAYPLRKETRPLA 350 (829)
T ss_pred hhhHHHHHHHHHccCCCCcccccccC--CcccccchhhhhhcCCccccccCC-----hhhHhhhhhhhhhhhhhhccccc
Confidence 45667899999999999 66555444 4456789999999853 111110 00122334455566777788999
Q ss_pred HHHhCCceeccCCCCcEEEeccCCCCcceEEEeeccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCCCCC
Q 003542 327 FLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTS 406 (811)
Q Consensus 327 yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~ 406 (811)
|||+.--+|+| ||+.... ..++.||+....+.... ......+|+.|+|||+....
T Consensus 351 ~l~~~~~~~~d----~~l~s~~------~~~~~~~~v~~~L~~~~--------~~~t~~~~~~~~~pev~~~~------- 405 (829)
T KOG0576|consen 351 ELHSSYKVHRD----NILGSEE------EVKLLDFAVPPQLTRTM--------KPRTAIGTPEPLAPEVIQEN------- 405 (829)
T ss_pred ccccccccCcc----ccccccc------ccccccccCCcccCccc--------ccccCCCCCCCCCchhhccc-------
Confidence 99998779999 8887664 68999999876554321 34567899999999988643
Q ss_pred CCCCCcccceecchhHHHHHhhCCCCCCCCccchHHHHHHHHhCCCCCCCC-----CC-hHHHHHHHhhhccCCCCCCCC
Q 003542 407 TSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPS-----GS-PKYLVNLTKKCWHTNPSQRPS 480 (811)
Q Consensus 407 ~~~~s~ksDIWSLGvILyELltG~~PF~~~~~~~~~i~~~i~~~~~~~~p~-----~~-~~~l~~LI~~cL~~DP~~RPS 480 (811)
.+....|.|++|.--.++.-|-+|-..... .....+..+..+. .. +..-.++...|+...|..|+.
T Consensus 406 --~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~------~~~~~g~~p~s~~L~~~~aw~~~~~~~~~~~~~~g~P~~pkv 477 (829)
T KOG0576|consen 406 --TIDGCPDSGSLAVSAIQMAPGLPPRSSPPA------VLPMIGNGPNSPMLTDKSAWSPVFHRDFPAPCLNGLPPTPKV 477 (829)
T ss_pred --ccccCCCccCCCcchhhcCCCCCCCCCCcc------ccCCCCCCCCccccchhhhcCcccccCCcccccCCCCCCCcc
Confidence 677889999999988888888777543100 0000111110010 00 111124667788888888888
Q ss_pred HHHHH
Q 003542 481 FSSIC 485 (811)
Q Consensus 481 ~~eIl 485 (811)
...++
T Consensus 478 ~mgac 482 (829)
T KOG0576|consen 478 HMGAC 482 (829)
T ss_pred hhhHH
Confidence 77765
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.23 E-value=3.7e-05 Score=95.73 Aligned_cols=162 Identities=12% Similarity=0.003 Sum_probs=119.5
Q ss_pred HHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEecCC-CCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 003542 250 ESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFL 328 (811)
Q Consensus 250 ~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~~-g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yL 328 (811)
+....|.+-++...|+++...+.-.-..+....|++|+||. |.+.+.|.+.. .+...+....+.....+.+.+..-+
T Consensus 1274 emll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~--ee~~~ld~~~v~~~~kvsvl~~~~~ 1351 (2724)
T KOG1826|consen 1274 EMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGL--EESPDLDRSPVHLRHKVSVLNRNVI 1351 (2724)
T ss_pred HhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhcc--ccCCcchhchHHHHHHHHHhccchh
Confidence 34555666677789999999886665555567799999999 68888887642 2223444444444444447778787
Q ss_pred HhCC-----ceeccCCCCcEEEeccCCCCcceEEEeeccccccccccCCCCCCCCCCCCCCCCCCccCChhHhhhhcCCC
Q 003542 329 HAQK-----IYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTG 403 (811)
Q Consensus 329 Hs~g-----IVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~ 403 (811)
|+.. .+|++||+-|.+|..+. .+|+.++|+.+..... ........+++.|++|++...-
T Consensus 1352 ls~tnlg~T~v~~~Lkf~lpmIVtny-----~v~~gk~gLdKIknp~-------~sf~Gl~l~sp~~v~qli~N~i---- 1415 (2724)
T KOG1826|consen 1352 LSLTNLGNTNVSKSLKFTLPMIVTNY-----NVKLGKGGLDKIKNPV-------LSFFGLELCSPIYVLQLIKNEI---- 1415 (2724)
T ss_pred hhcccCCccchhhhhhhhccceecCC-----cccccccccccccCch-------HhhhhhhhCCHHHHHHHHHHHH----
Confidence 7652 59999999999996654 8999999999844332 2233456788889999998754
Q ss_pred CCCCCCCCcccceecchhHHHHHhhCCCCCC
Q 003542 404 STSTSKCSEKADVYSFGMLCFELLTGKVPFE 434 (811)
Q Consensus 404 ~~~~~~~s~ksDIWSLGvILyELltG~~PF~ 434 (811)
.++.++|+|..|+-+|+...|..+|-
T Consensus 1416 -----k~t~rsdilr~s~~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1416 -----KFTKRSDILRRSLSLYLRSDGNAYFI 1441 (2724)
T ss_pred -----hhhhHHHHHHHHHHHHHHhcccHHHH
Confidence 67788999999999999999988874
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.0025 Score=66.97 Aligned_cols=55 Identities=15% Similarity=-0.000 Sum_probs=33.6
Q ss_pred CCEEEEEEecc--cHHHHHHHHHHHHhCCCC---ccceeeeeEEccC-CCeEEEEEecCCC
Q 003542 237 GDSFVLRHFYG--ELESLNAEISTMLSLSHP---NIVQYLCGFCDEE-KKEFFLVMELMSK 291 (811)
Q Consensus 237 g~~VAVK~~~~--~~~~~~~Ei~iL~~L~HP---NIVkl~~~~~~e~-~~~~yLVmEy~~g 291 (811)
+..+++|.... ....+.+|+++|..|... -+.++++.....+ ....|++|++++|
T Consensus 18 ~~~~VlR~~~~~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~G 78 (235)
T cd05155 18 GDDMSVRLPSAAGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLEG 78 (235)
T ss_pred CCceEEEcCCccchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeecC
Confidence 45688888754 345789999999888521 2334332111111 1235889999987
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.0028 Score=78.88 Aligned_cols=71 Identities=20% Similarity=0.371 Sum_probs=44.4
Q ss_pred eeeecccc---eEEEEEEcC---CEEEEEEecc-----cHHHHHHHHHHHHhCC-CCcc--ceeeeeEEccC--CCeEEE
Q 003542 221 RRRLGASS---QFKEIQWLG---DSFVLRHFYG-----ELESLNAEISTMLSLS-HPNI--VQYLCGFCDEE--KKEFFL 284 (811)
Q Consensus 221 ~~~lG~G~---vyk~v~~~g---~~VAVK~~~~-----~~~~~~~Ei~iL~~L~-HPNI--Vkl~~~~~~e~--~~~~yL 284 (811)
+..++.|. .|......+ ..+++|+... ....+.+|+.+|+.|. |++| .+++. ++.+. .+..|+
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~-~~~d~~v~G~~fl 121 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYC-LCTDASVIGTAFY 121 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEE-EecCCCcCCCceE
Confidence 34556663 555332222 4678887642 2357899999999995 6665 66663 33221 135789
Q ss_pred EEecCCCC
Q 003542 285 VMELMSKD 292 (811)
Q Consensus 285 VmEy~~g~ 292 (811)
||||++|.
T Consensus 122 VME~v~G~ 129 (822)
T PLN02876 122 IMEYLEGR 129 (822)
T ss_pred EEEecCCc
Confidence 99999983
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.0078 Score=62.08 Aligned_cols=120 Identities=21% Similarity=0.248 Sum_probs=84.7
Q ss_pred cceEEeeeecccc----eEEEEEEcCCEEEEEEecc-------------------------cHHHHHHHHHHHHhCC---
Q 003542 216 KKLMVRRRLGASS----QFKEIQWLGDSFVLRHFYG-------------------------ELESLNAEISTMLSLS--- 263 (811)
Q Consensus 216 k~~~i~~~lG~G~----vyk~v~~~g~~VAVK~~~~-------------------------~~~~~~~Ei~iL~~L~--- 263 (811)
.+++.++.||.|. ||+ +...|+.||+|.+.. ....|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~k-v~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFK-VEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEE-EEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 6789999999986 444 467999999999410 1245888988888774
Q ss_pred CCcc--ceeeeeEEccC----------------CCeEEEEEecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHH
Q 003542 264 HPNI--VQYLCGFCDEE----------------KKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGM 325 (811)
Q Consensus 264 HPNI--Vkl~~~~~~e~----------------~~~~yLVmEy~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL 325 (811)
+.++ |+.++++.-.. .....||.||.+..- .+. ..-+.+|.+-|
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------------~~~----~~~~~~~~~dl 177 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------------PLQ----IRDIPQMLRDL 177 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------------ccc----hhHHHHHHHHH
Confidence 5566 88875553221 123467888876431 111 22345788889
Q ss_pred HHHHhCCceeccCCCCcEEEeccCCCCcceEEEeecccc
Q 003542 326 EFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS 364 (811)
Q Consensus 326 ~yLHs~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA 364 (811)
..+|..||+-+|+++.|.. .-||+|||.+
T Consensus 178 ~~~~k~gI~~~Dv~~~ny~----------~G~lvDfs~~ 206 (207)
T PF13095_consen 178 KILHKLGIVPRDVKPRNYR----------GGKLVDFSSS 206 (207)
T ss_pred HHHHHCCeeeccCcccccc----------CCEEEecccC
Confidence 9999999999999999986 3589999864
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.016 Score=63.37 Aligned_cols=138 Identities=11% Similarity=0.166 Sum_probs=75.1
Q ss_pred eeeecccc---eEEEEEEcCCEEEEEEecc--cHHHHHHHHHHHHhCCCC--ccceeeee----EEccCCCeEEEEEecC
Q 003542 221 RRRLGASS---QFKEIQWLGDSFVLRHFYG--ELESLNAEISTMLSLSHP--NIVQYLCG----FCDEEKKEFFLVMELM 289 (811)
Q Consensus 221 ~~~lG~G~---vyk~v~~~g~~VAVK~~~~--~~~~~~~Ei~iL~~L~HP--NIVkl~~~----~~~e~~~~~yLVmEy~ 289 (811)
++.++.|. +|... ..+..+++|++.. ..+.+..|++++..|... .+.+++.. ......+..+++|||+
T Consensus 27 i~~~~~G~~n~~y~v~-t~~~~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~i 105 (307)
T TIGR00938 27 LKGIAEGVENSNYLLT-TDVGRYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEFL 105 (307)
T ss_pred ccccCCccccceEEEE-eCCCcEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEeC
Confidence 44555553 77643 3455788998754 346677888888887321 24444321 1112235678999999
Q ss_pred CC-CH----H-------HHHHHhhC--CC----CCC--CC-CHHHHH------------HHHHHHHHHHHHHHh------
Q 003542 290 SK-DL----S-------CYMRETFG--SR----RRN--SF-SLPVVV------------DIMLQIARGMEFLHA------ 330 (811)
Q Consensus 290 ~g-~L----~-------~~L~~~~~--~~----~~~--~l-s~~~i~------------~i~~QIa~gL~yLHs------ 330 (811)
+| .+ . ..+..... .. ... .+ .|.... .....+...+.++..
T Consensus 106 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~~ 185 (307)
T TIGR00938 106 QGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRDL 185 (307)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 87 21 1 11111100 00 000 00 010000 011123345555543
Q ss_pred -CCceeccCCCCcEEEeccCCCCcceEEEeecccc
Q 003542 331 -QKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS 364 (811)
Q Consensus 331 -~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA 364 (811)
.+++|+|+++.||+++.++ .+.|+||+.+
T Consensus 186 ~~~l~HgD~~~~Nvl~~~~~-----~~~vIDfd~~ 215 (307)
T TIGR00938 186 PRGVIHADLFPDNVLFDGDS-----VKGVIDFYFA 215 (307)
T ss_pred CCccCCCCCCcCcEEEECCc-----eEEEeecccc
Confidence 5799999999999998764 6789999976
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=96.89 E-value=0.0026 Score=65.01 Aligned_cols=99 Identities=18% Similarity=0.169 Sum_probs=75.8
Q ss_pred HHHHHHHHhCCC-CccceeeeeEEccCCCeEEEEEecCCC-CHHH---HHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 003542 253 NAEISTMLSLSH-PNIVQYLCGFCDEEKKEFFLVMELMSK-DLSC---YMRETFGSRRRNSFSLPVVVDIMLQIARGMEF 327 (811)
Q Consensus 253 ~~Ei~iL~~L~H-PNIVkl~~~~~~e~~~~~yLVmEy~~g-~L~~---~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~y 327 (811)
..|.-+|+.+.+ ++++++++ .|. -++|+||.+. .+.. .+.+. ...+|..+..|+.+++..+.+
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG-~CG-----~~~v~E~~~~~~~~~~~~~l~~~------~~~~w~~R~~iA~~lL~~l~~ 74 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLG-SCG-----RFYVVEYVGAGSLYGIYRPLSQF------LQSPWEQRAKIALQLLELLEE 74 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeee-ECC-----CEEEEEeecCccccccccccccc------cccCHHHHHHHHHHHHHHHHH
Confidence 458889999965 69999984 443 2678999984 4421 11111 346899999999999999999
Q ss_pred HHh---CCceeccCCCCcEEEeccCCCCcceEEEeecccccccc
Q 003542 328 LHA---QKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTART 368 (811)
Q Consensus 328 LHs---~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~~~ 368 (811)
|++ ..+.-.|++|+|+-++.++ .+|++|.......+
T Consensus 75 l~~~~~~~~~lcDv~~~nfgv~~~~-----~lk~iDld~v~~~~ 113 (188)
T PF12260_consen 75 LDHGPLGFFYLCDVSPDNFGVNDDG-----RLKLIDLDDVFVED 113 (188)
T ss_pred HhcCCCCcEEEeecchHHeEEeCCC-----cEEEEechhcchhH
Confidence 998 3477899999999998776 89999998765443
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.80 E-value=0.024 Score=62.25 Aligned_cols=29 Identities=14% Similarity=0.244 Sum_probs=24.5
Q ss_pred CceeccCCCCcEEEeccCCCCcceEEEeeccccc
Q 003542 332 KIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365 (811)
Q Consensus 332 gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~ 365 (811)
+++|+|+.|.|||++.+. ..-|+||+.+.
T Consensus 188 ~liHgD~~~~Nil~~~~~-----~~~iIDf~~~~ 216 (319)
T PRK05231 188 GVIHADLFRDNVLFEGDR-----LSGFIDFYFAC 216 (319)
T ss_pred ccCCCCCCCCcEEEECCc-----eEEEEeccccc
Confidence 799999999999998543 56899999763
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.011 Score=63.96 Aligned_cols=131 Identities=12% Similarity=0.101 Sum_probs=72.6
Q ss_pred eEEEEEEcCCEEEEEEecc-cHHHHHHHHHHHHhCCCC--ccceeeee----EEccCCCeEEEEEecCCC-CHH------
Q 003542 229 QFKEIQWLGDSFVLRHFYG-ELESLNAEISTMLSLSHP--NIVQYLCG----FCDEEKKEFFLVMELMSK-DLS------ 294 (811)
Q Consensus 229 vyk~v~~~g~~VAVK~~~~-~~~~~~~Ei~iL~~L~HP--NIVkl~~~----~~~e~~~~~yLVmEy~~g-~L~------ 294 (811)
+|.. ...+..+++|++.. ....+..|+.++..|.+- .+.+++.. ......+..++||+|++| .+.
T Consensus 30 ~y~v-~~~~~~~vLr~~~~~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i~G~~~~~~~~~~ 108 (296)
T cd05153 30 NYFV-TTDSGRYVLTLFEKVSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFLAGEHLTRPTAAH 108 (296)
T ss_pred eEEE-EeCCCcEEEEEcCCCChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeCCCCCCCCCCHHH
Confidence 6763 34566899999863 456788899998888432 24454421 111123456899999997 321
Q ss_pred -----HHHHHhhC--CCCC------CCCCHHHH----------HHHHHHHHHHHHHHHh-------CCceeccCCCCcEE
Q 003542 295 -----CYMRETFG--SRRR------NSFSLPVV----------VDIMLQIARGMEFLHA-------QKIYHGELNPSNIY 344 (811)
Q Consensus 295 -----~~L~~~~~--~~~~------~~ls~~~i----------~~i~~QIa~gL~yLHs-------~gIVHRDLKPsNIL 344 (811)
..+..... .... ....+... ......+..++.++.. .+++|+|+.|.|||
T Consensus 109 ~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil 188 (296)
T cd05153 109 CRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRGVIHADLFRDNVL 188 (296)
T ss_pred HHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCcCCccCcCcccEE
Confidence 11111000 0000 00111110 0011123334455543 36999999999999
Q ss_pred EeccCCCCcceEEEeeccccc
Q 003542 345 LKARSMEGYFHVKVSGFGLST 365 (811)
Q Consensus 345 I~~~g~d~~~~vKL~DFGlA~ 365 (811)
++.++ .+.|+||+.+.
T Consensus 189 ~~~~~-----~~~iIDfe~a~ 204 (296)
T cd05153 189 FDGDE-----LSGVIDFYFAC 204 (296)
T ss_pred EeCCc-----eEEEeehhhhc
Confidence 98764 56899998763
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.013 Score=61.10 Aligned_cols=29 Identities=21% Similarity=0.350 Sum_probs=24.7
Q ss_pred CceeccCCCCcEEEec-cCCCCcceEEEeeccccc
Q 003542 332 KIYHGELNPSNIYLKA-RSMEGYFHVKVSGFGLST 365 (811)
Q Consensus 332 gIVHRDLKPsNILI~~-~g~d~~~~vKL~DFGlA~ 365 (811)
+++|+|+.+.|||++. ++ .+.|+||..|.
T Consensus 171 ~l~H~Dl~~~Nil~~~~~~-----~~~lIDwe~a~ 200 (235)
T cd05157 171 VFCHNDLLSGNIIYNEEKN-----SVKFIDYEYAG 200 (235)
T ss_pred EEEcCCCCcCcEEEeCCCC-----CEEEEEcccCC
Confidence 5899999999999986 33 69999998764
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.58 E-value=0.011 Score=59.45 Aligned_cols=122 Identities=21% Similarity=0.258 Sum_probs=82.0
Q ss_pred Eeeeecccc---eEEEEEEcCCEEEEEEecc--cHHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEecCCC-CH
Q 003542 220 VRRRLGASS---QFKEIQWLGDSFVLRHFYG--ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DL 293 (811)
Q Consensus 220 i~~~lG~G~---vyk~v~~~g~~VAVK~~~~--~~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~~g-~L 293 (811)
..+.||+|+ ||. ..|.|..+|+|+-.. ....+..|+++|..+.-.++.+=+ .++++ -++.|||+.| .|
T Consensus 26 v~~~L~KG~~s~Vyl-~~~~~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~v-y~yg~----~~i~me~i~G~~L 99 (201)
T COG2112 26 VEKELAKGTTSVVYL-GEWRGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEV-YFYGE----DFIRMEYIDGRPL 99 (201)
T ss_pred hhhhhhcccccEEEE-eeccCceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceE-EEech----hhhhhhhhcCcch
Confidence 344566665 565 468889999999864 467899999999999877776533 23332 3567999998 66
Q ss_pred HHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCC--CcEEEeccCCCCcceEEEeecccccc
Q 003542 294 SCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNP--SNIYLKARSMEGYFHVKVSGFGLSTA 366 (811)
Q Consensus 294 ~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKP--sNILI~~~g~d~~~~vKL~DFGlA~~ 366 (811)
...-.. .+ .+-+..++..-.-|-..||-|+.|.- .||++..+ .+.|+||.-|+.
T Consensus 100 ~~~~~~---------~~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~------~~~iIDFd~At~ 155 (201)
T COG2112 100 GKLEIG---------GD----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDR------DVYIIDFDSATF 155 (201)
T ss_pred hhhhhc---------cc----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCC------cEEEEEccchhh
Confidence 554331 11 12233556665556678999999874 35655432 699999998763
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.58 E-value=0.028 Score=64.00 Aligned_cols=66 Identities=20% Similarity=0.251 Sum_probs=44.9
Q ss_pred eeecccc---eEEEEEEcC-CEEEEEEec-----------ccHHHHHHHHHHHHhCC---CCccceeeeeEEccCCCeEE
Q 003542 222 RRLGASS---QFKEIQWLG-DSFVLRHFY-----------GELESLNAEISTMLSLS---HPNIVQYLCGFCDEEKKEFF 283 (811)
Q Consensus 222 ~~lG~G~---vyk~v~~~g-~~VAVK~~~-----------~~~~~~~~Ei~iL~~L~---HPNIVkl~~~~~~e~~~~~y 283 (811)
+.+|.|. ||+....+| +.|+||.-. -..++...|.+.|..+. ..++.+++ .+ ++ ...+
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~-~~-D~--~~~~ 107 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVY-HY-DE--ELAV 107 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEE-EE-CC--CCCE
Confidence 4577775 777655555 489999842 13566788998888872 34577776 33 33 3468
Q ss_pred EEEecCCC
Q 003542 284 LVMELMSK 291 (811)
Q Consensus 284 LVmEy~~g 291 (811)
+||||+++
T Consensus 108 lVME~L~~ 115 (401)
T PRK09550 108 TVMEDLSD 115 (401)
T ss_pred EEEecCCC
Confidence 99999985
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.40 E-value=0.061 Score=58.55 Aligned_cols=62 Identities=15% Similarity=0.091 Sum_probs=39.1
Q ss_pred eEEEEEEcCCEEEEEEecccHHHHHHHHHHHHhCCCC--ccceeeee----EEccCCCeEEEEEecCCC
Q 003542 229 QFKEIQWLGDSFVLRHFYGELESLNAEISTMLSLSHP--NIVQYLCG----FCDEEKKEFFLVMELMSK 291 (811)
Q Consensus 229 vyk~v~~~g~~VAVK~~~~~~~~~~~Ei~iL~~L~HP--NIVkl~~~----~~~e~~~~~yLVmEy~~g 291 (811)
+|+.. ..+..+++|++......+..|+.++..|... .|++++.. .+...++..++|+||++|
T Consensus 12 v~~v~-t~~g~~~LK~~~~~~~~~~~~~~~~~~L~~~g~~vp~~i~t~~g~~~~~~~~~~~~l~~~i~G 79 (313)
T TIGR02906 12 VYKVE-TDSGNKCLKKINYPPERLLFILGAQEHLRKNGFNIPKILKTKDGELYVKYNGDLYVLTEWIEG 79 (313)
T ss_pred EEEEE-eCCCCeEEEEcCCCHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEehhccC
Confidence 77744 3445799999876656677788888777322 34444311 111224568999999997
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.09 E-value=0.028 Score=59.76 Aligned_cols=124 Identities=16% Similarity=0.209 Sum_probs=67.5
Q ss_pred eEEEEEEcCCEEEEEEecccH----HHHHHHHHHHHhCCCCcc-ceeeeeEEccCCCeEEEEEecCCC-CHH--------
Q 003542 229 QFKEIQWLGDSFVLRHFYGEL----ESLNAEISTMLSLSHPNI-VQYLCGFCDEEKKEFFLVMELMSK-DLS-------- 294 (811)
Q Consensus 229 vyk~v~~~g~~VAVK~~~~~~----~~~~~Ei~iL~~L~HPNI-Vkl~~~~~~e~~~~~yLVmEy~~g-~L~-------- 294 (811)
+|+. ...|..+++|...... -...+|..+++.+..-.+ .+++ .+ .+ -++||||++| .+.
T Consensus 12 ~y~~-~~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i-~~-~~----~~~v~e~i~G~~~~~~~~~~~~ 84 (256)
T TIGR02721 12 SWRI-EHPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPI-LV-NE----HWLLVEWLEGEVITLDQFVALD 84 (256)
T ss_pred eEEE-EeCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceE-EE-eC----CEEEEEeccCcccccccccCch
Confidence 6653 3567788998864322 235889999999954333 3333 22 12 2689999997 321
Q ss_pred ------HHHHHhhCCC-CCCCCCHH-HHHHHHHHH---------HHHHHHHHh--------CCceeccCCCCcEEEeccC
Q 003542 295 ------CYMRETFGSR-RRNSFSLP-VVVDIMLQI---------ARGMEFLHA--------QKIYHGELNPSNIYLKARS 349 (811)
Q Consensus 295 ------~~L~~~~~~~-~~~~ls~~-~i~~i~~QI---------a~gL~yLHs--------~gIVHRDLKPsNILI~~~g 349 (811)
..+....... ...+++.. .+..+..++ ...+..+-. ..++|+|+.|.|||++.++
T Consensus 85 ~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Nil~~~~~ 164 (256)
T TIGR02721 85 LLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNLVVTPQG 164 (256)
T ss_pred hHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcEEEeCCC
Confidence 1122211111 11122221 222222222 111222221 1479999999999997653
Q ss_pred CCCcceEEEeeccccc
Q 003542 350 MEGYFHVKVSGFGLST 365 (811)
Q Consensus 350 ~d~~~~vKL~DFGlA~ 365 (811)
+.|+||+.+.
T Consensus 165 ------~~lIDwE~a~ 174 (256)
T TIGR02721 165 ------LKLIDWEYAS 174 (256)
T ss_pred ------CEEEeccccC
Confidence 6899998764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.93 E-value=0.038 Score=61.47 Aligned_cols=130 Identities=15% Similarity=0.204 Sum_probs=89.5
Q ss_pred Eeeeecccc---eEEEEEEcCCEEEEEEeccc--------------------------HHH----HHHHHHHHHhCCCCc
Q 003542 220 VRRRLGASS---QFKEIQWLGDSFVLRHFYGE--------------------------LES----LNAEISTMLSLSHPN 266 (811)
Q Consensus 220 i~~~lG~G~---vyk~v~~~g~~VAVK~~~~~--------------------------~~~----~~~Ei~iL~~L~HPN 266 (811)
+-+.|..|. ||-+..-+|..+|||+++.. .+. ...|++-|++|....
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 334555564 99888889999999998421 111 367888888886544
Q ss_pred cceeeeeEEccCCCeEEEEEecCCC-C-HHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcE
Q 003542 267 IVQYLCGFCDEEKKEFFLVMELMSK-D-LSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHA-QKIYHGELNPSNI 343 (811)
Q Consensus 267 IVkl~~~~~~e~~~~~yLVmEy~~g-~-L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs-~gIVHRDLKPsNI 343 (811)
|.--- -+.. ..-.|||+|+++ + -.-.|+ ...++...+..+-.|++.-|.-|-+ .++||.||.--|+
T Consensus 228 IP~Pe-PIlL---k~hVLVM~FlGrdgw~aPkLK-------d~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~ 296 (520)
T KOG2270|consen 228 IPCPE-PILL---KNHVLVMEFLGRDGWAAPKLK-------DASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNL 296 (520)
T ss_pred CCCCC-ceee---ecceEeeeeccCCCCcCcccc-------cccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhh
Confidence 33211 1110 124799999985 2 111222 2567778889999999999988755 5899999999999
Q ss_pred EEeccCCCCcceEEEeecccccc
Q 003542 344 YLKARSMEGYFHVKVSGFGLSTA 366 (811)
Q Consensus 344 LI~~~g~d~~~~vKL~DFGlA~~ 366 (811)
|+... .+.|+|-+-+..
T Consensus 297 LyhdG------~lyiIDVSQSVE 313 (520)
T KOG2270|consen 297 LYHDG------KLYIIDVSQSVE 313 (520)
T ss_pred eEECC------EEEEEEcccccc
Confidence 99654 799999886643
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=95.86 E-value=0.037 Score=60.17 Aligned_cols=49 Identities=18% Similarity=0.191 Sum_probs=32.1
Q ss_pred CCEEEEEEeccc---HHHHHHHHHHHHhCCCCcc-ceeeeeEEccCCCeEEEEEecCCC
Q 003542 237 GDSFVLRHFYGE---LESLNAEISTMLSLSHPNI-VQYLCGFCDEEKKEFFLVMELMSK 291 (811)
Q Consensus 237 g~~VAVK~~~~~---~~~~~~Ei~iL~~L~HPNI-Vkl~~~~~~e~~~~~yLVmEy~~g 291 (811)
++.|++|+.... .....+|+.++..+....+ .++++.+ ++ .+||||++|
T Consensus 29 ~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~--~~----~~v~e~i~G 81 (302)
T cd05156 29 PRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIF--PN----GRIEEFIPS 81 (302)
T ss_pred CCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEe--CC----CchhheeCC
Confidence 578999998542 3456889999998843233 3444222 22 368999887
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.81 E-value=0.059 Score=60.45 Aligned_cols=71 Identities=17% Similarity=0.186 Sum_probs=44.6
Q ss_pred ecccc---eEEEEEEcC-CEEEEEEecc-----------cHHHHHHHHHHHHhCC--CC-ccceeeeeEEccCCCeEEEE
Q 003542 224 LGASS---QFKEIQWLG-DSFVLRHFYG-----------ELESLNAEISTMLSLS--HP-NIVQYLCGFCDEEKKEFFLV 285 (811)
Q Consensus 224 lG~G~---vyk~v~~~g-~~VAVK~~~~-----------~~~~~~~Ei~iL~~L~--HP-NIVkl~~~~~~e~~~~~yLV 285 (811)
+|.|. ||++....| +.|+||.-.. ..++..-|...|+... -| .+.++| ++++ ....+|
T Consensus 3 igdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy--~~D~--e~~~~v 78 (370)
T TIGR01767 3 VGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIF--HFDT--EMAVTV 78 (370)
T ss_pred CCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEE--EEcc--ccceeh
Confidence 56675 888665433 5899998521 2456677888887763 34 455565 3333 346799
Q ss_pred EecCCC--CHHHHHH
Q 003542 286 MELMSK--DLSCYMR 298 (811)
Q Consensus 286 mEy~~g--~L~~~L~ 298 (811)
||+++. .|...|.
T Consensus 79 MEdL~~~~ilR~~Li 93 (370)
T TIGR01767 79 MEDLSHHKIARKGLI 93 (370)
T ss_pred HhhCccchHHHHHHH
Confidence 999973 4544443
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=95.74 E-value=0.0074 Score=65.89 Aligned_cols=124 Identities=19% Similarity=0.208 Sum_probs=84.3
Q ss_pred eEEeeeecccc---eEEEEEEcCCEEEEEEec----------c----------------cHHHHHHHHHHHHhCC-CCcc
Q 003542 218 LMVRRRLGASS---QFKEIQWLGDSFVLRHFY----------G----------------ELESLNAEISTMLSLS-HPNI 267 (811)
Q Consensus 218 ~~i~~~lG~G~---vyk~v~~~g~~VAVK~~~----------~----------------~~~~~~~Ei~iL~~L~-HPNI 267 (811)
+.+.+.||-|. +|.+....|++.++|.=. . ..-...+|+..|+.|. |-.=
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 46777888875 888888889999999741 0 1233578999999983 4433
Q ss_pred ce-eeeeEEccCCCeEEEEEecCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE
Q 003542 268 VQ-YLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYL 345 (811)
Q Consensus 268 Vk-l~~~~~~e~~~~~yLVmEy~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIVHRDLKPsNILI 345 (811)
|+ .+ +....++|||++.| .|.. ++. ..+ +-.+...+..-+--|-.+|+||+|..-=||+|
T Consensus 174 VPkpi------D~~RH~Vvmelv~g~Pl~~-v~~--------v~d---~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv 235 (465)
T KOG2268|consen 174 VPKPI------DHNRHCVVMELVDGYPLRQ-VRH--------VED---PPTLYDDLMGLIVRLANHGLIHGDFNEFNIMV 235 (465)
T ss_pred CCCcc------cccceeeHHHhhcccceee-eee--------cCC---hHHHHHHHHHHHHHHHHcCceecccchheeEE
Confidence 33 22 22346899999987 4432 211 112 22334445555567788999999999999999
Q ss_pred eccCCCCcceEEEeecccc
Q 003542 346 KARSMEGYFHVKVSGFGLS 364 (811)
Q Consensus 346 ~~~g~d~~~~vKL~DFGlA 364 (811)
+.++ .++++||--.
T Consensus 236 ~dd~-----~i~vIDFPQm 249 (465)
T KOG2268|consen 236 KDDD-----KIVVIDFPQM 249 (465)
T ss_pred ecCC-----CEEEeechHh
Confidence 8765 8999999643
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.56 E-value=0.13 Score=56.48 Aligned_cols=65 Identities=17% Similarity=0.251 Sum_probs=42.1
Q ss_pred ccceEEEEEEcCCEEEEEEecccHHHHHHHHHHHHhCC---CCccceee----eeEEccCCCeEEEEEecCCC
Q 003542 226 ASSQFKEIQWLGDSFVLRHFYGELESLNAEISTMLSLS---HPNIVQYL----CGFCDEEKKEFFLVMELMSK 291 (811)
Q Consensus 226 ~G~vyk~v~~~g~~VAVK~~~~~~~~~~~Ei~iL~~L~---HPNIVkl~----~~~~~e~~~~~yLVmEy~~g 291 (811)
.|++|+.. .++..+++|.+....+.+...+.++..|. -+++++++ +..+...++..|++|++++|
T Consensus 19 ~~~v~~v~-T~~G~~~Lk~~~~~~~~l~~~~~~~~~L~~~G~~~~~~~~~t~~G~~~~~~~~~~~~L~~wi~G 90 (309)
T TIGR02904 19 TGKLFKVY-TDQGVFALKKLYADRNTIESFVSQIQVLSEKGFSRIVPVYPTKDGSYYLFHGHFLYYLMPWLDI 90 (309)
T ss_pred cCcEEEEE-eCCCCEEEEEeccchHhHHHHHHHHHHHHHcCCCcCCceeecCCCCeeeEECCEEEEEeCCccc
Confidence 56688854 45667999999877666666677777663 24566654 11121223456899999887
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.10 E-value=0.063 Score=61.93 Aligned_cols=51 Identities=22% Similarity=0.245 Sum_probs=38.8
Q ss_pred HHHHHHHHHHHHhCCCCccceeeeeEEccCCCeEEEEEecCCCCHHHHHHHh
Q 003542 249 LESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRET 300 (811)
Q Consensus 249 ~~~~~~Ei~iL~~L~HPNIVkl~~~~~~e~~~~~yLVmEy~~g~L~~~L~~~ 300 (811)
...+..-+..++.+.|+|...+++.. ........+|||+++.+|.++++..
T Consensus 26 s~~ilgr~~~lktl~~~~l~~yl~~~-r~~~~r~IVV~e~~~~Sled~~~~~ 76 (725)
T KOG1093|consen 26 SIQILGRFQYLKSLQHDNLCQYLDFS-RGKHERVIVVMEHYTMSLEDILKTG 76 (725)
T ss_pred HHHHhhhhHHHHhhcCccceeeEeee-cCccceEEEEehhhccchHHHHHhc
Confidence 34556677889999999999988433 2233458999999999999988763
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.08 E-value=0.11 Score=59.07 Aligned_cols=73 Identities=15% Similarity=0.132 Sum_probs=47.6
Q ss_pred eeeecccc---eEEEEEEc-CCEEEEEEecc----------cHHHHHHHHHHHHhCC--CC-ccceeeeeEEccCCCeEE
Q 003542 221 RRRLGASS---QFKEIQWL-GDSFVLRHFYG----------ELESLNAEISTMLSLS--HP-NIVQYLCGFCDEEKKEFF 283 (811)
Q Consensus 221 ~~~lG~G~---vyk~v~~~-g~~VAVK~~~~----------~~~~~~~Ei~iL~~L~--HP-NIVkl~~~~~~e~~~~~y 283 (811)
.+.||.|. ||++...+ +..|+||.-.. ..++..-|..+|+.+. -| ++.++| ++++ ....
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy--~~D~--e~~~ 109 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVY--LFDS--VMNC 109 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEE--EECc--HHhh
Confidence 45678886 88866432 56899998621 3577788888888773 34 456665 3333 3468
Q ss_pred EEEecCCC--CHHHHH
Q 003542 284 LVMELMSK--DLSCYM 297 (811)
Q Consensus 284 LVmEy~~g--~L~~~L 297 (811)
+|||+++. .|...|
T Consensus 110 ~vMEdL~~~~ilR~~L 125 (409)
T PRK12396 110 CVMEDLSDHTILRTAL 125 (409)
T ss_pred HHHHhCcccHHHHHHH
Confidence 99999974 444443
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=94.74 E-value=0.22 Score=54.05 Aligned_cols=31 Identities=16% Similarity=0.368 Sum_probs=24.6
Q ss_pred CceeccCCCCcEEEeccCCCCcceEEEeecccccc
Q 003542 332 KIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366 (811)
Q Consensus 332 gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~~ 366 (811)
.++|+|++|.|||++.++. ..-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~----~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDAR----VTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCC----EEEEECcHhccc
Confidence 3799999999999986331 567999998753
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF05659 RPW8: Arabidopsis broad-spectrum mildew resistance protein RPW8; InterPro: IPR008808 This entry represents the RPW8 domain found in several broad-spectrum mildew resistance proteins from Arabidopsis thaliana and other dicots | Back alignment and domain information |
|---|
Probab=94.42 E-value=0.17 Score=49.72 Aligned_cols=75 Identities=16% Similarity=0.262 Sum_probs=57.2
Q ss_pred HHHHHHHhhHHHhhcHHHHHHHHHHHHHHHHHHHHHHHHhhhcccccCCchHHHHHHHHHHHHHHHHHHHHHHhcCchhH
Q 003542 13 SLKALMVLKDDIQINQRQCCLLLDIFTLAFSTVAEEIRLFLKSEEKNTKWRALEQPLRELQKVFREGEHYVKQCLDYKDW 92 (811)
Q Consensus 13 ~~~~i~~~~~~~~~n~~qc~~l~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~el~~~l~~a~~~i~~c~~~~~~ 92 (811)
+++++....+....++.-+.+|...+ ..+.+++++|..-.. .-. ++-..-+.+|...|++|+.+|++|..-+ |
T Consensus 18 Llk~v~~~~~k~~~fk~~l~~L~sTl-~~i~P~i~eI~~~~~---eld--~~~~ee~e~L~~~L~~g~~LV~k~sk~~-r 90 (147)
T PF05659_consen 18 LLKAVIDASKKSLSFKSILKRLESTL-ESIIPIIKEIDKLNV---ELD--RPRQEEIERLKELLEKGKELVEKCSKVR-R 90 (147)
T ss_pred HHHHHHHHHHHHHhhhhHHHHHHHHH-HHhhhHHHHHHHHhh---hcC--CchhHHHHHHHHHHHHHHHHHHHhcccc-H
Confidence 45777888888888888899999999 999999999986522 110 1114458899999999999999999543 5
Q ss_pred HH
Q 003542 93 WG 94 (811)
Q Consensus 93 ~~ 94 (811)
|.
T Consensus 91 ~n 92 (147)
T PF05659_consen 91 WN 92 (147)
T ss_pred HH
Confidence 54
|
Plant disease resistance (R) genes control the recognition of specific pathogens and activate subsequent defence responses. The R protein-mediated defences typically involve a rapid, localized necrosis, or hypersensitive response (HR), at the site of infection, and the localised formation of antimicrobial chemicals and proteins that restrict growth of the pathogen. The A. thaliana locus Resistance to Powdery Mildew 8 (RPW8) contains two naturally polymorphic, dominant R genes: RPW8.1 and RPW8.2, which individually control resistance to a broad range of powdery mildew pathogens. They induce localised, salicylic acid-dependent defences similar to those induced by R genes that control specific resistance. Apparently, broad-spectrum resistance mediated by RPW8 uses the same mechanisms as specific resistance [, ]. RPW8.1 and RPW8.2 share similarity with an ~150 amino acid module forming the N terminus of a group of disease resistance proteins, which have a nucleotide-binding site (NBS) and leucine-rich repeats (LRRs) [, ]. The RPW8 domain sequences contain a predicted N-terminal transmembrane (TM) region or possibly a signal peptide, and a coiled-coil (CC) motif []. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=93.57 E-value=0.11 Score=53.41 Aligned_cols=30 Identities=30% Similarity=0.511 Sum_probs=19.2
Q ss_pred CceeccCCCCcEEE-eccCCCCcceEEEeecccccc
Q 003542 332 KIYHGELNPSNIYL-KARSMEGYFHVKVSGFGLSTA 366 (811)
Q Consensus 332 gIVHRDLKPsNILI-~~~g~d~~~~vKL~DFGlA~~ 366 (811)
.+.|.||.|.|||+ +.++ .++|+||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~-----~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDG-----EVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSS-----CEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCC-----eEEEecHHHHhh
Confidence 37899999999999 4444 899999998753
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.44 E-value=1.1 Score=49.74 Aligned_cols=63 Identities=14% Similarity=0.051 Sum_probs=38.9
Q ss_pred eEEEEEEcCCEEEEEEecc---cHHHHHHHHHHHHhCCCC--ccceee---eeEEccCCCeEEEEEecCCC
Q 003542 229 QFKEIQWLGDSFVLRHFYG---ELESLNAEISTMLSLSHP--NIVQYL---CGFCDEEKKEFFLVMELMSK 291 (811)
Q Consensus 229 vyk~v~~~g~~VAVK~~~~---~~~~~~~Ei~iL~~L~HP--NIVkl~---~~~~~e~~~~~yLVmEy~~g 291 (811)
+|....-+|..+++|+... ....+..|+..+..|... .++... +.....-++..+.|+++++|
T Consensus 41 vy~v~~~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G 111 (325)
T PRK11768 41 VYQFGDEDGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGG 111 (325)
T ss_pred EEEEecCCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCC
Confidence 7876555678899999853 456678898888877311 122211 11111223467889999887
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=93.06 E-value=0.27 Score=54.93 Aligned_cols=87 Identities=14% Similarity=0.139 Sum_probs=62.6
Q ss_pred CCCccceeeeeEEccCCCeEEEEEecCCCCHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCC
Q 003542 263 SHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQ-KIYHGELNPS 341 (811)
Q Consensus 263 ~HPNIVkl~~~~~~e~~~~~yLVmEy~~g~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~-gIVHRDLKPs 341 (811)
..++..+.+ .+-..+..+.|++|++-.+.+.. + ..-.++++..++++.+.-++-+..+ ..-||||.-.
T Consensus 283 g~~~~e~~~-vv~~de~~y~yl~~kdhgt~is~-i---------k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~ 351 (488)
T COG5072 283 GSVFLETLK-VVSLDETLYLYLHFKDHGTPISI-I---------KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLD 351 (488)
T ss_pred cchhhhcce-EEecCCceEEEEEEecCCceeee-e---------ecccHHHHHHHHHHHHHHHhhhhhcCCccccccccc
Confidence 345555543 22224456789999998776432 1 2235678888999888877777654 5789999999
Q ss_pred cEEEeccCCCCcceEEEeecccccc
Q 003542 342 NIYLKARSMEGYFHVKVSGFGLSTA 366 (811)
Q Consensus 342 NILI~~~g~d~~~~vKL~DFGlA~~ 366 (811)
||||+ .| .|-|+||-+++.
T Consensus 352 niLId-~G-----nvtLIDfklsRl 370 (488)
T COG5072 352 NILID-EG-----NVTLIDFKLSRL 370 (488)
T ss_pred ceeee-cC-----ceEEEEeeeeec
Confidence 99998 55 899999999973
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=93.05 E-value=1.4 Score=50.38 Aligned_cols=66 Identities=14% Similarity=0.224 Sum_probs=42.8
Q ss_pred eeeecccc---eEEEEEEcCCEEEEEEec------c-----cHHHHHHHHHHHHhCC---CCccceeeeeEEccCCCeEE
Q 003542 221 RRRLGASS---QFKEIQWLGDSFVLRHFY------G-----ELESLNAEISTMLSLS---HPNIVQYLCGFCDEEKKEFF 283 (811)
Q Consensus 221 ~~~lG~G~---vyk~v~~~g~~VAVK~~~------~-----~~~~~~~Ei~iL~~L~---HPNIVkl~~~~~~e~~~~~y 283 (811)
.+.+|.|. +|+... .+..|+||.-. + ...+-..|...|..+. ..++.++| .++ + ...+
T Consensus 37 ~~eiggGn~N~VyrV~~-~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy-~~d-e--d~~v 111 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVS-SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVY-HFD-R--TMAL 111 (418)
T ss_pred EEEcCCCceeeEEEEEc-CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEE-EEC-C--CCCE
Confidence 45677776 777443 56679999864 1 3455566777777663 24777776 343 3 2358
Q ss_pred EEEecCCC
Q 003542 284 LVMELMSK 291 (811)
Q Consensus 284 LVmEy~~g 291 (811)
++|||+++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 89999976
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=92.60 E-value=1.7 Score=48.20 Aligned_cols=123 Identities=21% Similarity=0.316 Sum_probs=69.9
Q ss_pred CCEEEEEEec------ccHHHHHHHHHHHHhCCC--CccceeeeeEEccCC-CeEEEEEecCCC----------------
Q 003542 237 GDSFVLRHFY------GELESLNAEISTMLSLSH--PNIVQYLCGFCDEEK-KEFFLVMELMSK---------------- 291 (811)
Q Consensus 237 g~~VAVK~~~------~~~~~~~~Ei~iL~~L~H--PNIVkl~~~~~~e~~-~~~yLVmEy~~g---------------- 291 (811)
++.+++. .. .......+|..+|+.+.- .-+...+ +.|.++. ...|.||+|++|
T Consensus 48 ~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~-~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~~~~ 125 (321)
T COG3173 48 GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAF-GLCGEGYLGTPFYVMEWVEGEVVWSALPPESLGRQF 125 (321)
T ss_pred CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccc-cccccCCCCCceEEEEEecceeccCcCCcccchHHH
Confidence 7788888 32 245667888888888742 1222333 3443333 466999999988
Q ss_pred ---CHHHHHHHhhCCC--------CCCCCCHHHHHHHHH--------------HHHHHHHHHHhC--------CceeccC
Q 003542 292 ---DLSCYMRETFGSR--------RRNSFSLPVVVDIML--------------QIARGMEFLHAQ--------KIYHGEL 338 (811)
Q Consensus 292 ---~L~~~L~~~~~~~--------~~~~ls~~~i~~i~~--------------QIa~gL~yLHs~--------gIVHRDL 338 (811)
+|.+.|.+..... ....+...++..+.. ....-..||+.+ .++|||+
T Consensus 126 ~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~ 205 (321)
T COG3173 126 ALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDY 205 (321)
T ss_pred HHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCc
Confidence 2222232221110 000011111111111 122334566553 3899999
Q ss_pred CCCcEEEeccCCCCcceEEEeecccccc
Q 003542 339 NPSNIYLKARSMEGYFHVKVSGFGLSTA 366 (811)
Q Consensus 339 KPsNILI~~~g~d~~~~vKL~DFGlA~~ 366 (811)
.+.|++|+..+ -+-+.||+++..
T Consensus 206 ~~gNlii~~~~-----~~gVlDwe~~~l 228 (321)
T COG3173 206 RPGNLIIDPGR-----PTGVLDWELATL 228 (321)
T ss_pred ccCCEEEeCCC-----eeEEEecccccc
Confidence 99999998876 588999998754
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=92.34 E-value=0.78 Score=50.98 Aligned_cols=29 Identities=17% Similarity=0.279 Sum_probs=24.0
Q ss_pred ceeccCCCCcEEEeccCCCCcceEEEeeccccc
Q 003542 333 IYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365 (811)
Q Consensus 333 IVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~ 365 (811)
++|.||.+.|||++.++. .++++||+.|.
T Consensus 184 ~CHnDl~~~NiL~~~~~~----~l~lID~EYag 212 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEG----KLYFIDFEYGS 212 (330)
T ss_pred EEECCCCcccEEEeCCCC----cEEEEcccccC
Confidence 699999999999975421 79999999763
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=92.21 E-value=1 Score=50.43 Aligned_cols=30 Identities=13% Similarity=0.360 Sum_probs=24.6
Q ss_pred CceeccCCCCcEEEeccCCCCcceEEEeeccccc
Q 003542 332 KIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365 (811)
Q Consensus 332 gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~ 365 (811)
.++|+|+++.|||++..+. .+.|+||..+.
T Consensus 201 ~~cH~Dl~~~Nil~~~~~~----~~~lID~Eya~ 230 (344)
T PLN02236 201 GFCHNDLQYGNIMIDEETR----AITIIDYEYAS 230 (344)
T ss_pred eEEeCCCCcCcEEEeCCCC----cEEEEeehhcc
Confidence 4799999999999975321 79999998764
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=90.99 E-value=1.6 Score=47.74 Aligned_cols=103 Identities=11% Similarity=-0.036 Sum_probs=64.5
Q ss_pred ceEEeeeecccc---eEEEEEEcCCEEEEEEecc--cHHHHHHHHHHHHhCC-C--CccceeeeeEEcc-CCCeEEEEEe
Q 003542 217 KLMVRRRLGASS---QFKEIQWLGDSFVLRHFYG--ELESLNAEISTMLSLS-H--PNIVQYLCGFCDE-EKKEFFLVME 287 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v~~~g~~VAVK~~~~--~~~~~~~Ei~iL~~L~-H--PNIVkl~~~~~~e-~~~~~yLVmE 287 (811)
...-.+.||.|. +|... ..+..+.+|..+. ....+.+|...|+.|. + -.+.++++.+.+. ..+..+||||
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~-~~~~~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE 93 (297)
T PRK10593 15 KLSRVECISEQPYAALWALY-DSQGNPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE 93 (297)
T ss_pred hhheeeecCCccceeEEEEE-cCCCCEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence 344455678874 44422 2334577788654 2468999999999884 2 3677777443221 2345799999
Q ss_pred cCCC-CHHHHHHHhhCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 003542 288 LMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQ 331 (811)
Q Consensus 288 y~~g-~L~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~ 331 (811)
+++| ++.+ . .........+..+++.+|.-||+.
T Consensus 94 ~i~G~~~~~-~----------~~~~~~~~~l~~~l~~~La~LH~~ 127 (297)
T PRK10593 94 RLRGVSVEA-P----------ARTPERWEQLKDQIVEGLLAWHRI 127 (297)
T ss_pred ccCCEecCC-C----------CCCHHHHHHHHHHHHHHHHHHhCC
Confidence 9997 4332 0 122334556677888999999974
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=90.29 E-value=2.6 Score=46.95 Aligned_cols=133 Identities=16% Similarity=0.197 Sum_probs=74.1
Q ss_pred cceEEEEEEcCCEEEEEEecc--cHHHHHHHHHHHHhCC-C--Cc---cceeeeeEEccCC--CeEEEEEecCCC-CHH-
Q 003542 227 SSQFKEIQWLGDSFVLRHFYG--ELESLNAEISTMLSLS-H--PN---IVQYLCGFCDEEK--KEFFLVMELMSK-DLS- 294 (811)
Q Consensus 227 G~vyk~v~~~g~~VAVK~~~~--~~~~~~~Ei~iL~~L~-H--PN---IVkl~~~~~~e~~--~~~yLVmEy~~g-~L~- 294 (811)
..+|....-+|.. ++|+... ....+.-|+..|..|. + |= |...=+.....-. .+.+-+.+|++| .+.
T Consensus 39 N~~f~~~~~~g~~-iLki~~~~~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~~~~~ 117 (331)
T COG2334 39 NSNFRVQTEDGRY-ILKIYRPGWTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGRPLER 117 (331)
T ss_pred CceEEEEecCCCe-EEEEecCCCCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCcCcCC
Confidence 3378755555555 9999875 4567888888888882 2 21 2221111111112 367889999998 333
Q ss_pred ----HH-------H---HHhhC-CC--CCC---CCCHH----H---------HHHHHHHHHHHHHHHHhC--------C-
Q 003542 295 ----CY-------M---RETFG-SR--RRN---SFSLP----V---------VVDIMLQIARGMEFLHAQ--------K- 332 (811)
Q Consensus 295 ----~~-------L---~~~~~-~~--~~~---~ls~~----~---------i~~i~~QIa~gL~yLHs~--------g- 332 (811)
.. + ..... .. ... ...|. . -.....++...+..+... +
T Consensus 118 ~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp~~~~ 197 (331)
T COG2334 118 DDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLPALGD 197 (331)
T ss_pred CCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCCcccc
Confidence 01 1 11100 00 001 11222 0 011334455555555542 3
Q ss_pred -ceeccCCCCcEEEeccCCCCcceEEEeecccc
Q 003542 333 -IYHGELNPSNIYLKARSMEGYFHVKVSGFGLS 364 (811)
Q Consensus 333 -IVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA 364 (811)
+||+|+.|.|||++.++. .+.++|||-+
T Consensus 198 ~iIH~D~~~~NVl~d~~~~----~~g~iDFdDa 226 (331)
T COG2334 198 QIIHGDLHPDNVLFDDDTD----VSGFIDFDDA 226 (331)
T ss_pred eeeecCCCccceeEcCCCC----eeeEEEcccc
Confidence 999999999999987641 4889999976
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=89.24 E-value=5.2 Score=51.31 Aligned_cols=33 Identities=21% Similarity=0.249 Sum_probs=25.4
Q ss_pred CCceeccCCCCcEEEeccCCCCcceEEEeeccccc
Q 003542 331 QKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365 (811)
Q Consensus 331 ~gIVHRDLKPsNILI~~~g~d~~~~vKL~DFGlA~ 365 (811)
.++||+|+.+.|||++.++. . -..-|+|||.+.
T Consensus 203 ~~vIHgDln~~NiLv~~~~~-~-~isGiIDFgDa~ 235 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDG-E-RISGLIDFGDAV 235 (1013)
T ss_pred cceECCCCCcccEEEcCCCC-c-ceEEEEECcccc
Confidence 46999999999999987641 1 145699999763
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=88.32 E-value=0.55 Score=52.09 Aligned_cols=57 Identities=23% Similarity=0.223 Sum_probs=37.3
Q ss_pred HHHHHHHHHHHHHHHHHH----hCCceeccCCCCcEEEeccCC-------------CCcceEEEeecccccccc
Q 003542 312 PVVVDIMLQIARGMEFLH----AQKIYHGELNPSNIYLKARSM-------------EGYFHVKVSGFGLSTART 368 (811)
Q Consensus 312 ~~i~~i~~QIa~gL~yLH----s~gIVHRDLKPsNILI~~~g~-------------d~~~~vKL~DFGlA~~~~ 368 (811)
+-++.++.||+.-.--+- -.+.+|-||||+||||-+... .....++|.||.+|+...
T Consensus 275 ~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~~ 348 (434)
T PF05445_consen 275 EYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVAN 348 (434)
T ss_pred HHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhcc
Confidence 456777788764331122 235899999999999966531 122357788888886543
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=87.34 E-value=7.2 Score=42.67 Aligned_cols=70 Identities=10% Similarity=0.169 Sum_probs=39.4
Q ss_pred EEeeeecccc---eEEEEEEcCCEEEEEEecc-cHHHHHHHHHHHHhCC---CCccceeeeeEEccCCCeEEEEEecCCC
Q 003542 219 MVRRRLGASS---QFKEIQWLGDSFVLRHFYG-ELESLNAEISTMLSLS---HPNIVQYLCGFCDEEKKEFFLVMELMSK 291 (811)
Q Consensus 219 ~i~~~lG~G~---vyk~v~~~g~~VAVK~~~~-~~~~~~~Ei~iL~~L~---HPNIVkl~~~~~~e~~~~~yLVmEy~~g 291 (811)
+-...+|.|. +|. +.-.++.+.||.-.. ....|..|..-|+.|. --.+.+.+..... ....||||||++.
T Consensus 20 ~~~~~v~GG~i~~a~~-~~~~~~~~FvK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~--~~~~fLlle~l~~ 96 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYR-LDTDGGSYFVKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEY--DDDAFLLLEFLEM 96 (288)
T ss_dssp -EEEEE--SSSSEEEE-EETTS-EEEEEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE---SSCCEEEEE----
T ss_pred eeeEecCCCChhheEE-EECCCccEEEEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEee--cCCceEEEEeecC
Confidence 3445667665 444 345788999998764 3567899999998883 3446666644422 2335999999873
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 811 | ||||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-21 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-21 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 7e-21 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 8e-21 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-20 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-20 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 5e-20 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-20 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-20 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 8e-20 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 9e-20 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 9e-20 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-19 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-19 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-19 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-19 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-19 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-19 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-19 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-19 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-19 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-19 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-19 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-19 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-19 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-19 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-19 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-19 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-19 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-19 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-19 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-19 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-19 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-19 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-19 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 5e-19 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 5e-19 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-19 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 6e-19 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 7e-19 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-18 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-18 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-18 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-18 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-18 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-18 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-18 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-18 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-18 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-18 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-18 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-18 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-18 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-18 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-18 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-18 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-18 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-18 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-18 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-18 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-17 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-17 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-17 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-17 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-17 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-17 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-17 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 6e-17 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-17 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-17 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 7e-17 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 8e-17 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 9e-17 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 9e-17 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-16 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-16 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-16 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-16 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-16 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-16 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-16 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-16 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 5e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 8e-16 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-15 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-15 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-15 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-15 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-15 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-15 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-15 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-15 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-15 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-15 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-15 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-15 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-15 | ||
| 3iok_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-15 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-15 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-15 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-15 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-15 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-15 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-15 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-15 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-15 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-15 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-15 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 5e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-15 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-15 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-15 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 5e-15 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 6e-15 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 6e-15 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 6e-15 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 7e-15 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 7e-15 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 8e-15 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 8e-15 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-15 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 8e-15 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 9e-15 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-15 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-14 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-14 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-14 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-14 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-14 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-14 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-14 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-14 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-14 | ||
| 1oec_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-14 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-14 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-14 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-14 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-14 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-14 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-14 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-14 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-14 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-14 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-14 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-14 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-14 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-14 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 5e-14 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 5e-14 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 6e-14 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 6e-14 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 6e-14 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-14 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 7e-14 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 7e-14 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 8e-14 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-14 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 9e-14 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-14 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-13 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-13 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-13 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-13 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-13 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-13 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-13 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-13 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-13 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-13 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-13 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-13 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-13 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-13 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-13 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-13 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-13 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-13 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-13 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-13 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-13 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-13 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-13 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-13 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-13 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-13 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-13 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-13 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-13 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-13 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-13 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-13 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-13 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 6e-13 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 6e-13 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 6e-13 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 6e-13 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 7e-13 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 7e-13 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-13 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 8e-13 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 8e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 8e-13 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-12 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-12 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-12 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-12 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-12 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-12 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-12 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-12 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-12 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-12 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-12 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-12 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-12 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-12 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-12 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-12 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-12 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-12 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-12 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-12 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-12 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-12 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-12 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-12 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-12 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-12 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 5e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-12 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 5e-12 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 5e-12 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 6e-12 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 7e-12 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 7e-12 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 8e-12 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 9e-12 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-11 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-11 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-11 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-11 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-11 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-11 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-11 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-11 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-11 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-11 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-11 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-11 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-11 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-11 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-11 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-11 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-11 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-11 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-11 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-11 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-11 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-11 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-11 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-11 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-11 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-11 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-11 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 5e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 5e-11 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-11 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 5e-11 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-11 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-11 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-11 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 6e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-11 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 6e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-11 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 6e-11 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 6e-11 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 7e-11 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 7e-11 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 8e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-11 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 9e-11 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-10 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-10 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-10 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-10 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-10 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-10 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-10 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-10 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-10 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-10 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-10 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-10 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 5e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-10 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 8e-10 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 8e-10 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 8e-10 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 8e-10 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 9e-10 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 9e-10 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 9e-10 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-09 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-09 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-09 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-09 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-09 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-09 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-09 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-09 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-09 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-09 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-09 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-09 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-09 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-09 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-09 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-09 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-09 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-09 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-09 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-09 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-09 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-09 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-09 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-09 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-09 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-09 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-09 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-09 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-09 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-09 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-09 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-09 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-09 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-09 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-09 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-09 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-09 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-09 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-09 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-09 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-09 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-09 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-09 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-09 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-09 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-09 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-09 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-09 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-09 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-09 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-09 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-09 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-09 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-09 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-09 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 4e-09 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-09 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-09 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-09 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-09 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 5e-09 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 5e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 5e-09 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 5e-09 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 5e-09 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-09 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 6e-09 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 6e-09 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-09 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 7e-09 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 7e-09 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 7e-09 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-09 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 8e-09 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 9e-09 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 9e-09 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-08 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-08 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-08 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-08 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-08 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-08 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-08 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-08 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-08 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-08 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-08 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-08 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-08 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-08 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-08 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-08 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-08 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-08 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-08 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-08 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-08 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-08 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-08 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-08 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-08 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-08 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-08 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-08 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-08 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-08 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-08 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-08 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-08 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-08 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-08 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-08 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-08 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-08 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-08 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-08 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-08 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-08 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 4e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-08 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-08 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-08 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 4e-08 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 4e-08 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-08 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-08 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-08 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 5e-08 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-08 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 5e-08 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-08 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-08 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 6e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 6e-08 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 7e-08 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 7e-08 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 7e-08 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-08 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 7e-08 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 8e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-08 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-08 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 8e-08 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 8e-08 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 8e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-08 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 9e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 9e-08 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-07 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-07 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-07 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-07 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-07 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-07 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-07 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-07 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-07 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-07 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-07 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-07 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-07 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-07 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-07 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 4e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-07 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-07 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-07 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-07 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-07 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-07 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-07 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-07 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-07 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-07 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-07 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 5e-07 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-07 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-07 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-07 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-07 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-07 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-07 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 5e-07 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-07 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 5e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-07 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-07 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 6e-07 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 6e-07 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 7e-07 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-07 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 7e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 7e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 9e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 9e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 9e-07 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-06 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-06 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-06 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-06 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-06 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-06 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-06 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-06 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-06 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-06 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-06 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-06 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-06 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-06 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-06 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-06 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-06 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-06 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-06 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-06 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-06 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-06 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-06 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-06 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-06 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-06 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-06 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 3e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 4e-06 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-06 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-06 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-06 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 5e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-06 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 5e-06 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 6e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 6e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 6e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 6e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 6e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 6e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 6e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 6e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 6e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 6e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 7e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 7e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 7e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 7e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 7e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 7e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 7e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 7e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 7e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 7e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 7e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 7e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 7e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 7e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 7e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 7e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 8e-06 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 8e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 8e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 8e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 8e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 8e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 8e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 8e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 8e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 8e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 8e-06 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 8e-06 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-06 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 8e-06 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-06 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-06 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 8e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-06 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 9e-06 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 9e-06 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-06 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 9e-06 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 9e-06 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 9e-06 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-05 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-05 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-05 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-05 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-05 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-05 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-05 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-05 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-05 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-05 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-05 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-05 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-05 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-05 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-05 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-05 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-05 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-05 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-05 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-05 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-05 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-05 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-05 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-05 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-05 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-05 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-05 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-05 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-05 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-05 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-05 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-05 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-05 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-05 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-05 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-05 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-05 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-05 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-05 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-05 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-05 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-05 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-05 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-05 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-05 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-05 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-05 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-05 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-05 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-05 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-05 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-05 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-05 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-05 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-05 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-05 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-05 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 5e-05 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 5e-05 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 6e-05 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 6e-05 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 6e-05 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 6e-05 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 6e-05 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 6e-05 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 7e-05 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 8e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-05 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 8e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 9e-05 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 9e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 9e-05 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 1e-04 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-04 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 1e-04 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 1e-04 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-04 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 1e-04 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-04 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-04 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-04 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-04 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-04 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-04 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-04 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-04 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-04 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-04 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-04 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-04 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-04 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-04 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-04 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-04 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-04 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-04 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-04 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-04 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-04 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-04 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-04 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-04 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-04 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-04 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-04 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-04 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-04 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-04 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-04 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-04 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-04 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 5e-04 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 5e-04 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-04 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 5e-04 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-04 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-04 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 5e-04 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 5e-04 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-04 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-04 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 5e-04 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 6e-04 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 6e-04 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 6e-04 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 6e-04 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 6e-04 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 6e-04 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 7e-04 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 7e-04 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 7e-04 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 7e-04 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 8e-04 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 8e-04 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 8e-04 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 8e-04 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 8e-04 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 8e-04 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 8e-04 |
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1OEC|A Chain A, Fgfr2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 9e-57
Identities = 68/251 (27%), Positives = 109/251 (43%), Gaps = 36/251 (14%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRR 306
+ + E+ M +L+HPNIV+ G +VME + DL + +
Sbjct: 66 KFQEFQREVFIMSNLNHPNIVKLY-GLM---HNPPRMVMEFVPCGDLYHRLL-----DKA 116
Query: 307 NSFSLPVVVDIMLQIARGMEFLHAQK--IYHGELNPSNIYLKARSMEGYFHVKVSGFGLS 364
+ V + +ML IA G+E++ Q I H +L NI+L++ KV+ FGLS
Sbjct: 117 HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS 176
Query: 365 TARTYASRN---TPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGM 421
++ W APE + +E +EKAD YSF M
Sbjct: 177 QQSVHSVSGLLGNFQ-------------WMAPETIGAEE-------ESYTEKADTYSFAM 216
Query: 422 LCFELLTGKVPFED-GHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPS 480
+ + +LTG+ PF++ + + + G RP P P L N+ + CW +P +RP
Sbjct: 217 ILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPH 276
Query: 481 FSSICRILRYI 491
FS I + L +
Sbjct: 277 FSYIVKELSEL 287
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 2e-54
Identities = 50/250 (20%), Positives = 96/250 (38%), Gaps = 23/250 (9%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRR 306
+L++ E+ H N+V ++ G C ++ L L +R +
Sbjct: 72 QLKAFKREVMAYRQTRHENVVLFM-GACMSPPH-LAIITSLCKGRTLYSVVR-----DAK 124
Query: 307 NSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST- 365
+ I +I +GM +LHA+ I H +L N++ V ++ FGL +
Sbjct: 125 IVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFY------DNGKVVITDFGLFSI 178
Query: 366 -ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCF 424
A R QN APE++ + S+ +DV++ G + +
Sbjct: 179 SGVLQAGRREDKLRIQNGW----LCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWY 234
Query: 425 ELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGS-PKYLVNLTKKCWHTNPSQRPSFSS 483
EL + PF+ + + + G +P K + ++ CW +RP+F+
Sbjct: 235 ELHAREWPFKT--QPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTK 292
Query: 484 ICRILRYIKK 493
+ +L + K
Sbjct: 293 LMDMLEKLPK 302
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 4e-54
Identities = 63/270 (23%), Positives = 115/270 (42%), Gaps = 40/270 (14%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRR 306
E ++ E+ + ++HPNIV+ G C LVME L + G+
Sbjct: 44 ERKAFIVELRQLSRVNHPNIVKLY-GAC---LNPVCLVMEYAEGGSLYNVLH---GAEPL 96
Query: 307 NSFSLPVVVDIMLQIARGMEFLHAQK---IYHGELNPSNIYLKARSMEGYFHVKVSGFGL 363
++ + LQ ++G+ +LH+ + + H +L P N+ L G +K+ FG
Sbjct: 97 PYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLV----AGGTVLKICDFGT 152
Query: 364 S---TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFG 420
+ ++ + W APEV SEK DV+S+G
Sbjct: 153 ACDIQTHMTNNKGSAA-------------WMAPEVFEGS---------NYSEKCDVFSWG 190
Query: 421 MLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPS 480
++ +E++T + PF++ ++ + G RP PK + +L +CW +PSQRPS
Sbjct: 191 IILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPS 250
Query: 481 FSSICRILRYIKKFMANNPDIARSEFQSPL 510
I +I+ ++ ++ + + Q L
Sbjct: 251 MEEIVKIMTHLMRYFPGADEPLQYPCQHSL 280
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 7e-53
Identities = 70/265 (26%), Positives = 118/265 (44%), Gaps = 38/265 (14%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRR 306
+ E++ M L HPNIV ++ G + +V E +S+ L + + S R
Sbjct: 77 RVNEFLREVAIMKRLRHPNIVLFM-GAVTQPPN-LSIVTEYLSRGSLYRLLHK---SGAR 131
Query: 307 NSFSLPVVVDIMLQIARGMEFLHAQK--IYHGELNPSNIYLKARSMEGYFHVKVSGFGLS 364
+ + +A+GM +LH + I H L N+ + + + VKV FGLS
Sbjct: 132 EQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKK-----YTVKVCDFGLS 186
Query: 365 T--ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGML 422
A T+ S + +P+ W APEVL ++ +EK+DVYSFG++
Sbjct: 187 RLKASTFLSSKSAAGTPE---------WMAPEVLRDE---------PSNEKSDVYSFGVI 228
Query: 423 CFELLTGKVPFEDGHLQGDKMTKNI-RAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSF 481
+EL T + P+ + L ++ + +R P + + + CW P +RPSF
Sbjct: 229 LWELATLQQPWGN--LNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSF 286
Query: 482 SSICRILRYIKKFMANNPDIARSEF 506
++I +LR + K P RS+
Sbjct: 287 ATIMDLLRPLIKSAV--PPPNRSDL 309
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 3e-51
Identities = 60/250 (24%), Positives = 93/250 (37%), Gaps = 33/250 (13%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFC-DEEKKEFFLVMELMSK-DLSCYMRETFGSRR 305
+ N E + SHPN++ L G C L+ M L + E
Sbjct: 50 KSRDFNEECPRLRIFSHPNVLPVL-GACQSPPAPHPTLITHWMPYGSLYNVLHE----GT 104
Query: 306 RNSFSLPVVVDIMLQIARGMEFLHAQK--IYHGELNPSNIYLKARSMEGYFHVKVSGFGL 363
V L +ARGM FLH + I LN ++ + ++S +
Sbjct: 105 NFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDED-----MTARISMADV 159
Query: 364 STARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLC 423
+ Q+ W APE L ++ AD++SF +L
Sbjct: 160 KFSF------------QSPGRMYAPAWVAPEALQKKP------EDTNRRSADMWSFAVLL 201
Query: 424 FELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSS 483
+EL+T +VPF D + K G RP P G ++ L K C + +P++RP F
Sbjct: 202 WELVTREVPFADLS-NMEIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDM 260
Query: 484 ICRILRYIKK 493
I IL ++
Sbjct: 261 IVPILEKMQD 270
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 5e-51
Identities = 61/249 (24%), Positives = 115/249 (46%), Gaps = 28/249 (11%)
Query: 249 LESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRN 307
L++ E+ + H NI+ ++ G+ + +V + L ++
Sbjct: 64 LQAFKNEVGVLRKTRHVNILLFM-GYSTAPQ--LAIVTQWCEGSSLYHHLH-----ASET 115
Query: 308 SFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTAR 367
F + ++DI Q ARGM++LHA+ I H +L +NI+L VK+ FGL+T +
Sbjct: 116 KFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHED-----NTVKIGDFGLATEK 170
Query: 368 TYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELL 427
+ S S Q + +W APEV+ Q+ + S ++DVY+FG++ +EL+
Sbjct: 171 SRWSG-----SHQFEQLSGSILWMAPEVIRMQDS------NPYSFQSDVYAFGIVLYELM 219
Query: 428 TGKVPFED-GHLQG--DKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSI 484
TG++P+ + + + + + + + S PK + L +C +RPSF I
Sbjct: 220 TGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRI 279
Query: 485 CRILRYIKK 493
+ + +
Sbjct: 280 LAEIEELAR 288
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 3e-50
Identities = 55/248 (22%), Positives = 96/248 (38%), Gaps = 29/248 (11%)
Query: 254 AEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFSLP 312
E+ M L HPN+++++ G ++K+ + E + L ++ + +
Sbjct: 56 KEVKVMRCLEHPNVLKFI-GVLYKDKR-LNFITEYIKGGTLRGIIK-----SMDSQYPWS 108
Query: 313 VVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS-------T 365
V IA GM +LH+ I H +LN N ++ +V V+ FGL+ T
Sbjct: 109 QRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVREN-----KNVVVADFGLARLMVDEKT 163
Query: 366 ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFE 425
P + T W APE++ + EK DV+SFG++ E
Sbjct: 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGR---------SYDEKVDVFSFGIVLCE 214
Query: 426 LLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSIC 485
++ D + N+R P P +T +C +P +RPSF +
Sbjct: 215 IIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLE 274
Query: 486 RILRYIKK 493
L ++
Sbjct: 275 HWLETLRM 282
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 5e-50
Identities = 72/251 (28%), Positives = 112/251 (44%), Gaps = 37/251 (14%)
Query: 249 LESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRN 307
+E++ E L HPNI+ G C +E LVME L+ +
Sbjct: 50 IENVRQEAKLFAMLKHPNIIALR-GVCLKEPN-LCLVMEFARGGPLNRVLS-------GK 100
Query: 308 SFSLPVVVDIMLQIARGMEFLHAQK---IYHGELNPSNIYLKARSMEGYFH---VKVSGF 361
++V+ +QIARGM +LH + I H +L SNI + + G +K++ F
Sbjct: 101 RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160
Query: 362 GLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGM 421
GL+ ++ + A Y W APEV+ S S+ +DV+S+G+
Sbjct: 161 GLAREWHRTTKMS---------AAGAYAWMAPEVI---------RASMFSKGSDVWSYGV 202
Query: 422 LCFELLTGKVPFEDGHLQGDKMTKNI-RAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPS 480
L +ELLTG+VPF + G + + PS P+ L + CW+ +P RPS
Sbjct: 203 LLWELLTGEVPFRG--IDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPS 260
Query: 481 FSSICRILRYI 491
F++I L I
Sbjct: 261 FTNILDQLTTI 271
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 1e-41
Identities = 56/268 (20%), Positives = 97/268 (36%), Gaps = 48/268 (17%)
Query: 254 AEISTMLSLSHPNIVQYL--CGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFS 310
E+ + L H NI+ ++ + +L+ L Y++ +
Sbjct: 51 TELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-------LTTLD 103
Query: 311 LPVVVDIMLQIARGMEFLHAQ--------KIYHGELNPSNIYLKARSMEGYFHVKVSGFG 362
+ I+L IA G+ LH + I H +L NI +K ++ G
Sbjct: 104 TVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKN-----GQCCIADLG 158
Query: 363 LSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGML 422
L A ++ N + APEVL + T ++ D+++FG++
Sbjct: 159 L--AVMHSQSTNQLDVGNNPRVGT-KRYMAPEVL---DETIQVDCFDSYKRVDIWAFGLV 212
Query: 423 CFELLTG----------KVPFED---GHLQGDKMTKNI-RAGERPLFPS-----GSPKYL 463
+E+ K PF D + M K + +RP P+ + L
Sbjct: 213 LWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSL 272
Query: 464 VNLTKKCWHTNPSQRPSFSSICRILRYI 491
L K+CW+ NPS R + I + L I
Sbjct: 273 AKLMKECWYQNPSARLTALRIKKTLTKI 300
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 4e-40
Identities = 51/270 (18%), Positives = 105/270 (38%), Gaps = 48/270 (17%)
Query: 254 AEISTMLSLSHPNIVQYL--CGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFS 310
AEI + L H NI+ ++ + + +LV + L Y+ R + +
Sbjct: 85 AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN-------RYTVT 137
Query: 311 LPVVVDIMLQIARGMEFLHAQ--------KIYHGELNPSNIYLKARSMEGYFHVKVSGFG 362
+ ++ + L A G+ LH + I H +L NI +K ++ G
Sbjct: 138 VEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-----GTCCIADLG 192
Query: 363 LSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGML 422
L A + S N + APEVL + + + + ++AD+Y+ G++
Sbjct: 193 L--AVRHDSATDTIDIAPNHRVGT-KRYMAPEVL---DDSINMKHFESFKRADIYAMGLV 246
Query: 423 CFELLTG----------KVPFED---GHLQGDKMTKNI-RAGERPLFPSG-----SPKYL 463
+E+ ++P+ D ++M K + RP P+ + + +
Sbjct: 247 FWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVM 306
Query: 464 VNLTKKCWHTNPSQRPSFSSICRILRYIKK 493
+ ++CW+ N + R + I + L + +
Sbjct: 307 AKIMRECWYANGAARLTALRIKKTLSQLSQ 336
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 3e-39
Identities = 48/270 (17%), Positives = 97/270 (35%), Gaps = 48/270 (17%)
Query: 254 AEISTMLSLSHPNIVQYL--CGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFS 310
EI + + H NI+ ++ + +L+ + L Y++ +
Sbjct: 80 TEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLK-------STTLD 132
Query: 311 LPVVVDIMLQIARGMEFLHAQ--------KIYHGELNPSNIYLKARSMEGYFHVKVSGFG 362
++ + G+ LH + I H +L NI +K ++ G
Sbjct: 133 AKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN-----GTCCIADLG 187
Query: 363 LSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGML 422
L A + S P N + PEVL + + + + + AD+YSFG++
Sbjct: 188 L--AVKFISDTNEVDIPPNTRVGT-KRYMPPEVL---DESLNRNHFQSYIMADMYSFGLI 241
Query: 423 CFELLTG----------KVPFED---GHLQGDKMTKNI-RAGERPLFPSGS-----PKYL 463
+E+ ++P+ D + M + + RP FP+ + +
Sbjct: 242 LWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQM 301
Query: 464 VNLTKKCWHTNPSQRPSFSSICRILRYIKK 493
L +CW NP+ R + + + L + +
Sbjct: 302 GKLMTECWAHNPASRLTALRVKKTLAKMSE 331
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-37
Identities = 66/245 (26%), Positives = 112/245 (45%), Gaps = 36/245 (14%)
Query: 254 AEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFSLP 312
E + SHPNIV+ L G C +++ ++VMEL+ D ++R +
Sbjct: 161 QEARILKQYSHPNIVR-LIGVCTQKQ-PIYIVMELVQGGDFLTFLRT-----EGARLRVK 213
Query: 313 VVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS---TARTY 369
++ ++ A GME+L ++ H +L N + +++ +K+S FG+S Y
Sbjct: 214 TLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNV-----LKISDFGMSREEADGVY 268
Query: 370 ASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT- 428
A+ P W APE L + S ++DV+SFG+L +E +
Sbjct: 269 AASGG--------LRQVPVKWTAPEALN---------YGRYSSESDVWSFGILLWETFSL 311
Query: 429 GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRIL 488
G P+ + L + + + G R P P + L ++CW P QRPSFS+I + L
Sbjct: 312 GASPYPN--LSNQQTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQEL 369
Query: 489 RYIKK 493
+ I+K
Sbjct: 370 QSIRK 374
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-36
Identities = 82/286 (28%), Positives = 127/286 (44%), Gaps = 45/286 (15%)
Query: 216 KKLMVRRRLGASSQFKEI---QWLGDSF-----VLRHFYGELESLNAEISTMLSLSHPNI 267
+ ++ +LG Q+ E+ W S L+ E+E E + M + HPN+
Sbjct: 220 TDITMKHKLG-GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNL 278
Query: 268 VQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGME 326
VQ L G C E F+++ E M+ +L Y+R R S V++ + QI+ ME
Sbjct: 279 VQ-LLGVCTREPP-FYIITEFMTYGNLLDYLR----ECNRQEVSAVVLLYMATQISSAME 332
Query: 327 FLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS---TARTYASRNTPPASPQNQT 383
+L + H L N + + VKV+ FGLS T TY +
Sbjct: 333 YLEKKNFIHRNLAARNCLVGENHL-----VKVADFGLSRLMTGDTYTAH---------AG 378
Query: 384 APNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGDK 442
A P W APE LA +K S K+DV++FG+L +E+ T G P+ + +
Sbjct: 379 AKFPIKWTAPESLAY---------NKFSIKSDVWAFGVLLWEIATYGMSPYPG--IDLSQ 427
Query: 443 MTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRIL 488
+ + + R P G P+ + L + CW NPS RPSF+ I +
Sbjct: 428 VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 473
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-36
Identities = 70/237 (29%), Positives = 104/237 (43%), Gaps = 33/237 (13%)
Query: 254 AEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFSLP 312
AE S M L H N+VQ L G EEK ++V E M+K L Y+R SR R+
Sbjct: 63 AEASVMTQLRHSNLVQ-LLGVIVEEKGGLYIVTEYMAKGSLVDYLR----SRGRSVLGGD 117
Query: 313 VVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASR 372
++ L + ME+L H +L N+ + ++ KVS FGL+ +
Sbjct: 118 CLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV-----AKVSDFGLTKEASSTQD 172
Query: 373 NTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKV 431
P W APE L E K S K+DV+SFG+L +E+ + G+V
Sbjct: 173 T----------GKLPVKWTAPEALRE---------KKFSTKSDVWSFGILLWEIYSFGRV 213
Query: 432 PFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRIL 488
P+ + + + G + P G P + + K CWH + + RPSF + L
Sbjct: 214 PYPR--IPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQL 268
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-36
Identities = 70/246 (28%), Positives = 110/246 (44%), Gaps = 33/246 (13%)
Query: 250 ESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNS 308
++ AE S M L H N+VQ L G EEK ++V E M+K L Y+R SR R+
Sbjct: 231 QAFLAEASVMTQLRHSNLVQ-LLGVIVEEKGGLYIVTEYMAKGSLVDYLR----SRGRSV 285
Query: 309 FSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTART 368
++ L + ME+L H +L N+ + ++ KVS FGL+ +
Sbjct: 286 LGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV-----AKVSDFGLTKEAS 340
Query: 369 YASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT 428
P W APE L E K S K+DV+SFG+L +E+ +
Sbjct: 341 STQDT----------GKLPVKWTAPEALRE---------KKFSTKSDVWSFGILLWEIYS 381
Query: 429 -GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRI 487
G+VP+ + + + G + P G P + ++ K CWH + + RP+F +
Sbjct: 382 FGRVPYPR--IPLKDVVPRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQ 439
Query: 488 LRYIKK 493
L +I+
Sbjct: 440 LEHIRT 445
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 7e-36
Identities = 57/256 (22%), Positives = 107/256 (41%), Gaps = 49/256 (19%)
Query: 254 AEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFSLP 312
E M S+ +P++ + L G C L+ +LM L Y+RE +++
Sbjct: 66 DEAYVMASVDNPHVCR-LLGIC--LTSTVQLITQLMPFGCLLDYVRE-----HKDNIGSQ 117
Query: 313 VVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTAR----- 367
+++ +QIA+GM +L +++ H +L N+ +K HVK++ FGL+ +
Sbjct: 118 YLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-----HVKITDFGLA--KLLGAE 170
Query: 368 --TYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFE 425
Y + P W A E + + ++DV+S+G+ +E
Sbjct: 171 EKEYHAEG----------GKVPIKWMALESIL---------HRIYTHQSDVWSYGVTVWE 211
Query: 426 LLT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSI 484
L+T G P++ + +++ + GER P + + +KCW + RP F +
Sbjct: 212 LMTFGSKPYDG--IPASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFREL 269
Query: 485 CRILRYIKKFMANNPD 500
MA +P
Sbjct: 270 IIEFSK----MARDPQ 281
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 8e-36
Identities = 69/285 (24%), Positives = 125/285 (43%), Gaps = 45/285 (15%)
Query: 216 KKLMVRRRLGASSQFKEI---QWLGDSFV----LRHFYGELESLNAEISTMLSLSHPNIV 268
+ L + RLG + QF E+ + G + V L+ ++ AE + M L H +V
Sbjct: 13 ETLKLVERLG-AGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 269 QYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEF 327
+ L +E +++ E M L +++ + ++ ++D+ QIA GM F
Sbjct: 72 R-LYAVVTQEP--IYIITEYMENGSLVDFLK----TPSGIKLTINKLLDMAAQIAEGMAF 124
Query: 328 LHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS---TARTYASRNTPPASPQNQTA 384
+ + H +L +NI + K++ FGL+ Y +R + A
Sbjct: 125 IEERNYIHRDLRAANILVSDTLS-----CKIADFGLARLIEDNEYTAR---------EGA 170
Query: 385 PNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGDKM 443
P W APE + + K+DV+SFG+L E++T G++P+ + ++
Sbjct: 171 KFPIKWTAPEAINY---------GTFTIKSDVWSFGILLTEIVTHGRIPYPG--MTNPEV 219
Query: 444 TKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRIL 488
+N+ G R + P P+ L L + CW P RP+F + +L
Sbjct: 220 IQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-35
Identities = 78/285 (27%), Positives = 123/285 (43%), Gaps = 45/285 (15%)
Query: 216 KKLMVRRRLGASSQFKEI---QWLGDSFV----LRHFYGELESLNAEISTMLSLSHPNIV 268
+L + +G S QF + WL V +R E E M+ LSHP +V
Sbjct: 8 SELTFVQEIG-SGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLV 66
Query: 269 QYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEF 327
Q L G C E+ LV E M LS Y+R +R F+ ++ + L + GM +
Sbjct: 67 Q-LYGVCLEQA-PICLVTEFMEHGCLSDYLRT-----QRGLFAAETLLGMCLDVCEGMAY 119
Query: 328 LHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS---TARTYASRNTPPASPQNQTA 384
L + H +L N + + +KVS FG++ Y S
Sbjct: 120 LEEACVIHRDLAARNCLVGENQV-----IKVSDFGMTRFVLDDQYTSS---------TGT 165
Query: 385 PNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGDKM 443
P W +PEV + S+ S K+DV+SFG+L +E+ + GK+P+E+ ++
Sbjct: 166 KFPVKWASPEVFSF---------SRYSSKSDVWSFGVLMWEVFSEGKIPYEN--RSNSEV 214
Query: 444 TKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRIL 488
++I G R P + ++ + CW P RP+FS + R L
Sbjct: 215 VEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQL 259
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-35
Identities = 82/286 (28%), Positives = 128/286 (44%), Gaps = 45/286 (15%)
Query: 216 KKLMVRRRLGASSQFKEI---QWLGDSF-----VLRHFYGELESLNAEISTMLSLSHPNI 267
+ ++ +LG Q+ E+ W S L+ E+E E + M + HPN+
Sbjct: 13 TDITMKHKLG-GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNL 71
Query: 268 VQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGME 326
VQ L G C E F+++ E M+ +L Y+R R S V++ + QI+ ME
Sbjct: 72 VQ-LLGVCTREPP-FYIITEFMTYGNLLDYLR----ECNRQEVSAVVLLYMATQISSAME 125
Query: 327 FLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS---TARTYASRNTPPASPQNQT 383
+L + H +L N + + VKV+ FGLS T TY +
Sbjct: 126 YLEKKNFIHRDLAARNCLVGENHL-----VKVADFGLSRLMTGDTYTAH---------AG 171
Query: 384 APNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGDK 442
A P W APE LA +K S K+DV++FG+L +E+ T G P+ + +
Sbjct: 172 AKFPIKWTAPESLAY---------NKFSIKSDVWAFGVLLWEIATYGMSPYPG--IDLSQ 220
Query: 443 MTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRIL 488
+ + + R P G P+ + L + CW NPS RPSF+ I +
Sbjct: 221 VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 266
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 5e-35
Identities = 55/260 (21%), Positives = 86/260 (33%), Gaps = 40/260 (15%)
Query: 254 AEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFSLP 312
S M LSH ++V G C E LV E + L Y+++ +N ++
Sbjct: 61 EAASMMSKLSHKHLVL-NYGVCVCGD-ENILVQEFVKFGSLDTYLKK-----NKNCINIL 113
Query: 313 VVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFH---VKVSGFGLSTARTY 369
+++ Q+A M FL + HG + NI L + +K+S G+S T
Sbjct: 114 WKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS--ITV 171
Query: 370 ASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT- 428
W PE + D +SFG +E+ +
Sbjct: 172 LP---------KDILQERIPWVPPECIEN----PKNLNLAT----DKWSFGTTLWEICSG 214
Query: 429 GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRIL 488
G P L + + + P + NL C P RPSF +I R L
Sbjct: 215 GDKPLSA--LDSQRKLQFYEDRHQLPAPKAAELA--NLINNCMDYEPDHRPSFRAIIRDL 270
Query: 489 RYIKKFMANNPDIARSEFQS 508
+ PD+
Sbjct: 271 NSLF-----TPDLVPRGSHH 285
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 6e-35
Identities = 76/282 (26%), Positives = 115/282 (40%), Gaps = 39/282 (13%)
Query: 216 KKLMVRRRLGASSQFKEI---QWLGDSFV----LRHFYGELESLNAEISTMLSLSHPNIV 268
+ L + +LG F E+ W G + V L+ E+ E M L H +V
Sbjct: 184 ESLRLEVKLG-QGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 242
Query: 269 QYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEF 327
Q L EE ++V E MSK L +++ LP +VD+ QIA GM +
Sbjct: 243 Q-LYAVVSEEP--IYIVTEYMSKGSLLDFLK----GETGKYLRLPQLVDMAAQIASGMAY 295
Query: 328 LHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNP 387
+ H +L +NI + + KV+ FGL AR P
Sbjct: 296 VERMNYVHRDLRAANILVGENLV-----CKVADFGL--ARLIEDNEYTARQGAKF----P 344
Query: 388 YIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGDKMTKN 446
W APE + + K+DV+SFG+L EL T G+VP+ + ++
Sbjct: 345 IKWTAPEAALYG---------RFTIKSDVWSFGILLTELTTKGRVPYPG--MVNREVLDQ 393
Query: 447 IRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRIL 488
+ G R P P+ L +L +CW P +RP+F + L
Sbjct: 394 VERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 435
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 7e-35
Identities = 68/290 (23%), Positives = 120/290 (41%), Gaps = 45/290 (15%)
Query: 216 KKLMVRRRLGASSQFKEI---QWLGDSFV----LRHFYGELESLNAEISTMLSLSHPNIV 268
+++ + + LG S QF + +W G V ++ + E TM+ LSHP +V
Sbjct: 8 EEITLLKELG-SGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLV 66
Query: 269 QYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEF 327
+ G C +E ++V E +S L Y+R ++++ + GM F
Sbjct: 67 K-FYGVCSKEYP-IYIVTEYISNGCLLNYLRS-----HGKGLEPSQLLEMCYDVCEGMAF 119
Query: 328 LHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS---TARTYASRNTPPASPQNQTA 384
L + + H +L N + VKVS FG++ Y S
Sbjct: 120 LESHQFIHRDLAARNCLVDRDLC-----VKVSDFGMTRYVLDDQYVSS---------VGT 165
Query: 385 PNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGDKM 443
P W APEV K S K+DV++FG+L +E+ + GK+P++ ++
Sbjct: 166 KFPVKWSAPEVFHY---------FKYSSKSDVWAFGILMWEVFSLGKMPYDL--YTNSEV 214
Query: 444 TKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKK 493
+ G R P + + + CWH P +RP+F + + +++
Sbjct: 215 VLKVSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-34
Identities = 73/285 (25%), Positives = 131/285 (45%), Gaps = 45/285 (15%)
Query: 216 KKLMVRRRLGASSQFKEI---QWLGDSFV----LRHFYGELESLNAEISTMLSLSHPNIV 268
+ L + ++LGA QF E+ + + V ++ +E+ AE + M +L H +V
Sbjct: 188 ESLKLEKKLGAG-QFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLV 246
Query: 269 QYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEF 327
+ L +E +++ E M+K L +++ S + LP ++D QIA GM F
Sbjct: 247 K-LHAVVTKEP--IYIITEFMAKGSLLDFLK----SDEGSKQPLPKLIDFSAQIAEGMAF 299
Query: 328 LHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS---TARTYASRNTPPASPQNQTA 384
+ + H +L +NI + A + K++ FGL+ Y +R + A
Sbjct: 300 IEQRNYIHRDLRAANILVSASLV-----CKIADFGLARVIEDNEYTAR---------EGA 345
Query: 385 PNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGDKM 443
P W APE + + K+DV+SFG+L E++T G++P+ + ++
Sbjct: 346 KFPIKWTAPEAINF---------GSFTIKSDVWSFGILLMEIVTYGRIPYPG--MSNPEV 394
Query: 444 TKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRIL 488
+ + G R P P+ L N+ +CW P +RP+F I +L
Sbjct: 395 IRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVL 439
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 51/247 (20%), Positives = 98/247 (39%), Gaps = 31/247 (12%)
Query: 248 ELESLNAEISTMLSLSHPN--IVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRR 305
L+S EI+ + L + I++ + + ++VME + DL+ +++ +
Sbjct: 69 TLDSYRNEIAYLNKLQQHSDKIIRLY-DYE-ITDQYIYMVMECGNIDLNSWLK------K 120
Query: 306 RNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365
+ S + + +H I H +L P+N + +G +K+ FG++
Sbjct: 121 KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DG--MLKLIDFGIAN 174
Query: 366 A----RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGT--GSTSTSKCSEKADVYSF 419
T +++ + + PE + + + S SK S K+DV+S
Sbjct: 175 QMQPDTTSVVKDSQVGTV---------NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 225
Query: 420 GMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRP 479
G + + + GK PF+ Q K+ I FP K L ++ K C +P QR
Sbjct: 226 GCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRI 285
Query: 480 SFSSICR 486
S +
Sbjct: 286 SIPELLA 292
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 73/285 (25%), Positives = 126/285 (44%), Gaps = 45/285 (15%)
Query: 216 KKLMVRRRLGASSQFKEI---QWLGDSFV----LRHFYGELESLNAEISTMLSLSHPNIV 268
K L + LG + QF + +W G V ++ + E M++LSH +V
Sbjct: 24 KDLTFLKELG-TGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLV 82
Query: 269 QYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEF 327
Q L G C +++ F++ E M+ L Y+RE R+ F ++++ + ME+
Sbjct: 83 Q-LYGVCTKQR-PIFIITEYMANGCLLNYLRE-----MRHRFQTQQLLEMCKDVCEAMEY 135
Query: 328 LHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS---TARTYASRNTPPASPQNQTA 384
L +++ H +L N + + + VKVS FGLS Y S +
Sbjct: 136 LESKQFLHRDLAARNCLVNDQGV-----VKVSDFGLSRYVLDDEYTSS---------VGS 181
Query: 385 PNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGDKM 443
P W PEVL SK S K+D+++FG+L +E+ + GK+P+E +
Sbjct: 182 KFPVRWSPPEVLMY---------SKFSSKSDIWAFGVLMWEIYSLGKMPYER--FTNSET 230
Query: 444 TKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRIL 488
++I G R P + + + + CWH +RP+F + +
Sbjct: 231 AEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 275
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 67/264 (25%), Positives = 106/264 (40%), Gaps = 54/264 (20%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKE-FFLVMELMSK-DLSCYMRETFGSRR 305
L EI + SL H NIV+Y G C + L+ME + L Y++ +
Sbjct: 54 HLRDFEREIEILKSLQHDNIVKYK-GVCYSAGRRNLKLIMEYLPYGSLRDYLQ-----KH 107
Query: 306 RNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS- 364
+ ++ QI +GME+L ++ H +L NI ++ VK+ FGL+
Sbjct: 108 KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENE-----NRVKIGDFGLTK 162
Query: 365 ---TARTYASRNTPPASPQNQTAPNPYI-WYAPEVLAEQEGTGSTSTSKCSEKADVYSFG 420
+ + P SP I WYAPE L E SK S +DV+SFG
Sbjct: 163 VLPQDKEFFKVKEPGESP---------IFWYAPESLTE---------SKFSVASDVWSFG 204
Query: 421 MLCFELLT----------------GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLV 464
++ +EL T G + + + ++ R P G P +
Sbjct: 205 VVLYELFTYIEKSKSPPAEFMRMIGNDKQGQ--MIVFHLIELLKNNGRLPRPDGCPDEIY 262
Query: 465 NLTKKCWHTNPSQRPSFSSICRIL 488
+ +CW+ N +QRPSF + +
Sbjct: 263 MIMTECWNNNVNQRPSFRDLALRV 286
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 1e-34
Identities = 66/258 (25%), Positives = 108/258 (41%), Gaps = 49/258 (18%)
Query: 254 AEISTMLSLSHPNIVQYLCGFCDEEKKE-FFLVMELMSK-DLSCYMRETFGSRRRNSFSL 311
EI + +L IV+Y G ++ LVME + L +++ R R
Sbjct: 73 REIQILKALHSDFIVKYR-GVSYGPGRQSLRLVMEYLPSGCLRDFLQ-----RHRARLDA 126
Query: 312 PVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS----TAR 367
++ QI +GME+L +++ H +L NI +++ + HVK++ FGL+ +
Sbjct: 127 SRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEA-----HVKIADFGLAKLLPLDK 181
Query: 368 TYASRNTPPASPQNQTAPNPYI-WYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFEL 426
Y P SP I WYAPE L++ + S ++DV+SFG++ +EL
Sbjct: 182 DYYVVREPGQSP---------IFWYAPESLSD---------NIFSRQSDVWSFGVVLYEL 223
Query: 427 LT-GKVPFEDGHLQGDKMT------------KNIRAGERPLFPSGSPKYLVNLTKKCWHT 473
T M + + G+R P P + L K CW
Sbjct: 224 FTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAP 283
Query: 474 NPSQRPSFSSICRILRYI 491
+P RPSFS++ L +
Sbjct: 284 SPQDRPSFSALGPQLDML 301
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 68/266 (25%), Positives = 110/266 (41%), Gaps = 49/266 (18%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKE-FFLVMELMSK-DLSCYMRETFGSRR 305
+ L EI + +L H NIV+Y G C E+ L+ME + L Y+ +
Sbjct: 66 HIADLKKEIEILRNLYHENIVKYK-GICTEDGGNGIKLIMEFLPSGSLKEYLP-----KN 119
Query: 306 RNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS- 364
+N +L + +QI +GM++L +++ H +L N+ +++ VK+ FGL+
Sbjct: 120 KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESE-----HQVKIGDFGLTK 174
Query: 365 ---TARTYASRNTPPASPQNQTAPNPYI-WYAPEVLAEQEGTGSTSTSKCSEKADVYSFG 420
T + Y + SP + WYAPE L + SK +DV+SFG
Sbjct: 175 AIETDKEYYTVKDDRDSP---------VFWYAPECLMQ---------SKFYIASDVWSFG 216
Query: 421 MLCFELLT-GKVPFEDGHLQGDKMT------------KNIRAGERPLFPSGSPKYLVNLT 467
+ ELLT L + ++ G+R P P + L
Sbjct: 217 VTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLM 276
Query: 468 KKCWHTNPSQRPSFSSICRILRYIKK 493
+KCW PS R SF ++ + K
Sbjct: 277 RKCWEFQPSNRTSFQNLIEGFEALLK 302
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-34
Identities = 55/238 (23%), Positives = 94/238 (39%), Gaps = 34/238 (14%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCD--EEKKEFFLVMELMSK-DLSCYMRETFGSR 304
E + E + L HPNIV++ + + KK LV ELM+ L Y++
Sbjct: 68 ERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF---- 123
Query: 305 RRNSFSLPVVVDIMLQIARGMEFLHAQK--IYHGELNPSNIYLKARSMEGYFHVKVSGFG 362
+ V+ QI +G++FLH + I H +L NI++ + VK+ G
Sbjct: 124 --KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGS----VKIGDLG 177
Query: 363 LSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGML 422
L+T + + +P+ + APE+ E K E DVY+FGM
Sbjct: 178 LATLKRASFAKAVIGTPE---------FMAPEMYEE----------KYDESVDVYAFGMC 218
Query: 423 CFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPS 480
E+ T + P+ + + + F + + + + C N +R S
Sbjct: 219 MLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYS 276
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-34
Identities = 68/264 (25%), Positives = 107/264 (40%), Gaps = 54/264 (20%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKE-FFLVMELMSK-DLSCYMRETFGSRR 305
L EI + SL H NIV+Y G C + L+ME + L Y++ +
Sbjct: 85 HLRDFEREIEILKSLQHDNIVKYK-GVCYSAGRRNLKLIMEYLPYGSLRDYLQ-----KH 138
Query: 306 RNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS- 364
+ ++ QI +GME+L ++ H +L NI ++ + VK+ FGL+
Sbjct: 139 KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN-----RVKIGDFGLTK 193
Query: 365 ---TARTYASRNTPPASPQNQTAPNPYI-WYAPEVLAEQEGTGSTSTSKCSEKADVYSFG 420
+ Y P SP I WYAPE L E SK S +DV+SFG
Sbjct: 194 VLPQDKEYYKVKEPGESP---------IFWYAPESLTE---------SKFSVASDVWSFG 235
Query: 421 MLCFELLT----------------GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLV 464
++ +EL T G + + + ++ R P G P +
Sbjct: 236 VVLYELFTYIEKSKSPPAEFMRMIGNDKQGQ--MIVFHLIELLKNNGRLPRPDGCPDEIY 293
Query: 465 NLTKKCWHTNPSQRPSFSSICRIL 488
+ +CW+ N +QRPSF + +
Sbjct: 294 MIMTECWNNNVNQRPSFRDLALRV 317
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-34
Identities = 67/259 (25%), Positives = 107/259 (41%), Gaps = 43/259 (16%)
Query: 254 AEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFSLP 312
E++ M SL H N+++ L G +V EL L +R+ + F L
Sbjct: 70 REVNAMHSLDHRNLIR-LYGVVLTPP--MKMVTELAPLGSLLDRLRK-----HQGHFLLG 121
Query: 313 VVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASR 372
+ +Q+A GM +L +++ H +L N+ L R VK+ FGL R
Sbjct: 122 TLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD-----LVKIGDFGLM-------R 169
Query: 373 NTPPASPQNQTAPN---PYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT- 428
P + P+ W APE L T S +D + FG+ +E+ T
Sbjct: 170 ALPQNDDHYVMQEHRKVPFAWCAPESLK---------TRTFSHASDTWMFGVTLWEMFTY 220
Query: 429 GKVPFEDGHLQGDKMTKNI-RAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRI 487
G+ P+ L G ++ I + GER P P+ + N+ +CW P RP+F ++
Sbjct: 221 GQEPWIG--LNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF 278
Query: 488 LRYIKKFMANNPDIARSEF 506
L + P R+EF
Sbjct: 279 LLEAQ------PTDMRAEF 291
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 4e-34
Identities = 75/315 (23%), Positives = 130/315 (41%), Gaps = 34/315 (10%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRR 306
E E E++ + ++ HPNIVQY F EE ++VM+ DL + ++
Sbjct: 66 EREESRREVAVLANMKHPNIVQYRESF--EENGSLYIVMDYCEGGDLFKRINA----QKG 119
Query: 307 NSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366
F ++D +QI ++ +H +KI H ++ NI+L + +G V++ FG++
Sbjct: 120 VLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL---TKDG--TVQLGDFGIARV 174
Query: 367 RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFEL 426
+ A T PY + +PE+ + + K+D+++ G + +EL
Sbjct: 175 ---LNSTVELARACIGT---PY-YLSPEICENK---------PYNNKSDIWALGCVLYEL 218
Query: 427 LTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486
T K FE G ++ + I +G P L +L + + NP RPS +SI
Sbjct: 219 CTLKHAFEAGSMKN--LVLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276
Query: 487 ---ILRYIKKFMANNPDIARSEFQSPLADYCDIEAGFVRKFVGEGCPDVAPVSQIPFQMF 543
I + I+KF+ + IA + + R G+ V P +I
Sbjct: 277 KGFIAKRIEKFL-SPQLIAEEFCLKTFSKFGSQPIPAKRPASGQNSISVMPAQKITKPAA 335
Query: 544 AYKIAEKEKANSSNK 558
Y I K K
Sbjct: 336 KYGIPLAYKKYGDKK 350
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 5e-34
Identities = 65/245 (26%), Positives = 104/245 (42%), Gaps = 40/245 (16%)
Query: 254 AEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFSLP 312
E M L +P IV+ L G C E LVME+ L ++ +R +
Sbjct: 59 REAQIMHQLDNPYIVR-LIGVCQAEA--LMLVMEMAGGGPLHKFLVG-----KREEIPVS 110
Query: 313 VVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA-----R 367
V +++ Q++ GM++L + H +L N+ L R K+S FGLS A
Sbjct: 111 NVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHY-----AKISDFGLSKALGADDS 165
Query: 368 TYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELL 427
Y +R P WYAPE + K S ++DV+S+G+ +E L
Sbjct: 166 YYTAR---------SAGKWPLKWYAPECIN---------FRKFSSRSDVWSYGVTMWEAL 207
Query: 428 T-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486
+ G+ P++ ++G ++ I G+R P P L L CW RP F ++ +
Sbjct: 208 SYGQKPYKK--MKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ 265
Query: 487 ILRYI 491
+R
Sbjct: 266 RMRAC 270
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 5e-34
Identities = 67/247 (27%), Positives = 112/247 (45%), Gaps = 35/247 (14%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRR 306
++E+ E M L+HPN++ L G + +++ M DL ++R +
Sbjct: 65 QVEAFLREGLLMRGLNHPNVLA-LIGIMLPPEGLPHVLLPYMCHGDLLQFIRS-----PQ 118
Query: 307 NSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS-- 364
+ ++ ++ LQ+ARGME+L QK H +L N L F VKV+ FGL+
Sbjct: 119 RNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDES-----FTVKVADFGLARD 173
Query: 365 --TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGML 422
Y+ + Q++ A P W A E L + + K+DV+SFG+L
Sbjct: 174 ILDREYYSVQ-------QHRHARLPVKWTALESLQTY---------RFTTKSDVWSFGVL 217
Query: 423 CFELLT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSF 481
+ELLT G P+ + +T + G R P P L + ++CW +P+ RP+F
Sbjct: 218 LWELLTRGAPPYRH--IDPFDLTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTF 275
Query: 482 SSICRIL 488
+ +
Sbjct: 276 RVLVGEV 282
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 5e-34
Identities = 72/247 (29%), Positives = 110/247 (44%), Gaps = 35/247 (14%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRR 306
E+ E M SHPN++ L G C + +V+ M DL ++R
Sbjct: 69 EVSQFLTEGIIMKDFSHPNVLS-LLGICLRSEGSPLVVLPYMKHGDLRNFIRN-----ET 122
Query: 307 NSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS-- 364
++ ++ ++ LQ+A+GM++L ++K H +L N L + F VKV+ FGL+
Sbjct: 123 HNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEK-----FTVKVADFGLARD 177
Query: 365 --TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGML 422
Y+ N A P W A E L Q K + K+DV+SFG+L
Sbjct: 178 MYDKEYYSVHNK-------TGAKLPVKWMALESLQTQ---------KFTTKSDVWSFGVL 221
Query: 423 CFELLT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSF 481
+EL+T G P+ D + +T + G R L P P L + KCWH RPSF
Sbjct: 222 LWELMTRGAPPYPD--VNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSF 279
Query: 482 SSICRIL 488
S + +
Sbjct: 280 SELVSRI 286
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 6e-34
Identities = 50/290 (17%), Positives = 97/290 (33%), Gaps = 59/290 (20%)
Query: 254 AEISTMLSLSHPNIVQYLCGFC----DEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNS 308
I + + H NI +++ + + E+ LVME L Y+ ++
Sbjct: 56 KNIYRVPLMEHDNIARFI-VGDERVTADGRMEYLLVMEYYPNGSLXKYLS-------LHT 107
Query: 309 FSLPVVVDIMLQIARGMEFLHAQ---------KIYHGELNPSNIYLKARSMEGYFHVKVS 359
+ + RG+ +LH + I H +LN N+ +K +S
Sbjct: 108 SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKND-----GTCVIS 162
Query: 360 GFGLSTARTYASRNTPPASPQNQTAPNP----YIWYAPEVLAEQEGTGSTSTSKCSEKAD 415
FGL + N + A + APEVL + ++ D
Sbjct: 163 DFGL--SMRLTG-NRLVRPGEEDNAAISEVGTIRYMAPEVL--EGAVNLRDXESALKQVD 217
Query: 416 VYSFGMLCFELLTG-------------KVPFED---GHLQGDKMTKNI-RAGERPLFP-- 456
+Y+ G++ +E+ ++ F+ H + M + R +RP FP
Sbjct: 218 MYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEA 277
Query: 457 ----SGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKKFMANNPDIA 502
S + + L + CW + R + + + N ++
Sbjct: 278 WKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVS 327
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 6e-34
Identities = 78/285 (27%), Positives = 119/285 (41%), Gaps = 45/285 (15%)
Query: 216 KKLMVRRRLGASSQFKEI---QWLGDSFV----LRHFYGELESLNAEISTMLSLSHPNIV 268
+ L + +LG F E+ W G + V L+ E+ E M L H +V
Sbjct: 267 ESLRLEVKLGQG-CFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 325
Query: 269 QYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEF 327
Q L EE ++V E MSK L +++ LP +VD+ QIA GM +
Sbjct: 326 Q-LYAVVSEEP--IYIVTEYMSKGSLLDFLK----GETGKYLRLPQLVDMAAQIASGMAY 378
Query: 328 LHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS---TARTYASRNTPPASPQNQTA 384
+ H +L +NI + + KV+ FGL+ Y +R Q A
Sbjct: 379 VERMNYVHRDLRAANILVGENLV-----CKVADFGLARLIEDNEYTAR---------QGA 424
Query: 385 PNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGDKM 443
P W APE + + K+DV+SFG+L EL T G+VP+ + ++
Sbjct: 425 KFPIKWTAPEAALY---------GRFTIKSDVWSFGILLTELTTKGRVPYPG--MVNREV 473
Query: 444 TKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRIL 488
+ G R P P+ L +L +CW P +RP+F + L
Sbjct: 474 LDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 518
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 6e-34
Identities = 60/273 (21%), Positives = 107/273 (39%), Gaps = 47/273 (17%)
Query: 254 AEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFSLP 312
+ + SL H +IV+ L G C LV + + L ++R+ R +
Sbjct: 64 DHMLAIGSLDHAHIVR-LLGLCPGSS--LQLVTQYLPLGSLLDHVRQ-----HRGALGPQ 115
Query: 313 VVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS----TART 368
++++ +QIA+GM +L + H L N+ LK+ V+V+ FG++
Sbjct: 116 LLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSP-----SQVQVADFGVADLLPPDDK 170
Query: 369 YASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT 428
A P W A E + K + ++DV+S+G+ +EL+T
Sbjct: 171 QLLY---------SEAKTPIKWMALESIH---------FGKYTHQSDVWSYGVTVWELMT 212
Query: 429 -GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRI 487
G P+ L+ ++ + GER P + + KCW + + RP+F +
Sbjct: 213 FGAEPYAG--LRLAEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270
Query: 488 L--------RYIKKFMANNPDIARSEFQSPLAD 512
RY+ + P IA L +
Sbjct: 271 FTRMARDPPRYLVIKRESGPGIAPGPEPHGLTN 303
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 7e-34
Identities = 52/274 (18%), Positives = 102/274 (37%), Gaps = 58/274 (21%)
Query: 255 EISTMLSLSHPNIVQYLCGFC---DEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFS 310
E+ ++ + H NI+Q++ G + +L+ K LS +++ N S
Sbjct: 68 EVYSLPGMKHENILQFI-GAEKRGTSVDVDLWLITAFHEKGSLSDFLK-------ANVVS 119
Query: 311 LPVVVDIMLQIARGMEFLHAQ----------KIYHGELNPSNIYLKARSMEGYFHVKVSG 360
+ I +ARG+ +LH I H ++ N+ LK ++
Sbjct: 120 WNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNN-----LTACIAD 174
Query: 361 FGLSTARTYASRNTPPAS-PQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSF 419
FGL A + + + + Q T + APEVL + D+Y+
Sbjct: 175 FGL--ALKFEAGKSAGDTHGQVGT----RRYMAPEVLEG----AINFQRDAFLRIDMYAM 224
Query: 420 GMLCFELLTGK-----------VPFED---GHLQGDKMTKNI-RAGERPLFPSGSPKY-- 462
G++ +EL + +PFE+ H + M + + +RP+ K+
Sbjct: 225 GLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAG 284
Query: 463 ---LVNLTKKCWHTNPSQRPSFSSICRILRYIKK 493
L ++CW + R S + + +++
Sbjct: 285 MAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-33
Identities = 51/247 (20%), Positives = 98/247 (39%), Gaps = 31/247 (12%)
Query: 248 ELESLNAEISTMLSLSHPN--IVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRR 305
L+S EI+ + L + I++ + + + ++VME + DL+ +++ +
Sbjct: 50 TLDSYRNEIAYLNKLQQHSDKIIRLY-DY-EITDQYIYMVMECGNIDLNSWLK------K 101
Query: 306 RNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365
+ S + + +H I H +L P+N + +G +K+ FG++
Sbjct: 102 KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DG--MLKLIDFGIAN 155
Query: 366 A----RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQ--EGTGSTSTSKCSEKADVYSF 419
T +++ + + PE + + S SK S K+DV+S
Sbjct: 156 QMQPDTTSVVKDSQVGTV---------NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 206
Query: 420 GMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRP 479
G + + + GK PF+ Q K+ I FP K L ++ K C +P QR
Sbjct: 207 GCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRI 266
Query: 480 SFSSICR 486
S +
Sbjct: 267 SIPELLA 273
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 72/273 (26%), Positives = 105/273 (38%), Gaps = 52/273 (19%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKE-FFLVMELMSK-DLSCYMRETFGSRR 305
EI + +L H +I++Y G C++ LVME + L Y+
Sbjct: 76 HRSGWKQEIDILRTLYHEHIIKYK-GCCEDAGAASLQLVMEYVPLGSLRDYLP------- 127
Query: 306 RNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS- 364
R+S L ++ QI GM +LHAQ H +L N+ L VK+ FGL+
Sbjct: 128 RHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDND-----RLVKIGDFGLAK 182
Query: 365 ---TARTYASRNTPPASPQNQTAPNPYI-WYAPEVLAEQEGTGSTSTSKCSEKADVYSFG 420
Y SP + WYAPE L E K +DV+SFG
Sbjct: 183 AVPEGHEYYRVREDGDSP---------VFWYAPECLKE---------YKFYYASDVWSFG 224
Query: 421 MLCFELLT-GKVPFEDGHLQGDKMT------------KNIRAGERPLFPSGSPKYLVNLT 467
+ +ELLT + + + + GER P P + +L
Sbjct: 225 VTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLM 284
Query: 468 KKCWHTNPSQRPSFSSICRIL-RYIKKFMANNP 499
K CW T S RP+F ++ IL +K+ P
Sbjct: 285 KNCWETEASFRPTFENLIPILKTVHEKYQGQAP 317
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 58/257 (22%), Positives = 103/257 (40%), Gaps = 38/257 (14%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRR 306
E + L +E++ + L HPNIV+Y D ++VME DL+ + + G++ R
Sbjct: 48 EKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITK--GTKER 105
Query: 307 NSFSLPVVVDIMLQIARGMEFLHAQK-----IYHGELNPSNIYLKARSMEGYFHVKVSGF 361
V+ +M Q+ ++ H + + H +L P+N++L + +VK+ F
Sbjct: 106 QYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ-----NVKLGDF 160
Query: 362 GLSTA--RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSF 419
GL+ + T +P Y+ +PE + +EK+D++S
Sbjct: 161 GLARILNHDTSFAKTFVGTP-------YYM--SPEQMNRM---------SYNEKSDIWSL 202
Query: 420 GMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRP 479
G L +EL PF + + IR G+ P L + + + RP
Sbjct: 203 GCLLYELCALMPPFTAFSQKE--LAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRP 260
Query: 480 SFSSICR---ILRYIKK 493
S I IL +
Sbjct: 261 SVEEILENPLILEHHHH 277
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 61/246 (24%), Positives = 106/246 (43%), Gaps = 44/246 (17%)
Query: 254 AEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFSLP 312
E TM HP+IV+ L G E +++MEL + +L +++ R+ S L
Sbjct: 65 QEALTMRQFDHPHIVK-LIGVITENP--VWIIMELCTLGELRSFLQV-----RKYSLDLA 116
Query: 313 VVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTAR----- 367
++ Q++ + +L +++ H ++ N+ + + VK+ FGLS R
Sbjct: 117 SLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN-----DCVKLGDFGLS--RYMEDS 169
Query: 368 -TYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFEL 426
Y + P W APE + + + +DV+ FG+ +E+
Sbjct: 170 TYYKASK----------GKLPIKWMAPESINF---------RRFTSASDVWMFGVCMWEI 210
Query: 427 LT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSIC 485
L G PF+ ++ + + I GER P P L +L KCW +PS+RP F+ +
Sbjct: 211 LMHGVKPFQG--VKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELK 268
Query: 486 RILRYI 491
L I
Sbjct: 269 AQLSTI 274
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 56/267 (20%), Positives = 100/267 (37%), Gaps = 27/267 (10%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEE--KKEFFLVMELMSK-DLSCYMRETFGSR 304
+ E E +HPNI++ + E K E +L++ + L +
Sbjct: 69 DREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERL--KD 126
Query: 305 RRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS 364
+ N + ++ ++L I RG+E +HA+ H +L P+NI L EG + G
Sbjct: 127 KGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILL---GDEG--QPVLMDLGSM 181
Query: 365 TARTYASRNTPPASPQNQTAPN---PYIWY-APEVLAEQEGTGSTSTSKCSEKADVYSFG 420
+ A A Y APE+ + Q E+ DV+S G
Sbjct: 182 NQACIHVEGSRQALTLQDWAAQRCTIS--YRAPELFSVQSHCVID------ERTDVWSLG 233
Query: 421 MLCFELLTGKVPFEDGHLQGDKMTKNIRAGER-PLFPSGSPKYLVNLTKKCWHTNPSQRP 479
+ + ++ G+ P++ +GD + ++ P P S L L +P QRP
Sbjct: 234 CVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSA-LWQLLNSMMTVDPHQRP 292
Query: 480 SFSSICRILRYIKKFMANNPDIARSEF 506
I +L ++ P ++
Sbjct: 293 ---HIPLLLSQLEALQPPAPGQHTTQI 316
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-33
Identities = 54/244 (22%), Positives = 103/244 (42%), Gaps = 41/244 (16%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFSLPV 313
E M S+ +P++ + L G C L+ +LM L Y+RE +++
Sbjct: 67 EAYVMASVDNPHVCR-LLGIC--LTSTVQLITQLMPFGCLLDYVRE-----HKDNIGSQY 118
Query: 314 VVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA-----RT 368
+++ +QIA+GM +L +++ H +L N+ +K HVK++ FGL+ +
Sbjct: 119 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTP-----QHVKITDFGLAKLLGAEEKE 173
Query: 369 YASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT 428
Y + P W A E + + ++DV+S+G+ +EL+T
Sbjct: 174 YHAEG----------GKVPIKWMALESIL---------HRIYTHQSDVWSYGVTVWELMT 214
Query: 429 -GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRI 487
G P++ + +++ + GER P + + KCW + RP F +
Sbjct: 215 FGSKPYDG--IPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272
Query: 488 LRYI 491
+
Sbjct: 273 FSKM 276
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-33
Identities = 60/257 (23%), Positives = 100/257 (38%), Gaps = 41/257 (15%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKE----------FFLVMELMSK-DLSCY 296
E + E+ + L HP IV+Y + ++ E ++ M+L K +L +
Sbjct: 46 AREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDW 105
Query: 297 MRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHV 356
M V + I LQIA +EFLH++ + H +L PSNI+ +M+ V
Sbjct: 106 MNG---RCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDD--VV 157
Query: 357 KVSGFGLSTA--RTYASRNTPPASPQNQTAPN----PYIWY-APEVLAEQEGTGSTSTSK 409
KV FGL TA + + P Y +PE +
Sbjct: 158 KVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKL--YMSPEQIHGN---------S 206
Query: 410 CSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKK 469
S K D++S G++ FELL PF + + ++R + P + + +
Sbjct: 207 YSHKVDIFSLGLILFELLY---PFSTQMERVRTL-TDVRNLKFPPLFTQKYPCEYVMVQD 262
Query: 470 CWHTNPSQRPSFSSICR 486
+P +RP +I
Sbjct: 263 MLSPSPMERPEAINIIE 279
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 6e-33
Identities = 66/253 (26%), Positives = 114/253 (45%), Gaps = 41/253 (16%)
Query: 254 AEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFSLP 312
AE + M L +P IV+ + G C+ E + LVME+ L+ Y+++
Sbjct: 67 AEANVMQQLDNPYIVR-MIGICEAES--WMLVMEMAELGPLNKYLQQ------NRHVKDK 117
Query: 313 VVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS-----TAR 367
+++++ Q++ GM++L H +L N+ L + K+S FGLS
Sbjct: 118 NIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY-----AKISDFGLSKALRADEN 172
Query: 368 TYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELL 427
Y ++ P WYAPE + K S K+DV+SFG+L +E
Sbjct: 173 YYKAQ---------THGKWPVKWYAPECIN---------YYKFSSKSDVWSFGVLMWEAF 214
Query: 428 T-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486
+ G+ P+ ++G ++T + GER P+G P+ + +L CW + RP F+++
Sbjct: 215 SYGQKPYRG--MKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272
Query: 487 ILRYIKKFMANNP 499
LR + N
Sbjct: 273 RLRNYYYDVVNEG 285
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 8e-33
Identities = 59/277 (21%), Positives = 107/277 (38%), Gaps = 35/277 (12%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRR 306
+ E + +H NIV+ G + F++MELM+ DL ++RET +
Sbjct: 76 DELDFLMEALIISKFNHQNIVR-CIGVSLQSLP-RFILMELMAGGDLKSFLRETRPRPSQ 133
Query: 307 NS-FSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS- 364
S ++ ++ + IA G ++L H ++ N L G K+ FG++
Sbjct: 134 PSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNC-LLTCPGPGR-VAKIGDFGMAR 191
Query: 365 ---TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGM 421
A Y A P W PE E + K D +SFG+
Sbjct: 192 DIYRASYYRKGGC---------AMLPVKWMPPEAFME---------GIFTSKTDTWSFGV 233
Query: 422 LCFELLT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPS 480
L +E+ + G +P+ ++ + + +G R P P + + +CW P RP+
Sbjct: 234 LLWEIFSLGYMPYPS--KSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPN 291
Query: 481 FSSICRILRYIKKFMANNPDIARSEFQSPLADYCDIE 517
F+ I + ++ +PD+ + + E
Sbjct: 292 FAIILERI----EYCTQDPDVINTALPIEYGPLVEEE 324
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 64/240 (26%), Positives = 101/240 (42%), Gaps = 35/240 (14%)
Query: 254 AEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFSLP 312
+E S M HPNI++ L G + +V E M L ++R F++
Sbjct: 99 SEASIMGQFDHPNIIR-LEGVVTRGRL-AMIVTEYMENGSLDTFLRT-----HDGQFTIM 151
Query: 313 VVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS---TARTY 369
+V ++ + GM +L H +L N+ + + + KVS FGLS
Sbjct: 152 QLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLV-----CKVSDFGLSRVLEDDPD 206
Query: 370 ASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT- 428
A+ T P W APE +A S +DV+SFG++ +E+L
Sbjct: 207 AAYTT-------TGGKIPIRWTAPEAIAF---------RTFSSASDVWSFGVVMWEVLAY 250
Query: 429 GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRIL 488
G+ P+ + + + ++ G R P G P L L CWH + +QRP FS I +L
Sbjct: 251 GERPYWN--MTNRDVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVL 308
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-32
Identities = 76/276 (27%), Positives = 115/276 (41%), Gaps = 40/276 (14%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRR 306
E+ E M SHPN++ L G C + +V+ M DL ++R
Sbjct: 133 EVSQFLTEGIIMKDFSHPNVLS-LLGICLRSEGSPLVVLPYMKHGDLRNFIRN-----ET 186
Query: 307 NSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366
++ ++ ++ LQ+A+GM+FL ++K H +L N L + F VKV+ FGL+
Sbjct: 187 HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEK-----FTVKVADFGLA-- 239
Query: 367 RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFEL 426
R + A P W A E L Q K + K+DV+SFG+L +EL
Sbjct: 240 R-DMYDKEFDSVHNKTGAKLPVKWMALESLQTQ---------KFTTKSDVWSFGVLLWEL 289
Query: 427 LT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSIC 485
+T G P+ D + +T + G R L P P L + KCWH RPSFS +
Sbjct: 290 MTRGAPPYPD--VNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELV 347
Query: 486 RILRYIKKFMANNPDIARSEFQSPLADYCDIEAGFV 521
+ I Y + A +V
Sbjct: 348 SRISAIFSTFIGE-------------HYVHVNATYV 370
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-32
Identities = 52/247 (21%), Positives = 100/247 (40%), Gaps = 31/247 (12%)
Query: 248 ELESLNAEISTMLSLSHPN--IVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRR 305
L+S EI+ + L + I++ + + + ++VME + DL+ +++ +
Sbjct: 97 TLDSYRNEIAYLNKLQQHSDKIIRLY-DY-EITDQYIYMVMECGNIDLNSWLK------K 148
Query: 306 RNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365
+ S + + +H I H +L P+N + +G +K+ FG++
Sbjct: 149 KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DG--MLKLIDFGIAN 202
Query: 366 A----RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGT--GSTSTSKCSEKADVYSF 419
T +++ + Y+ PE + + + S SK S K+DV+S
Sbjct: 203 QMQPDTTSVVKDSQVGAV-------NYM--PPEAIKDMSSSRENGKSKSKISPKSDVWSL 253
Query: 420 GMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRP 479
G + + + GK PF+ Q K+ I FP K L ++ K C +P QR
Sbjct: 254 GCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRI 313
Query: 480 SFSSICR 486
S +
Sbjct: 314 SIPELLA 320
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 70/264 (26%), Positives = 113/264 (42%), Gaps = 39/264 (14%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEE----KKEFFLVMELMSK-DLSCYMRETFG 302
E+E +E + M SHPN+++ L G C E + +++ M DL Y+ +
Sbjct: 79 EIEEFLSEAACMKDFSHPNVIR-LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRL 137
Query: 303 SRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFG 362
L ++ M+ IA GME+L + H +L N L+ V V+ FG
Sbjct: 138 ETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDD-----MTVCVADFG 192
Query: 363 LS----TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYS 418
LS + Y Q + A P W A E LA++ + K+DV++
Sbjct: 193 LSKKIYSGDYYR---------QGRIAKMPVKWIAIESLADR---------VYTSKSDVWA 234
Query: 419 FGMLCFELLT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQ 477
FG+ +E+ T G P+ +Q +M + G R P L + CW T+P
Sbjct: 235 FGVTMWEIATRGMTPYPG--VQNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLD 292
Query: 478 RPSFSSICRILRYIKKFMANNPDI 501
RP+FS + L +K + + PD+
Sbjct: 293 RPTFSVLRLQL---EKLLESLPDV 313
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 63/248 (25%), Positives = 105/248 (42%), Gaps = 44/248 (17%)
Query: 254 AEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFSLP 312
+E M +L HP+IV+ L G +EE +++MEL +L Y+ +NS +
Sbjct: 62 SEAVIMKNLDHPHIVK-LIGIIEEE--PTWIIMELYPYGELGHYLER-----NKNSLKVL 113
Query: 313 VVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTAR----- 367
+V LQI + M +L + H ++ NI + + VK+ FGLS R
Sbjct: 114 TLVLYSLQICKAMAYLESINCVHRDIAVRNILVASP-----ECVKLGDFGLS--RYIEDE 166
Query: 368 -TYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFEL 426
Y + P W +PE + + + +DV+ F + +E+
Sbjct: 167 DYYKA----------SVTRLPIKWMSPESIN---------FRRFTTASDVWMFAVCMWEI 207
Query: 427 LT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSIC 485
L+ GK PF L+ + + G+R P P L L +CW +PS RP F+ +
Sbjct: 208 LSFGKQPFFW--LENKDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELV 265
Query: 486 RILRYIKK 493
L + +
Sbjct: 266 CSLSDVYQ 273
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-32
Identities = 58/262 (22%), Positives = 109/262 (41%), Gaps = 31/262 (11%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRR 306
EI + L+HPN+++Y F E E +V+EL DLS ++ +++
Sbjct: 75 ARADCIKEIDLLKQLNHPNVIKYYASF--IEDNELNIVLELADAGDLSRMIKHF--KKQK 130
Query: 307 NSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366
V +Q+ +E +H++++ H ++ P+N+++ A + VK+ GL
Sbjct: 131 RLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGV-----VKLGDLGLGRF 185
Query: 367 RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFEL 426
S T A T PY + +PE + E + K+D++S G L +E+
Sbjct: 186 ---FSSKTTAAHSLVGT---PY-YMSPERIHEN---------GYNFKSDIWSLGCLLYEM 229
Query: 427 LTGKVPFEDGHLQGDKMTKNIRAGERPLFPSG--SPKYLVNLTKKCWHTNPSQRPSFSSI 484
+ PF + + K I + P PS S + L L C + +P +RP + +
Sbjct: 230 AALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEE-LRQLVNMCINPDPEKRPDVTYV 288
Query: 485 CRILRYIKKFMANNPDIARSEF 506
+ + + A +
Sbjct: 289 YDVAKRMHACTA--SSLEHHHH 308
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 4e-32
Identities = 65/281 (23%), Positives = 114/281 (40%), Gaps = 44/281 (15%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEE-----KKEFFLVMELMSK-DLSCYMRETF 301
++E E + M HP++ + L G +++ M DL ++ +
Sbjct: 68 DIEEFLREAACMKEFDHPHVAK-LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASR 126
Query: 302 GSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGF 361
+ L +V M+ IA GME+L ++ H +L N L V V+ F
Sbjct: 127 IGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAED-----MTVCVADF 181
Query: 362 GLS----TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVY 417
GLS + Y Q + P W A E LA+ + + +DV+
Sbjct: 182 GLSRKIYSGDYYR---------QGCASKLPVKWLALESLAD---------NLYTVHSDVW 223
Query: 418 SFGMLCFELLT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPS 476
+FG+ +E++T G+ P+ ++ ++ + G R P + + +L +CW +P
Sbjct: 224 AFGVTMWEIMTRGQTPYAG--IENAEIYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPK 281
Query: 477 QRPSFSSICRILRYIKKFMANNPDIARSEFQSPLADYCDIE 517
QRPSF+ + L I ++ S Q P Y +IE
Sbjct: 282 QRPSFTCLRMELENILGHLSVL-----STSQDP--LYINIE 315
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-31
Identities = 58/277 (20%), Positives = 107/277 (38%), Gaps = 35/277 (12%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRR 306
+ E + +H NIV+ G + F+++ELM+ DL ++RET +
Sbjct: 117 DELDFLMEALIISKFNHQNIVR-CIGVSLQSLP-RFILLELMAGGDLKSFLRETRPRPSQ 174
Query: 307 NS-FSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS- 364
S ++ ++ + IA G ++L H ++ N L G K+ FG++
Sbjct: 175 PSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNC-LLTCPGPGR-VAKIGDFGMAR 232
Query: 365 ---TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGM 421
A Y A P W PE E + K D +SFG+
Sbjct: 233 DIYRAGYYRKGGC---------AMLPVKWMPPEAFME---------GIFTSKTDTWSFGV 274
Query: 422 LCFELLT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPS 480
L +E+ + G +P+ ++ + + +G R P P + + +CW P RP+
Sbjct: 275 LLWEIFSLGYMPYPS--KSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPN 332
Query: 481 FSSICRILRYIKKFMANNPDIARSEFQSPLADYCDIE 517
F+ I + ++ +PD+ + + E
Sbjct: 333 FAIILERI----EYCTQDPDVINTALPIEYGPLVEEE 365
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 130 bits (327), Expect = 2e-31
Identities = 66/254 (25%), Positives = 108/254 (42%), Gaps = 40/254 (15%)
Query: 254 AEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFSLP 312
E M L +P IV+ L G C E LVME+ L ++ +R +
Sbjct: 385 REAQIMHQLDNPYIVR-LIGVCQAE--ALMLVMEMAGGGPLHKFLVG-----KREEIPVS 436
Query: 313 VVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA-----R 367
V +++ Q++ GM++L + H L N+ L R + K+S FGLS A
Sbjct: 437 NVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRH-----YAKISDFGLSKALGADDS 491
Query: 368 TYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELL 427
Y +R P WYAPE + K S ++DV+S+G+ +E L
Sbjct: 492 YYTAR---------SAGKWPLKWYAPECIN---------FRKFSSRSDVWSYGVTMWEAL 533
Query: 428 T-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486
+ G+ P++ ++G ++ I G+R P P L L CW RP F ++ +
Sbjct: 534 SYGQKPYKK--MKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ 591
Query: 487 ILRYIKKFMANNPD 500
+R +A+ +
Sbjct: 592 RMRACYYSLASKVE 605
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 60/302 (19%), Positives = 111/302 (36%), Gaps = 65/302 (21%)
Query: 227 SSQFKEIQWLGD-SF------------------VLRHFYGELESLNAEISTMLSLSHPNI 267
+S F+EI LG +F +RH +L ++ +E+ + SL+H +
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYV 64
Query: 268 VQYLCGFCD-----------EEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFSLPVVV 315
V+Y + + ++K F+ ME L + +
Sbjct: 65 VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS-----ENLNQQRDEYW 119
Query: 316 DIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTP 375
+ QI + ++H+Q I H +L P NI++ +VK+ FGL+ +
Sbjct: 120 RLFRQILEALSYIHSQGIIHRDLKPMNIFIDESR-----NVKIGDFGLAKNVHRSLDILK 174
Query: 376 PASPQNQTAPN--------PYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELL 427
S + + + A EVL EK D+YS G++ FE++
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAM-YVATEVLDGTGHYN--------EKIDMYSLGIIFFEMI 225
Query: 428 TGKVPFEDGHLQGDKMTKNIRAGER---PLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSI 484
PF G + + K +R+ P F K + + +P++RP ++
Sbjct: 226 Y---PFSTGMER-VNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTL 281
Query: 485 CR 486
Sbjct: 282 LN 283
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-31
Identities = 51/243 (20%), Positives = 97/243 (39%), Gaps = 37/243 (15%)
Query: 249 LESLNAEISTMLSLS-HPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRN 307
+ E+ + HPN+++Y C ++++ ++ +EL + L Y+ ++
Sbjct: 61 FSFADREVQLLRESDEHPNVIRYFCTE--KDRQFQYIAIELCAATLQEYVE-----QKDF 113
Query: 308 SFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST-- 365
+ + ++ Q G+ LH+ I H +L P NI + + G +S FGL
Sbjct: 114 AHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173
Query: 366 ---ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGML 422
+++ R+ P + W APE+L+E T D++S G +
Sbjct: 174 AVGRHSFSRRSGVPGTE---------GWIAPEMLSEDCKENPT------YTVDIFSAGCV 218
Query: 423 CFELLT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYL----VNLTKKCWHTNPSQ 477
+ +++ G PF + NI G L K+ L +K +P +
Sbjct: 219 FYYVISEGSHPFGKSL----QRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQK 274
Query: 478 RPS 480
RPS
Sbjct: 275 RPS 277
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 48/265 (18%), Positives = 96/265 (36%), Gaps = 47/265 (17%)
Query: 248 ELESLNAEISTMLSLS-HPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRR 305
+ ++ E+ L H ++V+Y + +++ + E + L+ + E R
Sbjct: 53 DEQNALREVYAHAVLGQHSHVVRYFSAWAEDDH--MLIQNEYCNGGSLADAISEN--YRI 108
Query: 306 RNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYL--------------KARSME 351
+ F + D++LQ+ RG+ ++H+ + H ++ PSNI++ +
Sbjct: 109 MSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWAS 168
Query: 352 GYFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCS 411
K+ G T + S + + A EVL E
Sbjct: 169 NKVMFKIGDLGHVTRIS--SPQVEEGDSR---------FLANEVLQENYT--------HL 209
Query: 412 EKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCW 471
KAD+++ + + +G IR G P P + L K
Sbjct: 210 PKADIFALALTVVCAAGAEPLPRNGDQW-----HEIRQGRLPRIPQVLSQEFTELLKVMI 264
Query: 472 HTNPSQRPSFSSICR---ILRYIKK 493
H +P +RPS ++ + +L +K
Sbjct: 265 HPDPERRPSAMALVKHSVLLSASRK 289
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 4e-31
Identities = 64/242 (26%), Positives = 102/242 (42%), Gaps = 39/242 (16%)
Query: 254 AEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFSLP 312
E M SH NI++ L G + K ++ E M L ++RE + FS+
Sbjct: 95 GEAGIMGQFSHHNIIR-LEGVISKYKP-MMIITEYMENGALDKFLRE-----KDGEFSVL 147
Query: 313 VVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS-----TAR 367
+V ++ IA GM++L H +L NI + + KVS FGLS
Sbjct: 148 QLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSN-----LVCKVSDFGLSRVLEDDPE 202
Query: 368 TYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELL 427
+ P W APE ++ K + +DV+SFG++ +E++
Sbjct: 203 ATYTT---------SGGKIPIRWTAPEAISY---------RKFTSASDVWSFGIVMWEVM 244
Query: 428 T-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486
T G+ P+ + L ++ K I G R P P + L +CW ++RP F+ I
Sbjct: 245 TYGERPYWE--LSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 302
Query: 487 IL 488
IL
Sbjct: 303 IL 304
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 6e-31
Identities = 64/261 (24%), Positives = 113/261 (43%), Gaps = 42/261 (16%)
Query: 248 ELESLNAEISTMLSL-SHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRE------ 299
E +L +E+ ++ + H N+V L G C + +++E +LS Y+R
Sbjct: 73 EHRALMSELKILIHIGHHLNVVN-LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFV 131
Query: 300 ----TFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFH 355
++ +L ++ Q+A+GMEFL ++K H +L NI L +
Sbjct: 132 PYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK-----NV 186
Query: 356 VKVSGFGLS----TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCS 411
VK+ FGL+ Y + A P W APE + ++ +
Sbjct: 187 VKICDFGLARDIYKDPDYVRK---------GDARLPLKWMAPETIFDR---------VYT 228
Query: 412 EKADVYSFGMLCFELLT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKC 470
++DV+SFG+L +E+ + G P+ G ++ + ++ G R P + + C
Sbjct: 229 IQSDVWSFGVLLWEIFSLGASPYP-GVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDC 287
Query: 471 WHTNPSQRPSFSSICRILRYI 491
WH PSQRP+FS + L +
Sbjct: 288 WHGEPSQRPTFSELVEHLGNL 308
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 6e-31
Identities = 64/252 (25%), Positives = 104/252 (41%), Gaps = 39/252 (15%)
Query: 254 AEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFSLP 312
E S M HPNI++ L G + K +V E M L ++R+ F++
Sbjct: 95 GEASIMGQFDHPNIIR-LEGVVTKSKP-VMIVTEYMENGSLDSFLRK-----HDAQFTVI 147
Query: 313 VVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS---TARTY 369
+V ++ IA GM++L H +L NI + + KVS FGL
Sbjct: 148 QLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSN-----LVCKVSDFGLGRVLEDDPE 202
Query: 370 ASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT- 428
A+ T + P W +PE +A K + +DV+S+G++ +E+++
Sbjct: 203 AAYTT-------RGGKIPIRWTSPEAIAY---------RKFTSASDVWSYGIVLWEVMSY 246
Query: 429 GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRIL 488
G+ P+ + + + K + G R P P L L CW + + RP F I IL
Sbjct: 247 GERPYWE--MSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304
Query: 489 RYIKKFMANNPD 500
+ NP
Sbjct: 305 DK----LIRNPG 312
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 6e-31
Identities = 61/246 (24%), Positives = 107/246 (43%), Gaps = 44/246 (17%)
Query: 254 AEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFSLP 312
E TM HP+IV+ L G E +++MEL + +L +++ R+ S L
Sbjct: 440 QEALTMRQFDHPHIVK-LIGVITENP--VWIIMELCTLGELRSFLQV-----RKFSLDLA 491
Query: 313 VVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTAR----- 367
++ Q++ + +L +++ H ++ N+ + + VK+ FGLS R
Sbjct: 492 SLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN-----DCVKLGDFGLS--RYMEDS 544
Query: 368 -TYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFEL 426
Y + P W APE + + + + +DV+ FG+ +E+
Sbjct: 545 TYYKASK----------GKLPIKWMAPESINFR---------RFTSASDVWMFGVCMWEI 585
Query: 427 LT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSIC 485
L G PF+ ++ + + I GER P P L +L KCW +PS+RP F+ +
Sbjct: 586 LMHGVKPFQG--VKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELK 643
Query: 486 RILRYI 491
L I
Sbjct: 644 AQLSTI 649
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 62/254 (24%), Positives = 101/254 (39%), Gaps = 41/254 (16%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRE----------TFGS 303
E + +L H +IV+ G C + +V E M DL+ ++R
Sbjct: 67 EAELLTNLQHEHIVK-FYGVCGDGDP-LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPR 124
Query: 304 RRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGL 363
+ + L ++ I QIA GM +L +Q H +L N + A VK+ FG+
Sbjct: 125 QAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN-----LLVKIGDFGM 179
Query: 364 S---TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFG 420
S + Y P W PE + K + ++DV+SFG
Sbjct: 180 SRDVYSTDYYRVGG--------HTMLPIRWMPPESIMY---------RKFTTESDVWSFG 222
Query: 421 MLCFELLT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRP 479
++ +E+ T GK P+ L ++ + I G P PK + ++ CW P QR
Sbjct: 223 VILWEIFTYGKQPWFQ--LSNTEVIECITQGRVLERPRVCPKEVYDVMLGCWQREPQQRL 280
Query: 480 SFSSICRILRYIKK 493
+ I +IL + K
Sbjct: 281 NIKEIYKILHALGK 294
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 48/249 (19%), Positives = 84/249 (33%), Gaps = 40/249 (16%)
Query: 248 ELESLNAEISTMLSL-SHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRR 306
+ AE+ + + HP V+ + EE +L EL L +
Sbjct: 99 DRARKLAEVGSHEKVGQHPCCVRLEQAW--EEGGILYLQTELCGPSLQQHCE-----AWG 151
Query: 307 NSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366
S V + + LH+Q + H ++ P+NI+L G K+ FGL
Sbjct: 152 ASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFL---GPRG--RCKLGDFGLLVE 206
Query: 367 -RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFE 425
T + P+ + APE+L ADV+S G+ E
Sbjct: 207 LGTAGAGEVQEGDPR---------YMAPELLQG----------SYGTAADVFSLGLTILE 247
Query: 426 LLTGKVPFEDGHLQGDKMTKNIRAGE-RPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSI 484
+ G + +R G P F +G L ++ +P R + ++
Sbjct: 248 VACNMELPHGGE-----GWQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEAL 302
Query: 485 CRILRYIKK 493
L +++
Sbjct: 303 LA-LPVLRQ 310
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 63/275 (22%), Positives = 107/275 (38%), Gaps = 37/275 (13%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMR----ETFG 302
E E S M + ++V+ L G + + ++MELM++ DL Y+R
Sbjct: 71 ERIEFLNEASVMKEFNCHHVVR-LLGVVSQGQP-TLVIMELMTRGDLKSYLRSLRPAMAN 128
Query: 303 SRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFG 362
+ SL ++ + +IA GM +L+A K H +L N + F VK+ FG
Sbjct: 129 NPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED-----FTVKIGDFG 183
Query: 363 LS----TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYS 418
++ Y P W +PE L + + +DV+S
Sbjct: 184 MTRDIYETDYYRKGG---------KGLLPVRWMSPESLKDG---------VFTTYSDVWS 225
Query: 419 FGMLCFELLT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQ 477
FG++ +E+ T + P++ L +++ + + G P P L L + CW NP
Sbjct: 226 FGVVLWEIATLAEQPYQG--LSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKM 283
Query: 478 RPSFSSICRILRYIKKFMANNPDIARSEFQSPLAD 512
RPSF I ++ + SE
Sbjct: 284 RPSFLEIISSIKEEMEPGFREVSFYYSEENKLPEP 318
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 65/235 (27%), Positives = 105/235 (44%), Gaps = 37/235 (15%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGS-RRRNSFSLPV 313
EIS SL+H ++V + F D + F+V+EL C R +RR + + P
Sbjct: 65 EISIHRSLAHQHVVGFHGFFEDNDF--VFVVLEL------CRRRSLLELHKRRKALTEPE 116
Query: 314 VVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYAS-- 371
+ QI G ++LH ++ H +L N++L +E VK+ FGL+T Y
Sbjct: 117 ARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNED-LE----VKIGDFGLATKVEYDGER 171
Query: 372 RNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKV 431
+ +P YI APEVL+++ S + DV+S G + + LL GK
Sbjct: 172 KKVLCGTP-------NYI--APEVLSKK---------GHSFEVDVWSIGCIMYTLLVGKP 213
Query: 432 PFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486
PFE L+ + I+ E P +L +K T+P+ RP+ + +
Sbjct: 214 PFETSCLK--ETYLRIKKNEYS-IPKHINPVAASLIQKMLQTDPTARPTINELLN 265
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-30
Identities = 58/269 (21%), Positives = 95/269 (35%), Gaps = 46/269 (17%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRE------- 299
+ E + L H +IV+ G C E + +V E M DL+ ++R
Sbjct: 86 ARQDFQREAELLTMLQHQHIVR-FFGVCTEGRP-LLMVFEYMRHGDLNRFLRSHGPDAKL 143
Query: 300 --TFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVK 357
L ++ + Q+A GM +L H +L N + VK
Sbjct: 144 LAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQG-----LVVK 198
Query: 358 VSGFGLS----TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEK 413
+ FG+S + Y P W PE + K + +
Sbjct: 199 IGDFGMSRDIYSTDYYRVGGR---------TMLPIRWMPPESILY---------RKFTTE 240
Query: 414 ADVYSFGMLCFELLT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWH 472
+DV+SFG++ +E+ T GK P+ L + I G P P + + + CW
Sbjct: 241 SDVWSFGVVLWEIFTYGKQPWYQ--LSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQ 298
Query: 473 TNPSQRPSFSSICRILRYIKKFMANNPDI 501
P QR S + L+ +A P +
Sbjct: 299 REPQQRHSIKDVHARLQA----LAQAPPV 323
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 66/265 (24%), Positives = 106/265 (40%), Gaps = 49/265 (18%)
Query: 248 ELESLNAEISTMLSL-SHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRE------ 299
E E+L +E+ + L +H NIV L G C ++ E DL ++R
Sbjct: 69 EREALMSELKVLSYLGNHMNIVN-LLGACTIGGP-TLVITEYCCYGDLLNFLRRKRDSFI 126
Query: 300 ------TFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGY 353
+ L ++ Q+A+GM FL ++ H +L NI L
Sbjct: 127 CSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG----- 181
Query: 354 FHVKVSGFGLSTAR------TYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTST 407
K+ FGL AR Y + A P W APE +
Sbjct: 182 RITKICDFGL--ARDIKNDSNYVVK---------GNARLPVKWMAPESIFNC-------- 222
Query: 408 SKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNL 466
+ ++DV+S+G+ +EL + G P+ G K K I+ G R L P +P + ++
Sbjct: 223 -VYTFESDVWSYGIFLWELFSLGSSPYP-GMPVDSKFYKMIKEGFRMLSPEHAPAEMYDI 280
Query: 467 TKKCWHTNPSQRPSFSSICRILRYI 491
K CW +P +RP+F I +++
Sbjct: 281 MKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-29
Identities = 65/235 (27%), Positives = 105/235 (44%), Gaps = 37/235 (15%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGS-RRRNSFSLPV 313
EIS SL+H ++V + F D + F+V+EL C R +RR + + P
Sbjct: 91 EISIHRSLAHQHVVGFHGFFEDNDF--VFVVLEL------CRRRSLLELHKRRKALTEPE 142
Query: 314 VVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYAS-- 371
+ QI G ++LH ++ H +L N++L +E VK+ FGL+T Y
Sbjct: 143 ARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNED-LE----VKIGDFGLATKVEYDGER 197
Query: 372 RNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKV 431
+ +P YI APEVL+++ S + DV+S G + + LL GK
Sbjct: 198 KKVLCGTP-------NYI--APEVLSKK---------GHSFEVDVWSIGCIMYTLLVGKP 239
Query: 432 PFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486
PFE L+ + I+ E P +L +K T+P+ RP+ + +
Sbjct: 240 PFETSCLK--ETYLRIKKNEYS-IPKHINPVAASLIQKMLQTDPTARPTINELLN 291
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 56/261 (21%), Positives = 102/261 (39%), Gaps = 49/261 (18%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEE--------------KKEFFLVMELMSK-D 292
E E+ + L H NIV Y + + K F+ ME K
Sbjct: 47 NNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGT 106
Query: 293 LSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEG 352
L ++ + RR + +++ QI +G++++H++K+ + +L PSNI+L
Sbjct: 107 LEQWIEK----RRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTK--- 159
Query: 353 YFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSE 412
VK+ FGL T+ + T ++ + +PE ++ Q+ +
Sbjct: 160 --QVKIGDFGLVTSLKNDGKRT-------RSKGTLR-YMSPEQISSQD---------YGK 200
Query: 413 KADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWH 472
+ D+Y+ G++ ELL + K ++R + K L +K
Sbjct: 201 EVDLYALGLILAELLHVCDTAFE----TSKFFTDLR---DGIISDIFDKKEKTLLQKLLS 253
Query: 473 TNPSQRPSFSSICRILRYIKK 493
P RP+ S I R L + K
Sbjct: 254 KKPEDRPNTSEILRTL-TVWK 273
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-29
Identities = 54/240 (22%), Positives = 97/240 (40%), Gaps = 35/240 (14%)
Query: 246 YGELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSR 304
G L E+ L HPNI++ F D + +L++E + ++
Sbjct: 50 AGVEHQLRREVEIQSHLRHPNILRLYGYFHDATR--VYLILEYAPLGTVYRELQ------ 101
Query: 305 RRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS 364
+ + F + ++A + + H++++ H ++ P N+ L + +K++ FG S
Sbjct: 102 KLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAG-----ELKIADFGWS 156
Query: 365 TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCF 424
+ R + Y+ PE++ + EK D++S G+LC+
Sbjct: 157 VHAPSSRRTDLCGTL-------DYL--PPEMIEGRM---------HDEKVDLWSLGVLCY 198
Query: 425 ELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSI 484
E L GK PFE Q + K I E FP + +L + NPSQRP +
Sbjct: 199 EFLVGKPPFEANTYQ--ETYKRISRVE-FTFPDFVTEGARDLISRLLKHNPSQRPMLREV 255
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 9e-29
Identities = 68/281 (24%), Positives = 117/281 (41%), Gaps = 51/281 (18%)
Query: 248 ELESLNAEISTMLSL-SHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRE------ 299
+L L +E+ M + H NI+ L G C ++ ++++E SK +L Y++
Sbjct: 117 DLSDLISEMEMMKMIGKHKNIIN-LLGACTQDGP-LYVIVEYASKGNLREYLQARRPPGL 174
Query: 300 ----TFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFH 355
S +V Q+ARGME+L ++K H +L N+ +
Sbjct: 175 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED-----NV 229
Query: 356 VKVSGFGLSTAR------TYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSK 409
+K++ FGL AR Y P W APE L ++
Sbjct: 230 MKIADFGL--ARDIHHIDYYKKT---------TNGRLPVKWMAPEALFDR---------I 269
Query: 410 CSEKADVYSFGMLCFELLT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTK 468
+ ++DV+SFG+L +E+ T G P+ + +++ K ++ G R PS L + +
Sbjct: 270 YTHQSDVWSFGVLLWEIFTLGGSPYPG--VPVEELFKLLKEGHRMDKPSNCTNELYMMMR 327
Query: 469 KCWHTNPSQRPSFSSICRILRYIKKFMANNPDIARSEFQSP 509
CWH PSQRP+F + L + +A + +
Sbjct: 328 DCWHAVPSQRPTFKQLVEDL---DRIVALTSNQEMGYYHHH 365
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 9e-29
Identities = 57/235 (24%), Positives = 96/235 (40%), Gaps = 36/235 (15%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFSLPV 313
E+ L HP+I++ F E+ +LV+E+ +++ Y++ R FS
Sbjct: 61 EVKIHCQLKHPSILELYNYF--EDSNYVYLVLEMCHNGEMNRYLK-----NRVKPFSENE 113
Query: 314 VVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYAS-- 371
M QI GM +LH+ I H +L SN+ L M +K++ FGL+T
Sbjct: 114 ARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRN-MN----IKIADFGLATQLKMPHEK 168
Query: 372 RNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKV 431
T +P YI +PE+ ++DV+S G + + LL G+
Sbjct: 169 HYTLCGTP-------NYI--SPEIATRSAH---------GLESDVWSLGCMFYTLLIGRP 210
Query: 432 PFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486
PF+ ++ + + PS +L + NP+ R S SS+
Sbjct: 211 PFDTDTVK--NTLNKVVLADYE-MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-28
Identities = 65/261 (24%), Positives = 111/261 (42%), Gaps = 45/261 (17%)
Query: 248 ELESLNAEISTMLSL-SHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMR------- 298
E E+L +E+ M L H NIV L G C ++ E DL ++R
Sbjct: 92 EKEALMSELKIMSHLGQHENIVN-LLGACTHGGP-VLVITEYCCYGDLLNFLRRKSRVLE 149
Query: 299 -ETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVK 357
+ + ++ S ++ Q+A+GM FL ++ H ++ N+ L K
Sbjct: 150 TDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNG-----HVAK 204
Query: 358 VSGFGLSTAR------TYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCS 411
+ FGL AR Y + A P W APE + + +
Sbjct: 205 IGDFGL--ARDIMNDSNYIVK---------GNARLPVKWMAPESIFDC---------VYT 244
Query: 412 EKADVYSFGMLCFELLT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKC 470
++DV+S+G+L +E+ + G P+ G L K K ++ G + P+ +PK + ++ + C
Sbjct: 245 VQSDVWSYGILLWEIFSLGLNPYP-GILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQAC 303
Query: 471 WHTNPSQRPSFSSICRILRYI 491
W P+ RP+F IC L+
Sbjct: 304 WALEPTHRPTFQQICSFLQEQ 324
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-28
Identities = 66/261 (25%), Positives = 111/261 (42%), Gaps = 44/261 (16%)
Query: 248 ELESLNAEISTMLSL-SHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRE------ 299
+L L +E+ M + H NI+ L G C + ++++E SK +L Y+R
Sbjct: 83 DLSDLVSEMEMMKMIGKHKNIIN-LLGAC-TQDGPLYVIVEYASKGNLREYLRARRPPGM 140
Query: 300 ----TFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFH 355
+ +V Q+ARGME+L +QK H +L N+ +
Sbjct: 141 EYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN-----NV 195
Query: 356 VKVSGFGLS----TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCS 411
+K++ FGL+ Y P W APE L ++ +
Sbjct: 196 MKIADFGLARDINNIDYYKKTTN---------GRLPVKWMAPEALFDR---------VYT 237
Query: 412 EKADVYSFGMLCFELLT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKC 470
++DV+SFG+L +E+ T G P+ + +++ K ++ G R P+ L + + C
Sbjct: 238 HQSDVWSFGVLMWEIFTLGGSPYPG--IPVEELFKLLKEGHRMDKPANCTNELYMMMRDC 295
Query: 471 WHTNPSQRPSFSSICRILRYI 491
WH PSQRP+F + L I
Sbjct: 296 WHAVPSQRPTFKQLVEDLDRI 316
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-28
Identities = 58/258 (22%), Positives = 108/258 (41%), Gaps = 41/258 (15%)
Query: 248 ELESLNAEISTMLSL-SHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRE------ 299
+ E+ + L HPNI+ L G C E + +L +E +L ++R+
Sbjct: 68 DHRDFAGELEVLCKLGHHPNIIN-LLGAC-EHRGYLYLAIEYAPHGNLLDFLRKSRVLET 125
Query: 300 ----TFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFH 355
+ ++ S ++ +ARGM++L ++ H +L NI L +
Sbjct: 126 DPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNI-LVGENYV---- 180
Query: 356 VKVSGFGLSTARTYASRNTPPASPQNQTAPNPYI-WYAPEVLAEQEGTGSTSTSKCSEKA 414
K++ FGLS + + T P + W A E L S + +
Sbjct: 181 AKIADFGLSRGQEVYVKKTMGRLP---------VRWMAIESLNY---------SVYTTNS 222
Query: 415 DVYSFGMLCFELLT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHT 473
DV+S+G+L +E+++ G P+ + ++ + + G R P + +L ++CW
Sbjct: 223 DVWSYGVLLWEIVSLGGTPYCG--MTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWRE 280
Query: 474 NPSQRPSFSSICRILRYI 491
P +RPSF+ I L +
Sbjct: 281 KPYERPSFAQILVSLNRM 298
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 58/251 (23%), Positives = 100/251 (39%), Gaps = 43/251 (17%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRE----------TFGS 303
E L HPN+V L G +++ ++ S DL ++
Sbjct: 62 EAMLRARLQHPNVVC-LLGVVTKDQP-LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDR 119
Query: 304 RRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGL 363
+++ P V ++ QIA GME+L + + H +L N+ + + +VK+S GL
Sbjct: 120 TVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDK-----LNVKISDLGL 174
Query: 364 S----TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSF 419
A Y + P W APE + K S +D++S+
Sbjct: 175 FREVYAADYYKLL---------GNSLLPIRWMAPEAIMYG---------KFSIDSDIWSY 216
Query: 420 GMLCFELLT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQR 478
G++ +E+ + G P+ + + IR + P P ++ L +CW+ PS+R
Sbjct: 217 GVVLWEVFSYGLQPYCG--YSNQDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRR 274
Query: 479 PSFSSICRILR 489
P F I LR
Sbjct: 275 PRFKDIHSRLR 285
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-28
Identities = 59/268 (22%), Positives = 112/268 (41%), Gaps = 51/268 (19%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRE------- 299
EL L +E + + ++HP++++ L G C + L++E L ++RE
Sbjct: 69 ELRDLLSEFNVLKQVNHPHVIK-LYGAC-SQDGPLLLIVEYAKYGSLRGFLRESRKVGPG 126
Query: 300 -----------TFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKAR 348
+ + ++ ++ QI++GM++L K+ H +L NI +
Sbjct: 127 YLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEG 186
Query: 349 SMEGYFHVKVSGFGLS----TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGS 404
+K+S FGLS +Y R P W A E L +
Sbjct: 187 -----RKMKISDFGLSRDVYEEDSYVKR---------SQGRIPVKWMAIESLFDH----- 227
Query: 405 TSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYL 463
+ ++DV+SFG+L +E++T G P+ + +++ ++ G R P + +
Sbjct: 228 ----IYTTQSDVWSFGVLLWEIVTLGGNPYPG--IPPERLFNLLKTGHRMERPDNCSEEM 281
Query: 464 VNLTKKCWHTNPSQRPSFSSICRILRYI 491
L +CW P +RP F+ I + L +
Sbjct: 282 YRLMLQCWKQEPDKRPVFADISKDLEKM 309
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 6e-28
Identities = 51/264 (19%), Positives = 99/264 (37%), Gaps = 38/264 (14%)
Query: 246 YGELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSR 304
G L EI L HPNI++ F D ++ +L++E + +L ++
Sbjct: 55 EGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKR--IYLMLEFAPRGELYKELQ------ 106
Query: 305 RRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS 364
+ F M ++A + + H +K+ H ++ P N+ + + +K++ FG S
Sbjct: 107 KHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKG-----ELKIADFGWS 161
Query: 365 TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCF 424
R T + Y+ PE++ + EK D++ G+LC+
Sbjct: 162 VHAPSLRRRTMCGTL-------DYL--PPEMIEGKTHD---------EKVDLWCAGVLCY 203
Query: 425 ELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSI 484
E L G PF+ + + I + FP +L K +P QR +
Sbjct: 204 EFLVGMPPFDSPSHT--ETHRRIVNVD-LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGV 260
Query: 485 CR---ILRYIKKFMANNPDIARSE 505
+ ++ + +S+
Sbjct: 261 MEHPWVKANSRRVLPPVYQSTQSK 284
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 115 bits (288), Expect = 9e-28
Identities = 38/286 (13%), Positives = 84/286 (29%), Gaps = 36/286 (12%)
Query: 202 VLTKNEQRLVDMLLKKLMVRRRLGASSQFKEIQWLGDSFVLRHFYGELESLNAEISTMLS 261
V E+ + + + ++ + + I+ + V F + +
Sbjct: 105 VPYFTERPPSNAIKQ---MKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDP------ 155
Query: 262 LSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFG-SRRRNSFSLPVVVDIMLQ 320
+++ D F + M +L + S S + + LQ
Sbjct: 156 -QKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQ 214
Query: 321 IARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTPPASPQ 380
+ R + LH + H L P +I L R V ++GF +R S
Sbjct: 215 VIRLLASLHHYGLVHTYLRPVDIVLDQRG-----GVFLTGFEH--LVRDGARVVSSVSRG 267
Query: 381 NQTAPNPYIWYAPEVLAEQEGTGSTSTSKC--SEKADVYSFGMLCFELLTGKVPFEDGHL 438
+ PE+ A + + + D ++ G++ + + +P
Sbjct: 268 -------FE--PPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAA 318
Query: 439 QGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSI 484
G ++ I + + P+ + L + R
Sbjct: 319 LG--GSEWIFRSCKNI-----PQPVRALLEGFLRYPKEDRLLPLQA 357
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 1e-27
Identities = 51/252 (20%), Positives = 103/252 (40%), Gaps = 22/252 (8%)
Query: 249 LESLNAEISTML-SLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYM-RETFGSRRR 306
+ EI + S HPN+++Y C + ++ +EL + +L + +
Sbjct: 52 CDIALMEIKLLTESDDHPNVIRYYCSE--TTDRFLYIALELCNLNLQDLVESKNVSDENL 109
Query: 307 NSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNI--------YLKARSMEGYFHVKV 358
+ ++ QIA G+ LH+ KI H +L P NI ++ + +
Sbjct: 110 KLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILI 169
Query: 359 SGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYS 418
S FGL + S + + N + W APE+L +E + + + D++S
Sbjct: 170 SDFGLC--KKLDSGQSSFRTNLNNPSGTSG-WRAPELL--EESNNLQTKRRLTRSIDIFS 224
Query: 419 FGMLCFELLT-GKVPFEDGHLQGDKMTK---NIRAGERPLFPSGSPKYLVNLTKKCWHTN 474
G + + +L+ GK PF D + + + + ++ + S + +L + +
Sbjct: 225 MGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAE-ATDLISQMIDHD 283
Query: 475 PSQRPSFSSICR 486
P +RP+ + R
Sbjct: 284 PLKRPTAMKVLR 295
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-27
Identities = 67/268 (25%), Positives = 105/268 (39%), Gaps = 50/268 (18%)
Query: 248 ELESLNAEISTMLSL-SHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRE------ 299
E E+L +E+ M L SH NIV L G C +L+ E DL Y+R
Sbjct: 91 EREALMSELKMMTQLGSHENIVN-LLGAC-TLSGPIYLIFEYCCYGDLLNYLRSKREKFS 148
Query: 300 -----------TFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKAR 348
N + ++ Q+A+GMEFL + H +L N+ +
Sbjct: 149 EDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHG 208
Query: 349 SMEGYFHVKVSGFGLS----TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGS 404
VK+ FGL+ + Y R A P W APE L E
Sbjct: 209 -----KVVKICDFGLARDIMSDSNYVVR---------GNARLPVKWMAPESLFEG----- 249
Query: 405 TSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYL 463
+ K+DV+S+G+L +E+ + G P+ G K I+ G + P + + +
Sbjct: 250 ----IYTIKSDVWSYGILLWEIFSLGVNPYP-GIPVDANFYKLIQNGFKMDQPFYATEEI 304
Query: 464 VNLTKKCWHTNPSQRPSFSSICRILRYI 491
+ + CW + +RPSF ++ L
Sbjct: 305 YIIMQSCWAFDSRKRPSFPNLTSFLGCQ 332
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-27
Identities = 66/261 (25%), Positives = 111/261 (42%), Gaps = 44/261 (16%)
Query: 248 ELESLNAEISTMLSL-SHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRE------ 299
+L L +E+ M + H NI+ L G C + ++++E SK +L Y+R
Sbjct: 129 DLSDLVSEMEMMKMIGKHKNIIN-LLGAC-TQDGPLYVIVEYASKGNLREYLRARRPPGM 186
Query: 300 ----TFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFH 355
+ +V Q+ARGME+L +QK H +L N+ +
Sbjct: 187 EYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN-----NV 241
Query: 356 VKVSGFGLS----TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCS 411
+K++ FGL+ Y P W APE L ++ +
Sbjct: 242 MKIADFGLARDINNIDYYKKT---------TNGRLPVKWMAPEALFDR---------VYT 283
Query: 412 EKADVYSFGMLCFELLT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKC 470
++DV+SFG+L +E+ T G P+ + +++ K ++ G R P+ L + + C
Sbjct: 284 HQSDVWSFGVLMWEIFTLGGSPYPG--IPVEELFKLLKEGHRMDKPANCTNELYMMMRDC 341
Query: 471 WHTNPSQRPSFSSICRILRYI 491
WH PSQRP+F + L I
Sbjct: 342 WHAVPSQRPTFKQLVEDLDRI 362
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-27
Identities = 48/308 (15%), Positives = 98/308 (31%), Gaps = 46/308 (14%)
Query: 199 GSVVLTKNEQRLVDM--LLKKLMVRRRLGASSQFKEIQWLGDSFVLRHFYGELESLNAEI 256
++L + + + + K L+ ++R S +I + E+
Sbjct: 45 NKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSK----------YDDFKNEL 94
Query: 257 STMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRE--TFGSRRRNSFSLPV 313
+ + + + E +++ E M + + + V
Sbjct: 95 QIITDIKNEYCLTCEGII--TNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQV 152
Query: 314 VVDIMLQIARGMEFLHAQK-IYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASR 372
+ I+ + ++H +K I H ++ PSNI + VK+S FG S
Sbjct: 153 IKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNG-----RVKLSDFGESEYMVDKKI 207
Query: 373 NTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVP 432
+ ++ PE + + K D++S G+ + + VP
Sbjct: 208 KGSRGTY-------EFM--PPEFFSNESSYNG-------AKVDIWSLGICLYVMFYNVVP 251
Query: 433 FEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIK 492
F ++ NIR +P +L LT K + S+ +K
Sbjct: 252 FSLKISL-VELFNNIRTKN-IEYPLDRNHFLYPLTNK---KSTCSNNFLSNEDIDF--LK 304
Query: 493 KFMANNPD 500
F+ NP
Sbjct: 305 LFLRKNPA 312
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 43/264 (16%), Positives = 85/264 (32%), Gaps = 22/264 (8%)
Query: 243 RHFYGELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETF 301
F ++ E + L+H NIV+ + + L+ME L + E
Sbjct: 45 ISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEE-- 102
Query: 302 GSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGF 361
+ ++ + GM L I H + P NI ++ +G K++ F
Sbjct: 103 -PSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNI-MRVIGEDGQSVYKLTDF 160
Query: 362 GLSTARTYASR-NTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFG 420
G + + + + Y+ P++ E+ K D++S G
Sbjct: 161 GAARELEDDEQFVSLYGTE-------EYL--HPDMY-ERAVLRKDHQKKYGATVDLWSIG 210
Query: 421 MLCFELLTGKVPFEDGHLQGD--KMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQR 478
+ + TG +PF ++ I G+ SG W +
Sbjct: 211 VTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGV--QKAENGPIDWSGDMPVS 268
Query: 479 PSFSSICRIL--RYIKKFMANNPD 500
S S ++L + + + +
Sbjct: 269 CSLSRGLQVLLTPVLANILEADQE 292
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 8e-27
Identities = 66/287 (22%), Positives = 107/287 (37%), Gaps = 47/287 (16%)
Query: 248 ELESLNAEISTMLSLS-HPNIVQYLCGFC------DEEKKEFFLVMELMSKDLSCYMRET 300
+ ++ E+ M LS HPNIVQ+ D + EF L+ EL L ++++
Sbjct: 68 KNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKM 127
Query: 301 FGSRRRNSFSLPVVVDIMLQIARGMEFLHAQK--IYHGELNPSNIYLKARSMEGYFHVKV 358
R S V+ I Q R ++ +H QK I H +L N+ L + +K+
Sbjct: 128 ---ESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQG-----TIKL 179
Query: 359 SGFGLSTARTYASRNTPPASPQNQ--------TAPNPYIWYAPEVLAEQEGTGSTSTSKC 410
FG +T ++ + A + T P Y PE++ S
Sbjct: 180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTP-MYR--TPEII--------DLYSNF 228
Query: 411 --SEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAG--ERPLFPSGSPKYLVNL 466
EK D+++ G + + L + PFEDG I G P + +L
Sbjct: 229 PIGEKQDIWALGCILYLLCFRQHPFEDGAK------LRIVNGKYSIPPHDTQYTV-FHSL 281
Query: 467 TKKCWHTNPSQRPSFSSICRILRYIKKFMANNPDIARSEFQSPLADY 513
+ NP +R S + + L+ I NP +E Y
Sbjct: 282 IRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPITELLEQNGGY 328
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 9e-27
Identities = 65/278 (23%), Positives = 109/278 (39%), Gaps = 51/278 (18%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRE------- 299
E + M +PNIV+ L G C K L+ E M+ DL+ ++R
Sbjct: 93 MQADFQREAALMAEFDNPNIVK-LLGVCAVGKP-MCLLFEYMAYGDLNEFLRSMSPHTVC 150
Query: 300 -----------TFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKAR 348
S S + I Q+A GM +L +K H +L N +
Sbjct: 151 SLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGEN 210
Query: 349 SMEGYFHVKVSGFGLS----TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGS 404
VK++ FGLS +A Y + P W PE +
Sbjct: 211 -----MVVKIADFGLSRNIYSADYYKADGN---------DAIPIRWMPPESIFY------ 250
Query: 405 TSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYL 463
++ + ++DV+++G++ +E+ + G P+ + +++ +R G P P L
Sbjct: 251 ---NRYTTESDVWAYGVVLWEIFSYGLQPY--YGMAHEEVIYYVRDGNILACPENCPLEL 305
Query: 464 VNLTKKCWHTNPSQRPSFSSICRILRYIKKFMANNPDI 501
NL + CW P+ RPSF SI RIL+ + + +
Sbjct: 306 YNLMRLCWSKLPADRPSFCSIHRILQRMCERAEGTVGV 343
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 112 bits (280), Expect = 9e-27
Identities = 32/225 (14%), Positives = 62/225 (27%), Gaps = 29/225 (12%)
Query: 263 SHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRE-TFGSRRRNSFSLPVVVDIMLQI 321
S P Q G D + L+M S DL F R + + + Q+
Sbjct: 144 SQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQL 203
Query: 322 ARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTPPASPQN 381
R L ++ + HG P N+++ + + +R + P
Sbjct: 204 IRLAANLQSKGLVHGHFTPDNLFIMPDG-----RLMLGDVSA--LWKVGTRGPASSVP-- 254
Query: 382 QTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGD 441
+ YAP T + + G+ + + +PF
Sbjct: 255 -------VTYAPREFLNASTATFT------HALNAWQLGLSIYRVWCLFLPFGLVTPGIK 301
Query: 442 KMTKNIRAGERPLFP------SGSPKYLVNLTKKCWHTNPSQRPS 480
K + P ++ L + + + +R
Sbjct: 302 GSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLL 346
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 60/236 (25%), Positives = 93/236 (39%), Gaps = 28/236 (11%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKD-LSCYMRETFGSRRR 306
+ L+ EI+ L H NIVQYL G E + ME + LS +R +G +
Sbjct: 62 YSQPLHEEIALHKHLKHKNIVQYL-GSFSENGF-IKIFMEQVPGGSLSALLRSKWGPLKD 119
Query: 307 NSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST- 365
N + QI G+++LH +I H ++ N+ + S G +K+S FG S
Sbjct: 120 NE---QTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYS--G--VLKISDFGTSKR 172
Query: 366 -ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCF 424
A T + Q + APE++ ++ G + AD++S G
Sbjct: 173 LAGINPCTETFTGTLQ---------YMAPEII-DKGPRG------YGKAADIWSLGCTII 216
Query: 425 ELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPS 480
E+ TGK PF + M K P P KC+ +P +R
Sbjct: 217 EMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRAC 272
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-26
Identities = 61/241 (25%), Positives = 97/241 (40%), Gaps = 35/241 (14%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFSLPV 313
+I M S N V L K ++ M+L K +L +M R V
Sbjct: 111 KIRRMDPFSTKNTVGQLQPS--SPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH---GV 165
Query: 314 VVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA----RTY 369
+ I +QIA +EFLH++ + H +L PSNI+ +M+ VKV FGL TA
Sbjct: 166 CLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDD--VVKVGDFGLVTAMDQDEEE 220
Query: 370 ASRNTPPASPQNQTA----PNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFE 425
+ TP + T Y+ +PE + S K D++S G++ FE
Sbjct: 221 QTVLTPMPAYATHTGQVGTKL-YM--SPEQIHGN---------NYSHKVDIFSLGLILFE 268
Query: 426 LLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSIC 485
LL F + +T +R + PL + + + +P++RP + I
Sbjct: 269 LLY---SFSTQMERVRIITD-VRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDII 324
Query: 486 R 486
Sbjct: 325 E 325
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 7e-26
Identities = 41/258 (15%), Positives = 81/258 (31%), Gaps = 18/258 (6%)
Query: 247 GELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRR 305
++ E + L+H NIV+ + + L+ME L + E
Sbjct: 49 RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEE---PSN 105
Query: 306 RNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365
+ ++ + GM L I H + P NI ++ +G K++ FG +
Sbjct: 106 AYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNI-MRVIGEDGQSVYKLTDFGAAR 164
Query: 366 ARTYASR-NTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCF 424
+ + + Y+ P++ E+ K D++S G+ +
Sbjct: 165 ELEDDEQFVSLYGTE-------EYL--HPDMY-ERAVLRKDHQKKYGATVDLWSIGVTFY 214
Query: 425 ELLTGKVPFEDGHLQGD--KMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFS 482
TG +PF ++ I G+ SG K S S
Sbjct: 215 HAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRG 274
Query: 483 SICRILRYIKKFMANNPD 500
+ + + + +
Sbjct: 275 LQVLLTPVLANILEADQE 292
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-25
Identities = 46/196 (23%), Positives = 79/196 (40%), Gaps = 29/196 (14%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMS----KDLSCYMRETFGS 303
+ L E+ +HPNIV Y F + E ++V M+ KDL + F
Sbjct: 69 MVTFLQGELHVSKLFNHPNIVPYRATFIADN--ELWVVTSFMAYGSAKDL---ICTHFM- 122
Query: 304 RRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGL 363
+ + + I+ + + ++++H H + S+I + S++G V +SG
Sbjct: 123 ---DGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI---SVDG--KVYLSGLRS 174
Query: 364 ST--ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGM 421
+ + P+ W +PEVL +Q G K+D+YS G+
Sbjct: 175 NLSMISHGQRQRVVHDFPKYSVK-VLP-WLSPEVL-QQNLQGYD------AKSDIYSVGI 225
Query: 422 LCFELLTGKVPFEDGH 437
EL G VPF+D
Sbjct: 226 TACELANGHVPFKDMP 241
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 7e-25
Identities = 59/237 (24%), Positives = 100/237 (42%), Gaps = 34/237 (14%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVV 314
EI + L H N++Q + +EEK++ ++VME C M+E S F +
Sbjct: 56 EIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCV----CGMQEMLDSVPEKRFPVCQA 111
Query: 315 VDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRN- 373
Q+ G+E+LH+Q I H ++ P N+ L +K+S G++ A + +
Sbjct: 112 HGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGG-----TLKISALGVAEALHPFAADD 166
Query: 374 ---TPPASPQNQTAPNPYIWYAPEVLAEQEG-TGSTSTSKCSEKADVYSFGMLCFELLTG 429
T SP + PE+ + +G K D++S G+ + + TG
Sbjct: 167 TCRTSQGSP-------AFQ--PPEIANGLDTFSGF--------KVDIWSAGVTLYNITTG 209
Query: 430 KVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486
PFE ++ K+ +NI G P L +L K P++R S I +
Sbjct: 210 LYPFEGDNIY--KLFENIGKGSYA-IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 63/297 (21%), Positives = 112/297 (37%), Gaps = 40/297 (13%)
Query: 199 GSVVLTKNEQ--RLVDM-LLKKLMVRRRLGASSQFKEIQWLGDSFVLRHFYGELESLNAE 255
G V L NE M +L K + R+ G + G +E + E
Sbjct: 27 GVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQE 86
Query: 256 ISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVV 315
I+ + L HPN+V+ + D + ++V EL+++ S
Sbjct: 87 IAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQG------PVMEVPTLKPLSEDQAR 140
Query: 316 DIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASR--N 373
+ +G+E+LH QKI H ++ PSN+ + H+K++ FG+S + +
Sbjct: 141 FYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDG-----HIKIADFGVSNEFKGSDALLS 195
Query: 374 TPPASPQNQTAPNPYIWYAPEVLAEQEG--TGSTSTSKCSEKADVYSFGMLCFELLTGKV 431
+P ++ APE L+E +G DV++ G+ + + G+
Sbjct: 196 NTVGTP-------AFM--APESLSETRKIFSGK--------ALDVWAMGVTLYCFVFGQC 238
Query: 432 PFEDGHLQGDKMTKNIRAGE--RPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486
PF D + + I++ P P + L +L + NP R I
Sbjct: 239 PFMDERIM--CLHSKIKSQALEFPDQPDIAED-LKDLITRMLDKNPESRIVVPEIKL 292
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-24
Identities = 61/241 (25%), Positives = 101/241 (41%), Gaps = 42/241 (17%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMS-KDLSCYMRETFGSRRR 306
L E++ + L HPNI++ F E+K+ ++LVME +L + R
Sbjct: 79 SNSKLLEEVAVLKLLDHPNIMKLYDFF--EDKRNYYLVMECYKGGELFDEIIH------R 130
Query: 307 NSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366
F+ I+ Q+ G+ +LH I H +L P N+ L+++ + +K+ FGL
Sbjct: 131 MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKD--ALIKIVDFGL--- 185
Query: 367 RTYASRNTPPASPQNQTAPNPYIWY-APEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFE 425
S + Y Y APEVL ++ EK DV+S G++ F
Sbjct: 186 ----SAVFENQKKMKERLGTAY--YIAPEVLRKKYD----------EKCDVWSIGVILFI 229
Query: 426 LLTGKVPFEDGHLQGDKMTKNIRAGE----RPLFPSGSP--KYLVNLTKKCWHTNPSQRP 479
LL G PF Q + + + G+ P + + S K L+ K+ + +R
Sbjct: 230 LLAGYPPFGGQTDQE--ILRKVEKGKYTFDSPEWKNVSEGAKDLI---KQMLQFDSQRRI 284
Query: 480 S 480
S
Sbjct: 285 S 285
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 6e-24
Identities = 66/242 (27%), Positives = 102/242 (42%), Gaps = 42/242 (17%)
Query: 247 GELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMS-KDLSCYMRETFGSRR 305
E + EIS + SL HPNI++ F E+KK F+LV E +L +
Sbjct: 88 KFHEEIYNEISLLKSLDHPNIIKLFDVF--EDKKYFYLVTEFYEGGELFEQIIN------ 139
Query: 306 RNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365
R+ F +IM QI G+ +LH I H ++ P NI L+ ++ ++K+ FGL
Sbjct: 140 RHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSL--LNIKIVDFGL-- 195
Query: 366 ARTYASRNTPPASPQNQTAPNPYIWY-APEVLAEQEGTGSTSTSKCSEKADVYSFGMLCF 424
S Y Y APEVL K +EK DV+S G++ +
Sbjct: 196 -----SSFFSKDYKLRDRLGTAY--YIAPEVL----------KKKYNEKCDVWSCGVIMY 238
Query: 425 ELLTGKVPFEDGHLQGDKMTKNIRAG----ERPLFPSGSP--KYLVNLTKKCWHTNPSQR 478
LL G PF + Q + K + G + + + S K L+ K + ++R
Sbjct: 239 ILLCGYPPFGGQNDQD--IIKKVEKGKYYFDFNDWKNISDEAKELI---KLMLTYDYNKR 293
Query: 479 PS 480
+
Sbjct: 294 CT 295
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 8e-24
Identities = 46/241 (19%), Positives = 76/241 (31%), Gaps = 37/241 (15%)
Query: 248 ELESLNA-EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGS--- 303
LE E+ LS P IV G E + MEL+ GS
Sbjct: 92 RLEVFRVEELVACAGLSSPRIVPLY-G-AVREGPWVNIFMELLEG----------GSLGQ 139
Query: 304 --RRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGF 361
++ + + Q G+E+LH ++I HG++ N+ L S +G + F
Sbjct: 140 LIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLL---SSDGS-RAALCDF 195
Query: 362 GLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGM 421
G + + APEV+ + C K D++S
Sbjct: 196 GHA-LCLQPDGLGKSLLTGDYIPGTET-HMAPEVV-MGKP--------CDAKVDIWSSCC 244
Query: 422 LCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLF--PSGSPKYLVNLTKKCWHTNPSQRP 479
+ +L G P+ + I + P+ P ++ P R
Sbjct: 245 MMLHMLNGCHPWTQ--YFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRA 302
Query: 480 S 480
S
Sbjct: 303 S 303
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-23
Identities = 65/241 (26%), Positives = 105/241 (43%), Gaps = 42/241 (17%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMS-KDLSCYMRETFGSRRR 306
+ ESL E+ + L HPNI++ F E+K F+LV E+ + +L + R
Sbjct: 69 DKESLLREVQLLKQLDHPNIMKLYEFF--EDKGYFYLVGEVYTGGELFDEIIS------R 120
Query: 307 NSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366
FS I+ Q+ G+ ++H KI H +L P N+ L+++S + ++++ FGL
Sbjct: 121 KRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKD--ANIRIIDFGL--- 175
Query: 367 RTYASRNTPPASPQNQTAPNPYIWY-APEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFE 425
S + + Y Y APEVL EK DV+S G++ +
Sbjct: 176 ----STHFEASKKMKDKIGTAY--YIAPEVLHGTYD----------EKCDVWSTGVILYI 219
Query: 426 LLTGKVPFEDGHLQGDKMTKNIRAGE----RPLFPSGSP--KYLVNLTKKCWHTNPSQRP 479
LL+G PF + + K + G+ P + S K L+ +K PS R
Sbjct: 220 LLSGCPPFNGANEYD--ILKKVEKGKYTFELPQWKKVSESAKDLI---RKMLTYVPSMRI 274
Query: 480 S 480
S
Sbjct: 275 S 275
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 59/245 (24%), Positives = 99/245 (40%), Gaps = 31/245 (12%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCY--MRETF--GS 303
++ L EI M HPNIV Y F +++ +LVM+L+S S ++ G
Sbjct: 56 SMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE--LWLVMKLLSGG-SVLDIIKHIVAKGE 112
Query: 304 RRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGL 363
+ + I+ ++ G+E+LH H ++ NI L +G V+++ FG+
Sbjct: 113 HKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILL---GEDG--SVQIADFGV 167
Query: 364 STARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLC 423
S A + + P W APEV+ + G KAD++SFG+
Sbjct: 168 S-AFLATGGDITRNKVRKTFVGTPC-WMAPEVMEQVRGYD--------FKADIWSFGITA 217
Query: 424 FELLTGKVPFEDGH--------LQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNP 475
EL TG P+ LQ D + ++ + K + C +P
Sbjct: 218 IELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYG-KSFRKMISLCLQKDP 276
Query: 476 SQRPS 480
+RP+
Sbjct: 277 EKRPT 281
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-23
Identities = 59/241 (24%), Positives = 101/241 (41%), Gaps = 42/241 (17%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMS-KDLSCYMRETFGSRRR 306
+ ++ E+ + L HPNI++ E+ F++V EL + +L + + R
Sbjct: 64 DTSTILREVELLKKLDHPNIMKLFEIL--EDSSSFYIVGELYTGGELFDEIIK------R 115
Query: 307 NSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366
FS I+ Q+ G+ ++H I H +L P NI L+++ + +K+ FGL
Sbjct: 116 KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKD--CDIKIIDFGL--- 170
Query: 367 RTYASRNTPPASPQNQTAPNPYIWY-APEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFE 425
S + Y Y APEVL EK DV+S G++ +
Sbjct: 171 ----STCFQQNTKMKDRIGTAY--YIAPEVL----------RGTYDEKCDVWSAGVILYI 214
Query: 426 LLTGKVPFEDGHLQGDKMTKNIRAGE----RPLFPSGSP--KYLVNLTKKCWHTNPSQRP 479
LL+G PF + + K + G+ P + + S K L+ +K +PS R
Sbjct: 215 LLSGTPPFYGKNEYD--ILKRVETGKYAFDLPQWRTISDDAKDLI---RKMLTFHPSLRI 269
Query: 480 S 480
+
Sbjct: 270 T 270
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 3e-23
Identities = 54/237 (22%), Positives = 89/237 (37%), Gaps = 61/237 (25%)
Query: 261 SLSHPNIVQ-YLCGFCDEEKKEFFLVMELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIM 318
LSH NIV EE ++LVME + LS Y+ S+ ++
Sbjct: 67 QLSHQNIVSMIDVD---EEDDCYYLVMEYIEGPTLSEYIES------HGPLSVDTAINFT 117
Query: 319 LQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTPPA- 377
QI G++ H +I H ++ P NI + +K+ FG++ A + S
Sbjct: 118 NQILDGIKHAHDMRIVHRDIKPQNILI---DSNK--TLKIFDFGIAKALSETSLTQTNHV 172
Query: 378 --SPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFED 435
+ Q Y +PE Q G + E D+YS G++ +E+L G+ PF +
Sbjct: 173 LGTVQ-------YF--SPE----Q-AKGEATD----ECTDIYSIGIVLYEMLVGEPPF-N 213
Query: 436 G---------HLQGDKMTKNIRAGERPLFPS----GSPKYLVNLTKKCWHTNPSQRP 479
G H+Q P + P+ L N+ + + + R
Sbjct: 214 GETAVSIAIKHIQDSV----------PNVTTDVRKDIPQSLSNVILRATEKDKANRY 260
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 4e-23
Identities = 52/202 (25%), Positives = 87/202 (43%), Gaps = 29/202 (14%)
Query: 295 CYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYF 354
E ++ +L ++ Q+A+GMEFL ++K H +L NI L +
Sbjct: 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK-----N 230
Query: 355 HVKVSGFGLS----TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKC 410
VK+ FGL+ Y + A P W APE + ++ T
Sbjct: 231 VVKICDFGLARDIYKDPDYVRK---------GDARLPLKWMAPETIFDRVYT-------- 273
Query: 411 SEKADVYSFGMLCFELLT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKK 469
++DV+SFG+L +E+ + G P+ G ++ + ++ G R P + +
Sbjct: 274 -IQSDVWSFGVLLWEIFSLGASPYP-GVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD 331
Query: 470 CWHTNPSQRPSFSSICRILRYI 491
CWH PSQRP+FS + L +
Sbjct: 332 CWHGEPSQRPTFSELVEHLGNL 353
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-23
Identities = 38/265 (14%), Positives = 78/265 (29%), Gaps = 36/265 (13%)
Query: 220 VRRRLGASSQFKEIQWLGDSFVLRHFYGELESLNAEISTMLSLSHPNIVQYLCGFCDEEK 279
++ + + I+ + V F + + +++ D
Sbjct: 125 MKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDP-------QKKKMIRVRLDERDMWV 177
Query: 280 KEFFLVMELMSKDLSCYMRETFG-SRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGEL 338
F + M +L + S S + + LQ+ R + LH + H L
Sbjct: 178 LSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL 237
Query: 339 NPSNIYLKARSMEGYFHVKVSGFGLST---ARTYASRNTPPASPQNQTAPNPYIWYAPEV 395
P +I L R V ++GF A + A P+ A +
Sbjct: 238 RPVDIVLDQRG-----GVFLTGFEHLVRDGASAVSPIGRGFAPPE-------TT--AERM 283
Query: 396 LAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLF 455
L + + T D ++ G+ + + +P D G ++ I + +
Sbjct: 284 LPFGQHHPTLMTFAF----DTWTLGLAIYWIWCADLPNTDDAALG--GSEWIFRSCKNI- 336
Query: 456 PSGSPKYLVNLTKKCWHTNPSQRPS 480
P+ + L + R
Sbjct: 337 ----PQPVRALLEGFLRYPKEDRLL 357
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 4e-22
Identities = 59/276 (21%), Positives = 94/276 (34%), Gaps = 63/276 (22%)
Query: 247 GELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMS---------------- 290
++E + E+ M L HPNI + + E+++ LVMEL
Sbjct: 70 KDVERIKTEVRLMKKLHHPNIARLYEVY--EDEQYICLVMELCHGGHLLDKLNVFIDDST 127
Query: 291 -------------------KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQ 331
++ F ++ +IM QI + +LH Q
Sbjct: 128 GKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ 187
Query: 332 KIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWY 391
I H ++ P N F +K+ FGLS + + N A PY +
Sbjct: 188 GICHRDIKPENFLFSTN---KSFEIKLVDFGLS--KEFYKLNNGEYYGMTTKAGTPY--F 240
Query: 392 -APEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAG 450
APEVL +T+ K D +S G+L LL G VPF + +
Sbjct: 241 VAPEVL-------NTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDAD--TISQVLNK 291
Query: 451 E----RPLFPSGSP--KYLVNLTKKCWHTNPSQRPS 480
+ P + SP + L+ + N +R
Sbjct: 292 KLCFENPNYNVLSPLARDLL---SNLLNRNVDERFD 324
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 7e-22
Identities = 59/182 (32%), Positives = 79/182 (43%), Gaps = 28/182 (15%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVV 314
EIS M L H NIV+ E K LV E M DL YM L +V
Sbjct: 53 EISLMKELKHENIVRLYDVIHTENK--LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLV 110
Query: 315 VDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNT 374
Q+ +G+ F H KI H +L P N+ + + G +K+ FGL AR +
Sbjct: 111 KYFQWQLLQGLAFCHENKILHRDLKPQNLLI---NKRG--QLKLGDFGL--ARAFGIPV- 162
Query: 375 PPASPQNQTAPNPYIWY-APEVLAEQEGTGST--STSKCSEKADVYSFGMLCFELLTGKV 431
S + T +WY AP+VL GS STS D++S G + E++TGK
Sbjct: 163 NTFSSEVVT-----LWYRAPDVL-----MGSRTYSTS-----IDIWSCGCILAEMITGKP 207
Query: 432 PF 433
F
Sbjct: 208 LF 209
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-21
Identities = 56/241 (23%), Positives = 88/241 (36%), Gaps = 64/241 (26%)
Query: 261 SLSHPNIVQ-YLCGFCDEEKKEF-FLVMELMS-KDLSCYMRETFGSRRRNSFSLPVVVDI 317
+L+HP IV Y G + ++VME + L + + +++
Sbjct: 68 ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT------EGPMTPKRAIEV 121
Query: 318 MLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTPPA 377
+ + + F H I H ++ P+NI + S VKV FG+ AR A
Sbjct: 122 IADACQALNFSHQNGIIHRDVKPANIMI---SATN--AVKVMDFGI--ARAIADSGNS-- 172
Query: 378 SPQNQTAPNP------YIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKV 431
T Y+ +PE Q G + ++DVYS G + +E+LTG+
Sbjct: 173 ----VTQTAAVIGTAQYL--SPE----Q-ARGDSVD----ARSDVYSLGCVLYEVLTGEP 217
Query: 432 PFEDG---------HLQGDKMTKNIRAGERPLFPS----GSPKYLVNLTKKCWHTNPSQR 478
PF G H++ E P+ PS G L + K NP R
Sbjct: 218 PF-TGDSPVSVAYQHVR-----------EDPIPPSARHEGLSADLDAVVLKALAKNPENR 265
Query: 479 P 479
Sbjct: 266 Y 266
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 60/249 (24%), Positives = 110/249 (44%), Gaps = 51/249 (20%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCD--EEKKEFFLVMELMSK-DLSCY------MR 298
L+ L E+ M L+HPNIV+ + E +K +L+ME S ++ Y M+
Sbjct: 57 SLQKLFREVRIMKILNHPNIVKLF----EVIETEKTLYLIMEYASGGEVFDYLVAHGRMK 112
Query: 299 ETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKV 358
E R+ F QI +++ H ++I H +L N+ L A ++K+
Sbjct: 113 E---KEARSKFR---------QIVSAVQYCHQKRIVHRDLKAENLLLDADM-----NIKI 155
Query: 359 SGFGLSTARTYASR-NTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVY 417
+ FG S T + + +P PY APE+ ++ G + DV+
Sbjct: 156 ADFGFSNEFTVGGKLDAFCGAP-------PYA--APELFQGKKYDGP--------EVDVW 198
Query: 418 SFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQ 477
S G++ + L++G +PF+ +L+ ++ + + G+ + P NL K+ NP +
Sbjct: 199 SLGVILYTLVSGSLPFDGQNLK--ELRERVLRGKYRI-PFYMSTDCENLLKRFLVLNPIK 255
Query: 478 RPSFSSICR 486
R + I +
Sbjct: 256 RGTLEQIMK 264
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 94.5 bits (236), Expect = 2e-21
Identities = 48/190 (25%), Positives = 77/190 (40%), Gaps = 37/190 (19%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVV 314
EI + L H NIV+ ++K LV E +DL Y +V
Sbjct: 51 EICLLKELKHKNIVRLHDVLHSDKK--LTLVFEFCDQDLKKYFD-----SCNGDLDPEIV 103
Query: 315 VDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNT 374
+ Q+ +G+ F H++ + H +L P N+ + + G +K++ FGL AR +
Sbjct: 104 KSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI---NRNG--ELKLANFGL--ARAFGIPV- 155
Query: 375 PPASPQNQTAPNPYIWY-APEVLAEQEGTGST--STSKCSEKADVYSFGMLCFELLTGKV 431
S + T +WY P+VL G+ STS D++S G + EL
Sbjct: 156 RCYSAEVVT-----LWYRPPDVL-----FGAKLYSTS-----IDMWSAGCIFAELANAGR 200
Query: 432 PFEDGHLQGD 441
P G+
Sbjct: 201 PL----FPGN 206
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 94.1 bits (235), Expect = 3e-21
Identities = 46/182 (25%), Positives = 79/182 (43%), Gaps = 33/182 (18%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVV 314
EIS + L H NIV+ +++ LV E + +DL +
Sbjct: 50 EISILKELKHSNIVKLYDVIHTKKR--LVLVFEHLDQDLKKLLD-----VCEGGLESVTA 102
Query: 315 VDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNT 374
+LQ+ G+ + H +++ H +L P N+ + + EG +K++ FGL AR +
Sbjct: 103 KSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI---NREG--ELKIADFGL--ARAFGIPV- 154
Query: 375 PPASPQNQTAPNPYIWY-APEVLAEQEGTGST--STSKCSEKADVYSFGMLCFELLTGKV 431
+ + T +WY AP+VL GS ST+ D++S G + E++ G
Sbjct: 155 RKYTHEIVT-----LWYRAPDVL-----MGSKKYSTT-----IDIWSVGCIFAEMVNGTP 199
Query: 432 PF 433
F
Sbjct: 200 LF 201
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 3e-21
Identities = 58/246 (23%), Positives = 95/246 (38%), Gaps = 47/246 (19%)
Query: 247 GELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETF----- 301
+E + AEI + SL HPNI++ F E+ ++VME C E
Sbjct: 62 VPMEQIEAEIEVLKSLDHPNIIKIFEVF--EDYHNMYIVMET------CEGGELLERIVS 113
Query: 302 GSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGF 361
R + S V ++M Q+ + + H+Q + H +L P NI + + +K+ F
Sbjct: 114 AQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQ--DTSPHSPIKIIDF 171
Query: 362 GLSTARTYASRNTPPASPQNQTAPNPYIWY-APEVLAEQEGTGSTSTSKCSEKADVYSFG 420
GL + A Y APEV K D++S G
Sbjct: 172 GL-------AELFKSDEHSTNAAGTAL--YMAPEVFKRDVT----------FKCDIWSAG 212
Query: 421 MLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFP------SGSPKYLVNLTKKCWHTN 474
++ + LLTG +PF L+ + + E P + + L+ K+ +
Sbjct: 213 VVMYFLLTGCLPFTGTSLEE--VQQKATYKE-PNYAVECRPLTPQAVDLL---KQMLTKD 266
Query: 475 PSQRPS 480
P +RPS
Sbjct: 267 PERRPS 272
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 3e-21
Identities = 54/190 (28%), Positives = 81/190 (42%), Gaps = 38/190 (20%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVV 314
EIS + L HPNIV + E LV E M KDL + + +
Sbjct: 69 EISLLKELHHPNIVSLIDVIHSERC--LTLVFEFMEKDLKKVLD-----ENKTGLQDSQI 121
Query: 315 VDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNT 374
+ Q+ RG+ H +I H +L P N+ + + +G +K++ FGL AR +
Sbjct: 122 KIYLYQLLRGVAHCHQHRILHRDLKPQNLLI---NSDG--ALKLADFGL--ARAFGIPV- 173
Query: 375 PPASPQNQTAPNPYIWY-APEVLAEQEGTGST--STSKCSEKADVYSFGMLCFELLTGKV 431
+ + T +WY AP+VL GS STS D++S G + E++TGK
Sbjct: 174 RSYTHEVVT-----LWYRAPDVL-----MGSKKYSTS-----VDIWSIGCIFAEMITGK- 217
Query: 432 PFEDGHLQGD 441
P G
Sbjct: 218 PL----FPGV 223
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 3e-21
Identities = 59/240 (24%), Positives = 101/240 (42%), Gaps = 48/240 (20%)
Query: 255 EISTMLSLSHPNIVQ-YLCGFCD--EEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSL 311
EIS + L HP+I++ Y D + +V+E +L Y+ E + +
Sbjct: 59 EISYLKLLRHPHIIKLY-----DVITTPTDIVMVIEYAGGELFDYIVE------KKRMTE 107
Query: 312 PVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYAS 371
QI +E+ H KI H +L P N+ L + +VK++ FGLS T +
Sbjct: 108 DEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLL-----DDNLNVKIADFGLSNIMTDGN 162
Query: 372 R-NTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGK 430
T SP Y APEV+ + G + DV+S G++ + +L G+
Sbjct: 163 FLKTSCGSP-------NYA--APEVINGKLYAGP--------EVDVWSCGIVLYVMLVGR 205
Query: 431 VPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYL----VNLTKKCWHTNPSQRPSFSSICR 486
+PF+D + + K + + + P +L +L ++ +P QR + I R
Sbjct: 206 LPFDDEFIP--NLFKKVNSCVYVM-----PDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 4e-21
Identities = 38/223 (17%), Positives = 70/223 (31%), Gaps = 48/223 (21%)
Query: 261 SLSHPNIVQ-YLCGFCDEEKKE--FFLVMELMS-KDLSCYMRETFGSRRRNSFSLPVVVD 316
+ HP+IVQ + + + ++VME + + L + + +
Sbjct: 135 EVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLK--------RSKGQKLPVAEAIA 186
Query: 317 IMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTPP 376
+L+I + +LH+ + + +L P NI L +K+ G S
Sbjct: 187 YLLEILPALSYLHSIGLVYNDLKPENIMLTEE------QLKLIDLGA--VSRINSFGYLY 238
Query: 377 ASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDG 436
+P + AP E TG T + D+Y+ G L
Sbjct: 239 GTPG-------FQ--AP----EIVRTGPTVAT------DIYTVGRTLAALTLDLPTRNGR 279
Query: 437 HLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRP 479
++ G E L ++ +P QR
Sbjct: 280 YVDG--------LPEDDPVLKT-YDSYGRLLRRAIDPDPRQRF 313
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 5e-21
Identities = 62/241 (25%), Positives = 98/241 (40%), Gaps = 42/241 (17%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGS-RRR 306
+ ++ E+ + L HPNI++ E+ F++V EL E F +R
Sbjct: 64 DTSTILREVELLKKLDHPNIMKLFEIL--EDSSSFYIVGEL------YTGGELFDEIIKR 115
Query: 307 NSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366
FS I+ Q+ G+ ++H I H +L P NI L+ S E +K+ FGL
Sbjct: 116 KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLE--SKEKDCDIKIIDFGL--- 170
Query: 367 RTYASRNTPPASPQNQTAPNPYIWY-APEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFE 425
S + Y Y APEVL EK DV+S G++ +
Sbjct: 171 ----STCFQQNTKMKDRIGTAY--YIAPEVLRGTYD----------EKCDVWSAGVILYI 214
Query: 426 LLTGKVPFEDGHLQGDKMTKNIRAGE----RPLFPSGSP--KYLVNLTKKCWHTNPSQRP 479
LL+G PF + + K + G+ P + + S K L+ +K +PS R
Sbjct: 215 LLSGTPPFYGKNEYD--ILKRVETGKYAFDLPQWRTISDDAKDLI---RKMLTFHPSLRI 269
Query: 480 S 480
+
Sbjct: 270 T 270
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 5e-21
Identities = 57/262 (21%), Positives = 98/262 (37%), Gaps = 60/262 (22%)
Query: 254 AEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMS-KDLSCYMRETFGSRRRNSFSLP 312
EI M H N+V+ L GF + + LV M L + S
Sbjct: 79 QEIKVMAKCQHENLVE-LLGFSSDGD-DLCLVYVYMPNGSLLDRL---SCLDGTPPLSWH 133
Query: 313 VVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASR 372
+ I A G+ FLH H ++ +NI L + F K+S FGL AR
Sbjct: 134 MRCKIAQGAANGINFLHENHHIHRDIKSANILL-----DEAFTAKISDFGL--AR----- 181
Query: 373 NTPPASPQNQTAPNP--------YIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCF 424
AS + Y+ APE L G + + K+D+YSFG++
Sbjct: 182 ----ASEKFAQTVMTSRIVGTTAYM--APEAL-----RG-----EITPKSDIYSFGVVLL 225
Query: 425 ELLTGKVPFEDG------------HLQGDKMTKNI---RAGERPLFPSGSPKYLVNLTKK 469
E++TG ++ +K ++ + + S S + + ++ +
Sbjct: 226 EIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMND---ADSTSVEAMYSVASQ 282
Query: 470 CWHTNPSQRPSFSSICRILRYI 491
C H ++RP + ++L+ +
Sbjct: 283 CLHEKKNKRPDIKKVQQLLQEM 304
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 97.1 bits (241), Expect = 5e-21
Identities = 50/261 (19%), Positives = 84/261 (32%), Gaps = 38/261 (14%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKK-----EFFLVMELMSK-DLSCYMRETF 301
E EI M L+HPN+V D +K L ME DL Y+ +
Sbjct: 55 NRERWCLEIQIMKKLNHPNVVS-AREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQ-- 111
Query: 302 GSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGF 361
+ ++ I+ + +LH +I H +L P NI L+ K+
Sbjct: 112 -FENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQ--PGPQRLIHKIIDL 168
Query: 362 GLSTARTYASRNTPPASPQNQTA---PNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYS 418
G + Y+ APE+L ++ K + D +S
Sbjct: 169 GYA--------KELDQGELCTEFVGTLQ-YL--APELLEQK---------KYTVTVDYWS 208
Query: 419 FGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQR 478
FG L FE +TG PF K + V + P+
Sbjct: 209 FGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVL--PTPNHL 266
Query: 479 PSFSSICRILRYIKKFMANNP 499
+ ++ R+++ + +
Sbjct: 267 SGILAG-KLERWLQCMLMWHQ 286
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 6e-21
Identities = 45/182 (24%), Positives = 73/182 (40%), Gaps = 29/182 (15%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVV 314
E+S + L H NI++ + L+ E DL YM + S+ V+
Sbjct: 83 EVSLLKELQHRNIIELKSVIHHNHR--LHLIFEYAENDLKKYMD------KNPDVSMRVI 134
Query: 315 VDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNT 374
+ Q+ G+ F H+++ H +L P N+ L +K+ FGL AR +
Sbjct: 135 KSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGL--ARAFGIPI- 191
Query: 375 PPASPQNQTAPNPYIWY-APEVLAEQEGTGST--STSKCSEKADVYSFGMLCFELLTGKV 431
+ + T +WY PE+L GS STS D++S + E+L
Sbjct: 192 RQFTHEIIT-----LWYRPPEIL-----LGSRHYSTS-----VDIWSIACIWAEMLMKTP 236
Query: 432 PF 433
F
Sbjct: 237 LF 238
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 7e-21
Identities = 50/182 (27%), Positives = 80/182 (43%), Gaps = 33/182 (18%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVV 314
E+S + L H NIV E+ LV E + KDL Y+ N ++ V
Sbjct: 50 EVSLLKDLKHANIVTLHDIIHTEKS--LTLVFEYLDKDLKQYLD-----DCGNIINMHNV 102
Query: 315 VDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNT 374
+ Q+ RG+ + H QK+ H +L P N+ + + G +K++ FGL AR +
Sbjct: 103 KLFLFQLLRGLAYCHRQKVLHRDLKPQNLLI---NERG--ELKLADFGL--ARAKSIPT- 154
Query: 375 PPASPQNQTAPNPYIWY-APEVLAEQEGTGST--STSKCSEKADVYSFGMLCFELLTGKV 431
+ T +WY P++L GST ST D++ G + +E+ TG+
Sbjct: 155 KTYDNEVVT-----LWYRPPDIL-----LGSTDYSTQ-----IDMWGVGCIFYEMATGRP 199
Query: 432 PF 433
F
Sbjct: 200 LF 201
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 1e-20
Identities = 56/239 (23%), Positives = 97/239 (40%), Gaps = 45/239 (18%)
Query: 255 EISTMLSLSHPNIVQ-YLCGFCD--EEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFS 310
EI + HP+I++ Y +FF+VME +S +L Y+ +
Sbjct: 61 EIQNLKLFRHPHIIKLY-----QVISTPTDFFMVMEYVSGGELFDYICK------HGRVE 109
Query: 311 LPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYA 370
+ QI +++ H + H +L P N+ L + + + K++ FGLS +
Sbjct: 110 EMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLL-----DAHMNAKIADFGLSNMMSDG 164
Query: 371 SR-NTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTG 429
T SP Y APEV++ + G + D++S G++ + LL G
Sbjct: 165 EFLRTSCGSP-------NYA--APEVISGRLYAGP--------EVDIWSCGVILYALLCG 207
Query: 430 KVPFEDGHLQGDKMTKNIRAGE--RPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486
+PF+D H+ + K IR G P + + S L +P +R + I
Sbjct: 208 TLPFDDEHVP--TLFKKIRGGVFYIPEYLNRSVA---TLLMHMLQVDPLKRATIKDIRE 261
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 1e-20
Identities = 56/190 (29%), Positives = 82/190 (43%), Gaps = 38/190 (20%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVV 314
EI + LSHPNI+ L F + LV + M DL ++ + +
Sbjct: 62 EIKLLQELSHPNIIGLLDAFGHKSN--ISLVFDFMETDLEVIIK-----DNSLVLTPSHI 114
Query: 315 VDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNT 374
ML +G+E+LH I H +L P+N+ L G +K++ FGL A+++ S N
Sbjct: 115 KAYMLMTLQGLEYLHQHWILHRDLKPNNLLL---DENG--VLKLADFGL--AKSFGSPN- 166
Query: 375 PPASPQNQTAPNPYIWY-APEVL--AEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKV 431
+ Q T WY APE+L A G G D+++ G + ELL
Sbjct: 167 RAYTHQVVT-----RWYRAPELLFGARMYGVG----------VDMWAVGCILAELLLRV- 210
Query: 432 PFEDGHLQGD 441
PF L GD
Sbjct: 211 PF----LPGD 216
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 1e-20
Identities = 57/237 (24%), Positives = 93/237 (39%), Gaps = 34/237 (14%)
Query: 250 ESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMS-KDLSCYMRETFGSRRRNS 308
++ EI + L+HP I++ + F D E +++V+ELM +L +
Sbjct: 185 LNVETEIEILKKLNHPCIIK-IKNFFDAED--YYIVLELMEGGELFDKVVG------NKR 235
Query: 309 FSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTART 368
Q+ +++LH I H +L P N+ L S E +K++ FG
Sbjct: 236 LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLS--SQEEDCLIKITDFGH----- 288
Query: 369 YASRNTPPASPQNQTAPNPYIWY-APEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELL 427
S+ S P Y APEVL G D +S G++ F L
Sbjct: 289 --SKILGETSLMRTLCGTPT--YLAPEVLVSVGTAGYN------RAVDCWSLGVILFICL 338
Query: 428 TGKVPFEDGHLQGDKMTKNIRAGE----RPLFPSGSPKYLVNLTKKCWHTNPSQRPS 480
+G PF + Q + I +G+ ++ S K L +L KK +P R +
Sbjct: 339 SGYPPFSEHRTQ-VSLKDQITSGKYNFIPEVWAEVSEKAL-DLVKKLLVVDPKARFT 393
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 2e-20
Identities = 60/246 (24%), Positives = 98/246 (39%), Gaps = 55/246 (22%)
Query: 255 EISTMLSLS-HPNIVQYLCGFCDE--EKKEFFLVMELMSKDLSCYMRETFG--------S 303
E+ S P+IV L + + K+ ++ME M G
Sbjct: 71 EVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECME-----------GGELFSRIQE 119
Query: 304 RRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGL 363
R +F+ +IM I ++FLH+ I H ++ P N+ S E +K++ FG
Sbjct: 120 RGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYT--SKEKDAVLKLTDFGF 177
Query: 364 STARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLC 423
+ T + TP +P Y+ APEVL + K + D++S G++
Sbjct: 178 AKETTQNALQTPCYTPY-------YV--APEVLGPE---------KYDKSCDMWSLGVIM 219
Query: 424 FELLTGKVPF--EDGHLQGDKMTKNIRAGERPLFP-------SGSPKYLVNLTKKCWHTN 474
+ LL G PF G M + IR G+ FP S K L+ + T+
Sbjct: 220 YILLCGFPPFYSNTGQAISPGMKRRIRLGQ-YGFPNPEWSEVSEDAKQLI---RLLLKTD 275
Query: 475 PSQRPS 480
P++R +
Sbjct: 276 PTERLT 281
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 2e-20
Identities = 56/241 (23%), Positives = 90/241 (37%), Gaps = 42/241 (17%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGS-RRR 306
+++ EI M SL HPNI++ F E+ + +LVMEL C E F +
Sbjct: 49 DVDRFKQEIEIMKSLDHPNIIRLYETF--EDNTDIYLVMEL------CTGGELFERVVHK 100
Query: 307 NSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366
F IM + + + H + H +L P N + +K+ FGL
Sbjct: 101 RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFL--TDSPDSPLKLIDFGL--- 155
Query: 367 RTYASRNTPPASPQNQTAPNPYIWY-APEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFE 425
+ P PY Y +P+VL G + D +S G++ +
Sbjct: 156 ----AARFKPGKMMRTKVGTPY--YVSPQVLEGLYG----------PECDEWSAGVMMYV 199
Query: 426 LLTGKVPFEDGHLQGDKMTKNIRAGE----RPLFPSGSP--KYLVNLTKKCWHTNPSQRP 479
LL G PF + IR G + + SP + L+ ++ +P QR
Sbjct: 200 LLCGYPPFSAPTDSE--VMLKIREGTFTFPEKDWLNVSPQAESLI---RRLLTKSPKQRI 254
Query: 480 S 480
+
Sbjct: 255 T 255
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 3e-20
Identities = 53/201 (26%), Positives = 82/201 (40%), Gaps = 53/201 (26%)
Query: 255 EISTMLSLS---HPNIVQYL---CGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNS 308
E++ + L HPN+V+ + + + + LV E + +DL Y+
Sbjct: 61 EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLD----KAPPPG 116
Query: 309 FSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTART 368
+ D+M Q RG++FLHA I H +L P NI + + G VK++ FGL AR
Sbjct: 117 LPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV---TSGG--TVKLADFGL--ARI 169
Query: 369 YASRNTPPASPQNQTAPNPY------IWY-APEVLAEQEGTGST-STSKCSEKADVYSFG 420
Y+ +WY APEVL ST +T D++S G
Sbjct: 170 YSY-------------QMALTPVVVTLWYRAPEVLL-----QSTYATP-----VDMWSVG 206
Query: 421 MLCFELLTGKVPFEDGHLQGD 441
+ E+ K P G+
Sbjct: 207 CIFAEMFRRK-PL----FCGN 222
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 3e-20
Identities = 47/190 (24%), Positives = 81/190 (42%), Gaps = 48/190 (25%)
Query: 255 EISTMLSLS---HPNIVQYLC---GFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNS 308
E++ + L HPN+V+ + + + LV E + +DL+ Y+
Sbjct: 61 EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLD----KVPEPG 116
Query: 309 FSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTART 368
+ D+M Q+ RG++FLH+ ++ H +L P NI + + G +K++ FGL AR
Sbjct: 117 VPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSG--QIKLADFGL--ARI 169
Query: 369 YASRNTPPASPQNQTAPNPY------IWY-APEVLAEQEGTGST-STSKCSEKADVYSFG 420
Y+ +WY APEVL S+ +T D++S G
Sbjct: 170 YSF-------------QMALTSVVVTLWYRAPEVLL-----QSSYATP-----VDLWSVG 206
Query: 421 MLCFELLTGK 430
+ E+ K
Sbjct: 207 CIFAEMFRRK 216
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 3e-20
Identities = 47/187 (25%), Positives = 78/187 (41%), Gaps = 26/187 (13%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYM---RETFGSRRRNSFSL 311
EI+ + L HPN++ F ++ +L+ + DL + R + +++
Sbjct: 68 EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPR 127
Query: 312 PVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYAS 371
+V ++ QI G+ +LHA + H +L P+NI L VK++ G AR + S
Sbjct: 128 GMVKSLLYQILDGIHYLHANWVLHRDLKPANI-LVMGEGPERGRVKIADMGF--ARLFNS 184
Query: 372 RNTPPASPQNQ--TAPNPYIWY-APEVL--AEQEGTGSTSTSKCSEKADVYSFGMLCFEL 426
P A T WY APE+L A D+++ G + EL
Sbjct: 185 PLKPLADLDPVVVT-----FWYRAPELLLGARHYTKA----------IDIWAIGCIFAEL 229
Query: 427 LTGKVPF 433
LT + F
Sbjct: 230 LTSEPIF 236
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 3e-20
Identities = 64/263 (24%), Positives = 96/263 (36%), Gaps = 73/263 (27%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVV 314
EI + L H N+V L +++ ++LV E + + + N VV
Sbjct: 74 EIKLLKQLRHENLVNLLEVCKKKKR--WYLVFEFVDHTILDDLE-----LFPNGLDYQVV 126
Query: 315 VDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNT 374
+ QI G+ F H+ I H ++ P NI + S G VK+ FG ART A+
Sbjct: 127 QKYLFQIINGIGFCHSHNIIHRDIKPENILV---SQSG--VVKLCDFGF--ARTLAAPG- 178
Query: 375 PPASPQNQTAPNPYIWY-APEVLAEQEGTGST--STSKCSEKADVYSFGMLCFELLTGKV 431
+ T WY APE+L G + DV++ G L E+ G+
Sbjct: 179 EVYDDEVAT-----RWYRAPELL-----VGDVKYGKA-----VDVWAIGCLVTEMFMGE- 222
Query: 432 PFEDGHLQGD----------------------KMTKN----------IRAGE--RPLFPS 457
P GD KN I+ E +P
Sbjct: 223 PL----FPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPK 278
Query: 458 GSPKYLVNLTKKCWHTNPSQRPS 480
S +++L KKC H +P +RP
Sbjct: 279 LSEV-VIDLAKKCLHIDPDKRPF 300
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 3e-20
Identities = 52/242 (21%), Positives = 88/242 (36%), Gaps = 45/242 (18%)
Query: 255 EISTMLSLSHPNIVQYLCGFCD--EEKKEFFLVMELMSKDLSCYMRETFG---SRRRNSF 309
EI L+H N+V++ E +L +E S E F
Sbjct: 55 EICINKMLNHENVVKFY----GHRREGNIQYLFLEYCSG------GELFDRIEPDIG--M 102
Query: 310 SLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTY 369
P Q+ G+ +LH I H ++ P N+ L + ++K+S FGL+T Y
Sbjct: 103 PEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL-----DERDNLKISDFGLATVFRY 157
Query: 370 ASR----NTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFE 425
+R N + PY+ APE+L +E DV+S G++
Sbjct: 158 NNRERLLNKMCGTL-------PYV--APELLKRREFHAE--------PVDVWSCGIVLTA 200
Query: 426 LLTGKVPFEDGHLQGDKMTKNIRAG-ERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSI 484
+L G++P++ + + + + L K NPS R + I
Sbjct: 201 MLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSA-PLALLHKILVENPSARITIPDI 259
Query: 485 CR 486
+
Sbjct: 260 KK 261
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 4e-20
Identities = 49/235 (20%), Positives = 86/235 (36%), Gaps = 59/235 (25%)
Query: 261 SLSHPNIVQ-YLCGFCDEEKKEFFLVMELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIM 318
L P++V + G E + ++ M L++ DL+ +R R+ + P V I+
Sbjct: 90 RLQEPHVVPIHDFG---EIDGQLYVDMRLINGVDLAAMLR------RQGPLAPPRAVAIV 140
Query: 319 LQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASR---NTP 375
QI ++ HA H ++ P NI + S + + FG+++A T
Sbjct: 141 RQIGSALDAAHAAGATHRDVKPENILV---SADD--FAYLVDFGIASATTDEKLTQLGNT 195
Query: 376 PASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFED 435
+ Y+ APE + S +T +AD+Y+ + +E LTG P++
Sbjct: 196 VGTLY-------YM--APERF-----SESHAT----YRADIYALTCVLYECLTGSPPYQG 237
Query: 436 -------GHLQGDKMTKNIRAGERPLFPS----GSPKYLVNLTKKCWHTNPSQRP 479
H+ PS G P + + NP R
Sbjct: 238 DQLSVMGAHINQA-----------IPRPSTVRPGIPVAFDAVIARGMAKNPEDRY 281
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 4e-20
Identities = 45/202 (22%), Positives = 80/202 (39%), Gaps = 50/202 (24%)
Query: 255 EISTMLSLSHPNIVQYL------CGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNS 308
EI + L H N+V + + K +LV + DL+ + S
Sbjct: 66 EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLL-----SNVLVK 120
Query: 309 FSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTART 368
F+L + +M + G+ ++H KI H ++ +N+ + + +G +K++ FGL AR
Sbjct: 121 FTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI---TRDG--VLKLADFGL--ARA 173
Query: 369 YASRNTPPASPQNQTAPNPY------IWY-APEVL--AEQEGTGSTSTSKCSEKADVYSF 419
+ S + PN Y +WY PE+L G D++
Sbjct: 174 F--------SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPP----------IDLWGA 215
Query: 420 GMLCFELLTGKVPFEDGHLQGD 441
G + E+ T P +QG+
Sbjct: 216 GCIMAEMWTRS-PI----MQGN 232
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 6e-20
Identities = 57/269 (21%), Positives = 105/269 (39%), Gaps = 43/269 (15%)
Query: 248 ELESLNAEISTMLSLS-HPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRR 306
E + L ++ ++ S P IVQ+ E ++ MELMS + + +
Sbjct: 63 EQKQLLMDLDVVMRSSDCPYIVQFYGALFREGD--CWICMELMSTSFDKFYKYVYSVLDD 120
Query: 307 NSFSLPVVVDIMLQIARGMEFLHAQ-KIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365
++ I L + + L KI H ++ PSNI L G ++K+ FG+S
Sbjct: 121 -VIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILL---DRSG--NIKLCDFGISG 174
Query: 366 --ARTYASRN---TPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFG 420
+ A P + APE + S S ++DV+S G
Sbjct: 175 QLVDSIAKTRDAGCRP-------------YMAPERID-----PSASRQGYDVRSDVWSLG 216
Query: 421 MLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSP----KYLVNLTKKCWHTNPS 476
+ +EL TG+ P+ + D++T+ + G+ P + +N C + S
Sbjct: 217 ITLYELATGRFPYPKWNSVFDQLTQ-VVKGDPPQLSNSEEREFSPSFINFVNLCLTKDES 275
Query: 477 QRPSFSSICRILR--YIKKFMANNPDIAR 503
+RP + +L+ +I + ++A
Sbjct: 276 KRPKYK---ELLKHPFILMYEERAVEVAC 301
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 6e-20
Identities = 45/236 (19%), Positives = 80/236 (33%), Gaps = 42/236 (17%)
Query: 255 EISTMLSLSH--PNIVQYLCGFCDEEKKEFFLVMELMS--KDLSCYMRETFGSRRRNSFS 310
E+ + +S +++ L F E F L++E +DL ++ E R +
Sbjct: 96 EVVLLKKVSSGFSGVIRLLDWF--ERPDSFVLILERPEPVQDLFDFITE------RGALQ 147
Query: 311 LPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYA 370
+ Q+ + H + H ++ NI + E +K+ FG
Sbjct: 148 EELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE----LKLIDFGSGALLKDT 203
Query: 371 SRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGK 430
+ Y PE + G A V+S G+L ++++ G
Sbjct: 204 VYTDFDGTR-------VYS--PPEWIRYHRYHGR--------SAAVWSLGILLYDMVCGD 246
Query: 431 VPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486
+PFE + I G+ F +L + C PS RP+F I
Sbjct: 247 IPFEH--------DEEIIRGQVF-FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 8e-20
Identities = 43/179 (24%), Positives = 66/179 (36%), Gaps = 33/179 (18%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVV 314
EI + L HPN+V L F + + LV E + + R + +V
Sbjct: 52 EIRMLKQLKHPNLVNLLEVFRRKRR--LHLVFEYCDHTVLHELD-----RYQRGVPEHLV 104
Query: 315 VDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNT 374
I Q + + F H H ++ P NI + S +K+ FG AR +
Sbjct: 105 KSITWQTLQAVNFCHKHNCIHRDVKPENILITKHS-----VIKLCDFGF--ARLLTG-PS 156
Query: 375 PPASPQNQTAPNPYIWY-APEVLAEQEGTGST--STSKCSEKADVYSFGMLCFELLTGK 430
+ T WY +PE+L G T DV++ G + ELL+G
Sbjct: 157 DYYDDEVAT-----RWYRSPELL-----VGDTQYGPP-----VDVWAIGCVFAELLSGV 200
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 1e-19
Identities = 56/267 (20%), Positives = 101/267 (37%), Gaps = 44/267 (16%)
Query: 248 ELESLNAEISTMLSLS-HPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRR 306
E + + ++ +L P IVQ F F+ MELM + G
Sbjct: 66 ENKRILMDLDVVLKSHDCPYIVQCFGTFITNTD--VFIAMELMGTCAEKLKKRMQGP--- 120
Query: 307 NSFSLPVVVDIMLQIARGMEFLHAQ-KIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365
++ + + I + + +L + + H ++ PSNI L G +K+ FG+S
Sbjct: 121 --IPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL---DERG--QIKLCDFGISG 173
Query: 366 --ARTYASRN---TPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFG 420
A + APE + + T +ADV+S G
Sbjct: 174 RLVDDKAKDRSAGCAA-------------YMAPERIDPPDPTKPDY----DIRADVWSLG 216
Query: 421 MLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGS--PKYLVNLTKKCWHTNPSQR 478
+ EL TG+ P+++ + +TK + E PL P + K C + +R
Sbjct: 217 ISLVELATGQFPYKNCKTDFEVLTK-VLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKR 275
Query: 479 PSFSSICRILR--YIKKFMANNPDIAR 503
P ++ ++L +IK++ D+A
Sbjct: 276 PKYN---KLLEHSFIKRYETLEVDVAS 299
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 58/238 (24%), Positives = 93/238 (39%), Gaps = 36/238 (15%)
Query: 250 ESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSR--RRN 307
++ EI + L+HP I++ + F D E +++V+ELM E F +
Sbjct: 60 LNVETEIEILKKLNHPCIIK-IKNFFDAED--YYIVLELMEG------GELF-DKVVGNK 109
Query: 308 SFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTAR 367
Q+ +++LH I H +L P N+ L S E +K++ FG
Sbjct: 110 RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLS--SQEEDCLIKITDFGH---- 163
Query: 368 TYASRNTPPASPQNQTAPNPYIWY-APEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFEL 426
S+ S P Y APEVL G D +S G++ F
Sbjct: 164 ---SKILGETSLMRTLCGTPT--YLAPEVLVSVGTAGYN------RAVDCWSLGVILFIC 212
Query: 427 LTGKVPFEDGHLQGDKMTKNIRAGE----RPLFPSGSPKYLVNLTKKCWHTNPSQRPS 480
L+G PF + Q + I +G+ ++ S K L +L KK +P R +
Sbjct: 213 LSGYPPFSEHRTQ-VSLKDQITSGKYNFIPEVWAEVSEKAL-DLVKKLLVVDPKARFT 268
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 58/243 (23%), Positives = 100/243 (41%), Gaps = 51/243 (20%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMS----KDLSCYMRETFGS 303
E+E + EI+ + P + +Y + + K +++ME + DL +
Sbjct: 63 EIEDIQQEITVLSQCDSPYVTKYYGSYLKDTK--LWIIMEYLGGGSALDL---LEP---- 113
Query: 304 RRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGL 363
+ I+ +I +G+++LH++K H ++ +N+ L S G VK++ FG+
Sbjct: 114 ---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL---SEHG--EVKLADFGV 165
Query: 364 ST--ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGM 421
+ T RNT P+ W APEV+ + S KAD++S G+
Sbjct: 166 AGQLTDTQIKRNT--------FVGTPF-WMAPEVIKQ---------SAYDSKADIWSLGI 207
Query: 422 LCFELLTGKVPFEDGH----LQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQ 477
EL G+ P + H L + KN P K L + C + PS
Sbjct: 208 TAIELARGEPPHSELHPMKVLF--LIPKN----NPPTLEGNYSKPLKEFVEACLNKEPSF 261
Query: 478 RPS 480
RP+
Sbjct: 262 RPT 264
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 53/240 (22%), Positives = 99/240 (41%), Gaps = 42/240 (17%)
Query: 250 ESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSR--RRN 307
E + E++ + + HPNI+ F E K + L++EL+S E F +
Sbjct: 53 EEIEREVNILREIRHPNIITLHDIF--ENKTDVVLILELVSG------GELF-DFLAEKE 103
Query: 308 SFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTAR 367
S + + QI G+ +LH+++I H +L P NI L +++ +K+ FG+
Sbjct: 104 SLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPN-PRIKLIDFGI---- 158
Query: 368 TYASRNTPPASPQNQTAPNPYIWY-APEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFEL 426
+ + P + APE++ + +AD++S G++ + L
Sbjct: 159 ---AHKIEAGNEFKNIFGTPE--FVAPEIVNYE---------PLGLEADMWSIGVITYIL 204
Query: 427 LTGKVPFEDGHLQGDKMTKNIRAG----ERPLFPSGSP--KYLVNLTKKCWHTNPSQRPS 480
L+G PF Q NI A + F + S K + ++ +P +R +
Sbjct: 205 LSGASPFLGETKQE--TLTNISAVNYDFDEEYFSNTSELAKDFI---RRLLVKDPKRRMT 259
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-19
Identities = 55/245 (22%), Positives = 95/245 (38%), Gaps = 45/245 (18%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETF-----G 302
E L E S L HP+IV+ L + ++V E M +
Sbjct: 69 STEDLKREASICHMLKHPHIVELLETY--SSDGMLYMVFEFMDGA------DLCFEIVKR 120
Query: 303 SRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFG 362
+ +S V M QI + + H I H ++ P + L S E VK+ GFG
Sbjct: 121 ADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLA--SKENSAPVKLGGFG 178
Query: 363 LSTARTYASRNTPPASPQNQTAPNPYIWY-APEVLAEQEGTGSTSTSKCSEKADVYSFGM 421
++ + P+ + APEV+ ++E G + DV+ G+
Sbjct: 179 VAI------QLGESGLVAGGRVGTPH--FMAPEVV-KREPYG--------KPVDVWGCGV 221
Query: 422 LCFELLTGKVPFEDGHLQGDKMTKNIRAGE----RPLFP--SGSPKYLVNLTKKCWHTNP 475
+ F LL+G +PF +++ + I G+ + S S K LV ++ +P
Sbjct: 222 ILFILLSGCLPFYG---TKERLFEGIIKGKYKMNPRQWSHISESAKDLV---RRMLMLDP 275
Query: 476 SQRPS 480
++R +
Sbjct: 276 AERIT 280
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 53/245 (21%), Positives = 90/245 (36%), Gaps = 51/245 (20%)
Query: 255 EISTMLSLSHPNIVQYLCGFCD--EEKKEFFLVMELMSK-DLSCY------MRETFGSRR 305
EI L+H N+V++ E +L +E S +L M E
Sbjct: 55 EICINKMLNHENVVKFY----GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE---PDA 107
Query: 306 RNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365
+ F Q+ G+ +LH I H ++ P N+ L + ++K+S FGL+T
Sbjct: 108 QRFFH---------QLMAGVVYLHGIGITHRDIKPENLLL-----DERDNLKISDFGLAT 153
Query: 366 ARTYASR----NTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGM 421
Y +R N + PY+ APE+L +E DV+S G+
Sbjct: 154 VFRYNNRERLLNKMCGTL-------PYV--APELLKRREFHAE--------PVDVWSCGI 196
Query: 422 LCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSF 481
+ +L G++P++ + + + L K NPS R +
Sbjct: 197 VLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITI 256
Query: 482 SSICR 486
I +
Sbjct: 257 PDIKK 261
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 89.6 bits (222), Expect = 2e-19
Identities = 32/270 (11%), Positives = 70/270 (25%), Gaps = 33/270 (12%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRR 306
E + + +++ + LV EL S L + + +
Sbjct: 110 EFYIGTQLMERLKPSMQHMFMKFYSAH--LFQNGSVLVGELYSYGTLLNAINL-YKNTPE 166
Query: 307 NSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGY------FHVKVSG 360
+V+ +++ +E +H +I HG++ P N L +E + +
Sbjct: 167 KVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALID 226
Query: 361 FGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFG 420
G S + T + E+L + D +
Sbjct: 227 LGQSIDMKLFPKGT-----IFTAKCETSGFQCVEML---SNKPWN------YQIDYFGVA 272
Query: 421 MLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPS 480
+ +L G K R + ++N+
Sbjct: 273 ATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNI-------PDCHHLP 325
Query: 481 FSSICRILRYIKKFMANNPDIARSEFQSPL 510
+ R +KK + ++ L
Sbjct: 326 SLDLLRQK--LKKVFQQHYTNKIRALRNRL 353
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 54/249 (21%), Positives = 98/249 (39%), Gaps = 50/249 (20%)
Query: 249 LESLNAEISTMLSLS-HPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSR--R 305
+ EI+ + HPNIV+ L ++ FLVMEL++ E F R +
Sbjct: 49 EANTQKEITALKLCEGHPNIVK-LHEVF-HDQLHTFLVMELLNGG------ELF-ERIKK 99
Query: 306 RNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365
+ FS IM ++ + +H + H +L P N+ +K+ FG +
Sbjct: 100 KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFT--DENDNLEIKIIDFGFAR 157
Query: 366 ARTYASR--NTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLC 423
+ ++ TP + Y APE+L + E D++S G++
Sbjct: 158 LKPPDNQPLKTPCFTLH-------YA--APELLNQN---------GYDESCDLWSLGVIL 199
Query: 424 FELLTGKVPFEDGHLQG-----DKMTKNIRAGERPLFP-------SGSPKYLVNLTKKCW 471
+ +L+G+VPF+ ++ K I+ G+ F S K L+ +
Sbjct: 200 YTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD-FSFEGEAWKNVSQEAKDLI---QGLL 255
Query: 472 HTNPSQRPS 480
+P++R
Sbjct: 256 TVDPNKRLK 264
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 59/260 (22%), Positives = 102/260 (39%), Gaps = 54/260 (20%)
Query: 250 ESLNAEISTMLSLS-HPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGS----- 303
+ E+ + H N+++ L F EE+ F+LV E M GS
Sbjct: 55 SRVFREVEMLYQCQGHRNVLE-LIEFF-EEEDRFYLVFEKMRG----------GSILSHI 102
Query: 304 RRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGL 363
+R F+ ++ +A ++FLH + I H +L P NI + VK+ F L
Sbjct: 103 HKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCE--HPNQVSPVKICDFDL 160
Query: 364 STARTYASRNTPPASPQNQTA---PNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFG 420
+ +P ++P+ T Y+ APEV+ S S ++ D++S G
Sbjct: 161 GSGIKLNGDCSPISTPELLTPCGSAE-YM--APEVVEAF----SEEASIYDKRCDLWSLG 213
Query: 421 MLCFELLTGKVPFEDGHLQG-------------DKMTKNIRAGERPLFP-------SGSP 460
++ + LL+G PF + + ++I+ G+ FP S +
Sbjct: 214 VILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGK-YEFPDKDWAHISCAA 272
Query: 461 KYLVNLTKKCWHTNPSQRPS 480
K L+ K + QR S
Sbjct: 273 KDLI---SKLLVRDAKQRLS 289
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 53/241 (21%), Positives = 94/241 (39%), Gaps = 40/241 (16%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGS-RRR 306
E + E+S + + H N++ + E + + L++EL+S E F ++
Sbjct: 58 SREEIEREVSILRQVLHHNVITLHDVY--ENRTDVVLILELVSGG------ELFDFLAQK 109
Query: 307 NSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366
S S + QI G+ +LH +KI H +L P NI L ++ H+K+ FGL
Sbjct: 110 ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKN-IPIPHIKLIDFGL--- 165
Query: 367 RTYASRNTPPASPQNQTAPNPYIWY-APEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFE 425
+ P + APE++ + +AD++S G++ +
Sbjct: 166 ----AHEIEDGVEFKNIFGTPE--FVAPEIVNYE---------PLGLEADMWSIGVITYI 210
Query: 426 LLTGKVPFEDGHLQGDKMTKNIRAG----ERPLFP--SGSPKYLVNLTKKCWHTNPSQRP 479
LL+G PF Q NI + + F S K + +K +R
Sbjct: 211 LLSGASPFLGDTKQE--TLANITSVSYDFDEEFFSHTSELAKDFI---RKLLVKETRKRL 265
Query: 480 S 480
+
Sbjct: 266 T 266
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 4e-19
Identities = 56/238 (23%), Positives = 101/238 (42%), Gaps = 40/238 (16%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRR 306
E+ ++ E+ M L HP +V F DEE F+V++L+ DL +++ +
Sbjct: 58 EVRNVFKELQIMQGLEHPFLVNLWYSFQDEED--MFMVVDLLLGGDLRYHLQ------QN 109
Query: 307 NSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366
F V + ++ +++L Q+I H ++ P NI L G HV ++ F ++
Sbjct: 110 VHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDE---HG--HVHITDFNIAAM 164
Query: 367 RTYASRN-----TPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGM 421
++ T P Y+ APE+ + ++G G + D +S G+
Sbjct: 165 LPRETQITTMAGTKP-----------YM--APEMFSSRKGAGYSFA------VDWWSLGV 205
Query: 422 LCFELLTGKVPFED-GHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQR 478
+ELL G+ P+ ++ +PS + +V+L KK NP QR
Sbjct: 206 TAYELLRGRRPYHIRSSTSSKEIVHTFETTV-VTYPSAWSQEMVSLLKKLLEPNPDQR 262
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 5e-19
Identities = 49/244 (20%), Positives = 85/244 (34%), Gaps = 56/244 (22%)
Query: 255 EISTMLSLS----HPNIVQYLCGFCDEEKKEFFLVMELMSK--DLSCY------MRETFG 302
E++ + + HP +++ L F E ++ F LV+E DL Y + E
Sbjct: 84 EVALLWKVGAGGGHPGVIRLLDWF--ETQEGFMLVLERPLPAQDLFDYITEKGPLGEGP- 140
Query: 303 SRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFG 362
SR Q+ ++ H++ + H ++ NI + R K+ FG
Sbjct: 141 SRC-----------FFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGC----AKLIDFG 185
Query: 363 LSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGML 422
+ Y PE ++ + A V+S G+L
Sbjct: 186 SGALLHDEPYTDFDGTR-------VYS--PPEWISRHQYHAL--------PATVWSLGIL 228
Query: 423 CFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFS 482
++++ G +PFE + I E FP+ L ++C PS RPS
Sbjct: 229 LYDMVCGDIPFER--------DQEILEAELH-FPAHVSPDCCALIRRCLAPKPSSRPSLE 279
Query: 483 SICR 486
I
Sbjct: 280 EILL 283
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 6e-19
Identities = 58/246 (23%), Positives = 97/246 (39%), Gaps = 40/246 (16%)
Query: 243 RHFYGELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFG 302
E + E+S + + HPNI+ + E + + L++EL+S E F
Sbjct: 53 SRRGVCREEIEREVSILRQVLHPNIITLHDVY--ENRTDVVLILELVSGG------ELFD 104
Query: 303 S-RRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGF 361
++ S S + QI G+ +LH +KI H +L P NI L +++ H+K+ F
Sbjct: 105 FLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIP-HIKLIDF 163
Query: 362 GLSTARTYASRNTPPASPQNQTAPNPYIWY-APEVLAEQEGTGSTSTSKCSEKADVYSFG 420
GL + P + APE++ E G +AD++S G
Sbjct: 164 GL-------AHEIEDGVEFKNIFGTPE--FVAPEIV-NYEPLG--------LEADMWSIG 205
Query: 421 MLCFELLTGKVPFEDGHLQGDKMTKNIRAG----ERPLFPSGSP--KYLVNLTKKCWHTN 474
++ + LL+G PF Q NI A + F S K + +K
Sbjct: 206 VITYILLSGASPFLGDTKQE--TLANITAVSYDFDEEFFSQTSELAKDFI---RKLLVKE 260
Query: 475 PSQRPS 480
+R +
Sbjct: 261 TRKRLT 266
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 7e-19
Identities = 50/280 (17%), Positives = 93/280 (33%), Gaps = 64/280 (22%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK--DLSCY------MRETFGSRRR 306
EI+ + + H NI++ L F E + F LVME DL + + E S
Sbjct: 79 EIAILSRVEHANIIKVLDIF--ENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASY-- 134
Query: 307 NSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366
I Q+ + +L + I H ++ NI + F +K+ FG +
Sbjct: 135 ----------IFRQLVSAVGYLRLKDIIHRDIKDENIVI-----AEDFTIKLIDFGSAAY 179
Query: 367 RTYASR-NTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFE 425
T + Y APEVL G + +++S G+ +
Sbjct: 180 LERGKLFYTFCGTI-------EYC--APEVLMGNPYRGP--------ELEMWSLGVTLYT 222
Query: 426 LLTGKVPFEDGHLQGDKMTKNIRAGE--RPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSS 483
L+ + PF + + P S L++L P +R +
Sbjct: 223 LVFEENPFCE--------LEETVEAAIHPPYLVSKE---LMSLVSGLLQPVPERRTTLEK 271
Query: 484 ICRILRYIKKFMANNPDIARSEFQSPLADYCDIEAGFVRK 523
+ ++ ++A ++ + E+G +
Sbjct: 272 LVT-----DPWVTQPVNLADYTWE-EVFRVNKPESGVLSA 305
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 8e-19
Identities = 65/266 (24%), Positives = 103/266 (38%), Gaps = 64/266 (24%)
Query: 254 AEISTMLS-LSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRR-RNSFS 310
EI LS HP++V L GFCDE E L+ + M +L ++ +GS S S
Sbjct: 84 TEI-ETLSFCRHPHLVS-LIGFCDERN-EMILIYKYMENGNLKRHL---YGSDLPTMSMS 137
Query: 311 LPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS-----T 365
++I + ARG+ +LH + I H ++ NI L + F K++ FG+S
Sbjct: 138 WEQRLEICIGAARGLHYLHTRAIIHRDVKSINILL-----DENFVPKITDFGISKKGTEL 192
Query: 366 ARTYAS---RNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGML 422
+T+ S + T YI PE + +EK+DVYSFG++
Sbjct: 193 DQTHLSTVVKGTL-----------GYI--DPEYF---------IKGRLTEKSDVYSFGVV 230
Query: 423 CFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLV-----------------N 465
FE+L + + N+ +G + +V +
Sbjct: 231 LFEVLCARSAIVQSLPREM---VNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGD 287
Query: 466 LTKKCWHTNPSQRPSFSSICRILRYI 491
KC + RPS + L Y
Sbjct: 288 TAVKCLALSSEDRPSMGDVLWKLEYA 313
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 8e-19
Identities = 55/242 (22%), Positives = 98/242 (40%), Gaps = 42/242 (17%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSR--R 305
E + E+S + + HPN++ + E K + L++EL E F
Sbjct: 57 SREDIEREVSILKEIQHPNVITLHEVY--ENKTDVILILEL------VAGGELF-DFLAE 107
Query: 306 RNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365
+ S + + + QI G+ +LH+ +I H +L P NI L R++ +K+ FGL
Sbjct: 108 KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPK-PRIKIIDFGL-- 164
Query: 366 ARTYASRNTPPASPQNQTAPNPYIWY-APEVLAEQEGTGSTSTSKCSEKADVYSFGMLCF 424
+ + P + APE++ E G +AD++S G++ +
Sbjct: 165 -----AHKIDFGNEFKNIFGTPE--FVAPEIV-NYEPLG--------LEADMWSIGVITY 208
Query: 425 ELLTGKVPFEDGHLQGDKMTKNIRAG----ERPLFPSGSP--KYLVNLTKKCWHTNPSQR 478
LL+G PF Q N+ A E F + S K + ++ +P +R
Sbjct: 209 ILLSGASPFLGDTKQE--TLANVSAVNYEFEDEYFSNTSALAKDFI---RRLLVKDPKKR 263
Query: 479 PS 480
+
Sbjct: 264 MT 265
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-18
Identities = 66/265 (24%), Positives = 103/265 (38%), Gaps = 64/265 (24%)
Query: 254 AEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMS-KDLSCYMRETFGSRRRNSFSLP 312
E+ + H N+++ L GFC E LV M+ ++ +RE S+ P
Sbjct: 76 TEVEMISMAVHRNLLR-LRGFCMTPT-ERLLVYPYMANGSVASCLRERPESQPP--LDWP 131
Query: 313 VVVDIMLQIARGMEFLHAQ---KIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTY 369
I L ARG+ +LH KI H ++ +NI L + F V FGL A+
Sbjct: 132 KRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILL-----DEEFEAVVGDFGL--AKLM 184
Query: 370 ASRNTPPASPQNQTAPNPYI---------WYAPEVLAEQEGTGSTSTSKCSEKADVYSFG 420
++T ++ APE L ST K SEK DV+ +G
Sbjct: 185 DYKDT-------------HVTTAVRGTIGHIAPEYL---------STGKSSEKTDVFGYG 222
Query: 421 MLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLV--NLTKK--------- 469
++ EL+TG+ F+ L D + + L + LV +L
Sbjct: 223 VMLLELITGQRAFDLARLANDDD-VMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQL 281
Query: 470 ------CWHTNPSQRPSFSSICRIL 488
C ++P +RP S + R+L
Sbjct: 282 IQVALLCTQSSPMERPKMSEVVRML 306
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 1e-18
Identities = 67/249 (26%), Positives = 98/249 (39%), Gaps = 47/249 (18%)
Query: 248 ELESLNAEISTMLSLS-HPNIVQY----LCGFCDEEKKEFFLVMELMS----KDLSCYMR 298
E E + EI+ + S H NI Y + + +LVME DL ++
Sbjct: 63 EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDL---IK 119
Query: 299 ETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKV 358
T + N+ + I +I RG+ LH K+ H ++ N+ L + VK+
Sbjct: 120 NT----KGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL---TENA--EVKL 170
Query: 359 SGFGLST--ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADV 416
FG+S RT RNT PY W APEV+A E +T K D+
Sbjct: 171 VDFGVSAQLDRTVGRRNT--------FIGTPY-WMAPEVIACDENPDATYDFKS----DL 217
Query: 417 YSFGMLCFELLTGKVPFEDGH----LQGDKMTKNIRAGERP-LFPSGSPKYLVNLTKKCW 471
+S G+ E+ G P D H L + +N P L K + + C
Sbjct: 218 WSLGITAIEMAEGAPPLCDMHPMRALF--LIPRN----PAPRLKSKKWSKKFQSFIESCL 271
Query: 472 HTNPSQRPS 480
N SQRP+
Sbjct: 272 VKNHSQRPA 280
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 2e-18
Identities = 57/241 (23%), Positives = 99/241 (41%), Gaps = 49/241 (20%)
Query: 255 EISTMLSLSHPNIVQ-YLCGFCD--EEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFS 310
EI + HP+I++ Y + F+VME +S +L Y+ +
Sbjct: 66 EIQNLKLFRHPHIIKLY-----QVISTPSDIFMVMEYVSGGELFDYICK------NGRLD 114
Query: 311 LPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYA 370
+ QI G+++ H + H +L P N+ L + + + K++ FGLS +
Sbjct: 115 EKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLL-----DAHMNAKIADFGLSNMMSDG 169
Query: 371 SR-NTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTG 429
T SP Y APEV++ + G + D++S G++ + LL G
Sbjct: 170 EFLRTSCGSP-------NYA--APEVISGRLYAGP--------EVDIWSSGVILYALLCG 212
Query: 430 KVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYL----VNLTKKCWHTNPSQRPSFSSIC 485
+PF+D H+ + K I G P+YL ++L K +P +R + I
Sbjct: 213 TLPFDDDHVP--TLFKKICDGIFYT-----PQYLNPSVISLLKHMLQVDPMKRATIKDIR 265
Query: 486 R 486
Sbjct: 266 E 266
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 2e-18
Identities = 52/240 (21%), Positives = 93/240 (38%), Gaps = 47/240 (19%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRR 306
++ + E M L HP V+ F D+EK + + +L Y+R +
Sbjct: 73 KVPYVTRERDVMSRLDHPFFVKLYFTFQDDEK--LYFGLSYAKNGELLKYIR------KI 124
Query: 307 NSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS-- 364
SF +I +E+LH + I H +L P NI L + H++++ FG +
Sbjct: 125 GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNE---DM--HIQITDFGTAKV 179
Query: 365 ------TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYS 418
AR + T Y+ +PE+L E+ +S D+++
Sbjct: 180 LSPESKQARANSFVGTAQ-----------YV--SPELLTEK-SACKSS--------DLWA 217
Query: 419 FGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQR 478
G + ++L+ G PF G + + I E FP +L +K + ++R
Sbjct: 218 LGCIIYQLVAGLPPFRAG--NEYLIFQKIIKLE-YDFPEKFFPKARDLVEKLLVLDATKR 274
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 3e-18
Identities = 51/247 (20%), Positives = 83/247 (33%), Gaps = 54/247 (21%)
Query: 250 ESLNAEISTMLSLSH-PNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFG------ 302
+ EI+ + P ++ + E E L++E + G
Sbjct: 73 AEILHEIAVLELAKSCPRVINLHEVY--ENTSEIILILEYAA-----------GGEIFSL 119
Query: 303 --SRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSG 360
S V+ ++ QI G+ +LH I H +L P NI L S+ +K+
Sbjct: 120 CLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLS--SIYPLGDIKIVD 177
Query: 361 FGLSTARTYASRNTPPASPQNQTAPNPYIWY-APEVLAEQEGTGSTSTSKCSEKADVYSF 419
FG+ SR A + P Y APE+L + D+++
Sbjct: 178 FGM-------SRKIGHACELREIMGTPE--YLAPEIL-NYDPIT--------TATDMWNI 219
Query: 420 GMLCFELLTGKVPFEDGHLQGDKMTKNIRAG----ERPLFP--SGSPKYLVNLTKKCWHT 473
G++ + LLT PF Q NI F S + +
Sbjct: 220 GIIAYMLLTHTSPFVGEDNQE--TYLNISQVNVDYSEETFSSVSQLATDFI---QSLLVK 274
Query: 474 NPSQRPS 480
NP +RP+
Sbjct: 275 NPEKRPT 281
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 3e-18
Identities = 61/238 (25%), Positives = 98/238 (41%), Gaps = 43/238 (18%)
Query: 255 EISTMLSLS-HPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSR--RRNSFSL 311
EI +L HPNI+ L ++ K ++V ELM E + R+ FS
Sbjct: 65 EIEILLRYGQHPNIIT-LKDVY-DDGKYVYVVTELMKGG------ELL-DKILRQKFFSE 115
Query: 312 PVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYAS 371
++ I + +E+LHAQ + H +L PSNI S +++ FG + +
Sbjct: 116 REASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDES-GNPESIRICDFGFAKQLRAEN 174
Query: 372 R--NTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTG 429
TP + ++ APEVL Q D++S G+L + +LTG
Sbjct: 175 GLLMTPCYTAN-------FV--APEVLERQ---------GYDAACDIWSLGVLLYTMLTG 216
Query: 430 KVPFEDGHLQGD-KMTKNIRAGE----RPLFP--SGSPKYLVNLTKKCWHTNPSQRPS 480
PF +G ++ I +G+ + S + K LV K H +P QR +
Sbjct: 217 YTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLV---SKMLHVDPHQRLT 271
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 5e-18
Identities = 56/240 (23%), Positives = 94/240 (39%), Gaps = 43/240 (17%)
Query: 250 ESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFG--SRRRN 307
++ EIS M L HP ++ F E+K E L++E +S E F +
Sbjct: 93 YTVKNEISIMNQLHHPKLINLHDAF--EDKYEMVLILEFLSG------GELFDRIAAEDY 144
Query: 308 SFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTAR 367
S V++ M Q G++ +H I H ++ P NI + + VK+ FGL
Sbjct: 145 KMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKAS---SVKIIDFGL---- 197
Query: 368 TYASRNTPPASPQNQTAPNPYIWY-APEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFEL 426
+ P T + APE++ ++E G D+++ G+L + L
Sbjct: 198 ---ATKLNPDEIVKVTTATAE--FAAPEIV-DREPVG--------FYTDMWAIGVLGYVL 243
Query: 427 LTGKVPFEDGHLQGDKMTKNIRAG----ERPLFPSGSP--KYLVNLTKKCWHTNPSQRPS 480
L+G PF +N++ + F S SP K + K P +R +
Sbjct: 244 LSGLSPFAGEDDLE--TLQNVKRCDWEFDEDAFSSVSPEAK---DFIKNLLQKEPRKRLT 298
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 5e-18
Identities = 50/235 (21%), Positives = 99/235 (42%), Gaps = 42/235 (17%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMS-KDLSCYMRETFGSRRR 306
++E E + +++ P +V+ F D ++VME ++ ++ ++R R
Sbjct: 84 QIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN--LYMVMEYVAGGEMFSHLR------RI 135
Query: 307 NSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS-- 364
FS P QI E+LH+ + + +L P N+ + +G +++V+ FG +
Sbjct: 136 GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQ---QG--YIQVTDFGFAKR 190
Query: 365 -TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLC 423
RT+ TP + APE++ + G D ++ G+L
Sbjct: 191 VKGRTWTLCGTPE-----------AL--APEIILSK-GYNKA--------VDWWALGVLI 228
Query: 424 FELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQR 478
+E+ G PF Q ++ + I +G + FPS L +L + + ++R
Sbjct: 229 YEMAAGYPPFFAD--QPIQIYEKIVSG-KVRFPSHFSSDLKDLLRNLLQVDLTKR 280
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 5e-18
Identities = 55/242 (22%), Positives = 93/242 (38%), Gaps = 43/242 (17%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSR--R 305
+ + L E L HPNIV+ +E+ +LV +L++ E F
Sbjct: 48 DFQKLEREARICRKLQHPNIVRLHDSI--QEESFHYLVFDLVTGG------ELF-EDIVA 98
Query: 306 RNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365
R +S + QI + + H+ I H L P N+ L S VK++ FGL
Sbjct: 99 REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLA--SKAKGAAVKLADFGL-- 154
Query: 366 ARTYASRNTPPASPQNQTAPNPYIWY-APEVLAEQEGTGSTSTSKCSEKADVYSFGMLCF 424
+ + + A P Y +PEVL +++ + D+++ G++ +
Sbjct: 155 -----AIEVNDSEAWHGFAGTPG--YLSPEVL-KKDPYS--------KPVDIWACGVILY 198
Query: 425 ELLTGKVPFEDGHLQGDKMTKNIRAGE----RPLFP--SGSPKYLVNLTKKCWHTNPSQR 478
LL G PF D + I+AG P + + K +L NP +R
Sbjct: 199 ILLVGYPPFWDEDQHR--LYAQIKAGAYDYPSPEWDTVTPEAK---SLIDSMLTVNPKKR 253
Query: 479 PS 480
+
Sbjct: 254 IT 255
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 6e-18
Identities = 62/241 (25%), Positives = 93/241 (38%), Gaps = 41/241 (17%)
Query: 255 EISTMLSLSHPNIVQYLCGFCD--EEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFSL 311
EI SL HPNIV+ F + ++ME S +L + FS
Sbjct: 66 EIINHRSLRHPNIVR----FKEVILTPTHLAIIMEYASGGELYERIC------NAGRFSE 115
Query: 312 PVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYAS 371
Q+ G+ + H+ +I H +L N L +K+ FG S + S
Sbjct: 116 DEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDG---SPAPRLKICDFGYSKSSVLHS 172
Query: 372 R-NTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGK 430
+ + +P YI APEVL QE G ADV+S G+ + +L G
Sbjct: 173 QPKSTVGTP-------AYI--APEVLLRQEYDGK--------IADVWSCGVTLYVMLVGA 215
Query: 431 VPFEDGHLQGD--KMTKNIRAGERPLFPSG---SPKYLVNLTKKCWHTNPSQRPSFSSIC 485
PFED D K + I + + P SP+ +L + + +P+ R S I
Sbjct: 216 YPFEDPEEPRDYRKTIQRILSVKYS-IPDDIRISPE-CCHLISRIFVADPATRISIPEIK 273
Query: 486 R 486
Sbjct: 274 T 274
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 6e-18
Identities = 57/239 (23%), Positives = 93/239 (38%), Gaps = 41/239 (17%)
Query: 250 ESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFG--SRRRN 307
E++ EI TM L HP +V F E+ E ++ E MS E F + N
Sbjct: 199 ETVRKEIQTMSVLRHPTLVNLHDAF--EDDNEMVMIYEFMSG------GELFEKVADEHN 250
Query: 308 SFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTAR 367
S V+ M Q+ +G+ +H H +L P NI + +K+ FGL
Sbjct: 251 KMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSN---ELKLIDFGL---- 303
Query: 368 TYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELL 427
+ + P T + APEV E + G D++S G+L + LL
Sbjct: 304 ---TAHLDPKQSVKVTTGTAE-FAAPEVA-EGKPVG--------YYTDMWSVGVLSYILL 350
Query: 428 TGKVPFEDGHLQGDKMTKNIRAG----ERPLFPSGSP--KYLVNLTKKCWHTNPSQRPS 480
+G PF + +N+++ + F S K + +K +P+ R +
Sbjct: 351 SGLSPFGGENDDE--TLRNVKSCDWNMDDSAFSGISEDGKDFI---RKLLLADPNTRMT 404
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 54/245 (22%), Positives = 101/245 (41%), Gaps = 46/245 (18%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMS----KDLSCYMRETFGS 303
ELE EI + + HP IV+ L + + K ++++E + M E
Sbjct: 59 ELEDYIVEIEILATCDHPYIVKLLGAYYHDGK--LWIMIEFCPGGAVDAI---MLEL--- 110
Query: 304 RRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGL 363
+ P + + Q+ + FLH+++I H +L N+ + ++EG ++++ FG+
Sbjct: 111 --DRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLM---TLEG--DIRLADFGV 163
Query: 364 ST--ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGM 421
S +T R++ + PY W APEV+ + + K D++S G+
Sbjct: 164 SAKNLKTLQKRDSFIGT--------PY-WMAPEVVMCETMKDTPYDYKA----DIWSLGI 210
Query: 422 LCFELLTGKVPFEDGH----LQGDKMTKNIRAGERPLFPSGSP--KYLVNLTKKCWHTNP 475
E+ + P + + L K+ K+ + P + S + K NP
Sbjct: 211 TLIEMAQIEPPHHELNPMRVLL--KIAKS----DPPTLLTPSKWSVEFRDFLKIALDKNP 264
Query: 476 SQRPS 480
RPS
Sbjct: 265 ETRPS 269
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 1e-17
Identities = 58/247 (23%), Positives = 96/247 (38%), Gaps = 56/247 (22%)
Query: 255 EISTMLSLS-HPNIVQYLCGFCD--EEKKEFFLVMELMSKDLSCYMRETFG--------S 303
E+ S P+IV+ + + + +K +VME + G
Sbjct: 104 EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD-----------GGELFSRIQD 152
Query: 304 RRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGL 363
R +F+ +IM I +++LH+ I H ++ P N+ S +K++ FG
Sbjct: 153 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYT--SKRPNAILKLTDFGF 210
Query: 364 STARTYASR-NTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGML 422
+ T + TP +P Y+ APEVL + K + D++S G++
Sbjct: 211 AKETTSHNSLTTPCYTPY-------YV--APEVLGPE---------KYDKSCDMWSLGVI 252
Query: 423 CFELLTGKVPF--EDGHLQGDKMTKNIRAGERPLFP-------SGSPKYLVNLTKKCWHT 473
+ LL G PF G M IR G+ FP S K L+ + T
Sbjct: 253 MYILLCGYPPFYSNHGLAISPGMKTRIRMGQ-YEFPNPEWSEVSEEVKMLI---RNLLKT 308
Query: 474 NPSQRPS 480
P+QR +
Sbjct: 309 EPTQRMT 315
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 60/241 (24%), Positives = 95/241 (39%), Gaps = 41/241 (17%)
Query: 250 ESLNAEISTMLSLS-HPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSR--RR 306
E+ E+ + +S HPNI+Q L E FFLV +LM K E F +
Sbjct: 68 EATLKEVDILRKVSGHPNIIQ-LKDTY-ETNTFFFLVFDLMKKG------ELF-DYLTEK 118
Query: 307 NSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366
+ S IM + + LH I H +L P NI L ++K++ FG
Sbjct: 119 VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDM-----NIKLTDFGF--- 170
Query: 367 RTYASRNTPPASPQNQTAPNPYIWY-APEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFE 425
S P + P Y APE++ E + + + ++ D++S G++ +
Sbjct: 171 ----SCQLDPGEKLREVCGTPS--YLAPEII---ECSMNDNHPGYGKEVDMWSTGVIMYT 221
Query: 426 LLTGKVPFEDGHLQGDKMTKNIRAGE----RPLFP--SGSPKYLVNLTKKCWHTNPSQRP 479
LL G PF M + I +G P + S + K LV + P +R
Sbjct: 222 LLAGSPPFWHRKQML--MLRMIMSGNYQFGSPEWDDYSDTVKDLV---SRFLVVQPQKRY 276
Query: 480 S 480
+
Sbjct: 277 T 277
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 2e-17
Identities = 60/240 (25%), Positives = 86/240 (35%), Gaps = 43/240 (17%)
Query: 250 ESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGS--RRRN 307
E + EIS M L H N++Q F E K + LVME + E F
Sbjct: 131 EEVKNEISVMNQLDHANLIQLYDAF--ESKNDIVLVMEYVDGG------ELFDRIIDESY 182
Query: 308 SFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTAR 367
+ + + M QI G+ +H I H +L P NI R + +K+ FGL
Sbjct: 183 NLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAK---QIKIIDFGL---- 235
Query: 368 TYASRNTPPASPQNQTAPNPYIWY-APEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFEL 426
+R P P + APEV+ + D++S G++ + L
Sbjct: 236 ---ARRYKPREKLKVNFGTPE--FLAPEVV-NYDFVS--------FPTDMWSVGVIAYML 281
Query: 427 LTGKVPFEDGHLQGDKMTKNIRAG----ERPLFPSGSP--KYLVNLTKKCWHTNPSQRPS 480
L+G PF + NI A E F S K + K S R S
Sbjct: 282 LSGLSPFLGDNDAE--TLNNILACRWDLEDEEFQDISEEAKEFI---SKLLIKEKSWRIS 336
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 48/267 (17%), Positives = 104/267 (38%), Gaps = 43/267 (16%)
Query: 248 ELESLNAEISTMLSLS-HPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRR 306
E + L ++ + P V + E + ++ MELM L + ++ +
Sbjct: 48 EQKRLLMDLDISMRTVDCPFTVTFYGALFREG--DVWICMELMDTSLDKFYKQVI--DKG 103
Query: 307 NSFSLPVVVDIMLQIARGMEFLHAQ-KIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365
+ ++ I + I + +E LH++ + H ++ PSN+ + + G VK+ FG+S
Sbjct: 104 QTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLI---NALG--QVKMCDFGISG 158
Query: 366 --ARTYASRN----TPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSF 419
A ++ P + APE + + S K+D++S
Sbjct: 159 YLVDDVA-KDIDAGCKP-------------YMAPERIN-----PELNQKGYSVKSDIWSL 199
Query: 420 GMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGS-PKYLVNLTKKCWHTNPSQR 478
G+ EL + P++ ++ + + P P+ V+ T +C N +R
Sbjct: 200 GITMIELAILRFPYDSWGTPFQQLKQ-VVEEPSPQLPADKFSAEFVDFTSQCLKKNSKER 258
Query: 479 PSFSSICRILR--YIKKFMANNPDIAR 503
P++ +++ + + D+A
Sbjct: 259 PTYP---ELMQHPFFTLHESKGTDVAS 282
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-17
Identities = 54/246 (21%), Positives = 92/246 (37%), Gaps = 51/246 (20%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGS---- 303
+ + L E L HPNIV+ +E+ +LV +L++ G
Sbjct: 71 DFQKLEREARICRKLQHPNIVRLHDSI--QEESFHYLVFDLVT-----------GGELFE 117
Query: 304 --RRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGF 361
R +S + QI + + H+ I H L P N+ L S VK++ F
Sbjct: 118 DIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLA--SKAKGAAVKLADF 175
Query: 362 GLSTARTYASRNTPPASPQNQTAPNPYIWY-APEVLAEQEGTGSTSTSKCSEKADVYSFG 420
GL + + + A P Y +PEVL +++ + D+++ G
Sbjct: 176 GL-------AIEVNDSEAWHGFAGTPG--YLSPEVL-KKDPYS--------KPVDIWACG 217
Query: 421 MLCFELLTGKVPFEDGHLQGDKMTKNIRAGE----RPLFP--SGSPKYLVNLTKKCWHTN 474
++ + LL G PF D + I+AG P + + K L+ N
Sbjct: 218 VILYILLVGYPPFWDEDQHR--LYAQIKAGAYDYPSPEWDTVTPEAKSLI---DSMLTVN 272
Query: 475 PSQRPS 480
P +R +
Sbjct: 273 PKKRIT 278
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 53/240 (22%), Positives = 99/240 (41%), Gaps = 43/240 (17%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGS---- 303
+ E + EI M +PNIV YL + ++ ++VME ++ GS
Sbjct: 60 KKELIINEILVMRENKNPNIVNYLDSYLVGDE--LWVVMEYLA----------GGSLTDV 107
Query: 304 RRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGL 363
+ + + + +EFLH+ ++ H ++ NI L M+G VK++ FG
Sbjct: 108 VTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDG--SVKLTDFG- 161
Query: 364 STARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLC 423
+ ++ TP S ++ PY W APEV+ + K D++S G++
Sbjct: 162 -----FCAQITPEQSKRSTMVGTPY-WMAPEVVTRKA---------YGPKVDIWSLGIMA 206
Query: 424 FELLTGKVPFEDGH-LQGDKMTKNIRAGERPLF--PSGSPKYLVNLTKKCWHTNPSQRPS 480
E++ G+ P+ + + L+ + I P P + +C + +R S
Sbjct: 207 IEMIEGEPPYLNENPLRALYL---IATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGS 263
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 3e-17
Identities = 55/239 (23%), Positives = 96/239 (40%), Gaps = 42/239 (17%)
Query: 250 ESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSR--RRN 307
SL EI+ + + H NIV + E ++LVM+L E F R R
Sbjct: 51 SSLENEIAVLKKIKHENIVTLEDIY--ESTTHYYLVMQL------VSGGELF-DRILERG 101
Query: 308 SFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTAR 367
++ ++ Q+ +++LH I H +L P N+ + E + ++ FGLS
Sbjct: 102 VYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYL--TPEENSKIMITDFGLSKME 159
Query: 368 TYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELL 427
+T +P Y+ APEVLA++ S+ D +S G++ + LL
Sbjct: 160 QNGIMSTACGTPG-------YV--APEVLAQK---------PYSKAVDCWSIGVITYILL 201
Query: 428 TGKVPFEDGHLQGDKMTKNIRAGE----RPLFPSGSP--KYLVNLTKKCWHTNPSQRPS 480
G PF + + + I+ G P + S K + +P++R +
Sbjct: 202 CGYPPFYEETESK--LFEKIKEGYYEFESPFWDDISESAKDFI---CHLLEKDPNERYT 255
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 4e-17
Identities = 48/202 (23%), Positives = 90/202 (44%), Gaps = 38/202 (18%)
Query: 255 EISTMLSLSHPNIVQYLCGF-CDEEKKEF---FLVMELMSKDLSCYMRETFGSRRRNSFS 310
E+ M + HPN+V F + +KK+ LV+E + + + R ++ + +
Sbjct: 82 ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHY--AKLKQTMP 139
Query: 311 LPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYA 370
+ ++ M Q+ R + ++H+ I H ++ P N+ L S +K+ FG A+
Sbjct: 140 MLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGV----LKLIDFGS--AKILI 193
Query: 371 SRNTPPASPQNQTAPN-PYI---WY-APEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFE 425
+ PN YI +Y APE++ G+T+ + D++S G + E
Sbjct: 194 AGE-----------PNVSYICSRYYRAPELIF-----GATNYTT---NIDIWSTGCVMAE 234
Query: 426 LLTGKVPF--EDGHLQGDKMTK 445
L+ G+ F E G Q ++ K
Sbjct: 235 LMQGQPLFPGESGIDQLVEIIK 256
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 4e-17
Identities = 61/237 (25%), Positives = 101/237 (42%), Gaps = 46/237 (19%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMR--ETFGS-R 304
++E N E + ++HP I++ F D ++ F++M+ Y+ E F R
Sbjct: 49 QVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQ--IFMIMD--------YIEGGELFSLLR 98
Query: 305 RRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS 364
+ F PV ++ +E+LH++ I + +L P NI L G H+K++ FG +
Sbjct: 99 KSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDK---NG--HIKITDFGFA 153
Query: 365 ---TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGM 421
TY TP YI APEV++ + + D +SFG+
Sbjct: 154 KYVPDVTYTLCGTPD-----------YI--APEVVSTK-PYNKS--------IDWWSFGI 191
Query: 422 LCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQR 478
L +E+L G PF D K + I E FP + + +L + + SQR
Sbjct: 192 LIYEMLAGYTPFYDS--NTMKTYEKILNAE-LRFPPFFNEDVKDLLSRLITRDLSQR 245
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 5e-17
Identities = 57/242 (23%), Positives = 93/242 (38%), Gaps = 42/242 (17%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSR--R 305
+ + L E L HPNIV+ E+ +L+ +L++ E F
Sbjct: 53 DHQKLEREARICRLLKHPNIVRLHDSI--SEEGHHYLIFDLVTG------GELF-EDIVA 103
Query: 306 RNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365
R +S + QI + H + H L P N+ L S VK++ FGL+
Sbjct: 104 REYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLA--SKLKGAAVKLADFGLAI 161
Query: 366 ARTYASRNTPPASPQNQTAPNPYIWY-APEVLAEQEGTGSTSTSKCSEKADVYSFGMLCF 424
A P Y +PEVL ++ G + D+++ G++ +
Sbjct: 162 ------EVEGEQQAWFGFAGTPG--YLSPEVL-RKDPYG--------KPVDLWACGVILY 204
Query: 425 ELLTGKVPFEDGHLQGDKMTKNIRAG----ERPLFPSGSP--KYLVNLTKKCWHTNPSQR 478
LL G PF D + + I+AG P + + +P K L+ K NPS+R
Sbjct: 205 ILLVGYPPFWDEDQHR--LYQQIKAGAYDFPSPEWDTVTPEAKDLI---NKMLTINPSKR 259
Query: 479 PS 480
+
Sbjct: 260 IT 261
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 6e-17
Identities = 50/245 (20%), Positives = 82/245 (33%), Gaps = 53/245 (21%)
Query: 250 ESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFG------- 302
+ EIS + H NI+ F E +E ++ E +S G
Sbjct: 46 VLVKKEISILNIARHRNILHLHESF--ESMEELVMIFEFIS-----------GLDIFERI 92
Query: 303 SRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFG 362
+ + +V + Q+ ++FLH+ I H ++ P NI + R +K+ FG
Sbjct: 93 NTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSS---TIKIIEFG 149
Query: 363 LSTARTYASRNTPPASPQNQTAPNPYIWY-APEVLAEQEGTGSTSTSKCSEKADVYSFGM 421
+R P P Y APEV + + D++S G
Sbjct: 150 Q-------ARQLKPGDNFRLLFTAPE--YYAPEVH-QHDVVS--------TATDMWSLGT 191
Query: 422 LCFELLTGKVPFEDGHLQGDKMTKNIRAG----ERPLFPSGSP--KYLVNLTKKCWHTNP 475
L + LL+G PF Q + +NI + F S V +
Sbjct: 192 LVYVLLSGINPFLAETNQQ--IIENIMNAEYTFDEEAFKEISIEAMDFV---DRLLVKER 246
Query: 476 SQRPS 480
R +
Sbjct: 247 KSRMT 251
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 6e-17
Identities = 46/242 (19%), Positives = 95/242 (39%), Gaps = 47/242 (19%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMS----KDLSCYMRETFGS 303
E L E+ M H N+V+ + E E +++ME + D+ + +
Sbjct: 85 RRELLFNEVVIMRDYQHFNVVEMYKSYLVGE--ELWVLMEFLQGGALTDI---VSQV--- 136
Query: 304 RRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGL 363
+ + + + + + +LHAQ + H ++ +I L +++G VK+S FG
Sbjct: 137 ----RLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILL---TLDG--RVKLSDFGF 187
Query: 364 ST--ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGM 421
++ R + PY W APEV++ + + D++S G+
Sbjct: 188 CAQISKDVPKRKS--------LVGTPY-WMAPEVISRSL---------YATEVDIWSLGI 229
Query: 422 LCFELLTGKVPFEDGH-LQGDKMTKNIRAGERPLF--PSGSPKYLVNLTKKCWHTNPSQR 478
+ E++ G+ P+ +Q K +R P L + ++ +P +R
Sbjct: 230 MVIEMVDGEPPYFSDSPVQAMKR---LRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQER 286
Query: 479 PS 480
+
Sbjct: 287 AT 288
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 9e-17
Identities = 53/248 (21%), Positives = 86/248 (34%), Gaps = 60/248 (24%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRN 307
+ + + E+ + L HPN +QY + E +LVME S + +
Sbjct: 97 KWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT--AWLVMEYCLGSASDLLEVH-----KK 149
Query: 308 SFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTAR 367
+ + +G+ +LH+ + H ++ NI L S G VK+ FG ++
Sbjct: 150 PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPG--LVKLGDFGSAS-- 202
Query: 368 TYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELL 427
A N+ + PY W APEV+ + K DV+S G+ C EL
Sbjct: 203 IMAPANSFVGT--------PY-WMAPEVILAMDEGQYD------GKVDVWSLGITCIELA 247
Query: 428 TGKVPFEDGH---------------LQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWH 472
K P + + LQ ++ R N C
Sbjct: 248 ERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFR----------------NFVDSCLQ 291
Query: 473 TNPSQRPS 480
P RP+
Sbjct: 292 KIPQDRPT 299
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 65/274 (23%), Positives = 101/274 (36%), Gaps = 58/274 (21%)
Query: 250 ESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSR--RRN 307
+ + EI +L LSHPNI++ F E E LV+EL E F R +
Sbjct: 93 KIVRTEIGVLLRLSHPNIIKLKEIF--ETPTEISLVLEL------VTGGELF-DRIVEKG 143
Query: 308 SFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTAR 367
+S D + QI + +LH I H +L P N+ + +K++ FGL
Sbjct: 144 YYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYA--TPAPDAPLKIADFGL---- 197
Query: 368 TYASRNTPPASPQNQTAPNPYIWY-APEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFEL 426
S+ P Y APE+L G + D++S G++ + L
Sbjct: 198 ---SKIVEHQVLMKTVCGTPG--YCAPEIL-RGCAYG--------PEVDMWSVGIITYIL 243
Query: 427 LTGKVPFEDGHLQGDKMTKNIRAGE----RPLFPSGSP--KYLVNLTKKCWHTNPSQR-- 478
L G PF D M + I E P + S K LV +K +P +R
Sbjct: 244 LCGFEPFYDERGD-QFMFRRILNCEYYFISPWWDEVSLNAKDLV---RKLIVLDPKKRLT 299
Query: 479 --------------PSFSSICRILRYIKKFMANN 498
+F + + +++F A
Sbjct: 300 TFQALQHPWVTGKAANFVHMDTAQKKLQEFNARR 333
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 50/246 (20%), Positives = 85/246 (34%), Gaps = 75/246 (30%)
Query: 255 EISTMLSLS-HPNIVQYLCGFCDE--EKKEFFLVMELMSKDLSCYMRETFG--------S 303
E+ S P+IV+ + + + +K +VME + G
Sbjct: 60 EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD-----------GGELFSRIQD 108
Query: 304 RRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGL 363
R +F+ +IM I +++LH+ I H ++ P N+ ++ +K++ FG
Sbjct: 109 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNA--ILKLTDFGF 166
Query: 364 STARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLC 423
A E E K + D++S G++
Sbjct: 167 ----------------------------AKETTGE----------KYDKSCDMWSLGVIM 188
Query: 424 FELLTGKVPF--EDGHLQGDKMTKNIRAGERPLFP-------SGSPKYLVNLTKKCWHTN 474
+ LL G PF G M IR G+ FP S K L+ + T
Sbjct: 189 YILLCGYPPFYSNHGLAISPGMKTRIRMGQ-YEFPNPEWSEVSEEVKMLI---RNLLKTE 244
Query: 475 PSQRPS 480
P+QR +
Sbjct: 245 PTQRMT 250
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 3e-16
Identities = 44/240 (18%), Positives = 87/240 (36%), Gaps = 41/240 (17%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRR 306
+ E + + IV F + LVM +M+ D+ ++
Sbjct: 228 GYQGAMVEKKILAKVHSRFIVSLAYAFETKTD--LCLVMTIMNGGDIRYHIYNVDEDNPG 285
Query: 307 NSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS-- 364
F P + QI G+E LH + I + +L P N+ L +G +V++S GL+
Sbjct: 286 --FQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDD---DG--NVRISDLGLAVE 338
Query: 365 ----TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFG 420
+T TP ++ APE+L +E S D ++ G
Sbjct: 339 LKAGQTKTKGYAGTPG-----------FM--APELLLGEEYDFS---------VDYFALG 376
Query: 421 MLCFELLTGKVPF--EDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQR 478
+ +E++ + PF ++ ++ + + +P + + +P +R
Sbjct: 377 VTLYEMIAARGPFRARGEKVENKELKQRVLEQA-VTYPDKFSPASKDFCEALLQKDPEKR 435
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 5e-16
Identities = 52/202 (25%), Positives = 87/202 (43%), Gaps = 38/202 (18%)
Query: 255 EISTMLSLSHPNIVQYLCGFC--DEEKKEFFL--VMELMSKDLSCYMRETFGSRRRNSFS 310
E+ M L H NIV+ F E+K E +L V++ + + + R SR + +
Sbjct: 97 ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHY--SRAKQTLP 154
Query: 311 LPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYA 370
+ V M Q+ R + ++H+ I H ++ P N+ L + +K+ FG A+
Sbjct: 155 VIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAV----LKLCDFGS--AKQLV 208
Query: 371 SRNTPPASPQNQTAPN-PYI---WY-APEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFE 425
PN YI +Y APE++ G+T + DV+S G + E
Sbjct: 209 RGE-----------PNVSYICSRYYRAPELIF-----GATDYTS---SIDVWSAGCVLAE 249
Query: 426 LLTGKVPF--EDGHLQGDKMTK 445
LL G+ F + G Q ++ K
Sbjct: 250 LLLGQPIFPGDSGVDQLVEIIK 271
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 5e-16
Identities = 60/251 (23%), Positives = 101/251 (40%), Gaps = 63/251 (25%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMS----KDLSCYMRETFGS 303
+L+ + EIS M P++V+Y + ++VME D+ +R
Sbjct: 67 DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTD--LWIVMEYCGAGSVSDI---IRLR--- 118
Query: 304 RRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGL 363
+ + + I+ +G+E+LH + H ++ NI L + EG H K++ FG+
Sbjct: 119 --NKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILL---NTEG--HAKLADFGV 171
Query: 364 ST--ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGM 421
+ T A RNT + P+ W APEV+ E + AD++S G+
Sbjct: 172 AGQLTDTMAKRNTVIGT--------PF-WMAPEVIQEIG---------YNCVADIWSLGI 213
Query: 422 LCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLF--PSGSP----------KYLVNLTKK 469
E+ GK P+ D H M R +F P+ P + K+
Sbjct: 214 TAIEMAEGKPPYADIH----PM--------RAIFMIPTNPPPTFRKPELWSDNFTDFVKQ 261
Query: 470 CWHTNPSQRPS 480
C +P QR +
Sbjct: 262 CLVKSPEQRAT 272
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 6e-16
Identities = 59/323 (18%), Positives = 109/323 (33%), Gaps = 70/323 (21%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRR 306
E + ++ +V + ++ LV+ LM+ DL ++ +
Sbjct: 227 GEAMALNEKQILEKVNSRFVVSLAYAYETKDA--LCLVLTLMNGGDLKFHIYHM----GQ 280
Query: 307 NSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS-- 364
F V +I G+E LH ++I + +L P NI L G H+++S GL+
Sbjct: 281 AGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDD---HG--HIRISDLGLAVH 335
Query: 365 -----TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSF 419
T + T Y+ APEV+ + T S D ++
Sbjct: 336 VPEGQTIKGRVG--TVG-----------YM--APEVVKNERYTFS---------PDWWAL 371
Query: 420 GMLCFELLTGKVPF--EDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQ 477
G L +E++ G+ PF ++ +++ + ++ + +L + +P++
Sbjct: 372 GCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVP-EEYSERFSPQARSLCSQLLCKDPAE 430
Query: 478 R--------------PSFSSICRILRYIKKFMAN-NPDIARSEFQSPLADYCDIEAGFVR 522
R P F + PD D DIE
Sbjct: 431 RLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKPDP----QAIYCKDVLDIEQFSTV 486
Query: 523 KFVGEGCPDVAPVSQIPFQMFAY 545
K ++ P Q +Q FA
Sbjct: 487 K-----GVELEPTDQDFYQKFAT 504
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 8e-16
Identities = 57/242 (23%), Positives = 92/242 (38%), Gaps = 43/242 (17%)
Query: 250 ESLNAEISTMLSLS-HPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSR--RR 306
E+ E + ++ HP+I+ L E FLV +LM K E F +
Sbjct: 144 EATRRETHILRQVAGHPHIIT-LIDSY-ESSSFMFLVFDLMRKG------ELF-DYLTEK 194
Query: 307 NSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366
+ S IM + + FLHA I H +L P NI L +++S FG
Sbjct: 195 VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNM-----QIRLSDFGF--- 246
Query: 367 RTYASRNTPPASPQNQTAPNPYIWY-APEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFE 425
S + P + P Y APE+L + + + ++ D+++ G++ F
Sbjct: 247 ----SCHLEPGEKLRELCGTPG--YLAPEIL---KCSMDETHPGYGKEVDLWACGVILFT 297
Query: 426 LLTGKVPFEDGHLQGDKMTKNIRAGERPLFP-------SGSPKYLVNLTKKCWHTNPSQR 478
LL G PF M + I G+ F S + K L+ + +P R
Sbjct: 298 LLAGSPPFWHRRQIL--MLRMIMEGQ-YQFSSPEWDDRSSTVKDLI---SRLLQVDPEAR 351
Query: 479 PS 480
+
Sbjct: 352 LT 353
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 1e-15
Identities = 64/257 (24%), Positives = 104/257 (40%), Gaps = 60/257 (23%)
Query: 248 ELESLNAEISTM-LSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRR 305
++E E + L+ HP + C F +E F VME ++ DL +++
Sbjct: 60 DVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN--LFFVMEYLNGGDLMYHIQ------S 111
Query: 306 RNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS- 364
+ F L +I G++FLH++ I + +L NI L +G H+K++ FG+
Sbjct: 112 CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDK---DG--HIKIADFGMCK 166
Query: 365 -------TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVY 417
T+ TP YI APE+L Q+ S D +
Sbjct: 167 ENMLGDAKTNTFCG--TPD-----------YI--APEILLGQKYNHS---------VDWW 202
Query: 418 SFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQ 477
SFG+L +E+L G+ PF +++ +IR P +P K +L K + P +
Sbjct: 203 SFGVLLYEMLIGQSPFHGQ--DEEELFHSIRMDN-PFYPRWLEKEAKDLLVKLFVREPEK 259
Query: 478 R----------PSFSSI 484
R P F I
Sbjct: 260 RLGVRGDIRQHPLFREI 276
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 2e-15
Identities = 47/240 (19%), Positives = 93/240 (38%), Gaps = 49/240 (20%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRR 306
E+ E + + HP + F ++ VME + +L ++ R
Sbjct: 48 EVAHTVTESRVLQNTRHPFLTALKYAFQTHDR--LCFVMEYANGGELFFHLS------RE 99
Query: 307 NSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS-- 364
F+ +I +E+LH++ + + ++ N+ L +G H+K++ FGL
Sbjct: 100 RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDK---DG--HIKITDFGLCKE 154
Query: 365 ------TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYS 418
T +T+ TP Y+ APEVL + + + D +
Sbjct: 155 GISDGATMKTFCG--TPE-----------YL--APEVLEDNDYGRA---------VDWWG 190
Query: 419 FGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQR 478
G++ +E++ G++PF + +++ + I E FP +L +P QR
Sbjct: 191 LGVVMYEMMCGRLPFYNQ--DHERLFELILMEE-IRFPRTLSPEAKSLLAGLLKKDPKQR 247
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 2e-15
Identities = 50/224 (22%), Positives = 88/224 (39%), Gaps = 41/224 (18%)
Query: 261 SLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIML 319
+ P IV F +K +++LM+ DL ++ + FS +
Sbjct: 248 TGDCPFIVCMSYAFHTPDK--LSFILDLMNGGDLHYHLS------QHGVFSEADMRFYAA 299
Query: 320 QIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS----TARTYASRNTP 375
+I G+E +H + + + +L P+NI L G HV++S GL+ + +AS T
Sbjct: 300 EIILGLEHMHNRFVVYRDLKPANILLDE---HG--HVRISDLGLACDFSKKKPHASVGTH 354
Query: 376 PASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFED 435
Y+ APEVL + S+ AD +S G + F+LL G PF
Sbjct: 355 G-----------YM--APEVLQKGVAYDSS--------ADWFSLGCMLFKLLRGHSPFRQ 393
Query: 436 GHLQ-GDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQR 478
+ ++ + P L +L + + ++R
Sbjct: 394 HKTKDKHEIDRMTLTMA-VELPDSFSPELRSLLEGLLQRDVNRR 436
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 51/270 (18%), Positives = 94/270 (34%), Gaps = 72/270 (26%)
Query: 255 EISTMLSLSHPNIV------------QYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFG 302
EI + L H NIV E ++V E M DL+ + +
Sbjct: 58 EIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPL 117
Query: 303 SRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFG 362
M Q+ RG++++H+ + H +L P+N+++ + +K+ FG
Sbjct: 118 LEEHARL-------FMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLV----LKIGDFG 166
Query: 363 LSTARTYASRNTPPASPQNQTAPNPYI---WY-APEVLAEQEGTGSTSTSKCSEKADVYS 418
L AR + + + + WY +P +L S + ++ D+++
Sbjct: 167 L--ARIMDP---HYSHKGHLS---EGLVTKWYRSPRLL--------LSPNNYTKAIDMWA 210
Query: 419 FGMLCFELLTGKVPF---------------------EDGHLQGDKMTKNIRA-GERP--- 453
G + E+LTGK F ED + IR P
Sbjct: 211 AGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKP 270
Query: 454 ---LFPSGSPKYLVNLTKKCWHTNPSQRPS 480
L P S + + + ++ +P R +
Sbjct: 271 LTQLLPGISREAV-DFLEQILTFSPMDRLT 299
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 3e-15
Identities = 41/254 (16%), Positives = 85/254 (33%), Gaps = 53/254 (20%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGS---- 303
+ E+ + + P IV + F + E + ME M GS
Sbjct: 74 IRNQIIRELQVLHECNSPYIVGFYGAFYSDG--EISICMEHMDG----------GSLDQV 121
Query: 304 -RRRNSFSLPVVVDIMLQIARGMEFLHAQ-KIYHGELNPSNIYLKARSMEGYFHVKVSGF 361
++ ++ + + + +G+ +L + KI H ++ PSNI + +R +K+ F
Sbjct: 122 LKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-----EIKLCDF 176
Query: 362 GLST------ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKAD 415
G+S A ++ T + +PE L S ++D
Sbjct: 177 GVSGQLIDSMANSFVG--TRS-------------YMSPERLQGT---------HYSVQSD 212
Query: 416 VYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNP 475
++S G+ E+ G+ P + ++ + P+ K +
Sbjct: 213 IWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSR 272
Query: 476 SQRPSFSSICRILR 489
F + I+
Sbjct: 273 PPMAIFELLDYIVN 286
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 3e-15
Identities = 52/293 (17%), Positives = 99/293 (33%), Gaps = 94/293 (32%)
Query: 255 EISTMLSLSHPNIVQYLCGFCD------------------------------------EE 278
E+ M L H NI++ + F +
Sbjct: 50 ELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQ 109
Query: 279 KKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGEL 338
K ++ME + L ++ R S + ++ + Q+ R + F+H+ I H ++
Sbjct: 110 NKYLNVIMEYVPDTLHKVLKSF--IRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDI 167
Query: 339 NPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTPPASPQNQTAPN-PYI---WY-AP 393
P N+ + ++ +K+ FG A+ + P+ YI +Y AP
Sbjct: 168 KPQNLLVNSKDNT----LKLCDFGS--AKKL-----------IPSEPSVAYICSRFYRAP 210
Query: 394 EVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPF--EDGHLQGDKMTK------ 445
E++ G+T + D++S G + EL+ GK F E Q ++ +
Sbjct: 211 ELML-----GATEYTP---SIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPT 262
Query: 446 -------NIRAGERPL-----------FPSGSPKYLVNLTKKCWHTNPSQRPS 480
N E P G+P ++L ++ P R +
Sbjct: 263 KEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRIN 315
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 3e-15
Identities = 54/263 (20%), Positives = 98/263 (37%), Gaps = 73/263 (27%)
Query: 255 EISTMLSLSHPNIVQ----YLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFS 310
E+ + + H N++ + +F+LVM M DL M F +
Sbjct: 73 ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYL- 131
Query: 311 LPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYA 370
+ Q+ +G++++H+ + H +L P N+ + +K+ FGL AR
Sbjct: 132 -------VYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDC-----ELKILDFGL--ARHAD 177
Query: 371 SRNTPPASPQNQTAPNPYI---WY-APEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFEL 426
+ T Y+ WY APEV+ S ++ D++S G + E+
Sbjct: 178 AEMT------------GYVVTRWYRAPEVI--------LSWMHYNQTVDIWSVGCIMAEM 217
Query: 427 LTGKVPF--EDGHLQGDKMT-----------------------KNIRAGERP----LFPS 457
LTGK F +D Q ++ +++ R LFP
Sbjct: 218 LTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPR 277
Query: 458 GSPKYLVNLTKKCWHTNPSQRPS 480
SP+ +L +K + +R +
Sbjct: 278 ASPQAA-DLLEKMLELDVDKRLT 299
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 5e-15
Identities = 25/226 (11%), Positives = 58/226 (25%), Gaps = 65/226 (28%)
Query: 261 SLSHPNIVQ-YLCGFCDEEKKEFFLVMELM-SKDLSCYMRETFGSRRRNSFSLPVVVDIM 318
+ P + + + +V E + L + + M
Sbjct: 87 RIDKPGVARVLDVV---HTRAGGLVVAEWIRGGSLQEVADTSPSPVG--------AIRAM 135
Query: 319 LQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTPPAS 378
+A + H + +PS + + S++G V ++ P A+
Sbjct: 136 QSLAAAADAAHRAGVALSIDHPSRVRV---SIDG--DVVLAYPAT----------MPDAN 180
Query: 379 PQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHL 438
PQ D+ G + LL + P + +
Sbjct: 181 PQ---------------------------------DDIRGIGASLYALLVNRWPLPEAGV 207
Query: 439 QGDKMTKNIRAGERPLFPS----GSPKYLVNLTKKCWHTNPSQRPS 480
+ +P+ P+ P + + + + R +
Sbjct: 208 RSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIRSA 253
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-14
Identities = 58/266 (21%), Positives = 99/266 (37%), Gaps = 65/266 (24%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEF---FLVMELMSKDLSCYMRETFGSRRRNSFSL 311
EI + H NI+ + + F +++ ELM DL + S +
Sbjct: 59 EIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQY-- 116
Query: 312 PVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYAS 371
+ Q R ++ LH + H +L PSN+ + + +KV FGL AR
Sbjct: 117 -----FIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNC-----DLKVCDFGL--ARIIDE 164
Query: 372 RNTPPASPQNQTAP-NPYI---WY-APEVLAEQEGTGSTSTSKCSEKADVYSFGMLCF-- 424
+ P Q + ++ WY APEV+ +++K S DV+S G C
Sbjct: 165 SAADNSEPTGQQSGMVEFVATRWYRAPEVM--------LTSAKYSRAMDVWSCG--CILA 214
Query: 425 ELLTGKVPF--EDGHLQGDKMT---------------KNIRA-------GERP------L 454
EL + F D Q + ++ RA P +
Sbjct: 215 ELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKM 274
Query: 455 FPSGSPKYLVNLTKKCWHTNPSQRPS 480
FP +PK + +L ++ +P++R +
Sbjct: 275 FPRVNPKGI-DLLQRMLVFDPAKRIT 299
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 1e-14
Identities = 43/219 (19%), Positives = 81/219 (36%), Gaps = 32/219 (14%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRR 306
E E +++ I F D+ +LVM+ DL + S+
Sbjct: 117 ETACFREERDVLVNGDSKWITTLHYAFQDDNN--LYLVMDYYVGGDLLTLL-----SKFE 169
Query: 307 NSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366
+ + + ++ ++ +H H ++ P NI + G H++++ FG
Sbjct: 170 DRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDM---NG--HIRLADFGSCL- 223
Query: 367 RTYASRNTPPASPQNQTA---PNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLC 423
+ + Q+ A P+ YI +PE+L EG +C D +S G+
Sbjct: 224 -----KLMEDGTVQSSVAVGTPD-YI--SPEILQAMEGGKGRYGPEC----DWWSLGVCM 271
Query: 424 FELLTGKVPFEDGHLQGDKMTKNIRAGERPL-FPSGSPK 461
+E+L G+ PF L + I + FP+
Sbjct: 272 YEMLYGETPFYAESLV--ETYGKIMNHKERFQFPTQVTD 308
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 50/187 (26%), Positives = 80/187 (42%), Gaps = 42/187 (22%)
Query: 255 EISTMLSLSHPNIVQYLCGFC----DEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFS 310
E+ M ++H NI+ L F EE ++ ++VMELM +L ++ R +
Sbjct: 74 ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL- 132
Query: 311 LPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYA 370
+ Q+ G++ LH+ I H +L PSNI +K+ +K+ FGL ART
Sbjct: 133 -------LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-----TLKILDFGL--ARTAG 178
Query: 371 SRNTPPASPQNQTAPNPYI---WY-APEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFEL 426
PY+ +Y APEV+ E D++S G + E+
Sbjct: 179 ----------TSFMMTPYVVTRYYRAPEVIL---------GMGYKENVDIWSVGCIMGEM 219
Query: 427 LTGKVPF 433
+ G V F
Sbjct: 220 IKGGVLF 226
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 54/226 (23%), Positives = 89/226 (39%), Gaps = 45/226 (19%)
Query: 260 LSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIM 318
L+ +HP + Q C F ++ F VME ++ DL +++ + F
Sbjct: 79 LARNHPFLTQLFCCFQTPDR--LFFVMEFVNGGDLMFHIQ------KSRRFDEARARFYA 130
Query: 319 LQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS------TARTYASR 372
+I + FLH + I + +L N+ L EG H K++ FG+ T
Sbjct: 131 AEIISALMFLHDKGIIYRDLKLDNVLLDH---EG--HCKLADFGMCKEGICNGVTTATFC 185
Query: 373 NTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVP 432
TP YI APE+L E + D ++ G+L +E+L G P
Sbjct: 186 GTPD-----------YI--APEILQEMLYGPA---------VDWWAMGVLLYEMLCGHAP 223
Query: 433 FEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQR 478
FE D + + I E ++P+ + + K NP+ R
Sbjct: 224 FEAE--NEDDLFEAILNDE-VVYPTWLHEDATGILKSFMTKNPTMR 266
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 57/263 (21%), Positives = 100/263 (38%), Gaps = 72/263 (27%)
Query: 255 EISTMLSLSHPNIVQ----YLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFS 310
E+ + + H N++ + ++ +F+LVM M DL M+ R F
Sbjct: 74 ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQF- 132
Query: 311 LPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYA 370
++ Q+ +G+ ++HA I H +L P N+ + +K+ FGL AR
Sbjct: 133 ------LVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDC-----ELKILDFGL--ARQAD 179
Query: 371 SRNTPPASPQNQTAPNPYI---WY-APEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFEL 426
S T Y+ WY APEV+ + + ++ D++S G + E+
Sbjct: 180 SEMT------------GYVVTRWYRAPEVI--------LNWMRYTQTVDIWSVGCIMAEM 219
Query: 427 LTGKVPF--EDGHLQGDKMTK--------------NIRA-------GERP------LFPS 457
+TGK F D Q ++ K + A E + +
Sbjct: 220 ITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTN 279
Query: 458 GSPKYLVNLTKKCWHTNPSQRPS 480
SP + NL +K + QR +
Sbjct: 280 ASPLAV-NLLEKMLVLDAEQRVT 301
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 3e-14
Identities = 57/263 (21%), Positives = 100/263 (38%), Gaps = 72/263 (27%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEFF----LVMELMSKDLSCYMRETFGSRRRNSFS 310
E+ + + H N++ L F E F LV LM DL+ ++ + F
Sbjct: 78 ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF- 136
Query: 311 LPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYA 370
++ QI RG++++H+ I H +L PSN+ + +K+ FGL AR A
Sbjct: 137 ------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-----ELKILDFGL--ARHTA 183
Query: 371 SRNTPPASPQNQTAPNPYI---WY-APEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFEL 426
T Y+ WY APE++ + ++ D++S G + EL
Sbjct: 184 DEMT------------GYVATRWYRAPEIM--------LNWMHYNQTVDIWSVGCIMAEL 223
Query: 427 LTGKVPF---------------------ED-GHLQGDKMTKNIRA-GERP------LFPS 457
LTG+ F E + + I++ + P +F
Sbjct: 224 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG 283
Query: 458 GSPKYLVNLTKKCWHTNPSQRPS 480
+P V+L +K + +R +
Sbjct: 284 ANPL-AVDLLEKMLVLDSDKRIT 305
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 75.8 bits (186), Expect = 3e-14
Identities = 59/241 (24%), Positives = 102/241 (42%), Gaps = 50/241 (20%)
Query: 248 ELESLNAEISTM-LSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRR 305
++E E + L P + Q F ++ + VME ++ DL +++ +
Sbjct: 384 DVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR--LYFVMEYVNGGDLMYHIQ------Q 435
Query: 306 RNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS- 364
F P V +IA G+ FL ++ I + +L N+ L + EG H+K++ FG+
Sbjct: 436 VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDS---EG--HIKIADFGMCK 490
Query: 365 -------TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVY 417
T +T+ TP YI APE++A Q S D +
Sbjct: 491 ENIWDGVTTKTFCG--TP-----------DYI--APEIIAYQPYGKS---------VDWW 526
Query: 418 SFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQ 477
+FG+L +E+L G+ PFE D++ ++I +P K V + K +P +
Sbjct: 527 AFGVLLYEMLAGQAPFEGE--DEDELFQSIMEHN-VAYPKSMSKEAVAICKGLMTKHPGK 583
Query: 478 R 478
R
Sbjct: 584 R 584
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 3e-14
Identities = 50/240 (20%), Positives = 91/240 (37%), Gaps = 48/240 (20%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRR 306
E+ E + + HP + F ++ VME + +L ++ R
Sbjct: 191 EVAHTLTENRVLQNSRHPFLTALKYSFQTHDR--LCFVMEYANGGELFFHLS------RE 242
Query: 307 NSFSLPVVVDIMLQIARGMEFLHAQK--IYHGELNPSNIYLKARSMEGYFHVKVSGFGLS 364
FS +I +++LH++K +Y +L N+ L +G H+K++ FGL
Sbjct: 243 RVFSEDRARFYGAEIVSALDYLHSEKNVVYR-DLKLENLMLDK---DG--HIKITDFGLC 296
Query: 365 ------TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYS 418
A TP Y+ APEVL + + + D +
Sbjct: 297 KEGIKDGATMKTFCGTPE-----------YL--APEVLEDNDYGRA---------VDWWG 334
Query: 419 FGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQR 478
G++ +E++ G++PF + +K+ + I E FP +L +P QR
Sbjct: 335 LGVVMYEMMCGRLPFYNQ--DHEKLFELILMEE-IRFPRTLGPEAKSLLSGLLKKDPKQR 391
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 73.7 bits (182), Expect = 3e-14
Identities = 54/238 (22%), Positives = 88/238 (36%), Gaps = 45/238 (18%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRR 306
+ AE + + + HP IV + F K +L++E +S +L + R
Sbjct: 64 DTAHTKAERNILEEVKHPFIVDLIYAFQTGGK--LYLILEYLSGGELFMQLE------RE 115
Query: 307 NSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS-- 364
F + +I+ + LH + I + +L P NI L +G HVK++ FGL
Sbjct: 116 GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNH---QG--HVKLTDFGLCKE 170
Query: 365 ----TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFG 420
T+ T Y+ APE+L + D +S G
Sbjct: 171 SIHDGTVTHTFCGTIE-----------YM--APEILMRSGHNRA---------VDWWSLG 208
Query: 421 MLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQR 478
L +++LTG PF + K I + P + +L KK N + R
Sbjct: 209 ALMYDMLTGAPPFTGENR--KKTIDKILKCK-LNLPPYLTQEARDLLKKLLKRNAASR 263
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 3e-14
Identities = 57/228 (25%), Positives = 97/228 (42%), Gaps = 49/228 (21%)
Query: 260 LSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIM 318
L P + Q F ++ + VME ++ DL +++ + F P V
Sbjct: 76 LPGKPPFLTQLHSCFQTMDR--LYFVMEYVNGGDLMYHIQ------QVGRFKEPHAVFYA 127
Query: 319 LQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS--------TARTYA 370
+IA G+ FL ++ I + +L N+ L + EG H+K++ FG+ T +T+
Sbjct: 128 AEIAIGLFFLQSKGIIYRDLKLDNVMLDS---EG--HIKIADFGMCKENIWDGVTTKTFC 182
Query: 371 SRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGK 430
TP YI APE++A Q S D ++FG+L +E+L G+
Sbjct: 183 G--TPD-----------YI--APEIIAYQPYGKS---------VDWWAFGVLLYEMLAGQ 218
Query: 431 VPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQR 478
PFE D++ ++I +P K V + K +P +R
Sbjct: 219 APFEGE--DEDELFQSIMEHN-VAYPKSMSKEAVAICKGLMTKHPGKR 263
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 5e-14
Identities = 50/187 (26%), Positives = 81/187 (43%), Gaps = 42/187 (22%)
Query: 255 EISTMLSLSHPNIVQYLCGFC----DEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFS 310
E+ M ++H NI+ L F EE ++ +LVMELM +L ++ R +
Sbjct: 111 ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL- 169
Query: 311 LPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYA 370
+ Q+ G++ LH+ I H +L PSNI +K+ +K+ FGL ART
Sbjct: 170 -------LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-----TLKILDFGL--ARTAG 215
Query: 371 SRNTPPASPQNQTAPNPYI---WY-APEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFEL 426
+ PY+ +Y APEV+ E D++S G + E+
Sbjct: 216 T----------SFMMTPYVVTRYYRAPEVIL---------GMGYKENVDIWSVGCIMGEM 256
Query: 427 LTGKVPF 433
+ K+ F
Sbjct: 257 VRHKILF 263
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 5e-14
Identities = 50/262 (19%), Positives = 87/262 (33%), Gaps = 57/262 (21%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEF---FLVMELMSKDLSCYMRETFGSRRRNSFSL 311
EI+ + L+H ++V+ L ++ ++F ++V+E+ D R +
Sbjct: 102 EIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFR------TPVYLTE 155
Query: 312 PVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYAS 371
+ ++ + G++++H+ I H +L P+N + VKV FGL ART
Sbjct: 156 LHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDC-----SVKVCDFGL--ARTVDY 208
Query: 372 RNTPPASPQNQTAPNPYI---------------------WY-APEVLAEQEGTGSTSTSK 409
+ + WY APE++
Sbjct: 209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELI--------LLQEN 260
Query: 410 CSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKK 469
+E DV+S G + ELL H PLFP S L K
Sbjct: 261 YTEAIDVWSIGCIFAELLNMIKENVAYHADR-----------GPLFPGSSCFPLSPDQKA 309
Query: 470 CWHTNPSQRPSFSSICRILRYI 491
R + + I +
Sbjct: 310 GNDFKFHTRGNRDQLNVIFNIL 331
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 8e-14
Identities = 51/225 (22%), Positives = 91/225 (40%), Gaps = 44/225 (19%)
Query: 264 HPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIA 322
P +V F E K L+++ ++ +L ++ +R F+ V + +I
Sbjct: 118 SPFLVTLHYAFQTETK--LHLILDYINGGELFTHLS------QRERFTEHEVQIYVGEIV 169
Query: 323 RGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS-------TARTYASRNTP 375
+E LH I + ++ NI L + G HV ++ FGLS T R Y T
Sbjct: 170 LALEHLHKLGIIYRDIKLENILLDS---NG--HVVLTDFGLSKEFVADETERAYDFCGTI 224
Query: 376 PASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPF-- 433
Y+ AP+++ + +G D +S G+L +ELLTG PF
Sbjct: 225 E-----------YM--APDIVRGGD-SGHDKA------VDWWSLGVLMYELLTGASPFTV 264
Query: 434 EDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQR 478
+ ++++ I E P +P +L ++ +P +R
Sbjct: 265 DGEKNSQAEISRRILKSE-PPYPQEMSALAKDLIQRLLMKDPKKR 308
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 8e-14
Identities = 52/243 (21%), Positives = 80/243 (32%), Gaps = 48/243 (19%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMR--ETFGSRR 305
+ E M + P +VQ F D+ ++VME YM +
Sbjct: 112 DSAFFWEERDIMAFANSPWVVQLFYAFQDDRY--LYMVME--------YMPGGDLVNLMS 161
Query: 306 RNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS- 364
++ ++ +H+ H ++ P N+ L G H+K++ FG
Sbjct: 162 NYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDK---SG--HLKLADFGTCM 216
Query: 365 ------TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYS 418
R + TP YI +PEVL Q G G D +S
Sbjct: 217 KMNKEGMVRCDTAVGTPD-----------YI--SPEVLKSQGGDGYYGRE-----CDWWS 258
Query: 419 FGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPL-FPSGS--PKYLVNLTKKCWHTNP 475
G+ +E+L G PF L I + L FP + K NL T+
Sbjct: 259 VGVFLYEMLVGDTPFYADSLV--GTYSKIMNHKNSLTFPDDNDISKEAKNLICAFL-TDR 315
Query: 476 SQR 478
R
Sbjct: 316 EVR 318
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 9e-14
Identities = 58/234 (24%), Positives = 99/234 (42%), Gaps = 49/234 (20%)
Query: 254 AEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMR--ETFGS-RRRNSFS 310
E ++ ++HP IV+ F E K +L+++ ++R + F + F+
Sbjct: 75 MERDILVEVNHPFIVKLHYAFQTEGK--LYLILD--------FLRGGDLFTRLSKEVMFT 124
Query: 311 LPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS------ 364
V + ++A ++ LH+ I + +L P NI L EG H+K++ FGLS
Sbjct: 125 EEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDE---EG--HIKLTDFGLSKESIDH 179
Query: 365 TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCF 424
+ Y+ T Y+ APEV+ + T S AD +SFG+L F
Sbjct: 180 EKKAYSFCGTVE-----------YM--APEVVNRRGHTQS---------ADWWSFGVLMF 217
Query: 425 ELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQR 478
E+LTG +PF+ + I + P +L + + NP+ R
Sbjct: 218 EMLTGTLPFQGKDR--KETMTMILKAK-LGMPQFLSPEAQSLLRMLFKRNPANR 268
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 9e-14
Identities = 46/245 (18%), Positives = 82/245 (33%), Gaps = 46/245 (18%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRR 306
E+ E +++ I Q F DE +LVME DL + S+
Sbjct: 104 EVSCFREERDVLVNGDRRWITQLHFAFQDENY--LYLVMEYYVGGDLLTLL-----SKFG 156
Query: 307 NSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS-- 364
+ + +I ++ +H H ++ P NI L G H++++ FG
Sbjct: 157 ERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDR---CG--HIRLADFGSCLK 211
Query: 365 -----TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSF 419
T R+ + TP Y+ +PE+L G T + D ++
Sbjct: 212 LRADGTVRSLVAVGTPD-----------YL--SPEILQAVGGGPGTGSYGPE--CDWWAL 256
Query: 420 GMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWH------T 473
G+ +E+ G+ PF + I + L P + ++
Sbjct: 257 GVFAYEMFYGQTPFYADST--AETYGKIVHYKEHL---SLPLVDEGVPEEARDFIQRLLC 311
Query: 474 NPSQR 478
P R
Sbjct: 312 PPETR 316
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 2e-13
Identities = 56/264 (21%), Positives = 100/264 (37%), Gaps = 69/264 (26%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEF---FLVMELMSKDLSCYMRETFGSRRRNSFSL 311
EI +L H NI+ ++ ++V +LM DL ++ S +
Sbjct: 75 EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-- 132
Query: 312 PVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYAS 371
+ QI RG++++H+ + H +L PSN+ L +K+ FGL AR
Sbjct: 133 -----FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC-----DLKICDFGL--ARV--- 177
Query: 372 RNTPPASPQNQTAPN--PYI---WY-APEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFE 425
A P + Y+ WY APE++ ++ ++ D++S G + E
Sbjct: 178 -----ADPDHDHTGFLTEYVATRWYRAPEIM--------LNSKGYTKSIDIWSVGCILAE 224
Query: 426 LLTGKVPF--EDGHLQGDKMT--------------KNIRA-------GERP------LFP 456
+L+ + F + Q + + N++A + LFP
Sbjct: 225 MLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFP 284
Query: 457 SGSPKYLVNLTKKCWHTNPSQRPS 480
+ K L +L K NP +R
Sbjct: 285 NADSKAL-DLLDKMLTFNPHKRIE 307
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 2e-13
Identities = 48/228 (21%), Positives = 86/228 (37%), Gaps = 49/228 (21%)
Query: 260 LSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIM 318
++ HP +V F +K + V++ ++ +L +++ R F P
Sbjct: 94 KNVKHPFLVGLHFSFQTADK--LYFVLDYINGGELFYHLQ------RERCFLEPRARFYA 145
Query: 319 LQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS--------TARTYA 370
+IA + +LH+ I + +L P NI L + +G H+ ++ FGL T T+
Sbjct: 146 AEIASALGYLHSLNIVYRDLKPENILLDS---QG--HIVLTDFGLCKENIEHNSTTSTFC 200
Query: 371 SRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGK 430
TP Y+ APEVL +Q + D + G + +E+L G
Sbjct: 201 G--TPE-----------YL--APEVLHKQPYDRT---------VDWWCLGAVLYEMLYGL 236
Query: 431 VPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQR 478
PF +M NI +L + + ++R
Sbjct: 237 PPFYSR--NTAEMYDNILNKP-LQLKPNITNSARHLLEGLLQKDRTKR 281
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 50/196 (25%), Positives = 85/196 (43%), Gaps = 39/196 (19%)
Query: 255 EISTMLSLS-HPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPV 313
EI + LS H NIV L + ++ +LV + M DL +R +
Sbjct: 58 EIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQY---- 113
Query: 314 VVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRN 373
++ Q+ + +++LH+ + H ++ PSNI L A HVKV+ FGL +R++ +
Sbjct: 114 ---VVYQLIKVIKYLHSGGLLHRDMKPSNILLNAEC-----HVKVADFGL--SRSFVNIR 163
Query: 374 TPPASPQNQTAPNP------------YI---WY-APEVLAEQEGTGSTSTSKCSEKADVY 417
+ N Y+ WY APE+L ++K ++ D++
Sbjct: 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEIL--------LGSTKYTKGIDMW 215
Query: 418 SFGMLCFELLTGKVPF 433
S G + E+L GK F
Sbjct: 216 SLGCILGEILCGKPIF 231
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 3e-13
Identities = 57/263 (21%), Positives = 90/263 (34%), Gaps = 68/263 (25%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEF---FLVMELMSKDLSCYMRETFGSRRRNSFSL 311
EI + HPNI+ F E+ +LV ELM DL+ + +R S
Sbjct: 79 EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIH-----DQRIVISP 133
Query: 312 PVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYAS 371
+ M I G+ LH + H +L+P NI L + + + F L AR
Sbjct: 134 QHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNN-----DITICDFNL--ARED-- 184
Query: 372 RNTPPASPQNQTAPNPYI---WY-APEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELL 427
+ N+T Y+ WY APE++ ++ D++S G + E+
Sbjct: 185 -----TADANKT---HYVTHRWYRAPELV--------MQFKGFTKLVDMWSAGCVMAEMF 228
Query: 428 TGKVPF---------------------EDGHLQGDKMTKNIRAGERP---------LFPS 457
K F ED + ++ + P+
Sbjct: 229 NRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPT 288
Query: 458 GSPKYLVNLTKKCWHTNPSQRPS 480
P L +L K NP +R S
Sbjct: 289 ADPVAL-DLIAKMLEFNPQRRIS 310
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 3e-13
Identities = 49/230 (21%), Positives = 91/230 (39%), Gaps = 44/230 (19%)
Query: 260 LSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIM 318
+ +HP +V F E + F V+E ++ DL +M+ R+
Sbjct: 65 QASNHPFLVGLHSCFQTESR--LFFVIEYVNGGDLMFHMQ------RQRKLPEEHARFYS 116
Query: 319 LQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTPPAS 378
+I+ + +LH + I + +L N+ L + EG H+K++ +G+ T
Sbjct: 117 AEISLALNYLHERGIIYRDLKLDNVLLDS---EG--HIKLTDYGMCKEGLRPGDTT---- 167
Query: 379 PQNQT---APNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFED 435
T PN YI APE+L ++ S D ++ G+L FE++ G+ PF+
Sbjct: 168 ---STFCGTPN-YI--APEILRGEDYGFS---------VDWWALGVLMFEMMAGRSPFDI 212
Query: 436 GHLQG-------DKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQR 478
D + + I + P ++ K + +P +R
Sbjct: 213 VGSSDNPDQNTEDYLFQVILEKQ-IRIPRSLSVKAASVLKSFLNKDPKER 261
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 4e-13
Identities = 49/230 (21%), Positives = 91/230 (39%), Gaps = 44/230 (19%)
Query: 260 LSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIM 318
+ +HP +V F E + F V+E ++ DL +M+ R+
Sbjct: 108 QASNHPFLVGLHSCFQTESR--LFFVIEYVNGGDLMFHMQ------RQRKLPEEHARFYS 159
Query: 319 LQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTPPAS 378
+I+ + +LH + I + +L N+ L + EG H+K++ +G+ T
Sbjct: 160 AEISLALNYLHERGIIYRDLKLDNVLLDS---EG--HIKLTDYGMCKEGLRPGDTT---- 210
Query: 379 PQNQT---APNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFED 435
T PN YI APE+L ++ S D ++ G+L FE++ G+ PF+
Sbjct: 211 ---STFCGTPN-YI--APEILRGEDYGFS---------VDWWALGVLMFEMMAGRSPFDI 255
Query: 436 GHLQG-------DKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQR 478
D + + I + P ++ K + +P +R
Sbjct: 256 VGSSDNPDQNTEDYLFQVILEKQ-IRIPRSLSVKAASVLKSFLNKDPKER 304
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 8e-13
Identities = 54/296 (18%), Positives = 90/296 (30%), Gaps = 71/296 (23%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEF---FLVMELMSKDLSCYMRETFGSRRRNSFSL 311
EI+ + L I++ ++ +F ++V+E+ DL + +
Sbjct: 75 EITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFK------TPIFLTE 128
Query: 312 PVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYAS 371
+ I+ + G F+H I H +L P+N L VKV FGL ART S
Sbjct: 129 EHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDC-----SVKVCDFGL--ARTINS 181
Query: 372 RNTPPASPQNQTAPNP-------------YI---WY-APEVLAEQEGTGSTSTSKCSEKA 414
+ P ++ WY APE++ ++
Sbjct: 182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELI--------LLQENYTKSI 233
Query: 415 DVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTN 474
D++S G + ELL + PLFP S L
Sbjct: 234 DIWSTGCIFAELLNMLQSHINDP-----------TNRFPLFPGSSCFPLSPDRNSKKVHE 282
Query: 475 PSQR------------PSFSSICRIL-RYIKKFMANNPDIARSEFQ------SPLA 511
S R P+ + I + K++ P + S
Sbjct: 283 KSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDG 338
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 71.4 bits (174), Expect = 9e-13
Identities = 95/665 (14%), Positives = 191/665 (28%), Gaps = 222/665 (33%)
Query: 23 DIQINQRQCCL--LLDIFTLAF------STVAEEIRLFLKSEEKNTKWRALEQPLRELQK 74
D + + Q +L +F AF V + + L EE + +
Sbjct: 8 DFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEID---HIIMSKDAVSGT 64
Query: 75 VFREGEHYVKQCLDYKDWWGKAISLHQNKDCVEFHIHNLLCY-FPAVIEAIEAAGEISGL 133
+ +W L + ++ V+ + +L + ++ I+
Sbjct: 65 --------------LRLFW---TLLSKQEEMVQKFVEEVLRINYKFLMSPIKT------- 100
Query: 134 DPDEMQRRRVAFARKYDREWNDPKLFQLRFGKEYLIPREVCNEFESAYKEDKWLLIDALK 193
+ + + + DR +ND ++F +Y + R + L AL
Sbjct: 101 EQRQPSMMTRMYIEQRDRLYNDNQVF-----AKYNVSRL----------QPYLKLRQALL 145
Query: 194 EKKRLGSVVLT------KNEQRLVDMLLKKLMVRRRLGASSQFKEIQWLGDSFVLRHFYG 247
E + +V++ K + + V+ ++ FK I WL +
Sbjct: 146 ELRPAKNVLIDGVLGSGK--TWVALDVCLSYKVQCKMD----FK-IFWL--NL------K 190
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRN 307
S + + L + I D +L + +R S+
Sbjct: 191 NCNSPETVLEMLQKLLY-QIDPNWTSRSDHSSNI-----KLRIHSIQAELRRLLKSKPYE 244
Query: 308 SFSLPVVVDI--------------MLQIARG---MEFLHAQKIYHGELNPSNIYLKARSM 350
+ L V++++ +L R +FL A H L+ ++ L +
Sbjct: 245 N-CLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEV 303
Query: 351 EGYF----HVK---------------VSGFG------LSTARTYASRNT----------- 374
+ + +S L+T + N
Sbjct: 304 KSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSL 363
Query: 375 ---PPAS-----------PQNQTAPNPY-----IWYAPEV--------------LAEQEG 401
PA P + A P IW+ L E++
Sbjct: 364 NVLEPAEYRKMFDRLSVFPPS--AHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQP 421
Query: 402 TGSTST---------SKCSEKADV-------YSFGMLCFELLTGKVPFEDG--------H 437
ST + K + + Y+ F+ P+ D H
Sbjct: 422 KESTISIPSIYLELKVKLENEYALHRSIVDHYNI-PKTFDSDDLIPPYLDQYFYSHIGHH 480
Query: 438 LQGDKMTKNIRAGER-PLFPSGSPKYLVN---LTKKCWHTNPS--QRPSFSSICRILRYI 491
L KNI ER LF +L + L +K H + + S + + L++
Sbjct: 481 L------KNIEHPERMTLFRM---VFL-DFRFLEQKIRHDSTAWNASGSILNTLQQLKFY 530
Query: 492 KKFMANNPDIARSEFQSPLADYCDIEAGFVRKFVGEGC--PDVAPVSQIPFQM---FAYK 546
K ++ +N +++ + D F+ K + E + +I ++
Sbjct: 531 KPYICDNDP----KYERLVNAILD----FLPK-IEENLICSKYTDLLRIALMAEDEAIFE 581
Query: 547 IAEKE 551
A K+
Sbjct: 582 EAHKQ 586
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 50.6 bits (120), Expect = 2e-06
Identities = 54/405 (13%), Positives = 115/405 (28%), Gaps = 138/405 (34%)
Query: 15 KALMVLKDDIQINQR-------QCCLLLDIFTLAFSTVAEEIRLFLKSEEKNTKWRALEQ 67
L+VL ++Q N + C +LL T F V + FL + T +L+
Sbjct: 245 NCLLVL-LNVQ-NAKAWNAFNLSCKILL---TTRFKQVTD----FLSA--ATTTHISLDH 293
Query: 68 PLRELQKVFREGEHYVKQCLDYKDWWGKAISL-HQNKDCVEFHI-------HNLLC---Y 116
L E + + + LD + L + + + L
Sbjct: 294 HSMTLTP--DEVKSLLLKYLDCR-----PQDLPREVLTTNPRRLSIIAESIRDGLATWDN 346
Query: 117 FP-----AVIEAIEAAGEISGLDPDEMQRRRVAFARKYDREWNDPKLFQLRFGKEYLIPR 171
+ + IE++ ++ L+P E ++ + +F IP
Sbjct: 347 WKHVNCDKLTTIIESS--LNVLEPAEYRKMFDRLS-----------VFP----PSAHIPT 389
Query: 172 EVCNEFESAYKEDKWLLIDALKEKKRLGSVVLTKNEQRLVDMLLKKLMVRRRLGASS--- 228
+ + W + + +V+ L K +V ++ S+
Sbjct: 390 ILLSLI--------WFDVI-------------KSDVMVVVNKLHKYSLVEKQPKESTISI 428
Query: 229 ---QFKEIQWLGDSFVLRH-----FYGELESLNAEISTMLSLSHPNIVQYLCGFC----- 275
+ L + + L H Y ++ +++ L P + QY
Sbjct: 429 PSIYLELKVKLENEYAL-HRSIVDHYNIPKTFDSD-----DLIPPYLDQYFYSHIGHHLK 482
Query: 276 ----DEEKKEF---FLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIML---QIARG- 324
E F FL + + + R + + L + + I
Sbjct: 483 NIEHPERMTLFRMVFLDFRFLEQKI----RHDSTAWNASGSILNTLQQLKFYKPYICDND 538
Query: 325 ----------MEFL--HAQKIYHGE---------LNPSN-IYLKA 347
++FL + + + + I+ +A
Sbjct: 539 PKYERLVNAILDFLPKIEENLICSKYTDLLRIALMAEDEAIFEEA 583
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.5 bits (99), Expect = 6e-04
Identities = 48/291 (16%), Positives = 81/291 (27%), Gaps = 104/291 (35%)
Query: 9 EVLGSL-KALMVLKDDIQINQRQCCLLLDIFTLAFSTVAEEIRLFL------KSEEKNTK 61
EV L K L D+ R+ S +AE IR L K +
Sbjct: 302 EVKSLLLKYLDCRPQDLP---REVL---TTNPRRLSIIAESIRDGLATWDNWKHVNCDKL 355
Query: 62 WRALEQPLR-----ELQK------VFREG--------------------EHYVKQCLDY- 89
+E L E +K VF V + Y
Sbjct: 356 TTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYS 415
Query: 90 ---KDWWGKAISLH--------QNKDCVEFH--------IHNLLC-----------YFPA 119
K IS+ + ++ H I YF +
Sbjct: 416 LVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYS 475
Query: 120 VI----EAIEAAGEISG-----LDPDEMQRRRVAFARKYDREWNDPK-----LFQLRFGK 165
I + IE ++ LD ++++ R WN L QL+F K
Sbjct: 476 HIGHHLKNIEHPERMTLFRMVFLDFRFLEQK----IRHDSTAWNASGSILNTLQQLKFYK 531
Query: 166 EYLIPREVCNEFESAYKEDKWLLIDALKE-KKRLGSVVLTKNEQRLVDMLL 215
Y+ ++E L++A+ + ++ ++ L+ + L
Sbjct: 532 PYICDN--DPKYER--------LVNAILDFLPKIEENLICSKYTDLLRIAL 572
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 1e-12
Identities = 43/205 (20%), Positives = 86/205 (41%), Gaps = 41/205 (20%)
Query: 255 EISTMLSLSHPNIVQ---YLCGFCDEEKKEFFL--VMELMSKDLSCYMRETFGSRRRNSF 309
+ + L HPNIVQ Y + ++++ +L VME + L R RR+ +
Sbjct: 69 IMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNY--YRRQVAP 126
Query: 310 SLPVVVDIMLQIARGMEFLH--AQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTAR 367
++ + Q+ R + LH + + H ++ P N+ + +K+ FG A+
Sbjct: 127 PPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGT----LKLCDFGS--AK 180
Query: 368 TYASRNTPPASPQNQTAPN-PYI---WY-APEVLAEQEGTGSTSTSKCSEKADVYSFGML 422
+ + PN YI +Y APE++ G+ + D++S G +
Sbjct: 181 KL-----------SPSEPNVAYICSRYYRAPELI-----FGNQHYTT---AVDIWSVGCI 221
Query: 423 CFELLTGKVPF--EDGHLQGDKMTK 445
E++ G+ F ++ Q ++ +
Sbjct: 222 FAEMMLGEPIFRGDNSAGQLHEIVR 246
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 32/189 (16%), Positives = 68/189 (35%), Gaps = 39/189 (20%)
Query: 255 EISTMLSLS-HPNIVQYLCGFCDE-EKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLP 312
EI + +L PNI+ D + + + + D + + +
Sbjct: 80 EIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ---------TLTDY 130
Query: 313 VVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASR 372
+ M +I + +++ H+ I H ++ P N+ + + +++ +GL A Y
Sbjct: 131 DIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRK----LRLIDWGL--AEFY--- 181
Query: 373 NTPPASPQNQTAPNPYI---WY-APEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT 428
P + N + ++ PE+L D++S G + ++
Sbjct: 182 -----HPGQEY--NVRVASRYFKGPELL--------VDYQMYDYSLDMWSLGCMLASMIF 226
Query: 429 GKVPFEDGH 437
K PF GH
Sbjct: 227 RKEPFFHGH 235
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 43/192 (22%), Positives = 80/192 (41%), Gaps = 30/192 (15%)
Query: 249 LESLN-AEISTMLSLSHPNIVQYLCGF--CDEEKKEFFLVMELMSKDLSCYMRETFGSRR 305
L+ +N A+ + S+ +I++ L F +V E++ ++L +++ + R
Sbjct: 69 LQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKK-YEHRG 127
Query: 306 RNSFSLPVVVDIMLQIARGMEFLHAQ-KIYHGELNPSNIYLKARSM-EGYFHVKVSGFGL 363
L V I Q+ G++++H + I H ++ P N+ ++ E +K++ G
Sbjct: 128 ---IPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGN 184
Query: 364 STARTYASRNTPPASPQNQTAPNPYIWY-APEVLAEQEGTGSTSTSKCSEKADVYSFGML 422
A + QT Y +PEVL + AD++S L
Sbjct: 185 ------ACWYDEHYTNSIQTRE-----YRSPEVLLG---------APWGCGADIWSTACL 224
Query: 423 CFELLTGKVPFE 434
FEL+TG FE
Sbjct: 225 IFELITGDFLFE 236
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 5e-11
Identities = 45/172 (26%), Positives = 72/172 (41%), Gaps = 36/172 (20%)
Query: 266 NIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGM 325
N++ L F + + EL+S +L +++ + FSLP+V I + +
Sbjct: 160 NVIHMLENF--TFRNHICMTFELLSMNLYELIKKN----KFQGFSLPLVRKFAHSILQCL 213
Query: 326 EFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTPPASPQNQTAP 385
+ LH +I H +L P NI LK + G +KV FG S ++Q
Sbjct: 214 DALHKNRIIHCDLKPENILLKQQGRSG---IKVIDFGSSC-------------YEHQR-V 256
Query: 386 NPYI---WY-APEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPF 433
YI +Y APEV+ ++ D++S G + ELLTG
Sbjct: 257 YTYIQSRFYRAPEVILG---------ARYGMPIDMWSLGCILAELLTGYPLL 299
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 33/186 (17%), Positives = 58/186 (31%), Gaps = 48/186 (25%)
Query: 284 LVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQ-KIYHGELNPSN 342
+V E++ L ++ + LP V I+ Q+ +G+++LH + +I H ++ P N
Sbjct: 122 MVFEVLGHHLLKWII-KSNYQG---LPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPEN 177
Query: 343 IYLKARSMEGYFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIW------------ 390
I L + + S + +P
Sbjct: 178 ILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKI 237
Query: 391 ----------------------YAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT 428
+ EVL S + AD++S + FEL T
Sbjct: 238 ADLGNACWVHKHFTEDIQTRQYRSLEVLIG---------SGYNTPADIWSTACMAFELAT 288
Query: 429 GKVPFE 434
G FE
Sbjct: 289 GDYLFE 294
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 38/174 (21%), Positives = 59/174 (33%), Gaps = 38/174 (21%)
Query: 266 NIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGM 325
IV F + LV E++S +L + + SL + Q+ +
Sbjct: 117 YIVHLKRHF--MFRNHLCLVFEMLSYNL----YDLLRNTNFRGVSLNLTRKFAQQMCTAL 170
Query: 326 EFLHAQK--IYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTPPASPQNQT 383
FL + I H +L P NI L +K+ FG + Q
Sbjct: 171 LFLATPELSIIHCDLKPENILLCN---PKRSAIKIVDFG-------------SSCQLGQR 214
Query: 384 APNPYI---WY-APEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPF 433
YI +Y +PEVL D++S G + E+ TG+ F
Sbjct: 215 -IYQYIQSRFYRSPEVLLGM---------PYDLAIDMWSLGCILVEMHTGEPLF 258
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 5e-08
Identities = 21/124 (16%), Positives = 42/124 (33%), Gaps = 30/124 (24%)
Query: 273 GFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQK 332
GF + K FLV+ + + L ++ S V+ + ++ +EFLH +
Sbjct: 124 GFGVHQDKYRFLVLPSLGRSLQ----SALDVSPKHVLSERSVLQVACRLLDALEFLHENE 179
Query: 333 IYHGELNPSNIYLKARSMEGYFHVKVSGFGLS----------------------TARTYA 370
HG + NI++ V ++G+G + +
Sbjct: 180 YVHGNVTAENIFVDPEDQS---QVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLE-FI 235
Query: 371 SRNT 374
S +
Sbjct: 236 SMDL 239
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 23/128 (17%), Positives = 51/128 (39%), Gaps = 33/128 (25%)
Query: 270 YLCGFCDEEKKEF-FLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFL 328
Y G + + + + F+VME + DL + G F V+ + +++ +E++
Sbjct: 114 YGSGLTEFKGRSYRFMVMERLGIDLQ----KISGQNGT--FKKSTVLQLGIRMLDVLEYI 167
Query: 329 HAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS----------------------TA 366
H + HG++ +N+ L ++ + V ++ +GLS T
Sbjct: 168 HENEYVHGDIKAANLLLGYKNPD---QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTI 224
Query: 367 RTYASRNT 374
+ S +
Sbjct: 225 E-FTSLDA 231
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 38/182 (20%), Positives = 63/182 (34%), Gaps = 32/182 (17%)
Query: 266 NIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGM 325
V F + EL+ K+ +++E + LP V + Q+ +
Sbjct: 83 LCVLMSDWF--NFHGHMCIAFELLGKNTFEFLKEN----NFQPYPLPHVRHMAYQLCHAL 136
Query: 326 EFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTART------YASRNTPPASP 379
FLH ++ H +L P NI E ++ S S T + S A+
Sbjct: 137 RFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGS-----ATF 191
Query: 380 QNQTAPNPYI---WY-APEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFED 435
++ + Y PEV+ E ++ DV+S G + FE G F
Sbjct: 192 DHEH-HTTIVATRHYRPPEVILE---------LGWAQPCDVWSIGCILFEYYRGFTLF-Q 240
Query: 436 GH 437
H
Sbjct: 241 TH 242
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 38/183 (20%), Positives = 64/183 (34%), Gaps = 28/183 (15%)
Query: 266 NIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGM 325
NIV+Y F L+ E + L + N F + + ++I + +
Sbjct: 97 NIVKYHGKF--MYYDHMCLIFEPLGPSLYEIITRN----NYNGFHIEDIKLYCIEILKAL 150
Query: 326 EFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNTP-------PAS 378
+L + H +L P NI L E + Y +++T A+
Sbjct: 151 NYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCAT 210
Query: 379 PQNQTAPNPYI---WY-APEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFE 434
++ I Y APEV+ +D++SFG + EL TG + F
Sbjct: 211 FKSDY-HGSIINTRQYRAPEVILN---------LGWDVSSDMWSFGCVLAELYTGSLLF- 259
Query: 435 DGH 437
H
Sbjct: 260 RTH 262
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 26/133 (19%), Positives = 52/133 (39%), Gaps = 34/133 (25%)
Query: 265 PNIVQYLCGFCDEEKKEF-FLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIAR 323
P + G D+ K + F++M+ DL ++R FS V+ + L+I
Sbjct: 111 PKY--WGSGLHDKNGKSYRFMIMDRFGSDLQKIYE--ANAKR---FSRKTVLQLSLRILD 163
Query: 324 GMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS------------------- 364
+E++H + HG++ SN+ L ++ + V + +GL+
Sbjct: 164 ILEYIHEHEYVHGDIKASNLLLNYKNPD---QVYLVDYGLAYRYCPEGVHKAYAADPKRC 220
Query: 365 ---TARTYASRNT 374
T + S +
Sbjct: 221 HDGTIE-FTSIDA 232
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 34/147 (23%), Positives = 54/147 (36%), Gaps = 33/147 (22%)
Query: 251 SLNAEISTMLSLSH-PNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSF 309
L+ E + I +C E +VMEL+ L F SR+ F
Sbjct: 50 QLHIESKIYKMMQGGVGIPTIR--WCGAEGDYNVMVMELLGPSLEDLFN--FCSRK---F 102
Query: 310 SLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS----- 364
SL V+ + Q+ +E++H++ H ++ P N + + + FGL+
Sbjct: 103 SLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVY--IIDFGLAKKYRD 160
Query: 365 -----------------TARTYASRNT 374
TAR YAS NT
Sbjct: 161 ARTHQHIPYRENKNLTGTAR-YASINT 186
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 7e-07
Identities = 26/155 (16%), Positives = 52/155 (33%), Gaps = 38/155 (24%)
Query: 250 ESLNAEISTMLSLSHPNIVQYLCG--------FCDEEKKEFFLVMELMSKDLSCYMRETF 301
E ++ + + L G + +E LV++L+ L +
Sbjct: 43 EPRRSDAPQLRDEYR--TYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLD--L 98
Query: 302 GSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGF 361
R+ FS+ V Q+ ++ +H + + + ++ P N + + + + V F
Sbjct: 99 CGRK---FSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDF 155
Query: 362 GLS----------------------TARTYASRNT 374
G+ TAR Y S NT
Sbjct: 156 GMVKFYRDPVTKQHIPYREKKNLSGTAR-YMSINT 189
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 29/156 (18%), Positives = 53/156 (33%), Gaps = 38/156 (24%)
Query: 249 LESLNAEISTMLSLSHPNIVQYLCG--------FCDEEKKEFFLVMELMSKDLSCYMRET 300
LE + + + + L + K +V+EL+ L
Sbjct: 41 LEPMKSRAPQLHLEYR--FYKQLGSGDGIPQVYYFGPCGKYNAMVLELLGPSLEDLFD-- 96
Query: 301 FGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSG 360
R FSL V+ I +Q+ ME++H++ + + ++ P N + + + +
Sbjct: 97 LCDRT---FSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIID 153
Query: 361 FGLS----------------------TARTYASRNT 374
F L+ TAR Y S NT
Sbjct: 154 FALAKEYIDPETKKHIPYREHKSLTGTAR-YMSINT 188
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 49/243 (20%), Positives = 84/243 (34%), Gaps = 47/243 (19%)
Query: 266 NIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGM 325
VQ L F E +V EL+ +++E F L + + QI + +
Sbjct: 78 RCVQMLEWF--EHHGHICIVFELLGLSTYDFIKEN----GFLPFRLDHIRKMAYQICKSV 131
Query: 326 EFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTART------YASRNTPPASP 379
FLH+ K+ H +L P NI ++ K+ + + S A+
Sbjct: 132 NFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGS-----ATY 186
Query: 380 QNQTAPNPYI---WY-APEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFED 435
++ + + Y APEV+ S+ DV+S G + E G F
Sbjct: 187 DDEH-HSTLVSTRHYRAPEVILA---------LGWSQPCDVWSIGCILIEYYLGFTVF-P 235
Query: 436 GHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKK---------CWHTNPSQRPSFSSICR 486
H + + R PK+++ T+K W + S S C+
Sbjct: 236 THDSKEHLAMMERILGPL------PKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACK 289
Query: 487 ILR 489
L+
Sbjct: 290 PLK 292
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 45.0 bits (106), Expect = 9e-05
Identities = 30/123 (24%), Positives = 47/123 (38%), Gaps = 30/123 (24%)
Query: 274 FCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKI 333
+ E LVM+L+ L F SR+ SL V+ + Q+ +EF+H++
Sbjct: 70 WFGVEGDYNVLVMDLLGPSLEDLFN--FCSRK---LSLKTVLMLADQMINRVEFVHSKSF 124
Query: 334 YHGELNPSNIYLKARSMEGYFHVKVSGFGLS----------------------TARTYAS 371
H ++ P N + + + FGL+ TAR YAS
Sbjct: 125 LHRDIKPDNFLMGLGRRANQVY--IIDFGLAKKYRDTSTHQHIPYRENKNLTGTAR-YAS 181
Query: 372 RNT 374
NT
Sbjct: 182 VNT 184
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 811 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-49 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 7e-47 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-44 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-43 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-42 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 6e-42 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-41 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-41 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 6e-41 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-40 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-40 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 8e-40 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-39 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 7e-39 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-38 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-38 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-38 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 7e-38 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-37 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-37 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-37 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-37 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 7e-37 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 8e-37 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-36 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-36 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 7e-36 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 8e-36 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-35 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-34 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-34 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-34 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-34 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-34 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 7e-34 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-33 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-33 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-33 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-32 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-32 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-32 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 6e-31 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-30 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-30 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-29 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-29 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-27 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-26 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-26 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-25 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-24 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-24 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-24 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-23 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 9e-23 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-22 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-22 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-22 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-21 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-20 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-16 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-14 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-08 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 3e-49
Identities = 58/252 (23%), Positives = 116/252 (46%), Gaps = 28/252 (11%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRR 306
+L++ E+ + H NI+ ++ G+ + +V + L ++
Sbjct: 47 QLQAFKNEVGVLRKTRHVNILLFM-GYSTAPQ--LAIVTQWCEGSSLYHHLH-----IIE 98
Query: 307 NSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366
F + ++DI Q A+GM++LHA+ I H +L +NI+L VK+ FGL+T
Sbjct: 99 TKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHED-----LTVKIGDFGLATV 153
Query: 367 RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFEL 426
++ S + Q + +W APEV+ Q+ + S ++DVY+FG++ +EL
Sbjct: 154 KSRWSGSH-----QFEQLSGSILWMAPEVIRMQDK------NPYSFQSDVYAFGIVLYEL 202
Query: 427 LTGKVPFEDGHLQG---DKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSS 483
+TG++P+ + + + + + + + S PK + L +C +RP F
Sbjct: 203 MTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQ 262
Query: 484 ICRILRYIKKFM 495
I + + + +
Sbjct: 263 ILASIELLARSL 274
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (420), Expect = 7e-47
Identities = 76/248 (30%), Positives = 111/248 (44%), Gaps = 33/248 (13%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRRR 306
++ AE S M L H N+VQ L G EEK ++V E M+K L Y+R SR R
Sbjct: 43 TAQAFLAEASVMTQLRHSNLVQLL-GVIVEEKGGLYIVTEYMAKGSLVDYLR----SRGR 97
Query: 307 NSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366
+ ++ L + ME+L H +L N+ + KVS FGL+
Sbjct: 98 SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED-----NVAKVSDFGLTKE 152
Query: 367 RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFEL 426
AS T P W APE L E+ K S K+DV+SFG+L +E+
Sbjct: 153 ----------ASSTQDTGKLPVKWTAPEALREK---------KFSTKSDVWSFGILLWEI 193
Query: 427 LT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSIC 485
+ G+VP+ L+ + + G + P G P + + K CWH + + RPSF +
Sbjct: 194 YSFGRVPYPRIPLK--DVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLR 251
Query: 486 RILRYIKK 493
L +IK
Sbjct: 252 EQLEHIKT 259
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 2e-44
Identities = 64/256 (25%), Positives = 112/256 (43%), Gaps = 30/256 (11%)
Query: 247 GELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRR 305
+ E + E M L +P IV+ + G C + + LVME+ L ++ +
Sbjct: 51 ADTEEMMREAQIMHQLDNPYIVRLI-GVC--QAEALMLVMEMAGGGPLHKFLV-----GK 102
Query: 306 RNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365
R + V +++ Q++ GM++L + H +L N+ L R + K+S FGLS
Sbjct: 103 REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNR-----HYAKISDFGLSK 157
Query: 366 ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFE 425
A S P WYAPE + + K S ++DV+S+G+ +E
Sbjct: 158 ALGADDSYYTARS----AGKWPLKWYAPECI---------NFRKFSSRSDVWSYGVTMWE 204
Query: 426 LLT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSI 484
L+ G+ P++ ++G ++ I G+R P P L L CW RP F ++
Sbjct: 205 ALSYGQKPYKK--MKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTV 262
Query: 485 CRILRYIKKFMANNPD 500
+ +R +A+ +
Sbjct: 263 EQRMRACYYSLASKVE 278
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 2e-43
Identities = 56/248 (22%), Positives = 99/248 (39%), Gaps = 27/248 (10%)
Query: 241 VLRHFYGELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRET 300
L+ ++ AE + M L H +V+ +E +++ E M +
Sbjct: 44 SLKQGSMSPDAFLAEANLMKQLQHQRLVRLY-AVVTQE--PIYIITEYMENGSLVDFLK- 99
Query: 301 FGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSG 360
+ ++ ++D+ QIA GM F+ + H +L +NI + K++
Sbjct: 100 --TPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS-----DTLSCKIAD 152
Query: 361 FGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFG 420
FGL A + A P W APE + + + K+DV+SFG
Sbjct: 153 FGL------ARLIEDNEYTAREGAKFPIKWTAPEAI---------NYGTFTIKSDVWSFG 197
Query: 421 MLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPS 480
+L E++T G ++ +N+ G R + P P+ L L + CW P RP+
Sbjct: 198 ILLTEIVTHGRIPYPGM-TNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPT 256
Query: 481 FSSICRIL 488
F + +L
Sbjct: 257 FDYLRSVL 264
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (389), Expect = 1e-42
Identities = 55/244 (22%), Positives = 100/244 (40%), Gaps = 31/244 (12%)
Query: 247 GELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRR 305
E + L +E++ + L HPNIV+Y D ++VME DL+ + + G++
Sbjct: 45 AEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITK--GTKE 102
Query: 306 RNSFSLPVVVDIMLQIARGMEFLH-----AQKIYHGELNPSNIYLKARSMEGYFHVKVSG 360
R V+ +M Q+ ++ H + H +L P+N++L +G +VK+
Sbjct: 103 RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL-----DGKQNVKLGD 157
Query: 361 FGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFG 420
FGL +R + + + +PE + + +EK+D++S G
Sbjct: 158 FGL-------ARILNHDTSFAKAFVGTPYYMSPEQM---------NRMSYNEKSDIWSLG 201
Query: 421 MLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPS 480
L +EL PF + ++ IR G+ P L + + + RPS
Sbjct: 202 CLLYELCALMPPFTAFSQK--ELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPS 259
Query: 481 FSSI 484
I
Sbjct: 260 VEEI 263
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 6e-42
Identities = 69/247 (27%), Positives = 104/247 (42%), Gaps = 23/247 (9%)
Query: 247 GELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRR 306
GE+ E M SHPN++ L G C + +V+ M F
Sbjct: 70 GEVSQFLTEGIIMKDFSHPNVLSLL-GICLRSEGSPLVVLPYMKHGD----LRNFIRNET 124
Query: 307 NSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366
++ ++ ++ LQ+A+GM+FL ++K H +L N L + F VKV+ FGL+
Sbjct: 125 HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML-----DEKFTVKVADFGLARD 179
Query: 367 RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFEL 426
++ A P W A E L T K + K+DV+SFG+L +EL
Sbjct: 180 MYDKEFDS---VHNKTGAKLPVKWMALESL---------QTQKFTTKSDVWSFGVLLWEL 227
Query: 427 LTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486
+T P + +T + G R L P P L + KCWH RPSFS +
Sbjct: 228 MTRGAPPYPD-VNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 286
Query: 487 ILRYIKK 493
+ I
Sbjct: 287 RISAIFS 293
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 1e-41
Identities = 52/241 (21%), Positives = 86/241 (35%), Gaps = 26/241 (10%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRN 307
ELE EI + S HPNIV+ L F E ++++E + +
Sbjct: 52 ELEDYMVEIDILASCDHPNIVKLLDAFYYENN--LWILIEFCAGGAVDAVML----ELER 105
Query: 308 SFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTAR 367
+ + + Q + +LH KI H +L NI +K++ FG+
Sbjct: 106 PLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLD-----GDIKLADFGV---- 156
Query: 368 TYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELL 427
S + + W APEV+ + KADV+S G+ E+
Sbjct: 157 ---SAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD----RPYDYKADVWSLGITLIEMA 209
Query: 428 TGKVPFEDGHLQGDKMTKNIRAGERPLF--PSGSPKYLVNLTKKCWHTNPSQRPSFSSIC 485
+ P + + ++ I E P PS + KKC N R + S +
Sbjct: 210 EIEPPHHELNPM--RVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLL 267
Query: 486 R 486
+
Sbjct: 268 Q 268
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 2e-41
Identities = 68/253 (26%), Positives = 117/253 (46%), Gaps = 31/253 (12%)
Query: 247 GELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMS-KDLSCYMRETFGSRR 305
+ L AE + M L +P IV+ + G C+ E + LVME+ L+ Y++ +
Sbjct: 50 ALKDELLAEANVMQQLDNPYIVRMI-GICEAES--WMLVMEMAELGPLNKYLQ------Q 100
Query: 306 RNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365
+++++ Q++ GM++L H +L N+ L + + K+S FGLS
Sbjct: 101 NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ-----HYAKISDFGLSK 155
Query: 366 ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFE 425
A R P WYAPE + + K S K+DV+SFG+L +E
Sbjct: 156 A----LRADENYYKAQTHGKWPVKWYAPECI---------NYYKFSSKSDVWSFGVLMWE 202
Query: 426 LLT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSI 484
+ G+ P+ ++G ++T + GER P+G P+ + +L CW + RP F+++
Sbjct: 203 AFSYGQKPYRG--MKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAV 260
Query: 485 CRILRYIKKFMAN 497
LR + N
Sbjct: 261 ELRLRNYYYDVVN 273
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 150 bits (379), Expect = 6e-41
Identities = 60/260 (23%), Positives = 103/260 (39%), Gaps = 31/260 (11%)
Query: 247 GELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRR 305
+ +E S M HPN++ + ++ E M L ++R+ G
Sbjct: 69 KQRRDFLSEASIMGQFDHPNVIHLEG--VVTKSTPVMIITEFMENGSLDSFLRQNDGQ-- 124
Query: 306 RNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365
F++ +V ++ IA GM++L H +L NI + + KVS FGL
Sbjct: 125 ---FTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSN-----LVCKVSDFGL-- 174
Query: 366 ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFE 425
+R + P P W APE + K + +DV+S+G++ +E
Sbjct: 175 SRFLEDDTSDPTYTSALGGKIPIRWTAPEAI---------QYRKFTSASDVWSYGIVMWE 225
Query: 426 LLT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSI 484
+++ G+ P+ D Q + I R P P L L CW + + RP F I
Sbjct: 226 VMSYGERPYWDMTNQ--DVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQI 283
Query: 485 CRILRYIKKFMANNPDIARS 504
L + + NP+ ++
Sbjct: 284 VNTLDKMIR----NPNSLKA 299
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 149 bits (378), Expect = 1e-40
Identities = 50/239 (20%), Positives = 84/239 (35%), Gaps = 30/239 (12%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRN 307
+ + + E+ + L HPN +QY C + +LVME S + +
Sbjct: 58 KWQDIIKEVRFLQKLRHPNTIQYRG--CYLREHTAWLVMEYCLGSASDLLE-----VHKK 110
Query: 308 SFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTAR 367
+ + +G+ +LH+ + H ++ NI L VK+ FG A
Sbjct: 111 PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP-----GLVKLGDFGS--AS 163
Query: 368 TYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELL 427
A N+ +P W APEV+ + K DV+S G+ C EL
Sbjct: 164 IMAPANSFVGTPY---------WMAPEVILAM------DEGQYDGKVDVWSLGITCIELA 208
Query: 428 TGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486
K P + + + + L +Y N C P RP+ + +
Sbjct: 209 ERKPPLFNMNAM-SALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 4e-40
Identities = 57/244 (23%), Positives = 100/244 (40%), Gaps = 36/244 (14%)
Query: 247 GELESLNAEISTMLSLSHPNIVQYL--CGFCDEEKKEFFLVMELMSK-DLSCYMRETFGS 303
E + E + L HPNIV++ + KK LV ELM+ L Y++
Sbjct: 50 SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK----- 104
Query: 304 RRRNSFSLPVVVDIMLQIARGMEFLHAQK--IYHGELNPSNIYLKARSMEGYFHVKVSGF 361
R + V+ QI +G++FLH + I H +L NI++ + VK+
Sbjct: 105 -RFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTG----SVKIGDL 159
Query: 362 GLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGM 421
GL+T + + +P+ + APE+ K E DVY+FGM
Sbjct: 160 GLATLKRASFAKAVIGTPE---------FMAPEMY----------EEKYDESVDVYAFGM 200
Query: 422 LCFELLTGKVPFEDGHLQGDKMTKNIRAGERPL-FPSGSPKYLVNLTKKCWHTNPSQRPS 480
E+ T + P+ + ++ + + +G +P F + + + + C N +R S
Sbjct: 201 CMLEMATSEYPYSECQ-NAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYS 259
Query: 481 FSSI 484
+
Sbjct: 260 IKDL 263
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (368), Expect = 8e-40
Identities = 65/254 (25%), Positives = 104/254 (40%), Gaps = 29/254 (11%)
Query: 241 VLRHFYGELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRE 299
+R E E M+ LSHP +VQ G C E+ LV E M LS Y+R
Sbjct: 36 TIREGAMSEEDFIEEAEVMMKLSHPKLVQLY-GVC-LEQAPICLVFEFMEHGCLSDYLR- 92
Query: 300 TFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVS 359
+R F+ ++ + L + GM +L + H +L N + +KVS
Sbjct: 93 ----TQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGEN-----QVIKVS 143
Query: 360 GFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSF 419
FG++ + P W +PEV S S+ S K+DV+SF
Sbjct: 144 DFGMT------RFVLDDQYTSSTGTKFPVKWASPEVF---------SFSRYSSKSDVWSF 188
Query: 420 GMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRP 479
G+L +E+ + + ++ ++I G R P + ++ + CW P RP
Sbjct: 189 GVLMWEVFSEGKIPYENR-SNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRP 247
Query: 480 SFSSICRILRYIKK 493
+FS + R L I +
Sbjct: 248 AFSRLLRQLAEIAE 261
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 144 bits (365), Expect = 3e-39
Identities = 66/253 (26%), Positives = 110/253 (43%), Gaps = 26/253 (10%)
Query: 241 VLRHFYGELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRET 300
L+ E+E E + M + HPN+VQ L + F+++ E M+ + +
Sbjct: 49 TLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC--TREPPFYIITEFMTYGN---LLDY 103
Query: 301 FGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSG 360
R S V++ + QI+ ME+L + H +L N + VKV+
Sbjct: 104 LRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN-----HLVKVAD 158
Query: 361 FGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFG 420
FGLS T + + A P W APE L + +K S K+DV++FG
Sbjct: 159 FGLSRLMTGDTYTA------HAGAKFPIKWTAPESL---------AYNKFSIKSDVWAFG 203
Query: 421 MLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPS 480
+L +E+ T + G + ++ + + R P G P+ + L + CW NPS RPS
Sbjct: 204 VLLWEIATYGMSPYPG-IDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPS 262
Query: 481 FSSICRILRYIKK 493
F+ I + + +
Sbjct: 263 FAEIHQAFETMFQ 275
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 7e-39
Identities = 63/248 (25%), Positives = 94/248 (37%), Gaps = 27/248 (10%)
Query: 241 VLRHFYGELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRET 300
L+ E+ E M L H +VQ +E ++V E MSK +
Sbjct: 48 TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP---IYIVTEYMSKGSLLDFLK- 103
Query: 301 FGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSG 360
LP +VD+ QIA GM ++ H +L +NI + KV+
Sbjct: 104 --GETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN-----LVCKVAD 156
Query: 361 FGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFG 420
FGL+ Q A P W APE + + K+DV+SFG
Sbjct: 157 FGLARLIE------DNEYTARQGAKFPIKWTAPEAA---------LYGRFTIKSDVWSFG 201
Query: 421 MLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPS 480
+L EL T G + + + + G R P P+ L +L +CW P +RP+
Sbjct: 202 ILLTELTTKGRVPYPGMVNREVL-DQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPT 260
Query: 481 FSSICRIL 488
F + L
Sbjct: 261 FEYLQAFL 268
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 1e-38
Identities = 56/242 (23%), Positives = 96/242 (39%), Gaps = 27/242 (11%)
Query: 249 LESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNS 308
++ E++ M SL H N+++ G +V EL + +
Sbjct: 55 MDDFIREVNAMHSLDHRNLIRLY-GVVLTP--PMKMVTELAPLGSLLDRLR----KHQGH 107
Query: 309 FSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTART 368
F L + +Q+A GM +L +++ H +L N+ L VK+ FGL A
Sbjct: 108 FLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL-----ATRDLVKIGDFGLMRALP 162
Query: 369 YASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT 428
+ + P+ W APE L T S +D + FG+ +E+ T
Sbjct: 163 QNDDHYV----MQEHRKVPFAWCAPESL---------KTRTFSHASDTWMFGVTLWEMFT 209
Query: 429 -GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRI 487
G+ P+ + + K + GER P P+ + N+ +CW P RP+F ++
Sbjct: 210 YGQEPWIGLNGS-QILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF 268
Query: 488 LR 489
L
Sbjct: 269 LL 270
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 3e-38
Identities = 57/250 (22%), Positives = 108/250 (43%), Gaps = 29/250 (11%)
Query: 241 VLRHFYGELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRET 300
+++ + E M++LSH +VQ G C +++ F++ E M+
Sbjct: 35 MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLY-GVC-TKQRPIFIITEYMANGCL----LN 88
Query: 301 FGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSG 360
+ R+ F ++++ + ME+L +++ H +L N + + VKVS
Sbjct: 89 YLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQ-----GVVKVSD 143
Query: 361 FGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFG 420
FGLS + + + P W PEVL SK S K+D+++FG
Sbjct: 144 FGLSRYVLDDEYTS------SVGSKFPVRWSPPEVL---------MYSKFSSKSDIWAFG 188
Query: 421 MLCFELLT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRP 479
+L +E+ + GK+P+E + ++I G R P + + + + CWH +RP
Sbjct: 189 VLMWEIYSLGKMPYER--FTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERP 246
Query: 480 SFSSICRILR 489
+F + +
Sbjct: 247 TFKILLSNIL 256
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 3e-38
Identities = 64/261 (24%), Positives = 100/261 (38%), Gaps = 40/261 (15%)
Query: 247 GELESLNAEISTMLSL-SHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFG-- 302
E E+L +E+ M L SH NIV L G C +L+ E DL Y+R
Sbjct: 82 SEREALMSELKMMTQLGSHENIVNLL-GAC-TLSGPIYLIFEYCCYGDLLNYLRSKREKF 139
Query: 303 ---------------SRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKA 347
N + ++ Q+A+GMEFL + H +L N+ +
Sbjct: 140 SEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTH 199
Query: 348 RSMEGYFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTST 407
VK+ FGL+ S A P W APE L
Sbjct: 200 G-----KVVKICDFGLARDIMSDSNYV-----VRGNARLPVKWMAPESL---------FE 240
Query: 408 SKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLT 467
+ K+DV+S+G+L +E+ + V G K I+ G + P + + + +
Sbjct: 241 GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIM 300
Query: 468 KKCWHTNPSQRPSFSSICRIL 488
+ CW + +RPSF ++ L
Sbjct: 301 QSCWAFDSRKRPSFPNLTSFL 321
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 7e-38
Identities = 64/267 (23%), Positives = 103/267 (38%), Gaps = 34/267 (12%)
Query: 247 GELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRR 306
+ E M SH NI++ + ++ E M +
Sbjct: 51 KQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK--PMMIITEYMENGALDKFLR----EKD 104
Query: 307 NSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366
FS+ +V ++ IA GM++L H +L NI + + KVS FGLS
Sbjct: 105 GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSN-----LVCKVSDFGLSRV 159
Query: 367 RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFEL 426
+ P A+ P W APE + S K + +DV+SFG++ +E+
Sbjct: 160 LE----DDPEATYTTSGGKIPIRWTAPEAI---------SYRKFTSASDVWSFGIVMWEV 206
Query: 427 LTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486
+T L ++ K I G R P P + L +CW ++RP F+ I
Sbjct: 207 MTYGERP-YWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265
Query: 487 ILRYIKKFMANNPDIARSEFQSPLADY 513
IL + + PD ++ LAD+
Sbjct: 266 ILDKLIR----APDSLKT-----LADF 283
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 140 bits (354), Expect = 1e-37
Identities = 61/266 (22%), Positives = 103/266 (38%), Gaps = 41/266 (15%)
Query: 247 GELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMS-KDLSCYMRET----- 300
E + M +PNIV+ L K L+ E M+ DL+ ++R
Sbjct: 58 DMQADFQREAALMAEFDNPNIVKLLG--VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTV 115
Query: 301 -------------FGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKA 347
S S + I Q+A GM +L +K H +L N +
Sbjct: 116 CSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGE 175
Query: 348 RSMEGYFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTST 407
VK++ FGLS A + P W PE +
Sbjct: 176 N-----MVVKIADFGLSRNIYSADYYK-----ADGNDAIPIRWMPPESI---------FY 216
Query: 408 SKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLT 467
++ + ++DV+++G++ +E+ + + G + +++ +R G P P L NL
Sbjct: 217 NRYTTESDVWAYGVVLWEIFSYGLQPYYG-MAHEEVIYYVRDGNILACPENCPLELYNLM 275
Query: 468 KKCWHTNPSQRPSFSSICRILRYIKK 493
+ CW P+ RPSF SI RIL+ + +
Sbjct: 276 RLCWSKLPADRPSFCSIHRILQRMCE 301
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 2e-37
Identities = 49/263 (18%), Positives = 100/263 (38%), Gaps = 29/263 (11%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRN 307
+ + E M S+ +P++ + L + + L Y+R ++
Sbjct: 54 ANKEILDEAYVMASVDNPHVCRLLG--ICLTSTVQLITQLMPFGCLLDYVR-----EHKD 106
Query: 308 SFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTAR 367
+ +++ +QIA+GM +L +++ H +L N+ +K HVK++ FGL+
Sbjct: 107 NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTP-----QHVKITDFGLA--- 158
Query: 368 TYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELL 427
+ P W A E + + ++DV+S+G+ +EL+
Sbjct: 159 --KLLGAEEKEYHAEGGKVPIKWMALESI---------LHRIYTHQSDVWSYGVTVWELM 207
Query: 428 T-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486
T G P++ + +++ + GER P + + KCW + RP F +
Sbjct: 208 TFGSKPYDG--IPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELII 265
Query: 487 ILRYIKKFMANNPDIARSEFQSP 509
+ + I E
Sbjct: 266 EFSKMARDPQRYLVIQGDERMHL 288
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 3e-37
Identities = 53/240 (22%), Positives = 94/240 (39%), Gaps = 33/240 (13%)
Query: 247 GELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRR 306
G L E+ L HPNI++ G+ + +L++E ++
Sbjct: 48 GVEHQLRREVEIQSHLRHPNILRLY-GYF-HDATRVYLILEYAPLGTVYREL-----QKL 100
Query: 307 NSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366
+ F + ++A + + H++++ H ++ P N+ L + +K++ FG S
Sbjct: 101 SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSA-----GELKIADFGWSVH 155
Query: 367 RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFEL 426
+ R T + + PE++ EK D++S G+LC+E
Sbjct: 156 APSSRRTTLCGTLD---------YLPPEMI---------EGRMHDEKVDLWSLGVLCYEF 197
Query: 427 LTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486
L GK PFE Q + K I E FP + +L + NPSQRP +
Sbjct: 198 LVGKPPFEANTYQ--ETYKRISRVE-FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 5e-37
Identities = 60/258 (23%), Positives = 106/258 (41%), Gaps = 30/258 (11%)
Query: 247 GELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFG--- 302
E +L +E+ ++ + H V L G C + +++E +LS Y+R
Sbjct: 58 SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFV 117
Query: 303 -------SRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFH 355
++ +L ++ Q+A+GMEFL ++K H +L NI L +
Sbjct: 118 PYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK-----NV 172
Query: 356 VKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKAD 415
VK+ FGL+ + A P W APE + + ++D
Sbjct: 173 VKICDFGLARDIYKDPDYV-----RKGDARLPLKWMAPETI---------FDRVYTIQSD 218
Query: 416 VYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNP 475
V+SFG+L +E+ + G ++ + ++ G R P + + CWH P
Sbjct: 219 VWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEP 278
Query: 476 SQRPSFSSICRILRYIKK 493
SQRP+FS + L + +
Sbjct: 279 SQRPTFSELVEHLGNLLQ 296
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 139 bits (352), Expect = 7e-37
Identities = 55/251 (21%), Positives = 97/251 (38%), Gaps = 33/251 (13%)
Query: 240 FVLRHFYGELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMS-KDLSCYMR 298
FV+ + E++ EI TM L HP +V F E+ E ++ E MS +L +
Sbjct: 58 FVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF--EDDNEMVMIYEFMSGGELFEKVA 115
Query: 299 ETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKV 358
N S V+ M Q+ +G+ +H H +L P NI + + +K+
Sbjct: 116 -----DEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMF---TTKRSNELKL 167
Query: 359 SGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYS 418
FGL + + P T + APEV D++S
Sbjct: 168 IDFGL-------TAHLDPKQSVKVTTGTAE-FAAPEVA---------EGKPVGYYTDMWS 210
Query: 419 FGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPL---FPSGSPKYLVNLTKKCWHTNP 475
G+L + LL+G PF + + +N+++ + + SG + + +K +P
Sbjct: 211 VGVLSYILLSGLSPFGGENDD--ETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADP 268
Query: 476 SQRPSFSSICR 486
+ R +
Sbjct: 269 NTRMTIHQALE 279
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 8e-37
Identities = 58/247 (23%), Positives = 100/247 (40%), Gaps = 28/247 (11%)
Query: 247 GELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRR 306
E E TM HP+IV+ + G E +++MEL + +F R+
Sbjct: 50 SVREKFLQEALTMRQFDHPHIVKLI-GVITENP--VWIIMELCTLGEL----RSFLQVRK 102
Query: 307 NSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366
S L ++ Q++ + +L +++ H ++ N+ + VK+ FGLS
Sbjct: 103 YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS-----SNDCVKLGDFGLSRY 157
Query: 367 RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFEL 426
+ P W APE + + + + +DV+ FG+ +E+
Sbjct: 158 ME------DSTYYKASKGKLPIKWMAPESI---------NFRRFTSASDVWMFGVCMWEI 202
Query: 427 LTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486
L V G + + + I GER P P L +L KCW +PS+RP F+ +
Sbjct: 203 LMHGVKPFQGV-KNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 261
Query: 487 ILRYIKK 493
L I +
Sbjct: 262 QLSTILE 268
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (347), Expect = 1e-36
Identities = 62/256 (24%), Positives = 100/256 (39%), Gaps = 35/256 (13%)
Query: 247 GELESLNAEISTMLSLS-HPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRE----- 299
E E+L +E+ + L H NIV L G C ++ E DL ++R
Sbjct: 68 TEREALMSELKVLSYLGNHMNIVNLL-GAC-TIGGPTLVITEYCCYGDLLNFLRRKRDSF 125
Query: 300 -------TFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEG 352
+ L ++ Q+A+GM FL ++ H +L NI L
Sbjct: 126 ICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG---- 181
Query: 353 YFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSE 412
K+ FGL+ S A P W APE + +
Sbjct: 182 -RITKICDFGLARDIKNDSNYV-----VKGNARLPVKWMAPESI---------FNCVYTF 226
Query: 413 KADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWH 472
++DV+S+G+ +EL + G K K I+ G R L P +P + ++ K CW
Sbjct: 227 ESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWD 286
Query: 473 TNPSQRPSFSSICRIL 488
+P +RP+F I +++
Sbjct: 287 ADPLKRPTFKQIVQLI 302
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 2e-36
Identities = 51/255 (20%), Positives = 91/255 (35%), Gaps = 28/255 (10%)
Query: 242 LRHFYGELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETF 301
++ E++ EI L+H N+V++ + +L +E S
Sbjct: 40 MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNI--QYLFLEYCSGGELFDRI--- 94
Query: 302 GSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGF 361
P Q+ G+ +LH I H ++ P N+ L R ++K+S F
Sbjct: 95 --EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER-----DNLKISDF 147
Query: 362 GLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGM 421
GL+T Y +R + APE+L +E E DV+S G+
Sbjct: 148 GLATVFRYNNRER-----LLNKMCGTLPYVAPELLKRREFHA--------EPVDVWSCGI 194
Query: 422 LCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSF 481
+ +L G++P++ + + + L K NPS R +
Sbjct: 195 VLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITI 254
Query: 482 SSICR---ILRYIKK 493
I + + +KK
Sbjct: 255 PDIKKDRWYNKPLKK 269
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 7e-36
Identities = 51/260 (19%), Positives = 94/260 (36%), Gaps = 33/260 (12%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRN 307
+ E + EI M +PNIV YL + E ++VME ++ +
Sbjct: 60 KKELIINEILVMRENKNPNIVNYLDSY--LVGDELWVVMEYLAGGSLTDVV------TET 111
Query: 308 SFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTAR 367
+ + + + +EFLH+ ++ H ++ NI L VK++ FG
Sbjct: 112 CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-----SVKLTDFGFCAQI 166
Query: 368 TYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELL 427
T T W APEV+ + K D++S G++ E++
Sbjct: 167 TPEQSKR-------STMVGTPYWMAPEVV---------TRKAYGPKVDIWSLGIMAIEMI 210
Query: 428 TGKVPFEDGHLQGDKMTKNIRAGERPL-FPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486
G+ P+ + + + G L P + +C + +R S + +
Sbjct: 211 EGEPPYLNENPL-RALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269
Query: 487 --ILRYIKKFMANNPDIARS 504
L+ K + P IA +
Sbjct: 270 HQFLKIAKPLSSLTPLIAAA 289
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 8e-36
Identities = 55/270 (20%), Positives = 107/270 (39%), Gaps = 37/270 (13%)
Query: 248 ELESLNAEISTMLSLS-HPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRE------ 299
+ E+ + L HPNI+ L E + +L +E +L ++R+
Sbjct: 53 DHRDFAGELEVLCKLGHHPNIINLLGAC--EHRGYLYLAIEYAPHGNLLDFLRKSRVLET 110
Query: 300 ----TFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFH 355
+ ++ S ++ +ARGM++L ++ H +L NI + +
Sbjct: 111 DPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN-----YV 165
Query: 356 VKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKAD 415
K++ FGLS + + T P W A E L + S + +D
Sbjct: 166 AKIADFGLSRGQEVYVKKT--------MGRLPVRWMAIESL---------NYSVYTTNSD 208
Query: 416 VYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNP 475
V+S+G+L +E+++ G + ++ + + G R P + +L ++CW P
Sbjct: 209 VWSYGVLLWEIVSLGGTPYCG-MTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKP 267
Query: 476 SQRPSFSSICRILRYIKKFMANNPDIARSE 505
+RPSF+ I L + + + E
Sbjct: 268 YERPSFAQILVSLNRMLEERKTYVNTTLYE 297
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (334), Expect = 5e-35
Identities = 44/239 (18%), Positives = 93/239 (38%), Gaps = 31/239 (12%)
Query: 247 GELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMS-KDLSCYMRETFGSRR 305
++ + E M L HP V+ F ++ ++ + + +L Y+R +
Sbjct: 50 NKVPYVTRERDVMSRLDHPFFVKLYFTF--QDDEKLYFGLSYAKNGELLKYIR------K 101
Query: 306 RNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365
SF +I +E+LH + I H +L P NI L H++++ FG +
Sbjct: 102 IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM-----HIQITDFGTAK 156
Query: 366 ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFE 425
+ S+ + + + +PE+L + + +D+++ G + ++
Sbjct: 157 VLSPESKQA-----RANSFVGTAQYVSPELL---------TEKSACKSSDLWALGCIIYQ 202
Query: 426 LLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSI 484
L+ G PF G+ + + I E FP +L +K + ++R +
Sbjct: 203 LVAGLPPFRAGNEY--LIFQKIIKLE-YDFPEKFFPKARDLVEKLLVLDATKRLGCEEM 258
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 2e-34
Identities = 50/299 (16%), Positives = 96/299 (32%), Gaps = 75/299 (25%)
Query: 247 GELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMS-KDLSCYMRETFGSRR 305
+ E+ + + P IV + F E + ME M L ++ +
Sbjct: 46 AIRNQIIRELQVLHECNSPYIVGFYGAF--YSDGEISICMEHMDGGSLDQVLK------K 97
Query: 306 RNSFSLPVVVDIMLQIARGMEFLH-AQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS 364
++ + + + +G+ +L KI H ++ PSNI + +R +K+ FG+S
Sbjct: 98 AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR-----GEIKLCDFGVS 152
Query: 365 TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCF 424
+ N+ + + +PE L + S ++D++S G+
Sbjct: 153 GQLIDSMANSFVGTRS---------YMSPERL---------QGTHYSVQSDIWSMGLSLV 194
Query: 425 ELLTGKVPFEDGHLQGD----------------------------------------KMT 444
E+ G+ P + ++
Sbjct: 195 EMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELL 254
Query: 445 KNIRAGERPLFPSGS-PKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKKFMANNPDIA 502
I P PSG + KC NP++R + +IK+ A D A
Sbjct: 255 DYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV-HAFIKRSDAEEVDFA 312
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 130 bits (327), Expect = 3e-34
Identities = 55/263 (20%), Positives = 100/263 (38%), Gaps = 32/263 (12%)
Query: 238 DSFVLRHFYGELESLNAEISTMLSLS-HPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSC 295
SF E+ E+ + +S HPNI+Q + E FFLV +LM K +L
Sbjct: 42 GSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY--ETNTFFFLVFDLMKKGELFD 99
Query: 296 YMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFH 355
Y+ + + S IM + + LH I H +L P NI L +
Sbjct: 100 YLT------EKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDD-----MN 148
Query: 356 VKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKAD 415
+K++ FG S + + + APE++ E + + + ++ D
Sbjct: 149 IKLTDFGFSCQLDPGEKLREVCGTPS--------YLAPEII---ECSMNDNHPGYGKEVD 197
Query: 416 VYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKY---LVNLTKKCWH 472
++S G++ + LL G PF M + I +G Y + +L +
Sbjct: 198 MWSTGVIMYTLLAGSPPFWHRKQM--LMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLV 255
Query: 473 TNPSQRPSFSSICRILRYIKKFM 495
P +R + + ++++
Sbjct: 256 VQPQKRYTAEEALA-HPFFQQYV 277
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 130 bits (328), Expect = 3e-34
Identities = 30/247 (12%), Positives = 78/247 (31%), Gaps = 20/247 (8%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRN 307
+ L E T L+ + + F +E LV++L+ L +
Sbjct: 43 DAPQLRDEYRTYKLLAGCTGIPNVYYFG-QEGLHNVLVIDLLGPSLEDLLD-----LCGR 96
Query: 308 SFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTAR 367
FS+ V Q+ ++ +H + + + ++ P N + + + + V FG+
Sbjct: 97 KFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156
Query: 368 TYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELL 427
+ + + + +E S + D+ + G + L
Sbjct: 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGRE---------QSRRDDLEALGHVFMYFL 207
Query: 428 TGKVPFEDGHLQG-----DKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFS 482
G +P++ +++ + ++ +G P+ + P +
Sbjct: 208 RGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYD 267
Query: 483 SICRILR 489
+ +
Sbjct: 268 YLQGLFS 274
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 130 bits (327), Expect = 5e-34
Identities = 38/245 (15%), Positives = 81/245 (33%), Gaps = 22/245 (8%)
Query: 250 ESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSF 309
L+ E + + + +C E +VMEL+ L F
Sbjct: 47 PQLHIESKIYKMMQGGVGIPTI-RWCGAEGDYNVMVMELLGPSLEDLFN-----FCSRKF 100
Query: 310 SLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTY 369
SL V+ + Q+ +E++H++ H ++ P N + V + FGL+
Sbjct: 101 SLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGN--LVYIIDFGLAKKYRD 158
Query: 370 ASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTG 429
A + +N+ + + E S + D+ S G + G
Sbjct: 159 ARTHQHIPYRENKNLTGTARYASINTHLGIE---------QSRRDDLESLGYVLMYFNLG 209
Query: 430 KVPFEDGHLQG-----DKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSI 484
+P++ +++++ + + G P C +P +S +
Sbjct: 210 SLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYL 269
Query: 485 CRILR 489
++ R
Sbjct: 270 RQLFR 274
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 5e-34
Identities = 63/258 (24%), Positives = 110/258 (42%), Gaps = 36/258 (13%)
Query: 247 GELESLNAEISTMLSLS-HPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMR------ 298
+L L +E+ M + H NI+ L + ++++E SK +L Y++
Sbjct: 60 KDLSDLISEMEMMKMIGKHKNIINLLGAC--TQDGPLYVIVEYASKGNLREYLQARRPPG 117
Query: 299 ----ETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYF 354
S +V Q+ARGME+L ++K H +L N+ +
Sbjct: 118 LEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED-----N 172
Query: 355 HVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKA 414
+K++ FGL+ + + P W APE L ++ + ++
Sbjct: 173 VMKIADFGLARDIHHIDYYK-----KTTNGRLPVKWMAPEALFDR---------IYTHQS 218
Query: 415 DVYSFGMLCFELLT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHT 473
DV+SFG+L +E+ T G P+ + +++ K ++ G R PS L + + CWH
Sbjct: 219 DVWSFGVLLWEIFTLGGSPYPG--VPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHA 276
Query: 474 NPSQRPSFSSICRILRYI 491
PSQRP+F + L I
Sbjct: 277 VPSQRPTFKQLVEDLDRI 294
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 131 bits (330), Expect = 7e-34
Identities = 50/251 (19%), Positives = 91/251 (36%), Gaps = 33/251 (13%)
Query: 240 FVLRHFYGELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMR 298
F+ + + ++ EIS M L HP ++ F E+K E L++E +S +L +
Sbjct: 61 FINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF--EDKYEMVLILEFLSGGELFDRIA 118
Query: 299 ETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKV 358
S V++ M Q G++ +H I H ++ P NI + VK+
Sbjct: 119 -----AEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMC---ETKKASSVKI 170
Query: 359 SGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYS 418
FGL + P T + APE++ + D+++
Sbjct: 171 IDFGL-------ATKLNPDEIVKVTTATAE-FAAPEIVDRE---------PVGFYTDMWA 213
Query: 419 FGMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPL---FPSGSPKYLVNLTKKCWHTNP 475
G+L + LL+G PF + +N++ + S + K P
Sbjct: 214 IGVLGYVLLSGLSPFAGEDDL--ETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEP 271
Query: 476 SQRPSFSSICR 486
+R +
Sbjct: 272 RKRLTVHDALE 282
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 2e-33
Identities = 46/250 (18%), Positives = 84/250 (33%), Gaps = 33/250 (13%)
Query: 241 VLRHFYGELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMS-KDLSCYMRE 299
++ + + EIS + H NI+ F E +E ++ E +S D+ +
Sbjct: 37 FVKVKGTDQVLVKKEISILNIARHRNILHLHESF--ESMEELVMIFEFISGLDIFERIN- 93
Query: 300 TFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVS 359
+ +V + Q+ ++FLH+ I H ++ P NI +K+
Sbjct: 94 ----TSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIY---QTRRSSTIKII 146
Query: 360 GFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSF 419
FG + +YAPEV S D++S
Sbjct: 147 EFGQARQLKPGDNFR--------LLFTAPEYYAPEVH---------QHDVVSTATDMWSL 189
Query: 420 GMLCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKY---LVNLTKKCWHTNPS 476
G L + LL+G PF Q ++ +NI E + ++ +
Sbjct: 190 GTLVYVLLSGINPFLAETNQ--QIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERK 247
Query: 477 QRPSFSSICR 486
R + S +
Sbjct: 248 SRMTASEALQ 257
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 2e-33
Identities = 46/270 (17%), Positives = 94/270 (34%), Gaps = 48/270 (17%)
Query: 254 AEISTMLSLSHPNIVQYLCGFCDEE--KKEFFLVMELMSK-DLSCYMRETFGSRRRNSFS 310
AEI + L H NI+ ++ + + +LV + L Y+ R + +
Sbjct: 46 AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN-------RYTVT 98
Query: 311 LPVVVDIMLQIARGMEFLHAQ--------KIYHGELNPSNIYLKARSMEGYFHVKVSGFG 362
+ ++ + L A G+ LH + I H +L NI +K ++ G
Sbjct: 99 VEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-----GTCCIADLG 153
Query: 363 LSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGML 422
L+ A+ A + APEVL + + ++AD+Y+ G++
Sbjct: 154 LAVRHDSATDTIDIAP---NHRVGTKRYMAPEVLDDSINMKHF---ESFKRADIYAMGLV 207
Query: 423 CFELLTGKVPFEDGHLQG--------------DKMTKNIRAGERPLFPSG-----SPKYL 463
+E+ + RP P+ + + +
Sbjct: 208 FWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVM 267
Query: 464 VNLTKKCWHTNPSQRPSFSSICRILRYIKK 493
+ ++CW+ N + R + I + L + +
Sbjct: 268 AKIMRECWYANGAARLTALRIKKTLSQLSQ 297
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 5e-33
Identities = 60/248 (24%), Positives = 99/248 (39%), Gaps = 27/248 (10%)
Query: 247 GELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRR 305
E E S M + ++V+ L + + ++MELM++ DL Y+R +
Sbjct: 65 RERIEFLNEASVMKEFNCHHVVRLLGVV--SQGQPTLVIMELMTRGDLKSYLRSLRPAMA 122
Query: 306 RNS----FSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGF 361
N SL ++ + +IA GM +L+A K H +L N + F VK+ F
Sbjct: 123 NNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED-----FTVKIGDF 177
Query: 362 GLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGM 421
G+ + P W +PE L + +DV+SFG+
Sbjct: 178 GM-----TRDIYETDYYRKGGKGLLPVRWMSPESL---------KDGVFTTYSDVWSFGV 223
Query: 422 LCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSF 481
+ +E+ T G L +++ + + G P P L L + CW NP RPSF
Sbjct: 224 VLWEIATLAEQPYQG-LSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSF 282
Query: 482 SSICRILR 489
I ++
Sbjct: 283 LEIISSIK 290
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 126 bits (318), Expect = 1e-32
Identities = 56/266 (21%), Positives = 107/266 (40%), Gaps = 34/266 (12%)
Query: 243 RHFYGELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMS-KDLSCYMRETF 301
+ G+ S+ EI+ + + HPNIV + E +L+M+L+S +L +
Sbjct: 45 KALEGKEGSMENEIAVLHKIKHPNIVALDDIY--ESGGHLYLIMQLVSGGELFDRIV--- 99
Query: 302 GSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGF 361
+ ++ ++ Q+ +++LH I H +L P N+ + + + +S F
Sbjct: 100 ---EKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDS--KIMISDF 154
Query: 362 GLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGM 421
GLS S + TA + APEVLA++ S+ D +S G+
Sbjct: 155 GLSKMEDPGSVLS--------TACGTPGYVAPEVLAQK---------PYSKAVDCWSIGV 197
Query: 422 LCFELLTGKVPFEDGHLQGDKMTKNIRAGERPL---FPSGSPKYLVNLTKKCWHTNPSQR 478
+ + LL G PF D + K+ + I E + + + +P +R
Sbjct: 198 IAYILLCGYPPFYDENDA--KLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKR 255
Query: 479 PSFSSICRILRYIKKFMANNPDIARS 504
+ + +I A + +I +S
Sbjct: 256 FTCEQALQ-HPWIAGDTALDKNIHQS 280
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (316), Expect = 3e-32
Identities = 52/246 (21%), Positives = 99/246 (40%), Gaps = 32/246 (13%)
Query: 248 ELESLNAEISTMLSLS-HPNIVQYLCGFCD--EEKKEFFLVMELMSK-DLSCYMRETFGS 303
+ E+ S P+IV+ + + + +K +VME + +L +++
Sbjct: 47 DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD---- 102
Query: 304 RRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGL 363
R +F+ +IM I +++LH+ I H ++ P N+ ++ +K++ FG
Sbjct: 103 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNA--ILKLTDFG- 159
Query: 364 STARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLC 423
++ T + PY + APEVL + K + D++S G++
Sbjct: 160 ------FAKETTSHNSLTTPCYTPY-YVAPEVLGPE---------KYDKSCDMWSLGVIM 203
Query: 424 FELLTGKVPFEDGH--LQGDKMTKNIRAGERPL---FPSGSPKYLVNLTKKCWHTNPSQR 478
+ LL G PF H M IR G+ S + + L + T P+QR
Sbjct: 204 YILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQR 263
Query: 479 PSFSSI 484
+ +
Sbjct: 264 MTITEF 269
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 5e-32
Identities = 60/264 (22%), Positives = 107/264 (40%), Gaps = 36/264 (13%)
Query: 248 ELESLNAEISTM-LSLSHPNIVQYLCGFCDEEKKEFFLVMELMSK-DLSCYMRETFGSRR 305
++E E + L+ HP + C F +E F VME ++ DL +++
Sbjct: 45 DVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN--LFFVMEYLNGGDLMYHIQ------S 96
Query: 306 RNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365
+ F L +I G++FLH++ I + +L NI ++ H+K++ FG+
Sbjct: 97 CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNIL-----LDKDGHIKIADFGM-- 149
Query: 366 ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFE 425
+ + T + APE+L Q K + D +SFG+L +E
Sbjct: 150 -----CKENMLGDAKTNTFCGTPDYIAPEILLGQ---------KYNHSVDWWSFGVLLYE 195
Query: 426 LLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSIC 485
+L G+ PF + ++ +IR P +P K +L K + P +R
Sbjct: 196 MLIGQSPFHGQDEE--ELFHSIRMD-NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDI 252
Query: 486 RILRYIKKFMANNPDIARSEFQSP 509
R ++ N ++ R E P
Sbjct: 253 RQHPLFREI--NWEELERKEIDPP 274
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 120 bits (302), Expect = 6e-31
Identities = 42/238 (17%), Positives = 77/238 (32%), Gaps = 28/238 (11%)
Query: 247 GELESLNAEISTMLSLSHPNIVQYLCGFCDEEK--KEFFLVMELMSKDLSCYMRETFGSR 304
E +L+HP IV E ++VME + + T G
Sbjct: 49 SFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP- 107
Query: 305 RRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS 364
+ ++++ + + F H I H ++ P+NI + A + ++
Sbjct: 108 ----MTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 163
Query: 365 TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCF 424
+ + + Q + +PE ++DVYS G + +
Sbjct: 164 SGNSVTQTAAVIGTAQ---------YLSPEQA---------RGDSVDARSDVYSLGCVLY 205
Query: 425 ELLTGKVPFEDGHLQGDKMTKNIRAGERP--LFPSGSPKYLVNLTKKCWHTNPSQRPS 480
E+LTG+ PF +++R P G L + K NP R
Sbjct: 206 EVLTGEPPFTGDSPV-SVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQ 262
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 2e-30
Identities = 38/241 (15%), Positives = 75/241 (31%), Gaps = 38/241 (15%)
Query: 248 ELESLNAEISTMLSLS--HPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRR 305
+ E+ + +S +++ L F + F L++E +
Sbjct: 50 NGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS--FVLILERPEPVQDLFDF----ITE 103
Query: 306 RNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365
R + + Q+ + H + H ++ NI + +K+ FG
Sbjct: 104 RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRG----ELKLIDFGSGA 159
Query: 366 ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFE 425
+ ++ PE + A V+S G+L ++
Sbjct: 160 LLKDTVYTDFDGTR---------VYSPPEWIRYHRY--------HGRSAAVWSLGILLYD 202
Query: 426 LLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSIC 485
++ G +PFE + I G+ F +L + C PS RP+F I
Sbjct: 203 MVCGDIPFEH--------DEEIIRGQ-VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQ 253
Query: 486 R 486
Sbjct: 254 N 254
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 2e-30
Identities = 50/265 (18%), Positives = 101/265 (38%), Gaps = 33/265 (12%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRN 307
E + E+S + + HPN++ + E K + L++EL++ +
Sbjct: 56 SREDIEREVSILKEIQHPNVITLHEVY--ENKTDVILILELVAGGELFDFL-----AEKE 108
Query: 308 SFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTAR 367
S + + + QI G+ +LH+ +I H +L P NI L +K+ FGL+
Sbjct: 109 SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKI 167
Query: 368 TYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELL 427
+ + + APE++ + +AD++S G++ + LL
Sbjct: 168 DFGNEFKNIFGTPE--------FVAPEIVNYE---------PLGLEADMWSIGVITYILL 210
Query: 428 TGKVPFEDGHLQGDKMTKNIRAGERPL---FPSGSPKYLVNLTKKCWHTNPSQRPSFSSI 484
+G PF Q + N+ A + S + + ++ +P +R +
Sbjct: 211 SGASPFLGDTKQ--ETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 268
Query: 485 CRILRYIKKFMANNPDIARSEFQSP 509
+ +IK + S + P
Sbjct: 269 LQ-HPWIKPK--DTQQALSSAWSHP 290
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 119 bits (298), Expect = 1e-29
Identities = 43/226 (19%), Positives = 81/226 (35%), Gaps = 29/226 (12%)
Query: 255 EISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVV 314
+S + + P IV F + +++LM+ Y + FS +
Sbjct: 57 MLSLVSTGDCPFIVCMSYAF--HTPDKLSFILDLMNGGDLHYHL-----SQHGVFSEADM 109
Query: 315 VDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYASRNT 374
+I G+E +H + + + +L P+NI L + + HV++S GL+ + +
Sbjct: 110 RFYAAEIILGLEHMHNRFVVYRDLKPANILL-----DEHGHVRISDLGLACDFSKKKPHA 164
Query: 375 PPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFE 434
+ + APEVL + AD +S G + F+LL G PF
Sbjct: 165 SVGTH---------GYMAPEVLQKGVAYD--------SSADWFSLGCMLFKLLRGHSPFR 207
Query: 435 DGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPS 480
+ + P L +L + + ++R
Sbjct: 208 QHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLG 253
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 3e-29
Identities = 52/298 (17%), Positives = 97/298 (32%), Gaps = 53/298 (17%)
Query: 250 ESLNAEISTMLSLSHPNIVQYLCGFCDEEKKE----FFLVMELMSKDLSCYMRETFGSRR 305
N E+ M L H NIV+ F +K+ LV++ + + + R SR
Sbjct: 58 RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH--YSRA 115
Query: 306 RNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365
+ + + V M Q+ R + ++H+ I H ++ P N+ L +K+ FG
Sbjct: 116 KQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL----DPDTAVLKLCDFGS-- 169
Query: 366 ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFE 425
++ P + Y + + + DV+S G + E
Sbjct: 170 -----AKQLVRGEPNVSYICSRYYRAPELIF---------GATDYTSSIDVWSAGCVLAE 215
Query: 426 LLTGKVPF--EDGHLQGDKMTKNIRAGERPLFPSGSPKY--------------------- 462
LL G+ F + G Q ++ K + R +P Y
Sbjct: 216 LLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRT 275
Query: 463 ---LVNLTKKCWHTNPSQRPSFSSICRILRYIKKFMANNPDIARSEFQSPLADYCDIE 517
+ L + P+ R + C + + N + L ++ E
Sbjct: 276 PPEAIALCSRLLEYTPTARLTPLEACA-HSFFDELRDPNVKLPNGRDTPALFNFTTQE 332
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 110 bits (277), Expect = 3e-27
Identities = 53/233 (22%), Positives = 96/233 (41%), Gaps = 34/233 (14%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRN 307
++E N E + ++HP I++ G + ++ F ++ + +L +R +
Sbjct: 47 QVEHTNDERLMLSIVTHPFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLLR------KSQ 99
Query: 308 SFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTAR 367
F PV ++ +E+LH++ I + +L P NI L H+K++ FG +
Sbjct: 100 RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKN-----GHIKITDFGFAKY- 153
Query: 368 TYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELL 427
T + APEV+ ST ++ D +SFG+L +E+L
Sbjct: 154 ---------VPDVTYTLCGTPDYIAPEVV---------STKPYNKSIDWWSFGILIYEML 195
Query: 428 TGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPS 480
G PF D + K + I E FP + + +L + + SQR
Sbjct: 196 AGYTPFYDSNTM--KTYEKILNAELR-FPPFFNEDVKDLLSRLITRDLSQRLG 245
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (271), Expect = 2e-26
Identities = 43/233 (18%), Positives = 81/233 (34%), Gaps = 25/233 (10%)
Query: 249 LESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNS 308
E E + + + L E K ++ + +L ++ +R
Sbjct: 72 TEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS------QRER 125
Query: 309 FSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTART 368
F+ V + +I +E LH I + ++ NI L + HV ++ FGL
Sbjct: 126 FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG-----HVVLTDFGL----- 175
Query: 369 YASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT 428
+ + + + AP+++ + S + D +S G+L +ELLT
Sbjct: 176 -SKEFVADETERAYDFCGTIEYMAPDIVRGGD-------SGHDKAVDWWSLGVLMYELLT 227
Query: 429 GKVPFE-DGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPS 480
G PF DG P +P +L ++ +P +R
Sbjct: 228 GASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLG 280
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 3e-26
Identities = 53/279 (18%), Positives = 92/279 (32%), Gaps = 57/279 (20%)
Query: 247 GELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRR 306
G + EI + LSHPNI+ L K LV + M E
Sbjct: 42 GINRTALREIKLLQELSHPNIIGLLD--AFGHKSNISLVFDFM-----ETDLEVIIKDNS 94
Query: 307 NSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366
+ + ML +G+E+LH I H +L P+N+ L + +K++ FG
Sbjct: 95 LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL-----DENGVLKLADFG---- 145
Query: 367 RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFEL 426
A P + + APE+L G D+++ G + EL
Sbjct: 146 --LAKSFGSPNRAYTHQVVTRW-YRAPELLFGARMYG--------VGVDMWAVGCILAEL 194
Query: 427 LTGKVPF--EDGHLQGDKMTKNIRAGERPLFP-----------------------SGSPK 461
L + Q ++ + + +P S +
Sbjct: 195 LLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGD 254
Query: 462 YLVNLTKKCWHTNPSQRPSFSSICRILRYIKKFMANNPD 500
L++L + + NP R + + + K+ +N P
Sbjct: 255 DLLDLIQGLFLFNPCARITATQALK-----MKYFSNRPG 288
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 2e-25
Identities = 51/272 (18%), Positives = 92/272 (33%), Gaps = 57/272 (20%)
Query: 247 GELESLNAEISTMLSLSHPNIVQYLCGFCD---EEKKEFFLVMELMSKDLSCYMRETFGS 303
+ EI +L H NI+ E+ K+ +LV LM DL ++
Sbjct: 48 TYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK----- 102
Query: 304 RRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGL 363
S + + QI RG++++H+ + H +L PSN+ L +K+ FGL
Sbjct: 103 --TQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTT-----CDLKICDFGL 155
Query: 364 STARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLC 423
+ A + + + + APE++ +G + D++S G +
Sbjct: 156 A---RVADPDHDHTGFLTEYVATRW-YRAPEIMLNSKGYT--------KSIDIWSVGCIL 203
Query: 424 FELLTGKVPFEDGHLQGD-----------------------------KMTKNIRAGERPL 454
E+L+ + F H + + L
Sbjct: 204 AEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRL 263
Query: 455 FPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486
FP+ K ++L K NP +R
Sbjct: 264 FPNADSK-ALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 102 bits (255), Expect = 1e-24
Identities = 51/267 (19%), Positives = 91/267 (34%), Gaps = 55/267 (20%)
Query: 247 GELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRR 306
G + EIS + L H NIV+ + K LV E + +DL +
Sbjct: 42 GIPSTTIREISILKELKHSNIVKLYDVIHTK--KRLVLVFEHLDQDLKKLLD-----VCE 94
Query: 307 NSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366
+LQ+ G+ + H +++ H +L P N+ + +K++ FGL+
Sbjct: 95 GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREG-----ELKIADFGLA-- 147
Query: 367 RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFEL 426
R + + AP+VL + K S D++S G + E+
Sbjct: 148 -----RAFGIPVRKYTHEIVTLWYRAPDVL--------MGSKKYSTTIDIWSVGCIFAEM 194
Query: 427 LTGKVPFEDGHLQGDKMTKNIRAGERP---------------------------LFPSGS 459
+ G F G + D++ + R P F G
Sbjct: 195 VNGTPLF-PGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGL 253
Query: 460 PKYLVNLTKKCWHTNPSQRPSFSSICR 486
+ ++L K +P+QR +
Sbjct: 254 DESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 2e-24
Identities = 38/239 (15%), Positives = 78/239 (32%), Gaps = 43/239 (17%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRN 307
E+ E + + HP + + F++ +L ++ R
Sbjct: 48 EVAHTVTESRVLQNTRHPFLTALKY-AFQTHDRLCFVMEYANGGELFFHLS------RER 100
Query: 308 SFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS--- 364
F+ +I +E+LH++ + + ++ N+ L + H+K++ FGL
Sbjct: 101 VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML-----DKDGHIKITDFGLCKEG 155
Query: 365 ---TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGM 421
A TP N Y D + G+
Sbjct: 156 ISDGATMKTFCGTPEYLAPEVLEDNDY----------------------GRAVDWWGLGV 193
Query: 422 LCFELLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPS 480
+ +E++ G++PF + + ++ + I E FP +L +P QR
Sbjct: 194 VMYEMMCGRLPFYNQDHE--RLFELILMEE-IRFPRTLSPEAKSLLAGLLKKDPKQRLG 249
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (254), Expect = 2e-24
Identities = 55/267 (20%), Positives = 102/267 (38%), Gaps = 54/267 (20%)
Query: 247 GELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRR 306
G + EIS + L+HPNIV+ L + + +LV E + +DL +M +
Sbjct: 43 GVPSTAIREISLLKELNHPNIVKLLD--VIHTENKLYLVFEFLHQDLKKFMD----ASAL 96
Query: 307 NSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366
LP++ + Q+ +G+ F H+ ++ H +L P N+ + +K++ FGL
Sbjct: 97 TGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTE-----GAIKLADFGL--- 148
Query: 367 RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFEL 426
A P + + APE+L S D++S G + E+
Sbjct: 149 ---ARAFGVPVRTYTHEVVTLW-YRAPEILL--------GCKYYSTAVDIWSLGCIFAEM 196
Query: 427 LTGKVPFEDGHLQGDKMTKNIRAGERP----------------LFPSGSPKYL------- 463
+T + F G + D++ + R P FP + +
Sbjct: 197 VTRRALF-PGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPL 255
Query: 464 ----VNLTKKCWHTNPSQRPSFSSICR 486
+L + H +P++R S +
Sbjct: 256 DEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 100 bits (250), Expect = 2e-23
Identities = 41/232 (17%), Positives = 85/232 (36%), Gaps = 34/232 (14%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRN 307
++E E + +++ P +V+ F D + + S R
Sbjct: 84 QIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR-------IG 136
Query: 308 SFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTAR 367
FS P QI E+LH+ + + +L P N+ + + +++V+ FG +
Sbjct: 137 RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-----GYIQVTDFGFAK-- 189
Query: 368 TYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELL 427
+ T APE++ + ++ D ++ G+L +E+
Sbjct: 190 --------RVKGRTWTLCGTPEALAPEIILSK---------GYNKAVDWWALGVLIYEMA 232
Query: 428 TGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRP 479
G PF ++ + I +G+ FPS L +L + + ++R
Sbjct: 233 AGYPPFFADQPI--QIYEKIVSGK-VRFPSHFSSDLKDLLRNLLQVDLTKRF 281
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.4 bits (244), Expect = 9e-23
Identities = 49/271 (18%), Positives = 95/271 (35%), Gaps = 62/271 (22%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKK----EFFLVMELMSKDLSCYMRETFGS 303
+ E+ + + H N++ L F +E +F+LVM M DL M+
Sbjct: 60 FAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK----- 114
Query: 304 RRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGL 363
+ ++ Q+ +G+ ++HA I H +L P N+ + +K+ FGL
Sbjct: 115 --HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDC-----ELKILDFGL 167
Query: 364 STARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLC 423
+ A + + APEV+ + ++ D++S G +
Sbjct: 168 AR----------QADSEMTGYVVTRWYRAPEVILNWM--------RYTQTVDIWSVGCIM 209
Query: 424 FELLTGKVPFEDGHLQG-------------DKMTKNIRAGERPLFPSGSPKY-------- 462
E++TGK F+ + + +++ E + G P+
Sbjct: 210 AEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASI 269
Query: 463 -------LVNLTKKCWHTNPSQRPSFSSICR 486
VNL +K + QR +
Sbjct: 270 LTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.2 bits (238), Expect = 2e-22
Identities = 51/276 (18%), Positives = 89/276 (32%), Gaps = 57/276 (20%)
Query: 247 GELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRR 306
G S EI + L H NIV+ + K+ LV E + +
Sbjct: 43 GVPSSALREICLLKELKHKNIVRLHDVLHSD--KKLTLVFEFC-----DQDLKKYFDSCN 95
Query: 307 NSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366
+V + Q+ +G+ F H++ + H +L P N+ + +K++ FGL+ A
Sbjct: 96 GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRN-----GELKLANFGLARA 150
Query: 367 RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFEL 426
P + + + P+VL + S D++S G + EL
Sbjct: 151 ------FGIPVRCYSAEVVTLW-YRPPDVLFGAK--------LYSTSIDMWSAGCIFAEL 195
Query: 427 LTGKVPFEDGHLQGDKMTKNIRAGERP----------------------------LFPSG 458
P G+ D++ + R P + P
Sbjct: 196 ANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKL 255
Query: 459 SPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKKF 494
+ +L + NP QR S + Y F
Sbjct: 256 NAT-GRDLLQNLLKCNPVQRISAEEALQ-HPYFSDF 289
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.7 bits (237), Expect = 5e-22
Identities = 44/275 (16%), Positives = 84/275 (30%), Gaps = 56/275 (20%)
Query: 247 GELESLNAEISTMLSLSHPNIVQYLCGFCD------EEKKEFFLVMELMSKDLSCYMRET 300
G + EI + L H N+V + K +LV + DL+ +
Sbjct: 51 GFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS-- 108
Query: 301 FGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSG 360
F+L + +M + G+ ++H KI H ++ +N+ + +K++
Sbjct: 109 ---NVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG-----VLKLAD 160
Query: 361 FGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFG 420
FGL AR ++ + WY P L E D++ G
Sbjct: 161 FGL--ARAFSLAKNSQPNRYTNRVVTL--WYRPPELLLGE-------RDYGPPIDLWGAG 209
Query: 421 MLCFELLTGKVPFED-----------------------------GHLQGDKMTKNIRAGE 451
+ E+ T + + + + + R +
Sbjct: 210 CIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVK 269
Query: 452 RPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486
L Y ++L K +P+QR
Sbjct: 270 DRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.9 bits (235), Expect = 6e-22
Identities = 48/260 (18%), Positives = 92/260 (35%), Gaps = 53/260 (20%)
Query: 254 AEISTMLSLSHPNIVQYLCGFCD---EEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFS 310
A + + + HPN+V+ + + + LV E + +DL+ Y+ +
Sbjct: 59 AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK----VPEPGVP 114
Query: 311 LPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTYA 370
+ D+M Q+ RG++FLH+ ++ H +L P NI + + +K++ FGL+ ++
Sbjct: 115 TETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS-----GQIKLADFGLARIYSFQ 169
Query: 371 SRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGK 430
T +WY + S + D++S G + E+ K
Sbjct: 170 MALTSVVVT---------LWYRAPEVLL--------QSSYATPVDLWSVGCIFAEMFRRK 212
Query: 431 VPFEDGHLQ------------------------GDKMTKNIRAGERPLFPSGSPKYLVNL 466
F + + A F + + +L
Sbjct: 213 PLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDL 272
Query: 467 TKKCWHTNPSQRPSFSSICR 486
KC NP++R S S
Sbjct: 273 LLKCLTFNPAKRISAYSALS 292
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 94.1 bits (233), Expect = 2e-21
Identities = 39/276 (14%), Positives = 85/276 (30%), Gaps = 66/276 (23%)
Query: 248 ELESLNAEISTMLSLS-HPNIVQYLCGFCDEEKKEFFLVMELMS-KDLSCYMRETFGSRR 305
+ + + EI + +L PNI+ D + LV E ++ D +
Sbjct: 72 KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ------- 124
Query: 306 RNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365
+ + + M +I + +++ H+ I H ++ P N+ + +++ +GL
Sbjct: 125 --TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR----KLRLIDWGL-- 176
Query: 366 ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFE 425
+ P N + Y + PE+L + + D++S G +
Sbjct: 177 -----AEFYHPGQEYNVRVASRY-FKGPELLVDYQM--------YDYSLDMWSLGCMLAS 222
Query: 426 LLTGKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKY----------------------- 462
++ K PF GH D++ + + KY
Sbjct: 223 MIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERF 282
Query: 463 ------------LVNLTKKCWHTNPSQRPSFSSICR 486
++ K + R +
Sbjct: 283 VHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.3 bits (223), Expect = 4e-20
Identities = 51/286 (17%), Positives = 101/286 (35%), Gaps = 67/286 (23%)
Query: 248 ELESLNAEISTMLSLSHPNIVQYLCGFCDE----EKKEFFLVMELMSKDLSCYMRETFGS 303
+ E+ + + H N++ L F E + +LV LM DL+ ++
Sbjct: 60 HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK----- 114
Query: 304 RRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGL 363
+ V ++ QI RG++++H+ I H +L PSN+ + +K+ FGL
Sbjct: 115 --CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLA-----VNEDCELKILDFGL 167
Query: 364 STARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLC 423
+ + + APE++ ++ D++S G +
Sbjct: 168 A----------RHTDDEMTGYVATRWYRAPEIMLNWM--------HYNQTVDIWSVGCIM 209
Query: 424 FELLTGKVPF-----------------------------EDGHLQGDKMTKNIRAGERPL 454
ELLTG+ F E +T+ + +
Sbjct: 210 AELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV 269
Query: 455 FPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKKFMANNPD 500
F +P V+L +K + +R + + Y ++ ++PD
Sbjct: 270 FIGANPL-AVDLLEKMLVLDSDKRITAAQALA-HAYFAQY--HDPD 311
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.1 bits (191), Expect = 5e-16
Identities = 54/243 (22%), Positives = 92/243 (37%), Gaps = 39/243 (16%)
Query: 247 GELESLNAEISTMLSLSHPNIVQYLCGFCD----EEKKEFFLVMELMSKDLSCYMRETFG 302
+ E+ M ++H NI+ L F EE ++ +LVMELM +L ++
Sbjct: 58 THAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD 117
Query: 303 SRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFG 362
R + ++ Q+ G++ LH+ I H +L PSNI +K+ +K+ FG
Sbjct: 118 HER--------MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-----CTLKILDFG 164
Query: 363 LSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGML 422
L+ + TP + AP + E D++S G +
Sbjct: 165 LARTAGTSFMMTPYVVTRYYRAPEVILGM-----------------GYKENVDIWSVGCI 207
Query: 423 CFELLTGKVPF--EDGHLQGDKMTKNIRAGERPLFPSGSP---KYLVNLTKKCWHTNPSQ 477
E++ K+ F D Q +K+ + + P Y+ N K T P
Sbjct: 208 MGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKL 267
Query: 478 RPS 480
P
Sbjct: 268 FPD 270
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 72.8 bits (177), Expect = 3e-14
Identities = 51/315 (16%), Positives = 99/315 (31%), Gaps = 48/315 (15%)
Query: 199 GSVVLTKNEQ--RLVDMLLKKLMVRRRLGASSQFKEIQWLGDSFVLRHFYGELESLNAEI 256
+V L K+ V M K++ ++ + EI+ L + A+
Sbjct: 27 STVWLAKDMVNNTHVAM---KIVRGDKVYTEAAEDEIKLLQR---VND---------ADN 71
Query: 257 STMLSLSHPNIVQYLCGFCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVD 316
+ S+ +I++ L F + +VM + L V
Sbjct: 72 TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLG--ENLLALIKKYEHRGIPLIYVKQ 129
Query: 317 IMLQIARGMEFLHAQ-KIYHGELNPSNIYLKARSMEGY-FHVKVSGFGLSTARTYASRNT 374
I Q+ G++++H + I H ++ P N+ ++ +K++ G +
Sbjct: 130 ISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD------ 183
Query: 375 PPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFE 434
+ + +PEVL + AD++S L FEL+TG FE
Sbjct: 184 ----EHYTNSIQTREYRSPEVL---------LGAPWGCGADIWSTACLIFELITGDFLFE 230
Query: 435 DGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKKF 494
+ A + L L R F+S + K
Sbjct: 231 PDEGHSYTKDDDHIA--------QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLK 282
Query: 495 MANNPDIARSEFQSP 509
D+ +++
Sbjct: 283 FWPLEDVLTEKYKFS 297
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 53.2 bits (127), Expect = 1e-08
Identities = 19/137 (13%), Positives = 43/137 (31%), Gaps = 24/137 (17%)
Query: 228 SQFKEIQWLGDSFVLRHFYGELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVME 287
+ FK+++ D L + S E + L + + + ++ME
Sbjct: 37 TSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY------AWEGNAVLME 90
Query: 288 LMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKA 347
L+ +R ++ I + + + I HG+L+ N+ +
Sbjct: 91 LIDAKELYRVRVENPDE------------VLDMILEEVAKFYHRGIVHGDLSQYNVLV-- 136
Query: 348 RSMEGYFHVKVSGFGLS 364
+ + F S
Sbjct: 137 ----SEEGIWIIDFPQS 149
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 811 | |||
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.85 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.29 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.94 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.76 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.07 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.74 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.33 |
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=369.93 Aligned_cols=240 Identities=22% Similarity=0.375 Sum_probs=195.9
Q ss_pred CCEEEEEEECCCC---EEEEEE-ECCCEEEEEEECC-------CHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEE
Q ss_conf 0568953416434---289999-9698999998064-------2789999999998089985012520388267986999
Q 003542 216 KKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG-------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFL 284 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~-~~g~~vAIK~l~~-------~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~e~~~~~~L 284 (811)
+.|+..+.||+|+ ||++.. .+|+.||||.+.. ..+.+.+|+.+|++++|||||++++.+. +.+.+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~--~~~~~~i 92 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL--REHTAWL 92 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE--ETTEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE--ECCEEEE
T ss_conf 85676279701888099999998999399999984444358899999999999999778999823899999--8998899
Q ss_pred EEECCCCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCCCCEEEEEECCCC
Q ss_conf 98467999889999860777889999789999999999999999869942026899948981267887315999103432
Q 003542 285 VMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS 364 (811)
Q Consensus 285 VmEy~~gsL~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIvHRDLKPsNILI~~~g~d~~~~vKL~DFGLa 364 (811)
|||||+|++...+... +..+++..++.++.||+.||.|||+++|+||||||+|||++.++ .+||+|||+|
T Consensus 93 v~E~~~~g~l~~~~~~-----~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~-----~~Kl~DFG~a 162 (309)
T d1u5ra_ 93 VMEYCLGSASDLLEVH-----KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG-----LVKLGDFGSA 162 (309)
T ss_dssp EEECCSEEHHHHHHHH-----TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT-----EEEECCCTTC
T ss_pred EEEECCCCCHHHHHHH-----CCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCEEEECCCC-----CEEEEECCCC
T ss_conf 9980699945789973-----79999999999999999999999868976667884217987999-----7898443653
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCCCCHHHHH
Q ss_conf 11235688999999998889998766783575420188988889999535321533579998619999988851137889
Q 003542 365 TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMT 444 (811)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIwSlGvILyELLtGk~PF~~~~~~~~~i~ 444 (811)
..... .....||+.|+|||++.+. ....|+.++|||||||++|||++|+.||.+.... ...
T Consensus 163 ~~~~~-----------~~~~~GT~~Y~APE~~~~~------~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~--~~~ 223 (309)
T d1u5ra_ 163 SIMAP-----------ANSFVGTPYWMAPEVILAM------DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SAL 223 (309)
T ss_dssp BSSSS-----------BCCCCSCGGGCCHHHHTTT------TSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHH
T ss_pred CCCCC-----------CCCCCCCCCCCCHHHHHCC------CCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHH--HHH
T ss_conf 34677-----------8731347663688998346------7888672145455899999998788999997999--999
Q ss_pred HHHHHCCCC-CCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHH
Q ss_conf 988718999-999999178799874101589999999999999
Q 003542 445 KNIRAGERP-LFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 445 ~~i~~~~~~-~~p~~~p~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
..+..+..+ ..+..+++.+.+||.+||+.||.+|||++++++
T Consensus 224 ~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 224 YHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp HHHHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 9998289998887888999999999977379657918999971
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=368.72 Aligned_cols=240 Identities=22% Similarity=0.394 Sum_probs=198.4
Q ss_pred CCEEEEEEECCCC---EEEEE-EECCCEEEEEEECC----CHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEEEE
Q ss_conf 0568953416434---28999-99698999998064----2789999999998089985012520388267986999984
Q 003542 216 KKLMVRRRLGASS---QFKEI-QWLGDSFVLRHFYG----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVME 287 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v-~~~g~~vAIK~l~~----~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~e~~~~~~LVmE 287 (811)
++|++.+.||+|+ ||++. ..+|+.||+|++.. ..+.+.+|+.+|+.++|||||++++.+. +.+.+|||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~--~~~~~~ivmE 97 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL--VGDELWVVME 97 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE--ETTEEEEEEE
T ss_pred CCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEE--ECCEEEEEEE
T ss_conf 05388789812858299999998999899999984301727999999999998679998805857798--8999899997
Q ss_pred CCCC-CHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCCCCEEEEEECCCCCC
Q ss_conf 6799-988999986077788999978999999999999999986994202689994898126788731599910343211
Q 003542 288 LMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366 (811)
Q Consensus 288 y~~g-sL~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIvHRDLKPsNILI~~~g~d~~~~vKL~DFGLa~~ 366 (811)
||+| +|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+.
T Consensus 98 y~~gg~L~~~~~~-------~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~-----~vkl~DFG~a~~ 165 (293)
T d1yhwa1 98 YLAGGSLTDVVTE-------TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-----SVKLTDFGFCAQ 165 (293)
T ss_dssp CCTTCBHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-----CEEECCCTTCEE
T ss_pred ECCCCCHHHHHHC-------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEECCCC-----CEEECCCHHHEE
T ss_conf 0379808988641-------5999999999999999999999987972267768886887899-----686425156413
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 23568899999999888999876678357542018898888999953532153357999861999998885113788998
Q 003542 367 RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKN 446 (811)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIwSlGvILyELLtGk~PF~~~~~~~~~i~~~ 446 (811)
..... ......+||+.|+|||++.+. .|+.++|||||||++|+|++|++||.+.... ..+...
T Consensus 166 ~~~~~-------~~~~~~~gt~~Y~aPE~~~~~---------~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-~~~~~~ 228 (293)
T d1yhwa1 166 ITPEQ-------SKRSTMVGTPYWMAPEVVTRK---------AYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-RALYLI 228 (293)
T ss_dssp CCSTT-------CCBCCCCSCGGGCCHHHHSSS---------CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-HHHHHH
T ss_pred ECCCC-------CCCCCCCCCCCCCCHHHHCCC---------CCCCHHCEEHHHHHHHHHHHCCCCCCCCCHH-HHHHHH
T ss_conf 21366-------644444447773682664479---------9880120313729999980488998997999-999999
Q ss_pred HHHCC-CCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHH
Q ss_conf 87189-99999999178799874101589999999999999
Q 003542 447 IRAGE-RPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 447 i~~~~-~~~~p~~~p~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
+..+. ....|..++..+.+||.+||+.||.+|||+.++++
T Consensus 229 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 229 ATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp HHHCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 85799988885537999999999986699668909999964
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=365.32 Aligned_cols=242 Identities=23% Similarity=0.422 Sum_probs=203.3
Q ss_pred HCCEEEEEEECCCC---EEEEEE-ECCCEEEEEEECC-------CHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEE
Q ss_conf 40568953416434---289999-9698999998064-------278999999999808998501252038826798699
Q 003542 215 LKKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG-------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFF 283 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~-~~g~~vAIK~l~~-------~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~e~~~~~~ 283 (811)
+++|++.+.||+|+ ||++.. .+|+.||+|++.. ....+.+|+.+|+.++|||||++++.+ ++.+.+|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~--~~~~~~~ 82 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF--HDATRVY 82 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE--ECSSEEE
T ss_pred HHHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEE--EECCEEE
T ss_conf 53769988985177858999999899949999998168856768999999999999856888888599999--9899989
Q ss_pred EEEECCC-CCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCCCCEEEEEECC
Q ss_conf 9984679-998899998607778899997899999999999999998699420268999489812678873159991034
Q 003542 284 LVMELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFG 362 (811)
Q Consensus 284 LVmEy~~-gsL~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIvHRDLKPsNILI~~~g~d~~~~vKL~DFG 362 (811)
||||||+ |+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||++.++ .+||+|||
T Consensus 83 ivmEy~~~g~L~~~l~~~------~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~-----~~kl~DFG 151 (263)
T d2j4za1 83 LILEYAPLGTVYRELQKL------SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAG-----ELKIADFG 151 (263)
T ss_dssp EEEECCTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-----CEEECCCC
T ss_pred EEEEECCCCCHHHHHHHC------CCCCHHHHHHHHHHHHHHHHHHHHCCEEEEEECCCCCEECCCC-----CEEECCCC
T ss_conf 998504798589887504------8999999999999999999999988946522023441466899-----87115556
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCCCCHHH
Q ss_conf 32112356889999999988899987667835754201889888899995353215335799986199999888511378
Q 003542 363 LSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDK 442 (811)
Q Consensus 363 La~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIwSlGvILyELLtGk~PF~~~~~~~~~ 442 (811)
+|+..... ......||+.|+|||++.+. .|+.++|||||||++|+|++|+.||.+.+. ..
T Consensus 152 ~a~~~~~~---------~~~~~~Gt~~Y~APE~~~~~---------~~~~~~DiwSlGvilyell~G~~Pf~~~~~--~~ 211 (263)
T d2j4za1 152 WSVHAPSS---------RRTTLCGTLDYLPPEMIEGR---------MHDEKVDLWSLGVLCYEFLVGKPPFEANTY--QE 211 (263)
T ss_dssp SCSCCCCC---------CCEETTEEGGGCCHHHHTTC---------CCCTTHHHHHHHHHHHHHHHSSCTTCCSSH--HH
T ss_pred EEEECCCC---------CCCCCCCCCCCCCHHHHCCC---------CCCCHHHHHHHHHHHHHHHCCCCCCCCCCH--HH
T ss_conf 33544888---------52355788763499997589---------989314404675999998329999888999--99
Q ss_pred HHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 8998871899999999917879987410158999999999999999999
Q 003542 443 MTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYI 491 (811)
Q Consensus 443 i~~~i~~~~~~~~p~~~p~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i 491 (811)
+...+..+ .+.+|..+++++.+||.+||+.||.+|||+.++++ ++++
T Consensus 212 ~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~-hp~~ 258 (263)
T d2j4za1 212 TYKRISRV-EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE-HPWI 258 (263)
T ss_dssp HHHHHHTT-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT-CHHH
T ss_pred HHHHHHCC-CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC-CCCC
T ss_conf 99999718-99998668999999999976479768909999971-9070
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=362.73 Aligned_cols=249 Identities=27% Similarity=0.482 Sum_probs=209.5
Q ss_pred CCEEEEEEECCCC---EEEEEEECCCEEEEEEECC---CHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEEEECC
Q ss_conf 0568953416434---2899999698999998064---278999999999808998501252038826798699998467
Q 003542 216 KKLMVRRRLGASS---QFKEIQWLGDSFVLRHFYG---ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELM 289 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~~~g~~vAIK~l~~---~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~e~~~~~~LVmEy~ 289 (811)
++|++.+.||+|+ ||++...++..||||++.. ..+.|.+|++++++++|||||++++.+. +.+.+|+|||||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~--~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL--EQAPICLVFEFM 82 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC--SSSSCEEEEECC
T ss_pred HHCEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCCCCHHHHHHHHHHHHHCCCCCCCCCCCEEC--CCCCEEEEEEEC
T ss_conf 995888898208882999999889999999998788676899999999999668997565352431--599337999836
Q ss_pred C-CCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCCCCEEEEEECCCCCCCC
Q ss_conf 9-998899998607778899997899999999999999998699420268999489812678873159991034321123
Q 003542 290 S-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTART 368 (811)
Q Consensus 290 ~-gsL~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIvHRDLKPsNILI~~~g~d~~~~vKL~DFGLa~~~~ 368 (811)
+ |+|.+++... ...+++..+..++.||+.||.|||+++|+||||||+|||++.++ .+||+|||+++...
T Consensus 83 ~~g~L~~~l~~~-----~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~-----~~Kl~DFGla~~~~ 152 (263)
T d1sm2a_ 83 EHGCLSDYLRTQ-----RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ-----VIKVSDFGMTRFVL 152 (263)
T ss_dssp TTCBHHHHHHTT-----TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGG-----CEEECSCC------
T ss_pred CCCCHHHHHHCC-----CCCCCHHHHHHHHHHHHHHHHHHHCCCEEECCCCHHHEEECCCC-----CEEECCCCHHEECC
T ss_conf 999189975201-----34788999999999999987765316431044315326666887-----76865532100236
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCEECCHHHHHHHHH-CCCCCCCCCCCHHHHHHHH
Q ss_conf 568899999999888999876678357542018898888999953532153357999861-9999988851137889988
Q 003542 369 YASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGDKMTKNI 447 (811)
Q Consensus 369 ~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIwSlGvILyELLt-Gk~PF~~~~~~~~~i~~~i 447 (811)
.... .......||+.|+|||++.+. .|+.++||||||+++|||++ |.+||... ....+...+
T Consensus 153 ~~~~------~~~~~~~gt~~y~aPE~l~~~---------~~~~k~DVwS~Gvil~el~t~~~~~~~~~--~~~~~~~~i 215 (263)
T d1sm2a_ 153 DDQY------TSSTGTKFPVKWASPEVFSFS---------RYSSKSDVWSFGVLMWEVFSEGKIPYENR--SNSEVVEDI 215 (263)
T ss_dssp ------------------CTTSCCHHHHTTC---------CCCHHHHHHHHHHHHHHHHTTSCCTTCSC--CHHHHHHHH
T ss_pred CCCC------EEECCEECCCCCCCHHHHCCC---------CCCCHHHHCCHHHHHHHHHHCCCCCCCCC--CHHHHHHHH
T ss_conf 8873------350430017666785786079---------99840332105999999987898887789--999999999
Q ss_pred HHCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 7189999999991787998741015899999999999999999999
Q 003542 448 RAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKK 493 (811)
Q Consensus 448 ~~~~~~~~p~~~p~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~~ 493 (811)
..+.++..|..+++.+.+||.+||+.||.+|||+++|++.|+.+..
T Consensus 216 ~~~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 216 STGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp HHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 8068889954367999999999765797689199999999999985
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=369.58 Aligned_cols=246 Identities=24% Similarity=0.371 Sum_probs=207.7
Q ss_pred CCEEEEEEECCCC---EEEEEE-ECCCEEEEEEECC------CHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEE
Q ss_conf 0568953416434---289999-9698999998064------27899999999980899850125203882679869999
Q 003542 216 KKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLV 285 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~-~~g~~vAIK~l~~------~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~e~~~~~~LV 285 (811)
.+|++.+.||+|+ ||++.. .+|+.||+|.+.. ..+.+.+|+++|++++|||||++++.+.++....+|||
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEE
T ss_conf 33799679830889199999999999799999987465797999999999999997789998248999991789989999
Q ss_pred EECCC-CCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----CEECCCCCCCEEEECCCCCCCCEEEEE
Q ss_conf 84679-998899998607778899997899999999999999998699-----420268999489812678873159991
Q 003542 286 MELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQK-----IYHGELNPSNIYLKARSMEGYFHVKVS 359 (811)
Q Consensus 286 mEy~~-gsL~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~g-----IvHRDLKPsNILI~~~g~d~~~~vKL~ 359 (811)
||||+ |+|.+++..... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+||+
T Consensus 84 mEy~~~g~L~~~i~~~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~-----~vkl~ 156 (269)
T d2java1 84 MEYCEGGDLASVITKGTK--ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ-----NVKLG 156 (269)
T ss_dssp EECCTTEEHHHHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTS-----CEEEC
T ss_pred EECCCCCCHHHHHHHCCC--CCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCC-----CEEEE
T ss_conf 956899938999985154--57899999999999999999999997167788788586765425747888-----57980
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCCCC
Q ss_conf 03432112356889999999988899987667835754201889888899995353215335799986199999888511
Q 003542 360 GFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQ 439 (811)
Q Consensus 360 DFGLa~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIwSlGvILyELLtGk~PF~~~~~~ 439 (811)
|||+|+...... .......||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+
T Consensus 157 DFG~a~~~~~~~-------~~~~~~~gt~~Y~APE~l~~~---------~~~~~~DIwSlGvilyel~tg~~Pf~~~~-- 218 (269)
T d2java1 157 DFGLARILNHDT-------SFAKAFVGTPYYMSPEQMNRM---------SYNEKSDIWSLGCLLYELCALMPPFTAFS-- 218 (269)
T ss_dssp CHHHHHHC------------------CCCSCCCHHHHTTC---------CCCHHHHHHHHHHHHHHHHHSSCSCCCSS--
T ss_pred ECCCEEECCCCC-------CCCCCCCCCCCCCCHHHHCCC---------CCCHHHHHHHHCHHHHHHHHCCCCCCCCC--
T ss_conf 010003224577-------755667788232799998399---------99938988752789999801889989989--
Q ss_pred HHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHH
Q ss_conf 37889988718999999999178799874101589999999999999
Q 003542 440 GDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 440 ~~~i~~~i~~~~~~~~p~~~p~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
...+...+..+..+.+|..+++++.+||.+||+.||.+|||++++++
T Consensus 219 ~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 219 QKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp HHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 99999999718998897435999999999976799557918999972
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=365.16 Aligned_cols=249 Identities=29% Similarity=0.467 Sum_probs=207.3
Q ss_pred HCCEEEEEEECCCC---EEEEEEE-CCCEEEEEEECC---CHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEEEE
Q ss_conf 40568953416434---2899999-698999998064---2789999999998089985012520388267986999984
Q 003542 215 LKKLMVRRRLGASS---QFKEIQW-LGDSFVLRHFYG---ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVME 287 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~~-~g~~vAIK~l~~---~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~e~~~~~~LVmE 287 (811)
.++|++.+.||+|+ ||++... +|..||||++.. +.+.|.+|+.+|++++|||||++++.+ .+.+.+|||||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~--~~~~~~~iv~E 93 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC--TREPPFYIITE 93 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEE--CSSSSCEEEEE
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCCCHHHHHHHHHHHHHHCCCCCEECCCCCE--EECCEEEEEEE
T ss_conf 7993986598208880899999999996999999777610399999999999867999882677527--45785478763
Q ss_pred CCC-CCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCCCCEEEEEECCCCCC
Q ss_conf 679-9988999986077788999978999999999999999986994202689994898126788731599910343211
Q 003542 288 LMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366 (811)
Q Consensus 288 y~~-gsL~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIvHRDLKPsNILI~~~g~d~~~~vKL~DFGLa~~ 366 (811)
||+ |+|.+++... ....+++..+..++.||+.||.|||+++|+||||||+|||++.++ .+||+|||+|+.
T Consensus 94 ~~~~g~l~~~l~~~----~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~-----~~Kl~DFG~a~~ 164 (287)
T d1opja_ 94 FMTYGNLLDYLREC----NRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-----LVKVADFGLSRL 164 (287)
T ss_dssp CCTTCBHHHHHHHS----CTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-----CEEECCCCCTTT
T ss_pred CCCCCCHHHHHHHC----CCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCC-----CEEECCCCCEEE
T ss_conf 14676067775303----554157999999999999978889878930576045768998999-----289832445465
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 23568899999999888999876678357542018898888999953532153357999861999998885113788998
Q 003542 367 RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKN 446 (811)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIwSlGvILyELLtGk~PF~~~~~~~~~i~~~ 446 (811)
...... .......|++.|+|||++.+. .|+.++|||||||++|||++|..||.... ....+...
T Consensus 165 ~~~~~~------~~~~~~~g~~~y~aPE~~~~~---------~~~~k~DiwS~Gv~l~ell~~~~p~~~~~-~~~~~~~~ 228 (287)
T d1opja_ 165 MTGDTY------TAHAGAKFPIKWTAPESLAYN---------KFSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYEL 228 (287)
T ss_dssp CCSSSS------EEETTEEECGGGCCHHHHHHC---------CCSHHHHHHHHHHHHHHHHTTSCCSSTTC-CHHHHHHH
T ss_pred CCCCCC------EEECCCCCCCCCCCHHHHCCC---------CCCCHHHHHHHHHHHHHHHHCCCCCCCCC-HHHHHHHH
T ss_conf 378872------210355665466692787279---------99810430217899999986799887742-59999999
Q ss_pred HHHCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHH
Q ss_conf 87189999999991787998741015899999999999999999
Q 003542 447 IRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRY 490 (811)
Q Consensus 447 i~~~~~~~~p~~~p~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~ 490 (811)
+..+.++.+|..+++.+.+||.+||+.||.+|||+.++++.|+.
T Consensus 229 i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~ 272 (287)
T d1opja_ 229 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 272 (287)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHCCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHH
T ss_conf 85588888874330999999999757797689399999999999
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=362.47 Aligned_cols=251 Identities=26% Similarity=0.497 Sum_probs=202.4
Q ss_pred CCEEEEEEECCCC---EEEEEEECCCEEEEEEECC------CHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEEE
Q ss_conf 0568953416434---2899999698999998064------278999999999808998501252038826798699998
Q 003542 216 KKLMVRRRLGASS---QFKEIQWLGDSFVLRHFYG------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVM 286 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~~~g~~vAIK~l~~------~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~e~~~~~~LVm 286 (811)
.+|.+.+.||+|+ ||++. .+..||||++.. ..+.|.+|+.+|.+++|||||+++ +++.+ +.+||||
T Consensus 8 ~~~~~~~~lG~G~fg~Vy~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~-~~~~~--~~~~lv~ 82 (276)
T d1uwha_ 8 GQITVGQRIGSGSFGTVYKGK--WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM-GYSTA--PQLAIVT 82 (276)
T ss_dssp TCCCCCSEEEECSSCEEEEEE--SSSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEE-EEECS--SSCEEEE
T ss_pred CCEEEEEEEEECCCCEEEEEE--ECCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEE-EEEEC--CEEEEEE
T ss_conf 518998898307885899999--999899999973469989999999999999847998786456-79715--5899999
Q ss_pred ECCC-CCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCCCCEEEEEECCCCC
Q ss_conf 4679-998899998607778899997899999999999999998699420268999489812678873159991034321
Q 003542 287 ELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365 (811)
Q Consensus 287 Ey~~-gsL~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIvHRDLKPsNILI~~~g~d~~~~vKL~DFGLa~ 365 (811)
|||+ |+|.+++... ...+++..+..++.||+.||.|||+++|+||||||+|||++.++ .+||+|||+|+
T Consensus 83 Ey~~~g~L~~~l~~~-----~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~-----~~Kl~DFGla~ 152 (276)
T d1uwha_ 83 QWCEGSSLYHHLHII-----ETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDL-----TVKIGDFGLAT 152 (276)
T ss_dssp ECCCEEEHHHHHHTS-----CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTS-----SEEECCCCCSC
T ss_pred ECCCCCCHHHHHHHC-----CCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCHHHEEECCCC-----CEEECCCCCEE
T ss_conf 658998889998523-----57899999999999999998887509995161478997981899-----78875002213
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 12356889999999988899987667835754201889888899995353215335799986199999888511378899
Q 003542 366 ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTK 445 (811)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIwSlGvILyELLtGk~PF~~~~~~~~~i~~ 445 (811)
....... ........||+.|+|||++.+. ....|+.++|||||||++|||++|+.||.+.... ..+..
T Consensus 153 ~~~~~~~-----~~~~~~~~gt~~y~APE~l~~~------~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~-~~~~~ 220 (276)
T d1uwha_ 153 VKSRWSG-----SHQFEQLSGSILWMAPEVIRMQ------DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-DQIIF 220 (276)
T ss_dssp C-----------------CCCCGGGCCHHHHTTC------SSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-HHHHH
T ss_pred ECCCCCC-----CCCCCCCCCCCCCCCHHHHHCC------CCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHH-HHHHH
T ss_conf 3355677-----6312566557431799999505------6899995315163599999999788998998969-99999
Q ss_pred HHHHCCCC----CCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 88718999----9999991787998741015899999999999999999999
Q 003542 446 NIRAGERP----LFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKK 493 (811)
Q Consensus 446 ~i~~~~~~----~~p~~~p~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~~ 493 (811)
.+..+..+ ..+..+|+.+.+||.+||..||.+|||+.+|++.|+.+.+
T Consensus 221 ~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 221 MVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp HHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHCCCCCCCCHHCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 9965888986000365554999999999758897689299999999999997
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=358.92 Aligned_cols=254 Identities=25% Similarity=0.447 Sum_probs=207.5
Q ss_pred CCEEEEE-EECCCC---EEEEEEE---CCCEEEEEEECC-----CHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEE
Q ss_conf 0568953-416434---2899999---698999998064-----278999999999808998501252038826798699
Q 003542 216 KKLMVRR-RLGASS---QFKEIQW---LGDSFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFF 283 (811)
Q Consensus 216 k~~~i~~-~lG~G~---vyk~v~~---~g~~vAIK~l~~-----~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~e~~~~~~ 283 (811)
.++.+.+ +||+|+ ||++... .+..||||.+.. ..+.|.+|+++|++++|||||++++.+ .. +.+|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~-~~--~~~~ 84 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QA--EALM 84 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ES--SSEE
T ss_pred CCEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEE-CC--CEEE
T ss_conf 47188784873060809999999608976899999988203978999999999999867998880686560-36--8079
Q ss_pred EEEECCCC-CHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCCCCEEEEEECC
Q ss_conf 99846799-98899998607778899997899999999999999998699420268999489812678873159991034
Q 003542 284 LVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFG 362 (811)
Q Consensus 284 LVmEy~~g-sL~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIvHRDLKPsNILI~~~g~d~~~~vKL~DFG 362 (811)
||||||+| +|.+++.. .+..+++..+..++.||+.||.|||+++|+||||||+|||++.++ .+||+|||
T Consensus 85 lvmE~~~~g~L~~~l~~-----~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~-----~~Kl~DFG 154 (285)
T d1u59a_ 85 LVMEMAGGGPLHKFLVG-----KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH-----YAKISDFG 154 (285)
T ss_dssp EEEECCTTEEHHHHHTT-----CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETT-----EEEECCCT
T ss_pred EEEEECCCCCHHHHHHC-----CCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEECCCC-----CEEECCCH
T ss_conf 99980789968997521-----256999999999999999987899868810576764660454688-----54203313
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCEECCHHHHHHHHH-CCCCCCCCCCCHH
Q ss_conf 321123568899999999888999876678357542018898888999953532153357999861-9999988851137
Q 003542 363 LSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGD 441 (811)
Q Consensus 363 La~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIwSlGvILyELLt-Gk~PF~~~~~~~~ 441 (811)
+|+........ ........||+.|+|||++.+. .++.++|||||||++|||++ |+.||.+.. ..
T Consensus 155 la~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~---------~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~--~~ 219 (285)
T d1u59a_ 155 LSKALGADDSY----YTARSAGKWPLKWYAPECINFR---------KFSSRSDVWSYGVTMWEALSYGQKPYKKMK--GP 219 (285)
T ss_dssp TCEECTTCSCE----ECCCCSSCCCGGGCCHHHHHHC---------EECHHHHHHHHHHHHHHHHTTSCCTTTTCC--TH
T ss_pred HHHCCCCCCCC----CCCCCCCCCCCCCCCHHHHHCC---------CCCCCCHHHCCHHHHHHHHHCCCCCCCCCC--HH
T ss_conf 42115543432----1135621137433586887279---------999541232201789999938999999979--99
Q ss_pred HHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHC
Q ss_conf 88998871899999999917879987410158999999999999999999998624
Q 003542 442 KMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKKFMAN 497 (811)
Q Consensus 442 ~i~~~i~~~~~~~~p~~~p~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~~~l~~ 497 (811)
++...+..+.++.+|..+|+++.+||.+||+.||.+||++.+|.+.|+.+...+..
T Consensus 220 ~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~ 275 (285)
T d1u59a_ 220 EVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 275 (285)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHHHH
T ss_conf 99999981899999976789999999997577976890999999999999998541
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=359.91 Aligned_cols=253 Identities=23% Similarity=0.421 Sum_probs=206.0
Q ss_pred CCEEEEEEECCCC---EEEEEEE-CCC---EEEEEEECC-----CHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEE
Q ss_conf 0568953416434---2899999-698---999998064-----278999999999808998501252038826798699
Q 003542 216 KKLMVRRRLGASS---QFKEIQW-LGD---SFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFF 283 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~~-~g~---~vAIK~l~~-----~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~e~~~~~~ 283 (811)
+.|.+.+.||+|+ ||++... +++ .||+|.+.. ..+.|.+|+.+|++++|||||++++.+ .+...+|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~--~~~~~~~ 103 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVV--TKSTPVM 103 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE--CSSSSCE
T ss_pred HHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEE--EECCEEE
T ss_conf 04278569802788299999995799788999999978445989999999999999857998886189999--6288779
Q ss_pred EEEECCCC-CHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCCCCEEEEEECC
Q ss_conf 99846799-98899998607778899997899999999999999998699420268999489812678873159991034
Q 003542 284 LVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFG 362 (811)
Q Consensus 284 LVmEy~~g-sL~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIvHRDLKPsNILI~~~g~d~~~~vKL~DFG 362 (811)
+|||||+| +|.+++... ...+++..+..++.||+.||.|||+++|+||||||+|||++.++ .+||+|||
T Consensus 104 iv~Ey~~~g~L~~~~~~~-----~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~-----~~Kl~DFG 173 (299)
T d1jpaa_ 104 IITEFMENGSLDSFLRQN-----DGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNL-----VCKVSDFG 173 (299)
T ss_dssp EEEECCTTEEHHHHHHTT-----TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-----CEEECCC-
T ss_pred EEEEECCCCCCEEEECCC-----CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCC-----CEEECCCC
T ss_conf 999722798530021045-----67999999999999999988988527983576150448988999-----19988844
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCEECCHHHHHHHHH-CCCCCCCCCCCHH
Q ss_conf 321123568899999999888999876678357542018898888999953532153357999861-9999988851137
Q 003542 363 LSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGD 441 (811)
Q Consensus 363 La~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIwSlGvILyELLt-Gk~PF~~~~~~~~ 441 (811)
+|+.......... ........||+.|+|||++.+. .|+.++|||||||++|||+| |++||.+.. ..
T Consensus 174 la~~~~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~---------~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~--~~ 240 (299)
T d1jpaa_ 174 LSRFLEDDTSDPT--YTSALGGKIPIRWTAPEAIQYR---------KFTSASDVWSYGIVMWEVMSYGERPYWDMT--NQ 240 (299)
T ss_dssp ------------------------CGGGSCHHHHHSC---------CCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--HH
T ss_pred CCEECCCCCCCCE--EEECCCCCCCCCCCCHHHHHCC---------CCCCCCCCCCCHHHHHHHHHCCCCCCCCCC--HH
T ss_conf 3157567777653--6502566688300387888369---------978612144535789999867999999999--99
Q ss_pred HHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 8899887189999999991787998741015899999999999999999999
Q 003542 442 KMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKK 493 (811)
Q Consensus 442 ~i~~~i~~~~~~~~p~~~p~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~~ 493 (811)
.+...+..+.+++.|..++..+.+||.+||+.||.+|||+.+|++.|+.+.+
T Consensus 241 ~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 241 DVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHC
T ss_conf 9999997378899974226999999999758797689299999999999841
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=360.92 Aligned_cols=240 Identities=18% Similarity=0.312 Sum_probs=204.1
Q ss_pred HCCEEEEEEECCCC---EEEEEE-ECCCEEEEEEECC-------CHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEE
Q ss_conf 40568953416434---289999-9698999998064-------278999999999808998501252038826798699
Q 003542 215 LKKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG-------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFF 283 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~-~~g~~vAIK~l~~-------~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~e~~~~~~ 283 (811)
+++|++.+.||.|+ ||++.. .+|+.||+|++.. ....+.+|+.+|+.++||||+++++.+ ++...+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~--~~~~~~~ 81 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF--QTHDRLC 81 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE--ECSSEEE
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEE--CCCCCCC
T ss_conf 47428988983176849999999899989999998156544979999999999999867999887787640--3564211
Q ss_pred EEEECCC-CCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCCCCEEEEEECC
Q ss_conf 9984679-998899998607778899997899999999999999998699420268999489812678873159991034
Q 003542 284 LVMELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFG 362 (811)
Q Consensus 284 LVmEy~~-gsL~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIvHRDLKPsNILI~~~g~d~~~~vKL~DFG 362 (811)
+|||||+ |+|..++... ..+++..++.++.||+.||.|||+++|+||||||+|||++.+| ++||+|||
T Consensus 82 iv~ey~~gg~L~~~~~~~------~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g-----~vkl~DFG 150 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRE------RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG-----HIKITDFG 150 (337)
T ss_dssp EEEECCTTCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-----CEEECCCT
T ss_pred CCEECCCCCCHHHHHHCC------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEECCCC-----CEEEEECC
T ss_conf 100035798605555325------6775999999999996521134315962246477784765899-----88882056
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCCCCHHH
Q ss_conf 32112356889999999988899987667835754201889888899995353215335799986199999888511378
Q 003542 363 LSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDK 442 (811)
Q Consensus 363 La~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIwSlGvILyELLtGk~PF~~~~~~~~~ 442 (811)
+|+...... ......+||+.|+|||++.+. .|+.++||||+||++|||++|++||.+.+. ..
T Consensus 151 ~a~~~~~~~-------~~~~~~~GT~~Y~aPE~~~~~---------~y~~~~DiwSlGvilyeml~G~~pf~~~~~--~~ 212 (337)
T d1o6la_ 151 LCKEGISDG-------ATMKTFCGTPEYLAPEVLEDN---------DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--ER 212 (337)
T ss_dssp TCBCSCCTT-------CCBCCCEECGGGCCGGGGSSS---------CBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HH
T ss_pred CCCCCCCCC-------CCCCCCEECHHHHHHHHCCCC---------CCCHHHCCCCHHHHHHHHHHCCCCCCCCCH--HH
T ss_conf 520035678-------620551008899666650489---------888333102230678899878999999699--99
Q ss_pred HHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCC-----HHHHHH
Q ss_conf 89988718999999999178799874101589999999-----999999
Q 003542 443 MTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPS-----FSSICR 486 (811)
Q Consensus 443 i~~~i~~~~~~~~p~~~p~~l~~LI~~cL~~DP~~RPS-----~~eIl~ 486 (811)
+...+..+. +.+|...++++.+||.+||+.||.+|++ +.++++
T Consensus 213 ~~~~i~~~~-~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 213 LFELILMEE-IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp HHHHHHHCC-CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HHHHHHCCC-CCCCCCCCHHHHHHHHHHCCCCCHHHCCCCCCCHHHHHC
T ss_conf 999985289-989866899999999866638934422565234999972
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=361.33 Aligned_cols=252 Identities=26% Similarity=0.426 Sum_probs=205.8
Q ss_pred CCEEEEEEECCCC---EEEEEEE-CC-----CEEEEEEECC-----CHHHHHHHHHHHHHC-CCCCCCEEEEEEECCCCC
Q ss_conf 0568953416434---2899999-69-----8999998064-----278999999999808-998501252038826798
Q 003542 216 KKLMVRRRLGASS---QFKEIQW-LG-----DSFVLRHFYG-----ELESLNAEISTMLSL-SHPNIVQYLCGFCDEEKK 280 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~~-~g-----~~vAIK~l~~-----~~~~~~~Ei~iL~~L-~HpNIV~l~~~~~~e~~~ 280 (811)
.+|++.+.||.|+ ||++... .+ ..||+|.+.. ....+.+|+.+|.++ +|||||++++.+ .+.+
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~--~~~~ 114 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC--TLSG 114 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE--CSSS
T ss_pred HHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEE--EECC
T ss_conf 99397019830788199999985788554204999999663358789999999999999715899686877888--6299
Q ss_pred EEEEEEECCC-CCHHHHHHHHHCC-----------------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCC
Q ss_conf 6999984679-9988999986077-----------------788999978999999999999999986994202689994
Q 003542 281 EFFLVMELMS-KDLSCYMRETFGS-----------------RRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSN 342 (811)
Q Consensus 281 ~~~LVmEy~~-gsL~~~L~~~~~~-----------------~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIvHRDLKPsN 342 (811)
.+|+|||||+ |+|.+++...... .....+++..++.++.||+.||.|||+++|+||||||+|
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~N 194 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN 194 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGG
T ss_pred EEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCHHC
T ss_conf 58999972799959999986257775102210000122200125778999999999999999999973990505270321
Q ss_pred EEEECCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCEECCHHH
Q ss_conf 89812678873159991034321123568899999999888999876678357542018898888999953532153357
Q 003542 343 IYLKARSMEGYFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGML 422 (811)
Q Consensus 343 ILI~~~g~d~~~~vKL~DFGLa~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIwSlGvI 422 (811)
||++.++ .+||+|||+|+........ .......||+.|+|||++.+. .|+.++|||||||+
T Consensus 195 ill~~~~-----~~Kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~---------~~~~~~DiwS~Gvi 255 (325)
T d1rjba_ 195 VLVTHGK-----VVKICDFGLARDIMSDSNY-----VVRGNARLPVKWMAPESLFEG---------IYTIKSDVWSYGIL 255 (325)
T ss_dssp EEEETTT-----EEEECCCGGGSCGGGCTTS-----EEETTEEECGGGCCHHHHHHC---------CCCHHHHHHHHHHH
T ss_pred CCCCCCC-----EEEEEECCCCCCCCCCCCE-----EEECCCCCCCCCCCHHHHCCC---------CCCCCEECCCHHHH
T ss_conf 4434598-----2898514222204577861-----562343578765783887279---------99963303000399
Q ss_pred HHHHHH-CCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH
Q ss_conf 999861-9999988851137889988718999999999178799874101589999999999999999
Q 003542 423 CFELLT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILR 489 (811)
Q Consensus 423 LyELLt-Gk~PF~~~~~~~~~i~~~i~~~~~~~~p~~~p~~l~~LI~~cL~~DP~~RPS~~eIl~~L~ 489 (811)
+|||++ |++||.+.... ..+...+..+.+++.|..+++.+.+||.+||+.||.+|||+++|+++|.
T Consensus 256 l~emlt~g~~Pf~~~~~~-~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 256 LWEIFSLGVNPYPGIPVD-ANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp HHHHTTTSCCSSTTCCCS-HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHCCCCCCCCCCHH-HHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf 999983899999998989-9999998569989988767899999999975889668939999999974
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=364.45 Aligned_cols=248 Identities=20% Similarity=0.339 Sum_probs=200.2
Q ss_pred HCCEEEEEEECCCC---EEEEEE-ECCCEEEEEEECC-----CHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEE
Q ss_conf 40568953416434---289999-9698999998064-----27899999999980899850125203882679869999
Q 003542 215 LKKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLV 285 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~-~~g~~vAIK~l~~-----~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~e~~~~~~LV 285 (811)
.++|++.+.||+|+ ||++.. .+|+.||+|++.. ....+.+|+.+|+.++|||||++++.|. +...+|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~--~~~~~~iV 82 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY--SDGEISIC 82 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEE--CSSEEEEE
T ss_pred CCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEE--ECCEEEEE
T ss_conf 5688897897127780999999989996999999875409789999999999998679999994999999--89999999
Q ss_pred EECCCC-CHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCEECCCCCCCEEEECCCCCCCCEEEEEECCC
Q ss_conf 846799-9889999860777889999789999999999999999869-94202689994898126788731599910343
Q 003542 286 MELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQ-KIYHGELNPSNIYLKARSMEGYFHVKVSGFGL 363 (811)
Q Consensus 286 mEy~~g-sL~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~-gIvHRDLKPsNILI~~~g~d~~~~vKL~DFGL 363 (811)
||||+| +|.+++.+. ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++ ++||+|||+
T Consensus 83 mEy~~gg~L~~~l~~~------~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~-----~vkl~DFGl 151 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKKA------GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-----EIKLCDFGV 151 (322)
T ss_dssp EECCTTEEHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC-----CEEECCCCC
T ss_pred EECCCCCCHHHHHHHC------CCCCHHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEECCCC-----CEEEEECCC
T ss_conf 9767998689987424------99999999999999999999999859997144577994687899-----899954877
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCCCCHHHH
Q ss_conf 21123568899999999888999876678357542018898888999953532153357999861999998885113788
Q 003542 364 STARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKM 443 (811)
Q Consensus 364 a~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIwSlGvILyELLtGk~PF~~~~~~~~~i 443 (811)
|+...... ....+||+.|+|||++.+. .|+.++||||+||++|||++|+.||.+........
T Consensus 152 a~~~~~~~---------~~~~~GT~~Y~APEvl~~~---------~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~ 213 (322)
T d1s9ja_ 152 SGQLIDSM---------ANSFVGTRSYMSPERLQGT---------HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 213 (322)
T ss_dssp CHHHHHHT---------C---CCSSCCCCHHHHHCS---------CCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHH
T ss_pred CCCCCCCC---------CCCCCCCCCCCCCHHHCCC---------CCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH
T ss_conf 62567886---------2111377141194687589---------98948889989999999998889989988789999
Q ss_pred ----------------------------------------HHHHHHCCCCCCC-CCCHHHHHHHHHHHCCCCCCCCCCHH
Q ss_conf ----------------------------------------9988718999999-99917879987410158999999999
Q 003542 444 ----------------------------------------TKNIRAGERPLFP-SGSPKYLVNLTKKCWHTNPSQRPSFS 482 (811)
Q Consensus 444 ----------------------------------------~~~i~~~~~~~~p-~~~p~~l~~LI~~cL~~DP~~RPS~~ 482 (811)
...+.....+.++ ...+.++.+||.+||..||.+|||++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ 293 (322)
T d1s9ja_ 214 MFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK 293 (322)
T ss_dssp HC------------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred HHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHH
T ss_conf 99887517754577421233322111122235413477887665026876676444899999999998689946790899
Q ss_pred HHHHHHHHHHHH
Q ss_conf 999999999998
Q 003542 483 SICRILRYIKKF 494 (811)
Q Consensus 483 eIl~~L~~i~~~ 494 (811)
++++ ++++...
T Consensus 294 e~L~-Hpf~~~~ 304 (322)
T d1s9ja_ 294 QLMV-HAFIKRS 304 (322)
T ss_dssp HHHT-SHHHHHH
T ss_pred HHHH-CHHHCCC
T ss_conf 9960-9864769
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=363.41 Aligned_cols=242 Identities=19% Similarity=0.352 Sum_probs=203.9
Q ss_pred CCEEEEEEECCCC---EEEEEE-ECCCEEEEEEECC-------CHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEE
Q ss_conf 0568953416434---289999-9698999998064-------2789999999998089985012520388267986999
Q 003542 216 KKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG-------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFL 284 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~-~~g~~vAIK~l~~-------~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~e~~~~~~L 284 (811)
.+|++.+.||+|+ ||++.. .+|+.||||++.. ..+.+.+|+++|++++||||+++++.+ ++.+.+|+
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~--~~~~~~~i 85 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF--QDDEKLYF 85 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEE--ECSSEEEE
T ss_pred CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEE--EECCEEEE
T ss_conf 8778988985087909999999899979999998657755777899999999999876888861799999--98998899
Q ss_pred EEECCCC-CHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCCCCEEEEEECCC
Q ss_conf 9846799-988999986077788999978999999999999999986994202689994898126788731599910343
Q 003542 285 VMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGL 363 (811)
Q Consensus 285 VmEy~~g-sL~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIvHRDLKPsNILI~~~g~d~~~~vKL~DFGL 363 (811)
|||||+| +|.+++... ..+++..++.++.|++.||.|||+.+|+||||||+|||++.++ .+||+|||+
T Consensus 86 vmEy~~gg~L~~~~~~~------~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~-----~vkl~DFG~ 154 (288)
T d1uu3a_ 86 GLSYAKNGELLKYIRKI------GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM-----HIQITDFGT 154 (288)
T ss_dssp EECCCTTEEHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-----CEEECCCTT
T ss_pred EEECCCCCCHHHHHHCC------CCCCHHHHHHHHHHHHHHHHHHCCCCEECCCCCCCCCCCCCCC-----EEEECCCCC
T ss_conf 99704898777765315------9999999999999999999762165088476774123668885-----388603210
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCCCCHHHH
Q ss_conf 21123568899999999888999876678357542018898888999953532153357999861999998885113788
Q 003542 364 STARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKM 443 (811)
Q Consensus 364 a~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIwSlGvILyELLtGk~PF~~~~~~~~~i 443 (811)
|+....... .......+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+ ...+
T Consensus 155 a~~~~~~~~-----~~~~~~~~GT~~Y~APE~~~~~---------~~~~~~DiwSlGvilyell~g~~Pf~~~~--~~~~ 218 (288)
T d1uu3a_ 155 AKVLSPESK-----QARANSFVGTAQYVSPELLTEK---------SACKSSDLWALGCIIYQLVAGLPPFRAGN--EYLI 218 (288)
T ss_dssp CEECC---------------CCCCGGGCCHHHHHTC---------CCCHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHH
T ss_pred CEECCCCCC-----CCCCCCCCCCCCCCCCEEECCC---------CCCCCCCEEHHHHHHHHHHHCCCCCCCCC--HHHH
T ss_conf 242256776-----4333555677552584400268---------98966623045699999803889989959--9999
Q ss_pred HHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 99887189999999991787998741015899999999999999
Q 003542 444 TKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRI 487 (811)
Q Consensus 444 ~~~i~~~~~~~~p~~~p~~l~~LI~~cL~~DP~~RPS~~eIl~~ 487 (811)
...+..+ .+.+|...++.+.+||.+||+.||.+|||+++++..
T Consensus 219 ~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 219 FQKIIKL-EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp HHHHHTT-CCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred HHHHHCC-CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHCCC
T ss_conf 9999718-999985479999999999855797689197897377
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=369.05 Aligned_cols=246 Identities=21% Similarity=0.280 Sum_probs=197.9
Q ss_pred HCCEEEEEEECCCC---EEEEEE-ECCCEEEEEEECC-----CHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEE
Q ss_conf 40568953416434---289999-9698999998064-----27899999999980899850125203882679869999
Q 003542 215 LKKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLV 285 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~-~~g~~vAIK~l~~-----~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~e~~~~~~LV 285 (811)
.++|++.+.||+|+ ||++.. .+|+.||+|++.. ..+.+.+|+.+|++++|||||++++.+. +.+.+|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~--~~~~~~iv 81 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR--EGNIQYLF 81 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEE--ETTEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEC--CCCEEEEE
T ss_conf 7460899897217480999999999997999999845664127999999999998579988846965404--67436798
Q ss_pred EECCCC-CHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCCCCEEEEEECCCC
Q ss_conf 846799-9889999860777889999789999999999999999869942026899948981267887315999103432
Q 003542 286 MELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS 364 (811)
Q Consensus 286 mEy~~g-sL~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIvHRDLKPsNILI~~~g~d~~~~vKL~DFGLa 364 (811)
||||+| +|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||++.++ .+||+|||+|
T Consensus 82 mEy~~gg~L~~~l~~~------~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~-----~~KL~DFG~a 150 (271)
T d1nvra_ 82 LEYCSGGELFDRIEPD------IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD-----NLKISDFGLA 150 (271)
T ss_dssp EECCTTEEGGGGSBTT------TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-----CEEECCCTTC
T ss_pred EECCCCCCHHHHHHCC------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEECCCC-----CEEECCCHHH
T ss_conf 8645898089997537------9999999999999999999999975983575468997887899-----8798323142
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCCCCHHHHH
Q ss_conf 11235688999999998889998766783575420188988889999535321533579998619999988851137889
Q 003542 365 TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMT 444 (811)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIwSlGvILyELLtGk~PF~~~~~~~~~i~ 444 (811)
+....... .......+||+.|+|||++.+. ..++.++||||+||++|||++|++||...........
T Consensus 151 ~~~~~~~~-----~~~~~~~~GT~~Y~APE~~~~~--------~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~ 217 (271)
T d1nvra_ 151 TVFRYNNR-----ERLLNKMCGTLPYVAPELLKRR--------EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 217 (271)
T ss_dssp EECEETTE-----ECCBCCCCSCGGGSCTHHHHCS--------SBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHH
T ss_pred EEECCCCC-----CCCCCCEEECCCCCCHHHHCCC--------CCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHHHHHH
T ss_conf 24046886-----5311132557474287286189--------9999710161737999999829978888985999999
Q ss_pred HHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHH
Q ss_conf 988718999999999178799874101589999999999999
Q 003542 445 KNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 445 ~~i~~~~~~~~p~~~p~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
...........+...++.+.+||.+||+.||.+|||+.++++
T Consensus 218 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 218 DWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp HHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 986388878864469999999999976799668909999961
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=359.29 Aligned_cols=248 Identities=24% Similarity=0.420 Sum_probs=203.4
Q ss_pred CCEEEEEEECCCC---EEEEEEECCCEEEEEEECC---CHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEEEECC
Q ss_conf 0568953416434---2899999698999998064---278999999999808998501252038826798699998467
Q 003542 216 KKLMVRRRLGASS---QFKEIQWLGDSFVLRHFYG---ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELM 289 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~~~g~~vAIK~l~~---~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~e~~~~~~LVmEy~ 289 (811)
++|++.+.||.|+ ||++....+..||||++.. ..+.|.+|+.+|.+++|||||++++ ++.+ +.+|+|||||
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g-~~~~--~~~~iv~Ey~ 89 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA-VVTQ--EPIYIITEYM 89 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEE-EECS--SSCEEEEECC
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCEEEEEEECCCCCCHHHHHHHHHHHHHCCCCCEEEEEE-EECC--CCEEEEEEEC
T ss_conf 993886798107982899999999999999998647688899999999998679998857873-1045--9769999957
Q ss_pred C-CCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCCCCEEEEEECCCCCCCC
Q ss_conf 9-998899998607778899997899999999999999998699420268999489812678873159991034321123
Q 003542 290 S-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTART 368 (811)
Q Consensus 290 ~-gsL~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIvHRDLKPsNILI~~~g~d~~~~vKL~DFGLa~~~~ 368 (811)
+ |+|.+++... ....+++..+..++.||+.||.|||+++|+||||||+|||++.++ .+||+|||+|+...
T Consensus 90 ~~g~L~~~~~~~----~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~-----~~Kl~DFGla~~~~ 160 (272)
T d1qpca_ 90 ENGSLVDFLKTP----SGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTL-----SCKIADFGLARLIE 160 (272)
T ss_dssp TTCBHHHHTTSH----HHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-----CEEECCCTTCEECS
T ss_pred CCCCHHHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEEECCC-----CEEECCCCCEEECC
T ss_conf 898288887514----789887889999999999999999748954675642251562024-----40423410147735
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCCCCHHHHHHHHH
Q ss_conf 56889999999988899987667835754201889888899995353215335799986199999888511378899887
Q 003542 369 YASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIR 448 (811)
Q Consensus 369 ~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIwSlGvILyELLtGk~PF~~~~~~~~~i~~~i~ 448 (811)
.... .......||+.|+|||++.+. .|+.++|||||||++|||+||..||.... ....+...+.
T Consensus 161 ~~~~------~~~~~~~gt~~y~APE~~~~~---------~~~~~sDvwS~Gvvl~ellt~~~~~~~~~-~~~~~~~~i~ 224 (272)
T d1qpca_ 161 DNEY------TAREGAKFPIKWTAPEAINYG---------TFTIKSDVWSFGILLTEIVTHGRIPYPGM-TNPEVIQNLE 224 (272)
T ss_dssp SSCE------ECCTTCCCCTTTSCHHHHHHC---------EECHHHHHHHHHHHHHHHHTTTCCSSTTC-CHHHHHHHHH
T ss_pred CCCC------CCCCCCCCCCCCCCHHHHHCC---------CCCCHHHHHHHHHHHHHHHHCCCCCCCCC-CHHHHHHHHH
T ss_conf 8864------420356774444582898379---------99824564525799999996898888888-9999999997
Q ss_pred HCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 1899999999917879987410158999999999999999999
Q 003542 449 AGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYI 491 (811)
Q Consensus 449 ~~~~~~~p~~~p~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i 491 (811)
.+.++..|..+++.+.+||.+||+.||.+|||++++++.|+.+
T Consensus 225 ~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 225 RGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf 0688889655719999999997588976893999999986113
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=363.12 Aligned_cols=246 Identities=23% Similarity=0.342 Sum_probs=201.0
Q ss_pred CCEEEEEEECCCC---EEEEEE-ECCCEEEEEEECC----CHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEEEE
Q ss_conf 0568953416434---289999-9698999998064----2789999999998089985012520388267986999984
Q 003542 216 KKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVME 287 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~-~~g~~vAIK~l~~----~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~e~~~~~~LVmE 287 (811)
+.|++.+.||+|+ ||++.. .+|..||+|++.. ..+.+.+|+++|++++|||||++++.+. +.+.+|||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~--~~~~~~lvmE 89 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY--YENNLWILIE 89 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEE--ETTEEEEEEE
T ss_pred CCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEE--ECCEEEEEEE
T ss_conf 37598479930778199999999999399999987289999999999999998679999884988980--0995899996
Q ss_pred CCCC-CHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCCCCEEEEEECCCCCC
Q ss_conf 6799-988999986077788999978999999999999999986994202689994898126788731599910343211
Q 003542 288 LMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366 (811)
Q Consensus 288 y~~g-sL~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIvHRDLKPsNILI~~~g~d~~~~vKL~DFGLa~~ 366 (811)
||+| +|.+++.+. ...+++..+..++.||+.||.|||+++|+||||||+|||++.++ .+||+|||+|+.
T Consensus 90 y~~~g~L~~~~~~~-----~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~-----~~Kl~DFG~a~~ 159 (288)
T d2jfla1 90 FCAGGAVDAVMLEL-----ERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDG-----DIKLADFGVSAK 159 (288)
T ss_dssp CCTTEEHHHHHHHH-----TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-----CEEECCCTTCEE
T ss_pred CCCCCCHHHHHHHC-----CCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEECCHHHEEECCCC-----CEEEEECHHHHC
T ss_conf 27998188999862-----89999999999999999999999988988714070031487899-----989971612303
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 23568899999999888999876678357542018898888999953532153357999861999998885113788998
Q 003542 367 RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKN 446 (811)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIwSlGvILyELLtGk~PF~~~~~~~~~i~~~ 446 (811)
...... ......||+.|+|||++.+.... ...|+.++|||||||++|||++|++||.+.... .....
T Consensus 160 ~~~~~~-------~~~~~~Gt~~y~APE~l~~~~~~----~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~--~~~~~ 226 (288)
T d2jfla1 160 NTRTIQ-------RRDSFIGTPYWMAPEVVMCETSK----DRPYDYKADVWSLGITLIEMAEIEPPHHELNPM--RVLLK 226 (288)
T ss_dssp CHHHHH-------HHTCCCSCCTTCCHHHHTTCSTT----TSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG--GHHHH
T ss_pred CCCCCC-------CCCCCCCCCCCCCHHHHHHCCCC----CCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHH--HHHHH
T ss_conf 577864-------10010256264799998320257----888880665787899999982088999998999--99999
Q ss_pred HHHCCCC--CCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHH
Q ss_conf 8718999--999999178799874101589999999999999
Q 003542 447 IRAGERP--LFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 447 i~~~~~~--~~p~~~p~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
+..+..+ ..|..+++.+.+||.+||+.||.+|||+.++++
T Consensus 227 i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 227 IAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp HHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 970799877765669999999999976699668919999962
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=356.92 Aligned_cols=241 Identities=27% Similarity=0.490 Sum_probs=200.1
Q ss_pred EEECCCC---EEEEEEE---CCCEEEEEEECC------CHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEEEECC
Q ss_conf 3416434---2899999---698999998064------278999999999808998501252038826798699998467
Q 003542 222 RRLGASS---QFKEIQW---LGDSFVLRHFYG------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELM 289 (811)
Q Consensus 222 ~~lG~G~---vyk~v~~---~g~~vAIK~l~~------~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~e~~~~~~LVmEy~ 289 (811)
++||+|+ ||++... +++.||||++.. ..+.|.+|+.+|++++|||||++++.+ . + +.+|||||||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~-~-~-~~~~lvmE~~ 89 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-E-A-ESWMLVMEMA 89 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-E-S-SSEEEEEECC
T ss_pred CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEE-C-C-CCEEEEEECC
T ss_conf 78345878299999981697385999999880108989999999999999867998985277775-0-5-9779999747
Q ss_pred C-CCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCCCCEEEEEECCCCCCCC
Q ss_conf 9-998899998607778899997899999999999999998699420268999489812678873159991034321123
Q 003542 290 S-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTART 368 (811)
Q Consensus 290 ~-gsL~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIvHRDLKPsNILI~~~g~d~~~~vKL~DFGLa~~~~ 368 (811)
+ |+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||++.++ .+||+|||+++...
T Consensus 90 ~~g~L~~~l~~~------~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~-----~~kl~DFGla~~~~ 158 (277)
T d1xbba_ 90 ELGPLNKYLQQN------RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH-----YAKISDFGLSKALR 158 (277)
T ss_dssp TTEEHHHHHHHC------TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-----EEEECCCTTCEECC
T ss_pred CCCCHHHHHHHC------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCCCCC-----CCCCCCHHHHHHCC
T ss_conf 889689997522------5789999999999999997668747955677761131023567-----51234134533134
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCEECCHHHHHHHHH-CCCCCCCCCCCHHHHHHHH
Q ss_conf 568899999999888999876678357542018898888999953532153357999861-9999988851137889988
Q 003542 369 YASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGDKMTKNI 447 (811)
Q Consensus 369 ~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIwSlGvILyELLt-Gk~PF~~~~~~~~~i~~~i 447 (811)
..... ........||+.|+|||++.+. .|+.++|||||||++|||++ |++||.+.. ..++...+
T Consensus 159 ~~~~~----~~~~~~~~gt~~y~APE~l~~~---------~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~--~~~~~~~i 223 (277)
T d1xbba_ 159 ADENY----YKAQTHGKWPVKWYAPECINYY---------KFSSKSDVWSFGVLMWEAFSYGQKPYRGMK--GSEVTAML 223 (277)
T ss_dssp TTCSE----EEC----CCCGGGCCHHHHHHC---------EEEHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHHH
T ss_pred CCCCC----CCCCCCCCCCCEECCCHHHCCC---------CCCCHHHHCCCHHHHHHHHHCCCCCCCCCC--HHHHHHHH
T ss_conf 32344----3224456778420391665379---------998434430340313289658999999989--99999999
Q ss_pred HHCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 71899999999917879987410158999999999999999999
Q 003542 448 RAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYI 491 (811)
Q Consensus 448 ~~~~~~~~p~~~p~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i 491 (811)
..+.++++|..+|..+.+||.+||+.||.+|||+++|...|+.+
T Consensus 224 ~~~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 224 EKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCH
T ss_conf 82899999865679999999997588976890989999985288
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=358.48 Aligned_cols=243 Identities=23% Similarity=0.324 Sum_probs=200.7
Q ss_pred HCCEEEEEEECCCC---EEEEEE-ECCCEEEEEEECC-----CHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEE
Q ss_conf 40568953416434---289999-9698999998064-----27899999999980899850125203882679869999
Q 003542 215 LKKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLV 285 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~-~~g~~vAIK~l~~-----~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~e~~~~~~LV 285 (811)
.+.|++.+.||.|+ ||++.. .+|+.||+|.+.. ....+.+|+.+|+.++|||||++++.+ ++.+.+|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~--~~~~~~~lv 85 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY--ESGGHLYLI 85 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEE--ECSSEEEEE
T ss_pred CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEE--EECCEEEEE
T ss_conf 666699889940658399999999999899999981577312899999999999867998999198999--989988898
Q ss_pred EECCC-CCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCCCCEEEEEECCCC
Q ss_conf 84679-99889999860777889999789999999999999999869942026899948981267887315999103432
Q 003542 286 MELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS 364 (811)
Q Consensus 286 mEy~~-gsL~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIvHRDLKPsNILI~~~g~d~~~~vKL~DFGLa 364 (811)
||||+ |+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||+.....++ .+||+|||+|
T Consensus 86 mE~~~gg~L~~~l~~~------~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~--~vkl~DFG~a 157 (307)
T d1a06a_ 86 MQLVSGGELFDRIVEK------GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDS--KIMISDFGLS 157 (307)
T ss_dssp ECCCCSCBHHHHHHTC------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTC--CEEECCC---
T ss_pred EECCCCCCHHHHHHCC------CCCCHHHHHHHHHHHHHHHHHHHHCEEEEEEECCCCEEECCCCCCC--EEEEECCCEE
T ss_conf 8526898488865303------6788789999999999998752413055687046300110468882--4998315435
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCCCCHHHHH
Q ss_conf 11235688999999998889998766783575420188988889999535321533579998619999988851137889
Q 003542 365 TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMT 444 (811)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIwSlGvILyELLtGk~PF~~~~~~~~~i~ 444 (811)
+...... .....+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+... ..+.
T Consensus 158 ~~~~~~~--------~~~~~~GT~~y~APE~~~~~---------~~~~~~DiwSlGvilyell~g~~Pf~~~~~--~~~~ 218 (307)
T d1a06a_ 158 KMEDPGS--------VLSTACGTPGYVAPEVLAQK---------PYSKAVDCWSIGVIAYILLCGYPPFYDEND--AKLF 218 (307)
T ss_dssp -----------------------CTTSCHHHHTTC---------CCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHH
T ss_pred EECCCCC--------EEEEEEECCCCCCCHHHCCC---------CCCCHHHHHHHHHHHHHHHHCCCCCCCCCH--HHHH
T ss_conf 8725897--------04400328422591887379---------998078734515999999859799999899--9999
Q ss_pred HHHHHCCCC---CCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHH
Q ss_conf 988718999---999999178799874101589999999999999
Q 003542 445 KNIRAGERP---LFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 445 ~~i~~~~~~---~~p~~~p~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
..+..+... +.+...++.+.+||.+||+.||.+|||+.++++
T Consensus 219 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 219 EQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp HHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 998616877787666678999999999976089757918999862
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=0 Score=355.47 Aligned_cols=242 Identities=20% Similarity=0.294 Sum_probs=196.4
Q ss_pred HCCEEEEEEECCCC---EEEEEE-ECCCEEEEEEECC-------CHHHHHH---HHHHHHHCCCCCCCEEEEEEECCCCC
Q ss_conf 40568953416434---289999-9698999998064-------2789999---99999808998501252038826798
Q 003542 215 LKKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG-------ELESLNA---EISTMLSLSHPNIVQYLCGFCDEEKK 280 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~-~~g~~vAIK~l~~-------~~~~~~~---Ei~iL~~L~HpNIV~l~~~~~~e~~~ 280 (811)
+++|.+.+.||+|+ ||++.. .+|+.||+|++.. ....+.+ |+.+++.++|||||++++.+ ++.+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~--~~~~ 80 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF--HTPD 80 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE--ECSS
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEE--EECC
T ss_conf 77685101884288909999999999979999998458754266799999999999998508998588999999--9899
Q ss_pred EEEEEEECCC-CCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCCCCEEEEE
Q ss_conf 6999984679-998899998607778899997899999999999999998699420268999489812678873159991
Q 003542 281 EFFLVMELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVS 359 (811)
Q Consensus 281 ~~~LVmEy~~-gsL~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIvHRDLKPsNILI~~~g~d~~~~vKL~ 359 (811)
.+|||||||+ |+|.+++... ..+++..++.++.||+.||.|||+++|+||||||+|||++.++ .+||+
T Consensus 81 ~~~ivmE~~~gg~L~~~l~~~------~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g-----~iKl~ 149 (364)
T d1omwa3 81 KLSFILDLMNGGDLHYHLSQH------GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG-----HVRIS 149 (364)
T ss_dssp EEEEEECCCCSCBHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSS-----CEEEC
T ss_pred EEEEEEEECCCCCHHHHHHHC------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCEEEECCCC-----CEEEE
T ss_conf 889999914898389998732------5532789999999999999999977962204442216785889-----67982
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCCCC
Q ss_conf 03432112356889999999988899987667835754201889888899995353215335799986199999888511
Q 003542 360 GFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQ 439 (811)
Q Consensus 360 DFGLa~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIwSlGvILyELLtGk~PF~~~~~~ 439 (811)
|||+|+..... ......||+.|+|||++... ..|+.++|||||||++|||++|+.||.+....
T Consensus 150 DFGla~~~~~~---------~~~~~~GT~~y~APE~~~~~--------~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~ 212 (364)
T d1omwa3 150 DLGLACDFSKK---------KPHASVGTHGYMAPEVLQKG--------VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 212 (364)
T ss_dssp CCTTCEECSSS---------CCCSCCSCGGGCCHHHHSTT--------CCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS
T ss_pred EECEEEECCCC---------CCCCCCCCCCCCHHHHHHCC--------CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHH
T ss_conf 20102333788---------64331134554216876038--------99984410467789999998599988889989
Q ss_pred HHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCC-----HHHHHH
Q ss_conf 37889988718999999999178799874101589999999-----999999
Q 003542 440 GDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPS-----FSSICR 486 (811)
Q Consensus 440 ~~~i~~~i~~~~~~~~p~~~p~~l~~LI~~cL~~DP~~RPS-----~~eIl~ 486 (811)
.............+.+|..+++.+.+||.+||..||.+||+ ++++++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 213 DKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp CHHHHHHHSSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred HHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHHCCCCCCCHHHHHC
T ss_conf 9999998604688878877899999999998566988808874357999974
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=349.87 Aligned_cols=252 Identities=25% Similarity=0.396 Sum_probs=203.6
Q ss_pred CCEEEEEEECCCC---EEEEEEEC-C----CEEEEEEECC-----CHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEE
Q ss_conf 0568953416434---28999996-9----8999998064-----27899999999980899850125203882679869
Q 003542 216 KKLMVRRRLGASS---QFKEIQWL-G----DSFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEF 282 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~~~-g----~~vAIK~l~~-----~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~e~~~~~ 282 (811)
..|...+.||+|+ ||++.... + ..||||.+.. ....|.+|+.+|.+++|||||++++.+ .+...+
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~--~~~~~~ 84 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVI--SKYKPM 84 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE--CSSSSE
T ss_pred HHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEE--ECCCCE
T ss_conf 996861598117790999999968998787999999988445968999999999999856898783236778--338803
Q ss_pred EEEEECCCC-CHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCCCCEEEEEEC
Q ss_conf 999846799-9889999860777889999789999999999999999869942026899948981267887315999103
Q 003542 283 FLVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGF 361 (811)
Q Consensus 283 ~LVmEy~~g-sL~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIvHRDLKPsNILI~~~g~d~~~~vKL~DF 361 (811)
++|||||.+ ++.+++... ...+++..+..++.||+.||.|||+.+|+||||||+|||++.++ .+||+||
T Consensus 85 ~~v~e~~~~~~l~~~~~~~-----~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~-----~~Kl~DF 154 (283)
T d1mqba_ 85 MIITEYMENGALDKFLREK-----DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNL-----VCKVSDF 154 (283)
T ss_dssp EEEEECCTTEEHHHHHHHT-----TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-----CEEECCC
T ss_pred EEEEEECCCCCCHHHHHCC-----CCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCC-----EEEECCC
T ss_conf 8999721357402221023-----45420899999999999854121212342576564427888998-----4998455
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCCCCHH
Q ss_conf 43211235688999999998889998766783575420188988889999535321533579998619999988851137
Q 003542 362 GLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGD 441 (811)
Q Consensus 362 GLa~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIwSlGvILyELLtGk~PF~~~~~~~~ 441 (811)
|+++........ ........||+.|+|||++.+. .|+.++||||||+++|||++|..||.... ...
T Consensus 155 Gla~~~~~~~~~----~~~~~~~~gt~~Y~APE~l~~~---------~~~~~sDI~S~Gvil~el~t~~~~~~~~~-~~~ 220 (283)
T d1mqba_ 155 GLSRVLEDDPEA----TYTTSGGKIPIRWTAPEAISYR---------KFTSASDVWSFGIVMWEVMTYGERPYWEL-SNH 220 (283)
T ss_dssp CC---------------------CCCGGGSCHHHHHSC---------CCCHHHHHHHHHHHHHHHHTTSCCTTTTC-CHH
T ss_pred CHHHCCCCCCCC----CEEECCCCCCCCCCCHHHHCCC---------CCCCCCCCCCCHHHHHHHHHCCCCCCCCC-CHH
T ss_conf 103003578765----2674267777343488887049---------99973556344898999996798865568-999
Q ss_pred HHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 8899887189999999991787998741015899999999999999999999
Q 003542 442 KMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKK 493 (811)
Q Consensus 442 ~i~~~i~~~~~~~~p~~~p~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~~ 493 (811)
.+...+..+.+++.|..++..+.+||.+||+.||.+||++.+|++.|+.+.+
T Consensus 221 ~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 221 EVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp HHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 9999986357899850457999999999776797689399999999999866
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=0 Score=357.23 Aligned_cols=244 Identities=23% Similarity=0.377 Sum_probs=199.5
Q ss_pred HHCCEEEEEEECCCC---EEEEEE-ECCCEEEEEEECC----CHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEE
Q ss_conf 740568953416434---289999-9698999998064----27899999999980899850125203882679869999
Q 003542 214 LLKKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLV 285 (811)
Q Consensus 214 l~k~~~i~~~lG~G~---vyk~v~-~~g~~vAIK~l~~----~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~e~~~~~~LV 285 (811)
++++|.+.+.||+|+ ||++.. .+|+.||+|++.. +.+.+.+|+.+|+.++|||||++++.+. +.+.+|||
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~--~~~~~~iv 101 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE--DDNEMVMI 101 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEE--ETTEEEEE
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEE--ECCEEEEE
T ss_conf 8657589889840768199999988999899999984524316999999999998679979992999999--89999999
Q ss_pred EECCC-CCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCCCCEEEEEECCCC
Q ss_conf 84679-99889999860777889999789999999999999999869942026899948981267887315999103432
Q 003542 286 MELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS 364 (811)
Q Consensus 286 mEy~~-gsL~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIvHRDLKPsNILI~~~g~d~~~~vKL~DFGLa 364 (811)
||||+ |+|.+++.+. ...+++..+..++.||+.||.|||+++|+||||||+|||++.++ ++ .+||+|||+|
T Consensus 102 mE~~~gg~L~~~l~~~-----~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~-~~--~vkL~DFG~a 173 (350)
T d1koaa2 102 YEFMSGGELFEKVADE-----HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKR-SN--ELKLIDFGLT 173 (350)
T ss_dssp ECCCCSCBHHHHHTCT-----TSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTT-SC--CEEECCCTTC
T ss_pred EECCCCCCHHHHHHHH-----CCCCCHHHHHHHHHHHHHHHHHHHHCCCEEEEECHHHEEECCCC-CC--EEEEEECCHH
T ss_conf 9857998899999762-----37899999999999999999999756976000154673641688-98--6999545210
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCCCCHHHHH
Q ss_conf 11235688999999998889998766783575420188988889999535321533579998619999988851137889
Q 003542 365 TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMT 444 (811)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIwSlGvILyELLtGk~PF~~~~~~~~~i~ 444 (811)
+...... ......||+.|+|||++.+. .|+.++|||||||++|+|++|+.||.+.+. ....
T Consensus 174 ~~~~~~~--------~~~~~~gT~~Y~aPEv~~~~---------~~~~~~DiwSlGvilyell~G~~Pf~~~~~--~~~~ 234 (350)
T d1koaa2 174 AHLDPKQ--------SVKVTTGTAEFAAPEVAEGK---------PVGYYTDMWSVGVLSYILLSGLSPFGGEND--DETL 234 (350)
T ss_dssp EECCTTS--------CEEEECSCTTTCCHHHHHTC---------CBCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHH
T ss_pred EECCCCC--------CCCEECCCCCCCCHHHHCCC---------CCCHHHHHHHHHHHHHHHHHCCCCCCCCCH--HHHH
T ss_conf 4425654--------32000686242188997589---------987267655465999999859899899799--9999
Q ss_pred HHHHHCCCC---CCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHH
Q ss_conf 988718999---999999178799874101589999999999999
Q 003542 445 KNIRAGERP---LFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 445 ~~i~~~~~~---~~p~~~p~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
..+..+... .....+++.+.+||.+||..||.+|||+.++++
T Consensus 235 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 235 RNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp HHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred HHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 999847889894223589999999999975689667908999862
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=356.31 Aligned_cols=238 Identities=25% Similarity=0.443 Sum_probs=195.0
Q ss_pred EEEEEEECCCC---EEEEEEE-CCCEEEEEEECC------CHHHHHHHHHHHHHCCCCCCCEEEEEEEC--CCCCEEEEE
Q ss_conf 68953416434---2899999-698999998064------27899999999980899850125203882--679869999
Q 003542 218 LMVRRRLGASS---QFKEIQW-LGDSFVLRHFYG------ELESLNAEISTMLSLSHPNIVQYLCGFCD--EEKKEFFLV 285 (811)
Q Consensus 218 ~~i~~~lG~G~---vyk~v~~-~g~~vAIK~l~~------~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~--e~~~~~~LV 285 (811)
+++...||+|+ ||++... ++..||+|.+.. ..+.+.+|+++|++++|||||++++.+.+ .....+|||
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCEEEEE
T ss_conf 88516970082849999999999959999998512279899999999999998579998506999984033458889999
Q ss_pred EECCC-CCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CEECCCCCCCEEEEC-CCCCCCCEEEEEEC
Q ss_conf 84679-998899998607778899997899999999999999998699--420268999489812-67887315999103
Q 003542 286 MELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQK--IYHGELNPSNIYLKA-RSMEGYFHVKVSGF 361 (811)
Q Consensus 286 mEy~~-gsL~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~g--IvHRDLKPsNILI~~-~g~d~~~~vKL~DF 361 (811)
||||+ |+|.+++.+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++. ++ .+||+||
T Consensus 91 mE~~~~g~L~~~l~~~------~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~-----~~Kl~DF 159 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRF------KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTG-----SVKIGDL 159 (270)
T ss_dssp EECCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTS-----CEEECCT
T ss_pred EECCCCCCHHHHHHCC------CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCHHHCEEECCCC-----CEEEEEC
T ss_conf 9578989489997513------5546999999999999999999978997996876743511667999-----8898005
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCCCCHH
Q ss_conf 43211235688999999998889998766783575420188988889999535321533579998619999988851137
Q 003542 362 GLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGD 441 (811)
Q Consensus 362 GLa~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIwSlGvILyELLtGk~PF~~~~~~~~ 441 (811)
|+|+..... .....+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+.. ...
T Consensus 160 Gla~~~~~~---------~~~~~~GT~~Y~aPE~~~~----------~~~~~~DIwSlGvilyel~~g~~Pf~~~~-~~~ 219 (270)
T d1t4ha_ 160 GLATLKRAS---------FAKAVIGTPEFMAPEMYEE----------KYDESVDVYAFGMCMLEMATSEYPYSECQ-NAA 219 (270)
T ss_dssp TGGGGCCTT---------SBEESCSSCCCCCGGGGGT----------CCCTHHHHHHHHHHHHHHHHSSCTTTTCS-SHH
T ss_pred CCCEECCCC---------CCCCCCCCCCCCCHHHHCC----------CCCCCCCHHHHHHHHHHHHHCCCCCCCCC-CHH
T ss_conf 765423687---------6677553813008988478----------99986711007999999987889998765-599
Q ss_pred HHHHHHHHCCCC-CCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHH
Q ss_conf 889988718999-999999178799874101589999999999999
Q 003542 442 KMTKNIRAGERP-LFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 442 ~i~~~i~~~~~~-~~p~~~p~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
.+...+..+..+ .++...++++.+||.+||..||.+|||+.++++
T Consensus 220 ~~~~~i~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 220 QIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp HHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 9999997389986567557899999999976379758929999967
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=353.88 Aligned_cols=237 Identities=20% Similarity=0.336 Sum_probs=201.4
Q ss_pred HCCEEEEEEECCCC---EEEEEE-ECCCEEEEEEECC-------CHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEE
Q ss_conf 40568953416434---289999-9698999998064-------278999999999808998501252038826798699
Q 003542 215 LKKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG-------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFF 283 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~-~~g~~vAIK~l~~-------~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~e~~~~~~ 283 (811)
+++|++.+.||.|+ ||++.. .+|+.||+|++.. ..+.+.+|+.+|+.++|||||++++.+ .+...+|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~--~~~~~~~ 117 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF--KDNSNLY 117 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE--ECSSEEE
T ss_pred CCCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCC--CCCCCCC
T ss_conf 23708988961176808999999899989999998267745889999999999999974877274034444--3222223
Q ss_pred EEEECCC-CCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCCCCEEEEEECC
Q ss_conf 9984679-998899998607778899997899999999999999998699420268999489812678873159991034
Q 003542 284 LVMELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFG 362 (811)
Q Consensus 284 LVmEy~~-gsL~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIvHRDLKPsNILI~~~g~d~~~~vKL~DFG 362 (811)
+|||||. |+|..++... ..+++..++.|+.||+.||.|||+++|+||||||+|||++.++ ++||+|||
T Consensus 118 ~v~e~~~~g~l~~~l~~~------~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g-----~ikL~DFG 186 (350)
T d1rdqe_ 118 MVMEYVAGGEMFSHLRRI------GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG-----YIQVTDFG 186 (350)
T ss_dssp EEEECCTTCBHHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-----CEEECCCT
T ss_pred CCCCCCCCCCHHHHHHHC------CCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHCCCCCCC-----CEEEEECE
T ss_conf 222233466226667515------8989999999999999989999859986176799993607789-----78861010
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCCCCHHH
Q ss_conf 32112356889999999988899987667835754201889888899995353215335799986199999888511378
Q 003542 363 LSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDK 442 (811)
Q Consensus 363 La~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIwSlGvILyELLtGk~PF~~~~~~~~~ 442 (811)
+|+..... .....||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+ ...
T Consensus 187 ~a~~~~~~----------~~~~~Gt~~Y~APE~~~~~---------~~~~~~DiwSlGvilyemltG~~Pf~~~~--~~~ 245 (350)
T d1rdqe_ 187 FAKRVKGR----------TWTLCGTPEALAPEIILSK---------GYNKAVDWWALGVLIYEMAAGYPPFFADQ--PIQ 245 (350)
T ss_dssp TCEECSSC----------BCCCEECGGGCCHHHHTTC---------CBCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHH
T ss_pred EEEECCCC----------CCCCCCCCCCCCHHHHCCC---------CCCCCCCCCCHHHHHHHHHHCCCCCCCCC--HHH
T ss_conf 33322566----------6433676356788997179---------98853311450078999975889989959--999
Q ss_pred HHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCCCCC-----CHHHHHH
Q ss_conf 8998871899999999917879987410158999999-----9999999
Q 003542 443 MTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRP-----SFSSICR 486 (811)
Q Consensus 443 i~~~i~~~~~~~~p~~~p~~l~~LI~~cL~~DP~~RP-----S~~eIl~ 486 (811)
+...+..+. +.+|..+++++.+||.+||..||.+|+ +++++++
T Consensus 246 ~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 246 IYEKIVSGK-VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp HHHHHHHCC-CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred HHHHHHCCC-CCCCCCCCHHHHHHHHHHHHHCHHHCCCCCCCCHHHHHC
T ss_conf 999986179-889766899999999998340998606553454999971
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=0 Score=355.15 Aligned_cols=243 Identities=22% Similarity=0.346 Sum_probs=198.8
Q ss_pred HCCEEEEEEECCCC---EEEEEE-ECCCEEEEEEECC----CHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEEE
Q ss_conf 40568953416434---289999-9698999998064----278999999999808998501252038826798699998
Q 003542 215 LKKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVM 286 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~-~~g~~vAIK~l~~----~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~e~~~~~~LVm 286 (811)
.+.|++.+.||.|+ ||++.. .+|+.||+|++.. +...+.+|+.+|+.++|||||++++.| ++...+||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~--~~~~~~~ivm 105 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF--EDKYEMVLIL 105 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEE--ECSSEEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEE--EECCEEEEEE
T ss_conf 40359989993177829999999899979999998872646799999999999867997989199999--9899999999
Q ss_pred ECCC-CCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCCCCEEEEEECCCCC
Q ss_conf 4679-998899998607778899997899999999999999998699420268999489812678873159991034321
Q 003542 287 ELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365 (811)
Q Consensus 287 Ey~~-gsL~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIvHRDLKPsNILI~~~g~d~~~~vKL~DFGLa~ 365 (811)
|||+ |+|.+++.. ....|++..++.++.||+.||.|||++||+||||||+|||++..+ ++ .+||+|||+|+
T Consensus 106 E~~~gg~L~~~~~~-----~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~-~~--~vkL~DFGla~ 177 (352)
T d1koba_ 106 EFLSGGELFDRIAA-----EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKK-AS--SVKIIDFGLAT 177 (352)
T ss_dssp ECCCCCBHHHHTTC-----TTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTT-CC--CEEECCCTTCE
T ss_pred ECCCCCHHHHHHHH-----CCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCCCCCCCC-CC--EEEEEECCCCE
T ss_conf 82899808888986-----389989999999999999999999977926513144553113467-88--48995256303
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 12356889999999988899987667835754201889888899995353215335799986199999888511378899
Q 003542 366 ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTK 445 (811)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIwSlGvILyELLtGk~PF~~~~~~~~~i~~ 445 (811)
...... ......||+.|+|||++.+. .|+.++||||+||++|+|++|++||.+.... ....
T Consensus 178 ~~~~~~--------~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--~~~~ 238 (352)
T d1koba_ 178 KLNPDE--------IVKVTTATAEFAAPEIVDRE---------PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL--ETLQ 238 (352)
T ss_dssp ECCTTS--------CEEEECSSGGGCCHHHHTTC---------CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHH
T ss_pred ECCCCC--------CEEECCCCCCCCCHHHHCCC---------CCCCCCCHHHHHHHHHHHHHCCCCCCCCCHH--HHHH
T ss_conf 437887--------20100476453489997479---------9897633389899999999688998997999--9999
Q ss_pred HHHHCCCC---CCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHH
Q ss_conf 88718999---999999178799874101589999999999999
Q 003542 446 NIRAGERP---LFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 446 ~i~~~~~~---~~p~~~p~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
.+..+... ..+...++++.+||.+||+.||.+|||+.++++
T Consensus 239 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 239 NVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp HHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 99847889893002479999999999975699668918999960
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=351.71 Aligned_cols=237 Identities=24% Similarity=0.401 Sum_probs=200.4
Q ss_pred HCCEEEEEEECCCC---EEEEEE-ECCCEEEEEEECC-------CHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEE
Q ss_conf 40568953416434---289999-9698999998064-------278999999999808998501252038826798699
Q 003542 215 LKKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG-------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFF 283 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~-~~g~~vAIK~l~~-------~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~e~~~~~~ 283 (811)
+++|++.+.||+|+ ||++.. .+|+.||+|++.. ..+.+.+|+.+|+.++|||||++++.+. +...+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~--~~~~~~ 80 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ--DAQQIF 80 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE--CSSEEE
T ss_pred HHHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEE--ECCEEE
T ss_conf 547088889720768089999998999799999984577548899999999999998636967533035685--288005
Q ss_pred EEEECCCC-CHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCCCCEEEEEECC
Q ss_conf 99846799-98899998607778899997899999999999999998699420268999489812678873159991034
Q 003542 284 LVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFG 362 (811)
Q Consensus 284 LVmEy~~g-sL~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIvHRDLKPsNILI~~~g~d~~~~vKL~DFG 362 (811)
+|||||+| +|..++... ..+++..+..++.||+.||.|||+++|+||||||+|||++.+| .+||+|||
T Consensus 81 ivmE~~~gg~l~~~~~~~------~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g-----~vkL~DFG 149 (316)
T d1fota_ 81 MIMDYIEGGELFSLLRKS------QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNG-----HIKITDFG 149 (316)
T ss_dssp EEECCCCSCBHHHHHHHT------SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTS-----CEEECCCS
T ss_pred EEEEECCCCCCCCCCCCC------CCCCCCHHHHHHHHHHHHHHHHCCCCEECCCCCCHHEEECCCC-----CEEEECCC
T ss_conf 676503786322343222------2111007999999998765541247677055681050386899-----88983175
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCCCCHHH
Q ss_conf 32112356889999999988899987667835754201889888899995353215335799986199999888511378
Q 003542 363 LSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDK 442 (811)
Q Consensus 363 La~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIwSlGvILyELLtGk~PF~~~~~~~~~ 442 (811)
+|+..... ....+||+.|+|||++.+. .|+.++||||+||++|+|++|+.||.+.+. ..
T Consensus 150 ~a~~~~~~----------~~~~~Gt~~Y~APE~l~~~---------~y~~~~DiwSlGvilyemltG~~Pf~~~~~--~~ 208 (316)
T d1fota_ 150 FAKYVPDV----------TYTLCGTPDYIAPEVVSTK---------PYNKSIDWWSFGILIYEMLAGYTPFYDSNT--MK 208 (316)
T ss_dssp SCEECSSC----------BCCCCSCTTTCCHHHHTTC---------CBCTTHHHHHHHHHHHHHHHSSCTTCCSSH--HH
T ss_pred CCEEECCC----------CCCCCCCCCCCCHHHHCCC---------CCCCHHHCCCCCHHHHHHHHCCCCCCCCCH--HH
T ss_conf 21671245----------6434576343599998389---------998043046533368999759899999699--99
Q ss_pred HHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCCCCC-----CHHHHHH
Q ss_conf 8998871899999999917879987410158999999-----9999999
Q 003542 443 MTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRP-----SFSSICR 486 (811)
Q Consensus 443 i~~~i~~~~~~~~p~~~p~~l~~LI~~cL~~DP~~RP-----S~~eIl~ 486 (811)
+...+..+. ..+|...++.+.+++.+||..||.+|+ +++++++
T Consensus 209 ~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 209 TYEKILNAE-LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp HHHHHHHCC-CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred HHHHHHCCC-CCCCCCCCHHHHHHHHHHHHHCHHHCCCCCHHHHHHHHC
T ss_conf 999997089-889977899999999999544997666431021999981
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=349.18 Aligned_cols=249 Identities=22% Similarity=0.424 Sum_probs=205.7
Q ss_pred CCEEEEEEECCCC---EEEEEEE-CCC----EEEEEEECC-----CHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEE
Q ss_conf 0568953416434---2899999-698----999998064-----27899999999980899850125203882679869
Q 003542 216 KKLMVRRRLGASS---QFKEIQW-LGD----SFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEF 282 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~~-~g~----~vAIK~l~~-----~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~e~~~~~ 282 (811)
.+|++.+.||.|+ ||++... +|+ .||+|.+.. ..+.|.+|+.+|++++|||||++++.+. +. ..
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~-~~--~~ 85 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL-TS--TV 85 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEE-SS--SE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE-CC--CE
T ss_conf 9997831982089929999999589988989999999651349799999999999998679988815899996-19--83
Q ss_pred EEEEECCC-CCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCCCCEEEEEEC
Q ss_conf 99984679-99889999860777889999789999999999999999869942026899948981267887315999103
Q 003542 283 FLVMELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGF 361 (811)
Q Consensus 283 ~LVmEy~~-gsL~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIvHRDLKPsNILI~~~g~d~~~~vKL~DF 361 (811)
+++||||. |+|.+++... ...+++..++.++.||+.||.|||+++|+||||||+|||++.++ ++||+||
T Consensus 86 ~~v~e~~~~~~l~~~~~~~-----~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~-----~~kl~DF 155 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREH-----KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-----HVKITDF 155 (317)
T ss_dssp EEEEECCTTCBHHHHHHHT-----SSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT-----EEEECCC
T ss_pred EEEEEECCCCCCCCCCCCC-----CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCHHHCCEECCCC-----CEEEECC
T ss_conf 6999842687401011133-----45799999999999999999999876950476212031167998-----7586025
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCEECCHHHHHHHHH-CCCCCCCCCCCH
Q ss_conf 4321123568899999999888999876678357542018898888999953532153357999861-999998885113
Q 003542 362 GLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQG 440 (811)
Q Consensus 362 GLa~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIwSlGvILyELLt-Gk~PF~~~~~~~ 440 (811)
|+|+....... ........||+.|+|||++.+. .|+.++||||||+++|||+| |.+||.+...
T Consensus 156 Gla~~~~~~~~-----~~~~~~~~gt~~y~APE~l~~~---------~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~-- 219 (317)
T d1xkka_ 156 GLAKLLGAEEK-----EYHAEGGKVPIKWMALESILHR---------IYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-- 219 (317)
T ss_dssp SHHHHTTTTCC-------------CCTTTSCHHHHHHC---------CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG--
T ss_pred CCCEECCCCCC-----CCCCCCCCCCCCCCCHHHHHCC---------CCCHHHHHHHHHHHHHHHHHCCCCCCCCCCH--
T ss_conf 52223354445-----3223651058644670887469---------9983565440799999999779999999998--
Q ss_pred HHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 78899887189999999991787998741015899999999999999999999
Q 003542 441 DKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKK 493 (811)
Q Consensus 441 ~~i~~~i~~~~~~~~p~~~p~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~~ 493 (811)
.++...+..+.+++.|..++..+.+||.+||..||.+|||+.+|+..|..+.+
T Consensus 220 ~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 220 SEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp GGHHHHHHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 99999997599899985568999999998478993469199999999999875
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=349.79 Aligned_cols=244 Identities=21% Similarity=0.346 Sum_probs=202.3
Q ss_pred HCCEEEEEEECCCC---EEEEEE-ECCCEEEEEEECC----------CHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCC
Q ss_conf 40568953416434---289999-9698999998064----------278999999999808998501252038826798
Q 003542 215 LKKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG----------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKK 280 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~-~~g~~vAIK~l~~----------~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~e~~~ 280 (811)
.++|++.+.||+|+ ||++.. .+|+.||+|++.. ..+.+.+|+.+|++++|||||++++.+ ++..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~--~~~~ 86 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY--ENKT 86 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE--ECSS
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEE--EECC
T ss_conf 56779827981178959999999999989999998756632134068999999999999867998999388999--9799
Q ss_pred EEEEEEECCC-CCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCCCCEEEEE
Q ss_conf 6999984679-998899998607778899997899999999999999998699420268999489812678873159991
Q 003542 281 EFFLVMELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVS 359 (811)
Q Consensus 281 ~~~LVmEy~~-gsL~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIvHRDLKPsNILI~~~g~d~~~~vKL~ 359 (811)
.+|||||||+ |+|.+++... ..+++..++.++.|++.||.|||+.+|+||||||+|||++.++ .....+||+
T Consensus 87 ~~~iv~E~~~gg~L~~~i~~~------~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~-~~~~~vkl~ 159 (293)
T d1jksa_ 87 DVILILELVAGGELFDFLAEK------ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRN-VPKPRIKII 159 (293)
T ss_dssp EEEEEEECCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSS-SSSCCEEEC
T ss_pred EEEEEEECCCCCCCCCHHCCC------CCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCEEEEECCC-CCCCCEEEC
T ss_conf 899999867786431001035------6421557899999999998766625422113330127982589-866646964
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCCCC
Q ss_conf 03432112356889999999988899987667835754201889888899995353215335799986199999888511
Q 003542 360 GFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQ 439 (811)
Q Consensus 360 DFGLa~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIwSlGvILyELLtGk~PF~~~~~~ 439 (811)
|||+|....... ......||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+...
T Consensus 160 DfG~a~~~~~~~--------~~~~~~~t~~y~APE~~~~~---------~~~~~~DiwSlGvilyell~g~~Pf~~~~~- 221 (293)
T d1jksa_ 160 DFGLAHKIDFGN--------EFKNIFGTPEFVAPEIVNYE---------PLGLEADMWSIGVITYILLSGASPFLGDTK- 221 (293)
T ss_dssp CCTTCEECTTSC--------BCSCCCCCGGGCCHHHHTTC---------CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-
T ss_pred CHHHHHHCCCCC--------CCCCCCCCCCCCCHHHHCCC---------CCCCCCCCHHHHHHHHHHHCCCCCCCCCCH-
T ss_conf 334421057776--------31224777743099998189---------999766522140999999708899889999-
Q ss_pred HHHHHHHHHHCCCC---CCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHH
Q ss_conf 37889988718999---999999178799874101589999999999999
Q 003542 440 GDKMTKNIRAGERP---LFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 440 ~~~i~~~i~~~~~~---~~p~~~p~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
......+..+... ..+..++..+.+||.+||..||.+|||++++++
T Consensus 222 -~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 222 -QETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp -HHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -HHHHHHHHHCCCCCCCHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf -9999999816888870104788999999999986389668919999961
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=352.47 Aligned_cols=245 Identities=25% Similarity=0.436 Sum_probs=206.8
Q ss_pred CCEEEEEEECCCC---EEEEEEECCCEEEEEEECC---CHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEEEECC
Q ss_conf 0568953416434---2899999698999998064---278999999999808998501252038826798699998467
Q 003542 216 KKLMVRRRLGASS---QFKEIQWLGDSFVLRHFYG---ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELM 289 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~~~g~~vAIK~l~~---~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~e~~~~~~LVmEy~ 289 (811)
++|++.+.||.|+ ||++...++..||||.++. ..+.|.+|+.++..++||||+++++.+ .+.+.+++|||||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~--~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC--TKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEE--CCSSSEEEEEECC
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCCCCHHHHHHHHHHHHHCCCCCEEEEEEEE--EECCCEEEEEECC
T ss_conf 99799689820788399999988998999999874757789999999999966898601588998--5078169999704
Q ss_pred C-CCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCCCCEEEEEECCCCCCCC
Q ss_conf 9-998899998607778899997899999999999999998699420268999489812678873159991034321123
Q 003542 290 S-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTART 368 (811)
Q Consensus 290 ~-gsL~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIvHRDLKPsNILI~~~g~d~~~~vKL~DFGLa~~~~ 368 (811)
+ |+|..++... ...+++..++.++.|++.||.|||+.+|+||||||+|||++.++ .+||+|||+++...
T Consensus 82 ~~g~l~~~~~~~-----~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~-----~~kl~DfG~a~~~~ 151 (258)
T d1k2pa_ 82 ANGCLLNYLREM-----RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQG-----VVKVSDFGLSRYVL 151 (258)
T ss_dssp TTEEHHHHHHSG-----GGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTC-----CEEECCCSSCCBCS
T ss_pred CCCCHHHHHHCC-----CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCEEEEECCCC-----CEEECCCHHHEECC
T ss_conf 899388864102-----46776899999999999999987546843466541358876998-----47988614420235
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCEECCHHHHHHHHH-CCCCCCCCCCCHHHHHHHH
Q ss_conf 568899999999888999876678357542018898888999953532153357999861-9999988851137889988
Q 003542 369 YASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGDKMTKNI 447 (811)
Q Consensus 369 ~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIwSlGvILyELLt-Gk~PF~~~~~~~~~i~~~i 447 (811)
.... .......||+.|+|||++.+. .|+.++||||||+++|||+| |+.||.+.. ..++...+
T Consensus 152 ~~~~------~~~~~~~~t~~y~aPE~~~~~---------~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~--~~~~~~~i 214 (258)
T d1k2pa_ 152 DDEY------TSSVGSKFPVRWSPPEVLMYS---------KFSSKSDIWAFGVLMWEIYSLGKMPYERFT--NSETAEHI 214 (258)
T ss_dssp SSSC------CCCCCSCCCGGGCCHHHHHHC---------CCCHHHHHHHHHHHHHHHHTTSCCTTTTSC--HHHHHHHH
T ss_pred CCCC------EEECCCCCCCCCCCCHHHCCC---------CCCCCEEECCCCHHHHHHHHCCCCCCCCCC--HHHHHHHH
T ss_conf 7872------252465788775780786379---------988521033643246739755999988999--99999999
Q ss_pred HHCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH
Q ss_conf 718999999999178799874101589999999999999999
Q 003542 448 RAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILR 489 (811)
Q Consensus 448 ~~~~~~~~p~~~p~~l~~LI~~cL~~DP~~RPS~~eIl~~L~ 489 (811)
..+.++..|..+++.+.+||.+||+.||.+|||+++|++.|.
T Consensus 215 ~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~ 256 (258)
T d1k2pa_ 215 AQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256 (258)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred HHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf 807978996546599999999976689768939999998741
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=347.21 Aligned_cols=258 Identities=24% Similarity=0.460 Sum_probs=208.5
Q ss_pred HCCEEEEEEECCCC---EEEEEEE------CCCEEEEEEECC-----CHHHHHHHHHHHHHC-CCCCCCEEEEEEECCCC
Q ss_conf 40568953416434---2899999------698999998064-----278999999999808-99850125203882679
Q 003542 215 LKKLMVRRRLGASS---QFKEIQW------LGDSFVLRHFYG-----ELESLNAEISTMLSL-SHPNIVQYLCGFCDEEK 279 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~~------~g~~vAIK~l~~-----~~~~~~~Ei~iL~~L-~HpNIV~l~~~~~~e~~ 279 (811)
..+|++.+.||+|+ ||++... +++.||+|++.. ....+.+|..++.++ +||||+.+++.+ .+..
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~-~~~~ 90 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC-TKPG 90 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-CSTT
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCEEEEEEEEE-CCCC
T ss_conf 799798449841678399999986777555783999999860017178999999999988614998499741154-0479
Q ss_pred CEEEEEEECCC-CCHHHHHHHHHCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECC
Q ss_conf 86999984679-9988999986077----------788999978999999999999999986994202689994898126
Q 003542 280 KEFFLVMELMS-KDLSCYMRETFGS----------RRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKAR 348 (811)
Q Consensus 280 ~~~~LVmEy~~-gsL~~~L~~~~~~----------~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIvHRDLKPsNILI~~~ 348 (811)
..+++|||||+ |+|.+++...... .....+++..+..++.||+.||.|||+++|+||||||+|||++.+
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~ 170 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 170 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGG
T ss_pred CEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCC
T ss_conf 75799998458992999998536666653222023321468999999999999999998873797178677310657799
Q ss_pred CCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCEECCHHHHHHHHH
Q ss_conf 78873159991034321123568899999999888999876678357542018898888999953532153357999861
Q 003542 349 SMEGYFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT 428 (811)
Q Consensus 349 g~d~~~~vKL~DFGLa~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIwSlGvILyELLt 428 (811)
+ .+||+|||+|+....... ........||+.|+|||++.+. .|+.++|||||||++|||++
T Consensus 171 ~-----~~Kl~DFGla~~~~~~~~-----~~~~~~~~gt~~y~APE~l~~~---------~~~~~sDiwS~Gvil~ellt 231 (299)
T d1ywna1 171 N-----VVKICDFGLARDIYKDPD-----YVRKGDARLPLKWMAPETIFDR---------VYTIQSDVWSFGVLLWEIFS 231 (299)
T ss_dssp G-----CEEECC------CCSCTT-----SCCTTSCCCGGGGCCHHHHHHC---------CCCHHHHHHHHHHHHHHHHT
T ss_pred C-----CEEECCCCCHHHCCCCCC-----CCCCCCEEECCCCCCHHHHHCC---------CCCCCCCEEEHHHHHHHHHH
T ss_conf 8-----289845752001135665-----2224751667210203686468---------89966322136789999986
Q ss_pred C-CCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 9-9999888511378899887189999999991787998741015899999999999999999999
Q 003542 429 G-KVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKK 493 (811)
Q Consensus 429 G-k~PF~~~~~~~~~i~~~i~~~~~~~~p~~~p~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~~ 493 (811)
| .+||.+.... ..+...+..+.++..|..+++.+.+||.+||+.||.+|||+.+++++|+.+.+
T Consensus 232 ~~~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 232 LGASPYPGVKID-EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp TSCCSSTTCCCS-HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHH-HHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 889999899989-99999996389888886578999999999767796679199999999979986
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=345.95 Aligned_cols=249 Identities=24% Similarity=0.457 Sum_probs=207.0
Q ss_pred HCCEEEEEEECCCC---EEEEEEE----CCCEEEEEEECC-----CHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEE
Q ss_conf 40568953416434---2899999----698999998064-----27899999999980899850125203882679869
Q 003542 215 LKKLMVRRRLGASS---QFKEIQW----LGDSFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEF 282 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~~----~g~~vAIK~l~~-----~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~e~~~~~ 282 (811)
..+|++.+.||.|+ ||++... .+..||+|.+.. ..+.+.+|+.+|++++|||||++++.+ . + +.+
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~-~-~-~~~ 82 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-T-E-NPV 82 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-C-S-SSC
T ss_pred HHHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEE-E-C-CEE
T ss_conf 899698779930788299999993699644999999936566879999999999999868999985698899-5-3-747
Q ss_pred EEEEECCCC-CHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCCCCEEEEEEC
Q ss_conf 999846799-9889999860777889999789999999999999999869942026899948981267887315999103
Q 003542 283 FLVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGF 361 (811)
Q Consensus 283 ~LVmEy~~g-sL~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIvHRDLKPsNILI~~~g~d~~~~vKL~DF 361 (811)
|+|||||++ +|..++... ...+++..++.++.||+.||.|||+++|+||||||+|||++.++ .+||+||
T Consensus 83 ~iv~E~~~~g~l~~~~~~~-----~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~-----~~Kl~Df 152 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVR-----KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND-----CVKLGDF 152 (273)
T ss_dssp EEEEECCTTEEHHHHHHHT-----TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-----EEEECC-
T ss_pred EEEEEECCCCCHHHHHHCC-----CCCCCHHHHHHHHHHHHHHHHHHCCCCEECCCCCHHHEEECCCC-----CEEECCC
T ss_conf 9999840698077654224-----78999999999999998775230226744141026553206789-----6787650
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCEECCHHHHHHHHH-CCCCCCCCCCCH
Q ss_conf 4321123568899999999888999876678357542018898888999953532153357999861-999998885113
Q 003542 362 GLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQG 440 (811)
Q Consensus 362 GLa~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIwSlGvILyELLt-Gk~PF~~~~~~~ 440 (811)
|+|+....... .......||+.|+|||++.+. .|+.++|||||||++|||++ |.+||.+...
T Consensus 153 G~a~~~~~~~~------~~~~~~~gt~~y~apE~l~~~---------~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~-- 215 (273)
T d1mp8a_ 153 GLSRYMEDSTY------YKASKGKLPIKWMAPESINFR---------RFTSASDVWMFGVCMWEILMHGVKPFQGVKN-- 215 (273)
T ss_dssp ------------------------CCGGGCCHHHHHHC---------CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG--
T ss_pred HHHEECCCCCC------EECCCEECCCCCCHHHHHCCC---------CCCCCCCCCCCHHHHHHHHHCCCCCCCCCCH--
T ss_conf 34213367762------330540058310326675169---------9887452444247899998269999888999--
Q ss_pred HHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 78899887189999999991787998741015899999999999999999999
Q 003542 441 DKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKK 493 (811)
Q Consensus 441 ~~i~~~i~~~~~~~~p~~~p~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~~ 493 (811)
.++...+..+.++++|..+|+.+.+||.+||..||.+|||+.+|++.|..+..
T Consensus 216 ~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 216 NDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268 (273)
T ss_dssp GGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 99999998189998987779999999999768797689299999999999977
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=348.64 Aligned_cols=247 Identities=30% Similarity=0.531 Sum_probs=209.8
Q ss_pred HCCEEEEEEECCCC---EEEEEEECCCEEEEEEECC--CHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEEEECC
Q ss_conf 40568953416434---2899999698999998064--278999999999808998501252038826798699998467
Q 003542 215 LKKLMVRRRLGASS---QFKEIQWLGDSFVLRHFYG--ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELM 289 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~~~g~~vAIK~l~~--~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~e~~~~~~LVmEy~ 289 (811)
.++|++.+.||.|+ ||++ .+.|..||+|+++. ..+.+.+|+++|++++||||+++++.+. ++.+.+|+|||||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~-~~~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~~~lv~ey~ 83 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLG-DYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV-EEKGGLYIVTEYM 83 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEE-EETTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEEC-CC--CCEEEECCC
T ss_pred HHHEEEEEEEECCCCEEEEEE-EECCEEEEEEEECCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE-ECCCCEEEEEECC
T ss_conf 899488579820798089999-99990999999885777999999999998678989854987887-2389289999636
Q ss_pred C-CCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCCCCEEEEEECCCCCCCC
Q ss_conf 9-998899998607778899997899999999999999998699420268999489812678873159991034321123
Q 003542 290 S-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTART 368 (811)
Q Consensus 290 ~-gsL~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIvHRDLKPsNILI~~~g~d~~~~vKL~DFGLa~~~~ 368 (811)
+ |+|.+++.... ...+++..++.++.||+.||.|||+.+|+||||||+|||++.++ .+||+|||+++...
T Consensus 84 ~~g~L~~~l~~~~----~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~-----~~kl~dfg~s~~~~ 154 (262)
T d1byga_ 84 AKGSLVDYLRSRG----RSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN-----VAKVSDFGLTKEAS 154 (262)
T ss_dssp TTEEHHHHHHHHH----HHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS-----CEEECCCCC-----
T ss_pred CCCCHHHHHHHCC----CCCCCHHHHHHHHHHHHHHCCCCCCCCEECCCCCHHHHEECCCC-----CEEECCCCCCEECC
T ss_conf 9998999987457----88889999999999998523211337655366656760146899-----77632456003447
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCEECCHHHHHHHHH-CCCCCCCCCCCHHHHHHHH
Q ss_conf 568899999999888999876678357542018898888999953532153357999861-9999988851137889988
Q 003542 369 YASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQGDKMTKNI 447 (811)
Q Consensus 369 ~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIwSlGvILyELLt-Gk~PF~~~~~~~~~i~~~i 447 (811)
.. .....+|..|+|||++.+. .++.++||||||+++|||++ |++||..... ..+...+
T Consensus 155 ~~----------~~~~~~~~~y~aPE~l~~~---------~~t~~sDIwSfG~il~el~t~~~~p~~~~~~--~~~~~~i 213 (262)
T d1byga_ 155 ST----------QDTGKLPVKWTAPEALREK---------KFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPRV 213 (262)
T ss_dssp -----------------CCTTTSCHHHHHHC---------CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG--GGHHHHH
T ss_pred CC----------CCCCCCCCCCCCHHHHHCC---------CCCHHHHHHHHHHHHHHHHHCCCCCCCCCCH--HHHHHHH
T ss_conf 87----------7655666467781787279---------8885887775799999999789999999999--9999999
Q ss_pred HHCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 7189999999991787998741015899999999999999999999
Q 003542 448 RAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKK 493 (811)
Q Consensus 448 ~~~~~~~~p~~~p~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~~ 493 (811)
..+.++++|..+++.+.+||.+||+.||.+|||+.++++.|+.++.
T Consensus 214 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 214 EKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp TTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 8089999976579999999999756697689399999999999986
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=345.20 Aligned_cols=254 Identities=25% Similarity=0.398 Sum_probs=208.5
Q ss_pred HCCEEEEEEECCCC---EEEEEEE------CCCEEEEEEECC-----CHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCC
Q ss_conf 40568953416434---2899999------698999998064-----278999999999808998501252038826798
Q 003542 215 LKKLMVRRRLGASS---QFKEIQW------LGDSFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKK 280 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~~------~g~~vAIK~l~~-----~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~e~~~ 280 (811)
..+|++++.||+|+ ||++... +++.||||++.. ..+.|.+|+.+|++++||||+++++.+ ....
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~--~~~~ 89 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC--AVGK 89 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE--CSSS
T ss_pred HHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCCCCCEEEE--CCCC
T ss_conf 88938867982078839999998887657788299999988210857999999999999966899765524666--0598
Q ss_pred EEEEEEECCC-CCHHHHHHHHHC------------------CCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCC
Q ss_conf 6999984679-998899998607------------------778899997899999999999999998699420268999
Q 003542 281 EFFLVMELMS-KDLSCYMRETFG------------------SRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPS 341 (811)
Q Consensus 281 ~~~LVmEy~~-gsL~~~L~~~~~------------------~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIvHRDLKPs 341 (811)
.+++|||||+ |+|.+++..... ......+++..+..++.|++.||.|||+.+++||||||+
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~ 169 (301)
T d1lufa_ 90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR 169 (301)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred CEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEECCC
T ss_conf 03899981589929999985275542100001110012103467889899999999999999855413578685488401
Q ss_pred CEEEECCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCEECCHH
Q ss_conf 48981267887315999103432112356889999999988899987667835754201889888899995353215335
Q 003542 342 NIYLKARSMEGYFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGM 421 (811)
Q Consensus 342 NILI~~~g~d~~~~vKL~DFGLa~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIwSlGv 421 (811)
|||++.++ .+||+|||+|+....... ........|++.|+|||++.+. .|+.++|||||||
T Consensus 170 NILld~~~-----~~Kl~DFGls~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~---------~~t~ksDVwS~Gv 230 (301)
T d1lufa_ 170 NCLVGENM-----VVKIADFGLSRNIYSADY-----YKADGNDAIPIRWMPPESIFYN---------RYTTESDVWAYGV 230 (301)
T ss_dssp GEEECGGG-----CEEECCCSCHHHHTGGGC-----BC----CCBCGGGCCHHHHHHC---------CCCHHHHHHHHHH
T ss_pred CEEECCCC-----CEEECCCHHHEECCCCCC-----CCCCCCCCCCCCCCCHHHHCCC---------CCCHHHHHCCCHH
T ss_conf 16898999-----289833144211367764-----1115777767676798997268---------8980563025236
Q ss_pred HHHHHHHCC-CCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 799986199-9998885113788998871899999999917879987410158999999999999999999
Q 003542 422 LCFELLTGK-VPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYI 491 (811)
Q Consensus 422 ILyELLtGk-~PF~~~~~~~~~i~~~i~~~~~~~~p~~~p~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i 491 (811)
++|||++|. +||.+.. ..++...+..+.++..|..+++.+.+||.+||+.||.+|||+.+|++.|+.+
T Consensus 231 vl~ell~~~~~p~~~~~--~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 231 VLWEIFSYGLQPYYGMA--HEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp HHHHHHTTTCCTTTTSC--HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred HHHHHHCCCCCCCCCCC--HHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf 29999806899999989--9999999973997888732529999999997488965793999999999984
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=343.79 Aligned_cols=246 Identities=26% Similarity=0.401 Sum_probs=201.9
Q ss_pred CCEEEEEEECCCC---EEEEEEECCCEEEEEEECC---CHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEEEECC
Q ss_conf 0568953416434---2899999698999998064---278999999999808998501252038826798699998467
Q 003542 216 KKLMVRRRLGASS---QFKEIQWLGDSFVLRHFYG---ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELM 289 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~~~g~~vAIK~l~~---~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~e~~~~~~LVmEy~ 289 (811)
.+|++.+.||+|+ ||++....+..||||++.. ..+.|.+|+.+|++++|||||++++.+ .+ +.+|+|||||
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~-~~--~~~~lv~Ey~ 93 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SE--EPIYIVTEYM 93 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEE-CS--SSCEEEECCC
T ss_pred HHEEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCCCCHHHHHHHHHHHHHCCCCCEEEEEEEE-EC--CCEEEEEEEC
T ss_conf 99798469930798099999999999999999880448889999999999866667886899998-23--9759999944
Q ss_pred C-CCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCCCCEEEEEECCCCCCCC
Q ss_conf 9-998899998607778899997899999999999999998699420268999489812678873159991034321123
Q 003542 290 S-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTART 368 (811)
Q Consensus 290 ~-gsL~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIvHRDLKPsNILI~~~g~d~~~~vKL~DFGLa~~~~ 368 (811)
+ |+|..++.... ...+++..++.++.||+.||.|||+.+|+||||||+|||++.++ .+||+|||+++...
T Consensus 94 ~~g~l~~~~~~~~----~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~-----~~kl~DfGla~~~~ 164 (285)
T d1fmka3 94 SKGSLLDFLKGET----GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL-----VCKVADFGLARLIE 164 (285)
T ss_dssp TTCBHHHHHSHHH----HTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-----CEEECCCCTTC---
T ss_pred CCCCHHHHHHHCC----CCCCHHHHHHHHHHHHHHHHHHHHHHHEECCCCCCEEEEECCCC-----CEEECCCCHHHHCC
T ss_conf 7994354200003----55305999999999999999987541143353123079998999-----29984425554256
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCCCCHHHHHHHHH
Q ss_conf 56889999999988899987667835754201889888899995353215335799986199999888511378899887
Q 003542 369 YASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIR 448 (811)
Q Consensus 369 ~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIwSlGvILyELLtGk~PF~~~~~~~~~i~~~i~ 448 (811)
... ........||+.|+|||++... .++.++||||||+++|||++|..||.... ...++...+.
T Consensus 165 ~~~------~~~~~~~~gt~~y~aPE~~~~~---------~~~~ksDI~S~Giil~el~t~~~p~~~~~-~~~~~~~~i~ 228 (285)
T d1fmka3 165 DNE------YTARQGAKFPIKWTAPEAALYG---------RFTIKSDVWSFGILLTELTTKGRVPYPGM-VNREVLDQVE 228 (285)
T ss_dssp -----------------CCGGGSCHHHHHHC---------CCCHHHHHHHHHHHHHHHHTTTCCSSTTC-CHHHHHHHHH
T ss_pred CCC------CEEECCCCCCCCCCCHHHHHCC---------CCCCHHHHHCCHHHHHHHHHCCCCCCCCC-CHHHHHHHHH
T ss_conf 887------3352454556654580898379---------98917741323589999986899999888-8999999998
Q ss_pred HCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH
Q ss_conf 18999999999178799874101589999999999999999
Q 003542 449 AGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILR 489 (811)
Q Consensus 449 ~~~~~~~p~~~p~~l~~LI~~cL~~DP~~RPS~~eIl~~L~ 489 (811)
.+.+++.+..+++.+.+||.+||+.||.+||++++|+..|+
T Consensus 229 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~ 269 (285)
T d1fmka3 229 RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 269 (285)
T ss_dssp TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf 26899998323799999999975669758919999999876
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=343.93 Aligned_cols=239 Identities=26% Similarity=0.457 Sum_probs=200.3
Q ss_pred CCEEEEEEECCCC---EEEEEE-ECCCEEEEEEECC-------CHHHHHHHHHHHH-HCCCCCCCEEEEEEECCCCCEEE
Q ss_conf 0568953416434---289999-9698999998064-------2789999999998-08998501252038826798699
Q 003542 216 KKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG-------ELESLNAEISTML-SLSHPNIVQYLCGFCDEEKKEFF 283 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~-~~g~~vAIK~l~~-------~~~~~~~Ei~iL~-~L~HpNIV~l~~~~~~e~~~~~~ 283 (811)
++|.+.+.||+|+ ||++.. .+|+.||+|++.. ..+.+..|+.++. .++|||||++++.+ ++.+.+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~--~~~~~~y 79 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF--QTKENLF 79 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE--ECSSEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEE--CCCCCEE
T ss_conf 97188658940878289999999999899999980555338489999999999999847999687898897--0498316
Q ss_pred EEEECCC-CCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCCCCEEEEEECC
Q ss_conf 9984679-998899998607778899997899999999999999998699420268999489812678873159991034
Q 003542 284 LVMELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFG 362 (811)
Q Consensus 284 LVmEy~~-gsL~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIvHRDLKPsNILI~~~g~d~~~~vKL~DFG 362 (811)
||||||+ |+|..++... ..+++..+..++.||+.||.|||+++|+||||||+|||++..+ ++||+|||
T Consensus 80 ivmEy~~~g~L~~~i~~~------~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~-----~~kl~DFG 148 (320)
T d1xjda_ 80 FVMEYLNGGDLMYHIQSC------HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG-----HIKIADFG 148 (320)
T ss_dssp EEEECCTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-----CEEECCCT
T ss_pred EEEEECCCCCHHHHHHCC------CCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCC-----CEECCCCC
T ss_conf 777503798089986404------7899999999999999999999868934034765404444899-----63015553
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCCCCHHH
Q ss_conf 32112356889999999988899987667835754201889888899995353215335799986199999888511378
Q 003542 363 LSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDK 442 (811)
Q Consensus 363 La~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIwSlGvILyELLtGk~PF~~~~~~~~~ 442 (811)
+++...... .......||+.|+|||++.+. .|+.++|||||||++|+|++|+.||.+.+. ..
T Consensus 149 ~a~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwSlGvilyemltG~~PF~~~~~--~~ 210 (320)
T d1xjda_ 149 MCKENMLGD-------AKTNTFCGTPDYIAPEILLGQ---------KYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--EE 210 (320)
T ss_dssp TCBCCCCTT-------CCBCCCCSCGGGCCHHHHTTC---------CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HH
T ss_pred HHHHCCCCC-------CCCCCCCCCCCCCCHHHHCCC---------CCCCHHHHHHHHHHHHHHHHCCCCCCCCCH--HH
T ss_conf 023235665-------334545787776899998279---------988323201122789898738899999899--99
Q ss_pred HHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHH-HHHH
Q ss_conf 8998871899999999917879987410158999999999-9999
Q 003542 443 MTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFS-SICR 486 (811)
Q Consensus 443 i~~~i~~~~~~~~p~~~p~~l~~LI~~cL~~DP~~RPS~~-eIl~ 486 (811)
+...+..+ .+.+|..+++.+.+||.+||..||.+||++. ++++
T Consensus 211 ~~~~i~~~-~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 211 LFHSIRMD-NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp HHHHHHHC-CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred HHHHHHCC-CCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHH
T ss_conf 99999718-998975679999999999654489878388999980
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=338.50 Aligned_cols=252 Identities=21% Similarity=0.400 Sum_probs=207.2
Q ss_pred CCEEEEEEECCCC---EEEEEEE-CCC--EEEEEEECC-----CHHHHHHHHHHHHHC-CCCCCCEEEEEEECCCCCEEE
Q ss_conf 0568953416434---2899999-698--999998064-----278999999999808-998501252038826798699
Q 003542 216 KKLMVRRRLGASS---QFKEIQW-LGD--SFVLRHFYG-----ELESLNAEISTMLSL-SHPNIVQYLCGFCDEEKKEFF 283 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~~-~g~--~vAIK~l~~-----~~~~~~~Ei~iL~~L-~HpNIV~l~~~~~~e~~~~~~ 283 (811)
++|++.+.||+|+ ||++... +|. .||||.+.. ..+.|.+|+++|.++ +|||||++++.+. +.+.+|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~--~~~~~~ 87 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE--HRGYLY 87 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEE--ETTEEE
T ss_pred HHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEE--CCCEEE
T ss_conf 996887798207882899999989996999999997823385799999999999986228998836788884--187369
Q ss_pred EEEECCC-CCHHHHHHHHHC----------CCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCC
Q ss_conf 9984679-998899998607----------77889999789999999999999999869942026899948981267887
Q 003542 284 LVMELMS-KDLSCYMRETFG----------SRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEG 352 (811)
Q Consensus 284 LVmEy~~-gsL~~~L~~~~~----------~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIvHRDLKPsNILI~~~g~d~ 352 (811)
+|||||+ |+|.+++..... ......+++..+..++.||+.||.|||+.+|+||||||+|||++.++
T Consensus 88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~--- 164 (309)
T d1fvra_ 88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY--- 164 (309)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG---
T ss_pred EEEEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCC---
T ss_conf 99980289869999864035555512310123457899999999999999998766308954555052048986887---
Q ss_pred CCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCEECCHHHHHHHHHCC-C
Q ss_conf 315999103432112356889999999988899987667835754201889888899995353215335799986199-9
Q 003542 353 YFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGK-V 431 (811)
Q Consensus 353 ~~~vKL~DFGLa~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIwSlGvILyELLtGk-~ 431 (811)
.+||+|||+|+...... ......||..|+|||.+.+. .|+.++||||||+++|||++|. +
T Consensus 165 --~~kl~DfG~a~~~~~~~--------~~~~~~gt~~y~aPE~l~~~---------~~~~~sDvwSfGvil~ell~~~~~ 225 (309)
T d1fvra_ 165 --VAKIADFGLSRGQEVYV--------KKTMGRLPVRWMAIESLNYS---------VYTTNSDVWSYGVLLWEIVSLGGT 225 (309)
T ss_dssp --CEEECCTTCEESSCEEC--------CC----CCTTTCCHHHHHHC---------EECHHHHHHHHHHHHHHHHTTSCC
T ss_pred --CEEECCCCCCCCCCCCC--------CCCCEECCCCCCCHHHHCCC---------CCCCCCEEEHHHHHHHHHHHCCCC
T ss_conf --63874344322444223--------45530137755553875269---------999622153138899999836899
Q ss_pred CCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 99888511378899887189999999991787998741015899999999999999999999
Q 003542 432 PFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKK 493 (811)
Q Consensus 432 PF~~~~~~~~~i~~~i~~~~~~~~p~~~p~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~~ 493 (811)
||.+. ....+...+..+.++..|..+++++.+||.+||+.||.+|||+.+|++.|+.+..
T Consensus 226 p~~~~--~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 226 PYCGM--TCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp TTTTC--CHHHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCC--CHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 99999--9999999998268888876678999999999767896689499999999999986
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=346.67 Aligned_cols=249 Identities=22% Similarity=0.374 Sum_probs=196.0
Q ss_pred HHCCEEEEEE-ECCCC---EEEEEE-ECCCEEEEEEECCCHHHHHHHHHHHHHC-CCCCCCEEEEEEEC--CCCCEEEEE
Q ss_conf 7405689534-16434---289999-9698999998064278999999999808-99850125203882--679869999
Q 003542 214 LLKKLMVRRR-LGASS---QFKEIQ-WLGDSFVLRHFYGELESLNAEISTMLSL-SHPNIVQYLCGFCD--EEKKEFFLV 285 (811)
Q Consensus 214 l~k~~~i~~~-lG~G~---vyk~v~-~~g~~vAIK~l~~~~~~~~~Ei~iL~~L-~HpNIV~l~~~~~~--e~~~~~~LV 285 (811)
+..+|.+.++ ||.|+ ||++.. .+|+.||||++.. ...+.+|+.++.++ +|||||++++.|.+ .....+|||
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~iv 87 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV 87 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred CCCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECC-CHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCCEEEEE
T ss_conf 014879810796545486999999889998999999897-4779999999998669999782989995034689789999
Q ss_pred EECCCC-CHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCCCCEEEEEECCCC
Q ss_conf 846799-9889999860777889999789999999999999999869942026899948981267887315999103432
Q 003542 286 MELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLS 364 (811)
Q Consensus 286 mEy~~g-sL~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIvHRDLKPsNILI~~~g~d~~~~vKL~DFGLa 364 (811)
||||+| +|.+++... ....|++..++.|+.||+.||.|||+.+|+||||||+|||++..+. ...+||+|||+|
T Consensus 88 mEy~~gg~L~~~i~~~----~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~--~~~~Kl~DFG~a 161 (335)
T d2ozaa1 88 MECLDGGELFSRIQDR----GDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRP--NAILKLTDFGFA 161 (335)
T ss_dssp EECCCSEEHHHHHHSC----SCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSST--TCCEEECCCTTC
T ss_pred EECCCCCCHHHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCEE
T ss_conf 9778998499999862----7877579999999999999999999769864441002201135555--663113545512
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCCCCHH--H
Q ss_conf 11235688999999998889998766783575420188988889999535321533579998619999988851137--8
Q 003542 365 TARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGD--K 442 (811)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIwSlGvILyELLtGk~PF~~~~~~~~--~ 442 (811)
+...... ......||+.|+|||++.+. .|+.++|||||||++|+|++|++||.+...... .
T Consensus 162 ~~~~~~~--------~~~~~~gt~~y~aPE~~~~~---------~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~ 224 (335)
T d2ozaa1 162 KETTSHN--------SLTTPCYTPYYVAPEVLGPE---------KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG 224 (335)
T ss_dssp EECCCCC--------CCCCCSCCCSSCCCCCCCGG---------GGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----
T ss_pred EECCCCC--------CCCCCCCCCCCCCCHHHCCC---------CCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHHH
T ss_conf 3336888--------64322677563792777489---------888888887645167788658899889887788999
Q ss_pred HHHHHHHCCCCCCC----CCCHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 89988718999999----9991787998741015899999999999999
Q 003542 443 MTKNIRAGERPLFP----SGSPKYLVNLTKKCWHTNPSQRPSFSSICRI 487 (811)
Q Consensus 443 i~~~i~~~~~~~~p----~~~p~~l~~LI~~cL~~DP~~RPS~~eIl~~ 487 (811)
+...+..+ ...+| ..+++++.+||.+||+.||.+|||+.+++.+
T Consensus 225 ~~~~i~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 225 MKTRIRMG-QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp ---CCCSC-SSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHCC-CCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 99998538-8888985434699999999999756996579099999709
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=336.23 Aligned_cols=250 Identities=27% Similarity=0.405 Sum_probs=200.9
Q ss_pred EEEEECCC---CEEEEEEEC----CCEEEEEEECC-----CHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEEEE
Q ss_conf 95341643---428999996----98999998064-----2789999999998089985012520388267986999984
Q 003542 220 VRRRLGAS---SQFKEIQWL----GDSFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVME 287 (811)
Q Consensus 220 i~~~lG~G---~vyk~v~~~----g~~vAIK~l~~-----~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~e~~~~~~LVmE 287 (811)
+.+.||+| .||++.... ...||||.+.. ..+.|.+|+++|++++||||+++++.+. +..+.+++|||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~~~lv~E 109 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL-RSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE-ETTTEEEEEEE
T ss_pred CCEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE-ECCCCEEEEEE
T ss_conf 66698136880999999977998799999999884369789999999999998678999867867898-06994389998
Q ss_pred CCC-CCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCCCCEEEEEECCCCCC
Q ss_conf 679-9988999986077788999978999999999999999986994202689994898126788731599910343211
Q 003542 288 LMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366 (811)
Q Consensus 288 y~~-gsL~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIvHRDLKPsNILI~~~g~d~~~~vKL~DFGLa~~ 366 (811)
||+ |+|.+++.. ....+++..++.++.|++.||.|||+.+|+||||||+|||++.++ .+||+|||+++.
T Consensus 110 ~~~~g~l~~~~~~-----~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~-----~~kL~DFG~~~~ 179 (311)
T d1r0pa_ 110 YMKHGDLRNFIRN-----ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF-----TVKVADFGLARD 179 (311)
T ss_dssp CCTTCBHHHHHHC-----TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC-----CEEECSSGGGCC
T ss_pred EEECCCHHHHHCC-----CCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHEEECCCC-----CEEEECCCCHHH
T ss_conf 7406741442101-----345404899999999988765200336762577668757677999-----889910652322
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 23568899999999888999876678357542018898888999953532153357999861999998885113788998
Q 003542 367 RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKN 446 (811)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIwSlGvILyELLtGk~PF~~~~~~~~~i~~~ 446 (811)
........ ........||+.|+|||++... .++.++||||||+++|||++|..||.... ....+...
T Consensus 180 ~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~---------~~~~ksDI~SfGivl~El~t~~~p~~~~~-~~~~~~~~ 246 (311)
T d1r0pa_ 180 MYDKEFDS---VHNKTGAKLPVKWMALESLQTQ---------KFTTKSDVWSFGVLLWELMTRGAPPYPDV-NTFDITVY 246 (311)
T ss_dssp TTTTTCCC---TTCTTCSSCCGGGSCHHHHHHC---------CCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHH
T ss_pred CCCCCCCC---CEECCCCCCCCCCCCHHHHHCC---------CCCCHHHHHHHHHHHHHHHHCCCCCCCCC-CHHHHHHH
T ss_conf 55665553---1002565556455676887437---------99974574661999999997899998889-99999999
Q ss_pred HHHCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 87189999999991787998741015899999999999999999999
Q 003542 447 IRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKK 493 (811)
Q Consensus 447 i~~~~~~~~p~~~p~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~~ 493 (811)
+..+.++..|..+++.+.+||.+||+.||.+||++.+|++.|+.+..
T Consensus 247 i~~g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 247 LLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 98089889964475999999999768897689399999999999997
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=340.50 Aligned_cols=247 Identities=26% Similarity=0.446 Sum_probs=201.1
Q ss_pred CCEEEEEEECCCC---EEEEEEE--CC--CEEEEEEECC-------CHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCE
Q ss_conf 0568953416434---2899999--69--8999998064-------2789999999998089985012520388267986
Q 003542 216 KKLMVRRRLGASS---QFKEIQW--LG--DSFVLRHFYG-------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKE 281 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~~--~g--~~vAIK~l~~-------~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~e~~~~ 281 (811)
++|++.+.||.|+ ||++... .+ ..||+|++.. ..+.|.+|+.+|++++||||+++++.+ .+ +.
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~--~~-~~ 84 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVV--LT-PP 84 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEE--CS-SS
T ss_pred HHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEE--EE-CC
T ss_conf 8919978980388839999999889990799999999835557989999999999999868999987898777--40-10
Q ss_pred EEEEEECCC-CCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCCCCEEEEEE
Q ss_conf 999984679-9988999986077788999978999999999999999986994202689994898126788731599910
Q 003542 282 FFLVMELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSG 360 (811)
Q Consensus 282 ~~LVmEy~~-gsL~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIvHRDLKPsNILI~~~g~d~~~~vKL~D 360 (811)
+++|||||+ |++.+++... ...+++..++.++.||+.||.|||+++|+||||||+|||++.++ .+||+|
T Consensus 85 ~~lv~e~~~~~~l~~~~~~~-----~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~-----~vkl~D 154 (273)
T d1u46a_ 85 MKMVTELAPLGSLLDRLRKH-----QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD-----LVKIGD 154 (273)
T ss_dssp CEEEEECCTTCBHHHHHHHH-----GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT-----EEEECC
T ss_pred HHEEEEEECCCCHHHHHHCC-----CCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEEECHHHHCCCCCC-----CEEECC
T ss_conf 01146542386125444212-----68999999999999999999875217875205668881565565-----433256
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCEECCHHHHHHHHH-CCCCCCCCCCC
Q ss_conf 34321123568899999999888999876678357542018898888999953532153357999861-99999888511
Q 003542 361 FGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLT-GKVPFEDGHLQ 439 (811)
Q Consensus 361 FGLa~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIwSlGvILyELLt-Gk~PF~~~~~~ 439 (811)
||+++........ ........||..|+|||++.+. .++.++||||||+++|||++ |++||.+.+..
T Consensus 155 fGl~~~~~~~~~~----~~~~~~~~~~~~~~aPE~~~~~---------~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~ 221 (273)
T d1u46a_ 155 FGLMRALPQNDDH----YVMQEHRKVPFAWCAPESLKTR---------TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS 221 (273)
T ss_dssp CTTCEECCC-CCE----EEC-----CCGGGCCHHHHHHC---------EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred CHHHHHCCCCCCC----CEECCCCCCCCCCCCHHHHHCC---------CCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHH
T ss_conf 1155530358875----2654763257310799998379---------99942156614899999996899999996999
Q ss_pred HHHHHHHH-HHCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHH
Q ss_conf 37889988-7189999999991787998741015899999999999999999
Q 003542 440 GDKMTKNI-RAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRY 490 (811)
Q Consensus 440 ~~~i~~~i-~~~~~~~~p~~~p~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~ 490 (811)
.+...+ ..+.+++.+..+|..+.+||.+||+.||.+|||+.+|.+.|..
T Consensus 222 --~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 222 --QILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp --HHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --HHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHH
T ss_conf --99999984799999854453999999999768896679299999999996
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=345.62 Aligned_cols=244 Identities=21% Similarity=0.319 Sum_probs=199.1
Q ss_pred HHCCEEEEEEECCCC---EEEEEE-ECCCEEEEEEECC---CHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEEE
Q ss_conf 740568953416434---289999-9698999998064---278999999999808998501252038826798699998
Q 003542 214 LLKKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG---ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVM 286 (811)
Q Consensus 214 l~k~~~i~~~lG~G~---vyk~v~-~~g~~vAIK~l~~---~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~e~~~~~~LVm 286 (811)
+..+|.+.+.||+|+ ||++.. .+|+.||+|.+.. +...+.+|+++|+.++|||||++++.| ++.+.+||||
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~--~~~~~~~lvm 80 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESF--ESMEELVMIF 80 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEE--EETTEEEEEE
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEE--EECCEEEEEE
T ss_conf 70105887898317783999999989996999999757866599999999999857997989098999--8899889999
Q ss_pred ECCCC-CHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCCCCEEEEEECCCCC
Q ss_conf 46799-98899998607778899997899999999999999998699420268999489812678873159991034321
Q 003542 287 ELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365 (811)
Q Consensus 287 Ey~~g-sL~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIvHRDLKPsNILI~~~g~d~~~~vKL~DFGLa~ 365 (811)
|||+| +|.+++... ...+++..++.|+.||+.||.|||+++|+||||||+|||++.++ ...+||+|||++.
T Consensus 81 E~~~gg~L~~~i~~~-----~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~---~~~ikl~DFG~~~ 152 (321)
T d1tkia_ 81 EFISGLDIFERINTS-----AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRR---SSTIKIIEFGQAR 152 (321)
T ss_dssp CCCCCCBHHHHHTSS-----SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSS---CCCEEECCCTTCE
T ss_pred ECCCCCCHHHHHHHC-----CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCC---CEEEEECCCCHHH
T ss_conf 538998088998753-----89999999999999999999999876997513554443443788---5189976441110
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 12356889999999988899987667835754201889888899995353215335799986199999888511378899
Q 003542 366 ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTK 445 (811)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIwSlGvILyELLtGk~PF~~~~~~~~~i~~ 445 (811)
...... ......||+.|+|||++.+. .|+.++||||+||++|+|++|+.||.+... ..+..
T Consensus 153 ~~~~~~--------~~~~~~~t~~y~ape~~~~~---------~~~~~~DiWSlGvily~ll~G~~Pf~~~~~--~~~~~ 213 (321)
T d1tkia_ 153 QLKPGD--------NFRLLFTAPEYYAPEVHQHD---------VVSTATDMWSLGTLVYVLLSGINPFLAETN--QQIIE 213 (321)
T ss_dssp ECCTTC--------EEEEEESCGGGSCHHHHTTC---------EECHHHHHHHHHHHHHHHHHSSCTTCCSSH--HHHHH
T ss_pred CCCCCC--------CCCCCCCCCCCCCCHHCCCC---------CCCCHHHCCCHHHHHHHHHHCCCCCCCCCH--HHHHH
T ss_conf 034677--------53212233222340210487---------778401130279999999828999999899--99999
Q ss_pred HHHHCCCCCCC----CCCHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 88718999999----9991787998741015899999999999999
Q 003542 446 NIRAGERPLFP----SGSPKYLVNLTKKCWHTNPSQRPSFSSICRI 487 (811)
Q Consensus 446 ~i~~~~~~~~p----~~~p~~l~~LI~~cL~~DP~~RPS~~eIl~~ 487 (811)
.+..+... ++ ..++.++.+||.+||..||.+|||+.+++++
T Consensus 214 ~i~~~~~~-~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 214 NIMNAEYT-FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHHHTCCC-CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHCCCC-CCHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 99838999-8802236789999999999866996689099999639
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=335.69 Aligned_cols=256 Identities=26% Similarity=0.467 Sum_probs=210.6
Q ss_pred HCCEEEEEEECCCC---EEEEEEE-C-------CCEEEEEEECC-----CHHHHHHHHHHHHHC-CCCCCCEEEEEEECC
Q ss_conf 40568953416434---2899999-6-------98999998064-----278999999999808-998501252038826
Q 003542 215 LKKLMVRRRLGASS---QFKEIQW-L-------GDSFVLRHFYG-----ELESLNAEISTMLSL-SHPNIVQYLCGFCDE 277 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~~-~-------g~~vAIK~l~~-----~~~~~~~Ei~iL~~L-~HpNIV~l~~~~~~e 277 (811)
..+|++++.||+|+ ||++... + +..||+|++.. ....+.+|...+.++ +|||||++++.+ .
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~--~ 89 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC--T 89 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE--C
T ss_pred HHHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCEEEECCCCC--C
T ss_conf 89969700985167828999998578755566754999999881128688999999999999813999697346522--0
Q ss_pred CCCEEEEEEECCC-CCHHHHHHHHHCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEE
Q ss_conf 7986999984679-9988999986077----------7889999789999999999999999869942026899948981
Q 003542 278 EKKEFFLVMELMS-KDLSCYMRETFGS----------RRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLK 346 (811)
Q Consensus 278 ~~~~~~LVmEy~~-gsL~~~L~~~~~~----------~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIvHRDLKPsNILI~ 346 (811)
+.+.+|+|||||+ |+|.+++...... .....+++..++.++.||+.||.|||+.+|+||||||+|||++
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 169 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred CCCEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEEECCCCEEEC
T ss_conf 18868999973699909999986067764322233457434679999999999999999876637978630221022454
Q ss_pred CCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCEECCHHHHHHH
Q ss_conf 26788731599910343211235688999999998889998766783575420188988889999535321533579998
Q 003542 347 ARSMEGYFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFEL 426 (811)
Q Consensus 347 ~~g~d~~~~vKL~DFGLa~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIwSlGvILyEL 426 (811)
.++ .+||+|||+++........ .......||+.|+|||++.+. .|+.++||||||+++|||
T Consensus 170 ~~~-----~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~l~~~---------~y~~k~DiwS~Gvvl~el 230 (299)
T d1fgka_ 170 EDN-----VMKIADFGLARDIHHIDYY-----KKTTNGRLPVKWMAPEALFDR---------IYTHQSDVWSFGVLLWEI 230 (299)
T ss_dssp TTC-----CEEECSTTCCCCGGGCCTT-----CCCTTSCCGGGGSCHHHHHHC---------CCCHHHHHHHHHHHHHHH
T ss_pred CCC-----CEEECCCHHHCCCCCCCCC-----CCCCCCCCCHHHHHHHHHCCC---------CCCCHHHHHHHHHHHHHH
T ss_conf 789-----7676221110113555554-----314667888466326675179---------888255547758888874
Q ss_pred HH-CCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 61-99999888511378899887189999999991787998741015899999999999999999999
Q 003542 427 LT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKK 493 (811)
Q Consensus 427 Lt-Gk~PF~~~~~~~~~i~~~i~~~~~~~~p~~~p~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~~ 493 (811)
++ |.+||.+... ..+...+..+.++.+|..+++.+.+||.+||+.||.+|||+.+|++.|+.+..
T Consensus 231 l~~g~~p~~~~~~--~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 231 FTLGGSPYPGVPV--EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp HTTSCCSSTTCCH--HHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCCCH--HHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 0179898999999--99999997288889874352999999999766797679399999999988860
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=0 Score=341.00 Aligned_cols=252 Identities=20% Similarity=0.291 Sum_probs=202.5
Q ss_pred HCCEEEEEEECCCC---EEEEEE-ECCCEEEEEEECC-------CHHHHHHHHHHHHHCCCCCCCEEEEEEECCCC--CE
Q ss_conf 40568953416434---289999-9698999998064-------27899999999980899850125203882679--86
Q 003542 215 LKKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG-------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEK--KE 281 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~-~~g~~vAIK~l~~-------~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~e~~--~~ 281 (811)
.++|++.+.||+|+ ||++.. .+|+.||+|++.. ....+.+|+.+|+.++||||+++++.+..++. ..
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCCE
T ss_conf 62069868996089929999999999989999998556646989999999999999856999887311435432688766
Q ss_pred EEEEEECCCC-CHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCCCCEEEEEE
Q ss_conf 9999846799-988999986077788999978999999999999999986994202689994898126788731599910
Q 003542 282 FFLVMELMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSG 360 (811)
Q Consensus 282 ~~LVmEy~~g-sL~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIvHRDLKPsNILI~~~g~d~~~~vKL~D 360 (811)
+|||||||+| +|..++... ..+++..++.++.||+.||.|||+++|+||||||+|||++.++ ..+++|
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~------~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~-----~~~l~d 154 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE------GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATN-----AVKVMD 154 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTS-----CEEECC
T ss_pred EEEEEECCCCCEEHHHHCCC------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCC-----CCEEEH
T ss_conf 99999778898710112035------8999999999999999999999857952763467556657543-----201003
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCCCCH
Q ss_conf 34321123568899999999888999876678357542018898888999953532153357999861999998885113
Q 003542 361 FGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQG 440 (811)
Q Consensus 361 FGLa~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIwSlGvILyELLtGk~PF~~~~~~~ 440 (811)
||.+......... .......+||+.|+|||++.+. .|+.++|||||||++|+|++|++||.+....
T Consensus 155 ~~~~~~~~~~~~~----~~~~~~~~Gt~~Y~aPE~~~~~---------~~~~~~DiwSlGvilyelltG~~Pf~~~~~~- 220 (277)
T d1o6ya_ 155 FGIARAIADSGNS----VTQTAAVIGTAQYLSPEQARGD---------SVDARSDVYSLGCVLYEVLTGEPPFTGDSPV- 220 (277)
T ss_dssp CTTCEECC--------------------TTCCHHHHTTC---------CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-
T ss_pred HHHHHHHCCCCCC----CCCCCCCCCCCCCCCHHHHCCC---------CCCCCEECCCCHHHHHHHHHCCCCCCCCCHH-
T ss_conf 4443221235443----3334642576243699998399---------9996632026528999997697998996999-
Q ss_pred HHHHHHHHHCCCC--CCCCCCHHHHHHHHHHHCCCCCCCCC-CHHHHHHHHHHH
Q ss_conf 7889988718999--99999917879987410158999999-999999999999
Q 003542 441 DKMTKNIRAGERP--LFPSGSPKYLVNLTKKCWHTNPSQRP-SFSSICRILRYI 491 (811)
Q Consensus 441 ~~i~~~i~~~~~~--~~p~~~p~~l~~LI~~cL~~DP~~RP-S~~eIl~~L~~i 491 (811)
..+...+.....+ ......|+.+.+||.+||+.||.+|| +++++++.|..+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 221 SVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp HHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred HHHHHHHHCCCCCCCHHCCCCCHHHHHHHHHHCCCCHHHCHHHHHHHHHHHHHH
T ss_conf 999999846999971003478999999999986679767773999999999997
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=337.27 Aligned_cols=256 Identities=26% Similarity=0.437 Sum_probs=207.7
Q ss_pred HCCEEEEEEECCCC---EEEEEEE------CCCEEEEEEECC-----CHHHHHHHHHHHHHC-CCCCCCEEEEEEECCCC
Q ss_conf 40568953416434---2899999------698999998064-----278999999999808-99850125203882679
Q 003542 215 LKKLMVRRRLGASS---QFKEIQW------LGDSFVLRHFYG-----ELESLNAEISTMLSL-SHPNIVQYLCGFCDEEK 279 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~~------~g~~vAIK~l~~-----~~~~~~~Ei~iL~~L-~HpNIV~l~~~~~~e~~ 279 (811)
..+|++.+.||.|+ ||++... .+..||||++.. +...+.+|+.+++.+ +|||||++++.+ ++.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~--~~~ 99 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC--TIG 99 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE--CSS
T ss_pred HHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEE--EEC
T ss_conf 899698549820688299999980664477886999999874248779999999999987626999887899898--319
Q ss_pred CEEEEEEECCC-CCHHHHHHHHHCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEE
Q ss_conf 86999984679-9988999986077------------7889999789999999999999999869942026899948981
Q 003542 280 KEFFLVMELMS-KDLSCYMRETFGS------------RRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLK 346 (811)
Q Consensus 280 ~~~~LVmEy~~-gsL~~~L~~~~~~------------~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIvHRDLKPsNILI~ 346 (811)
..+|+|||||+ |+|.+++...... .....+++..+..++.||+.||.|||+++++||||||+|||++
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT 179 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE
T ss_pred CEEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCCCCC
T ss_conf 97899997379987999998535665444445332223345889999999999999999988757926662410210000
Q ss_pred CCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCEECCHHHHHHH
Q ss_conf 26788731599910343211235688999999998889998766783575420188988889999535321533579998
Q 003542 347 ARSMEGYFHVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFEL 426 (811)
Q Consensus 347 ~~g~d~~~~vKL~DFGLa~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIwSlGvILyEL 426 (811)
..+ .+|++|||+++....... ........||+.|+|||++.+. .++.++||||||+++|||
T Consensus 180 ~~~-----~~ki~DfG~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~---------~~~~~~DIwS~G~~l~el 240 (311)
T d1t46a_ 180 HGR-----ITKICDFGLARDIKNDSN-----YVVKGNARLPVKWMAPESIFNC---------VYTFESDVWSYGIFLWEL 240 (311)
T ss_dssp TTT-----EEEECCCGGGSCTTSCTT-----SEECSSSEECGGGCCHHHHHHC---------CCCHHHHHHHHHHHHHHH
T ss_pred CCC-----CCCCCCCCHHEECCCCCC-----CEEEEECCCCHHHCCHHHHCCC---------CCCCCCCCCCHHHHHHHH
T ss_conf 257-----521023401023367886-----1586201359687677886179---------999740010258999999
Q ss_pred HH-CCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 61-9999988851137889988718999999999178799874101589999999999999999999
Q 003542 427 LT-GKVPFEDGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIK 492 (811)
Q Consensus 427 Lt-Gk~PF~~~~~~~~~i~~~i~~~~~~~~p~~~p~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~ 492 (811)
++ |.+||.+.. ....+...+..+.++..|..++..+.+||.+||+.||.+|||+.+|++.|+.+.
T Consensus 241 lt~g~p~~~~~~-~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i 306 (311)
T d1t46a_ 241 FSLGSSPYPGMP-VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (311)
T ss_dssp HTTTCCSSTTCC-SSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHCCCCCCCCCC-HHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf 858998877899-899999998668988985436599999999975779657929999999998765
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=0 Score=342.47 Aligned_cols=246 Identities=22% Similarity=0.291 Sum_probs=202.5
Q ss_pred HCCEEEEEEECCCC---EEEEEE-ECCCEEEEEEECCC-------------HHHHHHHHHHHHHCC-CCCCCEEEEEEEC
Q ss_conf 40568953416434---289999-96989999980642-------------789999999998089-9850125203882
Q 003542 215 LKKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYGE-------------LESLNAEISTMLSLS-HPNIVQYLCGFCD 276 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~-~~g~~vAIK~l~~~-------------~~~~~~Ei~iL~~L~-HpNIV~l~~~~~~ 276 (811)
.++|++.+.||+|+ ||++.. .+|+.||+|++... .+.+.+|+.+|++++ ||||+++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~-- 79 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY-- 79 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE--
T ss_pred CCCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEC--
T ss_conf 663888528841768499999999999899999996244641147888999999999999999850799747997621--
Q ss_pred CCCCEEEEEEECCC-CCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCCCCE
Q ss_conf 67986999984679-99889999860777889999789999999999999999869942026899948981267887315
Q 003542 277 EEKKEFFLVMELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFH 355 (811)
Q Consensus 277 e~~~~~~LVmEy~~-gsL~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIvHRDLKPsNILI~~~g~d~~~~ 355 (811)
++.+.+|||||||+ |+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||++.++ .
T Consensus 80 ~~~~~~~ivmE~~~~g~L~~~l~~~------~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~-----~ 148 (277)
T d1phka_ 80 ETNTFFFLVFDLMKKGELFDYLTEK------VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDM-----N 148 (277)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-----C
T ss_pred CCCCCEEEEEECCCCCHHHHHHHHC------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCC-----C
T ss_conf 4676059999768986689999865------9999999999999999999999875994323462548986899-----8
Q ss_pred EEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCC
Q ss_conf 99910343211235688999999998889998766783575420188988889999535321533579998619999988
Q 003542 356 VKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFED 435 (811)
Q Consensus 356 vKL~DFGLa~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIwSlGvILyELLtGk~PF~~ 435 (811)
+||+|||+++...... ......||+.|+|||++.+..... ...++.++||||+||++|+|++|+.||.+
T Consensus 149 ~kl~DFG~a~~~~~~~--------~~~~~~gt~~y~~PE~~~~~~~~~---~~~~~~~~DiwslGvilyeml~g~~Pf~~ 217 (277)
T d1phka_ 149 IKLTDFGFSCQLDPGE--------KLREVCGTPSYLAPEIIECSMNDN---HPGYGKEVDMWSTGVIMYTLLAGSPPFWH 217 (277)
T ss_dssp EEECCCTTCEECCTTC--------CBCCCCSCGGGCCHHHHHHHHCTT---SCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred EEECCCHHEEECCCCC--------CEEEEECCCCCCCHHHHHCCCCCC---CCCCCCHHEECCCCHHHHHHCCCCCCCCC
T ss_conf 3871240316726887--------213452467888988860534456---78899233185656023103228889889
Q ss_pred CCCCHHHHHHHHHHCCC-CC--CCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHH
Q ss_conf 85113788998871899-99--99999178799874101589999999999999
Q 003542 436 GHLQGDKMTKNIRAGER-PL--FPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 436 ~~~~~~~i~~~i~~~~~-~~--~p~~~p~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
... ......+..+.. +. .+..+++++.+|+.+||+.||.+||+++++++
T Consensus 218 ~~~--~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 218 RKQ--MLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp SSH--HHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CCH--HHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 999--9999999818988898543468999999999976589668919999973
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=338.62 Aligned_cols=240 Identities=22% Similarity=0.288 Sum_probs=186.7
Q ss_pred EEEEEEECCCCEEEEE-EECCCEEEEEEECCC---------HHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEEEE
Q ss_conf 6895341643428999-996989999980642---------789999999998089985012520388267986999984
Q 003542 218 LMVRRRLGASSQFKEI-QWLGDSFVLRHFYGE---------LESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVME 287 (811)
Q Consensus 218 ~~i~~~lG~G~vyk~v-~~~g~~vAIK~l~~~---------~~~~~~Ei~iL~~L~HpNIV~l~~~~~~e~~~~~~LVmE 287 (811)
+++++.++.|.||++. ..+|+.||||++... ...+.+|+.+|+.++|||||++++.+ .+.+.+|||||
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~--~~~~~~~ivmE 80 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF--GHKSNISLVFD 80 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE--CCTTCCEEEEE
T ss_pred CEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEE--CCCCCEEEHHH
T ss_conf 6385127282999999999996999999842021245679999999999999867999986898542--25874022045
Q ss_pred CCCCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCCCCEEEEEECCCCCCC
Q ss_conf 67999889999860777889999789999999999999999869942026899948981267887315999103432112
Q 003542 288 LMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTAR 367 (811)
Q Consensus 288 y~~gsL~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIvHRDLKPsNILI~~~g~d~~~~vKL~DFGLa~~~ 367 (811)
||.|++...+.. ....+++..+..++.||+.||.|||+++|+||||||+|||++.++ .+||+|||+|+..
T Consensus 81 ~~~~~~~~~~~~-----~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~-----~~KL~DFG~a~~~ 150 (299)
T d1ua2a_ 81 FMETDLEVIIKD-----NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENG-----VLKLADFGLAKSF 150 (299)
T ss_dssp CCSEEHHHHHTT-----CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-----CEEECCCGGGSTT
T ss_pred HHCCHHHHHHHH-----CCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCC-----CCCCCCCCCCCCC
T ss_conf 534507765541-----266778999999999999999886316355035776258853778-----4114657610005
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCCCCHHHHHHHH
Q ss_conf 35688999999998889998766783575420188988889999535321533579998619999988851137889988
Q 003542 368 TYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNI 447 (811)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIwSlGvILyELLtGk~PF~~~~~~~~~i~~~i 447 (811)
.... ......+||+.|+|||++.+. ..|+.++|||||||++|||++|.+||.+.+... . ...+
T Consensus 151 ~~~~-------~~~~~~~gt~~y~aPE~~~~~--------~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~-~-l~~i 213 (299)
T d1ua2a_ 151 GSPN-------RAYTHQVVTRWYRAPELLFGA--------RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD-Q-LTRI 213 (299)
T ss_dssp TSCC-------CCCCCSCCCCTTCCHHHHTTC--------SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-H-HHHH
T ss_pred CCCC-------CCCCCEECCHHHCCHHHHCCC--------CCCCHHHHHHHCCHHHHHHHHCCCCCCCCCHHH-H-HHHH
T ss_conf 7875-------543302047333639997267--------788805643630428999985969999999999-9-9999
Q ss_pred HH--CCC--C---------------CC--------CCCCHHHHHHHHHHHCCCCCCCCCCHHHHHH
Q ss_conf 71--899--9---------------99--------9999178799874101589999999999999
Q 003542 448 RA--GER--P---------------LF--------PSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 448 ~~--~~~--~---------------~~--------p~~~p~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
.. +.. . .+ ....++.+.+||.+||+.||.+|||+.++++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 214 FETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp HHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred HHHCCCCCHHHCCCHHCCCHHHHHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 985189972545210002134430347898867856568999999999976389456908999967
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=334.00 Aligned_cols=244 Identities=23% Similarity=0.422 Sum_probs=195.5
Q ss_pred CCEEEEEEECCCC---EEEEEE-ECCCEEEEEEECC------CHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEE
Q ss_conf 0568953416434---289999-9698999998064------27899999999980899850125203882679869999
Q 003542 216 KKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLV 285 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~-~~g~~vAIK~l~~------~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~e~~~~~~LV 285 (811)
++|++.+.||+|+ ||++.. .+|+.||+|++.. ....+.+|+++|++++|||||++++.+ ++...+|+|
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~--~~~~~~~iv 79 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI--HTENKLYLV 79 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEE--EETTEEEEE
T ss_pred CCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCC--CCCCCEEEE
T ss_conf 997765177237680999999999997999999802225758999999999999867998388744533--224320378
Q ss_pred EECCCCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCCCCEEEEEECCCCC
Q ss_conf 84679998899998607778899997899999999999999998699420268999489812678873159991034321
Q 003542 286 MELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365 (811)
Q Consensus 286 mEy~~gsL~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIvHRDLKPsNILI~~~g~d~~~~vKL~DFGLa~ 365 (811)
||||.+++..++... ....+++..+..++.||+.||.|||+++|+||||||+|||++.++ .+||+|||+|+
T Consensus 80 ~e~~~~~~~~~~~~~----~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~-----~~kl~DFG~a~ 150 (298)
T d1gz8a_ 80 FEFLHQDLKKFMDAS----ALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEG-----AIKLADFGLAR 150 (298)
T ss_dssp EECCSEEHHHHHHHT----TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-----CEEECSTTHHH
T ss_pred EEECCCCHHHHHHHH----CCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCHHEEECCCC-----CCEECCCCCCE
T ss_conf 862377445554420----256888899999999999999986528899213571140113467-----62103578613
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 12356889999999988899987667835754201889888899995353215335799986199999888511378899
Q 003542 366 ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTK 445 (811)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIwSlGvILyELLtGk~PF~~~~~~~~~i~~ 445 (811)
...... .......||+.|+|||++... ..++.++||||+||++|+|++|+.||.+.+.. ..+..
T Consensus 151 ~~~~~~-------~~~~~~~gt~~y~apE~~~~~--------~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~-~~~~~ 214 (298)
T d1gz8a_ 151 AFGVPV-------RTYTHEVVTLWYRAPEILLGC--------KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI-DQLFR 214 (298)
T ss_dssp HHCCCS-------BCTTCCBCCCTTCCHHHHTTC--------SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHH
T ss_pred ECCCCC-------CCCEEECCCCEEEEHHHHCCC--------CCCCCCCCCCCCCHHHHHHHHCCCCCCCCCHH-HHHHH
T ss_conf 436886-------410010365215411221366--------57774221033331342796687998988999-99999
Q ss_pred HHHH-CC---------------CCCCC-----------CCCHHHHHHHHHHHCCCCCCCCCCHHHHHH
Q ss_conf 8871-89---------------99999-----------999178799874101589999999999999
Q 003542 446 NIRA-GE---------------RPLFP-----------SGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 446 ~i~~-~~---------------~~~~p-----------~~~p~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
.... +. ...++ ...+..+.+|+.+||..||.+|||+.++++
T Consensus 215 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 215 IFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp HHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHCCCCCHHHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 99832898333144422242124345432222044416678999999999976399557918999967
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=336.68 Aligned_cols=251 Identities=20% Similarity=0.303 Sum_probs=193.9
Q ss_pred CEEEEEEECCCC---EEEEEE-ECCCEEEEEEECCCHHHHHHHHHHHHHCCCCCCCEEEEEEEC----CCCCEEEEEEEC
Q ss_conf 568953416434---289999-969899999806427899999999980899850125203882----679869999846
Q 003542 217 KLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYGELESLNAEISTMLSLSHPNIVQYLCGFCD----EEKKEFFLVMEL 288 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v~-~~g~~vAIK~l~~~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~----e~~~~~~LVmEy 288 (811)
+|...+.||.|+ ||++.. .+|+.||||++..+...+.+|+.+|++++||||+++++.|.. .+..++||||||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey 100 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY 100 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEEC
T ss_pred CCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEEEEEEEC
T ss_conf 76751698217683999999999997999999881606899999999866898987387899744765773189999841
Q ss_pred CCCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCCCCEEEEEECCCCCCCC
Q ss_conf 79998899998607778899997899999999999999998699420268999489812678873159991034321123
Q 003542 289 MSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTART 368 (811)
Q Consensus 289 ~~gsL~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIvHRDLKPsNILI~~~g~d~~~~vKL~DFGLa~~~~ 368 (811)
|++++...+..... ....+++..++.++.||+.||.|||++||+||||||+|||++.++. .+||+|||++....
T Consensus 101 ~~~~~~~~l~~~~~--~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~----~~kl~DFG~a~~~~ 174 (350)
T d1q5ka_ 101 VPETVYRVARHYSR--AKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA----VLKLCDFGSAKQLV 174 (350)
T ss_dssp CSEEHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTC----CEEECCCTTCEECC
T ss_pred CCCCCHHHHHHHHH--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEECCCC----CEEEECCCCHHHCC
T ss_conf 68860788886310--3689999999999999999999998668764578860378735897----11673366054404
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCCCCHHHHHHHHH
Q ss_conf 56889999999988899987667835754201889888899995353215335799986199999888511378899887
Q 003542 369 YASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKNIR 448 (811)
Q Consensus 369 ~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIwSlGvILyELLtGk~PF~~~~~~~~~i~~~i~ 448 (811)
... ......||..|+|||++.+. ..|+.++||||+||++|||++|++||.+..... .+...+.
T Consensus 175 ~~~--------~~~~~~gt~~y~aPE~~~~~--------~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~-~l~~i~~ 237 (350)
T d1q5ka_ 175 RGE--------PNVSYICSRYYRAPELIFGA--------TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD-QLVEIIK 237 (350)
T ss_dssp TTS--------CCCSCCSCTTSCCHHHHTTC--------SSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH-HHHHHHH
T ss_pred CCC--------CCCCCCCCCCCCCHHHHHCC--------CCCCCCEEECCCCEEEEEHHHCCCCCCCCCHHH-HHHHHHH
T ss_conf 776--------53200255555682776404--------688821000246527785502879989879999-9999999
Q ss_pred H-CC--------------CC------------CCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 1-89--------------99------------99999917879987410158999999999999999999
Q 003542 449 A-GE--------------RP------------LFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYI 491 (811)
Q Consensus 449 ~-~~--------------~~------------~~p~~~p~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i 491 (811)
. +. .. ......++.+.+||.+||..||.+|||+.++++ +.++
T Consensus 238 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~-Hp~f 306 (350)
T d1q5ka_ 238 VLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA-HSFF 306 (350)
T ss_dssp HHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT-SGGG
T ss_pred HHCCCHHHHHHHHCCCHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC-CHHH
T ss_conf 74898177654306210110355445674444315689999999999976589557929999966-9845
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=332.93 Aligned_cols=253 Identities=25% Similarity=0.405 Sum_probs=205.2
Q ss_pred HCCEEEEEEECCCC---EEEEEEE------CCCEEEEEEECC-----CHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCC
Q ss_conf 40568953416434---2899999------698999998064-----278999999999808998501252038826798
Q 003542 215 LKKLMVRRRLGASS---QFKEIQW------LGDSFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKK 280 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~~------~g~~vAIK~l~~-----~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~e~~~ 280 (811)
.++|++.++||+|+ ||++... .+..||||+++. +...|.+|+.++++++||||+++++.+. ...
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~--~~~ 96 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS--QGQ 96 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC--SSS
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE--CCC
T ss_conf 899188359820788189999987864477896899999870128689999999999999769998841254784--288
Q ss_pred EEEEEEECCC-CCHHHHHHHHHC----CCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCCCCE
Q ss_conf 6999984679-998899998607----77889999789999999999999999869942026899948981267887315
Q 003542 281 EFFLVMELMS-KDLSCYMRETFG----SRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFH 355 (811)
Q Consensus 281 ~~~LVmEy~~-gsL~~~L~~~~~----~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIvHRDLKPsNILI~~~g~d~~~~ 355 (811)
.+++|||||+ |+|.+++..... ......+++..+..++.|++.||.|||+++|+||||||+|||++.++ +
T Consensus 97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~-----~ 171 (308)
T d1p4oa_ 97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF-----T 171 (308)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC-----C
T ss_pred CEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECEECCCCEEECCCC-----E
T ss_conf 10677760489988999875033211344468879999999999999999987647965432867754035996-----4
Q ss_pred EEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCEECCHHHHHHHHHC-CCCCC
Q ss_conf 99910343211235688999999998889998766783575420188988889999535321533579998619-99998
Q 003542 356 VKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTG-KVPFE 434 (811)
Q Consensus 356 vKL~DFGLa~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIwSlGvILyELLtG-k~PF~ 434 (811)
+||+|||+|+....... ........||+.|+|||.+.+. .++.++||||||+++|||++| .+||.
T Consensus 172 ~Kl~DFGla~~~~~~~~-----~~~~~~~~~t~~y~aPe~l~~~---------~~~~~~Dv~S~G~il~El~t~~~~p~~ 237 (308)
T d1p4oa_ 172 VKIGDFGMTRDIYETDY-----YRKGGKGLLPVRWMSPESLKDG---------VFTTYSDVWSFGVVLWEIATLAEQPYQ 237 (308)
T ss_dssp EEECCTTCCCGGGGGGC-----EEGGGSSEECGGGCCHHHHHHC---------CCCHHHHHHHHHHHHHHHHHTSCCTTT
T ss_pred EEEEECCCCEECCCCCC-----EEECCCEECCCCCCCHHHHCCC---------CCCCCCCCCCHHHHHHHHHHCCCCCCC
T ss_conf 99942454202357763-----0313402316323788887369---------988333444378999999968999999
Q ss_pred CCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHH
Q ss_conf 88511378899887189999999991787998741015899999999999999999
Q 003542 435 DGHLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRY 490 (811)
Q Consensus 435 ~~~~~~~~i~~~i~~~~~~~~p~~~p~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~ 490 (811)
+.. ..++...+..+.++..|..++..+.+||.+||+.||.+|||+.+|++.|+.
T Consensus 238 ~~~--~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~ 291 (308)
T d1p4oa_ 238 GLS--NEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 291 (308)
T ss_dssp TSC--HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGG
T ss_pred CCC--HHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHH
T ss_conf 989--999999998088888863353999999999757796589399999999787
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=331.75 Aligned_cols=241 Identities=20% Similarity=0.360 Sum_probs=192.5
Q ss_pred HCCEEEEEEECCCC---EEEEEE-ECCCEEEEEEECC------CHHHHHHHHHHHHHCCCCCCCEEEEEEECCC----CC
Q ss_conf 40568953416434---289999-9698999998064------2789999999998089985012520388267----98
Q 003542 215 LKKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG------ELESLNAEISTMLSLSHPNIVQYLCGFCDEE----KK 280 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~-~~g~~vAIK~l~~------~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~e~----~~ 280 (811)
..+|++.+.||+|+ ||++.. .+|+.||||++.. ..+.+.+|+++|+.++|||||++++.|...+ ..
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCCC
T ss_conf 77189988980177819999999999989999998522259699999999999998668987547999863576555541
Q ss_pred EEEEEEECCCCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCCCCEEEEEE
Q ss_conf 69999846799988999986077788999978999999999999999986994202689994898126788731599910
Q 003542 281 EFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSG 360 (811)
Q Consensus 281 ~~~LVmEy~~gsL~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIvHRDLKPsNILI~~~g~d~~~~vKL~D 360 (811)
.+|+|||||+.+|..++.. ..|++..++.++.||+.||.|||+++|+||||||+|||++.++ .+|++|
T Consensus 97 ~~~lv~e~~~~~l~~~~~~-------~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~-----~~kl~D 164 (346)
T d1cm8a_ 97 DFYLVMPFMGTDLGKLMKH-------EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDC-----ELKILD 164 (346)
T ss_dssp CCEEEEECCSEEHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-----CEEECC
T ss_pred EEEEEEECCCCCHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHCCCCC-----CCCCCC
T ss_conf 5999984055218999874-------0226999999999999999998737876456685111121001-----221134
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCCCCH
Q ss_conf 34321123568899999999888999876678357542018898888999953532153357999861999998885113
Q 003542 361 FGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQG 440 (811)
Q Consensus 361 FGLa~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIwSlGvILyELLtGk~PF~~~~~~~ 440 (811)
||+|+.... ......||+.|+|||++.+. ..++.++||||+||++|+|++|++||.+.+...
T Consensus 165 fg~a~~~~~----------~~~~~~~t~~y~aPE~~~~~--------~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~ 226 (346)
T d1cm8a_ 165 FGLARQADS----------EMTGYVVTRWYRAPEVILNW--------MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD 226 (346)
T ss_dssp CTTCEECCS----------SCCSSCSCGGGCCTHHHHTT--------TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred CCCEECCCC----------CCCCCCCCCCCCCHHHHCCC--------CCCCCCCHHHCCHHHHHHHHHCCCCCCCCCHHH
T ss_conf 310220687----------63102455333588998178--------789965010300389999997869988897689
Q ss_pred HHHHHHHH-HCC-------------------------C---CCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHH
Q ss_conf 78899887-189-------------------------9---9999999178799874101589999999999999
Q 003542 441 DKMTKNIR-AGE-------------------------R---PLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 441 ~~i~~~i~-~~~-------------------------~---~~~p~~~p~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
. +..... .+. . .......++.+.+||.+||..||.+|||+.++++
T Consensus 227 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 227 Q-LKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp H-HHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred H-HHHHHHCCCCCCHHHHHHHCCHHHHHHHCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 9-9999850378848888653000344331157866655667755689999999999977299557929999963
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=327.80 Aligned_cols=261 Identities=15% Similarity=0.207 Sum_probs=201.7
Q ss_pred CCEEEEEEECCCC---EEEEEE-ECCCEEEEEEECC--CHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEEEECC
Q ss_conf 0568953416434---289999-9698999998064--278999999999808998501252038826798699998467
Q 003542 216 KKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG--ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVMELM 289 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~-~~g~~vAIK~l~~--~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~e~~~~~~LVmEy~ 289 (811)
++|++.+.||+|+ ||++.. .+|+.||||.+.. ....+..|+++++.++|+|++..++.+. .+...+++|||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~-~~~~~~~ivme~~ 85 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCG-AEGDYNVMVMELL 85 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEE-EETTEEEEEEECC
T ss_pred CEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHCCCHHHHHHHHHHHHCCCCCCCCEEEEEE-ECCCEEEEEEEEC
T ss_conf 889996898507880999999988998999999721005888999999999703899601799999-5198778999873
Q ss_pred CCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCCCCEEEEEECCCCCCCCC
Q ss_conf 99988999986077788999978999999999999999986994202689994898126788731599910343211235
Q 003542 290 SKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTARTY 369 (811)
Q Consensus 290 ~gsL~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIvHRDLKPsNILI~~~g~d~~~~vKL~DFGLa~~~~~ 369 (811)
+++|...+... ...+++..+..++.|++.||.|||+++|+||||||+|||+...+ ....+||+|||+|+....
T Consensus 86 ~~~l~~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~--~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 86 GPSLEDLFNFC-----SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGK--KGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp CCBHHHHHHHT-----TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGG--GTTCEEECCCSSCEECBC
T ss_pred CCCHHHHHHHC-----CCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCHHHCCCCCCC--CCCEEEEECCCCCEECCC
T ss_conf 87133324430-----68876899999999999999999979944266787660643357--776156504675134255
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCCCCHHHH--HHHH
Q ss_conf 68899999999888999876678357542018898888999953532153357999861999998885113788--9988
Q 003542 370 ASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKM--TKNI 447 (811)
Q Consensus 370 ~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIwSlGvILyELLtGk~PF~~~~~~~~~i--~~~i 447 (811)
................||+.|+|||++.+. .++.++||||||+++|||++|+.||.+........ ....
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~ 229 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGI---------EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS 229 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTB---------CCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHH
T ss_pred CCCCCCEECCCCCCCCCCCCCCCHHHHHCC---------CCCCHHHEEECCHHHHHHHHCCCCCCCCCHHHHHHHHHHHH
T ss_conf 445541000135776787353299999189---------98983218861778999984987665530577999999852
Q ss_pred ---HHCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf ---7189999999991787998741015899999999999999999999
Q 003542 448 ---RAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKK 493 (811)
Q Consensus 448 ---~~~~~~~~p~~~p~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~~ 493 (811)
.....+..+..+|+++.+||.+||..+|.+||++.++.+.|+.+..
T Consensus 230 ~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 230 EKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp HHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 3567898357534788999999999843995579199999999999999
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=333.13 Aligned_cols=234 Identities=20% Similarity=0.340 Sum_probs=191.8
Q ss_pred HCCEEEEEEECCCC---EEEEEE-ECCCEEEEEEECCC----------HHHHHHHHHHHHHCC--CCCCCEEEEEEECCC
Q ss_conf 40568953416434---289999-96989999980642----------789999999998089--985012520388267
Q 003542 215 LKKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYGE----------LESLNAEISTMLSLS--HPNIVQYLCGFCDEE 278 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~-~~g~~vAIK~l~~~----------~~~~~~Ei~iL~~L~--HpNIV~l~~~~~~e~ 278 (811)
.++|++.+.||+|+ ||++.. .+|+.||+|++... ...+.+|+.+|++++ |||||++++.+ ++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~--~~ 80 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF--ER 80 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE--EC
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEE--EE
T ss_conf 8837996798408783999999999997999999856884433455679999999999997435898812799998--30
Q ss_pred CCEEEEEEECCCC--CHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCCCCEE
Q ss_conf 9869999846799--98899998607778899997899999999999999998699420268999489812678873159
Q 003542 279 KKEFFLVMELMSK--DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHV 356 (811)
Q Consensus 279 ~~~~~LVmEy~~g--sL~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIvHRDLKPsNILI~~~g~d~~~~v 356 (811)
.+.+|+||||+.+ ++.+++... ..+++..++.++.||+.||.|||+++|+||||||+|||++.++ ..+
T Consensus 81 ~~~~~lv~e~~~~~~~l~~~~~~~------~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~----~~v 150 (273)
T d1xwsa_ 81 PDSFVLILERPEPVQDLFDFITER------GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR----GEL 150 (273)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTT----TEE
T ss_pred CCEEEEEEEECCCCCHHHHHHHCC------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCC----CEE
T ss_conf 996899998336862289998615------8999999999999999999999877975566761114774478----848
Q ss_pred EEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCC
Q ss_conf 99103432112356889999999988899987667835754201889888899995353215335799986199999888
Q 003542 357 KVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDG 436 (811)
Q Consensus 357 KL~DFGLa~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIwSlGvILyELLtGk~PF~~~ 436 (811)
||+|||+|+..... ......||+.|+|||++.+. ..++.++||||+||++|||++|+.||.+.
T Consensus 151 kl~DFG~a~~~~~~---------~~~~~~GT~~y~aPE~~~~~--------~~~~~~~DiwSlGvilyell~g~~Pf~~~ 213 (273)
T d1xwsa_ 151 KLIDFGSGALLKDT---------VYTDFDGTRVYSPPEWIRYH--------RYHGRSAAVWSLGILLYDMVCGDIPFEHD 213 (273)
T ss_dssp EECCCTTCEECCSS---------CBCCCCSCGGGSCHHHHHHS--------CBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred EECCCCCCEECCCC---------CCCCCCCCCCCCCHHHHCCC--------CCCCCCCCCCCCEEEEHHHHHCCCCCCCC
T ss_conf 97754653532444---------55665658774799998489--------97886533255403453675688998873
Q ss_pred CCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHH
Q ss_conf 51137889988718999999999178799874101589999999999999
Q 003542 437 HLQGDKMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 437 ~~~~~~i~~~i~~~~~~~~p~~~p~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
. .+..+ ...++...++++.+||.+||..||.+|||++++++
T Consensus 214 ~--------~i~~~-~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 214 E--------EIIRG-QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp H--------HHHHC-CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred H--------HHHHC-CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 6--------77615-44778779999999999976089758939999853
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=329.69 Aligned_cols=246 Identities=18% Similarity=0.283 Sum_probs=192.7
Q ss_pred CCEEEEEEECCCC---EEEEEE-ECCCEEEEEEECC-----CHHHHHHHHHHHHHCCCCCCCEEEEEEECCC---CCEEE
Q ss_conf 0568953416434---289999-9698999998064-----2789999999998089985012520388267---98699
Q 003542 216 KKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG-----ELESLNAEISTMLSLSHPNIVQYLCGFCDEE---KKEFF 283 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~-~~g~~vAIK~l~~-----~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~e~---~~~~~ 283 (811)
.+|++++.||.|+ ||++.. .+|+.||||++.. ..+.+.+|+.+|+.++||||+++++.+.... ...+|
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~ 87 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEE
T ss_conf 98599789940648099999999999499999980310958999999999999976898988588899505645541499
Q ss_pred EEEECCCCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCCCCEEEEEECCC
Q ss_conf 99846799988999986077788999978999999999999999986994202689994898126788731599910343
Q 003542 284 LVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGL 363 (811)
Q Consensus 284 LVmEy~~gsL~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIvHRDLKPsNILI~~~g~d~~~~vKL~DFGL 363 (811)
++|+++.|+|.+++.. ..+++..++.++.|++.||.|||+++|+||||||+|||++.++ .+||+|||+
T Consensus 88 l~~~~~~g~L~~~l~~-------~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~-----~~kl~DfG~ 155 (345)
T d1pmea_ 88 LVTHLMGADLYKLLKT-------QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC-----DLKICDFGL 155 (345)
T ss_dssp EEEECCCEEHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-----CEEECCCTT
T ss_pred EEEEECCCCHHHHHHC-------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCC-----CEEECCCCC
T ss_conf 9996259865664405-------8999999999999999999999978986777876437887999-----778754570
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCCCCHHHH
Q ss_conf 21123568899999999888999876678357542018898888999953532153357999861999998885113788
Q 003542 364 STARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKM 443 (811)
Q Consensus 364 a~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIwSlGvILyELLtGk~PF~~~~~~~~~i 443 (811)
|+........ .......+||+.|+|||++.. ...++.++||||+||++|+|++|+.||.+...... .
T Consensus 156 a~~~~~~~~~----~~~~~~~~gt~~y~aPE~l~~--------~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~-~ 222 (345)
T d1pmea_ 156 ARVADPDHDH----TGFLTEYVATRWYRAPEIMLN--------SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ-L 222 (345)
T ss_dssp CEECCGGGCB----CCTTCCCCSCGGGCCGGGTTT--------BCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-H
T ss_pred EEECCCCCCC----CEEECCCCCCCEECHHHHHHC--------CCCCCCHHHHHCCCCEEHHHHHCCCCCCCCCHHHH-H
T ss_conf 5650477764----101011026520003878604--------78887410100467013377669799788888999-9
Q ss_pred HHHHHH------------------------CCC--CC---CCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHH
Q ss_conf 998871------------------------899--99---99999178799874101589999999999999
Q 003542 444 TKNIRA------------------------GER--PL---FPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 444 ~~~i~~------------------------~~~--~~---~p~~~p~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
...+.. ... .+ .....+..+.+|+.+||..||.+|||+.++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 223 NHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp HHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 987652069975664234332222024467755778777837899999999999976489567908999861
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=325.92 Aligned_cols=244 Identities=23% Similarity=0.372 Sum_probs=190.8
Q ss_pred HCCEEEEEEECCCC---EEEEEEE-C-CCEEEEEEECC------CHHHHHHHHHHHHHC---CCCCCCEEEEEEEC---C
Q ss_conf 40568953416434---2899999-6-98999998064------278999999999808---99850125203882---6
Q 003542 215 LKKLMVRRRLGASS---QFKEIQW-L-GDSFVLRHFYG------ELESLNAEISTMLSL---SHPNIVQYLCGFCD---E 277 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~~-~-g~~vAIK~l~~------~~~~~~~Ei~iL~~L---~HpNIV~l~~~~~~---e 277 (811)
.++|++.+.||+|+ ||++... + ++.||||++.. ....+.+|+.+|+.+ +||||+++++.+.. +
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred CCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCC
T ss_conf 58979888992155869999999888998999999802324516799999999999987425898802366322146666
Q ss_pred CCCEEEEEEECCCCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCCCCEEE
Q ss_conf 79869999846799988999986077788999978999999999999999986994202689994898126788731599
Q 003542 278 EKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVK 357 (811)
Q Consensus 278 ~~~~~~LVmEy~~gsL~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIvHRDLKPsNILI~~~g~d~~~~vK 357 (811)
....+|++||||.+++..+.... ....+++..++.++.|++.||.|||+++|+||||||+|||++..+ .+|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~----~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~-----~~k 156 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKV----PEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG-----QIK 156 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHS----CTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-----CEE
T ss_pred CCCEEEEEEEECCCCCHHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCEEEECCCC-----CEE
T ss_conf 67469999974058714444430----378999899999999999999999758898357986278985899-----754
Q ss_pred EEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCC
Q ss_conf 91034321123568899999999888999876678357542018898888999953532153357999861999998885
Q 003542 358 VSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGH 437 (811)
Q Consensus 358 L~DFGLa~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIwSlGvILyELLtGk~PF~~~~ 437 (811)
|+|||+++...... ......||+.|+|||++.+. .|+.++||||+||++|||++|++||.+.+
T Consensus 157 l~dfg~~~~~~~~~--------~~~~~~gT~~Y~APE~~~~~---------~y~~~~DiwSlG~il~ell~g~~pf~~~~ 219 (305)
T d1blxa_ 157 LADFGLARIYSFQM--------ALTSVVVTLWYRAPEVLLQS---------SYATPVDLWSVGCIFAEMFRRKPLFRGSS 219 (305)
T ss_dssp ECSCCSCCCCCGGG--------GGCCCCCCCTTCCHHHHTTC---------CCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ECCHHHHHHHCCCC--------CCCCCCCCHHHCCCCHHCCC---------CCCHHEHHHCHHHHHHHHHHCCCCCCCCC
T ss_conf 21000101100234--------57776548511483100179---------88811100032899999987879989989
Q ss_pred CCHHHHHHHHHH--CC------------------------CCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHH
Q ss_conf 113788998871--89------------------------99999999178799874101589999999999999
Q 003542 438 LQGDKMTKNIRA--GE------------------------RPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 438 ~~~~~i~~~i~~--~~------------------------~~~~p~~~p~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
... .+ ..+.. +. ...++...++.+.+||.+||..||.+|||+.++++
T Consensus 220 ~~~-~~-~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 220 DVD-QL-GKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp HHH-HH-HHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHH-HH-HHHHHHHCCCCHHCCCCCCCCHHHHHCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 899-99-99998407996110532111103330223456454404458999999999987489667918999966
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=328.92 Aligned_cols=260 Identities=19% Similarity=0.352 Sum_probs=194.6
Q ss_pred CCEEEEEEECCCC---EEEEEEECCCEEEEEEECC-CHHHHHHHH--HHHHHCCCCCCCEEEEEEECCCC--CEEEEEEE
Q ss_conf 0568953416434---2899999698999998064-278999999--99980899850125203882679--86999984
Q 003542 216 KKLMVRRRLGASS---QFKEIQWLGDSFVLRHFYG-ELESLNAEI--STMLSLSHPNIVQYLCGFCDEEK--KEFFLVME 287 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~~~g~~vAIK~l~~-~~~~~~~Ei--~iL~~L~HpNIV~l~~~~~~e~~--~~~~LVmE 287 (811)
..+.+.++||+|+ ||++ .+.|..||||++.. ....+.+|. ..+..++||||+++++.+..++. ..+|+|||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~-~~~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~E 81 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRG-KWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEE-EETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred CEEEEEEEEEECCCEEEEEE-EECCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEEEEEE
T ss_conf 68999889820788199999-99998999999872004679999999999627998683268899837986048999996
Q ss_pred CCC-CCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHH--------CCCEECCCCCCCEEEECCCCCCCCEEEE
Q ss_conf 679-9988999986077788999978999999999999999986--------9942026899948981267887315999
Q 003542 288 LMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHA--------QKIYHGELNPSNIYLKARSMEGYFHVKV 358 (811)
Q Consensus 288 y~~-gsL~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs--------~gIvHRDLKPsNILI~~~g~d~~~~vKL 358 (811)
||+ |+|.+++.+ ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++ .+||
T Consensus 82 y~~~g~L~~~l~~-------~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~-----~~Kl 149 (303)
T d1vjya_ 82 YHEHGSLFDYLNR-------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-----TCCI 149 (303)
T ss_dssp CCTTCBHHHHHHH-------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTS-----CEEE
T ss_pred CCCCCCHHHHHHC-------CCCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCC-----CEEE
T ss_conf 4669898999865-------899989999999999999999887665204689866153173135786887-----7688
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCCC
Q ss_conf 10343211235688999999998889998766783575420188988889999535321533579998619999988851
Q 003542 359 SGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHL 438 (811)
Q Consensus 359 ~DFGLa~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIwSlGvILyELLtGk~PF~~~~~ 438 (811)
+|||+++......... ........||+.|+|||++.+.... ....++.++|||||||+||||+||.+||.....
T Consensus 150 ~DFGl~~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~---~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~ 223 (303)
T d1vjya_ 150 ADLGLAVRHDSATDTI---DIAPNHRVGTKRYMAPEVLDDSINM---KHFESFKRADIYAMGLVFWEIARRCSIGGIHED 223 (303)
T ss_dssp CCCTTCEEEETTTTEE---CC----CCSCGGGCCHHHHTTCSCT---TCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCC
T ss_pred EECCCCCCCCCCCCCE---ECCCCCEECCCCCCCHHHCCCCCCC---CCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCC
T ss_conf 7638662346777620---0135525035476782210565454---677767501220159999999628998876631
Q ss_pred -------------CHHHHHHHHHH-CCCCCCCCC-----CHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf -------------13788998871-899999999-----917879987410158999999999999999999998
Q 003542 439 -------------QGDKMTKNIRA-GERPLFPSG-----SPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKKF 494 (811)
Q Consensus 439 -------------~~~~i~~~i~~-~~~~~~p~~-----~p~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~~~ 494 (811)
....+...+.. +.+|.+|.. ++..+.+|+.+||+.||.+|||+.+|++.|..+...
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 224 YQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp CCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCHHHCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf 124101225564309999998750246888776557768999999999997606985895999999999988886
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=0 Score=324.82 Aligned_cols=243 Identities=23% Similarity=0.366 Sum_probs=195.5
Q ss_pred CCEEEEEEECCCC---EEEEEEECCCEEEEEEECC------CHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEEE
Q ss_conf 0568953416434---2899999698999998064------278999999999808998501252038826798699998
Q 003542 216 KKLMVRRRLGASS---QFKEIQWLGDSFVLRHFYG------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLVM 286 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~~~g~~vAIK~l~~------~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~e~~~~~~LVm 286 (811)
++|++.+.||+|+ ||++...+|+.||+|++.. ..+.+.+|+.+|++++||||+++++.+.+ ...+|++|
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~i~~ 79 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT--KKRLVLVF 79 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC--SSCEEEEE
T ss_pred CCCEECCEEECCCCCEEEEEEECCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEECCC--CCCEEEEE
T ss_conf 9963431872277818999996899999999981232685899999999999986799868766012046--77315899
Q ss_pred ECCCCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCCCCEEEEEECCCCCC
Q ss_conf 46799988999986077788999978999999999999999986994202689994898126788731599910343211
Q 003542 287 ELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366 (811)
Q Consensus 287 Ey~~gsL~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIvHRDLKPsNILI~~~g~d~~~~vKL~DFGLa~~ 366 (811)
||+.+++...+... ...+++..+..++.||+.||.|||+.+|+||||||+|||++.++ .+||+|||+|..
T Consensus 80 e~~~~~~~~~~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~-----~~kl~DfG~a~~ 149 (286)
T d1ob3a_ 80 EHLDQDLKKLLDVC-----EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREG-----ELKIADFGLARA 149 (286)
T ss_dssp ECCSEEHHHHHHTS-----TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-----CEEECCTTHHHH
T ss_pred EEEHHHHHHHHHHH-----CCCCCHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCEEEECCCC-----CEEECCCCCCEE
T ss_conf 74004567899860-----47751445689999999999986057488267877505686899-----787323664301
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 23568899999999888999876678357542018898888999953532153357999861999998885113788998
Q 003542 367 RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKN 446 (811)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIwSlGvILyELLtGk~PF~~~~~~~~~i~~~ 446 (811)
...... ......|++.|+|||++.+. ..++.++||||+||++|||++|++||.+.+... .+...
T Consensus 150 ~~~~~~-------~~~~~~~~~~y~~pE~~~~~--------~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~-~~~~i 213 (286)
T d1ob3a_ 150 FGIPVR-------KYTHEIVTLWYRAPDVLMGS--------KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD-QLMRI 213 (286)
T ss_dssp HCC----------------CCCTTCCHHHHTTC--------CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHH
T ss_pred CCCCCC-------CCCEECCCCHHHHHHHHHCC--------CCCCCCEEEHHCCCHHHHHHHCCCCCCCCCHHH-HHHHH
T ss_conf 146765-------41010243110137887178--------888841002111758999977979989889899-99999
Q ss_pred HH-HCCC--------------------------CCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHH
Q ss_conf 87-1899--------------------------9999999178799874101589999999999999
Q 003542 447 IR-AGER--------------------------PLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 447 i~-~~~~--------------------------~~~p~~~p~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
.. .+.. ..++...++.+.+||.+||+.||.+|||+.++++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 214 FRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp HHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHCCCCHHHCCCHHHHHHCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 9863899711042123332214333335676466651258999999999986689668909999856
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=319.44 Aligned_cols=249 Identities=20% Similarity=0.288 Sum_probs=193.3
Q ss_pred HCCEEEEEEECCCC---EEEEEE-ECCCEEEEEEECC------CHHHHHHHHHHHHHCCCCCCCEEEEEEECCC------
Q ss_conf 40568953416434---289999-9698999998064------2789999999998089985012520388267------
Q 003542 215 LKKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG------ELESLNAEISTMLSLSHPNIVQYLCGFCDEE------ 278 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~-~~g~~vAIK~l~~------~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~e~------ 278 (811)
..+|++.+.||+|+ ||++.. .+|+.||||++.. ....+.+|+.+|+.++||||+++++.+....
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCCC
T ss_conf 27988999972274829999999899979999998422246378999999999999835999660676540246544445
Q ss_pred CCEEEEEEECCCCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCCCCEEEE
Q ss_conf 98699998467999889999860777889999789999999999999999869942026899948981267887315999
Q 003542 279 KKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKV 358 (811)
Q Consensus 279 ~~~~~LVmEy~~gsL~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIvHRDLKPsNILI~~~g~d~~~~vKL 358 (811)
...+|+|||||++++...... ....+++..++.++.|++.||.|||+.+|+||||||+|||++.++ .+||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~-----~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~-----~~kl 158 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSN-----VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG-----VLKL 158 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTC-----TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS-----CEEE
T ss_pred CCEEEEEEECCCCCCCCHHHH-----CCCCCCCHHHHHHHHHHHHHHHHHCCCCEEECCCCCHHEEECCCC-----CEEE
T ss_conf 763899985357874101222-----034433089999999999999885229988567672220366899-----6876
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCCC
Q ss_conf 10343211235688999999998889998766783575420188988889999535321533579998619999988851
Q 003542 359 SGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHL 438 (811)
Q Consensus 359 ~DFGLa~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIwSlGvILyELLtGk~PF~~~~~ 438 (811)
+|||+++......... .......+||+.|+|||++.+. ..|+.++||||+||++|||++|++||.+...
T Consensus 159 ~dfg~~~~~~~~~~~~---~~~~~~~~gT~~Y~aPE~~~~~--------~~~~~k~DiwSlGvil~el~~g~~pf~~~~~ 227 (318)
T d3blha1 159 ADFGLARAFSLAKNSQ---PNRYTNRVVTLWYRPPELLLGE--------RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE 227 (318)
T ss_dssp CCCTTCEECCC--------CCCCCSCCSCGGGCCHHHHTTC--------SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred EECCEEEECCCCCCCC---CCCCCCEECCHHHHHHHHHCCC--------CCCCCHHHCCCCCCEEEEHHHCCCCCCCCCH
T ss_conf 3135002235544432---1135660249787428997079--------9989178700678646617448799899899
Q ss_pred CHHHHHHHHHH--CCC-CCCCC----------------------------CCHHHHHHHHHHHCCCCCCCCCCHHHHHH
Q ss_conf 13788998871--899-99999----------------------------99178799874101589999999999999
Q 003542 439 QGDKMTKNIRA--GER-PLFPS----------------------------GSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 439 ~~~~i~~~i~~--~~~-~~~p~----------------------------~~p~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
... ...+.. +.. +.... ..++.+.+||.+||..||.+|||+.++++
T Consensus 228 ~~~--~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 228 QHQ--LALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp HHH--HHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHH--HHHHHHHCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 999--99999841899825534432034443320133445550334044459989999999987389658909999974
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=0 Score=320.80 Aligned_cols=264 Identities=14% Similarity=0.170 Sum_probs=204.9
Q ss_pred HHCCEEEEEEECCCC---EEEEEE-ECCCEEEEEEECC--CHHHHHHHHHHHHHCCC-CCCCEEEEEEECCCCCEEEEEE
Q ss_conf 740568953416434---289999-9698999998064--27899999999980899-8501252038826798699998
Q 003542 214 LLKKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG--ELESLNAEISTMLSLSH-PNIVQYLCGFCDEEKKEFFLVM 286 (811)
Q Consensus 214 l~k~~~i~~~lG~G~---vyk~v~-~~g~~vAIK~l~~--~~~~~~~Ei~iL~~L~H-pNIV~l~~~~~~e~~~~~~LVm 286 (811)
+.++|++.+.||+|+ ||++.. .+|+.||+|++.. ....+.+|++++..+.| +||+.+++.+ +.....|+||
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~--~~~~~~~~vm 80 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFG--QEGLHNVLVI 80 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEE--EETTEEEEEE
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEE--ECCCCCEEEE
T ss_conf 89806997998417882999999988997999999750258299999999999964899987799996--0188117999
Q ss_pred ECCCCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCCCCEEEEEECCCCCC
Q ss_conf 46799988999986077788999978999999999999999986994202689994898126788731599910343211
Q 003542 287 ELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTA 366 (811)
Q Consensus 287 Ey~~gsL~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIvHRDLKPsNILI~~~g~d~~~~vKL~DFGLa~~ 366 (811)
|||+++|.+++... ...+++..+..++.|++.||.|||+++|+||||||+|||++.........+||+|||+|+.
T Consensus 81 e~~~~~l~~~~~~~-----~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 81 DLLGPSLEDLLDLC-----GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp ECCCCBHHHHHHHT-----TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EECCCCHHHHHHHH-----CCCHHHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCCCCCCEEECCCCEEEE
T ss_conf 96488879999752-----0311068999999999999999997796626677131523475434479568723660577
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCCCCHH-HHHH
Q ss_conf 235688999999998889998766783575420188988889999535321533579998619999988851137-8899
Q 003542 367 RTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGD-KMTK 445 (811)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIwSlGvILyELLtGk~PF~~~~~~~~-~i~~ 445 (811)
..................+||+.|+|||++.+. .++.++||||||+++|||++|..||.+...... ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~---------~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~ 226 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGR---------EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYE 226 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC---------CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHH
T ss_pred CCCCCCCCCEEECCCCCEEECHHHCCHHHHCCC---------CCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH
T ss_conf 146766541110246762775102679896488---------88869998983199999986987678853021999999
Q ss_pred HHHH----CCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 8871----89999999991787998741015899999999999999999999
Q 003542 446 NIRA----GERPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICRILRYIKK 493 (811)
Q Consensus 446 ~i~~----~~~~~~p~~~p~~l~~LI~~cL~~DP~~RPS~~eIl~~L~~i~~ 493 (811)
.+.. .....++..+|+++.+++..||..+|.+||+++.+.+.+..+..
T Consensus 227 ~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~ 278 (293)
T d1csna_ 227 RIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278 (293)
T ss_dssp HHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred HHHHCCCCCCHHHHCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHH
T ss_conf 9970567999589657998999999999843993008599999999999999
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=323.17 Aligned_cols=245 Identities=19% Similarity=0.321 Sum_probs=199.1
Q ss_pred HCCEEEEEEECCCC---EEEEEEE----CCCEEEEEEECC--------CHHHHHHHHHHHHHCCC-CCCCEEEEEEECCC
Q ss_conf 40568953416434---2899999----698999998064--------27899999999980899-85012520388267
Q 003542 215 LKKLMVRRRLGASS---QFKEIQW----LGDSFVLRHFYG--------ELESLNAEISTMLSLSH-PNIVQYLCGFCDEE 278 (811)
Q Consensus 215 ~k~~~i~~~lG~G~---vyk~v~~----~g~~vAIK~l~~--------~~~~~~~Ei~iL~~L~H-pNIV~l~~~~~~e~ 278 (811)
+++|++.+.||+|+ ||++... +|+.||+|.+.. ..+.+.+|+++|++++| |||+++++.+ ++
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~--~~ 100 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF--QT 100 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE--EE
T ss_pred HHCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE--CC
T ss_conf 1025999898328783999999876588794899999836772101689999999999998646798399962000--24
Q ss_pred CCEEEEEEECCC-CCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCCCCEEE
Q ss_conf 986999984679-9988999986077788999978999999999999999986994202689994898126788731599
Q 003542 279 KKEFFLVMELMS-KDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVK 357 (811)
Q Consensus 279 ~~~~~LVmEy~~-gsL~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIvHRDLKPsNILI~~~g~d~~~~vK 357 (811)
...+++|||||. |+|.+++... ..+++..+..++.||+.||.|||+.+|+||||||+|||++.++ .+|
T Consensus 101 ~~~~~~v~e~~~~~~L~~~i~~~------~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~-----~vk 169 (322)
T d1vzoa_ 101 ETKLHLILDYINGGELFTHLSQR------ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG-----HVV 169 (322)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-----CEE
T ss_pred CCCEEEEEECCCCCHHHHHHHHC------CCCCHHHHHHHHHHHHHHHHHHHCCCEEECCCCCCCEEECCCC-----CEE
T ss_conf 87300123123411799998730------4543788888899999999885149989654773201246999-----888
Q ss_pred EEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCC
Q ss_conf 91034321123568899999999888999876678357542018898888999953532153357999861999998885
Q 003542 358 VSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGH 437 (811)
Q Consensus 358 L~DFGLa~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIwSlGvILyELLtGk~PF~~~~ 437 (811)
|+|||+++....... .......|++.|+|||.+.+. ...++.++|||||||+||+|++|+.||.+..
T Consensus 170 L~DFG~a~~~~~~~~------~~~~~~~g~~~~~~pe~~~~~-------~~~~~~ksDIWSlG~iLyelltG~~PF~~~~ 236 (322)
T d1vzoa_ 170 LTDFGLSKEFVADET------ERAYDFCGTIEYMAPDIVRGG-------DSGHDKAVDWWSLGVLMYELLTGASPFTVDG 236 (322)
T ss_dssp ESCSSEEEECCGGGG------GGGCGGGSCCTTCCHHHHTTC-------C---CTHHHHHHHHHHHHHHHHSSCTTSCTT
T ss_pred EEECCCHHHHCCCCC------CCCCCCCCCCCCCHHHHHHCC-------CCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_conf 741320222034444------322122233333106876057-------7688713251777799999976899988887
Q ss_pred CCHH--HHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCC-----HHHHHH
Q ss_conf 1137--889988718999999999178799874101589999999-----999999
Q 003542 438 LQGD--KMTKNIRAGERPLFPSGSPKYLVNLTKKCWHTNPSQRPS-----FSSICR 486 (811)
Q Consensus 438 ~~~~--~i~~~i~~~~~~~~p~~~p~~l~~LI~~cL~~DP~~RPS-----~~eIl~ 486 (811)
.... .+. .......+.+|..++..+.+||.+||+.||.+||+ ++++++
T Consensus 237 ~~~~~~~i~-~~~~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 237 EKNSQAEIS-RRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp SCCCHHHHH-HHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred HHHHHHHHH-HHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCCCCCCHHHHHC
T ss_conf 777999999-8335689988654799999999997445898819997450999974
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=0 Score=320.48 Aligned_cols=242 Identities=17% Similarity=0.250 Sum_probs=191.0
Q ss_pred CCEEEEEEECCCC---EEEEEE-ECCCEEEEEEECC-CHHHHHHHHHHHHHCC-CCCCCEEEEEEECCCCCEEEEEEECC
Q ss_conf 0568953416434---289999-9698999998064-2789999999998089-98501252038826798699998467
Q 003542 216 KKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG-ELESLNAEISTMLSLS-HPNIVQYLCGFCDEEKKEFFLVMELM 289 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~-~~g~~vAIK~l~~-~~~~~~~Ei~iL~~L~-HpNIV~l~~~~~~e~~~~~~LVmEy~ 289 (811)
++|++.+.||+|+ ||++.. .+|+.||+|++.. ....+.+|+.+|..+. ||||+++++.|.......+++|||||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~ 114 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV 114 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECC
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCCEEEEEEEC
T ss_conf 67189789831748199999988999799999988899999999999998515799876799999816877126888631
Q ss_pred CC-CHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCCCCEEEEEECCCCCCCC
Q ss_conf 99-98899998607778899997899999999999999998699420268999489812678873159991034321123
Q 003542 290 SK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLSTART 368 (811)
Q Consensus 290 ~g-sL~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIvHRDLKPsNILI~~~g~d~~~~vKL~DFGLa~~~~ 368 (811)
++ +|..+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++. .+||+|||+|....
T Consensus 115 ~~~~L~~~~---------~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~----~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 115 NNTDFKQLY---------QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR----KLRLIDWGLAEFYH 181 (328)
T ss_dssp CSCBGGGTT---------TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT----EEEECCGGGCEECC
T ss_pred CCCCHHHHH---------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCC----EEEECCCCCCEECC
T ss_conf 798589974---------68999999999999999998876433443456441237748998----36641565426646
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCCCCHHHHHHH--
Q ss_conf 568899999999888999876678357542018898888999953532153357999861999998885113788998--
Q 003542 369 YASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTKN-- 446 (811)
Q Consensus 369 ~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIwSlGvILyELLtGk~PF~~~~~~~~~i~~~-- 446 (811)
... ......||+.|+|||++.+. ..++.++||||+||++|+|++|+.||.............
T Consensus 182 ~~~--------~~~~~~~t~~y~aPE~~~~~--------~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~ 245 (328)
T d3bqca1 182 PGQ--------EYNVRVASRYFKGPELLVDY--------QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 245 (328)
T ss_dssp TTC--------CCCSCCSCGGGCCHHHHTTC--------CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHH
T ss_pred CCC--------CCCCCCCCCCCCCCCCCCCC--------CCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHH
T ss_conf 887--------44432248642476102688--------88884523233545558760488999887601899999999
Q ss_pred ----------HHHCC-----------------------CCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHH
Q ss_conf ----------87189-----------------------99999999178799874101589999999999999
Q 003542 447 ----------IRAGE-----------------------RPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 447 ----------i~~~~-----------------------~~~~p~~~p~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
..... ........++++.+||.+||..||.+|||++++++
T Consensus 246 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 246 VLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHCCCHHHHHHHHCCCCCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 8788415555542254447430000033343311211552112448999999999986699568908999964
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=321.66 Aligned_cols=242 Identities=23% Similarity=0.339 Sum_probs=191.8
Q ss_pred HHCCEEEEEEECCCC---EEEEEE-ECCCEEEEEEECC------CHHHHHHHHHHHHHCCCCCCCEEEEEEECC----CC
Q ss_conf 740568953416434---289999-9698999998064------278999999999808998501252038826----79
Q 003542 214 LLKKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG------ELESLNAEISTMLSLSHPNIVQYLCGFCDE----EK 279 (811)
Q Consensus 214 l~k~~~i~~~lG~G~---vyk~v~-~~g~~vAIK~l~~------~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~e----~~ 279 (811)
+.++|++.+.||+|+ ||++.. .+|+.||||++.. ....+.+|+.+|+.++||||+++++.|..+ ..
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~ 94 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 94 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ECCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCCC
T ss_conf 33775998896217585999999999998999999882336979999999999999864898764899897025643457
Q ss_pred CEEEEEEECCCCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCCCCEEEEE
Q ss_conf 86999984679998899998607778899997899999999999999998699420268999489812678873159991
Q 003542 280 KEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVS 359 (811)
Q Consensus 280 ~~~~LVmEy~~gsL~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIvHRDLKPsNILI~~~g~d~~~~vKL~ 359 (811)
..+|+|||||.+++...+. ..+++..++.++.|++.||.|||+.||+||||||+|||++.++ .+|++
T Consensus 95 ~~~~iv~Ey~~~~l~~~~~--------~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~-----~~kl~ 161 (355)
T d2b1pa1 95 QDVYLVMELMDANLCQVIQ--------MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-----TLKIL 161 (355)
T ss_dssp CEEEEEEECCSEEHHHHHT--------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-----CEEEC
T ss_pred CEEEEEEECCCHHHHHHHH--------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCC-----CEEEE
T ss_conf 6269998414467787650--------3899999999999999999886522112456776321136544-----31320
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCCCC
Q ss_conf 03432112356889999999988899987667835754201889888899995353215335799986199999888511
Q 003542 360 GFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQ 439 (811)
Q Consensus 360 DFGLa~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIwSlGvILyELLtGk~PF~~~~~~ 439 (811)
|||+++...... ......||+.|+|||++.+. .++.++||||+||++|+|++|++||.+.+..
T Consensus 162 df~~~~~~~~~~--------~~~~~~~t~~y~aPE~l~~~---------~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~ 224 (355)
T d2b1pa1 162 DFGLARTAGTSF--------MMTPYVVTRYYRAPEVILGM---------GYKENVDIWSVGCIMGEMVRHKILFPGRDYI 224 (355)
T ss_dssp CCCC-----------------------CCTTCCHHHHTTC---------CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred CHHHHHCCCCCC--------CCCCCCCCCCCCCHHHHCCC---------CCCCCCCCCCCCCHHHHHHHCCCCCCCCCHH
T ss_conf 102321146665--------53322146555581331477---------7787743335662578986598998889778
Q ss_pred HHHHHHHH---------------------HHCCCCC-------------CC------CCCHHHHHHHHHHHCCCCCCCCC
Q ss_conf 37889988---------------------7189999-------------99------99917879987410158999999
Q 003542 440 GDKMTKNI---------------------RAGERPL-------------FP------SGSPKYLVNLTKKCWHTNPSQRP 479 (811)
Q Consensus 440 ~~~i~~~i---------------------~~~~~~~-------------~p------~~~p~~l~~LI~~cL~~DP~~RP 479 (811)
.. ....+ ....... .+ ...+..+.+||.+||..||.+||
T Consensus 225 ~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ 303 (355)
T d2b1pa1 225 DQ-WNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 303 (355)
T ss_dssp HH-HHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSC
T ss_pred HH-HHHHHHHCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCC
T ss_conf 89-99999720589879998765667777641754356664212643335432101333799999999998769945790
Q ss_pred CHHHHHH
Q ss_conf 9999999
Q 003542 480 SFSSICR 486 (811)
Q Consensus 480 S~~eIl~ 486 (811)
|++++++
T Consensus 304 ta~elL~ 310 (355)
T d2b1pa1 304 SVDDALQ 310 (355)
T ss_dssp CHHHHHT
T ss_pred CHHHHHC
T ss_conf 8999966
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=315.46 Aligned_cols=239 Identities=21% Similarity=0.317 Sum_probs=187.8
Q ss_pred CCEEEEEEECCCC---EEEEEE-ECCCEEEEEEECC------CHHHHHHHHHHHHHCCCCCCCEEEEEEEC----CCCCE
Q ss_conf 0568953416434---289999-9698999998064------27899999999980899850125203882----67986
Q 003542 216 KKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG------ELESLNAEISTMLSLSHPNIVQYLCGFCD----EEKKE 281 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~-~~g~~vAIK~l~~------~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~----e~~~~ 281 (811)
.+|++.+.||+|+ ||++.. .+|+.||||++.. ..+.+.+|+.+|+.++|||||++++.+.. ++...
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~ 97 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 97 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCCCE
T ss_conf 87188889831788399999999999799999988200286899999999999986689874259999963464566864
Q ss_pred EEEEEECCCCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCCCCEEEEEEC
Q ss_conf 99998467999889999860777889999789999999999999999869942026899948981267887315999103
Q 003542 282 FFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGF 361 (811)
Q Consensus 282 ~~LVmEy~~gsL~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIvHRDLKPsNILI~~~g~d~~~~vKL~DF 361 (811)
+|++|+++.|+|.+++.. ..+++..+..++.||+.||.|||+++|+||||||+|||++.++ .+|++||
T Consensus 98 ~~i~~~~~gg~L~~~~~~-------~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~-----~~kl~df 165 (348)
T d2gfsa1 98 VYLVTHLMGADLNNIVKC-------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-----ELKILDF 165 (348)
T ss_dssp CEEEEECCSEEHHHHHTT-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-----CEEECCC
T ss_pred EEEEEEECCCCHHHHCCC-------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCC-----CCCCCCC
T ss_conf 999996258862320022-------4530999999999999999999738876516677633455432-----2001321
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCCCCHH
Q ss_conf 43211235688999999998889998766783575420188988889999535321533579998619999988851137
Q 003542 362 GLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGD 441 (811)
Q Consensus 362 GLa~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIwSlGvILyELLtGk~PF~~~~~~~~ 441 (811)
|++...... .....|++.|+|||++.+. ..++.++||||+||++|+|++|++||.+.+...
T Consensus 166 g~a~~~~~~----------~~~~~g~~~y~apE~~~~~--------~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~- 226 (348)
T d2gfsa1 166 GLARHTDDE----------MTGYVATRWYRAPEIMLNW--------MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID- 226 (348)
T ss_dssp ----CCTGG----------GSSSCHHHHTSCHHHHTTC--------SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-
T ss_pred CHHCCCCCC----------CCCCCCCCCCCCCHHHCCC--------CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHH-
T ss_conf 000125754----------4443454355583553377--------567855124320589999976889978898899-
Q ss_pred HHHHHHHH--CC--------------------CCCC--------CCCCHHHHHHHHHHHCCCCCCCCCCHHHHHH
Q ss_conf 88998871--89--------------------9999--------9999178799874101589999999999999
Q 003542 442 KMTKNIRA--GE--------------------RPLF--------PSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 442 ~i~~~i~~--~~--------------------~~~~--------p~~~p~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
....+.. +. .... ....++.+.+||.+||..||.+|||+.++++
T Consensus 227 -~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 227 -QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp -HHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -HHHHHHHHCCCCCHHHHHHCCCHHHHHHHHHCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf -99999973079975773200102445444303557875556626789999999999977588345938999855
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=308.37 Aligned_cols=244 Identities=23% Similarity=0.310 Sum_probs=191.1
Q ss_pred CCEEEEEEECCCC---EEEEEE-ECCCEEEEEEECC------CHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEE
Q ss_conf 0568953416434---289999-9698999998064------27899999999980899850125203882679869999
Q 003542 216 KKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYG------ELESLNAEISTMLSLSHPNIVQYLCGFCDEEKKEFFLV 285 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~-~~g~~vAIK~l~~------~~~~~~~Ei~iL~~L~HpNIV~l~~~~~~e~~~~~~LV 285 (811)
++|++++.||+|+ ||++.. .+|+.||||+++. ....+.+|+.+|+.++||||+++++.+ .+...+++|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~--~~~~~~~iv 79 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL--HSDKKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEE--ECSSEEEEE
T ss_pred CCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCC--CCCCCEEEE
T ss_conf 997862697128681999999999996999999803217868999999999999856757888213544--444311588
Q ss_pred EECCCCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCCCCEEEEEECCCCC
Q ss_conf 84679998899998607778899997899999999999999998699420268999489812678873159991034321
Q 003542 286 MELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365 (811)
Q Consensus 286 mEy~~gsL~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIvHRDLKPsNILI~~~g~d~~~~vKL~DFGLa~ 365 (811)
||++.|++...+... ...+++..++.++.|++.||.|||+++|+||||||+|||++.++ .+||+|||.|+
T Consensus 80 ~~~~~~~~l~~~~~~-----~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~-----~~kl~DFG~a~ 149 (292)
T d1unla_ 80 FEFCDQDLKKYFDSC-----NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNG-----ELKLANFGLAR 149 (292)
T ss_dssp EECCSEEHHHHHHHT-----TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-----CEEECCCTTCE
T ss_pred EEECCCCCCCCCCCC-----CCCCCHHHHHHHHHHHHHHHHHHHCCCEEEECCCCCCCCCCCCC-----CEEEEECCHHH
T ss_conf 630233222112123-----56540367899999999998774339986001467612113378-----26652046011
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 12356889999999988899987667835754201889888899995353215335799986199999888511378899
Q 003542 366 ARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPFEDGHLQGDKMTK 445 (811)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIwSlGvILyELLtGk~PF~~~~~~~~~i~~ 445 (811)
....... ......++..|+|||++.+. ..++.++||||+||++|||++|+.||.........+..
T Consensus 150 ~~~~~~~-------~~~~~~~~~~~~~pe~~~~~--------~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~ 214 (292)
T d1unla_ 150 AFGIPVR-------CYSAEVVTLWYRPPDVLFGA--------KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKR 214 (292)
T ss_dssp ECCSCCS-------CCCSCCSCGGGCCHHHHTTC--------SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHH
T ss_pred CCCCCCC-------CCEEECCCCCHHHHHHHCCC--------CCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHHHH
T ss_conf 0468875-------10010344310146675069--------88880444026541889985189999889999999999
Q ss_pred HHHH-CC--------------------------CCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHH
Q ss_conf 8871-89--------------------------99999999178799874101589999999999999
Q 003542 446 NIRA-GE--------------------------RPLFPSGSPKYLVNLTKKCWHTNPSQRPSFSSICR 486 (811)
Q Consensus 446 ~i~~-~~--------------------------~~~~p~~~p~~l~~LI~~cL~~DP~~RPS~~eIl~ 486 (811)
.... +. ....+...++.+.+|+.+||+.||.+|||++++++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 215 IFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp HHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHHCCCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 98611899735513443222113344454431043306568999999999986499668909999964
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.7e-42 Score=280.33 Aligned_cols=252 Identities=19% Similarity=0.328 Sum_probs=187.2
Q ss_pred CCEEEEEEECCCC---EEEEEE-ECCCEEEEEEECCC---HHHHHHHHHHHHHCC-----------CCCCCEEEEEEECC
Q ss_conf 0568953416434---289999-96989999980642---789999999998089-----------98501252038826
Q 003542 216 KKLMVRRRLGASS---QFKEIQ-WLGDSFVLRHFYGE---LESLNAEISTMLSLS-----------HPNIVQYLCGFCDE 277 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~-~~g~~vAIK~l~~~---~~~~~~Ei~iL~~L~-----------HpNIV~l~~~~~~e 277 (811)
.+|++++.||+|+ ||++.. .+|+.||||++..+ .+.+.+|+++++.++ |+||+++++.+...
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEEEEEEC
T ss_conf 85799899750778189999999999799999983431336899999999998401455555422767647899876312
Q ss_pred CCCEEEEEEECCCC--CHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCEECCCCCCCEEEECCCC-CCC
Q ss_conf 79869999846799--988999986077788999978999999999999999986-99420268999489812678-873
Q 003542 278 EKKEFFLVMELMSK--DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHA-QKIYHGELNPSNIYLKARSM-EGY 353 (811)
Q Consensus 278 ~~~~~~LVmEy~~g--sL~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs-~gIvHRDLKPsNILI~~~g~-d~~ 353 (811)
.....+++|+++.. +....... .....+++..+..++.||+.||.|||+ .+|+||||||+|||++..+. ...
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKK----YEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHH----TTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred CCCCEEEEEEECCCCCCCCCCCCC----CCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEEECCCCCCCC
T ss_conf 565202343200035420000012----2346786899999999999998887640586465677057056305765644
Q ss_pred CEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCEECCHHHHHHHHHCCCCC
Q ss_conf 15999103432112356889999999988899987667835754201889888899995353215335799986199999
Q 003542 354 FHVKVSGFGLSTARTYASRNTPPASPQNQTAPNPYIWYAPEVLAEQEGTGSTSTSKCSEKADVYSFGMLCFELLTGKVPF 433 (811)
Q Consensus 354 ~~vKL~DFGLa~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~s~ksDIwSlGvILyELLtGk~PF 433 (811)
..++++|||.+..... .....+||+.|+|||++.+. .|+.++||||+||++++|++|+.||
T Consensus 169 ~~~kl~dfg~s~~~~~----------~~~~~~gt~~y~aPE~~~~~---------~~~~~~DiwSlG~il~el~~g~~pF 229 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDE----------HYTNSIQTREYRSPEVLLGA---------PWGCGADIWSTACLIFELITGDFLF 229 (362)
T ss_dssp EEEEECCCTTCEETTB----------CCCSCCSCGGGCCHHHHHTC---------CCCTHHHHHHHHHHHHHHHHSSCCC
T ss_pred CEEEEEECCCCCCCCC----------CCCCCCCCCCCCCHHHCCCC---------CCCCCCCCCCHHHHHHHHHHCCCCC
T ss_conf 3056753144212344----------54223665210571321466---------7776432012378999998788998
Q ss_pred CCCCCCH-----HHHHHHHHH-CC---------------------------------------CCCCCCCCHHHHHHHHH
Q ss_conf 8885113-----788998871-89---------------------------------------99999999178799874
Q 003542 434 EDGHLQG-----DKMTKNIRA-GE---------------------------------------RPLFPSGSPKYLVNLTK 468 (811)
Q Consensus 434 ~~~~~~~-----~~i~~~i~~-~~---------------------------------------~~~~p~~~p~~l~~LI~ 468 (811)
....... ..+...+.. +. ...++...++.+.+||.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~ 309 (362)
T d1q8ya_ 230 EPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 309 (362)
T ss_dssp ---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHG
T ss_pred CCCCCCCCCCHHHHHHHHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHH
T ss_conf 98755432102689999999837998788624532200013201220243235776444210001567435899999999
Q ss_pred HHCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 10158999999999999999999
Q 003542 469 KCWHTNPSQRPSFSSICRILRYI 491 (811)
Q Consensus 469 ~cL~~DP~~RPS~~eIl~~L~~i 491 (811)
+||..||.+|||+.++++ ++++
T Consensus 310 ~mL~~dP~~Rpta~e~L~-Hp~f 331 (362)
T d1q8ya_ 310 PMLQLDPRKRADAGGLVN-HPWL 331 (362)
T ss_dssp GGGCSSTTTCBCHHHHHT-CGGG
T ss_pred HHCCCCHHHCCCHHHHHC-CCCC
T ss_conf 987799457908999966-9340
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.85 E-value=3.4e-21 Score=149.13 Aligned_cols=125 Identities=14% Similarity=0.127 Sum_probs=97.6
Q ss_pred EEEEEECCCC---EEEEEEECCCEEEEEEECCC----------------------HHHHHHHHHHHHHCCCCCCCEEEEE
Q ss_conf 8953416434---28999996989999980642----------------------7899999999980899850125203
Q 003542 219 MVRRRLGASS---QFKEIQWLGDSFVLRHFYGE----------------------LESLNAEISTMLSLSHPNIVQYLCG 273 (811)
Q Consensus 219 ~i~~~lG~G~---vyk~v~~~g~~vAIK~l~~~----------------------~~~~~~Ei~iL~~L~HpNIV~l~~~ 273 (811)
.+.++||.|+ ||.+...+|+.||||+++.. .....+|+..+..+.|++++..++.
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred HHCCEEEECCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEE
T ss_conf 22778024856599999979999999999860443466655656300088899999977899999998169991449986
Q ss_pred EECCCCCEEEEEEECCCCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCCC
Q ss_conf 88267986999984679998899998607778899997899999999999999998699420268999489812678873
Q 003542 274 FCDEEKKEFFLVMELMSKDLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHAQKIYHGELNPSNIYLKARSMEGY 353 (811)
Q Consensus 274 ~~~e~~~~~~LVmEy~~gsL~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs~gIvHRDLKPsNILI~~~g~d~~ 353 (811)
. . .+++|||+++... ..++...+..++.|++.+|.|||+++|+||||||+|||++.+
T Consensus 83 ~---~---~~lvme~~~~~~~------------~~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~----- 139 (191)
T d1zara2 83 E---G---NAVLMELIDAKEL------------YRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE----- 139 (191)
T ss_dssp E---T---TEEEEECCCCEEG------------GGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-----
T ss_pred C---C---CEEEEEEECCCCC------------CCHHHHHHHHHHHHHHHHHHHHHHCCEEECCCCHHHEEEECC-----
T ss_conf 2---8---8899995045654------------200157899999999999999826888983689036114289-----
Q ss_pred CEEEEEECCCCCCC
Q ss_conf 15999103432112
Q 003542 354 FHVKVSGFGLSTAR 367 (811)
Q Consensus 354 ~~vKL~DFGLa~~~ 367 (811)
.++|+|||+|...
T Consensus 140 -~~~liDFG~a~~~ 152 (191)
T d1zara2 140 -GIWIIDFPQSVEV 152 (191)
T ss_dssp -EEEECCCTTCEET
T ss_pred -CEEEEECCCCCCC
T ss_conf -8999877884308
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.29 E-value=6.9e-06 Score=52.06 Aligned_cols=131 Identities=18% Similarity=0.121 Sum_probs=75.5
Q ss_pred CCEEEEEEECCCC---EEEEEEECCCEEEEEEECC----CHHHHHHHHHHHHHCC-CCCCCEEEEEEECCCCCEEEEEEE
Q ss_conf 0568953416434---2899999698999998064----2789999999998089-985012520388267986999984
Q 003542 216 KKLMVRRRLGASS---QFKEIQWLGDSFVLRHFYG----ELESLNAEISTMLSLS-HPNIVQYLCGFCDEEKKEFFLVME 287 (811)
Q Consensus 216 k~~~i~~~lG~G~---vyk~v~~~g~~vAIK~l~~----~~~~~~~Ei~iL~~L~-HpNIV~l~~~~~~e~~~~~~LVmE 287 (811)
..++..+..+.++ +|. +...+..+.+|+... ....+.+|...+..+. +--+.+++... +..+..|+||+
T Consensus 14 ~~~~~~~~~~G~s~~~v~r-v~~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~--~~~~~~~lv~~ 90 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYK-LVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFE--RHDGWSNLLMS 90 (263)
T ss_dssp TTSEEEECSCCCSSSEEEE-EECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEE--EETTEEEEEEE
T ss_pred HCEEEEECCCCCCCCCEEE-EEECCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEE--ECCCCEEEEEE
T ss_conf 3527997678998771899-99089869999848876532556999999999876069987289997--50896499998
Q ss_pred CCCC-CHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------
Q ss_conf 6799-988999986077788999978999999999999999986------------------------------------
Q 003542 288 LMSK-DLSCYMRETFGSRRRNSFSLPVVVDIMLQIARGMEFLHA------------------------------------ 330 (811)
Q Consensus 288 y~~g-sL~~~L~~~~~~~~~~~ls~~~i~~i~~QIa~gL~yLHs------------------------------------ 330 (811)
+.+| .+..... +......++.+++..|..||+
T Consensus 91 ~l~G~~~~~~~~-----------~~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T d1j7la_ 91 EADGVLCSEEYE-----------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp CCSSEEHHHHTT-----------TCSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred ECCCCCCCCCCC-----------CCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCCC
T ss_conf 604334354334-----------402699999989999999855684214357644656555778998776555543033
Q ss_pred -----------------C------CCEECCCCCCCEEEECCCCCCCCEEEEEECCCCC
Q ss_conf -----------------9------9420268999489812678873159991034321
Q 003542 331 -----------------Q------KIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365 (811)
Q Consensus 331 -----------------~------gIvHRDLKPsNILI~~~g~d~~~~vKL~DFGLa~ 365 (811)
. .++|+|+.|.|||++.++ .+-|+||+.+.
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~-----~~~lIDwe~a~ 212 (263)
T d1j7la_ 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGK-----VSGFIDLGRSG 212 (263)
T ss_dssp TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTE-----EEEECCCTTCE
T ss_pred CCCCCHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECCCC-----EEEEEECHHCC
T ss_conf 232005799999999844986781789860047642364996-----59996023144
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.94 E-value=0.00018 Score=43.08 Aligned_cols=66 Identities=18% Similarity=0.291 Sum_probs=39.9
Q ss_pred EEECCCC---EEEEEE-ECCCEEEEEEECC-----------CHHHHHHHHHHHHHC-CC-CC-CCEEEEEEECCCCCEEE
Q ss_conf 3416434---289999-9698999998064-----------278999999999808-99-85-01252038826798699
Q 003542 222 RRLGASS---QFKEIQ-WLGDSFVLRHFYG-----------ELESLNAEISTMLSL-SH-PN-IVQYLCGFCDEEKKEFF 283 (811)
Q Consensus 222 ~~lG~G~---vyk~v~-~~g~~vAIK~l~~-----------~~~~~~~Ei~iL~~L-~H-pN-IV~l~~~~~~e~~~~~~ 283 (811)
+.+|.|. +|.... -.+..+.+|.-.. ...+...|...|..+ .+ |. +.+++ .+ +++. .+
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~-~~-d~~~--~~ 107 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVF-YS-DTEM--AV 107 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEE-EE-ETTT--TE
T ss_pred EEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEE-EE-CCCC--CE
T ss_conf 98079852768999957998489996177130346777888778999999999986505798855289-98-5988--77
Q ss_pred EEEECCCC
Q ss_conf 99846799
Q 003542 284 LVMELMSK 291 (811)
Q Consensus 284 LVmEy~~g 291 (811)
+|||++++
T Consensus 108 lvmE~L~~ 115 (392)
T d2pula1 108 TVMEDLSH 115 (392)
T ss_dssp EEECCCTT
T ss_pred EEEECCCC
T ss_conf 98713577
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.76 E-value=8.3e-05 Score=45.22 Aligned_cols=130 Identities=16% Similarity=0.092 Sum_probs=69.2
Q ss_pred EEEEEEECCCEEEEEEECC-CHHHHHHHHHHHHHCCC--CCCCEEEEEEECCCCCEEEEEEECCCC-CHH----------
Q ss_conf 2899999698999998064-27899999999980899--850125203882679869999846799-988----------
Q 003542 229 QFKEIQWLGDSFVLRHFYG-ELESLNAEISTMLSLSH--PNIVQYLCGFCDEEKKEFFLVMELMSK-DLS---------- 294 (811)
Q Consensus 229 vyk~v~~~g~~vAIK~l~~-~~~~~~~Ei~iL~~L~H--pNIV~l~~~~~~e~~~~~~LVmEy~~g-sL~---------- 294 (811)
+|......+..+.+|.... ....+..|+..|..+.. -.+.+++... .+.+..++||++++| .+.
T Consensus 27 v~r~~~~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~--~~~~~~~~v~~~i~G~~~~~~~~~~~~~~ 104 (255)
T d1nd4a_ 27 VFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVV--TEAGRDWLLLGEVPGQDLLSSHLAPAEKV 104 (255)
T ss_dssp EEEEECTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEE--ECSSCEEEEEECCSSEETTTSCCCHHHHH
T ss_pred EEEEEECCCCEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEC--CCCCCEEEEEEEEECCCCCCCCCCHHHHH
T ss_conf 8999938987899995896677689999999999986599988613222--45661599987441355432212689999
Q ss_pred ----HHHHHHHCCC-CCCCCC--HHHHHHHHH--------------------HHHHHHHHHHHC-------CCEECCCCC
Q ss_conf ----9999860777-889999--789999999--------------------999999999869-------942026899
Q 003542 295 ----CYMRETFGSR-RRNSFS--LPVVVDIML--------------------QIARGMEFLHAQ-------KIYHGELNP 340 (811)
Q Consensus 295 ----~~L~~~~~~~-~~~~ls--~~~i~~i~~--------------------QIa~gL~yLHs~-------gIvHRDLKP 340 (811)
..+....... ...++. ......-.. .....+..+... .++|+|+.|
T Consensus 105 ~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~liHgD~~~ 184 (255)
T d1nd4a_ 105 SIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACL 184 (255)
T ss_dssp HHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCG
T ss_pred HHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCEEEECCCCC
T ss_conf 99999999873688544887554124688999999875411011340112137999999998718765795678678887
Q ss_pred CCEEEECCCCCCCCEEEEEECCCCC
Q ss_conf 9489812678873159991034321
Q 003542 341 SNIYLKARSMEGYFHVKVSGFGLST 365 (811)
Q Consensus 341 sNILI~~~g~d~~~~vKL~DFGLa~ 365 (811)
.|||++.++ .+-|+||+.+.
T Consensus 185 ~Nvl~~~~~-----~~~iID~~~~~ 204 (255)
T d1nd4a_ 185 PNIMVENGR-----FSGFIDCGRLG 204 (255)
T ss_dssp GGEEEETTE-----EEEECCCTTCE
T ss_pred CCEEEECCC-----EEEEEECHHCC
T ss_conf 635773796-----58999853326
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.07 E-value=0.0012 Score=37.96 Aligned_cols=130 Identities=12% Similarity=0.105 Sum_probs=68.4
Q ss_pred EEEEEEECCCEEEEEEECC---CHHHHHHHHHHHHHCCCCCC--C---EEEEEEECCCCCEEEEEEECCCCC-H----HH
Q ss_conf 2899999698999998064---27899999999980899850--1---252038826798699998467999-8----89
Q 003542 229 QFKEIQWLGDSFVLRHFYG---ELESLNAEISTMLSLSHPNI--V---QYLCGFCDEEKKEFFLVMELMSKD-L----SC 295 (811)
Q Consensus 229 vyk~v~~~g~~vAIK~l~~---~~~~~~~Ei~iL~~L~HpNI--V---~l~~~~~~e~~~~~~LVmEy~~gs-L----~~ 295 (811)
+|.....+|..|++|.... ..+.+..|...|..|....| + ..-+....+.....+.++++++|. + ..
T Consensus 38 vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~~~~ 117 (325)
T d1zyla1 38 VYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNID 117 (325)
T ss_dssp EEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHH
T ss_pred EEEEECCCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEECCCCCCCCCCHH
T ss_conf 69998389997999984787788999999999999998559987875206898056653479999865277688999999
Q ss_pred H----------HHHHHC---CCCCCCCCHH-------------------HHHHHHHHHHHHHHHHHH-------CCCEEC
Q ss_conf 9----------998607---7788999978-------------------999999999999999986-------994202
Q 003542 296 Y----------MRETFG---SRRRNSFSLP-------------------VVVDIMLQIARGMEFLHA-------QKIYHG 336 (811)
Q Consensus 296 ~----------L~~~~~---~~~~~~ls~~-------------------~i~~i~~QIa~gL~yLHs-------~gIvHR 336 (811)
. +..... ...+..++.. ....+...+...+..+.. .+++|+
T Consensus 118 ~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~liHg 197 (325)
T d1zyla1 118 QMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHG 197 (325)
T ss_dssp HHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCS
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCEEECC
T ss_conf 99998999999886303578655677897887665689998747699889899999999999999984545687120247
Q ss_pred CCCCCCEEEECCCCCCCCEEEEEECCCCC
Q ss_conf 68999489812678873159991034321
Q 003542 337 ELNPSNIYLKARSMEGYFHVKVSGFGLST 365 (811)
Q Consensus 337 DLKPsNILI~~~g~d~~~~vKL~DFGLa~ 365 (811)
|+.+.|||++. + ..++||+-+.
T Consensus 198 Dlh~~NvL~~~-~------~~~IDFdd~~ 219 (325)
T d1zyla1 198 DCHAGNILWRD-G------PMFVDLDDAR 219 (325)
T ss_dssp SCSGGGEEESS-S------EEECCCTTCC
T ss_pred CCCCCCEEEEC-C------CEEEECHHCC
T ss_conf 88804287838-9------3588652014
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.74 E-value=0.01 Score=31.99 Aligned_cols=68 Identities=18% Similarity=0.172 Sum_probs=39.1
Q ss_pred CEEEEEEECCCC---EEEEEEE--------CCCEEEEEEECC--CHHHHHHHHHHHHHCCCCCCC-EEEEEEECCCCCEE
Q ss_conf 568953416434---2899999--------698999998064--278999999999808998501-25203882679869
Q 003542 217 KLMVRRRLGASS---QFKEIQW--------LGDSFVLRHFYG--ELESLNAEISTMLSLSHPNIV-QYLCGFCDEEKKEF 282 (811)
Q Consensus 217 ~~~i~~~lG~G~---vyk~v~~--------~g~~vAIK~l~~--~~~~~~~Ei~iL~~L~HpNIV-~l~~~~~~e~~~~~ 282 (811)
.+++.. ++.|- +|+.... ..+.|.++++-. ......+|..+++.+.-.+++ +++ +++ ++
T Consensus 44 ~l~v~~-l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll-~~~-~~---- 116 (395)
T d1nw1a_ 44 HLRISR-IKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLY-GIF-SG---- 116 (395)
T ss_dssp GEEEEE-ECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEE-EEE-TT----
T ss_pred CEEEEE-CCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCCEEE-EEC-CC----
T ss_conf 169999-17853343489996887754457898179996599611658999999999997579998089-981-89----
Q ss_pred EEEEECCCC
Q ss_conf 999846799
Q 003542 283 FLVMELMSK 291 (811)
Q Consensus 283 ~LVmEy~~g 291 (811)
.+||||++|
T Consensus 117 g~I~efi~g 125 (395)
T d1nw1a_ 117 GRLEEYIPS 125 (395)
T ss_dssp EEEECCCCE
T ss_pred CEEEEEECC
T ss_conf 569997345
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.33 E-value=0.015 Score=30.91 Aligned_cols=141 Identities=13% Similarity=0.114 Sum_probs=68.2
Q ss_pred EEEEEECCCC---EEEEEEECCCEEEEEEECC--CHHHHHHHHHHHHHCCC-----CCCCEEEEEEE-CCCCCEEEEEEE
Q ss_conf 8953416434---2899999698999998064--27899999999980899-----85012520388-267986999984
Q 003542 219 MVRRRLGASS---QFKEIQWLGDSFVLRHFYG--ELESLNAEISTMLSLSH-----PNIVQYLCGFC-DEEKKEFFLVME 287 (811)
Q Consensus 219 ~i~~~lG~G~---vyk~v~~~g~~vAIK~l~~--~~~~~~~Ei~iL~~L~H-----pNIV~l~~~~~-~e~~~~~~LVmE 287 (811)
.-...+..|. .|. +...+..+++|++.. ....+..|+++|..|.. |..+...++.. ..-......++.
T Consensus 21 ~~~~~i~~G~~N~ny~-v~t~~g~yVLri~~~~~~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~ 99 (316)
T d2ppqa1 21 TSYKGIAEGVENSNFL-LHTTKDPLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS 99 (316)
T ss_dssp EEEEEECC---EEEEE-EEESSCCEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred EEEECCCCCCCCCEEE-EEECCCCEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCEECCCCCCEEEECCCCEEEE
T ss_conf 6852378885267389-997897289998078999889999999987543025554556410489762134125502453
Q ss_pred CCCC-CH--------------HHHHHHHH---CCCCCCCCCH------------------HHHHHHHHHHHHHHHHHHH-
Q ss_conf 6799-98--------------89999860---7778899997------------------8999999999999999986-
Q 003542 288 LMSK-DL--------------SCYMRETF---GSRRRNSFSL------------------PVVVDIMLQIARGMEFLHA- 330 (811)
Q Consensus 288 y~~g-sL--------------~~~L~~~~---~~~~~~~ls~------------------~~i~~i~~QIa~gL~yLHs- 330 (811)
+..| .. ...+.... .......... ......+..+...+.-.+.
T Consensus 100 ~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 179 (316)
T d2ppqa1 100 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK 179 (316)
T ss_dssp CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred ECCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCHHHHHHHHHHHHCCHHHHHHHHHHHHHHHCCCCC
T ss_conf 11465533320467888889987645444320245310111012002456777765311412799999998764204855
Q ss_pred ---CCCEECCCCCCCEEEECCCCCCCCEEEEEECCCCC
Q ss_conf ---99420268999489812678873159991034321
Q 003542 331 ---QKIYHGELNPSNIYLKARSMEGYFHVKVSGFGLST 365 (811)
Q Consensus 331 ---~gIvHRDLKPsNILI~~~g~d~~~~vKL~DFGLa~ 365 (811)
.+++|+|+.++|++++.++ ..-+.||+.+.
T Consensus 180 ~L~~giIHgDl~~dNvl~~~~~-----v~gvIDF~~~~ 212 (316)
T d2ppqa1 180 DLPAGVIHADLFQDNVFFLGDE-----LSGLIDFYFAC 212 (316)
T ss_dssp SSCEEEECSCCCGGGEEEETTE-----EEEECCCTTCE
T ss_pred CCCCCCCCCCCCHHHHHCCCCC-----CEEEECCCCCC
T ss_conf 4545033378636564020454-----12674222123
|